Our PRP$ O
data NNS O
suggest VBP O
that IN O
lipoxygenase NN B-Gene
metabolites NNS I-Gene
activate VBP O
ROI NNP O
formation NN O
which WDT O
then RB O
induce VBP O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
expression NN O
via IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
. . O

Human NNP O
immunodeficiency NN O
virus NN O
type NN O
2 CD O
( ( O
HIV NNP O
- : O
2 CD O
) ) O
, , O
like IN O
HIV NNP O
- : O
1 CD O
, , O
causes VBZ O
AIDS NNP O
and CC O
is VBZ O
associated VBN O
with IN O
AIDS NNP O
cases NNS O
primarily RB O
in IN O
West NNP O
Africa NNP O
. . O

This DT O
is VBZ O
the DT O
first JJ O
description NN O
of IN O
an DT O
HIV NNP B-Gene
- : I-Gene
2 CD I-Gene
enhancer NN I-Gene
element NN I-Gene
which WDT O
displays NNS O
such JJ O
monocyte JJ O
specificity NN O
, , O
and CC O
no DT O
comparable JJ O
enhancer NN B-Gene
element NN I-Gene
has VBZ O
been VBN O
clearly RB O
defined VBN O
for IN O
HIV NNP O
- : O
1 CD O
. . O

While IN O
a DT O
nuclear JJ B-Gene
factor NN I-Gene
( ( O
s PRP O
) ) O
from IN O
both DT O
peripheral JJ O
blood NN O
monocytes NNS O
and CC O
T NNP O
cells NNS O
binds VBZ O
the DT O
peri NN B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
site NN I-Gene
, , O
electrophoretic JJ O
mobility NN O
shift NN O
assays VBZ O
suggest VBP O
that IN O
either CC O
a DT O
different JJ O
protein NN O
binds VBZ O
to TO O
this DT O
site NN O
in IN O
monocytes NNS O
versus VBP O
T NNP O
cells NNS O
or CC O
that IN O
the DT O
protein NN O
recognizing VBG O
this DT O
enhancer NN B-Gene
element NN I-Gene
undergoes JJ O
differential JJ O
modification NN O
in IN O
monocytes NNS O
and CC O
T NNP O
cells NNS O
, , O
thus RB O
supporting VBG O
the DT O
transfection NN O
data NNS O
. . O

Understanding VBG O
the DT O
monocyte NN O
- : O
specific JJ O
function NN O
of IN O
the DT O
peri NN B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
factor NN I-Gene
may MD O
ultimately RB O
provide VB O
insight NN O
into IN O
the DT O
different JJ O
role NN O
monocytes NNS O
and CC O
T NNP O
cells NNS O
play VBP O
in IN O
HIV NNP O
pathogenesis NN O
. . O

Distinct NNP O
signaling VBG O
properties NNS O
identify VBP O
functionally RB O
different JJ O
CD4 NNP B-Gene
epitopes NNS I-Gene
. . O

Whereas NNP O
different JJ O
anti SYM B-Gene
- : I-Gene
CD4 NNP I-Gene
mAb NN I-Gene
or CC O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
gp120 NN I-Gene
could MD O
all VB O
trigger JJR O
activation NN O
of IN O
the DT O
protein NN B-Gene
tyrosine NN I-Gene
kinases VBZ I-Gene
p56lck NN B-Gene
and CC O
p59fyn NN B-Gene
and CC O
phosphorylation NN O
of IN O
the DT O
Shc NNP B-Gene
adaptor NN I-Gene
protein NN I-Gene
, , O
which WDT O
mediates VBZ O
signals NNS O
to TO O
Ras NNP B-Gene
, , O
they PRP O
differed VBD O
significantly RB O
in IN O
their PRP$ O
ability NN O
to TO O
activate VB O
NF NNP B-Gene
- : I-Gene
AT NN I-Gene
. . O

To TO O
address VB O
potential JJ O
mechanisms NNS O
by IN O
which WDT O
estrogens VBZ O
suppress JJ O
erythropoiesis NN O
, , O
we PRP O
have VBP O
examined VBN O
their PRP$ O
effects NNS O
on IN O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
an DT O
erythroid JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
that WDT O
participates VBZ O
in IN O
the DT O
regulation NN O
of IN O
the DT O
majority NN O
of IN O
erythroid NN B-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
genes NNS I-Gene
and CC O
is VBZ O
necessary JJ O
for IN O
full JJ O
maturation NN O
of IN O
erythrocytes NNS O
. . O

ER NNP B-Gene
- : O
mediated VBD O
repression NN O
of IN O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
activity NN O
occurs VBZ O
on IN O
an DT O
artificial JJ B-Gene
promoter NN I-Gene
containing VBG O
a DT O
single JJ O
GATA NNP B-Gene
- : I-Gene
binding NN I-Gene
site NN I-Gene
, , O
as RB O
well RB O
as IN O
in IN O
the DT O
context NN O
of IN O
an DT O
intact JJ B-Gene
promoter NN I-Gene
which WDT O
is VBZ O
normally RB O
regulated VBN O
by IN O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

In IN O
coimmunoprecipitatio NN O
experiments NNS O
using VBG O
transfected JJ O
COS NNP O
cells NNS O
, , O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
ER NNP B-Gene
associate VBP O
in IN O
a DT O
ligand NN O
- : O
dependent JJ O
manner NN O
. . O

( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

The DT O
transcriptional JJ O
response NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha JJ I-Gene
gene NN I-Gene
to TO O
stimulation NN O
by IN O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
+ NN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
biphasic JJ O
. . O

It PRP O
also RB O
primes VBZ O
cells NNS O
to TO O
become VB O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
responsive JJ O
and CC O
thereby JJ O
prepares VBZ O
the DT O
second JJ O
phase NN O
, , O
in IN O
which WDT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
induces NNS O
a DT O
100 CD O
- : O
fold NN O
further JJ O
increase NN O
in IN O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha NN I-Gene
transcripts NNS I-Gene
. . O

Transient JJ O
transfection NN O
experiments NNS O
show VBP O
that IN O
several JJ O
elements NNS O
in IN O
the DT O
promoter NN B-Gene
- : I-Gene
proximal JJ I-Gene
region NN I-Gene
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha JJ I-Gene
gene NN I-Gene
contribute NN O
to TO O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
responsiveness NN O
, , O
most RBS O
importantly RB O
an DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
site NN I-Gene
conserved VBN O
in IN O
the DT O
human JJ B-Gene
and CC I-Gene
mouse NN I-Gene
gene NN I-Gene
. . O

IL NNP B-Gene
- : I-Gene
2 CD I-Gene
responsiveness NN O
, , O
on IN O
the DT O
other JJ O
hand NN O
, , O
depends VBZ O
on IN O
a DT O
78 CD B-Gene
- : I-Gene
nucleotide NN I-Gene
segment NN I-Gene
1 CD O
. . O
3 CD O
kilobases NNS O
upstream RB O
of IN O
the DT O
major JJ B-Gene
transcription NN I-Gene
start NN I-Gene
site NN I-Gene
. . O

Epstein NNP O
- : O
Barr NNP O
virus NN O
( ( O
EBV NNP O
) ) O
is VBZ O
known VBN O
to TO O
infect VB O
B NNP O
cells NNS O
and CC O
epithelial JJ O
cells NNS O
. . O

The DT O
appearance NN O
of IN O
the DT O
BamHI NNP B-Gene
ZLF NNP I-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
product NN I-Gene
, , O
ZEBRA NNP B-Gene
, , O
by IN O
RT NNP O
- : O
PCR NN O
, , O
was VBD O
observed VBN O
within IN O
8 CD O
hr NN O
of IN O
infection NN O
. . O

Transcripts NNS O
encoding VBG O
gp350 NN B-Gene
/ $ I-Gene
220 CD I-Gene
, , O
the DT O
major JJ B-Gene
coat NN I-Gene
protein NN I-Gene
of IN O
EBV NNP O
, , O
were VBD O
identified VBN O
, , O
but CC O
we PRP O
did VBD O
not RB O
find VB O
any DT O
evidence NN O
of IN O
transcription NN O
from IN O
the DT O
LMP NNP B-Gene
- : I-Gene
2A CD I-Gene
or CC O
EBER NNP B-Gene
- : I-Gene
1 CD I-Gene
loci NN I-Gene
in IN O
infected JJ O
thymocytes NNS O
. . O

The DT O
main JJ O
difference NN O
is VBZ O
that IN O
with IN O
thymocytes NNS O
, , O
no DT O
evidence NN O
could MD O
be VB O
found VBN O
that IN O
the DT O
virus NN O
ever RB O
circularizes VBZ O
. . O

Rather RB O
, , O
EBV NNP O
remains VBZ O
in IN O
a DT O
linear JJ O
configuration NN O
from IN O
which WDT O
replicative JJ B-Gene
genes NNS I-Gene
are VBP O
transcribed VBN O
. . O

Several JJ O
recent JJ O
studies NNS O
have VBP O
implicated VBN O
Jak NNP O
kinases NNS O
in IN O
the DT O
signaling VBG O
pathway NN O
induced VBN O
by IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

We PRP O
demonstrate VBP O
, , O
through IN O
the DT O
deletion NN O
of IN O
the DT O
human JJ B-Gene
UDG NNP I-Gene
promoter NN I-Gene
sequences NNS I-Gene
, , O
that DT O
expression NN O
of IN O
E2F NNP B-Gene
- : I-Gene
1 CD I-Gene
activates VBZ O
the DT O
UDG NNP B-Gene
promoter NN I-Gene
through IN O
several JJ O
E2F NNP B-Gene
sites NNS I-Gene
. . O

Overexpression NN O
of IN O
UDG NNP B-Gene
in IN O
Saos NNP O
2 CD O
cells NNS O
was VBD O
observed VBN O
to TO O
delay VB O
growth NN O
late RB O
in IN O
G1 NNP O
phase NN O
and CC O
transiently RB O
arrest IN O
these DT O
cells NNS O
from IN O
progressing VBG O
into IN O
the DT O
S NNP O
phase NN O
. . O

Cellular JJ O
and CC O
molecular JJ O
mechanisms NNS O
of IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
production NN O
induced VBN O
by IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
in IN O
a DT O
human JJ O
NK NNP O
cell NN O
line NN O
. . O

In IN O
addition NN O
, , O
when WRB O
used VBN O
together RB O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
synergized VBN O
in IN O
the DT O
induction NN O
of IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
and CC O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
and CC O
this DT O
synergy NN O
was VBD O
attributed VBN O
to TO O
an DT O
increased VBN O
accumulation NN O
and CC O
stability NN O
of IN O
the DT O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
and CC I-Gene
GM NNP I-Gene
- : I-Gene
CSF NNP I-Gene
mRNAs NN I-Gene
. . O

To TO O
investigate VB O
the DT O
signaling NN O
pathways NNS O
involved VBN O
in IN O
the DT O
gene NN O
induction NN O
, , O
five CD O
inhibitors NNS O
, , O
cyclosporin VB O
A NNP O
( ( O
CsA NNP O
) ) O
, , O
transforming VBG B-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
beta NN I-Gene
, , O
cycloheximide NN O
, , O
genistein NN O
, , O
and CC O
staurosporine VB O
A NNP O
, , O
were VBD O
used VBN O
in IN O
analyzing VBG O
the DT O
effects NNS O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
on IN O
NK3 NNP O
. . O
3 CD O
cells NNS O
. . O

In IN O
addition NN O
, , O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
but CC O
not RB O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
induced JJ O
nuclear JJ B-Gene
factors NNS I-Gene
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
AP1 NNP B-Gene
, , O
and CC O
regulation NN O
of IN O
the DT O
nuclear JJ O
levels NNS O
of IN O
these DT O
two CD O
DNA NN B-Gene
binding VBG I-Gene
protein NN I-Gene
complexes NNS I-Gene
is VBZ O
correlated VBN O
with IN O
IFN NNP O
- : O
gamma NN O
and CC O
GM NNP O
- : O
CSF NNP O
gene NN O
expression NN O
. . O

One CD O
substrate NN O
is VBZ O
p95vav VBN B-Gene
, , O
which WDT O
is VBZ O
expressed VBN O
exclusively RB O
in IN O
hematopoietic JJ O
and CC O
trophoblast JJ O
cells NNS O
. . O

Furthermore RB O
, , O
p95vav JJ B-Gene
synergizes NNS O
with IN O
TCR NNP B-Gene
stimulation NN O
in IN O
inducing VBG O
NFAT NNP O
- : O
and CC O
interleukin VB O
- : O
2 CD O
- : O
dependent JJ O
transcription NN O
. . O

Furthermore RB O
, , O
the DT O
activating VBG O
function NN O
of IN O
p95vav NN B-Gene
is VBZ O
blocked VBN O
by IN O
FK506 NNP O
, , O
suggesting VBG O
that IN O
its PRP$ O
activity NN O
also RB O
depends VBZ O
on IN O
calcineurin NN B-Gene
. . O

alpha NN B-Gene
B NNP I-Gene
is VBZ O
the DT O
mouse NN B-Gene
homologue NN I-Gene
of IN O
human JJ B-Gene
AML1 NNP I-Gene
gene NN I-Gene
detected VBD O
at IN O
the DT O
breakpoints NNS O
of IN O
t NN O
( ( O
8 CD O
; : O
21 CD O
) ) O
and CC O
t NN O
( ( O
3 CD O
; : O
21 CD O
) ) O
myeloid NN O
leukemias NN O
. . O

We PRP O
examined VBD O
alpha RP B-Gene
A1 NNP I-Gene
( ( O
an DT O
alpha NN B-Gene
A NNP I-Gene
- : I-Gene
gene NN I-Gene
product NN I-Gene
) ) O
and CC O
alpha JJ B-Gene
B1 NNP I-Gene
and CC O
alpha JJ B-Gene
B2 NNP I-Gene
( ( O
two CD O
alpha NN B-Gene
B NNP I-Gene
- : I-Gene
encoded VBD I-Gene
isomers NNS I-Gene
) ) O
for IN O
their PRP$ O
effects NNS O
on IN O
the DT O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
promoter NN I-Gene
. . O

Although IN O
further JJ O
studies NNS O
are VBP O
required VBN O
to TO O
determine VB O
the DT O
precise JJ O
role NN O
of IN O
PEBP2 NNP B-Gene
in IN O
the DT O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
promoter NN O
activity NN O
, , O
the DT O
present JJ O
findings NNS O
suggested VBD O
the DT O
importance NN O
of IN O
the DT O
relative JJ O
ratio NN O
of IN O
different JJ O
PEBP2 NNP B-Gene
isoforms NNS I-Gene
in IN O
regulating VBG O
the DT O
levels NNS O
of IN O
the DT O
promoter NN O
activity NN O
. . O

IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
priming NN O
of IN O
monocytes NNS O
enhances NNS O
LPS NNP O
- : O
induced JJ O
TNF NNP B-Gene
production NN O
by IN O
augmenting VBG O
both DT O
transcription NN O
and CC O
MRNA NNP O
stability NN O
. . O

The DT O
induction NN O
of IN O
cytokine JJ B-Gene
expression NN O
in IN O
monocytes NNS O
/ JJ O
macrophages NNS O
by IN O
bacterial JJ B-Gene
endotoxin NN I-Gene
or CC O
lipopolysaccharide NN O
is VBZ O
a DT O
critical JJ O
, , O
highly RB O
regulated VBN O
host NN O
defence NN O
response NN O
. . O

The DT O
increased VBN O
transcriptional JJ O
rate NN O
correlated VBN O
with IN O
a DT O
marked JJ O
increase NN O
in IN O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activity NN O
in IN O
these DT O
cells NNS O
as IN O
determined VBN O
by IN O
electrophoretic JJ O
mobility NN O
shift NN O
assay VBP O
using VBG O
a DT O
consensus NN B-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
oligonucleotide NN I-Gene
. . O

Consistent JJ O
with IN O
the DT O
increased VBN O
mRNA NN B-Gene
stability NN O
, , O
the DT O
duration NN O
of IN O
mRNA JJ B-Gene
accumulation NN O
was VBD O
longer RBR O
following VBG O
LPS NNP O
stimulation NN O
in IN O
primed JJ O
monocytes NNS O
, , O
in IN O
addition NN O
to TO O
being VBG O
of IN O
greater JJR O
magnitude NN O
. . O

H NNP O
- : O
89 CD O
substantially RB O
suppressed VBN O
LPS NNP O
- : O
induced VBD O
TNF NNP B-Gene
mRNA NN I-Gene
accumulation NN O
in IN O
unprimed JJ O
cells NNS O
, , O
but CC O
had VBD O
no DT O
effect NN O
on IN O
primed VBN O
monocytes NNS O
following VBG O
LPS NNP O
stimulation NN O
. . O

A DT O
Myc NNP B-Gene
- : I-Gene
associated VBN I-Gene
zinc NN I-Gene
finger NN I-Gene
protein NN I-Gene
binding VBG I-Gene
site NN I-Gene
is VBZ O
one CD O
of IN O
four CD O
important JJ O
functional JJ B-Gene
regions NNS I-Gene
in IN O
the DT O
CD4 NNP B-Gene
promoter NN I-Gene
. . O

Since IN O
the DT O
terminal JJ O
events NNS O
of IN O
erythropoiesis NN O
are VBP O
controlled VBN O
by IN O
the DT O
glycoprotein NN B-Gene
hormone NN I-Gene
erythropoietin NN I-Gene
( ( O
Epo NNP B-Gene
) ) O
, , O
we PRP O
investigated VBD O
whether IN O
the DT O
expression NN O
or CC O
activity NN O
of IN O
the DT O
TAL1 NNP B-Gene
gene NN I-Gene
and CC O
its PRP$ O
protein NN B-Gene
products NNS I-Gene
were VBD O
affected VBN O
by IN O
Epo NNP B-Gene
in IN O
splenic JJ O
erythroblasts NNS O
from IN O
mice NNS O
infected VBN O
with IN O
an DT O
anemia NN O
- : O
inducing VBG O
strain NN O
of IN O
Friend NNP O
virus NN O
( ( O
FVA NNP O
cells NNS O
) ) O
. . O

The DT O
role NN O
of IN O
shared VBN B-Gene
receptor NN I-Gene
motifs NNS I-Gene
and CC O
common JJ B-Gene
Stat NNP I-Gene
proteins NNS I-Gene
in IN O
the DT O
generation NN O
of IN O
cytokine NN B-Gene
pleiotropy NN O
and CC O
redundancy NN O
by IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
7 CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
, , O
and CC O
IL NNP B-Gene
- : I-Gene
15 CD I-Gene
. . O

IL NNP B-Gene
- : I-Gene
13 CD I-Gene
Induced VBD O
the DT O
same JJ O
complexes NN O
as IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
a DT O
finding NN O
explained VBN O
by IN O
our PRP$ O
studies NNS O
implicating VBG O
IL NNP B-Gene
- : I-Gene
4R CD I-Gene
as IN O
a DT O
shared JJ O
component NN O
of IN O
the DT O
receptors NNS B-Gene
. . O

Control NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
- : I-Gene
alpha NN I-Gene
proteolysis NN O
by IN O
site NN O
- : O
specific JJ O
, , O
signal JJ O
- : O
induced JJ O
phosphorylation NN O
. . O

When WRB O
either DT O
serine NN O
- : O
32 CD O
or CC O
serine VB O
- : O
36 CD O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
- : I-Gene
alpha NN I-Gene
was VBD O
mutated VBN O
, , O
the DT O
protein NN O
did VBD O
not RB O
undergo JJ O
signal JJ O
- : O
induced JJ O
phosphorylation NN O
or CC O
degradation NN O
, , O
and CC O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
could MD O
not RB O
be VB O
activated VBN O
. . O

Regulation NN O
of IN O
transcription NN O
of IN O
the DT O
human JJ B-Gene
erythropoietin NN I-Gene
receptor NN I-Gene
gene NN I-Gene
by IN O
proteins NNS O
binding VBG O
to TO O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC I-Gene
Sp1 NNP I-Gene
motifs NNS I-Gene
. . O

Erythropoietin NNP B-Gene
( ( O
Epo NNP B-Gene
) ) O
, , O
the DT O
primary JJ O
regulator NN O
of IN O
the DT O
production NN O
of IN O
erythroid JJ O
cells NNS O
, , O
acts NNS O
by IN O
binding VBG O
to TO O
a DT O
cell NN B-Gene
surface NN I-Gene
receptor NN I-Gene
( ( O
EpoR NNP B-Gene
) ) O
on IN O
erythroid JJ O
progenitors NNS O
. . O

Interestingly RB O
, , O
when WRB O
we PRP O
mutated VBD O
the DT O
Sp1 NNP B-Gene
site NN I-Gene
, , O
resulting VBG O
in IN O
a DT O
marked JJ O
decrease NN O
in IN O
hEpoR JJ B-Gene
promoter NN I-Gene
activity NN O
, , O
we PRP O
could MD O
restore VB O
transactivation NN O
by IN O
increasing VBG O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
levels NNS O
in IN O
OCIM1 NNP O
cells NNS O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
while IN O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
can MD O
transactivate VB O
the DT O
EpoR NNP B-Gene
promoter NN I-Gene
, , O
the DT O
level NN O
of IN O
hEpoR JJ B-Gene
gene NN I-Gene
expression NN O
does VBZ O
not RB O
depend VB O
on IN O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
alone RB O
. . O

The DT O
deduced JJ O
amino NN O
acid NN O
sequence NN O
similarity NN O
to TO O
the DT O
proteins NNS O
encoded VBN O
by IN O
these DT O
two CD O
latter JJR O
genes NNS O
is VBZ O
approximately RB O
65 CD O
% NN O
and CC O
includes VBZ O
domains NNS O
and CC O
amino NN O
acid NN O
residues NNS O
( ( O
the DT O
leucine NN B-Gene
zipper SYM I-Gene
- : I-Gene
like IN I-Gene
and CC O
the DT O
RGD NNP B-Gene
domain NN I-Gene
, , O
a DT O
serine NN O
and CC O
a DT O
histidine NN O
residue NN O
in IN O
the DT O
NH2 NNP B-Gene
- : I-Gene
and CC O
in IN O
the DT O
COOH NNP B-Gene
- : I-Gene
terminal JJ I-Gene
portion NN I-Gene
of IN O
the DT O
protein NN O
, , O
respectively RB O
) ) O
postulated VBD O
to TO O
be VB O
important JJ O
for IN O
nm23 JJ B-Gene
function NN O
. . O

Treatment NN O
of IN O
U937 NNP O
with IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
for IN O
9 CD O
hr NN O
in IN O
the DT O
presence NN O
of IN O
cycloheximide NN O
led VBN O
to TO O
super VB O
- : O
induction NN O
of IN O
Fc NNP B-Gene
gamma NN I-Gene
RI NNP I-Gene
expression NN O
. . O

Genomic NNP O
sequence NN O
upstream NN O
of IN O
the DT O
Fc NNP B-Gene
gamma NN I-Gene
RIC NNP I-Gene
gene NN I-Gene
was VBD O
cloned VBN O
and CC O
subjected VBN O
to TO O
primer VB O
extension NN O
analysis NN O
, , O
which WDT O
demonstrated VBD O
a DT O
single JJ O
transcription NN B-Gene
initiation NN I-Gene
site NN I-Gene
without IN O
a DT O
TATA NNP B-Gene
box NN I-Gene
. . O

Double NNP B-Gene
- : I-Gene
stranded VBD I-Gene
GIRE NNP I-Gene
sequence NN I-Gene
, , O
but CC O
not RB O
a DT O
scrambled JJ B-Gene
sequence NN I-Gene
, , O
was VBD O
specifically RB O
bound VBN O
by IN O
nuclear JJ B-Gene
proteins NNS I-Gene
from IN O
IFN NNP O
- : O
gamma NN O
treated VBD O
U937 NNP O
cells NNS O
. . O

The DT O
Fc NNP B-Gene
gamma NN I-Gene
RIC NNP I-Gene
GIRE NNP I-Gene
is VBZ O
homologous JJ O
to TO O
the DT O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
activation NN I-Gene
sequence NN I-Gene
( ( O
GAS NNP B-Gene
) ) O
of IN O
the DT O
guanylate NN B-Gene
binding NN I-Gene
protein NN I-Gene
and CC O
to TO O
X NNP B-Gene
box NN I-Gene
elements NNS I-Gene
of IN O
class NN B-Gene
II NNP I-Gene
MHC NNP I-Gene
genes NNS I-Gene
. . O

In IN O
HTLV NNP O
- : O
I PRP O
- : O
infected VBN O
cord NN O
blood NN O
lymphocytes NNS O
, , O
the DT O
transition NN O
from IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
- : O
dependent NN O
to TO O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
- : O
independent JJ O
growth NN O
correlated VBD O
with IN O
the DT O
acquisition NN O
of IN O
a DT O
constitutively RB O
activated VBN O
Jak NNP B-Gene
- : B-Gene
STAT NNP I-Gene
pathway NN O
, , O
which WDT O
suggests VBZ O
that IN O
this DT O
pathway NN O
participates VBZ O
in IN O
HTLV NNP O
- : O
I PRP O
- : O
mediated VBD O
T NNP O
cell NN O
transformation NN O
. . O

Nitric NNP O
oxide MD O
selectively RB O
reduces VB O
endothelial JJ O
expression NN O
of IN O
adhesion NN B-Gene
molecules NNS I-Gene
and CC O
proinflammatory JJ B-Gene
cytokines NNS I-Gene
. . O

In IN O
a DT O
concentration NN O
- : O
dependent JJ O
manner NN O
, , O
NO NNP O
inhibited VBD O
interleukin FW B-Gene
( ( I-Gene
IL NNP I-Gene
) ) I-Gene
- : I-Gene
1 CD I-Gene
alpha SYM O
- : O
stimulated VBN O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
by IN O
35 CD O
- : O
55 CD O
% NN O
as IN O
determined VBN O
by IN O
cell NN O
surface NN O
enzyme NN O
immunoassays NNS O
and CC O
flow JJ O
cytometry NN O
. . O

Inhibition NN O
of IN O
endogenous JJ O
NO NNP O
production NN O
by IN O
L NNP O
- : O
N NNP O
- : O
monomethyl NN O
- : O
arginine NN O
also RB O
induced VBD O
the DT O
expression NN O
of IN O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
but CC O
did VBD O
not RB O
augment JJ O
cytokine NN O
- : O
induced JJ O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
. . O

Murine NNP B-Gene
macrophage NN I-Gene
inflammatory NN I-Gene
protein NN I-Gene
1 CD I-Gene
alpha NN I-Gene
( ( O
MIP NNP B-Gene
- : I-Gene
1 CD I-Gene
alpha NN I-Gene
) ) O
and CC O
its PRP$ O
human JJ B-Gene
equivalent NN I-Gene
( ( O
GOS19 NNP B-Gene
, , O
LD78 NNP B-Gene
, , O
or CC O
AT464 NNP B-Gene
) ) O
are VBP O
members NNS O
of IN O
the DT O
- : B-Gene
C NNP I-Gene
- : I-Gene
C NNP I-Gene
family NN I-Gene
of IN O
low JJ B-Gene
- : I-Gene
molecular JJ I-Gene
- : I-Gene
weight NN I-Gene
chemokines NNS I-Gene
. . O

It PRP O
also RB O
induces VBZ O
chemotaxis NN O
and CC O
inflammatory JJ O
responses NNS O
in IN O
mature NN O
cell NN O
types NNS O
. . O

One CD O
member NN O
, , O
ICK NNP B-Gene
- : I-Gene
1A CD I-Gene
, , O
behaves NNS O
as IN O
a DT O
strong JJ B-Gene
negative JJ I-Gene
regulator NN I-Gene
. . O

We PRP O
provide VBP O
evidence NN O
for IN O
an DT O
additional JJ O
binding NN B-Gene
site NN I-Gene
, , O
the DT O
MIP NNP B-Gene
- : I-Gene
1 CD I-Gene
alpha JJ I-Gene
nuclear JJ I-Gene
protein NN I-Gene
( ( I-Gene
MNP NNP I-Gene
) ) I-Gene
site NN I-Gene
, , O
which WDT O
overlaps VBZ O
the DT O
ICK NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
. . O

The DT O
signal NN O
is VBZ O
subsequently RB O
propagated VBN O
through IN O
the DT O
activation NN O
of IN O
Raf NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
MEK NNP B-Gene
, , O
and CC O
MAP NNP B-Gene
kinases VBZ I-Gene
as IN O
shown VBN O
by IN O
their PRP$ O
increased JJ O
autophosphorylation NN O
in IN O
vitro NN O
and CC O
phosphorylation NN O
in IN O
situ NN O
. . O

We PRP O
conclude VBP O
that IN O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
induced JJ O
signals NNS O
are VBP O
propagated VBN O
through IN O
two CD O
distinct JJ O
pathways NNS O
: : O
( ( O
1 CD O
) ) O
Lyn NNP B-Gene
- : O
- : O
> NN O
Ras NNP B-Gene
- : O
- : O
> NN O
Raf NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
- : O
> NN O
MEK NNP B-Gene
- : O
- : O
> NN O
MAP NNP B-Gene
kinase NN I-Gene
and CC O
( ( O
2 CD O
) ) O
Jak2 NNP B-Gene
- : O
- : O
> NN O
STAT1 NNP B-Gene
. . O

The DT O
retinoblastoma NN B-Gene
gene NN I-Gene
product NN I-Gene
negatively RB O
regulates VBZ O
transcriptional JJ O
activation NN O
mediated VBN O
by IN O
the DT O
human JJ B-Gene
cytomegalovirus NN I-Gene
IE2 NNP I-Gene
protein NN I-Gene
. . O

We PRP O
found VBD O
that IN O
the DT O
retinoblastoma NN B-Gene
susceptibility NN I-Gene
gene NN I-Gene
product NN I-Gene
( ( O
Rb NNP B-Gene
) ) O
dramatically RB O
suppressed VBD O
this DT O
IE2 NNP B-Gene
transactivation NN O
of IN O
various JJ B-Gene
promoters NNS I-Gene
. . O

However RB O
, , O
the DT O
relationship NN O
remains VBZ O
controversial JJ O
according VBG O
to TO O
the DT O
tumor NN O
cell NN O
types NNS O
and CC O
experimental JJ O
system NN O
, , O
with IN O
conflicting VBG O
results NNS O
from IN O
different JJ O
research NN O
groups NNS O
. . O

And CC O
there EX O
was VBD O
no DT O
statistically RB O
significant JJ O
difference NN O
in IN O
NDP NNP B-Gene
kinase VB I-Gene
expression NN O
between IN O
SCC NNP O
with IN O
metastasis NN O
and CC O
SCC NNP O
without IN O
metastasis NN O
. . O

Retinoblastoma NNP B-Gene
protein NN I-Gene
( ( O
RB NNP B-Gene
) ) O
is VBZ O
a DT O
tumor NN O
suppressor NN O
and CC O
functions NNS O
as IN O
a DT O
transcriptional JJ B-Gene
repressor NN I-Gene
by IN O
binding VBG O
and CC O
inactivating VBG O
the DT O
transactivator NN B-Gene
E2F NNP I-Gene
- : I-Gene
I PRP I-Gene
. . O

RB NNP O
- : O
defective JJ O
tumor NN O
lines NNS O
are VBP O
non JJ O
- : O
inducible JJ O
for IN O
MHC NNP B-Gene
class NN I-Gene
II NNP I-Gene
by IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
, , O
or CC O
very RB O
weakly JJ O
inducible NN O
, , O
but CC O
transfection NN O
of IN O
2 CD O
different JJ O
lines NNS O
with IN O
RB NNP B-Gene
expression NN I-Gene
vectors NNS I-Gene
re VBP O
- : O
establishes NNS O
or CC O
substantially RB O
enhances VBZ O
class NN O
II NNP O
inducibility NN O
. . O

We PRP O
also RB O
examined VBD O
the DT O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
induction NN O
of IN O
CIITA NNP B-Gene
in IN O
RB NNP B-Gene
- : O
defective JJ O
lines NNS O
. . O

We PRP O
have VBP O
recently RB O
demonstrated VBN O
that IN O
stimulation NN O
of IN O
human JJ O
T NNP O
and CC O
natural JJ O
killer NN O
cells NNS O
with IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
induces NNS O
tyrosine JJ O
phosphorylation NN O
of IN O
the DT O
Janus NNP B-Gene
family NN I-Gene
tyrosine NN I-Gene
kinase NN I-Gene
JAK2 NNP B-Gene
and CC O
Tyk2 NNP B-Gene
, , O
implicating VBG O
these DT O
kinases NNS B-Gene
in IN O
the DT O
immediate JJ O
biochemical JJ O
response NN O
to TO O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
. . O

Furthermore RB O
, , O
we PRP O
show VBP O
that IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
stimulates NNS O
formation NN O
of IN O
a DT O
DNA NNP B-Gene
- : I-Gene
binding NN I-Gene
complex NN I-Gene
that WDT O
recognizes VBZ O
a DT O
DNA NN O
sequence NN O
previously RB O
shown VBN O
to TO O
bind VB O
STAT NNP B-Gene
proteins NNS I-Gene
and CC O
that IN O
this DT O
complex JJ O
contains VBZ O
STAT4 NNP B-Gene
. . O

DESIGN NN O
: : O
The DT O
effects NNS O
of IN O
hypercortisolaemia NN O
, , O
hyperthermia NN O
and CC O
cellular JJ O
composition NN O
on IN O
number NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
per IN O
cell NN O
and CC O
their PRP$ O
affinity NN O
were VBD O
evaluated VBN O
, , O
both DT O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
, , O
in IN O
peripheral JJ O
blood NN O
mononuclear JJ O
leucocytes NNS O
of IN O
control NN O
subjects NNS O
and CC O
in IN O
patients NNS O
with IN O
sepsis NN O
or CC O
septic JJ O
shock NN O
. . O

RESULTS NN O
: : O
Hypercortisolaemia NNP O
, , O
in IN O
vitro NN O
, , O
resulted VBD O
in IN O
a DT O
decreased JJ O
affinity NN O
and CC O
a DT O
decreased JJ O
binding NN O
capacity NN O
of IN O
the DT O
glucocorticoid JJ B-Gene
receptor NN I-Gene
. . O

Integrin NNP O
- : O
mediated VBD O
tyrosine JJ O
phosphorylation NN O
and CC O
cytokine JJ B-Gene
message NN O
induction NN O
in IN O
monocytic JJ O
cells NNS O
. . O

The DT O
tyrosine NN O
kinase NN O
inhibitors NNS O
genistein VBP O
and CC O
herbimycin VBP O
A NNP O
block NN O
both DT O
integrin VBP B-Gene
- : O
mediated VBN O
tyrosine JJ O
phosphorylation NN O
and CC O
increases NNS O
in IN O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
beta JJ I-Gene
message NN O
levels NNS O
, , O
indicating VBG O
a DT O
causal NN O
relationship NN O
between IN O
the DT O
two CD O
events NNS O
. . O

These DT O
observations NNS O
indicate VBP O
that IN O
the DT O
Syk NNP B-Gene
tyrosine NN O
kinase NN O
may MD O
be VB O
an DT O
important JJ O
component NN O
of IN O
an DT O
integrin NN B-Gene
signaling VBG O
pathway NN O
in IN O
monocytic JJ O
cells NNS O
, , O
leading VBG O
to TO O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
to TO O
increased VBN O
levels NNS O
of IN O
cytokine NN B-Gene
messages NNS O
. . O

To TO O
determine VB O
if IN O
New NNP O
World NNP O
primates VBZ O
express VBP O
an DT O
inhibitor NN O
that WDT O
influences VBZ O
glucocorticoid JJ B-Gene
receptor NN I-Gene
( ( O
GR NNP B-Gene
) ) O
binding VBG O
characteristics NNS O
, , O
we PRP O
examined VBD O
[ $ O
3H CD O
] NNP O
dexamethasone NN O
binding NN O
in IN O
cytosol NN O
prepared VBN O
from IN O
B95 NNP O
- : O
8 CD O
lymphoid JJ O
cells NNS O
, , O
derived VBN O
from IN O
the DT O
cotton NN O
top NN O
tamarin NN O
( ( O
Saguinus NNP O
oedipus NN O
) ) O
, , O
in IN O
combination NN O
with IN O
cytosol NN O
prepared VBN O
from IN O
human JJ O
or CC O
rat NN O
tissues NNS O
. . O

Kinetic JJ O
studies NNS O
using VBG O
mixed JJ O
cytosol NN O
indicated VBD O
that IN O
B95 NNP O
- : O
8 CD O
cytosol NN O
did VBD O
not RB O
affect VB O
the DT O
apparent JJ O
dissociation NN O
rate NN O
of IN O
[ $ O
3H CD O
] NNP O
dexamethasone NN O
. . O

The DT O
results NNS O
further RBR O
demonstrated VBD O
the DT O
activation NN O
of IN O
S6 NNP B-Gene
kinase NNP I-Gene
( ( O
pp90rsk NN B-Gene
) ) O
, , O
evidenced VBN O
by IN O
phosphorylation NN O
of IN O
S6 NNP B-Gene
and CC O
serum JJ O
response NN O
factor NN O
( ( O
SRF NNP O
) ) O
peptides NNS O
, , O
in IN O
PWM NNP O
treated VBD O
B NNP O
cells NNS O
. . O

We PRP O
have VBP O
recently RB O
found VBN O
a DT O
novel JJ O
conserved VBN B-Gene
motif NN I-Gene
in IN O
the DT O
promoters NNS B-Gene
of IN O
several JJ O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
- : I-Gene
expressed VBN I-Gene
cytokines NNS I-Gene
[ NNP O
human JJ B-Gene
interleukin SYM I-Gene
- : I-Gene
2 CD I-Gene
, , I-Gene
- : I-Gene
4 CD I-Gene
, , I-Gene
- : I-Gene
5 CD I-Gene
and CC I-Gene
- : I-Gene
13 CD I-Gene
and CC O
human JJ B-Gene
and CC I-Gene
mouse NN I-Gene
granulocyte NN I-Gene
/ NNP I-Gene
macrophage NN I-Gene
- : I-Gene
colony NN I-Gene
stimulating VBG I-Gene
factor NN I-Gene
( ( O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
) ) O
] NN O
. . O

In IN O
transfection NN O
assays NNS O
, , O
the DT O
human JJ B-Gene
GM NNP I-Gene
- : I-Gene
CSF NNP I-Gene
element NN I-Gene
has VBZ O
a DT O
strong JJ O
positive JJ O
effect NN O
on IN O
the DT O
expression NN O
of IN O
a DT O
reporter NN B-Gene
gene NN I-Gene
by IN O
the DT O
human JJ O
T NNP O
cell NN O
line NN O
Jurkat NNP O
J6 NNP O
upon IN O
stimulation NN O
. . O

In IN O
different JJ O
genes NNS B-Gene
, , O
the DT O
core NN B-Gene
sequences NNS I-Gene
are VBP O
separated VBN O
by IN O
integer NN O
numbers NNS O
of IN O
helical JJ O
turns NNS O
. . O

Aspirin NNP O
inhibits NNS O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
mobilization NN O
and CC O
monocyte JJ O
adhesion NN O
in IN O
stimulated JJ O
human JJ O
endothelial JJ O
cells NNS O
. . O

These DT O
effects NNS O
of IN O
aspirin NNS O
were VBD O
not RB O
related VBN O
to TO O
the DT O
inhibition NN O
of IN O
cyclooxygenase NN B-Gene
activity NN O
, , O
since IN O
indomethacin NN O
was VBD O
ineffective JJ O
. . O

Activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
by IN O
various JJ O
cellular JJ O
stimuli NN O
involves VBZ O
the DT O
phosphorylation NN O
and CC O
subsequent JJ O
degradation NN O
of IN O
its PRP$ O
inhibitor NN O
, , O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
, , O
although IN O
the DT O
underlying JJ O
mechanism NN O
remains VBZ O
unclear JJ O
. . O

Together RB O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
phosphorylation NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
, , O
mediated VBN O
through IN O
both DT O
the DT O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
- : O
inducible JJ O
and CC O
the DT O
PP NNP B-Gene
- : I-Gene
2A CD I-Gene
- : I-Gene
opposing NN I-Gene
kinases NNS I-Gene
, , O
may MD O
serve VB O
to TO O
target VB O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
for IN O
proteasome JJ B-Gene
- : O
mediated VBN O
degradation NN O
. . O

The DT O
5 CD B-Gene
' POS I-Gene
flanking JJ I-Gene
region NN I-Gene
of IN O
the DT O
human JJ B-Gene
alpha NN I-Gene
- : I-Gene
globin NN I-Gene
gene NN I-Gene
is VBZ O
highly RB O
G NNP O
+ NNP O
C NNP O
rich JJ O
and CC O
contains VBZ O
multiple JJ O
copies NNS O
of IN O
the DT O
consensus NN B-Gene
sequence NN I-Gene
for IN O
the DT O
Sp1 NNP B-Gene
binding NN I-Gene
site NN I-Gene
. . O

Finally RB O
, , O
we PRP O
show VBP O
by IN O
both DT O
footprint JJ O
analysis NN O
and CC O
functional JJ O
assays NNS O
that IN O
the DT O
ability NN O
of IN O
the DT O
G NNP B-Gene
+ NNP I-Gene
C NNP I-Gene
- : I-Gene
rich JJ I-Gene
region NN I-Gene
to TO O
increase VB O
alpha JJ B-Gene
- : I-Gene
globin NN I-Gene
promoter NN I-Gene
activity NN O
from IN O
a DT O
stably RB O
integrated JJ O
alpha SYM B-Gene
- : I-Gene
globin NN I-Gene
gene NN I-Gene
is VBZ O
mediated VBN O
by IN O
its PRP$ O
multiple JJ B-Gene
binding NN I-Gene
sites NNS I-Gene
for IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
Sp1 NNP B-Gene
. . O

LFA NNP B-Gene
- : I-Gene
3 CD I-Gene
induced JJ O
moderate JJ O
levels NNS O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
but CC O
did VBD O
not RB O
influence VB O
the DT O
levels NNS O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
while IN O
B7 NNP B-Gene
costimulation NN O
strongly RB O
induced VBD O
both DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
substantially RB O
enhanced VBD O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
binding NN I-Gene
proteins NNS I-Gene
. . O

The DT O
Ah NNP B-Gene
receptor NN I-Gene
recognizes VBZ O
DNA NNP B-Gene
binding NN I-Gene
sites NNS I-Gene
for IN O
the DT O
B NNP B-Gene
cell NN I-Gene
transcription NN I-Gene
factor NN I-Gene
, , O
BSAP NNP B-Gene
: : O
a DT O
possible JJ O
mechanism NN O
for IN O
dioxin NN O
- : O
mediated VBN O
alteration NN O
of IN O
CD19 NNP B-Gene
gene NN I-Gene
expression NN O
in IN O
human JJ O
B NNP O
lymphocytes NNS O
. . O

In IN O
addition NN O
, , O
the DT O
Ah NNP B-Gene
receptor NN I-Gene
complex NN I-Gene
recognized VBD O
a DT O
DNA NN B-Gene
binding VBG I-Gene
site NN I-Gene
for IN O
B NNP B-Gene
cell NN I-Gene
lineage NN I-Gene
- : I-Gene
specific JJ I-Gene
activator NN I-Gene
protein NN I-Gene
( ( O
BSAP NNP B-Gene
) ) O
in IN O
the DT O
promoter NN B-Gene
region NN I-Gene
of IN O
the DT O
human JJ O
CD19 NNP B-Gene
gene NN I-Gene
which WDT O
is VBZ O
similar JJ O
to TO O
the DT O
consensus NN B-Gene
Ah NNP I-Gene
receptor NN I-Gene
DNA NNP I-Gene
binding NN I-Gene
site NN I-Gene
. . O

We PRP O
recently RB O
identified VBD O
a DT O
differentiation NN B-Gene
inhibitory NN I-Gene
factor NN I-Gene
( ( O
I PRP B-Gene
- : I-Gene
factor NN I-Gene
) ) O
in IN O
mouse NN O
myeloid NN O
leukemia NN O
M1 NNP O
cells NNS O
as IN O
a DT O
murine NN B-Gene
homolog NN I-Gene
of IN O
the DT O
human JJ B-Gene
nm23 SYM I-Gene
- : I-Gene
H2 NNP I-Gene
gene NN I-Gene
product NN I-Gene
. . O

In IN O
the DT O
present JJ O
experiment NN O
, , O
we PRP O
examined VBD O
the DT O
effect NN O
of IN O
nm23 JJ B-Gene
proteins NNS I-Gene
on IN O
various JJ O
differentiation NN O
induction NN O
systems NNS O
of IN O
human JJ O
leukemic JJ O
cells NNS O
including VBG O
HL NNP O
- : O
60 CD O
, , O
U937 NNP O
, , O
HEL NNP O
/ NNP O
S NNP O
, , O
KU812F NNP O
, , O
K562 NNP O
, , O
and CC O
HEL NNP O
cells NNS O
. . O

Delayed NNP O
administration NN O
of IN O
rBPI21 NN B-Gene
also RB O
affected VBD O
LPS NNP O
- : O
mediated VBD O
activation NN O
of IN O
the DT O
nuclear JJ B-Gene
factor NN I-Gene
, , O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

Two CD O
to TO O
4 CD O
h NN O
following VBG O
LPS NNP O
addition NN O
to TO O
endothelial JJ O
cells NNS O
, , O
when WRB O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
was VBD O
already RB O
activated VBN O
, , O
addition NN O
of IN O
rBPI21 NN B-Gene
resulted VBN O
in IN O
marked JJ O
reduction NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
detectable NN O
at IN O
4 CD O
or CC O
6 CD O
h NN O
. . O

GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
share NN O
common JJ O
control NN O
mechanisms NNS O
in IN O
response NN O
to TO O
costimulatory NN O
signals NNS O
in IN O
T NNP O
cells NNS O
. . O

Antigen NNP O
complexed VBD O
with IN O
major JJ B-Gene
histocompatibility NN I-Gene
complex JJ I-Gene
class NN I-Gene
I PRP I-Gene
or CC I-Gene
II NNP I-Gene
molecules NNS I-Gene
on IN O
the DT O
surface NN O
of IN O
antigen NN O
presenting VBG O
cells NNS O
interacts NNS O
with IN O
the DT O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
( ( O
TCR NNP B-Gene
) ) O
on IN O
the DT O
surface NN O
of IN O
T NNP O
cells NNS O
and CC O
initiates VBZ O
an DT O
activation NN O
cascade NN O
. . O

Costimulatory NN O
signals NNS O
, , O
such JJ O
as IN O
activation NN O
of IN O
the DT O
CD28 NNP B-Gene
cell NN I-Gene
surface NN I-Gene
molecule NN I-Gene
on IN O
T NNP O
cells NNS O
, , O
lead NN O
to TO O
activation NN O
through IN O
a DT O
distinct JJ O
region NN O
of IN O
the DT O
granulocyte NN B-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
( ( I-Gene
GM NNP I-Gene
- : I-Gene
CSF NN I-Gene
) ) I-Gene
promoter NN I-Gene
. . O

Human NNP O
T NNP O
leukemia NN O
virus NN O
type NN O
1 CD O
( ( O
HTLV NNP O
- : O
1 CD O
) ) O
infects NNS O
T NNP O
cells NNS O
and CC O
can MD O
lead VB O
to TO O
increase VB O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
expression NN O
. . O

This DT O
observation NN O
, , O
together RB O
with IN O
the DT O
fact NN O
that IN O
both DT O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
respond NN O
to TO O
TCR NNP B-Gene
signals NNS O
via IN O
NFAT NNP B-Gene
, , O
implies VBZ O
a DT O
high JJ O
degree NN O
of IN O
conservation NN O
in IN O
the DT O
regulation NN O
of IN O
cytokine JJ B-Gene
gene NN O
expression NN O
in IN O
T NNP O
cells NNS O
. . O

3 LS O
. . O
Danazol NNP O
decreased VBD O
the DT O
transcription NN O
rate NN O
of IN O
ER NNP B-Gene
gene NN I-Gene
to TO O
approximately RB O
50 CD O
% NN O
in IN O
monocytes NNS O
in IN O
a DT O
run NN O
- : O
on IN O
assay NN O
. . O

Formation NN O
of IN O
the DT O
NFAT NNP B-Gene
- : I-Gene
1 CD I-Gene
transcriptional JJ I-Gene
complex NN I-Gene
on IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
is VBZ O
essential JJ O
for IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
transcription NN O
. . O

WIN $ O
53071 CD O
inhibited VBN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
production NN O
induced VBN O
in IN O
the DT O
calcium NN O
- : O
dependent NN O
PMA NNP O
and CC O
ionomycin JJ O
pathway NN O
. . O

We PRP O
examined VBD O
mRNA JJ B-Gene
levels NNS O
of IN O
various JJ O
V NNP B-Gene
- : I-Gene
ATPase NNP I-Gene
subunits VBZ O
during IN O
differentiation NN O
of IN O
both DT O
native JJ O
monocytes NNS O
and CC O
the DT O
cell NN O
line NN O
THP NNP O
- : O
1 CD O
, , O
and CC O
found VBD O
that IN O
transcriptional JJ O
and CC O
post NN O
- : O
transcriptional JJ O
mechanisms NNS O
could MD O
account VB O
for IN O
increases NNS O
in IN O
cell NN O
V NNP B-Gene
- : I-Gene
ATPase NNP I-Gene
content NN O
. . O

From IN O
nuclear JJ O
runoff NN O
experiments NNS O
, , O
we PRP O
found VBD O
that IN O
one CD O
subunit NN O
in IN O
particular JJ O
, , O
the DT O
B2 NNP B-Gene
isoform NN I-Gene
( ( O
Mr NNP O
= NNP O
56 CD O
, , O
0 CD O
) ) O
, , O
was VBD O
amplified VBN O
primarily RB O
by IN O
transcriptional JJ O
means NNS O
. . O

Primer NNP O
extension NN O
and CC O
ribonuclease NN B-Gene
protection NN O
analyses VBZ O
indicate VBP O
a DT O
single JJ O
major JJ B-Gene
transcriptional JJ I-Gene
start NN I-Gene
site NN I-Gene
. . O

We PRP O
transfected VBD O
promoter NN B-Gene
- : I-Gene
luciferase NN I-Gene
reporter NN I-Gene
plasmids NNS I-Gene
into IN O
THP NNP O
- : O
1 CD O
cells NNS O
to TO O
define VB O
sequences NNS O
that WDT O
mediate VBP O
transcriptional JJ O
control NN O
during IN O
monocyte JJ O
differentiation NN O
. . O

We PRP O
have VBP O
examined VBN O
the DT O
function NN O
of IN O
these DT O
elements NNS O
in IN O
Burkitt NNP O
' POS O
s NN O
lymphoma NN O
cells NNS O
( ( O
Ramos NNP O
and CC O
Daudi NNP O
) ) O
as RB O
well RB O
as IN O
a DT O
T NNP O
lymphocytic JJ O
cell NN O
line NN O
( ( O
Jurkat NNP O
) ) O
. . O

Okadaic NNP O
acid NN O
augments NNS O
PMA NNP O
- : O
as RB O
well RB O
as IN O
calcium NN O
- : O
mediated VBN O
activation NN O
of IN O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
, , O
and CC O
has VBZ O
little RB O
or CC O
no DT O
effect NN O
when WRB O
combined VBN O
with IN O
cAMP NN O
. . O

The DT O
main JJ O
difference NN O
between IN O
Ramos NNP O
( ( O
B NNP O
cells NNS O
) ) O
and CC O
Jurkat NNP O
( ( O
T NNP O
cells NNS O
) ) O
in IN O
the DT O
regulation NN O
of IN O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
is VBZ O
that IN O
cAMP NN O
plus CC O
calcium NN O
is VBZ O
strongly RB O
synergistic JJ O
in IN O
Jurkat NNP O
and CC O
is VBZ O
without IN O
effect NN O
in IN O
Ramos NNP O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
cell NN O
- : O
specific JJ O
patterns NNS O
of IN O
synergy NN O
are VBP O
an DT O
essential JJ O
feature NN O
for IN O
c SYM B-Gene
- : I-Gene
fos JJ I-Gene
induction NN O
and CC O
may MD O
be VB O
relevant JJ O
for IN O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
control NN O
through IN O
B NNP B-Gene
and CC I-Gene
T NNP I-Gene
cell VBP I-Gene
antigen NN I-Gene
receptors NNS I-Gene
. . O

Multiple JJ O
signals NNS O
are VBP O
required VBN O
for IN O
function NN O
of IN O
the DT O
human JJ B-Gene
granulocyte NN I-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
gene NN I-Gene
promoter NN I-Gene
in IN O
T NNP O
cells NNS O
. . O

These DT O
results NNS O
imply VBP O
that DT O
at IN O
least JJS O
three CD O
signals NNS O
are VBP O
required VBN O
to TO O
activate VB O
the DT O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
proximal JJ I-Gene
promoter NN I-Gene
, , O
and CC O
that IN O
the DT O
signals NNS O
impinge VBP O
on IN O
distinct JJ O
transcription NN B-Gene
factors NNS I-Gene
that WDT O
bind VBP O
to TO O
the DT O
hCLEO NN B-Gene
and CC I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
regions NNS I-Gene
of IN O
the DT O
promoter NN B-Gene
. . O

In IN O
this DT O
report NN O
, , O
we PRP O
show VBP O
that IN O
in IN O
monocytes NNS O
and CC O
T NNP O
cells NNS O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
stimulates NNS O
tyrosine JJ O
phosphorylation NN O
of IN O
the DT O
signal JJ B-Gene
transducers NNS I-Gene
and CC O
activators NNS B-Gene
of IN I-Gene
transcription NN I-Gene
, , O
STAT1 NNP B-Gene
alpha NN I-Gene
and CC O
STAT3 NNP B-Gene
, , O
in IN O
a DT O
differential JJ O
manner NN O
such JJ O
that IN O
the DT O
relative JJ O
formation NN O
of IN O
homo NN B-Gene
- : I-Gene
and CC I-Gene
heterodimers NNS I-Gene
varies NNS O
between IN O
the DT O
two CD O
cell NN O
types NNS O
. . O

IL NNP B-Gene
- : I-Gene
10 CD I-Gene
treatment NN O
of IN O
both DT O
T NNP O
cells NNS O
and CC O
monocytes NNS O
results NNS O
in IN O
the DT O
ligand NN O
- : O
induced JJ O
tyrosine JJ O
phosphorylation NN O
of IN O
tyk2 NN B-Gene
and CC O
Jak1 NNP B-Gene
, , O
but CC O
not RB O
Jak2 NNP B-Gene
or CC O
Jak3 NNP B-Gene
. . O

Selective JJ O
modulation NN O
of IN O
immune JJ O
responsiveness NN O
by IN O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
in IN O
cells NNS O
such JJ O
as IN O
monocytes NNS O
and CC O
T NNP O
cells NNS O
may MD O
result VB O
in IN O
part NN O
from IN O
the DT O
differential JJ O
activation NN O
of IN O
STAT NNP B-Gene
protein NN I-Gene
pairs NNS I-Gene
. . O

However RB O
, , O
the DT O
real JJ O
effect NN O
of IN O
hormones NNS O
involved VBN O
in IN O
ovulation NN O
is VBZ O
expressed VBN O
by IN O
biological JJ O
modifications NNS O
on IN O
target NN O
tissues NNS O
. . O

They PRP O
also RB O
display VBP O
constitutively RB O
high JJ O
levels NNS O
of IN O
p59fyn NN B-Gene
and CC O
CD3 NNP B-Gene
zeta NNP I-Gene
tyrosine NN O
phosphorylation NN O
. . O

The DT O
generation NN O
of IN O
second JJ O
messengers NNS O
in IN O
T NNP O
cells NNS O
normally RB O
leads VBZ O
to TO O
downstream VB O
signaling VBG O
that DT O
results NNS O
in IN O
transcriptional JJ O
activation NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
. . O

Levels NNS O
of IN O
the DT O
octamer NN O
, , O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( O
p50 JJ B-Gene
- : I-Gene
p65 NN I-Gene
heterodimer NN I-Gene
) ) O
, , O
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
transcriptional JJ I-Gene
factors NNS I-Gene
are VBP O
constitutively RB O
elevated VBN O
in IN O
freshly RB O
isolated VBN O
Ipr NNP O
CD4 NNP O
- : O
8 CD O
- : O
T NN O
cells NNS O
, , O
consistent NN O
with IN O
the DT O
activated JJ O
phenotype NN O
of IN O
these DT O
cells NNS O
. . O

We PRP O
demonstrate VBP O
that IN O
cross NN O
- : O
linking VBG O
CD30 NNP B-Gene
with IN O
an DT O
anti JJ O
- : O
CD30 NNP B-Gene
- : O
specific JJ O
monoclonal JJ O
antibody NN O
, , O
which WDT O
mimics VBZ O
the DT O
described JJ O
biological JJ O
activities NNS O
of IN O
the DT O
CD30 NNP B-Gene
ligand NN I-Gene
( ( O
CD30L NNP B-Gene
) ) O
, , O
results NNS O
in IN O
HIV NNP O
expression NN O
. . O

Type NNP B-Gene
II NNP I-Gene
major JJ I-Gene
histocompatibility NN I-Gene
complex NN I-Gene
combined VBN O
immune JJ O
deficiency NN O
( ( O
type JJ O
II NNP O
MHC NNP B-Gene
CID NNP O
or CC O
bare VB O
lymphocyte JJ O
syndrome NN O
) ) O
is VBZ O
a DT O
congenital JJ O
immunodeficiency NN O
disease NN O
characterized VBN O
by IN O
absent JJ O
MHC NNP B-Gene
class NN I-Gene
II NNP I-Gene
expression NN O
. . O

Here RB O
, , O
we PRP O
demonstrate VBP O
that IN O
CIITA NNP B-Gene
is VBZ O
an DT O
MHC NNP B-Gene
class NN I-Gene
II NNP I-Gene
gene NN I-Gene
- : I-Gene
specific JJ I-Gene
transcription NN I-Gene
activator NN I-Gene
. . O

The DT O
transcription NN O
activation NN O
function NN O
is VBZ O
provided VBN O
by IN O
the DT O
N NNP B-Gene
- : I-Gene
terminal JJ I-Gene
acidic JJ I-Gene
domain NN I-Gene
( ( O
amino JJ B-Gene
acids NNS I-Gene
26 CD I-Gene
- : I-Gene
137 CD I-Gene
) ) O
, , O
which WDT O
is VBZ O
experimentally RB O
exchangeable JJ O
with IN O
a DT O
heterologous JJ B-Gene
viral JJ I-Gene
transcription NN I-Gene
- : I-Gene
activating VBG I-Gene
domain NN I-Gene
. . O

These DT O
results NNS O
demonstrate VBP O
that IN O
P NNP B-Gene
- : I-Gene
selectin NN I-Gene
, , O
through IN O
its PRP$ O
ligands NNS O
on IN O
monocytes NNS O
, , O
may MD O
locally RB O
regulate VB O
cytokine NN B-Gene
secretion NN O
in IN O
inflamed JJ O
tissues NNS O
. . O

Here RB O
, , O
we PRP O
report VBP O
that IN O
nitric JJ O
oxide NN O
( ( O
NO NNP O
) ) O
activates VBZ O
p21ras NNS B-Gene
in IN O
human JJ O
T NNP O
cells NNS O
as IN O
evidenced VBN O
by IN O
an DT O
increase NN O
in IN O
GTP NNP B-Gene
- : I-Gene
bound NN I-Gene
p21ras NNS I-Gene
. . O

In IN O
vitro JJ O
studies NNS O
using VBG O
pure NN B-Gene
recombinant NN I-Gene
p21ras NN I-Gene
demonstrate NN O
that IN O
the DT O
activation NN O
is VBZ O
direct JJ O
and CC O
reversible JJ O
. . O

Circular JJ O
dichroism NN O
analysis NN O
reveals NNS O
that IN O
NO NNP O
induces VBZ O
a DT O
profound JJ O
conformational JJ O
change NN O
in IN O
p21ras NNS B-Gene
in IN O
association NN O
with IN O
GDP NNP O
/ NNP O
GTP NNP O
exchange NN O
. . O

Furthermore RB O
, , O
we PRP O
demonstrate VBP O
that DT O
p21ras NN B-Gene
is VBZ O
essential JJ O
for IN O
NO NNP O
- : O
induced VBD O
downstream NN O
signaling VBG O
, , O
such JJ O
as IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
, , O
and CC O
that IN O
endogenous JJ O
NO NNP O
can MD O
activate VB O
p21ras NNS B-Gene
in IN O
the DT O
same JJ O
cell NN O
. . O

These DT O
studies NNS O
identify VBP O
p21ras NNS B-Gene
as IN O
a DT O
target NN O
of IN O
the DT O
same JJ O
cell NN O
. . O

These DT O
studies NNS O
identify VBP O
p21ras NNS B-Gene
as IN O
a DT O
target NN O
of IN O
NO NNP O
in IN O
T NNP O
cells NNS O
and CC O
suggest VBP O
that IN O
NO NNP O
activates VBZ O
p21ras NNS B-Gene
by IN O
an DT O
action NN O
which WDT O
mimics VBZ O
that IN O
of IN O
guanine NN B-Gene
nucleotide JJ I-Gene
exchange NN I-Gene
factors NNS I-Gene
. . O

In IN O
the DT O
present JJ O
study NN O
we PRP O
analyzed VBD O
the DT O
control NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
activity NN O
in IN O
Epstein NNP O
- : O
Barr NNP O
virus NN O
( ( O
EBV NNP O
) ) O
- : O
transformed VBN O
B NNP O
cell NN O
clones NNS O
which WDT O
are VBP O
capable JJ O
of IN O
secreting VBG O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
at IN O
a DT O
low JJ O
level NN O
after IN O
stimulation NN O
with IN O
phorbol NN O
12 CD O
- : O
myristate NN O
13 CD O
- : O
acetate NN O
and CC O
the DT O
Ca2 NNP O
+ NNP O
ionophore NN O
ionomycin NN O
. . O

Transient JJ O
transfections NNS O
using VBG O
reporter NN B-Gene
constructs NNS I-Gene
with IN O
multiples NNS O
of IN O
transcription NN B-Gene
factor NN I-Gene
binding VBG I-Gene
sites NNS I-Gene
from IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
[ NNP O
distal JJ B-Gene
nuclear JJ I-Gene
factor NN I-Gene
( ( I-Gene
NF NNP I-Gene
) ) I-Gene
- : I-Gene
AT NN I-Gene
, , O
proximal JJ B-Gene
NF NNP I-Gene
- : I-Gene
AT NNP I-Gene
, , O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
/ JJ I-Gene
Octamer NNP I-Gene
( ( O
UPS NNP B-Gene
) ) O
or CC O
NF NNP B-Gene
- : I-Gene
chi NN I-Gene
B NNP I-Gene
( ( O
TCEd NNP B-Gene
) ) O
sites VBZ O
] JJ O
were VBD O
performed VBN O
. . O

In IN O
EBV NNP O
- : O
transformed VBD O
B NNP O
clones NNS O
, , O
the DT O
chi NN B-Gene
B NNP I-Gene
site NN I-Gene
exerted VBD O
the DT O
strongest JJS O
inducible JJ O
activity NN O
; : O
the DT O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
binding NN I-Gene
sites NNS I-Gene
showed VBD O
either CC O
no DT O
or CC O
only RB O
weak JJ O
activity NN O
compared VBN O
to TO O
Jurkat NNP O
T NNP O
cells NNS O
. . O

In IN O
seven CD O
EBV NNP O
- : O
B NNP O
cell NN O
clones NNS O
or CC O
lines NNS O
differing VBG O
in IN O
their PRP$ O
capacity NN O
to TO O
secrete VB O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
the DT O
activity NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
correlated VBN O
well RB O
with IN O
the DT O
status NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
secretion NN O
. . O

Latent NNP B-Gene
membrane NN I-Gene
protein NN I-Gene
- : I-Gene
1 CD I-Gene
induces NNS O
cyclin VBP B-Gene
D2 NNP I-Gene
expression NN O
, , O
pRb JJ B-Gene
hyperphosphorylation NN O
, , O
and CC O
loss NN O
of IN O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
1 CD I-Gene
- : O
mediated VBN O
growth NN O
inhibition NN O
in IN O
EBV NNP O
- : O
positive JJ O
B NNP O
cells NNS O
. . O

Here RB O
, , O
we PRP O
show VBP O
that IN O
the DT O
presence NN O
of IN O
either CC O
wild JJ O
- : O
type NN O
EBV NNP O
or CC O
its PRP$ O
transforming JJ B-Gene
latent JJ I-Gene
membrane NN I-Gene
protein SYM I-Gene
- : I-Gene
1 CD I-Gene
( ( O
LMP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
results NNS O
in IN O
the DT O
loss NN O
of IN O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
1 CD I-Gene
- : O
mediated VBN O
growth NN O
inhibition NN O
in IN O
human JJ O
B NNP O
cells NNS O
. . O

Does NNP O
thyroidectomy VB O
, , O
radioactive JJ O
iodine NN O
therapy NN O
, , O
or CC O
antithyroid JJ O
drug NN O
treatment NN O
alter NN O
reactivity NN O
of IN O
patients NNS O
' POS O
T NNP O
cells NNS O
to TO O
epitopes NNS O
of IN O
thyrotropin NN B-Gene
receptor NN I-Gene
in IN O
autoimmune JJ O
thyroid NN O
diseases NNS O
? . O

A DT O
further JJ O
decrease NN O
in IN O
the DT O
T NNP O
cell NN O
reactivity NN O
to TO O
TSHR NNP B-Gene
peptides NNS O
was VBD O
observed VBN O
3 CD O
- : O
6 CD O
months NNS O
after IN O
surgery NN O
. . O

Six CD O
to TO O
8 CD O
weeks NNS O
after IN O
RAI NNP O
therapy NN O
, , O
the DT O
number NN O
of IN O
patients NNS O
responding VBG O
to TO O
any DT O
peptide NN O
and CC O
the DT O
average JJ O
number NN O
of IN O
recognized JJ O
peptides NNS O
increased VBD O
. . O

The DT O
reactivity NN O
of IN O
T NNP O
cell NN O
lines NNS O
in IN O
different JJ O
groups NNS O
reflected VBD O
a DT O
pattern NN O
similar JJ O
to TO O
PBMC VB O
after IN O
treatment NN O
. . O

TSHR NNP B-Gene
antibody NN I-Gene
and CC O
microsomal JJ B-Gene
antibody NN I-Gene
levels NNS O
decreased VBN O
after IN O
surgery NN O
, , O
but CC O
increased VBD O
after IN O
RAI NNP O
therapy NN O
. . O

We PRP O
have VBP O
identified VBN O
an DT O
in IN O
vivo NN O
footprint NN O
over IN O
the DT O
PuF NNP B-Gene
site NN I-Gene
on IN O
the DT O
translocated VBN O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
allele NN I-Gene
in IN O
Burkitt NNP O
' POS O
s NN O
lymphoma NN O
cells NNS O
. . O

Transfection NN O
experiments NNS O
with IN O
c JJ B-Gene
- : I-Gene
myc NN I-Gene
promoter NN I-Gene
constructs NNS I-Gene
in IN O
both DT O
DHL NNP O
- : O
9 CD O
and CC O
Raji NNP O
cells NNS O
revealed VBD O
that IN O
the DT O
PuF NNP B-Gene
site NN I-Gene
functioned VBD O
as IN O
a DT O
positive JJ B-Gene
regulatory JJ I-Gene
element NN I-Gene
in IN O
B NNP O
cells NNS O
with IN O
a DT O
drop NN O
in IN O
activity NN O
with IN O
mutation NN O
of IN O
this DT O
site NN O
. . O

Electromobility NNP O
shift NN O
assays VBZ O
utilizing VBG O
this DT O
sequence NN O
demonstrated VBD O
binding NN O
of IN O
a DT O
fetal JJ B-Gene
and CC I-Gene
erythroid JJ I-Gene
- : I-Gene
specific JJ I-Gene
protein NN I-Gene
. . O

These DT O
results NNS O
indicate VBP O
that IN O
the DT O
5 CD B-Gene
' POS I-Gene
- : I-Gene
UTR NN I-Gene
of IN O
the DT O
gamma NN B-Gene
- : I-Gene
gene NN I-Gene
contains NNS O
sequences NNS O
that WDT O
may MD O
be VB O
important JJ O
for IN O
its PRP$ O
transcriptional JJ O
and CC O
developmental JJ O
regulation NN O
. . O

However RB O
, , O
this DT O
deletion NN O
mutation NN O
prevented VBD O
the DT O
induced JJ O
phosphorylation NN O
, , O
degradative JJ O
loss NN O
, , O
and CC O
functional JJ O
release NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
from IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
Tax NNP O
- : O
expressing VBG O
cells NNS O
. . O

Alanine NNP O
substitutions NNS O
introduced VBN O
at IN O
two CD O
serine NN O
residues NNS O
positioned VBD O
within IN O
this DT O
N NNP B-Gene
- : I-Gene
terminal JJ I-Gene
regulatory JJ I-Gene
region NN I-Gene
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
also RB O
yielded VBD O
constitutive JJ O
repressors NNS O
that WDT O
escaped VBD O
from IN O
Tax NNP B-Gene
- : O
induced VBN O
turnover NN O
and CC O
that DT O
potently RB O
inhibited VBN O
immune JJ O
activation NN O
pathways NNS O
for IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
induction NN O
, , O
including VBG O
those DT O
initiated VBN O
from IN O
antigen NN B-Gene
and CC I-Gene
cytokine NN I-Gene
receptors NNS I-Gene
. . O

In IN O
contrast NN O
, , O
introduction NN O
of IN O
a DT O
phosphoserine JJ O
mimetic NN O
at IN O
these DT O
sites NNS O
rectified VBD O
this DT O
functional JJ O
defect NN O
, , O
a DT O
finding JJ O
consistent NN O
with IN O
a DT O
causal NN O
linkage NN O
between IN O
the DT O
phosphorylation NN O
status NN O
and CC O
proteolytic JJ O
stability NN O
of IN O
this DT O
cytoplasmic JJ B-Gene
inhibitor NN I-Gene
. . O

Together RB O
, , O
these DT O
in IN O
vivo NN O
studies NNS O
define VBP O
a DT O
critical JJ O
signal NN O
response NN O
domain NN O
in IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
that WDT O
coordinately RB O
controls VBZ O
the DT O
biologic JJ O
activities NNS O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
response NN O
to TO O
viral JJ O
and CC O
immune JJ O
stimuli NNS O
. . O

Human NNP O
prostatic JJ O
epithelial JJ O
cells NNS O
from IN O
an DT O
androgen NN O
- : O
dependent JJ O
LNCaP NNP O
cell NN O
line NN O
were VBD O
examined VBN O
in IN O
response NN O
to TO O
conditioned VBN O
medium NN O
( ( O
CM NNP O
) ) O
derived VBD O
from IN O
phytohemagglutinin NN O
( ( O
PHA NNP O
) ) O
- : O
stimulated VBN O
lymphocytes NNS O
. . O

Cell NNP O
morphology NN O
showed VBD O
dendritic JJ O
processes NNS O
extending VBG O
from IN O
cytoplasm NN O
and CC O
other JJ O
neuroendocrine NN O
cell NN O
characteristics NNS O
. . O

These DT O
included VBD O
vimentin NN B-Gene
, , O
correlating VBG O
to TO O
cell VB O
shape NN O
changes NNS O
, , O
cytokeratins VBZ B-Gene
8 CD I-Gene
and CC I-Gene
18 CD I-Gene
, , O
associated VBN O
with IN O
differentiated VBN O
cell NN O
types NNS O
of IN O
prostate NN O
epithelia NNS O
, , O
and CC O
neuron SYM B-Gene
- : I-Gene
specific JJ I-Gene
enolase NN I-Gene
and CC O
serotonin NN O
, , O
associated VBN O
with IN O
neuroendocrine JJ O
cells NNS O
. . O

Human NNP O
peripheral JJ O
blood NN O
monocytes NNS O
responded VBD O
to TO O
stimulation NN O
of IN O
platelet NN B-Gene
- : I-Gene
activating VBG I-Gene
factor NN I-Gene
( ( O
PAF NNP B-Gene
) ) O
with IN O
up RP O
- : O
regulation NN O
of IN O
the DT O
transcript NN O
for IN O
heparin JJ B-Gene
- : I-Gene
binding VBG I-Gene
epidermal JJ I-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
like IN I-Gene
growth NN I-Gene
factor NN I-Gene
( ( O
HB NNP B-Gene
- : I-Gene
EGF NN I-Gene
) ) O
, , O
a DT O
potent NN B-Gene
mitogen NN I-Gene
for IN O
vascular JJ O
smooth JJ O
muscle NN O
cells NNS O
. . O

This DT O
function NN O
of IN O
PAF NNP B-Gene
was VBD O
observed VBN O
at IN O
nanomolar JJ O
concentrations NNS O
of IN O
the DT O
ligand NN O
, , O
starting VBG O
at IN O
30 CD O
min NN O
after IN O
stimulation NN O
. . O

These DT O
functions NNS O
of IN O
PAF NNP B-Gene
appeared VBD O
to TO O
be VB O
mediated VBN O
through IN O
the DT O
cell NN B-Gene
surface NN I-Gene
PAF NNP I-Gene
receptors NNS I-Gene
, , O
as IN O
two CD O
PAF NNP B-Gene
receptor NN O
antagonists NNS O
, , O
WEB NNP O
2086 CD O
and CC O
L NNP O
- : O
659 CD O
, , O
989 CD O
, , O
blocked VBD O
both DT O
the DT O
up RP O
- : O
regulation NN O
of IN O
HB NNP B-Gene
- : I-Gene
EGF NNP I-Gene
mRNA NN I-Gene
and CC O
kappa NN O
B NNP O
binding NN O
activity NN O
induced VBN O
by IN O
PAF NNP B-Gene
. . O

The DT O
antagonists NNS O
, , O
however RB O
, , O
had VBD O
no DT O
effect NN O
on IN O
phorbol NN O
ester NN O
- : O
induced VBN O
up RP O
- : O
regulation NN O
of IN O
HB NNP B-Gene
- : I-Gene
EGF NNP I-Gene
mRNA NN I-Gene
and CC O
kappa NN O
B NNP O
binding NN O
activity NN O
. . O

Several JJ O
criteria NNS O
indicated VBD O
that IN O
the DT O
defect NN O
in IN O
this DT O
cell NN O
line NN O
influences VBZ O
the DT O
activity NN O
of IN O
an DT O
isotype NN B-Gene
- : I-Gene
specific JJ I-Gene
transcription NN I-Gene
factor NN I-Gene
. . O

The DT O
DQB NNP B-Gene
X2 NNP I-Gene
- : I-Gene
box NN I-Gene
was VBD O
able JJ O
to TO O
restore VB O
expression NN O
to TO O
the DT O
silent JJ B-Gene
DRA NNP I-Gene
reporter NN I-Gene
construct NN I-Gene
. . O

Moreover RB O
, , O
replacement NN O
of IN O
the DT O
DQB NNP B-Gene
X2 NNP I-Gene
- : I-Gene
box NN I-Gene
with IN O
the DT O
DRA NNP B-Gene
X2 NNP I-Gene
- : I-Gene
box NN I-Gene
markedly RB O
diminished VBD O
the DT O
activity NN O
of IN O
the DT O
DQB NNP B-Gene
promoter NN I-Gene
in IN O
the DT O
mutant NN O
cell NN O
. . O

ZEBRA NNP B-Gene
is VBZ O
a DT O
bZIP JJ B-Gene
transcriptional NN I-Gene
activator NN I-Gene
which WDT O
binds VBZ O
as IN O
a DT O
dimer NN O
to TO O
7 CD B-Gene
- : I-Gene
bp NN I-Gene
response NN I-Gene
elements NNS I-Gene
within IN O
EBV NNP B-Gene
promoters NNS I-Gene
and CC O
is VBZ O
directly RB O
involved VBN O
in IN O
the DT O
stimulation NN O
of IN O
virus NN O
replication NN O
at IN O
the DT O
EBV NNP B-Gene
lytic JJ I-Gene
origin NN I-Gene
. . O

Both DT O
chimeras NNS O
were VBD O
found VBN O
to TO O
transactivate VB O
model NN O
and CC O
native JJ O
promoters NNS O
at IN O
equivalent NN O
or CC O
better JJR O
levels NNS O
than IN O
ZEBRA NNP B-Gene
itself PRP O
. . O

These DT O
activation NN O
domains NNS O
restored VBD O
ZEBRA NNP B-Gene
' POS O
s NN O
ability NN O
to TO O
induce VB O
early JJ B-Gene
antigen NN I-Gene
and CC O
to TO O
stimulate VB O
origin JJ O
replication NN O
to TO O
levels NNS O
that WDT O
were VBD O
equal JJ O
to TO O
or CC O
greater JJR O
than IN O
those DT O
of IN O
wild JJ O
type NN O
. . O

Because IN O
these DT O
are VBP O
the DT O
characteristics NNS O
of IN O
a DT O
signal JJ B-Gene
transducer NN I-Gene
and CC I-Gene
activator NN I-Gene
of IN I-Gene
transcription NN I-Gene
( ( I-Gene
Stat NNP I-Gene
) ) I-Gene
protein NN I-Gene
, , O
we PRP O
determined VBD O
whether IN O
antibodies NNS B-Gene
to TO I-Gene
Stat NNP I-Gene
proteins NNS I-Gene
will MD O
interfere VB O
with IN O
gel JJ O
mobility NN O
shift NN O
and CC O
found VBD O
that IN O
antibodies NNS B-Gene
to TO I-Gene
IL NNP I-Gene
- : I-Gene
4 CD I-Gene
Stat NNP I-Gene
, , O
also RB O
known VBN O
as IN O
Stat6 NNP B-Gene
, , O
but CC O
not RB O
antibodies NNS B-Gene
to TO O
other JJ O
Stat NNP B-Gene
proteins NNS I-Gene
, , O
interfere RB O
with IN O
the DT O
formation NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
NAF NNP I-Gene
complex NN I-Gene
. . O

Monoallelic JJ O
expression NN O
of IN O
TAL1 NNP B-Gene
was VBD O
observed VBN O
in IN O
the DT O
leukemic JJ O
cells NNS O
of IN O
all DT O
patients NNS O
( ( O
8 CD O
of IN O
8 CD O
) ) O
bearing VBG O
a DT O
TAL1 NNP B-Gene
gene NN I-Gene
rearrangement NN O
. . O

In IN O
the DT O
leukemic JJ O
cells NNS O
of IN O
patients NNS O
without IN O
detectable JJ O
TAL1 NNP B-Gene
rearrangements NNS O
, , O
TAL1 NNP B-Gene
transcription NN O
occurred VBD O
in IN O
either CC O
a DT O
monoallelic NN O
( ( O
3 CD O
of IN O
7 CD O
patients NNS O
) ) O
or CC O
a DT O
biallelic JJ O
( ( O
4 CD O
of IN O
7 CD O
patients NNS O
) ) O
fashion NN O
. . O

Expression NN O
of IN O
erythroid JJ B-Gene
- : I-Gene
specific JJ I-Gene
genes NNS I-Gene
in IN O
acute JJ O
megakaryoblastic JJ O
leukaemia NN O
and CC O
transient JJ O
myeloproliferative JJ O
disorder NN O
in IN O
Down NNP O
' POS O
s JJ O
syndrome NN O
. . O

Acute NNP O
megakaryoblastic JJ O
leukaemia NN O
( ( O
M7 NNP O
) ) O
and CC O
transient JJ O
myeloproliferative JJ O
disorder NN O
in IN O
Down NNP O
' POS O
s JJ O
syndrome NN O
( ( O
TMD NNP O
) ) O
are VBP O
characterized VBN O
by IN O
rapid JJ O
growth NN O
of IN O
abnormal JJ O
blast NN O
cells NNS O
which WDT O
express VBP O
megakaryocytic JJ B-Gene
markers NNS I-Gene
. . O

Erythroid NNP B-Gene
- : I-Gene
specific JJ I-Gene
mRNAs NN I-Gene
encoding VBG O
gamma JJ B-Gene
- : I-Gene
globin NN I-Gene
and CC O
erythroid JJ B-Gene
delta NN I-Gene
- : I-Gene
aminolevulinate NN I-Gene
synthase NN I-Gene
were VBD O
found VBN O
to TO O
be VB O
expressed VBN O
in IN O
blasts NNS O
from IN O
most JJS O
of IN O
these DT O
cases NNS O
, , O
indicating VBG O
that IN O
majorities NNS O
of IN O
the DT O
blasts NNS O
in IN O
M7 NNP O
and CC O
TMD NNP O
cases NNS O
have VBP O
erythroid VBN O
and CC O
megakaryocytic JJ O
phenotypes NNS O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
M7 NNP O
blasts NNS O
and CC O
TMD NNP O
blasts VBZ O
correspond NN O
to TO O
the DT O
erythroid JJ O
/ NNP O
megakaryocytic JJ O
bipotential JJ O
progenitor NN O
cells NNS O
. . O

In IN O
this DT O
paper NN O
, , O
the DT O
expression NN O
of IN O
this DT O
gene NN O
in IN O
blood NN O
cells NNS O
was VBD O
first RB O
investigated VBN O
in IN O
fractions NNS O
of IN O
nucleated JJ O
cells NNS O
, , O
revealing VBG O
predominant JJ O
expression NN O
of IN O
the DT O
Ah NNP B-Gene
receptor NN I-Gene
gene NN I-Gene
in IN O
the DT O
monocyte NN O
fraction NN O
. . O

The DT O
incubation NN O
with IN O
transforming VBG B-Gene
growth NN I-Gene
factor NN I-Gene
beta NN I-Gene
1 CD I-Gene
and CC O
1 CD O
alpha NN O
, , O
25 CD O
- : O
dihydroxyvitamin NN O
D3 NNP O
resulted VBD O
in IN O
a DT O
5 CD O
- : O
to TO O
7 CD O
- : O
fold JJ O
increase NN O
of IN O
AhR NNP B-Gene
mRNA NN I-Gene
. . O

In IN O
vitro NN O
translated VBN O
Spi NNP B-Gene
- : I-Gene
B NNP I-Gene
protein NN I-Gene
can MD O
bind VB O
to TO O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
binding VBG I-Gene
sites NNS I-Gene
in IN O
myeloid JJ B-Gene
promoters NNS I-Gene
and CC O
transactivate VB O
these DT O
promoters NNS B-Gene
in IN O
nonmyeloid JJ O
cells NNS O
. . O

In IN O
contrast NN O
, , O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
is VBZ O
expressed VBN O
at IN O
high JJ O
levels NNS O
not RB O
only RB O
in IN O
monocytes NNS O
and CC O
macrophages NNS O
but CC O
also RB O
in IN O
neutrophils NNS O
, , O
indicating VBG O
that IN O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
can MD O
activate VB O
gene NN O
expression NN O
in IN O
both DT O
major JJ O
myeloid NN O
lineages NNS O
. . O

The DT O
promoters NNS B-Gene
were VBD O
used VBN O
without IN O
enhancers NNS B-Gene
, , O
or CC O
with IN O
enhancers NNS B-Gene
derived VBN O
from IN O
the DT O
beta NN B-Gene
- : I-Gene
globin NN I-Gene
locus NN I-Gene
control NN I-Gene
region NN I-Gene
and CC O
the DT O
alpha JJ B-Gene
- : I-Gene
globin NN I-Gene
HS NNP I-Gene
- : I-Gene
40 CD I-Gene
enhancer NN I-Gene
. . O

When WRB O
transfected VBN O
into IN O
K562 NNP O
cells NNS O
, , O
which WDT O
express VBP O
zeta SYM B-Gene
- : I-Gene
globin NN I-Gene
, , O
comparable JJ O
amounts NNS O
of IN O
activity NN O
were VBD O
obtained VBN O
from IN O
the DT O
- : B-Gene
557 CD I-Gene
and CC I-Gene
- : I-Gene
417 CD I-Gene
zeta SYM I-Gene
- : I-Gene
luciferase NN I-Gene
constructs NNS I-Gene
and CC O
the DT O
alpha JJ B-Gene
- : I-Gene
luciferase NN I-Gene
constructs NNS I-Gene
when WRB O
no DT O
enhancers NNS B-Gene
or CC O
the DT O
alpha JJ B-Gene
- : I-Gene
globin NN I-Gene
locus NN I-Gene
enhancers NNS I-Gene
were VBD O
used VBN O
. . O

This DT O
element NN O
requires VBZ O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
additional JJ B-Gene
unknown JJ I-Gene
factors NNS I-Gene
for IN O
maximal JJ O
activity NN O
. . O

To TO O
address VB O
this DT O
issue NN O
, , O
mutationally RB O
active JJ O
PKC NNP B-Gene
- : I-Gene
alpha NN I-Gene
, , I-Gene
- : I-Gene
epsilon NN I-Gene
, , I-Gene
or CC I-Gene
- : I-Gene
zeta NN I-Gene
have VBP O
been VBN O
transfected VBN O
into IN O
T NNP O
cells NNS O
and CC O
the DT O
consequences NNS O
for IN O
T NNP O
cell NN O
activation NN O
determined VBD O
. . O

Accordingly RB O
, , O
the DT O
effects NNS O
of IN O
the DT O
constitutively RB B-Gene
active JJ I-Gene
PKCs NNP I-Gene
were VBD O
compared VBN O
to TO O
the DT O
effects NNS O
of IN O
mutationally RB O
activated VBN O
p21ras NN B-Gene
. . O

The DT O
ability NN O
of IN O
PKC NNP B-Gene
- : I-Gene
epsilon NN I-Gene
to TO O
induce VB O
transactivation NN O
of IN O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
- : I-Gene
1 CD I-Gene
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
was VBD O
similar JJ O
to TO O
the DT O
stimulatory JJ O
effect NN O
of IN O
a DT O
constitutively RB B-Gene
activated VBN I-Gene
p21ras NN I-Gene
. . O

These DT O
results NNS O
indicate VBP O
selective JJ O
functions NNS O
for IN O
different JJ O
PKC NNP B-Gene
isotypes NNS I-Gene
in IN O
T NNP O
cells NNS O
. . O

Moreover RB O
, , O
the DT O
data NNS O
comparing VBG O
the DT O
effects NNS O
of IN O
activated JJ B-Gene
Ras NNP I-Gene
and CC O
PKC NNP B-Gene
mutants NNS I-Gene
suggest VBP O
that IN O
PKC NNP B-Gene
- : I-Gene
alpha NN I-Gene
, , O
p21ras NN B-Gene
, , O
and CC O
PKC NNP B-Gene
- : I-Gene
epsilon NN I-Gene
are VBP O
not RB O
positioned VBN O
linearly RB O
on IN O
a DT O
single JJ O
signal NN O
transduction NN O
pathway NN O
. . O

Differences NNS O
in IN O
binding NN O
of IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
to TO O
DNA NNP O
in IN O
steroid JJ O
- : O
resistant JJ O
asthma NN O
. . O

We PRP O
examined VBD O
the DT O
ability NN O
of IN O
nuclear JJ O
translocated VBN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
to TO O
bind VB O
to TO O
their PRP$ O
DNA NN B-Gene
binding NN I-Gene
sites NNS I-Gene
( ( O
GRE NNP B-Gene
) ) O
using VBG O
electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
in IN O
PBMC NNP O
from IN O
patients NNS O
with IN O
steroid JJ O
- : O
sensitive JJ O
and CC O
steroid JJ O
- : O
resistant JJ O
asthma NN O
. . O

Scatchard NNP O
analysis NN O
of IN O
glucocorticoid NN B-Gene
receptor NN I-Gene
- : O
GRE NNP B-Gene
binding NN O
showed VBD O
no DT O
change NN O
in IN O
binding VBG O
affinity NN O
but CC O
did VBD O
show VB O
a DT O
reduced JJ O
number NN O
of IN O
receptors NNS B-Gene
available JJ O
for IN O
DNA NNP O
binding NN O
in IN O
the DT O
steroid JJ O
- : O
resistant JJ O
patients NNS O
. . O

Interleukin NNP B-Gene
- : I-Gene
5 CD I-Gene
signaling VBG O
in IN O
human JJ O
eosinophils NNS O
involves VBZ O
JAK2 NNP B-Gene
tyrosine NN I-Gene
kinase NN I-Gene
and CC O
Stat1 NNP B-Gene
alpha NN I-Gene
. . O

Signaling VBG O
by IN O
a DT O
wide JJ O
variety NN O
of IN O
cytokines NNS B-Gene
, , O
including VBG O
interferons NNS B-Gene
, , O
interleukins NNS B-Gene
, , O
and CC O
growth NN B-Gene
factors NNS I-Gene
, , O
involves VBZ O
activation NN O
of IN O
JAK NNP B-Gene
kinases NNS I-Gene
and CC O
Stat NNP B-Gene
( ( I-Gene
Signal NNP I-Gene
transducers NNS I-Gene
and CC I-Gene
activators NNS I-Gene
of IN I-Gene
transcription NN I-Gene
) ) I-Gene
proteins VBZ I-Gene
. . O

From IN O
supershift NN O
experiments NNS O
it PRP O
was VBD O
concluded VBN O
that IN O
one CD O
DNA NNP B-Gene
- : I-Gene
binding NN I-Gene
complex JJ I-Gene
contained VBD O
Stat1 NNP B-Gene
alpha NN I-Gene
, , O
probably RB O
as IN O
a DT O
homodimer NN O
. . O

It PRP O
was VBD O
found VBN O
that IN O
the DT O
propagation NN O
of IN O
the DT O
Tat NNP B-Gene
mutants NNS I-Gene
containing VBG O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
LTRs NNP I-Gene
was VBD O
less RBR O
efficient JJ O
than IN O
that DT O
of IN O
the DT O
LTR NNP B-Gene
- : I-Gene
modified VBD I-Gene
Tat NNP I-Gene
mutants NNS I-Gene
. . O

Here RB O
we PRP O
show VBP O
that IN O
the DT O
lymphoid JJ B-Gene
- : I-Gene
specific JJ I-Gene
transcription NN I-Gene
factor NN I-Gene
Oct NNP I-Gene
- : I-Gene
2A CD I-Gene
plays VBZ O
a DT O
critical JJ O
role NN O
in IN O
HLA NNP B-Gene
- : I-Gene
DRA NNP I-Gene
gene NN I-Gene
expression NN O
in IN O
class NN O
II NNP O
- : O
positive JJ O
B NNP O
cell NN O
lines NNS O
, , O
and CC O
that IN O
the DT O
high JJ B-Gene
mobility NN I-Gene
group NN I-Gene
protein NN I-Gene
( ( O
HMG NNP B-Gene
) ) O
I PRP B-Gene
/ VBP I-Gene
Y JJ I-Gene
binds NNS O
to TO O
multiple VB O
sites NNS O
within IN O
the DT O
DRA NNP B-Gene
promoter NN I-Gene
, , O
including VBG O
the DT O
Oct NNP B-Gene
- : I-Gene
2A CD I-Gene
binding NN I-Gene
site NN I-Gene
. . O

We PRP O
conclude VBP O
that IN O
distinct JJ O
sets NNS O
of IN O
transcription NN B-Gene
factors NNS I-Gene
are VBP O
involved VBN O
in IN O
the DT O
two CD O
modes NNS O
of IN O
HLA NNP B-Gene
- : I-Gene
DRA NNP I-Gene
expression NN O
, , O
and CC O
that IN O
HMG NNP B-Gene
I PRP I-Gene
/ VBP I-Gene
Y NNP I-Gene
may MD O
be VB O
important JJ O
for IN O
B NNP O
cell NN O
- : O
specific JJ O
expression NN O
, , O
and CC O
is VBZ O
essential JJ O
for IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
induction NN O
. . O

In IN O
lymphoblastoid NN O
cell NN O
lines NNS O
, , O
six CD O
EBV NNP B-Gene
- : I-Gene
encoded VBD I-Gene
nuclear JJ I-Gene
antigens NNS I-Gene
( ( O
EBNA1 NNP B-Gene
, , I-Gene
2 CD I-Gene
, , I-Gene
3A CD I-Gene
, , I-Gene
3B CD I-Gene
, , I-Gene
3C CD I-Gene
, , I-Gene
- : I-Gene
LP NN I-Gene
) ) O
, , O
three CD O
latent NN B-Gene
membrane NN I-Gene
proteins NNS I-Gene
( ( O
LMP1 NNP B-Gene
, , O
2A CD B-Gene
, , O
2B CD B-Gene
) ) O
, , O
and CC O
two CD O
nuclear JJ B-Gene
RNAs NNP I-Gene
( ( O
EBERs NNP B-Gene
) ) O
are VBP O
expressed VBN O
. . O

In IN O
EBV NNP O
- : O
positive JJ O
cases NNS O
of IN O
Hodgkin NNP O
' POS O
s NN O
disease NN O
, , O
the DT O
EBERs NNP B-Gene
, , O
EBNA1 NNP B-Gene
, , O
and CC O
the DT O
LMPs NNP B-Gene
are VBP O
expressed VBN O
( ( O
latency NN O
II NNP O
) ) O
, , O
whereas RB O
in IN O
Burkitt NNP O
' POS O
s NN O
lymphoma NN O
( ( O
BL NNP O
) ) O
only RB O
the DT O
EBERs NNP B-Gene
and CC O
EBNA1 NNP B-Gene
have VBP O
been VBN O
detected VBN O
( ( O
latency NN O
I PRP O
) ) O
. . O

Expression NN O
of IN O
LMP1 NNP B-Gene
was VBD O
seen VBN O
in IN O
variable JJ O
proportions NNS O
of IN O
tumor NN O
cells NNS O
in IN O
two CD O
cases NNS O
and CC O
EBNA2 NNP B-Gene
was VBD O
detected VBN O
in IN O
some DT O
tumor NN O
cells NNS O
in IN O
three CD O
other JJ O
cases NNS O
. . O

Also RB O
, , O
the DT O
BZLF1 NNP B-Gene
trans VBZ I-Gene
- : I-Gene
activator NN I-Gene
protein NN I-Gene
was VBD O
expressed VBN O
in IN O
a DT O
few JJ O
tumor NN O
cells NNS O
in IN O
6 CD O
cases NNS O
, , O
indicating VBG O
entry NN O
into IN O
the DT O
lytic JJ O
cycle NN O
. . O

A DT O
phenotypic NN O
drift NN O
from IN O
latency NN O
I PRP O
to TO O
latency VB O
III NNP O
has VBZ O
been VBN O
observed VBN O
previously RB O
in IN O
some DT O
BL NNP O
cell NN O
lines NNS O
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
a DT O
similar JJ O
phenomenon NN O
may MD O
occur VB O
in IN O
BL NNP O
in IN O
vivo NN O
and CC O
indicate NN O
that IN O
the DT O
operational JJ O
definition NN O
of IN O
EBV NNP O
latencies NNS O
is VBZ O
not RB O
easily RB O
applied VBN O
to TO O
human JJ O
tumors NNS O
. . O

Eosinophils NNS O
were VBD O
purified VBN O
from IN O
peripheral JJ O
blood NN O
by IN O
discontinuous JJ O
Percoll NNP O
gradients NNS O
and CC O
stimulated VBN O
with IN O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
. . O

Immunosuppression NN O
has VBZ O
been VBN O
often RB O
associated VBN O
with IN O
the DT O
course NN O
of IN O
malignant JJ O
diseases NNS O
. . O

Whereas NNP O
PHA NNP B-Gene
- : O
induced JJ O
proliferation NN O
of IN O
PBMCs NNP O
derived VBD O
from IN O
patients NNS O
with IN O
breast JJ O
cancer NN O
preoperatively RB O
was VBD O
significantly RB O
decreased VBN O
when WRB O
compared VBN O
with IN O
data NNS O
obtained VBN O
in IN O
healthy JJ O
control NN O
individuals NNS O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
, , O
the DT O
degree NN O
of IN O
the DT O
defect NN O
in IN O
PHA NNP B-Gene
- : O
induced JJ O
proliferation NN O
of IN O
PBMCs NNP O
depended VBD O
upon IN O
the DT O
tumour JJ O
burden NN O
as IN O
manifested VBN O
by IN O
tumour JJ O
size NN O
and CC O
axillary JJ O
lymph NN O
node JJ O
involvement NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
3 CD O
in IN O
each DT O
case NN O
) ) O
. . O

PHA NNP B-Gene
- : O
induced JJ O
proliferation NN O
of IN O
PBMCs NNP O
dropped VBD O
significantly RB O
in IN O
patients NNS O
who WP O
received VBD O
adjuvant JJ O
chemotherapy NN O
consisting NN O
of IN O
cyclophosphamide NN O
, , O
methotrexate NN O
and CC O
fluorouracil NN O
( ( O
CMF NNP O
) ) O
after IN O
an DT O
observation NN O
period NN O
of IN O
6 CD O
months NNS O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
, , O
but CC O
not RB O
in IN O
patients NNS O
under IN O
adjuvant JJ O
treatment NN O
with IN O
tamoxifen NN O
only RB O
. . O

We PRP O
thus RB O
conclude VBP O
that IN O
PHA NNP B-Gene
- : O
induced JJ O
proliferation NN O
of IN O
PBMCs NNP O
derived VBD O
from IN O
patients NNS O
with IN O
breast JJ O
cancer NN O
depends VBZ O
upon IN O
the DT O
tumour NN O
load NN O
and CC O
is VBZ O
a DT O
good JJ O
clinical JJ O
predictor NN O
for IN O
the DT O
further JJ O
course NN O
of IN O
the DT O
disease NN O
. . O

A DT O
previously RB O
unrecognized JJ O
element NN O
, , O
located VBN O
downstream NN O
of IN O
the DT O
start NN B-Gene
site NN I-Gene
of IN I-Gene
transcription NN I-Gene
in IN O
the DT O
first JJ O
exon NN B-Gene
of IN O
the DT O
DR NNP B-Gene
alpha NN I-Gene
gene NN I-Gene
, , O
has VBZ O
been VBN O
defined VBN O
that IN O
enhances VBZ O
promoter NN O
activity NN O
up RB O
to TO O
eightfold VB O
in IN O
a DT O
position NN O
- : O
dependent JJ O
manner NN O
. . O

The DT O
nuclear JJ O
factor NN O
binds NNS O
to TO O
the DT O
DR NNP B-Gene
alpha NN I-Gene
and CC I-Gene
DP NNP I-Gene
alpha VBP I-Gene
element NN I-Gene
but CC O
not RB O
to TO O
the DT O
element NN O
in IN O
the DT O
DQ NNP B-Gene
alpha NN I-Gene
gene NN I-Gene
. . O

One CD O
of IN O
the DT O
genes NNS O
that WDT O
encodes VBZ O
a DT O
CBF NNP B-Gene
alpha NN I-Gene
subunit NN I-Gene
is VBZ O
AML1 NNP B-Gene
, , O
also RB O
called VBD O
Cbf NNP B-Gene
alpha VBD I-Gene
2 CD I-Gene
. . O

Three CD O
different JJ O
isoforms NNS O
of IN O
CBF NNP B-Gene
beta NN I-Gene
were VBD O
also RB O
tested VBN O
for IN O
transcriptional JJ O
activity NN O
on IN O
the DT O
SL3 NNP B-Gene
enhancer NN I-Gene
. . O

These DT O
results NNS O
indicated VBD O
that IN O
at IN O
least JJS O
in IN O
certain JJ O
cell NN O
types NNS O
, , O
the DT O
maximum JJ O
activity NN O
of IN O
CBF NNP B-Gene
required VBD O
both DT O
subunits NNS O
. . O

We PRP O
also RB O
examined VBD O
whether IN O
CBF NNP B-Gene
could MD O
distinguish VB O
a DT O
1 CD O
- : O
bp NN O
difference NN O
between IN O
the DT O
enhancer NN O
core NN O
of IN O
SL3 NNP O
and CC O
the DT O
core NN O
of IN O
the DT O
nonleukemogenic JJ O
virus NN O
, , O
Akv NNP O
. . O

However RB O
, , O
no DT O
combination NN O
of IN O
CBF NNP B-Gene
alpha NN I-Gene
and CC O
CBF NNP B-Gene
beta VBP I-Gene
subunits NNS O
that IN O
we PRP O
tested VBD O
was VBD O
able JJ O
to TO O
distinguish VB O
the DT O
1 CD O
- : O
bp NN O
difference NN O
in IN O
transcription NN O
assays NNS O
. . O

Using VBG O
electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
( ( O
EMSA NNP O
) ) O
, , O
we PRP O
now RB O
show VBP O
that IN O
, , O
in IN O
monocytes NNS O
stimulated VBN O
with IN O
LPS NNP O
or CC O
TNF NNP B-Gene
alpha NN I-Gene
, , O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
inhibits NNS O
nuclear JJ O
stimulation NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( O
NF NNP B-Gene
kappa NNP I-Gene
B NNP I-Gene
) ) O
, , O
a DT O
transcription NN B-Gene
factor NN I-Gene
involved VBN O
in IN O
the DT O
expression NN O
of IN O
inflammatory JJ B-Gene
cytokine NN I-Gene
genes NNS I-Gene
. . O
Several JJ O
other JJ O
transcription NN B-Gene
factors NNS I-Gene
including VBG O
NF NNP O
- : O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
, , O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
GR NNP B-Gene
, , O
CREB NNP B-Gene
, , O
Oct NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
Sp NNP B-Gene
- : I-Gene
1 CD I-Gene
are VBP O
not RB O
affected VBN O
by IN O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
. . O

Furthermore RB O
, , O
compounds NNS O
such JJ O
as IN O
tosylphenylalanyl JJ O
chloromethyl NN O
ketone NN O
and CC O
pyrrolidinedithiocar NN O
that WDT O
are VBP O
known VBN O
to TO O
selectively RB O
inhibit VB O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
block NN O
cytokine NN O
gene NN O
transcription NN O
in IN O
LPS NNP O
- : O
stimulated VBN O
monocytes NNS O
. . O

Taken VBN O
together RB O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
inhibition NN O
of IN O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
may MD O
be VB O
an DT O
important JJ O
mechanism NN O
for IN O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
suppression NN O
of IN O
cytokine JJ O
gene NN O
transcription NN O
in IN O
human JJ O
monocytes NNS O
. . O

In IN O
addition NN O
, , O
this DT O
TR2RE NNP B-Gene
- : I-Gene
SV40 NN I-Gene
can MD O
function VB O
as IN O
a DT O
repressor NN O
to TO O
suppress VB O
the DT O
transcriptional JJ O
activities NNS O
of IN O
both DT O
SV40 NNP B-Gene
early RB I-Gene
and CC I-Gene
late JJ I-Gene
promoters NNS I-Gene
. . O

We PRP O
have VBP O
analyzed VBN O
CBF NNP B-Gene
beta SYM I-Gene
- : I-Gene
MYH11 NNP I-Gene
fusion NN I-Gene
transcripts NNS I-Gene
by IN O
RT NNP O
- : O
PCR NN O
in IN O
myelomonocytic JJ O
leukemias NNS O
, , O
with IN O
or CC O
without IN O
eosinophilia NNS O
, , O
to TO O
determine VB O
whether IN O
their PRP$ O
presence NN O
correlates NNS O
with IN O
morphology NN O
. . O

Fifty NNP O
- : O
three CD O
cases NNS O
( ( O
11 CD O
AML NNP O
M4Eo NNP O
; : O
1 CD O
AML NNP O
M4 NNP O
with IN O
atypical JJ O
abnormal NN O
eosinophils NNS O
( ( O
AML NNP O
M4 NNP O
` `` O
` `` O
Eo NN O
' '' O
' POS O
) ) O
; : O
29 CD O
AML NNP O
M4 NNP O
; : O
8 CD O
AML NNP O
M5 NNP O
; : O
3 CD O
CMML NNP O
; : O
and CC O
1 CD O
AML NNP O
M2 NNP O
with IN O
eosinophilia NN O
) ) O
were VBD O
analyzed VBN O
. . O

Both DT O
cases NNS O
tested VBN O
also RB O
showed VBD O
MYH11 NNP B-Gene
genomic JJ O
rearrangement NN O
. . O

Follow NNP O
- : O
up NN O
of IN O
three CD O
patient NN O
showed VBD O
residual JJ O
positivity NN O
in IN O
apparent JJ O
complete JJ O
remission NN O
. . O

HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
Tat NNP I-Gene
potentiates NNS O
TNF NNP B-Gene
- : O
induced VBD O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
and CC O
cytotoxicity NN O
by IN O
altering VBG O
the DT O
cellular JJ O
redox NN O
state NN O
. . O

In IN O
HeLa NNP O
cells NNS O
stably RB O
transfected VBD O
with IN O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
tat JJ I-Gene
gene NN I-Gene
( ( O
HeLa NNP O
- : O
tat NN O
cells NNS O
) ) O
, , O
expression NN O
of IN O
the DT O
Tat NNP B-Gene
protein NN I-Gene
enhanced VBD O
both DT O
TNF NNP B-Gene
- : O
induced JJ O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
TNF NNP B-Gene
- : O
mediated VBN O
cytotoxicity NN O
. . O

Thus RB O
, , O
Mn NNP B-Gene
- : I-Gene
SOD NNP I-Gene
RNA NNP O
protein NN O
levels NNS O
and CC O
activity NN O
were VBD O
markedly RB O
reduced VBN O
in IN O
the DT O
presence NN O
of IN O
Tat NNP B-Gene
. . O

The DT O
use NN O
of IN O
glucocorticoids NNS O
in IN O
acute JJ O
lymphoblastic JJ O
leukemia NN O
of IN O
childhood NN O
. . O

Glucocorticoids NNS O
have VBP O
been VBN O
included VBN O
in IN O
almost RB O
all DT O
treatment NN O
regimens NNS O
for IN O
childhood NN O
acute NN O
lymphoblastic JJ O
leukemia NN O
for IN O
decades NNS O
. . O

New NNP O
data NNS O
on IN O
the DT O
pharmacokinetics NNS O
, , O
pharmacodynamics NNS O
, , O
and CC O
molecular JJ O
mechanisms NNS O
of IN O
action NN O
of IN O
glucocorticoids NNS O
have VBP O
suggested VBN O
alternative JJ O
approaches NNS O
in IN O
ALL NNP O
. . O

Blast NNP O
sensitivity NN O
to TO O
glucocorticoids VB O
correlates NNS O
closely RB O
with IN O
sensitivity NN O
to TO O
other JJ O
, , O
putatively RB O
non JJ O
- : O
cross NN O
- : O
resisting NN O
agents NNS O
and CC O
with IN O
outcome NN O
after IN O
multi SYM O
- : O
agent NN O
therapy NN O
, , O
suggesting VBG O
overlapping VBG O
mechanisms NNS O
of IN O
action NN O
, , O
and CC O
focusing VBG O
attention NN O
on IN O
the DT O
determinants NNS O
of IN O
the DT O
threshold NN O
for IN O
apoptosis NN O
. . O

Expression NN O
of IN O
the DT O
Epstein NNP B-Gene
- : I-Gene
Barr NNP I-Gene
virus NN I-Gene
( ( I-Gene
EBV NNP I-Gene
) ) I-Gene
latent NN I-Gene
membrane NN I-Gene
protein NN I-Gene
1 CD I-Gene
( ( I-Gene
LMP NNP I-Gene
- : I-Gene
1 CD I-Gene
) ) I-Gene
oncogene NN I-Gene
is VBZ O
regulated VBN O
by IN O
the DT O
EBV NNP B-Gene
nuclear JJ I-Gene
protein NN I-Gene
2 CD I-Gene
( ( I-Gene
EBNA NNP I-Gene
- : I-Gene
2 CD I-Gene
) ) I-Gene
transactivator NN I-Gene
. . O

EBNA NNP B-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
known VBN O
to TO O
interact VB O
with IN O
the DT O
cellular JJ B-Gene
DNA NNP I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
J NNP B-Gene
kappa NN I-Gene
and CC O
is VBZ O
recruited VBN O
to TO O
promoters NNS B-Gene
containing VBG O
the DT O
GTGGGAA NNP O
J NNP B-Gene
kappa POS I-Gene
recognition NN I-Gene
sequence NN I-Gene
. . O

The DT O
minimal JJ B-Gene
EBNA NNP I-Gene
- : I-Gene
2 CD I-Gene
- : I-Gene
responsive NN I-Gene
LMP NNP I-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
includes VBZ O
one CD O
J NNP B-Gene
kappa SYM I-Gene
- : I-Gene
binding NN I-Gene
site NN I-Gene
, , O
and CC O
we PRP O
now RB O
show VBP O
that IN O
mutation NN O
of IN O
that DT O
site NN O
, , O
such JJ O
that IN O
J NNP B-Gene
kappa VBD I-Gene
can MD O
not RB O
bind VB O
, , O
reduces NNS O
EBNA NNP B-Gene
- : I-Gene
2 CD I-Gene
responsiveness NN O
by IN O
60 CD O
% NN O
. . O

To TO O
identify VB O
other JJ O
factors NNS O
which WDT O
interact VBP O
with IN O
the DT O
LMP NNP B-Gene
- : I-Gene
1 CD I-Gene
EBNA NNP I-Gene
- : I-Gene
2 CD I-Gene
response NN I-Gene
element NN I-Gene
( ( O
E2RE NNP B-Gene
) ) O
, , O
a DT O
- : B-Gene
236 CD I-Gene
/ SYM I-Gene
- : I-Gene
145 CD I-Gene
minimal JJ I-Gene
E2RE NNP I-Gene
was VBD O
used VBN O
as IN O
a DT O
probe NN O
in IN O
an DT O
electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
. . O

LBF4 NNP B-Gene
is VBZ O
B NNP O
- : O
and CC O
T NNP O
- : O
cell NN O
specific JJ O
and CC O
recognizes VBZ O
the DT O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
GGAA NNP I-Gene
core NN I-Gene
sequence NN I-Gene
as IN O
shown VBN O
by IN O
methylation NN O
interference NN O
. . O

The DT O
efficacy NN O
of IN O
serotonin JJ O
reuptake NN O
inhibitors NNS O
( ( O
SRIs NNP O
) ) O
is VBZ O
uncertain JJ O
, , O
and CC O
response NN O
predictors NNS O
are VBP O
unavailable JJ O
. . O

Abnormal NNP O
fast JJ O
feedback NN O
and CC O
negative JJ O
feedback NN O
of IN O
the DT O
hypothalamic JJ O
- : O
pituitary JJ O
- : O
adrenal JJ O
axis NN O
implicates VBZ O
a DT O
dampened JJ O
limbic JJ B-Gene
- : I-Gene
hippocampal JJ I-Gene
glucocorticoid NN I-Gene
type NN I-Gene
II NNP I-Gene
receptor NN I-Gene
( ( O
GCII NNP B-Gene
) ) O
. . O

We PRP O
hypothesized VBD O
that IN O
lymphocyte NN B-Gene
GCII NNP I-Gene
is VBZ O
altered VBN O
in IN O
adolescent JJ O
MDD NNP O
and CC O
could MD O
serve VB O
as IN O
a DT O
marker NN O
for IN O
response NN O
to TO O
SRIs NNP O
. . O

The DT O
role NN O
of IN O
NFATp NNP B-Gene
in IN O
cyclosporin NN B-Gene
A NNP I-Gene
- : I-Gene
sensitive JJ I-Gene
tumor NN I-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
gene NN I-Gene
transcription NN O
. . O

Thus RB O
, , O
although IN O
the DT O
kappa NN B-Gene
3 CD I-Gene
element NN I-Gene
has VBZ O
little JJ O
sequence NN O
similarity NN O
to TO O
other JJ O
NFATp NNP B-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
, , O
it PRP O
appears VBZ O
to TO O
function VB O
as IN O
a DT O
cyclosporin NN B-Gene
- : I-Gene
sensitive JJ I-Gene
promoter NN I-Gene
element NN I-Gene
in IN O
T NNP O
cells NNS O
by IN O
virtue NN O
of IN O
its PRP$ O
ability NN O
to TO O
bind VB O
NFATp NNP B-Gene
. . O

By IN O
contrast NN O
, , O
three CD O
lymphoblastoid NN O
cell NN O
lines NNS O
( ( O
immortalized VBN O
in IN O
vitro NN O
with IN O
Epstein NNP O
- : O
Barr NNP O
virus NN O
) ) O
were VBD O
weakly JJ O
positive JJ O
and CC O
MNDA NNP B-Gene
was VBD O
up RP O
- : O
regulated VBN O
by IN O
interferon NN B-Gene
- : I-Gene
alpha NN I-Gene
( ( O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
treatment NN O
. . O

The DT O
results NNS O
varied VBD O
with IN O
the DT O
agent NN O
, , O
cell NN O
type NN O
, , O
and CC O
stage NN O
of IN O
differentiation NN O
. . O

Changes NNS O
in IN O
MNDA NNP B-Gene
expression NN O
occurred VBD O
slowly RB O
( ( O
hours NNS O
to TO O
days NNS O
) ) O
, , O
suggesting VBG O
that IN O
MNDA NNP B-Gene
could MD O
mediate VB O
changes NNS O
realized VBN O
over IN O
a DT O
long JJ O
period NN O
. . O

EBNA NNP B-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
able JJ O
to TO O
trans VB O
- : O
activate VB O
the DT O
expression NN O
of IN O
the DT O
LMP NNP B-Gene
gene NN I-Gene
in IN O
several JJ O
cell NN O
lines NNS O
. . O

Various JJ O
reports NNS O
have VBP O
delineated VBN O
the DT O
cis NN B-Gene
- : I-Gene
acting JJ I-Gene
elements NNS I-Gene
of IN O
the DT O
LMP NNP B-Gene
promoter NN I-Gene
through IN O
which WDT O
EBNA NNP B-Gene
- : I-Gene
2 CD I-Gene
mediates NNS O
trans NNS O
- : O
activation NN O
. . O

These DT O
complexes NNS O
were VBD O
destroyed VBN O
by IN O
detergent NN O
. . O

Enhanced NNP O
Ig NNP B-Gene
synthesis NN O
is VBZ O
a DT O
result NN O
of IN O
coordinated JJ O
transcriptional JJ O
activation NN O
of IN O
Ig NNP B-Gene
genes NNS I-Gene
without IN O
promoter NN O
or CC O
isotype JJ O
specificity NN O
, , O
and CC O
differential JJ O
accumulation NN O
of IN O
the DT O
mRNA NN B-Gene
encoding VBG O
the DT O
secreted JJ O
form NN O
of IN O
Ig NNP B-Gene
heavy JJ I-Gene
chain NN I-Gene
. . O

It PRP O
is VBZ O
saturable JJ O
and CC O
subject JJ O
to TO O
negative JJ O
control NN O
when WRB O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
stimulation NN O
is VBZ O
prolonged VBN O
. . O

Thus RB O
, , O
differentiation NN O
of IN O
B NNP O
cells NNS O
with IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
in IN O
vitro NN O
recapitulates VBZ O
the DT O
hallmarks NNS O
of IN O
terminal JJ O
B NNP O
differentiation NN O
in IN O
vivo NN O
; : O
Oct NNP B-Gene
- : I-Gene
2 CD I-Gene
may MD O
have VB O
a DT O
role NN O
in IN O
this DT O
process NN O
. . O

We PRP O
have VBP O
previously RB O
shown VBN O
that IN O
treatment NN O
of IN O
Jurkat NNP O
T NNP O
cells NNS O
with IN O
phytohemaglutinin NN B-Gene
( ( O
PHA NNP B-Gene
) ) O
and CC O
the DT O
phorbol NN O
ester NN O
, , O
PMA NNP O
, , O
activated VBD O
transcription NN O
initiation NN O
from IN O
the DT O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
gene NN I-Gene
. . O

We PRP O
also RB O
examined VBD O
the DT O
function NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
CK NNP I-Gene
- : I-Gene
1 CD I-Gene
/ NN I-Gene
CK NNP I-Gene
- : I-Gene
2 CD I-Gene
elements NNS I-Gene
that WDT O
are VBP O
present JJ O
in IN O
many JJ O
cytokine NN B-Gene
genes NNS I-Gene
and CC O
found VBD O
that IN O
they PRP O
acted VBD O
as IN O
a DT O
repressor NN O
of IN O
basal JJ O
level NN O
expression NN O
when WRB O
cloned VBN O
upstream NN O
of IN O
a DT O
heterologous JJ B-Gene
promoter NN I-Gene
but CC O
were VBD O
also RB O
inducible JJ O
by IN O
PMA NNP O
/ NNP B-Gene
PHA NNP I-Gene
. . O

Glucocorticoids NNS O
have VBP O
an DT O
inhibitory JJ O
effect NN O
on IN O
inflammatory NN O
and CC O
immune JJ O
responses NNS O
, , O
and CC O
this DT O
may MD O
be VB O
through IN O
the DT O
modulation NN O
of IN O
transcription NN B-Gene
factor NN I-Gene
binding VBG O
to TO O
DNA NNP O
. . O

TNF NNP O
- : O
alpha NN O
, , O
IL NNP O
- : O
1 CD O
beta NN O
and CC O
phorbol NN O
myristate NN O
acetate NN O
( ( O
PMA NNP O
) ) O
treatment NN O
increased VBD O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
NF NNP O
kappa NN O
B NNP O
DNA NNP O
binding NN O
by IN O
up IN O
to TO O
200 CD O
% NN O
but CC O
decreased JJ O
CREB NNP B-Gene
binding NN O
( ( O
38 CD O
% NN O
) ) O
over IN O
a DT O
60 CD O
- : O
min NN O
time NN O
course NN O
. . O

This DT O
may MD O
be VB O
an DT O
important JJ O
molecular JJ O
site NN O
of IN O
steroid JJ O
action NN O
. . O

During IN O
the DT O
induction NN O
of IN O
anergy NN O
, , O
T NNP O
cells NNS O
are VBP O
phenotypically RB O
similar JJ O
to TO O
cells NNS O
responding VBG O
to TO O
an DT O
immunogenic JJ O
stimulus NN O
. . O

When WRB O
restimulated VBN O
, , O
however RB O
, , O
anergic JJ O
T NNP O
cells NNS O
fail VBP O
to TO O
up RP O
- : O
regulate NN O
transcription NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
and CC O
in IN O
consequence NN O
do VBP O
not RB O
produce VB O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

The DT O
effect NN O
of IN O
BDP NNP O
was VBD O
greatly RB O
dependent JJ O
on IN O
the DT O
presence NN O
of IN O
Zn NNP O
+ NNP O
+ NNP O
ions NNS O
in IN O
the DT O
preparation NN O
, , O
since IN O
the DT O
augmenting VBG O
effect NN O
was VBD O
abolished VBN O
if IN O
BDP NNP O
did VBD O
not RB O
contain VB O
zinc NN O
. . O

The DT O
receptor NN O
concentration NN O
, , O
as IN O
measured VBN O
by IN O
staining VBG O
and CC O
steroid JJ O
binding NN O
test NN O
, , O
varied VBN O
considerably RB O
but CC O
showed VBD O
no DT O
clear JJ O
correlation NN O
to TO O
clinical JJ O
response NN O
. . O

Using VBG O
a DT O
highly RB O
sensitive JJ O
mutation NN O
screening VBG O
assay NN O
of IN O
the DT O
DNA NNP B-Gene
- : I-Gene
and CC I-Gene
the DT I-Gene
steroid JJ I-Gene
- : I-Gene
binding NN I-Gene
region NN I-Gene
, , O
none NN O
of IN O
the DT O
treated JJ O
patients NNS O
revealed VBD O
any DT O
mutation NN O
, , O
suggesting VBG O
that IN O
the DT O
glucocorticoid JJ B-Gene
receptor NN I-Gene
in IN O
the DT O
CLL NNP O
patients NNS O
tested VBD O
is VBZ O
not RB O
altered VBN O
in IN O
these DT O
domains NNS O
. . O

Expression NN O
of IN O
the DT O
kappa NNP O
immunoglobulin NN O
light NN O
chain NN O
gene NN O
requires VBZ O
developmental JJ O
- : O
and CC O
tissue VB O
- : O
specific JJ O
regulation NN O
by IN O
trans NNS B-Gene
- : I-Gene
acting VBG I-Gene
factors NNS I-Gene
which WDT O
interact VBP O
with IN O
two CD O
distinct JJ O
enhancer NN B-Gene
elements NNS I-Gene
. . O

Methylation NNP O
studies NNS O
indicated VBD O
that IN O
the DT O
tal JJ B-Gene
- : I-Gene
15 CD I-Gene
' '' I-Gene
GC NNP I-Gene
- : I-Gene
rich JJ I-Gene
region NN I-Gene
behaves NNS O
like IN O
a DT O
CpG NNP B-Gene
island NN I-Gene
, , O
hypomethylated VBN O
in IN O
normal JJ O
cells NNS O
, , O
and CC O
methylated VBD O
de FW O
novo FW O
on IN O
transcriptionally RB B-Gene
inactive JJ I-Gene
alleles NNS I-Gene
in IN O
established VBN O
cell NN O
lines NNS O
. . O

M NNP O
- : O
TAT NN O
is VBZ O
a DT O
cytokine JJ O
- : O
dependent NN O
cell NN O
line NN O
with IN O
the DT O
potential JJ O
to TO O
differentiate VB O
along IN O
the DT O
erythroid NN O
and CC O
megakaryocytic JJ O
lineages NNS O
. . O

In IN O
contrast NN O
, , O
the DT O
addition NN O
of IN O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
to TO O
the DT O
M NNP O
- : O
TAT NNP O
/ NNP O
EPO NNP O
cell NN O
culture NN O
decreased VBD O
the DT O
amount NN O
of IN O
hemoglobin NN O
, , O
even RB O
in IN O
the DT O
presence NN O
of IN O
EPO NNP B-Gene
, , O
indicating VBG O
that IN O
the DT O
EPO NNP B-Gene
signal NN O
for IN O
erythroid JJ O
differentiation NN O
is VBZ O
suppressed VBN O
by IN O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
. . O

Transient NNP O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
assay VB O
revealed VBD O
that IN O
the DT O
region NN O
containing VBG O
E2F NNP B-Gene
binding VBG I-Gene
site NN I-Gene
had VBD O
a DT O
strong JJ O
promoter NN O
activity NN O
, , O
and CC O
introduction NN O
of IN O
the DT O
mutation NN O
at IN O
the DT O
E2F NNP B-Gene
binding NN I-Gene
site NN I-Gene
resulted VBD O
in IN O
a DT O
significant JJ O
loss NN O
of IN O
the DT O
activity NN O
. . O

E2F NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC I-Gene
DP NNP I-Gene
- : I-Gene
1 CD I-Gene
mRNAs NNS I-Gene
were VBD O
not RB O
detectable JJ O
in IN O
granulocytes NNS O
, , O
monocytes NNS O
and CC O
resting VBG O
T NNP O
- : O
lymphocytes NNS O
but CC O
were VBD O
induced VBN O
after IN O
the DT O
mitogenic JJ O
stimulation NN O
of IN O
T NNP O
- : O
lymphocytes NNS O
. . O

Association NNP O
of IN O
alterations NNS O
in IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
moieties NNS I-Gene
with IN O
HIV NNP O
type NN O
1 CD O
proviral JJ O
latency NN O
in IN O
certain JJ O
monocytic JJ O
cells NNS O
. . O

Human NNP O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
replication NN O
is VBZ O
controlled VBN O
by IN O
a DT O
complex JJ O
array NN O
of IN O
virally RB B-Gene
encoded VBN I-Gene
and CC I-Gene
cellular JJ I-Gene
proteins NNS I-Gene
. . O

The DT O
NFATd NNP B-Gene
element NN I-Gene
, , O
which WDT O
binds VBZ O
the DT O
transcription NN B-Gene
factor NN I-Gene
NFAT NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
is VBZ O
very RB O
active JJ O
in IN O
T NNP O
cells NNS O
, , O
is VBZ O
only RB O
weakly JJ O
active JJ O
in IN O
one CD O
B NNP O
clone NN O
and CC O
not RB O
at IN O
all DT O
in IN O
another DT O
. . O

This DT O
parallels VBZ O
the DT O
increased VBN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
synthesis NN O
secondary JJ O
to TO O
increased VBN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
gene NN O
transcription NN O
, , O
i NN O
. . O
e NN O
. . O
, , O
increased VBD O
RNA NNP O
and CC O
transcriptional JJ O
activity NN O
of IN O
its PRP$ O
promoter NN O
- : O
enhancer NN O
. . O

Transcriptional JJ O
activity NN O
of IN O
p105 NN B-Gene
is VBZ O
also RB O
increased VBN O
in IN O
infected JJ O
cells NNS O
and CC O
is VBZ O
also RB O
mediated VBN O
by IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
through IN O
a DT O
specific JJ O
kappa NN B-Gene
B NNP I-Gene
motif NN I-Gene
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
show VBP O
that IN O
an DT O
activation NN B-Gene
- : I-Gene
deficient NN I-Gene
glucocorticoid NN I-Gene
receptor NN I-Gene
mutant NN I-Gene
is VBZ O
as RB O
effective JJ O
as IN O
the DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
receptor NN I-Gene
in IN O
repression NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
activity NN O
, , O
inhibition NN O
of IN O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
production NN O
, , O
inhibition NN O
of IN O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
expression NN O
and CC O
induction NN O
of IN O
apoptosis NN O
. . O

HIV NNP O
type NN O
1 CD O
protease NN B-Gene
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
within IN O
T NNP O
lymphoid JJ O
cells NNS O
. . O

It PRP O
has VBZ O
been VBN O
reported VBN O
that IN O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
protease NN I-Gene
may MD O
cleave VB O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
precursor NN O
to TO O
its PRP$ O
active JJ O
form NN O
in IN O
vitro NN O
. . O

Insertion NN O
of IN O
this DT O
chimeric JJ B-Gene
promoter NN I-Gene
( ( O
ISG15 NNP B-Gene
LTR NNP I-Gene
) ) O
upstream NN O
of IN O
the DT O
human JJ B-Gene
IFNA2 NNP I-Gene
gene NN I-Gene
directed VBD O
high JJ O
levels NNS O
of IN O
IFN NNP B-Gene
synthesis NN O
in IN O
Tat NNP O
- : O
expressing VBG O
cells NNS O
, , O
while IN O
this DT O
promoter NN O
was VBD O
not RB O
responsive JJ O
to TO O
tumor VB B-Gene
necrosis JJ I-Gene
factor NN I-Gene
alpha SYM I-Gene
- : O
mediated VBN O
activation NN O
. . O

Selected VBN O
transfected JJ O
clones NNS O
produced VBD O
low JJ O
levels NNS O
of IN O
IFN NNP B-Gene
A NNP I-Gene
( ( O
IFNA NNP B-Gene
) ) O
constitutively RB O
, , O
and CC O
their PRP$ O
abilities NNS O
to TO O
express VB O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
and CC O
interleukin VB B-Gene
- : I-Gene
2 CD I-Gene
receptor NN I-Gene
upon IN O
stimulation NN O
with IN O
phytohemagglutinin NN B-Gene
and CC O
phorbol NN O
myristate NN O
acetate NN O
were VBD O
retained VBN O
. . O

Flow NNP O
cytometric NN O
analysis NN O
also RB O
showed VBD O
that IN O
at IN O
72 CD O
h NN O
of IN O
virus NN O
exposure NN O
fewer JJR O
T NNP O
cells NNS O
from IN O
the DT O
elderly JJ O
produced VBN O
interferon NN B-Gene
- : I-Gene
gamma NN I-Gene
( ( O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
) ) O
, , O
suggesting VBG O
a DT O
link NN O
between IN O
the DT O
magnitude NN O
of IN O
the DT O
Fos NNP B-Gene
and CC O
Jun NNP B-Gene
and CC O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
responses NNS O
. . O

The DT O
regulation NN O
of IN O
HIV NNP O
by IN O
retinoic NN O
acid NN O
correlates VBZ O
with IN O
cellular JJ O
expression NN O
of IN O
the DT O
retinoic NN B-Gene
acid NN I-Gene
receptors NNS I-Gene
. . O

Even RB O
a DT O
moderate JJ O
increase NN O
in IN O
the DT O
cellular JJ O
cysteine NN O
supply NN O
elevates VBZ O
the DT O
intracellular JJ O
glutathione NN O
( ( O
GSH NNP O
) ) O
and CC O
glutathione JJ O
disulfide NN O
( ( O
GSSG NNP O
) ) O
levels NNS O
and CC O
potentiates VBZ O
immunological JJ O
functions NNS O
of IN O
lymphocytes NNS O
in IN O
vitro NN O
. . O

As IN O
signal JJ O
transduction NN O
is VBZ O
facilitated VBN O
by IN O
prooxidant JJ O
conditions NNS O
, , O
we PRP O
propose VBP O
that IN O
the DT O
well RB O
- : O
known VBN O
immunological JJ O
consequences NNS O
of IN O
GSH NNP O
depletion NN O
ultimately RB O
may MD O
be VB O
results NNS O
of IN O
the DT O
accompanying VBG O
GSSG NNP O
deficiency NN O
. . O

The DT O
second JJ O
abnormality NN O
in IN O
kappa NN O
B NNP O
- : O
binding NN O
activity NN O
in IN O
T NNP O
cells NNS O
from IN O
these DT O
patients NNS O
is VBZ O
that IN O
RelA NNP B-Gene
, , O
a DT O
member NN O
of IN O
the DT O
Rel NNP B-Gene
homology NN I-Gene
family NN I-Gene
which WDT O
is VBZ O
part NN O
of IN O
the DT O
normal JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
complex NN I-Gene
, , O
was VBD O
not RB O
induced VBN O
in IN O
the DT O
nucleus NN O
following VBG O
activation NN O
. . O

Cord NNP O
blood NN O
cultures NNS O
showed VBD O
an DT O
additive JJ O
combination NN O
of IN O
` `` O
` `` O
adult NN O
' '' O
' '' O
and CC O
` `` O
` `` O
fetal NN O
' '' O
' POS O
patterns NNS O
. . O

Our PRP$ O
studies NNS O
also RB O
demonstrate VBP O
that IN O
under IN O
anemic JJ O
stress NN O
, , O
recruitment NN O
of IN O
fetal JJ O
progenitors NNS O
may MD O
occur VB O
in IN O
adulthood NN O
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
data NNS O
suggest VBP O
that IN O
two CD O
interactive JJ O
mechanisms NNS O
regulate VBP O
monocytic JJ B-Gene
I PRP I-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
/ NNP I-Gene
MAD NNP I-Gene
- : I-Gene
3 CD I-Gene
mRNA NN I-Gene
levels NNS O
. . O

In IN O
extracts NNS O
from IN O
nonstimulated JJ O
cells NNS O
the DT O
receptor NN O
is VBZ O
recovered VBN O
in IN O
an DT O
inducible JJ O
cytoplasmic JJ O
form NN O
associated VBN O
with IN O
the DT O
90 CD B-Gene
- : I-Gene
kDa NN I-Gene
heat NN I-Gene
shock NN I-Gene
protein NN I-Gene
( ( O
hsp90 NN B-Gene
) ) O
, , O
a DT O
molecular JJ B-Gene
chaperone NN I-Gene
. . O

It PRP O
was VBD O
not RB O
possible JJ O
to TO O
reconstitute VB O
dioxin NN B-Gene
receptor NN I-Gene
function NN O
with IN O
proteins NNS O
expressed VBN O
in IN O
wheat NN O
germ JJ O
lysate NN O
. . O

In IN O
line NN O
with IN O
these DT O
observations NNS O
, , O
reticulocyte JJ O
lysate NN O
but CC O
not RB O
wheat JJ O
germ JJ O
lysate NN O
promoted VBD O
the DT O
association NN O
of IN O
de FW O
novo FW O
synthesized VBN O
dioxin NN B-Gene
receptor NN I-Gene
with IN O
hsp90 NN B-Gene
. . O

Induction NN O
of IN O
transcription NN B-Gene
factors NNS I-Gene
in IN O
human JJ O
T NNP O
lymphocytes NNS O
by IN O
aspirin JJ O
- : O
like IN O
drugs NNS O
. . O

Protein NNP B-Gene
kinase NNP I-Gene
C NNP I-Gene
is VBZ O
not RB O
a DT O
downstream NN O
effector NN O
of IN O
p21ras NNS B-Gene
in IN O
activated JJ O
T NNP O
cells NNS O
. . O

Data NNP O
is VBZ O
presented VBN O
, , O
using VBG O
the DT O
potent NN O
and CC O
selective JJ O
PKC NNP B-Gene
inhibitor NN O
Ro NNP O
31 CD O
- : O
8425 CD O
and CC O
transient JJ O
expression NN O
of IN O
a DT O
constitutively RB O
active JJ O
ras NNS O
mutant NN O
, , O
which WDT O
clearly RB O
shows VBZ O
that IN O
PKC NNP B-Gene
is VBZ O
not RB O
downstream NN O
of IN O
p21ras NNS B-Gene
in IN O
the DT O
induction NN O
of IN O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
transcriptional JJ O
activity NN O
and CC O
in IN O
the DT O
expression NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
in IN O
human JJ O
Jurkat NNP O
T NNP O
cells NNS O
. . O

The DT O
signaling NN O
pathways VBZ O
involving VBG O
PKC NNP B-Gene
activation NN O
, , O
calcium NN O
mobilization NN O
and CC O
ras VB B-Gene
activation NN O
combine NN O
to TO O
provide VB O
the DT O
necessary JJ O
components NNS O
for IN O
production NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
during IN O
T NNP O
cell NN O
activation NN O
. . O

Here RB O
, , O
we PRP O
report VBP O
that DT O
stimulation NN O
through IN O
the DT O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
induced JJ O
tyrosine NN O
phosphorylation NN O
and CC O
subsequent JJ O
nuclear JJ O
translocation NN O
of IN O
stat3 NN B-Gene
, , O
a DT O
newly RB O
identified VBN O
member NN O
of IN O
the DT O
signal JJ B-Gene
transducers NNS I-Gene
and CC I-Gene
activators NNS I-Gene
of IN I-Gene
transcription NN I-Gene
( ( I-Gene
STAT NNP I-Gene
) ) I-Gene
family NN I-Gene
of IN O
proteins NNS O
. . O

Apart RB O
from IN O
stat3 NN B-Gene
, , O
another DT O
cytoplasmic JJ B-Gene
protein NN I-Gene
was VBD O
tyrosine JJ O
phosphorylated VBN O
and CC O
subsequently RB O
translocated VBN O
to TO O
the DT O
nucleus NN O
in IN O
response NN O
to TO O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

This DT O
protein NN O
had VBD O
an DT O
apparent JJ O
molecular JJ O
mass NN O
of IN O
84 CD O
kDa NNS O
and CC O
was VBD O
not RB O
recognized VBN O
by IN O
stat3 NN B-Gene
or CC O
stat1 VB B-Gene
mAb NN I-Gene
or CC O
antisera NN O
. . O

Taken VBN O
together RB O
, , O
we PRP O
report VBP O
that IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
induces NNS O
tyrosine JJ O
phosphorylation NN O
and CC O
subsequent JJ O
nuclear JJ O
translocation NN O
of IN O
stat3 NN B-Gene
and CC O
an DT O
as IN O
yet RB O
undefined JJ O
84 CD B-Gene
- : I-Gene
kDa NN I-Gene
protein NN I-Gene
in IN O
antigen NN O
- : O
specific JJ O
human JJ O
T NNP O
cell NN O
lines NNS O
. . O

Human NNP O
T NNP O
- : O
cell NN O
leukemia NN O
virus NN O
type NN O
I PRP O
Tax NNP B-Gene
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
/ NNP I-Gene
Rel NNP I-Gene
involves VBZ O
phosphorylation NN O
and CC O
degradation NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
and CC O
RelA NNP B-Gene
( ( O
p65 NN B-Gene
) ) O
- : O
mediated VBN O
induction NN O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
rel NN I-Gene
gene NN I-Gene
. . O

The DT O
tax NN O
gene NN O
product NN O
of IN O
human JJ O
T NNP O
- : O
cell NN O
leukemia NN O
virus NN O
type NN O
I PRP O
( ( O
HTLV NNP O
- : O
I PRP O
) ) O
is VBZ O
a DT O
potent JJ O
transcriptional JJ B-Gene
activator NN I-Gene
that IN O
both DT O
stimulates VBZ O
viral JJ O
gene NN O
expression NN O
and CC O
activates VBZ O
an DT O
array NN O
of IN O
cellular JJ B-Gene
genes NNS I-Gene
involved VBN O
in IN O
T NNP O
- : O
cell NN O
growth NN O
. . O

In IN O
contrast NN O
to TO O
prior VB O
in IN O
vitro JJ O
studies NNS O
, , O
at IN O
least JJS O
a DT O
fraction NN O
of IN O
the DT O
phosphorylated JJ O
form NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
remains VBZ O
physically RB O
associated VBN O
with IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
complex NN I-Gene
in IN O
vivo NN O
but CC O
is VBZ O
subject JJ O
to TO O
rapid JJ O
degradation NN O
, , O
thereby RB O
promoting VBG O
the DT O
nuclear JJ O
translocation NN O
of IN O
the DT O
active JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
complex NN I-Gene
. . O

Therefore IN O
we PRP O
investigated VBD O
the DT O
modifications NNS O
imposed VBN O
on IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
/ NN I-Gene
I PRP I-Gene
kappa VBP I-Gene
B JJ I-Gene
components NNS I-Gene
following VBG O
stimulation NN O
and CC O
show NN O
that IN O
the DT O
final JJ O
step NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
induction NN O
in IN O
vivo JJ O
involves NNS O
phosphorylation NN O
of IN O
several JJ O
members NNS O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
/ NN I-Gene
I PRP I-Gene
kappa VBP I-Gene
B NNP I-Gene
protein NN I-Gene
families NNS I-Gene
. . O

Isolation NN O
of IN O
differentially RB O
expressed VBN O
sequence NN O
tags NN O
from IN O
steroid JJ O
- : O
responsive JJ O
cells NNS O
using VBG O
mRNA JJ B-Gene
differential JJ O
display NN O
. . O

Although IN O
much JJ O
is VBZ O
known VBN O
about IN O
the DT O
structure NN O
and CC O
function NN O
of IN O
steroid JJ O
receptors NNS O
, , O
relatively RB O
few JJ O
cell NN O
- : O
specific JJ O
steroid JJ O
- : O
regulated VBN O
genes NNS O
have VBP O
been VBN O
isolated VBN O
and CC O
characterized VBN O
. . O

In IN O
this DT O
paper NN O
we PRP O
describe VBP O
results NNS O
using VBG O
mRNA JJ B-Gene
differential JJ O
display NN O
reverse NN B-Gene
transcriptase NN I-Gene
PCR NNP O
( ( O
DDPCR NNP O
) ) O
to TO O
identify VB O
and CC O
isolate VB O
short JJ O
cDNA NN O
sequence NN O
tags NNS O
from IN O
thymocyte NN O
and CC O
prostate NN O
cells NNS O
under IN O
various JJ O
hormone NN O
conditions NNS O
. . O

GIG10 NNP B-Gene
is VBZ O
a DT O
novel JJ O
sequence NN O
and CC O
GIG18 NNP B-Gene
is VBZ O
the DT O
mouse NN O
homologue NN O
of IN O
a DT O
human JJ B-Gene
expressed VBN I-Gene
sequence NN I-Gene
tag NN I-Gene
isolated VBN O
from IN O
activated VBN O
B NNP O
lymphocytes NNS O
. . O

We PRP O
have VBP O
shown VBN O
that IN O
, , O
within IN O
the DT O
thymus NN O
, , O
a DT O
population NN O
of IN O
large JJ O
, , O
immature JJ O
cells NNS O
expresses VBZ O
CD21 NNP B-Gene
. . O

EBV RB O
altered VBD O
the DT O
activation NN O
responses NNS O
of IN O
immature NN O
thymocytes NNS O
in IN O
vitro NN O
. . O

This DT O
function NN O
was VBD O
a DT O
result NN O
of IN O
the DT O
interaction NN O
of IN O
EBV NNP O
with IN O
its PRP$ O
receptor NN O
, , O
CD21 NNP B-Gene
, , O
but CC O
was VBD O
caused VBN O
by IN O
infection NN O
rather RB O
than IN O
surface NN O
signaling NN O
, , O
because IN O
neither DT O
specific JJ B-Gene
mAb NN I-Gene
nor CC O
the DT O
P3HR NNP O
- : O
1 CD O
strain NN O
of IN O
virus NN O
mimicked VBD O
the DT O
effect NN O
of IN O
B95 NNP O
- : O
8 CD O
. . O

Consistent JJ O
with IN O
the DT O
activity NN O
of IN O
B95 NNP B-Gene
- : I-Gene
8 CD I-Gene
, , O
EBNA NNP B-Gene
- : I-Gene
2 CD I-Gene
transcripts NNS I-Gene
were VBD O
identified VBN O
within IN O
infected JJ O
thymocyte JJ O
populations NNS O
. . O

A DT O
second JJ O
transcript NN O
was VBD O
identified VBN O
as IN O
encoding VBG O
the DT O
recently RB O
characterized VBN O
RAZ NNP B-Gene
, , O
which WDT O
also RB O
is VBZ O
associated VBN O
with IN O
replicative JJ O
infection NN O
. . O

The DT O
regulation NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
( ( I-Gene
NF NNP I-Gene
) ) I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
by IN O
the DT O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
( ( I-Gene
TcR NNP I-Gene
) ) I-Gene
/ VBP I-Gene
CD3 NNP I-Gene
complex NN I-Gene
in IN O
primary JJ O
human JJ O
T NNP O
cells NNS O
has VBZ O
been VBN O
studied VBN O
at IN O
various JJ O
times NNS O
after IN O
activation NN O
. . O

p50 NN B-Gene
. . I-Gene
c SYM I-Gene
- : I-Gene
rel NN I-Gene
heterodimers NNS I-Gene
were VBD O
also RB O
detected VBN O
bound NN O
to TO O
this DT O
sequence NN O
at IN O
early JJ O
time NN O
points NNS O
( ( O
7 CD O
- : O
16 CD O
h NN O
; : O
early JJ O
) ) O
, , O
and CC O
both DT O
remained VBD O
active JJ O
at IN O
later JJ O
time NN O
points NNS O
( ( O
40 CD O
h NN O
; : O
late RB O
) ) O
after IN O
activation NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
the DT O
regulation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
during IN O
T NNP O
cell NN O
activation NN O
by IN O
TcR NNP B-Gene
/ NNP I-Gene
CD3 NNP I-Gene
signals NNS O
is VBZ O
biphasic JJ O
: : O
TcR NNP B-Gene
/ NNP I-Gene
CD3 NNP I-Gene
triggers VBZ O
its PRP$ O
immediate JJ O
translocation NN O
, , O
which WDT O
is VBZ O
transient JJ O
if IN O
no DT O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
is VBZ O
present JJ O
. . O

The DT O
cis NN B-Gene
- : I-Gene
acting JJ I-Gene
region NN I-Gene
, , O
GM NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
/ NNP I-Gene
GC NNP I-Gene
- : I-Gene
box NN I-Gene
( ( O
positions NNS B-Gene
- : I-Gene
95 CD I-Gene
and CC O
- : B-Gene
73 CD I-Gene
) ) O
, , O
within IN O
the DT O
murine NN B-Gene
GM NNP I-Gene
- : I-Gene
CSF NNP I-Gene
gene NN I-Gene
promoter NN I-Gene
is VBZ O
required VBN O
for IN O
maximal JJ O
induction NN O
by IN O
stimulation NN O
with IN O
phorbol NN O
- : O
12 CD O
- : O
myristate NN O
acetate NN O
( ( O
PMA NNP O
) ) O
and CC O
calcium NN O
ionophore NN O
( ( O
A23187 NNP O
) ) O
in IN O
T NNP O
cells NNS O
. . O

We PRP O
report VBP O
here RB O
that IN O
three CD O
copies NNS O
of IN O
the DT O
GC NNP B-Gene
- : I-Gene
box NN I-Gene
can MD O
functionally RB O
compensate VB O
for IN O
the DT O
GM NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
/ NNP I-Gene
GC NNP I-Gene
- : I-Gene
box NN I-Gene
region NN I-Gene
, , O
suggesting VBG O
that IN O
the DT O
GC NNP O
- : O
motif NN O
can MD O
function VB O
independently RB O
of IN O
the DT O
GM NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
motif NN I-Gene
. . O

A DT O
factor NN O
that WDT O
regulates VBZ O
the DT O
class NN B-Gene
II NNP I-Gene
major JJ I-Gene
histocompatibility NN I-Gene
complex JJ I-Gene
gene NN I-Gene
DPA NNP B-Gene
is VBZ O
a DT O
member NN O
of IN O
a DT O
subfamily NN O
of IN O
zinc NN B-Gene
finger NN I-Gene
proteins VBZ I-Gene
that WDT O
includes VBZ O
a DT O
Drosophila NNP B-Gene
developmental NN I-Gene
control NN I-Gene
protein NN I-Gene
. . O

It PRP O
encodes VBZ O
a DT O
protein NN O
predicted VBD O
to TO O
contain VB O
688 CD O
amino NN O
acid NN O
residues NNS O
, , O
including VBG O
11 CD O
zinc NN B-Gene
finger NN I-Gene
motifs NNS I-Gene
of IN O
the DT O
C2H2 NNP B-Gene
type NN I-Gene
in IN O
the DT O
C NNP B-Gene
- : I-Gene
terminal JJ I-Gene
region NN I-Gene
, , O
that WDT O
are VBP O
Kruppel NNP O
- : O
like IN O
in IN O
the DT O
conservation NN O
of IN O
the DT O
H NNP B-Gene
/ NNP I-Gene
C NNP I-Gene
link VBP I-Gene
sequence NN I-Gene
connecting VBG O
them PRP O
. . O

One CD O
of IN O
the DT O
Drosophila NNP B-Gene
sequences NNS I-Gene
, , O
ttk NN B-Gene
, , O
is VBZ O
a DT O
developmental JJ B-Gene
control NN I-Gene
gene NN I-Gene
, , O
while IN O
a DT O
second JJ O
does VBZ O
not RB O
contain VB O
a DT O
zinc NN B-Gene
finger NN I-Gene
region NN I-Gene
but CC O
encodes VBZ O
a DT O
structure NN O
important JJ O
in IN O
oocyte JJ O
development NN O
. . O

This DT O
protein NN O
appears VBZ O
to TO O
require VB O
both DT O
the DT O
S NNP B-Gene
and CC I-Gene
J NNP I-Gene
elements NNS I-Gene
, , O
which WDT O
are VBP O
separated VBN O
by IN O
10 CD O
bp NN O
for IN O
optimal JJ O
binding NN O
. . O

These DT O
initial JJ O
pathways NNS O
culminate VBP O
in IN O
a DT O
common JJ O
pathway NN O
through IN O
which WDT O
all DT O
of IN O
the DT O
stimulating JJ O
agents NNS O
ultimately RB O
signal JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
. . O

This DT O
Oct NNP B-Gene
- : I-Gene
2 CD I-Gene
- : O
dependent JJ O
transactivation NN O
is VBZ O
inhibited VBN O
by IN O
RA NNP O
. . O

We PRP O
also RB O
show VBP O
that IN O
both DT O
Fos NNP B-Gene
and CC O
Jun NNP B-Gene
components NNS O
of IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
factors NNS O
participate VBP O
in IN O
the DT O
OAP40 NNP B-Gene
complex NN I-Gene
. . O

OAP NNP B-Gene
confers NNS O
to TO O
Oct NNP B-Gene
- : I-Gene
2 CD I-Gene
responsivity NN O
to TO O
both DT O
TPA NNP O
/ NNP O
Ca2 NNP O
+ NNP O
and CC O
RA NNP O
, , O
since IN O
specific JJ O
mutations NNS O
of IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
/ NN I-Gene
OAP NNP I-Gene
- : I-Gene
binding NN I-Gene
site NN I-Gene
significantly RB O
reduce VB O
the DT O
transactivation NN O
by IN O
Oct NNP B-Gene
- : I-Gene
2 CD I-Gene
in IN O
response NN O
to TO O
TPA NNP O
and CC O
Ca2 NNP O
+ NNP O
and CC O
abolish VB O
the DT O
inhibition NN O
by IN O
RA NNP O
. . O

Therefore RB O
, , O
we PRP O
propose VBP O
that IN O
the DT O
TPA NNP O
/ NNP O
calcium NN O
- : O
activated VBN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
/ JJ B-Gene
OAP NNP I-Gene
element NN O
is VBZ O
the DT O
main JJ O
target NN O
of IN O
positive JJ O
or CC O
negative JJ O
regulatory JJ O
signals NNS O
influencing VBG O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
octamer NN I-Gene
motif NN I-Gene
, , O
through IN O
synergism NN O
with IN O
Oct NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
antagonism NN O
by IN O
RAR NNP B-Gene
. . O

As IN O
in IN O
XSCID NNP O
, , O
X NNP O
- : O
chromosome NN O
inactivation NN O
in IN O
obligate JJ O
carriers NNS O
of IN O
XCID NNP O
was VBD O
nonrandom RB O
in IN O
T NNP O
and CC O
B NNP O
lymphocytes NNS O
. . O

Both DT O
pyrrolidine JJ O
dithiocarbamate NN O
, , O
an DT O
oxidant JJ O
scavenger NN O
, , O
and CC O
N NNP O
- : O
acetyl NN O
- : O
cysteine NN O
, , O
a DT O
precursor NN O
of IN O
the DT O
endogenous JJ O
antioxidant NN O
glutathione NN O
, , O
inhibited JJ O
stimulation NN O
of IN O
macrophage NN O
procoagulant JJ O
activity NN O
by IN O
LPS NNP O
. . O

An DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
binding NN O
site NN O
is VBZ O
an DT O
essential JJ O
component NN O
of IN O
the DT O
element NN O
but CC O
alone RB O
is VBZ O
not RB O
sufficient JJ O
to TO O
account VB O
for IN O
the DT O
activity NN O
or CC O
the DT O
specificity NN O
of IN O
the DT O
element NN O
. . O

Thapsigargin NN O
( ( O
TG NNP O
) ) O
, , O
an DT O
inhibitor NN O
of IN O
Ca NNP B-Gene
( ( I-Gene
2 CD I-Gene
+ NN I-Gene
) ) I-Gene
- : I-Gene
ATPase NN I-Gene
, , O
depletes VBZ O
intracellular JJ O
Ca2 NNP O
+ NNP O
stores NNS O
and CC O
induces NNS O
a DT O
sustained JJ O
Ca2 NNP O
+ NNP O
influx NN O
without IN O
altering VBG O
phosphatidyl NN O
inositol NN O
levels NNS O
. . O

A DT O
similar JJ O
increase NN O
in IN O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha NN I-Gene
by IN O
TG NNP O
was VBD O
also RB O
observed VBN O
in IN O
human JJ O
peripheral JJ O
T NNP O
cells NNS O
. . O

However RB O
, , O
TG NNP O
and CC O
PMA NNP O
exhibited VBD O
a DT O
synergistic JJ O
action NN O
on IN O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha JJ I-Gene
expression NN O
, , O
suggesting VBG O
that IN O
TG NNP O
and CC O
PMA NNP O
induce VBP O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha NN I-Gene
through IN O
distinct JJ O
pathways NNS O
. . O

PMA NNP B-Gene
- : I-Gene
but CC I-Gene
not RB I-Gene
TG NNP I-Gene
- : I-Gene
induced VBD I-Gene
IL NNP I-Gene
- : I-Gene
2R CD I-Gene
alpha NN I-Gene
is VBZ O
inhibited VBN O
by IN O
the DT O
PKC NNP B-Gene
inhibitor NN O
H7 NNP O
, , O
whereas IN O
TG NNP B-Gene
- : I-Gene
but CC I-Gene
not RB I-Gene
PMA NNP I-Gene
- : I-Gene
induced VBD I-Gene
IL NNP I-Gene
- : I-Gene
2R CD I-Gene
alpha NN I-Gene
was VBD O
inhibited VBN O
by IN O
cholera NN O
toxin NN O
, , O
forskolin NN O
and CC O
1 CD O
, , O
9 CD O
- : O
dideoxy NN O
forskolin NN O
. . O

The DT O
agent NN O
, , O
17 CD O
beta SYM O
- : O
estradiol NN O
, , O
but CC O
not RB O
17 CD O
alpha JJ O
- : O
estradiol NN O
, , O
significantly RB O
reduced VBN O
PMNs NNP O
chemotaxis NN O
to TO O
FMLP NNP O
in IN O
a DT O
dose JJ O
- : O
dependent JJ O
manner NN O
( ( O
control NN O
vs NN O
estrogen NN O
10 CD O
( ( O
- : O
10 CD O
) ) O
- : O
( ( O
- : O
6 CD O
) ) O
M NNP O
, , O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
. . O

Physiological JJ O
concentrations NNS O
of IN O
estradiol NN O
significantly RB O
reduced VBD O
the DT O
chemotaxis NN O
of IN O
PMNs NNP O
( ( O
10 CD O
( ( O
- : O
10 CD O
) ) O
mol NN O
) ) O
. . O

Pre NNP O
- : O
incubation NN O
with IN O
clomiphene NN O
or CC O
tamoxifen NN O
which WDT O
are VBP O
estrogen JJ O
receptor NN O
antagonists NNS O
, , O
eliminated VBD O
the DT O
inhibitory JJ O
effect NN O
of IN O
17 CD O
beta NN O
- : O
estradiol NN O
on IN O
the DT O
chemotaxis NN O
of IN O
PMNs NNP O
, , O
restoring VBG O
it PRP O
to TO O
the DT O
control NN O
level NN O
. . O

In IN O
addition NN O
, , O
the DT O
level NN O
of IN O
estradiol NN O
in IN O
human JJ O
plasma NN O
, , O
which WDT O
PMNs NNP O
were VBD O
drawn VBN O
, , O
showed VBD O
a DT O
close NN O
, , O
inverse JJ O
correlation NN O
with IN O
the DT O
PMNs NNP O
chemotaxis NN O
to TO O
FMLP NNP O
( ( O
r NN O
= NNP O
- : O
0 CD O
. . O
821 CD O
p JJ O
< RB O
0 CD O
. . O
1 CD O
) ) O
. . O

Two CD O
gel JJ B-Gene
shift NN I-Gene
complexes NNS I-Gene
( ( O
Mono NNP B-Gene
A NNP I-Gene
and CC O
Mono NNP B-Gene
B NNP I-Gene
) ) O
were VBD O
formed VBN O
with IN O
separate JJ O
sequence NN O
elements NNS O
within IN O
this DT O
region NN O
. . O

Furthermore RB O
, , O
multimerized VBN B-Gene
region NN I-Gene
II NNP I-Gene
sequence NN I-Gene
elements NNS I-Gene
enhanced VBD O
the DT O
activity NN O
of IN O
a DT O
heterologous JJ O
thymidine NN O
kinase NN O
promoter NN O
in IN O
monocytic JJ O
cells NNS O
but CC O
not RB O
other JJ O
cell NN O
types NNS O
tested VBN O
. . O

Pyrrolidine NNP O
dithiocarbamate NN O
, , O
a DT O
potent JJ O
inhibitor NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
) ) O
activation NN O
, , O
prevents NNS O
apoptosis NN O
in IN O
human JJ O
promyelocytic JJ O
leukemia NN O
HL NNP O
- : O
60 CD O
cells NNS O
and CC O
thymocytes NNS O
. . O

However RB O
, , O
PDTC NNP O
failed VBD O
to TO O
inhibit VB O
the DT O
endonuclease NN B-Gene
activity NN O
contained VBN O
in IN O
the DT O
whole NN O
cell NN O
lysates VBZ O
. . O

Since IN O
PDTC NNP O
has VBZ O
both DT O
antioxidant JJ O
and CC O
metal JJ O
- : O
ion NN O
chelating NN O
activities NNS O
, , O
we PRP O
tested VBD O
the DT O
effects NNS O
of IN O
N NNP O
- : O
acetyl NN O
- : O
L NNP O
- : O
cysteine NN O
( ( O
NAC NNP O
) ) O
( ( O
antioxidant JJ O
) ) O
or CC O
o SYM O
- : O
phenanthroline NN O
( ( O
OP NNP O
) ) O
( ( O
metal JJ O
- : O
ion NN O
chelator NN O
) ) O
on IN O
the DT O
induction NN O
of IN O
apoptosis NN O
. . O

PKC NNP O
- : O
zeta NN O
cells NNS O
expressed VBD O
a DT O
more RBR O
differentiated JJ O
phenotype NN O
as IN O
assessed VBN O
by IN O
changes NNS O
in IN O
morphology NN O
, , O
surface NN O
antigen NN O
expression NN O
, , O
and CC O
lysosomal JJ B-Gene
enzyme NN I-Gene
activities NNS O
and CC O
were VBD O
distinct NNS O
from IN O
parental JJ O
U937 NNP O
cells NNS O
stimulated VBD O
to TO O
differentiate VB O
by IN O
exposure NN O
to TO O
phorbol VB O
esters NNS O
. . O

Increased VBN O
expression NN O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
jun NN I-Gene
protooncogene NN O
and CC O
an DT O
increase NN O
in IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
binding NN O
activity NN O
in IN O
PKC NNP O
- : O
zeta NN O
cells NNS O
provides VBZ O
a DT O
potential JJ O
mechanism NN O
for IN O
explaining VBG O
the DT O
altered JJ O
differentiation NN O
status NN O
of IN O
this DT O
cell NN O
. . O

It PRP O
is VBZ O
surprising JJ O
that IN O
the DT O
faster JJR B-Gene
- : I-Gene
migrating NN I-Gene
complex NN I-Gene
was VBD O
composed VBN O
also RB O
of IN O
p50 NN B-Gene
and CC O
p65 NN B-Gene
. . O

OBF NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
a DT O
novel NN B-Gene
B NNP I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
coactivator NN I-Gene
that WDT O
stimulates VBZ O
immunoglobulin JJ B-Gene
promoter NN I-Gene
activity NN O
through IN O
association NN O
with IN O
octamer JJ B-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
. . O

The DT O
OBF NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
is VBZ O
expressed VBN O
in IN O
a DT O
highly RB O
cell NN O
- : O
specific JJ O
manner NN O
, , O
being VBG O
most RBS O
abundant JJ O
in IN O
B NNP O
cells NNS O
and CC O
essentially RB O
absent JJ O
in IN O
most JJS O
of IN O
the DT O
other JJ O
cells NNS O
or CC O
tissues NNS O
tested VBN O
. . O

The DT O
first JJ O
early JJ O
- : O
induced JJ O
peak NN O
was VBD O
transient NN O
and CC O
likely JJ O
corresponds NNS O
to TO O
the DT O
well RB O
documented JJ O
typical JJ O
junB NN B-Gene
mRNA NN I-Gene
, , O
stimulated VBN O
in IN O
response NN O
to TO O
numerous JJ O
growth NN B-Gene
factors NNS I-Gene
, , O
including VBG O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
. . O

Second JJ O
, , O
tyrphostin NN O
, , O
a DT O
tyrosine JJ O
kinase NN O
inhibitor NN O
, , O
impaired VBD O
the DT O
expression NN O
of IN O
the DT O
first JJ O
but CC O
not RB O
the DT O
second JJ O
junB NN B-Gene
mRNA NN I-Gene
peak NN O
. . O

Erythropoietin NNP B-Gene
( ( O
Epo NNP B-Gene
) ) O
, , O
granulocyte JJ B-Gene
/ NN I-Gene
macrophage NN I-Gene
colony NN I-Gene
stimulating VBG I-Gene
factor NN I-Gene
( ( O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
) ) O
, , O
and CC O
interleukin JJ B-Gene
3 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
) ) O
promoted VBD O
the DT O
growth NN O
of IN O
NS NNP O
- : O
Meg NNP O
cells NNS O
. . O

Ten CD O
- : O
day NN O
exposure NN O
to TO O
Epo NNP B-Gene
induced JJ O
mature NN O
erythroblasts NNS O
and CC O
red JJ O
cells NNS O
. . O

These DT O
benzidine SYM O
- : O
positive JJ O
cells NNS O
were VBD O
positive JJ O
for IN O
hemoglobin NN B-Gene
F NNP O
staining NN O
. . O

The DT O
T NNP B-Gene
cell NN I-Gene
surface NN I-Gene
molecule NN I-Gene
CD28 NNP B-Gene
binds VBZ O
to TO O
ligands VB O
on IN O
accessory NN O
cells NNS O
and CC O
APCs NNP O
, , O
playing VBG O
an DT O
important JJ O
costimulatory NN O
role NN O
in IN O
the DT O
response NN O
of IN O
T NNP O
cells NNS O
to TO O
Ags NNP B-Gene
. . O

Our PRP$ O
knowledge NN O
of IN O
the DT O
intracellular JJ O
signaling NN O
pathways NNS O
coupled VBN O
to TO O
this DT O
receptor NN O
is VBZ O
incomplete JJ O
. . O

Enhanced NNP O
responsiveness NN O
to TO O
nuclear JJ B-Gene
factor NN I-Gene
kappa NN I-Gene
B NNP I-Gene
contributes VBZ O
to TO O
the DT O
unique JJ O
phenotype NN O
of IN O
simian JJ O
immunodeficiency NN O
virus NN O
variant JJ O
SIVsmmPBj14 NNP O
. . O

In IN O
a DT O
wide JJ O
range NN O
of IN O
cell NN O
types NNS O
, , O
the DT O
basal JJ O
transcriptional JJ O
activity NN O
of IN O
the DT O
LTR NNP B-Gene
from IN O
SIVsmmPBj14 NNP O
was VBD O
found VBN O
to TO O
be VB O
2 CD O
- : O
to TO O
4 CD O
. . O
5 CD O
- : O
fold NN O
higher JJR O
than IN O
that DT O
of IN O
an DT O
LTR NNP B-Gene
from IN O
a DT O
non JJ O
- : O
acutely RB O
pathogenic JJ O
strain NN O
. . O

Mutagenesis NNP O
studies NNS O
, , O
and CC O
the DT O
use NN O
of IN O
a DT O
reporter NN O
construct NN O
containing VBG O
an DT O
enhancerless NN O
promoter NN O
, , O
indicate VBP O
that IN O
these DT O
transcriptional JJ O
effects NNS O
are VBP O
due JJ O
principally RB O
to TO O
the DT O
22 CD B-Gene
- : I-Gene
bp NN I-Gene
sequence NN I-Gene
duplication NN I-Gene
and CC O
the DT O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
site NN I-Gene
contained VBD O
within IN O
it PRP O
. . O

In IN O
such JJ O
cells NNS O
, , O
DNA NNP O
binding VBG O
activity NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
can MD O
be VB O
detected VBN O
without IN O
intentional JJ O
stimulation NN O
. . O

This DT O
nuclear JJ B-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
was VBD O
still RB O
present JJ O
when WRB O
contaminant NN O
LPS NNP O
was VBD O
removed VBN O
by IN O
ultrafiltration NN O
and CC O
when WRB O
serum NN O
was VBD O
omitted VBN O
. . O

Using VBG O
LPS NNP O
- : O
free JJ O
and CC O
serum JJ O
- : O
free JJ O
conditions NNS O
, , O
constitutive JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
can MD O
be VB O
detected VBN O
in IN O
different JJ O
cell NN O
lines NNS O
of IN O
the DT O
monocytic JJ O
lineage NN O
( ( O
HL60 NNP O
, , O
U937 NNP O
, , O
THP NNP O
- : O
1 CD O
, , O
Mono NNP O
Mac NNP O
1 CD O
and CC O
Mono NNP O
Mac NNP O
6 CD O
) ) O
, , O
but CC O
not RB O
in IN O
Molt NNP O
4 CD O
T NNP O
cells NNS O
or CC O
K562 NNP O
stem NN O
cells NNS O
. . O

The DT O
constitutive JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
appears VBZ O
to TO O
be VB O
functionally RB O
active JJ O
, , O
since IN O
a DT O
low JJ O
level NN O
of IN O
tumour JJ B-Gene
necrosis NN I-Gene
factor NN I-Gene
( ( I-Gene
TNF NNP I-Gene
) ) I-Gene
transcript NN I-Gene
is VBZ O
detectable JJ O
in IN O
monocytes NNS O
, , O
and CC O
this DT O
level NN O
can MD O
be VB O
increased VBN O
by IN O
blocking VBG O
transcript JJ O
degradation NN O
using VBG O
cycloheximide NN O
. . O

In IN O
contrast NN O
, , O
SCL NNP B-Gene
mRNA NN I-Gene
levels NNS O
did VBD O
not RB O
decrease VB O
significantly RB O
between IN O
day NN O
7 CD O
and CC O
day NN O
14 CD O
cells NNS O
, , O
suggesting VBG O
that IN O
posttranscriptional JJ O
mechanisms NNS O
are VBP O
largely RB O
responsible JJ O
for IN O
the DT O
decrease NN O
in IN O
SCL NNP B-Gene
protein NN I-Gene
observed VBD O
. . O

In IN O
BFU NNP O
- : O
E NNP O
- : O
derived VBD O
colonies NNS O
cultured VBN O
with IN O
Steel NNP B-Gene
factor NN I-Gene
, , O
colony NN O
size NN O
was VBD O
significantly RB O
increased VBN O
compared VBN O
to TO O
control VB O
. . O

Activated VBN O
macrophages NNS O
contribute VBP O
to TO O
chronic JJ O
inflammation NN O
by IN O
the DT O
secretion NN O
of IN O
cytokines NNS B-Gene
and CC O
proteinases NNS B-Gene
. . O

Tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
alpha NN I-Gene
) ) O
is VBZ O
particularly RB O
important JJ O
in IN O
this DT O
process NN O
because IN O
of IN O
its PRP$ O
ability NN O
to TO O
regulate VB O
other JJ O
inflammatory JJ O
mediators NNS O
in IN O
an DT O
autocrine NN O
and CC O
paracrine JJ O
fashion NN O
. . O

We PRP O
present VBP O
data NNS O
to TO O
show VB O
that IN O
the DT O
expression NN O
of IN O
TNF NNP B-Gene
alpha NN I-Gene
is VBZ O
regulated VBN O
by IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
beta NN I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
IL6 NN I-Gene
) ) O
. . O

Calcium NNP B-Gene
/ NNP I-Gene
calmodulin SYM I-Gene
- : I-Gene
dependent JJ I-Gene
protein NN I-Gene
kinase NN I-Gene
II NNP I-Gene
downregulates VBZ O
both DT O
calcineurin NN O
and CC O
protein NN O
kinase NN O
C NNP O
- : O
mediated VBD O
pathways NNS O
for IN O
cytokine JJ B-Gene
gene NN I-Gene
transcription NN O
in IN O
human JJ O
T NNP O
cells NNS O
. . O

However RB O
, , O
the DT O
role NN O
of IN O
CaM NNP B-Gene
- : I-Gene
K NNP I-Gene
II NNP I-Gene
remains VBZ O
unknown JJ O
. . O

We PRP O
have VBP O
used VBN O
mutants NNS O
of IN O
these DT O
kinases NNS B-Gene
and CC O
phosphatases NNS B-Gene
( ( O
gamma NN B-Gene
B NNP I-Gene
* NNP I-Gene
CaM NNP I-Gene
- : I-Gene
K NNP I-Gene
and CC O
delta NN B-Gene
CaM NNP I-Gene
- : I-Gene
AI NNP I-Gene
, , O
respectively RB O
) ) O
to TO O
explore VB O
their PRP$ O
relative JJ O
role NN O
in IN O
cytokine JJ B-Gene
gene NN I-Gene
transcription NN O
and CC O
their PRP$ O
interactions NNS O
with IN O
PKC NNP B-Gene
- : O
dependent JJ O
signaling VBG O
systems NNS O
. . O

When WRB O
both DT O
mutants NNS O
were VBD O
used VBN O
in IN O
combination NN O
, , O
gamma NN B-Gene
B NNP I-Gene
* NNP I-Gene
CaM NNP I-Gene
- : I-Gene
K NNP I-Gene
inhibited VBD O
the DT O
induction NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
by IN O
delta NN B-Gene
CaM NNP I-Gene
- : I-Gene
AI NN I-Gene
. . O

Similar JJ O
results NNS O
were VBD O
obtained VBN O
when WRB O
a DT O
construct NN O
containing VBG O
the DT O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
promoter NN I-Gene
also RB O
was VBD O
used VBN O
. . O

Induction NN O
of IN O
TaxI NNP B-Gene
in IN O
a DT O
human JJ O
T NNP O
- : O
cell NN O
line NN O
Jurkat NNP O
carrying VBG O
the DT O
TaxI NNP B-Gene
gene NN I-Gene
under IN O
the DT O
metallothionein NN B-Gene
promoter NN I-Gene
led VBD O
to TO O
increases NNS O
in IN O
mRNA NN B-Gene
and CC O
surface NN O
expression NN O
of IN O
ICAM NNP B-Gene
- : I-Gene
I PRP I-Gene
. . O

Three CD O
other JJ O
ATL NNP O
cell NN O
lines NNS O
( ( O
TL NNP O
- : O
OmI NN O
, , O
H582 NNP O
, , O
HuT102 NNP O
) ) O
were VBD O
found VBN O
to TO O
have VB O
little JJ O
mRNA NN B-Gene
for IN O
the DT O
LFA NNP B-Gene
- : I-Gene
I PRP I-Gene
beta VBP I-Gene
chain NN I-Gene
( ( O
CD18 NNP B-Gene
) ) O
. . O

H582 NNP O
and CC O
HuT102 NNP O
were VBD O
also RB O
negative JJ O
for IN O
the DT O
LFA NNP B-Gene
- : I-Gene
I PRP I-Gene
alpha VBP I-Gene
chain NN I-Gene
( ( I-Gene
CDIIa NNP I-Gene
) ) I-Gene
mRNA NN I-Gene
. . O

Infection NN O
with IN O
Theileria NNP O
annulata NN O
induces NNS O
expression NN O
of IN O
matrix JJ B-Gene
metalloproteinase NN I-Gene
9 CD I-Gene
and CC O
transcription NN B-Gene
factor NN I-Gene
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
bovine NN O
leucocytes NNS O
. . O

T NNP O
. . O
annulata SYM O
- : O
infected VBN O
leucocytes VBZ O
produce VBP O
a DT O
number NN O
of IN O
novel JJ O
metalloproteinase NN B-Gene
activities NNS O
. . O

One CD O
of IN O
these DT O
, , O
previously RB O
called VBN O
B1 NNP B-Gene
, , O
is VBZ O
a DT O
97 CD B-Gene
- : I-Gene
kDa NN I-Gene
protein NN I-Gene
which WDT O
is VBZ O
secreted VBN O
in IN O
large JJ O
amounts NNS O
and CC O
has VBZ O
been VBN O
purified VBN O
from IN O
protein NN O
- : O
free JJ O
, , O
conditioned JJ O
medium NN O
. . O

In IN O
addition NN O
we PRP O
assayed VBD O
the DT O
level NN O
of IN O
mRNA NN B-Gene
encoding VBG O
c SYM B-Gene
- : I-Gene
Fos NNP I-Gene
, , O
a DT O
common JJ O
component NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
observed VBD O
that IN O
it PRP O
was VBD O
indeed RB O
up RP O
- : O
regulated VBN O
in IN O
infected JJ O
cells NNS O
. . O

We PRP O
generated VBD O
conditional JJ O
EBV NNP O
mutants NNS O
by IN O
expressing VBG O
EBNA2 NNP B-Gene
as IN O
chimeric JJ B-Gene
fusion NN I-Gene
protein NN I-Gene
with IN O
the DT O
hormone NN O
binding VBG O
domain NN O
of IN O
the DT O
estrogen NN B-Gene
receptor NN I-Gene
on IN O
the DT O
genetic JJ O
background NN O
of IN O
the DT O
virus NN O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
EBV NNP O
is VBZ O
using VBG O
a DT O
common JJ O
pathway NN O
for IN O
B NNP O
- : O
cell NN O
activation NN O
bypassing VBG O
the DT O
requirement NN O
for IN O
antigen NN O
, , O
T NNP O
- : O
cell NN O
signals NNS O
and CC O
growth NN B-Gene
factors NNS I-Gene
. . O

The DT O
synergistic JJ O
antigen NN B-Gene
receptor NN I-Gene
initiated VBN O
signals NNS O
are VBP O
mediated VBN O
through IN O
protein NN B-Gene
kinase NN I-Gene
C NNP I-Gene
because IN O
they PRP O
can MD O
be VB O
mimicked VBN O
by IN O
the DT O
phorbol NN O
ester NN O
, , O
12 CD O
- : O
O NNP O
- : O
tetradecanoylphorbol NN O
- : O
13 CD O
- : O
acetate NN O
, , O
but CC O
not RB O
with IN O
calcium NN O
ionophores NNS O
; : O
and CC O
are VBP O
staurosporine JJ O
sensitive JJ O
but CC O
cyclosporine JJ O
resistant NN O
. . O

The DT O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
induced VBN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
DNA NNP O
nuclear JJ O
localization NN O
is VBZ O
transient JJ O
and CC O
can MD O
be VB O
prolonged VBN O
either RB O
by IN O
an DT O
antigen NN O
receptor NN O
- : O
initiated JJ O
signal NN O
or CC O
by IN O
inhibiting VBG O
protein JJ O
synthesis NN O
. . O

A DT O
synthetic JJ O
oligodeoxyribonucleo NN O
containing VBG O
an DT O
SP1 NNP B-Gene
- : I-Gene
box NN I-Gene
( ( O
5 CD O
' '' O
- : O
GGGCGG NNP O
) ) O
could MD O
compete VB O
with IN O
factors NNS O
binding VBG O
to TO O
the DT O
12 CD B-Gene
- : I-Gene
bp NN I-Gene
insert NN I-Gene
. . O

Functional NNP O
Myc NNP B-Gene
- : I-Gene
Max NNP I-Gene
heterodimer NN I-Gene
is VBZ O
required VBN O
for IN O
activation NN O
- : O
induced JJ O
apoptosis NN O
in IN O
T NNP O
cell NN O
hybridomas NN O
. . O

T NNP O
cell NN O
hybridomas PRP$ O
respond NN O
to TO O
activation NN O
signals NNS O
by IN O
undergoing VBG O
apoptotic JJ O
cell NN O
death NN O
, , O
and CC O
this DT O
is VBZ O
likely JJ O
to TO O
represent VB O
comparable JJ O
events NNS O
related VBN O
to TO O
tolerance VB O
induction NN O
in IN O
immature NN O
and CC O
mature NN O
T NNP O
cells NNS O
in IN O
vivo NN O
. . O

Computer NNP O
analysis NN O
of IN O
the DT O
SM NNP B-Gene
protein NN I-Gene
sequence NN O
showed VBD O
a DT O
C NNP B-Gene
terminal JJ I-Gene
section NN I-Gene
of IN O
SM NNP B-Gene
to TO O
be VB O
related VBN O
to TO O
genome VB B-Gene
positional JJ I-Gene
homologues NNS I-Gene
of IN O
four CD O
other JJ O
herpesviruses NNS O
and CC O
revealed VBD O
consensus NN B-Gene
CKII NNP I-Gene
sites VBZ I-Gene
near IN O
the DT O
N NNP B-Gene
termini NN I-Gene
of IN O
the DT O
EBV NNP B-Gene
SM NNP I-Gene
protein NN I-Gene
, , O
the DT O
herpes NNS B-Gene
simplex JJ I-Gene
virus NN I-Gene
( ( I-Gene
HSV NNP I-Gene
) ) I-Gene
ICP27 NNP I-Gene
protein NN I-Gene
and CC O
the DT O
herpesvirus NN B-Gene
saimiri NN I-Gene
( ( I-Gene
HVS NNP I-Gene
) ) I-Gene
open VBP I-Gene
reading VBG I-Gene
frame NN I-Gene
57 CD I-Gene
protein NN I-Gene
. . O

Mutagenesis NN O
of IN O
the DT O
CKII NNP B-Gene
site NN O
in IN O
SM NNP B-Gene
made VBD O
no DT O
difference NN O
to TO O
the DT O
transactivation NN O
in IN O
this DT O
transient JJ O
transfection NN O
assay NN O
. . O

The DT O
proto NN B-Gene
- : I-Gene
oncogene NN I-Gene
c SYM I-Gene
- : I-Gene
fos NN I-Gene
is VBZ O
an DT O
immediate JJ B-Gene
- : I-Gene
early JJ I-Gene
gene NN I-Gene
, , O
and CC O
one CD O
of IN O
the DT O
first JJ O
genes NNS O
transcribed VBN O
after IN O
stimulation NN O
of IN O
most JJS O
cells NNS O
with IN O
a DT O
variety NN O
of IN O
ligands NNS O
. . O

The DT O
serum NN B-Gene
response NN I-Gene
element NN I-Gene
( ( O
SRE NNP B-Gene
) ) O
in IN O
the DT O
c NN B-Gene
- : I-Gene
fos JJ I-Gene
regulatory JJ I-Gene
region NN I-Gene
participates NNS O
in IN O
induction NN O
of IN O
transcription NN O
by IN O
various JJ O
growth NN B-Gene
factors NNS I-Gene
and CC O
by IN O
phorbol NN O
esters NNS O
and CC O
subsequent JJ O
squelching NN O
of IN O
transcription NN O
. . O

Band NNP B-Gene
A NNP I-Gene
contains VBZ O
the DT O
serum NN B-Gene
response NN I-Gene
factor NN I-Gene
plus CC O
additional JJ O
factor NN O
( ( O
s NN O
) ) O
. . O

The DT O
phosphorylated JJ O
tyrosine NN O
residue JJ O
itself PRP O
is VBZ O
important JJ O
for IN O
the DT O
protein NN O
- : O
protein NN O
interaction NN O
. . O

RJ NNP O
2 CD O
. . O
2 CD O
. . O
5 CD O
is VBZ O
a DT O
human JJ O
B NNP O
cell NN O
mutant NN O
derived VBN O
from IN O
the DT O
Burkitt NNP O
lymphoma NN O
Raji NNP O
cell NN O
which WDT O
is VBZ O
defective JJ O
in IN O
the DT O
AIR NNP O
- : O
1 CD O
locus NN O
function NN O
. . O

Thus RB O
, , O
the DT O
use NN O
of IN O
DNase NNP B-Gene
I PRP I-Gene
allowed VBD O
us PRP O
, , O
for IN O
the DT O
first JJ O
time NN O
, , O
to TO O
correlate VB O
the DT O
AIR NNP B-Gene
- : I-Gene
1 CD I-Gene
locus NN I-Gene
defect NN I-Gene
with IN O
class NN B-Gene
II NNP I-Gene
promoter NN I-Gene
occupancy NN O
alterations NNS O
and CC O
distinguish VB O
these DT O
alterations NNS O
from IN O
the DT O
ones NNS O
observed VBN O
in IN O
phenotypically RB O
similar JJ O
but CC O
genetically RB O
distinct JJ O
MHC NNP O
class NN O
II NNP O
- : O
negative JJ O
cells NNS O
. . O

The DT O
interleukin JJ B-Gene
2 CD I-Gene
receptor NN I-Gene
alpha SYM I-Gene
- : I-Gene
chain NN I-Gene
( ( I-Gene
IL NNP I-Gene
- : I-Gene
2R CD I-Gene
alpha NN I-Gene
) ) I-Gene
gene NN I-Gene
is VBZ O
rapidly RB O
and CC O
potently RB O
induced VBN O
in IN O
T NNP O
cells NNS O
in IN O
response NN O
to TO O
mitogenic JJ O
stimuli NNS O
. . O

This DT O
element NN O
had VBD O
maximal JJ O
activity NN O
in IN O
lymphoid JJ O
cells NNS O
, , O
paralleling VBG O
the DT O
cell NN O
type JJ O
specificity NN O
of IN O
Elf NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
. . O

Elf NNP B-Gene
- : I-Gene
1 CD I-Gene
physically RB O
associated VBN O
with IN O
HMG NNP B-Gene
- : I-Gene
I PRP I-Gene
and CC O
with IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
p50 NN B-Gene
and CC O
c SYM B-Gene
- : I-Gene
Rel NN I-Gene
in IN O
vitro NN O
, , O
suggesting VBG O
that IN O
protein SYM O
- : O
protein NN O
interactions NNS O
might MD O
functionally RB O
coordinate VB O
the DT O
actions NNS O
of IN O
the DT O
upstream NN B-Gene
and CC I-Gene
downstream NN I-Gene
positive JJ I-Gene
regulatory JJ I-Gene
elements NNS I-Gene
. . O

Northern NNP O
blot NN O
analysis NN O
showed VBD O
that IN O
a DT O
majority NN O
of IN O
these DT O
genes NNS O
were VBD O
expressed VBN O
at IN O
comparable JJ O
levels NNS O
in IN O
U NNP O
- : O
937 CD O
and CC O
HeLa NNP O
cells NNS O
. . O

Among IN O
258 CD O
X NNP O
chromosome NN O
- : O
containing VBG O
sperm NN O
, , O
19 CD O
% NN O
had VBD O
a DT O
repeat NN O
number NN O
equal JJ O
to TO O
the DT O
donor NN B-Gene
' POS I-Gene
s JJ I-Gene
somatic JJ I-Gene
DNA NNP I-Gene
( ( O
47 CD O
repeats NNS O
) ) O
, , O
66 CD O
% NN O
were VBD O
expansions NNS O
and CC O
15 CD O
% NN O
were VBD O
contractions NNS O
. . O

Aspirin NNP O
- : O
like IN O
drugs NNS O
can MD O
protect VB O
human JJ O
T NNP O
lymphocytes VBZ O
against IN O
benzoquinone NN O
cytotoxicity NN O
: : O
evidence NN O
for IN O
a DT O
NAD NNP B-Gene
( ( I-Gene
P NNP I-Gene
) ) I-Gene
H NNP I-Gene
: : I-Gene
quinone NN I-Gene
reductase NN I-Gene
- : O
dependent NN O
mechanism NN O
. . O

The DT O
expression NN O
of IN O
the DT O
QR NNP B-Gene
gene NN I-Gene
is VBZ O
regulated VBN O
by IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Both DT O
drugs NNS O
protected VBD O
the DT O
cells NNS O
against IN O
BQ NNP O
cytotoxicity NN O
in IN O
a DT O
dose JJ O
- : O
dependent JJ O
manner NN O
, , O
e NN O
. . O
g NN O
. . O
, , O
sodium JJ O
diclofenac NN O
at IN O
15 CD O
microM NN O
reduced VBD O
the DT O
fraction NN O
of IN O
BQ NNP O
- : O
treated VBN O
dead JJ O
cells NNS O
by IN O
70 CD O
% NN O
. . O

ALDs NNP O
induced VBD O
QR NNP B-Gene
activity NN O
in IN O
the DT O
M4 NNP O
cells NNS O
in IN O
the DT O
same JJ O
range NN O
of IN O
concentrations NNS O
that WDT O
protected VBD O
the DT O
cells NNS O
against IN O
BQ NNP O
toxicity NN O
. . O

A DT O
good JJ O
linear JJ O
correlation NN O
, , O
with IN O
an DT O
r NN O
value NN O
of IN O
0 CD O
. . O
91 CD O
, , O
between IN O
the DT O
ED50 NNP O
values NNS O
for IN O
the DT O
differentiation NN O
- : O
inducing NN O
activity NN O
towards NNS O
HL NNP O
- : O
60 CD O
cells NNS O
and CC O
that DT O
towards NNS O
NB4 NNP O
cells NNS O
was VBD O
found VBN O
. . O

These DT O
findings NNS O
suggest VBP O
a DT O
molecular JJ O
mechanism NN O
of IN O
positive JJ O
regulation NN O
of IN O
PAFR NNP B-Gene
gene NN O
expression NN O
by IN O
PAF NNP B-Gene
through IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
possibly RB O
by IN O
a DT O
phosphorylation NN O
reaction NN O
involving VBG O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
by IN O
PAF NNP B-Gene
. . O

One CD O
gene NN O
, , O
two CD O
transcripts NNS B-Gene
: : O
isolation NN O
of IN O
an DT O
alternative JJ O
transcript NN O
encoding VBG O
for IN O
the DT O
autoantigen NN B-Gene
La NNP I-Gene
/ NNP I-Gene
SS NNP I-Gene
- : I-Gene
B NN I-Gene
from IN O
a DT O
cDNA JJ B-Gene
library NN I-Gene
of IN O
a DT O
patient NN O
with IN O
primary JJ O
Sjogrens NNP O
' POS O
syndrome NN O
. . O

The DT O
B NNP B-Gene
cell NN I-Gene
- : I-Gene
associated VBN I-Gene
surface NN I-Gene
molecule NN I-Gene
CD40 NNP I-Gene
functions NNS O
to TO O
regulate VB O
B NNP O
cell NN O
responses NNS O
. . O

The DT O
activation NN O
is VBZ O
rapid JJ O
and CC O
is VBZ O
mediated VBN O
through IN O
a DT O
tyrosine JJ O
kinase NN O
- : O
dependent JJ O
pathway NN O
. . O

These DT O
inhibitors NNS O
specifically RB O
prevented VBD O
degradation NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
and CC O
nuclear JJ O
translocation NN O
of IN O
c SYM B-Gene
- : I-Gene
Rel NNP I-Gene
/ NNP I-Gene
p65 NN I-Gene
heterodimers NNS I-Gene
. . O

In IN O
contrast NN O
, , O
TPCK NNP O
and CC O
TLCK NNP O
did VBD O
not RB O
block VB O
induction NN O
of IN O
an DT O
immediate JJ B-Gene
- : I-Gene
early JJ I-Gene
gene NN I-Gene
encoding VBG O
the DT O
transcription NN B-Gene
factor NN I-Gene
, , O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

The DT O
median JJ O
dissociation NN O
constant NN O
( ( O
Kd NNP O
) ) O
was VBD O
similar JJ O
in IN O
all DT O
three CD O
groups NNS O
of IN O
patients NNS O
and CC O
in IN O
healthy JJ O
women NNS O
( ( O
mean JJ O
+ NNP O
/ NNP O
- : O
S NNP O
. . O
D NNP O
. . O
( ( O
range NN O
) ) O
: : O
PHP NNP O
, , O
1 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
0 CD O
( ( O
0 CD O
. . O
2 CD O
- : O
4 CD O
) ) O
x NN O
10 CD O
( ( O
- : O
10 CD O
) ) O
M NNP O
; : O
SH NNP O
, , O
0 CD O
. . O
6 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
4 CD O
( ( O
0 CD O
. . O
2 CD O
- : O
1 CD O
. . O
2 CD O
) ) O
x NN O
10 CD O
( ( O
- : O
10 CD O
) ) O
M NNP O
; : O
RT NNP O
, , O
1 CD O
. . O
1 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
5 CD O
( ( O
0 CD O
. . O
4 CD O
- : O
1 CD O
. . O
9 CD O
) ) O
x NN O
10 CD O
( ( O
- : O
10 CD O
) ) O
M NNP O
; : O
controls NNS O
, , O
1 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
6 CD O
( ( O
0 CD O
. . O
3 CD O
- : O
2 CD O
. . O
6 CD O
) ) O
x NN O
10 CD O
( ( O
- : O
10 CD O
) ) O
M NNP O
) ) O
. . O
However RB O
, , O
the DT O
maximal JJ O
binding NN O
capacity NN O
( ( O
Nmax NNP O
) ) O
was VBD O
significantly RB O
enhanced VBN O
in IN O
PHP NNP O
( ( O
3 CD O
. . O
9 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
9 CD O
( ( O
1 CD O
. . O
3 CD O
- : O
7 CD O
. . O
6 CD O
) ) O
fmol NN O
/ $ O
10 CD O
( ( O
7 CD O
) ) O
cells NNS O
vs VBP O
. . O
2 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
9 CD O
( ( O
1 CD O
. . O
1 CD O
- : O
4 CD O
. . O
4 CD O
) ) O
fmol NN O
/ $ O
10 CD O
( ( O
7 CD O
) ) O
cells NNS O
in IN O
controls NNS O
; : O
P NNP O
= VBD O
0 CD O
. . O
6 CD O
) ) O
and CC O
decreased VBN O
in IN O
SH NNP O
( ( O
0 CD O
. . O
8 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
5 CD O
( ( O
0 CD O
. . O
2 CD O
- : O
1 CD O
. . O
6 CD O
) ) O
fmol NN O
/ $ O
10 CD O
( ( O
7 CD O
) ) O
cells NNS O
vs VBP O
. . O
2 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
9 CD O
( ( O
1 CD O
. . O
1 CD O
- : O
4 CD O
. . O
4 CD O
) ) O
fmol NN O
/ $ O
10 CD O
( ( O
7 CD O
) ) O
cells NNS O
in IN O
controls NNS O
; : O
P NNP O
= VBD O
0 CD O
. . O
1 CD O
) ) O
, , O
whereas VBZ O
no DT O
changes NNS O
were VBD O
seen VBN O
in IN O
RT NNP O
( ( O
2 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
7 CD O
( ( O
1 CD O
. . O
2 CD O
- : O
3 CD O
. . O
3 CD O
) ) O
fmol NN O
/ $ O
10 CD O
( ( O
7 CD O
) ) O
cells NNS O
vs VBP O
. . O
2 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
9 CD O
( ( O
1 CD O
. . O
1 CD O
- : O
4 CD O
. . O
4 CD O
) ) O
fmol NN O
/ $ O
10 CD O
( ( O
7 CD O
) ) O
cells NNS O
in IN O
controls NNS O
) ) O
. . O

Changes NNS O
of IN O
calcitriol NN B-Gene
receptors NNS I-Gene
in IN O
primary JJ O
and CC O
secondary JJ O
hyperparathyroidism NN O
could MD O
magnify VB O
the DT O
consequences NNS O
of IN O
disturbances NNS O
in IN O
serum JJ O
concentration NN O
of IN O
calcitriol NN O
itself PRP O
and CC O
might MD O
play VB O
an DT O
important JJ O
role NN O
in IN O
the DT O
development NN O
of IN O
secondary JJ O
hyperparathyroidism NN O
in IN O
uremia NN O
. . O

Studies NNS O
of IN O
these DT O
females NNS O
show VBP O
that IN O
the DT O
XIST NNP B-Gene
locus NN I-Gene
on IN O
their PRP$ O
tiny JJ B-Gene
ring NN I-Gene
X NNP I-Gene
chromosomes VBZ I-Gene
is VBZ O
either RB O
not RB O
present JJ O
or CC O
not RB O
expressed VBN O
. . O

As IN O
XIST NNP B-Gene
transcription NN O
is VBZ O
well RB O
correlated VBN O
with IN O
inactivation NN O
of IN O
the DT O
X NNP B-Gene
chromosome NN I-Gene
in IN O
female JJ O
somatic JJ O
cells NNS O
and CC O
spermatogonia NN O
, , O
nonexpression NN O
of IN O
the DT O
locus NN O
even RB O
when WRB O
it PRP O
is VBZ O
present JJ O
suggests NNS O
that IN O
these DT O
chromosomes NNS B-Gene
are VBP O
transcriptionally RB O
active JJ O
. . O

We PRP O
examined VBD O
the DT O
transcriptional JJ O
activity NN O
of IN O
ring VBG O
X NNP B-Gene
chromosomes NNS I-Gene
lacking VBG O
XIST JJ B-Gene
expression NN O
( ( O
XISTE NNP O
- : O
) ) O
, , O
from IN O
three CD O
females NNS O
with IN O
severe JJ O
phenotypes NNS O
. . O

The DT O
increase NN O
in IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN O
expression NN O
triggered VBN O
by IN O
CD28 NNP B-Gene
involves VBZ O
a DT O
kappa NN B-Gene
B NNP I-Gene
- : I-Gene
like IN I-Gene
sequence NN I-Gene
in IN O
the DT O
5 CD B-Gene
' POS I-Gene
- : I-Gene
regulatory JJ I-Gene
region NN I-Gene
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
, , O
called VBN O
CD28 NNP B-Gene
- : I-Gene
responsive JJ I-Gene
element NN I-Gene
. . O

Here RB O
we PRP O
report VBP O
that IN O
CD28 NNP B-Gene
engagement NN O
, , O
however RB O
, , O
exerts VBZ O
opposite JJ O
effects NNS O
on IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
. . O

The DT O
activity NN O
of IN O
constructs NNS O
containing VBG O
5 CD B-Gene
' POS I-Gene
deletion NN I-Gene
mutants NNS I-Gene
of IN O
the DT O
alpha NN B-Gene
4 CD I-Gene
gene NN I-Gene
promoter NN I-Gene
was VBD O
compared VBN O
in IN O
transfection NN O
assays NNS O
into IN O
cell NN O
lines NNS O
that WDT O
express VBP O
alpha RB B-Gene
4 CD I-Gene
and CC O
cell NN O
lines NNS O
that WDT O
do VBP O
not RB O
. . O

The DT O
sequence NN O
between IN O
position NN O
- : B-Gene
42 CD I-Gene
and CC I-Gene
- : I-Gene
76 CD I-Gene
base NN I-Gene
pairs NN I-Gene
( ( O
bp NN O
) ) O
was VBD O
required VBN O
for IN O
efficient JJ O
transcription NN O
in IN O
cells NNS O
that IN O
express NN O
alpha RB B-Gene
4 CD I-Gene
, , O
but CC O
it PRP O
showed VBD O
no DT O
activity NN O
in IN O
HeLa NNP O
cells NNS O
, , O
which WDT O
do VBP O
not RB O
express VB O
alpha RB B-Gene
4 CD I-Gene
. . O

When WRB O
all DT O
three CD O
sites NNS O
were VBD O
present JJ O
, , O
a DT O
second JJ O
complex JJ O
` `` O
` `` O
a DT O
' '' O
' POS O
was VBD O
detected VBN O
, , O
which WDT O
contains VBZ O
an DT O
unknown JJ O
member NN O
of IN O
the DT O
Ets NNP B-Gene
family NN I-Gene
. . O

Formation NN O
of IN O
complex JJ O
a DT O
was VBD O
cell NN O
- : O
type NN O
specific NN O
and CC O
correlated VBN O
with IN O
a DT O
high JJ O
level NN O
of IN O
transcription NN O
. . O

This DT O
arrangement NN O
of IN O
Ets NNP B-Gene
sites NNS I-Gene
, , O
coupled VBN O
with IN O
the DT O
tissue NN O
- : O
and CC O
developmental JJ O
- : O
specific JJ O
expression NN O
of IN O
Ets NNP B-Gene
members NNS I-Gene
, , O
likely JJ O
play VBP O
a DT O
key JJ O
role NN O
in IN O
defining VBG O
the DT O
pattern NN O
of IN O
alpha $ B-Gene
4 CD I-Gene
integrin NN I-Gene
. . O

Antiandrogens NNS O
result VBP O
in IN O
protection NN O
of IN O
both CC O
the DT O
hinge NN B-Gene
region NN I-Gene
and CC O
C NNP B-Gene
- : I-Gene
terminus NN I-Gene
of IN O
the DT O
androgen NN B-Gene
receptor NN I-Gene
agonist JJ O
proteolytic JJ O
attack NN O
, , O
whereas IN O
other JJ O
studies NNS O
showed VBD O
that IN O
antiestrogens NNS O
and CC O
antiprogestagens NNS O
expose VBP O
the DT O
C NNP B-Gene
- : I-Gene
terminal JJ I-Gene
end NN I-Gene
of IN O
the DT O
ligand NN B-Gene
binding VBG I-Gene
domain NN I-Gene
of IN O
their PRP$ O
respective JJ O
receptors NNS O
to TO O
protease VB B-Gene
. . O

However RB O
, , O
reagents NNS O
such JJ O
as IN O
nerve NN B-Gene
growth NN I-Gene
factor NN I-Gene
( ( O
NGF NNP B-Gene
) ) O
and CC O
the DT O
phorbol NN O
ester NN O
phorbol NN O
12 CD O
- : O
myristate NN O
13 CD O
- : O
acetate NN O
( ( O
PMA NNP O
) ) O
, , O
which WDT O
induce VBP O
phenotypical JJ O
differentiation NN O
of IN O
the DT O
SH NNP O
- : O
SY5Y NNP O
neuroblastoma RB O
cell NN O
line NN O
, , O
activated VBD O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
but CC O
only RB O
in IN O
that DT O
particular JJ O
cell NN O
line NN O
. . O

To TO O
identify VB O
ets NNS B-Gene
- : I-Gene
related JJ I-Gene
transcriptional JJ I-Gene
regulators NNS I-Gene
expressed VBN O
in IN O
pre NN O
- : O
B NN O
lymphocytes VBZ O
that IN O
may MD O
interact VB O
with IN O
either DT O
the DT O
pi NN B-Gene
or CC O
the DT O
microB JJ B-Gene
site NN I-Gene
, , O
we PRP O
have VBP O
used VBN O
a DT O
PCR NNP O
approach NN O
with IN O
degenerate JJ O
oligonucleotides NNS O
encoding VBG O
conserved JJ O
sequences NNS O
in IN O
all DT O
members NNS O
of IN O
the DT O
ets NNS B-Gene
family NN I-Gene
. . O

We PRP O
have VBP O
cloned VBN O
the DT O
gene NN O
for IN O
a DT O
new JJ O
ets NNS B-Gene
- : I-Gene
related VBN I-Gene
transcription NN I-Gene
factor NN I-Gene
, , O
ERP NNP B-Gene
( ( O
ets NNS B-Gene
- : I-Gene
related VBN I-Gene
protein NN I-Gene
) ) O
, , O
from IN O
the DT O
murine NN O
pre NN O
- : O
B NNP O
cell NN O
line NN O
BASC NNP O
6C2 CD O
and CC O
from IN O
mouse NN O
lung NN O
tissue NN O
. . O

Full NNP O
- : O
length NN O
ERP NNP B-Gene
expresses VBZ O
only RB O
negligible JJ O
DNA NNP O
- : O
binding NN O
activity NN O
by IN O
itself PRP O
. . O

Two CD O
cis SYM B-Gene
- : I-Gene
acting VBG I-Gene
elements NNS I-Gene
GM NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
/ NNP I-Gene
GC NNP I-Gene
- : I-Gene
box NN I-Gene
and CC O
CLE0 NNP B-Gene
, , O
of IN O
the DT O
granulocyte NN B-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
( ( I-Gene
GM NNP I-Gene
- : I-Gene
CSF NNP I-Gene
) ) I-Gene
gene NN I-Gene
are VBP O
required VBN O
for IN O
maximal JJ O
induction NN O
in IN O
Jurkat NNP O
T NNP O
cells NNS O
by IN O
costimulation NN O
with IN O
phorbol NN O
- : O
12 CD O
- : O
myristate NN O
acetate NN O
( ( O
PMA NNP O
) ) O
and CC O
Ca2 NNP O
+ NNP O
ionophore NN O
( ( O
A23187 NNP O
) ) O
. . O

Nonpituitary JJ B-Gene
human JJ I-Gene
prolactin NN I-Gene
gene NN I-Gene
transcription NN O
is VBZ O
independent JJ O
of IN O
Pit NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
differentially RB O
controlled VBN O
in IN O
lymphocytes NNS O
and CC O
in IN O
endometrial JJ O
stroma NN O
. . O

Our PRP$ O
experiments NNS O
also RB O
show VBP O
that IN O
activated VBD O
PR NNP B-Gene
does VBZ O
not RB O
confer VB O
direct JJ O
transcriptional JJ O
control NN O
on IN O
the DT O
dPRL NN B-Gene
promoter NN I-Gene
. . O

One CD O
of IN O
the DT O
nuclear JJ B-Gene
factors NNS I-Gene
( ( O
NFs NNP B-Gene
) ) O
that WDT O
regulates VBZ O
the DT O
response NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
promoter NN I-Gene
to TO O
cAMP VB O
and CC O
PMA NNP O
has VBZ O
properties NNS O
similar JJ O
to TO O
NF NNP B-Gene
for IN O
activated VBN O
t NN O
cell NN O
. . O

JNK NNP B-Gene
is VBZ O
involved VBN O
in IN O
signal JJ O
integration NN O
during IN O
costimulation NN O
of IN O
T NNP O
lymphocytes NNS O
. . O

T NNP O
lymphocyte CC O
activation NN O
and CC O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
production NN O
require NN O
at IN O
least JJS O
two CD O
signals NNS O
, , O
generated VBN O
by IN O
phorbol NN O
ester NN O
( ( O
TPA NNP O
) ) O
and CC O
Ca2 NNP O
+ NNP O
ionophore NN O
or CC O
costimulation NN O
of IN O
the DT O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
( ( O
TCR NNP B-Gene
) ) O
and CC O
the DT O
CD28 NNP B-Gene
auxiliary JJ I-Gene
receptor NN I-Gene
. . O

Full NNP O
activation NN O
of IN O
the DT O
MAP NNP B-Gene
kinases VBZ I-Gene
that WDT O
phosphorylate VBP O
the DT O
Jun NNP B-Gene
activation NN I-Gene
domain NN I-Gene
, , O
JNK1 NNP B-Gene
and CC O
JNK2 NNP B-Gene
, , O
required VBN O
costimulation NN O
of IN O
T NNP O
cells NNS O
with IN O
either DT O
TPA NNP O
and CC O
Ca2 NNP O
+ NNP O
ionophore NN O
or CC O
antibodies NNS O
to TO O
TCR NNP B-Gene
and CC O
CD28 NNP B-Gene
. . O

The DT O
effect NN O
of IN O
a DT O
liposomal JJ O
formulation NN O
of IN O
methylprednisolone NN O
( ( O
MPL NNP O
) ) O
on IN O
the DT O
inhibition NN O
of IN O
lymphocyte JJ O
proliferation NN O
in IN O
spleen JJ O
cells NNS O
was VBD O
investigated VBN O
following VBG O
IV NNP O
dosing VBG O
in IN O
rats NNS O
. . O

Liposomes NNS O
do VBP O
not RB O
alter VB O
the DT O
suppressive JJ O
action NN O
of IN O
MPL NNP O
when WRB O
placed VBN O
in IN O
lymphocyte JJ O
culture NN O
. . O

Inhibition NN O
effects NNS O
versus JJ O
time NN O
were VBD O
described VBN O
by IN O
a DT O
pharmacodynamic JJ O
model NN O
using VBG O
MPL NNP O
concentrations NNS O
in IN O
plasma NN O
as IN O
an DT O
input NN O
function NN O
. . O

In IN O
vivo NN O
protein NN O
- : O
DNA NN O
contacts NNS O
are VBP O
detectable JJ O
at IN O
Ii NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
- : I-Gene
1 CD I-Gene
in IN O
cell NN O
lines NNS O
in IN O
which WDT O
this DT O
site NN O
is VBZ O
functional JJ O
as IN O
either CC O
a DT O
positive JJ B-Gene
or CC I-Gene
negative JJ I-Gene
regulator NN I-Gene
. . O

Ii NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
a DT O
site NN O
of IN O
positive JJ O
regulation NN O
in IN O
B NNP O
- : O
cell NN O
lines NNS O
and CC O
a DT O
site NN O
of IN O
negative JJ O
regulation NN O
in IN O
H9 NNP O
T NNP O
cells NNS O
, , O
myelomonocytic JJ O
, , O
and CC O
glial JJ O
cell NN O
lines NNS O
. . O

Again RB O
, , O
in IN O
vitro JJ O
supershift NN O
studies NNS O
indicate VBP O
that IN O
the DT O
presence NN O
of IN O
p50 NN B-Gene
, , O
p52 NN B-Gene
, , O
p65 NN B-Gene
, , O
and CC O
cRel VB B-Gene
correlates NNS O
with IN O
positive JJ O
function NN O
whereas IN O
the DT O
presence NN O
of IN O
only JJ O
p50 NN B-Gene
and CC O
p52 NN B-Gene
correlates NNS O
with IN O
negative JJ O
function NN O
. . O

OBJECTIVE NN O
: : O
To TO O
determine VB O
whether IN O
activation NN O
of IN O
Epstein NNP O
- : O
Barr NNP O
virus NN O
( ( O
EBV NNP O
) ) O
replication NN O
in IN O
tumour JJ O
cells NNS O
of IN O
AIDS NNP O
- : O
related VBN O
non JJ O
- : O
Hodgkin NNP O
' POS O
s NN O
lymphoma NN O
( ( O
ARNHL NNP O
) ) O
is VBZ O
correlated VBN O
with IN O
CD4 NNP B-Gene
+ NNP I-Gene
cell NN O
counts NNS O
and CC O
influences NNS O
antibody VBP O
response NN O
to TO O
EBV NNP O
[ NNP O
anti SYM B-Gene
- : I-Gene
Z NN I-Gene
Epstein NNP I-Gene
- : I-Gene
Barr NNP I-Gene
replicative JJ I-Gene
activator NN I-Gene
( ( O
ZEBRA NNP B-Gene
) ) O
, , O
anti SYM B-Gene
- : I-Gene
early JJ I-Gene
antigen NN I-Gene
( ( O
EA NNP B-Gene
) ) O
, , O
anti SYM B-Gene
- : I-Gene
viral JJ I-Gene
capsid NN I-Gene
antigen NN I-Gene
( ( O
VCA NNP B-Gene
) ) O
] NN O
. . O

DESIGN NN O
: : O
Retrospective NNP O
study NN O
based VBN O
on IN O
immunohistochemistry NN O
and CC O
in IN O
situ JJ O
hybridization NN O
to TO O
detect VB O
EBV NNP O
replicative JJ O
gene NN O
products NNS O
in IN O
tissue NN O
samples NNS O
from IN O
patients NNS O
affected VBN O
by IN O
ARNHL NNP O
and CC O
correlation NN O
with IN O
CD4 NNP B-Gene
+ NNP I-Gene
cell NN O
counts NNS O
and CC O
results NNS O
of IN O
EBV NNP O
serology NN O
( ( O
including VBG O
anti SYM O
- : O
ZEBRA NNP B-Gene
activity NN O
) ) O
in IN O
sera NN O
from IN O
the DT O
same JJ O
patients NNS O
. . O

In IN O
cells NNS O
stimulated VBN O
with IN O
anti JJ B-Gene
- : I-Gene
CD3 NNP I-Gene
mAb NN I-Gene
, , O
PGE2 NNP B-Gene
inhibited VBD O
cell NN O
proliferation NN O
and CC O
the DT O
production NN O
of IN O
all PDT O
the DT O
cytokines NNS B-Gene
examined VBD O
. . O

Addition NN O
of IN O
rIL NN B-Gene
- : I-Gene
2 CD I-Gene
fully RB O
restored VBD O
the DT O
proliferative JJ O
response NN O
and CC O
partially RB O
restored VBD O
the DT O
production NN O
of IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
, , O
but CC O
not RB O
that IN O
of IN O
other JJ O
cytokines NNS B-Gene
. . O

It PRP O
seems VBZ O
therefore IN O
that DT O
PGE2 NNP B-Gene
, , O
by IN O
elevating VBG O
cAMP NN O
levels NNS O
, , O
interferes VBZ O
with IN O
the DT O
activation NN O
pathway NN O
for IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
but CC O
not RB O
for IN O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
, , O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
or CC O
CLE0 NNP B-Gene
binding VBG I-Gene
protein NN I-Gene
. . O

Moreover RB O
, , O
rapamycin NN O
, , O
an DT O
inhibitor NN O
of IN O
pp70S6K JJ B-Gene
activation NN O
, , O
had VBD O
no DT O
effect NN O
on IN O
induction NN O
of IN O
EGR NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
. . O

In IN O
contrast NN O
, , O
analysis NN O
of IN O
pp90rsk NN B-Gene
activity NN O
by IN O
phosphorylation NN O
of IN O
a DT O
peptide NN O
derived VBN O
from IN O
S6 NNP B-Gene
protein NN I-Gene
demonstrated VBD O
stimulation NN O
of IN O
this DT O
kinase NN B-Gene
in IN O
TPA NNP O
- : O
treated VBD O
U NNP O
- : O
937 CD O
, , O
and CC O
not RB O
TUR NNP O
, , O
cells NNS O
. . O

PDTC NNP O
or CC O
N NNP O
- : O
acetylcysteine NN O
dose NN O
dependently RB O
reduced VBD O
TNF NNP B-Gene
- : I-Gene
induced VBD I-Gene
VCAM NNP I-Gene
- : I-Gene
1 CD I-Gene
but CC O
not RB O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
surface NN I-Gene
protein NN I-Gene
( ( O
also RB O
in IN O
human JJ O
umbilical JJ O
arterial JJ O
endothelial JJ O
cells NNS O
) ) O
and CC O
mRNA JJ O
expression NN O
( ( O
by IN O
70 CD O
% NN O
at IN O
100 CD O
mumol NN O
/ NNP O
L NNP O
PDTC NNP O
) ) O
in IN O
HUVECs NNP O
as IN O
assessed VBN O
by IN O
flow JJ O
cytometry NN O
and CC O
polymerase NN O
chain NN O
reaction NN O
. . O

We PRP O
have VBP O
identified VBN O
a DT O
` `` B-Gene
` `` I-Gene
two CD I-Gene
- : I-Gene
handed VBD I-Gene
' POS I-Gene
' '' I-Gene
zinc NN I-Gene
finger NN I-Gene
protein NN I-Gene
, , O
denoted VBD O
ZEB NNP B-Gene
, , O
the DT O
DNA NNP O
- : O
binding VBG O
specificity NN O
of IN O
which WDT O
mimics NNS O
that IN O
of IN O
the DT O
cellular JJ B-Gene
repressor NN I-Gene
. . O

By IN O
employing VBG O
a DT O
derivative JJ O
E NN B-Gene
box NN I-Gene
that IN O
binds VBZ O
ZEB NNP B-Gene
but CC O
not RB O
E2A NNP B-Gene
, , O
we PRP O
have VBP O
shown VBN O
that IN O
the DT O
repressor NN B-Gene
is VBZ O
active JJ O
in IN O
B NNP O
cells NNS O
and CC O
the DT O
IgH NNP B-Gene
enhancer NN I-Gene
is VBZ O
silenced VBN O
in IN O
the DT O
absence NN O
of IN O
binding VBG O
competition NN O
by IN O
bHLH NN B-Gene
proteins NNS I-Gene
. . O

Effects NNS O
of IN O
the DT O
antisense NN O
myb NN O
expression NN O
on IN O
hemin NN O
- : O
and CC O
erythropoietin VB O
- : O
induced VBN O
erythroid JJ O
differentiation NN O
of IN O
K562 NNP O
cells NNS O
. . O

In IN O
order NN O
to TO O
elucidate VB O
the DT O
role NN O
of IN O
c SYM B-Gene
- : I-Gene
myb NN I-Gene
gene NN I-Gene
in IN O
erythroid JJ O
differentiation NN O
of IN O
K562 NNP O
cell NN O
induced VBN O
by IN O
hemin NN B-Gene
( ( O
Hm NNP B-Gene
) ) O
and CC O
erythropoietin NN B-Gene
( ( O
Epo NNP B-Gene
) ) O
, , O
we PRP O
constructed VBD O
recombinant JJ B-Gene
plasmid NN I-Gene
that WDT O
could MD O
produce VB O
antisense JJ B-Gene
myb NN I-Gene
RNA NNP I-Gene
after IN O
induction NN O
with IN O
dexamethasone NN O
. . O

During IN O
treatment NN O
with IN O
Hm NNP B-Gene
, , O
K562 NNP O
cells NNS O
constitutively RB O
expressed VBD O
c SYM B-Gene
- : I-Gene
myb NN I-Gene
mRNA NN I-Gene
, , O
and CC O
50 CD O
% NN O
of IN O
them PRP O
began VBD O
to TO O
synthesize VB O
hemoglobin NN B-Gene
( ( O
Hb NNP B-Gene
) ) O
. . O

We PRP O
investigated VBD O
whether IN O
non JJ O
- : O
abortive JJ O
maternal JJ O
infections NNS O
would MD O
compromise VB O
fetal JJ O
brain NN O
development NN O
and CC O
alter NN O
hypothalamic JJ O
- : O
pituitary JJ O
- : O
adrenocortical JJ O
( ( O
HPA NNP O
) ) O
axis VBP O
functioning VBG O
when WRB O
adult NN O
. . O

The DT O
adult NN O
male NN O
progeny NN O
( ( O
3 CD O
mo RB O
old JJ O
) ) O
of IN O
both DT O
experimental JJ O
groups NNS O
showed VBD O
increased VBN O
basal NN O
plasma NN O
corticosterone NN O
levels NNS O
. . O

Both DT O
groups NNS O
showed VBD O
substantial JJ O
decreases NNS O
in IN O
mineralocorticoid NN O
( ( O
MR NNP O
) ) O
and CC O
glucocorticoid JJ O
receptor NN O
( ( O
GR NNP O
) ) O
levels NNS O
in IN O
the DT O
hippocampus NN O
, , O
a DT O
limbic JJ O
brain NN O
structure NN O
critical JJ O
for IN O
HPA NNP O
axis NN O
regulation NN O
, , O
whereas WP O
GR NNP B-Gene
concentrations NNS O
in IN O
the DT O
hypothalamus NN O
were VBD O
unchanged JJ O
and CC O
in IN O
anterior JJ O
pituitary JJ O
were VBD O
slightly RB O
increased VBN O
. . O

HRBC NNP O
and CC O
LPS NNP O
indeed RB O
stimulated VBD O
the DT O
maternal JJ O
immune NN O
system NN O
as IN O
revealed VBN O
by IN O
specific JJ O
anti JJ B-Gene
- : I-Gene
HRBC NN I-Gene
antibody NN I-Gene
production NN O
and CC O
enhanced VBD O
IL NNP O
- : O
1 CD O
beta NN O
mRNA NN O
expression NN O
in IN O
splenocytes NNS O
, , O
respectively RB O
. . O

NM23 NNP B-Gene
was VBD O
identified VBN O
in IN O
a DT O
system NN O
of IN O
murine NN O
melanoma NN O
cell NN O
lines NNS O
, , O
in IN O
which WDT O
an DT O
inverse NN O
relationship NN O
was VBD O
found VBN O
between IN O
NM23 NNP B-Gene
expression NN O
and CC O
metastatic JJ O
ability NN O
. . O

The DT O
transmission NN O
of IN O
signals NNS O
from IN O
the DT O
membrane NN O
to TO O
the DT O
nucleus NN O
is VBZ O
mediated VBN O
principally RB O
through IN O
the DT O
action NN O
of IN O
protein NN B-Gene
tyrosine NN I-Gene
and CC I-Gene
serine NN I-Gene
/ NNP I-Gene
threonine NN I-Gene
kinases NNS I-Gene
. . O

Fos NNP B-Gene
kinase NN I-Gene
may MD O
play VB O
a DT O
role NN O
in IN O
transcriptional JJ O
regulation NN O
through IN O
its PRP$ O
capacity NN O
to TO O
phosphorylate VB O
c SYM B-Gene
- : I-Gene
Fos NN I-Gene
at IN O
a DT O
site NN O
required VBN O
for IN O
expression NN O
of IN O
the DT O
transcriptional JJ O
transrepressive JJ O
activity NN O
of IN O
this DT O
molecule NN O
. . O

Each DT O
of IN O
the DT O
remaining VBG O
four CD O
patients NNS O
also RB O
yielded VBN O
at IN O
least JJS O
one CD O
type NN O
- : O
specific JJ O
T NNP O
- : O
cell NN O
clone NN O
reactive NN O
with IN O
an DT O
HSV NNP O
- : O
2 CD O
epitope NN O
mapping NN O
to TO O
approximately RB O
0 CD O
. . O
67 CD O
to TO O
0 CD O
. . O
73 CD O
map JJ O
units NNS O
. . O

Human NNP O
T NNP O
- : O
cell NN O
clones NNS O
reactive VBP O
with IN O
gC NN B-Gene
and CC O
VP16 NNP B-Gene
are VBP O
reported VBN O
here RB O
for IN O
the DT O
first JJ O
time NN O
. . O

We PRP O
studied VBD O
genomic JJ B-Gene
DNA NNP I-Gene
and CC O
RNA NNP O
extracted VBD O
from IN O
the DT O
patient NN O
' POS O
s JJ O
peripheral JJ O
leucocytes NNS O
in IN O
order NN O
to TO O
determine VB O
the DT O
origin NN O
of IN O
the DT O
basophils NNS O
. . O

The DT O
RAR NNP B-Gene
alpha NN I-Gene
rearranged VBD O
band NN O
in IN O
the DT O
Southern NNP O
blot NN O
analysis NN O
and CC O
a DT O
chimaeric JJ B-Gene
product NN I-Gene
of IN O
PML NNP B-Gene
- : I-Gene
RAR NNP I-Gene
alpha NN I-Gene
by IN O
polymerase NN O
chain NN O
reaction NN O
were VBD O
strongly RB O
visible JJ O
before IN O
ATRA NNP O
treatment NN O
, , O
but CC O
at IN O
the DT O
time NN O
of IN O
maximal JJ O
basophilia NNS O
both DT O
of IN O
them PRP O
were VBD O
markedly RB O
diminished VBN O
. . O

Activation NN O
of IN O
the DT O
interleukin JJ B-Gene
6 CD I-Gene
gene NN I-Gene
by IN O
Mycobacterium NNP O
tuberculosis NN O
or CC O
lipopolysaccharide NN O
is VBZ O
mediated VBN O
by IN O
nuclear JJ B-Gene
factors NNS I-Gene
NF NNP I-Gene
- : I-Gene
IL6 NN I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
[ NNP O
published VBD O
erratum JJ O
appears VBZ O
in IN O
Proc NNP O
Natl NNP O
Acad NNP O
Sci NNP O
U NNP O
S NNP O
A NNP O
1995 CD O
Apr NNP O
11 CD O
; : O
92 CD O
( ( O
8 CD O
) ) O
: : O
3632 CD O
] NN O

In IN O
this DT O
regard NN O
, , O
the DT O
cytokine NN B-Gene
interleukin NN B-Gene
6 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
) ) O
may MD O
play VB O
a DT O
role NN O
in IN O
the DT O
clinical JJ O
manifestations NNS O
and CC O
pathological JJ O
events NNS O
of IN O
tuberculosis NN O
infection NN O
. . O

LAM NNP B-Gene
and CC O
LPS NNP O
were VBD O
potent JJ O
inducers NNS O
of IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
gene NN I-Gene
expression NN O
in IN O
peripheral JJ O
blood NN O
monocytes NNS O
. . O

Two CD O
nuclear JJ B-Gene
factor NN I-Gene
NF NNP I-Gene
- : I-Gene
IL6 NNP I-Gene
( ( O
positions NNS O
- : B-Gene
153 CD I-Gene
to TO I-Gene
- : I-Gene
145 CD I-Gene
and CC O
- : O
83 CD O
to TO O
- : O
75 CD O
) ) O
and CC O
one CD O
nuclear JJ B-Gene
factor NN I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( I-Gene
positions NNS I-Gene
- : I-Gene
72 CD I-Gene
to TO I-Gene
- : I-Gene
63 CD I-Gene
) ) I-Gene
motifs NNS I-Gene
are VBP O
present JJ O
within IN O
this DT O
fragment NN O
. . O

We PRP O
conclude VBP O
that IN O
the DT O
NF NNP B-Gene
- : I-Gene
IL6 NN I-Gene
and CC I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
sites VBZ I-Gene
mediate VBP O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
induction NN O
in IN O
response NN O
to TO O
both DT O
LPS NNP O
and CC O
LAM NNP B-Gene
, , O
acting VBG O
as IN O
bacterial JJ B-Gene
or CC I-Gene
mycobacterial JJ I-Gene
response NN I-Gene
elements NNS I-Gene
. . O

Using VBG O
FACS NNP O
, , O
Northern NNP O
blotting NN O
, , O
and CC O
nuclear JJ O
run NN O
- : O
on IN O
analyses NNS O
, , O
we PRP O
demonstrate VBP O
that IN O
the DT O
up RP O
- : O
regulation NN O
of IN O
CD14 NNP B-Gene
expression NN O
during IN O
monocytic JJ O
cell NN O
maturation NN O
is VBZ O
regulated VBN O
mainly RB O
at IN O
the DT O
level NN O
of IN O
gene NN O
transcription NN O
, , O
and CC O
that IN O
new JJ O
protein JJ O
synthesis NN O
is VBZ O
required VBN O
for IN O
CD14 NNP B-Gene
induction NN O
. . O

This DT O
region NN O
contains VBZ O
two CD O
binding NN B-Gene
sites NNS I-Gene
for IN O
the DT O
Sp1 NNP B-Gene
transcription NN I-Gene
factor NN I-Gene
. . O

UV NNP O
irradiation NN O
and CC O
H2O2 NNP O
treatment NN O
of IN O
T NNP O
lymphocytes VBZ O
induce VBP O
protein JJ O
tyrosine NN O
phosphorylation NN O
and CC O
Ca2 NNP O
+ NNP O
signals NNS O
similar JJ O
to TO O
those DT O
observed VBN O
following VBG O
biological JJ O
stimulation NN O
. . O

Similarly RB O
, , O
Jurkat NNP O
T NNP O
cell NN O
lines NNS O
deficient NN O
in IN O
CD3 NNP O
or CC O
CD45 NNP O
expression NN O
also RB O
gave VBD O
impaired VBN O
UV NNP O
responses NNS O
. . O

Inhibition NN O
of IN O
the DT O
differentiation NN O
of IN O
human JJ O
myeloid NN O
cell NN O
lines NNS O
by IN O
redox NN O
changes NNS O
induced VBD O
through IN O
glutathione NN O
depletion NN O
. . O

The DT O
glutathione NN O
- : O
depleting NN O
agent NN O
diethyl NN O
maleate NN O
( ( O
DEM NNP O
) ) O
prevented VBD O
the DT O
development NN O
of IN O
differentiated JJ O
features NNS O
in IN O
response NN O
to TO O
phorbol NN O
esters NNS O
, , O
including VBG O
adherence NN O
of IN O
the DT O
cells NNS O
to TO O
plastic VB O
surfaces NNS O
and CC O
repression NN O
of IN O
the DT O
myeloperoxidase NN B-Gene
and CC I-Gene
CD34 NNP I-Gene
genes NNS I-Gene
. . O

This DT O
nuclear JJ B-Gene
complex NN I-Gene
was VBD O
activated VBN O
by IN O
LPS NNP O
with IN O
kinetics NNS O
that WDT O
preceded VBD O
induction NN O
of IN O
the DT O
TF NNP B-Gene
gene NN I-Gene
. . O

Human NNP O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
Nef NNP O
protein VBD O
down RP O
- : O
regulates VBZ O
transcription JJ B-Gene
factors NNS I-Gene
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
human JJ O
T NNP O
cells NNS O
in IN O
vitro NN O
after IN O
T NNP O
- : O
cell NN O
receptor NN O
stimulation NN O
. . O

To TO O
define VB O
the DT O
mechanism NN O
of IN O
action NN O
of IN O
the DT O
Nef NNP B-Gene
protein NN O
, , O
the DT O
signal JJ O
transduction NN O
pathways NNS O
which WDT O
may MD O
be VB O
affected VBN O
in IN O
T NNP O
cells NNS O
by IN O
constitutive JJ O
expression NN O
of IN O
the DT O
nef JJ O
gene NN O
were VBD O
examined VBN O
. . O

Stimulation NN O
of IN O
T NNP O
cells NNS O
with IN O
tumor NN O
necrosis NN O
factor NN O
, , O
interleukin JJ O
- : O
1 CD O
, , O
or CC O
lipopolysaccharide RB O
resulted VBN O
in IN O
the DT O
recruitment NN O
of IN O
transcriptional JJ O
factors NNS O
to TO O
a DT O
similar JJ O
level NN O
whether IN O
or CC O
not RB O
the DT O
cells NNS O
expressed VBD O
the DT O
nef JJ O
gene NN O
. . O

When WRB O
cells NNS O
were VBD O
preincubated VBN O
with IN O
dihydrolipoic JJ O
acid NN O
( ( O
0 CD O
. . O
2 CD O
mM NN O
) ) O
the DT O
expression NN O
of IN O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
mRNA NN I-Gene
was VBD O
suppressed VBN O
at IN O
30 CD O
min NN O
after IN O
stimulation NN O
of IN O
TPA NNP O
( ( O
0 CD O
. . O
5 CD O
microM NN O
) ) O
whereas NN O
in IN O
the DT O
case NN O
of IN O
preincubation NN O
of IN O
alpha JJ O
- : O
lipoic NN O
acid NN O
( ( O
0 CD O
. . O
2 CD O
microM NN O
) ) O
, , O
the DT O
expression NN O
was VBD O
enhanced VBN O
at IN O
30 CD O
min NN O
. . O

This DT O
resulted VBD O
in IN O
only RB O
a DT O
partial JJ O
inhibition NN O
of IN O
TNF NNP B-Gene
- : O
or CC O
PMA NNP O
- : O
induced VBD O
HIV NNP O
replication NN O
in IN O
U1 NNP O
cells NNS O
, , O
and CC O
no DT O
detectable JJ O
effect NN O
on IN O
HIV NNP O
replication NN O
in IN O
chronically RB O
infected VBN O
U937 NNP O
cells NNS O
. . O

Another DT O
limitation NN O
is VBZ O
that IN O
antioxidant JJ O
concentrations NNS O
high JJ O
enough RB O
to TO O
block VB O
NK NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
were VBD O
shown VBN O
to TO O
have VB O
a DT O
suppressive JJ O
effect NN O
on IN O
immune JJ O
functions NNS O
in IN O
vitro NN O
, , O
because IN O
NAC NNP O
and CC O
BHA NNP O
blocked VBD O
IL NNP O
- : O
2 CD O
- : O
induced VBN O
PBMC NNP O
proliferation NN O
. . O

We PRP O
have VBP O
developed VBN O
a DT O
three CD O
- : O
layer NN O
Percoll NNP O
density NN O
gradient NN O
that WDT O
allows VBZ O
separation NN O
of IN O
the DT O
different JJ O
granules NNS O
and CC O
vesicles NNS O
from IN O
human JJ O
neutrophils NNS O
; : O
in IN O
particular JJ O
, , O
it PRP O
allows VBZ O
separation NN O
of IN O
specific JJ O
and CC O
gelatinase JJ O
granules NNS O
. . O

This DT O
allows VBZ O
us PRP O
to TO O
characterize VB O
these DT O
two CD O
granule NN O
populations NNS O
with IN O
regard NN O
to TO O
their PRP$ O
content NN O
of IN O
membrane NN B-Gene
proteins NNS I-Gene
, , O
which WDT O
become VBP O
incorporated VBN O
into IN O
the DT O
plasma JJ O
membrane NN O
during IN O
exocytosis NN O
. . O

Furthermore RB O
, , O
we PRP O
found VBD O
that IN O
20 CD O
% NN O
to TO O
25 CD O
% NN O
of IN O
both CC O
the DT O
adhesion NN B-Gene
protein NN I-Gene
Mac NNP I-Gene
- : I-Gene
1 CD I-Gene
and CC O
the DT O
NADPH NNP B-Gene
- : I-Gene
oxidase NN I-Gene
component JJ I-Gene
cytochrome NN I-Gene
b558 NN B-Gene
is VBZ O
localized VBN O
in IN O
gelatinase NN B-Gene
granules NNS O
. . O

This DT O
shows VBZ O
that IN O
gelatinase NN B-Gene
granules NNS O
are VBP O
functionally RB O
important JJ O
relative NN O
to TO O
specific JJ O
granules NNS O
in IN O
mediating VBG O
early JJ O
inflammatory NN O
responses NNS O
. . O

Treatment NN O
of IN O
human JJ O
resting VBG O
T NNP O
cells NNS O
with IN O
phorbol NN O
esters NNS O
strongly RB O
induced VBD O
the DT O
expression NN O
of IN O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha NN I-Gene
and CC O
the DT O
activation NN O
of IN O
NF NNP B-Gene
. . I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

Rather RB O
, , O
the DT O
data NNS O
indicate VBP O
that IN O
mitogen NN O
increases VBZ O
the DT O
levels NNS O
of IN O
a DT O
nuclear JJ O
factor NN O
( ( O
s NN O
) ) O
that WDT O
dimerizes VBZ O
with IN O
CREB NNP B-Gene
. . O

We PRP O
have VBP O
examined VBN O
the DT O
effect NN O
of IN O
alpha NN O
- : O
tocopherol NN O
( ( O
alpha JJ O
- : O
tcp NN O
) ) O
on IN O
one CD O
cellular JJ O
event NN O
in IN O
atherosclerotic JJ O
plaque NN O
development NN O
, , O
monocyte JJ O
adhesion NN O
to TO O
stimulated VBN O
endothelial JJ O
cells NNS O
( ( O
ECs NNP O
) ) O
. . O

Agonist NNP O
- : O
induced VBD O
monocytic JJ O
cell NN O
adhesion NN O
, , O
but CC O
not RB O
basal JJ O
adhesion NN O
, , O
was VBD O
inhibited VBN O
in IN O
a DT O
time NN O
- : O
and CC O
concentration NN O
- : O
dependent JJ O
manner NN O
by IN O
alpha JJ O
- : O
tcp NN O
. . O

Central NNP O
nervous JJ O
system NN O
- : O
derived VBN O
cells NNS O
express RBR O
a DT O
kappa NN O
B NNP O
- : O
binding NN O
activity NN O
that WDT O
enhances VBZ O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
transcription NN O
in IN O
vitro NN O
and CC O
facilitates VBZ O
TAR NNP B-Gene
- : O
independent JJ O
transactivation NN O
by IN O
Tat NNP B-Gene
. . O

Tat NNP B-Gene
transactivation NN O
mediated VBN O
by IN O
the DT O
kappa NN B-Gene
B NNP I-Gene
domain NN I-Gene
is VBZ O
sufficient JJ O
to TO O
allow VB O
replication NN O
of IN O
TAR NNP B-Gene
- : O
deleted VBD O
mutant JJ O
HIV NNP O
- : O
1 CD O
in IN O
astrocytes NNS O
. . O

For IN O
one CD O
of IN O
these DT O
proteins NNS O
, , O
p57 NN B-Gene
, , O
binding VBG O
to TO O
the DT O
IRES NNP B-Gene
correlates VBZ O
with IN O
translation NN O
. . O

Retinoid NNP B-Gene
- : I-Gene
like IN I-Gene
receptors NNS I-Gene
play VBP O
a DT O
central JJ O
role NN O
in IN O
hormonal JJ O
responses NNS O
by IN O
forming VBG O
heterodimers NNS B-Gene
with IN O
other JJ O
nuclear JJ B-Gene
hormone NN I-Gene
receptors NNS I-Gene
. . O

Hence NNP O
, , O
PPAR NNP B-Gene
can MD O
positively RB O
or CC O
negatively RB O
influence JJ O
TH NNP O
action NN O
depending VBG O
on IN O
TRE NNP B-Gene
structure NN O
and CC O
THR NNP B-Gene
isotype NN I-Gene
. . O

Comparison NNP O
of IN O
retinoic NN O
acid NN O
and CC O
phorbol NN O
myristate NN O
acetate NN O
as IN O
inducers NNS O
of IN O
monocytic JJ O
differentiation NN O
. . O

Several JJ O
human JJ O
myeloid NN O
leukemia NN O
cell NN O
lines NNS O
growing VBG O
in IN O
vitro NN O
can MD O
be VB O
induced VBN O
to TO O
differentiate VB O
to TO O
more JJR O
mature JJ O
monocyte NN O
/ NN O
macrophage NN O
- : O
like IN O
cells NNS O
by IN O
treatment NN O
with IN O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
- : O
activating VBG O
phorbol NN O
esters NNS O
, , O
such JJ O
as IN O
PMA NNP O
. . O

Lymphoid NNP O
cells NNS O
transformed VBN O
by IN O
Abelson NNP O
murine NN O
leukemia NN O
virus NN O
have VBP O
provided VBN O
one CD O
of IN O
the DT O
classic JJ O
models NNS O
for IN O
study NN O
of IN O
early JJ O
B NNP O
- : O
cell NN O
development NN O
and CC O
immunoglobulin JJ B-Gene
rearrangement NN O
. . O

To TO O
test VB O
this DT O
hypothesis NN O
, , O
light JJ B-Gene
- : I-Gene
chain NN I-Gene
gene NN I-Gene
structure NN I-Gene
was VBD O
examined VBN O
in IN O
pre NN O
- : O
B NNP O
cells NNS O
transformed VBN O
by IN O
temperature NN O
- : O
sensitive JJ O
mutants NNS O
of IN O
the DT O
Abelson NNP O
virus NN O
and CC O
in IN O
derivatives NNS O
that WDT O
survive VBP O
at IN O
the DT O
nonpermissive JJ O
temperature NN O
because IN O
they PRP O
express VBP O
a DT O
human JJ B-Gene
BCL NNP I-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
. . O

Our PRP$ O
studies NNS O
reveal VBP O
that IN O
inactivation NN O
of IN O
the DT O
v NN B-Gene
- : I-Gene
abl NN I-Gene
protein NN I-Gene
tyrosine JJ I-Gene
kinase NN I-Gene
triggers NNS O
high JJ O
- : O
frequency NN O
rearrangement NN O
of IN O
kappa NN B-Gene
and CC I-Gene
lambda NN I-Gene
light JJ I-Gene
- : I-Gene
chain NN I-Gene
genes NNS I-Gene
. . O

Expression NN O
and CC O
genomic JJ O
configuration NN O
of IN O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
, , O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
, , O
M NNP B-Gene
- : I-Gene
CSF NNP I-Gene
receptor NN I-Gene
( ( O
C NNP B-Gene
- : I-Gene
FMS NN I-Gene
) ) O
, , O
early JJ B-Gene
growth NN I-Gene
response NN I-Gene
gene NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
EGR NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
and CC O
M NNP B-Gene
- : I-Gene
CSF NNP I-Gene
genes NNS I-Gene
in IN O
primary JJ O
myelodysplastic JJ O
syndromes NNS O
. . O

The DT O
expression NN O
of IN O
the DT O
M NNP B-Gene
- : I-Gene
CSF NNP I-Gene
gene NN I-Gene
, , O
that WDT O
has VBZ O
been VBN O
recently RB O
reassigned VBN O
to TO O
the DT O
short JJ B-Gene
arm NN I-Gene
of IN I-Gene
chromosome NN I-Gene
1 CD I-Gene
( ( O
lp NN B-Gene
) ) O
, , O
was VBD O
also RB O
investigated VBN O
. . O

Similar JJ O
analysis NN O
of IN O
poly NN B-Gene
( ( I-Gene
A DT I-Gene
) ) I-Gene
RNA NN I-Gene
from IN O
a DT O
variety NN O
of IN O
adult NN O
tissues NNS O
demonstrated VBD O
HB9 NNP B-Gene
transcripts NNS O
in IN O
pancreas NNS O
, , O
small JJ O
intestine NN O
, , O
and CC O
colon NN O
. . O

The DT O
observed JJ O
increase NN O
in IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
levels NNS O
might MD O
facilitate VB O
virus NNS O
spread VBP O
from IN O
or CC O
to TO O
T NNP O
cells NNS O
. . O

Recent JJ O
reports NNS O
demonstrated VBD O
that IN O
ionizing VBG O
radiation NN O
in IN O
the DT O
dose JJ O
range NN O
of IN O
2 CD O
- : O
50 CD O
Gy NNP O
results NNS O
in IN O
expression NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
human JJ O
KG NNP O
- : O
1 CD O
myeloid JJ O
leukemia NN O
cells NNS O
and CC O
human JJ O
B NNP O
- : O
lymphocyte NN O
precursor NN O
cells NNS O
; : O
the DT O
precise JJ O
mechanism NN O
involved VBN O
and CC O
the DT O
significance NN O
are VBP O
not RB O
yet RB O
known VBN O
. . O

The DT O
present JJ O
report NN O
demonstrates VBZ O
that IN O
even RB O
lower JJR O
doses NNS O
of IN O
ionizing VBG O
radiation NN O
, , O
0 CD O
. . O
25 CD O
- : O
2 CD O
. . O
0 CD O
Gy NNP O
, , O
are VBP O
capable JJ O
of IN O
inducing VBG O
expression NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
EBV NNP O
- : O
transformed VBD O
244B CD O
human JJ O
lymphoblastoid NN O
cells NNS O
. . O

The DT O
expression NN O
of IN O
the DT O
p50 NN B-Gene
and CC I-Gene
p65 NN I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
subunits NN I-Gene
was VBD O
also RB O
shown VBN O
to TO O
be VB O
regulated VBN O
differentially RB O
after IN O
exposures NNS O
to TO O
1 CD O
. . O
0 CD O
and CC O
2 CD O
. . O
0 CD O
Gy NNP O
. . O

The DT O
two CD O
human JJ B-Gene
GATA3 NNP I-Gene
zinc NN I-Gene
fingers NNS I-Gene
are VBP O
encoded VBN O
by IN O
two CD O
separate JJ O
exons NNS B-Gene
highly RB O
conserved VBN O
with IN O
those DT O
of IN O
GATA1 NNP B-Gene
, , O
but CC O
no DT O
other JJ O
structural JJ O
homologies NNS O
between IN O
these DT O
two CD O
genes NNS O
can MD O
be VB O
found VBN O
. . O

The DT O
human JJ B-Gene
and CC I-Gene
mouse NN I-Gene
GATA3 NNP I-Gene
transcription NN I-Gene
units NNS I-Gene
start VBP O
at IN O
a DT O
major JJ B-Gene
initiation NN I-Gene
site NN I-Gene
. . O

Retinoic NNP O
acid SYM O
- : O
induced JJ O
expression NN O
of IN O
CD38 NNP B-Gene
antigen NN I-Gene
in IN O
myeloid JJ O
cells NNS O
is VBZ O
mediated VBN O
through IN O
retinoic NN B-Gene
acid NN I-Gene
receptor NN I-Gene
- : I-Gene
alpha NN I-Gene
. . O

CD38 NNP B-Gene
is VBZ O
a DT O
leukocyte JJ B-Gene
differentiation NN I-Gene
antigen NN I-Gene
that WDT O
has VBZ O
been VBN O
thought VBN O
to TO O
be VB O
a DT O
phenotypic JJ O
marker NN O
of IN O
different JJ O
subpopulations NNS O
of IN O
T NNP O
- : O
and CC O
B NNP O
- : O
lymphocytes NNS O
. . O

In IN O
myeloid JJ O
cells NNS O
, , O
CD38 NNP B-Gene
is VBZ O
expressed VBN O
during IN O
early JJ O
stages NNS O
of IN O
differentiation NN O
. . O

Some DT O
antioxidants NNS O
inhibit VBP O
, , O
in IN O
a DT O
co NN O
- : O
ordinate NN O
fashion NN O
, , O
the DT O
production NN O
of IN O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
, , O
IL NNP B-Gene
- : I-Gene
beta NN I-Gene
, , O
and CC O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
by IN O
human JJ O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
. . O

Inhibition NN O
of IN O
cytokine NN B-Gene
production NN O
was VBD O
gene NN O
selective JJ O
and CC O
not RB O
due JJ O
to TO O
general JJ O
effects NNS O
on IN O
protein NN O
synthesis NN O
. . O

Much JJ O
higher JJR O
concentrations NNS O
of IN O
other JJ O
antioxidants NNS O
- : O
- : O
including VBG O
ascorbic JJ O
acid NN O
, , O
trolox NN O
, , O
alpha SYM O
- : O
tocopherol NN O
, , O
butylated VBN O
hydroxytoluene NN O
, , O
and CC O
the DT O
5 CD O
- : O
lipoxygenase NN O
inhibitor NN O
zileuton NNP O
- : O
- : O
did VBD O
not RB O
affect VB O
the DT O
production NN O
of IN O
these DT O
cytokines NNS B-Gene
. . O

Thus RB O
antioxidants NNS O
vary VBP O
widely RB O
in IN O
potency NN O
as IN O
inhibitors NNS O
of IN O
the DT O
activation NN O
of IN O
transcription NN B-Gene
factors NNS I-Gene
and CC O
of IN O
the DT O
transcription NN O
of IN O
genes NNS B-Gene
for IN O
pro JJ B-Gene
- : I-Gene
inflammatory NN I-Gene
cytokines NNS I-Gene
. . O

This DT O
protein NN O
has VBZ O
now RB O
been VBN O
purified VBN O
and CC O
its PRP$ O
encoding VBG O
gene NN O
cloned VBD O
. . O

Examination NN O
of IN O
the DT O
primary JJ O
amino NN O
acid JJ O
sequence NN O
of IN O
this DT O
protein NN O
indicates VBZ O
that IN O
it PRP O
is VBZ O
a DT O
member NN O
of IN O
the DT O
signal JJ B-Gene
transducers NNS I-Gene
and CC I-Gene
activators NNS I-Gene
of IN I-Gene
transcription NN I-Gene
( ( I-Gene
Stat NNP I-Gene
) ) I-Gene
family NN I-Gene
of IN O
DNA NNP B-Gene
binding VBG I-Gene
proteins NNS I-Gene
, , O
hereby RB O
designated VBN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
Stat NNP I-Gene
. . O

Such JJ O
observations NNS O
indicate VBP O
that IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
Stat NNP I-Gene
has VBZ O
the DT O
same JJ O
functional JJ B-Gene
domain NN I-Gene
for IN O
both DT O
receptor NN O
coupling NN O
and CC O
dimerization NN O
. . O

Lung NNP O
disease NN O
associated VBN O
with IN O
disorders NNS O
such JJ O
as IN O
cystic JJ O
fibrosis NN O
( ( O
CF NNP O
) ) O
may MD O
be VB O
amenable JJ O
to TO O
somatic JJ O
gene NN O
therapy NN O
in IN O
which WDT O
there EX O
is VBZ O
delivery NN O
of IN O
the DT O
normal JJ B-Gene
gene NN I-Gene
directly RB O
to TO O
the DT O
respiratory NN O
epithelium NN O
using VBG O
E1a NNP O
- : O
adenovirus NN O
( ( O
Ad NNP O
) ) O
type NN O
2 CD O
- : O
or CC O
5 CD O
- : O
based VBN O
vectors NNS O
. . O

In IN O
the DT O
E1a NNP O
- : O
positive JJ O
samples NNS O
, , O
the DT O
average NN O
of IN O
E1a NNP O
copy NN O
number NN O
was VBD O
55 CD O
+ JJ O
/ NNP O
- : O
18 CD O
/ JJ O
10 CD O
( ( O
3 CD O
) ) O
recovered VBD O
cells NNS O
. . O

Tumor NN O
cells NNS O
showed VBD O
an DT O
overexpression NN O
of IN O
p53 NN B-Gene
protein NNS I-Gene
and CC O
were VBD O
estrogen VBN B-Gene
receptor NN I-Gene
- : O
positive JJ O
. . O

The DT O
magnitude NN O
and CC O
time NN O
kinetics NNS O
of IN O
the DT O
LIF NNP B-Gene
effects NNS O
were VBD O
similar JJ O
to TO O
interleukin VB B-Gene
1 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
, , O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
, , O
and CC O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
( ( O
TNF NNP B-Gene
) ) O
, , O
other JJ O
cytokines NNS O
known VBN O
to TO O
induce VB O
HIV NNP O
replication NN O
in IN O
this DT O
cell NN O
line NN O
. . O

To TO O
characterize VB O
mechanisms NNS O
responsible JJ O
for IN O
these DT O
LIF NNP B-Gene
effects NNS O
, , O
levels NNS O
of IN O
HIV NNP B-Gene
mRNA NN I-Gene
, , O
activation NN O
of IN O
the DT O
DNA NNP B-Gene
binding NN I-Gene
protein NN I-Gene
nuclear JJ I-Gene
factor NN I-Gene
( ( B-Gene
NF NNP I-Gene
) ) I-Gene
- : I-Gene
kB NN I-Gene
, , O
signal JJ O
transduction NN O
pathways NNS O
, , O
and CC O
potential JJ O
interactions NNS O
with IN O
other JJ O
cytokines NNS B-Gene
were VBD O
analyzed VBN O
. . O

In IN O
both DT O
cell NN O
lines NNS O
LIF NNP B-Gene
increased VBD O
NF NNP B-Gene
- : I-Gene
kB NN I-Gene
activity NN O
. . O

Induction NN O
of IN O
NF NNP B-Gene
- : I-Gene
kB NN I-Gene
and CC O
HIV NNP O
replication NN O
by IN O
cytokines NNS B-Gene
are VBP O
at IN O
least JJS O
in IN O
part NN O
dependent NN O
on IN O
reactive JJ O
oxygen NN O
intermediates NNS O
. . O

The DT O
mechanisms NNS O
involved VBN O
in IN O
the DT O
inhibition NN O
of IN O
growth NN O
of IN O
a DT O
human JJ O
B NNP O
lymphoma NN O
cell NN O
line NN O
, , O
B104 NNP O
, , O
by IN O
anti JJ B-Gene
- : I-Gene
MHC NNP I-Gene
class NN I-Gene
II NNP I-Gene
antibodies NNS I-Gene
( ( O
Ab NNP B-Gene
) ) O
were VBD O
compared VBN O
with IN O
those DT O
in IN O
anti JJ B-Gene
- : I-Gene
IgM NNP I-Gene
Ab NNP I-Gene
- : O
induced VBD O
B104 NNP O
growth NN O
inhibition NN O
. . O

In IN O
order NN O
to TO O
study VB O
CD14 NNP B-Gene
gene NN I-Gene
regulation NN O
, , O
the DT O
human JJ B-Gene
CD14 NNP I-Gene
gene NN I-Gene
was VBD O
cloned VBN O
from IN O
a DT O
partial JJ O
EcoRI NNP B-Gene
digested VBD I-Gene
chromosome NN I-Gene
5 CD I-Gene
library NN I-Gene
. . O

Four CD O
regions NNS O
in IN O
this DT O
DNA NNP B-Gene
fragment NN I-Gene
interact NN O
with IN O
nuclear JJ B-Gene
proteins NNS I-Gene
isolated VBN O
from IN O
monocytic JJ O
cells NNS O
. . O

The DT O
Sp1 NNP B-Gene
transcription NN B-Gene
factor NN I-Gene
bound NN O
to TO O
three CD O
different JJ O
regions NNS O
in IN O
the DT O
CD14 NNP B-Gene
promoter NN I-Gene
. . O

Binding VBG O
data NNS O
were VBD O
derived VBN O
from IN O
Scatchard NNP O
analysis NN O
. . O

In IN O
fertile JJ O
women NNS O
remarkable JJ O
changes NNS O
in IN O
androgen NN B-Gene
binding NN I-Gene
sites NNS I-Gene
were VBD O
seen VBN O
in IN O
the DT O
course NN O
of IN O
the DT O
menstrual JJ O
cycle NN O
, , O
with IN O
a DT O
significant JJ O
increase NN O
in IN O
the DT O
immediate JJ O
preovulatory JJ O
period NN O
. . O

The DT O
immunological JJ O
implications NNS O
of IN O
these DT O
results NNS O
are VBP O
discussed VBN O
. . O

Stimulation NN O
of IN O
the DT O
CD28 NNP B-Gene
cell NN I-Gene
surface NN I-Gene
molecule NN I-Gene
delivers NNS O
costimulatory JJ O
signals NNS O
essential JJ O
for IN O
lymphokine JJ B-Gene
production NN O
in IN O
activated JJ O
T NNP O
cells NNS O
via IN O
a DT O
conserved JJ B-Gene
sequence NN I-Gene
element NN I-Gene
found VBN O
in IN O
the DT O
promoter NN B-Gene
of IN O
several JJ O
lymphokine JJ B-Gene
genes NNS I-Gene
. . O

Diminished VBN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
do VBP O
not RB O
result VB O
in IN O
glucocorticoid JJ O
resistance NN O
. . O

Corticosteroid NNP B-Gene
Type NNP I-Gene
I PRP I-Gene
and CC I-Gene
Type NNP I-Gene
II NNP I-Gene
receptors NNS I-Gene
are VBP O
inversely RB O
correlated VBN O
with IN O
age NN O
. . O

All DT O
- : O
trans NNS O
retinoic VBP O
acid NN O
and CC O
1 CD O
alpha NN O
, , O
25 CD O
- : O
dihydroxyvitamin NN O
D3 NNP O
co VBZ O
- : O
operate NN O
to TO O
promote VB O
differentiation NN O
of IN O
the DT O
human JJ O
promyeloid NN O
leukemia NN O
cell NN O
line NN O
HL60 NNP O
to TO O
monocytes NNS O
. . O

A DT O
basis NN O
for IN O
differentiation NN O
therapy NN O
of IN O
leukemias NN O
is VBZ O
provided VBN O
by IN O
knowledge NN O
of IN O
agents NNS O
which WDT O
induce VBP O
specific JJ O
lineage NN O
maturation NN O
. . O

That DT O
RA NNP O
promotes VBZ O
both DT O
neutrophil JJ O
and CC O
monocyte JJ O
differentiation NN O
has VBZ O
implications NNS O
for IN O
the DT O
use NN O
of IN O
RA NNP O
and CC O
D3 NNP O
in IN O
treatment NN O
of IN O
leukemias NN O
and CC O
provides VBZ O
insight JJ O
into IN O
mechanisms JJ O
whereby NN O
RAR NNP O
, , O
VDR NNP B-Gene
and CC O
RXR NNP B-Gene
facilitate VBP O
monocyte JJ O
differentiation NN O
. . O

Thrombin NNP B-Gene
and CC O
thrombin JJ B-Gene
receptor NN I-Gene
agonist NN O
peptide IN O
induce FW O
early JJ O
events NNS O
of IN O
T NNP O
cell NN O
activation NN O
and CC O
synergize VB O
with IN O
TCR NNP B-Gene
cross SYM O
- : O
linking VBG O
for IN O
CD69 NNP B-Gene
expression NN O
and CC O
interleukin JJ O
2 CD O
production NN O
. . O

There EX O
was VBD O
a DT O
good JJ O
correlation NN O
between IN O
thrombin JJ B-Gene
- : O
induced JJ O
tyrosine JJ O
phosphorylation NN O
of IN O
the DT O
latter JJ O
three CD O
proteins NNS O
and CC O
Ca2 NNP O
+ NNP O
mobilization NN O
. . O

Stress NNP O
response NN O
of IN O
senescent JJ O
T NNP O
lymphocytes NNS O
: : O
reduced VBN O
hsp70 NN B-Gene
is VBZ O
independent JJ O
of IN O
the DT O
proliferative JJ O
block NN O
. . O

Senescent NNP O
human JJ O
T NNP O
lymphocyte NN O
cultures NNS O
are VBP O
unable JJ O
to TO O
undergo VB O
proliferation NN O
, , O
but CC O
show VBP O
no DT O
difference NN O
from IN O
early JJ O
passage NN O
cells NNS O
in IN O
cytotoxic JJ O
function NN O
or CC O
surface NN O
antigenic JJ O
profile NN O
. . O

Interestingly RB O
, , O
the DT O
progressive JJ O
decline NN O
in IN O
the DT O
heat NN O
shock NN O
response NN O
of IN O
cultured JJ O
T NNP O
cells NNS O
correlates VBZ O
with IN O
the DT O
percent NN O
proliferative JJ O
life NN O
span NN O
completed VBD O
rather RB O
than IN O
with IN O
the DT O
actual JJ O
proliferative JJ O
activity NN O
at IN O
the DT O
time NN O
of IN O
heat NN O
shock NN O
. . O

Wortmannin NNP O
, , O
an DT O
inhibitor NN O
of IN O
receptor NN O
- : O
coupled VBN O
PLD NNP B-Gene
activation NN O
, , O
blocked VBD O
the DT O
anti JJ B-Gene
- : I-Gene
CD3 NNP I-Gene
- : O
induced JJ O
increases NNS O
in IN O
both DT O
PLD NNP B-Gene
activity NN O
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
enhancer NN I-Gene
activity NN O
. . O

We PRP O
found VBD O
a DT O
good JJ O
correlation NN O
in IN O
the DT O
transfected JJ O
cells NNS O
between IN O
PLD NNP B-Gene
activation NN O
and CC O
induction NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
enhancer NN I-Gene
activity NN O
under IN O
different JJ O
experimental JJ O
conditions NNS O
. . O

We PRP O
therefore RB O
reexamined VBD O
this DT O
issue NN O
by IN O
using VBG O
two CD O
different JJ O
experimental JJ O
approaches NNS O
that WDT O
allowed VBD O
LMP1 NNP B-Gene
- : O
induced JJ O
effects NNS O
to TO O
be VB O
monitored VBN O
immediately RB O
following VBG O
expression NN O
of IN O
the DT O
viral JJ O
protein NN O
and CC O
in IN O
the DT O
absence NN O
of IN O
selective JJ O
pressures NNS O
; : O
activation NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
transcription NN B-Gene
factor NN I-Gene
and CC O
upregulation NN O
of IN O
the DT O
cell NN B-Gene
adhesion NN I-Gene
molecule NN I-Gene
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
were VBD O
used VBN O
as IN O
early JJ O
indices NNS O
of IN O
LMP1 NNP B-Gene
function NN O
. . O

In IN O
the DT O
second JJ O
approach NN O
, , O
we PRP O
tested VBD O
the DT O
generality NN O
of IN O
this DT O
phenomenon NN O
by IN O
transiently RB O
expressing VBG O
LMP1 NNP B-Gene
from IN O
a DT O
strong JJ O
constitutively RB O
active JJ O
promoter NN O
in IN O
a DT O
range NN O
of IN O
different JJ O
cell NN O
types NNS O
. . O

In IN O
the DT O
same JJ O
experiments NNS O
, , O
all DT O
three CD O
non SYM O
- : O
B NNP O
- : O
cell NN O
lines NNS O
showed VBD O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
and CC O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
upregulation NN O
but CC O
never RB O
any DT O
effect NN O
upon IN O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

We PRP O
found VBD O
that IN O
tyrosine JJ B-Gene
kinase NN I-Gene
activity NN O
was VBD O
similar JJ O
for IN O
both DT O
mAbs NN B-Gene
over IN O
a DT O
period NN O
of IN O
hours NNS O
. . O

However RB O
, , O
the DT O
inositol JJ O
phosphate NN O
response NN O
was VBD O
stronger JJR O
for IN O
64 CD B-Gene
. . I-Gene
1 CD I-Gene
than IN O
for IN O
OKT3 NNP B-Gene
. . O

To TO O
tie VB O
these DT O
events NNS O
to TO O
gene NN O
activation NN O
, , O
we PRP O
measured VBD O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
AT NN I-Gene
activity NN O
in IN O
the DT O
nucleus NN O
after IN O
anti JJ B-Gene
- : I-Gene
CD3 JJ I-Gene
stimulation NN O
. . O

Both DT O
stimuli NNS O
induced VBD O
the DT O
appearance NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
components NNS I-Gene
( ( O
c SYM B-Gene
- : I-Gene
Rel NN I-Gene
, , O
p65 NN B-Gene
( ( O
RelA NNP B-Gene
) ) O
, , O
and CC O
p50 NN B-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B1 NNP I-Gene
) ) O
) ) O
and CC O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
DNA NNP O
binding VBG O
activity NN O
in IN O
the DT O
nucleus NN O
. . O

From IN O
a DT O
consecutive JJ O
series NN O
of IN O
350 CD O
cases NNS O
of IN O
adult NN O
de IN O
novo FW O
acute JJ O
myeloid NN O
leukemia NN O
( ( O
AML NNP O
) ) O
, , O
we PRP O
identified VBD O
20 CD O
cases NNS O
( ( O
6 CD O
% NN O
) ) O
with IN O
a DT O
unique JJ O
immunophenotype NN O
: : O
CD33 NNP O
+ NNP O
, , O
CD56 NNP O
+ NNP O
, , O
CD11a NNP O
+ NNP O
, , O
CD13lo NNP O
, , O
CD15lo NNP O
, , O
CD34 NNP O
+ NNP O
/ NNP O
- : O
, , O
HLA NNP B-Gene
- : I-Gene
DR NNP I-Gene
- : O
, , O
CD16 NNP B-Gene
- : O
. . O

This DT O
was VBD O
supported VBN O
by IN O
the DT O
observation NN O
that IN O
the DT O
down JJ O
- : O
regulatory JJ O
capacity NN O
of IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
appeared VBD O
to TO O
be VB O
dependent JJ O
on IN O
de IN O
novo FW O
protein JJ O
synthesis NN O
. . O

Although IN O
these DT O
data NNS O
suggest VBP O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
regulated JJ O
cytokine NN B-Gene
mRNA NN O
expression NN O
, , O
results NNS O
from IN O
PBMo NNP O
are VBP O
not RB O
in IN O
accordance NN O
with IN O
this DT O
notion NN O
. . O

These DT O
differences NNS O
may MD O
represent VB O
different JJ O
regulatory JJ O
pathways NNS O
of IN O
the DT O
two CD O
cell NN O
systems NNS O
. . O

Furthermore RB O
, , O
the DT O
present JJ O
results NNS O
demonstrate VBP O
clearly RB O
that IN O
mycoplasma NN B-Gene
products NNS I-Gene
can MD O
have VB O
a DT O
profound JJ O
impact NN O
on IN O
the DT O
activation NN O
status NN O
of IN O
eukaryotic JJ O
cells NNS O
. . O

Novel NNP B-Gene
membrane NN I-Gene
receptors NNS I-Gene
for IN O
aldosterone NN O
in IN O
human JJ O
lymphocytes NNS O
: : O
a DT O
50 CD B-Gene
kDa NN I-Gene
protein NN I-Gene
on IN O
SDS NNP O
- : O
PAGE NN O
. . O

The DT O
novel JJ O
aldosterone NN O
membrane NN O
receptor NN O
was VBD O
analyzed VBN O
on IN O
SDS NNP O
- : O
PAGE NN O
after IN O
labeling VBG O
of IN O
microsomal JJ O
membranes NNS O
from IN O
human JJ O
mononuclear JJ O
leukocytes NNS O
with IN O
a DT O
[ JJ O
125I CD O
] SYM O
- : O
aldosterone NN O
- : O
derivative NN O
by IN O
use NN O
of IN O
BASED NNP O
as IN O
a DT O
photoactivatable JJ O
crosslinker NN O
. . O

Binding NNP O
of IN O
1 CD O
nM JJ O
[ $ O
125I CD O
] NNP O
- : O
aldosterone NN O
was VBD O
found VBN O
at IN O
a DT O
molecular JJ O
weight NN O
of IN O
approximately RB O
50 CD O
kDa NNS O
which WDT O
was VBD O
absent NN O
with IN O
1 CD O
microM NNS O
cold JJ O
aldosterone NN O
, , O
but CC O
not RB O
cortisol VB O
in IN O
the DT O
binding NN O
media NNS O
. . O

It PRP O
, , O
thus RB O
, , O
appears VBZ O
as IN O
an DT O
integral JJ B-Gene
membrane NN I-Gene
protein NN I-Gene
. . O

Analysis NN O
of IN O
the DT O
chromatin JJ O
organization NN O
of IN O
the DT O
integrated JJ O
human JJ B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
type NN I-Gene
1 CD I-Gene
( ( I-Gene
HIV NNP I-Gene
- : I-Gene
1 CD I-Gene
) ) I-Gene
genome NN I-Gene
has VBZ O
previously RB O
revealed VBN O
a DT O
major JJ B-Gene
constitutive JJ I-Gene
DNase NNP I-Gene
I PRP I-Gene
- : I-Gene
hypersensitive JJ I-Gene
site NN I-Gene
associated VBN O
with IN O
the DT O
pol NN B-Gene
gene NN I-Gene
( ( O
E NNP O
. . O
Verdin NNP O
, , O
J NNP O
. . O
Virol NNP O
. . O
65 CD O
: : O
6790 CD O
- : O
6799 CD O
, , O
1991 CD O
) ) O
. . O

Site NNP B-Gene
D NNP I-Gene
( ( O
nt JJ B-Gene
4816 CD I-Gene
to TO I-Gene
4851 CD I-Gene
) ) O
specifically RB O
bound IN O
a DT O
ubiquitously RB B-Gene
expressed VBN I-Gene
factor NN I-Gene
. . O

NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
is VBZ O
a DT O
rapidly RB O
inducible JJ O
transcriptional JJ B-Gene
activator NN I-Gene
that WDT O
responds VBZ O
to TO O
a DT O
variety NN O
of IN O
signals NNS O
and CC O
influences VBZ O
the DT O
expression NN O
of IN O
many JJ O
genes NNS O
involved VBN O
in IN O
the DT O
immune JJ O
response NN O
. . O

Human NNP O
herpesvirus VBZ O
6 CD O
( ( O
HHV NNP O
- : O
6 CD O
) ) O
is VBZ O
a DT O
lymphotropic JJ O
herpesvirus NN O
, , O
and CC O
in IN O
vitro NN O
, , O
it PRP O
can MD O
productively RB O
infect VB O
human JJ O
CD4 NNP O
+ NNP O
T NNP O
cells NNS O
as IN O
HIV NNP O
- : O
1 CD O
. . O

Sequence NN O
analyses VBZ O
show VBP O
that IN O
this DT O
protein NN O
has VBZ O
significant JJ O
homology NN O
with IN O
the DT O
human JJ B-Gene
cytomegalovirus NN I-Gene
UL44 NNP I-Gene
gene NN I-Gene
coding VBG O
for IN O
the DT O
ICP36 NNP B-Gene
family NN I-Gene
of IN O
early JJ B-Gene
- : I-Gene
late JJ I-Gene
- : I-Gene
class NN I-Gene
phosphoprotein NN I-Gene
. . O

Sequence NN O
analyses NNS O
of IN O
pCD41 NN B-Gene
indicate VBP O
that IN O
there EX O
are VBP O
two CD O
potential JJ O
open JJ B-Gene
reading NN I-Gene
frames NNS I-Gene
( ( O
ORFs NNP B-Gene
) ) O
, , O
A NNP B-Gene
and CC O
B NNP B-Gene
, , O
which WDT O
are VBP O
homologous JJ O
to TO O
the DT O
ORFs NNP B-Gene
found VBD O
in IN O
the DT O
genomic JJ O
clone NN O
pGD41 NN B-Gene
. . O

CD14 NNP B-Gene
- : O
mediated VBD O
translocation NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
induced VBN O
by IN O
lipopolysaccharide NN O
does VBZ O
not RB O
require VB O
tyrosine JJ B-Gene
kinase NN I-Gene
activity NN O
. . O

Nuclear JJ O
translocation NN O
of IN O
cytosolic JJ O
NF NNP O
- : O
kappa NN O
B NNP O
is VBZ O
correlated VBN O
with IN O
a DT O
number NN O
of IN O
LPS NNP O
- : O
inducible JJ O
responses NNS O
. . O

LPS NNP O
- : O
stimulated VBD O
translocation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
CHO NNP O
/ NNP O
CD14 NNP O
cells NNS O
resembled VBD O
the DT O
same JJ O
response NN O
in IN O
the DT O
murine NN O
macrophage NN O
- : O
like IN O
cell NN O
line NN O
RAW NNP O
264 CD O
. . O
7 CD O
. . O

The DT O
stimulatory JJ O
effects NNS O
of IN O
gp160 NN O
are VBP O
mediated VBN O
through IN O
the DT O
CD4 NNP B-Gene
molecule NN I-Gene
, , O
since IN O
pretreatment NN O
with IN O
soluble JJ O
CD4 NNP B-Gene
abrogates VBZ O
its PRP$ O
activity NN O
. . O

The DT O
stimulatory JJ O
effect NN O
of IN O
gp160 NN O
on IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
is VBZ O
protein JJ O
synthesis NN O
independent JJ O
, , O
is VBZ O
dependent JJ O
upon IN O
protein JJ O
tyrosine JJ O
phosphorylation NN O
, , O
and CC O
abrogated VBN O
by IN O
inhibitors NNS O
of IN O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
. . O

No DT O
evidence NN O
for IN O
the DT O
expression NN O
of IN O
the DT O
progesterone NN B-Gene
receptor NN I-Gene
on IN O
peripheral JJ O
blood NN O
lymphocytes NNS O
during IN O
pregnancy NN O
[ NNP O
see VBP O
comments NNS O
] VB O

A DT O
role NN O
for IN O
the DT O
progesterone NN B-Gene
receptor NN I-Gene
in IN O
the DT O
mechanism NN O
of IN O
the DT O
known JJ O
effect NN O
of IN O
progesterone NN O
on IN O
peripheral JJ O
blood NN O
lymphocytes NNS O
is VBZ O
also RB O
excluded VBN O
. . O

In IN O
nuclear JJ O
run NN O
- : O
on IN O
analysis NN O
, , O
such JJ O
tolerant JJ O
cells NNS O
show VBP O
only RB O
a DT O
low JJ O
degree NN O
of IN O
transcription NN O
, , O
indicating VBG O
that IN O
tolerance NN O
operates VBZ O
at IN O
or CC O
upstream NN O
of IN O
the DT O
transcription NN O
level NN O
. . O

The DT O
CD14 NNP B-Gene
LPS NNP O
receptor NN O
is VBZ O
, , O
however RB O
, , O
up RP O
- : O
regulated VBN O
( ( O
not RB O
down RP O
- : O
regulated VBN O
) ) O
in IN O
tolerant NN O
cells NNS O
, , O
and CC O
LPS NNP O
can MD O
, , O
in IN O
fact NN O
, , O
still RB O
lead VBP O
to TO O
activation NN O
of IN O
tolerant JJ O
cells NNS O
as IN O
evidenced VBN O
by IN O
mobilization NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
nuclear JJ B-Gene
factor NN I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
) ) O
. . O

Resolution NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
complex NN I-Gene
in IN O
gel NN O
shift NN O
analysis NN O
shows VBZ O
that IN O
the DT O
binding NN B-Gene
protein NN I-Gene
, , O
mobilized VBN O
in IN O
naive JJ O
Mono NNP O
Mac NNP O
6 CD O
cells NNS O
, , O
consists VBZ O
mainly RB O
of IN O
p50 JJ B-Gene
- : I-Gene
p65 NN I-Gene
heterodimers NNS I-Gene
, , O
while IN O
in IN O
tolerant JJ O
cells NNS O
, , O
the DT O
p50 NN B-Gene
homodimer NN I-Gene
is VBZ O
predominant JJ O
. . O

This DT O
increase NN O
in IN O
p50 JJ B-Gene
homodimers NNS I-Gene
coincides NNS O
with IN O
an DT O
increase NN O
in IN O
p105 JJ B-Gene
mRNA NN I-Gene
, , O
suggestive NN O
of IN O
a DT O
transcriptional JJ O
up RP O
- : O
regulation NN O
of IN O
p50 NN B-Gene
. . O

Analysis NN O
of IN O
Oct2 NNP B-Gene
- : I-Gene
isoform NN I-Gene
expression NN O
in IN O
lipopolysaccharide JJ O
- : O
stimulated VBN O
B NNP O
lymphocytes NNS O
. . O

Oct2 NNP B-Gene
- : I-Gene
isoform NN I-Gene
expression NN O
in IN O
splenic JJ O
B NNP O
cells NNS O
stimulated VBD O
with IN O
lipopolysaccharide NN O
or CC O
lipopolysaccharide JJ O
plus CC O
phorbol JJ O
- : O
di NN O
- : O
butyrate NN O
was VBD O
analysed VBN O
by IN O
cDNA NN O
cloning NN O
. . O

A DT O
new JJ O
exon NN B-Gene
containing VBG O
a DT O
highly RB O
basic JJ O
region NN O
( ( O
4c CD O
) ) O
was VBD O
characterized VBN O
, , O
between IN B-Gene
exons NNS I-Gene
4 CD I-Gene
and CC I-Gene
5 CD I-Gene
. . O

In IN O
addition NN O
, , O
a DT O
new JJ O
combination NN O
isoform NN O
containing VBG O
Oct2a NNP B-Gene
' POS I-Gene
s NN I-Gene
amino IN I-Gene
terminal JJ I-Gene
insert NN I-Gene
( ( O
exon JJ B-Gene
7a CD I-Gene
) ) O
and CC O
Oct2b NNP B-Gene
' POS I-Gene
s NN I-Gene
carboxy VBP I-Gene
terminal NN I-Gene
insert NN I-Gene
( ( O
exon JJ B-Gene
13 CD I-Gene
) ) O
was VBD O
found VBN O
that IN O
created VBD O
a DT O
novel JJ O
large JJ O
isoform NN O
, , O
Oct2ab NNP B-Gene
. . O

Positive JJ O
regulators NNS O
of IN O
the DT O
lineage NN O
- : O
specific JJ O
transcription NN B-Gene
factor NN I-Gene
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
differentiating VBG O
erythroid JJ O
cells NNS O
. . O

Analyses NNS O
with IN O
cultured JJ O
cells NNS O
and CC O
cell NN O
- : O
free JJ O
systems NNS O
have VBP O
provided VBN O
strong JJ O
evidence NN O
that IN O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
involved VBN O
in IN O
control NN O
of IN O
globin JJ B-Gene
gene NN I-Gene
expression NN O
during IN O
erythroid JJ O
differentiation NN O
. . O

The DT O
role NN O
of IN O
the DT O
human JJ B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
( ( I-Gene
HIV NNP I-Gene
- : I-Gene
1 CD I-Gene
) ) I-Gene
Nef NNP I-Gene
protein NN I-Gene
in IN O
T NNP O
cell NN O
activation NN O
pathways NNS O
was VBD O
investigated VBN O
using VBG O
a DT O
Jurkat NNP O
CD4 NNP O
+ NNP O
cell NN O
line NN O
stably RB O
transfected VBD O
with IN O
a DT O
Nef NNP O
expression NN O
vector NN O
. . O

The DT O
response NN O
of IN O
mammalian JJ O
cells NNS O
to TO O
stress VB O
is VBZ O
controlled VBN O
by IN O
transcriptional JJ B-Gene
regulatory JJ I-Gene
proteins NNS I-Gene
such JJ O
as IN O
nuclear JJ B-Gene
factor NN I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
) ) O
to TO O
induce VB O
a DT O
wide JJ O
variety NN O
of IN O
early JJ B-Gene
response NN I-Gene
genes NNS I-Gene
. . O

In IN O
comparison NN O
to TO O
other JJ O
activators NNS O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
such JJ O
as IN O
phorbol NN O
myristate NN O
acetate NN O
or CC O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
, , O
we PRP O
did VBD O
not RB O
detect VB O
changes NNS O
in IN O
the DT O
tyrosine NN O
phosphorylation NN O
status NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
following VBG O
treatment NN O
with IN O
either DT O
of IN O
these DT O
agents NNS O
. . O

Molecular NNP O
, , O
biochemical JJ O
and CC O
epidemiological JJ O
evidence NN O
implicate NN O
HTLV NNP O
- : O
I PRP O
as IN O
an DT O
etiologic JJ O
agent NN O
of IN O
adult NN O
T NNP O
cell NN O
leukemia NN O
( ( O
ATL NNP O
) ) O
. . O

Furthermore RB O
, , O
the DT O
NFKB2 NNP B-Gene
precursor NN O
is VBZ O
physically RB O
associated VBN O
with IN O
c SYM B-Gene
- : I-Gene
Rel NN I-Gene
and CC O
with IN O
Tax NNP B-Gene
in IN O
HTLV NNP O
- : O
I PRP O
infected VBD O
cells NNS O
. . O

We PRP O
have VBP O
examined VBN O
the DT O
effects NNS O
of IN O
RA NNP O
on IN O
normal JJ O
hematopoiesis NN O
by IN O
using VBG O
early JJ O
hematopoietic JJ O
progenitor NN O
cells NNS O
( ( O
HPC NNP O
) ) O
stringently RB O
purified VBN O
from IN O
adult JJ O
peripheral JJ O
blood NN O
. . O

This DT O
phenomenon NN O
is VBZ O
correlated VBN O
with IN O
inhibition NN O
of IN O
GATA1 NNP B-Gene
induction NN O
in IN O
the DT O
early JJ O
stages NNS O
of IN O
erythropoietic JJ O
differentiation NN O
. . O

We PRP O
have VBP O
previously RB O
shown VBN O
that IN O
a DT O
human JJ O
B NNP O
lymphoma NN O
cell NN O
line NN O
, , O
B104 NNP O
, , O
expressed VBD O
surface NN B-Gene
IgM NNP I-Gene
( ( O
sIgM NN B-Gene
) ) O
and CC O
surface NN B-Gene
IgD NNP I-Gene
( ( O
sIgD NN B-Gene
) ) O
, , O
and CC O
that IN O
crosslinking VBG O
of IN O
sIgM NN B-Gene
and CC O
sIgD NN B-Gene
by IN O
anti JJ B-Gene
- : I-Gene
IgM NN I-Gene
antibody NN I-Gene
( ( I-Gene
Ab NNP I-Gene
) ) I-Gene
and CC O
anti $ B-Gene
- : I-Gene
IgD NNP I-Gene
Ab NNP I-Gene
, , O
respectively RB O
, , O
induced VBD O
Ca2 NNP O
+ NNP O
influx NN O
to TO O
almost RB O
the DT O
same JJ O
degree NN O
, , O
whereas IN O
only RB O
sIgM JJ B-Gene
- : O
crosslinking NN O
caused VBD O
B104 NNP O
cell NN O
death NN O
. . O

Phorbol NNP O
myristate NN O
acetate NN O
induced VBD O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA JJ I-Gene
expression NN O
but CC O
forskolin NN O
and CC O
dibutyryl VB O
cyclic JJ O
AMP NNP O
did VBD O
not RB O
. . O

Treatment NN O
of IN O
human JJ O
erythrocytes NNS O
with IN O
10 CD O
microM NNS O
sodium JJ O
orthovanadate NN O
( ( O
NaOV NNP O
) ) O
, , O
an DT O
inhibitor NN O
of IN O
plasma NN B-Gene
membrane NN I-Gene
Ca NNP I-Gene
- : I-Gene
ATPase NN I-Gene
and CC O
phosphotyrosine NN B-Gene
phosphatase NN I-Gene
, , O
decreased VBN O
parasitemia NN O
by IN O
30 CD O
% NN O
. . O

Because IN O
erythrocytes NNS O
are VBP O
anucleated VBN O
, , O
these DT O
results NNS O
are VBP O
discussed VBN O
as IN O
evidence NN O
for IN O
biochemical JJ O
changes NNS O
by IN O
TCDD NNP O
without IN O
requiring VBG O
the DT O
activation NN O
of IN O
gene NN B-Gene
products NNS I-Gene
. . O

Irrespective NNP O
of IN O
the DT O
human JJ O
cell NN O
partner NN O
used VBN O
for IN O
fusion NN O
, , O
a DT O
certain JJ O
number NN O
of IN O
hybrids NNS O
lost VBN O
CD5 NNP B-Gene
surface NN O
expression NN O
over IN O
a DT O
period NN O
of IN O
time NN O
in IN O
culture NN O
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
indicate VBP O
that IN O
MS NNP B-Gene
- : I-Gene
2beta CD I-Gene
and CC O
MS NNP B-Gene
- : I-Gene
2gamma CD I-Gene
interact NN O
with IN O
nuclear JJ B-Gene
factors NNS I-Gene
that WDT O
are VBP O
induced VBN O
during IN O
U937 NNP O
differentiation NN O
. . O

These DT O
factors NNS O
are VBP O
detected VBN O
at IN O
the DT O
time NN O
the DT O
CD11b NNP B-Gene
promoter NN I-Gene
is VBZ O
activated VBN O
. . O

The DT O
presence NN O
of IN O
multiple JJ O
potential JJ O
binding NN O
sites NNS O
for IN O
MS NNP B-Gene
- : I-Gene
2 CD I-Gene
in IN O
the DT O
promoter NN O
regions NNS O
of IN O
a DT O
wide JJ O
range NN O
of IN O
genes NNS O
expressed VBN O
in IN O
mature NN O
myeloid NN O
cells NNS O
suggests VBZ O
this DT O
factor NN O
plays VBZ O
a DT O
general JJ O
role NN O
in IN O
myeloid JJ O
differentiation NN O
. . O

Acetylsalicylic NNP O
acid NN O
and CC O
sodium NN O
salicylate NN O
inhibit NN O
LPS NNP O
- : O
induced VBD O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
/ NNP I-Gene
c SYM I-Gene
- : I-Gene
Rel JJ I-Gene
nuclear JJ O
translocation NN O
, , O
and CC O
synthesis NN O
of IN O
tissue NN B-Gene
factor NN I-Gene
( ( O
TF NNP B-Gene
) ) O
and CC O
tumor JJ B-Gene
necrosis NN I-Gene
factor NN I-Gene
alfa NN I-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
in IN O
human JJ O
monocytes NNS O
. . O

Interferon NNP O
augments NNS O
PML NNP B-Gene
and CC O
PML NNP B-Gene
/ NNP I-Gene
RAR NNP I-Gene
alpha JJ I-Gene
expression NN O
in IN O
normal JJ O
myeloid NN O
and CC O
acute JJ O
promyelocytic JJ O
cells NNS O
and CC O
cooperates NNS O
with IN O
all DT O
- : O
trans NNS O
retinoic VBP O
acid NN O
to TO O
induce VB O
maturation NN O
of IN O
a DT O
retinoid JJ O
- : O
resistant JJ O
promyelocytic JJ O
cell NN O
line NN O
. . O

PML NNP B-Gene
is VBZ O
expressed VBN O
in IN O
diverse NN O
tissues NNS O
and CC O
cell NN O
lines NNS O
and CC O
localized VBN O
in IN O
the DT O
nucleus NN O
with IN O
a DT O
typical JJ O
speckled JJ O
pattern NN O
. . O

Neutral JJ B-Gene
sphingomyelinase NN I-Gene
( ( O
SMase NNP B-Gene
) ) O
can MD O
be VB O
activated VBN O
by IN O
extracellular JJ O
signals NNS O
to TO O
produce VB O
ceramide NN O
, , O
which WDT O
may MD O
affect VB O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( O
MAPK NNP B-Gene
) ) O
activities NNS O
. . O

PMA NNP O
acted VBD O
synergistically RB O
with IN O
ionomycin NN O
to TO O
activate VB O
JNK NNP B-Gene
MAPKs NNP I-Gene
in IN O
Jurkat NNP O
and CC O
EL4 NNP O
within IN O
10 CD O
minutes NNS O
. . O

Ara NNP O
- : O
C NNP O
activated VBD O
JNKs NNP B-Gene
only RB O
after IN O
prolonged VBN O
incubation NN O
( ( O
90 CD O
- : O
120 CD O
minutes NNS O
) ) O
. . O

The DT O
transmembrane NN O
domains NNS O
are VBP O
well RB O
conserved VBN O
, , O
but CC O
there EX O
is VBZ O
striking VBG O
sequence NN O
divergence NN O
of IN O
the DT O
carboxy JJ B-Gene
- : I-Gene
terminal JJ I-Gene
cytoplasmic JJ I-Gene
domain NN I-Gene
essential JJ O
for IN O
B NNP O
- : O
cell NN O
immortalization NN O
and CC O
interaction NN O
with IN O
the DT O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
receptor NN I-Gene
signaling VBG O
pathway NN O
. . O

Distinct NNP O
patterns NNS O
of IN O
chromosome NN B-Gene
1 CD I-Gene
abnormalities NNS O
were VBD O
found VBN O
among IN O
the DT O
histologic JJ O
types NNS O
of IN O
breast NN O
carcinoma NN O
. . O

These DT O
results NNS O
indicate VBP O
the DT O
utility NN O
of IN O
this DT O
FISH NNP O
technique NN O
for IN O
a DT O
better JJR O
definition NN O
of IN O
the DT O
biological JJ O
characteristics NNS O
of IN O
ductal JJ O
carcinomas NN O
. . O

Increased VBN O
proliferation NN O
, , O
cytotoxicity NN O
, , O
and CC O
gene NN O
expression NN O
after IN O
stimulation NN O
of IN O
human JJ O
peripheral JJ O
blood NN O
T NNP O
lymphocytes VBZ O
through IN O
a DT O
surface NN O
ganglioside NN O
( ( O
GD3 NNP O
) ) O
[ NN O
published VBN O
erratum JJ O
appears VBZ O
in IN O
J NNP O
Immunol NNP O
1994 CD O
Jul NNP O
15 CD O
; : O
153 CD O
( ( O
2 CD O
) ) O
: : O
910 CD O
] NN O

However RB O
, , O
their PRP$ O
specific JJ O
function NN O
in IN O
these DT O
processes NNS O
has VBZ O
not RB O
been VBN O
clearly RB O
defined VBN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
have VBP O
investigated VBN O
the DT O
mechanisms NN O
by IN O
which WDT O
the DT O
R24 NNP B-Gene
mAb NN I-Gene
affects VBZ O
T NNP O
cell NN O
functions NNS O
. . O

We PRP O
have VBP O
observed VBN O
that IN O
the DT O
R24 NNP B-Gene
mAb NN I-Gene
stimulates VBZ O
GD3 NNP O
+ NNP O
T NNP O
cell NN O
proliferation NN O
, , O
cytotoxicity NN O
, , O
and CC O
surface NN O
marker NN O
expression NN O
of IN O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha JJ I-Gene
- : I-Gene
chain NN I-Gene
, , O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
beta NN I-Gene
- : I-Gene
chain NN I-Gene
, , O
HLA NNP B-Gene
- : I-Gene
DR NNP I-Gene
, , O
CD11a NNP B-Gene
, , O
and CC O
CD11c NNP B-Gene
. . O

R24 NNP B-Gene
- : O
stimulated VBD O
increases NNS O
in IN O
proliferation NN O
, , O
cytotoxicity NN O
, , O
and CC O
cell NN O
surface NN O
protein NN O
expression NN O
could MD O
be VB O
blocked VBN O
by IN O
cyclosporin NN O
and CC O
staurosporin NN O
, , O
indicating VBG O
that IN O
cyclophilin NN B-Gene
/ NNP I-Gene
calcineurin NN I-Gene
and CC O
protein NN B-Gene
kinase NN I-Gene
C NNP I-Gene
may MD O
be VB O
involved VBN O
in IN O
the DT O
R24 NNP B-Gene
signaling VBG O
pathway RB O
. . O

Additionally RB O
, , O
herbimycin PRP O
A NNP O
, , O
a DT O
tyrosine JJ B-Gene
kinase NN I-Gene
inhibitor NN O
, , O
blocked VBD O
the DT O
R24 NNP B-Gene
- : O
stimulated VBD O
increase NN O
in IN O
proliferation NN O
but CC O
not RB O
cytotoxicity NN O
at IN O
concentrations NNS O
consistent JJ O
with IN O
specificity NN O
for IN O
tyrosine NN B-Gene
kinases NNS I-Gene
. . O

Using VBG O
fluorescence NN O
in IN O
situ JJ O
hybridization NN O
( ( O
FISH NNP O
) ) O
, , O
we PRP O
show VBP O
here RB O
that IN O
the DT O
genes NNS B-Gene
encoding VBG O
the DT O
TATA NNP B-Gene
- : I-Gene
box NN I-Gene
binding VBG I-Gene
protein NN I-Gene
( ( O
TBP NNP B-Gene
) ) O
, , O
TFIIB NNP B-Gene
, , O
TFIIE NNP B-Gene
alpha NN I-Gene
, , O
TFIIE NNP B-Gene
beta NN I-Gene
, , O
RAP30 NNP B-Gene
, , O
RAP74 NNP B-Gene
and CC O
the DT O
62 CD B-Gene
kDa NN I-Gene
subunit NN I-Gene
, , O
of IN O
TFIIH NNP B-Gene
are VBP O
located VBN O
at IN O
the DT O
human JJ B-Gene
chromosomal JJ I-Gene
bands NNS I-Gene
6q26 CD I-Gene
- : I-Gene
27 CD I-Gene
, , I-Gene
1p21 CD I-Gene
- : I-Gene
22 CD I-Gene
, , I-Gene
3q21 CD I-Gene
- : I-Gene
24 CD I-Gene
, , I-Gene
8p12 CD I-Gene
, , I-Gene
13q14 CD I-Gene
, , I-Gene
19p13 CD I-Gene
. . I-Gene
3 CD I-Gene
and CC I-Gene
11p14 CD I-Gene
- : I-Gene
15 CD I-Gene
. . I-Gene
1 CD I-Gene
, , O
respectively RB O
. . O

Although IN O
no DT O
proof NN O
yet RB O
exists VBZ O
of IN O
a DT O
role NN O
for IN O
these DT O
lesions NNS O
in IN O
DLCL NNP O
pathogenesis NN O
, , O
the DT O
feature NN O
of IN O
the DT O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
gene NN I-Gene
product NN I-Gene
, , O
its PRP$ O
specific JJ O
pattern NN O
of IN O
expression NN O
in IN O
B NNP O
cells NNS O
, , O
and CC O
the DT O
clustering NN O
of IN O
lesions NNS O
disrupting VBG O
its PRP$ O
regulatory JJ O
domain NN O
strongly RB O
suggest VBP O
that IN O
deregulation NN O
of IN O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
expression NN O
may MD O
contribute VB O
to TO O
DLCL NNP O
development NN O
. . O

DLCL NNP O
represent VBP O
a DT O
heterogeneous JJ O
group NN O
of IN O
neoplasms NNS O
which WDT O
are VBP O
treated VBN O
homogeneously RB O
despite IN O
the DT O
fact NN O
that IN O
only RB O
50 CD O
% NN O
of IN O
patients NNS O
experience NN O
long RB O
- : O
term NN O
disease NN O
- : O
free JJ O
survival NN O
( ( O
Schneider NNP O
et VBZ O
al RB O
. . O
1990 CD O
) ) O
. . O

It PRP O
is VBZ O
thus RB O
generally RB O
believed VBN O
that IN O
the DT O
pancreatic JJ O
endocrine NN O
- : O
lineage NN O
possesses VBZ O
the DT O
ability NN O
to TO O
mature VB O
along RP O
a DT O
differentiation NN O
pathway NN O
that WDT O
shares NNS O
many JJ O
characteristics NNS O
with IN O
those DT O
of IN O
neuronal JJ O
differentiation NN O
. . O

Octamer NNP O
independent JJ O
activation NN O
of IN O
transcription NN O
from IN O
the DT O
kappa NN B-Gene
immunoglobulin NN I-Gene
germline NN I-Gene
promoter NN I-Gene
. . O

To TO O
further RBR O
elucidate VB O
the DT O
role NN O
of IN O
this DT O
variant JJ O
octamer NN B-Gene
motif NN I-Gene
in IN O
the DT O
regulation NN O
of IN O
germline JJ B-Gene
transcription NN O
from IN O
the DT O
unrearranged JJ O
kappa NN B-Gene
locus NN I-Gene
, , O
we PRP O
have VBP O
quantitated VBN O
the DT O
relative JJ O
binding NN O
affinity NN O
of IN O
Oct NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
Oct NNP B-Gene
- : I-Gene
2 CD I-Gene
for IN O
the DT O
variant JJ O
octamer NN B-Gene
motif NN I-Gene
and CC O
determined VBD O
the DT O
functional JJ O
role NN O
of IN O
this DT O
octamer NN B-Gene
motif NN I-Gene
in IN O
transcriptional JJ O
activation NN O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
showed VBD O
that IN O
CD14 NNP O
+ NNP O
adherent JJ O
human JJ O
monocytes NNS O
can MD O
differentiate VB O
into IN O
CD1 NNP O
+ NNP O
relB NN O
+ NNP O
dendritic JJ O
cells NNS O
( ( O
DC NNP O
) ) O
by IN O
the DT O
combination NN O
of IN O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
plus CC O
interleukin JJ B-Gene
- : I-Gene
4 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
) ) O
and CC O
that IN O
they PRP O
differentiate VBP O
into IN O
tartrate JJ O
- : O
resistant JJ O
acid JJ O
phosphatase NN O
( ( O
TRAP NNP O
) ) O
- : O
positive JJ O
osteoclast SYM O
- : O
like IN O
multinucleated VBN O
giant JJ O
cells NNS O
( ( O
MGC NNP O
) ) O
by IN O
the DT O
combination NN O
of IN O
M NNP B-Gene
- : I-Gene
CSF NNP I-Gene
plus CC O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
. . O

The DT O
mechanism NN O
of IN O
inhibition NN O
is VBZ O
related VBN O
to TO O
the DT O
surface NN O
expression NN O
of IN O
several JJ O
cell NN O
adhesion NN B-Gene
molecules NNS I-Gene
. . O

Flow NNP O
cytometry NN O
analyses NNS O
on IN O
cultured JJ O
cells NNS O
that WDT O
were VBD O
treated VBN O
with IN O
tepoxalin NN O
or CC O
antisense NN O
oligonucleotides NNS O
to TO O
the DT O
P65 NNP B-Gene
/ NNP I-Gene
p50 VBD I-Gene
subunit NN I-Gene
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
and CC O
then RB O
stimulated VBD O
with IN O
PMA NNP O
, , O
revealed VBD O
a DT O
reduced JJ O
expression NN O
of IN O
CD11b NNP B-Gene
/ NNP I-Gene
CD18 NNP I-Gene
on IN O
monocytic JJ O
HL60 NNP O
cells NNS O
, , O
and CC O
endothelial JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
CD62E NNP B-Gene
) ) O
and CC O
vascular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
CD106 NNP B-Gene
) ) O
on IN O
human JJ O
umbilical JJ O
vein NN O
endothelial JJ O
cells NNS O
. . O

Tepoxalin NNP O
also RB O
inhibited VBD O
the DT O
secretion NN O
of IN O
a DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
regulated VBD I-Gene
chemokine NN I-Gene
, , O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
, , O
a DT O
known JJ O
inducer NN O
of IN O
CD11b NNP B-Gene
/ NNP I-Gene
CD18 NNP I-Gene
expression NN O
. . O

Thus RB O
the DT O
suppression NN O
of IN O
CD11b NNP B-Gene
/ NNP I-Gene
CD18 NNP I-Gene
expression NN O
by IN O
tepoxalin NN O
may MD O
involve VB O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
. . O

Characterization NN O
of IN O
a DT O
CD43 NNP B-Gene
/ NNP I-Gene
leukosialin SYM I-Gene
- : O
mediated VBN O
pathway NN O
for IN O
inducing VBG O
apoptosis NN O
in IN O
human JJ O
T NNP O
- : O
lymphoblastoid NN O
cells NNS O
. . O

The DT O
monoclonal JJ B-Gene
antibody NN I-Gene
( ( O
mAb NN B-Gene
) ) O
J393 NNP B-Gene
induces VBZ O
apoptosis NN O
in IN O
Jurkat NNP O
T NNP O
- : O
cells NNS O
. . O

NH2 NNP B-Gene
- : O
terminal NN O
amino NN O
acid JJ O
sequence NN O
analysis NN O
identified VBD O
the DT O
140 CD B-Gene
- : I-Gene
kDa NN I-Gene
surface NN I-Gene
antigen NN I-Gene
for IN O
mAb NN B-Gene
J393 NNP I-Gene
as IN O
CD43 NNP B-Gene
/ NNP I-Gene
leukosialin NN I-Gene
, , O
the DT O
major JJ O
sialoglycoprotein NN B-Gene
of IN O
leukocytes NNS O
. . O

While IN O
Jurkat NNP O
cells NNS O
co VBP O
- : O
expressed VBN O
two CD O
discrete NN O
cell NN B-Gene
- : I-Gene
surface NN I-Gene
isoforms NNS I-Gene
of IN O
CD43 NNP B-Gene
, , O
recognized VBN O
by IN O
mAb NN B-Gene
J393 NNP I-Gene
and CC O
mAb VB B-Gene
G10 NNP I-Gene
- : I-Gene
2 CD I-Gene
, , O
respectively RB O
, , O
only RB O
J393 NNP B-Gene
/ NNP I-Gene
CD43 NNP I-Gene
signaled VBD O
apoptosis NN O
. . O

Tyrosine NNP B-Gene
kinase NN I-Gene
inhibition NN O
by IN O
herbimycin NN O
A NNP O
diminished VBD O
J393 NNP B-Gene
/ NNP I-Gene
CD43 NNP I-Gene
- : O
mediated VBD O
apoptosis NN O
, , O
whereas JJ O
inhibition NN O
of IN O
phosphotyrosine JJ B-Gene
phosphatase NN I-Gene
activity NN O
by IN O
bis NN O
( ( O
maltolato NN O
) ) O
oxovanadium NN O
- : O
IV NNP O
enhanced VBD O
cell NN O
death NN O
. . O

Consequently RB O
, , O
the DT O
present JJ O
study NN O
was VBD O
addressed VBN O
to TO O
understand VB O
this DT O
phenomenon NN O
and CC O
revealed VBD O
the DT O
existence NN O
of IN O
a DT O
unique JJ B-Gene
47 CD I-Gene
kDa NN I-Gene
protein NN I-Gene
factor NN I-Gene
having VBG O
affinity NN O
for IN O
this DT O
SRE NNP B-Gene
sequence NN I-Gene
in IN O
lymphocytes NNS O
from IN O
normal JJ O
subjects NNS O
as RB O
well RB O
as IN O
its PRP$ O
absence NN O
in IN O
lymphocytes NNS O
from IN O
untreated JJ O
CML NNP O
patients NNS O
. . O

To TO O
understand VB O
the DT O
mechanism NN O
by IN O
which WDT O
PRL NNP B-Gene
regulates VBZ O
the DT O
biphasic JJ O
expression NN O
of IN O
IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
we PRP O
cloned VBD O
the DT O
rat NN B-Gene
IRF NNP I-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
and CC O
functionally RB O
characterized VBD O
the DT O
IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
. . O

Hence NNP O
, , O
the DT O
PRL NNP B-Gene
- : O
induced JJ O
biphasic JJ O
expression NN O
of IN O
the DT O
IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
appears VBZ O
to TO O
be VB O
controlled VBN O
by IN O
separate JJ O
PRL NNP B-Gene
- : I-Gene
responsive JJ I-Gene
elements NNS I-Gene
: : O
elements NNS O
in IN O
the DT O
first JJ O
0 NNP O
. . O
2 CD O
kb NN O
of IN O
the DT O
IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
region NN I-Gene
act NN O
during IN O
early JJ O
activation NN O
, , O
and CC O
elements NNS O
between IN O
0 CD O
. . O
2 CD O
and CC O
1 CD O
. . O
7 CD O
kb NN O
act NN O
in IN O
concert NN O
with IN O
the DT O
proximal JJ O
0 NNP O
. . O
2 CD O
- : O
kb NN O
region NN O
during IN O
S NNP O
phase NN O
progression NN O
. . O

The DT O
SCL NNP B-Gene
protein NN I-Gene
displays NNS O
cell VBP O
- : O
specific JJ O
heterogeneity NN O
in IN O
size NN O
. . O

In IN O
most JJS O
cell NN O
lines NNS O
, , O
proteins NNS O
of IN O
molecular JJ O
weight NN O
49 CD O
and CC O
44 CD O
kDa NNS O
were VBD O
found VBN O
, , O
however RB O
two CD O
myeloid NN O
cell NN O
lines NNS O
expressed VBD O
only RB O
lower JJR O
molecular JJ B-Gene
weight NN I-Gene
species NNS I-Gene
of IN I-Gene
24 CD I-Gene
and CC I-Gene
22 CD I-Gene
kDa NN I-Gene
. . O

The DT O
restricted JJ O
pattern NN O
of IN O
SCL NNP B-Gene
protein NN I-Gene
synthesis NN O
is VBZ O
consistent JJ O
with IN O
the DT O
restricted JJ O
expression NN O
of IN O
SCL NNP B-Gene
mRNA NN I-Gene
documented VBD O
previously RB O
. . O

This DT O
effect NN O
required VBD O
surface NN O
expression NN O
of IN O
the DT O
CD45 NNP B-Gene
PTPase NNP I-Gene
and CC O
was VBD O
not RB O
observed VBN O
in IN O
CD45 NNP O
- : O
deficient NN O
variants NNS O
of IN O
Jurkat NNP O
cells NNS O
. . O

Pervanadate NNP B-Gene
activated VBD I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
as IN O
shown VBN O
by IN O
an DT O
increase NN O
in IN O
DNA NNP O
- : O
binding NN O
activity NN O
of IN O
this DT O
transcription NN B-Gene
factor NN I-Gene
. . O

Signals NNS O
transduced VBD O
via IN O
the DT O
TCR NNP B-Gene
activate VBP O
the DT O
transcription NN B-Gene
factor NN I-Gene
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
) ) O
, , O
which WDT O
, , O
in IN O
turn NN O
, , O
is VBZ O
critical JJ O
to TO O
the DT O
transcriptional JJ O
induction NN O
of IN O
many JJ O
genes NNS O
important JJ O
for IN O
the DT O
proliferation NN O
and CC O
expression NN O
of IN O
a DT O
differentiated JJ O
phenotype NN O
. . O

Here RB O
we PRP O
identify VBP O
intracellular JJ O
signaling VBG O
components NNS O
involved VBN O
in IN O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
following VBG O
TCR NNP B-Gene
stimulation NN O
. . O

We PRP O
have VBP O
shown VBN O
elsewhere RB O
that IN O
both CC O
the DT O
major JJ B-Gene
immediate JJ I-Gene
- : I-Gene
early JJ I-Gene
gene NN I-Gene
( ( O
MIE NNP B-Gene
) ) O
and CC O
lytic JJ O
cycle NN O
infectious JJ O
progeny NN O
virus NN O
expression NN O
can MD O
be VB O
induced VBN O
in IN O
otherwise RB O
nonpermissive JJ O
monocyte NN O
- : O
like IN O
U NNP O
- : O
937 CD O
cell NN O
cultures NNS O
infected VBN O
with IN O
either DT O
human JJ O
CMV NNP O
( ( O
HCMV NNP O
) ) O
or CC O
simian JJ O
CMV NNP O
( ( O
SCMV NNP O
) ) O
by IN O
treatment NN O
with IN O
the DT O
phorbol NN O
ester NN O
12 CD O
- : O
O NNP O
- : O
tetradecanoylphorbol NN O
- : O
13 CD O
- : O
acetate NN O
( ( O
TPA NNP O
) ) O
. . O

Therefore RB O
, , O
to TO O
evaluate VB O
the DT O
mechanism NN O
of IN O
TPA NNP O
responsiveness NN O
of IN O
the DT O
SNE NNP B-Gene
motifs NNS I-Gene
and CC O
of IN O
a DT O
related JJ O
16 CD O
- : O
bp NN O
SEE NNP B-Gene
( ( O
SRF NNP B-Gene
/ NNP I-Gene
ETS NNP I-Gene
element NN I-Gene
) ) O
motif NN O
found VBN O
in IN O
the DT O
HCMV NNP B-Gene
and CC I-Gene
chimpanzee VB I-Gene
CMV NNP I-Gene
MIE NNP I-Gene
enhancers NNS I-Gene
, , O
we PRP O
have VBP O
examined VBN O
the DT O
functional JJ O
responses NNS O
and CC O
protein NN O
binding VBG O
properties NNS O
of IN O
multimerized VBN B-Gene
wild JJ I-Gene
- : I-Gene
type NN I-Gene
and CC I-Gene
mutant JJ I-Gene
elements NNS I-Gene
added VBD O
upstream NN O
to TO O
the DT O
SCMV NNP B-Gene
MIE NNP I-Gene
or CC O
simian JJ B-Gene
virus NN I-Gene
40 CD I-Gene
minimal JJ I-Gene
promoter NN I-Gene
regions NNS I-Gene
in IN O
the DT O
U NNP O
- : O
937 CD O
, , O
K NNP O
- : O
562 CD O
, , O
HL NNP O
- : O
60 CD O
, , O
THP NNP O
- : O
1 CD O
, , O
and CC O
Jurkat NNP O
cell NN O
lines NNS O
. . O

T NNP O
- : O
cell NN O
- : O
directed VBN O
TAL NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
induces NNS O
T NNP O
- : O
cell NN O
malignancies NNS O
in IN O
transgenic JJ O
mice NN O
. . O

The DT O
survival JJ O
rate NN O
of IN O
tal JJ B-Gene
- : I-Gene
1 CD I-Gene
transgenic JJ O
animals NNS O
was VBD O
much RB O
lower JJR O
as IN O
compared VBN O
with IN O
control NN O
mice NN O
. . O

To TO O
further RBR O
unravel VB O
the DT O
tal JJ B-Gene
- : I-Gene
1 CD I-Gene
oncogenic JJ O
potential NN O
, , O
a DT O
strain NN O
of IN O
tal JJ B-Gene
- : I-Gene
1 CD I-Gene
transgenic JJ O
mice NN O
was VBD O
crossbred VBN O
with IN O
p53 NN O
- : O
/ SYM O
- : O
mice NN O
; : O
the DT O
survival NN O
rate NN O
in IN O
these DT O
animals NNS O
was VBD O
reduced VBN O
by IN O
more JJR O
than IN O
one CD O
- : O
half NN O
when WRB O
compared VBN O
with IN O
that DT O
of IN O
tal JJ B-Gene
- : I-Gene
1 CD I-Gene
mice NN O
, , O
and CC O
histopathological JJ O
analysis NN O
revealed VBD O
exclusively RB O
T NNP O
- : O
cell NN O
lymphomas NN O
. . O

TSC2 NNP B-Gene
is VBZ O
a DT O
gene NN O
on IN O
chromosome NN B-Gene
16p13 CD I-Gene
. . I-Gene
3 CD I-Gene
associated VBN O
with IN O
the DT O
autosomal JJ O
dominant JJ O
neurocutaneous JJ O
disorder NN O
, , O
tuberous JJ O
sclerosis NN O
complex NN O
( ( O
TSC NNP O
) ) O
. . O

TSC2 NNP B-Gene
messenger NN I-Gene
RNA NNP I-Gene
was VBD O
widely RB O
expressed VBN O
in IN O
various JJ O
cell NN O
types NNS O
throughout IN O
the DT O
body NN O
, , O
including VBG O
epithelia NNS O
, , O
lymphocytes NNS O
, , O
and CC O
cells NNS O
with IN O
endocrine JJ O
functions NNS O
, , O
e NN O
. . O
g NN O
. . O
, , O
adrenal JJ O
cortex NN O
and CC O
anterior JJ O
pituitary NN O
. . O

Fas NNP B-Gene
- : O
mediated VBD O
apoptosis NN O
plays NNS O
an DT O
important JJ O
role NN O
in IN O
regulating VBG O
the DT O
immune JJ O
response NN O
in IN O
peripheral JJ O
T NNP O
cells NNS O
. . O

In IN O
contrast NN O
, , O
interleukin JJ O
- : O
1beta CD O
- : O
converting VBG O
enzyme JJ O
family NN O
protease NN O
inhibitors NNS O
Ac NNP O
- : O
DEVD NNP O
- : O
CHO NN O
and CC O
CrmA NNP O
blocked VBD O
Fas NNP B-Gene
- : O
mediated VBD O
apoptosis NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
peripheral JJ O
T NNP O
cells NNS O
use VBP O
distinct JJ O
apoptosis NN O
signaling VBG O
pathways NNS O
with IN O
differential JJ O
sensitivity NN O
to TO O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
interleukin VB O
- : O
1beta CD O
- : O
converting VBG O
enzyme JJ O
family NN O
protease NN O
inhibitors NNS O
. . O

However RB O
, , O
in IN O
contrast NN O
to TO O
human JJ O
lymphocytes NNS O
, , O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
production NN O
was VBD O
inhibited VBN O
and CC O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
mRNA NN I-Gene
levels NNS O
were VBD O
unaffected VBN O
at IN O
24 CD O
h NN O
and CC O
only RB O
slightly RB O
upregulated VBN O
at IN O
48 CD O
and CC O
72 CD O
h NN O
of IN O
culture NN O
in IN O
murine NN O
splenocytes NNS O
incubated VBN O
with IN O
cipro NN O
( ( O
20 CD O
micrograms NNS O
/ NNP O
ml NN O
) ) O
. . O

Cipro NNP O
did VBD O
not RB O
affect VB O
the DT O
nuclear JJ B-Gene
transcription NN I-Gene
factors NNS I-Gene
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
or CC O
NFIL NNP B-Gene
- : I-Gene
2A CD I-Gene
. . O

An DT O
additional JJ O
distinguishing NN O
characteristic NN O
of IN O
HTLV NNP O
- : O
I PRP O
infection NN O
is VBZ O
the DT O
profound JJ O
state NN O
of IN O
viral JJ O
latency NN O
that WDT O
is VBZ O
present JJ O
in IN O
circulating VBG O
primary JJ O
leukemic JJ O
T NNP O
cells NNS O
. . O

Furthermore RB O
, , O
the DT O
physical JJ O
interaction NN O
of IN O
Tax NNP B-Gene
with IN O
p100 NN B-Gene
leads NNS O
to TO O
the DT O
inhibition NN O
of IN O
Tax NNP B-Gene
- : O
induced JJ O
activation NN O
of IN O
the DT O
HTLV NNP O
- : O
I PRP O
and CC O
human JJ B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
type VBD I-Gene
1 CD I-Gene
long JJ I-Gene
terminal JJ I-Gene
repeats NNS I-Gene
, , O
reflecting VBG O
p100 SYM B-Gene
- : O
mediated VBN O
cytoplasmic JJ O
sequestration NN O
of IN O
the DT O
normally RB O
nuclearly RB O
expressed VBN O
Tax NNP B-Gene
protein NN I-Gene
. . O

Selection NN O
against IN O
such JJ O
mutations NNS O
may MD O
be VB O
the DT O
result NN O
of IN O
functional JJ O
redundancy NN O
of IN O
these DT O
myogenic JJ B-Gene
transcription NN I-Gene
factors NNS I-Gene
. . O

In IN O
vertebrates NNS O
, , O
five CD O
distinct JJ O
DNA NN B-Gene
binding VBG I-Gene
subunits NNS I-Gene
are VBP O
currently RB O
known VBN O
which WDT O
might MD O
extensively RB O
heterodimerize VB O
, , O
thereby RB O
forming VBG O
complexes NNS O
with IN O
distinct JJ O
transcriptional JJ O
activity NN O
, , O
DNA NNP O
sequence NN O
specificity NN O
, , O
and CC O
cell NN O
type NN O
- : O
and CC O
cell NN O
stage NN O
- : O
specific JJ O
distribution NN O
. . O

Other JJ O
I PRP B-Gene
kappa VBP I-Gene
B JJ I-Gene
proteins NNS I-Gene
are VBP O
rather RB O
involved VBN O
in IN O
terminating VBG O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
' POS O
s NN O
activity NN O
in IN O
the DT O
nucleus NN O
. . O

The DT O
intracellular JJ O
events NNS O
that WDT O
lead VBP O
to TO O
the DT O
inactivation NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
, , O
i NN O
. . O
e NN O
. . O
the DT O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
are VBP O
complex JJ O
. . O

In IN O
previous JJ O
studies NNS O
, , O
it PRP O
was VBD O
shown VBN O
that IN O
the DT O
fusion NN O
region NN O
of IN O
the DT O
pml NN B-Gene
/ NNP I-Gene
RAR NNP I-Gene
- : I-Gene
alpha NN I-Gene
protein NN I-Gene
, , O
expressed VBN O
by IN O
acute JJ O
promyelocytic JJ O
leukemia NN O
( ( O
APL NNP O
) ) O
cells NNS O
, , O
can MD O
be VB O
specifically RB O
recognized VBN O
in IN O
vitro NN O
by IN O
donor NN O
( ( O
D NNP O
. . O
E NNP O
. . O
) ) O
CD4 NNP O
T NNP O
cells NNS O
in IN O
a DT O
HLA NNP B-Gene
class NN I-Gene
II NNP I-Gene
DR11 NNP O
- : O
restricted VBN O
fashion NN O
. . O

We PRP O
present VBP O
here RB O
the DT O
results NNS O
on IN O
the DT O
recognition NN O
of IN O
several JJ O
pml NNS O
/ VBP O
RAR NNP O
- : O
alpha NN O
peptides NNS O
by IN O
APL NNP O
patients NNS O
expressing VBG O
HLA NNP B-Gene
DR11 NNP I-Gene
. . O

These DT O
clones NNS O
were VBD O
tested VBN O
for IN O
their PRP$ O
recognition NN O
of IN O
BCR1 NNP O
/ NNP O
25 CD O
. . O

APL NNP O
blasts NNS O
, , O
available JJ O
only RB O
from IN O
patients NNS O
F NNP O
. . O
R NNP O
. . O
and CC O
P NNP O
. . O
G NNP O
. . O
, , O
were VBD O
not RB O
lysed VBN O
by IN O
C3 NNP O
/ NNP O
5 CD O
and CC O
were VBD O
unable JJ O
to TO O
present VB O
peptide JJ O
BCR1 NNP O
/ NNP O
25 CD O
. . O

No DT O
peptide NN O
- : O
specific JJ O
T NNP O
- : O
cell NN O
line NN O
or CC O
clone NN O
could MD O
be VB O
generated VBN O
from IN O
both DT O
donors NNS O
and CC O
patients NNS O
. . O

Interferon NNP B-Gene
- : I-Gene
gamma NN I-Gene
( ( O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
) ) O
is VBZ O
produced VBN O
by IN O
natural JJ O
killer NN O
cells NNS O
and CC O
certain JJ O
subsets NNS O
of IN O
T NNP O
cells NNS O
, , O
but CC O
the DT O
basis NN O
for IN O
its PRP$ O
selective JJ O
expression NN O
is VBZ O
unknown JJ O
. . O

The DT O
proximal JJ O
element NN O
is VBZ O
a DT O
composite JJ O
site NN O
that WDT O
binds VBZ O
members NNS O
of IN O
the DT O
CREB NNP B-Gene
/ NNP I-Gene
ATF NNP I-Gene
, , O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
octamer JJ B-Gene
families NNS I-Gene
of IN O
transcription NN B-Gene
factors NNS I-Gene
. . O

S107 NNP O
plasmacytoma NN O
cells NNS O
, , O
which WDT O
express VBP O
CD40 NNP B-Gene
but CC O
are VBP O
defective JJ O
for IN O
the DT O
nuclear JJ O
appearance NN O
of IN O
p50 NN B-Gene
/ NNP I-Gene
p65 VBZ I-Gene
- : I-Gene
NF NNP I-Gene
- : I-Gene
kappaB NN I-Gene
, , O
do VBP O
not RB O
express VB O
RelB NNP B-Gene
after IN O
CD40 NNP B-Gene
stimulation NN O
. . O

The DT O
nuclear JJ O
body NN O
( ( O
NB NNP O
) ) O
is VBZ O
a DT O
cellular JJ O
organelle NN O
that WDT O
is VBZ O
involved VBN O
in IN O
the DT O
pathogenesis NN O
of IN O
acute JJ O
promyelocytic JJ O
leukemia NN O
and CC O
viral JJ O
infection NN O
. . O

The DT O
predicted VBN O
amino NN O
acid JJ O
sequence NN O
of IN O
the DT O
amino NN B-Gene
- : I-Gene
terminal JJ I-Gene
portion NN I-Gene
of IN O
Sp140 NNP B-Gene
was VBD O
similar JJ O
to TO O
Sp100 NNP B-Gene
, , O
a DT O
previously RB O
identified VBN O
NB NNP B-Gene
protein NN I-Gene
. . O

B NNP O
lymphocyte JJ O
stimulation NN O
via IN O
both DT O
CD40 NNP B-Gene
and CC O
surface NN B-Gene
Ig NNP I-Gene
( ( I-Gene
sIg NN I-Gene
) ) I-Gene
receptors NNS I-Gene
substantially RB O
induced VBD O
fra JJ B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
, , O
and CC O
for IN O
both DT O
receptors NNS O
, , O
induction NN O
was VBD O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
( ( O
PKC NNP B-Gene
) ) O
dependent NN O
. . O

Induction NN O
of IN O
fra JJ B-Gene
- : I-Gene
1 CD I-Gene
following VBG O
engagement NN O
of IN O
CD40 NNP B-Gene
did VBD O
not RB O
require VB O
protein NN O
synthesis NN O
, , O
suggesting VBG O
that IN O
the DT O
PKC NNP B-Gene
- : O
dependent JJ O
linkage NN O
between IN O
CD40 NNP B-Gene
and CC O
fra SYM B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
direct JJ O
. . O

Pentoxifylline NN O
for IN O
the DT O
treatment NN O
of IN O
infection NN O
with IN O
human JJ O
immunodeficiency NN O
virus NN O
. . O

Cytokine NNP O
dysregulation NN O
in IN O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
infection NN O
has VBZ O
been VBN O
documented VBN O
in IN O
numerous JJ O
studies NNS O
and CC O
has VBZ O
been VBN O
cited VBN O
as IN O
an DT O
important JJ O
component NN O
in IN O
the DT O
pathogenesis NN O
of IN O
this DT O
retroviral JJ O
infection NN O
. . O

Pentoxifylline NNP O
, , O
a DT O
trisubstituted JJ O
xanthine NN O
derivative NN O
, , O
has VBZ O
been VBN O
used VBN O
to TO O
decrease VB O
blood NN O
viscosity NN O
and CC O
is VBZ O
reasonably RB O
well RB O
tolerated VBN O
by IN O
most JJS O
recipients NNS O
of IN O
the DT O
drug NN O
. . O

( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

The DT O
other JJ O
two CD O
SR NNP O
patients NNS O
had VBD O
an DT O
abnormally RB O
low JJ O
GR NNP B-Gene
number NN O
with IN O
normal JJ O
binding VBG O
affinity NN O
that WDT O
was VBD O
not RB O
limited VBN O
to TO O
T NNP O
cells NNS O
. . O

This DT O
may MD O
be VB O
due JJ O
to TO O
the DT O
low JJ O
prevalence NN O
of IN O
overexpressed JJ O
ER NNP B-Gene
and CC O
the DT O
small JJ O
number NN O
of IN O
controls NNS O
. . O

A DT O
large JJ O
prospective JJ O
trial NN O
is VBZ O
needed VBN O
to TO O
determine VB O
if IN O
one CD O
or CC O
more JJR O
of IN O
these DT O
biomarkers NNS O
, , O
is VBZ O
predictive JJ O
of IN O
breast NN O
cancer NN O
development NN O
. . O

Inhibition NN O
of IN O
RANTES NNP B-Gene
expression NN O
did VBD O
not RB O
appear VB O
to TO O
be VB O
secondary JJ O
to TO O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
inhibition NN O
and CC O
required VBD O
binding NN O
to TO O
the DT O
intracellular JJ O
glucocorticoid NN B-Gene
receptor NN I-Gene
. . O

Association NNP O
of IN O
TRAF1 NNP B-Gene
, , O
TRAF2 NNP B-Gene
, , O
and CC O
TRAF3 NNP B-Gene
with IN O
an DT O
Epstein NNP B-Gene
- : I-Gene
Barr NNP I-Gene
virus NN I-Gene
LMP1 NNP I-Gene
domain NN I-Gene
important JJ O
for IN O
B NNP O
- : O
lymphocyte NN O
transformation NN O
: : O
role NN O
in IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
. . O

The DT O
Epstein NNP B-Gene
- : I-Gene
Barr NNP I-Gene
virus NN I-Gene
( ( I-Gene
EBV NNP I-Gene
) ) I-Gene
transforming VBG I-Gene
protein NN I-Gene
LMP1 NNP I-Gene
appears VBZ O
to TO O
be VB O
a DT O
constitutively RB B-Gene
activated JJ I-Gene
tumor NN I-Gene
necrosis NN I-Gene
factor NN I-Gene
receptor NN I-Gene
( ( O
TNFR NNP B-Gene
) ) O
on IN O
the DT O
basis NN O
of IN O
an DT O
intrinsic JJ O
ability NN O
to TO O
aggregate VB O
in IN O
the DT O
plasma NN O
membrane NN O
and CC O
an DT O
association NN O
of IN O
its PRP$ O
cytoplasmic JJ B-Gene
carboxyl NN I-Gene
terminus NN I-Gene
( ( O
CT NNP B-Gene
) ) O
with IN O
TNFR NNP B-Gene
- : I-Gene
associated VBN I-Gene
factors NNS I-Gene
( ( O
TRAFs NNP B-Gene
) ) O
. . O

TRAF1 NNP B-Gene
, , O
TRAF2 NNP B-Gene
, , O
and CC O
TRAF3 NNP B-Gene
bind VBP O
to TO O
a DT O
single JJ O
site NN O
in IN O
the DT O
LMP1 NNP B-Gene
CT NNP I-Gene
corresponding VBG O
to TO O
amino VB O
acids NNS O
( ( O
aa NN O
) ) O
199 CD O
to TO O
214 CD O
, , O
within IN O
a DT O
domain NN O
which WDT O
is VBZ O
important JJ O
for IN O
B NNP O
- : O
lymphocyte NN O
growth NN O
transformation NN O
( ( O
aa JJ O
187 CD O
to TO O
231 CD O
) ) O
. . O

NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
by IN O
LMP1 NNP B-Gene
( ( O
1 CD O
- : O
231 CD O
) ) O
is VBZ O
likely JJ O
to TO O
be VB O
mediated VBN O
by IN O
TRAF1 NNP B-Gene
/ NNP B-Gene
TRAF2 NNP I-Gene
heteroaggregates VBZ O
since IN O
TRAF1 NNP B-Gene
is VBZ O
unique JJ O
among IN O
the DT O
TRAFs NNP B-Gene
in IN O
coactivating VBG O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
with IN O
LMP1 NNP B-Gene
( ( O
1 CD O
- : O
231 CD O
) ) O
, , O
a DT O
TRAF2 NNP B-Gene
dominant JJ O
- : O
negative JJ O
mutant NN O
can MD O
block VB O
LMP1 NNP B-Gene
( ( O
1 CD O
- : O
231 CD O
) ) O
- : O
mediated VBN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
as RB O
well RB O
as IN O
TRAF1 NNP B-Gene
coactivation NN O
, , O
and CC O
30 CD O
% NN O
of IN O
TRAF2 NNP B-Gene
is VBZ O
associated VBN O
with IN O
TRAF1 NNP B-Gene
in IN O
EBV NNP O
- : O
transformed VBD O
B NNP O
cells NNS O
. . O

The DT O
gene NN O
encoding VBG O
the DT O
Epstein NNP B-Gene
- : I-Gene
Barr NNP I-Gene
virus NN I-Gene
( ( I-Gene
EBV NNP I-Gene
) ) I-Gene
- : I-Gene
specific JJ I-Gene
dUTPase NN I-Gene
was VBD O
amplified VBN O
from IN O
virus NN B-Gene
DNA NN I-Gene
by IN O
PCR NNP O
. . O

Preliminary JJ O
experiments NNS O
yielded VBD O
a DT O
Km NNP O
value NN O
of IN O
about IN O
0 CD O
. . O
8 CD O
microM NN O
for IN O
dUTP NN O
. . O

This DT O
indicated VBD O
that IN O
the DT O
dUTPase NN O
is VBZ O
expressed VBN O
during IN O
EBV NNP O
replication NN O
and CC O
reactivation NN O
. . O

Two CD O
pp56 NN B-Gene
( ( I-Gene
lck NN I-Gene
) ) I-Gene
mutants VBZ I-Gene
lacking VBG O
either CC O
the DT O
entire JJ O
catalytic JJ B-Gene
domain NN I-Gene
or CC O
the DT O
entire JJ O
NH2 NNP B-Gene
regulatory JJ B-Gene
domain NN I-Gene
were VBD O
generated VBN O
, , O
and CC O
their PRP$ O
abilities NNS O
to TO O
trigger VB O
transactivation NN O
of IN O
the DT O
TCR NNP B-Gene
- : I-Gene
regulated VBD I-Gene
nuclear JJ I-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
cells NNS I-Gene
( ( I-Gene
NF NNP I-Gene
- : I-Gene
AT NNP I-Gene
) ) I-Gene
region NN I-Gene
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
were VBD O
compared VBN O
. . O

The DT O
results NNS O
showed VBD O
that IN O
the DT O
average JJ O
number NN O
of IN O
GCR NNP B-Gene
in IN O
asthmatics NNS O
was VBD O
significantly RB O
lower JJR O
than IN O
that DT O
in IN O
healthy JJ O
subjects NNS O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
, , O
and CC O
there RB O
was VBD O
a DT O
linear JJ O
correlation NN O
between IN O
the DT O
number NN O
of IN O
GCR NNP B-Gene
and CC O
the DT O
course NN O
of IN O
asthma NN O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
there EX O
is VBZ O
no DT O
primary JJ O
and CC O
general JJ O
impairment NN O
of IN O
glucocorticoid JJ O
metabolism NN O
in IN O
the DT O
asthmatics NNS O
, , O
but CC O
the DT O
number NN O
of IN O
GCR NNP B-Gene
in IN O
the DT O
asthmatics NNS O
is VBZ O
lower JJR O
than IN O
that DT O
in IN O
healthy JJ O
controls NNS O
. . O

Subsequently RB O
binding VBG O
sites NNS O
have VBP O
been VBN O
demonstrated VBN O
in IN O
the DT O
plasma JJ O
membrane NN O
of IN O
human NN O
lymphocytes NNS O
which WDT O
show VBP O
pharmacological JJ O
( ( O
aldosterone JJ O
specificity NN O
) ) O
and CC O
kinetic JJ O
( ( O
high JJ O
turnover NN O
) ) O
properties NNS O
identical JJ O
with IN O
those DT O
of IN O
the DT O
rapid JJ O
aldosterone NN O
effects NNS O
in IN O
the DT O
same JJ O
cells NNS O
. . O

The DT O
macrophage NN B-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
( ( I-Gene
M NNP I-Gene
- : I-Gene
CSF NNP I-Gene
) ) I-Gene
receptor NN I-Gene
is VBZ O
expressed VBN O
in IN O
a DT O
tissue NN O
- : O
specific JJ O
fashion NN O
from IN O
two CD O
distinct JJ O
promoters NNS B-Gene
in IN O
monocytes NNS O
/ JJ O
macrophages NNS O
and CC O
the DT O
placenta NN O
. . O

CONCLUSION NNP O
. . O

The DT O
number NN O
of IN O
GCR NNP B-Gene
may MD O
be VB O
improved VBN O
by IN O
inhalation NN O
of IN O
oxygen NN O
. . O

Signaling VBG O
via IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
in IN O
JAK3 NNP O
- : O
deficient NN O
severe JJ O
combined VBN O
immunodeficiency NN O
lymphocytes NNS O
: : O
JAK3 NNP B-Gene
- : O
dependent NN O
and CC O
independent JJ O
pathways NNS O
. . O

However RB O
, , O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
- : O
induced JJ O
effects NNS O
were VBD O
clearly RB O
improved VBN O
following VBG O
JAK3 NNP B-Gene
expression NN O
. . O

Interleukin NNP B-Gene
2 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
stimulates VBZ O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha NN I-Gene
. . O

We PRP O
identified VBD O
an DT O
86 CD O
- : O
nucleotide JJ O
fragment NN O
that WDT O
is VBZ O
90 CD O
% NN O
identical JJ O
to TO O
the DT O
recently RB O
characterized VBN O
murine NN B-Gene
IL NNP I-Gene
- : I-Gene
2 CD I-Gene
- : I-Gene
responsive JJ I-Gene
element NN I-Gene
( ( O
mIL JJ B-Gene
- : I-Gene
2rE CD I-Gene
) ) O
. . O

Tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
receptor NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
TNFR NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
and CC O
CD95 NNP B-Gene
( ( O
also RB O
called VBN O
Fas NNP B-Gene
or CC O
APO NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
are VBP O
cytokine JJ B-Gene
receptors NNS I-Gene
that WDT O
engage VBP O
the DT O
apoptosis NN O
pathway NN O
through IN O
a DT O
region NN O
of IN O
intracellular JJ O
homology NN O
, , O
designated VBD O
the DT O
` `` O
` `` O
death NN B-Gene
domain NN I-Gene
. . O
' '' O
' '' O
Another DT O
death NN B-Gene
domain NN I-Gene
- : I-Gene
containing VBG I-Gene
member NN I-Gene
of IN O
the DT O
TNFR NNP B-Gene
family NN I-Gene
, , O
death NN B-Gene
receptor NN I-Gene
3 CD I-Gene
( ( O
DR3 NNP B-Gene
) ) O
, , O
was VBD O
identified VBN O
and CC O
was VBD O
shown VBN O
to TO O
induce VB O
both DT O
apoptosis NN O
and CC O
activation NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
kappaB NN I-Gene
. . O

Differential JJ O
nuclear JJ O
localization NN O
of IN O
p50 NN B-Gene
, , O
p52 NN B-Gene
, , O
and CC O
RelB NNP B-Gene
proteins NNS O
in IN O
human JJ O
accessory NN O
cells NNS O
of IN O
the DT O
immune JJ O
response NN O
in IN O
situ NN O
. . O

The DT O
different JJ O
patterns NNS O
of IN O
p50 NN B-Gene
, , O
p52 NN B-Gene
and CC O
RelB NNP B-Gene
protein VBP O
nuclear JJ O
localization NN O
may MD O
provide VB O
insight NN O
into IN O
their PRP$ O
different JJ O
roles NNS O
during IN O
the DT O
immune JJ O
response NN O
in IN O
vivo NN O
. . O

Although IN O
mutation NN O
of IN O
either CC O
Y113 NNP O
and CC O
Y128 NNP O
has VBZ O
a DT O
minimal JJ O
effect NN O
on IN O
SLP NNP B-Gene
- : I-Gene
76 CD I-Gene
function NN O
, , O
mutation NN O
of IN O
both DT O
residues NNS O
decreases VBZ O
significantly RB O
the DT O
ability NN O
of IN O
SLP NNP B-Gene
- : I-Gene
76 CD I-Gene
to TO O
promote VB O
T NNP O
cell NN O
activation NN O
. . O

The DT O
IRF NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN B-Gene
region NN I-Gene
contains VBZ O
a DT O
CpG NNP O
island NN O
, , O
with IN O
several JJ O
GC NNP B-Gene
boxes NNS I-Gene
, , O
a DT O
putative JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
- : I-Gene
binding NN I-Gene
site NN I-Gene
, , O
and CC O
a DT O
CAAT NNP B-Gene
box NN I-Gene
, , O
but CC O
no DT O
TATA NNP B-Gene
box NN I-Gene
. . O

When WRB O
the DT O
promoter NN B-Gene
region NN I-Gene
was VBD O
linked VBN O
with IN O
a DT O
heterologous JJ B-Gene
reporter NN I-Gene
gene NN I-Gene
, , O
we PRP O
found VBD O
that IN O
the DT O
promoter NN B-Gene
region NN I-Gene
is VBZ O
inducible JJ O
by IN O
both DT O
interferons NNS B-Gene
( ( O
interferon VB B-Gene
- : I-Gene
alpha NN I-Gene
and CC I-Gene
- : I-Gene
gamma NN I-Gene
) ) O
and CC O
interferon $ B-Gene
regulatory JJ I-Gene
factor NN I-Gene
1 CD I-Gene
. . O

Interferon NNP B-Gene
alpha NN I-Gene
selectively RB O
affects VBZ O
expression NN O
of IN O
the DT O
human JJ B-Gene
myeloid NN I-Gene
cell NN I-Gene
nuclear JJ I-Gene
differentiation NN I-Gene
antigen NN I-Gene
in IN O
late JJ O
stage NN O
cells NNS O
in IN O
the DT O
monocytic JJ O
but CC O
not RB O
the DT O
granulocytic JJ O
lineage NN O
. . O

Although IN O
, , O
the DT O
level NN O
of IN O
MNDA NNP B-Gene
mRNA NN I-Gene
in IN O
primary JJ O
monocytes NNS O
is VBZ O
very RB O
low JJ O
it PRP O
was VBD O
up RP O
- : O
regulated VBN O
at IN O
6 CD O
h NN O
following VBG O
the DT O
addition NN O
of IN O
interferon NN B-Gene
alpha NN I-Gene
. . O

This DT O
reduced VBD O
level NN O
of IN O
mRNA NN B-Gene
could MD O
then RB O
be VB O
elevated VBN O
with IN O
subsequent JJ O
interferon NN B-Gene
alpha NN I-Gene
treatment NN O
. . O

We PRP O
identified VBD O
a DT O
protein NN O
, , O
p37 NN O
, , O
which WDT O
specifically RB O
bound VBD O
to TO O
DRE NNP B-Gene
1 CD I-Gene
. . O

Binding NN O
of IN O
the DT O
cDNA NN B-Gene
fusion NN I-Gene
protein NN I-Gene
, , O
similarly RB O
to TO O
the DT O
results NNS O
obtained VBD O
with IN O
purified JJ O
Jurkat NNP O
protein NN O
, , O
was VBD O
decreased VBN O
by IN O
introduction NN O
of IN O
site NN O
- : O
specific JJ O
mutations NNS O
in IN O
the DT O
DRE NNP B-Gene
1 CD I-Gene
regulatory JJ I-Gene
sequence NN I-Gene
. . O

Cotransfection NN O
of IN O
a DT O
YB NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN I-Gene
plasmid NN I-Gene
increases NNS O
HTLV NNP O
- : O
I PRP O
basal VBP O
transcription NN O
approximately RB O
14 CD O
- : O
fold NN O
in IN O
Jurkat NNP O
T NNP O
lymphocytes VBZ O
. . O

The DT O
subjects NNS O
were VBD O
exposed VBN O
to TO O
cold VB O
air NN O
( ( O
4 CD O
degrees NNS O
C NNP O
) ) O
twice RB O
/ NNP O
d NN O
, , O
30 CD O
min NN O
/ NN O
exposure NN O
, , O
for IN O
a DT O
total NN O
of IN O
80 CD O
exposures NNS O
. . O

These DT O
results NNS O
describe VBP O
for IN O
the DT O
first JJ O
time NN O
the DT O
rapid JJ O
modulation NN O
of IN O
the DT O
NT3R NNP B-Gene
in IN O
response NN O
to TO O
the DT O
combined JJ O
influence NN O
of IN O
cold JJ O
exposure NN O
and CC O
reduced JJ O
circulating NN O
T4 NNP O
and CC O
TSH NNP O
. . O

HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
activity NN O
in IN O
human JJ O
CD40 NNP O
- : O
activated VBD O
B NNP O
lymphocytes NNS O
is VBZ O
dependent JJ O
on IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
. . O

In IN O
these DT O
cells NNS O
, , O
nuclear JJ B-Gene
factors NNS I-Gene
involved VBN O
in IN O
activation NN O
of IN O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
, , O
which WDT O
contains VBZ O
the DT O
transcriptional JJ B-Gene
control NN I-Gene
elements NNS I-Gene
of IN O
the DT O
virus NN O
, , O
are VBP O
unknown JJ O
. . O

In IN O
preincubated JJ O
cells NNS O
, , O
the DT O
cycloheximide NN O
response NN O
is VBZ O
decreased VBN O
, , O
especially RB O
in IN O
the DT O
case NN O
of IN O
FOSB NNP B-Gene
. . O

Regions NNS O
of IN O
low JJ O
base NN O
order NN O
- : O
dependent NN O
stem NN O
- : O
loop NN O
potential NN O
in IN O
the DT O
region NN O
of IN O
the DT O
gene NN O
are VBP O
defined VBN O
. . O

Susceptibility NN O
of IN O
these DT O
transformed VBN O
cell NN O
lines NNS O
to TO O
NK NNP O
cells NNS O
was VBD O
determined VBN O
by IN O
cytolytic JJ O
assays NNS O
. . O

Cell NNP O
specific JJ O
expression NN O
of IN O
human JJ B-Gene
Bruton NNP I-Gene
' POS I-Gene
s NN I-Gene
agammaglobulinemia NN I-Gene
tyrosine NN I-Gene
kinase NN I-Gene
gene NN I-Gene
( ( O
Btk NNP B-Gene
) ) O
is VBZ O
regulated VBN O
by IN O
Sp1 NNP B-Gene
- : I-Gene
and CC O
Spi NNP B-Gene
- : I-Gene
1 CD I-Gene
/ JJ I-Gene
PU NNP I-Gene
. . I-Gene
1 CD I-Gene
- : I-Gene
family NN I-Gene
members NNS I-Gene
. . O

In IN O
vitro JJ O
footprinting NN O
analysis NN O
within IN O
this DT O
part NN O
of IN O
the DT O
promoter NN B-Gene
revealed VBD O
two CD O
Sp1 NNP B-Gene
binding VBG I-Gene
sites NNS I-Gene
as RB O
well RB O
as IN O
a DT O
PU NNP B-Gene
- : I-Gene
box NN I-Gene
. . O

In IN O
addition NN O
Spi NNP B-Gene
- : I-Gene
B NN I-Gene
as RB O
well RB O
as IN O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
were VBD O
able JJ O
to TO O
transactivate VB O
Btk NNP B-Gene
expression NN O
. . O

They PRP O
also RB O
demonstrate VBP O
for IN O
the DT O
first JJ O
time NN O
the DT O
occurrence NN O
of IN O
T NNP O
cell NN O
responses NNS O
against IN O
EBV NNP B-Gene
transactivating VBG I-Gene
factors NNS I-Gene
, , O
which WDT O
might MD O
be VB O
central JJ O
in IN O
the DT O
control NN O
of IN O
virus NN O
reactivation NN O
. . O

CD14 NNP B-Gene
- : O
mediated VBD O
signal JJ O
pathway NN O
of IN O
Porphyromonas NNP O
gingivalis NN O
lipopolysaccharide NN O
in IN O
human JJ O
gingival NN O
fibroblasts NNS O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
observed VBD O
unexpectedly RB O
by IN O
immunohistochemical JJ O
, , O
Western JJ O
blotting NN O
( ( O
immunoblotting VBG O
) ) O
, , O
and CC O
Northern NNP O
( ( O
RNA NNP O
) ) O
blotting NN O
assays NNS O
that IN O
CD14 NNP B-Gene
is VBZ O
expressed VBN O
at IN O
high JJ O
density NN O
in IN O
human JJ O
gingival NN O
fibroblasts NNS O
. . O

The DT O
inhibitor NN O
also RB O
dramatically RB O
inhibited JJ O
monocyte JJ O
chemotactic JJ O
activity NN O
of IN O
and CC O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
production NN O
by IN O
the DT O
cells NNS O
. . O

Thus RB O
, , O
the DT O
tyrosine NN B-Gene
kinase NN I-Gene
activated VBN O
by IN O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
appears VBZ O
to TO O
directly RB O
transduce VB O
a DT O
signal NN O
to TO O
a DT O
protein NN O
which WDT O
functions NNS O
as IN O
a DT O
transcriptional JJ B-Gene
regulator NN I-Gene
. . O

Thus RB O
, , O
we PRP O
focused VBD O
our PRP$ O
study NN O
on IN O
isolated JJ O
FDC NNP O
clusters NNS O
from IN O
normal JJ O
tonsils NNS O
. . O

As IN O
showed VBN O
on IN O
tissue NN O
sections NNS O
, , O
we PRP O
detected VBD O
the DT O
p50 NN B-Gene
in IN O
both DT O
cytoplasm NN O
and CC O
nucleus NN O
of IN O
FDC NNP O
. . O

Now RB O
that IN O
these DT O
proteins NNS O
are VBP O
purified VBN O
and CC O
cloned VBN O
, , O
the DT O
major JJ O
goals NNS O
will MD O
be VB O
to TO O
understand VB O
their PRP$ O
role NN O
and CC O
the DT O
roles NNS O
of IN O
other JJ O
family NN O
members NNS O
in IN O
thymic JJ O
development NN O
. . O

This DT O
effect NN O
is VBZ O
blocked VBN O
by IN O
anti JJ B-Gene
- : I-Gene
VCAM NN I-Gene
antibodies NNS I-Gene
. . O

This DT O
activity NN O
seems VBZ O
to TO O
be VB O
due JJ O
to TO O
increased VBN O
cAMP NN O
levels NNS O
because IN O
forskolin NN O
and CC O
IBMX NNP O
mimic VBD O
the DT O
effects NNS O
of IN O
PGE2 NNP O
. . O

These DT O
data NNS O
support VBD O
the DT O
positive JJ O
role NN O
for IN O
PGE2 NNP O
on IN O
some DT O
immune JJ O
functions NNS O
. . O

In IN O
addition NN O
, , O
analysis NN O
of IN O
EBV NNP O
protein NN O
expression NN O
by IN O
IH NNP O
revealed VBD O
a DT O
heterogeneous JJ O
pattern NN O
of IN O
EBV NNP B-Gene
gene NN I-Gene
expression NN O
at IN O
the DT O
single JJ O
- : O
cell NN O
level NN O
consisting NN O
of IN O
both DT O
LMP1 NNP O
+ NN O
and CC O
LMP1 NNP O
- : O
tumour NN O
cells NNS O
, , O
suggesting VBG O
a DT O
mixture NN O
of IN O
latency NN O
I PRP O
and CC O
II NNP O
. . O

This DT O
made VBD O
the DT O
need NN O
for IN O
VD NNP O
analogues NNS O
with IN O
selectively RB O
increased VBN O
cell NN O
regulatory JJ O
properties NNS O
. . O

Studies NNS O
with IN O
20 CD O
- : O
epi NN O
analogues NNS O
pointed VBD O
out RP O
the DT O
importance NN O
of IN O
the DT O
carbon NN O
- : O
20 CD O
position NN O
and CC O
led VBD O
to TO O
the DT O
development NN O
of IN O
20 CD O
- : O
methyl NN O
derivatives NNS O
of IN O
VD NNP O
. . O

Moreover RB O
, , O
ZK161422 NNP O
, , O
but CC O
not RB O
ZK157202 NNP O
, , O
showed VBD O
preference NN O
for IN O
gene NN O
activation NN O
from IN O
a DT O
promoter NN B-Gene
carrying VBG O
a DT O
VD NNP B-Gene
response NN I-Gene
element NN I-Gene
with IN O
a DT O
palindromic JJ O
arrangement NN O
of IN O
two CD O
hexameric JJ B-Gene
receptor NN I-Gene
binding VBG I-Gene
sites NNS I-Gene
spaced VBN O
by IN O
9 CD O
nucleotides NNS O
( ( O
IP9 NNP O
) ) O
rather RB O
than IN O
for IN O
activation NN O
from IN O
a DT O
response NN B-Gene
element NN I-Gene
formed VBN O
by IN O
a DT O
direct JJ O
repeat NN O
spaced VBN O
by IN O
3 CD O
nucleotides NNS O
( ( O
DR3 NNP O
) ) O
. . O

This DT O
observation NN O
supports VBZ O
a DT O
model NN O
, , O
in IN O
which WDT O
promoter NN O
selectivity NN O
reflects VBZ O
the DT O
selectively RB O
increased JJ O
antiproliferative JJ O
effect NN O
of IN O
VD NNP O
analogues NNS O
. . O

The DT O
process NN O
of IN O
activation NN O
involves VBZ O
calcium JJ O
mobilization NN O
, , O
activation NN O
of IN O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
( ( O
PKC NNP B-Gene
) ) O
, , O
and CC O
phosphorylation NN O
of IN O
tyrosine NN B-Gene
kinases NNS I-Gene
. . O

The DT O
involvement NN O
of IN O
p21 NN B-Gene
( ( I-Gene
ras NNS I-Gene
) ) I-Gene
in IN O
the DT O
regulation NN O
of IN O
calcium NN O
- : O
dependent NN O
signals NNS O
has VBZ O
been VBN O
suggested VBN O
through IN O
analysis NN O
of IN O
its PRP$ O
role NN O
in IN O
the DT O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
AT NN I-Gene
. . O

The DT O
expression NN O
of IN O
activated VBN O
p21 NN B-Gene
( ( I-Gene
ras NNS I-Gene
) ) I-Gene
negatively RB O
regulated VBD O
the DT O
induction NN O
of IN O
IE NNP B-Gene
genes NNS I-Gene
by IN O
calcium NN O
ionophore NN O
. . O

A DT O
later RBR O
result NN O
of IN O
inhibition NN O
of IN O
this DT O
activation NN O
pathway NN O
by IN O
p21 NN B-Gene
( ( I-Gene
ras FW I-Gene
) ) I-Gene
was VBD O
down RB O
- : O
regulation NN O
of IN O
the DT O
activity NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
subsequent JJ O
coordinate NN O
reductions NNS O
in IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
expression NN O
and CC O
protein NN O
production NN O
. . O

Calcineurin NNP B-Gene
acts VBZ O
in IN O
synergy NN O
with IN O
PMA NNP O
to TO O
inactivate VB O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
/ NNP I-Gene
MAD3 NNP I-Gene
, , O
an DT O
inhibitor NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

Calcineurin NNP B-Gene
stimulates VBZ O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
element NN I-Gene
by IN O
enhancing VBG O
inactivation NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
/ NNP I-Gene
MAD3 NNP I-Gene
, , O
an DT O
inhibitor NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
thereby RB O
increasing VBG O
the DT O
amount NN O
of IN O
nuclear JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
DNA NNP O
binding NN O
activity NN O
. . O

Inhibition NN O
of IN O
membrane NN O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha NN I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
beta NN I-Gene
expression NN O
by IN O
10 CD O
( ( O
- : O
6 CD O
) ) O
M NNP O
DM NNP O
was VBD O
partially RB O
reversible JJ O
by IN O
recombinant JJ B-Gene
human JJ I-Gene
IL NNP I-Gene
- : I-Gene
2 CD I-Gene
( ( O
rhIL VB B-Gene
- : I-Gene
2 CD I-Gene
) ) O
. . O

The DT O
mechanism NN O
of IN O
action NN O
of IN O
DM NNP O
on IN O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha JJ I-Gene
transcription NN O
was VBD O
examined VBN O
by IN O
determining VBG O
the DT O
mRNA NN O
levels NNS O
of IN O
the DT O
p50 JJ O
subunit NN O
of IN O
nuclear JJ O
factor NN O
kappa NN O
B NNP O
( ( O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
) ) O
, , O
a DT O
transcription NN B-Gene
factor NN I-Gene
that WDT O
stimulates VBZ O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha JJ I-Gene
gene NN O
expression NN O
. . O

However RB O
, , O
simultaneous JJ O
incubation NN O
of IN O
RU NNP O
486 CD O
with IN O
dexamethasone NN O
caused VBD O
a DT O
distinct JJ O
interference NN O
of IN O
RU NNP O
486 CD O
with IN O
dexamethasone NN O
. . O

The DT O
protein NN B-Gene
- : I-Gene
tyrosine NN I-Gene
kinase NN I-Gene
ZAP NNP B-Gene
- : I-Gene
70 CD I-Gene
is VBZ O
implicated VBN O
, , O
together RB O
with IN O
the DT O
Src NNP B-Gene
kinase NN I-Gene
p56 NN B-Gene
( ( I-Gene
lck NN I-Gene
) ) I-Gene
, , O
in IN O
controlling VBG O
the DT O
early JJ O
steps NNS O
of IN O
the DT O
T NNP O
- : O
cell NN O
antigen NN O
receptor NN O
( ( O
TCR NNP B-Gene
) ) O
signaling VBG O
cascade NN O
. . O

To TO O
help VB O
elucidate VB O
further RBR O
the DT O
mechanism NN O
by IN O
which WDT O
ZAP NNP B-Gene
- : I-Gene
70 CD I-Gene
regulates VBZ O
these DT O
initial JJ O
events NNS O
, , O
we PRP O
used VBD O
a DT O
dominant JJ O
- : O
negative JJ O
mutant JJ O
approach NN O
. . O

ZAP NNP B-Gene
- : I-Gene
70 CD I-Gene
will MD O
then RB O
be VB O
able JJ O
to TO O
effectively RB O
control VB O
phosphorylation NN O
of IN O
its PRP$ O
substrates NNS O
and CC O
lead NN O
to TO O
gene NN O
activation NN O
. . O

Peripheral JJ O
blood NN O
mononuclear NN O
cell NN O
GCR NNP B-Gene
binding NN O
affinities NNS O
for IN O
dexamethasone NN O
and CC O
budesonide NN O
were VBD O
also RB O
determined VBN O
for IN O
both DT O
patient JJ O
groups NNS O
by IN O
using VBG O
a DT O
radioligand NN O
binding VBG O
assay NN O
and CC O
Scatchard NNP O
analysis NN O
. . O

The DT O
GCR NNP B-Gene
binding NN O
affinity NN O
for IN O
budesonide NN O
was VBD O
significantly RB O
higher JJR O
in IN O
both DT O
groups NNS O
( ( O
i NN O
. . O
e NN O
. . O
, , O
lower JJR O
dissociation NN O
constant NN O
) ) O
than IN O
that DT O
obtained VBD O
for IN O
dexamethasone NN O
. . O

Characterization NN O
of IN O
the DT O
murine NN B-Gene
cyclin NN I-Gene
- : I-Gene
dependent JJ I-Gene
kinase NN I-Gene
inhibitor NN I-Gene
gene NN I-Gene
p27Kip1 NN B-Gene
. . O

The DT O
gene NN O
consists VBZ O
of IN O
at IN O
least JJS O
three CD O
exons NNS O
and CC O
spans VBZ O
more JJR O
than IN O
5 CD B-Gene
. . I-Gene
6 CD I-Gene
kb NN I-Gene
of IN I-Gene
DNA NNP I-Gene
. . O

Primer NNP O
extension NN O
and CC O
nuclease NN O
S1 NNP O
protection NN O
analysis NN O
revealed VBD O
two CD O
major JJ O
transcription NN B-Gene
initiation NN I-Gene
sites NNS I-Gene
. . O

The DT O
- : B-Gene
326 CD I-Gene
to TO I-Gene
- : I-Gene
615 CD I-Gene
region NN I-Gene
contained VBN O
positive JJ B-Gene
regulatory JJ I-Gene
elements NNS I-Gene
. . O

Constitutive JJ O
nuclear JJ O
appearance NN O
was VBD O
also RB O
observed VBN O
for IN O
NF NNP O
- : O
kB2 NN O
/ JJ O
p52 NN O
. . O

These DT O
findings NNS O
indicate VBP O
that IN O
T NNP O
cells NNS O
representing VBG O
different JJ O
activation NN O
and CC O
/ NN O
or CC O
differentiation NN O
stages NNS O
can MD O
be VB O
differentially RB O
responsive JJ O
to TO O
ROI NNP O
- : O
mediated VBN O
signals NNS O
. . O

Furthermore RB O
, , O
overexpression NN O
and CC O
constitutive JJ O
nuclear JJ O
localization NN O
of IN O
NF NNP B-Gene
- : I-Gene
AT NN I-Gene
, , O
but CC O
not RB O
Jun NNP B-Gene
, , I-Gene
Fos NNP I-Gene
, , I-Gene
NF NNP I-Gene
- : I-Gene
kappaB NN I-Gene
, , I-Gene
Oct NNP I-Gene
or CC I-Gene
Ets NNP I-Gene
family NN I-Gene
members NNS I-Gene
, , O
renders VBZ O
the DT O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
enhancer NN I-Gene
in IN O
Jurkat NNP O
T NNP O
lymphocytes VBZ O
resistant JJ O
to TO O
FK506 NNP O
and CC O
cyclosporin VB O
A NNP O
. . O

These DT O
findings NNS O
thus RB O
reveal VBP O
the DT O
presence NN O
of IN O
a DT O
second JJ O
inducible JJ O
autoregulated VBN O
inhibitory JJ O
pathway NN O
that WDT O
helps VBZ O
ensure VB O
the DT O
rapid JJ O
but CC O
transient JJ O
action NN O
of IN O
nuclear JJ B-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

Implications NNS O
for IN O
replication NN O
of IN O
HIV NNP O
- : O
1 CD O
. . O

First RB O
, , O
anti SYM B-Gene
- : I-Gene
CD45 JJ I-Gene
antibodies NNS I-Gene
did VBD O
not RB O
affect VB O
basal NN O
but CC O
decreased VBD O
activated JJ O
levels NNS O
of IN O
expression NN O
from IN O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
. . O

The DT O
expression NN O
of IN O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
inhibited VBN O
by IN O
immunosuppressive JJ O
drugs NNS O
such JJ O
as IN O
cyclosporin NN O
A NNP O
( ( O
CsA NNP O
) ) O
and CC O
FK506 NNP O
. . O

The DT O
constitutively RB O
active JJ O
type NN O
of IN O
the DT O
CN NNP B-Gene
A NNP I-Gene
subunit NN I-Gene
, , O
which WDT O
lacks VBZ O
the DT O
auto NN B-Gene
- : I-Gene
inhibitory NN I-Gene
and CC O
calmodulin NN B-Gene
- : I-Gene
binding NN I-Gene
domains NNS I-Gene
, , O
acts NNS O
in IN O
synergy NN O
with IN O
PMA NNP O
to TO O
activate VB O
transcription NN O
from IN O
the DT O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
promoter NN I-Gene
. . O

Alternate NNP O
immune NN O
system NN O
targets NNS O
for IN O
TCDD NNP O
: : O
lymphocyte JJ O
stem NN O
cells NNS O
and CC O
extrathymic JJ O
T NNP O
- : O
cell NN O
development NN O
. . O

TCDD NNP O
mediates VBZ O
atrophy JJ O
induction NN O
through IN O
its PRP$ O
specific JJ O
receptor NN O
( ( O
the DT O
AhR NNP B-Gene
) ) O
and CC O
not RB O
through IN O
effects NNS O
on IN O
the DT O
estrogen NN O
receptor NN O
. . O

Both DT O
TCDD NNP O
and CC O
estradiol JJ O
induce NN O
extrathymic JJ O
T NNP O
- : O
cell NN O
differentiation NN O
in IN O
the DT O
liver NN O
. . O

It PRP O
predicts VBZ O
for IN O
two CD O
open JJ B-Gene
reading VBG I-Gene
frames NNS I-Gene
( ( O
ORFs NNP B-Gene
) ) O
. . O

ORF1 NNP B-Gene
consists VBZ O
of IN O
240 CD O
bp NN O
that WDT O
would MD O
encode VB O
80 CD O
amino JJ O
acids NNS O
, , O
while IN O
the DT O
major JJ B-Gene
ORF2 NNP I-Gene
consists VBZ O
of IN O
648 CD O
bp NN O
capable JJ O
of IN O
coding VBG O
for IN O
216 CD O
amino JJ O
acids NNS O
. . O

To TO O
investigate VB O
the DT O
mechanisms NNS O
of IN O
transcriptional JJ O
activation NN O
of IN O
interleukin JJ B-Gene
- : I-Gene
1beta CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
) ) O
in IN O
non JJ O
- : O
monocytic JJ O
cells NNS O
, , O
we PRP O
constructed VBD O
a DT O
series NN O
of IN O
reporter JJ O
plasmids NNS O
with IN O
the DT O
bacterial JJ O
chloramphenicol NN O
acetyltransferase NN O
gene NN O
linked VBN O
to TO O
various JJ O
parts NNS O
of IN O
the DT O
human JJ B-Gene
IL NNP I-Gene
- : I-Gene
1beta CD I-Gene
promoter NN I-Gene
and CC O
performed VBD O
transient JJ O
transfection NN O
experiments NNS O
. . O

Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
correlates NNS O
with IN O
the DT O
cellular JJ O
phenotype NN O
and CC O
the DT O
specific JJ O
pattern NN O
of IN O
viral JJ O
latency NN O
established VBN O
within IN O
the DT O
individual NN O
cell NN O
lines NNS O
. . O

Several JJ O
forms NNS O
of IN O
EGR NNP B-Gene
- : I-Gene
1 CD I-Gene
protein NN I-Gene
are VBP O
found VBN O
within IN O
the DT O
different JJ O
groups NNS O
of IN O
cell NN O
lines NNS O
, , O
and CC O
the DT O
binding NN O
activity NN O
to TO O
DNA NNP B-Gene
consensus NN I-Gene
sequences NNS I-Gene
was VBD O
investigated VBN O
. . O

In IN O
all DT O
cells NNS O
tested VBN O
, , O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
activated JJ O
Stat1 NNP B-Gene
and CC O
Stat3 NNP B-Gene
and CC O
induced VBD O
the DT O
formation NN O
of IN O
three CD O
distinct JJ O
DNA NNP B-Gene
binding NN I-Gene
complexes NNS I-Gene
that WDT O
contained VBD O
different JJ O
combinations NNS O
of IN O
these DT O
two CD O
transcription NN B-Gene
factors NNS I-Gene
. . O

Using VBG O
a DT O
structure NN O
- : O
function NN O
mutagenesis NN O
approach NN O
, , O
two CD O
tyrosine NN O
residues NNS O
( ( O
Tyr427 NNP O
and CC O
Tyr477 NNP O
) ) O
in IN O
the DT O
intracellular JJ B-Gene
domain NN I-Gene
of IN O
the DT O
murine NN O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
receptor NN O
were VBD O
found VBN O
to TO O
be VB O
redundantly RB O
required VBN O
for IN O
receptor NN O
function NN O
and CC O
for IN O
activation NN O
of IN O
Stat3 NNP B-Gene
but CC O
not RB O
for IN O
Stat1 NNP B-Gene
or CC O
Stat5 NNP B-Gene
. . O

This DT O
study NN O
thus RB O
supports VBZ O
the DT O
concept NN O
that IN O
utilization NN O
of IN O
distinct JJ O
STAT NNP B-Gene
proteins NNS I-Gene
by IN O
different JJ O
cytokine NN B-Gene
receptors NNS I-Gene
is VBZ O
dependent JJ O
on IN O
the DT O
expression NN O
of IN O
particular JJ O
ligand NN O
- : O
activatable JJ O
, , O
tyrosine JJ B-Gene
- : I-Gene
containing VBG I-Gene
STAT NNP I-Gene
docking VBG I-Gene
sites NNS I-Gene
in IN O
receptor NN B-Gene
intracellular JJ I-Gene
domains NNS I-Gene
. . O

Silencing VBG O
of IN O
human JJ O
fetal JJ O
globin NN B-Gene
expression NN O
is VBZ O
impaired VBN O
in IN O
the DT O
absence NN O
of IN O
the DT O
adult NN B-Gene
beta SYM I-Gene
- : I-Gene
globin NN I-Gene
gene NN I-Gene
activator NN I-Gene
protein NN I-Gene
EKLF NNP B-Gene
. . O

Globin NNP B-Gene
genes NNS I-Gene
are VBP O
subject JJ O
to TO O
tissue VB O
- : O
specific NN O
and CC O
developmental JJ O
stage NN O
- : O
specific JJ O
regulation NN O
. . O

Stimulation NN O
of IN O
human JJ O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
by IN O
zinc NN O
and CC O
related JJ O
cations NNS O
. . O

Therefore RB O
, , O
monokine JJ O
induction NN O
is VBZ O
a DT O
zinc NN O
- : O
specific JJ O
effect NN O
influenced VBN O
by IN O
the DT O
physicochemical JJ O
properties NNS O
of IN O
the DT O
ion NN O
. . O

Confirmation NN O
of IN O
the DT O
unique JJ O
significance NN O
of IN O
zinc NN O
for IN O
immune JJ O
function NN O
provides VBZ O
a DT O
better JJR O
understanding NN O
of IN O
the DT O
mechanisms NN O
of IN O
specific JJ O
zinc NNP O
- : O
mediated VBD O
immune JJ O
modulation NN O
. . O

E3 NNP B-Gene
, , O
a DT O
hematopoietic JJ B-Gene
- : I-Gene
specific JJ I-Gene
transcript NN I-Gene
directly RB O
regulated VBN O
by IN O
the DT O
retinoic NN B-Gene
acid NN I-Gene
receptor NN I-Gene
alpha NN I-Gene
. . O

E3 NNP B-Gene
, , O
one CD O
of IN O
nine CD O
sequences NNS O
identified VBN O
, , O
was VBD O
upregulated VBN O
in IN O
an DT O
immediate JJ O
- : O
early JJ O
manner NN O
, , O
with IN O
transcript NN O
levels NNS O
peaking VBG O
after IN O
60 CD O
minutes NNS O
exposure VBP O
to TO O
RA NNP O
. . O

E3 NNP B-Gene
transcripts NNS I-Gene
were VBD O
RA NNP O
- : O
inducible JJ O
in IN O
HL60 NNP O
cells NNS O
, , O
but CC O
not RB O
in IN O
an DT O
RA NNP O
- : O
resistant NN O
subclone NN O
, , O
HL60R NNP O
, , O
that IN O
harbors VBZ O
a DT O
mutated JJ O
RAR NNP B-Gene
alpha NN I-Gene
gene NN I-Gene
. . O

These DT O
results NNS O
indicate VBP O
that IN O
E3 NNP B-Gene
is VBZ O
a DT O
hematopoietic JJ B-Gene
- : I-Gene
specific JJ I-Gene
gene NN I-Gene
that WDT O
is VBZ O
an DT O
immediate JJ O
target NN O
for IN O
the DT O
activated JJ O
RAR NNP B-Gene
alpha NN I-Gene
during IN O
myelopoiesis NN O
. . O

The DT O
molecular JJ O
mechanism NN O
underlying VBG O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
transcriptional JJ O
blockade NN O
in IN O
anergic JJ O
T NNP O
cell NN O
clones NNS O
is VBZ O
not RB O
fully RB O
understood JJ O
. . O

To TO O
examine VB O
whether IN O
an DT O
active JJ O
negative JJ O
regulatory JJ O
process NN O
occurs NNS O
, , O
we PRP O
created VBD O
a DT O
reporter NN B-Gene
construct NN I-Gene
containing VBG O
as IN O
an DT O
enhancer NN B-Gene
four CD O
copies NNS O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
site NN I-Gene
and CC O
one CD O
copy NN O
of IN O
the DT O
octamer NN B-Gene
site NN I-Gene
( ( O
4X CD B-Gene
NF NNP I-Gene
- : I-Gene
AT NNP I-Gene
- : I-Gene
Oct NN I-Gene
) ) O
. . O

The DT O
simplest JJS O
model NN O
to TO O
explain VB O
these DT O
results NNS O
is VBZ O
that IN O
anergy NN O
is VBZ O
mediated VBN O
by IN O
a DT O
complex NN O
of IN O
multiple JJ O
transcription NN B-Gene
factors NNS I-Gene
that IN O
exert VBP O
a DT O
cis NN O
- : O
acting VBG O
dominant JJ O
negative JJ O
regulatory JJ O
effect NN O
on IN O
the DT O
trans NNS O
- : O
activation NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
. . O

In IN O
contrast NN O
, , O
expression NN O
of IN O
the DT O
activation NN B-Gene
- : I-Gene
dependent NN I-Gene
cell NN I-Gene
surface NN I-Gene
markers NNS I-Gene
CD25 NNP B-Gene
and CC O
CD69 NNP B-Gene
was VBD O
within IN O
normal JJ O
limits NNS O
. . O

Whereas NNP O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
NF NNP O
- : O
kappa NN O
B NNP O
, , O
Oct NNP B-Gene
, , O
CREB NNP B-Gene
and CC O
SP1 NNP B-Gene
displayed VBD O
normal JJ O
binding NN O
activities NNS O
in IN O
nuclear JJ O
extracts NNS O
, , O
the DT O
binding NN O
of IN O
NF NNP B-Gene
- : I-Gene
AT NN I-Gene
to TO O
its PRP$ O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN O
response NN O
element NN O
was VBD O
barely RB O
detectable JJ O
both DT O
before IN O
and CC O
after IN O
T NNP O
cell NN O
stimulation NN O
. . O

Our PRP$ O
results NNS O
strongly RB O
suggest VBP O
that IN O
this DT O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
/ NNP O
DNA NNP O
binding VBG O
defect NN O
is VBZ O
responsible JJ O
for IN O
the DT O
multiple JJ O
cytokine NN B-Gene
deficiency NN O
and CC O
the DT O
SCID NNP O
phenotype NN O
observed VBD O
in IN O
the DT O
two CD O
infant NN O
brothers NNS O
. . O

During IN O
Epstein NNP O
- : O
Barr NNP O
virus NN O
latent JJ O
infection NN O
of IN O
B NNP O
lymphocytes NNS O
in IN O
vitro NN O
, , O
six CD O
viral JJ B-Gene
nuclear JJ I-Gene
antigens NNS I-Gene
( ( O
EBNAs NNP B-Gene
) ) O
are VBP O
expressed VBN O
from IN O
one CD O
of IN O
two CD O
promoters NNS B-Gene
, , O
Cp NNP B-Gene
or CC O
Wp NNP B-Gene
, , O
whose WP$ O
activities NNS O
are VBP O
mutually RB O
exclusive JJ O
. . O

Deletion NN O
of IN O
the DT O
EBNA2 NNP B-Gene
- : I-Gene
dependent JJ I-Gene
enhancer NN I-Gene
located VBN O
upstream NN O
of IN O
Cp NNP B-Gene
resulted VBD O
in IN O
a DT O
ca MD O
. . O
two CD O
- : O
to TO O
fivefold VB O
reduction NN O
in IN O
Cp NNP B-Gene
activity NN O
in IN O
the DT O
LCLs NNP O
assayed NN O
. . O

Deletion NN O
of IN O
the DT O
glucocorticoid JJ O
response NN O
elements NNS O
located VBN O
at IN O
ca MD B-Gene
. . I-Gene
bp VB I-Gene
- : I-Gene
850 CD I-Gene
upstream NN O
of IN O
Cp NNP B-Gene
did VBD O
not RB O
result VB O
in IN O
a DT O
significant JJ O
loss NN O
in IN O
activity NN O
. . O

The DT O
identification NN O
of IN O
oriP NN B-Gene
and CC O
the DT O
EBNA2 NNP B-Gene
- : I-Gene
dependent JJ I-Gene
enhancer NN I-Gene
as IN O
the DT O
major JJ O
positive JJ O
cis NN B-Gene
elements NNS I-Gene
involved VBN O
in IN O
regulating VBG O
Cp NNP B-Gene
activity NN O
in IN O
LCL NNP O
suggests VBZ O
that IN O
EBNA NNP B-Gene
gene NN I-Gene
transcription NN O
is VBZ O
largely RB O
autoregulated VBN O
by IN O
EBNA NNP B-Gene
1 CD I-Gene
and CC O
EBNA NNP B-Gene
2 CD I-Gene
. . O

Expression NN O
of IN O
interleukin JJ B-Gene
1beta CD I-Gene
and CC O
other JJ O
cytokines NNS B-Gene
, , O
such JJ O
as IN O
interleukin JJ B-Gene
6 CD I-Gene
and CC O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
, , O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
dependent JJ O
on IN O
the DT O
activation NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
, , O
NFkappaB NNP B-Gene
. . O

HIV NNP O
- : O
1 CD O
infection NN O
resulted VBD O
in IN O
constitutive JJ O
, , O
low JJ O
- : O
level NN O
expression NN O
of IN O
type NN B-Gene
1 CD I-Gene
interferon NN I-Gene
( ( O
IFN NNP B-Gene
) ) O
at IN O
the DT O
mRNA NN O
level NN O
. . O

We PRP O
suggest VBP O
that IN O
HIV NNP O
- : O
1 CD O
infection NN O
of IN O
myeloid JJ O
cells NNS O
induces NNS O
IFN NNP B-Gene
production NN O
and CC O
PKR NNP B-Gene
activity NN O
, , O
which WDT O
in IN O
turn NN O
contribute NN O
to TO O
enhanced VB O
IkappaBalpha NNP B-Gene
phosphorylation NN O
and CC O
subsequent JJ O
degradation NN O
. . O

Nuclear JJ O
translocation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
subunits NNS I-Gene
may MD O
ultimately RB O
increase VB O
the DT O
intracellular JJ O
pool NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
/ NN I-Gene
IkappaBalpha NNP I-Gene
by IN O
an DT O
autoregulatory NN O
mechanism NN O
. . O

The DT O
transcription NN O
and CC O
transformation NN O
activity NN O
of IN O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
is VBZ O
governed VBN O
by IN O
a DT O
27 CD B-Gene
- : I-Gene
amino NN I-Gene
acid JJ I-Gene
regulatory JJ I-Gene
motif NN I-Gene
, , O
labeled VBD O
the DT O
delta NN B-Gene
- : I-Gene
domain NN I-Gene
, , O
which WDT O
is VBZ O
deleted VBN O
in IN O
v JJ B-Gene
- : I-Gene
Jun NN I-Gene
. . O

Here RB O
, , O
we PRP O
report VBP O
that IN O
differentiated VBD O
B NNP O
cells NNS O
contain VBP O
a DT O
novel JJ O
substoichiometric JJ O
TAF NNP B-Gene
of IN O
105 CD O
kDa NNS O
not RB O
found VBN O
associated VBN O
with IN O
TFIID NNP B-Gene
isolated VBN O
from IN O
other JJ O
cell NN O
types NNS O
. . O

All DT O
cells NNS O
tested VBN O
express JJ O
TAFII105 NNP B-Gene
mRNA NN I-Gene
, , O
but CC O
only RB O
B NNP O
cells NNS O
contain VBP O
significant JJ O
levels NNS O
of IN O
protein NN O
associated VBN O
with IN O
TFIID NNP B-Gene
. . O

The DT O
association NN O
of IN O
20q CD B-Gene
deletions NNS I-Gene
with IN O
myeloid JJ O
` `` O
` `` O
stem NN O
cell NN O
' '' O
' POS O
disorders NNS O
suggests VBZ O
that IN O
the DT O
deletions NNS O
mark VBP O
the DT O
site NN O
of IN O
one CD O
or CC O
more JJR O
genes NNS O
, , O
loss NN O
or CC O
inactivation NN O
of IN O
which WDT O
plays VBZ O
a DT O
role NN O
in IN O
the DT O
regulation NN O
of IN O
normal JJ O
hematopoietic JJ O
progenitors NNS O
. . O

Seventeen NNP O
microsatellite NN B-Gene
markers NNS I-Gene
that WDT O
span VBP O
the DT O
common JJ O
deleted JJ O
region NN O
were VBD O
used VBN O
to TO O
search VB O
for IN O
loss NN O
of IN O
heterozygosity NN O
in IN O
granulocyte NN B-Gene
DNA NN I-Gene
. . O

Therefore RB O
, , O
the DT O
human JJ B-Gene
androgen NN I-Gene
receptor NN I-Gene
assay NN O
( ( O
HUMARA NNP O
) ) O
was VBD O
used VBN O
to TO O
determine VB O
granulocyte JJ O
clonality NN O
. . O

These DT O
results NNS O
show VBP O
that IN O
, , O
in IN O
the DT O
vast JJ O
majority NN O
of IN O
patients NNS O
presented VBN O
here RB O
, , O
the DT O
failure NN O
to TO O
detect VB O
loss NN O
of IN O
heterozygosity NN O
can MD O
not RB O
be VB O
attributed VBN O
to TO O
the DT O
presence NN O
of IN O
normal JJ O
polyclonal JJ O
granulocytes NNS O
. . O

In IN O
contrast NN O
to TO O
MM NNP O
cells NNS O
, , O
normal JJ O
splenic JJ O
B NNP O
cells NNS O
express RB O
dephosphorylated VBD B-Gene
pRB NN I-Gene
. . O

Although IN O
CD40 NNP B-Gene
ligand NN I-Gene
( ( O
CD40L NNP B-Gene
) ) O
triggers VBZ O
a DT O
shift NN O
from IN O
dephosphorylated VBN O
to TO O
phosphorylated VBN O
pRB NN B-Gene
and CC O
proliferation NN O
of IN O
B NNP O
cells NNS O
, , O
the DT O
addition NN O
of IN O
exogenous JJ O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
to TO O
CD40L NNP B-Gene
- : O
treated VBD O
B NNP O
cells NNS O
does VBZ O
not RB O
alter VB O
either CC O
pRB VB B-Gene
or CC O
proliferation NN O
, , O
as IN O
observed VBN O
in IN O
MM NNP O
cells NNS O
. . O

Soluble JJ B-Gene
factors NNS I-Gene
secreted VBN O
by IN O
activated JJ O
T NNP O
- : O
lymphocytes VBZ O
modulate VBP O
the DT O
transcription NN O
of IN O
the DT O
immunosuppressive JJ B-Gene
cytokine NN I-Gene
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
2 CD I-Gene
in IN O
glial JJ O
cells NNS O
. . O

These DT O
data NNS O
along IN O
with IN O
previous JJ O
observations NNS O
demonstrating VBG O
the DT O
potent JJ O
immunosuppressive JJ O
activity NN O
of IN O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
2 CD I-Gene
, , O
support NN O
a DT O
model NN O
for IN O
a DT O
feedback NN O
mechanism NN O
between IN O
the DT O
activated VBN O
T NNP O
- : O
lymphocytes NNS O
and CC O
astrocytes NNS O
via IN O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
2 CD I-Gene
to TO O
regulate VB O
the DT O
immune JJ O
response NN O
. . O

The DT O
transcriptionally RB B-Gene
regulatory JJ I-Gene
regions NNS I-Gene
of IN O
the DT O
lymphomagenic JJ O
Akv NNP O
and CC O
SL3 NNP O
- : O
3 CD O
murine NN O
leukemia NN O
retroviruses NNS O
( ( O
MLVs NNP O
) ) O
contain VBP O
two CD O
types NNS O
of IN O
E NNP B-Gene
- : I-Gene
box NN I-Gene
consensus NN I-Gene
motifs NNS I-Gene
, , O
CAGATG NNP O
. . O

We PRP O
have VBP O
examined VBN O
the DT O
requirements NNS O
of IN O
the DT O
individual JJ O
E NNP B-Gene
- : I-Gene
boxes NNS I-Gene
in IN O
MLV NNP O
transcriptional JJ O
regulation NN O
. . O

In IN O
lymphoid NN O
cell NN O
lines NNS O
only RB O
, , O
the DT O
E NNP B-Gene
( ( I-Gene
gre NN I-Gene
) ) I-Gene
- : I-Gene
binding VBG I-Gene
protein NN I-Gene
complexes NNS I-Gene
included VBD O
ALF1 NNP B-Gene
or CC O
HEB NNP B-Gene
and CC O
E2A NNP B-Gene
basic JJ I-Gene
helix NN I-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
proteins NNS I-Gene
. . O

ALF1 NNP B-Gene
transactivated VBD O
transcription NN O
of IN O
Akv NNP O
MLV NNP O
through IN O
the DT O
two CD O
E NNP B-Gene
( ( I-Gene
gre NN I-Gene
) ) I-Gene
motifs FW I-Gene
equally RB O
, , O
whereas NNS O
E2A NNP B-Gene
protein NN I-Gene
required VBD O
the DT O
promoter NN O
- : O
proximal JJ O
E NNP B-Gene
( ( I-Gene
gre NN I-Gene
) ) I-Gene
motif NN O
. . O

Moreover RB O
, , O
ectopic FW B-Gene
Id1 NNP I-Gene
repressed VBD O
E NNP B-Gene
( ( I-Gene
gre NN I-Gene
) ) I-Gene
- : O
directed VBN O
but CC O
not RB O
EA NNP B-Gene
/ NNP I-Gene
S NNP I-Gene
- : O
directed VBD O
MLV NNP O
transcription NN O
in IN O
lymphoid NN O
cell NN O
lines NNS O
. . O

In IN O
conclusion NN O
, , O
E NNP B-Gene
( ( I-Gene
gre NN I-Gene
) ) I-Gene
motifs NN O
and CC O
interacting VBG O
basic JJ B-Gene
helix NN I-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
proteins NNS I-Gene
are VBP O
important JJ O
determinants NNS O
for IN O
MLV NNP O
transcriptional JJ O
activity NN O
in IN O
lymphocytic JJ O
cell NN O
lines NNS O
. . O

Reversal NNP O
of IN O
apoptosis NN O
by IN O
the DT O
leukaemia NN O
- : O
associated VBN O
E2A NNP B-Gene
- : I-Gene
HLF NNP I-Gene
chimaeric JJ I-Gene
transcription NN I-Gene
factor NN I-Gene
. . O

We PRP O
cloned VBD O
human JJ O
nur77 JJ B-Gene
beta NN I-Gene
cDNA NN I-Gene
, , O
called VBN O
TINUR NNP B-Gene
. . O

Although IN O
NGFI NNP B-Gene
- : I-Gene
B NNP I-Gene
/ NNP I-Gene
nur77 NN I-Gene
is VBZ O
essential JJ O
for IN O
TCR NNP O
- : O
mediated VBD O
apoptosis NN O
in IN O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
hybridomas NN I-Gene
, , O
the DT O
reports NNS O
on IN O
nur77 JJ O
knock NN O
- : O
out IN O
mice NNS O
and CC O
nur77 JJ O
dominant JJ O
negative JJ O
transgenic JJ O
mice NN O
suggest VBP O
that IN O
there EX O
is VBZ O
a DT O
functional JJ O
redundancy NN O
among IN O
NGFI NNP B-Gene
- : I-Gene
B NNP I-Gene
/ NNP I-Gene
nur77 JJ I-Gene
family NN I-Gene
. . O

Correlations NNS O
were VBD O
found VBN O
between IN O
plasma NN B-Gene
IFN NNP I-Gene
alpha NN I-Gene
and CC O
receptor NN O
Kd NNP O
on IN O
monocytes NNS O
of IN O
AIDS NNP O
- : O
GR NNP O
( ( O
r VB O
= RB O
0 CD O
. . O
77 CD O
) ) O
and CC O
between IN O
IFN NNP B-Gene
alpha NN I-Gene
and CC O
plasma NN O
cortisol NN O
in IN O
the DT O
same JJ O
group NN O
( ( O
r NN O
= VBZ O
0 CD O
. . O
74 CD O
) ) O
. . O

By IN O
contrast NN O
, , O
glucocorticoids NNS O
failed VBD O
to TO O
inhibit VB O
IFNalpha NNP B-Gene
production NN O
from IN O
AIDS NNP O
- : O
GR NN O
monocytes NNS O
( ( O
approximately RB O
20 CD O
% NN O
inhibition NN O
) ) O
. . O

This DT O
activation NN O
differed VBD O
substantially RB O
from IN O
that IN O
mediated VBN O
by IN O
phorbol NN O
12 CD O
- : O
myristate NN O
13 CD O
- : O
acetate NN O
( ( O
PMA NNP O
) ) O
and CC O
Ca2 NNP O
+ NNP O
ionophore NN O
or CC O
produced VBN O
by IN O
costimulation NN O
with IN O
antibodies NNS B-Gene
against IN O
the DT O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
- : I-Gene
CD3 NNP I-Gene
complex JJ I-Gene
and CC O
to TO O
CD28 NNP B-Gene
. . O

The DT O
age NN O
- : O
associated VBN O
immune JJ O
dysfunction NN O
may MD O
be VB O
implicated VBN O
to TO O
some DT O
degree NN O
in IN O
the DT O
extreme JJ O
susceptibility NN O
of IN O
the DT O
elderly JJ O
to TO O
infection NN O
and CC O
neoplasia NN O
and CC O
may MD O
even RB O
participate VB O
in IN O
various JJ O
aspects NNS O
of IN O
senescence NN O
. . O

The DT O
biochemical JJ O
modifications NNS O
responsible JJ O
for IN O
the DT O
defect NN O
in IN O
transduction NN O
and CC O
execution NN O
of IN O
the DT O
proliferative JJ O
signal NN O
are VBP O
analyzed VBN O
as IN O
a DT O
function NN O
of IN O
age NN O
. . O

The DT O
multiple JJ O
alterations NNS O
observed VBN O
on IN O
the DT O
various JJ O
biochemical JJ O
pathways NNS O
may MD O
appear VB O
as IN O
a DT O
consequence NN O
of IN O
a DT O
unique JJ O
deleterious JJ O
mechanism NN O
more RBR O
fundamentally RB O
related VBN O
to TO O
the DT O
process NN O
of IN O
senescence NN O
such JJ O
as IN O
the DT O
inability NN O
to TO O
cope VB O
with IN O
oxidative JJ O
stress NN O
. . O

Induction NN O
of IN O
bcl NN B-Gene
- : I-Gene
2 CD I-Gene
expression NN O
by IN O
phosphorylated JJ O
CREB NNP O
proteins NNS O
during IN O
B NNP O
- : O
cell NN O
activation NN O
and CC O
rescue NN O
from IN O
apoptosis NN O
. . O

Engagement NN O
of IN O
surface NN O
immunoglobulin NN O
on IN O
mature NN O
B NNP O
cells NNS O
leads VBZ O
to TO O
rescue VB O
from IN O
apoptosis NN O
and CC O
to TO O
proliferation NN O
. . O

These DT O
stimuli NNS O
result VBP O
in IN O
phosphorylation NN O
of IN O
CREB NNP B-Gene
at IN O
serine JJ O
133 CD O
. . O

It PRP O
is VBZ O
possible JJ O
that IN O
the DT O
CRE NNP B-Gene
site NN I-Gene
is VBZ O
responsible JJ O
for IN O
induction NN O
of IN O
bcl NN B-Gene
- : I-Gene
2 CD I-Gene
expression NN O
in IN O
other JJ O
cell NN O
types NNS O
, , O
particularly RB O
those DT O
in IN O
which WDT O
protein NN B-Gene
kinase NN I-Gene
C NNP I-Gene
is VBZ O
involved VBN O
. . O

MNDA NNP B-Gene
( ( O
myeloid NN B-Gene
cell NN I-Gene
nuclear JJ I-Gene
differentiation NN I-Gene
antigen NN I-Gene
) ) O
is VBZ O
an DT O
interferon NN B-Gene
alpha NN I-Gene
regulated VBD I-Gene
nuclear JJ I-Gene
protein NN I-Gene
expressed VBD O
only RB O
in IN O
cells NNS O
of IN O
the DT O
human JJ O
myelomonocytic JJ O
lineage NN O
. . O

In IN O
addition NN O
, , O
DNA NNP O
methylation NN O
was VBD O
revealed VBN O
as IN O
one CD O
of IN O
the DT O
possible JJ O
factors NNS O
in IN O
establishing VBG O
MNDA NNP B-Gene
expression NN O
. . O

This DT O
abnormality NN O
was VBD O
not RB O
seen VBN O
in IN O
resting VBG O
T NNP O
cells NNS O
nor CC O
T NNP O
cells NNS O
from IN O
patients NNS O
with IN O
systemic JJ O
lupus NN O
erythematosus NN O
, , O
rheumatoid JJ O
arthritis NN O
( ( O
RA NNP O
) ) O
, , O
or CC O
SS NNP O
accompanied VBN O
by IN O
RA NNP O
. . O

Characterization NN O
of IN O
a DT O
new JJ O
isoform NN O
of IN O
the DT O
NFAT NNP B-Gene
( ( O
nuclear JJ B-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
cells NNS I-Gene
) ) O
gene NN O
family NN O
member NN O
NFATc NNP B-Gene
[ NNP O
published VBD O
erratum JJ O
appears VBZ O
in IN O
J NNP O
Biol NNP O
Chem NNP O
1996 CD O
Dec NNP O
27 CD O
; : O
271 CD O
( ( O
52 CD O
) ) O
: : O
33705 CD O
] NN O

The DT O
amino NN B-Gene
acid JJ I-Gene
sequence NN I-Gene
of IN O
NFATc NNP B-Gene
. . I-Gene
beta NN I-Gene
differs NNS O
from IN O
that DT O
of IN O
NFATc NNP B-Gene
. . O

Transient JJ O
expression NN O
of IN O
NFATc NNP B-Gene
. . I-Gene
beta NN I-Gene
was VBD O
capable JJ O
of IN O
activating VBG O
an DT O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
NFAT NNP I-Gene
- : I-Gene
driven VBN I-Gene
reporter NN I-Gene
gene NN I-Gene
in IN O
stimulated JJ O
Jurkat NNP O
cells NNS O
in IN O
a DT O
CsA NNP O
- : O
sensitive JJ O
manner NN O
. . O

However RB O
, , O
NFATc NNP B-Gene
. . I-Gene
beta NN I-Gene
neither CC O
bound NN O
to TO O
the DT O
kappa3 NN B-Gene
element NN I-Gene
( ( O
an DT O
NFAT NNP B-Gene
- : I-Gene
binding VBG I-Gene
site NN I-Gene
) ) O
in IN O
the DT O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
promoter NN I-Gene
nor CC O
activated VBD O
the DT O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
promoter NN I-Gene
in IN O
cotransfection NN O
assays NNS O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
examined VBD O
seven CD O
EBV NNP O
- : O
positive JJ O
gastric JJ O
carcinoma NN O
tissues NNS O
for IN O
viral JJ O
gene NN O
expression NN O
at IN O
the DT O
mRNA NN O
level NN O
, , O
from IN O
which WDT O
studies NNS O
on IN O
the DT O
EBV NNP O
oncogenicity NN O
in IN O
human JJ O
epithelial JJ O
cells NNS O
will MD O
benefit VB O
. . O

Both DT O
are VBP O
located VBN O
in IN O
the DT O
particulate JJ O
fraction NN O
following VBG O
platelet NN O
activation NN O
and CC O
are VBP O
also RB O
able JJ O
to TO O
bind VB O
to TO O
a DT O
GST NNP B-Gene
- : I-Gene
construct NN I-Gene
containing VBG O
the DT O
SH2 NNP B-Gene
and CC I-Gene
SH3 NNP I-Gene
domains NNS I-Gene
of IN O
phospholipase NN B-Gene
C NNP I-Gene
gamma NN I-Gene
1 CD I-Gene
. . O

Constitutive JJ O
expression NN O
of IN O
specific JJ O
interferon NN B-Gene
isotypes NNS I-Gene
in IN O
peripheral JJ O
blood NN O
leukocytes NNS O
from IN O
normal JJ O
individuals NNS O
and CC O
in IN O
promonocytic JJ O
U937 NNP O
cells NNS O
. . O

Constitutive JJ O
expression NN O
of IN O
IFN NNP B-Gene
- : I-Gene
alpha5 NN I-Gene
and CC O
IFN NNP B-Gene
- : I-Gene
beta NN I-Gene
was VBD O
detected VBN O
in IN O
different JJ O
lymphoid JJ O
cells NNS O
including VBG O
peripheral JJ O
blood NN O
mononuclear JJ O
cells NNS O
from IN O
normal JJ O
individuals NNS O
following VBG O
amplification NN O
of IN O
IFN NNP B-Gene
mRNA NN I-Gene
by IN O
reverse NN B-Gene
transcriptase NN I-Gene
- : O
polymerase NN O
chain NN O
reaction NN O
and CC O
direct JJ O
sequencing NN O
of IN O
the DT O
amplified JJ B-Gene
product NN I-Gene
. . O

These DT O
results NNS O
suggest VBP O
that IN O
IFN NNP B-Gene
- : I-Gene
alpha5 NN I-Gene
and CC O
IFN NNP B-Gene
- : I-Gene
beta NN I-Gene
are VBP O
produced VBN O
at IN O
low JJ O
levels NNS O
in IN O
normal JJ O
tissues NNS O
and CC O
play VB O
an DT O
important JJ O
role NN O
in IN O
the DT O
regulation NN O
of IN O
cell NN O
function NN O
and CC O
in IN O
the DT O
maintenance NN O
of IN O
homeostasis NN O
. . O

Thus RB O
, , O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
- : O
induced VBN O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha JJ I-Gene
promoter NN I-Gene
activity NN O
requires VBZ O
a DT O
complex JJ B-Gene
upstream NN I-Gene
element NN I-Gene
, , O
which WDT O
appears VBZ O
to TO O
contain VB O
binding NN B-Gene
sites NNS I-Gene
for IN O
both DT O
positive JJ B-Gene
and CC I-Gene
negative JJ I-Gene
regulatory JJ I-Gene
factors NNS I-Gene
. . O

Lymphocytes NNS O
from IN O
CML NNP O
patients NNS O
lack VBP O
a DT O
47 CD B-Gene
kDa NN I-Gene
factor NN I-Gene
having VBG O
affinity NN O
for IN O
a DT O
genomic JJ B-Gene
sterol NN I-Gene
regulatory JJ I-Gene
sequence NN I-Gene
. . O

The DT O
proximal JJ B-Gene
sequence NN I-Gene
element NN I-Gene
( ( I-Gene
PSE NNP I-Gene
) ) I-Gene
- : I-Gene
binding VBG I-Gene
transcription NN I-Gene
factor NN I-Gene
( ( O
PTF NNP B-Gene
) ) O
, , O
which WDT O
binds VBZ O
the DT O
PSE NNP B-Gene
of IN O
both DT O
RNA NNP B-Gene
polymerase NN I-Gene
II NNP I-Gene
- : I-Gene
and CC I-Gene
RNA NNP I-Gene
polymerase NN I-Gene
III NNP I-Gene
- : I-Gene
transcribed VBD I-Gene
mammalian JJ I-Gene
small JJ I-Gene
nuclear JJ I-Gene
RNA NNP I-Gene
( ( I-Gene
snRNA NN I-Gene
) ) I-Gene
genes NNS I-Gene
, , O
is VBZ O
essential JJ O
for IN O
their PRP$ O
transcription NN O
. . O

Here RB O
we PRP O
describe VBP O
the DT O
isolation NN O
and CC O
expression NN O
of IN O
a DT O
cDNA NN B-Gene
encoding VBG O
PTF NNP B-Gene
beta NN I-Gene
, , O
as RB O
well RB O
as IN O
functional JJ O
studies NNS O
using VBG O
anti JJ B-Gene
- : I-Gene
PTF NNP I-Gene
beta NN I-Gene
antibodies NNS I-Gene
. . O

We PRP O
report VBP O
here RB O
on IN O
the DT O
identification NN O
of IN O
a DT O
17 CD B-Gene
kDa NN I-Gene
variant NN I-Gene
of IN O
the DT O
14 CD B-Gene
kDa NN I-Gene
Id NNP I-Gene
- : I-Gene
3 CD I-Gene
protein NN O
termed VBD O
Id NNP B-Gene
- : I-Gene
3L CD I-Gene
( ( O
long JJ O
version NN O
) ) O
which WDT O
possesses VBZ O
a DT O
unique JJ O
60 CD B-Gene
amino NN I-Gene
acid NN I-Gene
carboxy SYM I-Gene
- : I-Gene
terminus NN I-Gene
generated VBN O
by IN O
read JJ O
through IN O
of IN O
a DT O
' POS O
coding VBG B-Gene
intron NN I-Gene
' '' O
and CC O
alternative JJ O
splicing NN O
. . O

Tyloxapol NNP O
inhibits VBZ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
cytokine NN B-Gene
release NN O
, , O
scavenges VBZ O
HOCI NNP B-Gene
, , O
and CC O
reduces VBZ O
viscosity NN O
of IN O
cystic JJ O
fibrosis NN O
sputum NN O
. . O

In IN O
the DT O
search NN O
for IN O
a DT O
potential JJ O
treatment NN O
, , O
we PRP O
have VBP O
tested VBN O
tyloxapol NN O
, , O
an DT O
alkylaryl NN O
polyether NN O
alcohol NN O
polymer NN O
detergent NN O
previously RB O
used VBN O
as IN O
a DT O
mucolytic JJ O
agent NN O
in IN O
adult NN O
chronic JJ O
bronchitis NN O
. . O

Tyloxapol NNP O
inhibits VBZ O
activation NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
nuclear JJ I-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( O
NK NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
) ) O
, , O
reduces VBZ O
resting VBG O
secretion NN O
of IN O
the DT O
cytokine NN B-Gene
interleukin SYM B-Gene
- : I-Gene
8 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
) ) O
in IN O
cultured JJ O
human JJ O
monocytes NNS O
, , O
and CC O
inhibits NNS O
lipopolysaccharide VBP O
( ( O
LPS NNP O
) ) O
- : O
stimulated VBN O
release NN O
of IN O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
, , O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
, , O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
, , O
granulocyte SYM B-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
( ( O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
) ) O
, , O
and CC O
the DT O
eiconsanoids NNS O
thromboxane NN O
A2 NNP O
and CC O
leukotriene JJ O
B4 NNP O
( ( O
LTB4 NNP O
) ) O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
examined VBD O
the DT O
molecular JJ O
mechanism NN O
by IN O
which WDT O
agents NNS O
that WDT O
elevate VBP O
intracellular JJ O
cAMP NN O
inhibit NN O
the DT O
expression NN O
of IN O
the DT O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
( ( O
TNFalpha NNP B-Gene
) ) O
, , O
tissue NN B-Gene
factor NN I-Gene
, , O
endothelial JJ B-Gene
leukocyte NN I-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
vascular JJ B-Gene
cell NN I-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
genes NNS I-Gene
. . O

We PRP O
propose VBP O
that IN O
direct JJ O
interaction NN O
between IN O
the DT O
glucocorticoid NN B-Gene
receptor NN I-Gene
and CC O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
factors NNS I-Gene
is VBZ O
at IN O
least JJS O
a DT O
partial JJ O
explanation NN O
for IN O
the DT O
effects NNS O
of IN O
this DT O
hormone NN O
in IN O
inflammatory JJ O
diseases NNS O
. . O

Abnormalities NNS O
in IN O
the DT O
p16 NN B-Gene
, , I-Gene
p15 NN I-Gene
and CC I-Gene
CDK4 NNP I-Gene
genes NNS I-Gene
that WDT O
regulate VBP O
transition NN O
through IN O
the DT O
G1 NNP O
phase NN O
of IN O
the DT O
cell NN O
cycle NN O
have VBP O
been VBN O
implicated VBN O
in IN O
the DT O
malignant JJ O
progression NN O
of IN O
astrocytomas NN O
. . O

The DT O
primary JJ O
and CC O
recurrent JJ O
tumors NNS O
in IN O
Group NNP O
A NNP O
did VBD O
not RB O
show VB O
structural JJ O
alterations NNS O
in IN O
the DT O
p16 NN B-Gene
, , I-Gene
p15 NN I-Gene
or CC I-Gene
CDK4 NNP I-Gene
genes NNS I-Gene
, , O
whereas RB O
homozygous JJ O
codeletion NN O
of IN O
p16 NN B-Gene
and CC O
p15 NN B-Gene
was VBD O
observed VBN O
in IN O
both DT O
primary JJ O
and CC O
recurrent JJ O
tumors NNS O
in IN O
Group NNP O
B NNP O
. . O

The DT O
primary JJ O
tumors NNS O
in IN O
Group NNP O
C NNP O
had VBD O
a DT O
normal JJ O
profile NN O
of IN O
p16 NN B-Gene
, , O
p15 NN B-Gene
and CC O
CDK4 NNP B-Gene
at IN O
presentation NN O
. . O

Approximately RB O
40 CD O
% NN O
of IN O
diffuse NN O
large JJ O
cell NN O
lymphoma NN O
are VBP O
associated VBN O
with IN O
chromosomal JJ O
translocations NNS O
that WDT O
deregulate VBP O
the DT O
expression NN O
of IN O
the DT O
BCL6 NNP B-Gene
gene NN I-Gene
by IN O
juxtaposing VBG O
heterologous JJ B-Gene
promoters NNS I-Gene
to TO O
the DT O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
coding VBG I-Gene
domain NN I-Gene
. . O

In IN O
transient JJ O
transfectin NN O
experiments NNS O
, , O
BCL6 NNP B-Gene
can MD O
repress VB O
transcription NN O
from IN O
promoters NNS B-Gene
linked VBN O
to TO O
its PRP$ O
DNA NNP B-Gene
target NN I-Gene
sequence NN I-Gene
and CC O
this DT O
activity NN O
is VBZ O
dependent JJ O
upon IN O
specific JJ O
DNA NNP O
- : O
binding NN O
and CC O
the DT O
presence NN O
of IN O
an DT O
intact JJ O
N NNP B-Gene
- : I-Gene
terminal JJ I-Gene
half NN I-Gene
of IN O
the DT O
protein NN O
. . O

As IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
transcription NN I-Gene
factor NN I-Gene
has VBZ O
a DT O
central JJ O
role NN O
in IN O
the DT O
control NN O
of IN O
transcription NN O
of IN O
several JJ O
genes NNS B-Gene
involved VBN O
in IN O
immune NN O
and CC O
inflammatory JJ O
responses NNS O
, , O
the DT O
authors NNS O
have VBP O
analysed VBN O
the DT O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
human JJ O
umbilical JJ O
cord NN O
T NNP O
lymphocytes VBZ O
. . O

The DT O
key JJ O
role NN O
of IN O
erythropoietin NN B-Gene
( ( O
Epo NNP B-Gene
) ) O
for IN O
colony NN O
formation NN O
by IN O
early JJ O
erythroid NN O
progenitors NNS O
( ( O
burst SYM O
- : O
forming VBG O
units NNS O
- : O
erythroid NN O
[ NN O
BFU NNP O
- : O
E NNP O
] NNP O
) ) O
has VBZ O
been VBN O
confirmed VBN O
. . O

High JJ O
concentrations NNS O
of IN O
either DT O
compound NN O
( ( O
1 CD O
) ) O
drastically RB O
reduced VBD O
the DT O
number NN O
of IN O
primary JJ O
HPP NNP O
- : O
CFC NNP O
colonies NNS O
and CC O
totally RB O
abolished VBD O
their PRP$ O
recloning NN O
capacity NN O
and CC O
( ( O
2 CD O
) ) O
inhibited VBN O
HSC NNP O
proliferation NN O
. . O

Altogether RB O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
ATRA NNP O
/ VBD O
9 CD O
- : O
cis NN O
RA NNP O
may MD O
play VB O
a DT O
key JJ O
role NN O
in IN O
FL NNP O
hematopoiesis NN O
via IN O
a DT O
dual JJ O
effect NN O
hypothetically RB O
mediated VBN O
by IN O
interaction NN O
with IN O
the DT O
RAR NNP B-Gene
/ NNP I-Gene
RXR NNP I-Gene
heterodimer NN I-Gene
, , O
ie NN O
, , O
inhibition NN O
of IN O
HSC NNP O
/ NNP O
primitive JJ O
HPC NNP O
proliferation NN O
and CC O
induction NN O
of IN O
CFU NNP O
- : O
GEMM NNP O
/ NNP O
BFU NNP O
- : O
E NN O
/ NNP O
CFU NNP O
- : O
M NNP O
shift NN O
from IN O
the DT O
multipotent NN O
/ NNP O
erythroid VBZ O
/ NNP O
monocytic JJ O
to TO O
the DT O
granulocytic JJ O
- : O
neutrophilic JJ O
differentiation NN O
program NN O
. . O

We PRP O
previously RB O
suggested VBD O
that IN O
the DT O
measurement NN O
of IN O
corticosteroid JJ B-Gene
receptors NNS I-Gene
in IN O
lymphocytes NNS O
is VBZ O
an DT O
index NN O
of IN O
an DT O
analogous JJ O
pattern NN O
in IN O
brain NN O
. . O

Receptors NNS O
were VBD O
measured VBN O
by IN O
radioreceptor NN O
assay NN O
. . O

Analysis NN O
of IN O
the DT O
ligand NN B-Gene
- : I-Gene
binding NN I-Gene
domain NN I-Gene
of IN O
human JJ B-Gene
retinoic NN I-Gene
acid NN I-Gene
receptor NN I-Gene
alpha NN I-Gene
by IN O
site NN O
- : O
directed JJ O
mutagenesis NN O
. . O

Three CD O
subtypes NNS O
of IN O
retinoic NN B-Gene
acid NN I-Gene
receptors NNS I-Gene
( ( O
RAR NNP B-Gene
) ) O
, , O
termed VBD O
RAR NNP B-Gene
alpha NN I-Gene
, , O
RAR NNP B-Gene
beta NN I-Gene
, , O
and CC O
RAR NNP B-Gene
gamma NN I-Gene
, , O
have VBP O
been VBN O
described VBN O
. . O

RARs NNP B-Gene
specifically RB O
bind VBP O
all DT O
- : O
trans NNS O
- : O
retinoic NN O
acid NN O
( ( O
RA NNP O
) ) O
, , O
9 CD O
- : O
cis NN O
- : O
RA NNP O
, , O
and CC O
retinoid JJ O
analogs NNS O
. . O

Interestingly RB O
, , O
residue JJ O
C NNP O
- : O
235 CD O
is VBZ O
specifically RB O
important JJ O
in IN O
antagonist JJ O
binding NN O
. . O

With IN O
respect NN O
to TO O
arginine VB O
residues NNS O
, , O
only RB O
the DT O
two CD O
single JJ O
mutations NNS O
of IN O
R NNP O
- : O
276 CD O
and CC O
R NNP O
- : O
394 CD O
to TO O
alanine VB O
showed PDT O
a DT O
dramatic JJ O
decrease NN O
of IN O
agonist NN O
and CC O
antagonist NN O
binding NN O
whereas IN O
the DT O
R272A NNP O
mutation NN O
showed VBD O
only RB O
a DT O
slight JJ O
effect NN O
. . O

For IN O
all DT O
other JJ O
arginine JJ O
mutations NNS O
, , O
no DT O
differences NNS O
in IN O
affinity NN O
were VBD O
detectable JJ O
. . O

The DT O
two CD O
mutations NNS O
R217A NNP O
and CC O
R294A NNP O
caused VBD O
an DT O
increased VBN O
binding NN O
efficiency NN O
for IN O
antagonists NNS O
but CC O
no DT O
change NN O
in IN O
agonist NN O
binding NN O
. . O

From IN O
these DT O
results NNS O
, , O
we PRP O
can MD O
conclude VB O
that DT O
electrostatic JJ O
interactions NNS O
of IN O
retinoids NNS O
with IN O
the DT O
RAR NNP B-Gene
alpha SYM I-Gene
- : I-Gene
LBD NNP I-Gene
play VB O
a DT O
significant JJ O
role NN O
in IN O
ligand NN O
binding NN O
. . O

In IN O
spite NN O
of IN O
this DT O
similar JJ O
downstream NN O
signalling NN O
, , O
IL4 NNP B-Gene
and CC O
IL13 NNP B-Gene
used VBD O
a DT O
different JJ O
set NN O
of IN O
Janus NNP B-Gene
kinases NNS I-Gene
: : O
IL13 NNP B-Gene
is VBZ O
unable JJ O
to TO O
activate VB O
JAK1 NNP B-Gene
and CC O
JAK3 NNP B-Gene
. . O

Our PRP$ O
findings NNS O
support VB O
the DT O
recently RB O
determined VBN O
calcineurin NN B-Gene
X NNP O
- : O
ray JJ O
crystal JJ O
structure NN O
, , O
provide VB O
evidence NN O
that IN O
calcineurin NN B-Gene
is VBZ O
the DT O
only JJ O
CsA NNP B-Gene
- : I-Gene
sensitive JJ I-Gene
component NN I-Gene
limiting VBG O
signaling VBG O
from IN O
the DT O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
to TO O
the DT O
nucleus NN O
, , O
and CC O
suggest VBP O
a DT O
means NN O
to TO O
render VB O
cells NNS O
and CC O
tissues NNS O
resistant VBP O
to TO O
the DT O
toxic JJ O
side NN O
effects NNS O
of IN O
CsA NNP O
and CC O
FK506 NNP O
. . O

Epstein NNP O
- : O
Barr NNP O
viral JJ O
latency NN O
is VBZ O
disrupted VBN O
by IN O
the DT O
immediate JJ B-Gene
- : I-Gene
early JJ I-Gene
BRLF1 NNP I-Gene
protein NN I-Gene
through IN O
a DT O
cell NN O
- : O
specific JJ O
mechanism NN O
. . O

Epithelial JJ O
cells NNS O
are VBP O
the DT O
major JJ O
site NN O
of IN O
lytic JJ O
EBV NNP O
replication NN O
within IN O
the DT O
human JJ O
host NN O
, , O
and CC O
viral JJ O
reactivation NN O
occurs VBZ O
in IN O
EBV NNP O
- : O
associated VBN O
nasopharyngeal JJ O
carcinomas NN O
. . O

Eosinophils NNS O
play VBP O
an DT O
important JJ O
role NN O
in IN O
the DT O
effector NN O
phase NN O
of IN O
allergic JJ O
inflammation NN O
. . O

The DT O
extent NN O
to TO O
which WDT O
peptides NNS O
containing VBG O
chemically RB O
and CC O
post VB O
- : O
translationally RB O
modified VBN O
amino NN B-Gene
acid JJ I-Gene
side NN I-Gene
chains NNS I-Gene
are VBP O
recognized VBN O
by IN O
primed JJ O
CTL NNP O
has VBZ O
not RB O
been VBN O
clearly RB O
defined VBN O
. . O

The DT O
CTL NNP O
specifically RB O
recognized VBD O
the DT O
succinimide NN O
- : O
containing VBG O
peptide IN O
showing VBG O
only RB O
weak JJ O
cross NN O
- : O
reactivity NN O
at IN O
high JJ O
concentrations NNS O
of IN O
the DT O
parent NN O
peptide IN O
containing VBG O
unmodified JJ O
asparagine NN O
. . O

Moreover RB O
, , O
since IN O
succinimide JJ O
intermediates NNS O
of IN O
deamidated JJ O
peptides NNS O
can MD O
occasionally RB O
be VB O
very RB O
stable JJ O
, , O
these DT O
peptides NNS O
have VBP O
the DT O
potential JJ O
to TO O
act VB O
as IN O
altered JJ O
self NN O
- : O
Ags NN O
with IN O
significant JJ O
implications NNS O
for IN O
autoimmunity NN O
. . O

A DT O
3 CD O
' POS O
- : O
- : O
> NN O
5 CD O
' '' O
XPB JJ B-Gene
helicase NN I-Gene
defect NN O
in IN O
repair NN B-Gene
/ JJ I-Gene
transcription NN I-Gene
factor NN I-Gene
TFIIH NNP B-Gene
of IN O
xeroderma NNP O
pigmentosum NN O
group NN O
B NNP O
affects VBZ O
both DT O
DNA NNP O
repair NN O
and CC O
transcription NN O
. . O

Although IN O
identical JJ O
in IN O
composition NN O
and CC O
stoichiometry NN O
to TO O
TFIIHwt NNP B-Gene
, , O
TFIIHmut NNP B-Gene
shows VBZ O
a DT O
reduced JJ O
3 CD O
' POS O
- : O
- : O
> NN O
5 CD O
' '' O
XPB JJ B-Gene
helicase NN O
activity NN O
. . O

The DT O
XPB NNP B-Gene
mutation NN O
causes VBZ O
a DT O
severe JJ O
NER NNP O
defect NN O
. . O

The DT O
latter JJ O
defect NN O
may MD O
provide VB O
an DT O
explanation NN O
for IN O
many JJ O
of IN O
the DT O
XP NNP O
and CC O
CS NNP O
symptoms NNS O
that WDT O
are VBP O
difficult JJ O
to TO O
rationalize VB O
based VBN O
solely RB O
on IN O
an DT O
NER NNP O
defect NN O
. . O

PU NNP B-Gene
. . I-Gene
1 CD I-Gene
is VBZ O
completely RB O
absent JJ O
from IN O
peripheral JJ O
T NNP O
cells NNS O
and CC O
most JJS O
T NNP O
cell NN O
lines NNS O
based VBN O
on IN O
sensitive JJ O
RT NNP O
- : O
PCR NNP O
assays NNS O
. . O

In IN O
contrast NN O
, , O
Spi NNP B-Gene
- : I-Gene
B NNP I-Gene
is VBZ O
expressed VBN O
exclusively RB O
in IN O
lymphoid JJ O
cells NNS O
and CC O
can MD O
be VB O
detected VBN O
in IN O
early JJ O
fetal JJ O
thymus NN O
and CC O
spleen NN O
. . O

In IN O
situ JJ O
hybridization NN O
and CC O
Northern NNP O
blot NN O
analysis NN O
suggest VBP O
that IN O
Spi NNP B-Gene
- : I-Gene
B NNP I-Gene
gene NN O
expression NN O
increases NNS O
during IN O
B NNP O
cell NN O
maturation NN O
and CC O
decreases NNS O
during IN O
T NNP O
cell NN O
maturation NN O
. . O

Taken VBN O
together RB O
, , O
these DT O
data NNS O
suggest VBP O
that IN O
differences NNS O
in IN O
patterns NNS O
of IN O
expression NN O
between IN O
Spi NNP B-Gene
- : I-Gene
B NN I-Gene
and CC O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
distinguish JJ O
the DT O
function NN O
of IN O
each DT O
protein NN O
during IN O
development NN O
of IN O
the DT O
immune NN O
system NN O
. . O

DNase NNP B-Gene
I PRP I-Gene
hypersensitive VBP I-Gene
site NN I-Gene
( ( O
DHS NNP B-Gene
) ) O
mapping NN O
revealed VBD O
that IN O
the DT O
perforin NN B-Gene
locus NN I-Gene
contained VBD O
six CD O
DHS NNP B-Gene
within IN O
7 CD O
. . O
0 CD O
kb NN O
of IN O
the DT O
5 CD B-Gene
' POS I-Gene
upstream JJ I-Gene
sequence NN I-Gene
( ( O
- : O
7 CD O
. . O
0 CD O
kb NN O
) ) O
and CC O
two CD O
DHS NNP B-Gene
in IN O
intron NN B-Gene
2 CD I-Gene
. . O

Chloramphenicol NNP B-Gene
acetyltransferase NN I-Gene
( ( O
CAT NNP B-Gene
) ) O
activities NNS O
directed VBN O
by IN O
5 CD B-Gene
' POS I-Gene
upstream JJ I-Gene
promoter NN I-Gene
were VBD O
detected VBN O
preferentially RB O
in IN O
perforin JJ O
- : O
expressing VBG O
cell NN O
lines NNS O
. . O

When WRB O
single JJ O
- : O
point NN O
mutation NN O
was VBD O
introduced VBN O
to TO O
each DT O
GC NNP B-Gene
box NN I-Gene
, , O
EBS NNP B-Gene
, , O
and CC O
GT NNP B-Gene
box NN I-Gene
in IN O
PFP9a20 NNP B-Gene
, , O
at IN O
least JJS O
3 CD O
- : O
fold NN O
less JJR O
CAT NNP B-Gene
activity NN O
was VBD O
observed VBN O
in IN O
CTLL NNP O
- : O
R8 NNP O
cells NNS O
. . O

The DT O
results NNS O
suggest VBP O
that IN O
a DT O
combination NN O
of IN O
the DT O
three CD O
proximal JJ O
cis SYM B-Gene
- : I-Gene
acting VBG I-Gene
elements NNS I-Gene
may MD O
constitute VB O
a DT O
minimal JJ O
region NN O
responsible JJ O
for IN O
CTL NNP O
- : O
specific JJ O
expression NN O
of IN O
perforin NN B-Gene
. . O

Thus RB O
Oct NNP B-Gene
- : I-Gene
2 CD I-Gene
plays NNS O
an DT O
important JJ O
role NN O
in IN O
the DT O
regulation NN O
of IN O
cellular JJ O
gene NN O
expression NN O
in IN O
both DT O
B NNP O
cells NNS O
and CC O
neuronal JJ O
cells NNS O
as RB O
well RB O
as IN O
in IN O
the DT O
control NN O
of IN O
viral JJ O
latency NN O
. . O

Instead RB O
, , O
ATF NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
Jun NNP B-Gene
proteins VBZ I-Gene
bind VB O
to TO O
the DT O
composite JJ B-Gene
kappa NN I-Gene
3 CD I-Gene
/ NNP I-Gene
CRE NNP I-Gene
site NN I-Gene
and CC O
NFATp NNP B-Gene
binds VBZ O
to TO O
a DT O
newly RB O
identified VBN O
second JJ O
NFAT NNP B-Gene
site NN I-Gene
centered VBD O
at IN O
- : B-Gene
76 CD I-Gene
nucleotides NNS I-Gene
relative JJ O
to TO O
the DT O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
transcription NN I-Gene
start NN I-Gene
site NN I-Gene
. . O

Consistent JJ O
with IN O
these DT O
results NNS O
, , O
quantitative JJ O
DNase NNP B-Gene
footprinting NN O
of IN O
the DT O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
promoter NN I-Gene
using VBG O
increasing VBG O
amounts NNS O
of IN O
recombinant JJ O
NFATp NNP B-Gene
demonstrated VBD O
that IN O
the DT O
- : B-Gene
76 CD I-Gene
site NN I-Gene
binds NNS O
to TO O
NFATp NNP B-Gene
with IN O
a DT O
higher JJR O
affinity NN O
than IN O
the DT O
kappa NN B-Gene
3 CD I-Gene
site NN I-Gene
. . O

Thus RB O
, , O
through IN O
the DT O
differential JJ O
use NN O
of IN O
the DT O
same JJ O
promoter NN B-Gene
element NN I-Gene
, , O
the DT O
composite JJ B-Gene
kappa NN I-Gene
3 CD I-Gene
/ NNP I-Gene
CRE NNP I-Gene
site NN I-Gene
, , O
the DT O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
gene NN I-Gene
is VBZ O
regulated VBN O
in IN O
a DT O
cell NN O
- : O
type NN O
- : O
specific JJ O
manner NN O
in IN O
response NN O
to TO O
the DT O
same JJ O
extracellular JJ O
signal NN O
. . O

To TO O
address VB O
possible JJ O
mechanisms NNS O
that WDT O
could MD O
explain VB O
this DT O
selective JJ O
activity NN O
of IN O
c SYM B-Gene
- : I-Gene
ErbB NN I-Gene
, , O
we PRP O
analyzed VBD O
the DT O
ability NN O
of IN O
these DT O
receptors NNS O
to TO O
activate VB O
the DT O
different JJ O
members NNS O
of IN O
the DT O
Stat NNP B-Gene
transcription NN I-Gene
factor NN I-Gene
family NN I-Gene
. . O

Ligand NNP O
activation NN O
of IN O
c SYM B-Gene
- : I-Gene
ErbB NN I-Gene
induced VBD O
the DT O
tyrosine NN O
phosphorylation NN O
, , O
DNA NNP O
- : O
binding NN O
, , O
and CC O
reporter NN B-Gene
gene NN I-Gene
transcription NN O
of IN O
Stat NNP B-Gene
5b CD I-Gene
in IN O
erythroblasts NNS O
. . O

In IN O
contrast NN O
, , O
ligand VBP O
activation NN O
of IN O
c SYM B-Gene
- : I-Gene
Kit NNP I-Gene
was VBD O
unable JJ O
to TO O
induce VB O
any DT O
of IN O
these DT O
effects NNS O
in IN O
the DT O
same JJ O
cells NNS O
. . O

Sequence NNP O
- : O
specific JJ O
DNA NNP O
binding NN O
of IN O
the DT O
B NNP B-Gene
- : I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
coactivator NN I-Gene
OCA NNP B-Gene
- : I-Gene
B NN I-Gene
. . O

While IN O
one CD O
of IN O
the DT O
twins NNS O
was VBD O
clinically RB O
affected VBN O
, , O
the DT O
other JJ O
was VBD O
asymptomatic JJ O
. . O

This DT O
is VBZ O
the DT O
first JJ O
documented JJ O
case NN O
of IN O
female JJ O
twins NNS O
discordant VBP O
for IN O
Fabry NNP O
disease NN O
. . O

Precise NNP O
alignment NN B-Gene
of IN I-Gene
sites NNS I-Gene
required VBN O
for IN O
mu JJ B-Gene
enhancer NN I-Gene
activation NN O
in IN O
B NNP O
cells NNS O
. . O

The DT O
lymphocyte NN B-Gene
- : I-Gene
specific JJ I-Gene
immunoglobulin NN I-Gene
mu NN I-Gene
heavy JJ I-Gene
- : I-Gene
chain NN I-Gene
gene NN I-Gene
intronic JJ I-Gene
enhancer NN I-Gene
is VBZ O
regulated VBN O
by IN O
multiple JJ O
nuclear JJ B-Gene
factors NNS I-Gene
. . O

The DT O
previously RB O
defined VBN O
minimal JJ B-Gene
enhancer NN I-Gene
containing VBG O
the DT O
muA NN B-Gene
, , I-Gene
muE3 NN I-Gene
, , I-Gene
and CC I-Gene
muB NN I-Gene
sites NNS I-Gene
is VBZ O
transactivated VBN O
by IN O
a DT O
combination NN O
of IN O
the DT O
ETS NNP B-Gene
- : I-Gene
domain NN I-Gene
proteins NNS I-Gene
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
and CC O
Ets NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
nonlymphoid JJ O
cells NNS O
. . O

The DT O
core NN O
GGAAs NNP O
of IN O
the DT O
muA NN B-Gene
and CC I-Gene
muB NN I-Gene
sites NNS I-Gene
are VBP O
separated VBN O
by IN O
30 CD O
nucleotides NNS O
, , O
suggesting VBG O
that IN O
ETS NNP B-Gene
proteins VBZ I-Gene
bind VB O
to TO O
these DT O
sites NNS O
from IN O
these DT O
same JJ O
side NN O
of IN O
the DT O
DNA NNP O
helix NN O
. . O

In IN O
allergic JJ O
bronchial JJ O
asthma NN O
, , O
inflammation NN O
seems VBZ O
to TO O
be VB O
orchestrated VBN O
predominantly RB O
by IN O
a DT O
subset NN O
of IN O
T NNP O
lymphocytes NNS O
, , O
with IN O
a DT O
phenotype NN O
similar JJ O
to TO O
the DT O
Th2 NNP O
subset NN O
able JJ O
to TO O
produce VB O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
. . O

Some DT O
criteria NNS O
which WDT O
can MD O
be VB O
used VBN O
to TO O
define VB O
steroid JJ O
- : O
resistant JJ O
bronchial JJ O
asthma NN O
are VBP O
listed VBN O
here RB O
. . O

Mechanisms NNP O
of IN O
transactivation NN O
by IN O
nuclear JJ B-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
cells NNS I-Gene
- : I-Gene
1 CD I-Gene
. . O

Nuclear JJ B-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
cells NNS I-Gene
- : I-Gene
family NN I-Gene
proteins NNS I-Gene
( ( O
NFAT1 NNP B-Gene
/ NNP I-Gene
NFATp NNP I-Gene
, , O
NFATc NNP B-Gene
, , O
NFAT3 NNP B-Gene
, , O
and CC O
NFAT4 NNP B-Gene
/ NNP I-Gene
NFATx NNP I-Gene
/ NNP I-Gene
NFATc3 NNP I-Gene
) ) O
play VBP O
a DT O
key JJ O
role NN O
in IN O
the DT O
transcription NN O
of IN O
cytokine NN B-Gene
genes NNS I-Gene
and CC O
other JJ O
genes NNS O
during IN O
the DT O
immune JJ O
response NN O
. . O

Our PRP$ O
results NNS O
emphasize VB O
the DT O
multiple NN O
levels NNS O
at IN O
which WDT O
NFAT NNP O
- : O
dependent JJ O
transactivation NN O
is VBZ O
regulated VBN O
, , O
and CC O
predict VBP O
significant JJ O
differences NNS O
in IN O
the DT O
architecture NN O
of IN O
cooperative JJ O
transcription NN B-Gene
complexes NNS I-Gene
containing VBG O
different JJ O
NFAT NNP B-Gene
- : I-Gene
family NN I-Gene
proteins NNS I-Gene
. . O

A DT O
major JJ O
obstacle NN O
in IN O
understanding VBG O
the DT O
signaling VBG O
events NNS O
that WDT O
follow VBP O
CD28 NNP B-Gene
receptor NN O
ligation NN O
arises VBZ O
from IN O
the DT O
fact NN O
that IN O
CD28 NNP B-Gene
acts VBZ O
as IN O
a DT O
costimulus NN O
to TO O
TCR NNP B-Gene
engagement NN O
, , O
making VBG O
it PRP O
difficult JJ O
to TO O
assess VB O
the DT O
relative JJ O
contribution NN O
of IN O
CD28 NNP B-Gene
signals NNS O
as IN O
distinct JJ O
from IN O
those DT O
of IN O
the DT O
TCR NNP B-Gene
. . O

This DT O
revealed VBD O
that IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
generation NN O
was VBD O
sensitive JJ O
to TO O
chloroquine VB O
, , O
an DT O
inhibitor NN O
of IN O
acidic JJ B-Gene
sphingomyelinase NN I-Gene
, , O
but CC O
not RB O
to TO O
the DT O
phosphatidylinositol NN B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
inhibitor NN O
, , O
wortmannin NN O
. . O

To TO O
investigate VB O
the DT O
presence NN O
of IN O
various JJ O
isoforms NNS O
of IN O
the DT O
estrogen NN B-Gene
receptor NN I-Gene
( ( O
ER NNP B-Gene
) ) O
in IN O
SLE NNP O
we PRP O
isolated VBD O
RNA NNP O
from IN O
mononuclear JJ O
cells NNS O
of IN O
lupus NN O
patients NNS O
and CC O
normal JJ O
controls NNS O
. . O

It PRP O
is VBZ O
expressed VBN O
on IN O
a DT O
subpopulation NN O
of IN O
macrophages NNS O
in IN O
lymphoid JJ O
tissues NNS O
and CC O
in IN O
chronic JJ O
inflammation NN O
( ( O
e NN O
. . O
g NN O
. . O
, , O
during IN O
autoimmune JJ O
diseases NNS O
) ) O
. . O

Sialoadhesin NNP B-Gene
expression NN O
was VBD O
functional JJ O
as IN O
shown VBN O
by IN O
cell NN O
adhesion NN O
assays VBZ O
with IN O
human JJ O
RBCs NNP O
. . O

Northern NNP O
blotting VBG O
experiments NNS O
indicated VBD O
that IN O
regulation NN O
predominantly RB O
occurred VBD O
at IN O
the DT O
mRNA NN O
level NN O
. . O

The DT O
results NNS O
suggest VBP O
a DT O
new JJ O
option NN O
for IN O
HIV NNP O
gene NN O
therapy NN O
; : O
bcl CC B-Gene
- : I-Gene
2 CD I-Gene
muteins NNS I-Gene
that WDT O
have VBP O
noncleavable JJ B-Gene
alterations NNS I-Gene
surrounding VBG O
the DT O
HIV NNP B-Gene
protease NN I-Gene
cleavage NN I-Gene
site NN I-Gene
. . O

In IN O
contrast NN O
to TO O
freshly RB O
isolated JJ O
T NNP O
cells NNS O
, , O
in IN O
vitro JJ O
- : O
cultured VBN O
T NNP O
cells NNS O
did VBD O
not RB O
require VB O
costimulation NN O
for IN O
cytokine JJ B-Gene
secretion NN O
in IN O
response NN O
to TO O
anti VB B-Gene
- : I-Gene
CD3 NNP I-Gene
alone RB O
. . O

The DT O
induction NN O
of IN O
T NNP O
cell NN O
proliferation NN O
requires VBZ O
signals NNS O
from IN O
the DT O
TCR NNP B-Gene
and CC O
a DT O
co NN B-Gene
- : I-Gene
receptor NN I-Gene
molecule NN I-Gene
, , O
such JJ O
as IN O
CD28 NNP B-Gene
, , O
that WDT O
activate VBP O
parallel NNS O
and CC O
partially RB O
cross VB O
- : O
reactive JJ O
signaling NN O
pathways NNS O
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
PKA NNP B-Gene
inhibits VBZ O
T NNP O
cell NN O
activation NN O
by IN O
interfering VBG O
with IN O
multiple JJ O
events NNS O
along IN O
the DT O
two CD O
signaling VBG O
pathways NNS O
operating VBG O
downstream NN O
of IN O
the DT O
TCR NNP B-Gene
and CC O
the DT O
CD28 NNP B-Gene
co SYM I-Gene
- : I-Gene
receptor NN I-Gene
molecules NNS I-Gene
. . O

This DT O
pattern NN O
of IN O
STAT NNP B-Gene
activation NN O
was VBD O
seen VBN O
in IN O
all DT O
BCP NNP O
- : O
ALL DT O
cases NNS O
that WDT O
respond VBP O
to TO O
IL NNP B-Gene
- : I-Gene
7 CD I-Gene
in IN O
proliferation NN O
assays NNS O
. . O

To TO O
determine VB O
the DT O
contribution NN O
of IN O
the DT O
cytoplasmic JJ B-Gene
domain NN I-Gene
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
7 CD I-Gene
receptor NN I-Gene
alpha NN I-Gene
chain NN I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
7R CD I-Gene
alpha NN I-Gene
) ) O
to TO O
activation NN O
of IN O
STAT NNP B-Gene
proteins NNS I-Gene
, , O
transfectants NNS O
of IN O
the DT O
murine JJ O
pro FW O
- : O
B NNP O
cell NN O
line NN O
BAF3 NNP O
were VBD O
made VBN O
that IN O
express NN O
chimeric JJ B-Gene
receptors NNS I-Gene
consisting VBG O
of IN O
the DT O
extracellular JJ B-Gene
domain NN I-Gene
of IN O
human JJ B-Gene
granulocyte NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
receptor NN I-Gene
( ( O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
- : I-Gene
R NN I-Gene
) ) O
and CC O
the DT O
transmembrane NN B-Gene
and CC I-Gene
intracellular JJ I-Gene
domains NNS I-Gene
of IN O
human JJ B-Gene
IL NNP I-Gene
- : I-Gene
7R CD I-Gene
alpha NN I-Gene
. . O

The DT O
oligo JJ O
sequence NN O
I PRP O
stimulated VBD O
proliferation NN O
of IN O
both DT O
T NNP O
and CC O
, , O
to TO O
a DT O
lesser JJR O
extent NN O
, , O
B NNP O
cells NNS O
. . O

The DT O
percentage NN O
of IN O
cells NNS O
expressing VBG O
CD40 NNP B-Gene
in IN O
T NNP O
and CC O
B NNP O
cell NN O
co SYM O
- : O
cultures NNS O
increased VBD O
from IN O
4 CD O
. . O
2 CD O
% NN O
to TO O
13 CD O
. . O
8 CD O
% NN O
after IN O
oligo JJ O
stimulation NN O
in IN O
patients NNS O
, , O
while IN O
it PRP O
increased VBD O
form NN O
4 CD O
. . O
7 CD O
% NN O
to TO O
48 CD O
. . O
6 CD O
% NN O
in IN O
healthy JJ O
controls NNS O
. . O

We PRP O
demonstrate VBP O
that IN O
CaMKIV NNP B-Gene
/ NNP I-Gene
Gr NNP I-Gene
reconstitutes VBZ O
the DT O
capacity NN O
of IN O
the DT O
cytosolic JJ O
component NN O
of IN O
NFAT NNP B-Gene
to TO O
direct VB O
transcription NN O
from IN O
NFAT NNP B-Gene
sites NNS I-Gene
in IN O
non JJ O
- : O
T NN O
cells NNS O
. . O

This DT O
was VBD O
identified VBN O
as IN O
the DT O
mRNA NN B-Gene
encoding VBG O
the DT O
transcription NN B-Gene
factor NN I-Gene
egr VBD B-Gene
- : I-Gene
1 CD I-Gene
, , O
which WDT O
is VBZ O
expressed VBN O
with IN O
fast JJ O
kinetics NNS O
in IN O
T NNP O
and CC O
NK NNP O
cells NNS O
upon IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
but CC O
not RB O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
, , O
stimulation NN O
. . O

Increasing VBG O
the DT O
levels NNS O
of IN O
BCL NNP B-Gene
- : I-Gene
2 CD I-Gene
retarded VBD O
the DT O
G0 NNP O
- : O
- : O
> NN O
S NNP O
transition NN O
, , O
sustained VBD O
the DT O
levels NNS O
of IN O
cyclin NN B-Gene
- : I-Gene
dependent JJ I-Gene
kinase NN I-Gene
inhibitor NN O
p27Kip1 NN O
, , O
and CC O
repressed VBD O
postactivation NN O
death NN O
. . O

However RB O
, , O
the DT O
transcription NN O
and CC O
synthesis NN O
of IN O
interleukin JJ B-Gene
2 CD I-Gene
and CC O
other JJ O
delayed VBD O
early JJ O
cytokines NNS B-Gene
were VBD O
markedly RB O
attenuated VBN O
by IN O
BCL NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

On IN O
the DT O
basis NN O
of IN O
several JJ O
independent JJ O
assays NNS O
, , O
we PRP O
now RB O
report VBP O
a DT O
physical JJ O
and CC O
functional JJ O
interaction NN O
between IN O
Tax NNP B-Gene
and CC O
the DT O
transcription NN B-Gene
factor NN I-Gene
, , O
TFIIA NNP B-Gene
. . O

Finally RB O
, , O
TFIIA NNP B-Gene
facilitates VBZ O
Tax NNP B-Gene
transactivation NN O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

Inhibition NN O
of IN O
transcription NN B-Gene
factor NN I-Gene
Stat1 NNP B-Gene
activity NN O
in IN O
mononuclear NN O
cell NN O
cultures NNS O
and CC O
T NNP O
cells NNS O
by IN O
the DT O
cyclic JJ O
AMP NNP O
signaling VBG O
pathway RB O
. . O

Suppression NN O
of IN O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
by IN O
antisense NN O
oligonucleotides NNS O
inhibits NNS O
cell VBP O
adhesion NN O
but CC O
not RB O
respiratory JJ O
burst NN O
during IN O
phorbol NN O
ester SYM O
- : O
induced JJ O
differentiation NN O
of IN O
U937 NNP O
human JJ O
monoblastic JJ O
cells NNS O
. . O

GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
gene NN I-Gene
activation NN O
in IN O
T NNP O
cells NNS O
is VBZ O
known VBN O
to TO O
involve VB O
the DT O
transcription NN B-Gene
factors NNS I-Gene
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
NFAT NNP B-Gene
, , O
and CC O
Sp1 NNP O
. . O

A DT O
2 CD B-Gene
- : I-Gene
bp NN I-Gene
mutation NN I-Gene
within IN O
the DT O
CBF NNP B-Gene
site NN O
resulted VBD O
in IN O
a DT O
2 CD O
- : O
3 CD O
- : O
fold NN O
decrease NN O
in IN O
the DT O
activities NNS O
of IN O
both DT O
a DT O
69 CD B-Gene
- : I-Gene
bp NN I-Gene
proximal JJ I-Gene
promoter NN I-Gene
fragment NN I-Gene
and CC O
a DT O
627 CD B-Gene
- : I-Gene
bp NN I-Gene
full JJ I-Gene
- : I-Gene
length NN I-Gene
promoter NN I-Gene
fragment NN I-Gene
. . O

The DT O
AML1 NNP B-Gene
and CC I-Gene
CBF NNP I-Gene
beta NN I-Gene
genes NNS I-Gene
that WDT O
encode VBP O
CBF NNP B-Gene
each DT O
have VBP O
the DT O
ability NN O
to TO O
influence VB O
cell NN O
growth NN O
and CC O
differentiation NN O
and CC O
have VBP O
been VBN O
implicated VBN O
as IN O
proto NN B-Gene
- : I-Gene
oncogenes NNS I-Gene
in IN O
acute JJ O
myeloid NN O
leukemia NN O
. . O

The DT O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
locus NN I-Gene
may MD O
represent VB O
one CD O
of IN O
several JJ O
target NN O
genes NNS B-Gene
that WDT O
are VBP O
dysregulated VBN O
in IN O
acute JJ O
myeloid NN O
leukemia NN O
. . O

The DT O
preferential JJ O
induction NN O
of IN O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
by IN O
H2O2 NNP O
did VBD O
not RB O
represent VB O
redox JJ O
stabilization NN O
of IN O
mRNA NN B-Gene
transcripts NNS I-Gene
, , O
and CC O
oxidative JJ O
signals NNS O
closely RB O
resembled VBD O
PHA NNP O
/ NNP O
PMA NNP O
stimulation NN O
by IN O
effectively RB O
transactivating VBG O
the DT O
full JJ O
length NN O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
promoter NN O
via IN O
the DT O
proximal JJ B-Gene
jun1 NN I-Gene
tumor NN I-Gene
promoter NN I-Gene
- : I-Gene
responsive JJ I-Gene
element NN I-Gene
( ( I-Gene
TRE NNP I-Gene
) ) I-Gene
- : I-Gene
like IN I-Gene
promoter NN I-Gene
element NN I-Gene
. . O

Furthermore RB O
, , O
sublethal JJ O
levels NNS O
of IN O
H2O2 NNP O
actively RB O
suppressed VBD O
the DT O
transcriptional JJ O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
reporters NNS I-Gene
as RB O
well RB O
as IN O
the DT O
expression NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
mRNA NN I-Gene
in IN O
cells NNS O
stimulated VBN O
with IN O
PHA NNP O
/ NNP O
PMA NNP O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
oxidative JJ O
signals NNS O
can MD O
positively RB O
and CC O
negatively RB O
regulate VB O
T NNP O
cell NN O
transcriptional JJ O
events NNS O
and CC O
that DT O
changes NNS O
in IN O
cellular JJ O
redox NN O
can MD O
uncouple VB O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
regulation NN O
of IN O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
from IN O
transcriptional JJ O
up RP O
- : O
regulation NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
via IN O
NF NNP B-Gene
- : I-Gene
AT NN I-Gene
. . O

Many JJ O
of IN O
Pb NNP O
' POS O
s JJ O
effects NNS O
on IN O
the DT O
immune NN O
system NN O
could MD O
be VB O
explained VBN O
through IN O
activation NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
, , O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

Tyrosine NNP B-Gene
kinase NN I-Gene
and CC O
cAMP NN B-Gene
- : I-Gene
dependent JJ I-Gene
protein NN I-Gene
kinase NN I-Gene
activities NNS O
in IN O
CD40 NNP O
- : O
activated VBD O
human JJ O
B NNP O
lymphocytes NNS O
. . O

In IN O
vitro NN O
, , O
human JJ O
B NNP O
lymphocytes VBZ O
undergo RB O
long JJ O
- : O
term NN O
proliferation NN O
when WRB O
activated VBN O
through IN O
CD40 NNP B-Gene
, , O
a DT O
protein NN O
expressed VBN O
on IN O
their PRP$ O
cell NN O
surface NN O
. . O

Rather RB O
, , O
tyrosine VB O
phosphorylation NN O
was VBD O
shown VBN O
to TO O
be VB O
directly RB O
involved VBN O
in IN O
mediating VBG O
CD40 NNP B-Gene
- : O
dependent NN O
signals NNS O
. . O

To TO O
examine VB O
the DT O
potential JJ O
effects NNS O
of IN O
stress NN O
on IN O
TH1 NNP O
/ NNP O
TH2 NNP O
balance NN O
, , O
we PRP O
studied VBD O
the DT O
ability NN O
of IN O
three CD O
prototype NN O
stress NN O
hormones NNS O
- : O
dexamethasone NN O
( ( O
a DT O
synthetic JJ O
glucocorticoid NN O
) ) O
and CC O
the DT O
catecholamines NNS O
norepinephrine NN O
and CC O
epinephrine VB O
- : O
to TO O
alter VB O
the DT O
production NN O
of IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
( ( O
p70 NN B-Gene
) ) O
and CC O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
induced VBN O
by IN O
bacterial JJ O
lipopolysaccharide NN O
( ( O
LPS NNP O
) ) O
in IN O
human JJ O
whole JJ O
blood NN O
. . O

The DT O
effects NNS O
of IN O
either DT O
catecholamine NN O
on IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
or CC O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
secretion NN O
were VBD O
blocked VBN O
completely RB O
by IN O
propranolol NN O
, , O
a DT O
beta NN O
- : O
adrenoreceptor NN O
antagonist NN O
, , O
indicating VBG O
that IN O
they PRP O
were VBD O
mediated VBN O
by IN O
the DT O
beta NN B-Gene
- : I-Gene
adrenergic JJ I-Gene
receptor NN I-Gene
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
the DT O
central JJ O
nervous JJ O
system NN O
may MD O
regulate VB O
IL NNP O
- : O
12 CD O
and CC O
IL NNP O
- : O
10 CD O
secretion NN O
and CC O
, , O
hence RB O
, , O
TH1 NNP O
/ NNP O
TH2 NNP O
balance NN O
via IN O
the DT O
peripheral JJ O
end NN O
- : O
effectors NNS O
of IN O
the DT O
stress NN O
system NN O
. . O

There EX O
is VBZ O
increasing VBG O
evidence NN O
that IN O
lipoproteins VBZ B-Gene
of IN O
Treponema NNP O
pallidum NN O
and CC O
Borrelia NNP O
burgdorferi NN O
are VBP O
key JJ O
inflammatory JJ O
mediators NNS O
during IN O
syphilis NN O
and CC O
Lyme NNP O
disease NN O
. . O

Acylation NN O
of IN O
OspA NNP B-Gene
and CC O
the DT O
synthetic JJ O
peptides NNS O
was VBD O
requisite JJ O
for IN O
cell NN O
activation NN O
. . O

Polymyxin NN O
B NNP O
abrogated VBD O
only RB O
the DT O
response NN O
to TO O
LPS NNP O
. . O

Finally RB O
, , O
the DT O
biological JJ O
relevance NN O
of IN O
the DT O
observation NN O
that IN O
T NNP B-Gene
. . I-Gene
pallidum NN I-Gene
lipoproteins VBZ I-Gene
- : O
lipopeptides NNS O
induce VBP O
both DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
cytokine JJ B-Gene
production NN O
in IN O
monocytes NNS O
was VBD O
supported VBN O
by IN O
the DT O
ability NN O
of IN O
the DT O
synthetic JJ O
analogs NNS O
to TO O
promote VB O
human JJ O
immunodeficiency NN O
virus NN O
replication NN O
in IN O
chronically RB O
infected VBN O
U1 NNP O
monocytoid JJ O
cells NNS O
; : O
these DT O
observations NNS O
also RB O
suggest VBP O
a DT O
potential JJ O
mechanism NN O
whereby WRB O
a DT O
syphilitic JJ O
chancre NN O
can MD O
serve VB O
as IN O
a DT O
cofactor NN O
for IN O
human JJ O
immunodeficiency NN O
virus NN O
transmission NN O
. . O

The DT O
present JJ O
study NN O
describes VBZ O
the DT O
cloning NN O
of IN O
a DT O
lymphoid JJ B-Gene
- : I-Gene
restricted VBN I-Gene
gene NN I-Gene
, , O
LYSP100 NNP B-Gene
, , O
that WDT O
is VBZ O
homologous JJ O
to TO O
another DT O
protein NN O
that WDT O
localizes VBZ O
to TO O
PML NNP O
NBs NNP O
, , O
SP100 NNP B-Gene
. . O

We PRP O
term NN O
the DT O
LYSP100 NNP B-Gene
structures NNS O
` `` O
` `` O
LANDs RB O
, , O
' '' O
' '' O
for IN O
LYSP100 NNP B-Gene
- : O
associated VBN O
nuclear JJ O
domains NNS O
. . O

Immunoelectron NNP O
microscopy NN O
revealed VBD O
LANDs NNP O
to TO O
be VB O
globular JJ O
, , O
electron SYM O
- : O
dense NN O
structures VBZ O
morphologically RB O
distinct JJ O
from IN O
the DT O
annular JJ O
structures NNS O
characteristic JJ O
of IN O
PML NNP O
NBs NNP O
. . O

Transcriptional NNP O
control NN O
of IN O
steroid JJ O
- : O
regulated VBN O
apoptosis NN O
in IN O
murine NN O
thymoma NN O
cells NNS O
. . O

Early JJ O
studies NNS O
in IN O
murine NN O
T NNP O
cell NN O
lines NNS O
indicated VBD O
that IN O
transcriptional JJ O
transactivation NN O
functions NNS O
encoded VBD O
in IN O
the DT O
glucocorticoid NN B-Gene
receptor NN I-Gene
( ( I-Gene
GR NNP I-Gene
) ) I-Gene
N NNP I-Gene
- : I-Gene
terminal NN I-Gene
domain NN I-Gene
are VBP O
required VBN O
for IN O
glucocorticoid JJ O
- : O
mediated VBN O
apoptosis NN O
. . O

To TO O
better RBR O
understand VB O
the DT O
contribution NN O
of IN O
the DT O
GR NNP B-Gene
N NNP I-Gene
- : I-Gene
terminal JJ I-Gene
transactivation NN I-Gene
domain NN I-Gene
in IN O
mediating VBG O
murine NN O
thymocyte NN O
apoptosis NN O
, , O
we PRP O
stably RB O
transfected VBD O
GR NNP B-Gene
, , O
GR NNP B-Gene
variants NNS I-Gene
, , O
and CC O
the DT O
androgen NN B-Gene
receptor NN I-Gene
( ( O
AR NNP B-Gene
) ) O
into IN O
receptor NN O
- : O
negative JJ O
S49 NNP O
murine NN O
thymoma NN O
cells NNS O
. . O

One CD O
p21ras NN B-Gene
effector NN O
pathway NN O
involves VBZ O
the DT O
MAP NNP B-Gene
kinase NN I-Gene
ERK NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
and CC O
we PRP O
have VBP O
examined VBN O
its PRP$ O
role NN O
in IN O
NFAT NNP B-Gene
regulation NN O
. . O

In IN O
vivo JJ O
differentiation NN O
therapy NN O
with IN O
retinoids NNS O
in IN O
APL NNP O
patients NNS O
follows VBZ O
strict JJ O
guidelines NNS O
related VBN O
both DT O
to TO O
the DT O
APL NNP O
cell NN O
and CC O
the DT O
biodisposal NN O
of IN O
all DT O
- : O
trans NNS O
retinoic VBP O
acid NN O
. . O

IL NNP O
- : O
2 CD O
- : O
, , O
IL NNP O
- : O
12 CD O
- : O
, , O
and CC O
IFN NNP O
- : O
alpha NN O
- : O
mediated VBN O
signaling VBG O
pathways NNS O
were VBD O
analyzed VBN O
in IN O
primary JJ O
NK NNP O
cells NNS O
and CC O
in IN O
the DT O
NK3 NNP O
. . O
3 CD O
cell NN O
line NN O
. . O

Gel NNP O
mobility NN O
shift NN O
and CC O
immunoprecipitation NN O
analyses NNS O
revealed VBD O
that IN O
in IN O
addition NN O
to TO O
activating VBG O
STAT3 NNP B-Gene
( ( O
signal JJ B-Gene
transducer NN I-Gene
and CC I-Gene
activator NN I-Gene
of IN I-Gene
transcription NN I-Gene
- : I-Gene
3 CD I-Gene
) ) O
and CC O
STAT5 NNP B-Gene
, , O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
induced JJ O
tyrosine NN O
and CC O
serine JJ O
phosphorylation NN O
of IN O
STAT1 NNP B-Gene
alpha NN I-Gene
, , O
which WDT O
formed VBD O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
- : I-Gene
activated VBN I-Gene
sequence NN I-Gene
- : I-Gene
binding NN I-Gene
complexes NNS I-Gene
by IN O
itself PRP O
and CC O
with IN O
STAT3 NNP B-Gene
. . O

Although IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
activated VBD O
STAT1 NNP B-Gene
alpha NN I-Gene
and CC O
STAT5 NNP B-Gene
, , O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
predominantly RB O
activated VBN O
STAT5 NNP B-Gene
, , O
while IN O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
predominantly RB O
activated VBD O
STAT1 NNP B-Gene
alpha NN I-Gene
. . O

STAT1 NNP B-Gene
alpha JJ I-Gene
activation NN O
by IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
correlated VBN O
with IN O
increased JJ O
phosphorylation NN O
of IN O
serine NN O
, , O
but CC O
not RB O
tyrosine VB O
. . O

Direct JJ O
evidence NN O
that IN O
N NNP O
- : O
acetylcysteine NN O
( ( O
NAC NNP O
) ) O
enhances VBZ O
the DT O
immune JJ O
response NN O
of IN O
peripheral JJ O
blood NN O
T NNP O
cells NNS O
at IN O
the DT O
level NN O
of IN O
NF NNP B-Gene
( ( I-Gene
kappa NN I-Gene
) ) I-Gene
B NNP I-Gene
is VBZ O
presented VBN O
. . O

In IN O
addition NN O
, , O
NAC NNP O
blocks VBZ O
the DT O
suppression NN O
of IN O
T NNP O
cell NN O
mitogenesis NN O
and CC O
cytokine NN B-Gene
production NN O
by IN O
protease NN O
inhibitors NNS O
such JJ O
as IN O
N NNP O
- : O
tosylphenylalanine NN O
chloromethyl NN O
ketone NN O
( ( O
TPCK NNP O
) ) O
. . O

Strikingly RB O
, , O
the DT O
immunosuppressive JJ O
effects NNS O
of IN O
TPCK NNP O
are VBP O
blocked VBN O
when WRB O
T NNP O
cells NNS O
are VBP O
pretreated VBN O
for IN O
15 CD O
min NN O
with IN O
5 CD O
mM NNS O
NAC NNP O
. . O

Our PRP$ O
data NNS O
support NN O
the DT O
notion NN O
that IN O
NF NNP B-Gene
( ( I-Gene
kappa NN I-Gene
) ) I-Gene
B NNP I-Gene
and CC O
I PRP B-Gene
( ( I-Gene
kappa NN I-Gene
) ) I-Gene
B NNP I-Gene
proteases VBZ I-Gene
play VB O
obligate JJ O
roles NNS O
in IN O
T NNP O
cell NN O
activation NN O
and CC O
mitogenesis NN O
, , O
roles NNS O
that WDT O
are VBP O
enhanced VBN O
significantly RB O
by IN O
NAC NNP O
. . O

Recently RB O
it PRP O
has VBZ O
become VBN O
clear JJ O
that IN O
these DT O
cytokines NNS B-Gene
activate VBP O
a DT O
number NN O
of IN O
important JJ O
intracellular JJ B-Gene
signaling NN I-Gene
molecules NNS I-Gene
, , O
including VBG O
the DT O
Janus NNP B-Gene
kinases VBZ I-Gene
JAK1 NNP B-Gene
and CC O
JAK3 NNP B-Gene
and CC O
members NNS O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
family NN I-Gene
of IN O
signal JJ B-Gene
transducers NNS I-Gene
and CC O
activators NNS B-Gene
of IN I-Gene
transcription NN I-Gene
( ( O
STATs NNP B-Gene
) ) O
. . O

In IN O
this DT O
review NN O
we PRP O
examine VBP O
the DT O
structure NN O
and CC O
function NN O
of IN O
cytokine NN B-Gene
receptors NNS I-Gene
and CC O
the DT O
signaling NN O
pathways NNS O
involved VBN O
in IN O
their PRP$ O
regulation NN O
of IN O
gene NN O
expression NN O
. . O

Retinoic NNP O
acid NN O
( ( O
RA NNP O
) ) O
and CC O
1 CD O
, , O
25 CD O
alpha SYM O
- : O
dihydroxycholecalcif NN O
( ( O
VitD3 NNP O
) ) O
are VBP O
potent JJ O
regulators NNS O
of IN O
hematopoletic JJ O
differentiation NN O
. . O

Yet RB O
, , O
little JJ O
is VBZ O
known VBN O
as IN O
to TO O
how WRB O
the DT O
RA NNP B-Gene
and CC I-Gene
VitD3 NNP I-Gene
receptor NN I-Gene
network NN I-Gene
operates VBZ O
in IN O
hematopoietic JJ O
cells NNS O
, , O
and CC O
whether IN O
receptor NN O
interactions NNS O
can MD O
explain VB O
the DT O
interplay NN O
between IN O
the DT O
RA NNP O
- : O
and CC O
VitD3 NNP O
- : O
signaling VBG O
pathways NNS O
during IN O
differentiation NN O
. . O

Therefore RB O
, , O
we PRP O
analyzed VBD O
the DT O
expression NN O
, , O
DNA NNP O
binding NN O
, , O
and CC O
transcriptional JJ O
activity NN O
of IN O
the DT O
endogenous JJ B-Gene
RA NNP I-Gene
and CC I-Gene
VitD3 NNP I-Gene
receptors NNS I-Gene
[ VBP O
retinoic JJ B-Gene
acid NN I-Gene
receptors NNS I-Gene
( ( O
RARs NNP B-Gene
) ) O
, , O
retinoid JJ B-Gene
X NN I-Gene
receptors NNS I-Gene
( ( O
RXRs NNP B-Gene
) ) O
, , O
and CC O
VitD3 NNP B-Gene
receptor NN I-Gene
( ( O
VDR NNP B-Gene
) ) O
] NN O
in IN O
the DT O
U NNP O
- : O
937 CD O
cell NN O
line NN O
, , O
in IN O
which WDT O
RA NNP O
and CC O
VitD3 NNP O
induce VBP O
distinct JJ O
monocytic JJ O
differentiation NN O
pathways NNS O
. . O

However RB O
, , O
transcriptional JJ O
activation NN O
was VBD O
only RB O
observed VBN O
from IN O
a DT O
VitD3 NNP B-Gene
response NN I-Gene
element NN I-Gene
- : I-Gene
driven JJ I-Gene
reporter NN I-Gene
construct NN I-Gene
. . O

Also RB O
, , O
VitD3 NNP O
inhibited VBD O
the DT O
expression NN O
of IN O
CD23 NNP B-Gene
and CC O
CD49f NNP B-Gene
, , O
characteristic JJ O
markers NNS O
of IN O
retinoid JJ O
- : O
induced JJ O
U NNP O
- : O
937 CD O
cell NN O
differentiation NN O
. . O

Freshly RB O
isolated VBN O
monocytes NNS O
expressed VBD O
94 CD B-Gene
- : I-Gene
kD NN I-Gene
STAT5A NNP I-Gene
, , O
92 CD O
- : O
kD NN O
STAT5B NNP B-Gene
, , O
and CC O
an DT O
80 CD B-Gene
- : I-Gene
kD NN I-Gene
STAT5A NNP I-Gene
molecule NN I-Gene
. . O

STAT5A NNP B-Gene
- : I-Gene
STAT5A NN I-Gene
homodimers NNS I-Gene
and CC O
STAT5A NNP B-Gene
- : I-Gene
STAT5B NN I-Gene
heterodimers NNS I-Gene
formed VBD O
in IN O
response NN O
to TO O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
. . O

Translocation NN B-Gene
( ( I-Gene
3 CD I-Gene
; : I-Gene
14 CD I-Gene
) ) I-Gene
( ( I-Gene
q27 NN I-Gene
; : I-Gene
q11 CC I-Gene
) ) I-Gene
: : O
a DT O
new JJ O
variant JJ O
translocation NN O
in IN O
a DT O
patient NN O
with IN O
non JJ O
- : O
Hodgkin NNP O
' POS O
s JJ O
lymphoma NN O
of IN O
B NNP O
- : O
cell NN O
type NN O
with IN O
BCL6 NNP B-Gene
rearrangement NN O
. . O

Southern NNP O
blot NN O
analysis NN O
showed VBD O
rearrangement NN O
of IN O
BCL6 NNP B-Gene
, , O
JH NNP B-Gene
, , O
and CC O
TCR NNP B-Gene
beta NN I-Gene
but CC O
not RB O
of IN O
TCR NNP B-Gene
delta NN I-Gene
. . O

Basal NNP O
total JJ O
white JJ O
blood NN O
cell NN O
and CC O
granulocyte NN O
counts NNS O
did VBD O
not RB O
appreciably RB O
differ VBP O
between IN O
PML NNP B-Gene
/ NNP I-Gene
RARalpha NNP I-Gene
transgenic JJ O
and CC O
control NN O
mice NN O
. . O

As IN O
expected VBN O
, , O
nearly RB O
all DT O
control NN O
mice NN O
( ( O
94 CD O
. . O
4 CD O
% NN O
) ) O
survived VBD O
irradiation NN O
, , O
yet RB O
this DT O
irradiation NN O
was VBD O
lethal JJ O
to TO O
45 CD O
. . O
8 CD O
% NN O
of IN O
PML NNP B-Gene
/ NNP I-Gene
RARalpha NNP I-Gene
transgenic JJ O
mice NN O
. . O

B NNP O
- : O
cell NN O
immortalization NN O
by IN O
Epstein NNP O
- : O
Barr NNP O
virus NN O
( ( O
EBV NNP O
) ) O
is VBZ O
dependent JJ O
on IN O
permanent JJ O
control NN O
of IN O
the DT O
cellular JJ O
processes NNS O
which WDT O
normally RB O
regulate VBP O
cell NN O
division NN O
and CC O
apoptosis NN O
, , O
functions NNS O
possessed VBN O
by IN O
p53 NN B-Gene
in IN O
a DT O
number NN O
of IN O
normal JJ O
cell NN O
types NNS O
. . O

Latent NNP B-Gene
membrane NN I-Gene
protein NN I-Gene
1 CD I-Gene
and CC O
, , O
to TO O
a DT O
lesser JJR O
extent NN O
, , O
EBV NNP B-Gene
nuclear JJ I-Gene
antigen NN I-Gene
2 CD I-Gene
mediated VBD O
the DT O
increase NN O
in IN O
p53 NN B-Gene
levels NNS O
via IN O
activation NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
transcription NN B-Gene
factor NN I-Gene
. . O

Tissue NNP O
- : O
specific JJ O
expression NN O
of IN O
interleukin JJ B-Gene
- : I-Gene
3 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
) ) O
is VBZ O
mediated VBN O
via IN O
cis NN B-Gene
- : I-Gene
acting JJ I-Gene
elements NNS I-Gene
located VBN O
within IN O
315 CD O
base NN O
pairs NN O
of IN O
the DT O
transcription NN B-Gene
start NN I-Gene
. . O

In IN O
addition NN O
to TO O
the DT O
already RB O
identified VBN O
NIP NNP B-Gene
repressor NN I-Gene
site NN I-Gene
, , O
evidence NN O
is VBZ O
presented VBN O
for IN O
a DT O
second JJ B-Gene
repressor NN I-Gene
region NN I-Gene
that WDT O
restricts VBZ O
promoter NN O
activity NN O
in IN O
fibroblasts NNS O
. . O

In IN O
the DT O
current JJ O
studies NNS O
, , O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
production NN O
by IN O
T NNP O
cells NNS O
from IN O
elderly JJ O
( ( O
mean JJ O
78 CD O
years NNS O
) ) O
and CC O
young JJ O
( ( O
mean JJ O
37 CD O
years NNS O
) ) O
humans NNS O
was VBD O
measured VBN O
in IN O
cultures NNS O
stimulated VBN O
with IN O
PHA NNP B-Gene
, , O
PHA NNP B-Gene
plus CC O
PMA NNP O
, , O
crosslinked VBD O
anti SYM O
- : O
CD3 NNP O
mAB NN O
OKT3 NNP O
plus CC O
PMA NNP O
, , O
or CC O
PMA NNP O
plus CC O
ionomycin NN O
. . O

By IN O
contrast NN O
, , O
T NNP O
cells NNS O
from IN O
elderly JJ O
subjects NNS O
with IN O
normal JJ O
levels NNS O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
production NN O
exhibited VBD O
normal JJ O
activation NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
AT NN I-Gene
. . O

IL NNP B-Gene
- : I-Gene
13 CD I-Gene
caused VBD O
rapid JJ O
phosphorylation NN O
of IN O
the DT O
three CD O
out IN O
of IN O
four CD O
members NNS O
of IN O
the DT O
known VBN O
Janus NNP B-Gene
family NN I-Gene
of IN I-Gene
kinases NNS I-Gene
( ( O
JAKs NNP B-Gene
) ) O
. . O

IL NNP B-Gene
- : I-Gene
4 CD I-Gene
also RB O
stimulated VBD O
all DT O
three CD O
kinases NNS B-Gene
and CC O
substrates NNS O
, , O
but CC O
unlike IN O
in IN O
immune NN O
cells NNS O
, , O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
did VBD O
not RB O
involve VB O
JAK3 NNP B-Gene
activation NN O
for IN O
its PRP$ O
signaling VBG O
in IN O
colon NN O
cancer NN O
cell NN O
lines NNS O
. . O

Furthermore RB O
, , O
JAK2 NNP B-Gene
associated VBN O
with IN O
the DT O
IL NNP B-Gene
- : I-Gene
4R CD I-Gene
p140 NN I-Gene
before IN O
and CC O
after IN O
stimulation NN O
with IN O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
. . O

Differential NNP O
regulation NN O
of IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
gene NN I-Gene
transcription NN O
and CC O
expression NN O
by IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
in IN O
human JJ O
monocytic JJ O
cell NN O
lines NNS O
. . O

To TO O
investigate VB O
the DT O
molecular JJ O
mechanism NN O
of IN O
the DT O
inhibitory JJ O
effect NN O
on IN O
transcriptional NN O
or CC O
post NN O
- : O
transcriptional JJ O
regulation NN O
of IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
gene NN I-Gene
expression NN O
by IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
, , O
we PRP O
studied VBD O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
production NN O
, , O
expression NN O
level NN O
of IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
mRNA NN I-Gene
, , O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
promoter NN O
activity NN O
, , O
transcriptional JJ O
activity NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
IL NNP I-Gene
- : I-Gene
6 CD I-Gene
, , O
and CC O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
mRNA NN I-Gene
stability NN O
in IN O
human JJ O
monocytic JJ O
cell NN O
lines NNS O
, , O
THP NNP O
- : O
1 CD O
and CC O
U937 NNP O
, , O
stimulated VBN O
by IN O
PMA NNP O
and CC O
LPS NNP O
in IN O
the DT O
absence NN O
or CC O
the DT O
presence NN O
of IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
or CC O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
. . O

In IN O
chloramphenicol JJ B-Gene
acetyltransferase NN I-Gene
assays NNS O
, , O
utilizing VBG O
the DT O
transient JJ O
transfection NN O
of IN O
a DT O
chloramphenicol JJ B-Gene
acetyltransferase NN I-Gene
reporter NN I-Gene
plasmid NN I-Gene
containing VBG O
the DT O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
gene NN I-Gene
promoter NN I-Gene
, , O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
but CC O
not RB O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
, , O
suppressed VBD O
the DT O
transcriptional JJ O
activity NN O
of IN O
the DT O
IL NNP O
- : O
6 CD O
gene NN O
promoter NN O
stimulated VBN O
by IN O
PMA NNP O
and CC O
LPS NNP O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
enhanced VBD O
the DT O
degradation NN O
of IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
mRNA NN I-Gene
in IN O
a DT O
mRNA JJ O
stability NN O
assay NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
may MD O
inhibit VB O
the DT O
transcription NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
gene NN I-Gene
by IN O
affecting VBG O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
binding NN O
activity NN O
, , O
while IN O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
may MD O
inhibit VB O
the DT O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
mRNA NN I-Gene
levels NNS O
post VBP O
- : O
transcriptionally RB O
, , O
without IN O
suppressing VBG O
promoter NN O
activity NN O
. . O

IL NNP B-Gene
- : I-Gene
2 CD I-Gene
production NN O
by IN O
CsA NNP O
- : O
treated JJ O
cells NNS O
is VBZ O
therefore RB O
dramatically RB O
reduced VBN O
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
assay VBP O
showed VBD O
the DT O
induction NN O
of IN O
a DT O
CsA NNP B-Gene
- : I-Gene
resistant JJ I-Gene
NFAT NNP I-Gene
complex NN I-Gene
in IN O
the DT O
nuclear JJ O
extracts NNS O
of IN O
peripheral JJ O
blood NN O
T NNP O
cells NNS O
stimulated VBD O
with IN O
PMA NNP O
plus CC O
alphaCD28 NN B-Gene
. . O

Deactivation NN O
of IN O
mononuclear JJ O
phagocytes NNS O
is VBZ O
critical JJ O
to TO O
limit VB O
the DT O
inflammatory JJ O
response NN O
but CC O
can MD O
be VB O
detrimental JJ O
in IN O
the DT O
face NN O
of IN O
progressive JJ O
infection NN O
. . O

We PRP O
compared VBN O
the DT O
effects NNS O
of IN O
the DT O
deactivating VBG B-Gene
cytokine NN I-Gene
interleukin NN B-Gene
10 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
) ) O
on IN O
human JJ O
peripheral JJ O
blood NN O
mononuclear NN O
cell NN O
( ( O
PBMC NNP O
) ) O
responses VBZ O
to TO O
lipopolysaccharide VB O
( ( O
LPS NNP O
) ) O
, , O
Cryptococcus NNP O
neoformans NNPS O
, , O
and CC O
Candida NNP O
albicans NNS O
. . O

Characterization NN O
and CC O
purification NN O
of IN O
a DT O
protein NN B-Gene
kinase NN I-Gene
C NNP I-Gene
substrate NN I-Gene
in IN O
human JJ O
B NNP O
cells NNS O
. . O

These DT O
findings NNS O
, , O
therefore RB O
, , O
could MD O
have VB O
clinical JJ O
significance NN O
to TO O
AIDS NNP O
patients NNS O
with IN O
malignancies NNS O
who WP O
are VBP O
undergoing VBG O
radiotherapy NN O
and CC O
chemotherapy NN O
. . O

To TO O
determine VB O
whether IN O
the DT O
IL NNP B-Gene
- : I-Gene
10R CD I-Gene
has VBZ O
signaling VBG O
functions NNS O
similar JJ O
to TO O
IL NNP B-Gene
- : I-Gene
6R CD I-Gene
in IN O
cells NNS O
normally RB O
expressing VBG O
these DT O
receptors NNS O
, , O
leukocytes NNS O
of IN O
the DT O
B NNP O
- : O
, , O
T NNP O
- : O
, , O
and CC O
NK NNP O
- : O
cell NN O
lineages NNS O
were VBD O
treated VBN O
with IN O
either DT O
cytokine NN O
. . O

The DT O
IL NNP B-Gene
- : I-Gene
10R CD I-Gene
, , O
together RB O
with IN O
reporter NN O
gene NN O
constructs NNS O
containing VBG O
different JJ O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
- : I-Gene
responsive JJ I-Gene
gene NN I-Gene
elements NNS I-Gene
, , O
reconstituted VBN O
in IN O
hepatoma NN O
cells NNS O
an DT O
induction NN O
of IN O
transcription NN O
by IN O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
that WDT O
was VBD O
comparable JJ O
to TO O
that DT O
by IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
. . O

These DT O
receptor NN O
functions NNS O
required VBD O
the DT O
presence NN O
of IN O
the DT O
box NN B-Gene
3 CD I-Gene
motifs NN I-Gene
, , O
as IN O
shown VBN O
by IN O
the DT O
analysis NN O
of IN O
the DT O
mouse NN O
IL NNP B-Gene
- : I-Gene
10R CD I-Gene
constructs NNS O
containing VBG O
progressively RB B-Gene
truncated VBN I-Gene
cytoplasmic JJ I-Gene
domains NNS I-Gene
. . O

These DT O
results NNS O
suggest VBP O
that IN O
both DT O
common JJ O
mechanisms NN O
, , O
such JJ O
as IN O
the DT O
one CD O
mediated VBN O
by IN O
the DT O
CIITA NNP B-Gene
trans VBZ I-Gene
- : I-Gene
activator NN I-Gene
, , O
and CC O
distinct JJ O
tissue NN O
- : O
specific JJ O
constraints NNS O
contribute VBP O
to TO O
the DT O
transcriptional JJ O
control NN O
of IN O
constitutive JJ O
and CC O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
- : O
induced JJ O
MHC NNP B-Gene
class NN I-Gene
II NNP I-Gene
gene NN I-Gene
expression NN O
. . O

E3330 RB O
inhibited VBN O
this DT O
induced JJ O
promoter NN O
activity NN O
in IN O
a DT O
dose JJ O
- : O
dependent JJ O
manner NN O
. . O

There EX O
are VBP O
four CD O
putative JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
binding NN I-Gene
sites NNS I-Gene
( ( O
kappa NN B-Gene
B NNP I-Gene
- : I-Gene
1 CD I-Gene
, , O
kappa NN B-Gene
B NNP I-Gene
- : I-Gene
2 CD I-Gene
, , O
kappa NN B-Gene
B NNP I-Gene
- : I-Gene
3 CD I-Gene
, , O
kappa NN B-Gene
B NNP I-Gene
- : I-Gene
4 CD I-Gene
) ) O
in IN O
human JJ B-Gene
TNF NNP I-Gene
- : I-Gene
alpha NN I-Gene
promoter NN I-Gene
. . O

In IN O
this DT O
study NN O
we PRP O
have VBP O
analysed VBN O
the DT O
structural JJ O
requirements NNS O
for IN O
transcriptional JJ O
activation NN O
by IN O
BSAP NNP B-Gene
. . O

We PRP O
have VBP O
demonstrated VBN O
that IN O
the DT O
level NN O
of IN O
CRE NNP B-Gene
binding VBG I-Gene
protein NN I-Gene
( ( O
CREB NNP B-Gene
) ) O
was VBD O
the DT O
same JJ O
in IN O
all DT O
cell NN O
lines NNS O
and CC O
that IN O
the DT O
putative JJ O
AR NNP B-Gene
- : I-Gene
CRE NN I-Gene
forms NNS O
specific JJ O
and CC O
compatible JJ O
protein NN O
interactions NNS O
with IN O
CREB NNP B-Gene
. . O

Structural JJ O
and CC O
functional JJ O
characterization NN O
of IN O
the DT O
human JJ B-Gene
CD36 NNP I-Gene
gene NN I-Gene
promoter NN I-Gene
: : O
identification NN O
of IN O
a DT O
proximal JJ O
PEBP2 NNP B-Gene
/ NNP I-Gene
CBF NNP I-Gene
site NN I-Gene
. . O

In IN O
these DT O
cells NNS O
, , O
CD36 NNP B-Gene
is VBZ O
involved VBN O
in IN O
phagocytosis NN O
of IN O
apoptotic JJ O
cells NNS O
, , O
and CC O
foam NN O
cell NN O
formation NN O
by IN O
uptake NN O
of IN O
oxidized JJ B-Gene
low JJ I-Gene
density NN I-Gene
lipoprotein NN I-Gene
. . O

Biochemical JJ O
analysis NN O
of IN O
the DT O
region NN O
- : B-Gene
158 CD I-Gene
/ SYM I-Gene
- : I-Gene
90 CD I-Gene
revealed VBD O
a DT O
binding NN O
site NN O
for IN O
transcription NN B-Gene
factors NNS I-Gene
of IN O
the DT O
polyomavirus NN B-Gene
enhancer SYM I-Gene
- : I-Gene
binding VBG I-Gene
protein NN I-Gene
2 CD I-Gene
/ NN I-Gene
core NN I-Gene
- : I-Gene
binding NN I-Gene
factor NN I-Gene
( ( I-Gene
PEBP2 NNP I-Gene
/ NNP I-Gene
CBF NNP I-Gene
) ) I-Gene
family NN I-Gene
at IN O
position NN B-Gene
- : I-Gene
103 CD I-Gene
. . O

Disruption NN O
of IN O
the DT O
PEBP2 NNP B-Gene
/ NNP I-Gene
CBF NNP I-Gene
site NN I-Gene
markedly RB O
diminished VBD O
the DT O
role NN O
of IN O
the DT O
PEBP2 NNP B-Gene
/ NNP I-Gene
CBF NNP I-Gene
factors NNS I-Gene
in IN O
the DT O
constitutive JJ O
transcription NN O
of IN O
the DT O
CD36 NNP B-Gene
gene NN I-Gene
. . O

The DT O
association NN O
of IN O
specific JJ O
HLA NNP B-Gene
- : I-Gene
DQ NNP I-Gene
alleles VBZ I-Gene
with IN O
autoimmunity NN O
is VBZ O
correlated VBN O
with IN O
discrete JJ O
polymorphisms NNS O
in IN O
the DT O
HLA NNP B-Gene
- : I-Gene
DQ NNP I-Gene
sequence NN I-Gene
that WDT O
are VBP O
localized VBN O
within IN O
sites NNS O
suitable JJ O
for IN O
peptide JJ O
recognition NN O
. . O

Appearance NN O
of IN O
the DT O
STAT1 NNP B-Gene
factor NN O
is VBZ O
significantly RB O
reduced VBN O
in IN O
the DT O
presence NN O
of IN O
cyclosporin NN O
A NNP O
, , O
and CC O
blocked VBN O
by IN O
cycloheximide NN O
, , O
indicating VBG O
that IN O
its PRP$ O
activation NN O
is VBZ O
dependent JJ O
upon IN O
a DT O
protein NN O
( ( O
s PRP O
) ) O
synthesized VBD O
in IN O
response NN O
to TO O
initial JJ O
signaling VBG O
events NNS O
. . O

Neutralizing VBG O
antiserum NN O
against IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
, , O
but CC O
not RB O
other JJ O
cytokines NNS B-Gene
tested VBN O
, , O
blocked JJ O
activation NN O
of IN O
the DT O
factor NN O
almost RB O
completely RB O
, , O
and CC O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
was VBD O
found VBN O
in IN O
the DT O
culture NN O
supernatants NNS O
of IN O
stimulated JJ O
cells NNS O
at IN O
levels NNS O
at IN O
which WDT O
recombinant VBP O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
could MD O
activate VB O
the DT O
factor NN O
in IN O
naive JJ O
cells NNS O
. . O

Therefore RB O
, , O
a DT O
STAT1 NNP B-Gene
transcription NN B-Gene
factor NN I-Gene
is VBZ O
activated VBN O
by IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
synthesized VBN O
and CC O
released VBN O
upon IN O
stimulation NN O
of IN O
T NNP O
lymphocyte JJ O
populations NNS O
. . O

While IN O
Jurkat NNP O
cells NNS O
both DT O
secrete JJ O
and CC O
respond NN O
to TO O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
in IN O
an DT O
autocrine NN O
loop NN O
, , O
it PRP O
seems VBZ O
likely JJ O
that IN O
the DT O
responding VBG O
cells NNS O
may MD O
differ VB O
from IN O
those DT O
synthesizing VBG O
this DT O
cytokine NN B-Gene
in IN O
the DT O
mononuclear NN O
cell NN O
cultures NNS O
in IN O
the DT O
light NN O
of IN O
the DT O
recent JJ O
report NN O
that IN O
Th1 NNP O
cells NNS O
lack VBP O
the DT O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
receptor NN O
chain NN O
necessary JJ O
for IN O
activation NN O
of IN O
STAT1 NNP B-Gene
( ( O
Pernis NNP O
, , O
A NNP O
. . O
, , O
Gupta NNP O
, , O
S NNP O
. . O
, , O
Gollob NNP O
, , O
K NNP O
. . O
J NNP O
. . O
, , O
Garfein NNP O
, , O
E NNP O
. . O
, , O
Coffman NNP O
, , O
R NNP O
. . O
L NNP O
. . O
, , O
Schindler NNP O
, , O
C NNP O
. . O
, , O
and CC O
Rothman NNP O
, , O
P NNP O
. . O
, , O
Science NN O
1995 CD O
. . O
269 CD O
: : O
245 CD O
) ) O
. . O

Based VBN O
on IN O
the DT O
presence NN O
of IN O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
- : I-Gene
beta NN I-Gene
( ( I-Gene
TcR NNP I-Gene
- : I-Gene
beta NN I-Gene
) ) I-Gene
gene NN I-Gene
rearrangements NNS I-Gene
in IN O
L428 NNP O
and CC O
HDLM NNP O
- : O
1 CD O
cells NNS O
, , O
the DT O
expression NN O
of IN O
CD2 NNP B-Gene
in IN O
HDLM NNP O
- : O
1 CD O
cells NNS O
, , O
and CC O
the DT O
presence NN O
of IN O
immunoglobulin NN B-Gene
heavy JJ I-Gene
- : I-Gene
chain NN I-Gene
( ( I-Gene
IgH NNP I-Gene
) ) I-Gene
gene NN I-Gene
rearrangement NN I-Gene
in IN O
KM NNP O
- : O
H2 NNP O
cells NNS O
, , O
some DT O
researchers NNS O
have VBP O
concluded VBN O
that IN O
these DT O
long JJ O
- : O
term NN O
cell NN O
lines NNS O
derived VBN O
from IN O
patients NNS O
with IN O
Hodgkin NNP O
' POS O
s NN O
disease NN O
are VBP O
lymphoid VBN O
in IN O
nature NN O
. . O

Expression NN O
of IN O
the DT O
MAP NNP B-Gene
kinase NNP I-Gene
- : I-Gene
specific JJ I-Gene
phosphatase NN I-Gene
, , O
MKP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
which WDT O
blocks VBZ O
ERK NNP B-Gene
activation NN O
, , O
inhibited VBN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
- : O
driven JJ O
transcription NN O
stimulated VBN O
by IN O
a DT O
calcium NN O
ionophore NN O
and CC O
PMA NNP O
, , O
and CC O
in IN O
addition NN O
, , O
MKP NNP B-Gene
- : I-Gene
1 CD I-Gene
neutralized VBD O
the DT O
transcriptional JJ O
enhancement NN O
caused VBN O
by IN O
active JJ O
Raf NNP O
- : O
1 CD O
and CC O
MEK1 NNP O
expression NN O
. . O

Although IN O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
does VBZ O
not RB O
appear VB O
to TO O
be VB O
essential JJ O
for IN O
normal JJ O
hemopoiesis NN O
, , O
overexpression NN O
of IN O
GM NNP O
- : O
CSF NN O
has VBZ O
been VBN O
implicated VBN O
in IN O
the DT O
pathogenesis NN O
of IN O
some DT O
diseases NNS O
such JJ O
as IN O
myeloid JJ O
leukemia NN O
and CC O
chronic JJ O
inflammation NN O
. . O

We PRP O
investigated VBD O
oligonucleotide JJ O
- : O
directed VBN O
triple JJ O
helix NN O
formation NN O
across IN O
this DT O
regulatory JJ B-Gene
sequence NN I-Gene
as IN O
a DT O
potential JJ O
tool NN O
to TO O
inhibit VB O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
gene NN O
transcription NN O
. . O

Triplex NNP O
formation NN O
by IN O
GM3 NNP O
blocked VBD O
recombinant JJ B-Gene
and CC I-Gene
nuclear JJ I-Gene
NF NNP I-Gene
- : I-Gene
kappaB NN I-Gene
proteins VBZ I-Gene
binding VBG O
to TO O
the DT O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
element NN I-Gene
. . O

Finally RB O
, , O
GM3 NNP O
greatly RB O
reduced VBD O
the DT O
concentration NN O
of IN O
endogenous JJ O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
mRNA NN I-Gene
induced VBN O
by IN O
different JJ O
stimuli NNS O
in IN O
Jurkat NNP O
T NNP O
cells NNS O
but CC O
did VBD O
not RB O
affect VB O
interleukin JJ B-Gene
3 CD I-Gene
mRNA NN I-Gene
levels NNS O
in IN O
the DT O
same JJ O
cells NNS O
. . O

We PRP O
conclude VBP O
that IN O
the DT O
kappaB NN B-Gene
element NN I-Gene
in IN O
the DT O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
promoter NN I-Gene
plays VBZ O
a DT O
central JJ O
role NN O
in IN O
the DT O
transcriptional JJ O
activation NN O
of IN O
the DT O
endogenous JJ O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
gene NN I-Gene
. . O

Colinear NNP O
triplex JJ O
formation NN O
acts NNS O
as IN O
a DT O
selective JJ O
transcriptional JJ O
repressor NN O
of IN O
the DT O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
gene NN I-Gene
and CC O
may MD O
have VB O
potential JJ O
therapeutic JJ O
application NN O
in IN O
cases NNS O
of IN O
undesirable JJ O
overexpression NN O
of IN O
this DT O
protein NN O
. . O

ML NNP O
- : O
9 CD O
induced JJ O
nitroblue JJ O
tetrazolium NN O
( ( O
NBT NNP O
) ) O
- : O
reducing VBG O
activity NN O
of IN O
U937 NNP O
cell NN O
more RBR O
rapidly RB O
than IN O
VD3 NNS O
: : O
This DT O
differentiation NN O
marker NN O
was VBD O
induced VBN O
significantly RB O
after IN O
incubation NN O
with IN O
ML NNP O
- : O
9 CD O
and CC O
VD3 NNP O
for IN O
4 CD O
hours NNS O
and CC O
1 CD O
day NN O
, , O
respectively RB O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
ML NNP O
- : O
9 CD O
should MD O
be VB O
useful JJ O
for IN O
studying VBG O
the DT O
mechanisms NN O
of IN O
monocytic JJ O
differentiation NN O
. . O

Modulation NN O
of IN O
endogenous JJ O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
receptor NN I-Gene
antagonist NN O
results NNS O
in IN O
opposing VBG O
effects NNS O
on IN O
HIV NNP O
expression NN O
in IN O
chronically RB O
infected VBN O
monocytic JJ O
cells NNS O
. . O

The DT O
present JJ O
study NN O
examines VBZ O
the DT O
mechanisms NNS O
involved VBN O
in IN O
LPS NNP O
- : O
mediated VBD O
induction NN O
of IN O
HIV NNP O
expression NN O
in IN O
U1 NNP O
cells NNS O
, , O
a DT O
promonocytic JJ O
cell NN O
line NN O
chronically RB O
infected VBN O
with IN O
HIV NNP O
. . O

Costimulation NN O
of IN O
U1 NNP O
cells NNS O
with IN O
LPS NNP O
plus CC O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
resulted VBD O
in IN O
the DT O
accumulation NN O
of IN O
steady JJ O
- : O
state NN O
levels NNS O
of IN O
HIV NNP B-Gene
RNA NNP I-Gene
; : O
however RB O
, , O
only RB O
a DT O
weak JJ O
induction NN O
of IN O
HIV NNP B-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
- : O
driven JJ O
transcription NN O
, , O
which WDT O
was VBD O
not RB O
associated VBN O
with IN O
the DT O
activation NN O
of IN O
the DT O
cellular JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
was VBD O
noted VBN O
. . O

IL NNP B-Gene
- : I-Gene
12 CD I-Gene
is VBZ O
a DT O
novel JJ O
heterodimeric JJ B-Gene
cytokine NN I-Gene
important JJ O
for IN O
the DT O
regulation NN O
and CC O
differentiation NN O
of IN O
lymphocytes NNS O
and CC O
NK NNP O
cells NNS O
. . O

Using VBG O
these DT O
T NNP O
cells NNS O
as IN O
a DT O
model NN O
of IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
signal JJ O
transduction NN O
, , O
we PRP O
confirmed VBD O
that IN O
these DT O
events NNS O
involve VBP O
members NNS O
of IN O
the DT O
Janus NNP B-Gene
kinase NNP I-Gene
family NN I-Gene
of IN O
nonreceptor NN B-Gene
tyrosine NN I-Gene
kinases VBZ I-Gene
JAK2 NNP B-Gene
, , O
TYK2 NNP B-Gene
, , O
and CC O
signal JJ B-Gene
transducer NN I-Gene
and CC I-Gene
activator NN I-Gene
of IN I-Gene
transcription NN I-Gene
4 CD I-Gene
. . O

These DT O
mechanisms NNS O
include VBP O
the DT O
assembly NN O
of IN O
higher JJR B-Gene
order NN I-Gene
nucleoprotein NN I-Gene
complexes NNS I-Gene
and CC O
other JJ O
protein NN O
- : O
protein NN O
interactions NNS O
that WDT O
enhance VBP O
the DT O
functional JJ O
specificity NN O
of IN O
transcriptional JJ B-Gene
regulators NNS I-Gene
in IN O
lymphocytes NNS O
. . O

Patients NNS O
with IN O
HIV NNP O
infections NNS O
often RB O
show VBP O
elevated JJ O
circulating NN O
levels NNS O
of IN O
cortisol NN O
, , O
suggesting VBG O
some DT O
misfunction NN O
in IN O
the DT O
regulatory JJ O
systems NNS O
that WDT O
maintain VBP O
the DT O
levels NNS O
of IN O
this DT O
critical JJ O
hormone NN O
. . O

At IN O
the DT O
cellular JJ O
level NN O
, , O
it PRP O
is VBZ O
known VBN O
that IN O
both DT O
acute JJ O
HIV NNP O
infection NN O
and CC O
glucocorticoids NNS O
can MD O
cause VB O
apoptotic JJ O
cell NN O
death NN O
in IN O
thymic JJ O
lymphocytes NNS O
. . O

In IN O
vitro NN O
, , O
chronically RB O
HIV NNP O
- : O
infected JJ O
cells NNS O
of IN O
the DT O
lymphoid JJ O
CEM NNP O
line NN O
displayed VBD O
resistance NN O
to TO O
glucocorticoid VB O
- : O
induced JJ O
apoptosis NN O
. . O

Thus RB O
it PRP O
appears VBZ O
that IN O
there EX O
may MD O
often RB O
be VB O
malfunction NN O
of IN O
the DT O
normal JJ O
glucocorticoid JJ O
response NN O
in IN O
HIV NNP O
- : O
infected JJ O
cells NNS O
probably RB O
due JJ O
to TO O
altered JJ O
interactions NNS O
between IN O
the DT O
glucocorticoid NN B-Gene
receptor NN I-Gene
and CC O
its PRP$ O
hormone NN O
. . O

Nuclei NNP O
of IN O
unstimulated JJ O
PBL NNP O
from IN O
different JJ O
donors NNS O
expressed VBD O
p62c JJ B-Gene
- : I-Gene
fos NN I-Gene
and CC O
p39c NN B-Gene
- : I-Gene
jun NN I-Gene
, , O
but CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
was VBD O
not RB O
detected VBN O
in IN O
the DT O
majority NN O
of IN O
samples NNS O
. . O

Following VBG O
PHA NNP B-Gene
stimulation NN O
of IN O
PBL NNP O
, , O
the DT O
increase NN O
in IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
activity NN O
was VBD O
delayed VBN O
with IN O
respect NN O
to TO O
the DT O
augmentation NN O
of IN O
p39c JJ B-Gene
- : I-Gene
jun NN I-Gene
expression NN O
. . O

However RB O
, , O
no DT O
cytoplasmic JJ B-Gene
p62c NN I-Gene
- : I-Gene
fos NN I-Gene
was VBD O
detected VBN O
in IN O
unstimulated JJ O
PBL NNP O
, , O
although IN O
in IN O
some DT O
cases NNS O
cytoplasmic VBP B-Gene
p39c JJ I-Gene
- : I-Gene
jun NN I-Gene
was VBD O
detected VBN O
, , O
suggesting VBG O
that IN O
subcellular JJ O
compartmentalization NN O
of IN O
these DT O
proteins NNS B-Gene
may MD O
occur VB O
under IN O
certain JJ O
circumstances NNS O
. . O

However RB O
, , O
the DT O
inducible JJ O
degradation NN O
of IN O
p105 NN B-Gene
is VBZ O
not RB O
coupled VBN O
with IN O
the DT O
generation NN O
of IN O
p50 NN B-Gene
. . O

Together RB O
, , O
these DT O
studies NNS O
demonstrate VBP O
that IN O
the DT O
processing NN O
and CC O
inducible JJ O
degradation NN O
of IN O
p105 NN B-Gene
are VBP O
differentially RB O
regulated VBN O
. . O

However RB O
, , O
synthesis NN O
of IN O
the DT O
26 CD B-Gene
- : I-Gene
kDa NN I-Gene
membrane JJ I-Gene
form NN I-Gene
of IN O
TNF NNP B-Gene
was VBD O
effectively RB O
blocked VBN O
by IN O
CNI NNP O
- : O
1493 CD O
. . O

r LS B-Gene
- : I-Gene
hTBP NN I-Gene
- : I-Gene
1 CD I-Gene
and CC O
rhu JJ B-Gene
TNFR NNP I-Gene
: : I-Gene
Fc NNP I-Gene
also RB O
decreased VBD O
p24 JJ B-Gene
antigen NN I-Gene
synthesized VBN O
by IN O
U1 NNP O
cells NNS O
in IN O
response NN O
to TO O
other JJ O
stimuli NNS O
, , O
including VBG O
phytohemagglutinin NN B-Gene
( ( I-Gene
PHA NNP I-Gene
) ) I-Gene
- : I-Gene
induced VBN I-Gene
supernatant NN I-Gene
, , O
granulocyte SYM B-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
, , O
interleukin JJ B-Gene
- : I-Gene
6 CD I-Gene
, , O
and CC O
TNF NNP B-Gene
. . O

Addition NN O
of IN O
r NN B-Gene
- : I-Gene
hTBP NN I-Gene
- : I-Gene
1 CD I-Gene
to TO O
U1 NNP O
cells NNS O
during IN O
the DT O
last JJ O
4 CD O
h NN O
of IN O
a DT O
24 CD O
h NN O
incubation NN O
with IN O
PMA NNP O
still RB O
inhibited VBD O
p24 JJ B-Gene
antigen NN I-Gene
production NN O
by IN O
15 CD O
% NN O
. . O

r LS B-Gene
- : I-Gene
hTBP NN I-Gene
- : I-Gene
1 CD I-Gene
also RB O
partially RB O
reversed JJ O
inhibition NN O
of IN O
U1 NNP O
cellular JJ O
proliferation NN O
caused VBN O
by IN O
PMA NNP O
. . O

Transcriptional JJ O
activation NN O
of IN O
RNA NNP B-Gene
polymerase NN I-Gene
III NNP I-Gene
- : I-Gene
dependent NN I-Gene
genes NNS I-Gene
by IN O
the DT O
human JJ B-Gene
T NNP I-Gene
- : I-Gene
cell NN I-Gene
leukemia NN I-Gene
virus NN I-Gene
type VBD I-Gene
1 CD I-Gene
tax NN I-Gene
protein NN I-Gene
. . O

The DT O
viral JJ B-Gene
protein NN I-Gene
Tax NNP I-Gene
was VBD O
likely JJ O
responsible JJ O
for IN O
this DT O
higher JJR O
level NN O
of IN O
class NN B-Gene
II NNP I-Gene
gene NN I-Gene
transcription NN O
, , O
as IN O
purified JJ B-Gene
Tax NNP I-Gene
was VBD O
found VBN O
to TO O
stimulate VB O
both DT O
genes NNS O
when WRB O
added VBN O
to TO O
the DT O
uninfected JJ O
cell NN O
extract NN O
or CC O
in IN O
reconstituted JJ O
systems NNS O
. . O

Expression NN O
of IN O
Retinoid NNP B-Gene
X NNP I-Gene
Receptor NNP I-Gene
alpha NN I-Gene
is VBZ O
increased VBN O
upon IN O
monocytic JJ O
cell NN O
differentiation NN O
. . O

Efficient JJ O
gene NN O
activation NN O
requires VBZ O
the DT O
heterodimerization NN O
of IN O
VDR NNP B-Gene
with IN O
Retinoid NNP B-Gene
X NNP I-Gene
Receptors NNP I-Gene
( ( O
RXR NNP B-Gene
) ) O
. . O

Combinations NNS O
of IN O
all DT O
- : O
trans NNS O
retinoic VBP O
acid NN O
( ( O
RA NNP O
) ) O
and CC O
VD NNP O
, , O
in IN O
some DT O
cases NNS O
, , O
increased VBD O
this DT O
effect NN O
. . O

We PRP O
have VBP O
generated VBN O
rabbit NN O
antisera NN O
against IN O
this DT O
putative JJ O
p13MTCP1 NN B-Gene
protein NN I-Gene
and CC O
screened VBD O
for IN O
expression NN O
of IN O
p13MTCP1 NN B-Gene
normal JJ O
lymphoid JJ O
tissues NNS O
and CC O
33 CD O
cases NNS O
of IN O
immature NN O
and CC O
mature NN O
lymphoid NN O
T NNP O
- : O
cell NN O
proliferations NNS O
using VBG O
a DT O
sensitive JJ O
Western JJ O
blot NN O
assay NN O
. . O

The DT O
p13MTCP1 NN B-Gene
protein NN I-Gene
was VBD O
detected VBN O
in IN O
the DT O
three CD O
T NNP O
- : O
cell NN O
proliferations NNS O
with IN O
MTCP1 NNP B-Gene
rearrangements NNS I-Gene
because IN O
of IN O
t NN O
( ( O
X NNP O
; : O
14 CD O
) ) O
translocations NNS O
, , O
but CC O
neither RB O
in IN O
normal JJ O
resting NN O
and CC O
activated JJ O
lymphocytes NNS O
nor CC O
in IN O
the DT O
other JJ O
T NNP O
- : O
cell NN O
leukemias NN O
. . O

A DT O
variety NN O
of IN O
cytokines NNS B-Gene
and CC O
growth NN B-Gene
factors NNS I-Gene
act VBP O
through IN O
an DT O
induction NN O
of IN O
gene NN O
expression NN O
mediated VBN O
by IN O
a DT O
family NN O
of IN O
latent JJ B-Gene
transcription NN I-Gene
factors NNS I-Gene
called VBD O
STAT NNP B-Gene
( ( I-Gene
signal JJ I-Gene
transducers NNS I-Gene
and CC I-Gene
activators NNS I-Gene
of IN I-Gene
transcription NN I-Gene
) ) I-Gene
proteins VBZ I-Gene
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
( ( O
EMSAs NNP O
) ) O
demonstrated VBD O
that IN O
unstimulated JJ O
monocytes NNS O
predominantly RB O
expressed VBD O
p50 NN B-Gene
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

However RB O
, , O
the DT O
combined JJ O
stimulation NN O
did VBD O
not RB O
result VB O
in IN O
enhanced JJ O
p50 NN B-Gene
and CC O
p65 NN B-Gene
protein NN I-Gene
expression NN O
. . O

The DT O
effects NNS O
of IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
on IN O
the DT O
transcription NN B-Gene
factors NNS I-Gene
were VBD O
specific JJ O
, , O
since IN O
no DT O
change NN O
was VBD O
observed VBN O
in IN O
the DT O
expression NN O
of IN O
NF NNP B-Gene
- : I-Gene
IL NNP I-Gene
- : I-Gene
6 CD I-Gene
or CC O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
, , O
the DT O
inhibitor NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

We PRP O
conclude VBP O
that IN O
the DT O
effects NNS O
of IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
on IN O
the DT O
expression NN O
of IN O
the DT O
transcription NN B-Gene
factors NNS I-Gene
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
may MD O
be VB O
important JJ O
for IN O
the DT O
modulatory JJ O
effects NNS O
of IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
on IN O
the DT O
cytokine NN B-Gene
expression NN O
in IN O
activated JJ O
human JJ O
monocytes NNS O
. . O

The DT O
expression NN O
of IN O
MIP NNP B-Gene
- : I-Gene
1 CD I-Gene
alpha NN I-Gene
is VBZ O
induced VBN O
during IN O
cellular JJ O
activation NN O
of IN O
CD4 NNP O
+ NNP O
T NNP O
- : O
cells NNS O
and CC O
monocytes NNS O
. . O

It PRP O
is VBZ O
also RB O
expressed VBN O
in IN O
transformed NN O
B NNP O
- : O
cells NNS O
. . O

We PRP O
have VBP O
previously RB O
identified VBN O
a DT O
new JJ O
transcription NN B-Gene
factor NN I-Gene
family NN I-Gene
( ( O
the DT O
MNP NNP B-Gene
family NN I-Gene
) ) O
whose WP$ O
expression NN O
is VBZ O
crucial JJ O
for IN O
the DT O
induction NN O
of IN O
MIP NNP B-Gene
- : I-Gene
1 CD I-Gene
alpha JJ I-Gene
transcription NN O
during IN O
cellular JJ O
activation NN O
and CC O
in IN O
transformed JJ O
B NNP O
cells NNS O
. . O

In IN O
this DT O
report NN O
we PRP O
show VBP O
induction NN O
of IN O
MNP NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
Jurkat NNP O
T NNP O
- : O
cells NNS O
expressing VBG O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
tat NN I-Gene
. . O

Differentiation NN O
of IN O
T NNP O
- : O
helper NN O
lymphocytes VBZ O
: : O
selective JJ O
regulation NN O
by IN O
members NNS O
of IN O
the DT O
STAT NNP B-Gene
family NN I-Gene
of IN O
transcription NN B-Gene
factors NNS I-Gene
. . O

Specific JJ O
docking VBG B-Gene
sites NNS I-Gene
within IN O
individual JJ O
cytokine NN B-Gene
receptors NNS I-Gene
have VBP O
been VBN O
identified VBN O
for IN O
almost RB O
all DT O
Stat NNP B-Gene
proteins NNS I-Gene
. . O

The DT O
direct JJ O
coupling NN O
between IN O
cytokine NN B-Gene
receptor NN I-Gene
and CC O
transcription NN B-Gene
factor NN I-Gene
helps VBZ O
to TO O
explain VB O
how WRB O
different JJ O
cytokines NNS B-Gene
elicit VBP O
distinct JJ O
patterns NNS O
of IN O
gene NN O
expression NN O
. . O

Here RB O
we PRP O
identify VBP O
the DT O
gene NN O
encoding VBG O
the DT O
lymphocyte NN B-Gene
homing NN I-Gene
and CC I-Gene
migration NN I-Gene
protein RB I-Gene
CD44 NNP B-Gene
as IN O
a DT O
target NN O
of IN O
EGR1 NNP B-Gene
regulation NN O
in IN O
B NNP O
cells NNS O
. . O

The DT O
EGR1 NNP B-Gene
binding NN I-Gene
motif NN I-Gene
was VBD O
shown VBN O
to TO O
be VB O
necessary JJ O
for IN O
stimulus JJ O
- : O
induced JJ O
expression NN O
of IN O
a DT O
CD44 NNP B-Gene
promoter NN B-Gene
- : I-Gene
chloramphenicol NN I-Gene
acetyltransferase NN I-Gene
reporter NN I-Gene
construct NN I-Gene
in IN O
nontransformed JJ O
B NNP O
lymphocytes NNS O
and CC O
was VBD O
required VBN O
for IN O
transactivation NN O
by IN O
an DT O
EGR1 NNP B-Gene
expression NN I-Gene
vector NN I-Gene
in IN O
a DT O
B NNP O
- : O
cell NN O
line NN O
. . O

These DT O
studies NNS O
identify VBP O
EGR1 NNP B-Gene
as IN O
an DT O
intermediary JJ O
linking NN O
BCR NNP B-Gene
- : O
derived VBN O
signals NNS O
to TO O
the DT O
induction NN O
of IN O
CD44 NNP B-Gene
. . O

In IN O
Jurkat NNP O
cells NNS O
that WDT O
are VBP O
not RB O
sensitive JJ O
to TO O
H2O2 NNP O
- : O
induced VBD O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
, , O
H2O2 NNP O
potentiated VBD O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
in IN O
the DT O
presence NN O
of IN O
sustained JJ O
high JJ O
[ NN O
Ca2 NNP O
+ NNP O
] NNP O
i NN O
following VBG O
thapsigargin NN O
treatment NN O
. . O

A DT O
mutant JJ O
Tax NNP B-Gene
protein NN I-Gene
deficient NN O
in IN O
transactivation NN O
of IN O
genes NNS O
by IN O
the DT O
nuclear JJ B-Gene
factor NN I-Gene
( ( I-Gene
NF NNP I-Gene
) ) I-Gene
- : I-Gene
kappaB NN I-Gene
pathway NN O
was VBD O
unable JJ O
to TO O
induce VB O
transcriptional JJ O
activity NN O
of IN O
IL NNP B-Gene
- : I-Gene
1alpha CD I-Gene
promoter NN I-Gene
- : I-Gene
CAT NNP I-Gene
constructs NNS I-Gene
, , O
but CC O
was VBD O
rescued VBN O
by IN O
exogenous JJ O
provision NN O
of IN O
p65 NN B-Gene
/ NNP I-Gene
p50 NN I-Gene
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
. . O

mRNA NN O
for IN O
c SYM O
- : O
fes NN O
has VBZ O
been VBN O
detected VBN O
exclusively RB O
in IN O
myeloid JJ O
cells NNS O
and CC O
vascular JJ O
endothelial JJ O
cells NNS O
in IN O
adult NN O
mammals NNS O
. . O

Although IN O
a DT O
13 CD B-Gene
- : I-Gene
kilobase NN I-Gene
- : I-Gene
pair NN I-Gene
( ( I-Gene
kb NN I-Gene
) ) I-Gene
human NN I-Gene
c SYM I-Gene
- : I-Gene
fes JJ I-Gene
transgene NN I-Gene
exhibits NNS O
high JJ O
levels NNS O
of IN O
expression NN O
in IN O
mice NN O
, , O
the DT O
sequences NNS O
that WDT O
confer VBP O
myeloid JJ O
- : O
cell NN O
- : O
specific JJ O
expression NN O
of IN O
the DT O
human JJ B-Gene
c SYM I-Gene
- : I-Gene
fes NN I-Gene
gene NN I-Gene
have VBP O
not RB O
been VBN O
defined VBN O
. . O

However RB O
, , O
the DT O
first JJ O
two CD O
footprints NNS O
resided VBD O
in IN O
sequences NNS O
that WDT O
were VBD O
largely RB O
dispensable JJ O
for IN O
transient JJ O
activity NN O
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
analyses NNS O
demonstrated VBD O
that IN O
the DT O
151 CD B-Gene
- : I-Gene
bp NN I-Gene
region NN I-Gene
contains VBZ O
nuclear JJ B-Gene
protein NN I-Gene
binding VBG I-Gene
sites NNS I-Gene
for IN O
Sp1 NNP B-Gene
, , O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
, , O
and CC O
/ NNP O
or CC O
Elf NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
a DT O
novel JJ B-Gene
factor NN I-Gene
. . O

IL NNP B-Gene
- : I-Gene
10 CD I-Gene
markedly RB O
reduces NNS O
nuclear JJ O
factor NN O
( ( B-Gene
NF NNP I-Gene
) ) I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
/ NNP I-Gene
Rel NNP I-Gene
nuclear JJ O
activity NN O
induced VBN O
in IN O
PBMC NNP O
by IN O
stimulation NN O
with IN O
the DT O
anti JJ B-Gene
- : I-Gene
CD3 NNP I-Gene
mAb NN I-Gene
OKT3 NNP B-Gene
. . O

As IN O
judged VBN O
by IN O
supershifting VBG O
the DT O
DNA NNP B-Gene
- : I-Gene
protein NN I-Gene
complexes NNS I-Gene
with IN O
Abs NNP B-Gene
recognizing VBG O
specific JJ O
components NNS O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
/ NNP I-Gene
Rel NNP I-Gene
protein VBD I-Gene
family NN I-Gene
, , O
the DT O
p50 NN B-Gene
/ NNP I-Gene
p65 NN I-Gene
( ( O
Rel NNP B-Gene
A NNP I-Gene
) ) O
heterodimeric JJ O
form NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
is VBZ O
primarily RB O
affected VBN O
. . O

The DT O
maximal JJ O
effect NN O
is VBZ O
observed VBN O
at IN O
the DT O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
concentration NN O
of IN O
20 CD O
U NNP O
/ NNP O
ml NN O
. . O

Our PRP$ O
results NNS O
demonstrate VBP O
that IN O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
can MD O
inhibit VB O
the DT O
induction NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
/ NNP I-Gene
Rel NNP I-Gene
nuclear JJ O
activity NN O
in IN O
CD3 NNP O
- : O
stimulated VBD O
T NNP O
lymphocytes NNS O
. . O

In IN O
a DT O
panel NN O
of IN O
32 CD O
B NNP O
- : O
cell NN O
lines NNS O
, , O
A NNP B-Gene
- : I-Gene
myb NN I-Gene
was VBD O
very RB O
strongly RB O
expressed VBN O
in IN O
most JJS O
Burkitt NNP O
' POS O
s NN O
lymphoma NN O
( ( O
BL NNP O
) ) O
cell NN O
lines NNS O
, , O
but CC O
weak JJ O
or CC O
negative JJ O
in IN O
2 CD O
pre NN O
- : O
B NNP O
acute NN O
lymphoblastic JJ O
leukemia NN O
( ( O
ALL NNP O
) ) O
, , O
4 CD O
non SYM O
- : O
Hodgkin NNP O
' POS O
s NN O
lymphoma NN O
( ( O
NHL NNP O
) ) O
, , O
6 CD O
Epstein NNP O
- : O
Barr NNP O
virus SYM O
- : O
immortalized VBN O
lymphoblastoid NN O
cell NN O
lines NNS O
, , O
and CC O
6 CD O
myeloma NN O
lines NNS O
. . O

C NNP O
- : O
myb NN O
and CC O
B NNP B-Gene
- : I-Gene
myb NN I-Gene
were VBD O
expressed VBN O
in IN O
all DT O
neoplastic JJ O
groups NNS O
, , O
except IN O
in IN O
CLL NNP O
cells NNS O
. . O

Thus RB O
, , O
A NNP B-Gene
- : I-Gene
myb NN I-Gene
expression NN O
, , O
unlike IN O
that DT O
of IN O
c SYM B-Gene
- : I-Gene
myb NN I-Gene
and CC O
B NNP B-Gene
- : I-Gene
myb NN I-Gene
, , O
is VBZ O
restricted VBN O
to TO O
a DT O
subset NN O
of IN O
B NNP O
- : O
cell NN O
neoplasias NNS O
( ( O
in IN O
particular JJ O
BL NNP O
and CC O
slg VB O
+ NN O
B NNP O
- : O
ALL DT O
) ) O
representative NN O
of IN O
a DT O
specific JJ O
stage NN O
of IN O
B NNP O
- : O
cell NN O
differentiation NN O
. . O

Here RB O
we PRP O
provide VBP O
evidence NN O
that IN O
this DT O
transformation NN O
is VBZ O
the DT O
result NN O
of IN O
double JJ O
infection NN O
of IN O
a DT O
cell NN O
with IN O
two CD O
virions NNS O
, , O
the DT O
P3HR1 NNP B-Gene
virus NN I-Gene
genome NN I-Gene
and CC O
a DT O
mini NN B-Gene
- : I-Gene
EBV NNP I-Gene
plasmid IN I-Gene
carrying VBG O
the DT O
chimeric JJ O
EBNA2 NNP B-Gene
gene NN I-Gene
. . O

It PRP O
remains VBZ O
open JJ O
whether IN O
the DT O
growth NN O
retarding VBG O
property NN O
of IN O
the DT O
EBNA2 NNP B-Gene
- : I-Gene
oestrogen NN I-Gene
receptor NN I-Gene
fusion NN I-Gene
protein NN I-Gene
in IN O
B NNP O
cell NN O
lymphoma NN O
lines NNS O
is VBZ O
due JJ O
to TO O
unphysiologically RB O
high JJ O
expression NN O
of IN O
the DT O
chimeric JJ B-Gene
protein NN I-Gene
or CC O
to TO O
interference VB O
with IN O
a DT O
cellular JJ O
programme NN O
driving VBG O
proliferation NN O
in IN O
these DT O
cell NN O
lines NNS O
. . O

These DT O
results NNS O
indicate VBP O
that DT O
, , O
as IN O
already RB O
reported VBN O
for IN O
the DT O
IL2Rbeta NNP B-Gene
promoter NN I-Gene
, , O
GA NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
is VBZ O
an DT O
essential JJ O
component NN O
of IN O
gammac NN O
basal NN O
promoter NN O
activity NN O
. . O

Detection NN O
of IN O
intracellular JJ B-Gene
signal JJ I-Gene
transduction NN I-Gene
molecules NNS I-Gene
in IN O
PBMC NNP O
from IN O
rhesus NN O
macaques NNS O
and CC O
sooty JJ O
mangabeys NNS O
. . O

The DT O
molecular JJ O
mechanisms NNS O
associated VBN O
with IN O
the DT O
T NNP O
- : O
cell NN O
dysfunction NN O
remain VBP O
to TO O
be VB O
elucidated VBN O
. . O

Because IN O
relatively RB O
little JJ O
is VBZ O
known VBN O
about IN O
these DT O
events NNS O
in IN O
nonhuman JJ O
primates NNS O
, , O
our PRP$ O
laboratory NN O
defined VBN O
optimal JJ O
conditions NNS O
, , O
reagents NNS O
, , O
and CC O
assays NNS O
for IN O
the DT O
study NN O
of IN O
signal JJ O
transduction NN O
events NNS O
in IN O
cells NNS O
from IN O
nonhuman JJ O
primates NNS O
. . O

The DT O
protein NN O
phosphorylation NN O
patterns NNS O
in IN O
the DT O
two CD O
monkeys NNS O
exhibited VBD O
quantitative JJ O
, , O
qualitative JJ O
, , O
and CC O
kinetic JJ O
differences NNS O
. . O

Expression NN O
of IN O
ATF NNP B-Gene
- : I-Gene
2 CD I-Gene
in IN O
S NNP O
. . O
cerevisiae NN O
did VBD O
not RB O
activate VB O
TRE NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
the DT O
presence NN O
of IN O
Tax NNP B-Gene
. . O

This DT O
shows VBZ O
that IN O
in IN O
a DT O
eukaryotic JJ O
nucleus NN O
, , O
Tax NNP B-Gene
specifically RB O
interacts VBZ O
with IN O
the DT O
basic JJ B-Gene
domain NN I-Gene
- : I-Gene
leucine NN I-Gene
zipper IN I-Gene
region NN I-Gene
of IN O
ATF NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
CREB NNP B-Gene
, , O
and CC O
CREM NNP B-Gene
. . O

Trapoxin NN O
is VBZ O
a DT O
microbially RB O
derived VBN O
cyclotetrapeptide NN O
that IN O
inhibits VBZ O
histone NN B-Gene
deacetylation NN O
in IN O
vivo NN O
and CC O
causes VBZ O
mammalian JJ O
cells NNS O
to TO O
arrest VB O
in IN O
the DT O
cell NN O
cycle NN O
. . O

The DT O
mechanisms NN O
by IN O
which WDT O
these DT O
promoters NNS O
of IN O
cell NN O
growth NN O
exert VBP O
their PRP$ O
inhibitory JJ O
effects NNS O
vary VBP O
, , O
but CC O
in IN O
most JJS O
instances NNS O
they PRP O
involve VBP O
a DT O
disruption NN O
of IN O
the DT O
IFN NNP O
- : O
alpha NN O
/ NN O
beta SYM O
- : O
induced JJ O
transcription NN O
complex JJ O
ISGF3 NNP O
such PDT O
that IN O
the DT O
DNA NNP O
- : O
binding VBG O
component NN O
of IN O
this DT O
complex NN O
( ( O
the DT O
48 CD O
- : O
kDa NN O
ISGF3gamma NNP O
protein NN O
) ) O
does VBZ O
not RB O
bind VB O
to TO O
the DT O
interferon NN O
- : O
stimulated VBN O
response NN O
element NN O
( ( O
ISRE NNP O
) ) O
. . O

Phorbol NNP O
ester NN O
treatment NN O
of IN O
monocytes NNS O
inhibited VBN O
IFN NNP O
alpha SYM O
- : O
stimulated VBN O
tyrosine JJ O
phosphorylation NN O
of IN O
the DT O
transcription NN B-Gene
factors NNS I-Gene
Stat1alpha NNP B-Gene
, , O
Stat2 NNP B-Gene
, , O
and CC O
Stat3 NNP B-Gene
and CC O
of IN O
the DT O
tyrosine JJ B-Gene
kinase NN I-Gene
Tyk2 NNP B-Gene
but CC O
had VBD O
no DT O
effect NN O
on IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
activation NN O
of IN O
Stat1alpha NNP B-Gene
. . O

Pretreatment NN O
of IN O
cells NNS O
with IN O
vanadate NN O
prevented VBD O
the DT O
effects NNS O
of IN O
PMA NNP O
with IN O
regard NN O
to TO O
PMA NNP O
- : O
induced VBD O
Tyk2 NNP B-Gene
dephosphorylation NN O
. . O

Interleukin NNP B-Gene
- : I-Gene
2 CD I-Gene
( ( I-Gene
IL NNP I-Gene
- : I-Gene
2 CD I-Gene
) ) I-Gene
promoter NN I-Gene
- : B-Gene
reporter NN I-Gene
gene NN I-Gene
behavior NN O
closely RB O
parallels VBZ O
the DT O
endogenous JJ B-Gene
gene NN I-Gene
in IN O
response NN O
to TO O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
and CC O
costimulatory NN O
signals NNS O
. . O

The DT O
RAR NNP B-Gene
- : I-Gene
RXR NN I-Gene
as RB O
well RB O
as IN O
the DT O
RXR NNP B-Gene
- : I-Gene
RXR NNP I-Gene
pathway NN O
is VBZ O
involved VBN O
in IN O
signaling VBG O
growth NN O
inhibition NN O
of IN O
human JJ O
CD34 NNP O
+ NNP O
erythroid JJ O
progenitor NN O
cells NNS O
. . O

Previous JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
retinoic NN O
acid NN O
( ( O
RA NNP O
) ) O
, , O
similar JJ O
to TO O
tumor VB B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
, , O
can MD O
act VB O
as IN O
a DT O
bifunctional JJ O
regulator NN O
of IN O
the DT O
growth NN O
of IN O
bone NN O
marrow NN O
progenitors NNS O
, , O
in IN O
that IN O
it PRP O
can MD O
stimulate VB O
granulocyte JJ O
- : O
macrophage NN O
colony NN O
- : O
stimulating NN O
factor NN O
( ( O
GM NNP O
- : O
CSF NN O
) ) O
- : O
or CC O
interleukin VB O
- : O
3 CD O
( ( O
IL NNP O
- : O
3 CD O
) ) O
- : O
induced VBN O
GM NNP O
colony NN O
formation NN O
, , O
but CC O
potently RB O
inhibit VB O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
- : O
induced JJ O
growth NN O
. . O

Erythroid JJ O
colony NN O
growth NN O
was VBD O
also RB O
inhibited VBN O
when WRB O
CD34 NNP O
+ NNP O
progenitors NNS O
were VBD O
seeded VBN O
at IN O
one CD O
cell NN O
per IN O
well RB O
, , O
suggesting VBG O
a DT O
direct JJ O
action NN O
of IN O
RA NNP O
. . O

At IN O
this DT O
concentration NN O
, , O
Ro NNP O
13 CD O
- : O
7410 CD O
potently RB O
inhibited VBN O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
- : O
stimulated VBD O
myeloid NN O
as RB O
well RB O
as IN O
SCF NNP B-Gene
+ NNP O
Epo NNP B-Gene
- : O
induced JJ O
erythroid JJ O
colony NN O
growth NN O
. . O

At IN O
the DT O
same JJ O
concentration NN O
, , O
Ro NNP O
25 CD O
- : O
6603 CD O
and CC O
Ro NNP O
25 CD O
- : O
7386 CD O
had VBD O
little JJ O
or CC O
no DT O
effect NN O
on IN O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
- : O
induced JJ O
colony NN O
formation NN O
, , O
whereas IN O
they PRP O
inhibited VBD O
75 CD O
% NN O
and CC O
53 CD O
% NN O
, , O
respectively RB O
, , O
of IN O
SCF NNP B-Gene
+ NNP O
Epo NNP B-Gene
- : O
stimulated VBD O
BFU NNP O
- : O
E NN O
colony NN O
growth NN O
. . O

Thus RB O
, , O
the DT O
RAR NNP B-Gene
- : I-Gene
RXR NNP I-Gene
response NN O
pathway NN O
can MD O
signal VB O
growth NN O
inhibition NN O
of IN O
normal JJ O
bone NN O
marrow NN O
myeloid NN O
and CC O
erythroid JJ O
progenitor NN O
cells NNS O
. . O

After IN O
treatment NN O
of IN O
APL NNP O
cells NNS O
with IN O
AM580 NNP O
either CC O
alone RB O
or CC O
in IN O
combination NN O
with IN O
granulocyte NN B-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
( ( O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
) ) O
, , O
the DT O
compound NN O
induces VBZ O
granulocytic JJ O
maturation NN O
, , O
as IN O
assessed VBN O
by IN O
determination NN O
of IN O
the DT O
levels NNS O
of IN O
leukocyte JJ B-Gene
alkaline NN I-Gene
phosphatase NN I-Gene
, , I-Gene
CD11b NNP I-Gene
, , I-Gene
CD33 NNP I-Gene
, , I-Gene
and CC I-Gene
G NNP I-Gene
- : I-Gene
CSF NNP I-Gene
receptor NN I-Gene
mRNA NN I-Gene
, , O
at IN O
concentrations NNS O
that WDT O
are VBP O
10 CD O
- : O
to TO O
100 CD O
- : O
fold NN O
lower JJR O
than IN O
those DT O
of IN O
ATRA NNP O
necessary JJ O
to TO O
produce VB O
similar JJ O
effects NNS O
. . O

By IN O
contrast NN O
, , O
AM580 NNP O
is VBZ O
not RB O
effective JJ O
as IN O
ATRA NNP O
in IN O
modulating VBG O
the DT O
expression NN O
of IN O
these DT O
differentiation NN B-Gene
markers NNS I-Gene
in IN O
the DT O
HL NNP O
- : O
60 CD O
cell NN O
line NN O
and CC O
in IN O
freshly RB O
isolated VBN O
granulocytes NNS O
obtained VBN O
from IN O
the DT O
peripheral JJ O
blood NN O
of IN O
chronic JJ O
myelogenous JJ O
leukemia NN O
patients NNS O
during IN O
the DT O
stable JJ O
phase NN O
of IN O
the DT O
disease NN O
. . O

In IN O
NB4 NNP O
cells NNS O
, , O
two CD O
other JJ O
synthetic JJ O
nonselective JJ O
RAR NNP O
ligands NNS O
are VBP O
capable JJ O
of IN O
inducing VBG O
LAP NNP B-Gene
as RB O
much RB O
as IN O
AM580 NNP O
, , O
whereas JJ O
RAR NNP O
beta NN O
- : O
or CC O
RAR NNP O
gamma SYM O
- : O
specific JJ O
ligands NNS O
are VBP O
totally RB O
ineffective JJ O
. . O

These DT O
results NNS O
show VBP O
that IN O
AM580 NNP O
is VBZ O
more RBR O
powerful JJ O
than IN O
ATRA NNP O
in IN O
modulating VBG O
the DT O
expression NN O
of IN O
differentiation NN O
antigens NNS O
only RB O
in IN O
cells NNS O
in IN O
which WDT O
PML NNP B-Gene
- : I-Gene
RAR NN I-Gene
is VBZ O
present JJ O
. . O

Binding VBG O
experiments NNS O
, , O
using VBG O
COS NNP O
- : O
7 CD O
cells NNS O
transiently RB O
transfected VBN O
with IN O
PML NNP B-Gene
- : I-Gene
RAR NN I-Gene
and CC O
the DT O
normal JJ O
RAR NNP B-Gene
alpha NN I-Gene
, , O
show VBP O
that IN O
AM580 NNP O
has VBZ O
a DT O
lower JJR O
affinity NN O
than IN O
ATRA NNP O
for IN O
both DT O
receptors NNS O
. . O

Inhibition NN O
of IN O
vitamin NN B-Gene
D NNP I-Gene
receptor NN I-Gene
- : I-Gene
retinoid NN I-Gene
X NNP I-Gene
receptor NN I-Gene
- : I-Gene
vitamin NN I-Gene
D NNP I-Gene
response NN I-Gene
element NN I-Gene
complex JJ I-Gene
formation NN O
by IN O
nuclear JJ O
extracts NNS O
of IN O
vitamin NN O
D NNP O
- : O
resistant JJ O
New NNP O
World NNP O
primate NN O
cells NNS O
. . O

Nuclear NN O
and CC O
post NN O
- : O
nuclear JJ O
extracts NNS O
were VBD O
prepared VBN O
from IN O
two CD O
B NNP O
- : O
lymphoblastoid NN O
cell NN O
lines NNS O
known VBN O
to TO O
be VB O
representative JJ O
of IN O
the DT O
vitamin NN O
D NNP O
- : O
resistant NN O
and CC O
wild JJ O
type NN O
phenotypes NNS O
, , O
respectively RB O
. . O

In IN O
addition NN O
, , O
vitamin NN O
D NNP O
- : O
resistant NN O
cell NN O
nuclear JJ O
extract NN O
contained VBD O
a DT O
protein NN O
( ( O
s NN O
) ) O
which WDT O
was VBD O
bound VBN O
specifically RB O
to TO O
the DT O
VDRE NNP B-Gene
and CC O
was VBD O
capable JJ O
of IN O
completely RB O
inhibiting VBG O
VDR NNP B-Gene
- : I-Gene
RXR NNP I-Gene
- : I-Gene
VDRE NNP I-Gene
complex JJ I-Gene
formation NN O
; : O
these DT O
effects NNS O
were VBD O
not RB O
demonstrated VBN O
with IN O
nuclear JJ O
extract NN O
from IN O
the DT O
wild JJ O
type NN O
cell NN O
line NN O
or CC O
with IN O
the DT O
post NN O
- : O
nuclear JJ O
extract NN O
of IN O
the DT O
vitamin NN O
D NNP O
- : O
resistant NN O
cell NN O
line NN O
. . O

We PRP O
conclude VBP O
that IN O
a DT O
VDRE NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
( ( O
s PRP O
) ) O
, , O
distinct JJ O
from IN O
IDBP NNP B-Gene
and CC O
present JJ O
in IN O
nuclear JJ O
extract NN O
of IN O
cells NNS O
from IN O
a DT O
prototypical JJ O
vitamin NN O
D NNP O
- : O
resistant NN O
NWP NNP O
, , O
is VBZ O
capable JJ O
of IN O
inhibiting VBG O
normal JJ O
VDR NNP B-Gene
- : I-Gene
RXR NNP I-Gene
heterodimer NN O
binding NN O
to TO O
the DT O
VDRE NNP B-Gene
. . O

Finally RB O
, , O
the DT O
activation NN O
- : O
induced JJ O
changes NNS O
in IN O
one CD O
set NN O
of IN O
phosphoproteins NNS B-Gene
were VBD O
dramatically RB O
inhibited VBN O
by IN O
cyclosporin NN O
A NNP O
. . O

Like IN O
IkappaBalpha NNP B-Gene
, , O
Tax NNP B-Gene
- : O
mediated VBD O
breakdown NN O
of IN O
IkappaBbeta NNP B-Gene
in IN O
transfected JJ O
T NNP O
lymphocytes VBZ O
is VBZ O
blocked VBN O
either RB O
by IN O
cell NN O
- : O
permeable JJ O
proteasome JJ O
inhibitors NNS O
or CC O
by IN O
mutation NN O
Of IN O
IkappaBbeta NNP B-Gene
at IN O
two CD O
serine NN O
residues NNS O
present JJ O
within IN O
its PRP$ O
N NNP B-Gene
- : I-Gene
terminal JJ I-Gene
region NN I-Gene
. . O

Although IN O
a DT O
role NN O
of IN O
p16 NN B-Gene
in IN O
this DT O
regulation NN O
has VBZ O
been VBN O
presumed VBN O
, , O
there EX O
is VBZ O
no DT O
proof NN O
so RB O
far RB O
that IN O
loss NN O
of IN O
this DT O
tumor NN B-Gene
suppressor NN I-Gene
gene NN I-Gene
really RB O
affects VBZ O
E2F NNP B-Gene
- : O
mediated VBD O
regulations NNS O
. . O

Nuclear JJ B-Gene
factors NNS I-Gene
from IN O
unstimulated JJ O
, , O
but CC O
not RB O
from IN O
activated VBN O
cells NNS O
, , O
bound IN O
a DT O
site NN O
, , O
META NNP B-Gene
( ( I-Gene
D NNP I-Gene
- : I-Gene
) ) I-Gene
, , O
adjacent JJ O
to TO O
META NNP B-Gene
( ( I-Gene
D NNP I-Gene
+ NNP I-Gene
) ) I-Gene
. . O

We PRP O
have VBP O
isolated VBN O
a DT O
novel JJ B-Gene
cDNA NN I-Gene
clone NN I-Gene
encoding VBG O
interferon NN B-Gene
( ( I-Gene
IFN NNP I-Gene
) ) I-Gene
consensus NN I-Gene
sequence NN I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
in IN O
adult NN O
T NNP O
- : O
cell NN O
leukemia NN O
cell NN O
line NN O
or CC O
activated VBN O
T NNP O
cells NNS O
( ( O
ICSAT NNP B-Gene
) ) O
; : O
this DT O
protein NN O
is VBZ O
the DT O
human JJ O
homolog NN O
of IN O
the DT O
recently RB O
cloned VBN O
Pip NNP B-Gene
/ NNP I-Gene
LSIRF NNP I-Gene
. . O

Here RB O
, , O
we PRP O
describe VBP O
the DT O
effect NN O
of IN O
383 CD B-Gene
- : I-Gene
bp NN I-Gene
( ( I-Gene
delta383 NN I-Gene
) ) I-Gene
and CC I-Gene
99 CD I-Gene
- : I-Gene
bp NN I-Gene
( ( I-Gene
delta99 NN I-Gene
) ) I-Gene
sequences VBZ I-Gene
containing VBG O
the DT O
PYBF NNP B-Gene
- : I-Gene
binding VBG I-Gene
site NN I-Gene
on IN O
transcription NN O
from IN O
various JJ O
globin NNS O
and CC O
non JJ O
- : O
globin NN O
promoters NNS O
, , O
using VBG O
a DT O
transient JJ O
assay NN O
with IN O
the DT O
cat NN B-Gene
reporter NN I-Gene
gene NN I-Gene
in IN O
murine JJ O
erythroleukemia NN O
( ( O
MEL NNP O
) ) O
cells NNS O
, , O
a DT O
cell NN O
line NN O
with IN O
abundant JJ O
PYBF NNP B-Gene
activity NN O
. . O

Translocation NN B-Gene
breakpoints NNS I-Gene
in IN O
three CD O
patients NNS O
with IN O
campomelic JJ O
dysplasia NN O
and CC O
autosomal JJ O
sex NN O
reversal NN O
map VBZ O
more JJR O
than IN O
130 CD O
kb NN O
from IN O
SOX9 NNP B-Gene
. . O

Campomelic JJ O
dysplasia NN O
( ( O
CMPD1 NNP O
) ) O
and CC O
autosomal JJ O
XY NNP O
sex NN O
reversal NN O
( ( O
SRA1 NNP O
) ) O
are VBP O
caused VBN O
by IN O
mutations NNS O
in IN O
the DT O
SRY NNP B-Gene
- : I-Gene
related JJ I-Gene
gene NN I-Gene
SOX9 NNP B-Gene
on IN O
17q CD B-Gene
. . O

Unexpectedly RB O
, , O
the DT O
17q CD B-Gene
breakpoints NNS I-Gene
in IN O
four CD O
CMPD1 NNP O
translocation NN O
cases NNS O
previously RB O
analyzed VBN O
by IN O
us PRP O
and CC O
others NNS O
map VBP O
50 CD O
kb NN O
or CC O
more JJR O
from IN O
SOX9 NNP B-Gene
. . O

DeltaSpi NNP B-Gene
- : I-Gene
B NNP I-Gene
product NN O
was VBD O
not RB O
able JJ O
to TO O
bind VB O
DNA NNP O
and CC O
was VBD O
recovered VBN O
in IN O
cytoplasmic JJ O
cellular JJ O
extracts NNS O
. . O

Both DT O
CIITA NNP B-Gene
and CC O
Bob1 NNP B-Gene
increase VB O
the DT O
expression NN O
from IN O
the DT O
DRA NNP B-Gene
promoter NN I-Gene
, , O
which WDT O
is VBZ O
a DT O
prototypic JJ O
class NN B-Gene
II NNP I-Gene
promoter NN I-Gene
. . O

However RB O
, , O
the DT O
growth NN O
of IN O
most JJS O
mutated JJ O
viruses NNS O
was VBD O
suppressed VBN O
in IN O
primary JJ O
rhesus NN O
monkey NN O
alveolar JJ O
macrophages NNS O
( ( O
SIVmacMER NNP O
approximately RB O
2xNFkappaB CD B-Gene
approximately RB O
substNFkappaB JJ B-Gene
> NNP O
deltaNFkappaB NN B-Gene
> NNP O
deltaNFkappaB NN B-Gene
deltaSpl234 NN B-Gene
approximately RB O
deltaNFkappaBdeltaSp JJ B-Gene
> NNP O
deltaSpl234 NN B-Gene
approximately RB O
substSpl2 JJ B-Gene
> NNP O
substSp23 NN B-Gene
approximately RB O
substSp34 JJ B-Gene
approximately RB O
substSpl234 JJ B-Gene
> NN O
or CC O
= VB O
SIVmac239 NNP O
) ) O
. . O

The DT O
ability NN O
of IN O
T NNP O
cells NNS O
to TO O
form VB O
high JJ O
intracellular JJ O
levels NNS O
of IN O
cAMP NN O
is VBZ O
acquired VBN O
during IN O
development NN O
in IN O
the DT O
human JJ O
thymus NN O
and CC O
is VBZ O
retained VBN O
by IN O
the DT O
majority NN O
of IN O
mature JJ O
peripheral JJ O
T NNP O
lymphocytes NNS O
. . O

A DT O
hydrophobic JJ O
domain NN O
of IN O
Ca2 NNP B-Gene
+ NNP I-Gene
- : I-Gene
modulating VBG I-Gene
cyclophilin NN I-Gene
ligand NN I-Gene
modulates VBZ O
calcium JJ O
influx NN O
signaling VBG O
in IN O
T NNP O
lymphocytes NNS O
. . O

Ca2 NNP B-Gene
+ NNP I-Gene
- : I-Gene
modulating VBG I-Gene
cyclophilin NN I-Gene
ligand NN I-Gene
( ( O
CAML NNP B-Gene
) ) O
was VBD O
originally RB O
described VBN O
as IN O
a DT O
cyclophilin NN B-Gene
B NNP I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
whose WP$ O
overexpression NN O
in IN O
T NNP O
cells NNS O
causes VBZ O
a DT O
rise NN O
in IN O
intracellular JJ O
calcium NN O
, , O
thus RB O
activating VBG O
transcription NN B-Gene
factors NNS I-Gene
responsible JJ O
for IN O
the DT O
early JJ O
immune NN O
response NN O
. . O

The DT O
Epstein NNP B-Gene
- : I-Gene
Barr NNP I-Gene
virus SYM I-Gene
- : I-Gene
encoded VBN I-Gene
nuclear JJ I-Gene
antigen NN I-Gene
EBNA NNP I-Gene
- : I-Gene
5 CD I-Gene
accumulates NNS O
in IN O
PML NNP O
- : O
containing VBG O
bodies NNS O
. . O

The DT O
chromosome NN B-Gene
17 CD I-Gene
breakpoint NN I-Gene
was VBD O
localized VBN O
to TO O
intron VB B-Gene
2 CD I-Gene
of IN O
RARA NNP B-Gene
by IN O
Southern NNP O
blotting NN O
, , O
and CC O
there EX O
was VBD O
no DT O
evidence NN O
at IN O
the DT O
molecular JJ O
level NN O
for IN O
rearrangement NN O
at IN O
PML NNP B-Gene
locus NN I-Gene
. . O

Immunocytochemistry NNP O
identified VBD O
the DT O
cells NNS O
in IN O
the DT O
infiltrate NN O
as IN O
cytotoxic NN O
T NNP O
cells NNS O
. . O

In IN O
these DT O
same JJ O
animals NNS O
, , O
E1A NNP B-Gene
protein NN I-Gene
was VBD O
detected VBN O
20 CD O
days NNS O
after IN O
infection NN O
in IN O
two CD O
and CC O
47 CD O
days NNS O
after IN O
infection NN O
in IN O
one CD O
while IN O
persistent JJ O
bronchiolitis NN O
was VBD O
observed VBN O
in IN O
four CD O
and CC O
three CD O
animals NNS O
20 CD O
and CC O
47 CD O
days NNS O
after IN O
infection NN O
, , O
respectively RB O
. . O

Cyclic NNP O
AMP NNP O
- : B-Gene
responsive JJ I-Gene
element NN I-Gene
- : O
dependent JJ O
activation NN O
of IN O
Epstein NNP O
- : O
Barr NNP O
virus NN O
zebra NN B-Gene
promoter NN I-Gene
by IN O
human JJ O
herpesvirus NN O
6 CD O
. . O

Mutation NN O
of IN O
the DT O
consensus NN B-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
/ JJ I-Gene
CRE NNP I-Gene
site NN I-Gene
within IN O
ZII NNP B-Gene
abolished VBD O
the DT O
inducibility NN O
of IN O
Zp NNP B-Gene
by IN O
HHV NNP O
- : O
6 CD O
, , O
whereas NNS O
positioning NN O
of IN O
the DT O
ZII NNP B-Gene
domain NN I-Gene
upstream NN O
of IN O
the DT O
beta NN B-Gene
- : I-Gene
globin NN I-Gene
minimal JJ I-Gene
promoter NN I-Gene
conferred VBD O
responsiveness NN O
following VBG O
HHV NNP O
- : O
6 CD O
infection NN O
. . O

Antibodies NNS O
against IN O
CRE NNP B-Gene
- : I-Gene
binding NN I-Gene
( ( I-Gene
CREB NNP I-Gene
) ) I-Gene
protein NN I-Gene
but CC O
not RB O
against IN O
c SYM B-Gene
- : I-Gene
Fos NN I-Gene
or CC O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
were VBD O
able JJ O
to TO O
supershift VB O
the DT O
DNA NNP B-Gene
- : I-Gene
protein NN I-Gene
complex JJ I-Gene
, , O
identifying VBG O
the DT O
nature NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
which WDT O
binds VBZ O
to TO O
ZII NNP B-Gene
as IN O
a DT O
member NN O
of IN O
the DT O
CREB NNP B-Gene
family NN I-Gene
of IN I-Gene
proteins NNS I-Gene
. . O

Regulation NN O
of IN O
the DT O
nuclear JJ B-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
cells NNS I-Gene
in IN O
stably RB O
transfected VBN O
Jurkat NNP O
cell NN O
clones NNS O
. . O

Glucocorticoids NNP O
induced VBD O
down RP O
- : O
regulation NN O
of IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
mRNA NN O
expression NN O
in IN O
asthma NN O
. . O

The DT O
lymphoid JJ B-Gene
- : I-Gene
specific JJ I-Gene
transcription NN I-Gene
factor NN I-Gene
Oct NNP B-Gene
- : I-Gene
2a CD I-Gene
is VBZ O
implicated VBN O
in IN O
B NNP O
cell NN O
- : O
specific JJ O
transcriptional JJ O
activity NN O
via IN O
the DT O
octamer NN O
motif NN O
. . O

Structure NN O
/ CD O
function NN O
analysis NN O
of IN O
various JJ O
Oct NNP B-Gene
- : I-Gene
2a CD I-Gene
effector NN I-Gene
regions NNS I-Gene
in IN O
the DT O
context NN O
of IN O
the DT O
GAL4 NNP B-Gene
DNA NNP I-Gene
- : I-Gene
binding NN I-Gene
domain NN I-Gene
revealed VBD O
that IN O
Oct NNP B-Gene
- : I-Gene
2a CD I-Gene
contains NNS O
two CD O
functionally RB O
different JJ O
activation NN B-Gene
domains NNS I-Gene
at IN O
the DT O
N NNP B-Gene
and CC I-Gene
the DT I-Gene
C NNP I-Gene
termini NN I-Gene
. . O

When WRB O
this DT O
domain NN O
was VBD O
transferred VBN O
to TO O
a DT O
potent JJ O
activator NN O
, , O
transcription NN O
was VBD O
strongly RB O
inhibited VBN O
. . O

In IN O
this DT O
study NN O
we PRP O
present VBP O
a DT O
deletion NN O
analysis NN O
of IN O
the DT O
N NNP B-Gene
- : I-Gene
terminal JJ I-Gene
region NN I-Gene
of IN O
Oct NNP B-Gene
- : I-Gene
2a CD I-Gene
to TO O
determine VB O
the DT O
minimal JJ B-Gene
repression NN I-Gene
domain NN I-Gene
. . O

The DT O
possibility NN O
that IN O
Oct NNP B-Gene
- : I-Gene
2a CD I-Gene
can MD O
act VB O
as IN O
an DT O
activator NN O
and CC O
/ NN O
or CC O
a DT O
repressor NN O
may MD O
have VB O
important JJ O
consequences NNS O
for IN O
the DT O
function NN O
of IN O
Oct NNP B-Gene
- : I-Gene
2a CD I-Gene
in IN O
B NNP O
cell NN O
differentiation NN O
and CC O
other JJ O
developmental JJ O
processes NNS O
. . O

Although IN O
there EX O
have VBP O
been VBN O
a DT O
number NN O
of IN O
reports NNS O
demonstrating VBG O
that IN O
glucocorticoids NNS O
( ( O
in IN O
particular JJ O
dexamethasone NN O
) ) O
antagonize VB O
the DT O
eosinophil JJ O
life NN O
- : O
prolonging VBG O
effects NNS O
of IN O
hemopoietins NNS B-Gene
, , O
direct JJ O
effects NNS O
of IN O
dexamethasone NN O
on IN O
eosinophil JJ O
apoptosis NN O
have VBP O
not RB O
been VBN O
documented VBN O
. . O

In IN O
contrast NN O
, , O
dexamethasone NN O
was VBD O
a DT O
potent JJ O
inhibitor NN O
of IN O
neutrophil JJ O
apoptosis NN O
. . O

For IN O
this DT O
purpose NN O
, , O
we PRP O
used VBD O
three CD O
main JJ O
approaches NNS O
. . O

The DT O
first JJ O
was VBD O
to TO O
abruptly RB O
terminate VB O
tumor NN O
necrosis NN O
factor NN O
- : O
induced JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
binding NN O
to TO O
the DT O
enhancer NN O
sequences NNS O
in IN O
U1 NNP O
monocytic JJ O
cells NNS O
, , O
using VBG O
a DT O
short JJ O
pulse NN O
of IN O
exogenous JJ B-Gene
tumor NN I-Gene
necrosis NN I-Gene
factor NN I-Gene
. . O

Together RB O
, , O
our PRP$ O
results NNS O
indicate VBP O
that IN O
occupancy NN O
of IN O
the DT O
viral JJ B-Gene
enhancer NN I-Gene
by IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
( ( I-Gene
p50 JJ I-Gene
/ NNP I-Gene
p65 NN I-Gene
) ) I-Gene
heterodimers NNS I-Gene
is VBZ O
required VBN O
for IN O
ongoing VBG O
transcription NN O
of IN O
integrated JJ O
HIV NNP O
provirus NN O
in IN O
monocytes NNS O
, , O
even RB O
in IN O
cells NNS O
chronically RB O
infected VBN O
and CC O
permanently RB O
producing VBG O
functional JJ O
HIV NNP B-Gene
Tat NNP I-Gene
protein NN I-Gene
. . O

In IN O
an DT O
attempt NN O
to TO O
identify VB O
changes NNS O
in IN O
gene NN O
expression NN O
that WDT O
accompany VBZ O
the DT O
T NNP O
- : O
cell NN O
stimulation NN O
defects NNS O
associated VBN O
with IN O
the DT O
loss NN O
of IN O
Rel NNP B-Gene
, , O
we PRP O
have VBP O
examined VBN O
the DT O
expression NN O
of IN O
cell NN B-Gene
surface NN I-Gene
activation NN I-Gene
markers NNS I-Gene
and CC O
cytokine JJ O
production NN O
in IN O
mitogen NN O
- : O
stimulated VBN O
Rel NNP O
- : O
/ SYM O
- : O
T NN O
cells NNS O
. . O

Exogenous JJ O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
which WDT O
restitutes VBZ O
the DT O
proliferative JJ O
response NN O
of IN O
the DT O
anti JJ O
- : O
CD3 NNP O
- : O
and CC O
anti VB O
- : O
CD28 NNP O
- : O
treated VBD O
Rel NNP O
- : O
/ SYM O
- : O
T NNP O
cells NNS O
, , O
restores VBZ O
production NN O
of IN O
IL NNP O
- : O
5 CD O
, , O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
, , O
and CC O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
, , O
but CC O
not RB O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
and CC O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
expression NN O
to TO O
approximately RB O
normal JJ O
levels NNS O
. . O

These DT O
findings NNS O
establish VB O
that IN O
Rel NNP B-Gene
can MD O
function VB O
as IN O
an DT O
activator NN O
or CC O
repressor NN O
of IN O
gene NN O
expression NN O
and CC O
is VBZ O
required VBN O
by IN O
T NNP O
lymphocytes NNS O
for IN O
production NN O
of IN O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
and CC O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
. . O

Nuclear JJ O
appearance NN O
of IN O
a DT O
factor NN O
that WDT O
binds VBZ O
the DT O
CD28 NNP B-Gene
response NN I-Gene
element NN I-Gene
within IN O
the DT O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
enhancer NN I-Gene
correlates NNS O
with IN O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
production NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
mitogenic JJ O
combinations NNS O
of IN O
T NNP O
cell NN O
activation NN O
signals NNS O
are VBP O
integrated VBN O
at IN O
the DT O
level NN O
of IN O
NF NNP B-Gene
- : I-Gene
MATp35 NNP I-Gene
induction NN O
. . O

Transcriptional JJ O
basis NN O
for IN O
hyporesponsiveness NN O
of IN O
the DT O
human JJ B-Gene
inducible JJ I-Gene
nitric JJ I-Gene
oxide IN I-Gene
synthase JJ I-Gene
gene NN I-Gene
to TO O
lipopolysaccharide VB O
/ NNP O
interferon NNP O
- : O
gamma NN O
. . O

Two CD O
explanations NNS O
for IN O
hyporesponsiveness NN O
of IN O
the DT O
human JJ B-Gene
iNOS NN I-Gene
promoter NN I-Gene
to TO O
LPS NNP O
+ NNP O
/ NNP O
- : O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
were VBD O
found VBN O
: : O
( ( O
1 CD O
) ) O
multiple NN O
inactivating VBG O
nucleotide JJ O
substitutions NNS O
in IN O
the DT O
human JJ O
counterpart NN O
of IN O
the DT O
enhancer NN B-Gene
element NN I-Gene
that WDT O
has VBZ O
been VBN O
shown VBN O
to TO O
regulate VB O
LPS NNP O
/ NNP O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
induced JJ O
expression NN O
of IN O
the DT O
mouse NN B-Gene
iNOS JJ I-Gene
gene NN I-Gene
; : O
and CC O
( ( O
2 CD O
) ) O
and CC O
absence NN O
of IN O
one CD O
or CC O
more JJR O
nuclear JJ B-Gene
factors NNS I-Gene
in IN O
human JJ O
macrophages NNS O
( ( O
e NN O
. . O
g NN O
. . O
, , O
an DT O
LPS NNP B-Gene
- : I-Gene
inducible JJ I-Gene
nuclear JJ I-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
/ NNP I-Gene
Rel NNP I-Gene
complex NN I-Gene
) ) O
, , O
that WDT O
is VBZ O
( ( O
are VBP O
) ) O
required VBN O
for IN O
maximal JJ O
expression NN O
of IN O
the DT O
gene NN O
. . O

Severe JJ O
skewing NN O
of IN O
X NNP O
inactivation NN O
resulting VBG O
in IN O
inactivity NN O
of IN O
the DT O
intact JJ O
X NNP B-Gene
was VBD O
found VBN O
in IN O
blood NN O
and CC O
cultures NNS O
of IN O
both DT O
types NNS O
of IN O
skin NN O
, , O
but CC O
analysis NN O
of IN O
DNA NN O
prepared VBN O
directly RB O
from IN O
hypopigmented VBN O
skin NN O
showed VBD O
significant JJ O
inactivation NN O
of IN O
the DT O
translocated JJ O
X NNP B-Gene
, , O
inconsistent NN O
with IN O
the DT O
usual JJ O
mechanism NN O
of IN O
phenotypic JJ O
expression NN O
in IN O
X NNP B-Gene
; : I-Gene
autosome JJ I-Gene
translocations NNS I-Gene
. . O

While IN O
partial JJ O
variable JJ O
monosomy NN O
of IN O
loci NN O
on IN O
chromosome NN B-Gene
17p CD I-Gene
can MD O
not RB O
be VB O
excluded VBN O
as IN O
contributing VBG O
to TO O
the DT O
phenotype NN O
in IN O
this DT O
patient NN O
, , O
it PRP O
is VBZ O
argued VBN O
that IN O
the DT O
major JJ O
likely JJ O
factor NN O
is VBZ O
partial JJ O
functional JJ O
disomy NN O
of IN O
sequences NNS O
on IN O
Xp NN B-Gene
in IN O
cell NN O
lineages NNS O
that WDT O
have VBP O
failed VBN O
to TO O
inactivate VB O
the DT O
intact JJ O
X NNP B-Gene
chromosome NN I-Gene
. . O

After IN O
several JJ O
round NN O
of IN O
subcloning VBG O
followed VBN O
by IN O
transfection NN O
, , O
oriP NN B-Gene
was VBD O
mapped VBN O
to TO O
a DT O
1 CD B-Gene
. . I-Gene
955 CD I-Gene
- : I-Gene
kb NN I-Gene
viral JJ I-Gene
segment NN I-Gene
. . O

Large JJ O
amounts NNS O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
significant JJ O
quantities NNS O
of IN O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
were VBD O
induced VBN O
in IN O
SEA NNP O
- : O
activated VBD O
CD4 NNP O
+ NNP O
spleen JJ O
T NNP O
cells NNS O
, , O
whereas NNS O
Oct NNP O
- : O
1 CD O
and CC O
Oct NNP O
- : O
2 CD O
DNA NNP O
binding NN O
activity NN O
was VBD O
similar JJ O
in IN O
both DT O
resting NN O
and CC O
activated VBD O
T NNP O
cells NNS O
. . O

Fas NNP B-Gene
ligation NN O
induces NNS O
apoptosis NN O
and CC O
Jun NNP B-Gene
kinase NNP I-Gene
activation NN O
independently RB O
of IN O
CD45 NNP B-Gene
and CC O
Lck NNP B-Gene
in IN O
human JJ O
T NNP O
cells NNS O
. . O

More RBR O
is VBZ O
known VBN O
regarding VBG O
signal JJ O
transduction NN O
events NNS O
that WDT O
occur VBP O
after IN O
ligation NN O
of IN O
the DT O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
antigen NN I-Gene
receptor NN I-Gene
( ( O
TCR NNP B-Gene
) ) O
. . O

Although IN O
prior JJ O
studies NNS O
suggest VBP O
a DT O
role NN O
for IN O
protein JJ B-Gene
tyrosine NN I-Gene
kinases NNS I-Gene
and CC O
phosphatases NNS O
in IN O
Fas NNP B-Gene
signaling NN O
, , O
we PRP O
report VBP O
here RB O
that IN O
Fas NNP O
ligation NN O
induces NNS O
apoptosis NN O
in IN O
T NNP O
cells NNS O
deficient NN O
in IN O
either CC O
CD45 NNP B-Gene
or CC O
Lck NNP B-Gene
. . O

Globin NNP O
gene NN O
switching NN O
. . O

In IN O
contrast NN O
, , O
in IN O
vivo JJ O
footprints NNS O
on IN O
GT NNP B-Gene
( ( I-Gene
CACCC NNP I-Gene
) ) I-Gene
motifs VBD I-Gene
differed VBN O
between IN O
the DT O
cells NNS O
expressing VBG O
the DT O
fetal NN O
or CC O
the DT O
adult JJ O
globin JJ O
program NN O
. . O

The DT O
active JJ O
vitamin NN O
D3 NNP O
metabolite RB O
1 CD O
, , O
25 CD O
- : O
dihydroxycholecalcif NN O
( ( O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
) ) O
acts NNS O
as IN O
an DT O
antiproliferative JJ O
and CC O
differentiating JJ O
agent NN O
for IN O
the DT O
monoblastoid NN O
cell NN O
line NN O
U937 NNP O
and CC O
as IN O
an DT O
important JJ O
immunologic NN O
mediator NN O
implicated VBD O
particularly RB O
in IN O
the DT O
function NN O
of IN O
cells NNS O
belonging VBG O
to TO O
the DT O
monocyte NN O
/ NNP O
macrophage NN O
lineage NN O
. . O

Cell NNP O
cycle NN O
analysis NN O
showed VBD O
shifts NNS O
in IN O
the DT O
distribution NN O
of IN O
cells NNS O
from IN O
G1 NNP O
to TO O
S NNP O
phase NN O
, , O
which WDT O
were VBD O
more RBR O
pronounced JJ O
after IN O
cadmium NN O
treatment NN O
. . O

These DT O
data NNS O
indicate VBP O
that IN O
, , O
in IN O
contrast NN O
to TO O
most RBS O
LPS NNP O
effects NNS O
, , O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
but CC O
not RB O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
, , O
mediates VBZ O
LPS NNP O
induction NN O
of IN O
collagenase NN B-Gene
transcription NN O
in IN O
macrophagelike NN O
cells NNS O
. . O

Activation NN O
of IN O
macrophages NNS O
by IN O
bacterial JJ O
lipopolysaccharide NN O
( ( O
LPS NNP O
) ) O
induces VBZ O
transcription NN O
of IN O
genes NNS O
that WDT O
encode VBP O
for IN O
proinflammatory JJ B-Gene
regulators NNS I-Gene
of IN O
the DT O
immune JJ O
response NN O
. . O

LPS NNP O
treatment NN O
of IN O
RAW NNP O
264 CD O
. . O
7 CD O
cells NNS O
, , O
murine VBP O
bone NN O
marrow NN O
- : O
derived VBN O
macrophages NNS O
, , O
and CC O
the DT O
human JJ O
monocyte NN O
cell NN O
line NN O
THP NNP O
- : O
1 CD O
resulted VBD O
in IN O
rapid JJ O
activation NN O
of IN O
the DT O
p46 NN B-Gene
and CC I-Gene
p54 NN I-Gene
isoforms NNS I-Gene
of IN O
JNK NNP B-Gene
. . O

These DT O
results NNS O
suggest VBP O
that IN O
LPS NNP O
activation NN O
of IN O
JNK NNP B-Gene
in IN O
monocyte NN O
/ NN O
macrophage NN O
cells NNS O
is VBZ O
a DT O
CD14 NNP O
- : O
and CC O
protein VB O
tyrosine JJ O
phosphorylation NN O
- : O
dependent JJ O
event NN O
that WDT O
may MD O
mediate VB O
the DT O
early JJ O
activation NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
regulating VBG O
LPS NNP O
- : O
triggered VBD O
gene NN O
induction NN O
. . O

A DT O
cell NN B-Gene
type NN I-Gene
- : I-Gene
specific JJ I-Gene
enhancer NN I-Gene
in IN O
the DT O
human JJ B-Gene
B7 NNP I-Gene
. . I-Gene
1 CD I-Gene
gene NN I-Gene
regulated VBN O
by IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
. . O

This DT O
183 CD B-Gene
- : I-Gene
bp NN I-Gene
region NN I-Gene
was VBD O
both DT O
cell NN O
type NN O
specific NN O
and CC O
responsive JJ O
to TO O
two CD O
distinct JJ O
stimuli NNS O
, , O
lipopolysaccharide NN O
and CC O
dibutyryl NN O
cAMP NN O
, , O
known VBN O
to TO O
regulate VB O
B7 NNP B-Gene
. . I-Gene
1 CD I-Gene
expression NN O
. . O

Deletional NNP O
and CC O
site NN O
- : O
directed VBN O
mutagenesis NN O
revealed VBD O
the DT O
presence NN O
of IN O
multiple JJ O
functionally RB O
critical JJ O
cis NN B-Gene
elements NNS I-Gene
within IN O
this DT O
region NN O
, , O
one CD O
of IN O
which WDT O
was VBD O
a DT O
nuclear JJ B-Gene
factor NN I-Gene
( ( I-Gene
NF NNP I-Gene
) ) I-Gene
- : I-Gene
kappaB NN I-Gene
consensus NN I-Gene
sequence NN I-Gene
. . O

This DT O
is VBZ O
the DT O
first JJ O
description NN O
, , O
to TO O
our PRP$ O
knowledge NN O
, , O
of IN O
regulatory JJ B-Gene
elements NNS I-Gene
that WDT O
control VBP O
expression NN O
of IN O
a DT O
gene NN O
encoding VBG O
a DT O
B7 NNP B-Gene
costimulatory NN I-Gene
molecule NN I-Gene
. . O

Recombinant NNP O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
and CC O
c SYM B-Gene
- : I-Gene
Fos NN I-Gene
were VBD O
ubiquitinylated VBN O
by IN O
the DT O
ubiquitin NN B-Gene
carrier NN I-Gene
enzymes NNS I-Gene
E214K NNP B-Gene
, , O
E220K NNP B-Gene
, , O
or CC O
E232K NNP B-Gene
in IN O
the DT O
presence NN O
of IN O
the DT O
ubiquitin JJ B-Gene
- : I-Gene
activating VBG I-Gene
enzyme NN I-Gene
, , O
E1 NNP B-Gene
. . O

We PRP O
have VBP O
also RB O
characterized VBN O
the DT O
genomic JJ B-Gene
mBob1 NN I-Gene
clone NN I-Gene
. . O

Analysis NN O
of IN O
its PRP$ O
intron NN O
- : O
exon NN O
structure NN O
has VBZ O
allowed VBN O
identification NN O
of IN O
a DT O
C NNP B-Gene
- : I-Gene
terminal JJ I-Gene
splice NN I-Gene
variant NN I-Gene
. . O

mBob1 NN B-Gene
interacts NNS O
with IN O
the DT O
octamer JJ B-Gene
transcription NN I-Gene
factors NNS I-Gene
Oct NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
Oct NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
stimulates NNS O
transcription NN O
mediated VBN O
by IN O
these DT O
factors NNS O
. . O

It PRP O
is VBZ O
well RB O
established VBN O
that IN O
the DT O
two CD O
major JJ O
glial JJ O
cells NNS O
in IN O
the DT O
central JJ O
nervous JJ O
system NN O
( ( O
CNS NNP O
) ) O
, , O
astrocytes NNS O
and CC O
microglia NNS O
, , O
are VBP O
key JJ O
participants NNS O
in IN O
mediating VBG O
the DT O
neurologic JJ O
dysfunction NN O
associated VBN O
with IN O
HIV NNP O
infection NN O
of IN O
the DT O
CNS NNP O
. . O

Moreover RB O
, , O
gp120 JJ B-Gene
induces NNS O
tyrosine JJ O
phosphorylation NN O
of IN O
signal JJ B-Gene
transducer NN I-Gene
and CC I-Gene
activator NN I-Gene
of IN I-Gene
transcription NN I-Gene
( ( O
STAT NNP B-Gene
- : I-Gene
1 CD I-Gene
alpha NN I-Gene
) ) O
as RB O
well RB O
as IN O
the DT O
Janus NNP B-Gene
kinase NN I-Gene
( ( O
JAK2 NNP B-Gene
) ) O
in IN O
glial JJ O
cells NNS O
. . O

Northern NNP O
blot NN O
analysis NN O
as RB O
well RB O
as IN O
Ab NNP O
blocking VBG O
and CC O
cytokine JJ B-Gene
secretion NN O
studies NNS O
indicated VBD O
that IN O
the DT O
induction NN O
of IN O
either DT O
endogenous JJ B-Gene
TNF NNP I-Gene
- : I-Gene
alpha NN I-Gene
or CC O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
was VBD O
not RB O
involved VBN O
in IN O
the DT O
cooperativity NN O
, , O
nor CC O
was VBD O
an DT O
up RP O
- : O
regulation NN O
of IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
receptors NNS I-Gene
. . O

Interaction NN O
of IN O
HTLV NNP B-Gene
- : I-Gene
I PRP I-Gene
Tax VBP I-Gene
with IN O
the DT O
human JJ B-Gene
proteasome NN I-Gene
: : O
implications NNS O
for IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
induction NN O
. . O

We PRP O
identified VBD O
a DT O
physical JJ O
interaction NN O
between IN O
Tax NNP B-Gene
and CC O
the DT O
HsN3 NNP B-Gene
subunit NN I-Gene
of IN O
the DT O
human JJ B-Gene
proteasome NN I-Gene
. . O

This DT O
raises VBZ O
the DT O
intriguing JJ O
possibility NN O
that IN O
physical JJ O
association NN O
of IN O
the DT O
HsN3 NNP B-Gene
proteasome NN I-Gene
subunit NN I-Gene
with IN O
HTLV NNP B-Gene
- : I-Gene
I PRP I-Gene
Tax VBP I-Gene
coupled VBN O
with IN O
the DT O
independent JJ O
interaction NN O
of IN O
Tax NNP B-Gene
with IN O
either DT O
p100 NN O
or CC O
p65 VB O
- : O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
targets NNS O
these DT O
cytoplasmic VBP B-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
/ NNP I-Gene
Rel NNP I-Gene
complexes NNS I-Gene
to TO O
the DT O
proteasome NN B-Gene
for IN O
processing NN O
. . O

Basement NNP O
membrane NN O
immunoreactivity NN O
for IN O
type NN B-Gene
IV NNP I-Gene
collagen NN I-Gene
and CC O
laminin NN B-Gene
was VBD O
discontinuous JJ O
in IN O
most JJS O
examples NNS O
of IN O
IDC NNP O
regardless NN O
of IN O
type NN O
, , O
with IN O
a DT O
trend NN O
toward IN O
more JJR O
intense JJ O
staining NN O
in IN O
comedo NN O
than IN O
in IN O
noncomedo JJ O
carcinomas NN O
. . O

Periductal JJ O
angiogenesis NN O
was VBD O
not RB O
significantly RB O
related VBN O
to TO O
the DT O
type NN O
of IN O
IDC NNP O
but CC O
was VBD O
more RBR O
pronounced JJ O
with IN O
comedo JJ O
carcinomas NN O
. . O

They PRP O
correlated VBD O
with IN O
markers NNS O
of IN O
tumor NN O
aggressivity NN O
( ( O
axillary JJ O
node NN O
involvement NN O
and CC O
especially RB O
with IN O
markers NNS O
of IN O
high JJ O
mitotic JJ O
rate NN O
as IN O
Ki NNP O
- : O
67 CD O
staining NN O
, , O
histological JJ O
grade NN O
) ) O
. . O

OBJECTIVE NN O
: : O
We PRP O
sought VBD O
to TO O
investigate VB O
the DT O
molecular JJ O
mechanisms NN O
regulating VBG O
this DT O
early JJ O
inflammatory NN O
response NN O
. . O

We PRP O
have VBP O
focused VBN O
on IN O
the DT O
study NN O
of IN O
the DT O
signal JJ O
transduction NN O
pathways NNS O
triggered VBN O
by IN O
CD23 NNP B-Gene
in IN O
human JJ O
monocytes NNS O
and CC O
the DT O
promonocytic JJ O
cell NN O
line NN O
U937 NNP O
. . O

IkappaBalpha NNP B-Gene
phosphorylation NN O
and CC O
degradation NN O
was VBD O
analyzed VBN O
by IN O
Western JJ O
blot NN O
. . O

Paclitaxel NNP O
and CC O
other JJ O
drugs NNS O
that IN O
disturb NN O
microtubule NN B-Gene
dynamics NNS O
kill VBP O
cells NNS O
in IN O
a DT O
Fas NNP B-Gene
/ NNP B-Gene
Fas NNP I-Gene
ligand NN I-Gene
( ( O
FasL NNP B-Gene
) ) O
- : O
dependent JJ O
manner NN O
; : O
antibody NN O
to TO O
FasL NNP B-Gene
inhibits NNS O
paclitaxel VBP O
- : O
induced JJ O
apoptosis NN O
. . O

Without IN O
NFAT NNP B-Gene
nuclear JJ O
translocation NN O
, , O
the DT O
FasL NNP B-Gene
gene NN O
is VBZ O
not RB O
transcribed VBN O
. . O

The DT O
effects NNS O
of IN O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
can MD O
be VB O
overcome VBN O
, , O
at IN O
least JJS O
partially RB O
, , O
through IN O
phosphorylation NN O
of IN O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

MHC NNP O
- : O
peptide NN O
ligand NN O
interactions NNS O
establish VB O
a DT O
functional JJ O
threshold NN O
for IN O
antigen NN O
- : O
specific JJ O
T NNP O
cell NN O
recognition NN O
. . O

Regulatory JJ O
effects NNS O
of IN O
interleukin JJ B-Gene
- : I-Gene
11 CD I-Gene
during IN O
acute JJ O
lung NN O
inflammatory JJ O
injury NN O
. . O

IL NNP B-Gene
- : I-Gene
11 CD I-Gene
mRNA NN I-Gene
and CC O
protein NN O
were VBD O
both DT O
up RP O
- : O
regulated VBN O
during IN O
the DT O
course NN O
of IN O
this DT O
inflammatory JJ O
response NN O
. . O

Recently RB O
, , O
we PRP O
and CC O
others NNS O
have VBP O
shown VBN O
that IN O
thrombopoietin NN B-Gene
induces NNS O
rapid JJ O
tyrosine JJ O
phosphorylation NN O
of IN O
Jak2 NNP B-Gene
and CC O
other JJ O
proteins NNS O
in IN O
human JJ O
platelets NNS O
and CC O
BaF3 NNP O
cells NNS O
, , O
genetically RB O
engineered VBN O
to TO O
express VB O
c SYM B-Gene
- : I-Gene
Mpl NNP I-Gene
, , O
a DT O
receptor NN O
for IN O
thrombopoietin NN B-Gene
. . O

Thus RB O
, , O
our PRP$ O
data NNS O
indicate VBP O
that IN O
Stat3 NNP B-Gene
and CC O
Stat5 NNP B-Gene
may MD O
be VB O
involved VBN O
in IN O
signal JJ O
transduction NN O
after IN O
ligand NN O
binding NN O
to TO O
c VB B-Gene
- : I-Gene
Mpl NNP I-Gene
and CC O
that IN O
this DT O
event NN O
may MD O
have VB O
a DT O
role NN O
in IN O
megakaryopoiesis NN O
/ JJ O
thrombopoiesis NN O
or CC O
possibly RB O
a DT O
mature NN O
platelet NN O
function NN O
such JJ O
as IN O
aggregation NN O
. . O

Damage NN O
to TO O
the DT O
genes NNS O
encoding VBG O
proteins NNS O
that WDT O
function VBP O
in IN O
intracellular JJ O
signaling NN O
, , O
transcription NN O
, , O
or CC O
regulation NN O
of IN O
the DT O
cell NN O
cycle NN O
has VBZ O
been VBN O
identified VBN O
and CC O
linked VBN O
at IN O
varying VBG O
degrees NNS O
to TO O
the DT O
progression NN O
of IN O
certain JJ O
lymphoid JJ O
malignancies NNS O
. . O

One CD O
such JJ O
example NN O
is VBZ O
the DT O
excessive JJ O
expression NN O
of IN O
` `` B-Gene
` `` I-Gene
normal JJ I-Gene
' '' I-Gene
' POS I-Gene
lymphokines NNS I-Gene
of IN O
cytokines NNS B-Gene
which WDT O
accompanies VBP O
many JJ O
lymphoproliferative JJ O
diseases NNS O
. . O

The DT O
dysregulated JJ O
expression NN O
of IN O
cytokines NNS B-Gene
during IN O
malignancy NN O
can MD O
result VB O
in IN O
the DT O
augmentation NN O
of IN O
growth NN O
of IN O
transformed JJ O
lymphocytes NNS O
, , O
as RB O
well RB O
as IN O
an DT O
alteration NN O
of IN O
the DT O
anti JJ O
- : O
tumor NN O
immune JJ O
response NN O
. . O

In IN O
addition NN O
to TO O
its PRP$ O
role NN O
as IN O
a DT O
precursor NN O
for IN O
other JJ O
steroid JJ O
hormones NNS O
, , O
DHEA NNP O
has VBZ O
been VBN O
proposed VBN O
to TO O
play VB O
an DT O
important JJ O
role NN O
in IN O
immunity NN O
. . O

Monocytes NNS O
stimulated VBD O
with IN O
LPS NNP O
concentrations NNS O
of IN O
1 CD O
. . O
0 CD O
micrograms NNS O
/ VBP O
ml RB O
displayed VBN O
the DT O
above JJ O
cytotoxic NN O
markers NNS O
, , O
whereas NNS O
monocytes NNS O
stimulated VBD O
with IN O
DHEA NNP O
alone RB O
or CC O
with IN O
LPS NNP O
at IN O
a DT O
lower JJR O
concentration NN O
of IN O
0 CD O
. . O
2 CD O
ng JJ O
/ NNP O
ml NN O
did VBD O
not RB O
. . O

Finally RB O
, , O
Scatchard NNP O
plot NN O
analysis NN O
demonstrated VBD O
the DT O
presence NN O
of IN O
a DT O
DHEA NNP O
receptor NN O
in IN O
monocytes NNS O
, , O
suggesting VBG O
that IN O
DHEA NNP O
effects NNS O
on IN O
LPS NNP O
- : O
stimulated VBN O
monocytes NNS O
are VBP O
mediated VBN O
through IN O
a DT O
receptor NN O
- : O
dependent JJ O
process NN O
. . O

IL NNP B-Gene
- : I-Gene
4 CD I-Gene
activates NNS O
gene NN O
expression NN O
by IN O
inducing VBG O
tyrosine JJ O
phosphorylation NN O
, , O
homodimerization NN O
, , O
and CC O
nuclear JJ O
translocation NN O
of IN O
the DT O
latent JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
, , O
STAT6 NNP B-Gene
( ( O
signal JJ B-Gene
transducer NN I-Gene
and CC I-Gene
activator NN I-Gene
of IN I-Gene
transcription NN I-Gene
- : I-Gene
6 CD I-Gene
) ) O
. . O

Because IN O
STAT6 NNP B-Gene
activation NN O
is VBZ O
essential JJ O
for IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
- : O
induced VBN O
gene NN O
expression NN O
, , O
we PRP O
examined VBD O
the DT O
ability NN O
of IN O
type NN O
I PRP O
and CC O
type VB O
II NNP O
IFNs NNP B-Gene
to TO O
regulate VB O
activation NN O
of IN O
STAT6 NNP B-Gene
by IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
in IN O
primary JJ O
human JJ O
monocytes NNS O
. . O

The DT O
shift NN O
from IN O
complex JJ B-Gene
I PRP I-Gene
to TO O
complex VB B-Gene
II NNP I-Gene
seen VBN O
only RB O
in IN O
SCM NNP O
- : O
1 CD O
- : O
producer NN O
T NNP O
cell NN O
lines NNS O
upon IN O
activation NN O
was VBD O
completely RB O
suppressed VBN O
by IN O
cyclosporin NN O
A NNP O
. . O

One CD O
- : O
hybrid NN O
assays NNS O
in IN O
yeast NN B-Gene
isolated JJ I-Gene
NF NNP I-Gene
- : I-Gene
ATp NNP I-Gene
as IN O
an DT O
E1 NNP B-Gene
binding NN I-Gene
protein NN I-Gene
, , O
and CC O
transfection NN O
of IN O
NF NNP B-Gene
- : I-Gene
ATp NNP I-Gene
into IN O
T NNP O
and CC O
B NNP O
cell NN O
lines NNS O
strongly RB O
enhanced VBD O
the DT O
activation NN B-Gene
- : I-Gene
dependent NN I-Gene
SCM NNP I-Gene
- : I-Gene
1 CD I-Gene
promoter NN O
activity NN O
. . O

Recent JJ O
studies NNS O
have VBP O
reported VBN O
that IN O
lymphocytes VBZ O
produce VBP O
, , O
transport NN O
and CC O
bind VB O
dopamine JJ O
present NN O
in IN O
plasma NN O
. . O

The DT O
importance NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
sites NNS I-Gene
was VBD O
confirmed VBN O
by IN O
using VBG O
vectors NNS O
containing VBG O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
or CC I-Gene
mutant JJ I-Gene
kappaB NN I-Gene
sites NNS I-Gene
in IN O
a DT O
heterologous JJ B-Gene
promoter NN I-Gene
. . O

Consistent JJ O
with IN O
the DT O
role NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
mediating VBG O
dopamine NN O
responsiveness NN O
, , O
the DT O
proteasome NN O
inhibitor NN O
MG132 NNP O
abolished VBD O
dopamine JJ O
- : O
induced JJ O
transcriptional JJ O
activation NN O
. . O

A DT O
significant JJ O
correlation NN O
between IN O
high JJ O
lymphocytic JJ O
infiltration NN O
( ( O
2 CD O
. . O
5 CD O
points NNS O
) ) O
, , O
low JJ O
body NN O
mass NN O
and CC O
fat NN O
was VBD O
identified VBN O
. . O

Moderate NNP O
body NN O
mass NN O
, , O
relatively RB O
low JJ O
fat JJ O
level NN O
and CC O
positive JJ O
receptor NN O
status NN O
are VBP O
among IN O
factors NNS O
of IN O
good JJ O
prognosis NN O
in IN O
breast NN O
cancer NN O
of IN O
early JJ O
stages NNS O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
analyzed VBD O
the DT O
binding NN O
activity NN O
of IN O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
- : I-Gene
and CC I-Gene
IFN NNP I-Gene
- : I-Gene
gamma NN I-Gene
- : I-Gene
activated VBN I-Gene
STAT NNP I-Gene
molecules NNS I-Gene
to TO O
two CD O
kinds NNS O
of IN O
GAS NNP B-Gene
- : O
motif NN O
sequences NNS O
. . O

This DT O
may MD O
explain VB O
the DT O
difference NN O
between IN O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
and CC O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
in IN O
biological JJ O
activity NN O
, , O
and CC O
the DT O
inhibitory JJ O
effect NN O
of IN O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
on IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
activities NNS O
. . O

Peptides NNS O
derived VBN O
from IN O
the DT O
HSV NNP B-Gene
- : I-Gene
2 CD I-Gene
VP16 NNP I-Gene
protein NN I-Gene
were VBD O
utilized VBN O
for IN O
studies NNS O
of IN O
peptide NN O
binding NN O
to TO O
DQ0302 NNP O
molecules NNS O
and CC O
T NNP O
cell NN O
activation NN O
at IN O
both DT O
neutral JJ O
and CC O
acidic JJ O
pH NN O
. . O

The DT O
short JJ O
truncated VBD O
analog RB O
433 CD O
- : O
442A CD O
binds NNS O
very RB O
poorly RB O
at IN O
both DT O
acidic JJ O
and CC O
neutral JJ O
pH NN O
. . O

Much JJ O
higher JJR O
concentrations NNS O
of IN O
wild JJ O
type NN O
peptides NNS O
were VBD O
needed VBN O
to TO O
activate VB O
T NNP O
cells NNS O
at IN O
neutral JJ O
pH NN O
. . O

To TO O
investigate VB O
a DT O
potential JJ O
role NN O
of IN O
E2F NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
differentiation NN O
, , O
we PRP O
assayed VBD O
the DT O
ability NN O
of IN O
megakaryocytes NNS O
to TO O
form VB O
platelets NNS O
in IN O
an DT O
in IN O
vivo NN O
transgenic JJ O
model NN O
. . O

Administration NN O
of IN O
megakaryocyte JJ B-Gene
growth NN I-Gene
and CC I-Gene
development NN I-Gene
factor NN I-Gene
or CC O
interleukin JJ B-Gene
6 CD I-Gene
could MD O
not RB O
overcome VB O
the DT O
differentiation NN O
block NN O
. . O

A DT O
recent JJ O
sib NN O
- : O
pair NN O
analysis NN O
revealed VBD O
a DT O
tight JJ O
linkage NN O
between IN O
markers NNS O
on IN O
5q31 CD B-Gene
. . I-Gene
1 CD I-Gene
and CC O
a DT O
major JJ B-Gene
susceptibility NN I-Gene
gene NN I-Gene
controlling VBG O
total JJ O
serum NN O
IgE NNP B-Gene
levels NNS O
. . O

Evidence NN O
for IN O
lowered JJ O
induction NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
activated JJ O
human JJ O
T NNP O
lymphocytes VBZ O
during IN O
aging VBG O
. . O

Inhibition NN O
of IN O
lipopolysaccharide JJ O
- : O
induced JJ O
monocyte NN B-Gene
interleukin SYM I-Gene
- : I-Gene
1 CD I-Gene
receptor NN I-Gene
antagonist JJ O
synthesis NN O
by IN O
cortisol NN O
: : O
involvement NN O
of IN O
the DT O
mineralocorticoid JJ B-Gene
receptor NN I-Gene
. . O

The DT O
mineralocorticoid NN O
aldosterone NN O
exerted VBD O
a DT O
significant JJ O
decrease NN O
in IN O
LPS NNP O
- : O
induced VBD O
monocyte JJ O
IL NNP B-Gene
- : I-Gene
1ra CD I-Gene
secretion NN O
in IN O
vitro NN O
, , O
which WDT O
was VBD O
blocked VBN O
by IN O
coincubation NN O
with IN O
spironolactone NN O
. . O

Moreover RB O
, , O
we PRP O
provide VBP O
evidence NN O
that IN O
, , O
in IN O
addition NN O
to TO O
a DT O
glucocorticoid NN B-Gene
receptor NN I-Gene
- : O
mediated JJ O
effect NN O
, , O
the DT O
mineralocorticoid NN B-Gene
receptor NN I-Gene
is VBZ O
involved VBN O
in IN O
the DT O
inhibition NN O
of IN O
monocyte NN O
IL NNP B-Gene
- : I-Gene
1ra CD I-Gene
secretion NN O
by IN O
cortisol NN O
. . O

Cell NNP O
- : O
mediated VBN O
immunity NN O
plays VBZ O
an DT O
essential JJ O
role NN O
in IN O
the DT O
control NN O
of IN O
infection NN O
with IN O
the DT O
human JJ O
cytomegalovirus NN O
( ( O
HCMV NNP O
) ) O
. . O

Here RB O
, , O
we PRP O
have VBP O
readdressed VBN O
the DT O
issue NN O
of IN O
CD8 NNP O
( ( O
+ NNP O
) ) O
T NNP O
cells NNS O
specific JJ O
for IN O
the DT O
72 CD B-Gene
- : I-Gene
kDa NN I-Gene
major JJ I-Gene
immediate JJ I-Gene
- : I-Gene
early JJ I-Gene
protein NN I-Gene
( ( O
IE NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
, , O
which WDT O
is VBZ O
nonstructural JJ O
but CC O
is VBZ O
found VBN O
very RB O
early RB O
and CC O
throughout IN O
the DT O
replicative JJ O
cycle NN O
. . O

In IN O
summary JJ O
, , O
our PRP$ O
results NNS O
suggest VBP O
that IN O
IE NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
far RB O
more RBR O
important JJ O
as IN O
a DT O
CD8 NNP O
( ( O
+ NNP O
) ) O
- : O
T SYM O
- : O
cell NN O
target NN O
than IN O
current JJ O
opinion NN O
suggests NNS O
. . O

E1A NNP B-Gene
oncogene JJ I-Gene
induction NN O
of IN O
cellular JJ O
susceptibility NN O
to TO O
killing VB O
by IN O
cytolytic JJ O
lymphocytes NNS O
through IN O
target NN O
cell NN O
sensitization NN O
to TO O
apoptotic JJ O
injury NN O
. . O

Since IN O
CLs NNP O
can MD O
induce VB O
either CC O
apoptotic JJ O
or CC O
necrotic JJ O
cell NN O
death NN O
, , O
we PRP O
asked VBD O
whether IN O
E1A NNP B-Gene
sensitization NN O
to TO O
injury VB O
- : O
induced JJ O
apoptosis NN O
is VBZ O
sufficient JJ O
to TO O
explain VB O
E1A NNP B-Gene
- : O
induced VBD O
cytolytic JJ O
susceptibility NN O
. . O

Copyright JJ O
1999 CD O
Academic NNP O
Press NNP O
. . O

TCL1 NNP B-Gene
oncogene MD I-Gene
expression VB O
in IN O
AIDS NNP O
- : O
related VBN O
lymphomas NN O
and CC O
lymphoid JJ O
tissues NNS O
. . O

We PRP O
find VBP O
that DT O
TCL1 NNP B-Gene
is VBZ O
expressed VBN O
in IN O
the DT O
majority NN O
of IN O
AIDS NNP O
IBLP NNP O
tumors NNS O
examined VBD O
. . O

They PRP O
also RB O
indicate VBP O
that IN O
abundant JJ O
TCL1 NNP B-Gene
expression NN O
in IN O
quiescent JJ O
mantle NN O
zone NN O
B NNP O
cells NNS O
is VBZ O
down RB O
- : O
regulated VBN O
in IN O
activated JJ O
germinal JJ O
center NN O
follicular NN O
B NNP O
cells NNS O
in IN O
parallel NN O
to TO O
the DT O
known VBN O
expression NN O
pattern NN O
of IN O
BCL NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

High JJ O
- : O
level NN O
expression NN O
in IN O
nonproliferating VBG O
B NNP O
cells NNS O
suggests VBZ O
that IN O
TCL1 NNP B-Gene
may MD O
function VB O
in IN O
protecting VBG O
naive JJ O
preactivated VBN O
B NNP O
cells NNS O
from IN O
apoptosis NN O
. . O

Here RB O
, , O
we PRP O
report VBP O
a DT O
model NN O
of IN O
CD28 NNP B-Gene
costimulation NN O
using VBG O
PMA NNP O
plus CC O
the DT O
natural JJ B-Gene
ligand NN I-Gene
CD80 NNP I-Gene
that WDT O
resulted VBD O
in IN O
very RB O
limited JJ O
stimulation NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
as IN O
evidenced VBN O
by IN O
both DT O
cytokine JJ B-Gene
production NN O
and CC O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
stimulation NN O
. . O

We PRP O
have VBP O
determined VBN O
that IN O
the DT O
JAK NNP B-Gene
/ NNP B-Gene
STAT NNP I-Gene
pathway RB O
positively RB O
regulates VBZ O
Qp NNP B-Gene
activity NN O
. . O

In IN O
transient JJ O
- : O
transfection NN O
assays NNS O
, , O
a DT O
Qp NNP B-Gene
- : I-Gene
CAT NNP I-Gene
reporter NN I-Gene
was VBD O
activated VBN O
by IN O
cotransfected JJ O
JAK NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
by IN O
treatment NN O
of IN O
cells NNS O
with IN O
the DT O
cytokine NN B-Gene
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
. . O

Consistent JJ O
with IN O
a DT O
role NN O
for IN O
STATs NNP B-Gene
in IN O
Qp NNP B-Gene
function NN O
, , O
Qp NNP B-Gene
using VBG O
Burkitt NNP O
' POS O
s NN O
lymphoma NN O
Rael NNP O
cells NNS O
and CC O
cultured VBD O
nasopharyngeal JJ O
carcinoma NN O
( ( O
NPC NNP O
) ) O
cells NNS O
contained VBN O
nuclear JJ O
STAT NNP B-Gene
protein NN I-Gene
. . O

This DT O
negative JJ O
regulation NN O
required VBN O
Zta NNP B-Gene
DNA NNP O
- : O
binding NN O
activity NN O
. . O

We PRP O
provide VBP O
evidence NN O
that WDT O
Zta NNP B-Gene
up RP O
- : O
regulation NN O
of IN O
p53 NN B-Gene
leads NNS O
to TO O
p53 VB B-Gene
- : O
mediated VBN O
interference NN O
with IN O
JAK NNP B-Gene
/ NNP B-Gene
STAT NNP I-Gene
activation NN O
of IN O
Qp NNP B-Gene
. . O

Reactive JJ O
oxygen NN O
intermediate JJ O
- : O
release NN O
of IN O
fibre JJ O
- : O
exposed VBN O
monocytes NNS O
increases VBZ O
inflammatory JJ O
cytokine NN B-Gene
- : I-Gene
mRNA NN I-Gene
level NN O
, , O
protein JJ B-Gene
tyrosine NN I-Gene
kinase NN I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activity NN O
in IN O
co NN O
- : O
cultured VBN O
bronchial JJ O
epithelial JJ O
cells NNS O
( ( O
BEAS NNP O
- : O
2B CD O
) ) O
. . O

We PRP O
show VBP O
here RB O
that IN O
the DT O
response NN O
of IN O
the DT O
HIV NNP O
- : O
1 CD O
long JJ O
terminal JJ O
repeat NN O
( ( O
LTR NNP B-Gene
) ) O
to TO O
mitogenic VB O
or CC O
Tat NNP B-Gene
- : O
mediated VBN O
activation NN O
is VBZ O
sensitive JJ O
to TO O
the DT O
suppressive JJ O
action NN O
of IN O
a DT O
Herpesvirus NNP O
saimiri NN O
( ( O
HVS NNP O
) ) O
- : O
transformed VBN O
CD8 NNP O
+ NNP O
T NNP O
cell VBP O
clone NN O
from IN O
an DT O
HIV NNP O
- : O
infected VBN O
individual JJ O
and CC O
supernatants NNS O
from IN O
CD8 NNP O
+ NNP O
T NNP O
cells NNS O
of IN O
HIV NNP O
- : O
1 CD O
- : O
infected VBN O
asymptomatic JJ O
subjects NNS O
( ( O
CD4 NNP B-Gene
+ NNP I-Gene
> VBD O
350 CD O
/ NNP O
microliters NNS O
) ) O
. . O

Mutagenesis NN O
of IN O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
or CC I-Gene
Sp NNP I-Gene
- : I-Gene
1 CD I-Gene
elements NNS I-Gene
within IN O
the DT O
LTR NNP B-Gene
resulted VBD O
in IN O
no DT O
change NN O
in IN O
the DT O
ability NN O
of IN O
CD8 NNP O
+ NNP O
T NNP O
cell NN O
supernatants NNS O
to TO O
inhibit VB O
Tat NNP O
- : O
or CC O
mitogen VB O
- : O
mediated VBN O
LTR NNP O
transcription NN O
. . O

Taken VBN O
together RB O
, , O
these DT O
observations NNS O
suggest VBP O
that IN O
mitogenic JJ O
activation NN O
, , O
mediated VBD O
primarily RB O
through IN O
the DT O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
enhancer NN I-Gene
, , O
is VBZ O
susceptible JJ O
to TO O
CD8 NNP B-Gene
- : O
mediated VBN O
inhibition NN O
, , O
however RB O
, , O
inhibition NN O
of IN O
Tat NNP B-Gene
- : O
mediated VBN O
activation NN O
may MD O
rely VB O
upon IN O
a DT O
different JJ O
pathway NN O
that WDT O
is VBZ O
NFAT NNP B-Gene
- : I-Gene
1 CD I-Gene
dependent NN O
. . O

Nuclear JJ B-Gene
factor NN I-Gene
( ( I-Gene
NF NNP I-Gene
) ) I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
is VBZ O
a DT O
redox JJ B-Gene
sensitive JJ I-Gene
cytosolic JJ I-Gene
transcription NN I-Gene
factor NN I-Gene
. . O

Induction NN O
of IN O
endothelial JJ B-Gene
adhesion NN I-Gene
molecules NNS I-Gene
by IN O
the DT O
cytokine NN B-Gene
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
) ) O
can MD O
occur VB O
independently RB O
of IN O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
and CC O
activation NN O
of IN O
a DT O
protein NN B-Gene
tyrosine NN I-Gene
kinase NN I-Gene
( ( O
PTK NNP B-Gene
) ) O
has VBZ O
recently RB O
been VBN O
implicated VBN O
in IN O
the DT O
upregulation NN O
of IN O
vascular JJ B-Gene
cell NN I-Gene
adhesion NN I-Gene
molecule NN I-Gene
1 CD I-Gene
( ( O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
by IN O
interleukin JJ B-Gene
- : I-Gene
4 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
) ) O
on IN O
endothelial JJ O
cells NNS O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
demonstrate VBP O
that IN O
constitutive JJ O
expression NN O
of IN O
bcl NN B-Gene
- : I-Gene
xl NN I-Gene
but CC O
not RB O
bcl VB B-Gene
- : I-Gene
2 CD I-Gene
, , O
bcl SYM B-Gene
- : I-Gene
xs NN I-Gene
, , O
bak NN B-Gene
, , O
bad JJ B-Gene
, , O
or CC O
bax NN B-Gene
was VBD O
associated VBN O
with IN O
apoptosis NN O
resistance NN O
after IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
deprivation NN O
in IN O
CTLL NNP O
- : O
2 CD O
cells NNS O
that WDT O
expressed VBD O
Tax NNP B-Gene
. . O

Transient NNP O
- : O
transfection NN O
assays NNS O
showed VBD O
that IN O
bcl SYM B-Gene
- : I-Gene
x NN I-Gene
promoter NN I-Gene
was VBD O
transactivated VBN O
by IN O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
Tax NN I-Gene
. . O

We PRP O
find VBP O
that DT O
recruitment NN O
of IN O
EKLF NNP B-Gene
to TO O
5 CD B-Gene
' '' I-Gene
HS2 NNP I-Gene
requires VBZ O
the DT O
TATA NNP B-Gene
box NN I-Gene
, , O
but CC O
recruitment NN O
to TO O
5 CD B-Gene
' '' I-Gene
HS3 NNP I-Gene
depends VBZ O
on IN O
the DT O
CACCC NNP O
and CC O
TATA NNP B-Gene
boxes NNS I-Gene
of IN O
the DT O
beta NN B-Gene
- : I-Gene
globin NN I-Gene
promoter NN I-Gene
. . O

We PRP O
have VBP O
found VBN O
that IN O
the DT O
recruitment NN O
of IN O
EKLF NNP B-Gene
to TO O
5 CD B-Gene
' '' I-Gene
HS3 NNP I-Gene
depends VBZ O
on IN O
the DT O
presence NN O
of IN O
5 CD B-Gene
' POS I-Gene
HS2 NNP I-Gene
in IN O
cis NN O
, , O
but CC O
the DT O
recruitment NN O
to TO O
5 CD B-Gene
' '' I-Gene
HS2 NNP I-Gene
does VBZ O
not RB O
depend VB O
on IN O
5 CD B-Gene
' POS I-Gene
HS3 NNP I-Gene
. . O

Based VBN O
on IN O
these DT O
results NNS O
, , O
we PRP O
present VBP O
a DT O
model NN O
that WDT O
illustrates VBZ O
how WRB O
EKLF NNP B-Gene
may MD O
be VB O
recruited VBN O
to TO O
the DT O
beta NN B-Gene
- : I-Gene
globin NN I-Gene
locus NN I-Gene
. . O

We PRP O
also RB O
report VBP O
that IN O
in IN O
RAW NNP O
264 CD O
. . O
7 CD O
cells NNS O
, , O
an DT O
E NNP O
( ( O
2 CD O
) ) O
receptor NN O
- : O
positive JJ O
murine NN O
monocytic JJ O
line NN O
, , O
E NNP O
( ( O
2 CD O
) ) O
downregulates VBZ O
cytokine JJ O
- : O
induced VBN O
TNF NNP B-Gene
gene NN O
expression NN O
by IN O
decreasing VBG O
the DT O
activity NN O
of IN O
the DT O
Jun NNP B-Gene
NH NNP I-Gene
( ( I-Gene
2 CD I-Gene
) ) I-Gene
- : I-Gene
terminal JJ I-Gene
kinase NN I-Gene
( ( O
JNK NNP B-Gene
) ) O
. . O

The DT O
resulting VBG O
diminished JJ O
phosphorylation NN O
of IN O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
and CC O
JunD NNP B-Gene
at IN O
their PRP$ O
NH NNP B-Gene
( ( I-Gene
2 CD I-Gene
) ) I-Gene
- : I-Gene
termini NN I-Gene
decreases VBZ O
the DT O
ability NN O
of IN O
these DT O
nuclear JJ O
proteins NNS O
to TO O
autostimulate VB O
the DT O
expression NN O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
Jun NN I-Gene
and CC I-Gene
JunD NNP I-Gene
genes NNS I-Gene
, , O
thus RB O
leading VBG O
to TO O
lower VB O
production NN O
of IN O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
and CC O
JunD NNP B-Gene
. . O

Recent JJ O
data NNS O
show VBP O
that IN O
TCR NNP B-Gene
/ NNP I-Gene
CD3 NNP I-Gene
stimulation NN O
induces NNS O
activation NN O
of IN O
Stat5 NNP B-Gene
in IN O
murine NN O
T NNP O
cells NNS O
. . O

In IN O
conclusion NN O
, , O
we PRP O
show VBP O
that IN O
CD3 NNP B-Gene
ligation NN O
by IN O
mAb NN B-Gene
and CC O
SE NNP O
triggers VBZ O
a DT O
rapid JJ O
, , O
PP1 NNP B-Gene
- : O
sensitive JJ O
tyrosine NN O
and CC O
serine JJ O
phosphorylation NN O
of IN O
Stat3 NNP B-Gene
in IN O
human JJ O
CD4 NNP O
+ NNP O
T NNP O
cells NNS O
. . O

Clusters NNS O
of IN O
genes NNS B-Gene
expressed VBN O
by IN O
stromal JJ O
cells NNS O
and CC O
lymphocytes NNS O
in IN O
the DT O
breast NN O
tumors NNS O
also RB O
were VBD O
identified VBN O
in IN O
this DT O
analysis NN O
. . O

Stimulation NN O
of IN O
T NNP O
cells NNS O
with IN O
calcium NN O
ionophore NN O
induced VBD O
a DT O
shift NN O
in IN O
the DT O
molecular JJ O
weight NN O
of IN O
NFATp NNP B-Gene
that WDT O
is VBZ O
due JJ O
to TO O
its PRP$ O
dephosphorylation NN O
. . O

This DT O
dephosphorylation NN O
was VBD O
inhibited VBN O
by IN O
treatment NN O
of IN O
T NNP O
cells NNS O
with IN O
cyclosporin NN O
A DT O
or CC O
FK506 NNP O
prior RB O
to TO O
stimulation NN O
. . O

The DT O
B NNP B-Gene
cell NN I-Gene
- : I-Gene
associated VBN I-Gene
surface NN I-Gene
molecule NN I-Gene
CD40 NNP B-Gene
plays VBZ O
a DT O
key JJ O
role NN O
in IN O
T NNP O
cell NN O
- : O
dependent NN O
B NNP O
cell NN O
maturation NN O
, , O
as IN O
individuals NNS O
with IN O
defects NNS O
in IN O
either DT O
CD40 NNP B-Gene
or CC O
its PRP$ O
ligand NN O
are VBP O
impaired VBN O
in IN O
immunoglobulin JJ B-Gene
isotype JJ O
class NN O
switching NN O
and CC O
germinal JJ O
center NN O
formation NN O
. . O

CD40 NNP B-Gene
signaling VBG O
activates NNS O
downstream JJ B-Gene
effectors NNS I-Gene
, , O
including VBG O
the DT O
tyrosine NN B-Gene
protein NN I-Gene
kinase NN I-Gene
, , O
Lyn NNP B-Gene
, , O
the DT O
phosphatidylinositol NN B-Gene
- : I-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
( ( O
PI NNP B-Gene
- : I-Gene
3 CD I-Gene
kinase NN I-Gene
) ) O
, , O
and CC O
the DT O
transcription NN O
factor NN O
, , O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
demonstrate VBP O
that IN O
stress NN B-Gene
- : I-Gene
activated VBN I-Gene
protein NN I-Gene
kinases NNS I-Gene
( ( O
SAPK NNP B-Gene
) ) O
are VBP O
activated VBN O
after IN O
CD40 NNP B-Gene
cross VBD O
- : O
linking VBG O
on IN O
various JJ O
B NNP O
cell NN O
lines NNS O
or CC O
human JJ O
tonsillar NN O
B NNP O
cells NNS O
. . O

In IN O
summary JJ O
, , O
CD40 NNP B-Gene
signaling VBG O
preferentially RB O
induces NNS O
SAPK NNP B-Gene
but CC O
not RB O
MAPK NNP B-Gene
. . O

Using VBG O
CD45 NNP O
- : O
or CC O
CD3 NNP O
- : O
negative JJ O
variants NNS O
of IN O
the DT O
Jurkat NNP O
leukemic JJ O
T NNP O
- : O
cell NN O
line NN O
we PRP O
show VBP O
that IN O
the DT O
different JJ O
biochemical JJ O
events NNS O
induced VBN O
by IN O
pervanadate NN O
appeared VBD O
to TO O
be VB O
dependent JJ O
on IN O
the DT O
presence NN O
at IN O
the DT O
cell NN O
surface NN O
of IN O
either DT O
CD45 NNP B-Gene
or CC O
CD3 NNP B-Gene
. . O

CD45 NNP B-Gene
- : O
dependent JJ O
events NNS O
such JJ O
as IN O
tyrosine JJ B-Gene
phosphorylation NN I-Gene
of IN O
Shc NNP B-Gene
, , O
activation NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
) ) O
, , O
activator NN B-Gene
protein SYM I-Gene
- : I-Gene
1 CD I-Gene
( ( O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
, , O
transcription NN B-Gene
factors NNS I-Gene
, , O
and CC O
stimulation NN O
of IN O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
( ( I-Gene
IL NNP I-Gene
- : I-Gene
2 CD I-Gene
) ) I-Gene
promoter NN I-Gene
and CC O
of IN O
CD69 NNP B-Gene
and CC O
CD25 NNP B-Gene
surface NN O
expression NN O
paralleled VBD O
activation NN O
of IN O
the DT O
tyrosine NN B-Gene
kinases VBZ I-Gene
lck JJ B-Gene
and CC O
fyn NN B-Gene
. . O

Previously RB O
, , O
the DT O
action NN O
of IN O
MC903 NNP O
and CC O
KH1060 NNP O
was VBD O
presumed VBN O
to TO O
be VB O
mediated VBN O
by IN O
the DT O
nuclear JJ B-Gene
vitamin NN I-Gene
D NNP I-Gene
receptor NN I-Gene
( ( O
VDRnuc NNP B-Gene
) ) O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
although IN O
MC903 NNP O
and CC O
KH1060 NNP O
may MD O
bind VB O
the DT O
VDRnuc NNP B-Gene
, , O
that IN O
the DT O
differentiative JJ O
activities NNS O
of IN O
these DT O
agents NNS O
requires VBZ O
nongenomic JJ O
signaling VBG O
pathways NNS O
. . O

Here RB O
we PRP O
show VBP O
that IN O
1alpha CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2 CD O
- : O
d5 NN O
- : O
previtamin NN O
D3 NNP O
( ( O
HF NNP O
) ) O
, , O
JN NNP O
, , O
KH1060 NNP O
, , O
and CC O
MC903 NNP O
induce VBP O
expression NN O
of IN O
PKC NNP B-Gene
alpha NN I-Gene
and CC O
PKC NNP B-Gene
delta NN I-Gene
and CC O
translocation NN O
of IN O
both DT O
isoforms NNS O
to TO O
the DT O
particulate NN O
fraction NN O
, , O
and CC O
PKC NNP B-Gene
alpha VBP I-Gene
to TO O
the DT O
nuclear JJ O
fraction NN O
. . O

Retinoic NNP O
acid NN O
can MD O
directly RB O
modulate VB O
gene NN O
expression NN O
via IN O
binding VBG O
to TO O
its PRP$ O
nuclear JJ B-Gene
receptors NNS I-Gene
, , O
which WDT O
can MD O
, , O
in IN O
turn NN O
, , O
activate JJ O
transcription NN O
of IN O
target NN B-Gene
genes NNS I-Gene
. . O

Tax NN B-Gene
has VBZ O
been VBN O
shown VBN O
to TO O
transactivate VB O
several JJ O
cellular JJ B-Gene
genes NNS I-Gene
. . O

Induced NNP O
MIP NNP B-Gene
- : I-Gene
1alpha CD I-Gene
expression NN O
and CC O
secretion NN O
in IN O
PMA NNP O
/ NNP O
PHA NNP O
stimulated VBD O
tax NN O
transfected VBN O
cells NNS O
correlate VBP O
with IN O
the DT O
noninduction NN O
of IN O
MNP NNP B-Gene
- : I-Gene
1 CD I-Gene
transcription NN B-Gene
factor NN I-Gene
, , O
which WDT O
is VBZ O
intimately RB O
involved VBN O
in IN O
downmodulating VBG O
the DT O
MIP NNP B-Gene
- : I-Gene
1alpha CD I-Gene
gene NN I-Gene
. . O

Copyright JJ O
1999 CD O
Academic NNP O
Press NNP O
. . O

Like IN O
a DT O
delayed JJ O
- : O
type NN O
hypersensitivity NN O
response NN O
, , O
the DT O
rheumatoid JJ O
synovium NN O
represents VBZ O
an DT O
effector NN O
site NN O
. . O

The DT O
other JJ O
major JJ O
subpopulation NN O
expressing VBG O
the DT O
CD4 NNP B-Gene
receptor NN I-Gene
, , O
namely RB O
, , O
the DT O
double JJ O
- : O
positive JJ O
( ( O
DP NNP O
) ) O
CD4 NNP O
( ( O
+ NNP O
) ) O
CD8 NNP O
( ( O
+ NNP O
) ) O
CD3 NNP O
( ( O
+ NNP O
/ NNP O
- : O
) ) O
thymocytes VBZ O
, , O
despite IN O
the DT O
entry NN O
of IN O
the DT O
virus NN O
, , O
do VBP O
not RB O
produce VB O
a DT O
significant JJ O
level NN O
of IN O
virus NN O
, , O
presumably RB O
because IN O
they PRP O
are VBP O
unresponsive JJ O
to TO O
TNF NNP B-Gene
and CC O
IL NNP B-Gene
- : I-Gene
7 CD I-Gene
. . O

Activation NN O
of IN O
CD40 NNP B-Gene
is VBZ O
essential JJ O
for IN O
thymus JJ O
- : O
dependent JJ O
humoral JJ O
immune NN O
responses NNS O
and CC O
rescuing VBG O
B NNP O
cells NNS O
from IN O
apoptosis NN O
. . O

MBP NNP B-Gene
over IN O
the DT O
concentration NN O
range NN O
of IN O
0 CD O
. . O
1 CD O
to TO O
10 CD O
microM NNS O
stimulated VBD O
the DT O
release NN O
of IN O
up IN O
to TO O
approximately RB O
8 CD O
ng JJ O
/ NNP O
ml NN O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
. . O

MBP NNP B-Gene
also RB O
induced VBD O
transient JJ O
increases NNS O
in IN O
mRNA NN B-Gene
for IN O
macrophage NN B-Gene
inflammatory NN I-Gene
protein NN I-Gene
( ( I-Gene
MIP NNP I-Gene
) ) I-Gene
- : I-Gene
1alpha CD I-Gene
and CC O
MIP NNP B-Gene
- : I-Gene
1beta CD I-Gene
, , O
but CC O
did VBD O
not RB O
stimulate VB O
the DT O
release NN O
of IN O
either DT O
chemokine NN B-Gene
. . O

Patients NNS O
with IN O
the DT O
recessively RB O
inherited JJ O
disorder NN O
ataxia NN O
telangiectasia NN O
( ( O
A DT O
- : O
T NN O
) ) O
have VBP O
a DT O
high JJ O
level NN O
of IN O
specific JJ O
chromosome NN B-Gene
translocations NNS I-Gene
which WDT O
can MD O
be VB O
easily RB O
observed VBN O
in IN O
peripheral JJ O
T NNP O
cells NNS O
and CC O
show VB O
a DT O
greatly RB O
increased JJ O
predisposition NN O
to TO O
leukaemia VB O
/ NNP O
lymphoma NN O
, , O
mainly RB O
of IN O
T NNP O
cell NN O
origin NN O
. . O

On IN O
the DT O
average NN O
, , O
no DT O
correlation NN O
was VBD O
established VBN O
between IN O
degree NN O
of IN O
lymphocyte JJ O
infiltration NN O
in IN O
breast NN O
tumor NN O
and CC O
age NN O
and CC O
menopause NN O
onset NN O
. . O

A DT O
high JJ O
- : O
affinity NN O
calcineurin SYM B-Gene
- : O
binding VBG O
peptide NN O
was VBD O
selected VBN O
from IN O
combinatorial JJ O
peptide NN O
libraries NNS O
based VBN O
on IN O
the DT O
calcineurin NN B-Gene
docking VBG I-Gene
motif NN I-Gene
of IN O
NFAT NNP B-Gene
. . O

Substitution NN O
of IN O
the DT O
optimized JJ O
peptide NN O
sequence NN O
into IN O
the DT O
natural JJ O
calcineurin NN B-Gene
docking VBG I-Gene
site NN I-Gene
increased VBD O
the DT O
calcineurin NN B-Gene
responsiveness NN O
of IN O
NFAT NNP B-Gene
. . O

Compounds NNS O
that WDT O
interfere VBP O
selectively RB O
with IN O
the DT O
calcineurin NN B-Gene
- : B-Gene
NFAT NNP I-Gene
interaction NN O
without IN O
affecting VBG O
calcineurin JJ B-Gene
phosphatase NN B-Gene
activity NN O
may MD O
be VB O
useful JJ O
as IN O
therapeutic JJ O
agents NNS O
that WDT O
are VBP O
less JJR O
toxic JJ O
than IN O
current JJ O
drugs NNS O
. . O

9 CD O
- : O
cis NN O
retinoic NN O
acid NN O
induces NNS O
monocyte VBP B-Gene
chemoattractant JJ I-Gene
protein NN I-Gene
- : I-Gene
1 CD I-Gene
secretion NN O
in IN O
human JJ O
monocytic JJ O
THP NNP O
- : O
1 CD O
cells NNS O
. . O

Thus RB O
, , O
both DT O
copies NNS O
of IN O
BRCA1 NNP B-Gene
were VBD O
retained VBN O
in IN O
tumor NN O
. . O

The DT O
DNA NNP O
variation NN O
, , O
233G CD O
- : O
- : O
> NN O
A DT O
, , O
does VBZ O
not RB O
result VB O
in IN O
an DT O
amino NN O
acid NN O
change NN O
, , O
and CC O
is VBZ O
considered VBN O
a DT O
benign JJ O
polymorphism NN O
. . O

Therefore RB O
, , O
we PRP O
investigated VBD O
whether IN O
IVS1 NNP O
- : O
10T CD O
- : O
- : O
> NN O
C NNP O
deleteriously RB O
affected VBD O
BRCA1 NNP B-Gene
splicing VBG O
or CC O
expression NN O
, , O
and CC O
thereby RB O
inactivated VBD O
the DT O
other JJ O
BRCA1 NNP B-Gene
allele NN I-Gene
. . O

For IN O
example NN O
dendritic JJ O
cells NNS O
( ( O
DC NNP O
) ) O
can MD O
be VB O
found VBN O
in IN O
colonies NNS O
of IN O
GM NNP O
- : O
CSF NNP O
- : O
responsive JJ O
bone NN O
marrow NN O
cells NNS O
, , O
and CC O
under IN O
experimental JJ O
conditions NNS O
are VBP O
routinely RB O
expanded VBN O
as IN O
a DT O
population NN O
in IN O
vitro NN O
from IN O
GM NNP O
- : O
CSF NNP O
- : O
responsive JJ O
progenitor NN O
cells NNS O
. . O

We PRP O
have VBP O
used VBN O
this DT O
MTHC NNP O
system NN O
to TO O
analyze VB O
differences NNS O
in IN O
gene NN O
expression NN O
as IN O
the DT O
cells NNS O
mature VBP O
along IN O
the DT O
DC NNP O
and CC O
macrophage NN O
pathways NNS O
. . O

We PRP O
have VBP O
investigated VBN O
mechanisms NNS O
and CC O
consequences NNS O
of IN O
STAT5 NNP B-Gene
activation NN O
through IN O
the DT O
human JJ B-Gene
IL NNP I-Gene
- : I-Gene
4 CD I-Gene
receptor NN I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
4R CD I-Gene
) ) O
. . O

By IN O
functionally RB O
expressing VBG O
receptor NN B-Gene
mutants NNS I-Gene
in IN O
the DT O
murine JJ O
pro FW O
- : O
B NNP O
cell NN O
line NN O
Ba NNP O
/ NNP O
F3 NNP O
, , O
we PRP O
could MD O
show VB O
that IN O
phosphorylated JJ O
tyrosine NN O
residues NNS O
within IN O
the DT O
IL NNP B-Gene
- : I-Gene
4R CD I-Gene
alpha NN I-Gene
chain NN I-Gene
are VBP O
dispensable JJ O
for IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
- : O
induced JJ O
STAT5 NNP B-Gene
activity NN O
. . O

An DT O
inhibitory NN O
, , O
` `` O
` `` O
dominant JJ O
- : O
negative JJ O
, , O
' '' O
' POS O
form NN O
of IN O
the DT O
calcineurin NN B-Gene
catalytic NN I-Gene
( ( I-Gene
A DT I-Gene
) ) I-Gene
subunit NN I-Gene
was VBD O
prepared VBN O
, , O
which WDT O
lacks VBZ O
the DT O
calmodulin NN B-Gene
- : I-Gene
binding NN I-Gene
domain NN I-Gene
, , O
autoinhibitory NN B-Gene
domain NN I-Gene
and CC O
most JJS O
of IN O
its PRP$ O
catalytic JJ O
core NN O
but CC O
possesses VBZ O
the DT O
regulatory JJ B-Gene
( ( I-Gene
B NNP I-Gene
) ) I-Gene
subunit NN I-Gene
binding VBG O
domain NN O
. . O

Immunoprecipitation NN O
of IN O
epitope NN B-Gene
- : I-Gene
labeled VBN I-Gene
BKO NNP I-Gene
demonstrated VBD O
for IN O
the DT O
formation NN O
of IN O
a DT O
tight JJ O
complex NN O
with IN O
endogenous JJ B-Gene
B NNP I-Gene
subunit NN I-Gene
in IN O
Jurkat NNP O
cells NNS O
, , O
consistent NN O
with IN O
an DT O
inhibitory NN O
mechanism NN O
that WDT O
involves VBZ O
the DT O
sequestration NN O
of IN O
the DT O
B NNP B-Gene
subunit NN I-Gene
. . O

Monoclonal NNP B-Gene
anti SYM I-Gene
- : I-Gene
D NN I-Gene
antibodies NNS I-Gene
submitted VBN O
to TO O
the DT O
Third NNP O
Monoclonal NNP O
International NNP O
Workshop NNP O
were VBD O
evaluated VBN O
against IN O
a DT O
number NN O
of IN O
D NNP O
variant NN O
cells NNS O
using VBG O
standard JJ O
serological JJ O
techniques NNS O
. . O

Cells NNS O
within IN O
each DT O
category NN O
did VBD O
not RB O
give VB O
any DT O
aberrant JJ O
results NNS O
. . O

B NNP O
cells NNS O
were VBD O
purified VBN O
from IN O
buffy NN O
coat NN O
preparations NNS O
of IN O
healthy JJ O
blood NN O
donors NNS O
by IN O
positive JJ O
selection NN O
using VBG O
an DT O
anti JJ B-Gene
CD20 NNP I-Gene
monoclonal NN I-Gene
antibody NN I-Gene
and CC O
a DT O
MiniMACS NNP O
separation NN O
unit NN O
. . O

RNA NNP B-Gene
was VBD O
extracted VBN O
by IN O
phenol NN O
/ NN O
chloroform NN O
and CC O
c SYM B-Gene
- : I-Gene
fos JJ I-Gene
expression NN O
was VBD O
analyzed VBN O
by IN O
PCR NNP O
assisted VBD O
mRNA JJ O
assay NN O
. . O

A DT O
significant JJ O
2 CD O
- : O
4 CD O
fold JJ O
increase NN O
of IN O
c JJ B-Gene
- : I-Gene
fos JJ I-Gene
expression NN O
was VBD O
observed VBN O
within IN O
30 CD O
min NN O
of IN O
stimulation NN O
with IN O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
( ( O
p NN O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
. . O

Since IN O
this DT O
is VBZ O
the DT O
first JJ O
report NN O
on IN O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
induced JJ O
signal JJ O
transduction NN O
, , O
these DT O
data NNS O
may MD O
help VB O
to TO O
identify VB O
the DT O
intracellular JJ O
mechanisms NNS O
by IN O
which WDT O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
stimulates NNS O
human JJ O
B NNP O
- : O
cells NNS O
. . O

MNDA NNP B-Gene
was VBD O
not RB O
detected VBN O
in IN O
normal JJ O
tissue NN O
histiocytes NNS O
but CC O
was VBD O
found VBN O
in IN O
activated JJ O
macrophages NNS O
and CC O
foreign JJ O
body NN O
giant JJ O
cells NNS O
associated VBN O
with IN O
inflammation NN O
. . O

Flow NNP O
cytometric NN O
cell NN O
sorting VBG O
of IN O
normal JJ O
bone NN O
marrow NN O
established VBD O
that IN O
MNDA NNP B-Gene
is VBZ O
initially RB O
expressed VBN O
in IN O
myeloid NN O
blast NN O
cells NNS O
. . O

Peroxisome NNP B-Gene
proliferator NN I-Gene
- : I-Gene
activated VBN I-Gene
receptors NNS I-Gene
( ( O
PPARs NNP B-Gene
) ) O
, , O
members NNS O
of IN O
the DT O
nuclear JJ B-Gene
receptor NN I-Gene
superfamily NN I-Gene
of IN O
transcription NN B-Gene
factors NNS I-Gene
, , O
are VBP O
activated VBN O
by IN O
fatty JJ O
acid NN O
metabolites NNS O
, , O
peroxisome JJ O
proliferators NNS O
, , O
and CC O
thiazolidinediones NNS O
and CC O
are VBP O
now RB O
recognized VBN O
as IN O
important JJ O
mediators NNS O
in IN O
the DT O
inflammatory JJ O
response NN O
. . O

Expression NN O
of IN O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
SHP1 NNP I-Gene
had VBD O
a DT O
very RB O
small JJ O
effect NN O
on IN O
the DT O
TCR NNP O
- : O
induced JJ O
tyrosine JJ O
phosphorylation NN O
of IN O
ZAP NNP B-Gene
- : I-Gene
70 CD I-Gene
and CC O
Syk NNP B-Gene
, , O
even RB O
when WRB O
SHP1 NNP B-Gene
was VBD O
overexpressed VBN O
20 CD O
- : O
100 CD O
- : O
fold NN O
over IN O
endogenous JJ B-Gene
SHP1 NNP I-Gene
. . O

However RB O
, , O
the DT O
two CD O
SH2 NNP B-Gene
domains NNS I-Gene
of IN O
SHP1 NNP B-Gene
did VBD O
not RB O
facilitate VB O
its PRP$ O
recognition NN O
of IN O
ZAP NNP B-Gene
- : I-Gene
70 CD I-Gene
and CC O
Syk NNP B-Gene
as IN O
substrates NNS O
in IN O
intact JJ O
cells NNS O
. . O

Eosinophil NNP B-Gene
granule NN I-Gene
major JJ I-Gene
basic JJ I-Gene
protein NN I-Gene
( ( O
MBP NNP B-Gene
) ) O
is VBZ O
expressed VBN O
exclusively RB O
in IN O
eosinophils NNS O
and CC O
basophils NNS O
in IN O
hematopoietic JJ O
cells NNS O
. . O

In IN O
the DT O
cell NN O
line NN O
HT93A NNP O
, , O
which WDT O
is VBZ O
capable JJ O
of IN O
differentiating VBG O
towards NNS O
both CC O
the DT O
eosinophil NN O
and CC O
neutrophil JJ O
lineages NNS O
in IN O
response NN O
to TO O
retinoic VB O
acid NN O
( ( O
RA NNP O
) ) O
, , O
C NNP B-Gene
/ NNP I-Gene
EBPalpha NNP I-Gene
mRNA POS I-Gene
expression NN O
decreased VBD O
significantly RB O
concomitant JJ O
with IN O
eosinophilic JJ O
and CC O
neutrophilic JJ O
differentiation NN O
, , O
whereas WP O
C NNP B-Gene
/ NNP I-Gene
EBPbeta NNP I-Gene
expression NN O
was VBD O
markedly RB O
increased VBN O
. . O

Furthermore RB O
, , O
we PRP O
have VBP O
demonstrated VBN O
that IN O
both DT O
C NNP B-Gene
/ NNP I-Gene
EBPbeta NNP I-Gene
and CC O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
can MD O
bind VB O
simultaneously RB O
to TO O
the DT O
C NNP O
/ NNP O
EBP NNP O
- : O
and CC O
GATA NNP B-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
in IN O
the DT O
MBP NNP B-Gene
promoter NN I-Gene
. . O

Role NNP O
of IN O
the DT O
camp NN B-Gene
response NN I-Gene
element NN I-Gene
site NN I-Gene
in IN O
mediating VBG O
repression NN O
by IN O
the DT O
upstream JJ B-Gene
regulatory JJ I-Gene
region NN I-Gene
. . O

DNase NNP B-Gene
I PRP I-Gene
footprinting VBG O
identified VBN O
several JJ O
protected JJ O
areas NNS O
including VBG O
Sp1 NNP B-Gene
, , I-Gene
Sp1 NNP I-Gene
/ NNP I-Gene
AP NNP I-Gene
- : I-Gene
2 CD I-Gene
, , I-Gene
and CC I-Gene
cAMP JJ I-Gene
response NN I-Gene
element NN I-Gene
( ( I-Gene
CRE NNP I-Gene
) ) I-Gene
binding VBG I-Gene
sites NNS I-Gene
within IN O
the DT O
201 CD O
- : O
bp NN O
core NN O
promoter NN O
region NN O
and CC O
Sp1 NNP B-Gene
, , I-Gene
NRE NNP I-Gene
- : I-Gene
2a CD I-Gene
, , I-Gene
TCF NNP I-Gene
- : I-Gene
1 CD I-Gene
/ NN I-Gene
LEF NNP I-Gene
- : I-Gene
1 CD I-Gene
, , I-Gene
and CC I-Gene
Sp1 NNP I-Gene
/ NNP I-Gene
NF NNP I-Gene
- : I-Gene
AT NNP I-Gene
binding VBG I-Gene
sites NNS I-Gene
in IN O
the DT O
upstream JJ B-Gene
regulatory JJ I-Gene
region NN I-Gene
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
assay VBP O
analysis NN O
of IN O
proteins NNS O
binding VBG O
to TO O
the DT O
CRE NNP B-Gene
site NN I-Gene
identified VBD O
both DT O
ATF NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
ATF NNP B-Gene
- : I-Gene
2 CD I-Gene
in IN O
Jurkat NNP O
cells NNS O
. . O

In IN O
summary JJ O
, , O
we PRP O
have VBP O
identified VBN O
a DT O
tissue NN B-Gene
- : I-Gene
specific JJ I-Gene
regulatory JJ I-Gene
region NN I-Gene
5 CD O
' '' O
of IN O
the DT O
ecto NN B-Gene
- : I-Gene
5 CD I-Gene
' '' I-Gene
- : I-Gene
NT NNP I-Gene
core NN I-Gene
promoter NN I-Gene
that WDT O
requires VBZ O
the DT O
presence NN O
of IN O
a DT O
functional JJ O
CRE NNP B-Gene
site NN I-Gene
within IN O
the DT O
basal NN B-Gene
promoter NN I-Gene
for IN O
its PRP$ O
suppressive JJ O
activity NN O
. . O

Extracellular JJ O
signal NN O
- : O
regulated VBN O
protein JJ O
kinase NN O
( ( O
ERK NNP O
) ) O
- : O
dependent NN O
and CC O
ERK NNP O
- : O
independent JJ O
pathways NNS O
target VBP O
STAT3 NNP B-Gene
on IN O
serine NN O
- : O
727 CD O
in IN O
human JJ O
neutrophils NNS O
stimulated VBN O
by IN O
chemotactic JJ B-Gene
factors NNS I-Gene
and CC O
cytokines NNS B-Gene
. . O

( ( O
2 CD O
- : O
Amino NNP O
- : O
3 CD O
' '' O
- : O
methoxyphenyl NN O
) ) O
oxanaphthalen VBZ O
- : O
4 CD O
- : O
one NN O
( ( O
PD NNP O
98059 CD O
) ) O
, , O
an DT O
inhibitor NN O
of IN O
extracellular JJ O
signal JJ B-Gene
- : I-Gene
regulated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( O
ERK NNP B-Gene
) ) O
activation NN O
, , O
blocked VBD O
the DT O
serine JJ O
phosphorylation NN O
of IN O
STAT3 NNP B-Gene
induced VBN O
by IN O
chemotactic JJ B-Gene
factors NNS I-Gene
or CC O
PMA NNP O
. . O

These DT O
foci NNS O
, , O
which WDT O
were VBD O
preferentially RB O
found VBN O
adjacent JJ O
to TO O
nucleoli VB O
or CC O
at IN O
the DT O
nuclear JJ O
periphery NN O
, , O
did VBD O
not RB O
represent VB O
sites NNS O
of IN O
active JJ O
transcription NN O
or CC O
binding NN O
of IN O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
to TO O
consensus VB B-Gene
sites NNS I-Gene
in IN O
the DT O
beta NN B-Gene
- : I-Gene
globin NN I-Gene
loci NN I-Gene
. . O

After IN O
exercise NN O
following VBG O
placebo JJ O
administration NN O
we PRP O
observed VBD O
increases NNS O
in IN O
concentrations NNS O
of IN O
blood NN O
substrates NNS O
, , O
plasma NN B-Gene
adrenocorticotropin NN I-Gene
( ( O
ACTH NNP B-Gene
) ) O
, , O
growth NN O
hormone NN O
and CC O
cortisol NN O
and CC O
in IN O
the DT O
number NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
lymphocytes NNS O
without IN O
changes NNS O
in IN O
the DT O
dissociation NN O
constant NN O
. . O

Intravenous JJ O
PCr NNP O
injection NN O
led VBD O
to TO O
smaller JJR O
changes NNS O
in IN O
ACTH NNP B-Gene
and CC O
cortisol JJ O
concentrations NNS O
as RB O
well RB O
as IN O
to TO O
a DT O
lower JJR O
activation NN O
of IN O
glucocorticoid JJ O
binding NN O
in IN O
lymphocytes NNS O
. . O

Putative JJ B-Gene
steroid NN I-Gene
binding VBG I-Gene
domain NN I-Gene
of IN O
the DT O
human JJ B-Gene
mineralocorticoid NN I-Gene
receptor NN I-Gene
, , O
expressed VBN O
in IN O
E NNP O
. . O
coli NN O
in IN O
the DT O
presence NN O
of IN O
heat NN B-Gene
shock NN I-Gene
proteins NNS I-Gene
shows VBZ O
typical JJ O
native JJ O
receptor NN O
characteristics NNS O
. . O

These DT O
bacterially RB B-Gene
- : I-Gene
produced VBN I-Gene
MR NNP I-Gene
constructs NNS I-Gene
had VBD O
no DT O
steroid JJ O
binding NN O
activity NN O
per IN O
se NN O
. . O

The DT O
Kd NNP O
value NN O
for IN O
aldosterone NN O
was VBD O
0 CD O
. . O
3 CD O
nM NN O
and CC O
the DT O
Bmax NNP O
= NNP O
32 CD O
pmol NN O
/ NNP O
mg NN O
. . O

Renal NNP O
cell NN O
carcinoma SYM O
- : O
derived VBN O
gangliosides NNS O
suppress JJ O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
in IN O
T NNP O
cells NNS O
. . O

Indeed RB O
, , O
we PRP O
detected VBD O
gangliosides NNS O
in IN O
supernatants NNS O
from IN O
RCC NNP O
explants NNS O
and CC O
not RB O
from IN O
adjacent JJ O
normal JJ O
kidney NN O
tissue NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
investigate VBP O
the DT O
role NN O
of IN O
TNFalpha NNP B-Gene
- : O
inducible JJ O
reactive JJ O
oxygen NN O
species NNS O
( ( O
ROS NNP O
) ) O
in IN O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
expression NN O
by IN O
` `` O
` `` O
monocyte VB O
- : O
like IN O
' '' O
' POS O
U937 NNP O
histiocytic JJ O
lymphoma NN O
cells NNS O
. . O

These DT O
data NNS O
indicate VBP O
that IN O
TNFalpha NNP B-Gene
induces VBZ O
a DT O
delayed JJ O
ROS NNP O
- : O
dependent NN O
signalling VBG O
pathway NN O
that WDT O
is VBZ O
required VBN O
for IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
transcriptional JJ O
activation NN O
and CC O
is VBZ O
separable JJ O
from IN O
that DT O
required VBN O
for IN O
its PRP$ O
nuclear JJ O
translocation NN O
. . O

Estrogen NN B-Gene
receptors NNS I-Gene
influence NN O
non SYM O
- : O
genomic JJ O
events NNS O
, , O
which WDT O
are VBP O
rapid JJ O
in IN O
onset NN O
and CC O
genomic JJ O
events NNS O
, , O
which WDT O
are VBP O
longer RBR O
acting JJ O
responses NNS O
. . O

Estrogens NNS O
also RB O
influence VBP O
production NN O
of IN O
mitogens NNS O
which WDT O
, , O
when WRB O
released VBN O
at IN O
sites NNS O
of IN O
vascular JJ O
injury NN O
, , O
affect VBP O
vascular JJ O
remodeling NN O
. . O

Protein NNP B-Gene
kinase VBD I-Gene
C NNP I-Gene
and CC O
calcineurin JJ B-Gene
synergize NN O
to TO O
activate VB O
IkappaB NNP B-Gene
kinase NN I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
T NNP O
lymphocytes NNS O
. . O

We PRP O
also RB O
demonstrate VBP O
that IN O
the DT O
IKK NNP B-Gene
complex JJ I-Gene
, , O
but CC O
not RB O
p90 VB B-Gene
( ( I-Gene
rsk NN I-Gene
) ) I-Gene
, , O
is VBZ O
responsible JJ O
for IN O
the DT O
in IN O
vivo JJ O
phosphorylation NN O
of IN O
IkappaBalpha NNP B-Gene
mediated VBN O
by IN O
the DT O
co NN O
- : O
activation NN O
of IN O
PKC NNP B-Gene
and CC O
calcineurin NN B-Gene
. . O

The DT O
p53 NN B-Gene
paradox NN O
in IN O
the DT O
pathogenesis NN O
of IN O
tumor NN O
progression NN O
. . O

Additional NNP O
upstream NN O
gene NN O
segments NNS O
dramatically RB O
affected VBD O
B29 NNP B-Gene
minimal JJ B-Gene
promoter NN I-Gene
activity NN O
. . O

These DT O
findings NNS O
indicate VBP O
that IN O
B29 NNP B-Gene
gene NN I-Gene
expression NN O
is VBZ O
controlled VBN O
by IN O
the DT O
complex JJ O
interplay NN O
of IN O
positive JJ O
and CC O
negative JJ B-Gene
regulatory JJ I-Gene
elements NNS I-Gene
. . O

A DT O
novel JJ O
immunosuppressive JJ B-Gene
factor NN I-Gene
in IN O
bovine NN O
colostrum NN O
blocks NNS O
activation NN O
of IN O
the DT O
interleukin JJ B-Gene
2 CD I-Gene
gene NN I-Gene
enhancer NN I-Gene
at IN O
the DT O
NFAT NNP B-Gene
site NN I-Gene
. . O

A DT O
factor NN O
in IN O
bovine NN O
colostrum NN O
( ( O
colostrum JJ B-Gene
inhibitory NN I-Gene
factor NN I-Gene
, , O
CIF NNP B-Gene
) ) O
inhibits VBZ O
interleukin JJ B-Gene
2 CD I-Gene
( ( O
IL2 NNP B-Gene
) ) O
production NN O
in IN O
activated JJ O
T NNP O
helper NN O
cells NNS O
by IN O
blocking VBG O
the DT O
accumulation NN O
of IN O
IL2 NNP B-Gene
mRNA NN I-Gene
. . O

To TO O
determine VB O
whether IN O
CIF NNP B-Gene
blocks NNS O
at IN O
the DT O
level NN O
of IN O
IL2 NNP B-Gene
transcription NN O
, , O
we PRP O
introduced VBD O
reporter NN O
plasmids NNS O
into IN O
the DT O
human JJ O
T NNP O
leukemia NN O
cell NN O
line NN O
Jurkat NNP O
by IN O
transient JJ O
transfection NN O
. . O

The DT O
NFAT NNP B-Gene
- : I-Gene
controlled VBD I-Gene
luciferase JJ I-Gene
gene NN I-Gene
system NN I-Gene
distinguishes NNS O
CIF NNP B-Gene
from IN O
other JJ O
T NNP O
cell NN O
inhibitory NN O
activities NNS O
present VBP O
in IN O
colostrum NN O
, , O
in IN O
particular JJ O
, , O
TGF NNP B-Gene
beta VBD I-Gene
1 CD I-Gene
and CC O
TGF NNP B-Gene
beta VBD I-Gene
2 CD I-Gene
and CC O
the DT O
glucocorticoids NNS O
. . O

The DT O
NFAT NNP B-Gene
- : O
luc NN O
assay NN O
is VBZ O
a DT O
useful JJ O
technique NN O
for IN O
the DT O
rapid JJ O
, , O
sensitive JJ O
measurement NN O
of IN O
CIF NNP B-Gene
or CC O
other JJ O
immunosuppressants NNS O
with IN O
a DT O
similar JJ O
mode NN O
of IN O
action NN O
. . O

To TO O
propel VB O
itself PRP O
in IN O
infected JJ O
cells NNS O
, , O
the DT O
pathogen NN O
Shigella NNP O
flexneri NN O
subverts VBZ O
the DT O
Cdc42 NNP B-Gene
- : O
controlled VBD O
machinery NN O
responsible JJ O
for IN O
actin NN B-Gene
assembly NN O
during IN O
filopodia JJ O
formation NN O
. . O

Using VBG O
a DT O
combination NN O
of IN O
bacterial JJ O
motility NN O
assays NNS O
in IN O
platelet NN O
extracts NNS O
with IN O
Escherichia NNP O
coli NNS O
expressing VBG O
the DT O
Shigella NNP B-Gene
IcsA NNP I-Gene
protein NN I-Gene
and CC O
in IN O
vitro JJ O
analysis NN O
of IN O
reconstituted JJ O
systems NNS O
from IN O
purified JJ B-Gene
proteins NNS I-Gene
, , O
we PRP O
show VBP O
here RB O
that IN O
the DT O
bacterial JJ B-Gene
protein NN I-Gene
IcsA NNP I-Gene
binds VBZ O
N NNP B-Gene
- : I-Gene
WASP NNP I-Gene
and CC O
activates VBZ O
it PRP O
in IN O
a DT O
Cdc42 NNP B-Gene
- : O
like IN O
fashion NN O
. . O

VASP NNP O
is VBZ O
not RB O
involved VBN O
in IN O
Shigella NNP O
movement NN O
, , O
and CC O
the DT O
function NN O
of IN O
profilin NN B-Gene
does VBZ O
not RB O
require VB O
its PRP$ O
binding NN O
to TO O
proline VB B-Gene
- : I-Gene
rich JJ I-Gene
regions NNS I-Gene
. . O

c SYM B-Gene
- : I-Gene
Maf NNP I-Gene
induces VBZ O
monocytic JJ O
differentiation NN O
and CC O
apoptosis NN O
in IN O
bipotent NN O
myeloid NN O
progenitors NNS O
. . O

We PRP O
have VBP O
shown VBN O
that IN O
the DT O
c SYM B-Gene
- : I-Gene
Maf NN I-Gene
and CC O
c SYM B-Gene
- : I-Gene
Myb JJ I-Gene
transcription NN I-Gene
factors NNS I-Gene
physically RB O
interact VBP O
in IN O
myeloid NN O
cells NNS O
to TO O
form VB O
inhibitory NN O
complexes NNS O
that WDT O
hinder VBP O
transactivation NN O
of IN O
c SYM B-Gene
- : I-Gene
Myb NNP I-Gene
target NN I-Gene
genes NNS I-Gene
through IN O
direct JJ O
binding NN O
to TO O
Myb NNP B-Gene
consensus NN I-Gene
sites NNS I-Gene
. . O

Elevated JJ O
levels NNS O
of IN O
c SYM B-Gene
- : I-Gene
Maf NNP I-Gene
protein NN I-Gene
led VBD O
to TO O
marked VB O
increases NNS O
in IN O
Myb NNP B-Gene
: : I-Gene
Maf NNP I-Gene
complexes NNS I-Gene
and CC O
the DT O
accumulation NN O
of IN O
monocyte NN O
/ NNP O
macrophage NN O
cells NNS O
, , O
followed VBN O
by IN O
eventual JJ O
programmed VBN O
cell NN O
death NN O
. . O

Analysis NN O
of IN O
targets NNS O
that WDT O
could MD O
mediate VB O
these DT O
phenotypic NNS O
changes NNS O
indicated VBD O
that IN O
c SYM B-Gene
- : I-Gene
Maf NNP I-Gene
likely JJ O
plays VBZ O
a DT O
key JJ O
role NN O
in IN O
myeloid NN O
cell NN O
development NN O
through IN O
dual JJ O
mechanisms NNS O
; : O
inhibition NN O
of IN O
a DT O
select JJ O
set NN O
of IN O
c JJ B-Gene
- : I-Gene
Myb NNP I-Gene
regulated VBD O
targets NNS O
, , O
such JJ O
as IN O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
CD13 NNP B-Gene
/ NNP I-Gene
APN NNP I-Gene
, , O
coupled VBN O
with IN O
the DT O
activation NN O
of IN O
as IN O
yet RB O
undefined VBN O
differentiation NN B-Gene
- : I-Gene
promoting NN I-Gene
genes NNS I-Gene
. . O

We PRP O
have VBP O
examined VBN O
the DT O
effect NN O
of IN O
Rb NNP B-Gene
expression NN O
on IN O
the DT O
activation NN O
of IN O
the DT O
promoter NN O
for IN O
HLA NNP B-Gene
- : I-Gene
DRA NN I-Gene
, , O
the DT O
prototype NN B-Gene
class NN I-Gene
II NNP I-Gene
gene NN I-Gene
. . O

Different NNP O
glucocorticoid NN O
hormones NNS O
( ( O
GCH NNP O
) ) O
show NN O
differences NNS O
in IN O
the DT O
intensity NN O
and CC O
in IN O
the DT O
kinetics NNS O
of IN O
their PRP$ O
immunomodulating NN O
activity NN O
. . O

The DT O
mechanism NN O
( ( O
s JJ O
) ) O
of IN O
action NN O
of IN O
GCH NNP O
is VBZ O
under IN O
investigation NN O
, , O
but CC O
is VBZ O
has VBZ O
been VBN O
noted VBN O
that IN O
they PRP O
exert VBP O
immune JJ O
activity NN O
via IN O
the DT O
genomic JJ O
pathway NN O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
may MD O
play VB O
a DT O
role NN O
in IN O
regulating VBG O
differentiation NN O
of IN O
normal JJ O
germinal JJ O
center NN O
B NNP O
cells NNS O
and CC O
that IN O
its PRP$ O
deregulated JJ O
expression NN O
caused VBN O
by IN O
rearrangements NNS O
may MD O
contribute VB O
to TO O
lymphomagenesis NN O
. . O

Activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
is VBZ O
induced VBN O
by IN O
prooxidants NNS O
and CC O
several JJ O
stimuli NNS O
eliciting VBG O
oxidative JJ O
stress NN O
, , O
such JJ O
as IN O
cytokines NNS B-Gene
, , O
lipopolysaccharide RB O
, , O
UV NNP O
irradiation NN O
and CC O
other JJ O
mediators NNS O
. . O

To TO O
better RBR O
understand VB O
the DT O
assembly NN O
mechanism NN O
for IN O
the DT O
progesterone NN B-Gene
receptor NN I-Gene
( ( O
PR NNP B-Gene
) ) O
, , O
we PRP O
have VBP O
developed VBN O
cell NN O
- : O
free JJ O
systems NNS O
for IN O
studying VBG O
interactions NNS O
of IN O
PR NNP B-Gene
, , O
hsp90 NN B-Gene
, , O
and CC O
other JJ O
associated JJ B-Gene
proteins NNS I-Gene
. . O

These DT O
interactions NNS O
require VBP O
ATP NNP O
/ NNP O
Mg2 NNP O
+ NNP O
and CC O
when WRB O
ATP NNP O
is VBZ O
limiting VBG O
the DT O
PR NNP B-Gene
complex NN O
is VBZ O
altered VBN O
to TO O
one CD O
containing VBG O
the DT O
proteins NNS O
p60 NN B-Gene
and CC O
p48 NN B-Gene
, , O
but CC O
lacking VBG O
immunophilins NNS B-Gene
and CC O
p23 NN B-Gene
. . O

One CD O
contains VBZ O
hsp90 NN B-Gene
bound NN O
to TO O
hsp70 VB B-Gene
and CC O
p60 VB B-Gene
and CC O
this DT O
complex JJ O
forms NNS O
spontaneously RB O
in IN O
the DT O
absence NN O
of IN O
ATP NNP O
. . O

This DT O
explains VBZ O
, , O
in IN O
part NN O
, , O
the DT O
known JJ O
effects NNS O
of IN O
ATP NNP O
and CC O
molybdate VB O
on IN O
assembly NN O
of IN O
PR NNP B-Gene
complexes NNS I-Gene
. . O

We PRP O
have VBP O
recently RB O
demonstrated VBN O
that IN O
hydrocortisone NN O
and CC O
other JJ O
glucocorticoids NNS O
inhibit VBP O
reactive JJ O
oxygen NN O
species NNS O
( ( O
ROS NNP O
) ) O
generation NN O
by IN O
mononuclear NN O
( ( O
MNC NNP O
) ) O
and CC O
polymorphonuclear JJ O
leucocytes NNS O
( ( O
PMNL NNP O
) ) O
. . O

Since IN O
NF NNP O
- : O
kappaB NN O
/ NNP O
IkappaB NNP B-Gene
system NN O
regulates VBZ O
the DT O
transcription NN O
of IN O
proinflammatory NN B-Gene
genes NNS I-Gene
, , O
including VBG O
those DT O
responsible JJ O
for IN O
ROS NNP O
generation NN O
, , O
we PRP O
tested VBD O
the DT O
hypothesis NN O
that IN O
hydrocortisone NN O
may MD O
stimulate VB O
IkappaB NNP B-Gene
production NN O
thus RB O
inhibiting VBG O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
translocation NN O
from IN O
the DT O
cytosol NN O
into IN O
the DT O
nucleus NN O
in IN O
MNC NNP O
, , O
in IN O
vivo NN O
. . O

Blood NN O
samples NNS O
were VBD O
obtained VBN O
prior RB O
to TO O
the DT O
injection NN O
and CC O
at IN O
1 CD O
, , O
2 CD O
, , O
4 CD O
, , O
8 CD O
and CC O
24 CD O
hr NN O
after IN O
the DT O
injection NN O
. . O

The DT O
total JJ O
protein NN O
content NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
subunit NN I-Gene
( ( O
P65 NNP B-Gene
) ) O
in IN O
MNC NNP O
lysates NNS O
also RB O
showed VBD O
a DT O
decrease NN O
following VBG O
hydrocortisone NN O
injection NN O
. . O

This DT O
decrease NN O
was VBD O
observed VBN O
at IN O
2 CD O
hr NN O
, , O
reached VBD O
a DT O
nadir NN O
at IN O
4 CD O
hr NN O
, , O
and CC O
returned VBD O
to TO O
baseline NN O
levels NNS O
at IN O
24 CD O
hr NN O
. . O

Our PRP$ O
data NNS O
demonstrate NN O
that IN O
hydrocortisone NN O
induces NNS O
IkappaB NNP B-Gene
and CC O
suppresses VBZ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
expression NN O
in IN O
MNC NNP O
in IN O
parallel NN O
. . O

However RB O
, , O
the DT O
exact JJ O
cellular JJ O
mechanisms NNS O
underlying VBG O
this DT O
anti JJ O
- : O
inflammatory NN O
capacity NN O
are VBP O
still RB O
unknown JJ O
. . O

In IN O
our PRP$ O
study NN O
, , O
we PRP O
determined VBD O
the DT O
induction NN O
of IN O
apoptosis NN O
by IN O
GC NNP O
in IN O
human JJ O
monocytes NNS O
. . O

Monocyte NNP O
apoptosis NN O
was VBD O
determined VBN O
by IN O
four CD O
independent JJ O
methods NNS O
, , O
including VBG O
annexin SYM O
- : O
V NNP O
staining NN O
, , O
TUNEL NNP O
, , O
DNA NNP O
- : O
laddering NN O
, , O
and CC O
typical JJ O
morphology NN O
by IN O
means NNS O
of IN O
transmission NN O
electron NN O
microscopy NN O
. . O

Necrosis NN O
was VBD O
excluded VBN O
by IN O
propidium NN O
iodide NN O
staining NN O
. . O

Proinflammatory NNP B-Gene
cytokines NNS I-Gene
such JJ O
as IN O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
and CC O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
were VBD O
down RB O
- : O
regulated VBN O
by IN O
GC NNP O
treatment NN O
. . O

Continuous JJ O
treatment NN O
of IN O
monocytes NNS O
with IN O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
, , O
but CC O
not RB O
with IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
, , O
could MD O
almost RB O
completely RB O
prevent JJ O
GC NNP O
- : O
induced VBD O
cell NN O
death NN O
. . O

The DT O
addition NN O
of IN O
mifepristone NN O
or CC O
caspase VB O
- : O
3 CD O
inhibitor NN O
could MD O
partially RB O
abrogate VB O
GC NNP O
- : O
induced JJ O
apoptosis NN O
as RB O
well RB O
as IN O
GC NNP O
- : O
induced JJ O
inhibition NN O
of IN O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
. . O

The DT O
inflammatory JJ O
mediators NNS O
lipopolysaccharide VBP O
( ( O
LPS NNP O
) ) O
and CC O
tumor JJ B-Gene
necrosis NN I-Gene
factor NN I-Gene
( ( O
TNF NNP B-Gene
) ) O
are VBP O
potent JJ O
activators NNS O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
. . O

Kinase NNP O
assays VBZ O
showed VBD O
that IN O
TNF NNP B-Gene
elicited VBD O
a DT O
rapid JJ O
but CC O
short JJ O
- : O
lived JJ O
induction NN O
of IN O
IKK NNP B-Gene
activity NN O
with IN O
a DT O
3 CD O
- : O
fold NN O
greater JJR O
effect NN O
on IN O
IKK NNP B-Gene
- : I-Gene
alpha NN I-Gene
than IN O
on IN O
IKK NNP B-Gene
- : I-Gene
beta NN I-Gene
, , O
peaking VBG O
at IN O
5 CD O
min NN O
. . O

Furthermore RB O
, , O
our PRP$ O
studies NNS O
showed VBD O
association NN O
of IN O
the DT O
IKK NNP B-Gene
- : I-Gene
alpha NN I-Gene
/ JJ I-Gene
beta NN I-Gene
heterodimer NN I-Gene
with IN O
NIK NNP B-Gene
, , O
IkappaB NNP B-Gene
- : I-Gene
alpha NN I-Gene
and CC O
- : B-Gene
epsilon NN I-Gene
in IN O
unstimulated JJ O
cells NNS O
. . O

The DT O
understanding NN O
of IN O
LPS NNP O
- : O
and CC O
TNF NNP O
- : O
induced VBD O
signaling NN O
may MD O
allow VB O
the DT O
development NN O
of IN O
specific JJ O
strategies NNS O
to TO O
treat VB O
sepsis NN O
- : O
associated JJ O
disease NN O
. . O

The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
examine VB O
the DT O
ability NN O
of IN O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
( ( O
TNFalpha NNP B-Gene
, , O
a DT O
proinflammatory JJ B-Gene
cytokine NN I-Gene
) ) O
and CC O
interleukin JJ B-Gene
( ( I-Gene
IL NNP I-Gene
) ) I-Gene
- : I-Gene
10 CD I-Gene
( ( O
an DT O
anti NN B-Gene
- : I-Gene
inflammatory JJ I-Gene
cytokine NN I-Gene
) ) O
to TO O
differentially RB O
regulate VB O
the DT O
sensitivity NN O
of IN O
human JJ O
monocytes NNS O
/ VBP O
macrophages NNS O
to TO O
glucocorticoids NNS O
. . O

Finally RB O
, , O
we PRP O
investigated VBD O
whether IN O
the DT O
modulation NN O
of IN O
corticosensitivity NN O
in IN O
TNFalpha NNP O
- : O
and CC O
IL NNP O
- : O
10 CD O
- : O
pretreated VBN O
U937 NNP O
cells NNS O
was VBD O
related VBN O
to TO O
a DT O
change NN O
of IN O
the DT O
glucocorticoid JJ B-Gene
receptor NN I-Gene
concentration NN O
and CC O
affinity NN O
. . O

TNFalpha NNP B-Gene
decreased VBD O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
, , O
while IN O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
increased VBD O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
, , O
the DT O
concentration NN O
of IN O
dexamethasone NN O
binding VBG O
sites NNS O
in IN O
these DT O
cells NNS O
, , O
with IN O
no DT O
discernible JJ O
effect NN O
on IN O
their PRP$ O
binding NN O
affinity NN O
. . O

We PRP O
conclude VBP O
that DT O
glucocorticoids NNS O
differentially RB O
modulate VBP O
TNFalpha NNP B-Gene
and CC O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
secretion NN O
by IN O
human JJ O
monocytes NNS O
in IN O
a DT O
LPS NNP O
dose SYM O
- : O
dependent JJ O
fashion NN O
and CC O
that IN O
the DT O
sensitivity NN O
of IN O
these DT O
cells NNS O
to TO O
glucocorticoids NNS O
is VBZ O
altered VBN O
by IN O
TNFalpha NNP B-Gene
or CC O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
pretreatment NN O
; : O
TNFalpha NNP B-Gene
blocks VBZ O
their PRP$ O
effects NNS O
, , O
whereas NNS O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
acts NNS O
synergistically RB O
with IN O
glucocorticoids NNS O
. . O

Because IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
contributes VBZ O
to TO O
the DT O
transcription NN O
of IN O
numerous JJ O
inflammatory JJ B-Gene
genes NNS I-Gene
and CC O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
a DT O
molecular JJ O
target NN O
of IN O
antiinflammatory JJ O
drugs NNS O
, , O
we PRP O
sought VBD O
to TO O
characterize VB O
the DT O
functional JJ O
role NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
protein NN I-Gene
complex NN I-Gene
in IN O
lupus NN O
T NNP O
cells NNS O
. . O

Also RB O
, , O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activity NN O
remained VBD O
absent NN O
in IN O
follow JJ O
- : O
up IN O
studies NNS O
. . O

As IN O
p65 NN B-Gene
complexes NNS I-Gene
are VBP O
transcriptionally RB O
active JJ O
in IN O
comparison NN O
to TO O
the DT O
p50 NN O
homodimer NN O
, , O
this DT O
novel JJ O
finding NN O
may MD O
provide VB O
insight NN O
on IN O
the DT O
origin NN O
of IN O
abnormal JJ B-Gene
cytokine NN I-Gene
or CC O
other JJ O
gene NN O
transcription NN O
in IN O
SLE NNP O
patients NNS O
. . O

Here RB O
, , O
we PRP O
investigate VBP O
further JJ O
the DT O
events NNS O
triggered VBN O
by IN O
TLR2 NNP B-Gene
in IN O
response NN O
to TO O
LPS NNP O
. . O

Intracellular JJ O
deletion NN O
variants NNS O
of IN O
TLR2 NNP B-Gene
lacking VBG O
C NNP O
- : O
terminal JJ O
13 CD O
or CC O
141 CD O
aa JJ O
fail NN O
to TO O
recruit VB O
IRAK NNP B-Gene
, , O
which WDT O
is VBZ O
consistent JJ O
with IN O
the DT O
inability NN O
of IN O
these DT O
mutants NNS O
to TO O
transmit VB O
LPS NNP O
cellular JJ O
signaling NN O
. . O

Here RB O
we PRP O
provide VBP O
novel JJ O
evidence NN O
that IN O
AG NNP O
- : O
490 CD O
potently RB O
inhibits VBZ O
the DT O
autokinase NN O
activity NN O
of IN O
JAK3 NNP B-Gene
and CC O
tyrosine JJ O
phosphorylation NN O
and CC O
DNA NNP O
binding NN O
of IN O
signal JJ B-Gene
transducer NN I-Gene
and CC I-Gene
activator NN I-Gene
of IN I-Gene
transcription NN I-Gene
5a CD I-Gene
and CC I-Gene
5b CD I-Gene
( ( I-Gene
STAT5a NNP I-Gene
/ NNP I-Gene
b NN I-Gene
) ) I-Gene
. . O

AG NNP O
- : O
490 CD O
also RB O
inhibited VBN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
- : O
mediated VBN O
proliferative JJ O
growth NN O
in IN O
human JJ O
T NNP O
cells NNS O
with IN O
an DT O
IC50 NNP O
) ) O
= VBD O
25 CD O
microM NN O
that WDT O
was VBD O
partially RB O
recoverable JJ O
. . O

Taken VBN O
together RB O
, , O
these DT O
findings NNS O
suggest VBP O
that IN O
AG NNP O
- : O
490 CD O
inhibits VBZ O
the DT O
JAK3 NNP B-Gene
- : O
mediated VBD O
Type NNP O
II NNP O
signaling VBG O
pathway RB O
but CC O
not RB O
the DT O
T NNP O
cell NN O
receptor NN O
- : O
derived VBN O
Type NNP O
I PRP O
pathway VBP O
and CC O
possesses VBZ O
therapeutic JJ O
potential NN O
for IN O
T NNP O
cell NN O
- : O
derived VBN O
pathologies NNS O
such JJ O
as IN O
graft NN O
- : O
versus NN O
- : O
host NN O
disease NN O
, , O
allergy NN O
, , O
and CC O
autoimmune NN O
disorders NNS O
. . O

Two CD O
- : O
color NN O
immunohistochemistry NN O
demonstrated VBD O
that IN O
both DT O
macrophages NNS O
and CC O
fibroblast JJ O
- : O
like IN O
synoviocytes NNS O
were VBD O
positive JJ O
for IN O
nuclear JJ O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
beta NN I-Gene
. . O

PU NNP B-Gene
. . I-Gene
1 CD I-Gene
is VBZ O
a DT O
hematopoietic JJ B-Gene
- : I-Gene
specific JJ I-Gene
Ets NNP I-Gene
family NN I-Gene
transcription NN I-Gene
factor NN I-Gene
that WDT O
is VBZ O
required VBN O
for IN O
development NN O
of IN O
some DT O
lymphoid NN O
and CC O
myeloid NN O
lineages NNS O
. . O

We PRP O
find VBP O
that DT O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
interacts NNS O
directly RB O
with IN O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
a DT O
zinc NN B-Gene
finger NN I-Gene
transcription NN I-Gene
factor NN I-Gene
required VBN O
for IN O
erythroid JJ O
differentiation NN O
. . O

Both DT O
the DT O
DNA NN B-Gene
binding NN I-Gene
and CC O
transactivation NN B-Gene
domains NNS I-Gene
of IN O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
are VBP O
required VBN O
for IN O
repression NN O
and CC O
both DT O
domains NNS O
are VBP O
also RB O
needed VBN O
to TO O
block VB O
terminal JJ O
differentiation NN O
in IN O
MEL NNP O
cells NNS O
. . O

To TO O
better RBR O
clarify VB O
the DT O
molecular JJ O
basis NN O
of IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
action NN O
, , O
we PRP O
set VBP O
out RP O
to TO O
characterize VB O
genes NNS O
up RP O
- : O
regulated VBN O
by IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
, , O
first RB O
by IN O
contrasting VBG O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
- : O
and CC O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
- : I-Gene
inducible JJ I-Gene
genes NNS I-Gene
. . O

We PRP O
identified VBD O
several JJ O
genes NNS O
up RP O
- : O
regulated VBN O
by IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
, , O
namely RB O
, , O
MIP NNP B-Gene
- : I-Gene
1alpha CD I-Gene
, , O
MIP NNP B-Gene
- : I-Gene
1beta CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
1RA CD I-Gene
, , O
and CC O
IFN NNP B-Gene
regulatory JJ I-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
( ( I-Gene
IRF NNP I-Gene
- : I-Gene
1 CD I-Gene
) ) I-Gene
. . O

Therefore RB O
, , O
IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
may MD O
be VB O
an DT O
important JJ O
contributor NN O
to TO O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
signaling NN O
, , O
and CC O
we PRP O
speculate VBP O
that IN O
the DT O
defective JJ O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
responses NNS O
seen VBN O
in IN O
IRF NNP B-Gene
- : O
1 CD O
- : O
/ NN O
- : O
mice NN O
might MD O
be VB O
attributable JJ O
, , O
in IN O
part NN O
, , O
to TO O
the DT O
absence NN O
of IN O
this DT O
transcription NN B-Gene
factor NN I-Gene
. . O

To TO O
determine VB O
whether IN O
it PRP O
is VBZ O
possible JJ O
to TO O
artificially RB O
enhance VB O
the DT O
opening NN O
of IN O
the DT O
chromatin NN O
structure NN O
of IN O
a DT O
minimal JJ B-Gene
beta NN I-Gene
- : I-Gene
globin NN I-Gene
promoter NN I-Gene
, , O
we PRP O
placed VBD O
a DT O
101bp CD O
, , O
erythroid SYM B-Gene
- : I-Gene
specific JJ I-Gene
DNase NNP I-Gene
1 CD I-Gene
hypersensitive JJ I-Gene
site NN I-Gene
- : I-Gene
forming NN I-Gene
element NN I-Gene
( ( O
HSFE NNP B-Gene
) ) O
immediately RB O
upstream NN O
of IN O
the DT O
beta NN B-Gene
- : I-Gene
globin NN I-Gene
promoter NN I-Gene
and CC I-Gene
gene NN I-Gene
. . O

This DT O
remodeling NN O
of IN O
promoter NN O
chromatin NN O
structure NN O
resulted VBD O
in IN O
3 CD O
- : O
fold NN O
increases NNS O
in IN O
beta NN B-Gene
- : I-Gene
globin NN I-Gene
gene NN I-Gene
transcription NN O
and CC O
induction NN O
, , O
and CC O
inhibited VBD O
long JJ O
- : O
term NN O
beta SYM B-Gene
- : I-Gene
globin NN I-Gene
gene NN I-Gene
silencing NN O
. . O

Regulation NN O
of IN O
low JJ O
shear NN O
flow NN O
- : O
induced JJ O
HAEC NNP O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
and CC O
monocyte JJ O
adhesion NN O
. . O

Here RB O
we PRP O
investigate VBP O
the DT O
hypothesis NN O
that WDT O
low JJ O
shear SYM O
- : O
induced JJ O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
is VBZ O
responsible JJ O
for IN O
enhanced JJ O
expression NN O
of IN O
vascular JJ B-Gene
cell NN I-Gene
adhesion NN I-Gene
molecule NN I-Gene
( ( O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
resulting VBG O
in IN O
augmented VBN O
endothelial NN O
cell NN O
- : O
monocyte NN O
( ( O
EC NNP O
- : O
Mn NN O
) ) O
adhesion NN O
and CC O
that IN O
this DT O
activation NN O
is VBZ O
dependent JJ O
on IN O
intracellular JJ O
oxidant JJ O
activity NN O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
plays VBZ O
a DT O
key JJ O
role NN O
in IN O
low JJ O
shear JJ O
- : O
induced JJ O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
and CC O
that DT O
pathways VBZ O
mediating VBG O
low JJ O
shear JJ O
- : O
and CC O
cytokine VB O
- : O
induced VBN O
EC NNP O
- : O
Mn NNP O
adhesion NN O
may MD O
be VB O
differentially RB O
regulated VBN O
. . O

Nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
90 CD I-Gene
of IN O
activated VBN O
T NNP O
- : O
cells NNS O
: : O
A DT O
double JJ B-Gene
- : I-Gene
stranded VBD I-Gene
RNA NNP I-Gene
- : O
binding NN O
protein NN O
and CC O
substrate NN O
for IN O
the DT O
double JJ B-Gene
- : I-Gene
stranded VBD I-Gene
RNA NNP I-Gene
- : I-Gene
dependent NN I-Gene
protein NN I-Gene
kinase NN I-Gene
, , O
PKR NNP B-Gene
. . O

Using VBG O
in IN O
vitro NN O
translated VBN O
polypeptides NNS O
, , O
we PRP O
have VBP O
demonstrated VBN O
that IN O
NF90 NNP B-Gene
specifically RB O
binds VBZ O
to TO O
double VB B-Gene
- : I-Gene
stranded VBN I-Gene
RNA NNP I-Gene
. . O

C5a NNP O
- : O
induced JJ O
reporter NN B-Gene
gene NN I-Gene
expression NN O
was VBD O
abolished VBN O
by IN O
introducing VBG O
mutations NNS O
into IN O
the DT O
kappaB NN B-Gene
sites NNS I-Gene
and CC O
by IN O
coexpression NN O
of IN O
a DT O
dominant JJ B-Gene
negative JJ I-Gene
IkappaBalpha NNP I-Gene
construct NN I-Gene
resistant NN O
to TO O
agonist VB O
- : O
induced JJ O
phosphorylation NN O
. . O

Pertussis NN O
toxin NN O
, , O
which WDT O
ADP NNP O
- : O
ribosylates VBZ O
the DT O
Gi NNP B-Gene
proteins VBZ I-Gene
known VBN O
to TO O
couple VB O
to TO O
the DT O
C5a NNP B-Gene
receptor NN I-Gene
, , O
produced VBD O
minimal JJ O
inhibition NN O
of IN O
C5a NNP O
- : O
induced VBD O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
expression NN O
and CC O
had VBD O
little JJ O
effect NN O
on IN O
C5a NNP O
- : O
induced JJ O
calcium NN O
mobilization NN O
in IN O
RAW264 NNP O
. . O
7 CD O
cells NNS O
. . O

Patients NNS O
with IN O
GC NNP O
- : O
insensitive JJ O
asthma NN O
expressed VBD O
a DT O
significantly RB O
higher JJR O
number NN O
of IN O
GCRbeta NNP O
- : O
immunoreactive JJ O
cells NNS O
in IN O
their PRP$ O
BAL NNP O
and CC O
peripheral JJ O
blood NN O
than IN O
GC NNP O
- : O
sensitive JJ O
asthmatics NNS O
or CC O
normal JJ O
control NN O
subjects NNS O
. . O

CD40 NNP B-Gene
/ NNP B-Gene
CD40 NNP I-Gene
ligand NN O
interactions NNS O
play VBP O
a DT O
key JJ O
role NN O
in IN O
the DT O
immune JJ O
responses NNS O
of IN O
B NNP O
lymphocytes NNS O
, , O
monocytes NNS O
, , O
and CC O
dendritic JJ O
cells NNS O
. . O

However RB O
, , O
the DT O
components NNS O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
complexes NNS I-Gene
were VBD O
different JJ O
in IN O
monocytes NNS O
and CC O
B NNP O
cells NNS O
, , O
because IN O
p50 NN B-Gene
is VBZ O
part NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
complex NN I-Gene
induced VBN O
by IN O
CD40 NNP B-Gene
triggering VBG O
in IN O
both DT O
monocytes NNS O
and CC O
B NNP O
cells NNS O
, , O
whereas NNS O
p65 NN B-Gene
was VBD O
only RB O
induced VBN O
in IN O
B NNP O
cells NNS O
. . O
In IN O
contrast NN O
, , O
although IN O
the DT O
Janus NNP B-Gene
kinase VBD I-Gene
3 CD I-Gene
tyrosine JJ I-Gene
kinase NN I-Gene
was VBD O
associated VBN O
with IN O
CD40 NNP B-Gene
molecules NNS O
in IN O
both DT O
monocytes NNS O
and CC O
resting VBG O
B NNP O
cells NNS O
, , O
Janus NNP B-Gene
kinase VBD I-Gene
3 CD I-Gene
phosphorylation NN O
induction NN O
was VBD O
observed VBN O
only RB O
in IN O
CD40 NNP O
- : O
activated VBN O
monocytes NNS O
, , O
with IN O
subsequent JJ O
induction NN O
of IN O
STAT5a NNP B-Gene
DNA NNP O
binding VBG O
activity NN O
in IN O
the DT O
nucleus NN O
. . O

Interestingly RB O
, , O
when WRB O
we PRP O
fused VBD O
HT NNP O
- : O
2 CD O
cells NNS O
expressing VBG O
the DT O
EPOR NNP B-Gene
with IN O
Ba NNP O
/ NNP O
F3 NNP O
cells NNS O
in IN O
a DT O
complementation NN O
assay NN O
, , O
the DT O
resulting VBG O
hybridomas NN O
proliferated VBN O
and CC O
potently RB O
activated VBN O
STAT NNP B-Gene
- : I-Gene
5 CD I-Gene
and CC O
MAPK NNP B-Gene
in IN O
response NN O
to TO O
EPO NNP B-Gene
. . O

Moreover RB O
, , O
Ba NNP O
/ NNP O
F3 NNP O
cells NNS O
apparently RB O
express VBP O
this DT O
factor NN O
( ( O
s NN O
) ) O
and CC O
somatic JJ O
fusions NNS O
can MD O
, , O
therefore RB O
, , O
confer VBP O
EPO NNP B-Gene
- : O
responsiveness NN O
to TO O
HT NNP O
- : O
2 CD O
cells NNS O
that WDT O
lack VBP O
this DT O
factor NN O
. . O

When WRB O
a DT O
drug NN O
appears VBZ O
to TO O
be VB O
less RBR O
effective JJ O
than IN O
preclinical JJ O
models NNS O
suggest VBP O
, , O
can MD O
failures NNS O
in IN O
effectiveness NN O
from IN O
delivery NN O
or CC O
dosing VBG O
be VB O
differentiated VBN O
? . O
The DT O
disappointing JJ O
results NNS O
of IN O
clinical JJ O
trials NNS O
with IN O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
- : O
- : O
so RB O
at IN O
odds NNS O
with IN O
the DT O
prediction NN O
of IN O
benefit NN O
from IN O
animal NN O
models NNS O
- : O
- : O
bring NN O
into IN O
question NN O
the DT O
validity NN O
of IN O
those DT O
models NNS O
as RB O
well RB O
as IN O
the DT O
soundness NN O
of IN O
design NN O
of IN O
the DT O
clinical JJ O
trials NNS O
on IN O
which WDT O
efficacy NN O
of IN O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
is VBZ O
judged VBN O
. . O

The DT O
variability NN O
of IN O
response NN O
even RB O
to TO O
the DT O
most RBS O
narrowly RB O
targeted JJ O
agents NNS O
suggests VBZ O
that IN O
these DT O
diseases NNS O
are VBP O
far RB O
more RBR O
heterogeneous JJ O
in IN O
humans NNS O
than IN O
in IN O
their PRP$ O
murine NN O
counterparts NNS O
. . O

Potent NN O
and CC O
stable JJ O
attenuation NN O
of IN O
live JJ O
- : O
HIV NNP O
- : O
1 CD O
by IN O
gain NN O
of IN O
a DT O
proteolysis NN B-Gene
- : I-Gene
resistant JJ I-Gene
inhibitor NN I-Gene
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
( ( O
IkappaB NNP B-Gene
- : I-Gene
alphaS32 NN I-Gene
/ $ I-Gene
36A CD I-Gene
) ) O
and CC O
the DT O
implications NNS O
for IN O
vaccine NN O
development NN O
. . O

These DT O
findings NNS O
illustrate VBP O
gain NN O
- : O
of IN O
- : O
function NN O
as IN O
a DT O
feasible JJ O
strategy NN O
for IN O
developing VBG O
safer JJR O
live JJ O
- : O
attenuated VBN O
HIVs NNP O
to TO O
be VB O
tested VBN O
as IN O
candidates NNS O
for IN O
AIDS NNP O
vaccine NN O
. . O

Multiple NNP O
NF NNP B-Gene
- : I-Gene
ATc NN I-Gene
isoforms NNS I-Gene
with IN O
individual JJ O
transcriptional JJ O
properties NNS O
are VBP O
synthesized VBN O
in IN O
T NNP O
lymphocytes NNS O
. . O

The DT O
transcription NN B-Gene
factor NN I-Gene
NF NNP B-Gene
- : I-Gene
ATc NN I-Gene
that IN O
controls VBZ O
gene NN O
expression NN O
in IN O
T NNP O
lymphocytes NNS O
and CC O
embryonic JJ O
cardiac NN O
cells NNS O
is VBZ O
expressed VBN O
in IN O
three CD O
prominent JJ O
isoforms NNS O
. . O

Various JJ O
stimuli NNS O
of IN O
T NNP O
cells NNS O
that WDT O
induce VBP O
the DT O
activity NN O
of IN O
TAD NNP B-Gene
- : I-Gene
A NNP I-Gene
also RB O
enhance VBZ O
the DT O
activity NN O
of IN O
TAD NNP B-Gene
- : I-Gene
B NN I-Gene
, , O
but CC O
, , O
unlike IN O
TAD NNP B-Gene
- : I-Gene
A NN I-Gene
, , O
TAD NNP B-Gene
- : I-Gene
B NN I-Gene
remains VBZ O
unphosphorylated JJ O
by IN O
protein NN O
from IN O
12 CD O
- : O
O NNP O
- : O
tetradecanoyl NN O
12 CD O
- : O
phorbol NN O
13 CD O
- : O
acetate NN O
- : O
stimulated VBN O
T NNP O
cells NNS O
. . O

Selection NN O
and CC O
long JJ O
- : O
term NN O
persistence NN O
of IN O
reactive JJ O
CTL NNP O
clones NNS O
during IN O
an DT O
EBV NNP O
chronic JJ O
response NN O
are VBP O
determined VBN O
by IN O
avidity NN O
, , O
CD8 NNP B-Gene
variable JJ O
contribution NN O
compensating VBG O
for IN O
differences NNS O
in IN O
TCR NNP B-Gene
affinities NNS O
. . O

We PRP O
found VBD O
a DT O
wide JJ O
range NN O
of IN O
TCR NNP B-Gene
affinities NNS O
among IN O
the DT O
different JJ O
clonotypes NNS O
that WDT O
segregated VBD O
with IN O
Vbeta NNP O
usage NN O
. . O

Nuclear JJ O
localization NN O
and CC O
formation NN O
of IN O
beta NN B-Gene
- : I-Gene
catenin NN I-Gene
- : I-Gene
lymphoid JJ I-Gene
enhancer NN I-Gene
factor NN I-Gene
1 CD I-Gene
complexes NNS I-Gene
are VBP O
not RB O
sufficient JJ O
for IN O
activation NN O
of IN O
gene NN O
expression NN O
. . O

Lymphoid NNP O
cell NN O
differentiation NN O
relies NNS O
on IN O
precisely RB O
orchestrated VBN O
gene NN O
activation NN O
and CC O
repression NN O
events NNS O
. . O

Packaging NN O
of IN O
viral JJ O
particles NNS O
, , O
integration NN O
into IN O
the DT O
target NN O
genome NN O
, , O
and CC O
stability NN O
of IN O
the DT O
integrated VBN O
provirus NN O
are VBP O
not RB O
affected VBN O
by IN O
the DT O
LTR NNP B-Gene
modification NN O
. . O

Enhancer NNP O
replacement NN O
is VBZ O
therefore RB O
an DT O
effective JJ O
strategy NN O
to TO O
target VB O
expression NN O
of IN O
a DT O
retroviral JJ B-Gene
transgene NN I-Gene
to TO O
a DT O
specific JJ O
progeny NN O
of IN O
transduced JJ O
hematopoietic JJ O
stem NN O
cells NNS O
. . O

Regulation NN O
of IN O
Fas NNP B-Gene
ligand NN I-Gene
expression NN O
and CC O
cell NN O
death NN O
by IN O
apoptosis NN B-Gene
- : I-Gene
linked VBN I-Gene
gene NN I-Gene
4 CD I-Gene
. . O

These DT O
results NNS O
indicate VBP O
that IN O
ALG NNP B-Gene
- : I-Gene
4 CD I-Gene
is VBZ O
necessary JJ O
and CC O
sufficient JJ O
for IN O
FasL NNP B-Gene
expression NN O
. . O

We PRP O
now RB O
find VBP O
that IN O
LMP1 NNP B-Gene
signaling VBG O
through IN O
TRADD NNP B-Gene
differs NNS O
from IN O
TNFR1 NNP B-Gene
signaling VBG O
through IN O
TRADD NNP B-Gene
. . O

Inhibition NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
resulted VBD O
in IN O
the DT O
externalization NN O
of IN O
phosphatidylserine NN O
, , O
induction NN O
of IN O
DNA NNP O
breaks NNS O
, , O
and CC O
morphological JJ O
changes NNS O
consistent VBP O
with IN O
apoptosis NN O
. . O

Among IN O
upstream JJ B-Gene
signaling VBG I-Gene
molecules NNS I-Gene
of IN O
ERK NNP B-Gene
, , O
Shc NNP B-Gene
was VBD O
constitutively RB O
associated VBN O
with IN O
Grb2 NNP O
and CC O
was VBD O
not RB O
tyrosine JJ O
- : O
phosphorylated VBN O
by IN O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
and CC O
FMLP NNP O
, , O
and CC O
Sos1 NNP B-Gene
and CC O
c SYM B-Gene
- : I-Gene
Raf NNP I-Gene
- : I-Gene
1 CD I-Gene
were VBD O
not RB O
phosphorylated VBN O
by IN O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
, , O
IL NNP O
- : O
3 CD O
, , O
TNF NNP O
, , O
and CC O
FMLP NNP O
in IN O
monocytes NNS O
, , O
whereas IN O
all PDT O
these DT O
signaling VBG O
molecules NNS O
were VBD O
affected JJ O
and CC O
/ JJ O
or CC O
utilized VBN O
by IN O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
in IN O
MO7e NNP O
cells NNS O
. . O

In IN O
contrast NN O
to TO O
neutrophils NNS O
, , O
p38 NN B-Gene
was VBD O
constitutively RB O
phosphorylated VBN O
and CC O
agonist JJ O
- : O
dependent JJ O
phosphorylation NN O
and CC O
activation NN O
was VBD O
not RB O
detected VBN O
in IN O
human JJ O
monocytes NNS O
. . O

Functional JJ O
analysis NN O
indicates VBZ O
that IN O
the DT O
BRs NNP B-Gene
are VBP O
involved VBN O
in IN O
control NN O
of IN O
hIL JJ B-Gene
- : I-Gene
5 CD I-Gene
promoter NN I-Gene
activity NN O
. . O

PNU156804 NNP O
action NN O
is VBZ O
restricted VBN O
to TO O
some DT O
signaling VBG O
pathways NNS O
; : O
it PRP O
does VBZ O
not RB O
affect VB O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
by IN O
PMA NNP O
in IN O
T NNP O
cells NNS O
but CC O
blocks NNS O
that WDT O
induced VBN O
by IN O
CD40 NNP B-Gene
cross NN O
- : O
linking NN O
in IN O
B NNP O
lymphocytes NNS O
. . O

The DT O
expression NN O
of IN O
STAT1 NNP B-Gene
and CC O
STAT5 NNP B-Gene
in IN O
a DT O
human JJ O
T NNP O
- : O
cell NN O
line NN O
was VBD O
induced VBN O
by IN O
Tax NNP B-Gene
. . O

Transcriptional NNP O
control NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
gene NN O
by IN O
human JJ O
helper NN O
T NNP O
cells NNS O
: : O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
synthesis NN O
is VBZ O
regulated VBN O
independently RB O
from IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
or CC O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
synthesis NN O
. . O

METHODS NN O
: : O
Allergen NNP O
- : O
specific JJ O
T NNP O
- : O
cell NN O
clones NNS O
and CC O
T NNP O
- : O
cell NN O
hybridomas NN O
were VBD O
established VBN O
from IN O
the DT O
peripheral JJ O
blood NN O
lymphocytes NNS O
of IN O
patients NNS O
with IN O
asthma NN O
, , O
and CC O
the DT O
transcriptional JJ O
regulation NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
gene NN I-Gene
was VBD O
investigated VBN O
with IN O
transient JJ O
transfection NN O
and CC O
electrophoretic JJ O
mobility NN O
shift NN O
analysis NN O
. . O

RESULTS NN O
: : O
A DT O
human JJ O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
promoter NN I-Gene
/ NN I-Gene
enhancer SYM I-Gene
- : I-Gene
luciferase NN I-Gene
gene NN I-Gene
construct NN I-Gene
, , O
pIL SYM B-Gene
- : I-Gene
5 CD I-Gene
( ( I-Gene
- : I-Gene
511 CD I-Gene
) ) I-Gene
Luc NNP I-Gene
, , O
was VBD O
transcribed VBN O
on IN O
activation NN O
of IN O
IL NNP O
- : O
5 CD O
- : O
producing VBG O
T NNP O
- : O
cell NN O
clones NNS O
, , O
but CC O
not RB O
IL NNP O
- : O
5 CD O
- : O
nonproducing NN O
clones NNS O
. . O

pIL SYM B-Gene
- : I-Gene
5 CD I-Gene
( ( I-Gene
- : I-Gene
511 CD I-Gene
) ) I-Gene
Luc NNP I-Gene
was VBD O
transcribed VBN O
by IN O
T NNP O
- : O
cell NN O
hybridomas NNS O
derived VBN O
from IN O
fusion NN O
between IN O
IL NNP O
- : O
5 CD O
- : O
producing VBG O
T NNP O
- : O
cell NN O
clones NNS O
and CC O
an DT O
IL NNP O
- : O
5 CD O
gene NN O
- : O
nonexpressing VBG O
T NNP O
- : O
cell NN O
line NN O
, , O
but CC O
not RB O
by IN O
hybridomas NNS O
derived VBN O
from IN O
IL NNP O
- : O
5 CD O
- : O
nonproducing NN O
T NNP O
- : O
cell NN O
clones NNS O
. . O

CONCLUSION NN O
: : O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
synthesis NN O
by IN O
human JJ O
helper NN O
T NNP O
cells NNS O
is VBZ O
regulated VBN O
at IN O
the DT O
transcriptional JJ O
level NN O
. . O

We PRP O
used VBD O
an DT O
adenoviral JJ O
technique NN O
of IN O
blocking VBG O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
through IN O
overexpression NN O
of IN O
the DT O
inhibitory JJ B-Gene
subunit NN I-Gene
IkappaBalpha NNP B-Gene
, , O
which WDT O
has VBZ O
the DT O
advantage NN O
that IN O
it PRP O
can MD O
be VB O
used VBN O
in IN O
the DT O
diseased JJ O
tissue NN O
itself PRP O
, , O
with IN O
> JJ O
90 CD O
% NN O
of IN O
the DT O
synovial JJ O
macrophages NNS O
, , O
fibroblasts NNS O
, , O
and CC O
T NNP O
cells NNS O
infected VBD O
. . O

Of IN O
even RB O
more JJR O
interest NN O
, , O
IkappaBalpha NNP B-Gene
overexpression NN O
inhibited VBD O
the DT O
production NN O
of IN O
matrix NN B-Gene
metalloproteinases NNS I-Gene
1 CD I-Gene
and CC I-Gene
3 CD I-Gene
while IN O
not RB O
affecting VBG O
their PRP$ O
tissue NN O
inhibitor NN O
. . O

This DT O
finding NN O
may MD O
provide VB O
a DT O
tool NN O
to TO O
improve VB O
current JJ O
protocols NNS O
of IN O
immunotherapy NN O
and CC O
insights NNS O
to TO O
how WRB O
tumor NN O
cells NNS O
are VBP O
or CC O
are VBP O
not RB O
killed VBN O
by IN O
LAK NNP O
cells NNS O
. . O

Clonality NNP O
analysis NN O
utilizing VBG O
X NNP B-Gene
- : I-Gene
chromosome NN I-Gene
inactivation NN O
has VBZ O
been VBN O
used VBN O
in IN O
the DT O
study NN O
of IN O
various JJ O
diseases NNS O
, , O
including VBG O
hematological JJ O
malignancies NNS O
. . O

One CD O
problem NN O
in IN O
using VBG O
these DT O
clonality NN O
analysis NN O
methods NNS O
, , O
however RB O
, , O
is VBZ O
that IN O
there EX O
may MD O
be VB O
significant JJ O
variation NN O
in IN O
Lyonization NNP O
in IN O
blood NN O
cells NNS O
in IN O
normal JJ O
individuals NNS O
. . O

We PRP O
also RB O
found VBD O
that IN O
the DT O
deviation NN O
of IN O
methylation NN O
in IN O
granulocytes NNS O
and CC O
T NNP O
cells NNS O
was VBD O
well RB O
correlated VBN O
. . O

Thus RB O
, , O
we PRP O
conclude VBP O
that DT O
appropriate JJ O
controls NNS O
from IN O
the DT O
same JJ O
individuals NNS O
, , O
such JJ O
as IN O
T NNP O
cells NNS O
in IN O
the DT O
case NN O
of IN O
stem NN O
cell NN O
disorders NNS O
, , O
should MD O
always RB O
be VB O
employed VBN O
to TO O
conclusively RB O
determine VB O
whether IN O
certain JJ O
cells NNS O
of IN O
hematopoietic JJ O
origin NN O
are VBP O
clonal JJ O
. . O

A DT O
high JJ O
expression NN O
of IN O
WT1 NNP B-Gene
has VBZ O
been VBN O
detected VBN O
in IN O
a DT O
range NN O
of IN O
acute NN O
leukemias NN O
, , O
and CC O
WT1 NNP B-Gene
is VBZ O
downregulated VBN O
during IN O
induced JJ O
differentiation NN O
of IN O
some DT O
leukemic JJ O
cell NN O
lines NNS O
. . O

K562 NNP O
cells NNS O
express RB O
endogenous JJ O
WT1 NNP B-Gene
, , O
which WDT O
is VBZ O
downregulated VBN O
as IN O
a DT O
response NN O
to TO O
induced VB O
differentiation NN O
along IN O
the DT O
erythroid NN O
and CC O
megakaryocytic JJ O
pathways NNS O
. . O

However RB O
, , O
activation NN O
of IN O
STAT6 NNP B-Gene
, , O
CD23 NNP B-Gene
expression NN O
, , O
and CC O
IgE NNP B-Gene
synthesis NN O
induced VBN O
by IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
were VBD O
not RB O
affected VBN O
in IN O
p47phox JJ O
- : O
deficient NN O
patients NNS O
, , O
which WDT O
raises VBZ O
the DT O
possibility NN O
that IN O
p47phox NN O
may MD O
be VB O
important JJ O
in IN O
other JJ O
signaling VBG O
activities NNS O
as RB O
well RB O
in IN O
B NNP O
cells NNS O
. . O

METHODS NN O
: : O
Protein NNP O
production NN O
in IN O
supernatants NNS O
was VBD O
assessed VBN O
by IN O
ELISA NNP O
, , O
and CC O
mRNA JJS B-Gene
expression NN O
was VBD O
evaluated VBN O
by IN O
semiquantitative JJ O
RT NNP O
- : O
PCR NN O
. . O

On IN O
the DT O
contrary JJ O
, , O
the DT O
release NN O
of IN O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
was VBD O
significantly RB O
inhibited VBN O
, , O
also RB O
in IN O
a DT O
dose JJ O
- : O
dependent JJ O
manner NN O
. . O

Messenger NNP B-Gene
RNA NNP I-Gene
production NN O
coding VBG O
for IN O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
, , O
RANTES NNP B-Gene
, , O
and CC O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
showed VBD O
parallel JJ O
variations NNS O
to TO O
the DT O
production NN O
of IN O
the DT O
correspondent NN B-Gene
proteins NNS I-Gene
. . O

Furthermore RB O
, , O
SLP NNP B-Gene
- : I-Gene
76 CD I-Gene
and CC O
Vav NNP B-Gene
have VBP O
a DT O
synergistic JJ O
effect NN O
on IN O
interleukin NN B-Gene
( ( I-Gene
IL NNP I-Gene
) ) I-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
activity NN O
in IN O
T NNP O
cells NNS O
. . O

Surprisingly RB O
, , O
we PRP O
find VBP O
also RB O
that IN O
the DT O
interaction NN O
between IN O
SLP NNP B-Gene
- : I-Gene
76 CD I-Gene
and CC O
Vav NNP B-Gene
is VBZ O
not RB O
required VBN O
for IN O
their PRP$ O
cooperation NN O
in IN O
augmenting VBG O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
activity NN O
, , O
as IN O
the DT O
two CD O
molecules NNS O
appear VBP O
to TO O
function VB O
in IN O
different JJ O
signaling VBG O
pathways JJ O
upstream NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
expression NN O
. . O

In IN O
contrast NN O
, , O
overexpression NN O
of IN O
Vav NNP B-Gene
leads VBZ O
to TO O
enhanced VB O
nuclear JJ B-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
cells NNS I-Gene
activity NN O
without IN O
affecting VBG O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Additionally RB O
, , O
overexpression NN O
of IN O
Vav NNP B-Gene
, , O
but CC O
not RB O
SLP NNP B-Gene
- : I-Gene
76 CD I-Gene
, , O
augments NNS O
CD28 NNP O
- : O
induced VBD O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
activity NN O
. . O

Here RB O
, , O
we PRP O
show VBP O
that IN O
Jagged1 NNP B-Gene
is VBZ O
a DT O
Rel NNP B-Gene
/ NNP I-Gene
NF NNP I-Gene
- : I-Gene
kappaB NN I-Gene
- : I-Gene
responsive JJ I-Gene
gene NN I-Gene
. . O

This DT O
correlated VBN O
with IN O
the DT O
initiation NN O
of IN O
signaling VBG O
downstream NN O
of IN O
Notch NNP O
, , O
as IN O
evidenced VBN O
by IN O
increased JJ O
levels NNS O
of IN O
HES NNP B-Gene
- : I-Gene
1 CD I-Gene
transcripts NNS I-Gene
in IN O
co NN O
- : O
cultivated VBN O
T NNP O
cells NNS O
and CC O
of IN O
CD23 NNP B-Gene
transcripts NNS I-Gene
in IN O
co NN O
- : O
cultivated VBN O
B NNP O
cells NNS O
. . O

Our PRP$ O
results NNS O
demonstrated VBD O
that IN O
: : O
( ( O
i NN O
) ) O
PGN NNP O
induced JJ O
phosphorylation NN O
of IN O
the DT O
transcription NN B-Gene
factors NNS I-Gene
ATF NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
CREB NNP B-Gene
; : O
( ( O
ii NN O
) ) O
ATF NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
CREB NNP B-Gene
bound RB O
DNA NNP O
as IN O
a DT O
dimer NN O
and CC O
induced JJ O
transcriptional JJ O
activation NN O
of IN O
a DT O
CRE NNP B-Gene
reporter NN I-Gene
plasmid NN I-Gene
, , O
which WDT O
was VBD O
inhibited VBN O
by IN O
dominant JJ O
negative JJ O
CREB NNP B-Gene
and CC O
ATF NNP B-Gene
- : I-Gene
1 CD I-Gene
; : O
( ( O
iii NN O
) ) O
PGN NNP O
induced JJ O
phosphorylation NN O
of IN O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
, , O
protein JJ O
synthesis NN O
of IN O
JunB NNP B-Gene
and CC O
c SYM B-Gene
- : I-Gene
Fos NN I-Gene
, , O
and CC O
transcriptional JJ O
activation NN O
of IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
reporter NN I-Gene
plasmid NN I-Gene
, , O
which WDT O
was VBD O
inhibited VBN O
by IN O
dominant JJ O
negative JJ O
c SYM B-Gene
- : I-Gene
Fos NN I-Gene
; : O
and CC O
( ( O
iv NN O
) ) O
PGN NNP O
- : O
induced JJ O
activation NN O
of IN O
CREB NNP B-Gene
/ NNP I-Gene
ATF NNP I-Gene
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
was VBD O
mediated VBN O
through IN O
CD14 NNP B-Gene
. . O

In IN O
contrast NN O
to TO O
these DT O
findings NNS O
, , O
mucosal NN O
hGR NN B-Gene
levels NNS O
were VBD O
significantly RB O
decreased VBN O
in IN O
both DT O
steroid JJ O
- : O
treated VBN O
( ( O
18 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
15 CD O
. . O
5 CD O
) ) O
and CC O
not RB O
steroid VB O
- : O
treated VBN O
( ( O
37 CD O
. . O
8 CD O
+ JJ O
/ NNP O
- : O
30 CD O
. . O
5 CD O
) ) O
patients NNS O
compared VBN O
with IN O
control NN O
subjects NNS O
( ( O
125 CD O
. . O
6 CD O
+ JJ O
/ NNP O
- : O
97 CD O
. . O
1 CD O
; : O
P NNP O
= VBD O
0 CD O
. . O
9 CD O
and CC O
P NNP O
= NNP O
0 CD O
. . O
8 CD O
respectively RB O
) ) O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
created VBD O
transgenic JJ O
mice NN O
overexpressing VBG O
ICSAT NNP B-Gene
in IN O
lymphocytes NNS O
. . O

Altered NNP O
memory NN O
T NNP O
cell NN O
differentiation NN O
in IN O
patients NNS O
with IN O
early JJ O
rheumatoid NN O
arthritis NN O
. . O

A DT O
cell NN O
culture NN O
system NN O
was VBD O
then RB O
employed VBN O
that IN O
permitted VBD O
the DT O
differentiation NN O
of IN O
Th NNP B-Gene
effectors NNS I-Gene
from IN O
resting VBG O
memory NN O
T NNP O
cells NNS O
by IN O
short JJ O
term NN O
priming NN O
. . O

Our PRP$ O
findings NNS O
offer VBP O
important JJ O
insights NNS O
into IN O
parasite JJ O
survival NN O
strategies NNS O
and CC O
demonstrate VB O
that IN O
parasite JJ O
- : O
induced JJ O
constitutive JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
is VBZ O
an DT O
essential JJ O
step NN O
in IN O
maintaining VBG O
the DT O
transformed JJ O
phenotype NN O
of IN O
the DT O
infected JJ O
cells NNS O
. . O

A DT O
polymorphism NN O
that WDT O
affects VBZ O
OCT NNP B-Gene
- : I-Gene
1 CD I-Gene
binding NN O
to TO O
the DT O
TNF NNP B-Gene
promoter NN I-Gene
region NN I-Gene
is VBZ O
associated VBN O
with IN O
severe JJ O
malaria NNS O
[ VBP O
see VBP O
comments NNS O
] VB O

The DT O
results NNS O
show VBP O
that IN O
the DT O
CYP1A1 NNP B-Gene
mRNA MD I-Gene
level VB O
induced VBN O
by IN O
UV NNP O
in IN O
the DT O
presence NN O
of IN O
tryptophan NN O
was VBD O
higher JJR O
than IN O
that DT O
induced VBN O
by IN O
UV NNP O
alone RB O
in IN O
both DT O
HaCaT NNP O
cells NNS O
and CC O
lymphocytes NNS O
after IN O
3 CD O
h NN O
of IN O
incubation NN O
post NN O
- : O
UV NNP O
irradiation NN O
. . O

Wild NNP O
- : O
type NN O
( ( O
wt NN O
) ) O
cells NNS O
were VBD O
inducible JJ O
either RB O
by IN O
the DT O
tryptophan NN O
photoproduct NN O
6 CD O
- : O
formylindolo NN O
[ VBZ O
3 CD O
, , O
2 CD O
- : O
b NN O
] JJ O
carbazole NN O
( ( O
FICZ NNP O
) ) O
or CC O
by IN O
UV NNP O
- : O
irradiation NN O
but CC O
very RB O
low JJ O
or CC O
undetectable JJ O
levels NNS O
were VBD O
observed VBN O
in IN O
the DT O
c12 NN O
cells NNS O
. . O

This DT O
shows VBZ O
that IN O
the DT O
induction NN O
of IN O
gene NN O
expression NN O
by IN O
FICZ NNP O
and CC O
UV NNP O
is VBZ O
Ah NNP B-Gene
receptor NN I-Gene
dependent NN O
. . O

Thus RB O
, , O
the DT O
photoproducts NNS O
of IN O
tryptophan NN O
are VBP O
suggested VBN O
to TO O
be VB O
mediators NNS O
of IN O
light JJ O
via IN O
binding VBG O
to TO O
the DT O
Ah NNP B-Gene
receptor NN I-Gene
and CC O
as IN O
such JJ O
also RB O
could MD O
have VB O
a DT O
role NN O
in IN O
light JJ O
- : O
regulated JJ O
biological JJ O
rhythms NN O
. . O

Repression NN O
by IN O
Ikaros NNP B-Gene
and CC O
Aiolos NNP B-Gene
is VBZ O
mediated VBN O
through IN O
histone NN B-Gene
deacetylase NN I-Gene
complexes NNS I-Gene
. . O

To TO O
better JJR O
understand NN O
signals NNS O
controlling VBG O
proliferation NN O
and CC O
viability NN O
, , O
erythroid JJ O
cells NNS O
that IN O
resist JJ O
apoptosis NN O
in IN O
the DT O
absence NN O
of IN O
EPO NNP B-Gene
were VBD O
subcloned VBN O
and CC O
characterized VBN O
( ( O
HCD57 NNP O
- : O
SREI NNP O
cells NNS O
) ) O
. . O

Enforced NNP O
expression NN O
of IN O
Id3 NNP B-Gene
, , O
which WDT O
has VBZ O
the DT O
capacity NN O
to TO O
inhibit VB O
many JJ O
basic JJ B-Gene
helix NN I-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
( ( I-Gene
bHLH NN I-Gene
) ) I-Gene
transcription NN I-Gene
factors NNS I-Gene
, , O
in IN O
human JJ O
CD34 NNP O
( ( O
+ NNP O
) ) O
hematopoietic JJ O
progenitor NN O
cells NNS O
that WDT O
have VBP O
not RB O
undergone JJ O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
( ( I-Gene
TCR NNP I-Gene
) ) I-Gene
gene NN I-Gene
rearrangements NNS I-Gene
inhibits VBZ O
development NN O
of IN O
the DT O
transduced JJ O
cells NNS O
into IN O
TCRalpha NNP O
beta NN O
and CC O
gamma NN O
delta NN O
cells NNS O
in IN O
a DT O
fetal JJ O
thymic JJ O
organ JJ O
culture NN O
( ( O
FTOC NNP O
) ) O
. . O

These DT O
cells NNS O
had VBD O
properties NNS O
of IN O
both DT O
natural JJ O
killer NN O
( ( O
NK NNP O
) ) O
and CC O
pre $ O
- : O
T NNP O
cells NNS O
. . O

HIV NNP O
- : O
1 CD O
reactivation NN O
in IN O
resting VBG O
peripheral JJ O
blood NN O
mononuclear JJ O
cells NNS O
of IN O
infected JJ O
adults NNS O
upon IN O
in IN O
vitro NN O
CD4 NNP B-Gene
cross NN O
- : O
linking NN O
by IN O
ligands NNS O
of IN O
the DT O
CDR2 NNP B-Gene
- : I-Gene
loop NN I-Gene
in IN O
extracellular JJ B-Gene
domain NN I-Gene
1 CD I-Gene
. . O

Additionally RB O
, , O
virus JJ O
reactivation NN O
in IN O
resting VBG O
PBMCs NNP O
infected VBN O
in IN O
vitro NN O
with IN O
HIV NNP O
- : O
1 CD O
was VBD O
found VBN O
to TO O
be VB O
specifically RB O
induced VBN O
by IN O
ligands NNS O
of IN O
the DT O
CDR2 NNP B-Gene
- : I-Gene
loop NN I-Gene
in IN O
domain NN B-Gene
1 CD I-Gene
( ( O
D1 NNP B-Gene
) ) O
of IN O
CD4 NNP B-Gene
( ( O
virus IN B-Gene
envelope NN I-Gene
and CC I-Gene
anti JJ I-Gene
- : I-Gene
CD4 NNP I-Gene
monoclonal JJ I-Gene
antibodies NNS I-Gene
) ) O
. . O

In IN O
contrast NN O
, , O
virus JJ O
reactivation NN O
was VBD O
not RB O
observed VBN O
following VBG O
CD4 NNP B-Gene
oligomerization NN O
by IN O
antibodies NNS B-Gene
that WDT O
bind VBP O
other JJ O
epitopes NNS O
in IN O
D1 NNP B-Gene
, , O
including VBG O
the DT O
D1 NNP B-Gene
/ NNP I-Gene
CDR3 NNP I-Gene
- : I-Gene
loop NN I-Gene
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
the DT O
signaling VBG O
events NNS O
initiated VBN O
in IN O
PBMCs NNP O
by IN O
oligomerization NN O
of IN O
CD4 NNP B-Gene
at IN O
the DT O
D1 NNP B-Gene
/ NNP I-Gene
CDR2 NNP I-Gene
- : I-Gene
loop NN I-Gene
can MD O
trigger VB O
HIV NNP O
- : O
1 CD O
upregulation NN O
in IN O
infected JJ O
individuals NNS O
. . O

Signaling VBG O
through IN O
the DT O
lymphotoxin NN B-Gene
- : I-Gene
beta NN I-Gene
receptor NN I-Gene
stimulates VBZ O
HIV NNP O
- : O
1 CD O
replication NN O
alone RB O
and CC O
in IN O
cooperation NN O
with IN O
soluble JJ O
or CC O
membrane JJ B-Gene
- : I-Gene
bound NN I-Gene
TNF NNP I-Gene
- : I-Gene
alpha NN I-Gene
. . O

The DT O
level NN O
of IN O
ongoing VBG O
HIV NNP O
- : O
1 CD O
replication NN O
within IN O
an DT O
individual NN O
is VBZ O
critical JJ O
to TO O
HIV NNP O
- : O
1 CD O
pathogenesis NN O
. . O

Given VBN O
the DT O
critical JJ O
role NN O
that IN O
LT NNP B-Gene
- : I-Gene
alpha1beta2 NN I-Gene
plays NNS O
in IN O
lymphoid JJ O
architecture NN O
, , O
we PRP O
speculate VBP O
that IN O
LT NNP B-Gene
- : I-Gene
alpha1beta2 NN I-Gene
may MD O
be VB O
involved VBN O
in IN O
HIV NNP O
- : O
associated JJ O
abnormalities NNS O
of IN O
the DT O
lymphoid JJ O
organs NNS O
. . O

The DT O
secretion NN O
levels NNS O
of IN O
interleukin JJ B-Gene
- : I-Gene
6 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
) ) O
and CC O
von JJ O
Willebrand NNP O
factor NN O
( ( O
vWF NN O
) ) O
were VBD O
determined VBN O
, , O
to TO O
serve VB O
as IN O
markers NNS O
for IN O
EC NNP O
activation NN O
. . O

In IN O
addition NN O
, , O
nuclear JJ O
extracts NNS O
of IN O
the DT O
mAECA NN O
- : O
treated VBN O
EC NNP O
were VBD O
analyzed VBN O
for IN O
the DT O
induction NN O
of IN O
translocation NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
kappaB NN I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
) ) O
, , O
using VBG O
a DT O
specific JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
oligoprobe NN O
in IN O
an DT O
electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
. . O

The DT O
mAECA NN B-Gene
, , O
but CC O
not RB O
normal JJ B-Gene
human JJ I-Gene
IgG NNP I-Gene
, , O
had VBD O
anti VBN O
- : O
human JJ O
aortic JJ O
EC NNP O
activity NN O
. . O

Four CD O
of IN O
the DT O
6 CD O
mAECA NN B-Gene
activated VBD O
EC NNP O
, , O
manifested VBN O
by IN O
increased JJ O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
and CC O
vWF JJ O
secretion NN O
. . O

However RB O
NF NNP B-Gene
- : I-Gene
ATs NN I-Gene
appear VBP O
in IN O
the DT O
nuclei NN O
of IN O
IL NNP O
- : O
4 CD O
- : O
, , O
IL NNP O
- : O
5 CD O
- : O
, , O
or CC O
ionomycin SYM O
- : O
stimulated VBN O
eosinophils NNS O
. . O

Both DT O
PPARalpha NNP B-Gene
activators NNS O
decreased VBD O
cytokine JJ O
- : O
induced JJ O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA JJ O
expression NN O
without IN O
altering VBG O
its PRP$ O
mRNA NN O
half NN O
- : O
life NN O
. . O

Such JJ O
findings NNS O
also RB O
have VBP O
implications NNS O
regarding VBG O
the DT O
clinical JJ O
use NN O
of IN O
lipid JJ O
- : O
lowering VBG O
agents NNS O
, , O
like IN O
fibric JJ O
acids NNS O
, , O
which WDT O
can MD O
activate VB O
PPARalpha NNP B-Gene
. . O

CBP NNP B-Gene
/ NNP I-Gene
p300 NN I-Gene
integrates VBZ O
Raf NNP B-Gene
/ NNP O
Rac NNP B-Gene
- : O
signaling VBG O
pathways NNS O
in IN O
the DT O
transcriptional JJ O
induction NN O
of IN O
NF NNP B-Gene
- : I-Gene
ATc NNP I-Gene
during IN O
T NNP O
cell NN O
activation NN O
. . O

We PRP O
have VBP O
carried VBN O
out RP O
a DT O
detailed JJ O
analysis NN O
of IN O
the DT O
cellular JJ O
immune JJ O
functions NNS O
of IN O
breast NN O
cancer NN O
patients NNS O
in IN O
comparison NN O
with IN O
healthy JJ O
controls NNS O
. . O

Inhibition NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
has VBZ O
been VBN O
achieved VBN O
by IN O
pharmacological JJ O
and CC O
genetic JJ O
approaches NNS O
; : O
however RB O
, , O
monocyte JJ O
interactions NNS O
with IN O
activated JJ O
endothelium NN O
in IN O
shear JJ O
flow NN O
following VBG O
gene NN O
transfer NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
inhibitor NN O
IkappaB NNP B-Gene
- : I-Gene
alpha NN I-Gene
have VBP O
not RB O
been VBN O
studied VBN O
. . O

This DT O
was VBD O
associated VBN O
with IN O
a DT O
reduction NN O
in IN O
endothelial JJ O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
secretion NN O
and CC O
GRO NNP B-Gene
- : I-Gene
alpha NN I-Gene
immobilization NN O
. . O

Adhesion NNP O
assays NNS O
under IN O
physiological JJ O
shear JJ O
flow NN O
conditions NNS O
showed VBD O
that IN O
firm NN O
arrest NN O
, , O
spreading NN O
, , O
and CC O
transmigration NN O
of IN O
monocytes NNS O
on IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
- : O
activated JJ O
endothelium NN O
was VBD O
markedly RB O
inhibited VBN O
by IN O
IkappaB NNP B-Gene
- : I-Gene
alpha NN I-Gene
overexpression NN O
. . O

In IN O
contrast NN O
, , O
rolling VBG O
of IN O
monocytes NNS O
was VBD O
increased VBN O
by IN O
IkappaB NNP B-Gene
- : I-Gene
alpha NN I-Gene
transfer NN O
and CC O
was VBD O
partly RB O
mediated VBN O
by IN O
P NNP B-Gene
- : I-Gene
selectin NN I-Gene
; : O
however RB O
, , O
it PRP O
appeared VBD O
to TO O
be VB O
unaffected VBN O
by IN O
the DT O
inhibition NN O
of IN O
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
induction NN O
. . O

Copyright JJ O
1999 CD O
Academic NNP O
Press NNP O
. . O

The DT O
effect NN O
of IN O
oestrogens NNS O
on IN O
oestrogen NN O
- : O
receptive JJ O
organs NNS O
and CC O
cells NNS O
is VBZ O
mediated VBN O
via IN O
intracellular JJ B-Gene
receptors NNS I-Gene
( ( O
ERalpha NNP B-Gene
and CC O
ERbeta NNP B-Gene
) ) O
. . O

All DT O
tissues NNS O
and CC O
cells NNS O
studied VBN O
were VBD O
homozygous JJ O
for IN O
the DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
gene NN I-Gene
, , O
and CC O
were VBD O
heterozygous JJ O
as RB O
well RB O
as IN O
homozygous JJ O
for IN O
the DT O
codon NN B-Gene
- : I-Gene
10 CD I-Gene
- : I-Gene
variant NN I-Gene
type NN I-Gene
. . O

These DT O
results NNS O
indicate VBP O
that IN O
the DT O
presence NN O
of IN O
the DT O
codon NN B-Gene
- : I-Gene
10 CD I-Gene
- : I-Gene
variant NN I-Gene
type NN I-Gene
is VBZ O
not RB O
a DT O
characteristic NN O
of IN O
breast NN O
cancer NN O
. . O

USF NNP B-Gene
/ NNP I-Gene
c SYM I-Gene
- : I-Gene
Myc NNP I-Gene
enhances NNS O
, , O
while IN O
Yin NNP B-Gene
- : I-Gene
Yang VBD I-Gene
1 CD I-Gene
suppresses NNS O
, , O
the DT O
promoter NN O
activity NN O
of IN O
CXCR4 NNP B-Gene
, , O
a DT O
coreceptor NN B-Gene
for IN O
HIV NNP O
- : O
1 CD O
entry NN O
. . O

We PRP O
have VBP O
identified VBN O
an DT O
E NNP B-Gene
box NN I-Gene
around IN O
- : B-Gene
260 CD I-Gene
and CC O
a DT O
YY1 NNP B-Gene
binding NN I-Gene
site NN I-Gene
around IN O
- : B-Gene
300 CD I-Gene
relative NN O
to TO O
the DT O
transcription NN B-Gene
start NN I-Gene
site NN I-Gene
. . O

RCC NNP O
- : O
S NN O
did VBD O
not RB O
alter VB O
the DT O
cytoplasmic JJ O
levels NNS O
of IN O
RelA NNP B-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappaB1 NN I-Gene
but CC O
did VBD O
suppress VB O
their PRP$ O
nuclear JJ O
localization NN O
and CC O
inhibited VBD O
the DT O
activation NN O
of IN O
RelA NNP B-Gene
/ NNP I-Gene
NF NNP I-Gene
- : I-Gene
kappaB1 NN I-Gene
binding NN I-Gene
complexes NNS I-Gene
. . O

These DT O
results NNS O
show VBP O
that IN O
RCC NNP O
- : O
S NN O
can MD O
induce VB O
in IN O
normal JJ O
T NNP O
cells NNS O
the DT O
same JJ O
phenotype NN O
of IN O
impaired JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
that WDT O
is VBZ O
detected VBN O
in IN O
T NNP O
cells NNS O
of IN O
RCC NNP O
patient NN O
. . O

Human NNP O
monocytes NNS O
isolated VBD O
from IN O
peripheral JJ O
blood NN O
of IN O
healthy JJ O
donors NNS O
show VBP O
a DT O
time NN O
- : O
dependent JJ O
differentiation NN O
into IN O
macrophages NNS O
upon IN O
in IN O
vitro JJ O
cultivation NN O
, , O
closely RB O
mimicking VBG O
their PRP$ O
in IN O
vivo NN O
migration NN O
and CC O
maturation NN O
into IN O
extravascular JJ O
tissues NNS O
. . O

The DT O
mediator NN O
( ( O
s JJ O
) ) O
of IN O
this DT O
maturation NN O
process NN O
has VBZ O
not RB O
been VBN O
yet RB O
defined VBN O
. . O

We PRP O
investigated VBD O
the DT O
involvement NN O
of IN O
signal JJ B-Gene
transducers NNS I-Gene
and CC I-Gene
activators NNS I-Gene
of IN I-Gene
transcription NN I-Gene
( ( I-Gene
STAT NNP I-Gene
) ) I-Gene
factors NNS I-Gene
in IN O
this DT O
phenomenon NN O
and CC O
reported VBD O
the DT O
specific NN O
, , O
time NN O
- : O
dependent NN O
, , O
activation NN O
of IN O
STAT1 NNP B-Gene
protein NN O
starting VBG O
at IN O
day NN O
0 CD O
/ JJ O
1 CD O
of IN O
cultivation NN O
and CC O
maximally RB O
expressed VBN O
at IN O
day NN O
5 CD O
. . O

STAT1 NNP B-Gene
activity NN O
was VBD O
evident JJ O
on IN O
the DT O
STAT NNP B-Gene
binding NN I-Gene
sequences NNS I-Gene
( ( O
SBE NNP B-Gene
) ) O
present NN O
in IN O
the DT O
promoters NNS B-Gene
of IN O
genes NNS O
which WDT O
are VBP O
up RP O
- : O
regulated VBN O
during IN O
monocyte NN O
to TO O
macrophage VB O
maturation NN O
such JJ O
as IN O
FcgammaRI NNP B-Gene
and CC O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
in IN O
the DT O
promoter NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
IFN NNP I-Gene
regulatory JJ I-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
. . O

Compared VBN O
with IN O
monocytes NNS O
adherent VBP O
on IN O
plastic NN O
surfaces NNS O
, , O
freshly RB O
isolated JJ O
cells NNS O
allowed VBN O
to TO O
adhere VB O
either RB O
to TO O
fibronectin VB O
- : O
or CC O
laminin VB O
- : O
coated VBN O
flasks NNS O
exhibited VBD O
an DT O
increased VBN O
STAT1 NNP B-Gene
binding NN O
activity NN O
both DT O
in IN O
control NN O
and CC O
in IN O
IFN NNP O
- : O
gamma NN O
- : O
treated JJ O
cells NNS O
. . O

Thereafter RB O
, , O
PML NNP B-Gene
is VBZ O
downmodulated VBN O
in IN O
late JJ O
granulocytic JJ O
maturation NN O
, , O
whereas IN O
it PRP O
is VBZ O
sustainably RB O
expressed VBN O
through IN O
the DT O
erythroid JJ O
pathway NN O
. . O

Furthermore RB O
, , O
PML NNP B-Gene
and CC O
pRb $ B-Gene
105 CD I-Gene
were VBD O
co VBN O
- : O
immunoprecipitated VBN O
in IN O
cellular JJ O
lysates NNS O
derived VBN O
from IN O
erythroid JJ O
precursors NNS O
indicating VBG O
that IN O
this DT O
functional JJ O
interaction NN O
may MD O
have VB O
a DT O
biochemical JJ O
basis NN O
. . O

Endogenous JJ O
and CC O
therapeutic JJ O
steroid NN O
hormones NNS O
affect VBP O
the DT O
immune NN O
system NN O
, , O
and CC O
inflammatory JJ O
diseases NNS O
are VBP O
associated VBN O
with IN O
activation NN O
of IN O
the DT O
hypothalamic JJ O
- : O
pituitary JJ O
- : O
adrenal JJ O
axis NN O
, , O
providing VBG O
evidence NN O
of IN O
an DT O
immune JJ O
- : O
endocrine NN O
interplay NN O
. . O

No DT O
effect NN O
of IN O
age NN O
, , O
sex NN O
, , O
course NN O
, , O
duration NN O
or CC O
severity NN O
of IN O
disease NN O
, , O
or CC O
prior RB O
steroid JJ O
treatments NNS O
was VBD O
detected VBN O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
the DT O
physiological JJ O
relationship NN O
between IN O
binding VBG O
and CC O
function NN O
of IN O
the DT O
glucocorticoid NN B-Gene
receptor NN I-Gene
is VBZ O
disturbed VBN O
in IN O
MS NNP O
. . O

Treatment NN O
of IN O
cells NNS O
with IN O
PD98059 NNP O
, , O
a DT O
specific JJ O
inhibitor NN O
of IN O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
kinase NN I-Gene
( ( O
MEK NNP B-Gene
) ) O
, , O
inhibited VBN O
TPA NNP O
- : O
induced JJ O
ERK2 NNP B-Gene
activity NN O
. . O

METHODS NN O
: : O
Twenty CD O
- : O
two CD O
patients NNS O
with IN O
severe JJ O
restrictive JJ O
anorexia NN O
nervosa NN O
, , O
10 CD O
patients NNS O
with IN O
active JJ O
Cushing NNP O
' POS O
s NN O
disease NN O
, , O
and CC O
24 CD O
healthy JJ O
volunteers NNS O
without IN O
psychiatric JJ O
disorders NNS O
or CC O
mood NN O
alterations NNS O
were VBD O
investigated VBN O
. . O

RESULTS NN O
: : O
The DT O
number NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
on IN O
mononuclear JJ O
leukocytes NNS O
( ( O
MNL NNP O
) ) O
was VBD O
comparable JJ O
in IN O
patients NNS O
with IN O
anorexia JJ O
nervosa NNS O
, , O
patients NNS O
with IN O
active JJ O
Cushing NNP O
' POS O
s NN O
disease NN O
, , O
and CC O
normal JJ O
subjects NNS O
( ( O
binding VBG O
capacity NN O
3 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
23 CD O
vs NN O
. . O
3 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
30 CD O
and CC O
3 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
20 CD O
fmol JJ O
/ NN O
10 CD O
( ( O
6 CD O
) ) O
cells NNS O
) ) O
. . O

In IN O
patients NNS O
with IN O
anorexia JJ O
nervosa NN O
, , O
the DT O
incorporation NN O
of IN O
[ $ O
3H CD O
] JJ O
thymidine NN O
into IN O
the DT O
MNL NNP O
was VBD O
inversely RB O
correlated VBN O
with IN O
urinary JJ O
free JJ O
cortisol NN O
levels NNS O
. . O

Different NN O
sequence NN O
requirements NNS O
for IN O
expression NN O
in IN O
erythroid NN O
and CC O
megakaryocytic JJ O
cells NNS O
within IN O
a DT O
regulatory JJ B-Gene
element NN I-Gene
upstream NN O
of IN O
the DT O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
. . O

We PRP O
have VBP O
localized VBN O
a DT O
317 CD O
base NN O
pair NN O
cis SYM B-Gene
- : I-Gene
acting VBG I-Gene
regulatory JJ I-Gene
element NN I-Gene
, , O
HS NNP B-Gene
I PRP I-Gene
, , O
associated VBN O
with IN O
a DT O
hematopoietic JJ B-Gene
- : I-Gene
specific JJ I-Gene
DNase NNP I-Gene
I PRP I-Gene
hypersensitive VBP I-Gene
site NN I-Gene
, , O
which WDT O
lies VBZ O
approx NN O
. . O

This DT O
core NN O
contains VBZ O
a DT O
GATA NNP B-Gene
site NN I-Gene
separated VBN O
by IN O
10 CD O
base NN O
pairs NN O
from IN O
an DT O
E NNP B-Gene
- : I-Gene
box NN I-Gene
motif NN I-Gene
. . O

In IN O
addition NN O
, , O
sodium NN O
salicylate NN O
and CC O
additional JJ O
NSAIDs NNP O
used VBD O
at IN O
concentrations NNS O
that WDT O
activate VBP O
HSF1 NNP B-Gene
also RB O
inhibited VBD O
the DT O
expression NN O
of IN O
other JJ O
monocytic JJ B-Gene
genes NNS I-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
, , O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
, , O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
activated VBN O
by IN O
exposure NN O
to TO O
a DT O
pro JJ O
- : O
inflammatory NN O
stimulus NN O
( ( O
lipopolysaccharide JJ O
, , O
LPS NNP O
) ) O
. . O

Copyright JJ O
1999 CD O
Academic NNP O
Press NNP O
. . O

Fibroblast NNP B-Gene
growth NN I-Gene
factors NNS I-Gene
( ( O
FGFs NNP B-Gene
) ) O
are VBP O
heparin JJ B-Gene
- : I-Gene
binding NN I-Gene
proteins VBZ I-Gene
crucial JJ O
to TO O
embryogenesis VB O
, , O
angiogenesis NN O
, , O
and CC O
wound IN O
healing NN O
. . O

FGF NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
abundantly RB O
expressed VBN O
in IN O
the DT O
synovium NN O
in IN O
rheumatoid JJ O
arthritis NN O
and CC O
in IN O
rejecting VBG O
allografts NNS O
, , O
sites NNS O
of IN O
chronic JJ O
immune JJ O
- : O
mediated VBN O
inflammation NN O
. . O

In IN O
this DT O
paper NN O
, , O
we PRP O
show VBP O
that IN O
HCMV NNP O
down RB O
regulates VBZ O
gamma JJ O
interferon NN O
( ( O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
) ) O
- : O
induced VBN O
HLA NNP B-Gene
- : I-Gene
DR NNP I-Gene
expression NN O
in IN O
U373 NNP O
MG NNP O
astrocytoma NN O
cells NNS O
due JJ O
to TO O
a DT O
defect JJ O
downstream NN O
of IN O
STAT1 NNP B-Gene
phosphorylation NN O
and CC O
nuclear JJ O
translocation NN O
. . O

Inhibition NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB JJ I-Gene
transcriptional JJ O
activity NN O
and CC O
promotion NN O
of IN O
IkappaBalpha NNP B-Gene
degradation NN O
. . O

DZA NNP O
inhibits VBZ O
the DT O
transcriptional JJ O
activity NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
through IN O
the DT O
hindrance NN O
of IN O
p65 NN B-Gene
( ( O
Rel NNP B-Gene
- : I-Gene
A DT I-Gene
) ) O
phosphorylation NN O
without IN O
reduction NN O
of IN O
its PRP$ O
nuclear JJ O
translocation NN O
and CC O
DNA NNP O
binding NN O
activity NN O
. . O

The DT O
inhibitory JJ O
effect NN O
of IN O
DZA NNP O
on IN O
NF NNP B-Gene
- : I-Gene
kappaB JJ I-Gene
transcriptional JJ O
activity NN O
is VBZ O
potentiated VBN O
by IN O
the DT O
addition NN O
of IN O
homocysteine NN O
. . O

Decidual JJ O
gammadelta NN O
T NNP O
cells NNS O
, , O
which WDT O
significantly RB O
increase VBZ O
in IN O
number NN O
during IN O
pregnancy NN O
, , O
might MD O
play VB O
a DT O
role NN O
in IN O
recognition NN O
of IN O
fetal JJ B-Gene
antigens NNS I-Gene
and CC O
also RB O
in IN O
determining VBG O
the DT O
quality NN O
of IN O
the DT O
response NN O
to TO O
these DT O
antigens NNS B-Gene
. . O

Here RB O
, , O
we PRP O
investigate VBP O
the DT O
role NN O
of IN O
Rho NNP B-Gene
in IN O
regulating VBG O
the DT O
distribution NN O
of IN O
the DT O
monocyte NN B-Gene
- : I-Gene
binding NN I-Gene
receptors NNS I-Gene
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
, , O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
human JJ O
endothelial JJ O
cells NNS O
. . O

C3 NNP O
transferase NN O
and CC O
cytochalasin NN O
D NNP O
did VBD O
not RB O
alter VB O
the DT O
expression NN O
levels NNS O
of IN O
monocyte NN B-Gene
- : I-Gene
binding NN I-Gene
receptors NNS I-Gene
on IN O
endothelial JJ O
cells NNS O
, , O
but CC O
did VBD O
inhibit VB O
clustering NN O
of IN O
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
, , O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
on IN O
the DT O
cell NN O
surface NN O
induced VBN O
by IN O
monocyte JJ O
adhesion NN O
or CC O
cross NN B-Gene
- : I-Gene
linking VBG I-Gene
antibodies NNS I-Gene
. . O

Similarly RB O
, , O
N19RhoA NNP B-Gene
inhibited VBD O
receptor NN O
clustering NN O
. . O

Finally RB O
, , O
receptor NN O
clusters NNS O
colocalized VBN O
with IN O
ezrin JJ B-Gene
/ NNP I-Gene
moesin NN I-Gene
/ NNP I-Gene
radixin NN I-Gene
proteins NNS I-Gene
. . O

Although IN O
recognized VBN O
as IN O
fundamental JJ O
aspects NNS O
of IN O
T NNP O
lymphocyte NN O
development NN O
, , O
only RB O
recently RB O
have VBP O
the DT O
mechanisms NNS O
governing VBG O
positive JJ O
and CC O
negative JJ O
selection NN O
been VBN O
examined VBN O
at IN O
a DT O
molecular JJ O
level NN O
. . O

Negative JJ O
selection NN O
refers NNS O
to TO O
the DT O
deletion NN O
or CC O
inactivation NN O
of IN O
potentially RB O
autoreactive JJ O
thymocytes NNS O
. . O

CD28 NNP B-Gene
costimulation NN O
augments NNS O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
secretion NN O
of IN O
activated JJ O
lamina NN O
propria NN O
T NNP O
cells NNS O
by IN O
increasing VBG O
mRNA JJ O
stability NN O
without IN O
enhancing VBG O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN O
transactivation NN O
. . O

Previous JJ O
studies NNS O
have VBP O
characterized VBN O
the DT O
CD28 NNP B-Gene
augmentation NN O
of IN O
TCR NNP B-Gene
- : O
mediated VBD O
signaling VBG O
in IN O
peripheral JJ O
blood NN O
T NNP O
cells NNS O
through IN O
transcriptional JJ O
activation NN O
of IN O
an DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN O
CD28 NNP B-Gene
response NN I-Gene
element NN I-Gene
( ( O
CD28RE NNP B-Gene
) ) O
, , O
along IN O
with IN O
enhanced JJ O
mRNA NN O
stability NN O
. . O

LPMC NNP O
exhibited VBD O
increased VBD O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
production NN O
in IN O
response NN O
to TO O
CD28 NNP B-Gene
costimulation NN O
, , O
compared VBN O
with IN O
cells NNS O
activated VBN O
through IN O
CD2 NNP B-Gene
alone RB O
. . O

In IN O
conclusion NN O
, , O
production NN O
of IN O
a DT O
Th1 NNP B-Gene
cytokine NN I-Gene
, , O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
, , O
by IN O
HBsAg NNP B-Gene
- : O
reactive JJ O
cells NNS O
was VBD O
associated VBN O
with IN O
hepatocyte JJ O
damage NN O
in IN O
chronic JJ O
hepatitis NN O
B NNP O
, , O
while IN O
no DT O
counteracting VBG O
effect NN O
of IN O
Th2 NNP B-Gene
cytokines NNS I-Gene
produced VBN O
by IN O
those DT O
cells NNS O
was VBD O
observed VBN O
. . O

BACKGROUND NN O
: : O
Arsenic JJ O
trioxide NN O
( ( O
As2O3 NNP O
) ) O
can MD O
induce VB O
clinical JJ O
remission NN O
in IN O
patients NNS O
with IN O
acute JJ O
promyelocytic JJ O
leukemia NN O
via IN O
induction NN O
of IN O
differentiation NN O
and CC O
programmed VBD O
cell NN O
death NN O
( ( O
apoptosis NN O
) ) O
. . O

We PRP O
investigated VBD O
the DT O
effects NNS O
of IN O
As2O3 NNP O
on IN O
a DT O
panel NN O
of IN O
malignant JJ O
lymphocytes NNS O
to TO O
determine VB O
whether IN O
growth NN O
- : O
inhibitory NN O
and CC O
apoptotic JJ O
effects NNS O
of IN O
As2O3 NNP O
can MD O
be VB O
observed VBN O
in IN O
these DT O
cells NNS O
at IN O
clinically RB O
achievable JJ O
concentrations NNS O
. . O

Caspase NNP B-Gene
- : I-Gene
3 CD I-Gene
activation NN O
, , O
usually RB O
resulting VBG O
from IN O
delta NN O
psi NN O
( ( O
m NN O
) ) O
collapse NN O
, , O
was VBD O
not RB O
always RB O
associated VBN O
with IN O
As2O3 NNP O
- : O
induced JJ O
apoptosis NN O
. . O

As2O3 NNP O
induced VBD O
PML NNP O
( ( O
promyelocytic JJ O
leukemia NN O
) ) O
protein NN O
degradation NN O
but CC O
did VBD O
not RB O
modulate VB O
expression NN O
of IN O
cell NN B-Gene
cycle NN I-Gene
- : I-Gene
related JJ I-Gene
proteins NNS I-Gene
, , O
including VBG O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
, , O
retinoblastoma NN B-Gene
protein NN I-Gene
, , O
cyclin SYM B-Gene
- : I-Gene
dependent JJ I-Gene
kinase NN I-Gene
4 CD I-Gene
, , O
cyclin NN B-Gene
D1 NNP I-Gene
, , O
and CC O
p53 NN B-Gene
, , O
or CC O
expression NN O
of IN O
differentiation NN B-Gene
- : I-Gene
related JJ I-Gene
antigens NNS I-Gene
. . O

A20 NNP O
can MD O
be VB O
regulated VBN O
by IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
transcription NN B-Gene
factor NN I-Gene
, , O
which WDT O
is VBZ O
known VBN O
to TO O
be VB O
activated VBN O
by IN O
the DT O
EBV NNP B-Gene
LMP NNP I-Gene
- : I-Gene
1 CD I-Gene
protein NN I-Gene
. . O

CTLA NNP B-Gene
- : I-Gene
4 CD I-Gene
ligation NN O
inhibited VBN O
CD3 NNP O
/ NNP O
CD28 NNP B-Gene
- : O
induced VBD O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
mRNA NN I-Gene
accumulation NN O
by IN O
inhibiting VBG O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
transcription NN O
, , O
which WDT O
appears VBZ O
to TO O
be VB O
mediated VBN O
in IN O
part NN O
through IN O
decreasing VBG O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
accumulation NN O
in IN O
the DT O
nuclei NN O
. . O

Further RB O
, , O
CTLA NNP B-Gene
- : I-Gene
4 CD I-Gene
engagement NN O
inhibited VBN O
progression NN O
through IN O
the DT O
cell NN O
cycle NN O
by IN O
inhibiting VBG O
the DT O
production NN O
of IN O
cyclin NN B-Gene
D3 NNP I-Gene
, , O
cyclin SYM B-Gene
- : I-Gene
dependent JJ I-Gene
kinase NN I-Gene
( ( B-Gene
cdk NN I-Gene
) ) I-Gene
4 CD I-Gene
, , O
and CC O
cdk6 NN B-Gene
when WRB O
the DT O
T NNP O
cells NNS O
were VBD O
stimulated VBN O
with IN O
anti JJ B-Gene
- : I-Gene
CD3 NNP I-Gene
/ NNP I-Gene
CD28 NNP I-Gene
and CC O
with IN O
anti JJ B-Gene
- : I-Gene
CD3 NNP I-Gene
alone RB O
. . O

Dexamethasone NNP O
( ( O
Dex NNP O
) ) O
, , O
a DT O
synthetic JJ O
glucocorticoid NN O
hormone NN O
, , O
cooperated VBN O
with IN O
Epo NNP B-Gene
and CC O
stem NN B-Gene
cell NN I-Gene
factor NN I-Gene
to TO O
induce VB O
erythroid JJ O
progenitors NNS O
to TO O
undergo VB O
15 CD O
to TO O
22 CD O
cell NN O
divisions NNS O
, , O
corresponding VBG O
to TO O
a DT O
10 CD O
( ( O
5 CD O
) ) O
- : O
to TO O
10 CD O
( ( O
6 CD O
) ) O
- : O
fold JJ O
amplification NN O
of IN O
erythroid JJ O
cells NNS O
. . O

Sustained VBN O
proliferation NN O
of IN O
erythroid JJ O
progenitors NNS O
could MD O
be VB O
induced VBN O
equally RB O
well RB O
from IN O
purified VBN O
erythroid NN O
burst SYM O
- : O
forming VBG O
units NNS O
( ( O
BFU NNP O
- : O
E NN O
) ) O
, , O
from IN O
CD34 NNP O
( ( O
+ NNP O
) ) O
blast NN O
cells NNS O
, , O
and CC O
from IN O
bone NN O
marrow NN O
depleted VBN O
from IN O
CD34 NNP O
( ( O
+ NNP O
) ) O
cells NNS O
. . O

We PRP O
conclude VBP O
that IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
is VBZ O
a DT O
context JJ O
- : O
dependent JJ O
apoptosis NN O
regulator NN O
. . O

SOCS NNP B-Gene
- : I-Gene
3 CD I-Gene
protein NN O
was VBD O
detectable JJ O
as RB O
early RB O
as IN O
30 CD O
min NN O
following VBG O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
stimulation NN O
, , O
while IN O
CIS NNP B-Gene
was VBD O
seen VBN O
only RB O
at IN O
low JJ O
levels NNS O
after IN O
2 CD O
h NN O
. . O

Tyrosine NNP O
phosphorylation NN O
of IN O
SOCS NNP B-Gene
- : I-Gene
3 CD I-Gene
was VBD O
observed VBN O
upon IN O
coexpression NN O
with IN O
Jak1 NNP B-Gene
and CC O
Jak2 NNP B-Gene
but CC O
only RB O
weakly RB O
with IN O
Jak3 NNP B-Gene
. . O

Finally RB O
, , O
proliferation NN O
induced VBN O
by IN O
both DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
- : O
and CC O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
was VBD O
significantly RB O
inhibited VBN O
in IN O
the DT O
presence NN O
of IN O
SOCS NNP B-Gene
- : I-Gene
3 CD I-Gene
. . O

There EX O
was VBD O
, , O
however RB O
, , O
a DT O
significant JJ O
difference NN O
in IN O
the DT O
amounts NNS O
of IN O
the DT O
nuclear JJ B-Gene
protein NN I-Gene
, , O
REF NNP B-Gene
- : I-Gene
1 CD I-Gene
( ( O
which WDT O
regulates VBZ O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
DNA NN O
binding NN O
by IN O
altering VBG O
the DT O
redox NN O
status NN O
of IN O
FOS NNP B-Gene
and CC O
JUN NNP B-Gene
proteins NNS I-Gene
) ) O
, , O
in IN O
alveolar JJ O
macrophages NNS O
compared VBN O
with IN O
monocytes NNS O
. . O

Finally RB O
, , O
addition NN O
of IN O
REF NNP B-Gene
- : I-Gene
1 CD I-Gene
from IN O
activated VBN O
monocytes NNS O
to TO O
alveolar JJ O
macrophage NN O
nuclear JJ O
proteins NNS O
resulted VBN O
in IN O
a DT O
marked JJ O
increase NN O
in IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
DNA NN O
binding NN O
. . O

Studies NNS O
over IN O
the DT O
past JJ O
few JJ O
years NNS O
have VBP O
identified VBN O
lymphotoxin NN O
as IN O
a DT O
critical JJ O
signaling NN O
molecule NN O
not RB O
only RB O
for IN O
the DT O
organogenesis NN O
of IN O
secondary JJ O
lymphoid JJ O
tissues NNS O
but CC O
for IN O
the DT O
maintenance NN O
of IN O
aspects NNS O
of IN O
their PRP$ O
microarchitecture NN O
as IN O
well RB O
. . O

This DT O
review NN O
focuses VBZ O
on IN O
studies NNS O
defining VBG O
recently RB O
identified VBN O
crucial JJ O
signals NNS O
for IN O
the DT O
biogenesis NN O
of IN O
secondary JJ O
lymphoid JJ O
organs NNS O
and CC O
for IN O
the DT O
maintenance NN O
of IN O
their PRP$ O
proper JJ O
microarchitecture NN O
. . O

The DT O
costimulatory NN B-Gene
molecule NN I-Gene
CD28 NNP B-Gene
has VBZ O
a DT O
restricted VBN O
tissue NN O
distribution NN O
and CC O
is VBZ O
expressed VBN O
on IN O
T NNP O
cells NNS O
and CC O
some DT O
plasmacytoma NN O
cells NNS O
. . O

In IN O
vivo NN O
, , O
CD8 NNP O
+ NNP O
T NNP O
cells NNS O
and CC O
, , O
less RBR O
frequently RB O
, , O
CD4 NNP O
+ NNP O
T NNP O
cells NNS O
may MD O
completely RB O
lose VB O
CD28 NNP B-Gene
surface NN O
expression NN O
during IN O
chronic JJ O
infections NNS O
and CC O
with IN O
aging VBG O
. . O

Both DT O
alpha SYM O
- : O
and CC O
beta VB O
- : O
bound NN O
complexes NNS O
are VBP O
found VBN O
only RB O
in IN O
lymphoid JJ O
tissues NNS O
, , O
in IN O
CD28 NNP O
+ NNP O
T NNP O
cells NNS O
, , O
and CC O
in IN O
some DT O
transformed JJ O
B NNP O
cells NNS O
. . O

A DT O
role NN O
for IN O
RanBP1 NNP B-Gene
in IN O
the DT O
release NN O
of IN O
CRM1 NNP B-Gene
from IN O
the DT O
nuclear JJ B-Gene
pore NN I-Gene
complex NN I-Gene
in IN O
a DT O
terminal JJ O
step NN O
of IN O
nuclear JJ O
export NN O
. . O

It PRP O
also RB O
stimulates VBZ O
nuclear JJ O
export NN O
in IN O
cells NNS O
that WDT O
have VBP O
not RB O
been VBN O
preincubated VBN O
with IN O
RanQ69L NNP B-Gene
. . O

In IN O
a DT O
model NN O
where WRB O
foreign JJ O
cells NNS O
( ( O
rat VB O
fibroblasts NNS O
) ) O
were VBD O
cocultured VBN O
with IN O
human JJ O
IL NNP O
- : O
2 CD O
activated JJ O
NK NNP O
cells NNS O
, , O
we PRP O
observed VBD O
that IN O
NK NNP O
cells NNS O
were VBD O
capable JJ O
of IN O
efficiently RB O
killing VBG O
their PRP$ O
targets NNS O
only RB O
if IN O
the DT O
cells NNS O
overexpressed VBD O
the DT O
oncogene NN O
c SYM B-Gene
- : I-Gene
Myc NN I-Gene
or CC O
E1A NNP B-Gene
. . O

These DT O
results NNS O
provided VBD O
evidence NN O
that IN O
c SYM B-Gene
- : I-Gene
Myc NN I-Gene
and CC O
E1A NNP B-Gene
activated VBD O
the DT O
NK NNP O
cell NN O
induced VBD O
cytolysis NN O
at IN O
a DT O
post NN O
- : O
triggering VBG O
stage NN O
of IN O
NK NNP O
cell NN O
- : O
target NN O
cell NN O
interaction NN O
. . O

Unicellular JJ O
- : O
unilineage JJ O
erythropoietic JJ O
cultures NNS O
: : O
molecular JJ O
analysis NN O
of IN O
regulatory JJ O
gene NN O
expression NN O
at IN O
sibling VBG O
cell NN O
level NN O
. . O

In IN O
the DT O
culture NN O
system NN O
reported VBD O
here RB O
, , O
( ( O
1 CD O
) ) O
the DT O
growth NN B-Gene
factor NN I-Gene
( ( O
GF NNP B-Gene
) ) O
stimulus NN O
induces NNS O
cord VBP O
blood NN O
( ( O
CB NNP O
) ) O
progenitor NN O
cells NNS O
to TO O
proliferate VB O
and CC O
differentiate VB O
/ JJ O
mature NN O
exclusively RB O
along IN O
the DT O
erythroid JJ O
lineage NN O
; : O
( ( O
2 CD O
) ) O
this DT O
erythropoietic JJ O
wave NN O
is VBZ O
characterized VBN O
by IN O
less JJR O
than IN O
4 CD O
% NN O
apoptotic JJ O
cells NNS O
; : O
( ( O
3 CD O
) ) O
asymmetric NN O
divisions NNS O
are VBP O
virtually RB O
absent JJ O
, , O
ie JJ O
, , O
nonresponsive JJ O
hematopoietic JJ O
progenitors NNS O
with IN O
no DT O
erythropoietic JJ O
potential NN O
are VBP O
forced VBN O
into IN O
apoptosis NN O
; : O
( ( O
4 CD O
) ) O
the DT O
system NN O
is VBZ O
cell JJ O
division NN O
controlled VBN O
( ( O
cdc NN O
) ) O
, , O
ie RB O
, , O
the DT O
number NN O
of IN O
divisions NNS O
performed VBN O
by IN O
each DT O
cell NN O
is VBZ O
monitored VBN O
. . O

Single NNP O
- : O
cell NN O
reverse NN B-Gene
transcriptase NN I-Gene
- : O
polymerase NN O
chain NN O
reaction NN O
( ( O
RT NNP O
- : O
PCR NN O
) ) O
analysis NN O
was VBD O
applied VBN O
to TO O
this DT O
culture NN O
system NN O
to TO O
investigate VB O
gene NN O
expression NN O
of IN O
diverse JJ O
receptors NNS B-Gene
, , O
markers NNS B-Gene
of IN I-Gene
differentiation NN I-Gene
, , O
and CC O
transcription NN B-Gene
factors NNS I-Gene
( ( O
EKLF NNP B-Gene
, , O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
GATA NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
p45 NN B-Gene
NF NNP I-Gene
- : I-Gene
E2 NN I-Gene
, , O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
, , O
and CC O
SCL NNP B-Gene
/ NNP I-Gene
Tal1 NNP I-Gene
) ) O
at IN O
discrete JJ O
stages NNS O
of IN O
erythropoietic JJ O
development NN O
. . O

However RB O
, , O
stimulation NN O
with IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
resulted VBD O
in IN O
Jak3 NNP B-Gene
and CC O
STAT5 NNP B-Gene
phosphorylation NN O
in IN O
both DT O
leukemic JJ O
ATLL NNP O
cells NNS O
and CC O
IL NNP O
- : O
2 CD O
- : O
dependent NN O
lines NNS O
. . O

A DT O
skewed JJ O
XCI NNP O
pattern NN O
with IN O
greater JJR O
than IN O
75 CD O
% NN O
amplification NN O
of IN O
1 CD O
allele NNS B-Gene
( ( O
allele JJ B-Gene
ratio NN O
> VBD O
3 CD O
: : O
1 CD O
) ) O
was VBD O
found VBN O
in IN O
22 CD O
( ( O
9 CD O
. . O
1 CD O
% NN O
) ) O
of IN O
242 CD O
control NN O
subjects NNS O
. . O

Although IN O
statistical JJ O
evaluation NN O
of IN O
the DT O
data NN O
showed VBD O
a DT O
significant JJ O
difference NN O
between IN O
patients NNS O
with IN O
a DT O
chronic JJ O
MPD NNP O
and CC O
control NN O
subjects NNS O
, , O
proof NN O
of IN O
clonality NN O
in IN O
individual JJ O
, , O
especially RB O
elderly JJ O
, , O
patients NNS O
is VBZ O
difficult JJ O
. . O

Here RB O
we PRP O
report VBP O
that IN O
in IN O
erythroid JJ O
cells NNS O
, , O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
strongly RB O
induces VBZ O
the DT O
expression NN O
of IN O
the DT O
anti JJ B-Gene
- : I-Gene
apoptotic JJ I-Gene
protein NN I-Gene
bcl SYM B-Gene
- : I-Gene
xL NN I-Gene
, , O
but CC O
not RB O
the DT O
related JJ O
proteins NNS O
bcl VBP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
mcl VB B-Gene
- : I-Gene
1 CD I-Gene
. . O

In IN O
T NNP O
lymphocytes NNS O
, , O
the DT O
hematopoietic JJ B-Gene
cytokine NN I-Gene
interleukin SYM B-Gene
- : I-Gene
2 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
uses VBZ O
phosphatidylinositol $ B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
( ( O
PI NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
) ) O
- : O
induced VBN O
signaling VBG O
pathways NNS O
to TO O
regulate VB O
E2F NNP B-Gene
transcriptional JJ O
activity NN O
, , O
a DT O
critical JJ O
cell NN O
cycle NN O
checkpoint NN O
. . O

PI NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
also RB O
regulates VBZ O
the DT O
activity NN O
of IN O
p70 NN B-Gene
( ( I-Gene
s6k NN I-Gene
) ) I-Gene
, , O
the DT O
40S CD B-Gene
ribosomal JJ I-Gene
protein NN I-Gene
S6 NNP I-Gene
kinase NN I-Gene
, , O
a DT O
response NN O
that WDT O
is VBZ O
abrogated VBN O
by IN O
the DT O
macrolide NN O
rapamycin NN O
. . O

Moreover RB O
, , O
the DT O
effects NNS O
of IN O
rapamycin NN O
on IN O
, , O
and CC O
the DT O
role NN O
of IN O
p70 NN B-Gene
( ( I-Gene
s6k NN I-Gene
) ) I-Gene
in IN O
, , O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
PI NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
activation NN O
of IN O
E2Fs NNP B-Gene
have VBP O
not RB O
been VBN O
characterized VBN O
. . O

Our PRP$ O
present JJ O
results NNS O
show VBP O
that IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
- : O
and CC O
PI NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
- : O
induced JJ O
pathways NNS O
for IN O
the DT O
regulation NN O
of IN O
E2F NNP B-Gene
transcriptional JJ O
activity NN O
include VBP O
both DT O
rapamycin JJ O
- : O
resistant NN O
and CC O
rapamycin NN O
- : O
sensitive JJ O
components NNS O
. . O

Thus RB O
, , O
the DT O
rapamycin NN O
- : O
controlled VBN O
processes NNS O
involved VBN O
in IN O
E2F NNP B-Gene
regulation NN O
appear NN O
to TO O
be VB O
mediated VBN O
by IN O
p70 NN B-Gene
( ( I-Gene
s6k NN I-Gene
) ) I-Gene
. . O

Since IN O
1988 CD O
, , O
several JJ O
families NNS O
of IN O
functionally RB O
important JJ O
T NNP B-Gene
cell NN I-Gene
transcription NN I-Gene
factors NNS I-Gene
have VBP O
been VBN O
identified VBN O
. . O

These DT O
include VBP O
the DT O
Ikaros NNP B-Gene
, , O
LKLF NNP B-Gene
, , O
and CC O
GATA3 NNP B-Gene
zinc NNP I-Gene
- : I-Gene
finger NN I-Gene
proteins VBZ I-Gene
; : O
the DT O
Ets NNP B-Gene
, , O
CREB NNP B-Gene
/ NNP I-Gene
ATF NNP I-Gene
, , O
and CC O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
/ NNP I-Gene
Rel NNP I-Gene
/ NNP I-Gene
NFAT NNP I-Gene
transcription NN I-Gene
factors NNS I-Gene
; : O
the DT O
Stat NNP B-Gene
proteins VBZ I-Gene
; : O
and CC O
HMG NNP B-Gene
box NN I-Gene
transcription NN I-Gene
factors NNS I-Gene
such JJ O
as IN O
LEF1 NNP B-Gene
, , O
TCF1 NNP B-Gene
, , O
and CC O
Sox4 NNP B-Gene
. . O

The DT O
proliferative JJ O
deficiency NN O
of IN O
the DT O
transgenic JJ O
T NNP O
cells NNS O
was VBD O
associated VBN O
with IN O
an DT O
increased VBN O
apoptosis NN O
. . O

Paradoxical JJ O
priming VBG O
effects NNS O
of IN O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
on IN O
cytokine NN B-Gene
production NN O
. . O

Interestingly RB O
, , O
an DT O
enhanced JJ O
frequency NN O
of IN O
CD16 NNP B-Gene
and CC O
CD68 NNP O
( ( O
+ NNP O
) ) O
cells NNS O
among IN O
the DT O
CD14 NNP O
( ( O
+ NNP O
) ) O
cells NNS O
was VBD O
observed VBN O
in IN O
the DT O
presence NN O
of IN O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
, , O
independently RB O
of IN O
the DT O
pre NN O
- : O
culture NN O
conditions NNS O
of IN O
the DT O
PBMC NNP O
. . O

Transcription NN B-Gene
factors NNS I-Gene
Sp1 NNP B-Gene
and CC O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
mediate JJ O
induction NN O
of IN O
acid JJ B-Gene
sphingomyelinase NN I-Gene
during IN O
monocytic JJ O
differentiation NN O
. . O

Cells NNS O
from IN O
the DT O
human JJ O
monocytic JJ O
leukemia NN O
cell NN O
line NN O
THP NNP O
- : O
1 CD O
differentiate NN O
towards NNS O
a DT O
macrophage NN O
- : O
like IN O
phenotype NN O
when WRB O
stimulated VBN O
with IN O
phorbol NN O
12 CD O
- : O
myristate NN O
- : O
13 CD O
- : O
acetate NN O
( ( O
PMA NNP O
) ) O
, , O
1 CD O
, , O
25 CD O
- : O
dihydroxy NN O
- : O
vitamin NN O
D3 NNP O
, , O
and CC O
various JJ O
other JJ O
agents NNS O
. . O

A DT O
PMA NNP B-Gene
responsive JJ I-Gene
element NN I-Gene
was VBD O
localized VBN O
to TO O
a DT O
region NN O
between IN O
- : B-Gene
319 CD I-Gene
and CC I-Gene
- : I-Gene
219 CD I-Gene
bp JJ I-Gene
upstream NN I-Gene
of IN O
the DT O
initiation NN O
codon NN O
and CC O
co NN O
- : O
transfections NNS O
with IN O
transcription NN B-Gene
factor NN I-Gene
expression NN I-Gene
plasmids NNS I-Gene
for IN O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
Sp1 NNP B-Gene
resulted VBD O
in IN O
augmented JJ O
ASM NNP O
promoter NN O
activity NN O
, , O
which WDT O
was VBD O
abolished VBN O
when WRB O
the DT O
binding NN B-Gene
sites VBZ I-Gene
for IN O
these DT O
two CD O
factors NNS O
were VBD O
deleted VBN O
. . O

However RB O
, , O
the DT O
intensity NN O
of IN O
the DT O
complex NN O
formed VBD O
appeared VBN O
to TO O
increase VB O
when WRB O
nuclear JJ O
extracts NNS O
from IN O
PMA NNP O
- : O
treated VBD O
cells NNS O
were VBD O
used VBN O
. . O

NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
DNA NNP O
binding NN O
was VBD O
evaluated VBN O
by IN O
electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
. . O

Direct JJ O
activation NN O
of IN O
PKC NNP B-Gene
with IN O
PMA NNP O
induced VBD O
both DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
and CC O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
production NN O
by IN O
human JJ O
monocytes NNS O
. . O

Furthermore RB O
, , O
our PRP$ O
results NNS O
provide VB O
evidence NN O
that IN O
PTK NNP B-Gene
plays VBZ O
a DT O
role NN O
in IN O
LPS NNP O
- : O
induced VBD O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
and CC O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
release NN O
in IN O
human JJ O
monocytes NNS O
and CC O
thus RB O
could MD O
be VB O
a DT O
potential JJ O
therapeutic JJ O
target NN O
in IN O
inflammatory JJ O
states NNS O
. . O

The DT O
effects NNS O
of IN O
GDSP NNP O
on IN O
pancreatic JJ O
weight NN O
, , O
serum JJ B-Gene
amylase NN I-Gene
and CC I-Gene
lipase NN I-Gene
, , O
morphologic JJ O
changes NNS O
in IN O
the DT O
pancreas NNS O
, , O
neutrophil JJ O
infiltration NN O
, , O
and CC O
nuclear JJ B-Gene
factor NN I-Gene
KB NNP I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
KB NNP I-Gene
) ) O
activation NN O
were VBD O
measured VBN O
in IN O
rats NNS O
infused VBN O
with IN O
supramaximal JJ O
dose NN O
of IN O
cerulein NN O
( ( O
5 CD O
( ( O
g JJ O
/ NNP O
kg NN O
/ NNP O
h NN O
) ) O
for IN O
6 CD O
h NN O
. . O

Elastatinal NNP O
had VBD O
some DT O
of IN O
the DT O
same JJ O
effects NNS O
as IN O
GDSP NNP O
but CC O
was VBD O
less CC O
potent JJ O
and CC O
effective JJ O
. . O

The DT O
nature NN O
of IN O
the DT O
nuclear JJ B-Gene
factor NN I-Gene
( ( O
s NN O
) ) O
that WDT O
control VBP O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
gene NN O
transcription NN O
in IN O
humans NNS O
remains VBZ O
obscure JJ O
, , O
although IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
has VBZ O
been VBN O
suggested VBN O
. . O

Our PRP$ O
previous JJ O
studies NNS O
pertaining VBG O
to TO O
macrophage VB O
response NN O
to TO O
LPS NNP O
identified VBD O
a DT O
novel JJ O
DNA NNP B-Gene
- : I-Gene
binding NN I-Gene
domain NN I-Gene
located VBN O
from IN O
- : O
550 CD O
to TO O
- : O
487 CD O
in IN O
the DT O
human JJ B-Gene
TNF NNP I-Gene
- : I-Gene
alpha NN I-Gene
promoter NN I-Gene
that WDT O
contains VBZ O
transcriptional JJ O
activity NN O
, , O
but CC O
lacks VBZ O
any DT O
known JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
- : B-Gene
binding NN I-Gene
sites NNS I-Gene
. . O

Inhibition NN O
of IN O
LITAF NNP B-Gene
mRNA FW I-Gene
expression NN O
in IN O
THP NNP O
- : O
1 CD O
cells NNS O
resulted VBN O
in IN O
a DT O
reduction NN O
of IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
transcripts NNS O
. . O

In IN O
addition NN O
, , O
high JJ O
level NN O
of IN O
expression NN O
of IN O
LITAF NNP B-Gene
mRNA NN I-Gene
was VBD O
observed VBN O
predominantly RB O
in IN O
the DT O
placenta NN O
, , O
peripheral JJ O
blood NN O
leukocytes NNS O
, , O
lymph NN O
nodes NNS O
, , O
and CC O
the DT O
spleen NN O
. . O

A DT O
human JJ B-Gene
IFNGR1 NNP I-Gene
small JJ I-Gene
deletion NN I-Gene
hotspot NN I-Gene
associated VBN O
with IN O
dominant JJ O
susceptibility NN O
to TO O
mycobacterial JJ O
infection NN O
[ NNP O
see VBP O
comments NNS O
] VB O

Characterization NN O
of IN O
expression NN O
of IN O
the DT O
gene NN O
for IN O
human JJ B-Gene
pterin NN I-Gene
carbinolamine NN I-Gene
dehydratase NN I-Gene
/ NNP I-Gene
dimerization NN I-Gene
cofactor NN I-Gene
of IN O
HNF1 NNP B-Gene
. . O

In IN O
the DT O
nucleus NN O
, , O
it PRP O
functions VBZ O
as IN O
a DT O
dimerization NN B-Gene
cofactor NN I-Gene
of IN O
HNF1 NNP B-Gene
and CC O
increases VBZ O
the DT O
transcriptional JJ O
activity NN O
of IN O
HNF1 NNP B-Gene
. . O

Transfection NN O
of IN O
Jurkat NNP O
cells NNS O
with IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
subunits NNS I-Gene
p50 NN B-Gene
and CC O
p65 NN B-Gene
confers NNS O
resistance NN O
against IN O
Fas NNP O
- : O
mediated VBD O
apoptosis NN O
. . O

Capacitance NNP O
would MD O
simply RB O
involve VB O
expression NN O
of IN O
IL NNP B-Gene
- : I-Gene
12R CD I-Gene
beta NN I-Gene
1 CD I-Gene
and CC I-Gene
beta $ I-Gene
2 CD I-Gene
subunits NNS I-Gene
, , O
regulated VBN O
by IN O
TCR NNP O
, , O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC O
IFNs NNP B-Gene
. . O

The DT O
activation NN O
of IN O
STAT3 NNP B-Gene
was VBD O
not RB O
found VBN O
in IN O
human JJ O
eosinophils NNS O
, , O
monocytes NNS O
, , O
and CC O
HL NNP O
- : O
60 CD O
cells NNS O
, , O
although IN O
the DT O
STAT3 NNP B-Gene
protein NN I-Gene
was VBD O
expressed VBN O
in IN O
these DT O
cells NNS O
. . O

The DT O
transcription NN B-Gene
factor NN I-Gene
NF NNP B-Gene
- : I-Gene
ATc NNP I-Gene
is VBZ O
synthesized VBN O
in IN O
three CD O
prominent JJ O
isoforms NNS B-Gene
. . O

These DT O
differ NN O
in IN O
the DT O
length NN O
of IN O
their PRP$ O
C NNP O
terminal NN O
peptides NNS O
and CC O
mode NN O
of IN O
synthesis NN O
. . O

Together RB O
, , O
these DT O
results NNS O
demonstrate VBP O
that IN O
ER NNP B-Gene
and CC O
PR NNP B-Gene
can MD O
be VB O
activated VBN O
by IN O
endogenous JJ O
or CC O
exogenous JJ O
ligands NNS O
to TO O
induce VB O
a DT O
genetic JJ O
response NN O
that WDT O
impairs VBZ O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
- : O
induced JJ O
apoptosis NN O
in IN O
U937 NNP O
cells NNS O
. . O

Retinoidal JJ O
antagonists NNS O
and CC O
potential JJ O
agonists NNS O
. . O

Inhibition NN O
of IN O
T NNP O
cell NN O
signaling VBG O
by IN O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein NN I-Gene
kinase SYM I-Gene
- : I-Gene
targeted VBN I-Gene
hematopoietic JJ I-Gene
tyrosine NN I-Gene
phosphatase NN I-Gene
( ( O
HePTP NNP B-Gene
) ) O
. . O

Activation NN O
of IN O
T NNP O
lymphocytes NNS O
to TO O
produce VB O
cytokines NNS B-Gene
is VBZ O
regulated VBN O
by IN O
the DT O
counterbalance NN O
of IN O
protein NN B-Gene
- : I-Gene
tyrosine NN I-Gene
kinases NNS I-Gene
and CC O
protein SYM O
- : O
tyrosine NN O
phosphatases NNS O
, , O
many JJ O
of IN O
which WDT O
have VBP O
a DT O
high JJ O
degree NN O
of IN O
substrate NN O
specificity NN O
because IN O
of IN O
physical JJ O
association NN O
with IN O
their PRP$ O
targets NNS O
. . O

In IN O
contrast NN O
, , O
HePTP NNP B-Gene
had VBD O
no DT O
effects NNS O
on IN O
N NNP B-Gene
- : I-Gene
terminal NN I-Gene
c SYM I-Gene
- : I-Gene
Jun JJ I-Gene
kinase NN I-Gene
or CC O
on IN O
events NNS O
upstream NN O
of IN O
the DT O
MAP NNP O
kinases NNS O
. . O

However RB O
, , O
p38 JJ B-Gene
MAPK NNP I-Gene
is VBZ O
activated VBN O
strongly RB O
and CC O
synergistically RB O
by IN O
either CC O
CD3 NNP B-Gene
/ NNP I-Gene
CD28 NNP I-Gene
coligation NN O
or CC O
PMA NNP O
/ NNP O
Ca2 NNP O
+ NNP O
ionophore NN O
stimulation NN O
, , O
which WDT O
mimics VBZ O
TCR NNP B-Gene
- : O
CD3 NNP B-Gene
/ NNP I-Gene
CD28 NNP I-Gene
- : O
mediated VBD O
signaling NN O
. . O

We PRP O
have VBP O
compared VBN O
the DT O
effects NNS O
of IN O
Epo NNP B-Gene
and CC O
the DT O
chemical NN O
inducers NNS O
, , O
delta JJ O
- : O
aminolaevulinic JJ O
acid NN O
( ( O
delta JJ O
- : O
ALA NN O
) ) O
and CC O
haemin $ O
on IN O
the DT O
differentiation NN O
capacity NN O
of IN O
UT NNP O
- : O
7 CD O
cells NNS O
. . O

Epo NNP B-Gene
alone RB O
promoted VBD O
relatively RB O
early JJ O
events NNS O
in IN O
erythroid JJ O
maturation NN O
, , O
without IN O
significant JJ O
changes NNS O
in IN O
haemoglobin NN O
production NN O
or CC O
morphology NN O
. . O

Epo NNP B-Gene
caused VBD O
an DT O
increase NN O
in IN O
the DT O
proportion NN O
of IN O
cells NNS O
expressing VBG O
cell NN O
surface NN O
glycophorin VBZ B-Gene
A NNP I-Gene
( ( O
GPA NNP B-Gene
) ) O
and CC O
up RB O
- : O
regulated VBN O
beta SYM B-Gene
- : I-Gene
and CC I-Gene
gamma VB I-Gene
- : I-Gene
globin NN I-Gene
by IN O
several JJ O
fold NN O
. . O

There EX O
is VBZ O
little JJ O
direct JJ O
evidence NN O
regarding VBG O
the DT O
role NN O
of IN O
alveolar JJ O
macrophages NNS O
in IN O
these DT O
activation NN O
events NNS O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
, , O
in IN O
this DT O
inflammatory JJ O
model NN O
, , O
initial JJ O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
occurs VBZ O
in IN O
alveolar JJ O
macrophages NNS O
and CC O
the DT O
ensuing VBG O
production NN O
of IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
may MD O
propagate VB O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
to TO O
other JJ O
cell NN O
types NNS O
in IN O
the DT O
lung NN O
. . O

Interferon NNP B-Gene
- : I-Gene
beta NN I-Gene
mediates NNS O
stromal JJ O
cell NN O
rescue NN O
of IN O
T NNP O
cells NNS O
from IN O
apoptosis NN O
. . O

Interferon NNP B-Gene
- : I-Gene
alpha NN I-Gene
and CC I-Gene
- : I-Gene
beta NN I-Gene
promote VBP O
the DT O
reversion NN O
of IN O
blast NN O
Tcells NNP O
to TO O
a DT O
resting VBG O
G0 NNP O
/ NNP O
G1 NNP O
configuration NN O
with IN O
all PDT O
the DT O
characteristic JJ O
features NNS O
of IN O
stromal JJ O
cell NN O
rescue NN O
; : O
such JJ O
as IN O
high JJ O
Bcl NNP B-Gene
- : I-Gene
XL NN I-Gene
expression NN O
and CC O
low JJ O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

We PRP O
also RB O
show VBP O
that IN O
DFX NNP O
treatment NN O
limits VBZ O
the DT O
in IN O
vivo JJ O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
, , O
a DT O
transcription NN B-Gene
factor NN I-Gene
involved VBN O
in IN O
both DT O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
gene NN O
transcription NN O
and CC O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
signalling NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
. . O

In IN O
this DT O
study NN O
, , O
the DT O
influence NN O
of IN O
the DT O
sequences NNS O
located VBN O
between IN B-Gene
- : I-Gene
3134 CD I-Gene
and CC I-Gene
- : I-Gene
2987 CD I-Gene
on IN O
the DT O
transcriptional JJ O
activity NN O
of IN O
the DT O
proIL NN B-Gene
- : I-Gene
1beta CD I-Gene
gene NN I-Gene
in IN O
LPS NNP O
- : O
stimulated VBD O
Raw JJ O
264 CD O
. . O
7 CD O
cells NNS O
was VBD O
examined VBN O
in IN O
detail NN O
. . O

These DT O
specific JJ O
bindings NNS O
were VBD O
time NN O
and CC O
LPS NNP O
dose VB O
dependent NN O
. . O

These DT O
data NNS O
indicated VBD O
that IN O
two CD O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
, , O
which WDT O
are VBP O
located VBN O
between IN O
- : B-Gene
3134 CD I-Gene
and CC I-Gene
- : I-Gene
3059 CD I-Gene
, , O
are VBP O
critical JJ O
for IN O
the DT O
activation NN O
of IN O
proIL JJ B-Gene
- : I-Gene
1beta CD I-Gene
gene NN I-Gene
transcription NN O
. . O

N NNP O
- : O
acetyl NN O
- : O
L NNP O
- : O
cysteine NN O
inhibits NNS O
primary JJ O
human JJ O
T NNP O
cell NN O
responses NNS O
at IN O
the DT O
dendritic JJ O
cell NN O
level NN O
: : O
association NN O
with IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
inhibition NN O
. . O

Altogether RB O
, , O
our PRP$ O
results NNS O
suggest VBP O
that IN O
NAC NNP O
might MD O
impair VB O
the DT O
generation NN O
of IN O
primary JJ O
immune JJ O
responses NNS O
in IN O
humans NNS O
through IN O
its PRP$ O
inhibitory JJ O
action NN O
on IN O
DC NNP O
. . O

Gel NNP O
supershift NN O
assays NNS O
demonstrated VBD O
that IN O
thrombin NN B-Gene
induced VBD O
binding NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
Bp65 NNP I-Gene
( ( O
Rel NNP B-Gene
A NNP I-Gene
) ) O
to TO O
downstream VB O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
site NN I-Gene
of IN O
the DT O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
. . O

Thrombin NNP B-Gene
receptor NN O
activation NN O
peptide NN O
, , O
a DT O
14 CD O
- : O
amino NN O
- : O
acid NN O
peptide IN O
representing VBG O
the DT O
new JJ O
NH2 NNP B-Gene
terminus NN I-Gene
of IN O
proteolytically RB O
activated VBN O
receptor NN B-Gene
- : I-Gene
1 CD I-Gene
, , O
mimicked VBD O
thrombin NN B-Gene
' '' O
s JJ O
action NN O
in IN O
inducing VBG O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
. . O

These DT O
data NNS O
indicate VBP O
that IN O
thrombin NN B-Gene
activates VBZ O
endothelial JJ O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
and CC O
polymorphonuclear JJ O
leukocyte NN O
adhesion NN O
by IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
Bp65 NNP I-Gene
binding NN O
to TO O
the DT O
downstream NN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
site NN I-Gene
of IN O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
after IN O
proteolytically RB O
activated VBN O
receptor NN O
- : O
1 CD O
activation NN O
. . O

Here RB O
we PRP O
demonstrate VBP O
that IN O
both DT O
Smad6 NNP B-Gene
and CC O
Smad7 NNP B-Gene
are VBP O
human JJ B-Gene
bone CD I-Gene
morphogenetic JJ I-Gene
protein NN I-Gene
- : I-Gene
2 CD I-Gene
( ( O
hBMP SYM B-Gene
- : I-Gene
2 CD I-Gene
) ) O
- : O
inducible JJ O
antagonists NNS O
of IN O
hBMP NN B-Gene
- : I-Gene
2 CD I-Gene
- : O
induced JJ O
growth NN O
arrest NN O
and CC O
apoptosis NN O
in IN O
mouse NN O
B NNP O
cell NN O
hybridoma NN O
HS NNP O
- : O
72 CD O
cells NNS O
. . O

The DT O
effect NN O
was VBD O
dose JJ O
dependent JJ O
and CC O
appeared VBD O
relatively RB O
late JJ O
. . O

Significant JJ O
differences NNS O
were VBD O
observed VBN O
from IN O
day NN O
4 CD O
onward NN O
. . O

RA NNP O
previously RB O
was VBD O
found VBN O
to TO O
inhibit VB O
granulocyte JJ B-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
- : O
- : O
and CC O
not RB O
granulocyte VB B-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
- : O
- : O
stimulated JJ O
proliferation NN O
of IN O
CD34 NNP O
+ NNP O
cells NNS O
. . O

Interestingly RB O
, , O
CyA NNP O
and CC O
indomethacin NN O
did VBD O
not RB O
suppress JJ O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
- : O
induced VBN O
adhesion NN O
molecule NN O
expression NN O
on IN O
HUVECs NNP O
, , O
whereas JJ O
aspirin NN O
had VBD O
an DT O
inhibitory JJ O
effect NN O
. . O

CONCLUSION NN O
: : O
Our PRP$ O
results NNS O
show VBP O
that IN O
the DT O
tested JJ O
agents NNS O
( ( O
except IN O
indomethacin NN O
) ) O
are VBP O
inhibitors NNS O
of IN O
the DT O
T NNP O
cell NN O
- : O
mediated VBN O
immune JJ O
response NN O
, , O
as IN O
expected VBN O
, , O
that DT O
aspirin NN O
is VBZ O
an DT O
effective JJ O
suppressor NN O
of IN O
adhesion NN B-Gene
molecule NN I-Gene
expression NN O
, , O
and CC O
that IN O
all DT O
three CD O
agents NNS O
can MD O
induce VB O
Hsp60 NNP B-Gene
in IN O
HUVECs NNP O
. . O

METHODS NN O
: : O
Ten CD O
atopic VBZ O
asthmatic JJ O
subjects NNS O
were VBD O
treated VBN O
with IN O
FP NNP O
250 CD O
microg NN O
twice RB O
daily RB O
for IN O
4 CD O
weeks NNS O
. . O

In IN O
addition NN O
, , O
a DT O
24 CD O
- : O
hour NN O
urinary JJ O
cortisol NN O
excretion NN O
and CC O
an DT O
adrenocorticotropic NN O
hormone NN O
test NN O
before IN O
and CC O
after IN O
treatment NN O
with IN O
FP NNP O
were VBD O
performed VBN O
. . O

However RB O
, , O
we PRP O
detected VBD O
a DT O
significant JJ O
reduction NN O
of IN O
the DT O
GR NNP B-Gene
mRNA NN I-Gene
levels NNS O
in IN O
the DT O
endobronchial JJ O
biopsy NN O
specimens NNS O
after IN O
FP NNP O
treatment NN O
( ( O
36 CD O
. . O
6 CD O
+ JJ O
/ NNP O
- : O
23 CD O
. . O
1 CD O
and CC O
25 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
10 CD O
. . O
9 CD O
amol JJ O
GR NNP B-Gene
mRNA NN I-Gene
/ NNP O
microg NN O
RNA NNP O
, , O
respectively RB O
; : O
P NNP O
< NNP O
. . O
1 CD O
) ) O
. . O

In IN O
the DT O
peripheral JJ O
blood NN O
lymphocytes VBZ O
an DT O
even RB O
more RBR O
striking JJ O
downregulation NN O
of IN O
the DT O
GR NNP O
by IN O
its PRP$ O
cognate NN O
ligand NN O
was VBD O
documented VBN O
( ( O
30 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
26 CD O
. . O
5 CD O
and CC O
8 CD O
. . O
8 CD O
+ JJ O
/ NNP O
- : O
5 CD O
amol NN O
GR NNP B-Gene
mRNA NN I-Gene
/ NNP O
microg NN O
RNA NNP O
, , O
respectively RB O
; : O
P NNP O
< NNP O
. . O
1 CD O
) ) O
, , O
possibly RB O
reflecting VBG O
differences NNS O
in IN O
glucocorticoid JJ O
sensitivity NN O
between IN O
tissues NNS O
. . O

Inflammation NN O
is VBZ O
constantly RB O
observed VBN O
in IN O
allergic JJ O
reactions NNS O
. . O

The DT O
action NN O
of IN O
glucocorticosteroids NNS O
is VBZ O
mediated VBN O
through IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
present VBP O
in IN O
the DT O
cellular JJ O
cytoplasm NN O
. . O

Interaction NN O
to TO O
DNA NNP O
induces NNS O
changes NNS O
in IN O
the DT O
transcription NN O
rate NN O
, , O
leading VBG O
to TO O
either DT O
gene NN O
induction NN O
or CC O
gene NN O
repression NN O
. . O

RESULTS NN O
: : O
Phorbol NNP O
- : O
myristate NN O
- : O
acetate NN O
and CC O
ionomycine NN O
strongly RB O
increase VB O
the DT O
percent NN O
- : O
age NN O
of IN O
IL NNP O
- : O
2 CD O
+ JJ O
cells NNS O
; : O
an DT O
additional JJ O
50 CD O
% NN O
HCSs NNP O
significantly RB O
suppresses VBZ O
the DT O
percentage NN O
to TO O
, , O
or CC O
below IN O
the DT O
level NN O
of IN O
unstimulated JJ O
cells NNS O
. . O

50 CD O
% NN O
HCS NNP O
downregulates VBZ O
the DT O
alpha JJ B-Gene
- : I-Gene
chain NN I-Gene
and CC O
slightly RB O
upregulates VBZ O
the DT O
beta NN B-Gene
- : I-Gene
chain NN I-Gene
. . O

Inhibition NN O
of IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
- : O
inducible JJ O
gene NN O
expression NN O
in IN O
human JJ O
monocytes NNS O
by IN O
type NN B-Gene
I PRP I-Gene
and CC I-Gene
type VB I-Gene
II NNP I-Gene
interferons NNS I-Gene
. . O

However RB O
, , O
the DT O
mechanism NN O
by IN O
which WDT O
IFNs NNP B-Gene
mediate NN O
this DT O
inhibition NN O
has VBZ O
not RB O
been VBN O
defined VBN O
. . O

Because IN O
STAT6 NNP B-Gene
activation NN O
plays VBZ O
an DT O
essential JJ O
role NN O
in IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
/ NN O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
- : O
induced VBN O
gene NN O
expression NN O
, , O
the DT O
ability NN O
of IN O
IFN NNP B-Gene
- : I-Gene
beta NN I-Gene
and CC O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
to TO O
inhibit VB O
STAT6 NNP B-Gene
activity NN O
provides VBZ O
an DT O
explanation NN O
for IN O
how WRB O
IFNs NNP B-Gene
can MD O
suppress VB O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
/ NN O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
- : O
inducible JJ O
gene NN O
expression NN O
. . O

HLA NNP B-Gene
class NN I-Gene
I PRP I-Gene
Ags VBP I-Gene
have VBP O
been VBN O
implicated VBN O
to TO O
play VB O
a DT O
major JJ O
role NN O
in IN O
this DT O
process NN O
, , O
since IN O
signaling VBG O
via IN O
HLA NNP B-Gene
class NN I-Gene
I PRP I-Gene
molecules NNS I-Gene
can MD O
induce VB O
the DT O
proliferation NN O
of IN O
aortic JJ O
endothelial NN O
as RB O
well RB O
as IN O
smooth JJ O
muscle NN O
cells NNS O
. . O

A DT O
cdk2 NN O
inhibitor NN O
, , O
Olomoucine NNP O
, , O
as RB O
well RB O
as IN O
a DT O
dominant JJ B-Gene
- : I-Gene
negative JJ I-Gene
cdk2 NN I-Gene
construct NN I-Gene
prevented VBD O
HLA NNP B-Gene
class NN I-Gene
I PRP I-Gene
- : O
mediated VBN O
inactivation NN O
of IN O
Rb NNP B-Gene
; : O
in IN O
contrast NN O
, , O
dominant JJ B-Gene
- : I-Gene
negative JJ I-Gene
cdk4 NN I-Gene
and CC I-Gene
cdk6 NN I-Gene
constructs NNS I-Gene
had VBD O
no DT O
effect NN O
. . O

PG490 NNP O
inhibits NNS O
interleukin FW B-Gene
( ( I-Gene
IL NNP I-Gene
) ) I-Gene
- : I-Gene
2 CD I-Gene
expression NN O
by IN O
normal JJ O
human JJ O
peripheral JJ O
blood NN O
lymphocytes NNS O
stimulated VBD O
with IN O
phorbol NN O
12 CD O
- : O
myristate NN O
13 CD O
- : O
acetate NN O
( ( O
PMA NNP O
) ) O
and CC O
antibody NN O
to TO O
CD3 NNP B-Gene
( ( O
IC50 NNP O
of IN O
10 CD O
ng JJ O
/ NNP O
ml NN O
) ) O
, , O
and CC O
with IN O
PMA NNP O
and CC O
ionomycin NN O
( ( O
Iono NNP O
, , O
IC50 NNP O
of IN O
40 CD O
ng JJ O
/ NNP O
ml NN O
) ) O
. . O

In IN O
Jurkat NNP O
T NNP O
- : O
cells NNS O
, , O
PG490 NNP O
inhibits VBZ O
PMA NNP O
/ NNP O
Iono NNP O
- : O
stimulated VBD O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
transcription NN O
. . O

PG490 NNP O
can MD O
completely RB O
inhibit VB O
transcriptional JJ O
activation NN O
at IN O
the DT O
purine NN B-Gene
- : I-Gene
box NN I-Gene
/ JJ I-Gene
ARRE NNP I-Gene
/ NNP I-Gene
NF NNP I-Gene
- : I-Gene
AT NNP I-Gene
and CC I-Gene
NF NNP I-Gene
- : I-Gene
kappaB NN I-Gene
target NN I-Gene
DNA NNP I-Gene
sequences NNS I-Gene
triggered VBN O
by IN O
all DT O
stimuli NNS O
examined VBN O
( ( O
PMA NNP O
, , O
PMA NNP O
/ NNP O
Iono NNP O
, , O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
) ) O
. . O

PG490 NNP O
also RB O
inhibits VBZ O
PMA NNP O
- : O
stimulated VBD O
activation NN O
of IN O
a DT O
chimeric JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
in IN O
which WDT O
the DT O
C NNP B-Gene
- : I-Gene
terminal JJ I-Gene
TA1 NNP I-Gene
transactivation NN I-Gene
domain NN I-Gene
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
p65 NN I-Gene
is VBZ O
fused VBN O
to TO O
the DT O
DNA NNP B-Gene
binding VBG I-Gene
domain NN I-Gene
of IN O
GAL4 NNP B-Gene
. . O

Unexpected VBN O
and CC O
coordinated VBN O
expression NN O
of IN O
Spi NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
Fli NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
megakaryocytic JJ B-Gene
genes NNS I-Gene
in IN O
four CD O
Epo NNP O
- : O
dependent NN O
cell NN O
lines NNS O
established VBN O
from IN O
transgenic JJ O
mice NN O
displaying VBG O
erythroid JJ O
- : O
specific JJ O
expression NN O
of IN O
a DT O
thermosensitive JJ B-Gene
SV40 NNP I-Gene
T NNP I-Gene
antigen NN I-Gene
. . O

Most JJS O
erythroleukemic JJ O
cell NN O
lines NNS O
established VBN O
in IN O
vitro NN O
coexpress NN O
erythrocytic JJ B-Gene
and CC I-Gene
megakaryocytic JJ I-Gene
markers NNS I-Gene
that WDT O
often RB O
are VBP O
associated VBN O
with IN O
expression NN O
of IN O
Spi NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
/ NNP O
or CC O
Fli NNP B-Gene
- : I-Gene
1 CD I-Gene
transcription NN I-Gene
factors NNS I-Gene
known VBN O
as IN O
transactivators NNS B-Gene
of IN I-Gene
megakaryocyte NN I-Gene
- : I-Gene
specific JJ I-Gene
promoters NNS I-Gene
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
examined VBD O
the DT O
possibility NN O
of IN O
establishing VBG O
new JJ O
cell NN O
lines NNS O
keeping VBG O
strictly RB O
erythroid SYM O
- : O
specific JJ O
properties NNS O
in IN O
vitro NN O
through IN O
the DT O
targeted JJ O
and CC O
conditional JJ O
immortalization NN O
of IN O
erythrocytic JJ O
progenitors NNS O
. . O

However RB O
, , O
like IN O
normal JJ O
Ter NNP O
119 CD O
erythroid NN O
cells NNS O
, , O
these DT O
Ter NNP O
119 CD O
positive JJ O
cells NNS O
from IN O
transgenic JJ O
mice NNS O
still RB O
expressed VBN O
high JJ O
levels NNS O
of IN O
beta NN B-Gene
- : I-Gene
globin NN I-Gene
and CC O
very RB O
low JJ O
or CC O
undetectable JJ O
glycoprotein NN B-Gene
IIb NNP I-Gene
and CC O
platelet VB B-Gene
factor NN I-Gene
4 CD I-Gene
megakaryocytic JJ I-Gene
transcripts NNS I-Gene
. . O

Taken VBN O
together RB O
, , O
these DT O
data NNS O
indicate VBP O
that IN O
the DT O
unexpected JJ O
expression NN O
of IN O
megakaryocytic JJ B-Gene
genes NNS I-Gene
is VBZ O
a DT O
specific JJ O
property NN O
of IN O
immortalized JJ O
cells NNS O
that WDT O
can MD O
not RB O
be VB O
explained VBN O
only RB O
by IN O
enhanced JJ O
expression NN O
of IN O
Spi NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC I-Gene
/ NNP I-Gene
or CC I-Gene
Fli NNP I-Gene
- : I-Gene
1 CD I-Gene
genes NNS I-Gene
. . O

Fludarabine NNP O
- : O
induced JJ O
immunosuppression NN O
is VBZ O
associated VBN O
with IN O
inhibition NN O
of IN O
STAT1 NNP B-Gene
signaling VBG O
. . O

Fludarabine NNP O
is VBZ O
a DT O
nucleoside JJ O
analog NN O
used VBN O
in IN O
the DT O
treatment NN O
of IN O
hematologic JJ O
malignancies NNS O
that WDT O
can MD O
induce VB O
severe JJ O
and CC O
prolonged JJ O
immunosuppression NN O
. . O

STAT1 NNP B-Gene
, , O
which WDT O
is VBZ O
activated VBN O
in IN O
response NN O
to TO O
many JJ O
lymphocyte JJ B-Gene
- : I-Gene
activating VBG I-Gene
cytokines NNS I-Gene
including VBG O
the DT O
interferons NNS B-Gene
, , O
is VBZ O
essential JJ O
for IN O
cell NN O
- : O
mediated VBN O
immunity NN O
, , O
as IN O
the DT O
absence NN O
of IN O
this DT O
protein NN O
is VBZ O
associated VBN O
with IN O
prominent JJ O
defects NNS O
in IN O
the DT O
ability NN O
to TO O
control VB O
viral JJ O
infections NNS O
. . O

Here RB O
we PRP O
show VBP O
that DT O
fludarabine NN O
, , O
but CC O
not RB O
the DT O
immunosuppressant JJ O
cyclosporine NN O
A NNP O
, , O
inhibits VBZ O
the DT O
cytokine NN B-Gene
- : O
induced JJ O
activation NN O
of IN O
STAT1 NNP B-Gene
and CC O
STAT1 NNP B-Gene
- : O
dependent JJ O
gene NN O
transcription NN O
in IN O
normal JJ O
resting NN O
or CC O
activated VBN O
lymphocytes NNS O
. . O

Fludarabine NNP O
caused VBD O
a DT O
specific JJ O
depletion NN O
of IN O
STAT1 NNP B-Gene
protein NN I-Gene
( ( O
and CC O
mRNA NN O
) ) O
but CC O
not RB O
of IN O
other JJ O
STATs NNP B-Gene
. . O

This DT O
loss NN O
of IN O
STAT1 NNP B-Gene
was VBD O
also RB O
seen VBN O
in IN O
cells NNS O
from IN O
patients NNS O
treated VBN O
with IN O
fludarabine NN O
in IN O
vivo NN O
. . O

Thus RB O
, , O
STAT1 NNP B-Gene
may MD O
be VB O
a DT O
useful JJ O
target NN O
in IN O
the DT O
development NN O
of IN O
new JJ O
immunosuppressive JJ O
and CC O
antineoplastic JJ O
agents NNS O
. . O

Furthermore RB O
, , O
it PRP O
demonstrates VBZ O
that IN O
aging VBG O
does VBZ O
not RB O
influence VB O
the DT O
sensitivity NN O
of IN O
this DT O
phosphatase NN B-Gene
. . O

Spi NNP B-Gene
- : I-Gene
C NNP I-Gene
, , O
a DT O
novel JJ O
Ets NNP B-Gene
protein NN I-Gene
that WDT O
is VBZ O
temporally RB O
regulated VBN O
during IN O
B NNP O
lymphocyte NN O
development NN O
. . O

Spi NNP B-Gene
- : I-Gene
C NNP I-Gene
interacted VBD O
with IN O
DNA NNP O
similarly RB O
to TO O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
as IN O
judged VBN O
by IN O
methylation NN O
interference NN O
, , O
band SYM O
- : O
shift NN O
and CC O
site NN O
selection NN O
analysis NN O
, , O
and CC O
activated VBD O
transcription NN O
of IN O
a DT O
kappaY JJ B-Gene
element NN I-Gene
reporter NN I-Gene
gene NN I-Gene
upon IN O
co JJ O
- : O
transfection NN O
of IN O
HeLa NNP O
cells NNS O
. . O

Spi NNP B-Gene
- : I-Gene
C NNP I-Gene
RNA NNP I-Gene
was VBD O
expressed VBN O
in IN O
mature NN O
B NNP O
lymphocytes VBZ O
and CC O
at IN O
lower JJR O
levels NNS O
in IN O
macrophages NNS O
. . O

Under IN O
these DT O
conditions NNS O
, , O
dexamethasone NN O
had VBD O
a DT O
minimal JJ O
effect NN O
on IN O
cell NN O
growth NN O
, , O
elicited VBD O
little JJ O
internucleosomal JJ O
DNA NNP O
fragmentation NN O
, , O
and CC O
induced VBD O
no DT O
cell NN O
cycle NN O
perturbation NN O
. . O

Human NNP O
T NNP O
- : O
cell NN O
leukemia NN O
virus NN O
type NN O
I PRP O
( ( O
HTLV NNP O
- : O
I PRP O
) ) O
is VBZ O
an DT O
etiologic JJ O
agent NN O
of IN O
adult NN O
T NNP O
- : O
cell NN O
leukemia NN O
( ( O
ATL NNP O
) ) O
. . O

The DT O
viral JJ B-Gene
protein NN I-Gene
Tax NNP B-Gene
induces VBZ O
the DT O
activation NN O
and CC O
nuclear JJ O
translocalization NN O
of IN O
transcription NN B-Gene
factor NN I-Gene
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
, , O
which WDT O
is VBZ O
proposed VBN O
to TO O
play VB O
a DT O
crucial JJ O
role NN O
in IN O
the DT O
transformation NN O
of IN O
T NNP O
cells NNS O
by IN O
HTLV NNP O
- : O
I PRP O
. . O

However RB O
, , O
the DT O
HTLV NNP B-Gene
- : I-Gene
I PRP I-Gene
genes NNS I-Gene
including VBG O
Tax NNP B-Gene
are VBP O
not RB O
expressed VBN O
significantly RB O
in IN O
primary JJ O
leukemic JJ O
cells NNS O
from IN O
ATL NNP O
patients NNS O
. . O

We PRP O
found VBD O
that IN O
leukemic JJ O
cells NNS O
from IN O
ATL NNP O
patients NNS O
, , O
like IN O
HTLV NNP O
- : O
I PRP O
- : O
infected VBN O
T NNP O
- : O
cell NN O
lines NNS O
, , O
display VBP O
constitutive JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
DNA NNP O
binding NN O
activity NN O
and CC O
increased JJ O
degradation NN O
of IN O
IkappaBalpha NNP B-Gene
( ( O
an DT O
inhibitor NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
) ) O
. . O

One CD O
T NNP O
- : O
cell NN O
line NN O
derived VBN O
from IN O
ATL NNP O
leukemic JJ O
cells NNS O
, , O
TL NNP O
- : O
Om1 NN O
, , O
displayed VBD O
constitutive JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activity NN O
, , O
as RB O
well RB O
as IN O
enhanced JJ O
degradation NN O
of IN O
IkappaBalpha NNP B-Gene
, , O
despite IN O
the DT O
lack NN O
of IN O
detectable JJ O
Tax NNP B-Gene
expression NN O
. . O

Interestingly RB O
, , O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
TL NNP O
- : O
Om1 NNP O
consists VBZ O
of IN O
p50 NN B-Gene
/ NNP I-Gene
p50 NN I-Gene
and CC O
p50 NN B-Gene
/ VBP I-Gene
p65 NN I-Gene
like IN O
that DT O
in IN O
fresh JJ O
primary JJ O
leukemic JJ O
cells NNS O
. . O

The DT O
most RBS O
characterized JJ O
pathway NN O
is VBZ O
via IN O
JAK NNP B-Gene
- : B-Gene
STAT NN I-Gene
signaling NN O
. . O

Therefore RB O
, , O
this DT O
study NN O
was VBD O
designed VBN O
to TO O
analyze VB O
the DT O
role NN O
of IN O
Lck NNP B-Gene
in IN O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
signaling NN O
by IN O
using VBG O
the DT O
Jurkat NNP O
, , O
JCam NNP O
( ( O
an DT O
Lck NNP O
- : O
defective JJ O
cell NN O
line NN O
derived VBN O
from IN O
Jurkat NNP O
) ) O
, , O
and CC O
JCam NNP O
/ NNP O
Lck NNP O
( ( O
JCam NNP O
cells NNS O
with IN O
Lck NNP B-Gene
restored VBD O
) ) O
. . O

Finally RB O
, , O
the DT O
results NNS O
demonstrate VBP O
that IN O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
exerts VBZ O
an DT O
antiproliferative JJ O
effect NN O
in IN O
all DT O
three CD O
cell NN O
lines NNS O
. . O

We PRP O
investigated VBD O
the DT O
MAPk NNP B-Gene
kinase NN I-Gene
( ( O
MKK NNP B-Gene
) ) O
that WDT O
activates VBZ O
p38 JJ B-Gene
MAPk NNP I-Gene
in IN O
response NN O
to TO O
LPS NNP O
, , O
the DT O
p38 NN B-Gene
MAPk NNP I-Gene
isoforms VBZ I-Gene
that WDT O
are VBP O
activated VBN O
as IN O
part NN O
of IN O
this DT O
pathway NN O
, , O
and CC O
the DT O
functional JJ O
responses NNS O
affected VBN O
by IN O
p38 NN B-Gene
MAPk NNP I-Gene
activation NN O
. . O

Although IN O
MKK3 NNP B-Gene
, , O
MKK4 NNP B-Gene
, , O
and CC O
MKK6 NNP B-Gene
all RB O
activated VBD O
p38 JJ B-Gene
MAPk NNP I-Gene
in IN O
experimental JJ O
models NNS O
, , O
only RB O
MKK3 NNP B-Gene
was VBD O
found VBN O
to TO O
activate VB O
recombinant JJ O
p38 NN B-Gene
MAPk NNP I-Gene
in IN O
LPS NNP O
- : O
treated VBD O
neutrophils NNS O
. . O

The DT O
I PRP B-Gene
gamma VBP I-Gene
3 CD I-Gene
ECS NNP B-Gene
lies VBZ O
upstream NN O
of IN O
the DT O
major JJ B-Gene
I PRP I-Gene
gamma VBP I-Gene
3 CD I-Gene
transcription NN I-Gene
initiation NN I-Gene
site NN I-Gene
and CC O
displays VBZ O
more JJR O
than IN O
90 CD O
% NN O
identity NN O
with IN O
the DT O
corresponding JJ O
human JJ B-Gene
I PRP I-Gene
gamma VBP I-Gene
1 CD I-Gene
, , O
I PRP B-Gene
gamma VBP I-Gene
2 CD I-Gene
, , O
and CC O
I PRP B-Gene
gamma VBP I-Gene
4 CD I-Gene
regions NNS O
. . O

In IN O
these DT O
transfected VBN O
CL NNP O
- : O
1 CD O
cells NNS O
, , O
CD40 NNP O
: : O
CD40L NNP B-Gene
engagement NN O
and CC O
exposure NN O
to TO O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
synergistically RB O
induced JJ O
gamma NN O
3 CD O
ECS NNP O
- : O
dependent JJ O
luciferase NN B-Gene
reporter NN I-Gene
gene NN I-Gene
activation NN O
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
showed VBD O
that IN O
p50 NN B-Gene
/ NNP I-Gene
p65 NN I-Gene
/ NNP I-Gene
c SYM I-Gene
- : I-Gene
Rel NN I-Gene
and CC O
STAT NNP B-Gene
- : I-Gene
6 CD I-Gene
are VBP O
effectively RB O
induced VBN O
by IN O
CD40L NNP B-Gene
and CC O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
respectively RB O
, , O
and CC O
bind NN O
to TO O
specific JJ O
DNA NNP B-Gene
motifs NN I-Gene
within IN O
the DT O
ECS NNP B-Gene
. . O

CIITA NNP B-Gene
- : O
induced JJ O
occupation NN O
of IN O
MHC NNP B-Gene
class NN I-Gene
II NNP I-Gene
promoters NNS I-Gene
is VBZ O
independent JJ O
of IN O
the DT O
cooperative JJ O
stabilization NN O
of IN O
the DT O
promoter NN B-Gene
- : I-Gene
bound NN I-Gene
multi SYM I-Gene
- : I-Gene
protein NN I-Gene
complexes NNS I-Gene
. . O

Activation NN O
of IN O
MHC NNP B-Gene
class NN I-Gene
II NNP I-Gene
promoters NNS I-Gene
requires VBZ O
binding VBG O
of IN O
at IN O
least JJS O
three CD O
distinct JJ O
multi SYM B-Gene
- : I-Gene
protein NN I-Gene
complexes NNS I-Gene
( ( O
RFX NNP B-Gene
, , O
X2BP NNP B-Gene
and CC O
NF NNP B-Gene
- : I-Gene
Y NN I-Gene
) ) O
. . O

We PRP O
show VBP O
, , O
however RB O
, , O
that IN O
the DT O
presence NN O
of IN O
CIITA NNP B-Gene
does VBZ O
not RB O
affect VB O
the DT O
stability NN O
of IN O
the DT O
higher JJR O
- : O
order NN O
protein NN O
complex NN O
formed VBN O
on IN O
DNA NN O
by IN O
RFX NNP B-Gene
, , O
X2BP NNP B-Gene
and CC O
NF NNP B-Gene
- : I-Gene
Y NN I-Gene
. . O

Finally RB O
, , O
we PRP O
conclude VBP O
that IN O
this DT O
effect NN O
of IN O
CIITA NNP B-Gene
is VBZ O
cell SYM O
- : O
type NN O
specific NN O
, , O
since IN O
expression NN O
of IN O
CIITA NNP B-Gene
is VBZ O
not RB O
required VBN O
for IN O
normal JJ O
occupation NN O
of IN O
MHC NNP B-Gene
class NN I-Gene
II NNP I-Gene
promoters NNS I-Gene
in IN O
B NNP O
lymphocytes NNS O
. . O

SH2 NNP B-Gene
domain NN I-Gene
- : I-Gene
containing VBG I-Gene
protein NN I-Gene
76 CD I-Gene
( ( O
SLP NNP B-Gene
- : I-Gene
76 CD I-Gene
) ) O
interacts NNS O
with IN O
the DT O
guanine NN B-Gene
nucleotide IN I-Gene
exchange NN I-Gene
factor NN I-Gene
Vav NNP B-Gene
to TO O
activate VB O
the DT O
nuclear JJ B-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
cells NNS I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
) ) O
, , O
and CC O
its PRP$ O
expression NN O
is VBZ O
required VBN O
for IN O
normal JJ O
T NNP O
cell NN O
development NN O
. . O

In IN O
contrast NN O
, , O
another DT O
inducible JJ O
gene NN O
expression NN O
of IN O
monocyte JJ B-Gene
chemotactic JJ I-Gene
protein NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
a DT O
CC NNP B-Gene
chemokine NN I-Gene
) ) O
and CC O
the DT O
activation NN O
of IN O
the DT O
transcriptional JJ B-Gene
factor NN I-Gene
( ( O
FcRFgamma NNP B-Gene
) ) O
bound NN O
to TO O
the DT O
gamma NN B-Gene
response NN I-Gene
region NN I-Gene
were VBD O
similarly RB O
or CC O
less RBR O
abundantly RB O
induced VBN O
by IN O
IFNgamma NNP B-Gene
treatment NN O
in IN O
PMA NNP O
- : O
or CC O
RA NNP O
- : O
differentiated VBD O
U937 NNP O
cells NNS O
, , O
indicating VBG O
that IN O
increased VBD O
IP NNP B-Gene
- : I-Gene
10 CD I-Gene
mRNA JJ I-Gene
induction NN O
was VBD O
not RB O
due JJ O
to TO O
the DT O
augmented JJ O
ability NN O
of IN O
the DT O
cells NNS O
to TO O
respond VB O
to TO O
the DT O
presence NN O
of IN O
IFNgamma NNP B-Gene
. . O

Role NNP O
of IN O
cellular JJ B-Gene
tumor NN I-Gene
necrosis NN I-Gene
factor NN I-Gene
receptor NN I-Gene
- : I-Gene
associated JJ I-Gene
factors NNS I-Gene
in IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
and CC O
lymphocyte JJ O
transformation NN O
by IN O
herpesvirus NN O
Saimiri NNP O
STP NNP B-Gene
. . O

In IN O
addition NN O
, , O
a DT O
somewhat RB O
divergent JJ O
region NN O
of IN O
STP NNP B-Gene
- : I-Gene
C488 NNP I-Gene
is VBZ O
critical JJ O
for IN O
TRAF NNP B-Gene
association NN O
. . O

In IN O
contrast NN O
, , O
caspase NN O
1 CD O
( ( O
ICE NNP O
) ) O
did VBD O
not RB O
cleave VB O
SP1 NNP B-Gene
in IN O
vitro NN O
. . O

Comparison NNP O
of IN O
tumor NN O
specimen NNS O
from IN O
MM NNP O
precursor NN O
lesions NNS O
, , O
primary JJ O
tumors NNS O
, , O
and CC O
metastases NNS O
revealed VBD O
that IN O
CD40 NNP B-Gene
surface NN O
expression NN O
is VBZ O
down RB O
- : O
regulated VBN O
during IN O
tumor NN O
progression NN O
. . O

CD40 NNP B-Gene
expression NN O
was VBD O
confirmed VBN O
in IN O
7 CD O
human JJ O
MM NNP O
cell NN O
lines NNS O
established VBN O
from IN O
immunogenic JJ O
primary JJ O
tumors NNS O
or CC O
metastases NNS O
, , O
whereas NNS O
11 CD O
cell NN O
lines NNS O
established VBN O
from IN O
advanced JJ O
stages NNS O
were VBD O
CD40 NNP B-Gene
negative JJ O
. . O

Furthermore RB O
, , O
CD40 NNP B-Gene
ligation NN O
of IN O
a DT O
HLA NNP O
- : O
A2 NNP O
+ NNP O
, , O
MelanA NNP O
/ NNP O
MART1 NNP O
+ NNP O
MM NNP O
cell NN O
line NN O
enhanced VBD O
its PRP$ O
susceptibility NN O
to TO O
specific JJ O
lysis NN O
by IN O
a DT O
HLA NNP O
- : O
A2 NNP O
- : O
restricted VBN O
, , O
MelanA NNP O
/ NNP O
MART NNP O
- : O
1 CD O
- : O
specific JJ O
CTL NNP O
clone NN O
. . O

Human NNP O
immunodeficiency NN O
virus NN O
- : O
associated VBN O
Hodgkin NNP O
' POS O
s JJ O
disease NN O
derives NNS O
from IN O
post NN O
- : O
germinal NN O
center NN O
B NNP O
cells NNS O
. . O

Human NNP O
immunodeficiency NN O
virus NN O
- : O
associated VBN O
Hodgkin NNP O
' POS O
s NN O
disease NN O
( ( O
HIV NNP O
- : O
HD NNP O
) ) O
displays VBZ O
several JJ O
peculiarities NNS O
when WRB O
compared VBN O
with IN O
HD NNP O
of IN O
the DT O
general JJ O
population NN O
. . O

MDS1 NNP B-Gene
/ NNP I-Gene
EVI1 NNP I-Gene
is VBZ O
inappropriately RB O
activated VBN O
in IN O
myeloid JJ O
leukemias NN O
following VBG O
chromosomal JJ O
rearrangements NNS O
involving VBG O
band NN B-Gene
3q26 CD I-Gene
. . O

This DT O
fusion NN O
protein NN O
contains VBZ O
the DT O
DNA NNP B-Gene
- : I-Gene
binding VBG I-Gene
domain NN I-Gene
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
AML1 NNP B-Gene
fused VBD O
in IN O
- : O
frame NN O
to TO O
the DT O
entire JJ O
MDS1 NNP B-Gene
/ NNP I-Gene
EVI1 NNP I-Gene
with IN O
the DT O
exclusion NN O
of IN O
its PRP$ O
first JJ O
12 CD O
amino NN O
acids NNS O
. . O

In IN O
this DT O
report NN O
, , O
we PRP O
have VBP O
analyzed VBN O
the DT O
response NN O
of IN O
the DT O
hematopoietic JJ O
precursor NN O
cell NN O
line NN O
32Dcl3 CD O
, , O
expressing VBG O
either CC O
the DT O
normal JJ B-Gene
protein NN I-Gene
MDS1 NNP I-Gene
/ NNP I-Gene
EVI1 NNP I-Gene
or CC O
the DT O
fusion NN B-Gene
protein NN I-Gene
AML1 NNP I-Gene
/ NNP I-Gene
MDS1 NNP I-Gene
/ NNP I-Gene
EVI1 NNP I-Gene
, , O
to TO O
factors NNS O
that IN O
control NN O
cell NN O
differentiation NN O
or CC O
cell NN O
replication NN O
. . O

This DT O
effect NN O
is VBZ O
similar JJ O
to TO O
that DT O
previously RB O
described VBN O
by IN O
others NNS O
for IN O
32Dcl3 CD O
cells NNS O
that IN O
express NN O
transgenic JJ B-Gene
Evil NNP I-Gene
. . O

By IN O
using VBG O
the DT O
yeast NN O
two CD O
- : O
hybrid NN O
system NN O
, , O
we PRP O
also RB O
show VBP O
that IN O
EVI1 NNP B-Gene
( ( O
contained VBN O
in IN O
its PRP$ O
entirety NN O
in IN O
MDS1 NNP B-Gene
/ NNP I-Gene
EVI1 NNP I-Gene
and CC O
AML1 NNP B-Gene
/ NNP I-Gene
MDS1 NNP I-Gene
/ NNP I-Gene
EVI1 NNP I-Gene
) ) O
physically RB O
interacts VBZ O
with IN O
SMAD3 NNP B-Gene
, , O
which WDT O
is VBZ O
an DT O
intracellular JJ O
mediator NN O
of IN O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
signaling NN O
. . O

The DT O
levels NNS O
of IN O
cAMP NN B-Gene
- : I-Gene
dependent JJ I-Gene
protein NN I-Gene
kinase NN I-Gene
and CC O
Rap1 NNP B-Gene
were VBD O
assessed VBN O
by IN O
Western JJ O
blot NN O
analysis NN O
, , O
immunostaining NN O
, , O
and CC O
computer NN O
- : O
assisted JJ O
imaging NN O
. . O

In IN O
many JJ O
pathological JJ O
situations NNS O
, , O
the DT O
balance NN O
between IN O
Th1 NNP O
and CC O
Th2 NNP O
immune VBP O
responses NNS O
determines VBZ O
the DT O
outcome NN O
of IN O
diverse NN O
immunologically RB O
mediated VBD O
clinical JJ O
syndromes NNS O
including VBG O
infectious JJ O
, , O
autoimmune JJ O
, , O
and CC O
allergic JJ O
diseases NNS O
. . O

Tcf NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
mediated VBN O
transcription NN O
in IN O
T NNP O
lymphocytes NNS O
: : O
differential JJ O
role NN O
for IN O
glycogen NN B-Gene
synthase NN I-Gene
kinase VBD I-Gene
- : I-Gene
3 CD I-Gene
in IN O
fibroblasts NNS O
and CC O
T NNP O
cells NNS O
. . O

Beta NNP O
- : O
catenin NN O
is VBZ O
the DT O
vertebrate JJ O
homolog NN O
of IN O
the DT O
Drosophila NNP B-Gene
segment NN I-Gene
polarity NN I-Gene
gene NN I-Gene
Armadillo NNP B-Gene
and CC O
plays NNS O
roles NNS O
in IN O
both DT O
cell NN O
- : O
cell NN O
adhesion NN O
and CC O
transduction NN O
of IN O
the DT O
Wnt NNP O
signaling VBG O
cascade NN O
. . O

Recently RB O
, , O
members NNS O
of IN O
the DT O
Lef NNP B-Gene
/ NNP I-Gene
Tcf NNP I-Gene
transcription NN I-Gene
factor NN I-Gene
family NN I-Gene
have VBP O
been VBN O
identified VBN O
as IN O
protein JJ O
partners NNS O
of IN O
beta NN B-Gene
- : I-Gene
catenin NN I-Gene
, , O
explaining VBG O
how WRB O
beta JJ B-Gene
- : I-Gene
catenin NN I-Gene
alters NNS O
gene NN O
expression NN O
. . O

In IN O
contrast NN O
, , O
in IN O
C57MG NNP O
fibroblast NN O
cells NNS O
, , O
lithium NN O
inactivates NNS O
GSK NNP B-Gene
- : I-Gene
3beta CD I-Gene
and CC O
induces NNS O
Tcf NNP O
- : O
controlled VBN O
transcription NN O
. . O

Overexpression NN O
of IN O
SIT NNP B-Gene
in IN O
Jurkat NNP O
cells NNS O
downmodulates VBZ O
T NNP O
cell NN O
receptor NN O
- : O
and CC O
phytohemagglutinin VB O
- : O
mediated VBN O
activation NN O
of IN O
the DT O
nuclear JJ B-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
cells NNS I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
AT NN I-Gene
) ) O
by IN O
interfering VBG O
with IN O
signaling VBG O
processes NNS O
that WDT O
are VBP O
probably RB O
located VBN O
upstream NN O
of IN O
activation NN O
of IN O
phospholipase NN B-Gene
C NNP I-Gene
. . O

However RB O
, , O
binding VBG O
of IN O
SHP2 NNP B-Gene
to TO O
SIT NNP B-Gene
is VBZ O
not RB O
required VBN O
for IN O
inhibition NN O
of IN O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
induction NN O
, , O
suggesting VBG O
that IN O
SIT NNP B-Gene
not RB O
only RB O
regulates VBZ O
NF NNP B-Gene
- : I-Gene
AT NN I-Gene
activity NN O
but CC O
also RB O
controls VBZ O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
unrelated JJ O
pathways NNS O
of IN O
T NNP O
cell NN O
activation NN O
involving VBG O
SHP2 NNP B-Gene
. . O

We PRP O
investigated VBD O
the DT O
function NN O
of IN O
conditionally RB O
expressed VBN O
EBNA2 NNP B-Gene
in IN O
the DT O
context NN O
of IN O
the DT O
IFN NNP B-Gene
response NN O
in IN O
Burkitt NNP O
' POS O
s NN O
lymphoma NN O
cell NN O
lines NNS O
. . O

Expression NN O
of IN O
EBNA2 NNP B-Gene
led VBD O
to TO O
the DT O
transcriptional JJ O
activation NN O
of IN O
both DT O
endogenous JJ O
or CC O
transfected VBN O
IFN NNP B-Gene
- : I-Gene
stimulated VBN I-Gene
genes NNS I-Gene
( ( O
ISGs NNP B-Gene
) ) O
, , O
genes NNS O
which WDT O
contain VBP O
within IN O
their PRP$ O
promoters NNS B-Gene
either CC O
the DT O
interferon NN B-Gene
- : I-Gene
stimulated VBN I-Gene
response NN I-Gene
element NN I-Gene
( ( O
ISRE NNP B-Gene
) ) O
or CC O
the DT O
gamma JJ B-Gene
interferon NN I-Gene
activation NN I-Gene
site NN I-Gene
( ( O
GAS NNP B-Gene
) ) O
. . O

PGG NNP O
- : O
Glucan NNP O
, , O
a DT O
soluble JJ O
beta NN O
- : O
( ( O
1 CD O
, , O
6 CD O
) ) O
- : O
branched VBN O
beta SYM O
- : O
( ( O
1 CD O
, , O
3 CD O
) ) O
- : O
linked VBN O
glucose JJ O
homopolymer NN O
derived VBN O
from IN O
the DT O
cell NN O
wall NN O
of IN O
the DT O
yeast NN O
Saccharomyces NNP O
cerevisiae NN O
, , O
is VBZ O
an DT O
immunomodulator NN O
which WDT O
enhances VBZ O
leukocyte NN O
anti SYM O
- : O
infective JJ O
activity NN O
and CC O
enhances NNS O
myeloid NN O
and CC O
megakaryocyte NN O
progenitor NN O
proliferation NN O
. . O

The DT O
binding NN O
of IN O
3H CD O
- : O
PGG NNP O
- : O
Glucan JJ O
to TO O
human JJ O
leukocyte NN O
membranes NNS O
was VBD O
specific JJ O
, , O
concentration NN O
- : O
dependent NN O
, , O
saturable JJ O
, , O
and CC O
high JJ O
affinity NN O
( ( O
Kd NNP O
approximately RB O
6 CD O
nM NNS O
) ) O
. . O

We PRP O
conclude VBP O
that DT O
potentiation NN O
of IN O
nonphlogistic JJ O
clearance NN O
of IN O
apoptotic JJ O
leukocytes NNS O
by IN O
phagocytes NNS O
is VBZ O
a DT O
hitherto JJ O
unrecognized JJ O
property NN O
of IN O
glucocorticoids NNS O
that WDT O
has VBZ O
potential JJ O
implications NNS O
for IN O
therapies NNS O
aimed VBN O
at IN O
promoting VBG O
the DT O
resolution NN O
of IN O
inflammatory JJ O
diseases NNS O
. . O

However RB O
, , O
the DT O
mechanisms NNS O
and CC O
strategies NNS O
to TO O
overcome VB O
RA NNP O
resistance NN O
by IN O
APL NNP O
cells NNS O
are VBP O
still RB O
unclear JJ O
. . O

Also RB O
, , O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
( ( O
10 CD O
( ( O
- : O
10 CD O
) ) O
to TO O
10 CD O
( ( O
- : O
7 CD O
) ) O
mol NN O
/ NNP O
L NNP O
) ) O
in IN O
combination NN O
with IN O
RA NNP O
markedly RB O
inhibits VBZ O
cellular JJ O
proliferation NN O
in IN O
a DT O
dose JJ O
- : O
and CC O
time NN O
- : O
dependent JJ O
manner NN O
. . O

Interestingly RB O
, , O
the DT O
combination NN O
of IN O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
and CC O
RA NNP O
markedly RB O
enhanced VBD O
the DT O
levels NNS O
of IN O
p27 NN B-Gene
( ( I-Gene
KIP1 NNP I-Gene
) ) I-Gene
transcript NN O
and CC O
protein NN O
as IN O
compared VBN O
with IN O
levels NNS O
induced VBN O
by IN O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
alone RB O
. . O

Molecular JJ O
mechanisms NNS O
of IN O
neutrophil JJ O
- : O
endothelial JJ O
cell NN O
adhesion NN O
induced VBN O
by IN O
redox JJ O
imbalance NN O
. . O

Previous JJ O
studies NNS O
have VBP O
implicated VBN O
a DT O
role NN O
for IN O
intracellular JJ O
thiols NNS O
in IN O
the DT O
activation NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
transcriptional JJ O
regulation NN O
of IN O
endothelial JJ B-Gene
cell NN I-Gene
adhesion NN I-Gene
molecules NNS I-Gene
. . O

This DT O
study NN O
was VBD O
designed VBN O
to TO O
determine VB O
whether IN O
changes NNS O
in IN O
endothelial JJ O
cell NN O
glutathione NN O
( ( O
GSH NNP O
) ) O
or CC O
oxidized VBN O
glutathione NN O
( ( O
GSSG NNP O
) ) O
can MD O
alter VB O
neutrophil JJ O
adhesivity NN O
and CC O
to TO O
define VB O
the DT O
molecular JJ O
mechanism NN O
that WDT O
underlies VBZ O
this DT O
GSSG NNP O
/ NNP O
GSH NNP O
- : O
induced JJ O
adhesion NN O
response NN O
. . O

Diamide NNP O
plus CC O
BSO NNP O
- : O
induced VBD O
thiol JJ O
/ NNP O
disulfide NN O
imbalance NN O
was VBD O
associated VBN O
with IN O
a DT O
biphasic JJ O
increase NN O
in IN O
neutrophil JJ O
adhesion NN O
to TO O
HUVECs NNP O
with IN O
peak JJ O
responses NNS O
observed VBD O
at IN O
15 CD O
minutes NNS O
( ( O
phase VB O
1 CD O
) ) O
and CC O
240 CD O
minutes NNS O
( ( O
phase VB O
2 CD O
) ) O
. . O

This DT O
study NN O
demonstrates VBZ O
that IN O
changes NNS O
in IN O
endothelial JJ O
cell NN O
GSSG NNP O
/ NNP O
GSH NNP O
cause NN O
transcription NN O
- : O
independent JJ O
and CC O
transcription JJ O
- : O
dependent JJ O
surface NN O
expression NN O
of IN O
different JJ O
endothelial JJ B-Gene
cell NN I-Gene
adhesion NN I-Gene
molecules NNS I-Gene
, , O
which WDT O
leads VBZ O
to TO O
a DT O
2 CD O
- : O
phase NN O
neutrophil SYM O
- : O
endothelial JJ O
adhesion NN O
response NN O
. . O

In IN O
- : O
situ JJ O
detection NN O
of IN O
fragmented JJ O
DNA NNP O
was VBD O
performed VBN O
to TO O
identify VB O
apoptotic JJ O
cells NNS O
. . O

Angiotensin NNP B-Gene
II NNP I-Gene
activates VBZ O
the DT O
proinflammatory JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
human JJ O
monocytes NNS O
. . O

ANG NNP B-Gene
II NNP I-Gene
, , O
like IN O
TNFalpha NNP B-Gene
, , O
caused VBD O
rapid JJ O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
human JJ O
mononuclear JJ O
cells NNS O
isolated VBN O
from IN O
peripheral JJ O
blood NN O
by IN O
Ficoll NNP O
density NN O
gradient NN O
. . O

Recently RB O
, , O
its PRP$ O
presence NN O
has VBZ O
been VBN O
demonstrated VBN O
in IN O
atherosclerotic JJ O
lesions NNS O
. . O

Increased VBN O
mRNA NN B-Gene
and CC O
surface NN O
expression NN O
of IN O
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
, , O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
were VBD O
noted VBN O
within IN O
hours NNS O
. . O

Transient NNP O
pseudo SYM O
- : O
hypoaldosteronism NN O
following VBG O
resection NN O
of IN O
the DT O
ileum NN O
: : O
normal JJ O
level NN O
of IN O
lymphocytic JJ B-Gene
aldosterone NN I-Gene
receptors NNS I-Gene
outside IN O
the DT O
acute JJ O
phase NN O
. . O

A DT O
urinary JJ O
steroidogram NN O
resulted VBD O
in IN O
highly RB O
elevated VBN O
tetrahydrocortisol NN O
( ( O
THF NNP O
: : O
13 CD O
. . O
3 CD O
mg JJ O
/ JJ O
24h CD O
; : O
N NNP O
: : O
1 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
8 CD O
) ) O
with IN O
no DT O
increase NN O
in IN O
tetrahydrocortisone NN O
( ( O
THE DT O
: : O
3 CD O
. . O
16 CD O
mg JJ O
/ JJ O
24h CD O
; : O
N NNP O
: : O
2 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
2 CD O
. . O
0 CD O
) ) O
excretion NN O
, , O
and CC O
with IN O
low JJ O
THE NNP O
/ NN O
THF NNP O
( ( O
0 CD O
. . O
24 CD O
; : O
N NNP O
: : O
1 CD O
. . O
87 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
36 CD O
) ) O
and CC O
alpha JJ O
THF NNP O
/ NNP O
THF NNP O
( ( O
0 CD O
. . O
35 CD O
; : O
N NNP O
: : O
0 CD O
. . O
92 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
42 CD O
) ) O
ratios NNS O
. . O

Small JJ O
- : O
bowel NN O
resection NN O
in IN O
ileostomized JJ O
patients NNS O
causes VBZ O
excessive JJ O
fecal JJ O
sodium NN O
losses NNS O
and CC O
results NNS O
in IN O
chronic JJ O
sodium NN O
depletion NN O
with IN O
contraction NN O
of IN O
the DT O
plasma NN O
volume NN O
and CC O
severe JJ O
secondary JJ O
hyperaldosteronism NN O
. . O

A DT O
decrease NN O
in IN O
the DT O
translation NN O
rate NN O
is VBZ O
observed VBN O
when WRB O
the DT O
cells NNS O
are VBP O
induced VBN O
to TO O
differentiate VB O
along IN O
the DT O
monocytic JJ O
/ NNP O
macrophage NN O
pathway NN O
or CC O
along IN O
the DT O
granulocytic JJ O
pathway NN O
. . O

In IN O
contrast NN O
, , O
treatment NN O
of IN O
HL NNP O
- : O
60 CD O
cells NNS O
with IN O
retinoic JJ O
acid NN O
or CC O
DMSO NNP O
, , O
which WDT O
results NNS O
in IN O
a DT O
granulocytic JJ O
differentiation NN O
of IN O
these DT O
cells NNS O
, , O
decreases VBZ O
4E CD B-Gene
- : I-Gene
BP1 NN I-Gene
amount NN O
without IN O
affecting VBG O
its PRP$ O
phosphorylation NN O
and CC O
strongly RB O
increases VBZ O
4E CD B-Gene
- : I-Gene
BP2 NN I-Gene
amount NN O
. . O

We PRP O
found VBD O
frequent JJ O
hypermutation NN O
in IN O
follicular JJ O
lymphoma NN O
( ( O
25 CD O
of IN O
59 CD O
= JJ O
42 CD O
% NN O
) ) O
( ( O
germinal JJ O
center NN O
cell NN O
origin NN O
) ) O
and CC O
mucosa $ O
- : O
associated VBN O
lymphoid JJ O
tissue NN O
( ( O
MALT NNP O
) ) O
lymphoma NN O
( ( O
19 CD O
of IN O
45 CD O
= JJ O
42 CD O
% NN O
) ) O
( ( O
postgerminal JJ O
center NN O
) ) O
, , O
but CC O
only RB O
occasionally RB O
in IN O
mantle NN O
cell NN O
lymphoma NN O
( ( O
1 CD O
of IN O
21 CD O
= JJ O
4 CD O
. . O
8 CD O
% NN O
) ) O
( ( O
pregerminal JJ O
center NN O
) ) O
. . O

Most JJS O
mutations NNS O
were VBD O
outside IN O
the DT O
motifs NNS O
potentially RB O
important JJ O
for IN O
transcription NN O
, , O
suggesting VBG O
they PRP O
were VBD O
not RB O
important JJ O
in IN O
lymphomagenesis NN O
but CC O
may MD O
, , O
like IN O
Ig NNP O
mutation NN O
, , O
represent VBP O
an DT O
inherent JJ O
feature NN O
of IN O
the DT O
lymphoma NN O
precursor NN O
cells NNS O
. . O

Markedly RB O
impaired JJ O
binding NN O
was VBD O
observed VBN O
, , O
consistent JJ O
with IN O
both DT O
the DT O
use NN O
of IN O
different JJ O
anchor NN O
residues NNS O
and CC O
with IN O
changes NNS O
in IN O
levels NNS O
of IN O
DQ NNP O
cis SYM O
- : O
dimer NN B-Gene
availability NN O
for IN O
peptide JJ O
binding NN O
interactions NNS O
. . O

Detection NN O
of IN O
intracellular JJ B-Gene
phosphorylated VBN I-Gene
STAT NNP I-Gene
- : I-Gene
1 CD I-Gene
by IN O
flow JJ O
cytometry NN O
. . O

In IN O
addition NN O
, , O
this DT O
technique NN O
should MD O
permit VB O
dissection NN O
of IN O
a DT O
full JJ O
range NN O
of IN O
cellular JJ O
signaling VBG O
pathways NNS O
at IN O
the DT O
protein NN O
level NN O
. . O

Consequently RB O
, , O
cytosolic JJ O
activation NN O
, , O
nuclear JJ O
translocation NN O
and CC O
DNA NNP O
- : O
binding NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
were VBD O
decreased VBN O
. . O

5 CD O
. . O
Neutrophil CC O
apoptosis NN O
and CC O
inhibition NN O
of IN O
neutrophil JJ O
function NN O
were VBD O
induced VBN O
at IN O
lower JJR O
concentrations NNS O
of IN O
SMX NNP O
- : O
NHOH NN O
and CC O
SMX NNP O
- : O
NO NN O
than IN O
those DT O
inducing JJ O
loss NN O
of IN O
membrane NN O
viability NN O
, , O
with IN O
SMX NNP O
having VBG O
no DT O
effect NN O
. . O

7 CD O
. . O
Our PRP$ O
results NNS O
suggest VBP O
that IN O
the DT O
balance NN O
between IN O
oxidation NN O
of IN O
SMX NNP O
to TO O
its PRP$ O
toxic NN O
metabolites NNS O
and CC O
their PRP$ O
reduction NN O
is VBZ O
an DT O
important JJ O
protective JJ O
cellular JJ O
mechanism NN O
. . O

Recently RB O
, , O
we PRP O
reported VBD O
cases NNS O
of IN O
angioimmunoblastic JJ O
T NNP O
- : O
cell NN O
lymphoma NN O
( ( O
AITL NNP O
) ) O
with IN O
hyperplastic JJ O
GCs NNP O
( ( O
AITL NNP O
/ NNP O
GC NNP O
) ) O
, , O
and CC O
observed VBD O
that IN O
borders NNS O
of IN O
enlarged JJ O
GCs NNP O
were VBD O
ill JJ O
defined VBN O
, , O
with IN O
features NNS O
suggestive VBP O
of IN O
an DT O
outward JJ O
migration NN O
of IN O
GC NNP O
cells NNS O
to TO O
surrounding VBG O
interfollicular JJ O
zones NNS O
. . O

In IN O
FL NNP O
, , O
follicles NNS O
were VBD O
densely RB O
populated VBN O
, , O
and CC O
their PRP$ O
borders NNS O
were VBD O
irregular JJ O
, , O
with IN O
some DT O
Bcl NNP O
- : O
6 CD O
+ JJ O
cells NNS O
in IN O
the DT O
interfollicular JJ O
zones NNS O
. . O

Double JJ O
staining VBG O
revealed VBD O
that IN O
these DT O
interfollicular JJ O
Bcl NNP O
- : O
6 CD O
+ JJ O
cells NNS O
in IN O
AITL NNP O
/ NNP O
GC NNP O
were VBD O
Bcl6 NNP O
+ NNP O
/ NNP O
CD3 NNP O
+ NNP O
/ NNP O
CD20 NNP O
- : O
/ NN O
CD57 NNP O
- : O
T NNP O
cells NNS O
. . O

In IN O
typical JJ O
AITL NNP O
, , O
some DT O
neoplastic JJ O
cells NNS O
were VBD O
positive JJ O
for IN O
Bcl NNP B-Gene
- : I-Gene
6 CD I-Gene
, , O
showing VBG O
variable JJ O
degrees NNS O
of IN O
staining NN O
. . O

( ( O
2 CD O
) ) O
Intrafollicular NNP O
CD3 NNP O
+ NNP O
T NNP O
cells NNS O
, , O
many JJ O
of IN O
which WDT O
were VBD O
also RB O
positive JJ O
for IN O
Bcl NNP B-Gene
- : I-Gene
6 CD I-Gene
, , O
were VBD O
markedly RB O
depleted VBN O
in IN O
AITL NNP O
/ NNP O
GC NNP O
, , O
with IN O
increased VBN O
interfollicular JJ O
Bcl NNP O
- : O
6 CD O
+ JJ O
/ NNP O
CD3 NNP O
+ NNP O
cells NNS O
, , O
suggesting VBG O
an DT O
outward JJ O
migration NN O
of IN O
intrafollicular JJ O
T NNP O
cells NNS O
in IN O
this DT O
condition NN O
. . O

( ( O
5 CD O
) ) O
Some DT O
neoplastic JJ O
cells NNS O
in IN O
AITL NNP O
stained VBD O
for IN O
Bcl NNP B-Gene
- : I-Gene
6 CD I-Gene
, , O
suggesting VBG O
up RP O
- : O
regulation NN O
of IN O
Bcl NNP B-Gene
- : I-Gene
6 CD I-Gene
expression NN O
in IN O
this DT O
tumor NN O
. . O

To TO O
continue VB O
our PRP$ O
investigation NN O
of IN O
the DT O
cellular JJ O
events NNS O
that WDT O
occur VBP O
following VBG O
human JJ O
CMV NNP O
( ( O
HCMV NNP O
) ) O
infection NN O
, , O
we PRP O
focused VBD O
on IN O
the DT O
regulation NN O
of IN O
cellular JJ O
activation NN O
following VBG O
viral JJ O
binding VBG O
to TO O
human JJ O
monocytes NNS O
. . O

Because IN O
these DT O
induced JJ O
gene NN O
products NNS O
have VBP O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
sites NNS I-Gene
in IN O
their PRP$ O
promoter NN B-Gene
regions NNS I-Gene
, , O
we PRP O
next VBP O
examined JJ O
whether IN O
there EX O
was VBD O
an DT O
up RP O
- : O
regulation NN O
of IN O
nuclear JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
levels NNS O
. . O

These DT O
results NNS O
support VBD O
our PRP$ O
hypothesis NN O
that IN O
HCMV NNP O
initiates VBZ O
a DT O
signal JJ O
transduction NN O
pathway NN O
that WDT O
leads VBZ O
to TO O
monocyte VB O
activation NN O
and CC O
pinpoints VBZ O
a DT O
potential JJ O
mechanism NN O
whereby WRB O
HCMV NNP O
infection NN O
of IN O
monocytes NNS O
can MD O
result VB O
in IN O
profound JJ O
pathogenesis NN O
, , O
especially RB O
in IN O
chronic JJ O
inflammatory NN O
- : O
type NN O
conditions NNS O
. . O

Glycoprotein NNP B-Gene
( ( I-Gene
GP NNP I-Gene
) ) I-Gene
IX NNP I-Gene
is VBZ O
a DT O
subunit NN O
of IN O
the DT O
von NN B-Gene
Willebrand NNP I-Gene
receptor NN I-Gene
, , O
GPIb NNP B-Gene
- : I-Gene
V NNP I-Gene
- : I-Gene
IX NNP I-Gene
, , O
which WDT O
mediates VBZ O
adhesion NN O
of IN O
platelets NNS O
to TO O
the DT O
subendothelium NN O
of IN O
damaged VBN O
blood NN O
vessels NNS O
. . O

Previous JJ O
characterization NN O
of IN O
the DT O
GPIX NNP B-Gene
promoter NN I-Gene
identified VBD O
a DT O
functional JJ O
Ets NNP O
site NN O
that IN O
, , O
when WRB O
disrupted VBN O
, , O
reduced JJ O
promoter NN O
activity NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
Fli NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
likely JJ O
to TO O
regulate VB O
lineage NN B-Gene
- : I-Gene
specific JJ I-Gene
genes NNS I-Gene
during IN O
megakaryocytopoiesis NN O
. . O

However RB O
, , O
I PRP B-Gene
( ( I-Gene
kappa NN I-Gene
) ) I-Gene
B NNP I-Gene
( ( I-Gene
alpha NN I-Gene
) ) I-Gene
has VBZ O
also RB O
been VBN O
detected VBN O
in IN O
the DT O
nucleus NN O
of IN O
cell NN O
lines NNS O
and CC O
when WRB O
overexpressed VBN O
by IN O
transient JJ O
transfection NN O
. . O

Immunoprecipitation NN O
experiments NNS O
failed VBD O
to TO O
demonstrate VB O
an DT O
association NN O
between IN O
nuclear JJ O
I PRP B-Gene
( ( I-Gene
kappa NN I-Gene
) ) I-Gene
B NNP I-Gene
( ( I-Gene
alpha NN I-Gene
) ) I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
proteins NNS O
. . O

SERCA NNP B-Gene
activity NN O
was VBD O
measured VBN O
as IN O
the DT O
thapsigargin NN O
sensitive JJ O
, , O
Ca2 NNP O
+ NNP O
dependent NN O
and CC O
ouabain NN O
resistant JJ O
, , O
ATP NNP O
hydrolyses VBZ O
in IN O
platelet NN O
membranes NNS O
. . O

Cobalt NNP O
chloride SYM O
- : O
induced JJ O
signaling NN O
in IN O
endothelium NN O
leading VBG O
to TO O
the DT O
augmented JJ O
adherence NN O
of IN O
sickle NN O
red JJ O
blood NN O
cells NNS O
and CC O
transendothelial JJ O
migration NN O
of IN O
monocyte JJ O
- : O
like IN O
HL NNP O
- : O
60 CD O
cells NNS O
is VBZ O
blocked VBN O
by IN O
PAF NNP O
- : O
receptor NN O
antagonist NN O
. . O

In IN O
response NN O
to TO O
hypoxia VB O
, , O
sickle VB O
red JJ O
blood NN O
cells NNS O
( ( O
SS NNP O
RBC NNP O
) ) O
and CC O
leukocytes VBZ O
exhibit NN O
increased VBD O
adherence NN O
to TO O
the DT O
vascular JJ O
endothelium NN O
, , O
while IN O
diapedesis NN O
of IN O
leukocytes NNS O
through IN O
the DT O
blood NN O
vessel NN O
increases NNS O
. . O

We PRP O
utilized VBD O
CoCl2 NNP O
as IN O
a DT O
mimetic JJ O
molecule NN O
for IN O
hypoxia NN O
to TO O
study VB O
cellular JJ O
signaling VBG O
pathways NNS O
. . O

Additionally RB O
, , O
CoCl2 NNP O
caused VBD O
a DT O
two CD O
- : O
to TO O
threefold VB O
increase NN O
in IN O
the DT O
rate NN O
of IN O
transendothelial JJ O
migration NN O
of IN O
monocyte JJ O
- : O
like IN O
HL NNP O
- : O
60 CD O
cells NNS O
and CC O
a DT O
twentyfold JJ O
increase NN O
in IN O
phosphorylation NN O
of IN O
platelet NN B-Gene
endothelial JJ I-Gene
cell NN I-Gene
adhesion NN I-Gene
molecules NNS I-Gene
( ( O
PECAM NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
. . O

Activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
is VBZ O
thought VBN O
to TO O
be VB O
required VBN O
for IN O
cytokine JJ O
release NN O
from IN O
LPS NNP O
- : O
responsive JJ O
cells NNS O
, , O
a DT O
critical JJ O
step NN O
for IN O
endotoxic JJ O
effects NNS O
. . O

LPS NNP O
- : O
induced VBD O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
was VBD O
not RB O
inhibited VBN O
by IN O
a DT O
dominant JJ O
negative JJ O
mutant NN O
of IN O
TRAF2 NNP B-Gene
that WDT O
is VBZ O
involved VBN O
in IN O
TNF NNP B-Gene
signaling NN O
. . O

Tyrosine NNP O
phosphorylation NN O
of IN O
IFN NNP B-Gene
- : I-Gene
gammaR NN I-Gene
, , O
Jak1 NNP B-Gene
, , O
Jak2 NNP B-Gene
, , O
and CC O
Stat1alpha NNP B-Gene
was VBD O
examined VBN O
by IN O
immunoblotting VBG O
. . O

In IN O
addition NN O
, , O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
enhanced VBD O
the DT O
DNA NNP O
- : O
binding NN O
activity NN O
of IN O
Stat1alpha NNP B-Gene
. . O

Moreover RB O
, , O
several JJ O
transgenic JJ O
mice NN O
developed VBD O
acute JJ O
leukemia NN O
, , O
classified VBD O
as IN O
T NNP O
- : O
ALL DT O
based VBN O
on IN O
the DT O
surface NN O
marker NN O
analysis NN O
and CC O
DNA NN O
rearrangements NNS O
, , O
suggesting VBG O
that IN O
an DT O
additional JJ O
event NN O
is VBZ O
required VBN O
for IN O
malignant JJ O
transformation NN O
of IN O
lymphoid JJ O
cells NNS O
expressing VBG O
E2A NNP B-Gene
- : I-Gene
HLF NN I-Gene
. . O

Our PRP$ O
findings NNS O
provide VB O
insight RB O
into IN O
the DT O
biological JJ O
function NN O
of IN O
E2A NNP B-Gene
- : I-Gene
HLF NN I-Gene
in IN O
lymphoid NN O
development NN O
and CC O
also RB O
its PRP$ O
role NN O
in IN O
leukemogenesis NN O
. . O

This DT O
RXR NNP B-Gene
agonist NN O
activity NN O
is VBZ O
blocked VBN O
by IN O
RAR NNP B-Gene
- : O
specific JJ O
antagonists NNS O
, , O
suggesting VBG O
extensive JJ O
cross NN O
- : O
talk NN O
between IN O
the DT O
partners NNS O
of IN O
the DT O
RXR NNP B-Gene
- : I-Gene
RARalpha403 NNP I-Gene
heterodimer NN I-Gene
. . O

We PRP O
found VBD O
IL NNP B-Gene
- : I-Gene
2Ralpha CD I-Gene
expression NN O
to TO O
be VB O
increased VBN O
in IN O
BAL NNP O
cells NNS O
from IN O
involved VBN O
sites NNS O
of IN O
active JJ O
pulmonary JJ O
tuberculosis NN O
. . O

Expression NN O
of IN O
the DT O
alpha JJ B-Gene
- : I-Gene
chain NN I-Gene
of IN O
IL NNP B-Gene
- : I-Gene
2Ralpha CD I-Gene
on IN O
peripheral JJ O
blood NN O
monocytes NNS O
( ( O
PBM NNP O
) ) O
was VBD O
induced VBN O
by IN O
M NNP O
. . O
tuberculosis NN O
by IN O
flow JJ O
cytometry NN O
evaluation NN O
. . O

Furthermore RB O
, , O
the DT O
two CD O
VDR NNP B-Gene
3 CD I-Gene
' '' I-Gene
- : I-Gene
UTR NNP I-Gene
haplotypes NNS O
conferred VBD O
an DT O
identical JJ O
half NN O
- : O
life NN O
on IN O
a DT O
heterologous JJ B-Gene
beta NN I-Gene
- : I-Gene
globin NN I-Gene
reporter NN I-Gene
gene NN I-Gene
, , O
in IN O
an DT O
in IN O
vitro NN O
assay NN O
. . O

The DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
growth NN O
hormone NN O
is VBZ O
the DT O
major JJ O
growth NN O
factor NN O
of IN O
activated JJ O
T NNP O
lymphocytes VBZ O
during IN O
a DT O
developing VBG O
immune JJ O
response NN O
. . O

In IN O
several JJ O
cell NN O
types NNS O
, , O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
/ NNP O
or CC O
activating VBG B-Gene
protein JJ I-Gene
- : I-Gene
1 CD I-Gene
( ( O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
has VBZ O
been VBN O
demonstrated VBN O
to TO O
be VB O
extremely RB O
important JJ O
in IN O
blocking VBG O
apoptosis NN O
. . O

Similarly RB O
, , O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
neither CC O
activates NNS O
JNK NNP B-Gene
nor CC O
increases VBZ O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
binding NN O
activity NN O
to TO O
a DT O
consensus NN O
o SYM B-Gene
- : I-Gene
tetradecanoylphorbol NN I-Gene
13 CD I-Gene
- : I-Gene
acetate NN I-Gene
( ( I-Gene
TPA NNP I-Gene
) ) I-Gene
response NN I-Gene
element NN I-Gene
. . O

In IN O
particular JJ O
, , O
our PRP$ O
findings NNS O
suggest VBP O
that IN O
local JJ O
metabolism NN O
of IN O
steroids NNS O
by IN O
normal JJ O
as RB O
well RB O
as IN O
leukemic JJ O
myeloid NN O
cells NNS O
influences VBZ O
their PRP$ O
responsiveness NN O
to TO O
D3 NNP O
and CC O
retinoids NNS O
. . O

The DT O
phosphorylation NN O
appears VBZ O
to TO O
be VB O
related VBN O
to TO O
the DT O
signaling VBG O
events NNS O
that WDT O
are VBP O
activated VBN O
by IN O
TRAF2 NNP B-Gene
under IN O
these DT O
circumstances NNS O
, , O
since IN O
two CD O
nonfunctional JJ O
mutants NNS O
were VBD O
found VBN O
to TO O
be VB O
phosphorylated VBN O
significantly RB O
less RBR O
than IN O
the DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
protein NN I-Gene
. . O

We PRP O
conclude VBP O
from IN O
these DT O
studies NNS O
that IN O
the DT O
phosphorylation NN O
of IN O
TRAF2 NNP B-Gene
is VBZ O
likely JJ O
to TO O
play VB O
an DT O
important JJ O
role NN O
in IN O
regulating VBG O
signaling NN O
by IN O
virtue NN O
of IN O
its PRP$ O
ability NN O
to TO O
influence VB O
the DT O
CD40 NNP B-Gene
- : B-Gene
TRAF2 NNP I-Gene
interaction NN O
. . O

Unlike IN O
the DT O
proposed VBN O
role NN O
of IN O
Cbl NNP B-Gene
as IN O
a DT O
negative JJ O
regulator NN O
, , O
our PRP$ O
results NNS O
suggest VBP O
that IN O
the DT O
Cbl NNP B-Gene
homologue NN O
Cbl NNP B-Gene
- : I-Gene
b NN I-Gene
has VBZ O
a DT O
positive JJ O
role NN O
in IN O
T NNP O
- : O
cell NN O
signaling VBG O
, , O
most JJS O
likely JJ O
via IN O
a DT O
direct JJ O
interaction NN O
with IN O
the DT O
upstream JJ B-Gene
kinase NN I-Gene
Zap NNP B-Gene
- : I-Gene
70 CD I-Gene
. . O

Grf40 NNP B-Gene
, , O
A NNP O
novel NN O
Grb2 NNP B-Gene
family NN I-Gene
member NN I-Gene
, , O
is VBZ O
involved VBN O
in IN O
T NNP O
cell NN O
signaling VBG O
through IN O
interaction NN O
with IN O
SLP NNP B-Gene
- : I-Gene
76 CD I-Gene
and CC O
LAT NNP B-Gene
. . O

As IN O
a DT O
result NN O
of IN O
its PRP$ O
transforming NN O
abilities NNS O
, , O
activated VBN B-Gene
Ras NNP I-Gene
is VBZ O
expressed VBN O
in IN O
a DT O
great JJ O
number NN O
of IN O
cancers NNS O
. . O

This DT O
review NN O
will MD O
discuss VB O
the DT O
mechanisms NNS O
by IN O
which WDT O
Ras NNP B-Gene
expressing NN O
tumors NNS O
are VBP O
able JJ O
to TO O
evade VB O
destruction NN O
by IN O
the DT O
immune NN O
system NN O
and CC O
enhance VB O
their PRP$ O
growth NN O
and CC O
metastatic JJ O
potential NN O
. . O

Though IN O
the DT O
levels NNS O
of IN O
DP1 NNP B-Gene
and CC I-Gene
- : I-Gene
2 CD I-Gene
increase NN O
when WRB O
cells NNS O
progress VBP O
from IN O
G0 NNP O
to TO O
S NNP O
, , O
the DT O
proportion NN O
of IN O
DP1 NNP B-Gene
to TO O
DP2 NNP B-Gene
remains VBZ O
relatively RB O
constant JJ O
during IN O
the DT O
cell NN O
cycle NN O
. . O

We PRP O
also RB O
observed VBD O
an DT O
increase NN O
in IN O
electrophoretic JJ O
mobility NN O
of IN O
the DT O
predominant JJ O
E2F NNP B-Gene
components NNS I-Gene
, , O
DP1 NNP B-Gene
and CC O
E2F4 NNP B-Gene
, , O
as IN O
B NNP O
- : O
lymphocytes NNS O
progressed VBN O
from IN O
G0 NNP O
into IN O
early JJ O
G1 NNP O
. . O

In IN O
addition NN O
, , O
DNA NNP O
- : O
binding NN O
activities NNS O
of IN O
Jun NNP B-Gene
- : I-Gene
Fos NN I-Gene
heterodimers NNS I-Gene
were VBD O
observed VBN O
by IN O
electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
during IN O
the DT O
course NN O
of IN O
natural JJ O
cytotoxicity NN O
. . O

The DT O
therapeutic JJ O
potential NN O
of IN O
drugs NNS O
that WDT O
block VBP O
the DT O
induction NN O
of IN O
cyclooxygenase NN B-Gene
- : I-Gene
2 CD I-Gene
has VBZ O
been VBN O
emphasized VBN O
. . O

When WRB O
two CD O
4 CD O
- : O
trifluoromethyl NN O
salicylate NN O
derivatives NNS O
[ VBP O
2 CD O
- : O
acetoxy JJ O
- : O
4 CD O
- : O
trifluoromethyl NN O
- : O
benzoic NN O
acid NN O
( ( O
triflusal NN O
) ) O
and CC O
its PRP$ O
deacetylated JJ O
metabolite NN O
2 CD O
- : O
hydroxy NN O
- : O
4 CD O
- : O
trifluoromethylbenzo NN O
acid NN O
( ( O
HTB NNP O
) ) O
] NN O
were VBD O
compared VBN O
with IN O
aspirin NN O
and CC O
sodium NN O
salicylate NN O
as IN O
cyclooxygenase NN B-Gene
- : I-Gene
2 CD I-Gene
( ( O
COX NNP O
- : O
2 CD O
) ) O
inhibitors NNS O
, , O
we PRP O
observed VBD O
that IN O
in IN O
bacterial JJ O
lipopolysaccharide NN O
- : O
activated VBN O
human JJ O
blood NN O
, , O
triflusal NN O
, , O
aspirin NN O
, , O
and CC O
HTB NNP O
, , O
but CC O
not RB O
sodium JJ O
salicylate NN O
, , O
inhibited VBN O
COX NNP O
- : O
2 CD O
- : O
mediated VBN O
prostaglandin NN O
E2 NNP O
( ( O
PGE2 NNP O
) ) O
production NN O
( ( O
IC50 NNP O
= VBZ O
0 CD O
. . O
16 CD O
, , O
0 CD O
. . O
18 CD O
, , O
0 CD O
. . O
39 CD O
, , O
and CC O
> $ O
10 CD O
mM NN O
, , O
respectively RB O
) ) O
. . O

Intracellular JJ O
signals NNS O
that WDT O
mediate VBP O
differentiation NN O
of IN O
pluripotent JJ O
hemopoietic JJ O
progenitors NNS O
to TO O
dendritic JJ O
cells NNS O
( ( O
DC NNP O
) ) O
are VBP O
largely RB O
undefined JJ O
. . O

The DT O
CD34 NNP O
+ NNP O
myelomonocytic JJ O
cell NN O
line NN O
KG1 NNP O
differentiates VBZ O
into IN O
dendritic JJ O
- : O
like IN O
cells NNS O
in IN O
response NN O
to TO O
granulocyte VB B-Gene
- : I-Gene
macrophage NN I-Gene
CSF NNP I-Gene
plus CC O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
, , O
or CC O
PMA NNP O
( ( O
with IN O
or CC O
without IN O
the DT O
calcium NN O
ionophore NN O
ionomycin NN O
, , O
or CC O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
, , O
with IN O
different JJ O
stimuli NNS O
mediating VBG O
different JJ O
aspects NNS O
of IN O
the DT O
process NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
examined VBD O
whether IN O
gp41 NN B-Gene
- : O
induced JJ O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
up IN O
- : O
regulation NN O
is VBZ O
mediated VBN O
by IN O
the DT O
previously RB O
described VBN O
synergistic JJ O
activation NN O
of IN O
cAMP NN O
and CC O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
pathways NNS O
. . O

Analysis NN O
of IN O
the DT O
modulation NN O
of IN O
transcriptional JJ O
activity NN O
in IN O
myelopoiesis NN O
and CC O
leukemogenesis NN O
. . O

The DT O
transcription NN B-Gene
factors NNS I-Gene
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
and CC O
C NNP B-Gene
/ NNP I-Gene
EBPalpha NNP I-Gene
are VBP O
responsible JJ O
for IN O
normal JJ O
myeloid JJ O
differentiation NN O
from IN O
stem NN O
cells NNS O
to TO O
monocytes NNS O
or CC O
granulocytes NNS O
. . O

However RB O
, , O
the DT O
phenotypic NN O
analysis NN O
of IN O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
- : O
deficient NN O
mice NN O
supports VBZ O
the DT O
idea NN O
that IN O
there EX O
are VBP O
tissue SYM O
- : O
and CC O
gene NN O
- : O
specific JJ O
functions NNS O
as IN O
well RB O
. . O

Despite IN O
minimal JJ O
discrepancies NNS O
in IN O
the DT O
coding NN B-Gene
region NN I-Gene
, , O
there EX O
are VBP O
striking VBG O
tissue NN O
- : O
and CC O
cell VB O
type NN O
- : O
specific JJ O
differences NNS O
in IN O
isoform JJ O
expression NN O
patterns NNS O
. . O

Thus RB O
CTL NNP O
clones NNS O
that WDT O
recognized VBD O
the DT O
viral NN O
, , O
self NN O
, , O
and CC O
bacterial JJ O
peptides NNS O
expressed VBD O
a DT O
highly RB O
restricted VBN O
alphabeta NN O
TCR NNP B-Gene
phenotype NN O
. . O

RFLAT NNP B-Gene
- : I-Gene
1 CD I-Gene
: : O
a DT O
new JJ O
zinc NN B-Gene
finger NN I-Gene
transcription NN I-Gene
factor NN I-Gene
that WDT O
activates VBZ O
RANTES NNP B-Gene
gene NN I-Gene
expression NN O
in IN O
T NNP O
lymphocytes NNS O
. . O

Furthermore RB O
, , O
these DT O
oxidative JJ O
stresses NNS O
inhibited JJ O
activity NN O
of IN O
calcineurin NN O
, , O
a DT O
serine NN O
/ NNP O
threonine NN B-Gene
phosphatase NN I-Gene
that WDT O
regulates VBZ O
NFAT NNP B-Gene
activation NN O
. . O

Several JJ O
intracellular JJ O
signaling VBG B-Gene
proteins NNS I-Gene
, , O
such JJ O
as IN O
CBL NNP B-Gene
and CC O
VAV NNP B-Gene
, , O
were VBD O
phosphorylated VBN O
on IN O
tyrosine NN O
in IN O
response NN O
to TO O
CD80 NNP B-Gene
, , O
CD86 NNP B-Gene
, , O
and CC O
anti SYM B-Gene
- : I-Gene
CD28 NNP I-Gene
mAb NN I-Gene
. . O

In IN O
addition NN O
, , O
the DT O
association NN O
of IN O
phosphoinositide NN B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
with IN O
CD28 NNP B-Gene
and CC O
enhanced VBD O
tyrosine JJ O
phosphorylation NN O
of IN O
phospholipase NN O
Cgamma NNP O
were VBD O
seen VBN O
after IN O
anti JJ O
- : O
CD28 NNP O
mAb NN O
and CC O
CHO NNP O
- : O
CD80 NNP O
stimulation NN O
but CC O
to TO O
a DT O
much RB O
lesser JJR O
extent NN O
after IN O
CHO NNP B-Gene
- : I-Gene
CD86 NNP I-Gene
stimulation NN O
. . O

However RB O
, , O
CD80 NNP B-Gene
and CC O
CD86 NNP B-Gene
also RB O
induce VBP O
distinct JJ O
signal JJ O
transduction NN O
pathways NNS O
including VBG O
the DT O
tyrosine JJ O
phosphorylation NN O
of IN O
CD28 NNP B-Gene
and CC O
phospholipase VB B-Gene
Cgamma1 NNP I-Gene
and CC O
the DT O
SH2 NNP B-Gene
- : O
dependent JJ O
association NN O
of IN O
phosphoinositide NN B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
with IN O
CD28 NNP B-Gene
. . O

Binding NNP O
of IN O
HMG NNP B-Gene
- : I-Gene
I PRP I-Gene
( ( I-Gene
Y NNP I-Gene
) ) I-Gene
elicits VBZ O
structural JJ O
changes NNS O
in IN O
a DT O
silencer NN O
of IN O
the DT O
human JJ B-Gene
beta NN I-Gene
- : I-Gene
globin NN I-Gene
gene NN I-Gene
. . O

If IN O
there EX O
is VBZ O
a DT O
reciprocal JJ O
elevation NN O
of IN O
gamma NN B-Gene
- : I-Gene
globin NN I-Gene
expression NN O
upon IN O
repression NN O
, , O
this DT O
approach NN O
could MD O
be VB O
useful JJ O
in IN O
additional JJ O
hemoglobinopathies NNS O
. . O

We PRP O
demonstrate VBP O
that IN O
binding NN O
of IN O
HMG NNP B-Gene
- : I-Gene
I PRP I-Gene
( ( I-Gene
Y NNP I-Gene
) ) I-Gene
to TO O
this DT O
oligonucleotide JJ O
causes VBZ O
bending VBG O
/ JJ O
flexure NN O
of IN O
the DT O
DNA NN O
. . O

The DT O
master NN O
switch NN O
for IN O
the DT O
expression NN O
of IN O
these DT O
genes NNS O
is VBZ O
the DT O
class NN B-Gene
II NNP I-Gene
transactivator NN I-Gene
( ( O
CIITA NNP B-Gene
) ) O
. . O

In IN O
contrast NN O
, , O
overexpression NN O
of IN O
CREB NNP B-Gene
inhibited VBD O
GAL4 NNP B-Gene
- : O
p65 NN O
( ( O
286 CD O
- : O
551 CD O
) ) O
- : O
mediated VBN O
transcription NN O
. . O

Glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
cord NN O
blood NN O
lymphocytes NNS O
of IN O
healthy JJ O
neonates NNS O
and CC O
of IN O
preterms NNS O
suffering VBG O
from IN O
respiratory JJ O
distress JJ O
syndrome NN O
. . O

We PRP O
measured VBD O
the DT O
number NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
( ( O
GR NNP B-Gene
) ) O
in IN O
cord NN O
blood NN O
lymphocytes NNS O
and CC O
the DT O
binding NN O
affinity NN O
( ( O
Kd NNP O
) ) O
in IN O
15 CD O
term NN O
and CC O
in IN O
20 CD O
preterm JJ O
babies NNS O
. . O

Thirteen JJ O
preterms NNS O
of IN O
the DT O
latter JJ O
group NN O
received VBD O
prenatal JJ O
steroid JJ O
treatment NN O
. . O

The DT O
number NN O
of IN O
GR NNP B-Gene
and CC O
the DT O
Kd NNP O
were VBD O
similar JJ O
in IN O
the DT O
term NN O
and CC O
preterm NN O
( ( O
with IN O
and CC O
without IN O
NRDS NNP O
) ) O
babies NNS O
. . O

In IN O
order NN O
to TO O
elucidate VB O
the DT O
role NN O
of IN O
NF NNP B-Gene
- : I-Gene
ATp NNP I-Gene
, , O
one CD O
of IN O
the DT O
most RBS O
prominent JJ O
members NNS O
of IN O
family NN O
of IN O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
transcription NN I-Gene
factors NNS I-Gene
in IN O
peripheral JJ O
T NNP O
lymphocytes NNS O
, , O
in IN O
T NNP O
cell NN O
activation NN O
and CC O
differentiation NN O
we PRP O
created VBD O
NF NNP B-Gene
- : I-Gene
ATp NNP I-Gene
- : O
deficient NN O
mice NN O
by IN O
gene NN O
targeting NN O
. . O

Apart RB O
from IN O
clear JJ O
- : O
cut NN O
defects NNS O
in IN O
the DT O
synthesis NN O
of IN O
mRNAs NN B-Gene
for IN O
Th2 NNP B-Gene
- : I-Gene
type NN I-Gene
lymphokines NNS I-Gene
, , O
such JJ O
as IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
, , O
in IN O
primary JJ O
and CC O
secondary JJ O
stimulations NNS O
of IN O
spleen JJ O
cells NNS O
in IN O
vitro NN O
, , O
of IN O
a DT O
distinct JJ O
impaired JJ O
deletion NN O
of IN O
V NNP O
beta NN O
11 CD O
+ NN O
/ NNP O
CD4 NNP O
+ NNP O
T NNP O
lymphocytes VBZ O
from IN O
these DT O
mice NN O
was VBD O
detected VBN O
after IN O
superantigen NN O
injection NN O
. . O

Moreover RB O
, , O
NF NNP B-Gene
- : I-Gene
ATp NNP I-Gene
- : O
/ SYM O
- : O
mice NN O
older JJR O
than IN O
6 CD O
weeks NNS O
show VBP O
an DT O
2 CD O
- : O
5 CD O
fold JJ O
increase NN O
in IN O
number NN O
of IN O
lymphocytes NNS O
. . O

Our PRP$ O
data NNS O
constitute VBP O
a DT O
starting NN O
point NN O
for IN O
studies NNS O
to TO O
elucidate VB O
the DT O
molecular JJ O
mechanism NN O
by IN O
which WDT O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
regulates VBZ O
IgA NNP B-Gene
production NN O
. . O

Daidzein NNP O
and CC O
genistein NN O
glucuronides NNS O
in IN O
vitro NN O
are VBP O
weakly JJ O
estrogenic JJ O
and CC O
activate JJ O
human JJ O
natural JJ O
killer NN O
cells NNS O
at IN O
nutritionally RB O
relevant JJ O
concentrations NNS O
. . O

Daidzein NNP O
and CC O
genistein NN O
glucuronides NNS O
( ( O
DG NNP O
and CC O
GG NNP O
) ) O
, , O
major JJ O
isoflavone NN O
metabolites NNS O
, , O
may MD O
be VB O
partly RB O
responsible JJ O
for IN O
biological JJ O
effects NNS O
of IN O
isoflavones NNS O
, , O
such JJ O
as IN O
estrogen NN O
receptor NN O
binding NN O
and CC O
natural JJ O
killer NN O
cell NN O
( ( O
NK NNP O
) ) O
activation NN O
or CC O
inhibition NN O
. . O

DG NNP O
and CC O
GG NNP O
were VBD O
synthesized VBN O
using VBG O
3 CD O
- : O
methylcholanthrene NN O
- : O
induced JJ O
rat NN O
liver NN O
microsomes NNS O
. . O

DG NNP O
and CC O
GG NNP O
were VBD O
further RB O
purified VBN O
by IN O
a DT O
Sephadex NNP O
LH NNP O
- : O
20 CD O
column NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
propose VBP O
a DT O
novel JJ O
function NN O
for IN O
CD44 NNP O
. . O

Using VBG O
synovial JJ O
cells NNS O
from IN O
rheumatoid JJ O
arthritis NN O
( ( O
RA NNP O
) ) O
patients NNS O
, , O
we PRP O
demonstrated VBD O
that IN O
CD44 NNP O
cross SYM O
- : O
linking NN O
and CC O
binding NN O
to TO O
hyaluronan VB O
augmented JJ O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
and CC O
subsequently RB O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
mediated VBN O
cell NN O
adhesion NN O
. . O

In IN O
neutrophils NNS O
, , O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
caused VBD O
a DT O
gliotoxin NN O
- : O
inhibitable JJ O
activation NN O
of IN O
an DT O
inducible JJ O
form NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
, , O
a DT O
response NN O
that WDT O
may MD O
underlie VB O
the DT O
ability NN O
of IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
to TO O
delay VB O
apoptosis NN O
at IN O
later RB O
times NNS O
( ( O
12 CD O
- : O
24 CD O
h NN O
) ) O
and CC O
limit VB O
its PRP$ O
early JJ O
killing NN O
effect NN O
. . O

We PRP O
previously RB O
identified VBD O
a DT O
Fas NNP B-Gene
ligand NN I-Gene
regulatory JJ I-Gene
element NN I-Gene
( ( O
FLRE NNP B-Gene
) ) O
in IN O
the DT O
Fas NNP B-Gene
ligand NN I-Gene
( ( I-Gene
fasL NN I-Gene
) ) I-Gene
promoter NN I-Gene
that WDT O
binds VBZ O
Egr NNP B-Gene
family NN I-Gene
proteins NNS I-Gene
and CC O
demonstrated VBD O
that IN O
Egr NNP B-Gene
- : I-Gene
3 CD I-Gene
( ( O
PILOT NNP B-Gene
) ) O
but CC O
not RB O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
( ( O
NGFI NNP B-Gene
- : I-Gene
A NN I-Gene
, , O
Krox NNP B-Gene
- : I-Gene
24 CD I-Gene
, , O
Tis NNP B-Gene
- : I-Gene
8 CD I-Gene
, , O
and CC O
Zif NNP B-Gene
- : I-Gene
268 CD I-Gene
) ) O
induces NNS O
transcription NN O
of IN O
fasL NN B-Gene
. . O

The DT O
aberrant JJ O
CD4 NNP O
( ( O
- : O
) ) O
CD8 NNP O
( ( O
- : O
) ) O
T VBP O
cells NNS O
from IN O
lpr JJ O
/ NNP O
lpr NN O
and CC O
gld NN O
/ NNP O
gld NN O
mice NN O
, , O
which WDT O
have VBP O
mutations NNS O
in IN O
the DT O
genes NNS O
encoding VBG O
Fas NNP B-Gene
and CC O
FasL NNP B-Gene
, , O
respectively RB O
, , O
have VBP O
an DT O
activated VBN O
phenotype NN O
and CC O
constitutively RB O
express JJ O
high JJ O
levels NNS O
of IN O
fasL NN B-Gene
mRNA NN I-Gene
, , O
prompting VBG O
us PRP O
to TO O
ask VB O
what WP O
role NN O
if IN O
any DT O
the DT O
FLRE NNP B-Gene
and CC O
Egr NNP B-Gene
family NN I-Gene
proteins NNS I-Gene
have VBP O
in IN O
this DT O
aberrant JJ O
expression NN O
of IN O
fasL NN B-Gene
. . O

Although IN O
overexpressed VBN O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
was VBD O
ineffective JJ O
, , O
overexpressed VBD O
Egr NNP B-Gene
- : I-Gene
2 CD I-Gene
was VBD O
as RB O
potent JJ O
as IN O
Egr NNP B-Gene
- : I-Gene
3 CD I-Gene
in IN O
inducing VBG O
fasL NN B-Gene
promoter NN I-Gene
- : I-Gene
dependent JJ I-Gene
reporter NN I-Gene
constructs NNS I-Gene
in IN O
T NNP O
cell NN O
hybridomas NN O
and CC O
HeLa NNP O
cells NNS O
, , O
and CC O
both DT O
up RP O
- : O
regulated VBN O
endogenous JJ O
fasL NN B-Gene
mRNA NN I-Gene
in IN O
HeLa NNP O
cells NNS O
. . O

FasL NNP B-Gene
- : I-Gene
dependent NN I-Gene
reporter NN I-Gene
constructs NNS I-Gene
in IN O
MRL NNP O
- : O
lpr NN O
/ NN O
lpr NN O
and CC O
C3H NNP O
- : O
gld NN O
/ JJ O
gld NN O
CD4 NNP O
( ( O
- : O
) ) O
CD8 NNP O
( ( O
- : O
) ) O
T NNP O
cells NNS O
were VBD O
constitutively RB O
active JJ O
, , O
and CC O
this DT O
activity NN O
was VBD O
largely RB O
prevented VBN O
by IN O
mutation NN O
of IN O
the DT O
critical JJ O
Egr NNP B-Gene
family NN I-Gene
binding VBG I-Gene
element NN I-Gene
. . O

The DT O
activity NN O
of IN O
the DT O
CCAAT NNP B-Gene
- : I-Gene
box NN I-Gene
binding VBG I-Gene
factor NN I-Gene
NF NNP I-Gene
- : I-Gene
Y NN I-Gene
is VBZ O
modulated VBN O
through IN O
the DT O
regulated JJ O
expression NN O
of IN O
its PRP$ O
A NNP B-Gene
subunit NN I-Gene
during IN O
monocyte NN O
to TO O
macrophage VB O
differentiation NN O
: : O
regulation NN O
of IN O
tissue NN B-Gene
- : I-Gene
specific JJ I-Gene
genes NNS I-Gene
through IN O
a DT O
ubiquitous JJ O
transcription NN B-Gene
factor NN I-Gene
. . O

Recent JJ O
studies NNS O
have VBP O
suggested VBN O
that IN O
Y319 NNP O
also RB O
positively RB O
regulate VB O
ZAP NNP B-Gene
- : I-Gene
70 CD I-Gene
function NN O
. . O

Deletion NN O
of IN O
interdomain NN B-Gene
B NNP I-Gene
did VBD O
not RB O
affect VB O
the DT O
ability NN O
of IN O
ZAP NNP B-Gene
- : I-Gene
70 CD I-Gene
to TO O
bind VB O
to TO O
the DT O
receptor NN O
. . O

Differential JJ O
induction NN O
of IN O
DNA NNP B-Gene
- : I-Gene
binding NN I-Gene
activities NNS I-Gene
following VBG O
CD19 NNP B-Gene
cross SYM O
- : O
linking VBG O
in IN O
human JJ O
B NNP O
lineage NN O
cells NNS O
. . O

The DT O
B NNP B-Gene
cell NN I-Gene
- : I-Gene
specific NN I-Gene
cell NN I-Gene
surface NN I-Gene
molecule NN I-Gene
CD19 NNP B-Gene
is VBZ O
expressed VBN O
at IN O
all DT O
stages NNS O
of IN O
B NNP O
cell NN O
development NN O
, , O
including VBG O
normal JJ O
plasma NN O
cells NNS O
, , O
and CC O
mediates VBZ O
signal JJ O
transduction NN O
via IN O
interaction NN O
with IN O
cytoplasmic JJ B-Gene
effector NN I-Gene
proteins NNS I-Gene
. . O

Oxidants NNS O
, , O
transcription NN B-Gene
factors NNS I-Gene
, , O
and CC O
intestinal JJ O
inflammation NN O
. . O

It PRP O
is VBZ O
now RB O
well RB O
appreciated VBN O
that IN O
chronic JJ O
gut NN O
inflammation NN O
is VBZ O
characterized VBN O
by IN O
enhanced JJ O
production NN O
of IN O
reactive JJ O
metabolites NNS O
of IN O
oxygen NN O
and CC O
nitrogen NN O
. . O

Finally RB O
, , O
oxidants NNS O
are VBP O
believed VBN O
to TO O
promote VB O
intestinal JJ O
epithelial JJ O
cell NN O
apoptosis NN O
, , O
and CC O
the DT O
B NNP B-Gene
- : I-Gene
cell NN I-Gene
lymphoma VBZ I-Gene
/ NNP I-Gene
leukemia SYM I-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
product NN I-Gene
is VBZ O
believed VBN O
to TO O
inhibit VB O
this DT O
phenomenon NN O
in IN O
an DT O
antioxidant JJ O
- : O
dependent JJ O
manner NN O
. . O

The DT O
regulatory JJ B-Gene
regions NNS I-Gene
of IN O
several JJ O
genes NNS O
specifically RB O
expressed VBN O
in IN O
B NNP O
cells NNS O
contain VBP O
functional JJ B-Gene
binding NN I-Gene
sites NNS I-Gene
for IN O
Oct2 NNP B-Gene
. . O

These DT O
target NN B-Gene
genes NNS I-Gene
show VBP O
quite RB O
distinct JJ O
expression NN O
patterns NNS O
demonstrating VBG O
that IN O
transcription NN B-Gene
factors NNS I-Gene
in IN O
addition NN O
to TO O
Oct2 NNP B-Gene
are VBP O
involved VBN O
in IN O
their PRP$ O
regulation NN O
. . O

The DT O
protein NN O
has VBZ O
no DT O
known VBN O
DNA NNP B-Gene
- : I-Gene
binding NN I-Gene
domain NN I-Gene
but CC O
does VBZ O
contain VB O
three CD O
ankyrin NN O
repeats NNS O
that WDT O
are VBP O
likely JJ O
to TO O
be VB O
important JJ O
in IN O
protein JJ O
- : O
protein NN O
interactions NNS O
. . O

Binding NNP O
of IN O
c SYM B-Gene
- : I-Gene
Rel NN I-Gene
to TO O
STAT5 NNP B-Gene
target NN I-Gene
sequences NNS I-Gene
in IN O
HTLV NNP O
- : O
I PRP O
- : O
transformed VBD O
T NNP O
cells NNS O
. . O

Fas NNP B-Gene
( ( O
CD95 NNP B-Gene
) ) O
and CC O
Fas NNP B-Gene
ligand NN I-Gene
( ( O
CD95L NNP B-Gene
) ) O
are VBP O
an DT O
interacting VBG O
receptor NN O
- : O
ligand NN O
pair NN O
required VBN O
for IN O
immune JJ O
homeostasis NN O
. . O

Although IN O
resting VBG O
Jurkat NNP O
cells NNS O
express JJ O
Fas NNP B-Gene
, , O
Fas NNP B-Gene
mRNA NN I-Gene
was VBD O
induced VBN O
approximately RB O
10 CD O
- : O
fold NN O
in IN O
2 CD O
h NN O
upon IN O
P NNP O
/ NNP O
I PRP O
stimulation NN O
. . O

The DT O
functional JJ O
contribution NN O
of IN O
the DT O
kappaB NN B-Gene
- : I-Gene
Sp1 NNP I-Gene
composite JJ I-Gene
site NN I-Gene
in IN O
P NNP B-Gene
/ NNP I-Gene
I PRP I-Gene
- : I-Gene
inducible JJ I-Gene
fas JJ I-Gene
promoter NN I-Gene
activation NN O
was VBD O
verified VBN O
by IN O
using VBG O
kappaB SYM O
- : O
Sp1 NN B-Gene
concatamers NNS O
( ( O
- : B-Gene
295 CD I-Gene
to TO I-Gene
- : I-Gene
286 CD I-Gene
) ) O
in IN O
a DT O
thymidine JJ B-Gene
kinase NN I-Gene
promoter NN I-Gene
- : I-Gene
driven RB I-Gene
reporter JJR I-Gene
construct NN I-Gene
and CC O
native JJ B-Gene
promoter NN I-Gene
constructs NNS I-Gene
in IN O
Jurkat NNP O
cells NNS O
overexpressing VBG O
IkappaB NNP B-Gene
- : I-Gene
alpha NN I-Gene
. . O

The DT O
induction NN O
of IN O
clonal JJ O
anergy NN O
in IN O
a DT O
T NNP O
cell NN O
inhibits NNS O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
secretion NN O
because IN O
of IN O
the DT O
development NN O
of IN O
a DT O
proximal JJ O
signal JJ O
transduction NN O
defect NN O
. . O

Members NNS O
of IN O
the DT O
cyclic JJ B-Gene
adenosine NN I-Gene
monophosphate NN I-Gene
( ( I-Gene
cAMP NN I-Gene
) ) I-Gene
response NN I-Gene
element NN I-Gene
binding NN I-Gene
( ( I-Gene
CREB NNP I-Gene
) ) I-Gene
/ VBP I-Gene
activating VBG I-Gene
transcription NN I-Gene
factor NN I-Gene
1 CD I-Gene
( ( I-Gene
ATF NNP I-Gene
- : I-Gene
1 CD I-Gene
) ) I-Gene
family NN I-Gene
of IN O
transcription NN B-Gene
factors NNS I-Gene
bind VBP O
three CD O
21 CD B-Gene
- : I-Gene
bp NN I-Gene
repeats NNS I-Gene
( ( O
Tax NNP B-Gene
- : I-Gene
responsive NN I-Gene
element NN I-Gene
- : I-Gene
1 CD I-Gene
, , O
or CC O
TRE NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
within IN O
the DT O
viral JJ B-Gene
promoter NN I-Gene
and CC O
are VBP O
important JJ O
for IN O
basal NN O
and CC O
Tax NNP O
- : O
mediated VBN O
transcription NN O
. . O

Exposing VBG O
human JJ O
umbilical JJ O
vein NN O
endothelial JJ O
cells NNS O
( ( O
HUVECs NNP O
) ) O
to TO O
anoxia VB O
/ JJ O
reoxygenation NN O
( ( O
A DT O
/ NNP O
R NNP O
) ) O
results NNS O
in IN O
an DT O
increase NN O
in IN O
polymorphonuclear JJ O
leukocyte NN O
( ( O
PMN NNP O
) ) O
adhesion NN O
to TO O
HUVECs NNP O
. . O

NO DT O
production NN O
by IN O
HUVECs NNP O
is VBZ O
increased VBN O
after IN O
the DT O
second JJ O
A NNP O
/ NNP O
R NNP O
challenge NN O
, , O
but CC O
not RB O
after IN O
the DT O
first JJ O
A NNP O
/ NNP O
R NNP O
challenge NN O
. . O

However RB O
, , O
while IN O
HUVECs NNP O
contained VBD O
endothelial JJ O
NOS NNP B-Gene
protein NN I-Gene
, , O
no DT O
inducible JJ O
NOS NNP B-Gene
was VBD O
detected VBN O
in IN O
either DT O
tolerant NN O
or CC O
nontolerant JJ O
cells NNS O
. . O

The DT O
inhibition NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
production NN O
was VBD O
observed VBN O
in IN O
the DT O
CD3 NNP B-Gene
( ( O
+ NNP O
) ) O
T NNP O
- : O
lymphocyte NN O
cytoplasm NN O
as RB O
early RB O
as IN O
4 CD O
h NN O
after IN O
activation NN O
by IN O
PMA NNP O
+ NNP O
ionomycin NN O
. . O

Delta NNP O
- : O
opioid JJ O
receptors NNS O
expressed VBN O
by IN O
Jurkat NNP O
T NNP O
cells NNS O
enhance NN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
secretion NN O
by IN O
increasing VBG O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
complexes NNS I-Gene
and CC O
activity NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
/ NNP I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
binding NN I-Gene
promoter NN I-Gene
element NN I-Gene
. . O

Reporter NNP O
gene NN O
constructs NNS O
were VBD O
used VBN O
to TO O
map VB O
this DT O
effect NN O
of IN O
deltorphin NN O
to TO O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
and CC I-Gene
NF NNP I-Gene
- : I-Gene
AT NNP I-Gene
/ NNP I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
. . O

These DT O
cells NNS O
, , O
stimulated VBN O
by IN O
an DT O
agonistic JJ O
monoclonal NN O
antibody NN O
against IN O
CD40 NNP B-Gene
or CC O
by IN O
transfection NN O
with IN O
a DT O
CD40L NNP B-Gene
expression NN I-Gene
vector NN I-Gene
, , O
secreted VBN O
p40 NN B-Gene
and CC O
showed VBD O
enhanced VBN O
p40 NN B-Gene
mRNA NN I-Gene
expression NN O
. . O

No DT O
mutation NN O
was VBD O
identified VBN O
in IN O
either DT O
of IN O
the DT O
genes NNS O
in IN O
the DT O
gynecomastias NN O
. . O

We PRP O
have VBP O
mapped VBN O
the DT O
DNase NNP B-Gene
- : I-Gene
I PRP I-Gene
- : I-Gene
hypersensitive NN I-Gene
( ( I-Gene
HS NNP I-Gene
) ) I-Gene
regions NNS I-Gene
of IN O
the DT O
human JJ B-Gene
GATA NNP I-Gene
- : I-Gene
3 CD I-Gene
gene NN I-Gene
in IN O
T NNP O
- : O
cells NNS O
and CC O
non JJ O
- : O
T NNP O
- : O
cells NNS O
and CC O
studied VBD O
their PRP$ O
transcriptional JJ O
activities NNS O
. . O

HS NNP B-Gene
I PRP I-Gene
- : I-Gene
III NN I-Gene
, , O
located VBN O
5 CD O
' '' O
from IN O
the DT O
transcriptional JJ B-Gene
initiation NN I-Gene
site NN I-Gene
, , O
were VBD O
found VBN O
in IN O
hematopoietic JJ O
and CC O
non JJ O
- : O
hematopoietic JJ O
cells NNS O
, , O
whereas NNS O
HS NNP B-Gene
IV NNP I-Gene
- : I-Gene
VII NNP I-Gene
, , O
located VBD O
3 CD O
' '' O
from IN O
the DT O
transcriptional JJ B-Gene
start NN I-Gene
site NN I-Gene
, , O
were VBD O
exclusively RB O
observed VBN O
in IN O
T NNP O
- : O
cells NNS O
. . O

Among IN O
these DT O
hypersensitive JJ B-Gene
sites NNS I-Gene
, , O
two CD O
transcriptional JJ B-Gene
control NN I-Gene
elements NNS I-Gene
were VBD O
found VBN O
, , O
one CD O
in IN O
the DT O
first JJ B-Gene
intron NN I-Gene
of IN O
the DT O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
gene NN I-Gene
and CC O
the DT O
other JJ O
between IN B-Gene
8 CD I-Gene
. . I-Gene
3 CD I-Gene
and CC I-Gene
5 CD I-Gene
. . I-Gene
9 CD I-Gene
kilobases VBZ I-Gene
5 CD O
' '' O
from IN O
the DT O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
transcriptional JJ I-Gene
initiation NN I-Gene
site NN I-Gene
. . O

Two CD O
CAGGTG NNP O
E NNP O
- : O
boxes NNS O
, , O
located VBN O
at IN O
the DT O
5 CD B-Gene
' POS I-Gene
- : I-Gene
and CC I-Gene
3 CD I-Gene
' '' I-Gene
- : I-Gene
ends NNS I-Gene
of IN O
the DT O
silencer NN O
, , O
were VBD O
necessary JJ O
for IN O
this DT O
silencer NN O
activity NN O
. . O

The DT O
3 CD B-Gene
' POS I-Gene
- : I-Gene
CAGGTG NNP I-Gene
E NNP I-Gene
- : I-Gene
box NN I-Gene
could MD O
bind VB O
USF NNP B-Gene
proteins NNS I-Gene
, , O
the DT O
ubiquitous JJ B-Gene
repressor NN I-Gene
ZEB NNP B-Gene
, , O
or CC O
the DT O
basic JJ B-Gene
helix NN I-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
proteins VBZ I-Gene
E2A NNP B-Gene
and CC O
HEB NNP B-Gene
, , O
and CC O
we PRP O
showed VBD O
that IN O
a DT O
competition NN O
between IN O
ZEB NNP B-Gene
and CC O
E2A NNP B-Gene
/ NNP I-Gene
HEB NNP I-Gene
proteins VBZ I-Gene
is VBZ O
involved VBN O
in IN O
the DT O
silencer NN O
activity NN O
. . O

Reactive JJ O
oxygen NN O
intermediate JJ O
- : O
dependent NN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
by IN O
interleukin JJ B-Gene
- : I-Gene
1beta CD I-Gene
requires VBZ O
5 CD B-Gene
- : I-Gene
lipoxygenase NN I-Gene
or CC O
NADPH NNP O
oxidase NN O
activity NN O
. . O

However RB O
, , O
the DT O
sources NNS O
for IN O
ROIs NNP O
in IN O
various JJ O
cell NN O
types NNS O
are VBP O
yet RB O
to TO O
be VB O
determined VBN O
and CC O
might MD O
include VB O
5 CD B-Gene
- : I-Gene
lipoxygenase NN I-Gene
( ( O
5 CD B-Gene
- : I-Gene
LOX NN I-Gene
) ) O
and CC O
NADPH NNP O
oxidase NN O
. . O

Stimulation NN O
of IN O
lymphoid JJ O
cells NNS O
with IN O
interleukin JJ B-Gene
- : I-Gene
1beta CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
) ) O
led VBD O
to TO O
ROI NNP O
production NN O
and CC O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
, , O
which WDT O
could MD O
both DT O
be VB O
blocked VBN O
by IN O
antioxidants NNS O
or CC O
FLAP NNP B-Gene
inhibitors NNS O
, , O
confirming VBG O
that IN O
5 CD B-Gene
- : I-Gene
LOX NN I-Gene
was VBD O
the DT O
source NN O
of IN O
ROIs NNP O
and CC O
was VBD O
required VBN O
for IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
in IN O
these DT O
cells NNS O
. . O

Cutting VBG O
edge NN O
: : O
dominant JJ O
effect NN O
of IN O
Ile50Val NNP B-Gene
variant NN I-Gene
of IN O
the DT O
human JJ B-Gene
IL NNP I-Gene
- : I-Gene
4 CD I-Gene
receptor NN I-Gene
alpha SYM I-Gene
- : I-Gene
chain NN I-Gene
in IN O
IgE NNP B-Gene
synthesis NN O
. . O

Constitutive JJ O
expression NN O
of IN O
human JJ B-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
receptor NN I-Gene
( ( O
CSF NNP B-Gene
- : I-Gene
1R CD I-Gene
) ) O
confers NNS O
long JJ O
- : O
lasting NN O
CSF NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
dependent JJ O
proliferation NN O
to TO O
mouse VB O
myeloid NN O
cell NN O
lines NNS O
. . O

Morphologic NNP O
and CC O
cytofluorometry NN O
analysis NN O
established VBN O
that IN O
most JJS O
47 CD O
. . O
10 CD O
cells NNS O
are VBP O
immature JJ O
myelomonocytic JJ O
cells NNS O
. . O

In IN O
agar NN O
cultures NNS O
, , O
47 CD O
. . O
10 CD O
cells NNS O
form RB O
7 CD O
- : O
and CC O
14 CD O
- : O
day NN O
colonies NNS O
in IN O
response NN O
to TO O
a DT O
cocktail NN O
of IN O
granulocyte NN B-Gene
/ NNP I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
( ( O
2 CD O
. . O
5 CD O
ng JJ O
/ NNP O
mL NN O
) ) O
, , O
interleukin JJ B-Gene
- : I-Gene
3 CD I-Gene
( ( O
1 CD O
ng RB O
/ NNP O
mL NN O
) ) O
, , O
and CC O
mouse NN O
CSF NNP B-Gene
- : I-Gene
1 CD I-Gene
( ( O
10 CD O
ng RB O
/ NNP O
mL NN O
) ) O
. . O

In IN O
conclusion NN O
, , O
we PRP O
have VBP O
characterized VBN O
a DT O
novel JJ O
continuous JJ O
myeloid NN O
cell NN O
line NN O
presenting VBG O
a DT O
hierarchical JJ O
structure NN O
similar JJ O
to TO O
that DT O
of IN O
the DT O
bone NN O
marrow NN O
progenitor NN O
cell NN O
compartment NN O
. . O

Regulation NN O
of IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
expression NN O
by IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
JunB NNP B-Gene
during IN O
T NNP O
helper NN O
cell NN O
differentiation NN O
. . O

Here RB O
we PRP O
show VBP O
that IN O
JunB NNP B-Gene
, , O
but CC O
not RB O
the DT O
other JJ O
Jun NNP B-Gene
family NN I-Gene
members NNS I-Gene
, , O
was VBD O
selectively RB O
induced VBN O
in IN O
Th2 NNP O
cells NNS O
and CC O
not RB O
in IN O
Th1 NNP O
cells NNS O
during IN O
differentiation NN O
. . O

The DT O
finding NN O
of IN O
Tax NNP B-Gene
mutants NNS O
segregating VBG O
these DT O
two CD O
pathways NNS O
suggested VBD O
that IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
pathway NN O
was VBD O
essential JJ O
for IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
- : O
independent JJ O
growth NN O
of IN O
CTLL NNP O
- : O
2 CD O
cells NNS O
while IN O
the DT O
CRE NNP B-Gene
pathway NN O
was VBD O
unnecessary JJ O
. . O

However RB O
, , O
both DT O
pathways NNS O
were VBD O
necessary JJ O
for IN O
another DT O
transformation NN O
- : O
related JJ O
activity NN O
( ( O
colony NN O
formation NN O
in IN O
soft JJ O
agar NN O
) ) O
of IN O
CTLL NNP B-Gene
- : I-Gene
2 CD I-Gene
/ JJ I-Gene
Tax NNP I-Gene
. . O

Our PRP$ O
results NNS O
show VBP O
that IN O
Tax NNP B-Gene
has VBZ O
at IN O
least JJS O
two CD O
distinct JJ O
activities NNS O
on IN O
T NNP O
cells NNS O
, , O
and CC O
suggest VBP O
that IN O
Tax NNP B-Gene
plays VBZ O
a DT O
crucial JJ O
role NN O
in IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
- : O
independent JJ O
T NNP O
- : O
cell NN O
transformation NN O
induced VBN O
by IN O
HTLV NNP O
- : O
1 CD O
, , O
in IN O
addition NN O
to TO O
its PRP$ O
well RB O
- : O
known VBN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
- : O
dependent NN O
cell NN O
transformation NN O
. . O

First RB O
, , O
it PRP O
gives VBZ O
no DT O
information NN O
on IN O
memory NN O
to TO O
lytic JJ B-Gene
cycle NN I-Gene
antigens NNS I-Gene
; : O
second JJ O
, , O
it PRP O
preferentially RB O
amplifies VBZ O
the DT O
dominant JJ O
components NNS O
of IN O
latent JJ O
antigen NN O
- : O
specific JJ O
memory NN O
at IN O
the DT O
expense NN O
of IN O
key JJ O
subdominant JJ O
reactivities NNS O
. . O

Here RB O
we PRP O
describe VBP O
an DT O
alternative JJ O
approach NN O
, , O
based VBN O
on IN O
in IN O
vitro JJ O
stimulation NN O
with IN O
epitope NN O
peptide IN O
- : O
loaded JJ O
dendritic JJ O
cells NNS O
( ( O
DCs NNP O
) ) O
, , O
which WDT O
allows VBZ O
one CD O
to TO O
probe VB O
the DT O
CTL NNP O
repertoire NN O
for IN O
any DT O
individual JJ O
reactivity NN O
of IN O
choice NN O
; : O
this DT O
method NN O
proved VBD O
significantly RB O
more RBR O
efficient JJ O
than IN O
stimulation NN O
with IN O
peptide JJ O
alone RB O
. . O

The DT O
present JJ O
study NN O
was VBD O
designed VBN O
to TO O
analyze VB O
the DT O
roles NNS O
of IN O
the DT O
two CD O
GR NNP B-Gene
isoforms NNS I-Gene
on IN O
glucocorticoid JJ O
- : O
mediated VBN O
transrepression NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
. . O

Furthermore RB O
, , O
GRbeta NNP B-Gene
did VBD O
not RB O
antagonize VB O
the DT O
repressive JJ O
effects NNS O
of IN O
GRalpha NNP B-Gene
on IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
activity NN O
. . O

Surprisingly RB O
, , O
overexpression NN O
of IN O
GRbeta NNP B-Gene
in IN O
Jurkat NNP O
cells NNS O
did VBD O
not RB O
cause VB O
significant JJ O
inhibition NN O
of IN O
GRalpha NNP B-Gene
- : O
induced JJ O
transactivation NN O
of IN O
a DT O
GRE NNP B-Gene
- : I-Gene
dependent JJ I-Gene
luciferase NN I-Gene
reporter NN I-Gene
gene NN I-Gene
either DT O
. . O

Extinction NN O
of IN O
immunoglobulin JJ B-Gene
gene NN I-Gene
expression NN O
in IN O
B NNP O
cells NNS O
upon IN O
fusion NN O
with IN O
HeLa NNP O
cells NNS O
is VBZ O
preceded VBN O
by IN O
rapid JJ O
nuclear JJ O
depletion NN O
of IN O
essential JJ B-Gene
transcription NN I-Gene
factors NNS I-Gene
and CC O
is VBZ O
accompanied VBN O
by IN O
widespread JJ O
inactivation NN O
of IN O
genes NNS O
expressed VBN O
in IN O
a DT O
B NNP O
cell NN O
- : O
specific JJ O
manner NN O
. . O

Evidence NN O
for IN O
suppressed JJ O
activity NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
NFAT1 NNP B-Gene
at IN O
its PRP$ O
proximal JJ B-Gene
binding NN I-Gene
element NN I-Gene
P0 NNP B-Gene
in IN O
the DT O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
promoter NN I-Gene
associated VBN O
with IN O
enhanced JJ O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
gene NN I-Gene
transcription NN O
in IN O
T NNP O
cells NNS O
of IN O
atopic NN O
patients NNS O
. . O

In IN O
a DT O
series NN O
of IN O
electrophoretic JJ O
mobility NN O
shift NN O
assays VBZ O
with IN O
protein JJ O
extracts NNS O
of IN O
highly RB O
polarized VBN O
Th2 NNP O
clones NNS O
from IN O
atopics NNS O
and CC O
Th1 NNP O
clones NNS O
from IN O
controls NNS O
we PRP O
compared VBN O
DNA NNP O
- : O
binding NN O
activities NNS O
at IN O
the DT O
two CD O
NFAT NNP B-Gene
- : I-Gene
binding NN I-Gene
elements NNS I-Gene
P0 NNP B-Gene
and CC O
P1 NNP B-Gene
of IN O
the DT O
crucial JJ O
proximal JJ O
human JJ O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
promoter NN I-Gene
. . O

At IN O
the DT O
most RBS O
proximal JJ O
P0 NNP B-Gene
site NN O
, , O
NFAT NNP O
- : O
containing NN O
complexes NNS O
devoid NN O
of IN O
NFAT2 NNP B-Gene
were VBD O
readily RB O
inducible JJ O
in IN O
the DT O
Th1 NNP O
clones NNS O
, , O
but CC O
hardly RB O
or CC O
not RB O
in IN O
the DT O
Th2 NNP O
clones NNS O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
high JJ O
- : O
level NN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
production NN O
in IN O
atopic NN O
Th2 NNP O
cells NNS O
is VBZ O
associated VBN O
with IN O
selective JJ O
reduction NN O
of IN O
suppressive JJ O
NFAT1 NNP B-Gene
activity NN O
at IN O
the DT O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
P0 NNP I-Gene
element NN I-Gene
and CC O
that IN O
some DT O
patients NNS O
with IN O
this DT O
multifactorial JJ O
disease NN O
may MD O
have VB O
a DT O
putative JJ O
systemic JJ O
disorder NN O
at IN O
this DT O
level NN O
. . O

Rather RB O
, , O
squirrel VB O
monkeys NNS O
express VB O
a DT O
soluble JJ O
factor NN O
that IN O
, , O
in IN O
mixing VBG O
studies NNS O
of IN O
cytosol NN O
from IN O
squirrel NN O
monkey NN O
lymphocytes NNS O
( ( O
SML NNP O
) ) O
and CC O
mouse $ O
L929 NNP O
cells NNS O
, , O
reduced VBD O
GR NNP O
binding VBG O
affinity NN O
by IN O
11 CD O
- : O
fold NN O
. . O

A DT O
role NN O
for IN O
changes NNS O
in IN O
immunophilins NNS B-Gene
, , O
causing VBG O
glucocorticoid JJ O
resistance NN O
in IN O
neotropical JJ O
primates NNS O
, , O
is VBZ O
supported VBN O
by IN O
the DT O
following NN O
: : O
the DT O
changes NNS O
in IN O
FKBP51 NNP B-Gene
and CC O
FKBP52 NNP B-Gene
were VBD O
observed VBN O
in IN O
cells NNS O
from IN O
other JJ O
neotropical JJ O
primates NNS O
with IN O
glucocorticoid JJ O
resistance NN O
; : O
the DT O
elevated JJ O
level NN O
of IN O
FKBP51 NNP B-Gene
was VBD O
reflected VBN O
in IN O
an DT O
abundance NN O
of IN O
FKBP51 NNP B-Gene
in IN O
heat NN B-Gene
shock NN I-Gene
protein VBD I-Gene
90 CD I-Gene
complexes NNS I-Gene
in IN O
SML NNP O
; : O
when WRB O
cytosols NNS O
of IN O
SML NNP O
and CC O
L929 NNP O
cells NNS O
were VBD O
mixed JJ O
, , O
the DT O
decrease NN O
in IN O
GR NNP O
binding NN O
was VBD O
associated VBN O
with IN O
incorporation NN O
of IN O
FKBP51 NNP B-Gene
into IN O
GR NNP B-Gene
heterocomplexes NNS I-Gene
; : O
the DT O
effect NN O
of IN O
SML NNP O
cytosol NN O
on IN O
GR NNP O
binding NN O
was VBD O
reproduced VBN O
with IN O
cytosol NN O
from IN O
COS NNP O
cells NNS O
expressing VBG O
squirrel NN O
monkey NN O
FKBP51 NNP B-Gene
; : O
and CC O
both DT O
the DT O
effect NN O
of IN O
SML NNP O
cytosol NN O
on IN O
GR NNP O
binding NN O
and CC O
the DT O
incorporation NN O
of IN O
FKBP51 NNP B-Gene
into IN O
GR NNP B-Gene
heterocomplexes NNS I-Gene
were VBD O
blocked VBN O
by IN O
FK506 NNP O
. . O

The DT O
prevalent NN O
complex NN O
is VBZ O
the DT O
heterodimer NN B-Gene
p50 SYM I-Gene
- : I-Gene
p65 NN I-Gene
. . O

NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activity NN O
is VBZ O
tightly RB O
correlated VBN O
with IN O
the DT O
transcriptional JJ O
activity NN O
of IN O
a DT O
long JJ B-Gene
terminal JJ I-Gene
repeat NN I-Gene
( ( O
LTR NNP B-Gene
) ) O
of IN O
HIV NNP O
- : O
1 CD O
transfected VBN O
in IN O
thymocytes NNS O
. . O

GCs NNP O
induce NN O
apoptosis NN O
in IN O
neoplastic JJ O
lymphoid NN O
cells NNS O
; : O
and CC O
, , O
defective JJ O
apoptosis NN O
is VBZ O
implicated VBN O
in IN O
the DT O
genesis NN O
of IN O
chronic JJ O
lymphocytic JJ O
leukemia NN O
( ( O
CLL NNP O
) ) O
. . O

These DT O
findings NNS O
indicate VBP O
that IN O
imbalanced JJ O
expression NN O
of IN O
the DT O
GR NNP B-Gene
isoforms NNS I-Gene
may MD O
be VB O
a DT O
mechanism NN O
of IN O
GC NNP O
resistance NN O
, , O
and CC O
may MD O
have VB O
implications NNS O
for IN O
tumorigenesis NN O
by IN O
enhancing VBG O
cell NN O
survival NN O
. . O

A DT O
second JJ O
hypersensitive JJ O
site NN O
( ( O
HS NNP O
2 CD O
) ) O
was VBD O
identified VBN O
within IN O
the DT O
first JJ O
intron NN O
in IN O
pre JJ O
- : O
monocytic JJ O
cells NNS O
, , O
which WDT O
express VBP O
Elk NNP O
- : O
1 CD O
only RB O
when WRB O
differentiating VBG O
to TO O
monocytes NNS O
. . O

Twenty NNP O
- : O
seven CD O
patients NNS O
with IN O
tumors NNS O
of IN O
the DT O
oral JJ O
cavity NN O
, , O
oropharynx NN O
, , O
and CC O
maxillary JJ O
sinus NN O
were VBD O
examined VBN O
, , O
all DT O
of IN O
which WDT O
were VBD O
confirmed VBN O
as IN O
squamous JJ O
cell NN O
carcinomas NN O
. . O

Serial JJ O
sectioning NN O
of IN O
6 CD O
micrometer NN O
was VBD O
performed VBN O
using VBG O
a DT O
cryostat NN O
, , O
and CC O
samples NNS O
were VBD O
immunohistochemicall JJ O
stained VBN O
using VBG O
the DT O
streptoavidin NN B-Gene
- : B-Gene
biotin NN I-Gene
peroxidase NN I-Gene
method NN O
and CC O
a DT O
monoclonal JJ O
antibody NN O
against IN O
c SYM O
- : O
fos NN O
. . O

Three CD O
of IN O
the DT O
27 CD O
patients NNS O
with IN O
squamous JJ O
cell NN O
carcinoma NN O
showed VBD O
slight JJ O
expression NN O
of IN O
c SYM O
- : O
fos NN O
in IN O
their PRP$ O
tumor NN O
cells NNS O
before IN O
and CC O
/ VB O
or CC O
at IN O
4 CD O
or CC O
10 CD O
Gy NNP O
of IN O
radiotherapy NN O
. . O

In IN O
patients NNS O
whose WP$ O
infiltration NN O
of IN O
c SYM B-Gene
- : I-Gene
fos JJ I-Gene
- : I-Gene
positive JJ I-Gene
lymphocytes NNS I-Gene
into IN O
tumor NN O
tissues NNS O
were VBD O
moderate JJ O
or CC O
remarkable JJ O
at IN O
4 CD O
Gy NNP O
of IN O
radiotherapy NN O
, , O
the DT O
tumors NNS O
responded VBD O
significantly RB O
well RB O
to TO O
radiation NN O
therapy NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
25 CD O
, , O
chi2 JJ O
test NN O
) ) O
, , O
and CC O
the DT O
patients NNS O
took VBD O
a DT O
significantly RB O
favorable JJ O
clinical JJ O
course NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
, , O
chi2 JJ O
test NN O
) ) O
. . O

The DT O
allele NN O
- : O
specific JJ O
expression NN O
profiles NNS O
of IN O
other JJ O
imprinted JJ B-Gene
genes NNS I-Gene
, , O
IGF2 NNP B-Gene
and CC O
H19 NNP B-Gene
, , O
on IN O
human JJ B-Gene
chromosome NN I-Gene
11 CD I-Gene
were VBD O
constant JJ O
and CC O
consistent JJ O
with IN O
those DT O
in IN O
other JJ O
tissues NNS O
. . O

Our PRP$ O
unexpected JJ O
observations NNS O
of IN O
paternal JJ O
or CC O
biallelic JJ O
expression NN O
of IN O
WT1 NNP B-Gene
in IN O
fibroblasts NNS O
and CC O
lymphocytes NNS O
, , O
together RB O
with IN O
the DT O
previous JJ O
findings NNS O
of IN O
maternal JJ O
or CC O
biallelic JJ O
expression NN O
in IN O
placentae NN O
and CC O
brains NNS O
, , O
suggest VBP O
that IN O
the DT O
allele NN O
- : O
specific JJ O
regulatory JJ O
system NN O
of IN O
WT1 NNP B-Gene
is VBZ O
unique JJ O
and CC O
may MD O
be VB O
controlled VBN O
by IN O
a DT O
putative JJ O
tissue NN O
- : O
and CC O
individual JJ O
- : O
specific JJ O
modifier NN O
. . O

T NNP O
cell NN O
responses NNS O
to TO O
some DT O
nuclear JJ O
antigens NNS O
, , O
particularly RB O
U1RNP NNP B-Gene
, , O
have VBP O
been VBN O
detected VBN O
in IN O
patients NNS O
with IN O
systemic JJ O
lupus NN O
erythematosus NN O
( ( O
SLE NNP O
) ) O
and CC O
in IN O
healthy JJ O
subjects NNS O
. . O

METHODS NNP O
. . O

HLA NNP O
- : O
DR NNP O
typing NN O
was VBD O
by IN O
polymerase NN O
chain NN O
reaction NN O
and CC O
sequence NN O
specific JJ O
oligonucleotide IN O
typing VBG O
. . O

RESULTS NNP O
. . O

Six CD O
of IN O
20 CD O
patients NNS O
with IN O
SS NNP O
and CC O
10 CD O
/ NN O
19 CD O
controls NNS O
proliferated VBN O
to TO O
La NNP O
( ( O
rSSB NN B-Gene
) ) O
. . O

Tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
( ( I-Gene
TNF NNP I-Gene
) ) I-Gene
- : I-Gene
alpha NN I-Gene
- : O
induced JJ O
HIV NNP O
- : O
1 CD O
replication NN O
in IN O
OM10 NNP O
. . O
1 CD O
or CC O
Ach2 NNP O
cells NNS O
was VBD O
significantly RB O
inhibited VBN O
by IN O
non JJ O
- : O
cytotoxic NN O
doses NNS O
of IN O
AuTG NNP O
( ( O
> $ O
10 CD O
microM NN O
in IN O
OM10 NNP O
. . O
1 CD O
cells NNS O
and CC O
> $ O
25 CD O
F NNP O
. . O
M NNP O
in IN O
Ach2 NNP O
cells NNS O
) ) O
, , O
while IN O
25 CD O
microM NNS O
of IN O
the DT O
counter NN B-Gene
- : I-Gene
anion NN I-Gene
thioglucose NN I-Gene
( ( O
TG NNP B-Gene
) ) O
or CC O
gold NN O
compound NN O
containing VBG O
divalent JJ O
gold NN O
ion NN O
, , O
HAuCl3 NNP O
, , O
had VBD O
no DT O
effect NN O
. . O

Specific JJ O
staining NN O
as RB O
well RB O
as IN O
electron NN O
microscopic NN O
examinations NNS O
revealed VBD O
the DT O
accumulation NN O
of IN O
metal NN O
gold NN O
in IN O
the DT O
cells NNS O
, , O
supporting VBG O
our PRP$ O
previous JJ O
hypothesis NN O
that WDT O
gold NN O
ions NNS O
could MD O
block VB O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
- : O
DNA NN O
binding NN O
by IN O
a DT O
redox NN O
mechanism NN O
. . O

In IN O
the DT O
absence NN O
of IN O
karyotypic NN O
abnormalities NNS O
, , O
there EX O
is VBZ O
no DT O
specific JJ O
test NN O
to TO O
detect VB O
clonal JJ O
eosinophilia NNS O
in IN O
IHES NNP O
. . O

Peripheral JJ O
blood NN O
eosinophils NNS O
were VBD O
isolated VBN O
by IN O
their PRP$ O
autofluoresence NN O
using VBG O
flow JJ O
cytometric JJ O
sorting NN O
. . O

After IN O
corticosteroid JJ O
suppression NN O
of IN O
her PRP$ O
blood NN O
eosinophilia NN O
, , O
a DT O
clonal JJ O
population NN O
of IN O
eosinophils NNS O
could MD O
no RB O
longer RB O
be VB O
detected VBN O
in IN O
purified JJ O
eosinophils NNS O
. . O

This DT O
pro JJ B-Gene
- : I-Gene
IL NNP I-Gene
- : I-Gene
16 CD I-Gene
is VBZ O
subsequently RB O
processed VBN O
to TO O
the DT O
mature NN O
cytokine NN O
of IN O
13 CD B-Gene
kDa NNS I-Gene
. . O

The DT O
5 CD B-Gene
' POS I-Gene
sequences NNS I-Gene
up IN O
to TO O
nucleotide VB O
- : O
120 CD O
of IN O
the DT O
human JJ O
and CC O
murine JJ O
IL NNP B-Gene
- : I-Gene
16 CD I-Gene
genes NNS O
share NN O
> VBZ O
84 CD O
% NN O
sequence NN O
homology NN O
and CC O
harbor NN B-Gene
promoter NN I-Gene
elements NNS I-Gene
for IN O
constitutive NN O
and CC O
inducible JJ O
transcription NN O
in IN O
T NNP O
cells NNS O
. . O

Therefore RB O
, , O
this DT O
genetic JJ O
variant NN O
, , O
which WDT O
predisposes VBZ O
to TO O
low VB O
bone RB O
mineral JJ O
density NN O
in IN O
many JJ O
populations NNS O
, , O
may MD O
confer VB O
resistance NN O
to TO O
certain JJ O
infectious JJ O
diseases NNS O
. . O

Indeed RB O
, , O
the DT O
availability NN O
of IN O
selective JJ O
and CC O
orally RB O
active JJ O
proteasome NN O
inhibitors NNS O
should MD O
prove VB O
useful JJ O
in IN O
delineating VBG O
the DT O
roles NNS O
of IN O
the DT O
proteasome NN O
and CC O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
other JJ O
pathophysiological JJ O
conditions NNS O
such JJ O
as IN O
cancer NN O
and CC O
heart NN O
disease NN O
. . O

Lysophosphatidyletha NNP O
( ( O
lysoPE NN O
) ) O
and CC O
other JJ O
lysophospholipids NNS O
did VBD O
not RB O
affect VB O
LPS NNP O
- : O
induced JJ O
TF NNP O
activity NN O
of IN O
human JJ O
monocytes NNS O
. . O

TF NNP O
antigen NN O
expression NN O
as IN O
elicited VBN O
by IN O
LPS NNP O
was VBD O
also RB O
lowered VBN O
by IN O
lysoPC NN O
. . O

LysoPC NNP O
inhibited VBD O
the DT O
TF NNP O
activity NN O
of IN O
Mono NNP O
Mac NNP O
- : O
6 CD O
cells NNS O
to TO O
a DT O
similar JJ O
extent NN O
as IN O
in IN O
the DT O
monocytes NNS O
. . O

A DT O
Taq NNP B-Gene
I PRP I-Gene
polymorphism NN I-Gene
was VBD O
identified VBN O
which WDT O
enabled VBD O
chicken NN O
IL2 NNP B-Gene
to TO O
be VB O
mapped VBN O
to TO O
chromosome VB B-Gene
4 CD I-Gene
, , O
linked VBN O
to TO O
ANX5 NNP B-Gene
, , O
with IN O
synteny NN O
with IN O
mouse NN B-Gene
chromosome NN I-Gene
3 CD I-Gene
and CC O
human JJ B-Gene
chromosome NN I-Gene
4 CD I-Gene
. . O

There EX O
is VBZ O
increasing VBG O
evidence NN O
that IN O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
has VBZ O
an DT O
important JJ O
role NN O
in IN O
T NNP O
- : O
cell NN O
biology NN O
. . O

The DT O
induction NN O
of IN O
these DT O
genes NNS O
is VBZ O
associated VBN O
with IN O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
- : O
induced VBN O
T NNP O
- : O
cell NN O
proliferation NN O
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
results NNS O
suggest VBP O
that IN O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
, , O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
, , O
and CC O
IL NNP B-Gene
- : I-Gene
15 CD I-Gene
have VBP O
overlapping VBG O
activities NNS O
on IN O
human JJ O
T NNP O
cells NNS O
. . O

The DT O
Megakaryocyte NNP B-Gene
/ NNP I-Gene
Platelet NNP I-Gene
- : I-Gene
specific JJ I-Gene
enhancer NN I-Gene
of IN O
the DT O
alpha2beta1 NN B-Gene
integrin JJ I-Gene
gene NN I-Gene
: : O
two CD O
tandem NN O
AP1 NNP B-Gene
sites NNS I-Gene
and CC O
the DT O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
signaling VBG O
cascade NN O
. . O

Transcriptional JJ O
regulation NN O
of IN O
the DT O
alpha2 NN B-Gene
integrin JJ I-Gene
gene NN I-Gene
in IN O
cells NNS O
undergoing JJ O
megakaryocytic JJ O
differentiation NN O
requires VBZ O
a DT O
core NN B-Gene
promoter NN I-Gene
between IN O
bp SYM O
- : O
30 CD O
and CC O
- : O
92 CD O
, , O
a DT O
silencer NN B-Gene
between IN O
bp SYM O
- : O
92 CD O
and CC O
- : O
351 CD O
, , O
and CC O
megakaryocytic JJ B-Gene
enhancers NNS I-Gene
in IN O
the DT O
distal JJ B-Gene
5 CD I-Gene
' POS I-Gene
flank NN I-Gene
. . O

Therefore RB O
, , O
our PRP$ O
data NNS O
not RB O
only RB O
reveal VB O
that IN O
Nmi NNP B-Gene
can MD O
potentiate VB O
STAT NNP B-Gene
- : O
dependent JJ O
transcription NN O
, , O
but CC O
also RB O
suggest VBP O
that IN O
it PRP O
can MD O
augment VB O
coactivator NN O
protein NN O
recruitment NN O
to TO O
at IN O
least JJS O
some DT O
members NNS O
of IN O
a DT O
group NN O
of IN O
sequence NN B-Gene
- : I-Gene
specific JJ I-Gene
transcription NN I-Gene
factors NNS I-Gene
. . O

In IN O
contrast NN O
, , O
activation NN O
in IN O
THP NNP B-Gene
- : I-Gene
1 CD I-Gene
cells NNS I-Gene
occurred VBD O
in IN O
the DT O
absence NN O
of IN O
vanadate NN O
and CC O
was VBD O
unaffected VBN O
by IN O
catalase NN B-Gene
. . O

These DT O
findings NNS O
suggest VBP O
the DT O
presence NN O
in IN O
vaginal JJ O
fluid NN O
of IN O
agent NN O
( ( O
s PRP O
) ) O
derived VBD O
from IN O
indigenous JJ O
bacteria NNS O
that WDT O
can MD O
activate VB O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
, , O
cytokine NN B-Gene
production NN O
, , O
and CC O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
cells NNS O
of IN O
macrophage NN O
lineage NN O
, , O
with IN O
possible JJ O
influence NN O
on IN O
vaginal JJ O
physiology NN O
and CC O
host NN O
defense NN O
. . O

Activated NNP O
primed VBD O
CD4 NNP O
T NNP O
cells NNS O
contain VBP O
more JJR O
NFAT1 NNP B-Gene
and CC O
support NN O
greater JJR O
NFAT NNP B-Gene
- : O
directed VBD O
transcription NN O
than IN O
unprimed JJ O
CD4 NNP O
T NNP O
cells NNS O
, , O
while IN O
activator NN B-Gene
protein VBP I-Gene
1 CD I-Gene
binding NN O
and CC O
activator NN B-Gene
protein NN I-Gene
1 CD I-Gene
- : O
mediated VBN O
transcription NN O
by IN O
both DT O
cell NN O
types NNS O
is VBZ O
similar JJ O
. . O

These DT O
agents NNS O
also RB O
significantly RB O
decreased VBN O
TNF NNP B-Gene
- : O
and CC O
LPS NNP O
- : O
stimulated VBD O
increases NNS O
in IN O
HUVEC NNP B-Gene
surface NN I-Gene
VCAM NNP I-Gene
- : I-Gene
1 CD I-Gene
. . O

TNF NNP B-Gene
stimulated VBD O
expression NN O
of IN O
both DT O
intercellular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
and CC O
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
in IN O
HUVECs NNP O
, , O
but CC O
in IN O
HUAECs NNP O
, , O
only RB O
intercellular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
was VBD O
increased VBN O
. . O

Functional NNP O
testosterone NN B-Gene
receptors NNS I-Gene
in IN O
plasma JJ O
membranes NNS O
of IN O
T NNP O
cells NNS O
. . O

AR NNP B-Gene
can MD O
be VB O
visualized VBN O
with IN O
the DT O
anti JJ B-Gene
- : I-Gene
AR NN I-Gene
antibodies NNS I-Gene
in IN O
the DT O
cytoplasm NN O
of IN O
permeabilized JJ O
T NNP O
cells NNS O
by IN O
using VBG O
CLSM NNP O
, , O
though IN O
AR NNP B-Gene
are VBP O
not RB O
detectable JJ O
in IN O
cytosol NN O
fractions NNS O
when WRB O
using VBG O
the DT O
charcoal NN O
binding VBG O
assay NN O
with IN O
3H CD O
- : O
R1881 NN O
as IN O
ligand NN O
. . O

Cytoplasmic NNP B-Gene
AR NNP I-Gene
do VBP O
not RB O
translocate VB O
to TO O
the DT O
nucleus NN O
of IN O
T NNP O
cells NNS O
in IN O
the DT O
presence NN O
of IN O
testosterone NN O
, , O
in IN O
contrast NN O
to TO O
cytoplasmic VB B-Gene
AR NNP I-Gene
in IN O
human JJ O
cancer NN O
LNCaP NNP O
cells NNS O
. . O

By IN O
contrast NN O
, , O
the DT O
cell NN B-Gene
surface NN I-Gene
receptors NNS I-Gene
for IN O
testosterone NN O
are VBP O
in IN O
a DT O
functionally RB O
active JJ O
state NN O
, , O
enabling VBG O
T NNP O
cells NNS O
a DT O
nongenomic JJ O
response NN O
to TO O
testosterone NN O
. . O

Limited JJ O
proteolysis NN O
for IN O
assaying VBG O
ligand NN O
binding VBG O
affinities NNS O
of IN O
nuclear JJ B-Gene
receptors NNS I-Gene
. . O

Using VBG O
the DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
or CC I-Gene
mutated VBN I-Gene
human JJ I-Gene
retinoic NN I-Gene
acid NN I-Gene
receptor NN I-Gene
alpha NN I-Gene
as IN O
a DT O
model NN O
, , O
kDa FW O
values NNS O
determined VBN O
by IN O
classical JJ O
competition NN O
binding NN O
assays NNS O
using VBG O
tritiated JJ O
ligands NNS O
are VBP O
in IN O
agreement NN O
with IN O
those DT O
measured VBN O
by IN O
the DT O
proteolytic JJ O
assay NN O
. . O

B NNP O
lymphocytes VBZ O
from IN O
patients NNS O
with IN O
chronic JJ O
lymphocytic JJ O
leukemia NN O
contain VBP O
signal JJ B-Gene
transducer NN I-Gene
and CC I-Gene
activator NN I-Gene
of IN I-Gene
transcription NN I-Gene
( ( I-Gene
STAT NNP I-Gene
) ) I-Gene
1 CD I-Gene
and CC O
STAT3 NNP B-Gene
constitutively RB O
phosphorylated VBD O
on IN O
serine NN O
residues NNS O
. . O

In IN O
summary JJ O
, , O
the DT O
constitutive JJ O
serine NN O
phosphorylation NN O
of IN O
STAT1 NNP B-Gene
and CC O
STAT3 NNP B-Gene
is VBZ O
present JJ O
in IN O
all DT O
CLL NNP O
samples NNS O
tested VBD O
to TO O
date NN O
, , O
although IN O
the DT O
physiologic JJ O
significance NN O
of IN O
this DT O
modification NN O
remains VBZ O
to TO O
be VB O
determined VBN O
. . O

G NNP O
. . O
vaginalis NN O
lysates VBZ O
also RB O
activated VBN O
HIV NNP O
expression NN O
in IN O
certain JJ O
T NNP O
cell NN O
lines NNS O
. . O

Highly NNP O
purified JJ O
monocytes NNS O
were VBD O
incubated VBN O
with IN O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
for IN O
60 CD O
to TO O
90 CD O
minutes NNS O
before IN O
the DT O
addition NN O
of IN O
IFNgamma NNP B-Gene
or CC O
IFNalpha NNP B-Gene
. . O

IL NNP B-Gene
- : I-Gene
10 CD I-Gene
preincubation NN O
resulted VBD O
in IN O
the DT O
inhibition NN O
of IN O
gene NN O
expression NN O
for IN O
several JJ O
IFN NNP B-Gene
- : I-Gene
induced JJ I-Gene
genes NNS I-Gene
, , O
such JJ O
as IN O
IP NNP B-Gene
- : I-Gene
10 CD I-Gene
, , O
ISG54 NNP B-Gene
, , O
and CC O
intercellular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
. . O

The DT O
development NN O
of IN O
ringed JJ O
sideroblasts NNS O
in IN O
erythroid JJ O
colonies NNS O
by IN O
iron NN O
staining NN O
and CC O
their PRP$ O
X NN O
- : O
inactivation NN O
pattern NN O
were VBD O
also RB O
examined VBN O
. . O

Granulosa NNP O
cell NN O
tumor NN O
of IN O
the DT O
ovary JJ O
. . O

All DT O
of IN O
the DT O
tumors NNS O
exhibited VBD O
typical JJ O
morphology NN O
, , O
were VBD O
limited VBN O
to TO O
the DT O
ovary JJ O
( ( O
stage NN O
I PRP O
) ) O
, , O
and CC O
7 CD O
cases NNS O
followed VBD O
a DT O
benign JJ O
clinical JJ O
course NN O
. . O

Comparison NNP O
of IN O
primary JJ O
sensitization NN O
of IN O
naive JJ O
human JJ O
T NNP O
cells NNS O
to TO O
varicella VB O
- : O
zoster NN O
virus NN O
peptides NNS O
by IN O
dendritic JJ O
cells NNS O
in IN O
vitro NN O
with IN O
responses NNS O
elicited VBN O
in IN O
vivo NN O
by IN O
varicella NN O
vaccination NN O
. . O

Dendritic JJ O
cells NNS O
( ( O
DC NNP O
) ) O
are VBP O
potent JJ O
APC NNP O
during IN O
primary JJ O
and CC O
secondary JJ O
immune NN O
responses NNS O
. . O

Monocytes NNS O
were VBD O
effective JJ O
APC NNP O
for IN O
VZV NNP O
peptides NNS O
only RB O
after IN O
immunization NN O
. . O

IL NNP B-Gene
- : I-Gene
10 CD I-Gene
treatment NN O
prevented VBD O
the DT O
downregulation NN O
of IN O
p27 NN B-Gene
( ( I-Gene
Kip1 NNP I-Gene
) ) O
, , O
an DT O
inhibitory NN B-Gene
protein NN I-Gene
that WDT O
controls VBZ O
progression NN O
out IN O
of IN O
the DT O
G0 NNP O
phase NN O
of IN O
the DT O
cell NN O
cycle NN O
. . O

Associated VBN O
with IN O
the DT O
inhibition NN O
of IN O
the DT O
cell NN O
cycle NN O
, , O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
suppressed VBD O
SEB NNP B-Gene
induction NN O
of IN O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
. . O

Although IN O
this DT O
reversal NN O
by IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
was VBD O
pronounced VBN O
, , O
it PRP O
was VBD O
not RB O
complete JJ O
, , O
suggesting VBG O
that IN O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
may MD O
have VB O
some DT O
effects NNS O
not RB O
directly RB O
related VBN O
to TO O
the DT O
suppression NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
production NN O
. . O

IL NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
induced VBD O
dose JJ O
- : O
and CC O
time NN O
- : O
dependent NN O
increases NNS O
in IN O
IL NNP O
- : O
1RI CD O
and CC O
IL NNP O
- : O
1RII CD O
mRNA NN O
levels NNS O
. . O

IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
decreased VBD O
basal JJ O
expression NN O
as RB O
well RB O
as IN O
the DT O
induction NN O
of IN O
these DT O
genes NNS O
by IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
. . O

Inhibition NN O
of IN O
IL NNP B-Gene
- : I-Gene
1RI CD I-Gene
and CC O
IL NNP O
- : O
1RII CD O
mRNA NN O
levels NNS O
by IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
was VBD O
transcriptionally RB O
mediated VBN O
, , O
and CC O
correlated VBD O
directly RB O
with IN O
decreased JJ O
production NN O
of IN O
soluble JJ O
IL NNP B-Gene
- : I-Gene
1RII CD I-Gene
. . O

In IN O
both DT O
cell NN O
types NNS O
, , O
the DT O
cytokine NN B-Gene
that WDT O
inhibits VBZ O
the DT O
induction NN O
of IN O
IkappaBalpha NNP B-Gene
by IN O
DEX NNP O
, , O
also RB O
rescues VBZ O
these DT O
cells NNS O
from IN O
DEX NNP O
- : O
induced JJ O
apoptosis NN O
, , O
although IN O
the DT O
rescue NN O
cytokine NN O
is VBZ O
different JJ O
in IN O
Th1 NNP O
and CC O
Th2 NNP O
cells NNS O
. . O

Infection NN O
of IN O
human JJ O
monocytes NNS O
with IN O
influenza NN O
A NNP O
virus NN O
induces VBZ O
a DT O
broad JJ O
range NN O
of IN O
proinflammatory NN B-Gene
cytokines NNS I-Gene
and CC O
mononuclear VBP O
cell NN O
attracting VBG O
chemokines NNS B-Gene
before IN O
the DT O
infected JJ O
cells NNS O
undergo JJ O
apoptosis NN O
. . O

In IN O
conclusion NN O
, , O
the DT O
long JJ O
- : O
term NN O
regulation NN O
of IN O
transcription NN B-Gene
factor NN I-Gene
gene NN O
expression NN O
in IN O
non JJ O
- : O
proliferating NN O
cells NNS O
seems VBZ O
to TO O
be VB O
of IN O
minor JJ O
importance NN O
after IN O
influenza JJ O
infection NN O
since IN O
in IN O
apoptosisprone NN O
cells NNS O
an DT O
immediate JJ O
availability NN O
of IN O
transcription NN B-Gene
factor NN I-Gene
proteins NNS I-Gene
is VBZ O
required VBN O
. . O

Patients NNS O
with IN O
diabetic JJ O
nephropathy NN O
showed VBD O
higher JJR O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
binding NN O
activity NN O
in IN O
Electrophoretic NNP O
Mobility NNP O
Shift NNP O
Assays NNP O
and CC O
stronger JJR O
immunohistological JJ O
staining NN O
for IN O
activated VBN O
NF NNP B-Gene
- : I-Gene
kappaBp65 NN I-Gene
than IN O
patients NNS O
without IN O
renal JJ O
complications NNS O
. . O

Resorption NNP O
lacunae NN O
can MD O
be VB O
observed VBN O
by IN O
day NN O
22 CD O
. . O

We PRP O
incubated VBD O
sodium JJ O
oleate NN O
with IN O
human JJ O
umbilical JJ O
vein NN O
endothelial JJ O
cells NNS O
for IN O
0 CD O
to TO O
72 CD O
hours NNS O
, , O
followed VBN O
by IN O
coincubation NN O
of IN O
oleate NN O
with IN O
human JJ B-Gene
recombinant JJ I-Gene
tumor NN I-Gene
necrosis NN I-Gene
factor NN I-Gene
, , O
interleukin FW B-Gene
( ( I-Gene
IL NNP I-Gene
) ) I-Gene
- : I-Gene
1alpha CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
Escherichia NNP O
coli VBZ O
lipopolysaccharide NN O
( ( O
LPS NNP O
) ) O
, , O
or CC O
phorbol NN O
12 CD O
- : O
myristate NN O
13 CD O
- : O
acetate NN O
for IN O
a DT O
further JJ O
6 CD O
to TO O
24 CD O
hours NNS O
. . O

The DT O
endothelial JJ O
expression NN O
of IN O
vascular JJ B-Gene
cell NN I-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
, , O
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
, , O
and CC O
intercellular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
was VBD O
monitored VBN O
by IN O
cell NN O
surface NN O
enzyme VBP O
immunoassays NNS O
or CC O
flow JJ O
cytometry NN O
, , O
and CC O
steady JJ O
- : O
state NN O
levels NNS O
of IN O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA NNS I-Gene
were VBD O
assessed VBN O
by IN O
Northern NNP O
blot NN O
analysis NN O
. . O

Incubation NN O
of IN O
endothelial JJ O
cells NNS O
with IN O
oleate NN O
for IN O
72 CD O
hours NNS O
decreased VBD O
the DT O
relative JJ O
proportions NNS O
of IN O
saturated VBN O
( ( O
palmitic JJ O
and CC O
stearic JJ O
) ) O
acids NNS O
in IN O
total JJ O
cell NN O
lipids NNS O
and CC O
increased VBD O
the DT O
proportions NNS O
of IN O
oleate NN O
in IN O
total JJ O
cell NN O
lipids NNS O
without IN O
significantly RB O
changing VBG O
the DT O
relative JJ O
proportions NNS O
of IN O
polyunsaturated JJ O
fatty JJ O
acids NNS O
. . O

The DT O
importance NN O
of IN O
BCL2 NNP B-Gene
and CC O
Stat3 NNP B-Gene
on IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
- : O
induced VBN O
macrophage NN O
- : O
differentiation NN O
and CC O
apoptosis NN O
was VBD O
studied VBN O
with IN O
1A9 CD O
- : O
M NNP O
cells NNS O
expressing VBG O
human JJ B-Gene
BCL2 NNP I-Gene
or CC O
a DT O
dominant JJ O
- : O
negative JJ O
form NN O
of IN O
Stat3 NNP B-Gene
, , O
respectively RB O
. . O

IL NNP B-Gene
- : I-Gene
6 CD I-Gene
- : O
induced JJ O
apoptosis NN O
, , O
but CC O
not RB O
macrophage VB O
- : O
differentiation NN O
, , O
was VBD O
blocked VBN O
by IN O
continuously RB O
expressed VBN O
BCL2 NNP B-Gene
. . O

Interleukin NNP B-Gene
- : I-Gene
8 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
) ) O
is VBZ O
a DT O
chemokine NN B-Gene
that WDT O
belongs VBZ O
to TO O
the DT O
alpha NN B-Gene
- : I-Gene
chemokine NN I-Gene
or CC O
CXC NNP B-Gene
subfamily RB I-Gene
and CC O
is VBZ O
produced VBN O
by IN O
a DT O
wide JJ O
variety NN O
of IN O
human JJ O
cells NNS O
, , O
including VBG O
monocytes NNS O
and CC O
polymorphonuclear JJ O
cells NNS O
( ( O
PMN NNP O
) ) O
. . O

IL NNP B-Gene
- : I-Gene
8 CD I-Gene
is VBZ O
secreted VBN O
in IN O
response NN O
to TO O
inflammatory JJ O
stimuli NNS O
, , O
notably RB O
bacterial JJ O
products NNS O
such JJ O
as IN O
lipopolysaccharide NN O
( ( O
LPS NNP O
) ) O
, , O
but CC O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
mechanisms NNS O
by IN O
which WDT O
these DT O
agents NNS O
mediate VBP O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
induction NN O
. . O

In IN O
this DT O
report NN O
, , O
we PRP O
show VBP O
that IN O
Mycoplasma NNP B-Gene
fermentans VBZ I-Gene
lipid JJ I-Gene
- : I-Gene
associated VBN I-Gene
membrane NN I-Gene
proteins NNS I-Gene
( ( O
LAMPf NNP B-Gene
) ) O
induce VBP O
the DT O
production NN O
of IN O
high JJ O
levels NNS O
of IN O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
by IN O
THP NNP O
- : O
1 CD O
( ( O
human JJ O
monocyte NN O
) ) O
cells NNS O
and CC O
PMN NNP O
at IN O
the DT O
same JJ O
extent NN O
as IN O
LPS NNP O
. . O

In IN O
this DT O
study NN O
we PRP O
investigated VBD O
the DT O
effects NNS O
of IN O
C3a NNP B-Gene
and CC O
C3a NNP B-Gene
( ( I-Gene
desArg NN I-Gene
) ) I-Gene
on IN O
gene NN O
expression NN O
and CC O
protein JJ O
secretion NN O
of IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
in IN O
human JJ O
PBMCs NNP O
, , O
either RB O
alone RB O
or CC O
in IN O
combination NN O
with IN O
LPS NNP O
or CC O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
. . O

Furthermore RB O
, , O
we PRP O
investigated VBD O
the DT O
effects NNS O
of IN O
C3a NNP B-Gene
and CC O
C3a NNP B-Gene
( ( I-Gene
desArg NN I-Gene
) ) I-Gene
on IN O
induction NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
activating VBG B-Gene
protein NN I-Gene
- : I-Gene
1 CD I-Gene
binding NN O
. . O

These DT O
results NNS O
demonstrate VBP O
the DT O
capacity NN O
of IN O
intact JJ O
C3a NNP B-Gene
and CC O
its PRP$ O
circulating NN O
des NNS B-Gene
- : I-Gene
Arg NNP I-Gene
form NN I-Gene
to TO O
exert VB O
immunmodulatory JJ O
effects NNS O
in IN O
vitro NN O
. . O

Phenylarsine NNP O
oxide MD O
inhibits VB O
ex FW O
vivo FW O
HIV NNP O
- : O
1 CD O
expression NN O
. . O

Pharmacological NNP O
control NN O
of IN O
antigen NN O
responsiveness NN O
in IN O
genetically RB O
modified VBN O
T NNP O
lymphocytes NNS O
. . O

Recently RB O
, , O
fibromyalgia NN O
( ( O
FMS NNP O
) ) O
was VBD O
shown VBN O
to TO O
be VB O
a DT O
disorder NN O
associated VBN O
with IN O
an DT O
altered JJ O
functioning NN O
of IN O
the DT O
stress NN O
response NN O
system NN O
. . O

FMS NNP O
patients NNS O
display VBP O
a DT O
hyperreactive JJ O
pituitary JJ O
adrenocorticotropic NN O
hormone NN O
( ( O
ACTH NNP O
) ) O
release NN O
in IN O
response NN O
to TO O
corticotropin VB O
- : O
releasing VBG O
hormone NN O
( ( O
CRH NNP O
) ) O
and CC O
to TO O
insulin VB O
- : O
induced JJ O
hypoglycemia NN O
. . O

Therefore IN O
we PRP O
investigated VBD O
the DT O
properties NNS O
and CC O
function NN O
of IN O
the DT O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
( ( O
GR NNP B-Gene
) ) O
in IN O
FMS NNP O
patients NNS O
and CC O
compared VBN O
the DT O
results NNS O
with IN O
those DT O
of IN O
healthy JJ O
persons NNS O
and CC O
patients NNS O
with IN O
chronic JJ O
low JJ O
back RB O
pain NN O
( ( O
LBP NNP O
a DT O
localized JJ O
pain NN O
condition NN O
) ) O
. . O

Forty NNP O
primary JJ O
FMS NNP O
patients NNS O
( ( O
F NNP O
: : O
M NNP O
= VBZ O
36 CD O
: : O
4 CD O
) ) O
, , O
28 CD O
LBP NNP O
patients NNS O
( ( O
25 CD O
: : O
3 CD O
) ) O
and CC O
14 CD O
( ( O
12 CD O
: : O
2 CD O
) ) O
healthy JJ O
, , O
sedentary JJ O
control NN O
persons NNS O
were VBD O
recruited VBN O
for IN O
the DT O
study NN O
. . O

Urinary JJ O
free JJ O
cortisol NN O
excretion NN O
in IN O
FMS NNP O
and CC O
LBP NNP O
patients NNS O
was VBD O
lower JJR O
compared VBN O
to TO O
controls NNS O
. . O

We PRP O
conclude VBP O
that IN O
FMS NNP O
patients NNS O
have VBP O
a DT O
mild JJ O
hypocortisolemia NN O
, , O
increased VBD O
cortisol JJ O
feedback NN O
resistance NN O
in IN O
combination NN O
probably RB O
with IN O
a DT O
reduced JJ O
CRH NNP O
synthesis NN O
or CC O
release NN O
in IN O
the DT O
hypothalamus NN O
. . O

The DT O
suggested JJ O
roles NNS O
of IN O
the DT O
downstream NN B-Gene
3 CD I-Gene
' POS I-Gene
regions NNS I-Gene
acting VBG O
as IN O
a DT O
Locus NNP B-Gene
Control NNP I-Gene
Region NNP I-Gene
( ( O
LCR NNP B-Gene
) ) O
, , O
have VBP O
allowed VBN O
comparisons NNS O
to TO O
be VB O
made VBN O
between IN O
the DT O
regulation NN O
of IN O
the DT O
IgH NNP B-Gene
locus NN I-Gene
with IN O
other JJ O
model NN O
systems NNS O
whose WP$ O
gene NN O
expression NN O
is VBZ O
governed VBN O
by IN O
LCR NNP B-Gene
activity NN O
. . O

T NNP O
lymphocytes VBZ O
recognize VBP O
antigens NNS O
in IN O
the DT O
form NN O
of IN O
peptides NNS O
bound IN O
to TO O
HLA NNP B-Gene
- : I-Gene
molecules NNS I-Gene
. . O

MATERIALS NNP O
AND CC O
METHODS NNP O
: : O
Peptides NNS O
derived VBN O
from IN O
oncogenic JJ B-Gene
proteins NNS I-Gene
were VBD O
screened VBN O
for IN O
the DT O
presence NN O
of IN O
HLA NNP B-Gene
binding VBG I-Gene
motifs NNS I-Gene
; : O
actual JJ O
binding NN O
were VBD O
evaluated VBN O
by IN O
HLA NNP O
stabilization NN O
experiments NNS O
using VBG O
transfectants NNS O
and CC O
specific JJ O
anti SYM B-Gene
- : I-Gene
HLA NNP I-Gene
antibodies NNS I-Gene
. . O

Specific JJ O
lymphocytes NNS O
were VBD O
induced VBN O
by IN O
in IN O
vitro JJ O
peptide JJ O
sensitization NN O
and CC O
screened VBN O
by IN O
thymidine JJ O
uptake NN O
or CC O
cellular JJ O
cytotoxic NN O
assays NNS O
. . O

RESULTS NNS O
: : O
We PRP O
identified VBD O
peptides NNS O
derived VBN O
from IN O
EWS NNP B-Gene
/ NNP I-Gene
FLI NNP I-Gene
- : I-Gene
1 CD I-Gene
fusion NN I-Gene
protein NN I-Gene
and CC O
from IN O
mutated VBN B-Gene
K NNP I-Gene
- : I-Gene
RAS NNP I-Gene
protein NN I-Gene
( ( O
encompassing VBG O
respectively RB O
the DT O
fusion NN B-Gene
point NN I-Gene
and CC O
the DT O
mutation NN O
at IN O
position NN B-Gene
12 CD I-Gene
) ) O
that WDT O
showed VBD O
binding VBG B-Gene
motif NN I-Gene
for IN O
HLA NNP B-Gene
- : I-Gene
Cw NNP I-Gene
* NN I-Gene
702 CD I-Gene
and CC O
HLA NNP B-Gene
- : I-Gene
A3 NNP I-Gene
respectively RB O
. . O

OCA NNP B-Gene
- : I-Gene
B NN I-Gene
is VBZ O
a DT O
functional JJ O
analog NN O
of IN O
VP16 NNP B-Gene
but CC O
targets VBZ O
a DT O
separate JJ O
surface NN O
of IN O
the DT O
Oct NNP B-Gene
- : I-Gene
1 CD I-Gene
POU NNP I-Gene
domain NN I-Gene
[ NNP O
published VBD O
erratum JJ O
appears VBZ O
in IN O
Mol NNP O
Cell NNP O
Biol NNP O
1998 CD O
Apr NNP O
; : O
18 CD O
( ( O
4 CD O
) ) O
: : O
2430 CD O
] NN O

Here RB O
, , O
we PRP O
show VBP O
that IN O
OCA NNP B-Gene
- : I-Gene
B NN I-Gene
alters VBZ O
the DT O
activity NN O
of IN O
Oct NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
two CD O
ways NNS O
. . O

These DT O
results NNS O
emphasize VBP O
the DT O
structural JJ O
versatility NN O
of IN O
the DT O
Oct NNP B-Gene
- : I-Gene
1 CD I-Gene
POU NNP I-Gene
domain NN I-Gene
in IN O
its PRP$ O
interaction NN O
with IN O
coregulators NNS O
. . O

Phosphatidylinositol NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
couples VBZ O
the DT O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
receptor NN I-Gene
to TO O
the DT O
cell NN B-Gene
cycle NN I-Gene
regulator NN I-Gene
E2F NNP B-Gene
. . O

We PRP O
eliminate VBP O
both DT O
Stat5 NNP B-Gene
and CC O
Raf NNP B-Gene
/ NNP B-Gene
MEK NNP I-Gene
pathways VBZ O
from IN O
E2F NNP B-Gene
regulation NN O
. . O

TRADD NNP B-Gene
was VBD O
the DT O
only JJ O
protein NN O
that WDT O
interacted VBD O
with IN O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
TES2 NNP I-Gene
and CC O
not RB O
with IN O
isoleucine JJ B-Gene
- : I-Gene
mutated VBN I-Gene
TES2 NNP I-Gene
. . O

In IN O
transfection NN O
assays NNS O
, , O
TRADD NNP B-Gene
and CC O
TES2 NNP B-Gene
synergistically RB O
mediated VBD O
high JJ O
- : O
level NN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
. . O

Bipotential NNP O
T NNP O
/ NNP O
natural JJ O
killer NN O
( ( O
NK NNP O
) ) O
progenitor NN O
cells NNS O
are VBP O
present JJ O
in IN O
the DT O
human JJ O
thymus NN O
. . O

Although IN O
experimental JJ O
evidence NN O
is VBZ O
lacking VBG O
, , O
lytic JJ O
viral JJ O
DNA NNP O
replication NN O
is VBZ O
believed VBN O
to TO O
remove VB O
modifications NNS O
or CC O
binding VBG B-Gene
factors NNS I-Gene
from IN O
the DT O
genome NN O
which WDT O
serve VBP O
to TO O
repress VB O
late JJ O
gene NN O
expression NN O
during IN O
latency NN O
or CC O
the DT O
early JJ O
lytic JJ O
cycle NN O
. . O

Thus RB O
, , O
replication NN O
of IN O
the DT O
transcriptional JJ B-Gene
template NN I-Gene
is VBZ O
not RB O
a DT O
prerequisite NN O
for IN O
expression NN O
with IN O
late JJ O
kinetics NNS O
, , O
a DT O
finding JJ O
inconsistent NN O
with IN O
the DT O
current JJ O
models NNS O
which WDT O
posit VBP O
a DT O
cis NN O
- : O
active JJ O
relationship NN O
between IN O
lytic JJ O
EBV NNP O
DNA NNP O
replication NN O
and CC O
late JJ O
gene NN O
expression NN O
. . O

This DT O
induction NN O
of IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
epsilon NN I-Gene
mRNA NN I-Gene
expression NN O
is VBZ O
transcriptionally RB O
mediated VBN O
and CC O
occurs VBZ O
in IN O
the DT O
absence NN O
of IN O
synthesis NN O
of IN O
additional JJ O
protein NN B-Gene
factors NNS I-Gene
. . O

We PRP O
suspect VBP O
that IN O
the DT O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
epsilon NN I-Gene
promoter NN I-Gene
/ NNP I-Gene
enhancer NN I-Gene
contains VBZ O
a DT O
retinoic NN B-Gene
acid SYM I-Gene
- : I-Gene
response NN I-Gene
element NN I-Gene
that WDT O
is VBZ O
directly RB O
stimulated VBN O
by IN O
retinoids NNS O
. . O

Core NNP B-Gene
- : I-Gene
specific JJ I-Gene
mAb NN I-Gene
inhibited VBD O
mCD14 SYM B-Gene
- : O
mediated VBN O
uptake NN O
of IN O
homologous JJ O
and CC O
heterologous JJ O
LPS NNP O
, , O
while IN O
producing VBG O
less RBR O
concurrent JJ O
enhancement NN O
of IN O
non JJ O
- : O
mCD14 NN B-Gene
- : O
mediated VBN O
LPS NNP O
uptake NN O
. . O

Transfection NN O
of IN O
EL NNP O
- : O
4 CD O
cells NNS O
with IN O
the DT O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
promoter NN I-Gene
- : I-Gene
reporter NN I-Gene
constructs NNS I-Gene
carrying VBG O
mutated VBD B-Gene
P NNP I-Gene
- : I-Gene
like IN I-Gene
elements NNS I-Gene
showed VBD O
that IN O
four CD O
P NNP B-Gene
- : I-Gene
like IN I-Gene
elements NNS I-Gene
, , O
CLE0 NNP B-Gene
, , O
P NNP B-Gene
, , O
P2 NNP B-Gene
and CC O
P4 NNP B-Gene
, , O
but CC O
not RB O
P3 NNP B-Gene
, , O
were VBD O
required VBN O
for IN O
optimal JJ O
activation NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
promoter NN I-Gene
. . O

The DT O
initiating JJ O
event NN O
is VBZ O
still RB O
uncertain JJ O
, , O
but CC O
activation NN O
of IN O
a DT O
recently RB O
described VBN O
receptor NN B-Gene
- : I-Gene
associated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
is VBZ O
one CD O
of IN O
the DT O
earliest JJS O
events NNS O
detectable JJ O
( ( O
Martin NNP O
et RB O
al RB O
. . O
, , O
Eur NNP O
. . O
J NNP O
. . O
Immunol NNP O
. . O
1994 CD O
. . O
24 CD O
: : O
1566 CD O
) ) O
. . O

From IN O
these DT O
observations NNS O
we PRP O
conclude VBP O
that DT O
free JJ O
thiols NNS O
in IN O
the DT O
IL NNP B-Gene
- : I-Gene
1RI CD I-Gene
complex NN I-Gene
are VBP O
essential JJ O
for IN O
the DT O
activation NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
1RI CD I-Gene
- : I-Gene
associated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
and CC O
that IN O
this DT O
process NN O
is VBZ O
mandatory JJ O
for IN O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
signaling VBG O
leading VBG O
to TO O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
. . O

Strikingly RB O
, , O
Western JJ O
blotting NN O
and CC O
immunocytochemical JJ O
experiments NNS O
indicated VBD O
that IN O
PDTC NNP O
promoted VBD O
a DT O
transient NN O
and CC O
rapid JJ O
shuttling NN O
of IN O
NFATp NNP B-Gene
and CC O
NFATc NNP B-Gene
, , O
leading VBG O
to TO O
their PRP$ O
accelerated VBN O
export NN O
from IN O
the DT O
nucleus NN O
of IN O
activated JJ O
T NNP O
cells NNS O
. . O

The DT O
A NNP B-Gene
- : I-Gene
myb NN I-Gene
transcription NN I-Gene
factor NN I-Gene
in IN O
neoplastic JJ O
and CC O
normal JJ O
B NNP O
cells NNS O
. . O

Its PRP$ O
normal JJ O
cellular JJ O
equivalent NN O
c SYM B-Gene
- : I-Gene
myb NN I-Gene
, , O
has VBZ O
been VBN O
shown VBN O
to TO O
promote VB O
the DT O
proliferation NN O
and CC O
block VB O
the DT O
differentiation NN O
of IN O
haematopoietic JJ O
cells NNS O
in IN O
several JJ O
experimental JJ O
models NNS O
and CC O
is VBZ O
required VBN O
for IN O
fetal JJ O
haematopoiesis NN O
. . O

Both DT O
have VBP O
been VBN O
shown VBN O
to TO O
be VB O
transcription JJ B-Gene
factors NNS I-Gene
. . O

These DT O
studies NNS O
indicate VBP O
that IN O
A NNP B-Gene
- : I-Gene
myb NN I-Gene
plays VBZ O
a DT O
role NN O
during IN O
a DT O
narrow JJ O
window NN O
of IN O
normal JJ O
B NNP O
cell NN O
differentiation NN O
. . O

Expression NN O
of IN O
bcl NN B-Gene
- : I-Gene
6 CD I-Gene
protein NN I-Gene
in IN O
normal JJ O
skin NN O
and CC O
epidermal JJ O
neoplasms NNS O
. . O

It PRP O
was VBD O
recently RB O
shown VBN O
by IN O
us PRP O
that IN O
the DT O
protein NN O
is VBZ O
located VBN O
in IN O
germinal JJ O
center NN O
B NNP O
cells NNS O
and CC O
their PRP$ O
neoplastic JJ O
counterparts NNS O
. . O

Squamous JJ O
cell NN O
carcinomas NN O
showed VBD O
a DT O
variety NN O
of IN O
expression NN O
levels NNS O
, , O
while IN O
two CD O
undifferentiated JJ O
spindle JJ O
- : O
shaped VBN O
carcinomas NN O
and CC O
one CD O
undifferentiated JJ O
SCC NNP O
cell NN O
line NN O
remained VBD O
unstained JJ O
. . O

We PRP O
recently RB O
identified VBD O
the DT O
winged JJ B-Gene
- : I-Gene
helix NN I-Gene
transcription NN I-Gene
factor NN I-Gene
Trident NNP B-Gene
and CC O
described VBD O
its PRP$ O
expression NN O
pattern NN O
in IN O
synchronized JJ O
fibroblasts NNS O
. . O

During IN O
T NNP O
cell NN O
differentiation NN O
, , O
expression NN O
peaked VBD O
in IN O
the DT O
actively RB O
dividing JJ O
immature NN O
single JJ O
positive JJ O
cells NNS O
. . O

The DT O
estrogen NN B-Gene
receptor NN I-Gene
( ( O
ER NNP B-Gene
) ) O
repressed VBD O
erythroid JJ O
differentiation NN O
and CC O
erythroid JJ B-Gene
- : I-Gene
specific JJ I-Gene
gene NN I-Gene
expression NN O
. . O

These DT O
bHLH JJ B-Gene
antagonists NNS I-Gene
are VBP O
induced VBN O
during IN O
a DT O
mitogenic JJ O
signalling NN O
response NN O
, , O
and CC O
they PRP O
function VBP O
by IN O
sequestering VBG O
their PRP$ O
bHLH NN B-Gene
targets NNS I-Gene
in IN O
inactive JJ B-Gene
heterodimers NNS I-Gene
that WDT O
are VBP O
unable JJ O
to TO O
bind VB O
to TO O
specific JJ O
gene NN B-Gene
regulatory JJ I-Gene
( ( I-Gene
E NNP I-Gene
box NN I-Gene
) ) I-Gene
sequences NNS I-Gene
. . O

Recently RB O
, , O
cyclin NN O
E NNP O
- : O
Cdk2 NNP O
- : O
and CC O
cyclin VB O
A NNP O
- : O
Cdk2 NNP O
- : O
dependent JJ O
phosphorylation NN O
of IN O
a DT O
single JJ O
conserved JJ O
serine NN O
residue NN O
( ( O
Ser5 NNP O
) ) O
in IN O
Id2 NNP B-Gene
has VBZ O
been VBN O
shown VBN O
to TO O
occur VB O
during IN O
late JJ O
G1 NNP O
- : O
to TO O
- : O
S NNP O
phase NN O
transition NN O
of IN O
the DT O
cell NN O
cycle NN O
, , O
and CC O
this DT O
neutralizes VBZ O
the DT O
function NN O
of IN O
Id2 NNP B-Gene
in IN O
abrogating VBG O
E NNP B-Gene
- : I-Gene
box NN I-Gene
- : I-Gene
dependent JJ I-Gene
bHLH NN I-Gene
homo NN O
- : O
or CC O
heterodimer VB O
complex JJ O
formation NN O
in IN O
vitro NN O
( ( O
E NNP O
. . O
Hara NNP O
, , O
M NNP O
. . O
Hall NNP O
, , O
and CC O
G NNP O
. . O
Peters NNP O
, , O
EMBO NNP O
J NNP O
. . O
16 CD O
: : O
332 CD O
- : O
342 CD O
, , O
1997 CD O
) ) O
. . O

Furthermore RB O
, , O
compared VBN O
with IN O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
Id3 NNP I-Gene
, , O
an DT O
Id3 NNP B-Gene
Asp5 NNP I-Gene
mutant NN I-Gene
( ( O
mimicking VBG O
phosphorylation NN O
) ) O
is VBZ O
unable JJ O
to TO O
promote VB O
cell NN O
cycle NN O
S NNP O
phase NN O
entry NN O
in IN O
transfected JJ O
fibroblasts NNS O
, , O
whereas IN O
an DT O
Id3 NNP B-Gene
Ala5 NNP I-Gene
mutant NN I-Gene
( ( O
ablating VBG O
phosphorylation NN O
) ) O
displays VBZ O
an DT O
activity NN O
significantly RB O
greater JJR O
than IN O
that DT O
of IN O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
Id3 NNP I-Gene
protein NN I-Gene
. . O

Here RB O
we PRP O
describe VBP O
cloning VBG O
and CC O
characterization NN O
of IN O
full JJ O
- : O
length NN O
cDNA NN B-Gene
encoding VBG I-Gene
murine NN I-Gene
( ( I-Gene
m NN I-Gene
) ) I-Gene
NFATc NNP I-Gene
which WDT O
predicts VBZ O
that IN O
the DT O
protein NN O
has VBZ O
all PDT O
the DT O
conserved JJ B-Gene
structural JJ I-Gene
motifs NNS I-Gene
of IN O
NFAT NNP B-Gene
family NN I-Gene
members NNS I-Gene
, , O
including VBG O
the DT O
rel NN O
homology NN O
domain NN O
, , O
the DT O
NFAT NNP B-Gene
homology NN I-Gene
domain NN I-Gene
and CC O
the DT O
nuclear JJ O
translocation NN O
signals NNS O
. . O

In IN O
the DT O
mouse NN O
embryo NN O
, , O
mNFATc FW B-Gene
transcript NN I-Gene
was VBD O
strongly RB O
expressed VBN O
in IN O
thymus NN O
, , O
lung NN O
and CC O
submandibular JJ O
gland NN O
and CC O
weakly NN O
in IN O
skeletal JJ O
muscle NN O
and CC O
heart NN O
suggesting VBG O
that IN O
mNFATc NN B-Gene
may MD O
have VB O
a DT O
role NN O
both DT O
in IN O
embryogenesis NN O
and CC O
in IN O
mature NN O
T NNP O
cells NNS O
. . O

These DT O
data NNS O
indicate VBP O
that IN O
the DT O
TRE NNP B-Gene
- : I-Gene
like IN I-Gene
cAMP SYM I-Gene
- : I-Gene
responsive JJ I-Gene
DSE NNP I-Gene
sites NNS I-Gene
within IN O
the DT O
5 CD B-Gene
' POS I-Gene
- : I-Gene
untranslated JJ I-Gene
leader NN I-Gene
can MD O
mediate VB O
the DT O
transcriptional JJ O
cooperativity NN O
between IN O
TNFalpha NNP B-Gene
and CC O
the DT O
cAMP NN O
/ NNP B-Gene
PKA NNP I-Gene
pathway NN O
. . O

Copyright JJ O
1997 CD O
Academic NNP O
Press NNP O
. . O

In IN O
many JJ O
chronic JJ O
inflammatory NN O
disorders NNS O
, , O
glucocorticoid NN O
( ( O
GC NNP O
) ) O
insensitivity NN O
is VBZ O
a DT O
challenging VBG O
clinical JJ O
problem NN O
associated VBN O
with IN O
life NN O
- : O
threatening JJ O
disease NN O
progression NN O
. . O

Furthermore RB O
, , O
we PRP O
show VBP O
that IN O
patients NNS O
with IN O
GC NNP O
- : O
insensitive JJ O
asthma NNS O
have VBP O
cytokine VBN O
- : O
induced JJ O
abnormalities NNS O
in IN O
the DT O
DNA NN O
binding VBG O
capability NN O
of IN O
the DT O
GCR NNP B-Gene
. . O

Mutation NN O
of IN O
the DT O
CBF1 NNP B-Gene
/ NNP I-Gene
RBP NNP I-Gene
- : I-Gene
Jkappa NNP I-Gene
binding VBG I-Gene
site NN I-Gene
in IN O
EBNA3C NNP B-Gene
abrogated VBD O
repression NN O
, , O
strongly RB O
suggesting VBG O
that IN O
CBF1 NNP B-Gene
/ NNP I-Gene
RBP NNP I-Gene
- : I-Gene
Jkappa NN I-Gene
is VBZ O
necessary JJ O
for IN O
targeting VBG O
the DT O
viral JJ O
protein NN O
to TO O
Cp NNP B-Gene
. . O

PURPOSE NN O
: : O
To TO O
clarify VB O
the DT O
relationship NN O
between IN O
the DT O
glucocorticoid NN B-Gene
receptor NN I-Gene
and CC O
the DT O
effectiveness NN O
of IN O
glucocorticoid JJ O
therapy NN O
in IN O
patients NNS O
with IN O
ulcerative JJ O
colitis NN O
, , O
we PRP O
investigated VBD O
the DT O
number NN O
and CC O
apparent JJ O
dissociation NN O
constant NN O
of IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
in IN O
peripheral JJ O
blood NN O
mononuclear JJ O
leukocytes NNS O
of IN O
patients NNS O
with IN O
ulcerative JJ O
colitis NN O
. . O

The DT O
apparent JJ O
dissociation NN O
constant NN O
of IN O
the DT O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
from IN O
the DT O
nonresponders NNS O
, , O
responders NNS O
, , O
and CC O
healthy JJ O
controls NNS O
were VBD O
7 CD O
. . O
3 CD O
( ( O
range NN O
, , O
5 CD O
. . O
66 CD O
- : O
10 CD O
) ) O
, , O
4 CD O
. . O
27 CD O
( ( O
range NN O
, , O
4 CD O
- : O
5 CD O
. . O
13 CD O
) ) O
, , O
and CC O
6 CD O
. . O
18 CD O
( ( O
range NN O
, , O
5 CD O
. . O
86 CD O
- : O
6 CD O
. . O
74 CD O
) ) O
nM NN O
, , O
respectively RB O
. . O

Nonresponders NNS O
had VBD O
a DT O
significant JJ O
increase NN O
both DT O
in IN O
the DT O
number NN O
of IN O
binding VBG B-Gene
sites NNS I-Gene
and CC O
in IN O
the DT O
apparent JJ O
dissociation NN O
constant JJ O
compared VBN O
with IN O
responders NNS O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
45 CD O
; : O
P NNP O
= VBD O
0 CD O
. . O
29 CD O
) ) O
. . O

Cooperation NN O
of IN O
binding VBG B-Gene
sites NNS I-Gene
for IN O
STAT6 NNP B-Gene
and CC O
NF NNP B-Gene
kappa NNP I-Gene
B NNP I-Gene
/ NNP I-Gene
rel NN I-Gene
in IN O
the DT O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
- : O
induced VBN O
up RP O
- : O
regulation NN O
of IN O
the DT O
human JJ B-Gene
IgE NNP I-Gene
germline NN I-Gene
promoter NN I-Gene
. . O

In IN O
contrast NN O
, , O
lipopolysaccharide JJ O
stimulation NN O
primarily RB O
induced VBD O
the DT O
p65 NN B-Gene
/ NNP I-Gene
p50 NN I-Gene
heterodimer NN I-Gene
that WDT O
has VBZ O
been VBN O
shown VBN O
to TO O
result VB O
in IN O
gene NN O
activation NN O
. . O

Cyclosporin VB O
A DT O
inhibits NNS O
early RB O
mRNA JJ O
expression NN O
of IN O
G0 NNP B-Gene
/ NNP I-Gene
G1 NNP I-Gene
switch VB I-Gene
gene NN I-Gene
2 CD I-Gene
( ( O
G0S2 NNP B-Gene
) ) O
in IN O
cultured JJ O
human JJ O
blood NN O
mononuclear NN O
cells NNS O
. . O

In IN O
cells NNS O
that WDT O
have VBP O
been VBN O
preincubated VBN O
to TO O
lower VB O
mRNA NN O
levels NNS O
, , O
there EX O
is VBZ O
a DT O
transient JJ O
increase NN O
in IN O
G0S2 NNP B-Gene
mRNA NN I-Gene
, , O
peaking VBG O
between IN O
1 CD O
- : O
2 CD O
h NN O
, , O
in IN O
response NN O
to TO O
Concanavalin NNP O
- : O
A DT O
( ( O
ConA NNP O
) ) O
, , O
or CC O
to TO O
the DT O
combination NN O
of IN O
phorbol NN O
ester NN O
( ( O
TPA NNP O
) ) O
, , O
and CC O
the DT O
calcium NN O
ionophore NN O
, , O
ionomycin NN O
. . O

YY1 NNP B-Gene
, , O
a DT O
widely RB O
distributed VBN O
human JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
, , O
is VBZ O
known VBN O
to TO O
inhibit VB O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
( ( O
LTR NNP B-Gene
) ) O
transcription NN O
and CC O
virus NN O
production NN O
. . O

LSF NNP B-Gene
( ( O
also RB O
known VBN O
as IN O
LBP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
UBP NNP B-Gene
, , O
and CC O
CP NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
has VBZ O
been VBN O
shown VBN O
to TO O
repress VB O
LTR NNP O
transcription NN O
in IN O
vitro NN O
, , O
but CC O
transient JJ O
expression NN O
of IN O
LSF NNP B-Gene
has VBZ O
no DT O
effect NN O
on IN O
LTR NNP B-Gene
activity NN O
in IN O
vivo NN O
. . O

Relative JJ O
affinities NNS O
of IN O
transcriptional JJ B-Gene
regulatory JJ I-Gene
elements NNS I-Gene
for IN O
their PRP$ O
respective JJ O
factor NN O
have VBP O
been VBN O
essentially RB O
studied VBN O
by IN O
bandshift NN O
analysis NN O
. . O

Here RB O
we PRP O
report VBP O
a DT O
real JJ O
- : O
time NN O
study NN O
of IN O
factor NN O
/ NNP O
DNA NNP O
interactions NNS O
using VBG O
a DT O
surface NN O
plasmon NN O
resonance NN O
approach NN O
and CC O
further JJ O
characterization NN O
of IN O
recovered JJ B-Gene
proteins NNS I-Gene
involved VBN O
in IN O
this DT O
interaction NN O
. . O

This DT O
result NN O
, , O
confirmed VBN O
by IN O
competitions NNS O
with IN O
each DT O
GATA NNP B-Gene
site NN I-Gene
, , O
demonstrated VBD O
the DT O
higher JJR O
relative JJ O
affinity NN O
( ( O
at IN O
least JJS O
sevenfold JJ O
) ) O
of IN O
site NN O
3 CD O
. . O

Stable JJ O
transfection NN O
of IN O
U937 NNP O
cells NNS O
with IN O
sense NN O
or CC O
antisense NN B-Gene
RXR NNP I-Gene
- : I-Gene
alpha NN I-Gene
cDNA NN I-Gene
suggests VBZ O
a DT O
role NN O
for IN O
RXR NNP B-Gene
- : I-Gene
alpha NN I-Gene
in IN O
the DT O
control NN O
of IN O
monoblastic JJ O
differentiation NN O
induced VBN O
by IN O
retinoic NN O
acid NN O
and CC O
vitamin NN O
D NNP O
. . O

The DT O
role NN O
of IN O
the DT O
viral JJ B-Gene
trans NNS I-Gene
- : I-Gene
activator NN I-Gene
Tax NNP I-Gene
protein NN I-Gene
in IN O
the DT O
induction NN O
of IN O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
was VBD O
first RB O
indicated VBN O
by IN O
the DT O
detection NN O
of IN O
this DT O
adhesion NN B-Gene
molecule NN I-Gene
on IN O
Jurkat NNP O
T NNP O
- : O
cell NN O
clones NNS O
stably RB O
expressing VBG O
the DT O
tax NN O
gene NN O
. . O

The DT O
effect NN O
of IN O
Tax NNP B-Gene
on IN O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
gene NN O
transcription NN O
was VBD O
next JJ O
confirmed VBN O
in IN O
JPX NNP O
- : O
9 CD O
cells NNS O
, , O
a DT O
subclone NN O
of IN O
Jurkat NNP O
cells NNS O
, , O
carrying VBG O
the DT O
tax NN B-Gene
sequences NNS I-Gene
under IN O
the DT O
control NN O
of IN O
an DT O
inducible JJ B-Gene
promoter NN I-Gene
. . O

Furthermore RB O
, , O
deletion NN O
and CC O
mutation NN O
analyses NNS O
of IN O
the DT O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
performed VBN O
with IN O
chloramphenicol JJ B-Gene
acetyltransferase NN I-Gene
constructs NNS I-Gene
revealed VBD O
that IN O
Tax NNP B-Gene
was VBD O
trans NNS O
activating VBG O
the DT O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
via IN O
two CD O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
sites VBZ I-Gene
present JJ O
at IN O
bp SYM O
- : O
72 CD O
and CC O
- : O
57 CD O
in IN O
the DT O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
promoter NN I-Gene
, , O
with IN O
both DT O
of IN O
them PRP O
being VBG O
required VBN O
for IN O
the DT O
Tax NNP B-Gene
- : O
induced JJ O
expression NN O
of IN O
this DT O
adhesion NN B-Gene
molecule NN I-Gene
. . O

We PRP O
have VBP O
investigated VBN O
the DT O
effects NNS O
of IN O
Vpr NNP B-Gene
on IN O
host NN O
cell NN O
activation NN O
and CC O
confirm NN O
that IN O
it PRP O
influences VBZ O
cellular JJ O
proliferation NN O
. . O

In IN O
the DT O
absence NN O
of IN O
TCR NNP B-Gene
- : O
mediated VBN O
activation NN O
, , O
Vpr NNP B-Gene
induces VBZ O
apoptosis NN O
whereas NNS O
in IN O
its PRP$ O
presence NN O
, , O
Vpr NNP B-Gene
interrupts VBZ O
the DT O
expected JJ O
induction NN O
of IN O
apoptosis NN O
. . O

Our PRP$ O
finding VBG O
that IN O
Vpr NNP B-Gene
can MD O
regulate VB O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
supports VBZ O
the DT O
hypothesis NN O
that IN O
some DT O
aspects NNS O
of IN O
viral JJ O
pathogenesis NN O
are VBP O
the DT O
consequence NN O
of IN O
cell NN O
dysregulation NN O
by IN O
Vpr NNP B-Gene
. . O

In IN O
fact NN O
, , O
by IN O
employing VBG O
a DT O
novel JJ O
haptenized JJ O
lysis NN O
synthetic JJ O
substrate NN O
which WDT O
allows VBZ O
the DT O
isolation NN O
of IN O
glutaminyl JJ O
- : O
tTG NN O
substrates NNS O
in IN O
vivo NN O
, , O
we PRP O
identified VBD O
pRB NN B-Gene
as IN O
a DT O
potential JJ O
tTG NN O
substrate NN O
in IN O
U937 NNP O
cells NNS O
undergoing JJ O
apoptosis NN O
. . O

Interleukin NNP B-Gene
2 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
induces NNS O
tyrosine JJ O
phosphorylation NN O
of IN O
STATs NNP B-Gene
3 CD I-Gene
and CC I-Gene
5 CD I-Gene
( ( O
signal JJ O
transducer NN O
and CC O
activator NN O
of IN O
transcription NN O
) ) O
. . O

IL NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
T NNP B-Gene
cell VBP I-Gene
antigen JJ I-Gene
receptor NN I-Gene
complex JJ I-Gene
induction NN O
of IN O
STAT3alpha NNP B-Gene
serine VBP O
727 CD O
phosphorylation NN O
is VBZ O
dependent JJ O
on IN O
the DT O
activity NN O
of IN O
the DT O
MEK NNP B-Gene
/ NNP B-Gene
ERK NNP I-Gene
pathway NN O
. . O

These DT O
results NNS O
thus RB O
show VBP O
that IN O
STAT3 NNP B-Gene
proteins NNS I-Gene
are VBP O
targets NNS O
for IN O
multiple JJ O
kinase NN O
pathways NNS O
in IN O
T NNP O
cells NNS O
and CC O
can MD O
integrate VB O
signals NNS O
from IN O
both DT O
cytokine JJ B-Gene
receptors NNS I-Gene
and CC O
antigen NN B-Gene
receptors NNS I-Gene
. . O

In IN O
addition NN O
, , O
both DT O
RelA NNP B-Gene
and CC O
c SYM B-Gene
- : I-Gene
Rel NN I-Gene
, , O
but CC O
not RB O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B1 NNP I-Gene
, , O
were VBD O
shown VBN O
to TO O
transactivate VB O
an DT O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
kappa NN I-Gene
B NNP I-Gene
- : I-Gene
reporter NN I-Gene
construct NN I-Gene
. . O

Competent JJ O
transcription NN O
initiation NN O
by IN O
RNA NNP B-Gene
polymerase NN I-Gene
II NNP I-Gene
in IN O
cell NN O
- : O
free JJ O
extracts NNS O
from IN O
xeroderma JJ O
pigmentosum NN O
groups NNS O
B NNP O
and CC O
D NNP O
in IN O
an DT O
optimized JJ O
RNA NNP O
transcription NN O
assay NN O
. . O

We PRP O
have VBP O
employed VBN O
an DT O
optimized VBN O
cell NN O
- : O
free JJ O
RNA NNP O
transcription NN O
assay NN O
to TO O
analyze VB O
transcription NN O
activity NN O
of IN O
XP NNP O
- : O
B NN O
and CC O
XP NNP O
- : O
D NN O
. . O

Binding VBG O
capacity NN O
( ( O
4978 CD O
+ NNP O
/ NNP O
- : O
391 CD O
versus NN O
4131 CD O
+ NN O
/ NNP O
- : O
321 CD O
sites NNS O
/ NNP O
cell NN O
) ) O
, , O
Kd NNP O
values VBZ O
for IN O
dexamethasone NN O
( ( O
6 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
5 CD O
versus NN O
5 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
3 CD O
nmol JJ O
/ NNP O
L NNP O
) ) O
, , O
and CC O
IC50 NNP O
values NNS O
for IN O
dexamethasone NN O
( ( O
3 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
3 CD O
versus NN O
3 CD O
. . O
1 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
2 CD O
nmol JJ O
/ NNP O
L NNP O
) ) O
and CC O
cortisol NN O
( ( O
12 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
6 CD O
versus NN O
9 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
3 CD O
nmol JJ O
/ NNP O
L NNP O
) ) O
were VBD O
not RB O
significantly RB O
different JJ O
. . O

Patients NNS O
with IN O
renin JJ B-Gene
values NNS O
less RBR O
than IN O
0 CD O
. . O
13 CD O
ng JJ O
angiotensin NN O
I PRP O
/ VBP O
L NNP O
per IN O
second NN O
were VBD O
markedly RB O
less RBR O
sensitive JJ O
to TO O
cortisol VB O
than IN O
those DT O
with IN O
higher JJR O
values NNS O
. . O

The DT O
composite JJ B-Gene
PU NNP I-Gene
. . I-Gene
1 CD I-Gene
and CC I-Gene
Pip NNP I-Gene
site NN I-Gene
likely JJ O
accounts NNS O
for IN O
both DT O
lineage NN O
and CC O
stage NN O
- : O
specific JJ O
expression NN O
of IN O
CD20 NNP B-Gene
whereas IN O
the DT O
CD20 NNP B-Gene
E NNP I-Gene
box NN I-Gene
binding VBG I-Gene
proteins NNS I-Gene
enhance VB O
overall JJ O
promoter NN O
activity NN O
and CC O
may MD O
link VB O
the DT O
promoter NN O
to TO O
a DT O
distant JJ B-Gene
enhancer NN I-Gene
. . O

HIV NNP O
infection NN O
is VBZ O
also RB O
associated VBN O
with IN O
activation NN O
of IN O
the DT O
hypothalamo NN O
- : O
pituitary JJ O
- : O
adrenal JJ O
axis NN O
function NN O
and CC O
increased VBD O
plasma NN O
and CC O
urinary JJ O
cortisol NN O
concentrations NNS O
. . O

After IN O
DMSO NNP O
treatment NN O
, , O
HL NNP O
- : O
60 CD O
cells NNS O
eventually RB O
died VBD O
via IN O
apoptosis NN O
, , O
whereas IN O
the DT O
viability NN O
of IN O
PDBu NNP O
- : O
treated VBD O
cells NNS O
was VBD O
not RB O
affected VBN O
during IN O
the DT O
same JJ O
interval NN O
. . O

The DT O
generality NN O
of IN O
this DT O
finding NN O
was VBD O
confirmed VBN O
by IN O
the DT O
induction NN O
of IN O
Bcl NNP B-Gene
- : I-Gene
xL NN I-Gene
in IN O
human JJ O
myeloid NN O
U NNP O
- : O
937 CD O
cells NNS O
, , O
human JJ O
peripheral JJ O
blood NN O
monocytes NNS O
exposed VBD O
to TO O
phorbol VB O
ester NN O
, , O
and CC O
mouse NN O
thioglycollate NN O
- : O
activated VBN O
and CC O
resident JJ O
peritoneal NN O
macrophages NNS O
. . O

Monochloramine NNP O
derivatives NNS O
are VBP O
long RB O
lived JJ O
physiological JJ O
oxidants NNS O
produced VBN O
by IN O
neutrophils NNS O
during IN O
the DT O
respiratory NN O
burst NN O
. . O

Cyclosporine NNP O
( ( O
CsA NNP O
) ) O
is VBZ O
both DT O
a DT O
clinical JJ O
immunosuppressive JJ O
drug NN O
and CC O
a DT O
probe NN O
to TO O
dissect VB O
intracellular JJ O
signaling VBG O
pathways NNS O
. . O

Furthermore RB O
, , O
the DT O
degree NN O
of IN O
CN NNP B-Gene
inhibition NN O
was VBD O
reflected VBN O
by IN O
a DT O
similar JJ O
degree NN O
of IN O
reduction NN O
in IN O
lymphocyte JJ O
proliferation NN O
and CC O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
production NN O
in IN O
the DT O
allogeneic NN O
mixed JJ O
lymphocyte NN O
cultures NNS O
. . O

Thus RB O
, , O
the DT O
reduction NN O
of IN O
CN NNP B-Gene
activity NN O
observed VBD O
in IN O
CsA NNP O
- : O
treated JJ O
patients NNS O
is VBZ O
accompanied VBN O
by IN O
a DT O
similar JJ O
degree NN O
of IN O
reduction NN O
in IN O
lymphocyte JJ B-Gene
gene NN I-Gene
activation NN O
, , O
and CC O
accounts NNS O
for IN O
the DT O
immunosuppression NN O
observed VBD O
. . O

Control NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activity NN O
by IN O
the DT O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
beta NN I-Gene
inhibitor NN I-Gene
. . O

The DT O
transcription NN B-Gene
factor NN I-Gene
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
is VBZ O
maintained VBN O
in IN O
an DT O
inactive JJ O
cytoplasmic NN O
state NN O
by IN O
I PRP B-Gene
kappa VBP I-Gene
B JJ I-Gene
inhibitors NNS I-Gene
. . O

G28 NNP B-Gene
- : I-Gene
5 CD I-Gene
sFv NN I-Gene
was VBD O
a DT O
more RBR O
potent JJ O
agonist NN O
than IN O
G28 NNP B-Gene
- : I-Gene
5 CD I-Gene
IgG NNP I-Gene
and CC O
was VBD O
able JJ O
to TO O
stimulate VB O
CD40 NNP B-Gene
responses NNS O
by IN O
B NNP O
cells NNS O
and CC O
monocytes NNS O
. . O

Increased VBN O
CRH NNP B-Gene
promoter NN O
activity NN O
following VBG O
phorbol NN O
ester FW O
treatment NN O
was VBD O
inhibited VBN O
by IN O
a DT O
dominant JJ O
negative JJ O
NF NNP B-Gene
- : I-Gene
IL6 NNP I-Gene
mutant NN I-Gene
, , O
showing VBG O
that IN O
the DT O
effects NNS O
of IN O
phorbol NN O
ester NN O
were VBD O
principally RB O
mediated VBN O
by IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
. . O

We PRP O
screened VBD O
TSG101 NNP B-Gene
for IN O
somatic JJ O
mutations NNS O
in IN O
DNA NNP O
and CC O
RNA NNP O
samples NNS O
isolated VBD O
from IN O
a DT O
variety NN O
of IN O
common JJ O
human JJ O
malignancies NNS O
, , O
EBV NNP O
- : O
immortalised VBD O
B NNP O
- : O
cells NNS O
, , O
and CC O
normal JJ O
lung NN O
parenchyma NN O
. . O

Intragenic NNP O
TSG101 NNP B-Gene
deletions NNS O
in IN O
RNA NNP B-Gene
transcripts NNS I-Gene
were VBD O
frequently RB O
found VBN O
in IN O
all DT O
types NNS O
of IN O
samples NNS O
. . O

A DT O
similar JJ O
spectrum NN O
of IN O
transcript NN O
deletions NNS O
has VBZ O
previously RB O
been VBN O
described VBN O
in IN O
the DT O
putative JJ B-Gene
tumour NN I-Gene
suppressor NN I-Gene
gene NN I-Gene
FHIT NNP B-Gene
. . O

Interleukin NNP B-Gene
- : I-Gene
7 CD I-Gene
upregulates VBZ O
the DT O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
- : I-Gene
gene NN I-Gene
expression NN O
in IN O
activated JJ O
human JJ O
T NNP O
lymphocytes VBZ O
at IN O
the DT O
transcriptional JJ O
level NN O
by IN O
enhancing VBG O
the DT O
DNA NN O
binding VBG O
activities NNS O
of IN O
both DT O
nuclear JJ O
factor NN O
of IN O
activated JJ O
T NNP O
cells NNS O
and CC O
activator NN B-Gene
protein VBP I-Gene
- : I-Gene
1 CD I-Gene
. . O

Production NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
requires VBZ O
the DT O
formation NN O
of IN O
transcription NN B-Gene
factors NNS I-Gene
involved VBN O
in IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
- : I-Gene
gene NN I-Gene
regulation NN O
. . O

The DT O
three CD O
- : O
dimensional JJ O
positioning NN O
of IN O
immunoglobulin NN B-Gene
( ( I-Gene
Ig NNP I-Gene
) ) I-Gene
genes NNS I-Gene
within IN O
the DT O
nucleus NN O
of IN O
human JJ O
cells NNS O
was VBD O
investigated VBN O
using VBG O
in IN O
situ JJ O
hybridization NN O
and CC O
confocal JJ O
microscopy NN O
. . O

The DT O
visualization NN O
of IN O
heavy JJ B-Gene
and CC I-Gene
light JJ I-Gene
chain NN I-Gene
genes NNS I-Gene
in IN O
B NNP O
- : O
lymphoid NN O
cells NNS O
showed VBD O
that IN O
the DT O
three CD O
Ig NNP B-Gene
genes NNS I-Gene
are VBP O
differentially RB O
and CC O
nonrandomly RB O
distributed VBN O
in IN O
different JJ O
nuclear JJ O
subvolumes NNS O
: : O
the DT O
kappa NN B-Gene
genes NNS I-Gene
were VBD O
found VBN O
to TO O
be VB O
preferentially RB O
confined VBN O
to TO O
an DT O
outer JJ O
nuclear JJ O
volume NN O
, , O
whereas IN O
the DT O
gamma NN B-Gene
and CC I-Gene
lambda JJ I-Gene
genes NNS I-Gene
consistently RB O
occupied VBD O
more RBR O
central JJ O
positions NNS O
within IN O
the DT O
nucleus NN O
, , O
the DT O
lambda NN B-Gene
genes NNS I-Gene
being VBG O
more JJR O
interior JJ O
when WRB O
compared VBN O
with IN O
the DT O
gamma NN B-Gene
genes NNS I-Gene
. . O

These DT O
findings NNS O
show VBP O
that IN O
healthy JJ O
virus NN O
carriers NNS O
maintain VBP O
a DT O
high JJ O
frequency NN O
of IN O
BZLF1 NNP O
- : O
specific JJ O
memory NN O
T NNP O
cells NNS O
, , O
potentially RB O
to TO O
control VB O
virus JJ O
spread NN O
from IN O
lytically RB O
infected VBN O
cells NNS O
. . O

We PRP O
have VBP O
therefore RB O
investigated VBN O
the DT O
transcriptional JJ O
activity NN O
of IN O
A NNP B-Gene
- : I-Gene
MYB NN I-Gene
and CC O
its PRP$ O
regulation NN O
in IN O
several JJ O
human JJ O
lymphoid NN O
cell NN O
lines NNS O
using VBG O
co JJ O
- : O
transfection NN O
assays NNS O
and CC O
show VBP O
that IN O
A NNP B-Gene
- : I-Gene
MYB NN I-Gene
is VBZ O
transcriptionally RB O
active JJ O
in IN O
all PDT O
the DT O
B NNP O
cell NN O
lines NNS O
studied VBN O
, , O
but CC O
not RB O
in IN O
T NNP O
cells NNS O
. . O

Transcription NNP O
factor NN O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
activity NN O
down RB O
- : O
regulates VBZ O
Fas NNP O
and CC O
CD23 NNP O
expression NN O
in IN O
B NNP O
cells NNS O
. . O

Transcription NNP B-Gene
factor NN I-Gene
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
must MD O
be VB O
released VBN O
from IN O
cytoplasmic JJ B-Gene
inhibitory NN I-Gene
molecules NNS I-Gene
( ( O
I PRP B-Gene
kappa VBP I-Gene
Bs NNP I-Gene
) ) O
in IN O
order NN O
to TO O
move VB O
to TO O
the DT O
nucleus NN O
and CC O
to TO O
activate VB O
its PRP$ O
target NN B-Gene
genes NNS I-Gene
. . O

The DT O
half NN O
- : O
life NN O
of IN O
both DT O
inhibitors NNS O
is VBZ O
increased VBN O
in IN O
HeLa NNP O
cells NNS O
. . O

PCR NNP O
analysis NN O
of IN O
spontaneous JJ O
EBV NNP O
- : O
transformed VBD O
lymphoblastoid JJ O
cell NN O
lines NNS O
( ( O
LCL NNP O
) ) O
from IN O
three CD O
individuals NNS O
with IN O
primary JJ O
infection NN O
showed VBD O
that IN O
two CD O
were VBD O
infected VBN O
with IN O
type NN O
A DT O
and CC O
one CD O
with IN O
type NN O
B NNP O
EBV NNP O
. . O

TCR NNP B-Gene
beta NN I-Gene
analysis NN O
showed VBD O
that IN O
while IN O
there EX O
was VBD O
loop JJ O
length JJ O
restriction NN O
in IN O
the DT O
putative JJ O
peptide NN O
contact NN O
site NN O
of IN O
all DT O
responding VBG O
beta NN B-Gene
chains NNS I-Gene
, , O
diverse NN O
and CC O
unique NN O
( ( O
non JJ O
- : O
recurrent NN O
) ) O
TCR NNP O
beta NN O
clonotypes NNS O
were VBD O
selected VBN O
in IN O
individuals NNS O
during IN O
primary JJ O
infection NN O
and CC O
continued VBD O
to TO O
emerge VB O
after IN O
long JJ O
- : O
term NN O
virus NN O
exposure NN O
. . O

CD40 NNP B-Gene
ligation NN O
leads VBZ O
to TO O
B NNP O
cell NN O
activation NN O
events NNS O
such JJ O
as IN O
proliferation NN O
, , O
Ig NNP O
secretion NN O
, , O
isotype NN O
switching NN O
, , O
and CC O
up RB O
- : O
regulation NN O
of IN O
cell NN B-Gene
surface NN I-Gene
molecules NNS I-Gene
, , O
as RB O
well RB O
as IN O
the DT O
generation NN O
of IN O
memory NN O
B NNP O
cells NNS O
. . O

Many JJ O
of IN O
these DT O
events NNS O
are VBP O
dependent JJ O
upon IN O
the DT O
ability NN O
of IN O
CD40 NNP B-Gene
to TO O
activate VB O
the DT O
transcription NN O
factor NN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
) ) O
. . O

To TO O
define VB O
the DT O
CD40 NNP B-Gene
signaling VBG O
components NNS O
upstream NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
and CC O
the DT O
functional JJ O
consequences NNS O
downstream NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
, , O
we PRP O
examined VBD O
mouse NN O
B NNP O
cell NN O
transfectants NNS O
expressing VBG O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
or CC I-Gene
mutant JJ I-Gene
human JJ I-Gene
CD40 NNP I-Gene
. . O

A DT O
threonine NN O
residue NN O
at IN O
position NN B-Gene
234 CD I-Gene
, , O
previously RB O
shown VBN O
to TO O
be VB O
important JJ O
for IN O
CD40 NNP B-Gene
association NN O
with IN O
TNF NNP B-Gene
receptor NN I-Gene
- : I-Gene
associated VBN I-Gene
factor NN I-Gene
2 CD I-Gene
( ( O
TRAF2 NNP B-Gene
) ) O
, , O
TRAF3 NNP B-Gene
, , O
and CC O
TRAF5 NNP B-Gene
, , O
was VBD O
not RB O
required VBN O
for IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
. . O

NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
was VBD O
independent JJ O
of IN O
the DT O
transmembrane NN B-Gene
domain NN I-Gene
of IN O
CD40 NNP B-Gene
, , O
suggesting VBG O
that IN O
it PRP O
is VBZ O
independent JJ O
of IN O
p23 NN B-Gene
, , O
a DT O
molecule NN O
that WDT O
associates VBZ O
with IN O
CD40 NNP B-Gene
in IN O
a DT O
region NN O
other JJ O
than IN O
the DT O
cytoplasmic JJ B-Gene
domain NN I-Gene
. . O

CD40 NNP O
- : O
or CC O
pervanadate VB O
- : O
mediated VBN O
I PRP O
kappa VBP O
B NNP O
tyrosine NN O
phosphorylation NN O
was VBD O
not RB O
detected VBN O
. . O

NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
correlated VBD O
with IN O
the DT O
ability NN O
of IN O
CD40 NNP B-Gene
to TO O
induce VB O
Ab NNP O
secretion NN O
and CC O
the DT O
up RP O
- : O
regulation NN O
of IN O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
LFA NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

The DT O
M NNP B-Gene
- : I-Gene
CSF NNP I-Gene
receptor NN I-Gene
was VBD O
first JJ O
detectable JJ O
in IN O
the DT O
myeloid JJ O
- : O
committed JJ O
CD34 NNP O
+ NNP O
Thy NNP O
- : O
l NN O
- : O
CD45RA NNP O
+ NNP O
subset NN O
. . O

All DT O
other JJ O
molecules NNS O
studied VBN O
were VBD O
found VBN O
to TO O
be VB O
expressed VBN O
at IN O
this DT O
stage NN O
of IN O
differentiation NN O
. . O

Addition NN O
of IN O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
to TO O
this DT O
basic JJ O
cocktail NN O
consistently RB O
increased VBD O
the DT O
clonogenic JJ O
capacity NN O
of IN O
single JJ O
CD34 NNP O
+ NNP O
Thy NNP O
- : O
1 CD O
+ NN O
cells NNS O
, , O
and CC O
this DT O
effect NN O
was VBD O
further RBR O
enhanced VBN O
( ( O
up IN O
to TO O
72 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
4 CD O
. . O
3 CD O
% NN O
on IN O
day NN O
7 CD O
) ) O
by IN O
the DT O
inclusion NN O
of IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
. . O

Induction NN O
of IN O
endothelial JJ B-Gene
cell NN I-Gene
surface NN I-Gene
adhesion NN I-Gene
molecules NNS I-Gene
by IN O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
is VBZ O
blocked VBN O
by IN O
protein NN O
tyrosine NN O
phosphatase NN O
inhibitors NNS O
: : O
role NN O
of IN O
the DT O
nuclear JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

The DT O
induction NN O
of IN O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
ELAM NNP B-Gene
- : I-Gene
1 CD I-Gene
by IN O
TNF NNP B-Gene
in IN O
MVEC NNP O
occurred VBD O
within IN O
6 CD O
h NN O
and CC O
was VBD O
also RB O
completely RB O
down IN O
- : O
regulated VBN O
by IN O
PAO NNP O
in IN O
a DT O
dose JJ O
- : O
dependent JJ O
manner NN O
. . O

Further RB O
, , O
monocytes NNS O
from IN O
patients NNS O
demonstrate VBP O
an DT O
augmented JJ O
susceptibility NN O
to TO O
a DT O
productive JJ O
infection NN O
with IN O
HIV NNP O
- : O
1 CD O
in IN O
vitro NN O
. . O

In IN O
contrast NN O
, , O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
- : I-Gene
alpha NN I-Gene
levels NNS O
in IN O
PBMC NNP O
and CC O
monocytes NNS O
from IN O
healthy JJ O
subjects NNS O
or CC O
from IN O
patients NNS O
with IN O
nontuberculous JJ O
pulmonary JJ O
conditions NNS O
were VBD O
intact JJ O
. . O

Further RB O
, , O
M NNP O
. . O
tuberculosis NN O
and CC O
its PRP$ O
tuberculin NN B-Gene
, , O
purified VBD B-Gene
protein JJ I-Gene
derivative JJ I-Gene
, , O
induced VBD O
the DT O
degradation NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
- : I-Gene
alpha NN I-Gene
and CC O
the DT O
expression NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
- : I-Gene
alpha NN I-Gene
mRNA NN I-Gene
, , O
and CC O
purified VBD O
protein NNS O
derivative JJ O
induced VBD O
the DT O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
monocytes NNS O
. . O

Spi NNP B-Gene
- : I-Gene
1 CD I-Gene
/ JJ I-Gene
PU NNP I-Gene
. . I-Gene
1 CD I-Gene
is VBZ O
a DT O
myeloid JJ B-Gene
- : I-Gene
and CC I-Gene
B NNP I-Gene
- : I-Gene
cell NN I-Gene
specific JJ I-Gene
transcription NN I-Gene
factor NN I-Gene
which WDT O
is VBZ O
also RB O
involved VBN O
in IN O
Friend NNP O
virus NN O
- : O
induced JJ O
murine NN O
erythroleukemia NN O
. . O

We PRP O
developed VBD O
a DT O
heterologous JJ O
system NN O
to TO O
analyze VB O
the DT O
contribution NN O
of IN O
these DT O
alterations NNS O
to TO O
the DT O
induction NN O
of IN O
primary JJ O
erythroblast JJ O
transformation NN O
. . O

These DT O
results NNS O
show VBP O
that IN O
Spi NNP O
- : O
1 CD O
/ JJ O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
requires VBZ O
signals NNS O
emanating VBG O
from IN O
specific JJ O
cytokine NN O
and CC O
growth NN O
factor NN O
receptors NNS O
to TO O
affect VB O
the DT O
survival NN O
, , O
proliferation NN O
and CC O
differentiation NN O
control NN O
of IN O
primary JJ O
erythroblasts NNS O
. . O

They PRP O
also RB O
suggest VBP O
that IN O
the DT O
function NN O
of IN O
Spi NNP B-Gene
- : I-Gene
1 CD I-Gene
/ JJ I-Gene
PU NNP I-Gene
. . I-Gene
1 CD I-Gene
in IN O
the DT O
late JJ O
phase NN O
of IN O
Friend NNP O
leukemia NN O
requires VBZ O
specific JJ O
signaling VBG O
from IN O
the DT O
gp55 NN B-Gene
- : I-Gene
modified VBN I-Gene
EpoR NNP I-Gene
generated VBD O
during IN O
the DT O
early JJ O
phase NN O
of IN O
the DT O
disease NN O
. . O

METHODS NN O
: : O
Allergen NNP O
- : O
specific JJ O
T NNP O
cell NN O
clones NNS O
and CC O
T NNP O
cell VBP O
hybridomas NN O
were VBD O
established VBN O
from IN O
the DT O
peripheral JJ O
blood NN O
lymphocytes NNS O
of IN O
patients NNS O
with IN O
asthma NN O
, , O
and CC O
the DT O
responses NNS O
to TO O
various JJ O
stimuli NNS O
were VBD O
determined VBN O
. . O

BACKGROUND NN O
: : O
Fibrin NNP O
deposition NN O
and CC O
thrombosis NN O
have VBP O
been VBN O
implicated VBN O
in IN O
both DT O
allograft JJ O
rejection NN O
and CC O
vasculopathy NN O
after IN O
cardiac JJ O
transplantation NN O
. . O

Inhibition NN O
of IN O
TF NNP B-Gene
induction NN O
in IN O
the DT O
presence NN O
of IN O
high JJ O
CsA NNP O
blood NN O
concentrations NNS O
was VBD O
also RB O
observed VBN O
when WRB O
stimulation NN O
of IN O
cells NNS O
was VBD O
performed VBN O
with IN O
interferon NN B-Gene
- : I-Gene
gamma NN I-Gene
or CC O
interleukin VB B-Gene
- : I-Gene
1beta CD I-Gene
. . O

As IN O
shown VBN O
by IN O
reverse NN O
transcription NN O
- : O
polymerase NN O
chain NN O
reaction NN O
and CC O
electrophoretic JJ O
mobility NN O
shift NN O
assay VBP O
, , O
respectively RB O
, , O
treatment NN O
with IN O
CsA NNP O
leads VBZ O
to TO O
decreased VB O
TF NNP B-Gene
mRNA JJ I-Gene
expression NN O
and CC O
reduced JJ O
activation NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
transcription NN I-Gene
factor NN I-Gene
, , O
which WDT O
is VBZ O
known VBN O
to TO O
contribute VB O
to TO O
the DT O
induction NN O
of IN O
the DT O
TF NNP B-Gene
promotor NN I-Gene
in IN O
human JJ O
monocytes NNS O
. . O

Inhibition NN O
of IN O
monocyte NN O
TF NNP B-Gene
induction NN O
by IN O
CsA NNP O
may MD O
contribute VB O
to TO O
its PRP$ O
successful JJ O
use NN O
in IN O
cardiac JJ O
transplant NN O
medicine NN O
and CC O
might MD O
be VB O
useful JJ O
in IN O
managing VBG O
further JJ O
settings NNS O
of IN O
vascular JJ O
pathology NN O
also RB O
known VBN O
to TO O
involve VB O
TF NNP B-Gene
expression NN O
and CC O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
. . O

Both DT O
cytokines NNS B-Gene
induced VBD O
assembly NN O
of IN O
STAT5A NNP B-Gene
and CC O
STAT5B NNP B-Gene
containing VBG O
complexes NNS O
capable JJ O
of IN O
binding VBG O
to TO O
the DT O
interferon NN B-Gene
- : I-Gene
gamma NN I-Gene
activation NN I-Gene
sequence NN I-Gene
( ( O
GAS NNP B-Gene
) ) O
, , O
and CC O
these DT O
complexes NNS O
rapidly RB O
translocated VBD O
( ( O
within IN O
1 CD O
min NN O
) ) O
into IN O
the DT O
nucleus NN O
of IN O
IL NNP O
- : O
2 CD O
- : O
or CC O
IL NNP O
- : O
7 CD O
- : O
treated VBN O
cells NNS O
. . O

IL NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
7 CD I-Gene
were VBD O
equivalent VBN O
in IN O
their PRP$ O
ability NN O
to TO O
induce VB O
tyrosine JJ O
phosphorylation NN O
of IN O
STAT5A NNP B-Gene
and CC O
STAT5B NNP B-Gene
and CC O
to TO O
facilitate VB O
binding NN O
of IN O
these DT O
STATs NNP B-Gene
to TO O
an DT O
immobilized VBN B-Gene
GAS NNP I-Gene
element NN I-Gene
. . O

These DT O
data NNS O
suggest VBP O
that IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
7 CD I-Gene
induce NN O
assembly NN O
of IN O
STAT NNP B-Gene
heterodimers NNS I-Gene
in IN O
a DT O
similar JJ O
manner NN O
and CC O
that DT O
subsequent JJ O
cellular JJ O
responses NNS O
may MD O
be VB O
driven VBN O
by IN O
induction NN O
of IN O
similar JJ O
sets NNS O
of IN O
genes NNS B-Gene
. . O

The DT O
POU NNP B-Gene
transcription NN I-Gene
factors NNS I-Gene
Oct NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
Oct NNP B-Gene
- : I-Gene
2 CD I-Gene
regulate VBP O
the DT O
activity NN O
of IN O
octamer JJR B-Gene
- : I-Gene
dependent NN I-Gene
promoters NNS I-Gene
, , O
including VBG O
those DT O
that IN O
direct JJ O
transcription NN O
from IN O
rearranged VBN O
immunoglobulin NN B-Gene
genes NNS I-Gene
. . O

The DT O
class NN B-Gene
II NNP I-Gene
trans VBZ I-Gene
- : I-Gene
activator NN I-Gene
( ( O
CIITA NNP B-Gene
) ) O
is VBZ O
a DT O
bi JJ B-Gene
- : I-Gene
or CC I-Gene
multi VB I-Gene
- : I-Gene
functional JJ I-Gene
domain NN I-Gene
protein NN I-Gene
which WDT O
plays VBZ O
a DT O
critical JJ O
role NN O
in IN O
the DT O
expression NN O
of IN O
MHC NNP B-Gene
class NN I-Gene
II NNP I-Gene
genes NNS I-Gene
. . O

Transient JJ O
transfection NN O
of IN O
a DT O
B NNP O
lymphoma NN O
line NN O
resulted VBD O
in IN O
up IN O
to TO O
89 CD O
% NN O
reduction NN O
of IN O
constitutive JJ O
MHC NNP B-Gene
class NN I-Gene
II NNP I-Gene
expression NN O
within IN O
5 CD O
days NNS O
and CC O
suppression NN O
of IN O
HLA NNP B-Gene
- : I-Gene
DRA NNP I-Gene
mRNA JJ I-Gene
synthesis NN O
. . O

The DT O
active JJ O
ingredients NNS O
mediating VBG O
the DT O
pharmacological JJ O
effect NN O
are VBP O
mainly RB O
sesquiterpene JJ O
lactones NNS O
, , O
such JJ O
as IN O
helenalin NN O
, , O
11alpha CD O
, , O
13 CD O
- : O
dihydrohelenalin NN O
, , O
chamissonolid NN O
and CC O
their PRP$ O
ester NN O
derivatives NNS O
. . O

We PRP O
show VBP O
here RB O
that IN O
helenalin NN O
, , O
and CC O
, , O
to TO O
a DT O
much RB O
lesser JJR O
degree NN O
, , O
11alpha CD O
, , O
13 CD O
- : O
dihydrohelenalin NN O
and CC O
chamissonolid NN O
, , O
inhibit JJ O
activation NN O
of IN O
transcription NN B-Gene
factor NN I-Gene
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
. . O

Rather RB O
, , O
helenalin VB O
modifies VBZ O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
/ JJ I-Gene
IkappaB NNP I-Gene
complex NN I-Gene
, , O
preventing VBG O
the DT O
release NN O
of IN O
IkappaB NNP B-Gene
. . O

The DT O
tax NN B-Gene
protein NN I-Gene
of IN O
human JJ O
T NNP O
- : O
cell NN O
leukemia NN O
virus NN O
type NN O
1 CD O
mediates VBZ O
the DT O
transactivation NN O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
sis NN I-Gene
/ JJ I-Gene
platelet NN I-Gene
- : I-Gene
derived JJ I-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
B NN I-Gene
promoter NN I-Gene
through IN O
interactions NNS O
with IN O
the DT O
zinc NN B-Gene
finger NN I-Gene
transcription NN I-Gene
factors NNS I-Gene
Sp1 NNP B-Gene
and CC O
NGFI NNP B-Gene
- : I-Gene
A DT I-Gene
/ JJ I-Gene
Egr NNP I-Gene
- : I-Gene
1 CD I-Gene
. . O

In IN O
the DT O
present JJ O
work NN O
, , O
we PRP O
have VBP O
investigated VBN O
the DT O
mechanism NN O
( ( O
s PRP O
) ) O
whereby WRB O
Tax NNP B-Gene
transactivates VBZ O
the DT O
c JJ B-Gene
- : I-Gene
sis NN I-Gene
/ NN I-Gene
PDGF NNP I-Gene
- : I-Gene
B NNP I-Gene
proto NN I-Gene
- : I-Gene
oncogene NN I-Gene
. . O

Interestingly RB O
, , O
co SYM O
- : O
immunoprecipitation NN O
analysis NN O
also RB O
revealed VBD O
that IN O
Tax NNP B-Gene
mutant NN O
IEXC29S NNP B-Gene
is VBZ O
unable JJ O
to TO O
interact VB O
with IN O
NGFI NNP B-Gene
- : I-Gene
A DT I-Gene
/ JJ I-Gene
Egr NNP I-Gene
- : I-Gene
1 CD I-Gene
, , O
whereas NNS O
Tax VBP B-Gene
mutant JJ O
IEXL320G NNP B-Gene
is VBZ O
able JJ O
to TO O
interact VB O
with IN O
NGFI NNP B-Gene
- : I-Gene
A DT I-Gene
/ JJ I-Gene
Egr NNP I-Gene
- : I-Gene
1 CD I-Gene
. . O

Dendritic JJ O
cells NNS O
( ( O
DC NNP O
) ) O
are VBP O
potent JJ O
APCs NNP O
that IN O
enter NN O
resting VBG O
tissues NNS O
as IN O
precursors NNS O
and CC O
, , O
after IN O
Ag NNP O
exposure NN O
, , O
differentiate NN O
and CC O
migrate NN O
to TO O
draining VBG O
lymph JJ O
nodes NNS O
. . O

Immunohistochemical JJ O
staining NN O
demonstrated VBD O
RelB NNP B-Gene
within IN O
the DT O
differentiated JJ O
lymph NN O
node NN O
interdigitating VBG O
DC NNP O
and CC O
follicular JJ O
DC NNP O
, , O
but CC O
not RB O
undifferentiated JJ O
DC NNP O
in IN O
normal JJ O
skin NN O
. . O

NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
activation NN O
induced VBN O
by IN O
a DT O
CAML NNP B-Gene
- : O
interacting VBG O
member NN O
of IN O
the DT O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
receptor NN I-Gene
superfamily RB I-Gene
. . O

The DT O
CAML NNP B-Gene
( ( I-Gene
calcium NN I-Gene
- : I-Gene
modulator NN I-Gene
and CC I-Gene
cyclophilin NN I-Gene
ligand NN I-Gene
) ) I-Gene
protein NN I-Gene
is VBZ O
a DT O
coinducer NN O
of IN O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
activation NN O
when WRB O
overexpressed VBN O
in IN O
Jurkat NNP O
T NNP O
cells NNS O
. . O

In IN O
most JJS O
cells NNS O
, , O
Rel NNP B-Gene
/ NNP I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
transcription NN B-Gene
factors NNS I-Gene
appear VBP O
to TO O
mediate VB O
survival JJ O
signals NNS O
that WDT O
protect VBP O
cells NNS O
from IN O
apoptosis NN O
; : O
however RB O
, , O
under IN O
some DT O
circumstances NNS O
, , O
activation NN O
of IN O
these DT O
factors NNS O
may MD O
also RB O
promote VB O
apoptosis NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
coordination NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
STAT6 NNP B-Gene
may MD O
be VB O
required VBN O
for IN O
induction NN O
of IN O
germline NN B-Gene
Cepsilon NNP O
transcription NN O
by IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
and CC O
that IN O
CD40 NNP B-Gene
- : O
mediated VBD O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
may MD O
be VB O
important JJ O
in IN O
regulating VBG O
both DT O
enhancement NN O
of IN O
germline NN B-Gene
Cepsilon NNP O
transcription NN O
and CC O
class NN O
switching NN O
to TO O
IgE NNP B-Gene
. . O

There EX O
are VBP O
many JJ O
hypotheses NNS O
concerning VBG O
the DT O
pathogenesis NN O
of IN O
endometriosis NN O
, , O
though IN O
no DT O
single JJ O
theory NN O
can MD O
explain VB O
all DT O
cases NNS O
. . O

This DT O
review NN O
considers VBZ O
the DT O
evidence NN O
for IN O
different JJ O
theories NNS O
of IN O
the DT O
histogenesis NN O
of IN O
endometriosis NN O
and CC O
discusses VBZ O
possible JJ O
immune JJ O
factors NNS O
that WDT O
may MD O
be VB O
involved VBN O
in IN O
the DT O
pathophysiology NN O
of IN O
the DT O
disease NN O
. . O

Proteins NNS O
of IN O
the DT O
ATF NNP O
/ NNP O
CREB NNP B-Gene
class NN O
of IN O
transcription NN B-Gene
factors NNS I-Gene
stimulate VBP O
gene NN O
expression NN O
of IN O
several JJ O
cell NN B-Gene
growth NN I-Gene
- : I-Gene
related VBN I-Gene
genes NNS I-Gene
through IN O
protein NN B-Gene
kinase VBD I-Gene
A NNP I-Gene
- : I-Gene
related JJ I-Gene
cAMP NN I-Gene
response NN I-Gene
elements NNS I-Gene
. . O

One CD O
ATF NNP B-Gene
/ NNP I-Gene
CRE NNP I-Gene
motif NN I-Gene
is VBZ O
located VBN O
in IN O
the DT O
distal JJ B-Gene
promoter NN I-Gene
at IN O
the DT O
nuclear JJ B-Gene
matrix NN I-Gene
- : I-Gene
associated VBN I-Gene
Site NNP I-Gene
IV NNP I-Gene
, , O
and CC O
the DT O
second JJ O
motif NN O
is VBZ O
present JJ O
in IN O
the DT O
proximal JJ B-Gene
promoter NN I-Gene
at IN O
Site NNP B-Gene
I PRP I-Gene
. . O

Site NNP O
- : O
directed VBD O
mutational JJ O
studies NNS O
demonstrate VBP O
that IN O
Site NNP B-Gene
I PRP I-Gene
and CC O
Site NNP B-Gene
IV NNP I-Gene
together RB O
support NN O
ATF1 NNP O
- : O
and CC O
CREB NNP O
- : O
induced VBD O
trans NNS O
- : O
activation NN O
of IN O
the DT O
H4 NNP B-Gene
promoter NN I-Gene
. . O

Thus RB O
, , O
our PRP$ O
data NNS O
establish VB O
that IN O
ATF NNP B-Gene
/ NNP I-Gene
CREB NNP I-Gene
factors NNS I-Gene
functionally RB O
modulate VBP O
histone NN B-Gene
H4 NNP I-Gene
gene NN I-Gene
transcription NN O
at IN O
distal JJ B-Gene
and CC I-Gene
proximal JJ I-Gene
promoter NN I-Gene
elements NNS I-Gene
. . O

Abnormal JJ O
apoptosis NN O
and CC O
cell NN O
cycle NN O
progression NN O
in IN O
humans NNS O
exposed VBN O
to TO O
methyl VB O
tertiary JJ O
- : O
butyl NN O
ether NN O
and CC O
benzene NN O
contaminating NN O
water NN O
. . O

Because IN O
cell NN O
cycle NN O
analysis NN O
showed VBD O
that IN O
in IN O
PBL NNP O
from IN O
chemically RB O
- : O
exposed VBN O
individuals NNS O
, , O
between IN O
20 CD O
- : O
50 CD O
% NN O
of IN O
cells NNS O
were VBD O
accumulated VBN O
at IN O
the DT O
S NNP O
- : O
G2 NNP O
/ NNP O
M NNP O
boundaries NNS O
. . O

Indeed RB O
, , O
addition NN O
of IN O
inhibitors NNS O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
pyrrolidine NN O
dithiocarbamate NN O
( ( O
PDTC NNP O
) ) O
, , O
to TO O
the DT O
lymphocytes NNS O
of IN O
the DT O
chemically RB O
- : O
exposed VBN O
group NN O
was VBD O
capable JJ O
of IN O
inhibiting VBG O
programmed VBN O
cell NN O
death NN O
by IN O
40 CD O
% NN O
. . O

This DT O
reversal NN O
of IN O
apoptosis NN O
almost RB O
to TO O
the DT O
control NN O
level NN O
by IN O
inhibitor NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
may MD O
indicate VB O
involvement NN O
of IN O
this DT O
signaling VBG B-Gene
molecule NN I-Gene
in IN O
MTBE NNP O
and CC O
benzene JJ O
induction NN O
of IN O
programmed JJ O
cell NN O
death NN O
. . O

Purification NN O
and CC O
characterization NN O
of IN O
the DT O
human JJ B-Gene
SR NNP I-Gene
31747A CD I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
. . O

A DT O
nuclear JJ B-Gene
membrane NN I-Gene
protein RB I-Gene
related VBN O
to TO O
yeast VB B-Gene
sterol JJ I-Gene
isomerase NN I-Gene
. . O

SR NNP O
31747A CD O
, , O
defined VBN O
as IN O
a DT O
sigma NN O
ligand NN O
, , O
is VBZ O
a DT O
novel JJ O
immunosuppressive JJ O
agent NN O
that WDT O
blocks VBZ O
proliferation NN O
of IN O
human JJ O
and CC O
mouse NN O
lymphocytes NNS O
. . O

Using VBG O
a DT O
radiolabeled JJ O
chemical NN O
probe NN O
, , O
we PRP O
here RB O
purified VBD O
a DT O
target NN O
of IN O
SR NNP O
31747A CD O
and CC O
called VBD O
it PRP O
SR NNP B-Gene
31747A CD I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
( ( O
SR NNP B-Gene
- : I-Gene
BP NNP I-Gene
) ) O
. . O

Purified NNP B-Gene
SR NNP I-Gene
- : I-Gene
BP NNP I-Gene
retained VBD O
its PRP$ O
binding NN O
properties NNS O
and CC O
migrated VBN O
on IN O
SDS NNP O
- : O
polyacrylamide NN O
gel NN O
as IN O
a DT O
Mr NNP B-Gene
28 CD I-Gene
, , I-Gene
0 CD I-Gene
protein NN I-Gene
. . O

Northern NNP O
blot NN O
analysis NN O
of IN O
SR NNP B-Gene
- : I-Gene
BP NNP I-Gene
gene NN O
expression NN O
revealed VBD O
a DT O
single JJ O
transcript NN O
of IN O
2 CD B-Gene
kilobases NNS I-Gene
which WDT O
was VBD O
widely RB O
expressed VBN O
among IN O
organs NNS O
, , O
with IN O
the DT O
highest JJS O
abundance NN O
in IN O
liver NN O
and CC O
the DT O
lowest JJS O
abundance NN O
in IN O
brain NN O
. . O

Here RB O
we PRP O
report VBP O
the DT O
induction NN O
of IN O
the DT O
synthesis NN O
and CC O
of IN O
the DT O
hydrolytic JJ O
activity NN O
of IN O
phospholipase NN B-Gene
C NNP I-Gene
gamma NN I-Gene
1 CD I-Gene
( ( O
PLC NNP B-Gene
gamma RB I-Gene
1 CD I-Gene
) ) O
in IN O
human JJ O
T NNP O
lymphocytes NNS O
by IN O
IFN NNP B-Gene
- : I-Gene
beta NN I-Gene
. . O

The DT O
increased JJ O
level NN O
of IN O
PLC NNP B-Gene
gamma FW I-Gene
1 CD I-Gene
becomes NNS O
evident JJ O
after IN O
90 CD O
min NN O
of IN O
IFN NNP B-Gene
- : I-Gene
beta NN I-Gene
treatment NN O
and CC O
is VBZ O
still RB O
detectable JJ O
after IN O
24 CD O
h NN O
. . O

Neither CC O
the DT O
PLC NNP B-Gene
gamma NN I-Gene
1 CD I-Gene
overexpression NN O
induced VBN O
by IN O
IFN NNP B-Gene
nor CC O
the DT O
increased VBN O
hydrolytic JJ O
activity NN O
of IN O
the DT O
enzyme NN B-Gene
appear VBP O
to TO O
be VB O
affected VBN O
by IN O
pretreatment NN O
of IN O
the DT O
cells NNS O
with IN O
the DT O
protein NN O
tyrosine JJ B-Gene
kinase NN I-Gene
inhibitor NN O
genistein NN O
, , O
which WDT O
is VBZ O
known VBN O
to TO O
prevent VB O
the DT O
association NN O
of IN O
ISGF3 NNP B-Gene
components NNS O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
in IN O
human JJ O
T NNP O
lymphocytes VBZ O
IFN NNP B-Gene
- : I-Gene
beta NN I-Gene
can MD O
activate VB O
other JJ O
transcription NN B-Gene
factor NN I-Gene
( ( O
s PRP O
) ) O
distinct VBP O
from IN O
ISGF3 NNP B-Gene
to TO O
regulate VB O
PLC NNP B-Gene
gamma NN I-Gene
1 CD I-Gene
expression NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
used VBD O
a DT O
RT NNP O
- : O
PCR NN O
based VBN O
approach NN O
to TO O
compare VB O
the DT O
stability NN O
of IN O
the DT O
big JJ B-Gene
T NNP I-Gene
and CC I-Gene
small JJ I-Gene
t NN I-Gene
allele NN I-Gene
in IN O
normal JJ O
heterozygous JJ O
lymphocytes NNS O
and CC O
the DT O
heterozygous JJ O
cell NN O
lines NNS O
NB4 NNP O
( ( O
myeloid JJ O
leukemia NN O
) ) O
and CC O
PC NNP O
- : O
3 CD O
and CC O
DU NNP O
145 CD O
( ( O
prostate NN O
cancers NNS O
) ) O
. . O

Interestingly RB O
, , O
we PRP O
consistently RB O
observed VBD O
30 CD O
% NN O
less JJR O
RT NNP B-Gene
- : I-Gene
PCR NNP I-Gene
product NN I-Gene
derived VBN O
from IN O
the DT O
small JJ B-Gene
t NN I-Gene
allele JJ I-Gene
mRNA NN I-Gene
in IN O
steady JJ O
state NN O
, , O
a DT O
finding NN O
which WDT O
also RB O
speaks VBZ O
against IN O
a DT O
higher JJR O
stability NN O
of IN O
the DT O
small JJ B-Gene
t NN I-Gene
allele JJ I-Gene
mRNA NN I-Gene
. . O

Moreover RB O
, , O
anti SYM B-Gene
- : I-Gene
TNF NNP I-Gene
- : I-Gene
alpha NN I-Gene
inhibited VBD O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
( ( O
LTR NNP B-Gene
) ) O
- : O
driven VBN O
transcription NN O
of IN O
a DT O
reporter NN B-Gene
gene NN I-Gene
in IN O
primary JJ O
T NNP O
cells NNS O
in IN O
response NN O
to TO O
activation NN O
, , O
either RB O
in IN O
the DT O
presence NN O
or CC O
the DT O
absence NN O
of IN O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
Tat NNP I-Gene
. . O

Our PRP$ O
results NNS O
support VB O
an DT O
important JJ O
role NN O
for IN O
autocrine NN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
secretion NN O
in IN O
controlling VBG O
HIV NNP O
replication NN O
in IN O
primary JJ O
T NNP O
cells NNS O
because IN O
of IN O
its PRP$ O
ability NN O
to TO O
maintain VB O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
elevated VBD O
in IN O
the DT O
nucleus NN O
of IN O
T NNP O
cells NNS O
. . O

Intercellular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
1 CD I-Gene
( ( O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
is VBZ O
an DT O
important JJ O
molecule NN O
in IN O
promotion NN O
of IN O
polymorphonuclear JJ O
neutrophil JJ O
transendothelial JJ O
migration NN O
during IN O
inflammation NN O
. . O

The DT O
compound NN O
induced VBD O
G1 NNP O
arrest NN O
and CC O
granulocytic JJ O
differentiation NN O
of IN O
HL NNP O
- : O
60 CD O
cells NNS O
, , O
although IN O
the DT O
differentiation NN O
- : O
inducing VBG O
effect NN O
was VBD O
modest JJ O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
JAK2 NNP B-Gene
/ NNP B-Gene
STAT5 NNP I-Gene
activation NN O
is VBZ O
a DT O
common JJ O
JAK NNP B-Gene
/ NNP B-Gene
STAT NNP I-Gene
pathway NN O
for IN O
hIL NN B-Gene
- : I-Gene
5 CD I-Gene
- : O
mediated VBN O
signal NN O
in IN O
these DT O
cells NNS O
. . O

Nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
) ) I-Gene
/ VBP I-Gene
Rel NNP I-Gene
transcription NN I-Gene
factors NNS I-Gene
may MD O
be VB O
involved VBN O
in IN O
atherosclerosis NN O
, , O
as IN O
is VBZ O
suggested VBN O
by IN O
the DT O
presence NN O
of IN O
activated JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
human JJ O
atherosclerotic JJ O
lesions NNS O
. . O

Our PRP$ O
results NNS O
demonstrate VBP O
that IN O
short JJ O
- : O
term NN O
incubation NN O
of IN O
these DT O
cells NNS O
with IN O
oxLDL JJ B-Gene
activated VBN I-Gene
p50 NN I-Gene
/ NNP I-Gene
p65 NN I-Gene
containing VBG O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
dimers NNS I-Gene
and CC O
induced VBD O
the DT O
expression NN O
of IN O
the DT O
target NN B-Gene
gene NN I-Gene
IL NNP I-Gene
- : I-Gene
8 CD I-Gene
. . O

This DT O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
was VBD O
inhibited VBN O
by IN O
the DT O
antioxidant NN O
and CC O
H2O2 NNP O
scavenger JJR O
pyrrolidine NN O
dithiocarbamate NN O
and CC O
the DT O
proteasome JJ B-Gene
inhibitor NN O
PSI NNP O
. . O

The DT O
oxLDL JJ B-Gene
- : O
induced JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
was VBD O
accompanied VBN O
by IN O
an DT O
initial JJ O
depletion NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
- : I-Gene
alpha NN I-Gene
followed VBN O
by IN O
a DT O
slight JJ O
transient NN O
increase NN O
in IN O
the DT O
level NN O
of IN O
this DT O
inhibitor NN O
protein NN O
. . O

These DT O
observations NNS O
provide VBP O
additional JJ O
evidence NN O
that IN O
oxLDL NN B-Gene
is VBZ O
a DT O
potent JJ O
modulator NN O
of IN O
gene NN O
expression NN O
and CC O
suggest VBP O
that IN O
( ( O
dys NN O
) ) O
regulation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
/ NNP I-Gene
Rel NNP I-Gene
is VBZ O
likely JJ O
to TO O
play VB O
an DT O
important JJ O
role NN O
in IN O
atherogenesis NN O
. . O

PURPOSE NN O
: : O
To TO O
demonstrate VB O
that IN O
leukocyte JJ O
adhesion NN O
to TO O
cultured VB O
corneal JJ O
endothelial JJ O
cells NNS O
is VBZ O
mediated VBN O
by IN O
the DT O
CD18 NNP B-Gene
antigen NN I-Gene
, , O
and CC O
to TO O
determine VB O
whether IN O
dexamethasone NN O
directly RB O
suppresses VBZ O
adhesion NN O
by IN O
inhibiting VBG O
activation NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( O
NFkappaB NNP B-Gene
) ) O
. . O

Nonadherent NN O
neutrophils NNS O
were VBD O
removed VBN O
by IN O
sealing VBG O
and CC O
inverting VBG O
the DT O
culture NN O
well RB O
. . O

RESULTS NN O
: : O
Neutrophil JJ O
adhesion NN O
to TO O
cultured VB O
corneal JJ O
endothelial JJ O
cells NNS O
increased VBD O
significantly RB O
on IN O
exposure NN O
to TO O
TNFalpha NNP B-Gene
( ( O
451 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
45 CD O
. . O
4 CD O
cells NNS O
/ JJ O
mm2 NN O
, , O
n JJ O
= NNP O
16 CD O
) ) O
compared VBN O
to TO O
control VB O
( ( O
156 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
27 CD O
. . O
3 CD O
cells NNS O
/ JJ O
mm2 NN O
, , O
n JJ O
= NN O
16 CD O
, , O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
. . O

The DT O
transcriptional JJ B-Gene
start NN I-Gene
sites NNS I-Gene
were VBD O
identified VBN O
by IN O
an DT O
RNase NNP B-Gene
protection NN O
assay NN O
. . O

Since IN O
GH NNP B-Gene
stimulates VBZ O
the DT O
development NN O
and CC O
function NN O
of IN O
granulocytes NNS O
, , O
we PRP O
investigated VBD O
the DT O
expression NN O
of IN O
GH NNP B-Gene
in IN O
granulocyte JJ O
subsets NNS O
. . O

Restriction NN O
analysis NN O
revealed VBD O
that IN O
neutrophils NNS O
express VBP O
the DT O
GH NNP B-Gene
- : I-Gene
N NNP I-Gene
gene NN I-Gene
but CC O
not RB O
the DT O
GH NNP B-Gene
- : I-Gene
V NNP I-Gene
gene NN I-Gene
. . O

In IN O
addition NN O
, , O
BHRF1 NNP B-Gene
protected VBD O
these DT O
cells NNS O
from IN O
monocyte JJ O
- : O
mediated VBN O
killing VBG O
but CC O
failed VBD O
to TO O
protect VB O
them PRP O
from IN O
killing VBG O
mediated VBN O
by IN O
lymphokine JJ O
- : O
activated VBN O
killer NN O
cells NNS O
. . O

Genomic NNP O
organization NN O
, , O
sequence NN O
, , O
and CC O
transcriptional JJ O
regulation NN O
of IN O
the DT O
human JJ B-Gene
eotaxin NN I-Gene
gene NN I-Gene
. . O

Eotaxin NN B-Gene
is VBZ O
an DT O
eosinophil JJ B-Gene
specific JJ I-Gene
beta NN I-Gene
- : I-Gene
chemokine NN I-Gene
assumed VBD O
to TO O
be VB O
involved VBN O
in IN O
eosinophilic JJ O
inflammatory NN O
diseases NNS O
such JJ O
as IN O
atopic NN O
dermatitis NN O
, , O
allergic JJ O
rhinitis NN O
, , O
asthma NN O
and CC O
parasitic JJ O
infections NNS O
. . O

Here RB O
we PRP O
describe VBP O
the DT O
functional JJ O
characterization NN O
of IN O
this DT O
promoter NN O
and CC O
identification NN O
of IN O
the DT O
factors NNS O
in IN O
B NNP O
and CC O
T NNP O
cells NNS O
that WDT O
regulate VBP O
its PRP$ O
activity NN O
. . O

The DT O
pp52 NN B-Gene
promoter NN I-Gene
contains VBZ O
an DT O
initiator NN O
specifying VBG O
the DT O
unique JJ O
5 CD B-Gene
' POS I-Gene
terminus NN I-Gene
of IN O
pp52 NN B-Gene
mRNA NN I-Gene
, , O
tandem JJ O
pairs NNS O
of IN O
Ets NNP B-Gene
and CC I-Gene
SP1 NNP I-Gene
motifs NNS I-Gene
, , O
and CC O
a DT O
lone NN B-Gene
C NNP I-Gene
/ NNP I-Gene
EBP NNP I-Gene
motif NN I-Gene
. . O

BACKGROUND NN O
: : O
Recent JJ O
studies NNS O
have VBP O
raised VBN O
the DT O
hypothesis NN O
that WDT O
glucocorticoids NNS O
could MD O
diminish VB O
the DT O
ability NN O
of IN O
endothelial JJ O
cells NNS O
to TO O
direct VB O
leukocyte NN O
traffic NN O
into IN O
inflamed VBN O
tissues NNS O
by IN O
inhibiting VBG O
expression NN O
of IN O
the DT O
adhesion NN B-Gene
molecules VBZ I-Gene
endothelial JJ B-Gene
- : I-Gene
leukocyte NN I-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
and CC O
intercellular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
. . O

The DT O
immediate JJ O
- : O
early JJ O
gene NN O
product NN O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
regulates VBZ O
the DT O
human JJ B-Gene
interleukin NN I-Gene
- : I-Gene
2 CD I-Gene
receptor NN I-Gene
beta NN I-Gene
- : I-Gene
chain NN I-Gene
promoter NN I-Gene
through IN O
noncanonical JJ B-Gene
Egr NNP I-Gene
and CC I-Gene
Sp1 NNP I-Gene
binding NN I-Gene
sites NNS I-Gene
. . O

In IN O
Jurkat NNP O
cells NNS O
, , O
both DT O
sites NNS O
were VBD O
required VBN O
for IN O
maximal JJ O
IL NNP B-Gene
- : I-Gene
2Rbeta CD I-Gene
promoter NN O
activity NN O
, , O
and CC O
in IN O
HeLaS3 NNP O
cells NNS O
, , O
transfection NN O
of IN O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
could MD O
drive VB O
activity NN O
of IN O
a DT O
reporter NN O
construct NN O
containing VBG O
both DT O
sites NNS O
. . O

Acquisition NNP O
of IN O
heat NN O
shock NN O
factor NN O
2 CD O
( ( O
HSF2 NNP O
) ) O
DNA NNP O
binding VBG O
activity NN O
is VBZ O
accompanied VBN O
by IN O
induced JJ O
transcription NN O
of IN O
heat NN B-Gene
shock NN I-Gene
genes NNS I-Gene
in IN O
hemin NN O
- : O
treated VBN O
K562 NNP O
cells NNS O
undergoing VBG O
erythroid JJ O
differentiation NN O
. . O

Sequential NNP O
development NN O
of IN O
structural JJ O
and CC O
functional JJ O
alterations NNS O
in IN O
T NNP O
cells NNS O
from IN O
tumor NN O
- : O
bearing NN O
mice NN O
. . O

These DT O
defects NNS O
are VBP O
paralleled VBN O
by IN O
an DT O
impaired JJ O
ability NN O
to TO O
produce VB O
Th1 NNP B-Gene
cytokines NNS I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
) ) O
. . O

Like IN O
the DT O
class NN B-Gene
II NNP I-Gene
genes NNS I-Gene
, , O
the DT O
HLA NNP B-Gene
- : I-Gene
DM NNP I-Gene
genes NNS I-Gene
contain VBP O
upstream JJ O
regulatory JJ O
sequences NNS O
similar JJ O
to TO O
the DT O
S NNP B-Gene
- : I-Gene
X SYM I-Gene
- : I-Gene
Y JJ I-Gene
regulatory JJ I-Gene
region NN I-Gene
as RB O
well RB O
as IN O
additional JJ O
putative JJ O
regulatory JJ O
sites NNS O
. . O

The DT O
class NN B-Gene
II NNP I-Gene
- : I-Gene
specific JJ I-Gene
transcription NN I-Gene
factors NNS I-Gene
RFX NNP B-Gene
and CC O
CIITA NNP B-Gene
are VBP O
also RB O
required VBN O
for IN O
expression NN O
, , O
as IN O
cell NN O
lines NNS O
deficient NN O
in IN O
these DT O
factors NNS O
failed VBD O
to TO O
allow VB O
transcription NN O
from IN O
the DT O
DM NNP B-Gene
promoters NNS I-Gene
. . O

In IN O
addition NN O
, , O
in IN O
vivo JJ O
footprint NN O
analysis NN O
showed VBD O
the DT O
putative JJ O
X NN B-Gene
and CC I-Gene
Y NNP I-Gene
boxes NNS I-Gene
to TO O
be VB O
occupied VBN O
by IN O
transcription NN B-Gene
factors NNS I-Gene
in IN O
wild JJ O
- : O
type NN O
B NNP O
cells NNS O
, , O
but CC O
not RB O
in IN O
RFX NNP O
- : O
deficient NN O
B NNP O
cells NNS O
. . O

None NN O
of IN O
the DT O
other JJ O
putative JJ O
regulatory JJ O
sites NNS O
was VBD O
occupied VBN O
in IN O
vivo NN O
, , O
indicating VBG O
that IN O
they PRP O
may MD O
not RB O
be VB O
functional JJ O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
Ad2 NNP O
was VBD O
internalized VBN O
by IN O
macrophages NNS O
. . O

Critical JJ O
cytoplasmic NN B-Gene
domains NNS I-Gene
of IN O
human JJ B-Gene
interleukin JJ I-Gene
- : I-Gene
9 CD I-Gene
receptor NN I-Gene
alpha NN I-Gene
chain NN I-Gene
in IN O
interleukin JJ B-Gene
- : O
9 CD O
- : O
mediated VBN O
cell NN O
proliferation NN O
and CC O
signal JJ O
transduction NN O
. . O

In IN O
a DT O
previous JJ O
study NN O
, , O
we PRP O
demonstrated VBD O
that IN O
bufalin NN O
, , O
which WDT O
is VBZ O
an DT O
active JJ O
principle NN O
of IN O
Chinese JJ O
medicine NN O
, , O
chan NN O
' '' O
su NN O
, , O
caused VBD O
apoptosis NN O
in IN O
human JJ O
leukemia NN O
U937 NNP O
cells NNS O
by IN O
anomalous JJ O
activation NN O
of IN O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( O
MAPK NNP B-Gene
) ) O
via IN O
the DT O
signaling VBG O
pathway NN O
of IN O
Ras NNP B-Gene
, , O
Raf NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
MAPK NNP B-Gene
kinase NNP I-Gene
- : I-Gene
1 CD I-Gene
. . O

Here RB O
, , O
we PRP O
report VBP O
the DT O
effect NN O
of IN O
overexpression NN O
of IN O
bcl NN B-Gene
- : I-Gene
2 CD I-Gene
in IN O
U937 NNP O
cells NNS O
on IN O
the DT O
signaling VBG O
pathway NN O
of IN O
apoptosis NN O
that WDT O
is VBZ O
induced VBN O
by IN O
bufalin NN O
. . O

The DT O
genes NNS O
encoding VBG O
the DT O
functionally RB O
related JJ O
hepatocyte JJ B-Gene
nuclear JJ I-Gene
factors NNS I-Gene
HNF NNP B-Gene
- : I-Gene
1alpha CD I-Gene
and CC O
HNF NNP B-Gene
- : I-Gene
4alpha CD I-Gene
play NN O
a DT O
critical JJ O
role NN O
in IN O
normal JJ O
pancreatic JJ O
beta NN O
- : O
cell NN O
function NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
show VBP O
that IN O
HNF NNP B-Gene
- : I-Gene
3alpha CD I-Gene
, , I-Gene
- : I-Gene
3beta CD I-Gene
, , I-Gene
- : I-Gene
3gamma CD I-Gene
, , I-Gene
- : I-Gene
4gamma CD I-Gene
, , I-Gene
and CC I-Gene
- : I-Gene
6 CD I-Gene
are VBP O
expressed VBN O
in IN O
pancreatic JJ O
beta NN O
- : O
cells NNS O
. . O

We PRP O
report VBP O
the DT O
identification NN O
and CC O
characterization NN O
of IN O
simple JJ B-Gene
tandem JJ I-Gene
repeat NN I-Gene
DNA NNP I-Gene
polymorphisms NN I-Gene
in IN O
the DT O
genes NNS O
encoding VBG O
HNF NNP B-Gene
- : I-Gene
3alpha CD I-Gene
, , O
- : B-Gene
3beta CD I-Gene
, , O
- : B-Gene
3gamma CD I-Gene
, , O
- : B-Gene
4gamma CD I-Gene
, , O
and CC O
- : B-Gene
6 CD I-Gene
and CC O
the DT O
mapping NN O
of IN O
HNF NNP B-Gene
- : I-Gene
6 CD I-Gene
to TO O
chromosome VB B-Gene
bands NNS I-Gene
15q21 CD B-Gene
. . I-Gene
1 CD I-Gene
- : I-Gene
21 CD I-Gene
. . I-Gene
2 CD I-Gene
by IN O
fluorescence NN O
in IN O
situ JJ O
hybridization NN O
. . O

Anti NNP B-Gene
- : I-Gene
E NN I-Gene
. . I-Gene
chaffeensis NN I-Gene
antibody NN I-Gene
complexed VBD O
with IN O
E NNP O
. . O
chaffeensis NN O
significantly RB O
enhanced VBD O
mRNA JJ O
expression NN O
of IN O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
in IN O
THP NNP O
- : O
1 CD O
cells NNS O
. . O

Decreased VBN O
transcriptional JJ O
activation NN O
by IN O
N NNP B-Gene
- : I-Gene
terminal JJ I-Gene
deletions NNS I-Gene
of IN O
CIITA NNP B-Gene
is VBZ O
correlated VBN O
directly RB O
with IN O
their PRP$ O
reduced VBN O
binding NN O
to TO O
TAFII32 NNP B-Gene
. . O

Ligand NNP O
binding NN O
and CC O
activation NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
receptor NN I-Gene
expressed VBN O
on IN O
B NNP O
- : O
CLL NNP O
cells NNS O
results NNS O
in IN O
the DT O
phosphorylation NN O
of IN O
signal JJ B-Gene
transducer NN I-Gene
and CC I-Gene
activator NN I-Gene
of IN I-Gene
transcription NN I-Gene
1 CD I-Gene
( ( O
STAT1 NNP B-Gene
) ) O
and CC O
STAT3 NNP B-Gene
proteins NNS O
. . O

When WRB O
18C7 CD B-Gene
was VBD O
incubated VBN O
with IN O
MR NNP B-Gene
before IN O
aldosterone NN O
or CC O
progesterone NN O
, , O
the DT O
antibody NN O
inhibited VBD O
75 CD O
- : O
80 CD O
% NN O
of IN O
the DT O
binding NN O
. . O

Molecular JJ O
cloning NN O
of IN O
SLAP NNP B-Gene
- : I-Gene
130 CD I-Gene
, , O
an DT O
SLP NNP B-Gene
- : I-Gene
76 CD I-Gene
- : I-Gene
associated VBN I-Gene
substrate NN I-Gene
of IN O
the DT O
T NNP B-Gene
cell NN I-Gene
antigen NN I-Gene
receptor NN I-Gene
- : I-Gene
stimulated VBN I-Gene
protein JJ I-Gene
tyrosine NN I-Gene
kinases NNS I-Gene
. . O

These DT O
data NNS O
suggest VBP O
that IN O
SLP NNP B-Gene
- : I-Gene
76 CD I-Gene
recruits VBZ O
a DT O
negative JJ O
regulator NN O
, , O
SLAP NNP B-Gene
- : I-Gene
130 CD I-Gene
, , O
as RB O
well RB O
as IN O
positive JJ O
regulators NNS O
of IN O
signal JJ O
transduction NN O
in IN O
T NNP O
cells NNS O
. . O

This DT O
review NN O
focuses VBZ O
on IN O
the DT O
molecular JJ O
actions NNS O
of IN O
prolactin NN O
in IN O
the DT O
immune NN O
system NN O
. . O

From IN O
analyses NNS O
of IN O
mice JJ O
deficient NN O
in IN O
transcription NN B-Gene
factor NN I-Gene
genes NNS I-Gene
and CC O
from IN O
the DT O
characterizations NNS O
of IN O
chromosome NN B-Gene
breakpoints NNS I-Gene
in IN O
human JJ O
leukemias NN O
, , O
it PRP O
has VBZ O
become VBN O
evident JJ O
that IN O
transcription NN B-Gene
factors NNS I-Gene
are VBP O
important JJ O
regulators NNS O
of IN O
hematopoiesis NN O
. . O

Induction NN O
of IN O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
expression NN O
in IN O
monocytic JJ O
cells NNS O
by IN O
Cryptococcus NNP O
neoformans NNS O
and CC O
Candida NNP O
albicans NNS O
. . O

Because IN O
candidiasis NN O
and CC O
cryptococcosis NN O
are VBP O
common JJ O
in IN O
human JJ O
immunodeficiency NN O
virus NN O
( ( O
HIV NNP O
) ) O
- : O
infected JJ O
persons NNS O
, , O
the DT O
effect NN O
of IN O
Cryptococcus NNP O
neoformans NNS O
and CC O
Candida NNP O
albicans NNS O
on IN O
HIV NNP O
expression NN O
in IN O
monocytic JJ O
cells NNS O
was VBD O
examined VBN O
. . O

Stimulation NN O
of IN O
the DT O
latently RB O
HIV NNP O
- : O
infected VBN O
myelomonocytic JJ O
cell NN O
line NN O
OM NNP O
- : O
10 CD O
. . O
1 CD O
with IN O
C NNP O
. . O
neoformans NNS O
and CC O
C NNP O
. . O
albicans NNS O
in IN O
the DT O
presence NN O
of IN O
pooled JJ O
human JJ O
serum NN O
caused VBD O
a DT O
ratio NN O
- : O
dependent JJ O
increase NN O
in IN O
HIV NNP O
production NN O
. . O

In IN O
THP NNP O
- : O
1 CD O
cells NNS O
transfected VBN O
with IN O
HIV NNP B-Gene
plasmid NN I-Gene
constructs NNS I-Gene
, , O
both DT O
organisms NNS O
induced VBN O
transcription NN O
from IN O
the DT O
HIV NNP B-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
that WDT O
was VBD O
dependent JJ O
on IN O
intact JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
binding NN I-Gene
sequences NNS I-Gene
. . O

Thus RB O
, , O
C NNP O
. . O
neoformans NNS O
and CC O
C NNP O
. . O
albicans NNS O
enhance VBP O
HIV NNP O
expression NN O
in IN O
monocytic JJ O
cells NNS O
through IN O
a DT O
TNF NNP O
- : O
alpha NN O
- : O
and CC O
NF NNP O
- : O
kappaB NN O
- : O
dependent NN O
mechanism NN O
. . O

In IN O
this DT O
report NN O
we PRP O
present VBP O
the DT O
characterisation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
subunits NNS I-Gene
engaged VBN O
in IN O
complexes NNS O
binding VBG O
to TO O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
NF NNP I-Gene
- : I-Gene
kappaB NN I-Gene
site NN I-Gene
in IN O
human JJ O
8E+051 CD O
T NNP O
- : O
cells NNS O
, , O
that IN O
harbour PDT O
a DT O
defective JJ O
HIV NNP O
- : O
1 CD O
. . O

With IN O
the DT O
use NN O
of IN O
specific JJ B-Gene
antibodies NNS I-Gene
we PRP O
have VBP O
determined VBN O
the DT O
composition NN O
of IN O
each DT O
complex JJ O
using VBG O
electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
. . O

c SYM B-Gene
- : I-Gene
Myb NN I-Gene
and CC O
Ets NNP B-Gene
proteins VBZ I-Gene
synergize VB O
to TO O
overcome VB O
transcriptional JJ O
repression NN O
by IN O
ZEB NNP B-Gene
. . O

IL NNP B-Gene
- : I-Gene
4 CD I-Gene
- : O
dependent JJ O
activation NN O
of IN O
Stat6 NNP B-Gene
was VBD O
also RB O
observed VBN O
in IN O
HC11 NNP O
mammary JJ O
epithelial JJ O
cells NNS O
. . O

In IN O
these DT O
cells NNS O
, , O
Stat6 NNP B-Gene
activation NN O
led VBD O
to TO O
the DT O
induction NN O
of IN O
the DT O
beta NN B-Gene
- : I-Gene
casein NN I-Gene
gene NN I-Gene
promoter NN I-Gene
. . O

In IN O
pre JJ O
- : O
B NN O
cells NNS O
( ( O
Ba NNP O
/ NNP O
F3 NNP O
) ) O
, , O
the DT O
transactivation NN O
domain NN O
of IN O
Stat6 NNP B-Gene
was VBD O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
regulated VBN O
, , O
independently RB O
from IN O
its PRP$ O
DNA NNP O
binding NN O
function NN O
. . O

Activation NN O
of IN O
helper NN O
T NNP O
cells NNS O
results NNS O
in IN O
coordinate JJ O
expression NN O
of IN O
a DT O
number NN O
of IN O
cytokines NNS B-Gene
involved VBN O
in IN O
differentiation NN O
, , O
proliferation NN O
and CC O
activation NN O
of IN O
the DT O
haematopoietic JJ O
system NN O
. . O

Granulocyte NNP B-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
stimulating VBG I-Gene
factor NN I-Gene
( ( O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
) ) O
is VBZ O
one CD O
such JJ O
cytokine NN B-Gene
, , O
whose WP$ O
increased JJ O
expression NN O
results NNS O
mostly RB O
from IN O
increases NNS O
in IN O
transcription NN O
. . O

ETS1 NNP B-Gene
is VBZ O
a DT O
transcription NN B-Gene
factor NN I-Gene
of IN O
the DT O
ETS NNP B-Gene
family NN I-Gene
that WDT O
is VBZ O
expressed VBN O
in IN O
T NNP O
cells NNS O
. . O

We PRP O
have VBP O
previously RB O
shown VBN O
that IN O
ETS1 NNP B-Gene
can MD O
transactivate VB O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
in IN O
Jurkat NNP O
T NNP O
cells NNS O
, , O
but CC O
only RB O
after IN O
the DT O
cells NNS O
have VBP O
been VBN O
stimulated VBN O
by IN O
treatment NN O
with IN O
PMA NNP O
and CC O
ionomycin NN O
, , O
agents NNS O
that IN O
mimic JJ O
T NNP O
cell NN O
activation NN O
. . O

This DT O
defect NN O
in IN O
maturation NN O
resulted VBD O
in IN O
a DT O
transgene NN O
dose SYM O
- : O
dependent JJ O
reduction NN O
in IN O
peripheral JJ O
T NNP O
lymphocytes NNS O
, , O
with IN O
the DT O
CD8 NNP O
lineage NN O
being VBG O
more RBR O
severely RB O
affected JJ O
. . O

CD40 NNP B-Gene
is VBZ O
an DT O
important JJ O
signaling NN O
and CC O
activation NN O
Ag NNP O
found VBD O
on IN O
certain JJ O
bone NN O
marrow NN O
- : O
derived JJ O
cells NNS O
. . O

Recently RB O
, , O
CD40 NNP B-Gene
also RB O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
expressed VBN O
by IN O
mesenchymal JJ O
cells NNS O
, , O
including VBG O
human JJ O
fibroblasts NNS O
. . O

Little JJ O
is VBZ O
known VBN O
about IN O
the DT O
role NN O
of IN O
CD40 NNP B-Gene
in IN O
fibroblasts NNS O
. . O

The DT O
current JJ O
study NN O
investigates VBZ O
the DT O
hypothesis NN O
that WDT O
CD40 NNP B-Gene
expressed VBD O
on IN O
lung NN O
fibroblasts NNS O
is VBZ O
an DT O
activation NN O
structure NN O
and CC O
mechanism NN O
for IN O
interaction NN O
with IN O
hemopoietic JJ O
cells NNS O
. . O

Signaling VBG O
through IN O
CD40 NNP B-Gene
with IN O
soluble JJ O
CD40 NNP B-Gene
ligand NN O
stimulated VBD O
fibroblast JJ O
activation NN O
, , O
as IN O
evidenced VBN O
by IN O
mobilization NN O
of IN O
nuclear JJ O
factor NN O
- : O
kappaB NN O
and CC O
by IN O
induction NN O
of IN O
the DT O
proinflammatory NN O
and CC O
chemoattractant JJ O
cytokines NNS B-Gene
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
. . O

In IN O
contrast NN O
, , O
it PRP O
was VBD O
found VBN O
to TO O
be VB O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
independent JJ O
in IN O
the DT O
early JJ O
time NN O
point NN O
. . O

In IN O
fact NN O
, , O
mAb JJ B-Gene
L243 NNP I-Gene
but CC O
not RB O
the DT O
staphylococcal JJ B-Gene
superantigens NNS I-Gene
, , O
staphylococcal JJ B-Gene
exotoxin NN I-Gene
toxic NN I-Gene
shock NN I-Gene
syndrome NN I-Gene
toxin NN I-Gene
- : I-Gene
I PRP I-Gene
or CC O
staphylococcal JJ B-Gene
enterotoxin NN I-Gene
B NNP I-Gene
, , O
regulate VB O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
binding NN O
activity NN O
. . O

Regulation NN O
of IN O
inosine JJ B-Gene
- : I-Gene
5 CD I-Gene
' '' I-Gene
- : I-Gene
monophosphate NN I-Gene
dehydrogenase NN I-Gene
type NN I-Gene
II NNP I-Gene
gene NN O
expression NN O
in IN O
human JJ O
T NNP O
cells NNS O
. . O

Additional JJ O
major JJ O
protein NN O
- : O
DNA NN O
interactions NNS O
do VBP O
not RB O
occur VB O
within IN O
the DT O
promoter NN O
region NN O
after IN O
T NNP O
lymphocyte JJ O
activation NN O
, , O
indicating VBG O
a DT O
requirement NN O
for IN O
additional JJ O
protein NN O
- : O
protein NN O
interactions NNS O
and CC O
/ NNP O
or CC O
post VB O
- : O
translational JJ O
modifications NNS O
of IN O
pre JJ B-Gene
- : I-Gene
bound NN I-Gene
transcription NN I-Gene
factors NNS I-Gene
to TO O
account VB O
for IN O
the DT O
observed JJ O
increase NN O
in IN O
IMPDH NNP O
type NN O
II NNP O
gene NN O
expression NN O
. . O

NAC NNP O
had VBD O
no DT O
effect NN O
on IN O
the DT O
half NN O
- : O
life NN O
of IN O
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
or CC I-Gene
VCAM NNP I-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
. . O

Fusion NN O
proteins VBZ O
involving VBG O
the DT O
retinoic NN O
acid NN O
receptor NN B-Gene
alpha NN I-Gene
( ( O
RAR NNP B-Gene
alpha NN I-Gene
) ) O
and CC O
the DT O
PML NNP B-Gene
or CC O
PLZF NNP B-Gene
nuclear JJ I-Gene
protein NN I-Gene
are VBP O
the DT O
genetic JJ O
markers NNS O
of IN O
acute JJ O
promyelocytic JJ O
leukemias NN O
( ( O
APLs NNP O
) ) O
. . O

Cytomegalovirus NNP O
( ( O
CMV NNP O
) ) O
infection NN O
induced VBD O
interleukin JJ B-Gene
- : I-Gene
8 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
) ) O
gene NN O
transcription NN O
in IN O
a DT O
human JJ O
monocytic JJ O
cell NN O
line NN O
, , O
THP NNP O
- : O
1 CD O
cells NNS O
, , O
leading VBG O
to TO O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
secretion NN O
. . O

Moreover RB O
, , O
electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
demonstrated VBD O
that IN O
CMV NNP O
induced VBD O
the DT O
formation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
complexes NNS I-Gene
. . O

Interleukin NNP B-Gene
- : I-Gene
12 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
) ) O
is VBZ O
a DT O
cytokine NN B-Gene
that IN O
exhibits VBZ O
pleiotropic JJ O
effects NNS O
on IN O
lymphocytes NNS O
and CC O
natural JJ O
killer NN O
cells NNS O
and CC O
has VBZ O
been VBN O
shown VBN O
to TO O
have VB O
promise NN O
for IN O
the DT O
immunotherapy NN O
of IN O
cancer NN O
. . O

This DT O
presents VBZ O
several JJ O
problems NNS O
in IN O
vectors NNS O
, , O
particularly RB O
those DT O
in IN O
which WDT O
additional JJ O
genes NNS O
, , O
either CC O
a DT O
co NN B-Gene
- : I-Gene
stimulatory NN I-Gene
gene NN I-Gene
or CC O
a DT O
selectable JJ O
marker NN O
, , O
are VBP O
inserted VBN O
. . O

Direct JJ O
analysis NN O
of IN O
these DT O
modified VBN O
cells NNS O
acting VBG O
as IN O
tumor NN O
vaccines NNS O
is VBZ O
underway RB O
. . O

Plasma NNP O
sialyltransferase NN B-Gene
levels NNS O
in IN O
psychiatric JJ O
disorders NNS O
as IN O
a DT O
possible JJ O
indicator NN O
of IN O
HPA NNP O
axis JJ O
function NN O
. . O

While IN O
there EX O
was VBD O
a DT O
significant JJ O
increase NN O
in IN O
plasma JJ O
cortisol NN O
levels NNS O
in IN O
the DT O
depressed JJ O
group NN O
, , O
there EX O
were VBD O
no DT O
changes NNS O
in IN O
the DT O
lymphocyte NN O
GR NNP B-Gene
binding NN O
parameters NNS O
( ( O
K NNP O
( ( O
m NN O
) ) O
and CC O
Bmax NNP O
) ) O
. . O

There EX O
was VBD O
, , O
however RB O
, , O
a DT O
significant JJ O
decrease NN O
in IN O
the DT O
plasma JJ B-Gene
sialyltransferase NN I-Gene
: : I-Gene
cortisol NN O
ratio NN O
in IN O
the DT O
depressed JJ O
group NN O
suggesting VBG O
an DT O
inability NN O
of IN O
the DT O
raised VBN O
cortisol NN O
levels NNS O
to TO O
induce VB O
enzyme JJ O
expression NN O
and CC O
this DT O
ratio NN O
may MD O
provide VB O
a DT O
useful JJ O
biochemical JJ O
marker NN O
of IN O
cortisol NN O
receptor NN O
function NN O
. . O

Therefore RB O
, , O
while IN O
the DT O
total JJ O
plasma JJ B-Gene
sialyltransferase NN I-Gene
: : O
cortisol NN O
ratio NN O
reflects VBZ O
HPA NNP O
axis JJ O
function NN O
, , O
alterations NNS O
in IN O
specific JJ O
isozyme JJ O
activity NN O
may MD O
also RB O
be VB O
associated VBN O
with IN O
other JJ O
CNS NNP O
disease NN O
states NNS O
. . O

Using VBG O
a DT O
previously RB O
described VBN O
mutant NN O
of IN O
the DT O
Jurkat NNP O
T NNP O
cell NN O
line NN O
, , O
we PRP O
show VBP O
that IN O
proximal JJ O
signaling VBG O
events NNS O
dependent NN O
on IN O
the DT O
presence NN O
of IN O
the DT O
CD45 NNP B-Gene
tyrosine NN I-Gene
phosphatase NN I-Gene
are VBP O
required VBN O
for IN O
TCR NNP B-Gene
- : O
stimulated VBD O
CD95 NNP B-Gene
ligand NN I-Gene
expression NN O
. . O

Together RB O
, , O
these DT O
studies NNS O
begin VBP O
a DT O
dissection NN O
of IN O
the DT O
biochemical JJ O
events NNS O
that WDT O
lead VBP O
to TO O
expression NN O
of IN O
CD95 NNP B-Gene
ligand NN I-Gene
, , O
a DT O
required JJ O
step NN O
for IN O
TCR NNP B-Gene
- : O
induced JJ O
apoptosis NN O
. . O

This DT O
paper NN O
aims VBZ O
to TO O
review VB O
the DT O
role NN O
of IN O
free JJ O
radical JJ O
- : O
induced JJ O
tissue NN O
damage NN O
and CC O
antioxidant JJ O
defence NN O
mechanisms NNS O
in IN O
inflammatory NN O
diseases NNS O
that WDT O
involve VBP O
pathogenic JJ O
processes NNS O
similar JJ O
to TO O
the DT O
periodontal JJ O
diseases NNS O
. . O

There EX O
is VBZ O
a DT O
clearly RB O
defined VBN O
and CC O
substantial JJ O
role NN O
for IN O
free JJ O
radicals NNS O
or CC O
reactive JJ O
oxygen NN O
species NNS O
( ( O
ROS NNP O
) ) O
in IN O
periodontitis NN O
, , O
but CC O
little JJ O
research NN O
has VBZ O
been VBN O
performed VBN O
in IN O
this DT O
area NN O
. . O

Large JJ O
germline JJ O
deletions NNS O
of IN O
TSC2 NNP B-Gene
occur VBP O
in IN O
< JJ O
5 CD O
% NN O
of IN O
cases NNS O
, , O
and CC O
a DT O
number NN O
of IN O
small JJ O
intragenic JJ O
mutations NNS O
have VBP O
been VBN O
described VBN O
. . O

TCP NNP O
succinate NN O
( ( O
200 CD O
microM NN O
, , O
24 CD O
h NN O
) ) O
reduced VBD O
TNF NNP B-Gene
- : I-Gene
induced VBD I-Gene
VCAM NNP I-Gene
- : I-Gene
1 CD I-Gene
and CC O
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
expression NN O
from IN O
a DT O
specific JJ O
mean JJ O
fluorescence NN O
intensity NN O
of IN O
151 CD O
+ NNS O
/ SYM O
- : O
28 CD O
to TO O
12 CD O
+ NNS O
/ SYM O
- : O
4 CD O
channels NNS O
and CC O
from IN O
225 CD O
+ NNS O
/ SYM O
- : O
38 CD O
to TO O
79 CD O
+ NNS O
/ SYM O
- : O
21 CD O
channels NNS O
, , O
respectively RB O
. . O

The DT O
Eed NNP B-Gene
- : O
mediated VBD O
transcriptional JJ O
effects NNS O
are VBP O
likely JJ O
to TO O
reflect VB O
the DT O
interaction NN O
of IN O
Eed NNP B-Gene
with IN O
multiple JJ O
molecular JJ O
partners NNS O
, , O
including VBG O
K NNP B-Gene
protein NN I-Gene
. . O

When WRB O
macrophages NNS O
were VBD O
pretreated VBN O
with IN O
low JJ O
doses NNS O
of IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
and CC O
then RB O
stimulated VBD O
with IN O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
, , O
clearly RB O
enhanced JJ O
formation NN O
of IN O
specific JJ O
transcription NN B-Gene
factor NN I-Gene
complexes NN O
was VBD O
detected VBN O
. . O

Activation NN O
and CC O
regulation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
are VBP O
tightly RB O
controlled VBN O
by IN O
a DT O
group NN O
of IN O
inhibitory NN B-Gene
proteins NNS I-Gene
( ( O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
) ) O
that IN O
sequester NN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
the DT O
cytoplasm NN O
of IN O
immune JJ O
/ NNP O
inflammatory NN O
effector NN O
cells NNS O
. . O

Liberated VBN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
migrates VBZ O
to TO O
the DT O
nucleus NN O
, , O
where WRB O
it PRP O
binds VBZ O
to TO O
specific JJ B-Gene
promoter NN I-Gene
sites NNS I-Gene
and CC O
activates NNS O
gene NN O
transcription NN O
. . O

Constitutive JJ O
expression NN O
of IN O
E2a NNP B-Gene
- : I-Gene
Pbx1 NN I-Gene
did VBD O
not RB O
induce VB O
apoptosis NN O
or CC O
continued JJ O
cycling NN O
of IN O
Rat NNP O
- : O
1 CD O
fibroblasts NNS O
in IN O
low JJ O
serum NN O
conditions NNS O
. . O

The DT O
human JJ B-Gene
C NNP I-Gene
/ NNP I-Gene
EBPepsilon NNP I-Gene
gene NN I-Gene
is VBZ O
transcribed VBN O
by IN O
two CD O
alternative JJ O
promoters NNS B-Gene
, , O
Palpha NNP B-Gene
and CC O
Pbeta NNP B-Gene
. . O

A DT O
combination NN O
of IN O
differential JJ O
splicing NN O
and CC O
alternative JJ O
use NN O
of IN O
promoters NNS B-Gene
generates NNS O
four CD O
mRNA NN B-Gene
isoforms NNS I-Gene
, , O
of IN O
2 CD O
. . O
6 CD O
kb NN O
and CC O
1 CD O
. . O
3 CD O
- : O
1 CD O
. . O
5 CD O
kb NN O
in IN O
size NN O
. . O

C NNP B-Gene
/ NNP I-Gene
EBPepsilon NNP I-Gene
mRNA NN I-Gene
was VBD O
greatly RB O
induced JJ O
during IN O
in IN O
vitro JJ O
granulocytic JJ O
differentiation NN O
of IN O
human JJ O
primary JJ O
CD34 NNP O
( ( O
+ NNP O
) ) O
cells NNS O
. . O

Thus RB O
, , O
C NNP B-Gene
/ NNP I-Gene
EBPepsilon NNP I-Gene
is VBZ O
regulated VBN O
in IN O
a DT O
complex JJ O
fashion NN O
and CC O
may MD O
play VB O
a DT O
role NN O
in IN O
the DT O
regulation NN O
of IN O
genes NNS O
involved VBN O
in IN O
myeloid JJ O
differentiation NN O
. . O

We PRP O
now RB O
report VBP O
that IN O
PO NNP B-Gene
- : I-Gene
B NNP I-Gene
DNA NNP O
- : O
binding NN O
in IN O
HL NNP O
- : O
60 CD O
cells NNS O
is VBZ O
similarly RB O
induced VBN O
during IN O
differentiation NN O
to TO O
the DT O
granulocytic JJ O
lineage NN O
( ( O
with IN O
either DT O
retinoic JJ O
acid NN O
or CC O
dimethylsulfoxide NN O
) ) O
. . O

Recent JJ O
studies NNS O
have VBP O
revealed VBN O
that IN O
interactions NNS O
between IN O
transcription NN B-Gene
factors NNS I-Gene
play VBP O
an DT O
important JJ O
role NN O
in IN O
regulation NN O
of IN O
gene NN O
expression NN O
in IN O
eukaryotic JJ O
cells NNS O
. . O

Oct NNP B-Gene
- : I-Gene
2 CD I-Gene
expressed VBN O
in IN O
this DT O
tester NN O
strain NN O
represses VBZ O
the DT O
expression NN O
of IN O
the DT O
reporter NN O
gene NN O
and CC O
changes VBZ O
the DT O
phenotype NN O
of IN O
the DT O
cell NN O
from IN O
Lac NNP O
+ NNP O
to TO O
Lac NNP O
- : O
. . O

One CD O
of IN O
them PRP O
, , O
hT86 NN O
, , O
encoding VBG O
a DT O
putative JJ B-Gene
zinc NN I-Gene
finger NN I-Gene
protein NN I-Gene
was VBD O
found VBN O
to TO O
derepress VB O
beta SYM B-Gene
- : I-Gene
galactosidase NN I-Gene
activity NN O
in IN O
the DT O
Oct NNP B-Gene
- : I-Gene
2 CD I-Gene
- : O
harboring NN O
tester NN O
strain NN O
at IN O
the DT O
transcriptional JJ O
level NN O
. . O

Thus RB O
, , O
Tap NNP B-Gene
is VBZ O
likely JJ O
to TO O
be VB O
an DT O
important JJ O
cellular JJ O
mediator NN O
of IN O
Tip NNP B-Gene
function NN O
in IN O
T NNP O
cell NN O
transformation NN O
by IN O
herpesvirus NN O
saimiri NN O
. . O

Triggering VBG O
of IN O
the DT O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
receptor NN I-Gene
- : I-Gene
CD3 NNP I-Gene
complex JJ I-Gene
activates NNS O
two CD O
major JJ O
signal NN O
cascades NNS O
in IN O
T NNP O
lymphocytes NNS O
, , O
( ( O
i NN O
) ) O
Ca2 NNP O
+ NNP O
- : O
dependent JJ O
signal NN O
cascades NNS O
and CC O
( ( O
ii NN O
) ) O
protein NN B-Gene
kinase NN I-Gene
cascades NNS O
. . O

Both DT O
signal JJ O
cascades NNS O
contribute VBP O
to TO O
the DT O
induction NN O
of IN O
the DT O
interleukin JJ B-Gene
2 CD I-Gene
( ( I-Gene
IL NNP I-Gene
- : I-Gene
2 CD I-Gene
) ) I-Gene
gene NN I-Gene
during IN O
T NNP O
- : O
cell NN O
activation NN O
. . O

Functional JJ O
analysis NN O
of IN O
monocytic JJ O
THP NNP O
- : O
1 CD O
cells NNS O
transfected VBN O
with IN O
plasmids NNS B-Gene
containing VBG O
various JJ O
lengths NNS O
of IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
promoter NN I-Gene
localized VBD O
enhancer JJ B-Gene
elements NNS I-Gene
in IN O
a DT O
region NN O
( ( O
- : B-Gene
182 CD I-Gene
to TO I-Gene
- : I-Gene
37 CD I-Gene
base NN I-Gene
pairs NN I-Gene
( ( O
bp NN O
) ) O
) ) O
that WDT O
were VBD O
required VBN O
for IN O
optimal JJ O
transcription NN O
of IN O
the DT O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
gene NN I-Gene
in IN O
response NN O
to TO O
LPS NNP O
. . O

In IN O
unstimulated JJ O
THP NNP O
- : O
1 CD O
, , O
CRE NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
and CC O
, , O
to TO O
a DT O
lesser JJR O
extent NN O
, , O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
complexes NNS I-Gene
were VBD O
found VBN O
to TO O
bind VB O
to TO O
the DT O
CRE NNP B-Gene
site NN I-Gene
. . O

The DT O
CRE NNP B-Gene
and CC I-Gene
kappaB3 VB I-Gene
sites NNS I-Gene
in IN O
region NN B-Gene
II NNP I-Gene
together RB O
conferred VBD O
strong JJ O
LPS NNP O
responsiveness NN O
to TO O
a DT O
heterologous JJ B-Gene
promoter NN I-Gene
, , O
whereas WP O
individually RB O
they PRP O
failed VBD O
to TO O
provide VB O
transcriptional JJ O
activation NN O
. . O

Furthermore RB O
, , O
increasing VBG O
the DT O
spacing NN O
between IN O
the DT O
CRE NNP B-Gene
and CC I-Gene
the DT I-Gene
kappaB3 NN I-Gene
sites VBZ I-Gene
completely RB O
abolished VBN O
LPS NNP O
induction NN O
, , O
suggesting VBG O
a DT O
cooperative JJ O
interaction NN O
between IN O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
complexes NNS I-Gene
and CC O
p50 NN B-Gene
/ NNP I-Gene
p65 NN I-Gene
. . O

IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
/ JJ I-Gene
beta NN I-Gene
specifically RB O
induced JJ O
tyrosine NN O
phosphorylation NN O
and CC O
translocation NN O
into IN O
nucleus NN O
of IN O
signal JJ B-Gene
transducers NNS I-Gene
and CC I-Gene
activators NNS I-Gene
of IN I-Gene
transcription NN I-Gene
( ( I-Gene
STAT NNP I-Gene
) ) I-Gene
2 CD I-Gene
protein NN I-Gene
in IN O
the DT O
T NNP O
cell NN O
clones NNS O
. . O

IL NNP B-Gene
- : I-Gene
10 CD I-Gene
inhibition NN O
of IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
- : O
induced JJ O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
was VBD O
apparent JJ O
as RB O
early RB O
as IN O
3 CD O
hours NNS O
and CC O
was VBD O
blocked VBN O
by IN O
an DT O
anti JJ B-Gene
- : I-Gene
IL NNP I-Gene
- : I-Gene
10 CD I-Gene
antibody NN I-Gene
but CC O
not RB O
by IN O
an DT O
isotype JJ B-Gene
- : I-Gene
matched VBN I-Gene
control NN I-Gene
antibody NN I-Gene
. . O

The DT O
other JJ O
, , O
CIITA NNP B-Gene
, , O
encodes VBZ O
a DT O
large JJ O
protein NN O
with IN O
a DT O
defined JJ O
acidic JJ B-Gene
transcriptional JJ I-Gene
activation NN I-Gene
domain NN I-Gene
; : O
this DT O
protein NN O
does VBZ O
not RB O
interact VB O
with IN O
DNA NNP O
. . O

However RB O
, , O
these DT O
plasmids NNS B-Gene
produced VBD O
transcriptional JJ O
activity NN O
in IN O
HeLa NNP O
cells NNS O
only RB O
in IN O
conjunction NN O
with IN O
interferon NN B-Gene
gamma NN I-Gene
stimulation NN O
, , O
a DT O
condition NN O
in IN O
which WDT O
expression NN O
of IN O
both DT O
CIITA NNP B-Gene
and CC O
class NN B-Gene
II NNP I-Gene
major JJ I-Gene
histocompatibility NN I-Gene
complex JJ I-Gene
surface NN I-Gene
proteins NNS I-Gene
are VBP O
induced VBN O
. . O

Thus RB O
, , O
RFX5 NNP B-Gene
can MD O
activate VB O
transcription NN O
only RB O
in IN O
cooperation NN O
with IN O
CIITA NNP B-Gene
. . O

Phosphatidylinositol NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
( ( O
PI3 NNP B-Gene
- : I-Gene
K NNP I-Gene
) ) O
has VBZ O
been VBN O
implicated VBN O
in IN O
the DT O
regulation NN O
of IN O
cell NN O
proliferation NN O
in IN O
many JJ O
cell NN O
types NNS O
. . O

Acute NNP O
promyelocytic JJ O
leukemia NN O
( ( O
APL NNP O
) ) O
is VBZ O
associated VBN O
with IN O
reciprocal JJ O
chromosomal JJ O
translocations NNS O
involving VBG O
the DT O
retinoic NN B-Gene
acid NN I-Gene
receptor NN I-Gene
alpha NN I-Gene
( ( I-Gene
RARalpha NNP I-Gene
) ) I-Gene
locus NN I-Gene
on IN O
chromosome NN B-Gene
17 CD I-Gene
. . O

The DT O
resulting VBG O
fusion NN B-Gene
genes NNS I-Gene
encode VBP O
the DT O
two CD O
structurally RB O
unique JJ O
PML NNP B-Gene
/ NNP I-Gene
RARalpha NNP I-Gene
and CC O
RARalpha NNP B-Gene
/ NNP I-Gene
PML NNP I-Gene
fusion NN I-Gene
proteins NNS I-Gene
as RB O
well RB O
as IN O
aberrant JJ B-Gene
PML NNP I-Gene
gene NN I-Gene
products NNS I-Gene
, , O
the DT O
respective JJ O
pathogenetic JJ O
roles NNS O
of IN O
which WDT O
have VBP O
not RB O
been VBN O
elucidated VBN O
. . O

Interferon NNP O
- : O
gamma NN O
( ( O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
) ) O
is VBZ O
a DT O
key JJ O
cytokine NN O
of IN O
T NNP O
lymphocytes VBZ O
with IN O
major JJ O
regulatory JJ O
functions NNS O
in IN O
the DT O
immune NN O
system NN O
. . O

This DT O
novel JJ B-Gene
target NN I-Gene
site NN I-Gene
, , O
denoted VBD O
the DT O
C NNP B-Gene
- : I-Gene
site NN I-Gene
, , O
was VBD O
shown VBN O
by IN O
several JJ O
criteria NNS O
, , O
including VBG O
cell NN O
distribution NN O
studies NNS O
, , O
stimulation NN O
experiments NNS O
, , O
supershift NN O
assays NNS O
, , O
and CC O
cross SYM O
- : O
competition NN O
electrophoretic JJ O
mobility NN O
shift NN O
assays VBZ O
to TO O
bind VB O
the DT O
transcription NN B-Gene
factor NN I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
. . O

Mutation NN O
of IN O
the DT O
C NNP B-Gene
- : I-Gene
site NN I-Gene
that WDT O
prevented VBD O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
binding NN O
to TO O
this DT O
site NN O
was VBD O
sufficient JJ O
strikingly RB O
to TO O
reduce VB O
inducible JJ O
promoter NN O
activity NN O
in IN O
primary JJ O
CD45R0 NNP O
T NNP O
cells NNS O
. . O

Latent JJ O
infection NN O
of IN O
B NNP O
lymphocytes NNS O
by IN O
Epstein NNP O
- : O
Barr NNP O
virus NN O
( ( O
EBV NNP O
) ) O
can MD O
be VB O
disrupted VBN O
by IN O
expression NN O
of IN O
the DT O
EBV NNP B-Gene
ZEBRA NNP I-Gene
protein NN I-Gene
. . O

The DT O
studies NNS O
described VBD O
herein JJ O
demonstrate NN O
that IN O
the DT O
activation NN O
domain NN O
. . O

The DT O
involvement NN O
of IN O
the DT O
CCK NNP B-Gene
( ( I-Gene
B NNP I-Gene
) ) I-Gene
receptor NN I-Gene
in IN O
such JJ O
a DT O
stimulation NN O
was VBD O
demonstrated VBN O
by IN O
the DT O
inhibiting VBG O
effect NN O
of IN O
the DT O
selective JJ O
CCK NNP B-Gene
( ( I-Gene
B NNP I-Gene
) ) I-Gene
receptor NN I-Gene
antagonist NN O
PD NNP O
- : O
135 CD O
, , O
158 CD O
. . O

To TO O
better RBR O
understand VB O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
dependent JJ O
luciferase NN B-Gene
expression NN O
in IN O
Jurkat NNP O
T NNP O
cells NNS O
, , O
we PRP O
tested VBD O
two CD O
specific JJ O
inhibitors NNS O
of IN O
serine NN B-Gene
/ NNP I-Gene
threonine NN I-Gene
phosphatases VBZ I-Gene
- : I-Gene
1 CD I-Gene
and CC I-Gene
- : I-Gene
2A CD I-Gene
: : O
okadaic JJ O
acid NN O
and CC O
calyculin VB O
A NNP O
. . O

In IN O
Jurkat NNP O
T NNP O
cells NNS O
activated VBN O
by IN O
phorbol NN O
- : O
12 CD O
- : O
myristate NN O
- : O
13 CD O
- : O
acetate NN O
and CC O
phytohemagglutinin NN B-Gene
, , O
CCK NNP O
- : O
8 CD O
induced JJ O
IL NNP O
- : O
2 CD O
expression NN O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
CCK NNP O
- : O
8 CD O
exerts VBZ O
a DT O
trophic JJ O
effect NN O
in IN O
Jurkat NNP O
T NNP O
cells NNS O
through IN O
stimulation NN O
of IN O
CCK NNP B-Gene
( ( I-Gene
B NNP I-Gene
) ) I-Gene
receptors NNS I-Gene
by IN O
modulation NN O
of IN O
expression NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
regulated VBN I-Gene
genes NNS I-Gene
. . O

Binding VBG B-Gene
sites NNS I-Gene
at IN O
the DT O
core NN O
region NN O
show NN O
little JJ O
conservation NN O
with IN O
consensus NN B-Gene
sites NNS I-Gene
. . O

While IN O
the DT O
activation NN O
of IN O
JAK2 NNP B-Gene
, , O
Shc NNP B-Gene
, , O
Erk NNP B-Gene
, , O
and CC O
STAT5 NNP B-Gene
proteins NNS I-Gene
correlated VBN O
with IN O
hGM JJ B-Gene
- : I-Gene
CSF NNP I-Gene
- : O
mediated VBD O
cell NN O
growth NN O
, , O
cellular JJ O
differentiation NN O
occurred VBD O
in IN O
the DT O
absence NN O
of IN O
activation NN O
of IN O
these DT O
signal JJ O
transduction NN O
pathways NNS O
. . O

We PRP O
utilized VBD O
THP NNP O
- : O
1 CD O
cells NNS O
to TO O
examine VB O
the DT O
response NN O
to TO O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
with IN O
macrophage NN O
activation NN O
. . O

Molecular JJ O
cloning NN O
and CC O
characterization NN O
of IN O
a DT O
cDNA NN B-Gene
, , O
CHEMR1 NNP B-Gene
, , O
encoding VBG O
a DT O
chemokine NN B-Gene
receptor NN I-Gene
with IN O
a DT O
homology NN O
to TO O
the DT O
human JJ B-Gene
C NNP I-Gene
- : I-Gene
C NNP I-Gene
chemokine NN I-Gene
receptor NN I-Gene
, , O
CCR NNP B-Gene
- : I-Gene
4 CD I-Gene
. . O

Chemokines NNS B-Gene
refer VBP O
to TO O
a DT O
rapidly RB O
expanding VBG O
family NN O
of IN O
small JJ O
cytokines NNS B-Gene
whose WP$ O
primary JJ O
function NN O
is VBZ O
recruitment NN O
of IN O
leukocytes NNS O
to TO O
inflammatory VB O
sites NNS O
. . O

These DT O
are VBP O
known VBN O
to TO O
bind VB O
to TO O
seven CD B-Gene
- : I-Gene
transmembrane NN I-Gene
- : I-Gene
domain NN I-Gene
containing VBG I-Gene
receptors NNS I-Gene
. . O

Northern NNP O
blot NN O
analysis NN O
in IN O
mouse NN O
cell NN O
lines NNS O
suggests VBZ O
that IN O
its PRP$ O
expression NN O
is VBZ O
found VBN O
in IN O
a DT O
variety NN O
of IN O
cells NNS O
, , O
including VBG O
T NNP O
cells NNS O
, , O
B NNP O
cells NNS O
, , O
and CC O
macrophages NNS O
. . O

This DT O
suggests VBZ O
that IN O
CHEMR1 NNP B-Gene
may MD O
be VB O
a DT O
receptor NN O
for IN O
unidentified JJ O
C NNP B-Gene
- : I-Gene
C NNP I-Gene
chemokine NN I-Gene
or CC O
a DT O
low JJ O
- : O
affinity NN O
receptor NN O
for IN O
MIP NNP B-Gene
- : I-Gene
1alpha CD I-Gene
. . O

Its PRP$ O
N NNP B-Gene
- : I-Gene
terminal JJ I-Gene
region NN I-Gene
is VBZ O
capable JJ O
of IN O
activating VBG O
transcription NN O
from IN O
a DT O
reporter NN O
gene NN O
when WRB O
fused VBN O
to TO O
a DT O
DNA NN B-Gene
binding VBG I-Gene
domain NN I-Gene
. . O

To TO O
understand VB O
the DT O
mechanisms NN O
underlined VBD O
in IN O
this DT O
regulation NN O
in IN O
normal JJ O
human JJ O
cells NNS O
, , O
we PRP O
have VBP O
analysed VBN O
in IN O
vivo NN O
protein NN O
- : O
DNA NN O
interactions NNS O
at IN O
the DT O
Cyclin NNP B-Gene
A NNP I-Gene
locus NN O
in IN O
primary JJ O
T NNP O
lymphocytes NNS O
. . O

The DT O
third JJ O
site NN O
was VBD O
occupied VBN O
in IN O
quiescent JJ O
cells NNS O
or CC O
in IN O
cells NNS O
stimulated VBN O
by IN O
anti JJ B-Gene
CD2 NNP I-Gene
or CC O
anti JJ B-Gene
CD28 NNP I-Gene
alone RB O
. . O

We PRP O
have VBP O
recently RB O
reported VBN O
a DT O
series NN O
( ( O
A NNP O
) ) O
of IN O
1 CD O
, , O
25D3 CD O
- : O
resistant JJ O
variants NNS O
of IN O
HL60 NNP O
cells NNS O
which WDT O
proliferate VBP O
in IN O
the DT O
presence NN O
of IN O
1 CD O
, , O
25D3 CD O
and CC O
do VB O
not RB O
express VB O
differentiation NN O
markers NNS O
( ( O
Exp NNP O
. . O
Cell NNP O
Res NNP O
. . O
224 CD O
, , O
312 CD O
, , O
1996 CD O
) ) O
. . O

Human NNP B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
type NN I-Gene
1 CD I-Gene
( ( I-Gene
HIV NNP I-Gene
- : I-Gene
1 CD I-Gene
) ) I-Gene
Tat NNP I-Gene
, , O
an DT O
early JJ O
regulatory JJ B-Gene
protein NN I-Gene
that WDT O
is VBZ O
critical JJ O
for IN O
viral JJ O
gene NN O
expression NN O
and CC O
replication NN O
, , O
transactivates VBZ O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
( ( O
LTR NNP B-Gene
) ) O
via IN O
its PRP$ O
binding NN O
to TO O
the DT O
transactivation NN B-Gene
response NN I-Gene
element NN I-Gene
( ( O
TAR NNP B-Gene
) ) O
and CC O
, , O
along IN O
with IN O
other JJ O
cellular JJ O
factors NNS O
, , O
increases VBZ O
viral JJ O
transcription NN O
initiation NN O
and CC O
elongation NN O
. . O

In IN O
this DT O
study NN O
, , O
a DT O
combined JJ O
pharmacologic NN O
and CC O
genetic JJ O
strategy NN O
using VBG O
two CD O
PKC NNP B-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
) ) O
inhibitors NNS O
, , O
pentoxifylline NN O
( ( O
PTX NNP O
) ) O
and CC O
Go NNP O
- : O
6976 CD O
, , O
and CC O
a DT O
stably RB O
expressed VBN O
anti JJ B-Gene
- : I-Gene
Tat NN I-Gene
single JJ I-Gene
- : I-Gene
chain NN I-Gene
intracellular JJ I-Gene
antibody NN I-Gene
( ( O
sFv JJ B-Gene
intrabody NN I-Gene
) ) O
was VBD O
employed VBN O
to TO O
obtain VB O
cooperative JJ O
inhibition NN O
of IN O
both DT O
HIV NNP O
- : O
1 CD O
LTR NNP B-Gene
- : O
driven VBN O
gene NN O
expression NN O
and CC O
HIV NNP O
- : O
1 CD O
replication NN O
. . O

Treatment NN O
of IN O
cells NNS O
with IN O
PTX NNP O
and CC O
Go NNP O
- : O
6976 CD O
resulted VBD O
in IN O
cooperative JJ O
inhibition NN O
of IN O
both DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
- : O
driven VBN O
gene NN O
expression NN O
and CC O
HIV NNP O
- : O
1 CD O
replication NN O
. . O

The DT O
combined JJ O
treatment NN O
resulted VBD O
in IN O
more RBR O
durable JJ O
inhibition NN O
of IN O
HIV NNP O
- : O
1 CD O
replication NN O
than IN O
was VBD O
seen VBN O
with IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
inhibitors NNS O
alone RB O
or CC O
the DT O
anti JJ O
- : O
Tat NN B-Gene
sFv JJ I-Gene
intrabodies NNS I-Gene
alone RB O
. . O

CD28 NNP B-Gene
is VBZ O
an DT O
important JJ O
costimulatory NN B-Gene
molecule NN I-Gene
in IN O
the DT O
activation NN O
of IN O
human JJ O
T NNP O
cells NNS O
. . O

Also RB O
in IN O
the DT O
current JJ O
study NN O
, , O
binding VBG O
activity NN O
to TO O
the DT O
CD28RE NNP B-Gene
/ NNP I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
sequence NN I-Gene
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
is VBZ O
evaluated VBN O
. . O

These DT O
data NNS O
indicate VBP O
that IN O
functional JJ O
complexes NNS O
encompassing VBG O
both DT O
the DT O
CD28RE NNP B-Gene
and CC O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
influence VBP O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
activity NN O
in IN O
CD28 NNP B-Gene
- : O
costimulated VBD O
T NNP O
cells NNS O
. . O

Inducible JJ O
expression NN O
and CC O
phosphorylation NN O
of IN O
coactivator NN B-Gene
BOB NNP I-Gene
. . I-Gene
1 CD I-Gene
/ JJ I-Gene
OBF NNP I-Gene
. . I-Gene
1 CD I-Gene
in IN O
T NNP O
cells NNS O
[ NNP O
see VBP O
comments NNS O
] VB O

Upon IN O
activation NN O
of IN O
Jurkat NNP O
T NNP O
cells NNS O
and CC O
primary JJ O
murine NN O
thymocytes NNS O
with IN O
phorbol NN O
esters NNS O
and CC O
ionomycin NN O
, , O
BOB NNP B-Gene
. . I-Gene
1 CD I-Gene
/ JJ I-Gene
OBF NNP I-Gene
. . I-Gene
1 CD I-Gene
expression NN O
and CC O
transactivation NN O
function NN O
were VBD O
induced VBN O
. . O

Mutation NN O
of IN O
Ser184 NNP O
also RB O
diminished VBD O
transactivation NN O
function NN O
in IN O
B NNP O
cells NNS O
, , O
suggesting VBG O
that IN O
the DT O
activating VBG O
phosphorylation NN O
that WDT O
is VBZ O
inducible JJ O
in IN O
T NNP O
cells NNS O
is VBZ O
constitutively RB O
present JJ O
in IN O
B NNP O
cells NNS O
. . O

In IN O
fact NN O
, , O
the DT O
offspring NN O
of IN O
alcoholics NNS O
have VBP O
higher JJR O
levels NNS O
of IN O
G NNP B-Gene
( ( I-Gene
S NNP I-Gene
) ) I-Gene
alpha VBP I-Gene
expression NN O
in IN O
certain JJ O
tissues NNS O
compared VBN O
with IN O
the DT O
offspring NN O
of IN O
nonalcoholics NNS O
. . O

The DT O
aim NN O
of IN O
this DT O
research NN O
was VBD O
to TO O
test VB O
the DT O
hypothesis NN O
that IN O
a DT O
causal NN O
relationship NN O
exists VBZ O
between IN O
the DT O
level NN O
of IN O
expression NN O
of IN O
G NNP B-Gene
( ( I-Gene
S NNP I-Gene
) ) I-Gene
alpha NN I-Gene
and CC O
induction NN O
of IN O
the DT O
adenylyl JJ B-Gene
cyclase NN I-Gene
( ( O
AC NNP O
) ) O
cascade NN O
. . O

The DT O
methodology NN O
employed VBD O
transient JJ O
transfection NN O
of IN O
HEK NNP O
293 CD O
cells NNS O
with IN O
a DT O
cDNA NN O
for IN O
the DT O
52 CD O
- : O
kDa NN O
form NN O
of IN O
G NNP B-Gene
( ( I-Gene
S NNP I-Gene
) ) I-Gene
alpha NN I-Gene
under IN O
regulation NN O
by IN O
inducible JJ B-Gene
metallothionein NN I-Gene
promoters NNS I-Gene
. . O

VSMCs NNP O
derived VBD O
from IN O
human JJ O
coronary JJ O
atherosclerotic JJ O
plaques NNS O
that IN O
apoptose RB O
even RB O
in IN O
serum NN O
also RB O
generated VBD O
thrombin NN B-Gene
( ( O
AUC NNP O
of IN O
260 CD O
+ NNS O
/ SYM O
- : O
2 CD O
nmol JJ O
x NNP O
min NN O
/ NNP O
L NNP O
; : O
PT NNP O
of IN O
128 CD O
+ NNS O
/ SYM O
- : O
4 CD O
nmol JJ O
/ NNP O
L NNP O
) ) O
. . O

Patients NNS O
with IN O
one CD O
type NN O
of IN O
major JJ B-Gene
histocompatibility NN I-Gene
complex JJ I-Gene
class NN I-Gene
II NNP I-Gene
combined VBD O
immunodeficiency NN O
have VBP O
mutations NNS O
in IN O
a DT O
gene NN O
termed VBD O
class NN B-Gene
II NNP I-Gene
transactivator NN I-Gene
( ( O
CIITA NNP B-Gene
) ) O
, , O
which WDT O
coordinately RB O
controls VBZ O
the DT O
transcription NN O
of IN O
the DT O
three CD O
major JJ O
human JJ B-Gene
class NN I-Gene
II NNP I-Gene
genes NNS I-Gene
, , O
HLA NNP B-Gene
- : I-Gene
DR NNP I-Gene
, , I-Gene
- : I-Gene
DQ NN I-Gene
, , I-Gene
and CC I-Gene
- : I-Gene
DP NN I-Gene
. . O

We PRP O
report VBP O
here RB O
that IN O
ectopic JJ O
expression NN O
of IN O
CIITA NNP B-Gene
cDNAs NN I-Gene
derived VBN O
by IN O
reverse NN O
transcriptase NN O
polymerase NN O
chain NN O
reaction NN O
from IN O
clone NN O
13 CD O
do VBP O
not RB O
restore VB O
expression NN O
of IN O
HLA NNP B-Gene
- : I-Gene
DQ NN I-Gene
in IN O
another DT O
CIITA NNP O
- : O
deficient NN O
cell NN O
line NN O
, , O
RJ2 NNP O
. . O
2 CD O
. . O
5 CD O
. . O

In IN O
contrast NN O
, , O
somatic JJ O
cell NN O
fusion NN O
between IN O
clone NN O
13 CD O
and CC O
RJ2 NNP O
. . O
2 CD O
. . O
5 CD O
restored JJ O
expression NN O
of IN O
the DT O
HLA NNP B-Gene
- : I-Gene
DQ NNP I-Gene
haplotype NN O
encoded VBN O
by IN O
the DT O
RJ2 NNP B-Gene
. . I-Gene
2 CD I-Gene
. . I-Gene
5 CD I-Gene
DQB NNP I-Gene
gene NN I-Gene
. . O

The DT O
cytokines NNS B-Gene
interleukin FW B-Gene
( ( I-Gene
IL NNP I-Gene
) ) I-Gene
- : I-Gene
4 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
play NN O
a DT O
critical JJ O
role NN O
in IN O
inducing VBG O
Cepsilon NNP B-Gene
germline NN I-Gene
transcripts NNS I-Gene
and CC O
IgE NNP B-Gene
isotype NN I-Gene
switching VBG O
in IN O
human JJ O
B NNP O
cells NNS O
. . O

We PRP O
show VBP O
that IN O
ligand VBP O
- : O
induced JJ O
homodimerization NN O
of IN O
chimeric JJ B-Gene
surface NN I-Gene
receptors NNS I-Gene
consisting VBG O
of IN O
the DT O
extracellular JJ B-Gene
and CC I-Gene
transmembrane JJ I-Gene
domains NNS I-Gene
of IN O
the DT O
erythropoietin NN B-Gene
receptor NN I-Gene
and CC O
of IN O
the DT O
intracellular JJ B-Gene
domain NN I-Gene
of IN O
IL NNP B-Gene
- : I-Gene
4Ralpha CD I-Gene
induces NNS O
Janus NNP B-Gene
kinase VBD I-Gene
1 CD I-Gene
( ( O
Jak1 NNP B-Gene
) ) O
activation NN O
, , O
STAT6 NNP B-Gene
activation NN O
, , O
and CC O
Cepsilon NNP B-Gene
germline NN I-Gene
transcripts NNS I-Gene
in IN O
human JJ O
B NNP O
cell NN O
line NN O
BJAB NNP O
. . O

Characterization NN O
of IN O
peripheral JJ O
blood NN O
T NNP O
- : O
lymphocytes NNS O
transduced VBD O
with IN O
HTLV NNP B-Gene
- : I-Gene
I PRP I-Gene
Tax VBP I-Gene
mutants NNS I-Gene
with IN O
different JJ O
trans NNS O
- : O
activating VBG O
phenotypes NNS O
. . O

Analysis NN O
of IN O
these DT O
PBLs NNP O
revealed VBD O
that DT O
activation NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
pathway NN O
is VBZ O
sufficient JJ O
to TO O
promote VB O
the DT O
growth NN O
response NN O
to TO O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

Some DT O
of IN O
the DT O
most RBS O
potent JJ O
antiinflammatory NN O
and CC O
immunosuppressive JJ O
agents NNS O
are VBP O
synthetic JJ O
glucocorticoids NNS O
. . O

The DT O
development NN O
of IN O
improved VBN O
glucocorticoid NN O
- : O
based VBN O
drugs NNS O
will MD O
require VB O
the DT O
separation NN O
of IN O
beneficial JJ O
from IN O
deleterious JJ O
effects NNS O
. . O

One CD O
possibility NN O
toward IN O
this DT O
goal NN O
is VBZ O
to TO O
try VB O
to TO O
dissociate VB O
two CD O
main JJ O
activities NNS O
of IN O
glucocorticoids NNS O
, , O
i NN O
. . O
e NN O
. . O
transactivation NN O
and CC O
transrepression NN O
. . O

To TO O
understand VB O
the DT O
molecular JJ O
mechanisms NNS O
controlling VBG O
CD19 NNP B-Gene
gene NN O
expression NN O
, , O
we PRP O
isolated VBD O
and CC O
functionally RB O
characterized VBD O
the DT O
CD19 NNP B-Gene
promoter NN I-Gene
using VBG O
in IN O
vivo NN O
footprinting NN O
, , O
gel JJ O
shift NN O
assays NNS O
, , O
and CC O
transfection NN O
studies NNS O
. . O

EBF NNP B-Gene
and CC O
E47 NNP B-Gene
collaborate VBP O
to TO O
induce VB O
expression NN O
of IN O
the DT O
endogenous JJ B-Gene
immunoglobulin NN I-Gene
surrogate NN I-Gene
light NN I-Gene
chain NN I-Gene
genes NNS I-Gene
. . O

Taken VBN O
together RB O
, , O
these DT O
data NNS O
suggest VBP O
that IN O
EBF NNP B-Gene
and CC O
E47 NNP B-Gene
synergize VB O
to TO O
activate VB O
expression NN O
of IN O
a DT O
subset NN O
of IN O
genes NNS O
that WDT O
define VBP O
an DT O
early JJ O
stage NN O
of IN O
the DT O
B NNP O
cell NN O
lineage NN O
. . O

Treatment NN O
of IN O
cells NNS O
expressing VBG O
the DT O
chimeric JJ B-Gene
receptor NN I-Gene
kit NN B-Gene
/ NNP I-Gene
IL NNP I-Gene
- : I-Gene
4R CD I-Gene
alpha NN I-Gene
with IN O
SCF NNP B-Gene
induces NNS O
activation NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
4R CD I-Gene
alpha SYM I-Gene
- : I-Gene
associated VBN I-Gene
kinase NN I-Gene
JAK NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
the DT O
transcription NN B-Gene
factor NN I-Gene
STAT6 NNP B-Gene
. . O

Dose NNP O
- : O
dependence NN O
studies NNS O
using VBG O
histamine NN O
and CC O
dimaprit NN O
showed VBD O
that IN O
the DT O
EC50 NNP O
values NNS O
for IN O
cAMP NN O
production NN O
and CC O
c SYM B-Gene
- : I-Gene
fos JJ I-Gene
increase NN O
were VBD O
similar JJ O
, , O
suggesting VBG O
that IN O
cAMP NN O
might MD O
be VB O
involved VBN O
in IN O
c SYM B-Gene
- : I-Gene
fos JJ I-Gene
induction NN O
via IN O
H2 NNP B-Gene
receptors NNS I-Gene
. . O

BACKGROUND NN O
: : O
Activated VBN O
platelets NNS O
tether RB O
and CC O
activate VB O
myeloid NN O
leukocytes NNS O
. . O

Throughout IN O
the DT O
study NN O
period NN O
, , O
CD41 NNP O
immunofluorescence NN O
of IN O
leukocytes NNS O
( ( O
flow JJ O
cytometry NN O
) ) O
revealed VBD O
increased VBN O
leukocyte JJ O
- : O
platelet NN O
adhesion NN O
in IN O
patients NNS O
with IN O
AMI NNP O
compared VBN O
with IN O
control NN O
patients NNS O
( ( O
mean JJ O
+ NNP O
/ NNP O
- : O
SE NN O
of IN O
fluorescence NN O
[ NN O
channels NNS O
] VBP O
before IN O
PTCA NNP O
: : O
77 CD O
+ NN O
/ NNP O
- : O
16 CD O
versus NN O
35 CD O
+ NN O
/ NNP O
- : O
9 CD O
; : O
P NNP O
= NNP O
. . O
3 CD O
) ) O
. . O

After IN O
4 CD O
hours NNS O
, , O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
concentration NN O
of IN O
the DT O
cell NN O
- : O
free JJ O
supernatant NN O
had VBD O
increased VBN O
by IN O
268 CD O
+ NNS O
/ SYM O
- : O
36 CD O
% NN O
and CC O
210 CD O
+ NN O
/ NNP O
- : O
7 CD O
% NN O
, , O
respectively RB O
, , O
and CC O
cellular JJ O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
content NN O
had VBD O
increased VBN O
by IN O
170 CD O
+ NNS O
/ SYM O
- : O
8 CD O
% NN O
. . O

The DT O
present JJ O
work NN O
shows NNS O
that IN O
the DT O
primary JJ O
CD8 NNP O
+ NNP O
CTL NNP O
response NN O
to TO O
EBV NNP O
in IN O
infectious JJ O
mononucleosis NN O
patients NNS O
contains VBZ O
multiple JJ O
lytic JJ O
antigen NN O
- : O
specific JJ O
reactivities NNS O
at IN O
levels NNS O
at IN O
least JJS O
as RB O
high JJ O
as IN O
those DT O
seen VBN O
against IN O
latent JJ B-Gene
antigens NNS I-Gene
; : O
similar JJ O
reactivities NNS O
are VBP O
also RB O
detectable JJ O
in IN O
CTL NNP O
memory NN O
. . O

Clonal JJ O
analysis NN O
revealed VBD O
individual JJ O
responses NNS O
to TO O
the DT O
two CD O
immediate VBP B-Gene
early JJ I-Gene
proteins NNS I-Gene
BZLF1 NNP B-Gene
and CC O
BRLF1 NNP B-Gene
, , O
and CC O
to TO O
three CD O
( ( O
BMLF1 NNP B-Gene
, , O
BMRF1 NNP B-Gene
, , O
and CC O
BALF2 NNP B-Gene
) ) O
of IN O
the DT O
six CD O
early JJ B-Gene
proteins NNS I-Gene
tested VBN O
. . O

The DT O
unique JJ O
capacity NN O
of IN O
gamma NN O
- : O
herpesvirus NN O
to TO O
amplify VB O
the DT O
viral JJ O
load NN O
in IN O
vivo NN O
through IN O
a DT O
latent JJ O
growth NN O
- : O
transforming VBG O
infection NN O
may MD O
have VB O
rendered VBN O
these DT O
agents NNS O
less CC O
dependent JJ O
upon IN O
viral JJ O
replication NN O
as IN O
a DT O
means NN O
of IN O
successfully RB O
colonizing VBG O
their PRP$ O
hosts NNS O
. . O

Triggering VBG O
of IN O
HLA NNP B-Gene
class NN I-Gene
II NNP I-Gene
antigens NNS I-Gene
by IN O
the DT O
anti JJ B-Gene
- : I-Gene
HLA NNP I-Gene
- : I-Gene
DR NNP I-Gene
monoclonal JJ I-Gene
antibody NN I-Gene
( ( I-Gene
mAb NN I-Gene
) ) I-Gene
L243 NNP I-Gene
significantly RB O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
and CC O
differentially RB O
enhanced VBD O
the DT O
release NN O
of IN O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
by IN O
the DT O
non JJ O
- : O
Hodgkin NNP O
' POS O
s NN O
lymphoma NN O
cells NNS O
Ri NNP O
- : O
I PRP O
, , O
Ci NNP O
- : O
I PRP O
, , O
and CC O
Sc NNP O
- : O
I PRP O
, , O
which WDT O
are VBP O
at IN O
a DT O
distinct JJ O
stage NN O
of IN O
B NNP O
- : O
cell NN O
differentiation NN O
, , O
and CC O
by IN O
the DT O
more JJR O
mature JJ O
Burkitt NNP O
lymphoma NN O
cell NN O
Raji NNP O
; : O
in IN O
contrast NN O
, , O
it PRP O
did VBD O
not RB O
induce VB O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
release NN O
by IN O
the DT O
pre NN O
- : O
B NNP O
leukemia NN O
cells NNS O
Nalm NNP O
- : O
6 CD O
and CC O
BV173 NNP O
. . O

Altogether RB O
, , O
our PRP$ O
data NNS O
demonstrate NN O
that IN O
: : O
( ( O
a DT O
) ) O
the DT O
ability NN O
of IN O
B NNP O
cells NNS O
to TO O
release VB O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
after IN O
triggering VBG O
of IN O
HLA NNP B-Gene
- : I-Gene
DR NN I-Gene
antigens VBZ I-Gene
depends VBZ O
on IN O
their PRP$ O
stage NN O
of IN O
differentiation NN O
; : O
( ( O
b NN O
) ) O
levels NNS O
of IN O
released VBN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
seem VBP O
to TO O
correlate VB O
with IN O
the DT O
stage NN O
of IN O
B NNP O
- : O
cell NN O
maturation NN O
but CC O
do VBP O
not RB O
correlate VB O
with IN O
the DT O
amounts NNS O
of IN O
cell NN B-Gene
surface NN I-Gene
HLA NNP I-Gene
- : I-Gene
DR NNP I-Gene
antigens VBZ I-Gene
; : O
( ( O
c NN O
) ) O
secreted VBD O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
regulates VBZ O
the DT O
levels NNS O
of IN O
expression NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
by IN O
an DT O
autocrine JJ O
loop NN O
; : O
and CC O
( ( O
d NN O
) ) O
intracellular NN O
signals NNS O
mediating VBG O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
release NN O
by IN O
B NNP O
cells NNS O
are VBP O
distinct JJ O
from IN O
those DT O
regulating VBG O
homotypic JJ O
aggregation NN O
and CC O
proliferation NN O
. . O

To TO O
identify VB O
genes NNS O
that WDT O
are VBP O
expressed VBN O
in IN O
T NNP O
cells NNS O
after IN O
stimulation NN O
, , O
mRNA NN O
from IN O
T NNP O
lymphocytes VBZ O
that IN O
had VBD O
been VBN O
activated VBN O
by IN O
the DT O
simultaneous JJ O
stimulation NN O
of IN O
the DT O
CD3 NNP B-Gene
and CC O
CD28 NNP B-Gene
trigger NN O
molecules NNS O
was VBD O
transcribed VBN O
for IN O
a DT O
differential JJ O
mRNA NN O
display NN O
analysis NN O
into IN O
cDNA NN O
and CC O
was VBD O
compared VBN O
with IN O
cDNA NN O
from IN O
CD28 NNP B-Gene
- : O
or CC O
CD3 NNP B-Gene
- : O
activated VBD O
or CC O
resting VBG O
lymphocytes NNS O
. . O

The DT O
predictive JJ B-Gene
protein NN I-Gene
- : I-Gene
coding VBG I-Gene
region NN I-Gene
of IN O
RP1 NNP B-Gene
had VBD O
a DT O
significant JJ O
homology NN O
to TO O
members NNS O
of IN O
the DT O
recently RB O
found VBN O
adenomatous JJ B-Gene
polyposis NN I-Gene
coli NN I-Gene
( ( I-Gene
APC NNP I-Gene
) ) I-Gene
protein VBP I-Gene
- : I-Gene
binding NN I-Gene
EB1 NNP I-Gene
gene NN I-Gene
family NN I-Gene
, , O
which WDT O
codes VBZ O
for IN O
yet RB O
unknown JJ O
protein NN O
( ( O
s JJ O
) ) O
. . O

Bacterially RB O
expressed VBN O
RP1 NNP B-Gene
protein NN I-Gene
revealed VBD O
specific JJ O
binding VBG O
to TO O
wild VB B-Gene
- : I-Gene
type NN I-Gene
but CC O
not RB O
to TO O
mutated VBN B-Gene
APC NNP I-Gene
protein NN I-Gene
. . O

Cyclosporin NNP O
A NNP O
interferes VBZ O
with IN O
the DT O
inducible JJ O
degradation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
inhibitors NNS O
, , O
but CC O
not RB O
with IN O
the DT O
processing NN O
of IN O
p105 NN O
/ NNP O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B1 NNP I-Gene
in IN O
T NNP O
cells NNS O
. . O

We PRP O
show VBP O
for IN O
human JJ O
Jurkat NNP O
T NNP O
leukemia NN O
cells NNS O
, , O
as RB O
well RB O
as IN O
human JJ O
and CC O
mouse NN O
primary JJ O
T NNP O
lymphocytes VBZ O
, , O
that IN O
this DT O
inhibitory JJ O
effect NN O
is VBZ O
accompanied VBN O
by IN O
an DT O
impaired JJ O
nuclear JJ O
translocation NN O
of IN O
the DT O
Rel NNP B-Gene
proteins VBZ I-Gene
c SYM B-Gene
- : I-Gene
Rel NN I-Gene
, , O
RelA NNP B-Gene
/ NNP I-Gene
p65 NN I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B1 NNP I-Gene
/ NNP I-Gene
p50 NN I-Gene
, , O
whereas IN O
the DT O
nuclear JJ O
appearance NN O
of IN O
RelB NNP B-Gene
remains VBZ O
unaffected JJ O
. . O

Accordingly RB O
, , O
immunoblot NN O
experiments NNS O
showed VBD O
that IN O
amongst NN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
/ NNP B-Gene
Rel NNP I-Gene
proteins VBZ I-Gene
, , O
RelA NNP B-Gene
and CC O
p50 NN B-Gene
are VBP O
mobilized VBN O
to TO O
the DT O
nucleus NN O
following VBG O
microglial JJ O
cell NN O
stimulation NN O
with IN O
A NNP O
beta NN O
( ( O
25 CD O
- : O
35 CD O
) ) O
plus CC O
IFN NNP B-Gene
gamma NN I-Gene
. . O

Higher JJR O
concentrations NNS O
of IN O
A NNP O
beta NN O
( ( O
25 CD O
- : O
35 CD O
) ) O
were VBD O
effective JJ O
by IN O
themselves PRP O
in IN O
inducing VBG O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
, , O
both DT O
in IN O
the DT O
N9 NNP O
microglial NN O
cell NN O
line NN O
and CC O
in IN O
rat NN O
primary JJ O
microglia NN O
, , O
as RB O
well RB O
as IN O
in IN O
human JJ O
monocytes NNS O
. . O

For IN O
purposes NNS O
of IN O
comparison NN O
, , O
microglia NN O
were VBD O
also RB O
stimulated VBN O
with IN O
bacterial JJ O
LPS NNP O
, , O
a DT O
known VBN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
inducer NN O
. . O

As IN O
expected VBN O
, , O
LPS NNP O
strongly RB O
induced VBD O
the DT O
formation NN O
of IN O
two CD O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
DNA NNP O
- : O
binding NN O
activities NNS O
, , O
one CD O
of IN O
which WDT O
was VBD O
identified VBN O
as IN O
RelA NNP B-Gene
/ NNP I-Gene
p50 NN I-Gene
. . O

Collectively RB O
, , O
these DT O
findings NNS O
indicate VBP O
that IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
might MD O
constitute VB O
one CD O
of IN O
the DT O
mechanisms NNS O
underlying VBG O
the DT O
inducible JJ O
expression NN O
of IN O
kappa NN B-Gene
B NNP I-Gene
- : I-Gene
dependent NN I-Gene
genes NNS I-Gene
in IN O
microglia NN O
stimulated VBN O
by IN O
A NNP O
beta NN O
peptides NNS O
and CC O
IFN NNP B-Gene
gamma NN I-Gene
, , O
or CC O
by IN O
LPS NNP O
. . O

The DT O
persistence NN O
of IN O
TGF NNP O
- : O
beta1 NN O
- : O
transcribing NN O
macrophages NNS O
, , O
despite IN O
paralysis NN O
of IN O
T NNP O
cell NN O
function NN O
, , O
may MD O
provide VB O
an DT O
explanation NN O
for IN O
the DT O
chronicity NN O
of IN O
the DT O
disease NN O
, , O
and CC O
may MD O
identify VB O
a DT O
novel JJ O
therapeutic JJ O
target NN O
in IN O
this DT O
inflammatory NN O
vasculopathy NN O
. . O

We PRP O
have VBP O
generated VBN O
transgenic JJ O
mice NN O
that WDT O
express VBZ O
a DT O
catalytically RB B-Gene
inactive JJ I-Gene
form NN I-Gene
of IN O
Ca2 NNP B-Gene
+ NNP I-Gene
/ NNP I-Gene
calmodulin SYM I-Gene
- : I-Gene
dependent JJ I-Gene
protein NN I-Gene
kinase NN I-Gene
IV NNP I-Gene
( ( O
CaMKIV NNP B-Gene
) ) O
specifically RB O
in IN O
thymic JJ O
T NNP O
cells NNS O
. . O

We PRP O
isolated VBD O
a DT O
new JJ O
mouse NN B-Gene
gene NN I-Gene
that WDT O
is VBZ O
highly RB O
expressed VBN O
in IN O
thymocytes NNS O
, , O
testis NN O
, , O
and CC O
brain NN O
. . O

Rabbit NNP O
antiserum NN O
raised VBN O
against IN O
a DT O
COOH NNP O
- : O
terminal JJ O
polypeptide NN O
of IN O
the DT O
SRG3 NNP B-Gene
recognized VBD O
a DT O
protein NN O
with IN O
an DT O
apparent JJ O
molecular JJ O
mass NN O
of IN O
155 CD O
kD NNS O
. . O

The DT O
serum NN O
also RB O
detected VBD O
a DT O
170 CD B-Gene
- : I-Gene
kD NN I-Gene
protein NN I-Gene
that WDT O
seems VBZ O
to TO O
be VB O
a DT O
mouse NN O
homologue NN O
of IN O
human JJ B-Gene
BAF170 NNP I-Gene
. . O

Transcriptional JJ O
induction NN O
of IN O
collagenase NN B-Gene
- : I-Gene
1 CD I-Gene
in IN O
differentiated VBN O
monocyte NN O
- : O
like IN O
( ( O
U937 NNP O
) ) O
cells NNS O
is VBZ O
regulated VBN O
by IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
an DT O
upstream JJ B-Gene
C NNP I-Gene
/ NNP I-Gene
EBP NNP I-Gene
- : I-Gene
beta NN I-Gene
site NN I-Gene
. . O

Chloramphenicol NNP B-Gene
acetyltransferase NN I-Gene
expression NN I-Gene
constructs NNS I-Gene
containing VBG O
regions NNS O
of IN O
the DT O
human JJ B-Gene
collagenase NN I-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
were VBD O
stably RB O
or CC O
transiently RB O
transfected VBN O
into IN O
U937 NNP O
cells NNS O
, , O
and CC O
reporter NN O
activity NN O
was VBD O
assessed VBN O
at IN O
various JJ O
times NNS O
after IN O
the DT O
onset NN O
of IN O
phorbol NN O
12 CD O
- : O
myristate NN O
13 CD O
- : O
acetate NN O
( ( O
PMA NNP O
) ) O
- : O
mediated VBN O
differentiation NN O
. . O

In IN O
particular JJ O
, , O
Western JJ O
, , O
supershift NN O
, , O
and CC O
promoter NN O
deletion NN O
analyses NNS O
suggested VBD O
a DT O
role NN O
for IN O
CCAAT NNP B-Gene
/ NNP I-Gene
enhancer SYM I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
- : I-Gene
beta NN I-Gene
( ( I-Gene
C NNP I-Gene
/ NNP I-Gene
EBP NNP I-Gene
- : I-Gene
beta NN I-Gene
) ) I-Gene
binding VBG I-Gene
site NN I-Gene
between IN O
- : B-Gene
2010 CD I-Gene
and CC I-Gene
- : I-Gene
1954 CD I-Gene
in IN O
regulating VBG O
transcription NN O
of IN O
collagenase NN B-Gene
- : I-Gene
1 CD I-Gene
in IN O
monocytic JJ O
cells NNS O
. . O

It PRP O
has VBZ O
been VBN O
recently RB O
claimed VBD O
that IN O
polymorphism NN O
for IN O
the DT O
vitamin NN B-Gene
D NNP I-Gene
receptor NN I-Gene
( ( O
VDR NNP B-Gene
) ) O
influences VBZ O
several JJ O
aspects NNS O
of IN O
calcium NN O
and CC O
bone NN O
metabolism NN O
. . O

To TO O
evaluate VB O
the DT O
physiologic JJ O
plausibility NN O
of IN O
these DT O
claims NNS O
, , O
we PRP O
compared VBN O
the DT O
abundance NN O
of IN O
the DT O
VDR NNP B-Gene
mRNA NN I-Gene
in IN O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
( ( O
PBMCs NNP O
) ) O
between IN O
different JJ O
VDR NNP B-Gene
genotypes NNS I-Gene
using VBG O
a DT O
quantitative JJ O
reverse NN O
transcribed VBD O
polymerase NN O
chain NN O
reaction NN O
- : O
based VBN O
method NN O
. . O

The DT O
concentration NN O
of IN O
the DT O
VDR NNP B-Gene
mRNA NN I-Gene
, , O
corrected VBN O
for IN O
the DT O
number NN O
of IN O
monocytes NNS O
, , O
was VBD O
similar JJ O
among IN O
the DT O
three CD O
genotype NN O
groups NNS O
, , O
as IN O
were VBD O
the DT O
other JJ O
variables NNS O
examined VBN O
: : O
serum NN B-Gene
calcitriol NN I-Gene
, , O
serum NN B-Gene
osteocalcin NN I-Gene
, , O
and CC O
vertebral JJ O
and CC O
hip JJ O
bone NN O
density NN O
. . O

Both DT O
truncated VBD O
forms NNS O
also RB O
bound VBP O
to TO O
the DT O
transcription NN B-Gene
factor NN I-Gene
RBP NNP I-Gene
- : I-Gene
Jkappa NN I-Gene
in IN O
extracts NNS O
prepared VBN O
from IN O
human JJ O
and CC O
murine JJ O
T NNP O
- : O
ALL DT O
cell NN O
lines NNS O
. . O

Unexpectedly RB O
, , O
a DT O
second JJ O
, , O
stronger JJR O
RBP NNP B-Gene
- : I-Gene
Jkappa NNP I-Gene
- : I-Gene
binding NN I-Gene
site NN I-Gene
, , O
which WDT O
lies VBZ O
within IN O
the DT O
intracellular JJ B-Gene
domain NN I-Gene
close RB O
to TO O
the DT O
transmembrane NN O
region NN O
and CC O
significantly RB O
augments NNS O
association NN O
with IN O
RBP NNP B-Gene
- : I-Gene
Jkappa NNP I-Gene
, , O
was VBD O
not RB O
needed VBN O
for IN O
oncogenesis NN O
or CC O
for IN O
transcriptional JJ O
activation NN O
. . O

In IN O
support NN O
of IN O
this DT O
interpretation NN O
, , O
mutation NN O
of IN O
putative JJ O
nuclear JJ B-Gene
localization NN I-Gene
sequences NNS I-Gene
decreased VBD O
nuclear JJ O
localization NN O
and CC O
increased VBD O
transcriptional JJ O
activation NN O
by IN O
membrane NN B-Gene
- : I-Gene
bound NN I-Gene
DeltaE NNP I-Gene
. . O

These DT O
studies NNS O
have VBP O
indicated VBN O
that IN O
the DT O
individual JJ O
repeats NNS O
are VBP O
not RB O
identical JJ O
with IN O
respect NN O
to TO O
the DT O
cellular JJ B-Gene
factors NNS I-Gene
with IN O
which WDT O
they PRP O
interact VBP O
. . O

EMS NNP O
analyses VBZ O
utilizing VBG O
a DT O
series NN O
of IN O
mutated JJ B-Gene
pp NN I-Gene
repeat NN I-Gene
elements NNS I-Gene
demonstrate VBP O
that IN O
the DT O
nucleotide JJ O
sequence NN O
requirements NNS O
for IN O
U1 NNP B-Gene
( ( O
U1A NNP B-Gene
/ NNP I-Gene
U1B NNP I-Gene
) ) O
and CC O
U2 NNP B-Gene
formation NN O
are VBP O
separable JJ O
from IN O
those DT O
required VBN O
for IN O
C1 NNP B-Gene
- : I-Gene
C3 NNP I-Gene
formation NN O
. . O

EMS NNP O
supershift NN O
analyses NNS O
have VBP O
demonstrated VBN O
that IN O
Sp1 NNP B-Gene
is VBZ O
involved VBN O
in IN O
U1A NNP O
formation NN O
while IN O
Sp3 NNP B-Gene
is VBZ O
involved VBN O
in IN O
U1B NNP O
and CC O
U2 NNP O
formation NN O
. . O

In IN O
the DT O
adult NN O
bone NN O
marrow NN O
, , O
we PRP O
found VBD O
expression NN O
of IN O
runt NN O
polypeptides NNS O
in IN O
differentiating VBG O
myeloid JJ O
cells NNS O
and CC O
in IN O
B NNP O
lymphocytes NNS O
. . O

Signal JJ B-Gene
transducer NN I-Gene
and CC I-Gene
activator NN I-Gene
of IN I-Gene
transcription NN I-Gene
- : I-Gene
3 CD I-Gene
( ( O
STAT3 NNP B-Gene
) ) O
is VBZ O
constitutively RB O
activated VBN O
in IN O
normal JJ O
, , O
self PRP O
- : O
renewing VBG O
B NNP O
- : O
1 CD O
cells NNS O
but CC O
only RB O
inducibly RB O
expressed VBN O
in IN O
conventional JJ O
B NNP O
lymphocytes VBZ O
[ NNP O
see NN O
comments NNS O
] VB O

Cytokine NNP B-Gene
and CC O
growth NN B-Gene
factor NN I-Gene
receptor NN I-Gene
engagement NN O
leads VBZ O
to TO O
the DT O
rapid JJ O
phosphorylation NN O
and CC O
activation NN O
of IN O
latent NN O
, , O
cytosolic JJ B-Gene
signal NN I-Gene
transducers NNS I-Gene
and CC I-Gene
activators NNS I-Gene
of IN I-Gene
transcription NN I-Gene
( ( I-Gene
STAT NNP I-Gene
) ) I-Gene
proteins NNS I-Gene
, , O
which WDT O
then RB O
translocate VBP O
to TO O
the DT O
nucleus NN O
where WRB O
they PRP O
regulate VBP O
transcriptional JJ O
events NNS O
from IN O
specific JJ B-Gene
promoter NN I-Gene
sequences NNS I-Gene
. . O

B NNP O
- : O
1 CD O
lymphocytes NNS O
are VBP O
self JJ O
- : O
renewing NN O
, , O
CD5 NNP O
+ NNP O
B NNP O
cells NNS O
that WDT O
display VBP O
a DT O
propensity NN O
for IN O
malignant JJ O
transformation NN O
and CC O
are VBP O
the DT O
normal JJ O
counterpart NN O
to TO O
human JJ O
chronic JJ O
lymphocytic JJ O
leukemias NN O
. . O

Further RB O
, , O
B NNP O
- : O
1 CD O
cells NNS O
are VBP O
characterized VBN O
by IN O
aberrant JJ O
intracellular JJ O
signaling NN O
, , O
including VBG O
hyperresponsiveness NN O
to TO O
phorbol VB O
ester NN O
PKC NNP O
agonists NNS O
. . O

Induction NN O
of IN O
STAT3 NNP B-Gene
is VBZ O
inhibited VBN O
by IN O
both DT O
the DT O
serine NN O
/ NNP O
threonine NN O
protein NN O
kinase NN O
inhibitor NN O
H NNP O
- : O
7 CD O
and CC O
the DT O
immunosuppressive JJ O
drug NN O
rapamycin NN O
and CC O
requires VBZ O
de FW O
novo FW O
protein FW O
synthesis NN O
, , O
demonstrating VBG O
novel JJ O
coupling VBG O
between IN O
sIg NN B-Gene
and CC O
STAT NNP B-Gene
proteins VBZ I-Gene
that IN O
differs NNS O
from IN O
the DT O
classical JJ O
paradigm NN O
for IN O
STAT NNP B-Gene
induction NN O
by IN O
cytokine NN B-Gene
receptors NNS I-Gene
. . O

One CD O
of IN O
the DT O
potential JJ O
advantages NNS O
of IN O
autologous JJ O
PBSCT NNP O
is VBZ O
the DT O
possibility NN O
that IN O
peripheral JJ O
blood NN O
stem NN O
cells NNS O
( ( O
PBSC NNP O
) ) O
are VBP O
less RBR O
likely JJ O
to TO O
be VB O
contaminated VBN O
by IN O
leukemic JJ O
cells NNS O
than IN O
bone NN O
marrow NN O
grafts NNS O
. . O

This DT O
effect NN O
was VBD O
specifically RB O
due JJ O
to TO O
Tat NNP B-Gene
, , O
since IN O
Jurkat NNP O
and CC O
U937 NNP O
cells NNS O
cotransfected VBD O
either RB O
with IN O
tat JJ B-Gene
cDNA NN I-Gene
in IN O
antisense JJ O
orientation NN O
( ( O
tat JJ B-Gene
/ NNP I-Gene
AS NNP I-Gene
) ) O
, , O
tat EX B-Gene
carrying VBG O
a DT O
mutation NN O
in IN O
the DT O
aminoacid NN B-Gene
cys22 SYM I-Gene
- : I-Gene
gly22 NN I-Gene
( ( O
tat JJ B-Gene
22 CD I-Gene
/ NNP I-Gene
S NNP I-Gene
) ) O
or CC O
with IN O
the DT O
backbone NN B-Gene
vector NN I-Gene
alone RB I-Gene
( ( O
pRPneo JJ B-Gene
- : I-Gene
SL3 NN I-Gene
) ) O
did VBD O
not RB O
show VB O
any DT O
significant JJ O
difference NN O
in IN O
c JJ B-Gene
- : I-Gene
fos JJ I-Gene
promoter NN I-Gene
activity NN O
as IN O
compared VBN O
to TO O
cells NNS O
transfected VBN O
with IN O
FC3 NNP B-Gene
plasmid NN I-Gene
alone RB O
. . O

c SYM B-Gene
- : I-Gene
Fos NNP I-Gene
protein NN O
was VBD O
shown VBN O
essential JJ O
for IN O
an DT O
optimal JJ O
transactivation NN O
of IN O
the DT O
HIV NNP O
- : O
1 CD O
long JJ B-Gene
terminal JJ I-Gene
repeat NN I-Gene
( ( O
LTR NNP B-Gene
) ) O
by IN O
Tat NN B-Gene
: : O
incubation NN O
of IN O
Jurkat NNP O
cells NNS O
with IN O
antisense NN O
, , O
but CC O
not RB O
sense NN O
, , O
c SYM O
- : O
fos NN O
oligonucleotides VBZ O
significantly RB O
reduced VBN O
either CC O
the DT O
Tat NNP B-Gene
- : O
enhanced JJ O
expression NN O
of IN O
an DT O
LTR NNP B-Gene
- : I-Gene
CAT NNP I-Gene
reporter NN I-Gene
construct NN I-Gene
or CC O
the DT O
levels NNS O
of IN O
gag NN B-Gene
p24 NN I-Gene
in IN O
the DT O
culture NN O
supernatants NNS O
of IN O
Jurkat NNP O
cells NNS O
and CC O
PBMC NNP O
acutely RB O
infected VBD O
with IN O
HIV NNP O
- : O
1 CD O
. . O

Regulation NN O
of IN O
the DT O
tissue NN B-Gene
factor NN I-Gene
gene NN I-Gene
in IN O
human JJ O
monocytic JJ O
cells NNS O
. . O

Role NNP O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
/ NNP I-Gene
Rel NNP I-Gene
, , O
and CC O
Sp1 NNP B-Gene
proteins NNS O
in IN O
uninduced JJ O
and CC O
lipopolysaccharide JJ O
- : O
induced JJ O
expression NN O
. . O

The DT O
human JJ B-Gene
TF NNP I-Gene
promoter NN I-Gene
contains VBZ O
binding VBG O
sites NNS O
for IN O
the DT O
transcription NN O
factors NNS O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
c SYM B-Gene
- : I-Gene
Rel NNP I-Gene
/ NNP I-Gene
p65 NN I-Gene
, , O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
Sp1 NNP B-Gene
. . O

The DT O
two CD O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
sites NNS I-Gene
bound IN O
c SYM B-Gene
- : I-Gene
Fos NNP I-Gene
/ NNP I-Gene
c SYM I-Gene
- : I-Gene
Jun NN I-Gene
heterodimers NNS I-Gene
in IN O
both DT O
unstimulated JJ O
and CC O
LPS NNP O
- : O
stimulated VBD O
cells NNS O
. . O

Inhibitory JJ O
effect NN O
of IN O
growth NN O
hormone NN O
on IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
secretion NN O
and CC O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
translocation NN O
in IN O
lipopolysaccharide JJ O
- : O
stimulated VBN O
human JJ O
monocytes NNS O
. . O

The DT O
present JJ O
study NN O
demonstrates VBZ O
that IN O
human JJ O
THP NNP O
- : O
1 CD O
promonocytic JJ O
cells NNS O
, , O
engineered VBN O
by IN O
gene NN O
transfer NN O
to TO O
constitutively RB O
produce VB O
human JJ O
growth NN O
hormone NN O
( ( O
hGH NN O
) ) O
, , O
secreted VBD O
depressed JJ O
amounts NNS O
of IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
in IN O
response NN O
to TO O
challenge VB O
by IN O
LPS NNP O
. . O

Previously RB O
, , O
we PRP O
showed VBD O
that IN O
fibroblast NN O
conditioned VBD O
medium NN O
( ( O
FCM NNP O
) ) O
is VBZ O
able JJ O
to TO O
inhibit VB O
both DT O
TNF NNP B-Gene
mRNA NN I-Gene
accumulation NN O
and CC O
protein NN O
release NN O
in IN O
peripheral JJ O
blood NN O
- : O
derived VBN O
human JJ O
monocytes NNS O
( ( O
PBM NNP O
) ) O
stimulated VBD O
with IN O
lipopolysaccharide NN O
( ( O
LPS NNP O
) ) O
. . O

Furthermore RB O
, , O
we PRP O
show VBP O
that IN O
exogenous JJ O
PGE2 NNP O
mimics NNS O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
inhibitory JJ O
effect NN O
of IN O
FCM NNP O
. . O

Two CD O
main JJ O
pieces NNS O
of IN O
data NNS O
prompted VBD O
us PRP O
to TO O
focus VB O
on IN O
the DT O
activation NN O
of IN O
the DT O
platelet NN B-Gene
fibrinogen NN I-Gene
receptor NN I-Gene
, , O
the DT O
alphaIIbbeta3 NN B-Gene
integrin NN I-Gene
. . O

Immunoblot NN O
and CC O
flow JJ O
cytometry NN O
analysis NN O
revealed VBD O
a DT O
limited JJ O
proteolysis NN O
of IN O
the DT O
carboxyl JJ B-Gene
terminus NN I-Gene
of IN O
the DT O
alphaIIb NN B-Gene
subunit NN I-Gene
heavy JJ I-Gene
chain NN I-Gene
( ( O
alphaIIbH NN B-Gene
) ) O
, , O
as IN O
judged VBN O
by IN O
the DT O
disappearance NN O
of IN O
the DT O
epitope NN O
for IN O
the DT O
monoclonal JJ B-Gene
antibody NN I-Gene
PMI NNP I-Gene
- : I-Gene
1 CD I-Gene
. . O

Treatment NN O
by IN O
NE NNP B-Gene
of IN O
ATP NNP O
- : O
depleted VBN O
platelets NNS O
or CC O
Chinese JJ O
hamster NN O
ovary JJ O
cells NNS O
expressing VBG O
human JJ B-Gene
recombinant NN I-Gene
alphaIIbbeta3 VBD I-Gene
clearly RB O
established VBN O
that IN O
activation NN O
of IN O
the DT O
integrin NN B-Gene
was VBD O
independent JJ O
of IN O
signal JJ O
transduction NN O
events NNS O
and CC O
was VBD O
concomitant VBN O
with IN O
the DT O
proteolysis NN O
of IN O
alphaIIbH NN B-Gene
. . O

In IN O
contrast NN O
, , O
LAI NNP O
replicates VBZ O
well RB O
in IN O
memory NN O
CD4 NNP O
T NNP O
cells NNS O
stimulated VBN O
in IN O
the DT O
same JJ O
way NN O
. . O

These DT O
studies NNS O
were VBD O
conducted VBN O
with IN O
highly RB O
purified VBN O
( ( O
FACS NNP O
- : O
isolated VBN O
) ) O
subsets NNS O
of IN O
CD4 NNP O
T NNP O
cells NNS O
identified VBN O
by IN O
expression NN O
of IN O
both DT O
CD45RA NNP B-Gene
and CC O
CD62L NNP B-Gene
. . O

The DT O
suppression NN O
of IN O
productive JJ O
LAI NNP O
replication NN O
in IN O
naive JJ O
T NNP O
cells NNS O
is VBZ O
not RB O
due JJ O
to TO O
differential JJ O
expression NN O
of IN O
viral JJ B-Gene
coreceptors NNS I-Gene
, , O
nor CC O
is VBZ O
it PRP O
due JJ O
to TO O
inhibition NN O
of IN O
activation NN O
of IN O
the DT O
important JJ O
HIV NNP O
transcription NN B-Gene
factors NNS I-Gene
, , O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
activator NN B-Gene
protein VBP I-Gene
- : I-Gene
1 CD I-Gene
. . O

To TO O
test VB O
the DT O
hypothesis NN O
that IN O
the DT O
chimera NN B-Gene
PMLRAR NNP I-Gene
alpha NN I-Gene
plays VBZ O
a DT O
role NN O
in IN O
leukemogenesis NN O
, , O
we PRP O
expressed VBD O
a DT O
PMLRAR NNP B-Gene
alpha NN I-Gene
cDNA NN I-Gene
in IN O
myeloid JJ O
cells NNS O
of IN O
transgenic JJ O
mice NN O
. . O

Retinoic NNP O
acid NN O
caused VBD O
the DT O
leukemic JJ O
cells NNS O
to TO O
differentiate VB O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
, , O
eliciting VBG O
remissions NNS O
of IN O
both DT O
the DT O
preleukemic JJ O
state NN O
and CC O
APL NNP O
in IN O
mice NN O
. . O

Our PRP$ O
results NNS O
demonstrate VBP O
that IN O
PMLRAR NNP B-Gene
alpha VBP I-Gene
impairs NNS O
neutrophil JJ O
differentiation NN O
and CC O
initiates VBZ O
the DT O
development NN O
of IN O
APL NNP O
. . O

The DT O
transgenic JJ O
mice NN O
described VBD O
here RB O
provide VB O
an DT O
apparently RB O
accurate JJ O
model NN O
for IN O
human JJ O
APL NNP O
that WDT O
includes VBZ O
clear JJ O
evidence NN O
of IN O
tumor NN O
progression NN O
. . O

Such JJ O
hypermethylation NN O
- : O
associated VBN O
silencing NN O
of IN O
gene NN O
expression NN O
has VBZ O
been VBN O
shown VBN O
for IN O
several JJ O
genes NNS O
regulating VBG O
the DT O
growth NN O
and CC O
differentiation NN O
of IN O
hematopoietic JJ O
cells NNS O
, , O
including VBG O
the DT O
estrogen NN B-Gene
receptor NN I-Gene
( ( I-Gene
ER NNP I-Gene
) ) I-Gene
gene NN I-Gene
, , O
P15 NNP O
, , O
P16 NNP O
and CC O
others NNS O
. . O

The DT O
high JJ O
prevalence NN O
of IN O
promoter NN O
methylation NN O
suggests VBZ O
that IN O
this DT O
molecular JJ O
abnormality NN O
can MD O
be VB O
used VBN O
to TO O
monitor VB O
disease JJ O
activity NN O
during IN O
therapy NN O
. . O

Finally RB O
, , O
reactivation NN O
of IN O
tumor NN O
- : O
suppressor NN O
gene NN O
expression NN O
through IN O
pharmacologic JJ O
inhibition NN O
of IN O
DNA NNP B-Gene
methyltransferase NN I-Gene
and CC O
resultant JJ O
DNA NNP O
demethylation NN O
appears VBZ O
to TO O
be VB O
a DT O
promising JJ O
new JJ O
avenue NN O
of IN O
therapy NN O
in IN O
acute JJ O
leukemia NN O
. . O

Redox NNP O
regulation NN O
of IN O
the DT O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase VB I-Gene
pathway NN O
during IN O
lymphocyte JJ O
activation NN O
. . O

In IN O
earlier JJR O
studies NNS O
, , O
we PRP O
have VBP O
identified VBN O
the DT O
transcription NN B-Gene
factors NNS I-Gene
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
as IN O
molecular JJ O
targets NNS O
for IN O
oxidative JJ O
signalling NN O
processes NNS O
during IN O
cell NN O
cycle NN O
entry NN O
, , O
and CC O
have VBP O
shown VBN O
that IN O
oxidative JJ O
signalling NN O
is VBZ O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
early JJ O
changes NNS O
in IN O
gene NN O
expression NN O
during IN O
the DT O
G0 NNP O
to TO O
G1 NNP O
phase NN O
transition NN O
. . O

Using VBG O
the DT O
yeast NN O
two CD O
- : O
hybrid NN O
system NN O
to TO O
screen VB O
for IN O
proteins NNS O
which WDT O
interact VBP O
with IN O
Tax1 NNP B-Gene
, , O
we PRP O
isolated VBD O
the DT O
B NNP B-Gene
subunit NN I-Gene
of IN O
the DT O
CCAAT NNP B-Gene
binding NN I-Gene
protein NN I-Gene
NF NNP B-Gene
- : I-Gene
Y NN I-Gene
from IN O
a DT O
HeLa NNP B-Gene
cDNA NN I-Gene
library NN I-Gene
. . O

The DT O
interaction NN O
of IN O
Tax1 NNP B-Gene
with IN O
NF NNP B-Gene
- : I-Gene
YB NN I-Gene
was VBD O
specific JJ O
in IN O
that DT O
NF NNP B-Gene
- : I-Gene
YB NN I-Gene
did VBD O
not RB O
interact VB O
with IN O
a DT O
variety NN O
of IN O
other JJ O
transcription NN B-Gene
factors NNS I-Gene
, , O
including VBG O
human JJ B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
Tat NNP I-Gene
, , O
human JJ B-Gene
papillomavirus NN I-Gene
E6 NNP I-Gene
, , O
and CC O
Bicoid NNP B-Gene
, , O
or CC O
with IN O
the DT O
M7 NNP B-Gene
( ( I-Gene
amino JJ I-Gene
acids NNS I-Gene
29CP CD I-Gene
- : I-Gene
AS IN I-Gene
) ) I-Gene
Tax1 NNP I-Gene
mutant NN I-Gene
. . O

However RB O
, , O
NF NNP B-Gene
- : I-Gene
YB NN I-Gene
did VBD O
interact VB O
with IN O
the DT O
C NNP B-Gene
- : I-Gene
terminal JJ I-Gene
Tax1 NNP I-Gene
mutants NNS I-Gene
M22 NNP B-Gene
( ( O
130TL CD B-Gene
- : I-Gene
AS IN I-Gene
) ) O
and CC O
M47 NNP B-Gene
( ( O
319LL CD B-Gene
- : I-Gene
RS NN I-Gene
) ) O
. . O

Through IN O
activation NN O
of IN O
this DT O
and CC O
other JJ O
NF NNP B-Gene
- : I-Gene
Y NN I-Gene
driven JJ O
promoters NNS B-Gene
, , O
the DT O
Tax1 NNP B-Gene
- : B-Gene
NF NNP I-Gene
- : I-Gene
Y PRP$ I-Gene
interaction NN O
may MD O
play VB O
a DT O
critical JJ O
role NN O
in IN O
causing VBG O
cellular JJ O
transformation NN O
and CC O
HTLV NNP O
- : O
1 CD O
pathogenesis NN O
. . O

In IN O
murine JJ O
Ba NNP O
/ NNP O
F3 NNP O
cells NNS O
transfected VBN O
with IN O
the DT O
human JJ B-Gene
G NNP I-Gene
- : I-Gene
CSFR NN I-Gene
and CC O
NFS NNP O
- : O
60 CD O
cells NNS O
constitutively RB O
expressing VBG O
the DT O
murine NN B-Gene
G NNP I-Gene
- : I-Gene
CSFR NNP I-Gene
, , O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
induced VBD O
tyrosine JJ O
phosphorylation NN O
and CC O
activation NN O
of IN O
Jak1 NNP B-Gene
, , O
Jak2 NNP B-Gene
, , O
and CC O
Tyk2 NNP B-Gene
. . O

Using VBG O
a DT O
mitogenically RB B-Gene
incompetent JJ I-Gene
human JJ I-Gene
G NNP I-Gene
- : I-Gene
CSFR NNP I-Gene
mutant NN I-Gene
in IN O
which WDT O
Pro639 NNP O
and CC O
Pro641 NNP O
were VBD O
substituted VBN O
by IN O
alanine NN O
, , O
the DT O
box NN B-Gene
1 CD I-Gene
PDP NNP I-Gene
motif NN I-Gene
was VBD O
found VBN O
to TO O
be VB O
required VBN O
for IN O
activation NN O
of IN O
Jak NNP B-Gene
kinases NNS I-Gene
, , O
tyrosine JJ O
phosphorylation NN O
of IN O
the DT O
G NNP B-Gene
- : I-Gene
CSFR NNP I-Gene
, , O
and CC O
recruitment NN O
of IN O
Stat NNP B-Gene
proteins NNS I-Gene
. . O

Activation NN O
of IN O
the DT O
Jak NNP B-Gene
- : B-Gene
Stat NNP I-Gene
pathway NN O
correlates NNS O
with IN O
proliferative JJ O
signaling NN O
by IN O
the DT O
G NNP B-Gene
- : I-Gene
CSFR NN I-Gene
and CC O
requires VBZ O
the DT O
membrane NN B-Gene
- : I-Gene
proximal NN I-Gene
box NN I-Gene
1 CD I-Gene
PXP NNP I-Gene
motif NN I-Gene
, , O
which WDT O
is VBZ O
conserved VBN O
in IN O
members NNS O
of IN O
the DT O
cytokine NN B-Gene
receptor NN I-Gene
superfamily RB I-Gene
. . O

Impaired NNP O
induction NN O
of IN O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
/ NNP I-Gene
c SYM I-Gene
- : I-Gene
jun NN I-Gene
genes NNS I-Gene
and CC O
of IN O
transcriptional JJ B-Gene
regulatory JJ I-Gene
proteins NNS I-Gene
binding VBG O
distinct JJ O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
/ NNP I-Gene
c SYM I-Gene
- : I-Gene
jun NN I-Gene
promoter NN I-Gene
elements NNS I-Gene
in IN O
activated JJ O
human JJ O
T NNP O
cells NNS O
during IN O
aging VBG O
. . O

In IN O
addition NN O
, , O
RNase NNP B-Gene
protection NN O
assays NNS O
revealed VBD O
that IN O
anti JJ O
- : O
CD3 NNP O
/ NNP O
PMA NNP O
- : O
stimulated VBD O
T NNP O
cells NNS O
from IN O
a DT O
substantial JJ O
proportion NN O
of IN O
elderly JJ O
subjects NNS O
exhibited VBD O
decreased JJ O
levels NNS O
of IN O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
and CC I-Gene
/ NN I-Gene
or CC I-Gene
c SYM I-Gene
- : I-Gene
jun NN I-Gene
mRNA NN I-Gene
compared VBN O
to TO O
T NNP O
cells NNS O
from IN O
young JJ O
subjects NNS O
. . O

BACKGROUND NN O
: : O
Retinoic NNP O
acid NN O
( ( O
RA NNP O
) ) O
has VBZ O
important JJ O
immune NNS O
- : O
modulating VBG O
effects NNS O
on IN O
both DT O
T NNP O
and CC O
B NNP O
cell NN O
function NN O
. . O

CONCLUSION NN O
: : O
These DT O
studies NNS O
suggest VBP O
that IN O
RA NNP O
can MD O
augment VB O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
mRNA NN I-Gene
production NN O
by IN O
T NNP O
cells NNS O
with IN O
a DT O
possible JJ O
paracrine NN O
effect NN O
on IN O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
- : I-Gene
alpha NN I-Gene
expression NN O
. . O

Interleukin NNP B-Gene
- : I-Gene
6 CD I-Gene
levels NNS O
are VBP O
increased VBN O
in IN O
lung NN O
transplant NN O
patients NNS O
clinically RB O
diagnosed VBN O
with IN O
CMV NNP O
pneumonitis NN O
. . O

In IN O
contrast NN O
, , O
the DT O
RelA NNP B-Gene
( ( I-Gene
p65 NN I-Gene
) ) I-Gene
subunit NN I-Gene
was VBD O
barely RB O
detectable JJ O
in IN O
monocytes NNS O
, , O
but CC O
its PRP$ O
level NN O
increased VBD O
markedly RB O
in IN O
MDMs NNP O
. . O

In IN O
MDMs NNP O
, , O
an DT O
upregulation NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
synthesis NN O
as RB O
well RB O
as IN O
the DT O
appearance NN O
of IN O
a DT O
novel JJ O
M NNP O
( ( O
r NN O
) ) O
40 CD O
, , O
0 CD O
form NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
were VBD O
also RB O
observed VBN O
. . O

However RB O
, , O
the DT O
intensity NN O
of IN O
p65 NN B-Gene
labeling NN O
was VBD O
much JJ O
higher JJR O
in IN O
several JJ O
thymocytes NNS O
from IN O
the DT O
medulla NN O
. . O

p65 NN O
, , O
p50 NN O
, , O
and CC O
c SYM O
- : O
Rel JJ O
activities NNS O
were VBD O
found VBN O
in IN O
both DT O
CD4 NNP O
- : O
and CC O
CD8 NNP O
- : O
positive JJ O
thymocytes NNS O
. . O

These DT O
observations NNS O
suggest VBP O
that IN O
p65 NN B-Gene
and CC I-Gene
c SYM I-Gene
- : I-Gene
Rel NN I-Gene
complexes NNS I-Gene
play VBP O
distinct JJ O
roles NNS O
in IN O
gene NN O
expression NN O
and CC O
that IN O
both DT O
forms NNS O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
play NN O
critical JJ O
roles NNS O
during IN O
late JJ O
stages NNS O
of IN O
the DT O
intrathymic JJ O
maturation NN O
of IN O
T NNP O
cells NNS O
. . O

The DT O
function NN O
of IN O
LEF NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
dependent JJ O
, , O
in IN O
part NN O
, , O
on IN O
the DT O
HMG NNP B-Gene
domain NN I-Gene
that WDT O
induces VBZ O
a DT O
sharp JJ O
bend NN O
in IN O
the DT O
DNA NNP O
helix NN O
, , O
and CC O
on IN O
an DT O
activation NN B-Gene
domain NN I-Gene
that WDT O
stimulates VBZ O
transcription NN O
only RB O
in IN O
a DT O
specific JJ O
context NN O
of IN O
other JJ O
enhancer FW B-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
. . O

Overexpression NN O
of IN O
ALY NNP B-Gene
stimulates VBZ O
the DT O
activity NN O
of IN O
the DT O
TCR NNP B-Gene
alpha JJ I-Gene
enhancer NN I-Gene
complex NN I-Gene
reconstituted VBN O
in IN O
transfected JJ O
nonlymphoid JJ O
HeLa NNP O
cells NNS O
, , O
whereas VBP O
down RP O
- : O
regulation NN O
of IN O
ALY NNP B-Gene
by IN O
anti JJ O
- : O
sense NN O
oligonucleotides VBZ O
virtually RB O
eliminates VBZ O
TCR NNP B-Gene
alpha JJ I-Gene
enhancer NN I-Gene
activity NN O
in IN O
T NNP O
cells NNS O
. . O

AML1 NNP B-Gene
may MD O
play VB O
a DT O
role NN O
in IN O
growth NN O
and CC O
differentiation NN O
of IN O
cells NNS O
along IN O
erythroid NN O
and CC O
/ NN O
or CC O
megakaryocytic JJ O
lineages NNS O
, , O
because IN O
a DT O
significant JJ O
level NN O
of IN O
the DT O
AML1 NNP B-Gene
gene NN O
is VBZ O
expressed VBN O
in IN O
these DT O
cells NNS O
. . O

We PRP O
overexpressed VBD O
AML1a NNP B-Gene
( ( O
without IN O
the DT O
transcription NN B-Gene
- : I-Gene
activating VBG I-Gene
domain NN I-Gene
) ) O
and CC O
AML1b NNP B-Gene
( ( O
with IN O
the DT O
domain NN O
) ) O
proteins VBZ O
in IN O
K562 NNP O
leukemia NN O
cells NNS O
, , O
which WDT O
can MD O
be VB O
induced VBN O
to TO O
differentiate VB O
into IN O
hemoglobin JJ O
- : O
producing VBG O
cells NNS O
and CC O
megakaryocytes NNS O
. . O

The DT O
AML1a NNP O
- : O
transfected VBD O
K562 NNP O
cells NNS O
had VBD O
a DT O
reduced VBN O
capacity NN O
to TO O
differentiate VB O
in IN O
the DT O
presence NN O
of IN O
sodium NN O
n SYM O
- : O
butyrate NN O
but CC O
not RB O
in IN O
the DT O
presence NN O
of IN O
other JJ O
inducers NNS O
, , O
such JJ O
as IN O
hemin NN O
, , O
1 CD O
- : O
beta NN O
- : O
D NNP O
- : O
arabinofuranosylcyto NN O
, , O
and CC O
herbimycin VBZ O
A DT O
. . O

We PRP O
have VBP O
cloned VBN O
and CC O
sequenced VBD O
a DT O
portion NN O
of IN O
the DT O
ER NNP B-Gene
upstream JJ B-Gene
regulatory JJ I-Gene
region NN I-Gene
from IN O
the DT O
ER NNP O
- : O
positive JJ O
MCF NNP O
- : O
7 CD O
and CC O
the DT O
ER NNP O
- : O
negative JJ O
MDA NNP O
- : O
MB NNP O
- : O
231 CD O
breast NN O
cancer NN O
cell NN O
lines NNS O
to TO O
determine VB O
if IN O
sequence JJ O
alterations NNS O
in IN O
this DT O
region NN O
account NN O
for IN O
the DT O
ER NNP B-Gene
- : O
negative JJ O
phenotype NN O
of IN O
some DT O
tumors NNS O
. . O

The DT O
influence NN O
of IN O
the DT O
anti JJ O
- : O
allergy NN O
agent NN O
azelastine NN O
hydrochloride NN O
( ( O
Azeptin NNP O
) ) O
on IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
associated VBN O
with IN O
the DT O
generation NN O
of IN O
cytokines NNS B-Gene
and CC O
nitric JJ O
oxide NN O
( ( O
NO NNP O
) ) O
was VBD O
investigated VBN O
in IN O
various JJ O
kinds NNS O
of IN O
human JJ O
and CC O
mouse NN O
cells NNS O
. . O

In IN O
parallel NN O
with IN O
the DT O
decreased JJ O
cytokine NN B-Gene
generation NN O
, , O
each DT O
cytokine NN B-Gene
mRNA NN I-Gene
was VBD O
less JJR O
expressed VBN O
in IN O
the DT O
presence NN O
of IN O
10 CD O
( ( O
- : O
5 CD O
) ) O
M NNP O
Azeptin NNP O
. . O

In IN O
addition NN O
, , O
both DT O
inducible JJ O
nitric JJ B-Gene
oxide NN I-Gene
synthase NN I-Gene
- : O
mRNA NN O
level NN O
and CC O
NO DT O
generation NN O
in IN O
mouse NN O
peritoneal NN O
macrophages NNS O
were VBD O
suppressed VBN O
by IN O
10 CD O
( ( O
- : O
5 CD O
) ) O
M NNP O
Azeptin NNP O
. . O

Using VBG O
anti SYM B-Gene
- : I-Gene
C NNP I-Gene
/ NNP I-Gene
EBPbeta NNP I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
IL6 NN I-Gene
) ) O
, , O
anti SYM B-Gene
- : I-Gene
C NNP I-Gene
/ NNP I-Gene
EBPdelta NNP I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
IL6beta NN I-Gene
) ) O
, , O
anti SYM B-Gene
- : I-Gene
NF NNP I-Gene
- : I-Gene
ATc NNP I-Gene
, , O
anti SYM B-Gene
- : I-Gene
NF NNP I-Gene
- : I-Gene
ATp NNP I-Gene
, , O
anti SYM B-Gene
- : I-Gene
Fos NN I-Gene
, , O
and CC O
anti SYM B-Gene
- : I-Gene
Jun NNP I-Gene
Abs NNP I-Gene
we PRP O
demonstrate VBP O
that IN O
the DT O
previously RB O
identified VBN O
PRE NNP B-Gene
- : I-Gene
I PRP I-Gene
binding VBG I-Gene
factor NN I-Gene
POS NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
composed VBN O
of IN O
different JJ O
transcription NN B-Gene
factors NNS I-Gene
in IN O
different JJ O
Th NNP O
cell NN O
subsets NNS O
. . O

Different NNP O
cytokines NNS B-Gene
activate VBP O
transcription NN O
at IN O
the DT O
appropriate JJ O
germline NN B-Gene
promoter NN I-Gene
. . O

Experimental JJ O
expression NN O
in IN O
mice NN O
and CC O
spontaneous JJ O
expression NN O
in IN O
human JJ O
SLE NNP O
of IN O
polyomavirus NN B-Gene
T NNP I-Gene
- : I-Gene
antigen NN I-Gene
. . O

A DT O
molecular JJ O
basis NN O
for IN O
induction NN O
of IN O
antibodies NNS B-Gene
to TO O
DNA NNP O
and CC O
eukaryotic JJ B-Gene
transcription NN I-Gene
factors NNS I-Gene
. . O

We PRP O
have VBP O
previously RB O
demonstrated VBN O
that IN O
experimental JJ O
expression NN O
of IN O
the DT O
polyomavirus NN B-Gene
transcription NN I-Gene
factor NN I-Gene
T NNP I-Gene
- : I-Gene
antigen NN I-Gene
has VBZ O
the DT O
potential JJ O
to TO O
induce VB O
anti JJ B-Gene
- : I-Gene
DNA NN I-Gene
antibodies NNS I-Gene
in IN O
mice NN O
. . O

Two CD O
sets NNS O
of IN O
independent JJ O
evidences NNS O
are VBP O
presented VBN O
here RB O
that DT O
demonstrate VBP O
a DT O
biological JJ O
relevance NN O
for IN O
this DT O
model NN O
. . O

Secondly RB O
, , O
we PRP O
investigated VBD O
whether IN O
polyomavirus NN O
reactivation NN O
occurs VBZ O
in IN O
SLE NNP O
patients NNS O
, , O
and CC O
whether IN O
antibodies NNS B-Gene
to TO O
T NNP B-Gene
- : I-Gene
antigen NN I-Gene
, , O
DNA NNP O
, , O
and CC O
to TO O
TBP NNP B-Gene
and CC O
CREB NNP B-Gene
are VBP O
linked VBN O
to TO O
such JJ O
events NNS O
. . O

Both DT O
within IN O
and CC O
among IN O
these DT O
SLE NNP O
patients NNS O
, , O
frequent JJ O
polyomavirus NN O
reactivations NNS O
were VBD O
observed VBN O
that DT O
could MD O
not RB O
be VB O
explained VBN O
by IN O
certain JJ O
rearrangements NNS O
of IN O
the DT O
noncoding VBG O
control NN O
regions NNS O
, , O
nor CC O
by IN O
corticosteroid JJ O
treatment NN O
. . O

Antibodies NNS O
recognizing VBG O
double JJ O
- : O
stranded VBN O
DNA NN O
were VBD O
confined VBN O
to TO O
patients NNS O
with IN O
frequent JJ O
polyomavirus NN O
reactivations NNS O
. . O

The DT O
results NNS O
described VBD O
here RB O
indicate JJ O
that IN O
cognate JJ O
interaction NN O
of IN O
B NNP O
cells NNS O
recognizing VBG O
DNA NN O
or CC O
DNA NNP B-Gene
- : I-Gene
associated JJ I-Gene
proteins NNS I-Gene
and CC O
T NNP O
cells NNS O
recognizing VBG O
T NNP B-Gene
antigen NN I-Gene
had VBD O
taken VBN O
place NN O
as IN O
a DT O
consequence NN O
of IN O
complex JJ O
formation NN O
between IN O
T NNP B-Gene
ag NN I-Gene
and CC O
DNA NN O
in IN O
vivo NN O
in IN O
the DT O
context NN O
of IN O
polyomavirus NN O
reactivations NNS O
. . O

Intimate NNP O
interactions NNS O
between IN O
multipotential JJ O
hemopoietic JJ O
stem NN O
cells NNS O
and CC O
their PRP$ O
microenvironment NN O
work NN O
towards NNS O
redefining VBG O
the DT O
identity NN O
and CC O
the DT O
differentiative JJ O
fate NN O
of IN O
these DT O
primitive JJ O
cells NNS O
. . O

Thus RB O
, , O
gammac NN B-Gene
is VBZ O
not RB O
necessary JJ O
to TO O
trigger VB O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
- : O
mediated VBN O
responses NNS O
in IN O
B NNP O
cells NNS O
, , O
but CC O
its PRP$ O
presence NN O
is VBZ O
important JJ O
for IN O
optimal JJ O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
- : O
signaling NN O
. . O

Cell NNP O
- : O
to TO O
- : O
cell NN O
contact NN O
activates VBZ O
the DT O
long JJ B-Gene
terminal JJ I-Gene
repeat NN I-Gene
of IN O
human JJ O
immunodeficiency NN O
virus NN O
1 CD O
through IN O
its PRP$ O
kappaB NN B-Gene
motif NN I-Gene
. . O

Cell NNP O
- : O
to TO O
- : O
cell NN O
contact NN O
between IN O
peripheral JJ O
blood NN O
lymphocytes NNS O
and CC O
transfected JJ O
human JJ O
colonic JJ O
carcinoma NN O
cell NN O
line NN O
HT29 NNP O
activates VBZ O
transcription NN O
of IN O
the DT O
long JJ B-Gene
terminal JJ I-Gene
repeats NNS I-Gene
( ( O
LTR NNP B-Gene
) ) O
of IN O
human JJ O
immunodeficiency NN O
virus NN O
. . O

HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
transcription NN O
is VBZ O
controlled VBN O
by IN O
a DT O
complex JJ O
array NN O
of IN O
virus NN B-Gene
- : I-Gene
encoded VBN I-Gene
and CC I-Gene
cellular JJ I-Gene
proteins NNS I-Gene
. . O

Identification NN O
of IN O
nucleotide JJ B-Gene
sequences NNS I-Gene
that WDT O
regulate VBP O
transcription NN O
of IN O
the DT O
MCF13 NNP O
murine NN O
leukemia NN O
virus NN O
long JJ B-Gene
terminal JJ I-Gene
repeat NN I-Gene
in IN O
activated JJ O
T NNP O
cells NNS O
. . O

Differentiation NN O
of IN O
U NNP O
- : O
937 CD O
promonocytic JJ O
cells NNS O
by IN O
etoposide NN O
and CC O
ICRF NNP O
- : O
193 CD O
, , O
two CD O
antitumour VBP O
DNA NN B-Gene
topoisomerase NN I-Gene
II NNP I-Gene
inhibitors NNS O
with IN O
different JJ O
mechanisms NNS O
of IN O
action NN O
. . O

By IN O
contrast NN O
, , O
these DT O
effects NNS O
were VBD O
not RB O
observed VBN O
upon IN O
pulse JJ O
- : O
treatment NN O
with IN O
6 CD O
microM NNS O
ICRF NNP O
- : O
193 CD O
. . O

By IN O
contrast NN O
, , O
ICRF NNP O
- : O
193 CD O
only RB O
provoked VBD O
a DT O
late JJ O
activation NN O
( ( O
from IN O
hours NNS O
72 CD O
to TO O
96 CD O
) ) O
of IN O
the DT O
total JJ O
enzyme NN O
. . O

By IN O
contrast NN O
, , O
the DT O
binding NN O
activity NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
( ( I-Gene
B NNP I-Gene
) ) I-Gene
and CC O
EGR NNP B-Gene
- : I-Gene
1 CD I-Gene
transcription NN B-Gene
factors NNS I-Gene
was VBD O
little JJ O
affected JJ O
. . O

GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
DNA NNP O
binding NN O
activity NN O
is VBZ O
down RB O
- : O
regulated VBN O
in IN O
late JJ O
S NNP O
phase NN O
in IN O
erythroid JJ O
cells NNS O
. . O

These DT O
results NNS O
may MD O
also RB O
relate VB O
to TO O
recent JJ O
data NNS O
implicating VBG O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
function NN O
in IN O
apoptosis NN O
and CC O
cell NN O
cycle NN O
progression NN O

Activated VBN O
neutrophils NNS O
have VBP O
the DT O
ability NN O
to TO O
upregulate VB O
the DT O
expression NN O
of IN O
many JJ O
genes NNS O
, , O
in IN O
particular JJ O
those DT O
encoding VBG O
cytokines NNS B-Gene
and CC O
chemokines NNS B-Gene
, , O
and CC O
to TO O
subsequently RB O
release VB O
the DT O
corresponding JJ O
proteins NNS O
. . O

Following VBG O
neutrophil JJ O
stimulation NN O
with IN O
proinflammatory JJ O
agonists NNS O
( ( O
such JJ O
as IN O
lipopolysaccharide JJ O
[ NNP O
LPS NNP O
] NNP O
, , O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
[ NN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
] NN O
, , O
and CC O
fMet SYM O
- : O
Leu NNP O
- : O
Phe NN O
) ) O
that WDT O
induce VBP O
the DT O
production NN O
of IN O
cytokines NNS B-Gene
and CC O
chemokines NNS B-Gene
in IN O
these DT O
cells NNS O
, , O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
/ JJ I-Gene
Rel NNP I-Gene
proteins NNS I-Gene
translocated VBD O
to TO O
nuclear JJ O
fractions NNS O
, , O
resulting VBG O
in IN O
a DT O
transient JJ O
induction NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
DNA NNP O
binding NN O
activity NN O
, , O
as IN O
determined VBN O
in IN O
gel JJ O
mobility NN O
shift NN O
assays NNS O
. . O

The DT O
onset NN O
of IN O
both DT O
processes NNS O
was VBD O
found VBN O
to TO O
be VB O
closely RB O
paralleled VBN O
by IN O
, , O
and CC O
dependent NN O
on IN O
, , O
IkappaB NNP B-Gene
- : I-Gene
alpha NN I-Gene
degradation NN O
. . O

Two CD O
distinct JJ O
pathways NNS O
of IN O
interleukin JJ B-Gene
- : I-Gene
5 CD I-Gene
synthesis NN O
in IN O
allergen NN O
- : O
specific JJ O
human JJ O
T NNP O
- : O
cell NN O
clones NNS O
are VBP O
suppressed VBN O
by IN O
glucocorticoids NNS O
. . O

Glucocorticoids NNP O
( ( O
GC NNP O
) ) O
have VBP O
long RB O
been VBN O
used VBN O
as IN O
the DT O
most RBS O
effective JJ O
agents NNS O
for IN O
the DT O
treatment NN O
of IN O
allergic JJ O
diseases NNS O
accompanied VBN O
by IN O
eosinophilia NNS O
such JJ O
as IN O
chronic JJ O
asthma NN O
and CC O
atopic NN O
dermatitis NN O
. . O

GC NNP O
efficiently RB O
suppressed VBD O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
synthesis NN O
of IN O
T NNP O
- : O
cell NN O
clones NNS O
activated VBD O
via IN O
either DT O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
receptor NN I-Gene
( ( O
TCR NNP B-Gene
) ) O
or CC O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
receptor NN I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
) ) O
. . O

Stimulation NN O
of IN O
CD2 NNP B-Gene
or CC O
TCR NNP B-Gene
/ NNP I-Gene
CD3 NNP I-Gene
induced VBD O
activation NN O
of IN O
the DT O
nuclear JJ B-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
cells NNS I-Gene
( ( O
NFAT NNP B-Gene
) ) O
, , O
the DT O
binding VBG B-Gene
site NN I-Gene
of IN O
which WDT O
is VBZ O
included VBN O
in IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
promoter NN I-Gene
. . O

The DT O
LAZ3 NNP B-Gene
/ NNP I-Gene
BCL6 NNP I-Gene
transcript NN I-Gene
was VBD O
found VBN O
in IN O
a DT O
variety NN O
of IN O
tissues NNS O
, , O
including VBG O
skeletal JJ O
muscle NN O
, , O
peripheral JJ O
blood NN O
leukocytes NNS O
, , O
and CC O
weakly RB O
in IN O
normal JJ O
lymph NN O
nodes NNS O
. . O

IL NNP O
- : O
4 CD O
treatment NN O
rapidly RB O
induced VBD O
tyrosine JJ O
phosphorylation NN O
of IN O
insulin NN B-Gene
receptor NN I-Gene
substrate NN I-Gene
( ( I-Gene
IRS NNP I-Gene
) ) I-Gene
- : I-Gene
1 CD I-Gene
and CC O
IRS NNP B-Gene
- : I-Gene
2 CD I-Gene
in IN O
1D4 CD O
but CC O
not RB O
in IN O
E1C3 NNP O
cells NNS O
. . O

Nuclear JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
kB NN I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
) ) O
is VBZ O
a DT O
ubiquitous JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
and CC O
pleiotropic NN B-Gene
regulator NN I-Gene
of IN O
numerous JJ O
genes NNS O
involved VBN O
in IN O
the DT O
immune NN O
and CC O
inflammatory JJ O
responses NNS O
. . O

This DT O
transcription NN B-Gene
factor NN I-Gene
is VBZ O
activated VBN O
via IN O
the DT O
selective JJ O
phosphorylation NN O
, , O
ubiquination NN O
and CC O
degradation NN O
of IN O
its PRP$ O
inhibitor NN B-Gene
protein NN I-Gene
I PRP I-Gene
- : I-Gene
kB NN I-Gene
thereby RB O
allowing VBG O
translocation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
into IN O
the DT O
nucleus NN O
where WRB O
it PRP O
upregulates VBZ O
the DT O
transcription NN O
of IN O
a DT O
variety NN O
of IN O
adhesion NN B-Gene
molecules NNS I-Gene
( ( O
e NN O
. . O
g NN O
. . O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
, , O
cytokines NNS B-Gene
( ( O
TNF NNP B-Gene
, , O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
) ) O
and CC O
enzymes $ B-Gene
( ( O
iNOS NN B-Gene
) ) O
. . O

Based VBN O
upon JJ O
work NN O
from IN O
our PRP$ O
laboratory NN O
, , O
we PRP O
propose VBP O
that DT O
inhibition NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
produces VBZ O
significant JJ O
anti JJ O
inflammatory NN O
activity NN O
which WDT O
may MD O
be VB O
mediated VBN O
by IN O
the DT O
inhibition NN O
of IN O
transcription NN O
of IN O
certain JJ O
pro JJ B-Gene
- : I-Gene
inflammatory NN I-Gene
mediators NNS I-Gene
and CC O
adhesion NN B-Gene
molecules NNS I-Gene
. . O

Generation NN O
of IN O
cytotoxic JJ O
T NNP O
lymphocytes VBZ O
against IN O
immunorecessive JJ B-Gene
epitopes NNS I-Gene
after IN O
multiple JJ O
immunizations NNS O
with IN O
adenovirus JJ O
vectors NNS O
is VBZ O
dependent JJ O
on IN O
haplotype NN O
. . O

However RB O
, , O
the DT O
cytotoxic NN O
T NNP O
lymphocyte NN O
( ( O
CTL NNP O
) ) O
response NN O
to TO O
Ad NNP O
could MD O
limit VB O
the DT O
effectiveness NN O
of IN O
such JJ O
approaches NNS O
. . O

The DT O
immune JJ O
response NN O
to TO O
Ad NNP O
in IN O
BALB NNP O
/ NNP O
c VBD O
mice NN O
was VBD O
more RBR O
complex JJ O
. . O

Understanding VBG O
the DT O
cis NN B-Gene
- : I-Gene
and CC I-Gene
transacting VBG I-Gene
factors NNS I-Gene
that WDT O
regulate VBP O
the DT O
tissue NN O
- : O
specific JJ O
expression NN O
of IN O
PECAM NNP B-Gene
- : I-Gene
1 CD I-Gene
should MD O
increase VB O
our PRP$ O
understanding NN O
of IN O
the DT O
mechanisms NNS O
by IN O
which WDT O
vascular JJ O
- : O
specific JJ O
gene NN O
expression NN O
is VBZ O
achieved VBN O
. . O

However RB O
, , O
little JJ O
is VBZ O
known VBN O
about IN O
negative JJ O
regulation NN O
of IN O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
expression NN O
at IN O
the DT O
transcriptional JJ O
level NN O
, , O
which WDT O
may MD O
play VB O
an DT O
important JJ O
role NN O
in IN O
anti JJ O
- : O
inflammatory NN O
and CC O
immunosuppressive JJ O
effects NNS O
. . O

Interaction NN O
of IN O
transcription NN B-Gene
factors NNS I-Gene
RFX1 NNP B-Gene
and CC O
MIBP1 NNP B-Gene
with IN O
the DT O
gamma NN B-Gene
motif NN I-Gene
of IN O
the DT O
negative JJ B-Gene
regulatory JJ I-Gene
element NN I-Gene
of IN O
the DT O
hepatitis NN B-Gene
B NNP I-Gene
virus NN I-Gene
core NN I-Gene
promoter NN I-Gene
. . O

The DT O
negative JJ B-Gene
regulatory JJ I-Gene
element NN I-Gene
( ( O
NRE NNP B-Gene
) ) O
of IN O
the DT O
hepatitis NN B-Gene
B NNP I-Gene
virus NN I-Gene
( ( I-Gene
HBV NNP I-Gene
) ) I-Gene
core NN I-Gene
promoter NN I-Gene
contains VBZ O
three CD O
subregions NNS O
which WDT O
act VBP O
synergistically RB O
to TO O
suppress VB O
core NN O
promoter NN O
activity NN O
. . O

In IN O
addition NN O
, , O
RFX1 NNP B-Gene
can MD O
bind VB O
simultaneously RB O
, , O
most JJS O
likely RB O
as IN O
a DT O
heterodimer NN B-Gene
, , O
with IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
MIBP1 NNP B-Gene
to TO O
NRE NNP B-Gene
gamma NN I-Gene
. . O

Use NNP O
of IN O
arsenic JJ O
trioxide NN O
( ( O
As2O3 NNP O
) ) O
in IN O
the DT O
treatment NN O
of IN O
acute JJ O
promyelocytic JJ O
leukemia NN O
( ( O
APL NNP O
) ) O
: : O
II NN O
. . O

Pharmacokinetic JJ O
studies NNS O
, , O
which WDT O
were VBD O
performed VBN O
in IN O
eight CD O
patients NNS O
, , O
showed VBD O
that IN O
after IN O
a DT O
peak JJ O
level NN O
of IN O
5 CD O
. . O
54 CD O
micromol JJ O
/ NNP O
L NNP O
to TO O
7 CD O
. . O
30 CD O
micromol JJ O
/ NNP O
L NNP O
, , O
plasma NN O
arsenic NN O
was VBD O
rapidly RB O
eliminated VBN O
, , O
and CC O
the DT O
continuous JJ O
administration NN O
of IN O
As2O3 NNP O
did VBD O
not RB O
alter VB O
its PRP$ O
pharmacokinetic JJ O
behaviors NNS O
. . O

We PRP O
conclude VBP O
that IN O
As2O3 NNP O
treatment NN O
is VBZ O
an DT O
effective JJ O
and CC O
relatively RB O
safe JJ O
drug NN O
in IN O
APL NNP O
patients NNS O
refractory NN O
to TO O
ATRA NNP O
and CC O
conventional JJ O
chemotherapy NN O
. . O

LR1 NNP B-Gene
also RB O
binds VBZ O
Ig NNP B-Gene
heavy NN I-Gene
chain NN I-Gene
switch JJ O
region NN O
sequences NNS O
and CC O
may MD O
function VB O
in IN O
class NN O
switch NN O
recombination NN O
. . O

Both DT O
of IN O
these DT O
parameters NNS O
, , O
however RB O
, , O
did VBD O
not RB O
change VB O
significantly RB O
after IN O
mitogen NN B-Gene
stimulation NN O
. . O

There EX O
was VBD O
a DT O
significant JJ O
negative JJ O
correlation NN O
between IN O
IC50S NNP O
of IN O
prednisolone NN O
and CC O
increase VB O
- : O
ratios NNS O
( ( O
post NN O
/ NNP O
pre NN O
ratio NN O
) ) O
of IN O
Bmax NNP O
after IN O
mitogen NN B-Gene
stimulation NN O
( ( O
p JJ O
< NN O
0 CD O
. . O
5 CD O
) ) O
. . O

The DT O
Bmax NNP O
and CC O
Kd NNP O
were VBD O
not RB O
significantly RB O
changed VBN O
after IN O
mitogen NN B-Gene
stimulation NN O
in IN O
both DT O
subgroups NNS O
of IN O
CRF NNP O
. . O

The DT O
ZEBRA NNP B-Gene
protein NN I-Gene
from IN O
Epstein NNP O
- : O
Barr NNP O
virus NN O
( ( O
EBV NNP O
) ) O
activates VBZ O
a DT O
switch NN O
from IN O
the DT O
latent NN O
to TO O
the DT O
lytic JJ O
expression NN O
program NN O
of IN O
the DT O
virus NN O
. . O

The DT O
additional JJ O
function NN O
that WDT O
is VBZ O
required VBN O
for IN O
initiation NN O
of IN O
the DT O
lytic JJ O
viral JJ O
life NN O
cycle NN O
is VBZ O
likely JJ O
to TO O
require VB O
phosphorylation NN O
of IN O
serine JJ O
186 CD O
of IN O
the DT O
ZEBRA NNP B-Gene
protein NN I-Gene
, , O
which WDT O
may MD O
influence VB O
either CC O
DNA NNP O
recognition NN O
or CC O
transcriptional JJ O
activation NN O
of IN O
lytic JJ B-Gene
viral JJ I-Gene
promoters NNS I-Gene
in IN O
a DT O
chromatinized JJ B-Gene
viral JJ I-Gene
episome NN I-Gene
. . O

Immune NNP O
hyperactivation NN O
of IN O
HIV NNP O
- : O
1 CD O
- : O
infected VBN O
T NNP O
cells NNS O
mediated VBN O
by IN O
Tat NNP B-Gene
and CC O
the DT O
CD28 NNP B-Gene
pathway NN O
. . O

CONCLUSIONS NN O
: : O
The DT O
reduction NN O
of IN O
symptoms NNS O
due JJ O
to TO O
topical JJ O
fluticasone NN O
propionate NN O
in IN O
patients NNS O
with IN O
rhinitis NN O
and CC O
allergy NN O
to TO O
house NN O
dust NN O
mite NN O
is VBZ O
not RB O
correlated VBN O
with IN O
the DT O
characteristics NNS O
of IN O
the DT O
glucocorticoid JJ B-Gene
receptor NN I-Gene
. . O

Human NNP O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
replicates VBZ O
more RBR O
efficiently RB O
in IN O
vitro NN O
in IN O
differentiated JJ O
macrophages NNS O
than IN O
in IN O
freshly JJ O
isolated JJ O
monocytes NNS O
. . O

We PRP O
demonstrated VBD O
that IN O
constitutive JJ O
expression NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
primary JJ O
human JJ O
monocytes NNS O
changed VBD O
significantly RB O
with IN O
differentiation NN O
in IN O
vitro NN O
to TO O
monocyte VB O
- : O
derived VBN O
macrophages NNS O
( ( O
MDMs NNP O
) ) O
and CC O
differentiation NN O
in IN O
vivo NN O
to TO O
alveolar JJ O
macrophages NNS O
( ( O
AMs NNP O
) ) O
. . O

NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
- : O
independent JJ O
suppression NN O
of IN O
HIV NNP O
expression NN O
by IN O
ascorbic JJ O
acid NN O
. . O

Pretreatment NN O
of IN O
ACH NNP O
- : O
2 CD O
T NNP O
cells NNS O
by IN O
NAC NNP O
followed VBN O
by IN O
stimulation NN O
with IN O
PMA NNP O
, , O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
, , O
or CC O
hydrogen NN O
peroxide NN O
( ( O
H2O2 NNP O
) ) O
resulted VBD O
in IN O
strong JJ O
suppression NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
molecular JJ O
mechanism NN O
of IN O
HIV NNP O
inhibition NN O
by IN O
ascorbate NN O
is VBZ O
not RB O
mediated VBN O
via IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
inhibition NN O
, , O
unlike IN O
that DT O
seen VBN O
with IN O
other JJ O
antioxidants NNS O
. . O

A DT O
T NNP B-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
enhancer NN I-Gene
in IN O
the DT O
interleukin JJ B-Gene
- : I-Gene
3 CD I-Gene
locus NN I-Gene
is VBZ O
activated VBN O
cooperatively RB O
by IN O
Oct NNP B-Gene
and CC I-Gene
NFAT NNP I-Gene
elements NNS I-Gene
within IN O
a DT O
DNase NNP B-Gene
I PRP I-Gene
- : I-Gene
hypersensitive JJ I-Gene
site NN I-Gene
. . O

Interleukin NNP B-Gene
- : I-Gene
3 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
) ) O
is VBZ O
a DT O
cytokine NN B-Gene
that WDT O
is VBZ O
expressed VBN O
primarily RB O
in IN O
activated JJ O
T NNP O
cells NNS O
. . O

We PRP O
suggest VBP O
that IN O
the DT O
T NNP O
cell NN O
- : O
specific JJ O
expression NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
gene NN I-Gene
is VBZ O
partly RB O
controlled VBN O
through IN O
the DT O
enhancer NN O
by IN O
cooperation NN O
between IN O
Oct NNP B-Gene
and CC I-Gene
NFAT NNP I-Gene
family NN I-Gene
proteins NNS I-Gene
. . O

The DT O
adenovirus NN B-Gene
E1B NNP I-Gene
19K CD I-Gene
gene NN I-Gene
plays NNS O
an DT O
essential JJ O
role NN O
in IN O
transformation NN O
of IN O
primary JJ O
rodent NN O
cells NNS O
in IN O
cooperation NN O
with IN O
E1A NNP B-Gene
and CC O
in IN O
the DT O
inhibition NN O
of IN O
apoptosis NN O
during IN O
lytic JJ O
infection NN O
. . O

It PRP O
has VBZ O
been VBN O
shown VBN O
that IN O
this DT O
E1B NNP B-Gene
19K CD I-Gene
protein NN I-Gene
is VBZ O
not RB O
necessary JJ O
for IN O
viral JJ O
DNA NNP O
replication NN O
in IN O
human JJ O
cell NN O
lines NNS O
, , O
such JJ O
as IN O
HeLa NNP O
and CC O
KB NNP O
. . O

Activation NN O
of IN O
Ras NNP O
and CC O
mitogen SYM B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
pathway NN O
by IN O
terminal JJ B-Gene
complement NN I-Gene
complexes NNS I-Gene
is VBZ O
G NNP B-Gene
protein NN I-Gene
dependent NN O
. . O

Spontaneous JJ O
occurrence NN O
of IN O
early JJ O
region NN O
1A CD O
reiteration NN O
mutants NNS O
of IN O
type NN O
5 CD O
adenovirus NN O
in IN O
persistently RB O
infected VBN O
human JJ O
T NNP O
- : O
lymphocytes NNS O
. . O

Mutants NNS O
of IN O
type NN O
5 CD O
adenovirus NN O
( ( O
Ad5 NNP O
) ) O
with IN O
reiterated VBN B-Gene
DNA NN I-Gene
sequences NNS I-Gene
in IN O
the DT O
E1a NNP B-Gene
region NN I-Gene
appeared VBD O
in IN O
a DT O
human JJ O
T NNP O
- : O
lymphocyte NN O
cell NN O
line NN O
, , O
Molt NNP O
- : O
4 CD O
, , O
persistently RB O
infected VBN O
with IN O
H5sub304 NNP O
, , O
a DT O
deletion NN O
/ POS O
substitution NN O
mutant NN O
that WDT O
has VBZ O
a DT O
wild JJ O
- : O
type NN O
phenotype NN O
in IN O
viral JJ O
replication NN O
. . O

There EX O
was VBD O
not RB O
any DT O
DNA NNP O
homology NN O
between IN O
the DT O
breakpoints NNS O
in IN O
the DT O
second JJ O
exon NN B-Gene
and CC O
the DT O
inserting NN B-Gene
sequences NNS I-Gene
( ( O
starting VBG O
at IN O
nt JJ O
532 CD O
, , O
710 CD O
, , O
or CC O
792 CD O
) ) O
. . O

The DT O
observed JJ O
E1a NNP B-Gene
reiterations NNS I-Gene
provide VBP O
a DT O
model NN O
to TO O
gain VB O
insight JJ O
into IN O
understanding VBG O
the DT O
evolutionary JJ O
events NNS O
of IN O
some DT O
, , O
if IN O
not RB O
all DT O
, , O
adenovirus JJ O
types NNS O
during IN O
many JJ O
years NNS O
of IN O
symbiotic JJ O
, , O
persistent JJ O
relationship NN O
in IN O
human JJ O
tonsils NNS O
and CC O
adenoids NNS O
and CC O
possibly RB O
other JJ O
lymphoid JJ O
organs NNS O
. . O

Residues NNS O
432 CD O
, , O
435 CD O
, , O
437 CD O
, , O
438 CD O
, , O
and CC O
440 CD O
( ( O
position NN B-Gene
P1 NNP I-Gene
, , I-Gene
P4 NNP I-Gene
, , I-Gene
P6 NNP I-Gene
, , I-Gene
P7 NNP I-Gene
, , I-Gene
and CC I-Gene
P9 NNP I-Gene
) ) O
contributed VBD O
to TO O
DQ2 NNP B-Gene
binding NN O
, , O
whereas WP O
residues VBZ O
431 CD O
, , O
433 CD O
, , O
434 CD O
, , O
and CC O
436 CD O
( ( O
positions NNS B-Gene
P NNP I-Gene
1 CD I-Gene
, , I-Gene
P2 NNP I-Gene
, , I-Gene
P3 NNP I-Gene
, , I-Gene
and CC I-Gene
P5 NNP I-Gene
) ) O
contributed VBD O
to TO O
TCR NNP B-Gene
contact NN O
. . O

The DT O
hypothesis NN O
that IN O
the DT O
nuclear JJ B-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
cells NNS I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
) ) O
may MD O
influence VB O
HIV NNP O
- : O
1 CD O
replication NN O
is VBZ O
therefore RB O
compelling JJ O
given VBN O
the DT O
tight JJ O
correlation NN O
of IN O
HIV NNP O
- : O
1 CD O
transcriptional JJ O
induction NN O
to TO O
T NNP O
cell NN O
activation NN O
. . O

These DT O
results NNS O
link VBP O
regulatory JJ B-Gene
factors NNS I-Gene
critical JJ O
to TO O
T NNP O
cell NN O
commitment NN O
directly RB O
to TO O
HIV NNP O
- : O
1 CD O
replication NN O
. . O

eTh2 NN O
cells NNS O
are VBP O
the DT O
major JJ O
source NN O
of IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
while IN O
gamma JJ B-Gene
interferon NN I-Gene
is VBZ O
produced VBN O
by IN O
eTh1 JJ O
cells NNS O
. . O

However RB O
, , O
although IN O
NFAT NNP B-Gene
DNA NNP O
binding NN O
is VBZ O
similarly RB O
induced VBN O
in IN O
both DT O
eTh1 NN O
and CC O
eTh2 NN O
cells NNS O
upon IN O
antigen NN O
stimulation NN O
, , O
only RB O
the DT O
NFAT NNP B-Gene
complexes NNS I-Gene
present NN O
in IN O
eTh2 NN O
cells NNS O
are VBP O
able JJ O
to TO O
mediate VB O
high JJ O
- : O
level NN O
transcription NN O
, , O
and CC O
relatively RB O
little JJ O
NFAT NNP B-Gene
transcriptional JJ O
activity NN O
was VBD O
induced VBN O
in IN O
eTh1 JJ O
cells NNS O
. . O

The DT O
greater JJR O
selectivity NN O
of IN O
PF NNP O
, , O
compared VBN O
with IN O
FK506 NNP O
, , O
at IN O
both DT O
the DT O
molecular JJ O
and CC O
cellular JJ O
levels NNS O
may MD O
prove VB O
advantageous JJ O
in IN O
manipulating VBG O
T NNP O
cell NN O
responses NNS O
in IN O
vivo NN O
. . O

V3 NNP B-Gene
loop NN I-Gene
of IN O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
suppresses NNS O
interleukin VBP B-Gene
2 CD I-Gene
- : O
induced VBN O
T NNP O
cell NN O
growth NN O
[ NNP O
published VBN O
erratum NN O
appears VBZ O
in IN O
AIDS NNP O
Res NNP O
Hum NNP O
Retroviruses NNP O
1997 CD O
May NNP O
1 CD O
; : O
13 CD O
( ( O
7 CD O
) ) O
: : O
633 CD O
] NN O

V3 NNP B-Gene
- : I-Gene
BH10 NNP I-Gene
neither CC O
blocked VBD O
radiolabeled VBN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
binding NN O
to TO O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
receptors NNS I-Gene
nor CC O
affected JJ O
tyrosyl NN O
phosphorylation NN O
of IN O
several JJ O
cellular JJ B-Gene
proteins NNS I-Gene
( ( O
p120 NN B-Gene
, , O
p98 NN B-Gene
, , O
p96 NN B-Gene
, , O
p54 NN B-Gene
, , O
and CC O
p38 NN B-Gene
) ) O
, , O
which WDT O
is VBZ O
immediately RB O
induced VBN O
by IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
stimulation NN O
. . O

However RB O
, , O
V3 NNP B-Gene
- : I-Gene
BH10 NNP I-Gene
enhanced VBD O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
- : B-Gene
induced VBN I-Gene
mRNA JJ I-Gene
expression NN O
of IN O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
but CC O
not RB O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
or CC O
junB NN B-Gene
. . O

CONCLUSIONS NN O
: : O
Our PRP$ O
results NNS O
establish VB O
that IN O
PI NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
can MD O
both VB O
positively RB O
and CC O
negatively RB O
regulate VB O
T NNP O
- : O
cell NN O
function NN O
, , O
and CC O
uncover RB O
a DT O
previously RB O
unrecognized JJ O
function NN O
for IN O
PI NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
in IN O
T NNP O
cells NNS O
as IN O
a DT O
selective JJ O
negative JJ O
regulator NN O
of IN O
TCR NNP B-Gene
- : O
signalling VBG O
events NNS O
and CC O
therefore RB O
as IN O
a DT O
determinant NN O
of IN O
T NNP O
- : O
cell NN O
homeostasis NN O
. . O

Pax NNP B-Gene
- : I-Gene
5a CD I-Gene
was VBD O
detectable JJ O
in IN O
pro JJ O
- : O
, , O
pre SYM O
- : O
, , O
and CC O
mature NN O
B NNP O
- : O
cell NN O
lines NNS O
, , O
but CC O
not RB O
in IN O
two CD O
plasmacytomas NN O
; : O
Pax NNP B-Gene
- : I-Gene
5b CD I-Gene
was VBD O
shown VBN O
to TO O
be VB O
present JJ O
at IN O
low JJ O
levels NNS O
in IN O
mature NN O
B NNP O
- : O
cell NN O
lines NNS O
and CC O
, , O
unexpectedly RB O
, , O
in IN O
one CD O
plasma NN O
cell NN O
line NN O
, , O
but CC O
not RB O
in IN O
pro JJ O
- : O
B SYM O
- : O
cell NN O
or CC O
T NNP O
- : O
cell NN O
lines NNS O
. . O

The DT O
two CD O
related JJ O
protein NNS B-Gene
- : I-Gene
tyrosine NN I-Gene
kinases VBZ I-Gene
Syk NNP B-Gene
and CC O
Zap NNP B-Gene
are VBP O
rapidly RB O
phosphorylated VBN O
on IN O
tyrosine NN O
residues NNS O
and CC O
enzymatically RB O
activated VBN O
upon IN O
crosslinking NN O
of IN O
the DT O
T NNP B-Gene
cell NN I-Gene
antigen NN I-Gene
receptor NN I-Gene
. . O

One CD O
means VBZ O
of IN O
understanding VBG O
the DT O
role NN O
of IN O
p38 NN B-Gene
in IN O
these DT O
responses NNS O
is VBZ O
to TO O
identify VB O
proteins NNS O
with IN O
functions NNS O
regulated VBN O
by IN O
p38 JJ B-Gene
- : O
catalysed JJ O
phosphorylation NN O
. . O

Altogether RB O
, , O
these DT O
results NNS O
support VBD O
the DT O
hypothesis NN O
that IN O
the DT O
activation NN O
of IN O
NK NNP O
cells NNS O
involved VBN O
transcriptional JJ O
and CC O
post NN O
- : O
transcriptional JJ O
events NNS O
, , O
and CC O
that IN O
reactive JJ O
intermediates NNS O
may MD O
play VB O
an DT O
important JJ O
role NN O
in IN O
the DT O
molecular JJ O
processes NNS O
related VBN O
with IN O
the DT O
generation NN O
of IN O
a DT O
cytotoxic JJ O
response NN O
by IN O
NK NNP O
cells NNS O
. . O

The DT O
predominant JJ O
E2F NNP B-Gene
complex NN I-Gene
in IN O
human JJ O
primary JJ O
haemopoietic JJ O
cells NNS O
and CC O
in IN O
AML NNP O
blasts NNS O
contains VBZ O
E2F NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
DP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
p130 NN B-Gene
. . O

We PRP O
also RB O
studied VBD O
blasts NNS O
from IN O
18 CD O
patients NNS O
with IN O
acute JJ O
myeloid NN O
leukaemia NN O
( ( O
AML NNP O
) ) O
. . O

An DT O
E2F NNP B-Gene
- : I-Gene
4 CD I-Gene
/ JJ I-Gene
p130 NN I-Gene
complex NN I-Gene
was VBD O
detected VBN O
in IN O
representative JJ O
samples NNS O
of IN O
all DT O
FAB NNP B-Gene
types NNS O
analysed VBD O
. . O

Associated VBN O
with IN O
its PRP$ O
inhibitor NN O
, , O
I PRP B-Gene
kappaB VBP I-Gene
, , O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
resides NNS O
as IN O
an DT O
inactive JJ O
form NN O
in IN O
the DT O
cytoplasm NN O
. . O

The DT O
transduction NN O
pathways VBZ O
that IN O
lead NN O
to TO O
I PRP B-Gene
kappaB VB I-Gene
inactivation NN O
remain VBP O
poorly RB O
understood JJ O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
have VBP O
characterized VBN O
a DT O
cellular JJ O
mutant NN O
, , O
the DT O
70 CD O
/ NN O
Z3 NNP O
- : O
derived VBD O
1 CD O
. . O
300 CD O
murine NN O
pre NN O
- : O
B NNP O
cell NN O
line NN O
, , O
that WDT O
does VBZ O
not RB O
activate VB O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
response NN O
to TO O
several JJ O
stimuli NNS O
. . O

Our PRP$ O
results NNS O
demonstrate VBP O
that IN O
1 CD O
. . O
300 CD O
is VBZ O
a DT O
cellular JJ B-Gene
transduction NN I-Gene
mutant NN I-Gene
exhibiting VBG O
a DT O
defect NN O
in IN O
a DT O
step NN O
that WDT O
is VBZ O
required VBN O
by IN O
several JJ O
different JJ O
stimuli NNS O
to TO O
activate VB O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
. . O

In IN O
order NN O
to TO O
evaluate VB O
the DT O
conditions NNS O
for IN O
optimal JJ O
expression NN O
and CC O
immunogenicity NN O
of IN O
varicella NN B-Gene
- : I-Gene
zoster NN I-Gene
virus NN I-Gene
( ( I-Gene
VZV NNP I-Gene
) ) I-Gene
proteins VBZ I-Gene
in IN O
a DT O
herpes NNS O
simplex JJ O
virus SYM O
- : O
1 CD O
( ( O
HSV NNP O
- : O
1 CD O
) ) O
vector NN O
, , O
we PRP O
selected VBD O
the DT O
VZV NNP B-Gene
glycoprotein NN I-Gene
E NNP I-Gene
( ( O
gE NN B-Gene
) ) O
, , O
encoded VBN O
by IN O
ORF NNP B-Gene
68 CD I-Gene
and CC O
the DT O
VZV NNP B-Gene
product NN I-Gene
of IN O
ORF NNP B-Gene
62 CD I-Gene
, , O
an DT O
immediate JJ B-Gene
- : I-Gene
early JJ I-Gene
major JJ I-Gene
tegument NN I-Gene
protein NN I-Gene
( ( O
IE62 NNP B-Gene
) ) O
. . O

Immunoblot NNP O
analysis NN O
and CC O
immunoperoxidase NN O
staining NN O
of IN O
infected VBN O
cell NN O
monolayers NNS O
demonstrated VBD O
vector JJ O
expression NN O
of IN O
VZV NNP B-Gene
proteins NNS I-Gene
. . O

When WRB O
tested VBN O
in IN O
cytotoxicity NN O
assays NNS O
using VBG O
T NNP O
- : O
lymphocytes VBZ O
from IN O
VZV NNP O
immune JJ O
human JJ O
donors NNS O
, , O
the DT O
range NN O
of IN O
precursor NN O
frequencies NNS O
for IN O
T NNP O
- : O
lymphocytes VBZ O
that IN O
recognized VBN O
VZV NNP B-Gene
gE NN I-Gene
or CC O
VZV NNP B-Gene
IE62 NNP I-Gene
was VBD O
similar JJ O
whether IN O
these DT O
proteins NNS O
were VBD O
expressed VBN O
by IN O
HSV NNP O
- : O
1 CD O
or CC O
a DT O
vaccinia JJ O
vector NN O
. . O

In IN O
this DT O
report NN O
, , O
we PRP O
demonstrate VBP O
that IN O
the DT O
active JJ O
form NN O
of IN O
NF NNP B-Gene
- : I-Gene
AT1 NN I-Gene
is VBZ O
also RB O
present JJ O
in IN O
the DT O
nuclei NN O
of IN O
HTLV NNP O
- : O
I PRP O
- : O
transformed VBD O
T NNP O
cells NNS O
that WDT O
express VBP O
the DT O
Tax NNP B-Gene
protein NN I-Gene
. . O

Interestingly RB O
, , O
the DT O
constitutive JJ O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
AT1 NN I-Gene
in IN O
these DT O
T NNP O
cells NNS O
is VBZ O
associated VBN O
with IN O
its PRP$ O
dephosphorylation NN O
. . O

Expression NN O
of IN O
NFAT NNP B-Gene
- : I-Gene
family NN I-Gene
proteins VBZ I-Gene
in IN O
normal JJ O
human JJ O
T NNP O
cells NNS O
. . O

Higher JJR B-Gene
- : I-Gene
molecular JJ I-Gene
- : I-Gene
weight NN I-Gene
species NNS I-Gene
of IN O
NFATc NNP B-Gene
( ( O
of IN O
110 CD O
and CC O
140 CD O
kDa NN O
) ) O
were VBD O
also RB O
detected VBN O
. . O

In IN O
contrast NN O
to TO O
ionomycin VB O
treatment NN O
, , O
exposure NN O
of IN O
cells NNS O
to TO O
phorbol VB O
myristate JJ O
acetate NN O
( ( O
PMA NNP O
) ) O
plus CC O
anti JJ B-Gene
- : I-Gene
CD28 NN I-Gene
did VBD O
not RB O
induce VB O
NFATc NNP B-Gene
, , O
indicating VBG O
that IN O
under IN O
these DT O
conditions NNS O
, , O
interleukin VBP B-Gene
- : I-Gene
2 CD I-Gene
synthesis NN O
by IN O
these DT O
cells NNS O
is VBZ O
apparently RB O
independent JJ O
of IN O
NFATc NNP B-Gene
. . O

Cotransfection NN O
experiments NNS O
revealed VBD O
that IN O
both DT O
hGATA SYM B-Gene
- : I-Gene
4 CD I-Gene
and CC O
PMA NNP O
/ NNP O
A23187 NNP O
stimulation NN O
are VBP O
necessary JJ O
for IN O
the DT O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
promoter NN I-Gene
activation NN O
. . O

The DT O
requirement NN O
of IN O
another DT O
regulatory JJ B-Gene
element NN I-Gene
called VBN O
CLE0 NNP B-Gene
, , O
which WDT O
lies VBZ O
downstream NN O
of IN O
the DT O
- : B-Gene
70 CD I-Gene
GATA NNP I-Gene
site NN I-Gene
, , O
was VBD O
also RB O
demonstrated VBN O
. . O

The DT O
electrophoretic JJ O
mobility NN O
shift NN O
assay VBP O
with IN O
extracts NNS O
of IN O
COS NNP O
cells NNS O
expressing VBG O
GATA NNP B-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
showed VBD O
that IN O
GATA NNP B-Gene
- : I-Gene
4 CD I-Gene
has VBZ O
the DT O
highest JJS O
binding NN O
affinity NN O
to TO O
the DT O
- : B-Gene
70 CD I-Gene
GATA NNP I-Gene
site NN I-Gene
among IN O
the DT O
three CD O
GATA NNP B-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
. . O

These DT O
results NNS O
demonstrate VBP O
the DT O
selective JJ O
role NN O
of IN O
GATA NNP B-Gene
- : I-Gene
4 CD I-Gene
in IN O
the DT O
transcriptional JJ O
regulation NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
gene NN I-Gene
in IN O
a DT O
circumstance NN O
where WRB O
multiple JJ O
members NNS O
of IN O
the DT O
GATA NNP B-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
are VBP O
expressed VBN O
. . O

We PRP O
found VBD O
that IN O
NFATx1 NNP B-Gene
DNA NNP O
binding NN O
activity NN O
and CC O
interaction NN O
with IN O
AP NNP O
- : O
1 CD O
polypeptides NNS O
were VBD O
dependent JJ O
on IN O
its PRP$ O
central JJ B-Gene
Rel NNP I-Gene
similarity NN I-Gene
region NN I-Gene
and CC O
that IN O
transcriptional JJ O
activation NN O
was VBD O
reduced VBN O
by IN O
deletions NNS O
of IN O
either CC O
its PRP$ O
N NNP B-Gene
- : I-Gene
terminal NN I-Gene
domain NN I-Gene
or CC O
its PRP$ O
C NNP B-Gene
- : I-Gene
terminal NN I-Gene
domain NN I-Gene
, , O
suggesting VBG O
the DT O
presence NN O
of IN O
intrinsic JJ B-Gene
transcriptional JJ I-Gene
activation NN I-Gene
motifs NNS I-Gene
in IN O
both DT O
regions NNS O
. . O

NO DT O
is VBZ O
produced VBN O
from IN O
at IN O
least JJS O
three CD O
different JJ O
NO NNP B-Gene
synthase NN I-Gene
( ( I-Gene
NOS NNP I-Gene
) ) I-Gene
isoforms NNS I-Gene
: : O
neuronal JJ B-Gene
NOS NNP I-Gene
( ( O
nNOS NN B-Gene
) ) O
, , O
endothelial JJ B-Gene
NOS NNP I-Gene
, , O
and CC O
immunologic JJ B-Gene
NOS NNP I-Gene
( ( O
iNOS NN B-Gene
) ) O
. . O

Pyrrolidine NNP O
dithiocarbamate NN O
( ( O
PDTC NNP O
) ) O
is VBZ O
an DT O
inhibitor NN O
of IN O
NF NNP B-Gene
kappaB NN I-Gene
in IN O
most JJS O
cells NNS O
; : O
however RB O
, , O
we PRP O
show VBP O
that IN O
PDTC NNP O
is VBZ O
also RB O
a DT O
potent JJ O
scavenger NN O
of IN O
NO NNP O
through IN O
formation NN O
of IN O
mononitrosyl NN O
iron NN O
complexes NNS O
with IN O
PDTC NNP O
. . O

Contrary JJ O
to TO O
the DT O
results NNS O
in IN O
Jurkat NNP O
cells NNS O
, , O
PDTC NNP O
did VBD O
not RB O
inhibit VB O
tumor JJ B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
- : O
induced JJ O
NF NNP B-Gene
kappaB NN I-Gene
activation NN O
in IN O
astrocytes NNS O
; : O
instead RB O
PDTC NNP O
itself PRP O
induces VBZ O
NF NNP B-Gene
kappaB NNP I-Gene
activation NN O
in IN O
astrocytes NNS O
, , O
and CC O
this DT O
may MD O
be VB O
related VBN O
to TO O
scavenging VBG O
of IN O
endogenously RB O
produced VBN O
NO NNP O
by IN O
the DT O
PDTC NNP O
iron NN O
complex NN O
. . O

In IN O
astrocytes NNS O
PDTC NNP O
also RB O
dramatically RB O
induces VBZ O
the DT O
NF NNP B-Gene
kappaB NNP I-Gene
- : I-Gene
dependent NN I-Gene
enzyme NN I-Gene
, , O
iNOS NN B-Gene
, , O
supporting VBG O
the DT O
physiologic JJ O
relevance NN O
of IN O
endogenous JJ O
NO NNP O
regulation NN O
of IN O
NF NNP B-Gene
kappaB NN I-Gene
. . O

Involvement NN O
of IN O
Stat3 NNP B-Gene
in IN O
interleukin JJ B-Gene
- : I-Gene
6 CD I-Gene
- : O
induced JJ O
IgM NNP B-Gene
production NN O
in IN O
a DT O
human JJ O
B NNP O
- : O
cell NN O
line NN O
. . O

EGF NNP O
treatment NN O
induced VBD O
IgM NNP B-Gene
production NN O
in IN O
cells NNS O
transfected VBN O
with IN O
an DT O
intact JJ O
gp130 JJ B-Gene
cytoplasmic JJ I-Gene
tail NN I-Gene
, , O
but CC O
not RB O
in IN O
untransfected JJ O
cells NNS O
or CC O
cells NNS O
transfected VBN O
with IN O
a DT O
cytoplasmic JJ B-Gene
tail NN I-Gene
lacking VBG O
all DT O
four CD O
signal NN B-Gene
transducers NNS I-Gene
and CC I-Gene
activators NNS I-Gene
of IN I-Gene
transcription NN I-Gene
( ( I-Gene
Stat NNP I-Gene
) ) I-Gene
binding VBG I-Gene
sites NNS I-Gene
. . O

Moreover RB O
, , O
EGF NNP O
treatment NN O
induced VBD O
Stat3 NNP B-Gene
phosphorylation NN O
in IN O
cells NNS O
transfected VBN O
with IN O
the DT O
intact JJ O
chimeric JJ B-Gene
EGF NNP I-Gene
- : I-Gene
gp130 NN I-Gene
receptor NN I-Gene
along IN O
with IN O
induction NN O
of IN O
DNA NNP O
- : O
mobility NN O
shift NN O
of IN O
a DT O
classical JJ B-Gene
interferon NN I-Gene
- : I-Gene
gamma NN I-Gene
- : I-Gene
activated VBN I-Gene
site NN I-Gene
. . O

The DT O
in IN O
vitro JJ O
transendothelial JJ O
migration NN O
of IN O
circulating VBG O
filarial JJ O
antigen NN O
- : O
specific JJ O
T NNP O
- : O
cells NNS O
was VBD O
examined VBN O
in IN O
Wuchereria NNP O
banerofti NN O
infection NN O
. . O

This DT O
cis JJ B-Gene
element NN I-Gene
binds VBZ O
a DT O
protein NN O
complex NN O
referred VBD O
to TO O
as IN O
HRF NNP B-Gene
( ( O
heme JJ B-Gene
- : I-Gene
responsive JJ I-Gene
factor NN I-Gene
) ) O
, , O
which WDT O
is VBZ O
greatly RB O
enhanced JJ O
both DT O
in IN O
heme NN O
- : O
treated VBN O
FLCs NNP O
and CC O
during IN O
monocyte JJ O
- : O
to TO O
- : O
macrophage NN O
differentiation NN O
. . O

One CD O
of IN O
the DT O
latter JJ O
elements NNS O
, , O
the DT O
IgH NNP B-Gene
3 CD I-Gene
' '' I-Gene
enhancer NN I-Gene
, , O
is VBZ O
of IN O
particular JJ O
interest NN O
: : O
( ( O
1 CD O
) ) O
it PRP O
is VBZ O
B NNP O
cell NN O
- : O
specific NN O
and CC O
active JJ O
only RB O
in IN O
late JJ O
B NNP O
cell NN O
development NN O
; : O
( ( O
2 CD O
) ) O
in IN O
rodent NN O
plasmacytomas NN O
and CC O
in IN O
some DT O
human JJ O
Burkitt NNP O
' POS O
s NN O
lymphomas NN O
it PRP O
is VBZ O
part NN O
of IN O
a DT O
locus NN B-Gene
control NN I-Gene
region NN I-Gene
( ( O
LCR NNP B-Gene
) ) O
that WDT O
is VBZ O
involved VBN O
in IN O
deregulation NN O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
myc NN I-Gene
oncogene NN I-Gene
as IN O
a DT O
result NN O
of IN O
translocation NN O
into IN O
the DT O
IgH NNP B-Gene
locus NN I-Gene
; : O
and CC O
( ( O
3 CD O
) ) O
it PRP O
has VBZ O
been VBN O
implicated VBN O
in IN O
the DT O
mechanisms NNS O
that WDT O
control VBP O
Ig NNP B-Gene
gene NN I-Gene
class NN I-Gene
switch NN O
recombination NN O
. . O

Reactive JJ O
oxygen NN O
species NNS O
( ( O
ROS NNP O
) ) O
such JJ O
as IN O
hydrogen NN O
peroxide NN O
serve VBP O
as IN O
second JJ O
messengers NNS O
in IN O
the DT O
induction NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
, , O
and CC O
hence RB O
in IN O
the DT O
activation NN O
and CC O
replication NN O
of IN O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
in IN O
human JJ O
cells NNS O
. . O

NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
was VBD O
very RB O
effective JJ O
when WRB O
cells NNS O
were VBD O
subjected VBN O
to TO O
hyperthermia VB O
before IN O
being VBG O
treated VBN O
with IN O
HOCl NNP O
. . O

Collectively RB O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
HOCl NNP O
should MD O
be VB O
considered VBN O
as IN O
an DT O
oxidative JJ O
species NNS O
capable JJ O
of IN O
inducing VBG O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
a DT O
T NNP O
- : O
lymphocytic JJ O
cell NN O
line NN O
through IN O
a DT O
transduction NN O
mechanism NN O
involving VBG O
ROS NNP O
, , O
and CC O
having VBG O
a DT O
long JJ O
- : O
distance NN O
effect NN O
through IN O
subsequent JJ O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
release NN O
. . O

Rap1 NNP B-Gene
is VBZ O
a DT O
small JJ O
, , O
Ras NNP B-Gene
- : I-Gene
like IN I-Gene
GTPase NNP I-Gene
whose WP$ O
function NN O
and CC O
regulation NN O
are VBP O
still RB O
largely RB O
unknown JJ O
. . O

Stimulation NN O
of IN O
blood NN O
platelets NNS O
with IN O
alpha JJ B-Gene
- : I-Gene
thrombin NN I-Gene
or CC O
other JJ O
platelet NN O
activators NNS O
caused VBD O
a DT O
rapid JJ O
and CC O
strong JJ O
induction NN O
of IN O
Rap1 NNP B-Gene
that WDT O
associated VBD O
with IN O
RBD NNP B-Gene
in IN O
vitro NN O
. . O

From IN O
our PRP$ O
results NNS O
, , O
we PRP O
conclude VBP O
that IN O
Rap1 NNP B-Gene
activation NN O
in IN O
platelets NNS O
is VBZ O
an DT O
important JJ O
common JJ O
event NN O
in IN O
early JJ O
agonist NN O
- : O
induced JJ O
signalling NN O
, , O
and CC O
that IN O
this DT O
activation NN O
is VBZ O
mediated VBN O
by IN O
an DT O
increased VBN O
intracellular NN O
Ca2 NNP O
+ NNP O
concentration NN O

The DT O
transcriptional JJ B-Gene
regulatory JJ I-Gene
elements NNS I-Gene
of IN O
many JJ O
inducible JJ B-Gene
T NNP I-Gene
- : I-Gene
cell NN I-Gene
genes NNS I-Gene
contain VBP O
adjacent JJ O
or CC O
overlapping VBG B-Gene
binding VBG I-Gene
sites NNS I-Gene
for IN O
the DT O
Ets NNP B-Gene
and CC I-Gene
NF NNP I-Gene
- : I-Gene
kappaB NN I-Gene
/ JJ I-Gene
NFAT NNP I-Gene
families NNS I-Gene
of IN O
transcription NN B-Gene
factors NNS I-Gene
. . O

From IN O
AML1 NNP B-Gene
gene NN I-Gene
, , O
two CD O
representative JJ O
forms NNS O
of IN O
proteins NNS O
, , O
AML1a NNP B-Gene
and CC O
AML1b NNP B-Gene
, , O
are VBP O
produced VBN O
by IN O
an DT O
alternative JJ O
splicing NN O
. . O

These DT O
data NNS O
strongly RB O
suggest VBP O
that IN O
a DT O
transcriptionally RB O
active JJ O
form NN O
of IN O
AML1 NNP B-Gene
is VBZ O
essential JJ O
for IN O
the DT O
myeloid NN O
cell NN O
differentiation NN O
. . O

When WRB O
introduced VBN O
into IN O
interleukin JJ B-Gene
3 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
) ) O
- : O
dependent NN O
mouse NN O
pro FW O
- : O
B NN O
lymphocytes NNS O
, , O
E2A NNP B-Gene
- : I-Gene
HLF NN I-Gene
prevents NNS O
apoptosis NN O
induced VBN O
by IN O
growth NN B-Gene
factor NN I-Gene
deprivation NN O
, , O
suggesting VBG O
that IN O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
mediates NNS O
cell VBP O
survival JJ O
through IN O
activation NN O
of IN O
a DT O
transcription NN B-Gene
factor NN I-Gene
whose WP$ O
activity NN O
can MD O
be VB O
constitutively RB O
replaced VBN O
by IN O
the DT O
chimeric JJ B-Gene
oncoprotein NN I-Gene
. . O

The DT O
expression NN O
and CC O
binding NN O
activity NN O
of IN O
the DT O
Nfil3 NNP B-Gene
protein NN I-Gene
( ( O
also RB O
called VBN O
E4bp4 NNP B-Gene
) ) O
, , O
but CC O
not RB O
of IN O
Hlf NNP B-Gene
, , O
Dbp NNP B-Gene
, , O
or CC O
Tef NNP B-Gene
, , O
was VBD O
found VBN O
to TO O
be VB O
regulated VBN O
by IN O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
in IN O
mouse NN O
pro FW O
- : O
B NN O
cell NN O
lines NNS O
( ( O
Baf NNP O
- : O
3 CD O
and CC O
FL5 NNP O
. . O
12 CD O
) ) O
. . O

Detection NN O
of IN O
adenovirus NN O
DNA NNP O
in IN O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
by IN O
polymerase NN O
chain NN O
reaction NN O
assay NN O
. . O

The DT O
E1A NNP B-Gene
and CC I-Gene
hexon JJ I-Gene
primers NNS I-Gene
amplified VBD O
DNA NN O
from IN O
representative JJ O
adenoviral JJ O
serotypes NNS O
in IN O
all DT O
six CD O
adenoviral JJ O
groups NNS O
( ( O
A DT O
- : O
F NN O
) ) O
. . O

In IN O
addition NN O
, , O
assay NN O
of IN O
PBMC NNP O
by IN O
the DT O
adenovirus NN O
- : O
specific JJ O
PCR NNP O
may MD O
help VB O
detect VB O
early JJ O
invasive JJ O
disease NN O
and CC O
warrants NNS O
further JJ O
evaluation NN O
. . O

Common JJ O
and CC O
distinct JJ O
intracellular JJ O
signaling VBG O
pathways NNS O
in IN O
human JJ O
neutrophils NNS O
utilized VBN O
by IN O
platelet NN B-Gene
activating VBG I-Gene
factor NN I-Gene
and CC O
FMLP NNP B-Gene
. . O

Stimulation NN O
of IN O
human JJ O
neutrophils NNS O
with IN O
chemoattractants NNS B-Gene
FMLP NNP B-Gene
or CC O
platelet VB B-Gene
activating VBG I-Gene
factor NN I-Gene
( ( O
PAF NNP B-Gene
) ) O
results NNS O
in IN O
different JJ O
but CC O
overlapping VBG O
functional JJ O
responses NNS O
. . O

We PRP O
questioned VBD O
whether IN O
these DT O
differences NNS O
might MD O
reflect VB O
patterns NNS O
of IN O
intracellular JJ O
signal JJ O
transduction NN O
. . O

Stimulation NN O
with IN O
either DT O
PAF NNP B-Gene
or CC O
FMLP NNP B-Gene
resulted VBD O
in IN O
equivalent JJ O
phosphorylation NN O
and CC O
activation NN O
of IN O
the DT O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( I-Gene
MAPk NNP I-Gene
) ) I-Gene
homologue NN I-Gene
38 CD B-Gene
- : I-Gene
kD NN I-Gene
murine NN I-Gene
MAP NNP I-Gene
kinase NNP I-Gene
homologous JJ O
to TO O
HOG NNP B-Gene
- : I-Gene
1 CD I-Gene
( ( I-Gene
p38 NN I-Gene
) ) I-Gene
MAPk NNP I-Gene
. . O

A DT O
specific JJ O
p38 NN B-Gene
MAPk NNP I-Gene
inhibitor NN O
( ( O
SK NNP O
& CC O
F NNP O
86002 CD O
) ) O
blocked VBD O
superoxide JJ O
anion NN O
production NN O
in IN O
response NN O
to TO O
FMLP NNP B-Gene
and CC O
reduced VBN O
adhesion NN O
and CC O
chemotaxis NN O
in IN O
response NN O
to TO O
PAF NNP B-Gene
or CC O
FMLP NNP B-Gene
. . O

Chicken NNP B-Gene
NF NNP I-Gene
- : I-Gene
M NNP I-Gene
transcription NN I-Gene
factor NN I-Gene
, , O
in IN O
cooperation NN O
with IN O
either DT O
c SYM B-Gene
- : I-Gene
Myb NN I-Gene
or CC O
v NN B-Gene
- : I-Gene
Myb NNP I-Gene
, , O
is VBZ O
active JJ O
in IN O
the DT O
combinatorial JJ O
activation NN O
of IN O
myeloid JJ B-Gene
- : I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
genes NNS I-Gene
in IN O
heterologous JJ O
cell NN O
types NNS O
, , O
such JJ O
as IN O
embryonic JJ O
fibroblasts NNS O
. . O

In IN O
the DT O
present JJ O
report NN O
, , O
we PRP O
show VBP O
that IN O
A6H NNP B-Gene
costimulated VBD O
cell NN O
proliferation NN O
and CC O
cytokine NN B-Gene
production NN O
in IN O
purified JJ O
CD4 NNP O
+ NNP O
T NNP O
cells NNS O
. . O

Co NNP O
- : O
ligation NN O
of IN O
the DT O
A6H NNP B-Gene
antigen NN O
and CC O
the DT O
CD3 NNP B-Gene
complex NN I-Gene
induced VBD O
expression NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
CD4 NNP O
+ NNP O
T NNP O
cells NNS O
, , O
whereas IN O
no DT O
increase NN O
in IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
octamer SYM B-Gene
- : I-Gene
binding NN I-Gene
( ( I-Gene
Oct NNP I-Gene
) ) I-Gene
proteins VBZ I-Gene
was VBD O
seen VBN O
compared VBN O
to TO O
T NNP O
cells NNS O
stimulated VBD O
with IN O
anti JJ B-Gene
- : I-Gene
CD3 NNP I-Gene
alone RB O
. . O

Molecular JJ O
differences NNS O
of IN O
the DT O
A6H NNP B-Gene
molecule NN I-Gene
or CC O
distinct JJ O
regulation NN O
of IN O
the DT O
A6H NNP B-Gene
transduced VBD O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
activation NN O
pathway NN O
may MD O
exist VB O
in IN O
CD4 NNP O
+ NNP O
and CC O
CD8 NNP O
+ NNP O
T NNP O
cell NN O
subpopulations NNS O
. . O

The DT O
DNA NNP B-Gene
- : I-Gene
binding NN I-Gene
domain NN I-Gene
( ( O
amino JJ B-Gene
acids NNS I-Gene
421 CD I-Gene
- : I-Gene
486 CD I-Gene
) ) O
is VBZ O
completely RB O
conserved VBN O
among IN O
human JJ B-Gene
, , I-Gene
squirrel JJ I-Gene
monkey NN I-Gene
, , I-Gene
owl NN I-Gene
monkey NN I-Gene
, , I-Gene
and CC I-Gene
cotton NN I-Gene
- : I-Gene
top JJ I-Gene
tamarin NN I-Gene
receptors NNS I-Gene
. . O

Expressions NNS O
of IN O
human JJ O
and CC O
squirrel JJ O
monkey NN O
glucocorticoid NN B-Gene
receptors NNS I-Gene
and CC O
a DT O
squirrel NN B-Gene
monkey NN I-Gene
receptor NN I-Gene
in IN O
which WDT O
Phe774 NNP O
was VBD O
mutated VBN O
to TO O
Leu NNP O
( ( O
F774L NNP O
) ) O
were VBD O
similar JJ O
. . O

Shared VBN O
gamma NN B-Gene
( ( I-Gene
c NN I-Gene
) ) I-Gene
subunit NN I-Gene
within IN O
the DT O
human JJ B-Gene
interleukin NN I-Gene
- : I-Gene
7 CD I-Gene
receptor NN I-Gene
complex NN I-Gene
. . O

The DT O
gamma NN B-Gene
( ( I-Gene
c NN I-Gene
) ) I-Gene
subunit NN I-Gene
can MD O
be VB O
employed VBN O
in IN O
receptor NN B-Gene
complexes NNS I-Gene
for IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
, , I-Gene
- : I-Gene
4 CD I-Gene
, , I-Gene
- : I-Gene
7 CD I-Gene
, , I-Gene
- : I-Gene
9 CD I-Gene
, , I-Gene
and CC I-Gene
- : I-Gene
15 CD I-Gene
, , O
and CC O
the DT O
multiple JJ O
signaling NN O
defects NNS O
that WDT O
would MD O
result VB O
from IN O
a DT O
defective JJ O
gamma NN B-Gene
( ( I-Gene
c NN I-Gene
) ) I-Gene
chain NN I-Gene
in IN O
these DT O
receptors NNS O
are VBP O
proposed VBN O
to TO O
cause VB O
the DT O
severe JJ O
phenotype NN O
of IN O
X NNP O
- : O
SCID JJ O
patients NNS O
. . O

These DT O
observations NNS O
suggest VBP O
the DT O
functional JJ O
importance NN O
of IN O
gamma NN B-Gene
( ( I-Gene
c NN I-Gene
) ) I-Gene
in IN O
the DT O
IL NNP B-Gene
- : I-Gene
7R CD I-Gene
complex NN I-Gene
. . O

In IN O
this DT O
study NN O
we PRP O
determined VBD O
the DT O
effects NNS O
of IN O
SAC NNP O
on IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
in IN O
human JJ O
T NNP O
lymphocytes NNS O
( ( O
Jurkat NNP O
cells NNS O
) ) O
induced VBN O
by IN O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
and CC O
H2O2 NNP O
. . O

Elf NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
a DT O
rhombotin NN B-Gene
- : I-Gene
2 CD I-Gene
binding VBG I-Gene
ets NNS I-Gene
transcription JJ I-Gene
factor NN I-Gene
: : O
discovery NN O
and CC O
potential JJ O
role NN O
in IN O
T NNP O
cell NN O
leukemia NN O
. . O

By IN O
screening VBG O
a DT O
T NNP O
cell NN O
cDNA NN B-Gene
library NN I-Gene
, , O
we PRP O
identified VBD O
a DT O
novel JJ B-Gene
ets NNS I-Gene
transcription NN I-Gene
factor NN I-Gene
that WDT O
binds VBZ O
RBTN NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

Thymocytes NNS O
expressed VBD O
four CD O
- : O
to TO O
10 CD O
- : O
fold NN O
greater JJR O
amounts NNS O
of IN O
the DT O
3 CD B-Gene
. . I-Gene
5 CD I-Gene
kb NN I-Gene
transcript NN I-Gene
than IN O
other JJ O
tissues NNS O
. . O

The DT O
expression NN O
patterns VBZ O
suggest VBP O
that IN O
RBTN NNP B-Gene
- : I-Gene
2 CD I-Gene
normally RB O
interacts NNS O
equally RB O
with IN O
elf PRP B-Gene
- : I-Gene
2a CD I-Gene
and CC O
elf PRP B-Gene
- : I-Gene
2b CD I-Gene
. . O

In IN O
contrast NN O
, , O
when WRB O
RBTN NNP B-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
inappropriately RB O
expressed VBN O
in IN O
T NNP O
cells NNS O
, , O
RBTN NNP B-Gene
- : I-Gene
2 CD I-Gene
would MD O
interact VB O
predominantly RB O
with IN O
elf PRP B-Gene
- : I-Gene
2b CD I-Gene
; : O
this DT O
interaction NN O
may MD O
lead VB O
to TO O
T NNP O
cell NN O
proliferation NN O
. . O

When WRB O
immunoglobulin NN O
( ( O
Ig NNP O
) ) O
- : O
secreting VBG O
plasmacytomas NNS O
are VBP O
fused VBN O
to TO O
a DT O
T NNP O
- : O
cell NN O
lymphoma NN O
, , O
Ig NNP B-Gene
gene NN I-Gene
expression NN O
ceases NNS O
in IN O
greater JJR O
than IN O
95 CD O
% NN O
of IN O
the DT O
resulting JJ O
hybrids NNS O
. . O

In IN O
the DT O
rare JJ O
hybrids NNS O
that WDT O
continue VBP O
to TO O
express VB O
Ig NNP O
, , O
all DT O
other JJ O
tested VBN O
B NNP B-Gene
lymphocyte SYM I-Gene
- : I-Gene
specific JJ I-Gene
genes NNS I-Gene
also RB O
remain VBP O
active JJ O
. . O

The DT O
low JJ O
frequency NN O
with IN O
which WDT O
these DT O
Ig NNP O
- : O
expressing NN O
hybrids NNS O
are VBP O
recovered VBN O
, , O
along IN O
with IN O
the DT O
fact NN O
that IN O
cell NN O
fusions NNS O
can MD O
lead VB O
to TO O
chromosome VB O
loss NN O
, , O
led VBD O
us PRP O
to TO O
propose VB O
that IN O
this DT O
rare JJ O
phenotype NN O
was VBD O
due JJ O
to TO O
loss NN O
of IN O
a DT O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
- : I-Gene
derived VBN I-Gene
chromosome NN I-Gene
encoding VBG I-Gene
a DT I-Gene
factor NN I-Gene
or CC O
factors NNS O
with IN O
gene NN O
silencing VBG O
activity NN O
. . O

To TO O
identify VB O
the DT O
relevant JJ O
chromosome NN O
, , O
we PRP O
have VBP O
used VBN O
a DT O
polymerase NN O
chain NN O
reaction NN O
( ( O
PCR NNP O
) ) O
- : O
assisted VBN O
method NN O
of IN O
chromosome NN O
mapping NN O
to TO O
analyze VB O
both DT O
Ig NNP O
- : O
silenced VBD O
( ( O
common JJ O
) ) O
and CC O
Ig NNP O
- : O
expressing NN O
( ( O
rare JJ O
) ) O
hybrids NNS O
. . O

Kaposi NNP O
' POS O
s NN O
sarcoma NN O
( ( O
KS NNP O
) ) O
- : O
associated VBN O
herpesvirus NN O
( ( O
KSHV NNP O
) ) O
, , O
or CC O
human JJ O
herpesvirus NN O
8 CD O
, , O
is VBZ O
a DT O
lymphotropic JJ O
virus NN O
strongly RB O
linked VBN O
to TO O
several JJ O
AIDS NNP O
- : O
related JJ O
neoplasms NNS O
. . O

Nuclear JJ B-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
cells NNS I-Gene
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
are VBP O
insufficient JJ O
for IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
activation NN O
: : O
requirement NN O
for IN O
CD28 NNP B-Gene
up RP O
- : O
regulation NN O
of IN O
RE NNP B-Gene
/ NNP I-Gene
AP NNP I-Gene
. . O

Uncontrolled VBN O
replication NN O
of IN O
a DT O
virus NN O
, , O
which WDT O
is VBZ O
harmful JJ O
to TO O
the DT O
host NN O
is VBZ O
also RB O
disadvantageous JJ O
to TO O
the DT O
virus NN O
. . O

Therefore RB O
, , O
only RB O
the DT O
time NN O
between IN O
infection NN O
and CC O
eradication NN O
remains VBZ O
for IN O
these DT O
viruses NNS O
to TO O
proliferate VB O
. . O

Both DT O
are VBP O
true JJ O
for IN O
the DT O
Epstein NNP O
- : O
Barr NNP O
virus NN O
( ( O
EBV NNP O
) ) O
. . O

Disturbance NN O
of IN O
both CC O
the DT O
immune JJ O
surveillance NN O
as RB O
well RB O
as IN O
viral JJ B-Gene
gene NN I-Gene
regulation NN O
may MD O
result VB O
in IN O
EBV NNP O
- : O
associated JJ O
disease NN O
. . O

3BP2 CD B-Gene
was VBD O
selectively RB O
expressed VBN O
in IN O
hematopoietic JJ O
/ NNP O
lymphoid NN O
tissues NNS O
and CC O
bound NN O
via IN O
its PRP$ O
SH2 NNP B-Gene
domain NN I-Gene
activated VBD I-Gene
Syk NNP I-Gene
- : I-Gene
family NN I-Gene
kinases NNS I-Gene
in IN O
mammalian JJ O
cells NNS O
, , O
including VBG O
in IN O
antigen NN O
receptor NN O
- : O
stimulated VBN O
T NNP O
cells NNS O
. . O

In IN O
this DT O
study NN O
, , O
a DT O
series NN O
of IN O
Burkitt NNP O
' POS O
s NN O
lymphoma NN O
( ( O
BL NNP O
) ) O
cell NN O
lines NNS O
were VBD O
assayed VBN O
for IN O
their PRP$ O
expression NN O
of IN O
tissue NN B-Gene
inhibitor NN I-Gene
of IN I-Gene
metalloproteinases NNS I-Gene
( ( I-Gene
TIMP NNP I-Gene
) ) I-Gene
- : I-Gene
1 CD I-Gene
. . O

Results NNS O
indicate VBP O
that IN O
TIMP NNP O
- : O
1 CD O
- : O
positive JJ O
BL NNP O
lines NNS O
show VBP O
resistance NN O
to TO O
cold VB O
- : O
shock NN O
- : O
induced JJ O
apoptosis NN O
. . O

Furthermore RB O
, , O
recombinant JJ O
TIMP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
but CC O
not RB O
TIMP NNP B-Gene
- : I-Gene
2 CD I-Gene
or CC O
a DT O
synthetic JJ O
metalloproteinase NN O
inhibitor NN O
( ( O
BB NNP O
- : O
94 CD O
) ) O
, , O
confers NNS O
resistance VBP O
to TO O
apoptosis VB O
induced VBN O
by IN O
both DT O
CD95 NNP O
- : O
dependent NN O
and CC O
- : O
independent JJ O
( ( O
cold JJ O
shock NN O
, , O
serum JJ O
deprivation NN O
, , O
and CC O
gamma SYM O
- : O
radiation NN O
) ) O
pathways VBZ O
in IN O
TIMP NNP O
- : O
1 CD O
- : O
negative JJ O
BL NNP O
lines NNS O
. . O

The DT O
spi NN O
- : O
1 CD O
transfected JJ O
cells NNS O
showed VBD O
reduced JJ O
growth NN O
rates NNS O
and CC O
reduced JJ O
clonogenic NN O
cell NN O
growth NN O
. . O

To TO O
investigate VB O
in IN O
vivo JJ O
regulatory JJ O
mechanisms NNS O
that WDT O
control VBP O
the DT O
population NN O
of IN O
type NN O
2 CD O
T NNP O
cells NNS O
and CC O
disease NN O
susceptibility NN O
, , O
we PRP O
have VBP O
created VBN O
lines NNS O
of IN O
transgenic JJ O
mice NN O
in IN O
which WDT O
expression NN O
of IN O
a DT O
chimeric JJ B-Gene
cytokine NN I-Gene
receptor NN I-Gene
( ( O
the DT O
mouse NN B-Gene
interleukin VBZ I-Gene
2 CD I-Gene
receptor NN I-Gene
beta NN I-Gene
chain NN I-Gene
[ NNP I-Gene
IL NNP I-Gene
- : I-Gene
2Rbeta CD I-Gene
] JJ I-Gene
extracellular JJ I-Gene
domain NN I-Gene
fused VBD O
to TO O
the DT O
cytoplasmic JJ B-Gene
tail NN I-Gene
of IN O
IL NNP B-Gene
- : I-Gene
4Ralpha CD I-Gene
) ) O
is VBZ O
targeted VBN O
to TO O
the DT O
T NNP O
lymphoid JJ O
lineage NN O
using VBG O
the DT O
proximal JJ B-Gene
lck NN I-Gene
promoter NN I-Gene
. . O

We PRP O
have VBP O
recently RB O
cloned VBN O
the DT O
carboxylesterase NN B-Gene
upstream JJ I-Gene
sequence NN I-Gene
and CC O
showed VBD O
its PRP$ O
basal JJ B-Gene
promoter NN I-Gene
activity NN O
in IN O
CHO NNP O
cells NNS O
. . O

The DT O
role NN O
of IN O
the DT O
Ikaros NNP B-Gene
gene NN I-Gene
in IN O
lymphocyte NN O
development NN O
and CC O
homeostasis NN O
. . O

In IN O
the DT O
adult NN O
, , O
however RB O
, , O
lymphoid JJ O
lineages NNS O
rely VBP O
on IN O
Ikaros NNP B-Gene
at IN O
distinct JJ O
phases NNS O
of IN O
their PRP$ O
development NN O
. . O

Its PRP$ O
activity NN O
is VBZ O
essential JJ O
for IN O
the DT O
generation NN O
of IN O
B NNP O
cell NN O
but CC O
not RB O
of IN O
T NNP O
cell NN O
precursors NNS O
, , O
although IN O
the DT O
differentiation NN O
of IN O
the DT O
latter NN O
is VBZ O
not RB O
normal JJ O
. . O

A DT O
significant JJ O
increase NN O
in IN O
CD4 NNP O
thymocytes NNS O
and CC O
their PRP$ O
immediate JJ O
precursors NNS O
is VBZ O
detected VBN O
, , O
and CC O
because IN O
these DT O
cells NNS O
lack VBP O
markers NNS O
that WDT O
correlate VBP O
with IN O
positive JJ O
selection NN O
, , O
a DT O
deregulation NN O
in IN O
their PRP$ O
maturation NN O
process NN O
is VBZ O
suggested VBN O
. . O

Furthermore RB O
, , O
Ikaros NNP O
- : O
null NN O
thymocytes NNS O
hyperproliferate VBP O
in IN O
response NN O
to TO O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
( ( O
TCR NNP B-Gene
) ) O
signaling NN O
; : O
within IN O
days NNS O
after IN O
their PRP$ O
appearance NN O
in IN O
the DT O
thymus NN O
, , O
clonally RB O
expanding VBG O
populations NNS O
are VBP O
detected VBN O
. . O

Deregulated VBN O
TCR NNP B-Gene
- : O
mediated VBN O
responses NNS O
and CC O
the DT O
fast JJ O
kinetics NNS O
of IN O
tumor NN O
development NN O
in IN O
these DT O
mutant JJ O
thymocytes NNS O
implicate VBP O
Ikaros NNP O
as IN O
a DT O
central JJ B-Gene
tumor NN I-Gene
suppressor NN I-Gene
gene NN I-Gene
for IN O
the DT O
T NNP O
cell NN O
lineage NN O
. . O

The DT O
role NN O
of IN O
Aiolos NNP B-Gene
, , O
a DT O
lymphoid JJ B-Gene
- : I-Gene
restricted VBN I-Gene
and CC I-Gene
structurally RB I-Gene
related JJ I-Gene
gene NN I-Gene
, , O
in IN O
lymphoid JJ O
differentiation NN O
is VBZ O
discussed VBN O
. . O

Changes NNS O
in IN O
this DT O
regulatory JJ O
network NN O
may MD O
reflect VB O
differentiation NN O
and CC O
proliferation NN O
adjustments NNS O
made VBN O
in IN O
hemo JJ O
- : O
lymphoid JJ O
progenitors NNS O
and CC O
precursors NNS O
as IN O
they PRP O
give VBP O
rise NN O
to TO O
the DT O
cells NNS O
of IN O
our PRP$ O
immune NN O
system NN O
. . O

STAT1 NNP B-Gene
pathway NN O
is VBZ O
involved VBN O
in IN O
activation NN O
of IN O
caprine NN O
arthritis NN B-Gene
- : I-Gene
encephalitis NN I-Gene
virus NN I-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
in IN O
monocytes NNS O
. . O

Substitution NN O
mutations NNS O
in IN O
this DT O
consensus NN B-Gene
sequence NN I-Gene
eliminate NN O
binding NN O
of IN O
the DT O
inducible JJ B-Gene
factor NN I-Gene
. . O

1 CD B-Gene
, , I-Gene
25 CD I-Gene
- : I-Gene
Dihydroxyvitamin NNP I-Gene
D3 NNP I-Gene
receptors NNS I-Gene
in IN O
peripheral JJ O
blood NN O
mononuclear JJ O
cells NNS O
from IN O
patients NNS O
with IN O
renal JJ O
insufficiency NN O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
have VBP O
investigated VBN O
the DT O
specific JJ O
uptake NN O
of IN O
[ $ O
3H CD O
] NNP O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
by IN O
PBMC NNP O
of IN O
11 CD O
women NNS O
with IN O
advanced JJ O
chronic JJ O
renal JJ O
failure NN O
( ( O
A DT O
- : O
CRF NN O
) ) O
, , O
6 CD O
women NNS O
with IN O
mild JJ O
- : O
moderate JJ O
renal JJ O
insufficiency NN O
( ( O
M NNP O
- : O
CRF NN O
) ) O
, , O
and CC O
23 CD O
healthy JJ O
women NNS O
. . O

The DT O
mean JJ O
dissociation NN O
constant NN O
( ( O
KD NNP O
) ) O
was VBD O
similar JJ O
in IN O
both DT O
groups NNS O
of IN O
patients NNS O
and CC O
in IN O
healthy JJ O
women NNS O
( ( O
A DT O
- : O
CRF NN O
: : O
0 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
5 CD O
x JJ O
10 CD O
( ( O
- : O
10 CD O
) ) O
M NNP O
; : O
M NNP O
- : O
CRF NN O
: : O
1 CD O
. . O
1 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
9 CD O
x JJ O
10 CD O
( ( O
- : O
10 CD O
) ) O
M NNP O
; : O
controls NNS O
: : O
1 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
6 CD O
x JJ O
10 CD O
( ( O
- : O
10 CD O
) ) O
M NNP O
) ) O
. . O

No DT O
correlation NN O
was VBD O
seen VBN O
between IN O
VDR NNP B-Gene
and CC O
serum VB O
calcitriol NN O
or CC O
PTH NNP O
levels NNS O
, , O
when WRB O
considering VBG O
both DT O
groups NNS O
of IN O
patients NNS O
together RB O
or CC O
separately RB O
. . O

Conversely RB O
, , O
a DT O
significant JJ O
negative JJ O
correlation NN O
was VBD O
found VBN O
between IN O
VDR NNP B-Gene
and CC O
serum JJ O
creatinine NN O
values NNS O
when WRB O
A DT O
- : O
CRF NN O
and CC O
M NNP O
- : O
CRF NN O
were VBD O
considered VBN O
altogether RB O
( ( O
r NN O
= NNP O
- : O
0 CD O
. . O
63 CD O
; : O
p NN O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
. . O

These DT O
data NNS O
are VBP O
well RB O
in IN O
line NN O
with IN O
the DT O
long JJ O
- : O
standing VBG O
notion NN O
that IN O
interindividual JJ O
differences NNS O
in IN O
platelet NN B-Gene
monoamine NN I-Gene
oxidase NN I-Gene
may MD O
represent VB O
differences NNS O
in IN O
expression NN O
of IN O
the DT O
enzyme NN O
rather RB O
than IN O
genotypic VB O
variation NN O
. . O

Ciprofibrate NNP O
, , O
an DT O
hypolipidaemic JJ O
peroxisome NN O
proliferator NN O
, , O
induced JJ O
differentiation NN O
of IN O
HL NNP O
- : O
60 CD O
cells NNS O
. . O

In IN O
particular JJ O
, , O
TRAF6 NNP B-Gene
interacted VBD O
with IN O
membrane NN B-Gene
- : I-Gene
proximal JJ I-Gene
determinants NNS I-Gene
distinct VBP O
from IN O
those DT O
binding VBG O
TRAFs NNP B-Gene
1 CD I-Gene
, , I-Gene
2 CD I-Gene
, , I-Gene
3 CD I-Gene
, , I-Gene
and CC I-Gene
5 CD I-Gene
. . O

The DT O
molecular JJ O
mechanisms NNS O
by IN O
which WDT O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
induces NNS O
expression NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
gene NN I-Gene
are VBP O
not RB O
known VBN O
, , O
although IN O
the DT O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
- : I-Gene
activated VBN I-Gene
transcription NN I-Gene
factor NN I-Gene
signal JJ I-Gene
transducer NN I-Gene
and CC I-Gene
activator NN I-Gene
of IN I-Gene
transcription NN I-Gene
6 CD I-Gene
( ( O
Stat6 NNP B-Gene
) ) O
is VBZ O
required VBN O
for IN O
this DT O
effect NN O
. . O

CONCLUSIONS NN O
: : O
Intestinal JJ O
epithelial JJ O
cells NNS O
initiate VBP O
an DT O
inflammatory JJ O
response NN O
with IN O
resulting VBG O
neutrophil JJ O
- : O
mediated VBN O
tissue NN O
damage NN O
in IN O
response NN O
to TO O
E NNP O
. . O
histolytica NN O
infection NN O
; : O
this DT O
inflammatory NN O
cascade NN O
can MD O
be VB O
blocked VBN O
by IN O
inhibiting VBG O
the DT O
transcription NN O
of IN O
genes NNS O
regulated VBN O
by IN O
nuclear JJ B-Gene
factor NN I-Gene
kappaB NN I-Gene
. . O

The DT O
triptolide JJ O
- : O
induced JJ O
apoptosis NN O
is VBZ O
accompanied VBN O
by IN O
increase NN O
of IN O
DEVD NNP O
- : O
cleavable JJ O
caspases NNS B-Gene
activity NN O
and CC O
degradation NN O
of IN O
caspase NN B-Gene
substrate NN I-Gene
poly NN I-Gene
( ( I-Gene
ADP NNP I-Gene
- : I-Gene
ribose NN I-Gene
) ) I-Gene
polymerase NN I-Gene
( ( O
PARP NNP B-Gene
) ) O
. . O

A DT O
specific JJ O
inhibitor NN O
of IN O
caspases NNS B-Gene
, , O
zVAD SYM O
- : O
FMK NN O
, , O
prevents NNS O
triptolide IN O
- : O
induced JJ O
PARP NNP B-Gene
degradation NN O
and CC O
DNA NNP O
fragmentation NN O
but CC O
not RB O
growth NN O
arrest NN O
. . O

A DT O
novel JJ O
transcription NN B-Gene
factor NN I-Gene
regulates VBZ O
expression NN O
of IN O
the DT O
vacuolar JJ B-Gene
H NNP I-Gene
+ NNP I-Gene
- : I-Gene
ATPase NNP I-Gene
B2 NNP I-Gene
subunit NN I-Gene
through IN O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
sites NNS I-Gene
during IN O
monocytic JJ O
differentiation NN O
. . O

In IN O
mobility NN O
shift NN O
assays NNS O
, , O
a DT O
nuclear JJ B-Gene
factor NN I-Gene
from IN O
THP NNP O
- : O
1 CD O
and CC O
U NNP O
- : O
937 CD O
cells NNS O
was VBD O
identified VBN O
that IN O
binds VBZ O
to TO O
several JJ O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
response NN I-Gene
elements NNS I-Gene
within IN O
the DT O
B2 NNP B-Gene
promoter NN I-Gene
, , O
but CC O
does VBZ O
not RB O
react VB O
with IN O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
antibodies NNS I-Gene
, , O
and CC O
has VBZ O
a DT O
DNA NN B-Gene
sequence NN I-Gene
binding VBG O
affinity NN O
profile NN O
that WDT O
differs VBZ O
from IN O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
a DT O
novel JJ O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
- : I-Gene
like IN I-Gene
transcription NN I-Gene
factor NN I-Gene
is VBZ O
responsible JJ O
for IN O
V NNP B-Gene
- : I-Gene
ATPase NN I-Gene
B NNP I-Gene
subunit NN I-Gene
amplification NN O
during IN O
monocyte JJ O
differentiation NN O
. . O

c SYM O
- : O
Jun NN O
and CC O
GST NNP O
- : O
pi NN O
expression NN O
in IN O
human JJ O
plasma NN O
cells NNS O
. . O

The DT O
expression NN O
of IN O
these DT O
two CD O
proteins NNS O
was VBD O
not RB O
related VBN O
to TO O
clinical JJ O
or CC O
laboratory JJ O
data NNS O
. . O

It PRP O
has VBZ O
been VBN O
shown VBN O
that IN O
eosinophil JJ O
stimulation NN O
by IN O
these DT O
cytokines NNS B-Gene
is VBZ O
associated VBN O
with IN O
increases NNS O
in IN O
tyrosine JJ O
phosphorylation NN O
of IN O
several JJ O
cellular JJ O
substrates NNS O
. . O

This DT O
review NN O
will MD O
concentrate VB O
on IN O
this DT O
topic NN O
and CC O
on IN O
its PRP$ O
role NN O
for IN O
the DT O
regulation NN O
of IN O
eosinophil JJ O
apoptosis NN O
. . O

Time NNP O
- : O
course NN O
experiments NNS O
showed VBD O
that IN O
nuclear JJ O
levels NNS O
of IN O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
p45 VB B-Gene
NF NNP I-Gene
- : I-Gene
E2 JJ I-Gene
proteins NNS O
increased VBD O
during IN O
BA NNP O
treatment NN O
. . O

The DT O
upstream JJ O
regions NNS O
UAS3 NNP B-Gene
( ( O
- : B-Gene
1168 CD I-Gene
to TO I-Gene
- : I-Gene
440 CD I-Gene
) ) O
and CC O
UAS2 NNP B-Gene
( ( O
- : B-Gene
352 CD I-Gene
to TO I-Gene
- : I-Gene
264 CD I-Gene
) ) O
both DT O
functioned VBN O
in IN O
a DT O
cell NN O
lineage NN O
- : O
independent JJ O
manner NN O
and CC O
were VBD O
together RB O
responsible JJ O
for IN O
the DT O
bulk NN O
of IN O
Wp NNP O
activity NN O
in IN O
non JJ O
- : O
B NNP O
cells NNS O
; : O
mutational JJ O
analysis NN O
indicated VBD O
the DT O
importance NN O
of IN O
a DT O
YY1 NNP B-Gene
binding NN I-Gene
site NN I-Gene
in IN O
UAS2 NNP B-Gene
in IN O
that DT O
context NN O
. . O

By IN O
contrast NN O
, , O
UAS1 NNP B-Gene
( ( O
- : B-Gene
140 CD I-Gene
to TO I-Gene
- : I-Gene
87 CD I-Gene
) ) O
was VBD O
B NNP O
cell NN O
specific NN O
and CC O
was VBD O
the DT O
key JJ O
determinant NN O
of IN O
the DT O
promoter NN O
' POS O
s NNS O
increased VBD O
activity NN O
in IN O
B NNP O
cell NN O
lines NNS O
. . O

When WRB O
mutations NNS O
that IN O
abolished VBD O
factor NN O
binding NN O
in IN O
bandshift NN O
assays NNS O
were VBD O
introduced VBN O
into IN O
a DT O
Wp NNP B-Gene
reporter NN I-Gene
construct NN I-Gene
, , O
the DT O
loss NN O
of IN O
any DT O
one CD O
of IN O
the DT O
three CD O
UAS1 NNP B-Gene
binding VBG I-Gene
sites NNS I-Gene
was VBD O
sufficient JJ O
to TO O
reduce VB O
promoter NN O
activity NN O
by IN O
10 CD O
- : O
to TO O
30 CD O
- : O
fold NN O
in IN O
B NNP O
cells NNS O
. . O

Both DT O
BZLF1 NNP B-Gene
and CC I-Gene
BRLF1 NNP I-Gene
immediate VBP I-Gene
- : I-Gene
early JJ I-Gene
transcripts NNS I-Gene
, , O
but CC O
not RB O
BMLF1 NNP B-Gene
transcript NN I-Gene
, , O
could MD O
be VB O
detected VBN O
in IN O
individual JJ O
CD4 NNP O
+ NNP O
and CC O
CD8 NNP O
+ NNP O
T NNP O
cells NNS O
infected VBN O
with IN O
EBV NNP O
. . O

T NNP O
- : O
lineage NN O
precursor NN O
populations NNS O
from IN O
the DT O
adult NN O
mouse NN O
thymus NN O
, , O
prior RB O
to TO O
T NNP O
- : O
cell NN O
receptor NN O
gene NN O
rearrangement NN O
, , O
display VBP O
a DT O
capacity NN O
to TO O
produce VB O
DC NNP O
as RB O
well RB O
as IN O
T NNP O
cells NNS O
in IN O
the DT O
thymus NN O
, , O
and CC O
are VBP O
very RB O
efficient JJ O
precursors NNS O
of IN O
DC NNP O
in IN O
culture NN O
. . O

These DT O
lymphoid JJ O
/ NN O
DC NNP O
precursors NNS O
have VBP O
little JJ O
capacity NN O
to TO O
form VB O
myeloid JJ O
cells NNS O
, , O
indicating VBG O
that IN O
thymic JJ O
DC NNP O
are VBP O
a DT O
lymphoid JJ O
- : O
related VBN O
rather RB O
than IN O
myeloid VB O
- : O
related JJ O
lineage NN O
. . O

Pharmacologic NNP O
blockade NN O
of IN O
endogenous JJ B-Gene
NFAT NNP I-Gene
activity NN O
by IN O
FK506 NNP O
or CC O
CsA NNP O
inhibited JJ O
synthesis NN O
of IN O
reverse NN O
transcription NN O
and CC O
also RB O
potently RB O
blocked VBN O
HIV NNP O
- : O
1 CD O
replication NN O
. . O

The DT O
first JJ O
step NN O
in IN O
the DT O
nuclear JJ O
import NN O
process NN O
is VBZ O
recognition NN O
of IN O
a DT O
nuclear JJ B-Gene
localization NN I-Gene
sequence NN I-Gene
( ( O
NLS NNP B-Gene
) ) O
within IN O
the DT O
karyophilic JJ B-Gene
protein NN I-Gene
by IN O
a DT O
cytoplasmic JJ B-Gene
receptor NN I-Gene
such JJ O
as IN O
the DT O
importin NN B-Gene
( ( I-Gene
karyopherin NN I-Gene
) ) I-Gene
- : I-Gene
alpha NN I-Gene
subunit NN I-Gene
. . O

NLS NNP B-Gene
peptide SYM O
- : O
mediated VBN O
disruption NN O
of IN O
the DT O
nuclear JJ O
import NN O
of IN O
these DT O
transcription NN B-Gene
factors NNS I-Gene
results NNS O
in IN O
inhibition NN O
of IN O
I PRP O
kappa VBP O
B NNP O
alpha NN O
and CC O
IL NNP O
- : O
2 CD O
gene NN O
expression NN O
, , O
processes VBZ O
dependent NN O
on IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
or CC O
the DT O
combination NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
NFAT NNP B-Gene
. . O

Further RB O
, , O
we PRP O
show VBP O
that IN O
inhibitory JJ O
NLS NNP B-Gene
peptide NN O
interacts NNS O
in IN O
vitro NN O
with IN O
a DT O
cytoplasmic JJ B-Gene
NLS NNP I-Gene
receptor NN I-Gene
complex NN I-Gene
comprised VBD O
of IN O
the DT O
Rch1 NNP B-Gene
/ NNP I-Gene
importin NN I-Gene
( ( I-Gene
karyopherin NN I-Gene
) ) I-Gene
- : I-Gene
beta NN I-Gene
heterodimer NN I-Gene
expressed VBN O
in IN O
Jurkat NNP O
T NNP O
cells NNS O
. . O

Forty NNP O
- : O
eight CD O
hours NNS O
after IN O
transfection NN O
, , O
EC NNP O
were VBD O
stimulated VBN O
with IN O
NK NNP O
cells NNS O
or CC O
NK NNP O
cell VBP O
membrane NN O
extracts NNS O
for IN O
7 CD O
hr NN O
and CC O
activation NN O
was VBD O
measured VBN O
by IN O
a DT O
luciferase NN B-Gene
assay NN O
. . O

CONCLUSIONS NN O
: : O
Human NNP O
NK NNP O
cell NN O
membrane NN O
- : O
bound NN O
LT NNP O
signals NNS O
across IN O
species NNS O
via IN O
TNFRI NNP B-Gene
, , O
leading VBG O
to TO O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
nuclear JJ O
translocation NN O
and CC O
transcription NN O
of IN O
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
, , O
which WDT O
results NNS O
in IN O
EC NNP O
activation NN O
. . O

The DT O
discrepancy NN O
in IN O
the DT O
degree NN O
of IN O
inhibition NN O
by IN O
membrane NN O
extracts NNS O
and CC O
NK NNP O
cells NNS O
with IN O
mutant JJ B-Gene
TNFRI NNP I-Gene
suggests VBZ O
that IN O
additional JJ O
pathways NNS O
are VBP O
utilized VBN O
by IN O
NK NNP O
cells NNS O
to TO O
activate VB O
EC NNP O

Ras NNP B-Gene
- : O
dependent NN O
, , O
Ca2 NNP O
+ NNP O
- : O
stimulated VBD O
activation NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
cells NNS I-Gene
by IN O
a DT O
constitutively RB O
active JJ O
Cbl NNP B-Gene
mutant NN I-Gene
in IN O
T NNP O
cells NNS O
. . O

Blood NNP O
monocytes VBZ O
spontaneously RB O
activate JJ O
endothelial JJ O
cells NNS O
in IN O
culture NN O
, , O
leading VBG O
to TO O
adhesion NN O
of IN O
monocytic JJ O
cells NNS O
onto IN O
the DT O
endothelial JJ O
surface NN O
and CC O
overproduction NN O
of IN O
endothelial JJ O
proteins NNS O
such JJ O
as IN O
von NNS B-Gene
Willebrand NNP I-Gene
factor NN I-Gene
( ( O
vWf NN B-Gene
) ) O
and CC O
plasminogen NN B-Gene
activator NN I-Gene
inhibitor NN I-Gene
type NN I-Gene
1 CD I-Gene
( ( O
PAI NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
. . O

Addition NN O
of IN O
untreated JJ O
THP NNP O
- : O
1 CD O
cells NNS O
had VBD O
little JJ O
effect NN O
on IN O
HUVEC NNP O
adhesiveness NN O
. . O

Under IN O
these DT O
conditions NNS O
HUVEC VBP B-Gene
adhesion NN I-Gene
molecules NNS I-Gene
, , O
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
, , O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
were VBD O
increased VBN O
at IN O
3 CD O
h NN O
with IN O
only JJ O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
remaining VBG O
overexpressed VBN O
at IN O
24 CD O
h NN O
. . O

Quantitative JJ O
reverse NN B-Gene
transcriptase NN I-Gene
- : O
polymerase NN O
chain NN O
reaction NN O
( ( O
RT NNP O
- : O
PCR NN O
) ) O
showed VBD O
an DT O
increase NN O
in IN O
steady JJ O
- : O
state NN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
mRNA NN I-Gene
after IN O
3 CD O
to TO O
4 CD O
hours NNS O
of IN O
cross NN O
- : O
linking NN O
. . O

CD2 NNP B-Gene
cross SYM O
- : O
linking VBG O
concurrently RB O
increased VBN O
phosphorylation NN O
of IN O
CREB NNP B-Gene
detected VBN O
by IN O
immunoblot NN O
assay NN O
eightfold NN O
. . O

These DT O
data NNS O
indicate VBP O
specific JJ O
modulation NN O
of IN O
the DT O
CREB NNP B-Gene
/ NNP I-Gene
ATF NNP I-Gene
- : I-Gene
1 CD I-Gene
family NN I-Gene
of IN O
transcription NN B-Gene
factors NNS I-Gene
by IN O
the DT O
CD2 NNP B-Gene
signalling VBG O
pathway RB O
and CC O
suggest JJS O
CD2 NNP B-Gene
receptor NN O
modulation NN O
of IN O
CRE NNP B-Gene
- : O
mediated VBN O
transcription NN O
following VBG O
ligand NN O
engagement NN O
( ( O
e NN O
. . O
g NN O
. . O
cell NN O
- : O
to TO O
- : O
cell NN O
contact NN O
) ) O
. . O

In IN O
the DT O
present JJ O
report NN O
we PRP O
show VBP O
that IN O
in IN O
various JJ O
transiently RB O
or CC O
stably RB O
transfected VBN O
cell NN O
lines NNS O
, , O
X NNP O
- : O
ray NN O
irradiation NN O
up IN O
- : O
regulates NNS O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
transcription NN O
through IN O
the DT O
kappaB NN B-Gene
regulatory JJ I-Gene
elements NNS I-Gene
. . O

In IN O
addition NN O
, , O
X NNP O
- : O
ray JJ O
activation NN O
of IN O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
in IN O
transiently RB O
or CC O
stably RB O
transfected VBN O
cell NN O
lines NNS O
is VBZ O
inhibited VBN O
by IN O
a DT O
potent JJ O
antioxidant JJ O
drug NN O
, , O
pyrrolidine NN O
dithiocarbamate NN O
and CC O
by IN O
another DT O
drug NN O
, , O
known VBN O
for IN O
its PRP$ O
role NN O
in IN O
the DT O
trapping NN O
of IN O
growth NN B-Gene
factors NNS I-Gene
, , O
suramin NN O
. . O

The DT O
importance NN O
of IN O
these DT O
observations NNS O
in IN O
the DT O
pathophysiology NN O
of IN O
patients NNS O
with IN O
AIDS NNP O
- : O
related JJ O
cancers NNS O
treated VBN O
by IN O
radiotherapy NN O
remains NNS O
to TO O
be VB O
established VBN O
. . O

Restoration NN O
of IN O
the DT O
CCAAT NNP B-Gene
box NN I-Gene
at IN O
- : B-Gene
70 CD I-Gene
bp NN I-Gene
, , O
or CC O
insertion NN O
of IN O
an DT O
EKLF NNP B-Gene
binding NN I-Gene
site NN I-Gene
at IN O
- : B-Gene
85 CD I-Gene
bp NN I-Gene
or CC O
- : B-Gene
95 CD I-Gene
bp NN I-Gene
in IN O
the DT O
promoter NN B-Gene
significantly RB O
increased VBD O
delta JJ O
globin NN O
gene NN O
expression NN O
in IN O
hAEC NN O
. . O

Constitutive NNP O
association NN O
of IN O
JAK1 NNP B-Gene
and CC O
STAT5 NNP B-Gene
in IN O
pro JJ O
- : O
B NN O
cells NNS O
is VBZ O
dissolved VBN O
by IN O
interleukin JJ B-Gene
- : I-Gene
4 CD I-Gene
- : O
induced JJ O
tyrosine JJ O
phosphorylation NN O
of IN O
both DT O
proteins NNS O
. . O

Nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
was VBD O
found VBN O
to TO O
be VB O
activated VBN O
in IN O
ventilated JJ O
macrophages NNS O
. . O

To TO O
determine VB O
the DT O
mechanisms NNS O
responsible JJ O
for IN O
these DT O
differences NNS O
, , O
we PRP O
turned VBD O
to TO O
human JJ O
U937 NNP O
promonocytic JJ O
cells NNS O
. . O

Based VBN O
on IN O
the DT O
high JJ O
specificity NN O
of IN O
this DT O
compound NN O
for IN O
PKC NNP B-Gene
, , O
we PRP O
conclude VBP O
that DT O
PKC NNP B-Gene
is VBZ O
necessary JJ O
for IN O
FN NNP B-Gene
- : O
induced VBD O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
protein NN O
production NN O
. . O

A DT O
novel JJ O
member NN O
of IN O
the DT O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
( ( I-Gene
TNF NNP I-Gene
) ) I-Gene
receptor NN I-Gene
family NN I-Gene
, , O
designated VBN O
TRAMP NNP B-Gene
, , O
has VBZ O
been VBN O
identified VBN O
. . O

Overexpression NN O
of IN O
TRAMP NNP B-Gene
leads VBZ O
to TO O
two CD O
major JJ O
responses NNS O
, , O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
and CC O
apoptosis NN O
. . O

Using VBG O
a DT O
nuclear JJ O
run NN O
- : O
on IN O
assay NN O
, , O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
stimulation NN O
was VBD O
shown VBN O
to TO O
enhance VB O
transcription NN O
by IN O
two CD O
- : O
to TO O
threefold VB O
. . O

Conversely RB O
, , O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
markedly RB O
and CC O
significantly RB O
inhibited VBN O
HIV NNP O
replication NN O
at IN O
the DT O
transcriptional JJ O
level NN O
in IN O
monocyte JJ O
- : O
derived VBN O
macrophages NNS O
, , O
and CC O
this DT O
occurred VBD O
whether IN O
these DT O
cytokines NNS B-Gene
were VBD O
added VBN O
before IN O
or CC O
after IN O
HIV NNP O
infection NN O
. . O

Interleukin NNP B-Gene
- : I-Gene
10 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
) ) O
protects NNS O
animals NNS O
from IN O
lethal JJ O
endotoxemia NN O
. . O

Evidence NN O
suggests VBZ O
that IN O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
may MD O
inhibit VB O
activation NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
) ) O
through IN O
an DT O
unknown JJ O
mechanism NN O
. . O

We PRP O
hypothesized VBD O
that IN O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
prevents NNS O
human JJ O
monocyte NN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
and CC O
resultant NN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
production NN O
by IN O
stabilization NN O
of IN O
IkappaB NNP B-Gene
- : I-Gene
alpha NN I-Gene
. . O

Cells NNS O
were VBD O
stimulated VBN O
with IN O
endotoxin NN B-Gene
( ( O
LPS NNP O
, , O
100 CD O
ng JJ O
/ NNP O
mL NN O
) ) O
with IN O
and CC O
without IN O
human JJ O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
( ( O
10 CD O
ng RB O
/ NNP O
mL NN O
) ) O
. . O

IL NNP B-Gene
- : I-Gene
10 CD I-Gene
attenuated VBD O
LPS NNP O
- : O
stimulated VBD O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
production NN O
( ( O
297 CD O
+ NN O
/ NNP O
- : O
54 CD O
; : O
p NN O
< NN O
. . O
1 CD O
versus NN O
LPS NNP O
alone RB O
) ) O
. . O

IL NNP B-Gene
- : I-Gene
10 CD I-Gene
appears VBZ O
to TO O
prevent VB O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
by IN O
preserving VBG O
IkappaB NNP B-Gene
- : I-Gene
alpha NN I-Gene
protein NN O
levels NNS O
, , O
leading VBG O
to TO O
a DT O
reduction NN O
in IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
release NN O
. . O

Down NNP O
- : O
regulation NN O
of IN O
human JJ O
granzyme NN B-Gene
B NNP I-Gene
expression NN O
by IN O
glucocorticoids NNS O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
dexamethasone NN O
is VBZ O
able JJ O
to TO O
abrogate VB O
the DT O
transcriptional JJ O
activity NN O
of IN O
the DT O
human JJ B-Gene
granzyme NN I-Gene
B NNP I-Gene
gene NN I-Gene
promoter NN I-Gene
by IN O
inhibiting VBG O
the DT O
binding NN O
of IN O
nuclear JJ B-Gene
factors NNS I-Gene
at IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC I-Gene
Ikaros NNP I-Gene
sites NNS I-Gene
. . O

Therefore RB O
in IN O
this DT O
study NN O
, , O
we PRP O
have VBP O
examined VBN O
the DT O
role NN O
of IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
/ NN I-Gene
s NN I-Gene
( ( O
GR NNP B-Gene
) ) O
characteristics NNS O
in IN O
the DT O
developing NN O
of IN O
these DT O
abnormalities NNS O
in IN O
patients NNS O
with IN O
PCOS NNP O
. . O

ngal JJ O
gene NN O
expression NN O
was VBD O
found VBN O
at IN O
moderate JJ O
levels NNS O
in IN O
only RB O
2 CD O
of IN O
17 CD O
human JJ O
tissues NNS O
examined VBN O
, , O
breast NN O
and CC O
lung NN O
. . O

Immuno NNP O
- : O
histochemical JJ O
analysis NN O
confirmed VBD O
the DT O
presence NN O
of IN O
NGAL NNP B-Gene
within IN O
breast NN O
carcinoma NN O
cells NNS O
but CC O
detected VBD O
only RB O
low JJ O
levels NNS O
of IN O
this DT O
protein NN O
in IN O
normal JJ O
ductal JJ O
epithelium NN O
. . O

In IN O
contrast NN O
, , O
a DT O
significant JJ O
correlation NN O
between IN O
NGAL NNP B-Gene
expression NN O
in IN O
breast NN O
cancer NN O
was VBD O
found VBN O
with IN O
several JJ O
other JJ O
markers NNS O
of IN O
poor JJ O
prognosis NN O
, , O
including VBG O
estrogen NN O
and CC O
progesterone NN B-Gene
receptor NN I-Gene
- : O
negative JJ O
status NN O
and CC O
high JJ O
proliferation NN O
( ( O
S NNP O
- : O
phase NN O
fraction NN O
) ) O
. . O

BASH NNP B-Gene
, , O
a DT O
novel JJ B-Gene
signaling NN I-Gene
molecule NN I-Gene
preferentially RB O
expressed VBN O
in IN O
B NNP O
cells NNS O
of IN O
the DT O
bursa NN O
of IN O
Fabricius NNP O
. . O

The DT O
gene NN O
encodes VBZ O
an DT O
85 CD B-Gene
- : I-Gene
kDa NN I-Gene
protein NN I-Gene
, , O
designated VBN O
BASH NNP B-Gene
( ( O
B NNP B-Gene
cell NN I-Gene
adaptor NN I-Gene
containing VBG I-Gene
SH2 NNP I-Gene
domain NN I-Gene
) ) O
, , O
that WDT O
contains VBZ O
N NNP B-Gene
- : I-Gene
terminal JJ I-Gene
acidic JJ I-Gene
domains NNS I-Gene
with IN O
SH2 NNP B-Gene
domain VBP I-Gene
- : I-Gene
binding NN I-Gene
phosphotyrosine NN I-Gene
- : I-Gene
based VBN I-Gene
motifs NNS I-Gene
, , O
a DT O
proline NN B-Gene
- : I-Gene
rich JJ I-Gene
domain NN I-Gene
, , O
and CC O
a DT O
C NNP B-Gene
- : I-Gene
terminal JJ I-Gene
SH2 NNP I-Gene
domain NN I-Gene
. . O

These DT O
studies NNS O
revealed VBD O
that IN O
the DT O
major JJ B-Gene
protein NN I-Gene
in IN O
extracts NNS O
of IN O
PMN NNP O
activated VBN O
by IN O
G NNP B-Gene
- : I-Gene
CSF NN I-Gene
to TO O
bind VB O
the DT O
high JJ B-Gene
- : I-Gene
affinity NN I-Gene
serum SYM I-Gene
- : I-Gene
inducible JJ I-Gene
element NN I-Gene
( ( O
hSIE NN B-Gene
) ) O
is VBZ O
a DT O
72 CD B-Gene
- : I-Gene
kDa NN I-Gene
protein NN I-Gene
that WDT O
cross VBZ O
- : O
reacts NNS O
with IN O
Stat3 NNP B-Gene
monoclonal JJ I-Gene
antibody NN I-Gene
, , O
which WDT O
we PRP O
have VBP O
designated VBN O
Stat3gamma NNP B-Gene
. . O

In IN O
order NN O
to TO O
investigate VB O
the DT O
factors NNS O
that WDT O
influence VBP O
the DT O
induction NN O
of IN O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
molecules NNS O
, , O
Northern NNP O
blot NN O
analysis NN O
to TO O
measure VB O
the DT O
expression NN O
level NN O
of IN O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNAs NN I-Gene
and CC O
Southern NNP O
blot NN O
hybridization NN O
to TO O
analyze VB O
the DT O
integration NN O
of IN O
human JJ O
T NNP O
- : O
cell NN O
- : O
leukemia NN O
virus NN O
type NN O
1 CD O
( ( O
HTLV NNP O
- : O
1 CD O
) ) O
provirus NN O
were VBD O
done VBN O
. . O

These DT O
sequences NNS O
were VBD O
chosen VBN O
for IN O
study NN O
because IN O
mass NN O
- : O
spectrometric JJ O
analysis NN O
( ( O
MS NNP O
) ) O
of IN O
a DT O
CTL NNP O
active JJ O
HPLC NNP O
peptide NN O
fraction NN O
eluted VBN O
from IN O
immunoaffinity NN B-Gene
precipitated VBN I-Gene
HLA NNP I-Gene
- : I-Gene
A2 NNP I-Gene
molecule NN I-Gene
, , O
revealed VBN O
: : O
( ( O
a DT O
) ) O
the DT O
presence NN O
of IN O
an DT O
ion NN O
with IN O
a DT O
mass NN O
- : O
to TO O
- : O
charge NN O
ratio NN O
( ( O
m JJ O
/ NNP O
z NN O
) ) O
of IN O
793 CD O
which WDT O
was VBD O
more RBR O
abundant JJ O
than IN O
other JJ O
ions NNS O
of IN O
similar JJ O
masses NNS O
; : O
( ( O
b NN O
) ) O
the DT O
tentatively RB O
reconstituted JJ O
sequence NN O
of IN O
the DT O
ion NN O
793 CD O
matched VBD O
the DT O
sequence NN O
of IN O
peptide JJ O
G76 NNP O
. . O

These DT O
concentrations NNS O
are VBP O
lower JJR O
than IN O
concentrations NNS O
reported VBN O
to TO O
activate VB O
effector NN O
function NN O
of IN O
CTL NNP O
recognizing VBG O
other JJ O
epithelial JJ B-Gene
tumor NN I-Gene
Ag NNP I-Gene
. . O

Furthermore RB O
, , O
analysis NN O
with IN O
cloned JJ O
CD8 NNP O
+ NNP O
T NNP O
cells NNS O
indicated VBD O
that IN O
G75 NNP O
and CC O
G76 NNP O
were VBD O
not RB O
cross JJ O
- : O
reactive JJ O
specificities NNS O
, , O
suggesting VBG O
a DT O
key JJ O
role NN O
for IN O
the DT O
N NNP B-Gene
- : I-Gene
terminal JJ I-Gene
residues NNS I-Gene
of IN O
the DT O
variant JJ O
peptide NN O
in IN O
dictating VBG O
specificities NNS O
. . O

Since IN O
the DT O
AES NNP B-Gene
proteins NNS I-Gene
are VBP O
part NN O
of IN O
a DT O
set NN O
of IN O
transcriptional JJ O
repressors NNS O
encoded VBN O
by IN O
the DT O
Enhancer NNP B-Gene
of IN I-Gene
split NN I-Gene
[ NNP I-Gene
E NNP I-Gene
( ( I-Gene
spl NN I-Gene
) ) I-Gene
] NN I-Gene
genes NNS I-Gene
, , O
and CC O
since IN O
these DT O
repressors NNS O
are VBP O
activated VBN O
to TO O
suppress VB O
cell NN O
differentiation NN O
in IN O
response NN O
to TO O
Notch NNP B-Gene
receptors NNS I-Gene
signalling VBG O
, , O
the DT O
AES NNP O
peptides NNS O
may MD O
represent VB O
a DT O
novel JJ O
class NN O
of IN O
self NN B-Gene
- : I-Gene
antigens VBZ I-Gene
that IN O
deserve VB O
further JJ O
consideration NN O
as IN O
tumor NN B-Gene
Ag NNP I-Gene
in IN O
epithelial JJ O
cancers NNS O
. . O

Our PRP$ O
data NNS O
show VBP O
that IN O
IFNs NNP B-Gene
and CC O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
upregulate JJ O
PML NNP O
transcript NN O
and CC O
protein JJ O
expression NN O
in IN O
a DT O
time NN O
and CC O
dose VB O
- : O
dependent JJ O
manner NN O
. . O

Glucocorticoid JJ B-Gene
receptors NNS I-Gene
( ( O
GR NNP B-Gene
) ) O
and CC O
3 CD O
- : O
O NNP O
- : O
methyl NN O
- : O
D NNP O
glucose NN O
( ( O
3 CD O
- : O
O NNP O
- : O
MG NNP O
) ) O
transport NN O
were VBD O
determined VBN O
in IN O
mononuclear JJ O
leukocytes NNS O
( ( O
MNL NNP O
) ) O
from IN O
11 CD O
abdominal JJ O
obese JJ O
subjects NNS O
, , O
10 CD O
pituitary JJ O
- : O
dependent NN O
Cushing VBG O
' '' O
s JJ O
syndrome NN O
( ( O
Cushing VBG O
' '' O
s JJ O
disease NN O
) ) O
and CC O
10 CD O
healthy JJ O
controls NNS O
. . O

Interleukin NNP B-Gene
- : I-Gene
10 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
) ) O
and CC O
transforming VBG B-Gene
growth NN I-Gene
factor NN I-Gene
beta NN I-Gene
( ( O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
) ) O
are VBP O
inhibitory JJ O
for IN O
B NNP O
and CC O
T NNP O
cells NNS O
, , O
IgE NNP B-Gene
production NN O
, , O
and CC O
mast RB O
cell NN O
proliferation NN O
, , O
and CC O
they PRP O
induce VBP O
apoptosis NN O
in IN O
eosinophils NNS O
. . O

The DT O
IL NNP B-Gene
- : I-Gene
10 CD I-Gene
gene NN O
polymorphism NN O
was VBD O
a DT O
C NNP O
- : O
to TO O
- : O
A DT O
exchange NN O
571 CD B-Gene
base NN I-Gene
pairs NNS I-Gene
upstream RB I-Gene
from IN O
the DT O
translation NN B-Gene
start NN I-Gene
site NN I-Gene
and CC O
was VBD O
present JJ O
between IN O
consensus NN B-Gene
binding NN I-Gene
sequences NNS I-Gene
for IN O
Sp1 NNP B-Gene
and CC O
elevated VBD O
total JJ O
serum NN O
. . O

This DT O
polymorphism NN O
was VBD O
associated VBN O
with IN O
elevated JJ O
total JJ B-Gene
serum NN I-Gene
IgE NNP I-Gene
in IN O
subjects NNS O
heterozygotic JJ O
or CC O
homozygotic JJ O
for IN O
this DT O
base JJ O
exchange NN O
( ( O
p JJ O
< NN O
0 CD O
. . O
9 CD O
) ) O
. . O

This DT O
polymorphism NN O
represented VBD O
a DT O
C NNP O
- : O
to TO O
- : O
T NNP O
base NN O
exchange NN O
which WDT O
induced VBD O
a DT O
YY1 NNP B-Gene
consensus NN I-Gene
sequence NN I-Gene
and CC O
is VBZ O
present JJ O
in IN O
a DT O
region NN O
of IN O
the DT O
promoter NN O
associated VBN O
with IN O
negative JJ O
transcription NN O
regulation NN O
. . O

However RB O
, , O
it PRP O
was VBD O
only RB O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
whose WP$ O
activation NN O
by IN O
Tpl NNP B-Gene
- : I-Gene
2 CD I-Gene
was VBD O
fully RB O
blocked VBN O
by IN O
the DT O
dominant JJ B-Gene
negative JJ I-Gene
mutant NN I-Gene
MEK1S218 NNP I-Gene
/ VBZ I-Gene
222A CD I-Gene
and CC O
the DT O
MEK1 NNP O
/ NNP O
MEK2 NNP O
inhibitor NN O
PD098059 NNP O
. . O

Since IN O
the DT O
protein NN O
has VBZ O
a DT O
homeodomain NN B-Gene
and CC O
can MD O
activate VB O
transcription NN O
, , O
it PRP O
probably RB O
exerts VBZ O
at IN O
least JJS O
some DT O
of IN O
its PRP$ O
effects NNS O
in IN O
vivo NN O
by IN O
regulation NN O
of IN O
target NN B-Gene
genes NNS I-Gene
. . O

We PRP O
investigated VBD O
the DT O
function NN O
of IN O
the DT O
evolutionary JJ O
conserved VBD O
X2 NNP B-Gene
box NN I-Gene
in IN O
the DT O
promoter NN B-Gene
of IN O
the DT O
HLA NNP B-Gene
- : I-Gene
DRA NNP I-Gene
gene NN I-Gene
from IN O
the DT O
human JJ B-Gene
major JJ I-Gene
histocompatibility NN I-Gene
complex NN I-Gene
( ( O
MHC NNP B-Gene
) ) O
in IN O
resting VBG O
and CC O
activated VBN O
B NNP O
cells NNS O
. . O

Thymocytes NNS O
control VBP O
the DT O
CD4 NNP B-Gene
gene NN I-Gene
differently RB O
from IN O
mature NN O
T NNP O
lymphocytes VBZ O
. . O

Glucocorticoids NNS O
are VBP O
physiological JJ O
molecules NNS O
that WDT O
are VBP O
also RB O
extensively RB O
used VBN O
in IN O
clinics NNS O
as IN O
anti JJ O
- : O
inflammatory NN O
, , O
immunosuppressive JJ O
or CC O
anti JJ O
- : O
tumoral JJ O
agents NNS O
. . O

The DT O
action NN O
of IN O
adenoviral JJ B-Gene
E1A NNP I-Gene
oncoprotein NN I-Gene
on IN O
host NN B-Gene
immune JJ I-Gene
- : I-Gene
response NN I-Gene
genes NNS I-Gene
has VBZ O
been VBN O
attributed VBN O
to TO O
interaction NN O
with IN O
p300 JJ B-Gene
/ NNP I-Gene
CBP NNP I-Gene
- : I-Gene
type NN I-Gene
transcriptional JJ I-Gene
coactivators NNS I-Gene
in IN O
competition NN O
with IN O
endogenous JJ B-Gene
transcription NN I-Gene
factors NNS I-Gene
such JJ O
as IN O
signal JJ B-Gene
transducer NN I-Gene
and CC I-Gene
activator NN I-Gene
of IN I-Gene
transcription NN I-Gene
( ( I-Gene
STAT NNP I-Gene
) ) I-Gene
proteins VBZ I-Gene
. . O

Effect NN O
of IN O
environmental JJ O
estrogens NNS O
on IN O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
promoter NN I-Gene
activity NN O
in IN O
a DT O
macrophage NN O
cell NN O
line NN O
. . O

17beta CD O
- : O
estradiol NN O
( ( O
E2 NNP O
) ) O
markedly RB O
enhanced VBD O
lipopolysaccharide JJ O
- : O
( ( O
LPS NNP O
) ) O
induced VBD O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
promoter NN I-Gene
- : O
driven JJ O
CAT NNP B-Gene
activity NN O
in IN O
a DT O
dose JJ O
- : O
dependent JJ O
manner NN O
. . O

Unlike IN O
the DT O
mycoestrogens NNS O
, , O
none NN O
of IN O
the DT O
compounds NNS O
, , O
with IN O
the DT O
exception NN O
of IN O
genistein NN O
, , O
synergized VBN O
with IN O
LPS NNP O
to TO O
enhance VB O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
promoter NN I-Gene
activity NN O
. . O

Naringenin NNP O
, , O
a DT O
plant NN O
flavonoid NN O
, , O
showed VBD O
little JJ O
or CC O
no DT O
ability NN O
to TO O
antagonize VB O
the DT O
response NN O
to TO O
E2 NNP O
. . O

Isolation NN O
and CC O
utilization NN O
of IN O
human JJ O
dendritic JJ O
cells NNS O
from IN O
peripheral JJ O
blood NN O
to TO O
assay VB O
an DT O
in IN O
vitro JJ O
primary JJ O
immune JJ O
response NN O
to TO O
varicella VB O
- : O
zoster NN O
virus NN O
peptides NNS O
. . O

Here RB O
we PRP O
evaluated VBD O
whether IN O
xenogeneic JJ O
serum NN O
, , O
as IN O
a DT O
source NN O
of IN O
xenoreactive JJ B-Gene
natural JJ I-Gene
antibodies NNS I-Gene
and CC O
complement NN O
, , O
induced VBN O
endothelial JJ O
cell NN O
activation NN O
with IN O
consequent JJ O
leukocyte JJ O
adhesion NN O
under IN O
flow JJ O
conditions NNS O
. . O

Adherent JJ O
cells NNS O
were VBD O
counted VBN O
by IN O
digital JJ O
image NN O
analysis NN O
. . O

In IN O
order NN O
to TO O
elucidate VB O
possible JJ O
mechanisms NNS O
underlying VBG O
endothelial JJ O
cell NN O
activation NN O
by IN O
xenogeneic NNP O
serum NN O
, , O
we PRP O
focussed VBD O
on IN O
transcription NN B-Gene
factor NN I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
a DT O
central JJ O
regulator NN O
for IN O
the DT O
induction NN O
of IN O
different JJ O
genes NNS O
, , O
including VBG O
adhesive JJ B-Gene
molecules NNS I-Gene
and CC O
chemoattractants NNS B-Gene
. . O

Anaphylatoxins NNS B-Gene
C5a NNP B-Gene
and CC O
C3a NNP B-Gene
induce VBP O
nuclear JJ B-Gene
factor NN I-Gene
kappaB NN I-Gene
activation NN O
in IN O
human JJ O
peripheral JJ O
blood NN O
monocytes NNS O
. . O

These DT O
results NNS O
imply VBP O
a DT O
potential JJ O
role NN O
of IN O
the DT O
anaphylatoxins NNS B-Gene
C5a NNP B-Gene
and CC O
C3a NNP B-Gene
in IN O
regulating VBG O
leukocytes NNS O
gene NN O
expression NN O
through IN O
G NNP O
protein SYM O
- : O
coupled VBN O
transcription NN O
factor NN O
activation NN O
. . O

Plasma NNP O
TPO NNP B-Gene
levels NNS O
are VBP O
regulated VBN O
by IN O
the DT O
platelet NN O
and CC O
megakaryocyte NN O
mass NN O
through IN O
Mpl NNP B-Gene
receptor NN I-Gene
binding NN O
, , O
internalization NN O
and CC O
degradation NN O
. . O

The DT O
Mpl NNP B-Gene
receptor NN I-Gene
is VBZ O
a DT O
member NN O
of IN O
the DT O
hematopoietin NN B-Gene
receptor NN I-Gene
superfamily RB I-Gene
lacking VBG O
intrinsic JJ O
kinase NN O
activity NN O
. . O

Promoter NN O
analysis NN O
revealed VBD O
that IN O
a DT O
GATA NNP B-Gene
site NN I-Gene
in IN O
a DT O
cryptic JJ B-Gene
promoter NN I-Gene
in IN O
the DT O
second JJ B-Gene
intron NN I-Gene
was VBD O
essential JJ O
and CC O
sufficient JJ O
for IN O
the DT O
TAL1 NNP O
- : O
and CC O
LMO NNP O
- : O
dependent JJ O
transcriptional JJ O
activation NN O
, , O
and CC O
GATA3 NNP B-Gene
binds VBZ O
to TO O
this DT O
site NN O
. . O

Glucocorticoids NNS O
are VBP O
important JJ O
for IN O
maintaining VBG O
cellular JJ O
and CC O
humoral JJ O
homeostasis NN O
and CC O
are VBP O
key JJ O
mediators NNS O
of IN O
neuroendocrine JJ O
- : O
immune JJ O
regulatory JJ O
interactions NNS O
. . O

Several JJ O
neuroendocrine SYM O
- : O
immune JJ O
interactions NNS O
could MD O
be VB O
responsible JJ O
for IN O
reduced JJ O
GR NNP B-Gene
levels NNS O
with IN O
age NN O
and CC O
sport NN O
activity NN O
in IN O
man NN O
. . O

Glycation NNP O
- : O
dependent NN O
, , O
reactive JJ O
oxygen NN O
species NNS O
- : O
mediated VBN O
suppression NN O
of IN O
the DT O
insulin NN O
gene NN O
promoter NN O
activity NN O
in IN O
HIT NNP O
cells NNS O
. . O

In IN O
non JJ O
- : O
rheumatoid NN O
arthritis NN O
, , O
binding NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
synovial JJ O
T NNP O
cells NNS O
was VBD O
exclusively RB O
mediated VBN O
by IN O
p50 NN B-Gene
/ NNP I-Gene
p50 NN I-Gene
homodimers NNS I-Gene
. . O

X JJ B-Gene
chromosome NN I-Gene
inactivation NN O
patterns NNS O
in IN O
normal JJ O
females NNS O
. . O

Since IN O
one CD O
of IN O
the DT O
two CD O
X NNP B-Gene
chromosomes NNS I-Gene
is VBZ O
randomly RB O
inactivated VBN O
at IN O
an DT O
early JJ O
stage NN O
of IN O
female JJ O
embryonic JJ O
development NN O
, , O
X NNP B-Gene
- : I-Gene
linked VBD I-Gene
markers NNS I-Gene
have VBP O
been VBN O
used VBN O
to TO O
study VB O
the DT O
origin NN O
and CC O
development NN O
of IN O
various JJ O
neoplastic JJ O
disorders NNS O
in IN O
affected JJ O
heterozygous JJ O
women NNS O
; : O
clonality NN O
assays NNS O
have VBP O
provided VBN O
a DT O
useful JJ O
tool NN O
to TO O
the DT O
understanding NN O
of IN O
the DT O
mechanisms NNS O
underlying VBG O
the DT O
development NN O
of IN O
neoplasia NN O
. . O

Recently RB O
, , O
a DT O
technique NN O
of IN O
clonal JJ O
analysis NN O
has VBZ O
been VBN O
devised VBN O
that IN O
takes VBZ O
advantage NN O
of IN O
a DT O
highly RB O
polymorphic JJ O
short JJ B-Gene
tandem NN I-Gene
repeat NN I-Gene
within IN O
the DT O
X NNP B-Gene
- : I-Gene
linked VBN I-Gene
human JJ I-Gene
androgen NN I-Gene
receptor NN I-Gene
( ( I-Gene
AR NNP I-Gene
) ) I-Gene
gene NN I-Gene
, , O
resulting VBG O
in IN O
a DT O
heterozygosity NN O
rate NN O
approaching VBG O
90 CD O
% NN O
. . O

The DT O
rapid JJ O
expansion NN O
of IN O
the DT O
number NN O
of IN O
women NNS O
now RB O
suitable JJ O
for IN O
X NNP O
inactivation NN O
analysis NN O
has VBZ O
however RB O
given VBN O
rise NN O
to TO O
new JJ O
controversies NNS O
, , O
one CD O
of IN O
the DT O
more RBR O
troublesome JJ O
being VBG O
the DT O
possibility NN O
of IN O
a DT O
modification NN O
of IN O
the DT O
pattern NN O
of IN O
X NNP B-Gene
- : I-Gene
chromosome NN I-Gene
inactivation NN O
pattern NN O
in IN O
blood NN O
cells NNS O
of IN O
elderly JJ O
women NNS O
. . O

In IN O
the DT O
present JJ O
study NN O
we PRP O
analyze VBP O
with IN O
the DT O
AR NNP O
assay VBP O
a DT O
group NN O
of IN O
166 CD O
healthy JJ O
females NNS O
aged VBN O
between IN O
8 CD O
and CC O
94 CD O
years NNS O
, , O
with IN O
no DT O
history NN O
of IN O
genetic JJ O
or CC O
neoplastic JJ O
familial JJ O
disorders NNS O
. . O

We PRP O
show VBP O
here RB O
that IN O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
/ NNP I-Gene
beta NN I-Gene
act NN O
directly RB O
on IN O
human JJ O
T NNP O
cells NNS O
to TO O
drive VB O
Th1 NNP O
development NN O
, , O
bypassing VBG O
the DT O
need NN O
for IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
- : O
induced JJ O
signaling NN O
, , O
whereas WP O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
can MD O
not RB O
substitute VB O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
for IN O
mouse NN O
Th1 NNP O
development NN O
. . O

Unlike IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
, , O
which WDT O
acts VBZ O
only RB O
on IN O
Th1 NNP O
cells NNS O
, , O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
/ IN I-Gene
beta NN I-Gene
can MD O
activate VB O
Stat4 NNP B-Gene
not RB O
only RB O
in IN O
human JJ O
Th1 NNP O
, , O
but CC O
also RB O
in IN O
Th2 NNP O
cells NNS O
. . O

We PRP O
have VBP O
generated VBN O
antibodies NNS O
that WDT O
specifically RB O
immunoprecipitated VBD O
the DT O
in IN B-Gene
- : I-Gene
vitro NN I-Gene
- : I-Gene
translated VBD I-Gene
20 CD I-Gene
- : I-Gene
kDa NN I-Gene
protein NN I-Gene
. . O

The DT O
mRNA NN O
levels NNS O
for IN O
fkhrl1 NN B-Gene
is VBZ O
elevated VBN O
in IN O
T NNP O
helper SYM O
- : O
induced JJ O
lymphocytes NNS O
in IN O
comparison NN O
to TO O
PHA NNP O
- : O
stimulated VBD O
T NNP O
lymphocytes NNS O
. . O

Further JJ O
characterization NN O
of IN O
FKHRL1 NNP B-Gene
and CC O
its PRP$ O
related JJ O
family NN O
members NNS O
should MD O
shed VB O
light NN O
on IN O
the DT O
transcriptional JJ O
mechanisms NN O
of IN O
this DT O
fork NN B-Gene
head NN I-Gene
gene NN I-Gene
subfamily RB I-Gene
and CC O
their PRP$ O
role NN O
in IN O
T NNP O
helper NN O
cell NN O
differentiation NN O
and CC O
regulation NN O
of IN O
cell NN O
growth NN O
. . O

Inhibition NN O
of IN O
Th1 NNP O
development NN O
mediated VBN O
by IN O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
through IN O
an DT O
IL NNP O
- : O
4 CD O
- : O
independent JJ O
mechanism NN O
. . O

These DT O
motifs NNS O
are VBP O
regulatory JJ B-Gene
sequences NNS I-Gene
within IN O
the DT O
so RB O
- : O
called VBN O
AU NNP B-Gene
- : I-Gene
rich JJ I-Gene
elements NNS I-Gene
( ( O
AREs NNP B-Gene
) ) O
often RB O
found VBN O
in IN O
3 CD B-Gene
' POS I-Gene
untranslated JJ I-Gene
regions NNS I-Gene
of IN O
genes NNS O
such JJ O
as IN O
cytokines NNS B-Gene
, , O
proto SYM B-Gene
- : I-Gene
oncogenes NNS I-Gene
, , O
and CC O
transcription NN B-Gene
factors NNS I-Gene
. . O

Copyright JJ O
1998 CD O
Academic NNP O
Press NNP O
. . O

Transcription NNP O
factor NN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
regulation NN O
of IN O
renal JJ O
fibrosis NN O
during IN O
ureteral JJ O
obstruction NN O
. . O

Irrespective NNP O
of IN O
the DT O
etiology NN O
, , O
many JJ O
kidney NN O
diseases NNS O
result VBP O
in IN O
inflammation NN O
and CC O
fibrosis NN O
of IN O
the DT O
tubulointerstitium NN O
, , O
with IN O
the DT O
subsequent JJ O
loss NN O
of IN O
renal JJ O
function NN O
. . O

The DT O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( I-Gene
NF NNP I-Gene
- : I-Gene
kappaB NN I-Gene
) ) I-Gene
family NN I-Gene
of IN O
transcription NN B-Gene
factors NNS I-Gene
regulates VBZ O
genes NNS O
involved VBN O
in IN O
inflammation NN O
, , O
cell NN O
proliferation NN O
, , O
and CC O
cell NN O
differentiation NN O
. . O

Morphological JJ O
studies NNS O
demonstrated VBD O
characteristic JJ O
features NNS O
of IN O
erythroid JJ O
differentiation NN O
and CC O
maturation NN O
. . O

At IN O
the DT O
same JJ O
time NN O
there EX O
was VBD O
no DT O
change NN O
in IN O
the DT O
level NN O
of IN O
expression NN O
of IN O
the DT O
cell NN B-Gene
surface NN I-Gene
antigenes NNS I-Gene
CD33 NNP B-Gene
, , O
CD34 NNP B-Gene
, , O
CD45 NNP B-Gene
, , O
CD71 NNP B-Gene
and CC O
glycophorin VB B-Gene
A NNP I-Gene
. . O

The DT O
class NN B-Gene
II NNP I-Gene
transactivator NN I-Gene
( ( O
CIITA NNP B-Gene
) ) O
is VBZ O
essential JJ O
for IN O
the DT O
expression NN O
of IN O
major JJ B-Gene
histocompatibility NN I-Gene
complex NN I-Gene
( ( I-Gene
MHC NNP I-Gene
) ) I-Gene
class NN I-Gene
II NNP I-Gene
antigens VBZ I-Gene
. . O

In IN O
contrast NN O
, , O
luciferase JJ B-Gene
expression NN O
was VBD O
not RB O
stimulated VBN O
after IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
treatment NN O
when WRB O
the DT O
construct NN O
was VBD O
transfected VBN O
in IN O
macrophage NN O
or CC O
in IN O
epithelial JJ O
cell NN O
lines NNS O
. . O

These DT O
studies NNS O
investigate VBP O
the DT O
relationship NN O
between IN O
leukocyte NN O
populations NNS O
, , O
steroid VBP B-Gene
hormone NN I-Gene
receptor NN I-Gene
expression NN O
, , O
proliferative JJ O
activity NN O
, , O
bcl SYM B-Gene
- : I-Gene
2 CD I-Gene
expression NN O
and CC O
apoptosis NN O
in IN O
eutopic NN O
and CC O
ectopic JJ O
endometrium NN O
from IN O
women NNS O
with IN O
endometriosis NN O
or CC O
adenomyosis NN O
at IN O
different JJ O
phases NNS O
of IN O
the DT O
menstrual JJ O
cycle NN O
. . O

Here RB O
, , O
we PRP O
demonstrate VBP O
through IN O
the DT O
use NN O
of IN O
intracellular JJ O
staining NN O
that WDT O
interleukin VBZ B-Gene
- : I-Gene
1beta CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
) ) O
is VBZ O
expressed VBN O
in IN O
LCLs NNP O
and CC O
investigate VB O
the DT O
influence NN O
of IN O
the DT O
individual JJ O
latent NN B-Gene
proteins NNS I-Gene
on IN O
the DT O
expression NN O
of IN O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
( ( O
EMSAs NNP O
) ) O
demonstrated VBD O
that IN O
the DT O
- : O
300 CD O
region NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
promoter NN O
, , O
which WDT O
contains VBZ O
a DT O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
( ( I-Gene
NF NNP I-Gene
- : I-Gene
kappaB NN I-Gene
) ) I-Gene
binding NN I-Gene
site NN I-Gene
, , O
contained VBD O
a DT O
functional JJ B-Gene
RBP NNP I-Gene
binding NN I-Gene
site NN I-Gene
. . O

CD27 NNP B-Gene
/ NNP O
CD70 NNP O
interaction NN O
augments NNS O
IgE NNP B-Gene
secretion NN O
by IN O
promoting VBG O
the DT O
differentiation NN O
of IN O
memory NN O
B NNP O
cells NNS O
into IN O
plasma JJ O
cells NNS O
. . O

The DT O
induction NN O
of IN O
IgE NNP B-Gene
switching VBG O
in IN O
B NNP O
cells NNS O
requires VBZ O
several JJ O
signals NNS O
given VBN O
by IN O
cytokines NNS B-Gene
and CC O
cell NN O
contact NN O
- : O
delivered VBN O
signals NNS O
. . O

Here RB O
, , O
we PRP O
investigated VBD O
the DT O
role NN O
of IN O
CD27 NNP B-Gene
/ NNP O
CD70 NNP O
interaction NN O
in IN O
B NNP O
cell NN O
IgE NNP B-Gene
synthesis NN O
. . O

The DT O
effect NN O
of IN O
CD70 NNP O
transfectants NNS O
was VBD O
dose JJ O
dependent JJ O
and CC O
was VBD O
completely RB O
blocked VBN O
by IN O
anti JJ B-Gene
- : I-Gene
CD70 NNP I-Gene
mAb NN I-Gene
. . I-Gene

CD27 NNP B-Gene
/ NNP O
CD70 NNP O
interaction NN O
enhanced VBD O
B NNP O
cell NN O
proliferation NN O
in IN O
the DT O
presence NN O
of IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
or CC O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
plus CC O
anti JJ B-Gene
- : I-Gene
CD40 NN I-Gene
. . O

Recent JJ O
studies NNS O
, , O
however RB O
, , O
demonstrate VBP O
that IN O
the DT O
transcribed JJ O
5 CD B-Gene
' POS I-Gene
- : I-Gene
untranslated JJ I-Gene
leader NN I-Gene
region NN I-Gene
( ( O
5 CD B-Gene
' '' I-Gene
- : I-Gene
UTR NN I-Gene
) ) O
also RB O
contains VBZ O
important JJ O
transcriptional JJ B-Gene
elements NNS I-Gene
. . O

These DT O
regulatory JJ B-Gene
elements NNS I-Gene
situated VBD O
downstream NN O
of IN O
transcription NN O
interact NN O
with IN O
constitutive JJ O
and CC O
inducible JJ O
transcription NN B-Gene
factors NNS I-Gene
, , O
mediate JJ O
transmission NN O
of IN O
cellular JJ O
activation NN O
signals NNS O
, , O
and CC O
are VBP O
important JJ O
for IN O
efficient JJ O
HIV NNP O
- : O
1 CD O
transcription NN O
and CC O
replication NN O
. . O

Regulation NN O
of IN O
PAK NNP O
activation NN O
and CC O
the DT O
T NNP O
cell NN O
cytoskeleton NN O
by IN O
the DT O
linker NN B-Gene
protein NN I-Gene
SLP NNP B-Gene
- : I-Gene
76 CD I-Gene
. . O

In IN O
turn NN O
, , O
assembly NN O
of IN O
this DT O
complex JJ O
mediates VBZ O
the DT O
enzymatic JJ O
activation NN O
of IN O
the DT O
p21 NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
1 CD I-Gene
and CC O
facilitates NNS O
actin JJ B-Gene
polymerization NN O
. . O

Copyright JJ O
1998 CD O
Academic NNP O
Press NNP O
. . O

LOX NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
an DT O
endothelial JJ B-Gene
receptor NN I-Gene
for IN O
oxidized VBN B-Gene
low JJ I-Gene
- : I-Gene
density NN I-Gene
lipoprotein VBZ I-Gene
that IN O
plays VBZ O
essential JJ O
roles NNS O
in IN O
atherogenesis NN O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
cloned VBD O
and CC O
characterized VBD O
the DT O
human JJ B-Gene
LOX NNP I-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
( ( O
HGMW NNP B-Gene
- : I-Gene
approved VBD I-Gene
symbol JJ I-Gene
OLR1 NNP I-Gene
) ) O
. . O

In IN O
contrast NN O
, , O
the DT O
expression NN O
pattern NN O
of IN O
LOX NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
different JJ O
from IN O
that DT O
of IN O
the DT O
natural JJ B-Gene
killer NN I-Gene
cell NN I-Gene
receptors NNS I-Gene
; : O
LOX NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
expressed VBN O
in IN O
vascular JJ O
- : O
rich JJ O
organs NNS O
, , O
but CC O
not RB O
in IN O
lymphocytes NNS O
. . O

These DT O
results NNS O
demonstrate VBP O
that IN O
the DT O
human JJ B-Gene
LOX NNP I-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
is VBZ O
a DT O
new JJ O
member NN O
of IN O
the DT O
natural JJ B-Gene
killer NN I-Gene
gene NN I-Gene
complex JJ I-Gene
with IN O
a DT O
unique JJ O
expression NN O
profile NN O
. . O

In IN O
this DT O
report NN O
, , O
we PRP O
describe VBP O
the DT O
transcriptional JJ O
regulation NN O
of IN O
the DT O
beta NN B-Gene
- : I-Gene
casein NN I-Gene
gene NN I-Gene
by IN O
cytokines NNS B-Gene
in IN O
T NNP O
cells NNS O
. . O

Coincidentally RB O
, , O
a DT O
deletion NN O
of IN O
this DT O
region NN O
enhanced VBD O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
- : O
induced JJ O
expression NN O
of IN O
beta NN B-Gene
- : I-Gene
casein NN I-Gene
. . O

In IN O
addition NN O
, , O
Ras NNP B-Gene
( ( I-Gene
G12V NNP I-Gene
) ) I-Gene
complemented VBD O
signaling VBG O
by IN O
an DT O
erythropoietin NN B-Gene
receptor NN I-Gene
mutant JJ I-Gene
defective NN O
in IN O
Ras NNP B-Gene
activation NN O
and CC O
augmented VBD O
the DT O
activation NN O
of IN O
the DT O
beta NN B-Gene
- : I-Gene
casein NN I-Gene
promoter NN I-Gene
by IN O
the DT O
mutant JJ B-Gene
erythropoietin NN I-Gene
receptor NN I-Gene
signaling NN O
, , O
suggesting VBG O
a DT O
possible JJ O
role NN O
of IN O
Ras NNP B-Gene
in IN O
Stat5 NNP B-Gene
- : O
mediated VBD O
gene NN O
expression NN O
. . O

GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
represses NNS O
gp91phox JJ B-Gene
gene NN I-Gene
expression NN O
in IN O
eosinophil JJ O
- : O
committed VBN O
HL NNP O
- : O
60 CD O
- : O
C15 NN O
cells NNS O
. . O

An DT O
81 CD O
% NN O
increment NN O
in IN O
promoter NN O
activity NN O
was VBD O
obtained VBN O
when WRB O
a DT O
mutation NN O
was VBD O
introduced VBN O
in IN O
the DT O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
binding VBG I-Gene
site NN I-Gene
of IN O
the DT O
bp NN B-Gene
- : I-Gene
267 CD I-Gene
to TO I-Gene
+ VB I-Gene
12 CD I-Gene
construct NN I-Gene
, , O
which WDT O
is VBZ O
comparable JJ O
to TO O
that DT O
of IN O
the DT O
bp NN B-Gene
- : I-Gene
245 CD I-Gene
to TO I-Gene
+ VB I-Gene
12 CD I-Gene
construct NN I-Gene
. . O

Ligation NN O
of IN O
CD3 NNP B-Gene
also RB O
induces VBZ O
the DT O
tyrosine JJ O
phosphorylation NN O
of IN O
HS1 NNP B-Gene
, , O
a DT O
75 CD B-Gene
- : I-Gene
kDa NN I-Gene
hematopoietic JJ I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
intracellular JJ I-Gene
signaling VBG I-Gene
protein NN I-Gene
of IN O
unknown JJ O
function NN O
. . O

Costimulation NNP O
through IN O
CD28 NNP B-Gene
and CC O
/ NNP O
or CC O
CD2 NNP B-Gene
did VBD O
not RB O
modulate VB O
the DT O
CD3 NNP B-Gene
- : O
dependent JJ O
phosphorylation NN O
of IN O
HS1 NNP B-Gene
. . O

c SYM O
- : O
fos NN O
and CC O
c SYM O
- : O
jun NN O
mRNA JJ O
expression NN O
in IN O
activated JJ O
cord NN O
and CC O
adult NN O
lymphocytes NNS O
: : O
an DT O
analysis NN O
by IN O
Northern NNP O
hybridization NN O
. . O

In IN O
addition NN O
, , O
Northern NNP O
blot NN O
analysis NN O
of IN O
cord NN O
and CC O
adult NN O
samples NNS O
revealed VBD O
similar JJ O
maximal NN O
increases NNS O
in IN O
c JJ B-Gene
- : I-Gene
fos NN I-Gene
( ( O
99 CD O
+ NN O
/ NNP O
- : O
15 CD O
and CC O
126 CD O
+ NN O
/ NNP O
- : O
11 CD O
% NN O
, , O
p NN O
= VBD O
0 CD O
. . O
126 CD O
) ) O
and CC O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
( ( I-Gene
123 CD I-Gene
+ NN I-Gene
/ NNP I-Gene
- : I-Gene
9 CD I-Gene
and CC I-Gene
185 CD I-Gene
+ NN I-Gene
/ NNP I-Gene
- : I-Gene
38 CD I-Gene
% NN I-Gene
, , I-Gene
p NN I-Gene
= VBD I-Gene
0 CD I-Gene
. . I-Gene
291 CD I-Gene
) ) I-Gene
mRNA NN I-Gene
expression NN O
, , O
respectively RB O
, , O
as RB O
early RB O
as IN O
15 CD O
min NN O
post NN O
- : O
alphaCD3 NN B-Gene
stimulation NN O
. . O

Receptors NNS O
for IN O
the DT O
Fc NNP B-Gene
portion NN I-Gene
of IN O
immunoglobulin NN B-Gene
molecules NNS I-Gene
( ( O
FcR NNP B-Gene
) ) O
present NN O
on IN O
leukocyte NN O
cell NN O
membranes NNS O
mediate VBP O
a DT O
large JJ O
number NN O
of IN O
cellular JJ O
responses NNS O
that WDT O
are VBP O
very RB O
important JJ O
in IN O
host NN O
defense NN O
, , O
including VBG O
phagocytosis NN O
, , O
cell NN O
cytotoxicity NN O
, , O
production NN O
and CC O
secretion NN O
of IN O
inflammatory JJ B-Gene
mediators NNS I-Gene
, , O
and CC O
modulation NN O
of IN O
the DT O
immune JJ O
response NN O
. . O

Cross NNP O
- : O
linking NN O
of IN O
FcR NNP B-Gene
, , O
on IN O
the DT O
THP NNP O
- : O
1 CD O
monocytic JJ O
cell NN O
line NN O
, , O
by IN O
immune NN B-Gene
complexes NNS I-Gene
resulted VBD O
in IN O
both DT O
activation NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
interleukin JJ B-Gene
1 CD I-Gene
production NN O
. . O

BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
mutations NNS O
in IN O
normal JJ O
germinal JJ O
center NN O
B NNP O
cells NNS O
: : O
evidence NN O
of IN O
somatic JJ O
hypermutation NN O
acting VBG O
outside JJ O
Ig NNP B-Gene
loci NN I-Gene
. . O

Thirty NNP O
percent NN O
of IN O
GC NNP O
B NNP O
cells NNS O
, , O
but CC O
not RB O
naive JJ O
B NNP O
cells NNS O
, , O
displayed VBD O
mutations NNS O
in IN O
the DT O
742 CD B-Gene
bp JJ I-Gene
region NN I-Gene
analyzed VBD O
within IN O
the DT O
first JJ O
intron NN O
of IN O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
( ( O
overall JJ O
frequency NN O
: : O
5 CD O
x $ O
10 CD O
( ( O
- : O
4 CD O
) ) O
/ FW O
bp NN O
) ) O
. . O

The DT O
ability NN O
of IN O
E2A NNP B-Gene
- : I-Gene
HLF NN I-Gene
to TO O
prolong VB O
the DT O
survival NN O
of IN O
interleukin JJ O
- : O
3 CD O
( ( O
IL NNP O
- : O
3 CD O
) ) O
- : O
dependent JJ O
murine JJ O
pro FW O
- : O
B NN O
cells NNS O
after IN O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
withdrawal NN O
suggests VBZ O
that IN O
it PRP O
disrupts VBZ O
signaling VBG O
pathways NNS O
normally RB O
responsible JJ O
for IN O
cell NN O
suicide NN O
, , O
allowing VBG O
the DT O
cells NNS O
to TO O
accumulate VB O
as IN O
transformed JJ O
lymphoblasts NNS O
. . O

Neither CC O
the DT O
E12 NNP B-Gene
nor CC O
the DT O
E47 NNP B-Gene
product NN O
of IN O
the DT O
E2A NNP B-Gene
gene NN I-Gene
nor CC O
the DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
HLF NNP I-Gene
protein NN I-Gene
was VBD O
able JJ O
to TO O
protect VB O
the DT O
cells NNS O
from IN O
apoptosis NN O
induced VBN O
by IN O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
deprivation NN O
. . O

Surprisingly RB O
, , O
different JJ O
combinations NNS O
of IN O
disabling VBG O
mutations NNS O
within IN O
the DT O
HLF NNP B-Gene
bZIP NN I-Gene
domain NN I-Gene
had VBD O
little JJ O
effect NN O
on IN O
the DT O
antiapoptotic JJ O
property NN O
of IN O
the DT O
chimeric JJ B-Gene
protein NN I-Gene
, , O
so RB O
long RB O
as IN O
the DT O
amino NN O
- : O
terminal JJ O
portion NN O
of IN O
E2A NNP B-Gene
remained VBD O
intact JJ O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
1 CD O
) ) O
lipid VBD O
A DT O
myristoyl NN O
fatty JJ O
acid NN O
, , O
although IN O
it PRP O
is VBZ O
important JJ O
for IN O
the DT O
induction NN O
of IN O
inflammatory JJ B-Gene
cytokine NN I-Gene
production NN O
by IN O
human JJ O
monocytes NNS O
, , O
is VBZ O
not RB O
necessary JJ O
for IN O
the DT O
induction NN O
of IN O
Mn NNP B-Gene
SOD NNP I-Gene
, , O
2 CD O
) ) O
endotoxin NN B-Gene
- : O
mediated VBN O
induction NN O
of IN O
Mn NNP B-Gene
SOD NNP I-Gene
and CC O
inflammatory JJ O
cytokines NNS B-Gene
are VBP O
regulated VBN O
, , O
at IN O
least JJS O
in IN O
part NN O
, , O
through IN O
different JJ O
signal JJ O
transduction NN O
pathways NNS O
, , O
and CC O
3 CD O
) ) O
failure NN O
of IN O
the DT O
mutant JJ B-Gene
endotoxin NN I-Gene
to TO O
induce VB O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
production NN O
is VBZ O
, , O
at IN O
least JJS O
in IN O
part NN O
, , O
due JJ O
to TO O
its PRP$ O
inability NN O
to TO O
activate VB O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
. . O

Characterization NN O
of IN O
cytokine JJ B-Gene
differential JJ O
induction NN O
of IN O
STAT NNP B-Gene
complexes NNS I-Gene
in IN O
primary JJ O
human JJ O
T NNP O
and CC O
NK NNP O
cells NNS O
. . O

Finally RB O
, , O
we PRP O
observed VBD O
that IN O
activated JJ O
STAT5a NNP B-Gene
and CC O
STAT5b NNP B-Gene
proteins VBZ O
form VB O
distinct JJ O
Fc NNP O
gamma NN O
RI NNP O
GAS NNP O
binding NN O
patterns NNS O
in IN O
T NNP O
and CC O
NK NNP O
cells NNS O
, , O
suggesting VBG O
that IN O
they PRP O
might MD O
have VB O
different JJ O
roles NNS O
in IN O
gene NN O
regulation NN O
. . O

A DT O
regulatory JJ B-Gene
element NN I-Gene
in IN O
the DT O
CD95 NNP B-Gene
( ( I-Gene
APO NNP I-Gene
- : I-Gene
1 CD I-Gene
/ NNP I-Gene
Fas NNP I-Gene
) ) I-Gene
ligand VBP I-Gene
promoter NN I-Gene
is VBZ O
essential JJ O
for IN O
responsiveness NN O
to TO O
TCR NNP B-Gene
- : O
mediated VBN O
activation NN O
. . O

The DT O
DNA NN O
sequence NN O
at IN O
- : B-Gene
120 CD I-Gene
also RB O
contains VBZ O
two CD O
DNA NNP B-Gene
motifs NNS I-Gene
homologous JJ O
to TO O
the DT O
binding NN O
site NN O
for IN O
NF NNP B-Gene
- : I-Gene
AT NN I-Gene
. . O

NF NNP B-Gene
- : I-Gene
AT NN I-Gene
does VBZ O
not RB O
directly RB O
bind VB O
to TO O
this DT O
element NN O
. . O

Progesterone NN O
acts VBZ O
distally RB O
to TO O
the DT O
initial JJ O
steps NNS O
of IN O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
( ( O
TCR NNP B-Gene
) ) O
- : O
mediated VBN O
signal JJ O
transduction NN O
, , O
since IN O
it PRP O
blocks VBZ O
sustained VBN O
Ca2 NNP O
+ NNP O
signals NNS O
after IN O
thapsigargin JJ O
stimulation NN O
, , O
as RB O
well RB O
as IN O
oscillatory JJ O
Ca2 NNP O
+ NNP O
signals NNS O
, , O
but CC O
not RB O
the DT O
Ca2 NNP O
+ NNP O
transient NN O
after IN O
TCR NNP B-Gene
stimulation NN O
. . O

Progesterone NNP O
effectively RB O
blocked VBD O
a DT O
broad JJ O
spectrum NN O
of IN O
K NNP B-Gene
+ NNP I-Gene
channels NNS I-Gene
, , O
reducing VBG O
both DT O
Kv1 NNP B-Gene
. . I-Gene
3 CD I-Gene
and CC O
charybdotoxin VB B-Gene
- : I-Gene
resistant JJ I-Gene
components NNS I-Gene
of IN O
KV NNP B-Gene
current JJ O
and CC O
KCa NNP B-Gene
current JJ O
in IN O
T NNP O
cells NNS O
, , O
as RB O
well RB O
as IN O
blocking VBG O
several JJ O
cloned VBN B-Gene
KV NNP I-Gene
channels NNS I-Gene
expressed VBN O
in IN O
cell NN O
lines NNS O
. . O

A DT O
mouse NN O
carrying VBG O
genetic JJ O
defect NN O
in IN O
the DT O
choice NN O
between IN O
T NNP O
and CC O
B NNP O
lymphocytes NNS O
. . O

The DT O
present JJ O
study NN O
shows VBZ O
that IN O
, , O
instead RB O
of IN O
T NNP O
cells NNS O
, , O
B NNP O
cells NNS O
are VBP O
generated VBN O
in IN O
the DT O
thymus NN O
of IN O
a DT O
line NN O
, , O
tg NN O
epsilon26 NN O
, , O
of IN O
the DT O
human JJ O
CD3epsilon NNP O
transgenic NN O
mice NN O
. . O

The DT O
accumulation NN O
of IN O
mature NN O
B NNP O
cells NNS O
in IN O
the DT O
thymus NN O
was VBD O
found VBN O
only RB O
in IN O
tg JJ O
epsilon26 NN O
mice NN O
, , O
not RB O
in IN O
other JJ O
human JJ O
CD3epsilon NNP O
transgenic NN O
mouse NN O
lines NNS O
or CC O
other JJ O
T NNP O
cell NN O
- : O
deficient NN O
mice NN O
, , O
including VBG O
CD3 NNP O
- : O
epsilon NN O
knockout NN O
mice NN O
and CC O
TCR NNP O
- : O
beta NN O
/ NN O
TCR NNP O
- : O
delta NN O
double JJ O
knockout NN O
mice NN O
. . O

The DT O
chemokine NN B-Gene
receptor NN I-Gene
, , O
BLR1 NNP B-Gene
, , O
is VBZ O
a DT O
major JJ O
regulator NN O
of IN O
the DT O
microenvironmental JJ O
homing NN O
of IN O
B NNP O
cells NNS O
in IN O
lymphoid JJ O
organs NNS O
. . O

Activation NN O
of IN O
the DT O
CD4 NNP B-Gene
promoter NN I-Gene
occurs VBZ O
in IN O
the DT O
presence NN O
of IN O
the DT O
viral JJ O
DNA NNP O
polymerase NN O
inhibitor NN O
phosphonoformic JJ O
acid NN O
, , O
which WDT O
limits VBZ O
expression NN O
to TO O
the DT O
immediate JJ B-Gene
- : I-Gene
early JJ I-Gene
and CC I-Gene
early JJ I-Gene
classes NNS I-Gene
of IN I-Gene
viral JJ I-Gene
genes NNS I-Gene
. . O

Both DT O
Tax NNP B-Gene
- : O
mediated VBN O
apoptosis NN O
and CC O
oxidative JJ O
stress NN O
can MD O
be VB O
potently RB O
suppressed VBN O
by IN O
antioxidants NNS O
, , O
as IN O
is VBZ O
seen VBN O
with IN O
the DT O
administration NN O
of IN O
recombinant JJ B-Gene
thioredoxin NN I-Gene
( ( O
adult JJ B-Gene
T NNP I-Gene
cell NN I-Gene
leukemia SYM I-Gene
- : I-Gene
derived VBN I-Gene
factor NN I-Gene
) ) O
or CC O
pyrrolidine JJ O
dithiocarbamate NN O
. . O

The DT O
efficacy NN O
of IN O
o NN O
, , O
o NN O
' '' O
- : O
bismyristoyl NN O
thiamine NN O
disulfide NN O
( ( O
BMT NNP O
) ) O
was VBD O
examined VBN O
in IN O
detail NN O
against IN O
HIV NNP O
- : O
1 CD O
laboratory NN O
isolates NNS O
( ( O
HTLV NNP O
- : O
IIIB NNP O
, , O
JRFL NNP O
, , O
and CC O
MN NNP O
) ) O
, , O
primary JJ O
isolates NNS O
( ( O
KMT NNP O
and CC O
KMO NNP O
) ) O
, , O
and CC O
simian JJ O
immunodeficiency NN O
virus NN O
( ( O
SIVmac251 NNP O
) ) O
in IN O
vitro NN O
. . O

In IN O
addition NN O
, , O
BMT NNP O
exhibited VBD O
antiviral JJ O
activity NN O
against IN O
SIVmac251 NNP O
. . O

Minimizing VBG O
energy NN O
studies NNS O
of IN O
BMT NNP O
structure NN O
reveal NN O
that IN O
a DT O
trans NNS O
- : O
disulfide NN O
of IN O
thiamine NN O
( ( O
holo JJ O
drug NN O
) ) O
disulfide NN O
( ( O
TDS NNP O
, , O
protodrug NN O
) ) O
is VBZ O
allosterically RB O
transited VBN O
to TO O
the DT O
reactive NN O
twisted VBD O
disulfide NN O
of IN O
BMT NNP O
( ( O
allo JJ O
drug NN O
) ) O
by IN O
o NN O
, , O
o NN O
' '' O
- : O
bismyristoyl NN O
esterification NN O
of IN O
TDS NNP O
. . O

Nor CC O
was VBD O
fragmentation NN O
observed VBN O
after IN O
treatment NN O
with IN O
RU38486 NNP O
, , O
indicating VBG O
that IN O
repression NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
activity NN O
is VBZ O
not RB O
involved VBN O
. . O

Dexamethasone NNP O
treatment NN O
completely RB O
blocked VBD O
12 CD O
- : O
O NNP O
- : O
tetradecanoylphorbol NN O
13 CD O
- : O
acetate NN O
induction NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
) ) O
activity NN O
and CC O
elicited VBD O
an DT O
increase NN O
in IN O
the DT O
amount NN O
of IN O
immunoreactive JJ B-Gene
IkappaB NNP I-Gene
alpha NN I-Gene
in IN O
sensitive JJ O
6TG1 CD O
. . O
1 CD O
cells NNS O
but CC O
not RB O
in IN O
resistant JJ O
ICR27TK NNP O
. . O
3 CD O
cells NNS O
. . O

It PRP O
was VBD O
proposed VBN O
that IN O
the DT O
mechanism NN O
of IN O
antiviral JJ O
action NN O
of IN O
S9a NNP O
was VBD O
on IN O
the DT O
host NN O
cell NN O
, , O
by IN O
blocking VBG O
TNF NNP B-Gene
- : I-Gene
alpha JJ I-Gene
transcription NN O
via IN O
a DT O
Tat NNP B-Gene
- : O
induced VBD O
tar JJ O
- : O
independent JJ O
loop NN O
, , O
which WDT O
decreases VBZ O
downstream NN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
of IN O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
( ( O
LTR NNP B-Gene
) ) O
. . O

S9a NNP O
was VBD O
superior JJ O
to TO O
the DT O
first JJ O
generation NN O
compound NN O
Canventol NNP O
, , O
which WDT O
was VBD O
superior JJ O
to TO O
the DT O
natural JJ O
compound NN O
sarcophytol VBD O
A NNP O
, , O
demonstrating VBG O
that IN O
further JJ O
structure NN O
- : O
based VBN O
enhancement NN O
of IN O
potency NN O
of IN O
these DT O
compounds NNS O
is VBZ O
feasible JJ O
. . O

Intestinal JJ O
epithelial JJ O
cells NNS O
can MD O
express VB O
HLA NNP B-Gene
class NN I-Gene
II NNP I-Gene
antigens NNS I-Gene
and CC O
may MD O
function VB O
as IN O
antigen NN O
- : O
presenting NN O
cells NNS O
to TO O
CD4 NNP O
( ( O
+ NNP O
) ) O
T NNP O
cells NNS O
within IN O
the DT O
intestinal JJ O
mucosa NN O
. . O

These DT O
data NNS O
indicate VBP O
a DT O
highly RB O
polarized JJ O
functional JJ O
architecture NN O
for IN O
antigen NN O
processing NN O
and CC O
presentation NN O
by IN O
intestinal JJ O
epithelial JJ O
cells NNS O
, , O
and CC O
suggest VBP O
that IN O
the DT O
functional JJ O
outcome NN O
of IN O
antigen NN O
processing NN O
by IN O
the DT O
intestinal JJ O
epithelium NN O
is VBZ O
both DT O
dependent JJ O
on IN O
the DT O
cellular JJ O
surface NN O
at IN O
which WDT O
the DT O
foreign JJ O
antigen NN O
is VBZ O
internalized VBN O
and CC O
by IN O
the DT O
underlying JJ O
degree NN O
of IN O
mucosal NN O
inflammation NN O

We PRP O
determined VBD O
whether IN O
Hsp70 NNP B-Gene
induction NN O
by IN O
TS NNP O
was VBD O
mediated VBN O
by IN O
the DT O
activation NN O
of IN O
the DT O
HS NNP B-Gene
transcription NN I-Gene
factor NN I-Gene
, , O
HSF NNP B-Gene
. . O

Thus RB O
, , O
we PRP O
also RB O
determined VBD O
the DT O
effects NNS O
of IN O
TS NNP O
on IN O
NFkappaB NNP B-Gene
. . O

TS NNP O
activated VBD O
HSF NNP B-Gene
, , O
which WDT O
was VBD O
associated VBN O
with IN O
Hsp70 NNP B-Gene
overexpression NN O
and CC O
inhibition NN O
of IN O
NFkappaB NNP B-Gene
binding VBG O
activity NN O
and CC O
TNFalpha NNP B-Gene
release NN O
. . O

[ JJ O
Molecular NNP O
mechanism NN O
of IN O
cytokine JJ B-Gene
gene NN I-Gene
expression NN O
in IN O
Th1 NNP O
and CC O
Th2 NNP O
] NNP O

Among IN O
them PRP O
, , O
both CC O
the DT O
activation NN O
of IN O
PKC NNP O
/ NNP O
Ras NNP O
- : O
and CC O
CaM NNP O
/ NNP O
CN NNP O
- : O
mediated VBD O
pathways NNS O
play VB O
a DT O
central JJ O
role NN O
in IN O
the DT O
signal JJ O
transduction NN O
of IN O
cytokine JJ B-Gene
gene NN I-Gene
expression NN O
. . O

Activation NN O
of IN O
T NNP O
cells NNS O
results NNS O
in IN O
the DT O
rapid JJ O
calcineurin NN B-Gene
- : O
dependent JJ O
translocation NN O
of IN O
NFAT NNP B-Gene
transcription NN B-Gene
factors NNS I-Gene
from IN O
the DT O
cytoplasm NN O
to TO O
the DT O
nucleus NN O
. . O

Replication NN O
of IN O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
- : O
1 CD O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
is VBZ O
highly RB O
dependent JJ O
on IN O
the DT O
state NN O
of IN O
activation NN O
of IN O
the DT O
infected JJ O
cells NNS O
and CC O
is VBZ O
modulated VBN O
by IN O
interactions NNS O
between IN O
viral JJ B-Gene
and CC I-Gene
host JJ I-Gene
cellular JJ I-Gene
factors NNS I-Gene
. . O

These DT O
results NNS O
suggest VBP O
that IN O
secretion NN O
of IN O
PGE2 NNP O
by IN O
macrophages NNS O
in IN O
response NN O
to TO O
infection NN O
or CC O
inflammatory JJ O
activators NNS O
could MD O
induce VB O
signaling VBG O
events NNS O
resulting VBG O
in IN O
activation NN O
of IN O
proviral JJ O
DNA NNP O
present NN O
into IN O
T NNP O
cells NNS O
latently RB O
infected VBN O
with IN O
HIV NNP O
- : O
1 CD O
. . O

Unexpectedly RB O
, , O
we PRP O
found VBD O
that IN O
conventional JJ O
procedures NNS O
employed VBN O
to TO O
prepare VB O
cellular JJ O
extracts NNS O
cause VBP O
the DT O
release NN O
of IN O
proteolytic JJ O
activities NNS O
that WDT O
are VBP O
normally RB O
stored VBN O
in IN O
intracellular JJ O
granules NNS O
, , O
resulting VBG O
in IN O
the DT O
degradation NN O
of IN O
various JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
/ NN I-Gene
Rel NNP I-Gene
and CC O
STAT NNP B-Gene
proteins NNS I-Gene
. . O

In IN O
addition NN O
, , O
the DT O
procedure NN O
described VBD O
herein NN O
could MD O
prove VB O
useful JJ O
in IN O
other JJ O
cell NN O
types NNS O
that IN O
express NN O
high JJ O
levels NNS O
of IN O
endogenous JJ B-Gene
proteases NNS I-Gene
. . O

The DT O
capacity NN O
of IN O
neonatal JJ O
T NNP O
cells NNS O
to TO O
secrete VB O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
has VBZ O
been VBN O
reported VBN O
to TO O
be VB O
variable JJ O
. . O

PDBu NNP O
+ NNP O
iono NN O
induced VBD O
equally RB O
high JJ O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
levels NNS O
in IN O
both DT O
groups NNS O
and CC O
, , O
when WRB O
stimulated VBN O
with IN O
plate NN O
- : O
bound NN O
anti IN B-Gene
- : I-Gene
CD3 NNP I-Gene
monoclonal JJ I-Gene
antibody NN I-Gene
( ( O
mAb NN B-Gene
) ) O
, , O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
secretion NN O
by IN O
neonatal JJ O
cells NNS O
was VBD O
undetectable JJ O
and CC O
adult JJ O
cells NNS O
produced VBD O
low JJ O
amounts NNS O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
( ( O
mean JJ O
331 CD O
+ NN O
/ NNP O
- : O
86 CD O
pg NN O
/ NNP O
ml NN O
) ) O
. . O

As IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
is VBZ O
a DT O
critical JJ O
transcription NN B-Gene
factor NN I-Gene
in IN O
the DT O
control NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
expression NN O
, , O
we PRP O
next VBP O
analysed VBD O
its PRP$ O
nuclear JJ O
translocation NN O
in IN O
neonatal JJ O
and CC O
adult JJ O
T NNP O
cells NNS O
using VBG O
the DT O
electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
and CC O
, , O
because IN O
induction NN O
of IN O
reactive JJ O
oxygen NN O
intermediates NNS O
( ( O
ROI NNP O
) ) O
is VBZ O
required VBN O
for IN O
the DT O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
we PRP O
also RB O
analysed VBD O
levels NNS O
of IN O
intracellular JJ O
ROI NNP O
in IN O
these DT O
cells NNS O
using VBG O
the DT O
ROI NNP O
- : O
reactive JJ O
fluorochrome NN O
DCFH NNP O
- : O
DA NN O
and CC O
flow JJ O
cytometry NN O
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
reduced VBD O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
production NN O
by IN O
neonatal JJ O
T NNP O
cells NNS O
is VBZ O
specific JJ O
for IN O
anti JJ B-Gene
- : I-Gene
CD3 NN I-Gene
and CC O
anti JJ B-Gene
- : I-Gene
CD3 NNP I-Gene
+ NNP O
anti SYM B-Gene
- : I-Gene
CD28 NNP I-Gene
- : O
mediated VBN O
stimulation NN O
and CC O
that IN O
these DT O
activators NNS O
can MD O
not RB O
effectively RB O
activate VBP O
the DT O
ROI NNP O
- : B-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
signalling VBG O
pathway NN O
in IN O
neonatal JJ O
T NNP O
cells NNS O
. . O

CL NNP O
- : O
1 CD O
cells NNS O
are VBP O
IgM NNP B-Gene
+ NNP O
IgD NNP B-Gene
+ NNP O
CD30 NNP B-Gene
+ NNP O
and CC O
switch VB O
to TO O
IgG NNP B-Gene
, , O
IgA NNP B-Gene
, , O
and CC O
IgE NNP B-Gene
when WRB O
exposed VBN O
to TO O
CD40L NNP B-Gene
and CC O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
. . O

Switching VBG O
is VBZ O
hampered VBN O
by IN O
CD30 NNP B-Gene
coengagement NN O
, , O
possibly RB O
through IN O
interference NN O
with IN O
the DT O
CD40 NNP B-Gene
- : O
mediated VBD O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
- : O
dependent JJ O
transcriptional JJ O
activation NN O
of IN O
downstream NN B-Gene
C NNP I-Gene
( ( I-Gene
H NNP I-Gene
) ) I-Gene
genes NNS I-Gene
. . O

Are NNP O
there EX O
effects NNS O
of IN O
CyA NNP O
and CC O
FK NNP O
506 CD O
all DT O
attributable JJ O
to TO O
CN NNP O
inhibition NN O
, , O
and CC O
how WRB O
much JJ O
of IN O
them PRP O
are VBP O
mediated VBN O
through IN O
the DT O
NFATC NNP B-Gene
family NN I-Gene
of IN O
transcription NN B-Gene
factors NNS I-Gene
? . O

To TO O
investigate VB O
processes NNS O
related VBN O
to TO O
B NNP O
and CC O
T NNP O
cell NN O
activation NN O
, , O
the DT O
gene NN O
expression NN O
of IN O
stimulated VBN O
and CC O
nonstimulated VBN O
Ramos NNP O
and CC O
Jurkat NNP O
cells NNS O
was VBD O
studied VBN O
using VBG O
cDNA NN O
microarray NN O
technology NN O
. . O

Simultaneous JJ O
analysis NN O
of IN O
close NN O
to TO O
600 CD B-Gene
genes NNS I-Gene
indicated VBD O
highest JJS O
increase NN O
in IN O
the DT O
expression NN O
of IN O
certain JJ O
transcription NN B-Gene
, , I-Gene
differentiation NN I-Gene
and CC I-Gene
proliferation NN I-Gene
factors NNS I-Gene
. . O

Also RB O
genes NNS O
encoding VBG O
proteins NNS O
involved VBN O
in IN O
DNA NNP O
replication NN O
, , O
binding NN O
, , O
transcription NN O
and CC O
translation NN O
were VBD O
induced VBN O
. . O

Signal JJ B-Gene
transducer NN I-Gene
and CC I-Gene
activator NN I-Gene
of IN I-Gene
transcription NN I-Gene
3 CD I-Gene
( ( O
Stat3 NNP B-Gene
) ) O
has VBZ O
recently RB O
been VBN O
shown VBN O
to TO O
exist VB O
in IN O
two CD O
alternatively RB O
spliced JJ O
isoforms NNS O
, , O
a DT O
short JJ O
form NN O
, , O
Stat3beta NNP B-Gene
, , O
and CC O
a DT O
longer RBR O
form NN O
, , O
Stat3alpha NNP B-Gene
, , O
displaying VBG O
differences NNS O
in IN O
transcriptional JJ O
activity NN O
. . O

It PRP O
is VBZ O
unknown JJ O
which WDT O
Stat3 NNP B-Gene
isoform NN I-Gene
( ( O
s NN O
) ) O
is VBZ O
activated VBN O
in IN O
response NN O
to TO O
interleukin VB B-Gene
( ( I-Gene
IL NNP I-Gene
) ) I-Gene
- : I-Gene
2 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
15 CD I-Gene
. . O

It PRP O
is VBZ O
shown VBN O
here RB O
that IN O
during IN O
monocyte NN O
to TO O
macrophage VB O
differentiation NN O
, , O
the DT O
expression NN O
of IN O
LAL NNP B-Gene
- : I-Gene
mRNA NN I-Gene
is VBZ O
induced VBN O
. . O

Relationship NN O
between IN O
IkappaBalpha NNP B-Gene
constitutive JJ O
expression NN O
, , O
TNFalpha NNP B-Gene
synthesis NN O
, , O
and CC O
apoptosis NN O
in IN O
EBV NNP O
- : O
infected VBN O
lymphoblastoid JJ O
cells NNS O
. . O

In IN O
order NN O
to TO O
understand VB O
the DT O
role NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
EBV NNP O
transformation NN O
we PRP O
have VBP O
established VBN O
stably RB O
transfected VBN O
IkappaBalpha NNP B-Gene
into IN O
lymphoblastoid JJ O
cells NNS O
. . O

Protein NNP O
latency NN O
expression NN O
was VBD O
determined VBN O
by IN O
immunocytochemistry NN O
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
the DT O
TNFalpha NNP B-Gene
gene NN I-Gene
could MD O
be VB O
one CD O
of IN O
the DT O
targets NNS O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
EBV NNP O
infected VBD O
cells NNS O
and CC O
that DT O
NF NNP O
- : O
kappaB NN O
protects VBZ O
EBV NNP O
- : O
infected JJ O
cells NNS O
from IN O
apoptosis NN O
induced VBN O
by IN O
TNFalpha NNP B-Gene
, , O
which WDT O
may MD O
favour VB O
the DT O
proliferative JJ O
effect NN O
of IN O
this DT O
cytokine NN B-Gene
. . O

We PRP O
report VBP O
an DT O
unusual JJ O
case NN O
of IN O
a DT O
55 CD O
year NN O
old JJ O
Japanese JJ O
woman NN O
with IN O
a DT O
seminoma NN O
but CC O
relatively RB O
normal JJ O
menses NNS O
. . O

A DT O
typical JJ O
seminoma NN O
was VBD O
removed VBN O
from IN O
the DT O
left NN O
adnexal JJ O
region NN O
and CC O
an DT O
immature NN O
testis NN O
was VBD O
identified VBN O
separately RB O
as IN O
an DT O
associated JJ O
right NN O
adnexal NN O
mass NN O
. . O

Repeated VBN O
karyotypic NN O
studies NNS O
on IN O
peripheral JJ O
blood NN O
lymphocyte NN O
cultures NNS O
showed VBD O
only RB O
46 CD O
, , O
X NNP O
, , O
- : O
Y NN O
, , O
t NN O
( ( O
Y NNP O
; : O
15 CD O
) ) O
( ( O
q12 NN O
; : O
p13 NN O
) ) O
. . O

Two CD O
chronically RB O
HIV NNP O
- : O
1 CD O
- : O
infected VBN O
cell NN O
lines NNS O
, , O
U1 NNP O
( ( O
monocytic JJ O
) ) O
and CC O
ACH NNP O
- : O
2 CD O
( ( O
T NNP O
lymphocytic NN O
) ) O
, , O
were VBD O
stimulated VBN O
with IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
or CC O
PMA NNP O
and CC O
cultured VBN O
in IN O
the DT O
presence NN O
of IN O
various JJ O
concentrations NNS O
of IN O
the DT O
compound NN O
. . O

Its PRP$ O
50 CD O
% NN O
effective JJ O
and CC O
cytotoxic JJ O
concentrations NNS O
were VBD O
0 CD O
. . O
16 CD O
and CC O
2 CD O
. . O
2 CD O
microg JJ O
/ NNP O
ml NN O
in IN O
PMA NNP O
- : O
stimulated VBD O
U1 NNP O
cells NNS O
, , O
respectively RB O
. . O

These DT O
results NNS O
indicate VBP O
that DT O
cepharanthine NN O
is VBZ O
a DT O
highly RB O
potent JJ O
inhibitor NN O
of IN O
HIV NNP O
- : O
1 CD O
replication NN O
in IN O
a DT O
chronically RB O
infected VBN O
monocytic JJ O
cell NN O
line NN O
. . O

This DT O
study NN O
shows VBZ O
that IN O
expression NN O
of IN O
LMP1 NNP B-Gene
activates NNS O
transcription NN O
from IN O
p50 JJ B-Gene
/ NNP I-Gene
p65 NN I-Gene
- : I-Gene
and CC I-Gene
c SYM I-Gene
- : I-Gene
Rel NNP I-Gene
- : I-Gene
responsive JJ I-Gene
promoters NNS I-Gene
, , O
and CC O
that IN O
this DT O
activity NN O
can MD O
be VB O
completely RB O
inhibited VBN O
by IN O
expression NN O
of IN O
a DT O
dominant JJ O
inhibitory NN B-Gene
IkappaB NNP I-Gene
mutant NN I-Gene
. . O

Furthermore RB O
, , O
LMP1 NNP B-Gene
- : O
induced VBD O
cell NN O
size NN O
increase NN O
of IN O
primary JJ O
B NNP O
cells NNS O
was VBD O
unaffected VBN O
by IN O
IkappaB NNP B-Gene
expression NN O
. . O

When WRB O
cultured VBN O
in IN O
RPMI NNP O
1640 CD O
medium NN O
containing VBG O
10 CD O
% NN O
fetal JJ O
bovine NN O
serum NN O
, , O
most JJS O
YJ JJ O
cells NNS O
were VBD O
myeloblastoid JJ O
with IN O
a DT O
small JJ O
number NN O
of IN O
the DT O
cells NNS O
having VBG O
eosinophilic JJ O
granules NNS O
. . O

The DT O
eosinophilic JJ O
characteristics NNS O
of IN O
YJ NNP O
cells NNS O
were VBD O
confirmed VBN O
by IN O
histochemical JJ O
staining VBG O
with IN O
Fast NNP O
- : O
Green JJ O
/ NNP O
Neutral NNP O
- : O
Red NN O
and CC O
by IN O
the DT O
expression NN O
of IN O
mRNAs NN B-Gene
for IN O
eosinophil JJ B-Gene
- : I-Gene
associated VBN I-Gene
granule NN I-Gene
proteins NNS I-Gene
, , O
eosinophil VBP B-Gene
cationic JJ I-Gene
protein NN I-Gene
( ( O
ECP NNP B-Gene
) ) O
, , O
eosinophil SYM B-Gene
- : I-Gene
derived VBN I-Gene
neurotoxin NN I-Gene
( ( O
EDN NNP B-Gene
) ) O
, , O
eosinophil JJ B-Gene
peroxidase NN I-Gene
( ( O
EPO NNP B-Gene
) ) O
, , O
and CC O
major JJ B-Gene
basic JJ I-Gene
protein NN I-Gene
( ( O
MBP NNP B-Gene
) ) O
, , O
and CC O
for IN O
the DT O
Charcot NNP B-Gene
- : I-Gene
Leyden NNP I-Gene
crystal NN I-Gene
( ( I-Gene
CLC NNP I-Gene
) ) I-Gene
protein NN I-Gene
. . O

The DT O
expression NN O
of IN O
genes NNS O
for IN O
transcription NN B-Gene
factors NNS I-Gene
involved VBN O
in IN O
myeloid JJ O
differentiation NN O
was VBD O
evaluated VBN O
by IN O
Northern NNP O
blot NN O
analysis NN O
. . O

The DT O
YJ NNP O
cell NN O
line NN O
should MD O
be VB O
useful JJ O
for IN O
elucidating VBG O
the DT O
molecular JJ O
mechanisms NNS O
governing VBG O
lineage NN O
switching VBG O
from IN O
the DT O
eosinophil NN O
to TO O
monocytic VB O
or CC O
neutrophil JJ O
lineages NNS O
. . O

To TO O
examine VB O
the DT O
hypothesis NN O
that WDT O
interleukin VBZ B-Gene
- : I-Gene
6 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
) ) O
contributes NNS O
to TO O
PMN NNP O
infiltration NN O
and CC O
lung NN O
damage NN O
in IN O
HS NNP O
, , O
we PRP O
examined VBD O
the DT O
lungs NNS O
of IN O
rats NNS O
subjected VBN O
to TO O
unresuscitated JJ O
and CC O
resuscitated VBD O
HS NNP O
for IN O
the DT O
production NN O
of IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
and CC O
activation NN O
of IN O
Stat3 NNP B-Gene
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
of IN O
protein NN O
extracts NNS O
from IN O
shock NN O
lungs NNS O
exhibited VBD O
an DT O
increase NN O
in IN O
Stat3 NNP B-Gene
activation NN O
with IN O
kinetics NNS O
similar JJ O
to TO O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
mRNA NN I-Gene
. . O

The DT O
MHC NNP B-Gene
class NN I-Gene
II NNP I-Gene
transactivator NN I-Gene
( ( O
CIITA NNP B-Gene
) ) O
requires VBZ O
conserved JJ O
leucine NN B-Gene
charged VBN I-Gene
domains NNS I-Gene
for IN O
interactions NNS O
with IN O
the DT O
conserved JJ O
W NNP B-Gene
box NN I-Gene
promoter NN I-Gene
element NN I-Gene
. . O

The DT O
ability NN O
of IN O
mutants NNS O
to TO O
activate VB O
a DT O
reporter NN O
gene NN O
under IN O
the DT O
control NN O
of IN O
MHC NNP B-Gene
class NN I-Gene
II NNP I-Gene
conserved VBD O
W NNP B-Gene
- : I-Gene
X SYM I-Gene
- : I-Gene
Y NN I-Gene
or CC I-Gene
X NNP I-Gene
- : I-Gene
Y NNP I-Gene
regulatory JJ I-Gene
elements NNS I-Gene
was VBD O
determined VBN O
. . O

Two CD O
mutants NNS O
displayed JJ O
differential JJ O
activity NN O
between IN O
the DT O
two CD O
promoters NNS B-Gene
, , O
activating VBG O
transcription NN O
with IN O
the DT O
W NNP B-Gene
- : I-Gene
X SYM I-Gene
- : I-Gene
Y NN I-Gene
but CC I-Gene
not RB I-Gene
the DT I-Gene
X NNP I-Gene
- : I-Gene
Y JJ I-Gene
elements NNS I-Gene
. . O

All DT O
mutants NNS O
were VBD O
tested VBN O
for IN O
their PRP$ O
ability NN O
to TO O
interfere VB O
with IN O
wild JJ O
- : O
type NN O
CIITA NNP B-Gene
activity NN O
. . O

The DT O
characterization NN O
of IN O
CIITA NNP B-Gene
mutants NNS I-Gene
that WDT O
are VBP O
able JJ O
to TO O
discriminate VB O
between IN O
promoters NNS O
with IN O
or CC O
without IN O
the DT O
W NNP B-Gene
box NN I-Gene
strongly RB O
suggests VBZ O
that IN O
CIITA NNP B-Gene
requires VBZ O
such JJ O
interactions NNS O
for IN O
function NN O
. . O

Recently RB O
, , O
it PRP O
was VBD O
suggested VBN O
that IN O
activation NN O
of IN O
the DT O
alpha JJ B-Gene
isoform NN I-Gene
of IN O
PPAR NNP B-Gene
by IN O
the DT O
potent JJ O
proinflammatory NN O
mediator NN O
leukotriene NN O
B4 NNP O
( ( O
LTB4 NNP O
) ) O
enhanced VBD O
degradation NN O
of IN O
this DT O
eicosanoid NN O
, , O
offersuggesting VBG O
a DT O
new JJ O
aspect NN O
of IN O
down JJ O
- : O
regulation NN O
of IN O
inflammation NN O
. . O

Thus RB O
, , O
this DT O
study NN O
provides VBZ O
no DT O
evidence NN O
indicating VBG O
a DT O
regulatory JJ O
function NN O
of IN O
PPARalpha NNP B-Gene
in IN O
LTB4 NNP O
induced VBD O
adhesive JJ O
interactions NNS O
between IN O
endothelial JJ O
cells NNS O
and CC O
neutrophils NNS O

We PRP O
determined VBD O
whether IN O
the DT O
interaction NN O
of IN O
SS NNP O
RBC NNP O
with IN O
cultured JJ O
endothelial JJ O
cells NNS O
induced VBD O
cellular JJ O
oxidant JJ O
stress NN O
that WDT O
would MD O
culminate VB O
in IN O
expression NN O
of IN O
cell NN B-Gene
adhesion NN I-Gene
molecules NNS I-Gene
( ( O
CAMs NNP B-Gene
) ) O
involved VBN O
in IN O
the DT O
adhesion NN O
and CC O
diapedesis NN O
of IN O
monocytes NNS O
and CC O
the DT O
adherence NN O
of IN O
SS NNP O
reticulocytes NNS O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
adherence NN O
/ NNP O
contact NN O
of IN O
SS NNP O
RBC NNP O
to TO O
endothelial VB O
cells NNS O
in IN O
large JJ O
vessel NN O
can MD O
generate VB O
enhanced VBN O
oxidant JJ O
stress NN O
leading VBG O
to TO O
increased VBN O
adhesion NN O
and CC O
diapedesis NN O
of IN O
monocytes NNS O
, , O
as RB O
well RB O
as IN O
heightened VBN O
adherence NN O
of IN O
SS NNP O
reticulocytes NNS O
, , O
indicating VBG O
that IN O
injury NN O
/ NNP O
activation NN O
of IN O
endothelium NN O
can MD O
contribute VB O
to TO O
vaso VB O
- : O
occlusion NN O
in IN O
SCD NNP O
. . O

Relative JJ O
levels NNS O
were VBD O
then RB O
correlated VBN O
with IN O
a DT O
series NN O
of IN O
clinical JJ O
variables NNS O
including VBG O
response NN O
to TO O
therapy VB O
, , O
performance NN O
status NN O
, , O
survival NN O
, , O
disease NN O
sites NNS O
, , O
age NN O
, , O
and CC O
others NNS O
. . O

Changes NNS O
in IN O
these DT O
signaling VBG O
molecules NNS O
during IN O
cytokine JJ B-Gene
treatment NN O
were VBD O
also RB O
investigated VBN O
. . O

Correlations NNS O
of IN O
TCRzeta NNP B-Gene
or CC O
p56 NN B-Gene
( ( I-Gene
lck NN I-Gene
) ) I-Gene
levels NNS O
with IN O
response NN O
or CC O
disease NN O
variables NNS O
, , O
except IN O
for IN O
lower JJR O
TCRzeta NN B-Gene
levels NNS O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
in IN O
the DT O
presence NN O
of IN O
bone NN O
metastases NNS O
, , O
were VBD O
not RB O
found VBN O
. . O

In IN O
the DT O
majority NN O
of IN O
patients NNS O
with IN O
advanced JJ O
RCC NNP O
, , O
peripheral JJ O
blood NN O
T NNP O
cells NNS O
express JJ O
TCRzeta NNP B-Gene
and CC O
p56 NN B-Gene
( ( I-Gene
lck NN I-Gene
) ) I-Gene
, , O
and CC O
in IN O
a DT O
subset NN O
, , O
reduced JJ O
levels NNS O
of IN O
these DT O
TCRzeta NNP B-Gene
associated VBD I-Gene
molecules NNS I-Gene
are VBP O
seen VBN O
that IN O
may MD O
increase VB O
during IN O
cytokine JJ B-Gene
- : O
based VBN O
therapy NN O
. . O

Identification NN O
of IN O
transcription NN B-Gene
factors NNS I-Gene
expressed VBD O
during IN O
ATRA NNP O
- : O
induced VBD O
neutrophil JJ O
differentiation NN O
of IN O
HL60 NNP O
cells NNS O
. . O

In IN O
order NN O
to TO O
understand VB O
this DT O
block NN O
the DT O
cascade NN O
of IN O
molecular JJ O
events NNS O
needs VBZ O
to TO O
be VB O
characterized VBN O
. . O

CD38 NNP O
+ NNP O
cells NNS O
committed VBD O
towards NNS O
this DT O
lineage NN O
were VBD O
enriched VBN O
and CC O
a DT O
population NN O
of IN O
these DT O
cells NNS O
treated VBD O
with IN O
dihydroxyvitamin NN O
D3 NNP O
to TO O
induce VB O
neutrophil JJ O
maturation NN O
. . O

The DT O
differential JJ O
expression NN O
of IN O
the DT O
genes NNS O
in IN O
the DT O
zinc NN B-Gene
finger NN I-Gene
and CC I-Gene
POU NNP I-Gene
families NNS I-Gene
will MD O
lead VB O
to TO O
a DT O
better JJR O
understanding NN O
of IN O
the DT O
cascade NN O
of IN O
gene NN O
expression NN O
which WDT O
occurs VBZ O
following VBG O
ATRA NNP O
- : O
induced JJ O
differentiation NN O
. . O

Interleukin NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC I-Gene
- : I-Gene
13 CD I-Gene
induce JJ O
upregulation NN O
of IN O
the DT O
murine NN O
macrophage NN O
12 CD B-Gene
/ NN I-Gene
15 CD I-Gene
- : I-Gene
lipoxygenase NN I-Gene
activity NN I-Gene
: : O
evidence NN O
for IN O
the DT O
involvement NN O
of IN O
transcription NN B-Gene
factor NN I-Gene
STAT6 NNP B-Gene
. . O

Moreover RB O
, , O
a DT O
strong JJ O
induction NN O
of IN O
the DT O
enzyme NN O
was VBD O
observed VBN O
in IN O
red JJ O
cells NNS O
during IN O
experimental JJ O
anemia NN O
in IN O
mice NN O
. . O

The DT O
cytokine NN B-Gene
- : O
dependent JJ O
upregulation NN O
of IN O
the DT O
murine NN B-Gene
macrophage NN I-Gene
12 CD I-Gene
- : I-Gene
lipoxygenase NN I-Gene
and CC O
its PRP$ O
induction NN O
during IN O
experimental JJ O
anemia NN O
suggests VBZ O
its PRP$ O
close JJ O
relatedness NN O
with IN O
the DT O
human JJ B-Gene
reticulocyte NN I-Gene
- : I-Gene
type NN I-Gene
15 CD I-Gene
- : I-Gene
lipoxygenase NN I-Gene
despite IN O
their PRP$ O
differences NNS O
in IN O
the DT O
positional JJ O
specificity NN O
of IN O
arachidonic JJ O
acid NN O
oxygenation NN O
. . O

Interferon NNP B-Gene
- : I-Gene
gamma NN I-Gene
- : I-Gene
induced JJ I-Gene
factor NN I-Gene
binding VBG O
to TO O
the DT O
interleukin JJ B-Gene
- : I-Gene
4 CD I-Gene
- : I-Gene
responsive JJ I-Gene
element NN I-Gene
of IN O
CD23b NNP B-Gene
promoter NN I-Gene
in IN O
human JJ O
tonsillar JJ O
mononuclear NN O
cells NNS O
: : O
role NN O
in IN O
transient NN O
up IN O
- : O
regulation NN O
of IN O
the DT O
interleukin JJ B-Gene
- : I-Gene
4 CD I-Gene
- : I-Gene
induced VBN I-Gene
CD23b NNP I-Gene
mRNA NN I-Gene
. . O

Activation NN O
of IN O
E2F NNP B-Gene
- : O
mediated VBN O
transcription NN O
by IN O
human JJ B-Gene
T NNP I-Gene
- : I-Gene
cell NN I-Gene
leukemia NN I-Gene
virus NN I-Gene
type NN I-Gene
I PRP I-Gene
Tax VBP I-Gene
protein NN I-Gene
in IN O
a DT O
p16 NN O
( ( O
INK4A NNP O
) ) O
- : O
negative JJ O
T NNP O
- : O
cell NN O
line NN O
. . O

Consequently RB O
, , O
Tax NNP B-Gene
can MD O
activate VB O
the DT O
signaling VBG O
pathway NN O
that WDT O
lead VBP O
to TO O
the DT O
release NN O
of IN O
E2F NNP B-Gene
that IN O
in IN O
turn NN O
induces NNS O
expression NN O
of IN O
factors NNS O
required VBN O
for IN O
cell NN O
cycle NN O
progression NN O
. . O

In IN O
addition NN O
, , O
Tax NNP B-Gene
also RB O
stimulates VBZ O
the DT O
transcription NN O
of IN O
the DT O
E2F NNP B-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
itself PRP O
. . O

Inducible JJ O
nitric JJ O
oxide NN O
: : O
an DT O
autoregulatory JJ O
feedback NN O
inhibitor NN O
of IN O
vascular JJ O
inflammation NN O
. . O

These DT O
studies NNS O
indicate VBP O
that IN O
iNO NN O
attenuates NNS O
iNOS VBP B-Gene
expression NN O
in IN O
macrophages NNS O
and CC O
inhibits NNS O
monocyte VBP O
adhesion NN O
to TO O
endothelial JJ O
cells NNS O
, , O
and CC O
suggest VBP O
that IN O
endogenously RB O
derived VBN O
iNO NN O
may MD O
be VB O
an DT O
important JJ O
autoregulatory NN O
inhibitor NN O
of IN O
vascular JJ O
inflammation NN O

These DT O
results NNS O
corroborate VBP O
previous JJ O
findings NNS O
that IN O
the DT O
presence NN O
of IN O
ER NNP B-Gene
variants NNS O
is VBZ O
not RB O
a DT O
characteristic NN O
of IN O
breast NN O
cancer NN O
. . O

p21ras NNS B-Gene
initiates VBZ O
Rac NNP B-Gene
- : I-Gene
1 CD I-Gene
but CC O
not RB O
phosphatidyl JJ B-Gene
inositol NN I-Gene
3 CD I-Gene
kinase NN I-Gene
/ NNP I-Gene
PKB NNP I-Gene
, , O
mediated VBD O
signaling VBG O
pathways NNS O
in IN O
T NNP O
lymphocytes NNS O
. . O

We PRP O
also RB O
examined VBD O
the DT O
possibility NN O
that IN O
Akt NNP B-Gene
/ NNP I-Gene
PKB NNP I-Gene
is VBZ O
regulated VBN O
by IN O
Ras NNP O
signaling VBG O
pathways NNS O
in IN O
T NNP O
lymphocytes NNS O
. . O

Moreover RB O
, , O
neither CC O
TCR NNP B-Gene
or CC O
Ras NNP B-Gene
activation NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
dependent VBN O
on IN O
PtdIns NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
. . O

The DT O
present JJ O
data NNS O
thus RB O
highlight VBD O
that IN O
PtdIns NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
and CC O
Akt NNP B-Gene
/ NNP I-Gene
PKB NNP I-Gene
are VBP O
not RB O
universal JJ O
Ras NNP B-Gene
effector NN I-Gene
molecules NNS I-Gene
. . O

LNCaP NNP O
cells NNS O
treated VBD O
with IN O
prostaglandin NN O
E2 NNP O
showed VBD O
neither CC O
a DT O
reduction NN O
in IN O
proliferation NN O
nor CC O
a DT O
down RP O
- : O
regulation NN O
of IN O
AR NNP B-Gene
and CC O
PSA NNP B-Gene
levels NNS O
. . O

In IN O
addition NN O
, , O
recombinant JJ O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
was VBD O
able JJ O
to TO O
replace VB O
MCM NNP O
for IN O
the DT O
inhibition NN O
of IN O
proliferation NN O
and CC O
down IN O
- : O
regulation NN O
of IN O
AR NNP B-Gene
and CC O
PSA NNP B-Gene
proteins NNS O
. . O

LNCaP NNP O
cells NNS O
were VBD O
shown VBN O
to TO O
express VB O
the DT O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
receptor NN O
type NN O
1 CD O
, , O
which WDT O
transduces VBZ O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
signal NN O
. . O

Differential NNP O
responsiveness NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
and CC I-Gene
IL NNP I-Gene
- : I-Gene
4 CD I-Gene
genes NNS I-Gene
to TO O
transcription VB B-Gene
factor NN I-Gene
GATA NNP I-Gene
- : I-Gene
3 CD I-Gene
. . O

Here RB O
, , O
we PRP O
show VBP O
that IN O
ectopic JJ O
expression NN O
of IN O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
is VBZ O
sufficient JJ O
to TO O
drive VB O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
but CC O
not RB O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
gene NN O
expression NN O
. . O

Mutations NNS O
of IN O
sites NNS O
that IN O
suppress NN O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
binding VBG O
impair NN O
the DT O
induction NN O
and CC O
strong JJ O
NF NNP B-Gene
- : I-Gene
ATp NNP I-Gene
- : O
mediated VBD O
transactivation NN O
of IN O
the DT O
CD25 NNP B-Gene
promoter NN I-Gene
in IN O
T NNP O
cells NNS O
. . O

Antibodies NNS B-Gene
to TO O
Duffy NNP B-Gene
antigens NNS I-Gene
are VBP O
responsible JJ O
for IN O
some DT O
cases NNS O
of IN O
transfusion NN O
incompatibility NN O
and CC O
newborn JJ O
hemolytic JJ O
disease NN O
. . O

The DT O
Duffy NNP B-Gene
protein NN I-Gene
is VBZ O
a DT O
receptor NN O
for IN O
the DT O
Plasmodium NNP B-Gene
vivax NN I-Gene
erythrocyte SYM I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
and CC O
is VBZ O
also RB O
a DT O
receptor NN O
for IN O
various JJ O
chemokines NNS B-Gene
( ( O
thus RB O
renamed VBN O
Duffy NNP B-Gene
Antigen NNP I-Gene
Receptor NNP I-Gene
for IN I-Gene
Chemokines NNP I-Gene
[ NNP O
DARC NNP B-Gene
] NNP O
) ) O
. . O

The DT O
Fy NNP O
( ( O
a DT O
- : O
b SYM O
- : O
) ) O
phenotype NN O
is VBZ O
the DT O
predominant JJ O
one NN O
in IN O
populations NNS O
of IN O
black JJ O
people NNS O
and CC O
also RB O
occurs VBZ O
in IN O
other JJ O
populations NNS O
, , O
including VBG O
some DT O
non JJ O
- : O
Ashkenazi JJ O
Jewish JJ O
groups NNS O
. . O

The DT O
Fy NNP O
( ( O
a DT O
- : O
b SYM O
- : O
) ) O
phenotype NN O
has VBZ O
been VBN O
associated VBN O
with IN O
a DT O
mutation NN O
in IN O
the DT O
FY NNP B-Gene
* NNP I-Gene
B NNP I-Gene
promoter NN I-Gene
at IN O
the DT O
GATA NNP B-Gene
box NN I-Gene
that WDT O
abolishes VBZ O
the DT O
expression NN O
of IN O
erythrocyte JJ B-Gene
Duffy NNP I-Gene
protein NN I-Gene
. . O

The DT O
271C CD O
- : O
- : O
> NN O
T NNP O
substitution NN O
represents VBZ O
a DT O
considerable JJ O
change NN O
in IN O
chemical JJ O
nature NN O
( ( O
Arg91 NNP O
- : O
- : O
> NN O
Cys NNP O
) ) O
, , O
one CD O
which WDT O
may MD O
affect VB O
the DT O
antigenic JJ O
determinants NNS O
of IN O
DARC NNP B-Gene
, , O
and CC O
thus RB O
be VB O
of IN O
clinical JJ O
significance NN O
. . O

The DT O
functions NNS O
of IN O
NFAT NNP B-Gene
proteins NNS I-Gene
are VBP O
directly RB O
controlled VBN O
by IN O
the DT O
calcium NN B-Gene
- : I-Gene
and CC I-Gene
calmodulin VB I-Gene
- : I-Gene
dependent JJ I-Gene
phosphatase NN I-Gene
calcineurin NN B-Gene
. . O

Expression NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
requires VBZ O
activation NN O
of IN O
T NNP O
cells NNS O
through IN O
stimulation NN O
of IN O
the DT O
TCR NNP B-Gene
and CC O
costimulation NN O
through IN O
accessory JJ B-Gene
receptors NNS I-Gene
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
analyzed VBD O
whether IN O
activities NNS O
of IN O
these DT O
phosphatases NNS O
are VBP O
necessary JJ O
for IN O
the DT O
expression NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
. . O

In IN O
both DT O
activated JJ O
peripheral JJ O
blood NN O
T NNP O
lymphocytes VBZ O
and CC O
activated VBD O
tumorigenic JJ O
T NNP O
cell NN O
lines NNS O
, , O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN O
expression NN O
was VBD O
blocked VBN O
at IN O
the DT O
transcriptional JJ O
level NN O
by IN O
okadaic JJ O
acid NN O
. . O

The DT O
transcription NN B-Gene
factors NNS I-Gene
active JJ O
at IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
were VBD O
differentially RB O
influenced VBN O
: : O
upon IN O
down IN O
- : O
modulation NN O
of IN O
okadaic JJ B-Gene
acid SYM I-Gene
- : I-Gene
sensitive JJ I-Gene
phosphatases NNS I-Gene
, , O
transactivation NN O
by IN O
octamer NN O
, , O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
and CC O
NF NNP B-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
cells NNS I-Gene
proteins VBZ I-Gene
was VBD O
abrogated VBN O
, , O
while IN O
transactivation NN O
by IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
proteins NNS I-Gene
was VBD I-Gene
even RB I-Gene
enhanced VBN I-Gene
. . I-Gene

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
examine VB O
the DT O
effects NNS O
of IN O
bis NN O
[ $ O
4 CD O
- : O
[ NN O
2 CD O
, , O
4 CD O
- : O
dioxo NN O
- : O
5 CD O
- : O
thiazolidinyl NN O
) ) O
methyl NN O
] NNP O
phenyl NN O
] NNP O
methane NN O
( ( O
YM NNP O
- : O
268 CD O
) ) O
, , O
a DT O
thiazolidinedione NN O
derivative NN O
, , O
on IN O
glucose JJ O
uptake NN O
, , O
adipocyte JJ O
differentiation NN O
through IN O
peroxisome NN B-Gene
proliferator NN I-Gene
- : I-Gene
activated VBN I-Gene
receptor NN I-Gene
gamma NN I-Gene
( ( O
PPARgamma NNP B-Gene
) ) O
, , O
and CC O
phosphatidylinositol VBZ B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
( ( O
PI NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
) ) O
activity NN O
in IN O
cultured JJ O
cells NNS O
. . O

YM268 NN O
and CC O
pioglitazone NN O
dose NN O
- : O
dependently RB O
increased VBD O
the DT O
2 CD O
- : O
deoxyglucose JJ O
uptake NN O
in IN O
3T3 CD O
- : O
L1 NNP O
cells NNS O
. . O

The DT O
nuclear JJ B-Gene
receptor NN I-Gene
PPARgamma NNP B-Gene
- : O
bigger JJR O
than IN O
fat NN O
. . O

PPARgamma NNP B-Gene
has VBZ O
also RB O
been VBN O
implicated VBN O
recently RB O
in IN O
the DT O
biology NN O
of IN O
monocytes NNS O
and CC O
in IN O
cell NN O
- : O
cycle NN O
regulation NN O
and CC O
cancer NN O
. . O

Although IN O
common JJ O
members NNS O
of IN O
the DT O
apoptotic JJ O
cascade NN O
are VBP O
shared VBN O
between IN O
different JJ O
cell NN O
types NNS O
, , O
it PRP O
appears VBZ O
that IN O
cell NN B-Gene
- : I-Gene
specific JJ I-Gene
factors NNS I-Gene
can MD O
influence VB O
the DT O
response NN O
to TO O
a DT O
given VBN O
apoptotic JJ O
stimuli NNS O
. . O

These DT O
results NNS O
establish VB O
an DT O
independent JJ O
role NN O
for IN O
enhanced JJ O
p75TNF NN B-Gene
- : I-Gene
R NN I-Gene
production NN O
in IN O
the DT O
pathogenesis NN O
of IN O
inflammatory JJ O
disease NN O
and CC O
implicate VB O
the DT O
direct JJ O
involvement NN O
of IN O
this DT O
receptor NN O
in IN O
a DT O
wide JJ O
range NN O
of IN O
human JJ O
inflammatory JJ O
pathologies NNS O
. . O

Molecular JJ O
and CC O
cellular JJ O
analysis NN O
of IN O
human JJ O
immunodeficiency NN O
virus NN O
- : O
induced JJ O
apoptosis NN O
in IN O
lymphoblastoid JJ B-Gene
T NNP I-Gene
- : I-Gene
cell NN I-Gene
- : I-Gene
line NN I-Gene
- : I-Gene
expressing VBG I-Gene
wild JJ I-Gene
- : I-Gene
type NN I-Gene
and CC I-Gene
mutated VBD I-Gene
CD4 NNP I-Gene
receptors NNS I-Gene
. . O

We PRP O
have VBP O
determined VBN O
how WRB O
the DT O
phosphorylation NN O
of IN O
the DT O
retinoblastoma NN B-Gene
family NN I-Gene
( ( O
pRb NN B-Gene
, , O
p107 NN B-Gene
, , O
and CC O
p130 NN B-Gene
) ) O
is VBZ O
governed VBN O
in IN O
individual JJ O
cell NN O
cycle NN O
phases NNS O
of IN O
Daudi NNP O
B NNP O
- : O
cells NNS O
during IN O
cell NN O
cycle NN O
exit NN O
triggered VBN O
by IN O
alpha JJ B-Gene
- : I-Gene
interferon NN I-Gene
( ( O
alpha JJ B-Gene
- : I-Gene
IFN NN I-Gene
) ) O
. . O

alpha SYM B-Gene
- : I-Gene
IFN JJ I-Gene
causes NNS O
dephosphorylation NN O
of IN O
pRb NN B-Gene
and CC O
loss NN O
of IN O
p130 NN B-Gene
phosphorylated VBN I-Gene
Form NNP I-Gene
3 CD I-Gene
. . O

However RB O
, , O
the DT O
change NN O
in IN O
p130 JJ B-Gene
phosphorylation NN O
in IN O
response NN O
to TO O
alpha VB B-Gene
- : I-Gene
IFN NNP I-Gene
occurs VBZ O
before IN O
dephosphorylation NN O
of IN O
pRb NN B-Gene
is VBZ O
complete JJ O
because IN O
loss NN O
of IN O
p130 JJ B-Gene
Form NNP I-Gene
3 CD I-Gene
occurs NNS O
throughout IN O
the DT O
cell NN O
cycle NN O
prior RB O
to TO O
complete VB O
arrest NN O
in IN O
G1 NNP O
, , O
whereas JJ O
pRb NN B-Gene
is VBZ O
dephosphorylated VBN O
only RB O
in IN O
G1 NNP O
. . O

p130 NN B-Gene
, , O
predominantly RB O
in IN O
Form NNP O
1 CD O
, , O
and CC O
hypophosphorylated VBD B-Gene
pRb NN I-Gene
bind IN O
an DT O
E2F NNP B-Gene
DNA NNP I-Gene
binding VBG I-Gene
site NN I-Gene
; : O
p130 CC B-Gene
complexes NNS O
E2F NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
whereas NNS O
pRb VBP B-Gene
binds VBZ O
both DT O
E2F NNP O
- : O
4 CD O
and CC O
E2F NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

The DT O
phosphorylated JJ O
forms NNS O
of IN O
E2F NNP B-Gene
- : I-Gene
4 CD I-Gene
that WDT O
bind NN O
to TO O
the DT O
E2F NNP B-Gene
DNA NNP I-Gene
site NN I-Gene
are VBP O
different JJ O
from IN O
hyperphosphorylated VBN O
E2F NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
which WDT O
predominates VBZ O
in IN O
primary JJ O
hemopoietic JJ O
cells NNS O
in IN O
G0 NNP O
. . O

Macrophages NNS O
and CC O
granulocytes NNS O
, , O
which WDT O
are VBP O
developed VBN O
from IN O
a DT O
common JJ O
progenitor NN O
cell NN O
, , O
are VBP O
the DT O
cellular JJ O
components NNS O
of IN O
the DT O
specific NN O
and CC O
non JJ O
- : O
specific JJ O
immunoreaction NN O
. . O

In IN O
contrast NN O
, , O
v FW B-Gene
- : I-Gene
myb NN I-Gene
reduces NNS O
MRP14 NNP B-Gene
promoter NN I-Gene
activity NN O
. . O

Northern NNP O
blot NN O
analysis NN O
of IN O
L132 NNP O
cells NNS O
transfected VBN O
with IN O
the DT O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
alpha POS I-Gene
expression NN O
vector NN O
demonstrate NN O
that WDT O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
alpha NN I-Gene
is VBZ O
sufficient JJ O
to TO O
enhance VB O
MRP14 NNP B-Gene
expression NN O
in IN O
the DT O
context NN O
of IN O
the DT O
whole JJ O
genome NN O
. . O

This DT O
observation NN O
prompted VBD O
us PRP O
to TO O
postulate VB O
that DT O
signal JJ O
2 CD O
( ( O
costimulatory JJ O
signal NN O
) ) O
alone RB O
without IN O
signal JJ O
1 CD O
( ( O
TCR NNP B-Gene
signal NN O
) ) O
can MD O
activate VB O
T NNP O
cells NNS O
. . O

This DT O
pathway NN O
resulted VBD O
in IN O
the DT O
induction NN O
of IN O
the DT O
transcription NN B-Gene
factors NNS I-Gene
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
, , O
and CC O
proteins VBZ O
binding VBG O
to TO O
the DT O
CD28 NNP B-Gene
response NN O
element NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
. . O

In IN O
contrast NN O
to TO O
the DT O
differential JJ O
signaling NN O
of IN O
BW NNP B-Gene
828 CD I-Gene
and CC O
9 CD B-Gene
. . I-Gene
3 CD I-Gene
in IN O
resting VBG O
T NNP O
cells NNS O
, , O
the DT O
two CD O
mAbs NN O
exhibited VBD O
a DT O
similar JJ O
pattern NN O
of IN O
early JJ O
signaling VBG O
events NNS O
in IN O
activated JJ O
T NNP O
cells NNS O
and CC O
Jurkat NNP O
cells NNS O
( ( O
p56 NN B-Gene
( ( I-Gene
lck NN I-Gene
) ) I-Gene
activation NN O
, , O
association NN O
of IN O
phosphatidylinositol NN B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
with IN O
CD28 NNP B-Gene
) ) O
, , O
indicating VBG O
that IN O
the DT O
signaling VBG O
capacity NN O
of IN O
CD28 NNP B-Gene
changes NNS O
with IN O
activation NN O
. . O

IL NNP B-Gene
- : I-Gene
12 CD I-Gene
is VBZ O
a DT O
75 CD B-Gene
- : I-Gene
kDa NN I-Gene
heterodimeric JJ I-Gene
cytokine NN I-Gene
composed VBN O
of IN O
two CD O
covalently RB O
linked VBN O
p35 NN B-Gene
and CC I-Gene
p40 NN I-Gene
chains NNS I-Gene
. . O

Th1 NNP O
cell NN O
- : O
mediated VBN O
immune JJ O
responses NNS O
have VBP O
been VBN O
implicated VBN O
in IN O
the DT O
pathogenesis NN O
of IN O
chronic JJ O
inflammatory NN O
autoimmune NN O
diseases NNS O
. . O

This DT O
was VBD O
associated VBN O
with IN O
the DT O
down RP O
- : O
regulation NN O
of IN O
IL NNP B-Gene
- : I-Gene
12p40 CD I-Gene
mRNA JJ I-Gene
expression NN O
. . O

Metabolic NNP O
labeling NN O
combined VBN O
with IN O
pulse JJ O
- : O
chase NN O
experiments NNS O
and CC O
biochemical JJ O
analysis NN O
showed VBD O
that IN O
the DT O
majority NN O
of IN O
class NN B-Gene
II NNP I-Gene
molecules NNS I-Gene
in IN O
infected JJ O
cells NNS O
became VBD O
resistant JJ O
to TO O
endoglycosidase VB B-Gene
H NNP I-Gene
, , O
consistent JJ O
with IN O
normal JJ O
Golgi NNP O
processing NN O
. . O

However RB O
, , O
results NNS O
of IN O
intracellular JJ O
staining NN O
and CC O
dual JJ O
color NN O
confocal JJ O
microscopy NN O
revealed VBD O
a DT O
significant JJ O
defect NN O
in IN O
transport NN O
of IN O
newly RB O
synthesized VBN O
class NN B-Gene
II NNP I-Gene
molecules VBZ I-Gene
through IN O
the DT O
endocytic JJ O
compartment NN O
. . O

Thus RB O
, , O
compared VBN O
with IN O
findings NNS O
in IN O
control NN O
cells NNS O
, , O
class NN B-Gene
II NNP I-Gene
molecules NNS I-Gene
in IN O
infected JJ O
cells NNS O
colocalized VBN O
to TO O
a DT O
minimal JJ O
extent NN O
with IN O
a DT O
lysosomal JJ B-Gene
- : I-Gene
associated VBN I-Gene
membrane NN I-Gene
protein NN I-Gene
- : I-Gene
1 CD I-Gene
+ NN O
endosomal JJ O
compartment NN O
. . O

Analyzed NNP O
DNA NNP B-Gene
sequences NNS I-Gene
included VBD O
delta NN B-Gene
and CC I-Gene
beta NN I-Gene
5 CD I-Gene
' '' I-Gene
flanking VBG I-Gene
regions NNS I-Gene
extending VBG O
from IN O
approximately RB O
- : B-Gene
500 CD I-Gene
to TO I-Gene
+ VB I-Gene
50bp CD I-Gene
( ( O
promoter NN B-Gene
regions NNS I-Gene
) ) O
, , O
truncated VBN O
delta NN O
and CC O
beta NN B-Gene
5 CD I-Gene
' '' I-Gene
flanking VBG I-Gene
regions NNS I-Gene
extending VBG O
from IN O
approximately RB O
- : B-Gene
250 CD I-Gene
to TO I-Gene
+ VB I-Gene
50 CD I-Gene
bp NN I-Gene
, , O
and CC O
chimeric JJ B-Gene
promoter NN I-Gene
constructions NNS I-Gene
, , O
which WDT O
consisted VBD O
of IN O
a DT O
distal JJ O
delta NN B-Gene
or CC I-Gene
beta NN I-Gene
fragment NN I-Gene
fused VBD O
to TO O
a DT O
proximal JJ B-Gene
beta NN I-Gene
or CC I-Gene
delta JJ I-Gene
sequence NN I-Gene
. . O

In IN O
CAT NNP B-Gene
reporter NN I-Gene
constructions NNS I-Gene
no DT O
appreciable JJ O
level NN O
of IN O
CAT NNP B-Gene
activity NN O
was VBD O
supported VBN O
by IN O
the DT O
beta NN B-Gene
globin NN I-Gene
promoter NN I-Gene
, , O
and CC O
only RB O
low JJ O
level NN O
activity NN O
by IN O
the DT O
delta NN B-Gene
promoter NN I-Gene
. . O

Fusion NN O
of IN O
the DT O
upstream JJ B-Gene
portion NN I-Gene
of IN O
the DT O
delta NN B-Gene
promoter NN I-Gene
to TO O
the DT O
truncated VBN O
beta NN B-Gene
globin NN I-Gene
promoter NN I-Gene
yielded VBD O
a DT O
modest JJ O
increase NN O
in IN O
promoter JJ O
strength NN O
relative NN O
to TO O
the DT O
truncated VBN B-Gene
beta NN I-Gene
gene NN I-Gene
promoter NN I-Gene
, , O
indicating VBG O
the DT O
presence NN O
of IN O
a DT O
positive JJ B-Gene
transcriptional JJ I-Gene
element NN I-Gene
( ( O
s NN O
) ) O
in IN O
the DT O
upstream JJ B-Gene
delta NN I-Gene
globin NN I-Gene
regulatory JJ I-Gene
region NN I-Gene
. . O

The DT O
induction NN O
of IN O
IgE NNP B-Gene
by IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
occurs NNS O
through IN O
the DT O
activation NN O
of IN O
the DT O
intracellular JJ B-Gene
signal NN I-Gene
- : I-Gene
transducing VBG I-Gene
protein NN I-Gene
Stat6 NNP I-Gene
, , O
whereas IN O
the DT O
inhibition NN O
of IN O
IgE NNP B-Gene
class NN O
switching NN O
by IN O
interferon NN B-Gene
- : I-Gene
y NN I-Gene
( ( O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
) ) O
occurs VBZ O
through IN O
the DT O
activation NN O
of IN O
Statl NNP B-Gene
. . O

NFAT NNP B-Gene
regulates VBZ O
transcription NN O
of IN O
a DT O
number NN O
of IN O
cytokine NN O
and CC O
other JJ O
immunoregulatory NN B-Gene
genes NNS I-Gene
. . O

We PRP O
also RB O
report VBP O
three CD O
additional JJ O
isoforms NNS O
of IN O
NFATx NNP B-Gene
, , O
designated VBD O
NFATx2 NNP B-Gene
, , O
NFATx3 NNP B-Gene
, , O
and CC O
NFATx4 NNP B-Gene
. . O

This DT O
transactivation NN O
sequence NN O
is VBZ O
altered VBN O
by IN O
tissue NN O
- : O
specific JJ O
alternative JJ O
splicing NN O
in IN O
newly RB O
isolated VBN O
NFATx NNP B-Gene
isoforms NNS I-Gene
, , O
resulting VBG O
in IN O
lower JJR O
transactivation NN O
activity NN O
in IN O
Jurkat NNP O
T NNP O
cells NNS O
. . O

5 CD B-Gene
' '' I-Gene
HS3 NNP I-Gene
contains VBZ O
six CD O
G NNP O
- : O
rich JJ O
motifs NNS O
that WDT O
are VBP O
essential JJ O
for IN O
its PRP$ O
activity NN O
. . O

We PRP O
show VBP O
that IN O
the DT O
function NN O
of IN O
such JJ O
closely RB O
related JJ O
proteins NNS O
can MD O
be VB O
distinguished VBN O
in IN O
vivo NN O
by IN O
matching VBG O
point NN O
mutations NNS O
in IN O
5 CD B-Gene
' POS I-Gene
HS3 NNP I-Gene
with IN O
amino NN O
acid NN O
changes NNS O
in IN O
the DT O
zinc NN B-Gene
fingers NNS I-Gene
of IN O
Sp1 NNP B-Gene
and CC O
EKLF NNP B-Gene
. . O

The DT O
transition NN O
of IN O
Epstein NNP O
- : O
Barr NNP O
virus NN O
( ( O
EBV NNP O
) ) O
from IN O
latency NN O
into IN O
the DT O
lytic JJ O
cycle NN O
is VBZ O
associated VBN O
with IN O
the DT O
expression NN O
of IN O
two CD O
immediate JJ B-Gene
- : I-Gene
early JJ I-Gene
viral JJ I-Gene
genes NNS I-Gene
, , O
BZLF1 NNP B-Gene
and CC O
BRLF1 NNP B-Gene
. . O

In IN O
HH514 NNP O
- : O
16 CD O
cells NNS O
, , O
transfection NN O
of IN O
Rta NNP B-Gene
leads VBZ O
to TO O
synthesis NN O
of IN O
ZEBRA NNP B-Gene
, , O
viral JJ O
DNA NNP O
replication NN O
, , O
and CC O
late JJ O
gene NN O
expression NN O
. . O

Expression NN O
of IN O
either DT O
BZLF1 NNP B-Gene
or CC O
BRLF1 NNP B-Gene
triggers NNS O
expression NN O
of IN O
the DT O
other JJ O
immediate JJ B-Gene
- : I-Gene
early JJ I-Gene
factor NN I-Gene
, , O
and CC O
together RB O
these DT O
activators NNS O
act VBP O
individually RB O
or CC O
in IN O
synergy NN O
on IN O
downstream NN B-Gene
targets NNS I-Gene
to TO O
activate VB O
the DT O
viral JJ O
lytic JJ O
cycle NN O
. . O

We PRP O
first RB O
demonstrate VB O
, , O
in IN O
human JJ O
and CC O
mouse NN O
intraspecies NNS O
hybrids NNS O
, , O
the DT O
coordinate JJ O
suppression NN O
of IN O
MHC NNP B-Gene
class NN I-Gene
II NNP I-Gene
, , O
Ii NNP B-Gene
( ( O
invariant JJ B-Gene
chain NN I-Gene
) ) O
and CC O
HLA NNP B-Gene
- : I-Gene
DM NNP I-Gene
gene NN I-Gene
transcription NN O
, , O
and CC O
the DT O
release NN O
of IN O
the DT O
silencing NN O
by IN O
the DT O
addition NN O
of IN O
interferon NN B-Gene
gamma NN I-Gene
. . O

These DT O
data NNS O
indicate VBP O
that IN O
the DT O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
- : O
independent JJ O
component NN O
of IN O
the DT O
target NN O
cell NN O
HLA NNP B-Gene
- : I-Gene
DR NNP I-Gene
expression NN O
induced VBN O
by IN O
lymphocyte JJ O
adhesion NN O
uses VBZ O
a DT O
signaling VBG O
pathway NN O
that WDT O
is VBZ O
distinct JJ O
from IN O
the DT O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
- : O
dependent NN O
mechanism NN O
and CC O
also RB O
suggest VBP O
that IN O
CIITA NNP B-Gene
is VBZ O
not RB O
required VBN O
. . O

In IN O
this DT O
report NN O
expression NN O
profiles NNS O
and CC O
activation NN O
of IN O
PKC NNP B-Gene
were VBD O
analyzed VBN O
in IN O
human JJ O
Raji NNP O
B NNP O
lymphoblastoid NN O
cells NNS O
. . O

Transient JJ O
transfection NN O
analysis NN O
with IN O
target NN B-Gene
plasmids NNS I-Gene
containing VBG O
either CC O
DRA NNP B-Gene
promoter NN I-Gene
( ( O
wild JJ O
- : O
type NN O
or CC O
mutated VBN O
) ) O
or CC O
TPA NNP B-Gene
response NN I-Gene
elements NNS I-Gene
demonstrated VBD O
that IN O
pretreatment NN O
with IN O
the DT O
selective JJ O
PKC NNP B-Gene
inhibitor NN O
GF NNP O
109203X CD O
repressed VBD O
TPA NNP O
- : O
mediated VBN O
activation NN O
. . O

Together RB O
, , O
these DT O
results NNS O
show VBP O
that IN O
activated VBD O
HLA NNP B-Gene
- : I-Gene
DRA NNP I-Gene
expression NN O
in IN O
response NN O
to TO O
TPA NNP O
treatment NN O
is VBZ O
strictly RB O
dependent JJ O
on IN O
PKC NNP B-Gene
activation NN O
acting VBG O
on IN O
the DT O
X2 NNP B-Gene
box NN I-Gene
of IN O
the DT O
DRA NNP B-Gene
promoter NN I-Gene
and CC O
that IN O
selective JJ O
inhibition NN O
of IN O
PKC NNP B-Gene
enzymatic JJ O
activity NN O
does VBZ O
not RB O
influence VB O
subcellular JJ O
localization NN O
of IN O
expressed VBN O
PKC NNP B-Gene
isoenzymes NNS I-Gene
. . O

Multiple NNP O
cellular JJ B-Gene
DNA NNP I-Gene
- : I-Gene
binding NN I-Gene
transcription NN I-Gene
factors NNS I-Gene
are VBP O
required VBN O
by IN O
HIV NNP O
type NN O
1 CD O
for IN O
RNA NNP O
synthesis NN O
. . O

These DT O
synthetic JJ O
ligands NNS O
specifically RB O
inhibit VBP O
DNA NNP O
- : O
binding NN O
of IN O
each DT O
transcription NN B-Gene
factor NN I-Gene
and CC O
HIV NNP O
type VBD O
1 CD O
transcription NN O
in IN O
cell NN O
- : O
free JJ O
assays NNS O
. . O

In IN O
situ JJ O
hybridisation NN O
revealed VBD O
musculin JJ B-Gene
expression NN O
in IN O
embryos NN O
was VBD O
largely RB O
restricted VBN O
to TO O
the DT O
embryonic JJ O
skeletal JJ O
muscle NN O
lineage NN O
. . O

While IN O
all DT O
skeletal JJ O
muscles NNS O
expressed VBD O
the DT O
gene NN O
, , O
only RB O
a DT O
subset NN O
of IN O
myocytes NNS O
within IN O
each DT O
muscle NN O
were VBD O
positive JJ O
, , O
indicating VBG O
molecular JJ O
heterogeneity NN O
within IN O
fetal JJ O
muscle NN O
. . O

All DT O
Rights NNPS O
Reserved NNP O
. . O

The DT O
TT NNP O
- : O
selected VBN O
T NNP O
cell NN O
line NN O
could MD O
be VB O
rendered VBN O
unresponsive JJ O
to TO O
its PRP$ O
dominant JJ O
epitope NN O
in IN O
a DT O
dose JJ O
- : O
dependent JJ O
manner NN O
( ( O
IC50 NNP O
= VBZ O
0 CD O
. . O
3 CD O
microg JJ O
/ NNP O
ml NN O
) ) O
. . O

JNK NNP B-Gene
enzymatic JJ O
activity NN O
was VBD O
blocked VBN O
in IN O
anergized JJ O
T NNP O
cells NNS O
. . O

Copyright JJ O
1998 CD O
Academic NNP O
Press NNP O
. . O

Previously RB O
, , O
we PRP O
demonstrated VBD O
that IN O
granulocyte NN B-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
( ( I-Gene
G NNP I-Gene
- : I-Gene
CSF NNP I-Gene
) ) I-Gene
receptor NN I-Gene
mRNA NN I-Gene
was VBD O
undetectable JJ O
and CC O
granulocyte JJ O
maturation NN O
blocked VBN O
in IN O
CCAAT NNP B-Gene
enhancer NN I-Gene
binding VBG I-Gene
protein NN I-Gene
alpha NN I-Gene
( ( O
C NNP B-Gene
/ NNP I-Gene
EBPalpha NNP I-Gene
) ) O
- : O
deficient NN O
mice NN O
. . O

Although IN O
bacterial JJ O
lipopolysaccharides NNS O
( ( O
LPS NNP O
) ) O
and CC O
several JJ O
other JJ O
microbial JJ O
agonists NNS O
can MD O
bind VB O
to TO O
mCD14 VB B-Gene
( ( O
membrane FW B-Gene
CD14 NNP I-Gene
) ) O
, , O
a DT O
cell NN O
- : O
surface NN O
receptor NN O
found VBD O
principally RB O
on IN O
monocytes NNS O
and CC O
neutrophils NNS O
, , O
host NN O
- : O
derived VBN O
mCD14 JJ B-Gene
ligands NNS O
are VBP O
poorly RB O
defined VBN O
. . O

We PRP O
report VBP O
here RB O
that IN O
phosphatidylinositol NN O
( ( O
PtdIns NNP O
) ) O
, , O
phosphatidylinositol JJ O
- : O
4 CD O
- : O
phosphate NN O
, , O
and CC O
other JJ O
phosphatidylinositid NN O
can MD O
bind VB O
to TO O
mCD14 VB B-Gene
. . O

Despite IN O
progress NN O
in IN O
understanding VBG O
the DT O
death NN O
signals NNS O
transduced VBD O
from IN O
Fas NNP B-Gene
, , O
very RB O
little JJ O
is VBZ O
known VBN O
with IN O
regard NN O
to TO O
the DT O
mechanisms NNS O
by IN O
which WDT O
Fas NNP B-Gene
expression NN O
is VBZ O
regulated VBN O
. . O

PKC NNP B-Gene
- : O
dependent NN O
Fas NNP B-Gene
expression NN O
was VBD O
also RB O
observed VBN O
in IN O
several JJ O
murine NN O
and CC O
human JJ O
tumor NN O
cell NN O
lines NNS O
. . O

Since IN O
the DT O
inhibition NN O
of IN O
Ca2 NNP O
+ NNP O
redistribution NN O
by IN O
an DT O
inhibitor NN O
of IN O
intracellular JJ O
Ca2 NNP O
+ NNP O
mobilization NN O
, , O
8 CD O
- : O
( ( O
diethylamino NN O
) ) O
- : O
octyl SYM O
- : O
3 CD O
, , O
4 CD O
, , O
5 CD O
- : O
trimethoxybenzoate NN O
hydrochloride NN O
, , O
inhibited VBN O
TCR NNP B-Gene
- : I-Gene
induced JJ I-Gene
FasL NNP I-Gene
but CC O
not RB O
Fas NNP B-Gene
, , O
the DT O
expression NN O
of IN O
Fas NNP B-Gene
appears VBZ O
to TO O
be VB O
independent JJ O
of IN O
Ca2 NNP O
+ NNP O
mobilization NN O
. . O

Anti NNP B-Gene
- : I-Gene
CD40 NNP I-Gene
+ NNP O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
- : O
mediated VBN O
proliferation NN O
of IN O
PBMC NNP O
and CC O
B NNP O
cells NNS O
was VBD O
inhibited VBN O
by IN O
RA NNP O
in IN O
a DT O
dose JJ O
- : O
dependent JJ O
manner NN O
, , O
with IN O
maximal JJ O
inhibition NN O
of IN O
62 CD O
% NN O
+ NNP O
/ NNP O
- : O
5 CD O
% NN O
in IN O
PBMC NNP O
and CC O
55 CD O
% NN O
+ NNP O
/ NNP O
- : O
4 CD O
. . O
4 CD O
% NN O
in IN O
B NNP O
cells NNS O
by IN O
all DT O
- : O
trans NNS O
RA NNP O
, , O
and CC O
58 CD O
% NN O
+ NNP O
/ NNP O
- : O
6 CD O
. . O
7 CD O
% NN O
and CC O
51 CD O
% NN O
+ NNP O
/ NNP O
- : O
4 CD O
. . O
7 CD O
% NN O
, , O
respectively RB O
by IN O
13 CD O
- : O
cis NN O
RA NNP O
. . O

IgE NNP B-Gene
synthesis NN O
was VBD O
even RB O
more RBR O
markedly RB O
inhibited VBN O
by IN O
RA NNP O
starting VBG O
at IN O
concentrations NNS O
of IN O
> JJ O
10 CD O
( ( O
- : O
14 CD O
) ) O
mol NN O
/ NNP O
L NNP O
for IN O
B NNP O
cells NNS O
and CC O
> $ O
10 CD O
( ( O
- : O
10 CD O
) ) O
mol NN O
/ NNP O
L NNP O
for IN O
PBMC NNP O
. . O

Low JJ O
concentrations NNS O
of IN O
RA NNP O
inhibiting VBG O
IgE NNP B-Gene
synthesis NN O
( ( O
10 CD O
( ( O
- : O
10 CD O
) ) O
mol NN O
/ NNP O
L NNP O
) ) O
affected VBD O
neither DT O
B NNP O
- : O
cell NN O
proliferation NN O
nor CC O
the DT O
production NN O
of IN O
IgA NNP B-Gene
, , O
IgG NNP B-Gene
, , O
and CC O
IgM NNP B-Gene
. . O

To TO O
differentiate VB O
whether IN O
the DT O
RA NNP O
effect NN O
was VBD O
mediated VBN O
by IN O
RA NNP B-Gene
receptors NNS I-Gene
alpha VBP I-Gene
, , I-Gene
beta NN I-Gene
, , I-Gene
and CC I-Gene
gamma NN I-Gene
, , O
the DT O
expression NN O
of IN O
the DT O
retinoic NN B-Gene
acid NN I-Gene
receptors NNS I-Gene
( ( O
RAR NNP B-Gene
) ) O
was VBD O
examined VBN O
by IN O
reverse NN B-Gene
transcriptase NN I-Gene
- : O
polymerase NN O
chain NN O
reaction NN O
( ( O
RT NNP O
- : O
PCR NN O
) ) O
. . O

Taken VBN O
together RB O
, , O
this DT O
study NN O
shows VBZ O
that IN O
RA NNP O
inhibits VBZ O
IgE NNP B-Gene
production NN O
of IN O
anti JJ O
- : O
CD40 NNP O
+ NNP O
IL NNP O
- : O
4 CD O
- : O
stimulated VBN O
B NNP O
cells NNS O
in IN O
vitro NN O
. . O

Copyright JJ O
1998 CD O
by IN O
The DT O
American JJ O
Society NNP O
of IN O
Hematology NNP O
. . O

In IN O
contrast NN O
, , O
a DT O
mutant NN O
of IN O
Tax NNP B-Gene
termed VBD O
M22 NNP B-Gene
, , O
which WDT O
does VBZ O
not RB O
induce VB O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
, , O
fails VBZ O
to TO O
activate VB O
either DT O
IKKalpha NNP B-Gene
or CC O
IKKbeta NNP B-Gene
. . O

The DT O
pathological JJ O
alteration NN O
of IN O
this DT O
cytokine NN O
pathway RB O
leading VBG O
to TO O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
by IN O
Tax NNP B-Gene
may MD O
play VB O
a DT O
central JJ O
role NN O
in IN O
HTLV NNP O
- : O
1 CD O
- : O
mediated VBN O
transformation NN O
of IN O
human JJ O
T NNP O
cells NNS O
, , O
clinically RB O
manifested VBN O
as IN O
the DT O
adult NN O
T NNP O
- : O
cell NN O
leukemia NN O

Recently RB O
, , O
we PRP O
have VBP O
reported VBN O
that IN O
the DT O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
and CC O
interleukin JJ B-Gene
1 CD I-Gene
signaling VBG O
pathways NNS O
activate VBP O
two CD O
kinases NNS O
, , O
IKK1 NNP B-Gene
and CC O
IKK2 NNP B-Gene
. . O

Here RB O
, , O
we PRP O
report VBP O
that DT O
LPS NNP O
induces VBZ O
IKK NNP B-Gene
activity NN O
in IN O
human JJ O
monocytes NNS O
and CC O
THP NNP O
- : O
1 CD O
monocytic JJ O
cells NNS O
. . O

In IN O
contrast NN O
, , O
a DT O
dominant JJ O
negative JJ O
mutant NN O
of IN O
IKK2 NNP B-Gene
inhibited VBD O
LPS NNP O
induction NN O
of IN O
kappaB FW B-Gene
- : O
dependent JJ O
transcription NN O
in IN O
a DT O
dose JJ O
- : O
dependent JJ O
manner NN O
. . O

IL NNP B-Gene
- : I-Gene
7 CD I-Gene
did VBD O
not RB O
maintain VB O
v IN B-Gene
- : I-Gene
Abl NNP I-Gene
- : O
mediated VBN O
differentiation NN O
arrest NN O
of IN O
the DT O
pre NN O
- : O
B NNP O
cells NNS O
, , O
as IN O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
RAG NNP B-Gene
gene NN I-Gene
transcription NN O
was VBD O
unaffected VBN O
by IN O
IL NNP B-Gene
- : I-Gene
7 CD I-Gene
. . O

Functional JJ O
analysis NN O
of IN O
the DT O
promoter NN O
by IN O
transient JJ O
transfection NN O
assays NNS O
indicated VBD O
that IN O
synergistic JJ O
action NN O
between IN O
an DT O
SP NNP B-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
like IN I-Gene
element NN I-Gene
at IN O
- : O
21 CD O
/ SYM O
- : O
12 CD O
, , O
a DT O
GATA NNP B-Gene
site NN I-Gene
at IN O
- : O
59 CD O
/ SYM O
- : O
54 CD O
, , O
and CC O
a DT O
novel JJ B-Gene
regulatory JJ I-Gene
element NN I-Gene
, , O
CPRE NNP B-Gene
( ( O
- : O
GGACTACAG NNP B-Gene
- : O
) ) O
at IN O
- : O
49 CD O
/ SYM O
- : O
41 CD O
, , O
is VBZ O
essential JJ O
for IN O
the DT O
promoter NN O
activity NN O
in IN O
murine NN O
erythroleukemia NN O
( ( O
MEL NNP O
) ) O
cells NNS O
. . O

Administration NN O
of IN O
the DT O
cytokine NN B-Gene
interleukin SYM I-Gene
- : I-Gene
2 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
can MD O
result VB O
in IN O
therapeutic JJ O
benefits NNS O
for IN O
individuals NNS O
with IN O
renal JJ O
cell NN O
carcinoma NN O
and CC O
melanoma NN O
. . O

Here RB O
we PRP O
report VBP O
an DT O
analysis NN O
of IN O
the DT O
transcription NN O
factor NN O
families NNS O
AP NNP O
- : O
1 CD O
, , O
Sp1 NNP O
, , O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
, , O
and CC O
signal JJ B-Gene
transducers NNS I-Gene
and CC I-Gene
activators NNS I-Gene
of IN I-Gene
transcription NN I-Gene
( ( O
STAT NNP B-Gene
) ) O
in IN O
cancer NN O
patients NNS O
' POS O
lymphocytes NNS O
before IN O
and CC O
after IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
immunotherapy NN O
, , O
as IN O
assessed VBN O
by IN O
a DT O
gel JJ O
- : O
shift NN O
assay NN O
. . O

The DT O
role NN O
of IN O
platelets NNS O
for IN O
monocyte NN B-Gene
chemotactic JJ I-Gene
protein NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
secretion NN O
and CC O
surface NN O
expression NN O
of IN O
intercellular JJ O
adhesion NN O
molecule NN O
- : O
1 CD O
( ( O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
on IN O
endothelial JJ O
cells NNS O
has VBZ O
been VBN O
assessed VBN O
. . O

Nuclear JJ B-Gene
receptors NNS I-Gene
are VBP O
important JJ O
regulators NNS O
of IN O
erythroid NN O
cell NN O
development NN O
. . O

Here RB O
we PRP O
investigated VBD O
the DT O
impact NN O
of IN O
retinoid JJ B-Gene
X NNP I-Gene
receptor NN I-Gene
( ( O
RXR NNP B-Gene
) ) O
, , O
retinoic JJ B-Gene
acid NN I-Gene
receptor NN I-Gene
( ( O
RAR NNP B-Gene
) ) O
, , O
and CC O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
erbA NN I-Gene
/ JJ I-Gene
thyroid NN I-Gene
hormone NN I-Gene
( ( I-Gene
T3 NNP I-Gene
) ) I-Gene
receptor NN I-Gene
( ( O
c SYM B-Gene
- : I-Gene
erbA NN I-Gene
/ NNP I-Gene
TR NNP I-Gene
) ) O
on IN O
growth NN O
and CC O
differentiation NN O
of IN O
erythroid JJ O
cells NNS O
using VBG O
an DT O
in IN O
vitro JJ O
culture NN O
system NN O
of IN O
stem NN O
cell NN O
factor NN O
- : O
dependent NN O
erythroid JJ O
progenitors NNS O
. . O

RXR NNP B-Gene
, , O
RAR NNP B-Gene
, , O
and CC O
c SYM B-Gene
- : I-Gene
erbA NN I-Gene
/ NN I-Gene
TR NNP I-Gene
- : O
specific JJ O
ligands NNS O
were VBD O
found VBN O
to TO O
induce VB O
erythroid JJ B-Gene
- : I-Gene
specific JJ I-Gene
gene NN I-Gene
expression NN O
and CC O
to TO O
accelerate VB O
erythroid JJ O
differentiation NN O
in IN O
culture NN O
, , O
with IN O
T3 NNP O
being VBG O
most RBS O
effective JJ O
. . O

Thus RB O
, , O
c SYM B-Gene
- : I-Gene
erbA NN I-Gene
/ NN I-Gene
TR NNP I-Gene
appears VBZ O
to TO O
act VB O
as IN O
a DT O
binary JJ O
switch NN O
affecting VBG O
erythroid JJ O
cell NN O
fate NN O
: : O
unliganded JJ O
c SYM B-Gene
- : I-Gene
erbA NN I-Gene
/ JJ I-Gene
TR NNP I-Gene
supports NNS O
growth NN O
while IN O
ligand SYM O
- : O
activated VBN O
c SYM B-Gene
- : I-Gene
erbA NN I-Gene
/ JJ I-Gene
TR NNP I-Gene
induces NNS O
differentiation NN O
. . O

In IN O
marked VBN O
contrast NN O
, , O
expression NN O
of IN O
the DT O
dominant JJ B-Gene
interfering NN I-Gene
deltaDNA NN I-Gene
- : I-Gene
binding NN I-Gene
domain NN I-Gene
RXR NNP B-Gene
, , O
containing VBG O
a DT O
deletion NN O
of IN O
the DT O
entire JJ B-Gene
DNA NNP I-Gene
- : I-Gene
binding NN I-Gene
domain NN I-Gene
, , O
was VBD O
incompatible JJ O
with IN O
erythroid JJ O
cell NN O
growth NN O
in IN O
vitro NN O
, , O
suggesting VBG O
a DT O
pivotal JJ O
role NN O
of IN O
RXR NNP B-Gene
for IN O
erythroid NN O
cell NN O
development NN O
. . O

We PRP O
examined VBD O
signaling VBG O
molecules NNS O
of IN O
peripheral JJ O
blood NN O
T NNP O
lymphocytes NNS O
obtained VBD O
from IN O
women NNS O
with IN O
breast NN O
cancer NN O
. . O

This DT O
observation NN O
was VBD O
made VBN O
despite IN O
normal JJ O
cytoplasmic JJ O
levels NNS O
of IN O
the DT O
Rel NNP B-Gene
- : I-Gene
A DT I-Gene
protein NN I-Gene
. . O

T NNP O
lymphocytes VBZ O
from IN O
6 CD O
of IN O
the DT O
14 CD O
patients NNS O
also RB O
exhibited VBD O
an DT O
increased JJ O
expression NN O
of IN O
the DT O
dual JJ O
specificity NN B-Gene
phosphatase NN I-Gene
, , O
map JJ B-Gene
kinase NN I-Gene
phosphatase NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
MKP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
. . O

We PRP O
studied VBD O
the DT O
number NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
and CC O
dissociation NN O
constant NN O
in IN O
isolated JJ O
human JJ O
lymphocytes VBZ O
as RB O
well RB O
as IN O
blood NN O
concentrations NNS O
of IN O
hormones NNS O
produced VBN O
by IN O
the DT O
hypothalamic JJ O
- : O
hypophyseal NN O
- : O
adrenocortical JJ O
system NN O
in IN O
three CD O
experimental JJ O
series NN O
: : O
at IN O
normal JJ O
( ( O
17 CD O
subjects NNS O
) ) O
, , O
decreased VBN O
( ( O
10 CD O
subjects NNS O
, , O
a DT O
360 CD O
- : O
d NN O
head NN O
- : O
down RB O
bed RB O
rest NN O
) ) O
and CC O
increased VBN O
( ( O
8 CD O
subjects NNS O
, , O
physical JJ O
exercise NN O
on IN O
bicycle NN O
ergometer NN O
) ) O
levels NNS O
of IN O
motor NN O
activity NN O
. . O

The DT O
small JJ B-Gene
GTP NNP I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
Rho NNP I-Gene
potentiates VBZ O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
transcription NN O
in IN O
T NNP O
cells NNS O
. . O

The DT O
effect NN O
of IN O
Rho NNP B-Gene
on IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
independent JJ O
of IN O
the DT O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
pathway RB O
, , O
as IN O
a DT O
dominant JJ B-Gene
- : I-Gene
negative JJ I-Gene
MEK NNP I-Gene
and CC O
a DT O
MEK NNP B-Gene
inhibitor NN O
( ( O
PD98059 NNP O
) ) O
did VBD O
not RB O
affect VB O
Rho NNP B-Gene
- : O
induced VBD O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
activity NN O
. . O

These DT O
cells NNS O
exhibit VBP O
many JJ O
alterations NNS O
in IN O
function NN O
compared VBN O
with IN O
their PRP$ O
precursor NN O
cells NNS O
, , O
blood NN O
monocytes NNS O
. . O

To TO O
evaluate VB O
a DT O
potential JJ O
mechanism NN O
for IN O
these DT O
differences NNS O
in IN O
function NN O
, , O
we PRP O
evaluated VBD O
expression NN O
of IN O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
( ( I-Gene
PKC NNP I-Gene
) ) I-Gene
isoforms NNS I-Gene
. . O

Using VBG O
mRNA JJ O
differential JJ O
display NN O
we PRP O
demonstrated VBD O
abnormally RB O
high JJ O
expression NN O
of IN O
the DT O
signal JJ B-Gene
transducer NN I-Gene
and CC I-Gene
activator NN I-Gene
of IN I-Gene
transcription NN I-Gene
( ( O
STAT1alpha NNP B-Gene
) ) O
in IN O
monocytes NNS O
from IN O
the DT O
proband NN O
II NNP O
- : O
2 CD O
. . O

Analysis NN O
of IN O
monocytes NNS O
from IN O
familial JJ O
hypercholesterolemic NN O
( ( O
FH NNP O
) ) O
subjects NNS O
, , O
who WP O
frequently RB O
develop VBP O
xanthomatosis NN O
, , O
revealed VBD O
a DT O
significant JJ O
number NN O
of IN O
subjects NNS O
with IN O
elevated JJ O
STAT1alpha NNP O
and CC O
IP NNP O
- : O
10 CD O
expression NN O
. . O

The DT O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
has VBZ O
been VBN O
recognized VBN O
to TO O
regulate VB O
a DT O
number NN O
of IN O
genes NNS O
necessary JJ O
for IN O
normal JJ O
T NNP O
cell NN O
responses NNS O
including VBG O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
, , O
and CC O
several JJ O
T NNP B-Gene
cell NN I-Gene
surface NN I-Gene
receptors NNS I-Gene
. . O

Uncoupling NN O
of IN O
nonreceptor NN O
tyrosine NN B-Gene
kinases VBZ I-Gene
from IN O
PLC NNP B-Gene
- : I-Gene
gamma1 NN I-Gene
in IN O
an DT O
SLP NNP O
- : O
76 CD O
- : O
deficient NN O
T NNP O
cell NN O
. . O

SLP NNP B-Gene
- : I-Gene
76 CD I-Gene
was VBD O
not RB O
required VBN O
for IN O
TCR NNP B-Gene
- : O
induced JJ O
tyrosine JJ O
phosphorylation NN O
of IN O
most JJS O
proteins NNS O
, , O
but CC O
was VBD O
required VBN O
for IN O
optimal JJ O
tyrosine NN O
phosphorylation NN O
and CC O
activation NN O
of IN O
phospholipase NN B-Gene
C NNP I-Gene
- : I-Gene
gamma1 NN I-Gene
( ( O
PLC NNP B-Gene
- : I-Gene
gamma1 NN I-Gene
) ) O
, , O
as RB O
well RB O
as IN O
Ras NNP B-Gene
pathway NN O
activation NN O
. . O

Thus RB O
, , O
coupling VBG O
of IN O
TCR NNP B-Gene
- : I-Gene
regulated VBD I-Gene
PTKs NNP I-Gene
to TO O
downstream VB O
signaling VBG O
pathways NNS O
requires VBZ O
SLP NNP B-Gene
- : I-Gene
76 CD I-Gene
. . O

In IN O
addition NN O
, , O
we PRP O
have VBP O
shown VBN O
that IN O
Stat1alpha NNP B-Gene
, , O
but CC O
not RB O
Stat3 NNP B-Gene
, , O
is VBZ O
involved VBN O
in IN O
EPO NNP B-Gene
- : O
induced VBD O
cellular JJ O
proliferation NN O
. . O

Dominant JJ O
negative JJ O
forms NNS O
of IN O
Stat1alpha NNP B-Gene
or CC O
Stat3 NNP B-Gene
promoted VBD O
the DT O
EPO NNP B-Gene
- : O
induced JJ O
erythroid JJ O
differentiation NN O
of IN O
UT NNP O
- : O
7 CD O
/ JJ O
GM NNP O
cells NNS O
, , O
even RB O
in IN O
the DT O
presence NN O
of IN O
granulocyte JJ B-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
, , O
although IN O
this DT O
cytokine NN O
never RB O
induced VBN O
erythroid JJ O
differentiation NN O
of IN O
the DT O
parent NN O
UT NNP O
- : O
7 CD O
/ JJ O
GM NNP O
cells NNS O
with IN O
or CC O
without IN O
EPO NNP B-Gene
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
data NNS O
suggest VBP O
that IN O
Stat1alpha NNP B-Gene
and CC O
Stat3 NNP B-Gene
act NN O
as IN O
negative JJ O
regulators NNS O
in IN O
EPO NNP B-Gene
- : O
induced JJ O
erythroid JJ O
differentiation NN O
. . O

Data NNS O
obtained VBN O
by IN O
electrophoretic JJ O
mobility NN O
shift NN O
assay VBP O
suggested VBN O
that IN O
the DT O
activated JJ B-Gene
Stat NNP I-Gene
- : I-Gene
3 CD I-Gene
protein NN I-Gene
associates NNS O
with IN O
the DT O
human JJ B-Gene
serum NN I-Gene
- : I-Gene
inducible JJ I-Gene
element NN I-Gene
( ( I-Gene
hSIE NN I-Gene
) ) I-Gene
DNA NNP I-Gene
- : I-Gene
probe NN I-Gene
derived VBN O
from IN O
the DT O
interferon NN B-Gene
- : I-Gene
gamma NN I-Gene
activated VBN I-Gene
site NN I-Gene
( ( O
GAS NNP B-Gene
) ) O
in IN O
the DT O
c NN B-Gene
- : I-Gene
fos NN I-Gene
promoter NN I-Gene
, , O
a DT O
common JJ O
DNA NNP O
sequence NN O
for IN O
Stat NNP B-Gene
protein NN I-Gene
binding NN O
. . O

In IN O
conclusion NN O
, , O
our PRP$ O
data NNS O
suggest VBP O
the DT O
involvement NN O
of IN O
the DT O
Jak NNP B-Gene
/ NNP I-Gene
Stat NNP I-Gene
signal JJ O
pathway NN O
in IN O
MHC NNP B-Gene
- : I-Gene
I PRP I-Gene
- : O
induced VBD O
signal JJ O
transduction NN O
in IN O
T NNP O
cells NNS O
. . O

These DT O
apparent JJ O
inconsistencies NNS O
reflect VBP O
the DT O
complexity NN O
of IN O
the DT O
DTCs NNP O
biological JJ O
activities NNS O
and CC O
are VBP O
probably RB O
due JJ O
in IN O
part NN O
to TO O
differences NNS O
in IN O
dose NN O
, , O
route NN O
of IN O
exposure NN O
, , O
animal JJ O
species NNS O
used VBN O
and CC O
/ CD O
or CC O
specific JJ O
compound NN O
tested VBD O
. . O

The DT O
studies NNS O
described VBD O
herein NNS O
were VBD O
undertaken VBN O
to TO O
investigate VB O
the DT O
immunotoxicity NN O
of IN O
one CD O
member NN O
of IN O
this DT O
family NN O
, , O
dimethyldithiocarbam NN O
( ( O
DMDTC NNP O
) ) O
. . O

This DT O
inhibition NN O
is VBZ O
not RB O
accompanied VBN O
by IN O
a DT O
loss NN O
in IN O
viability NN O
, , O
and CC O
DMDTC NNP O
- : O
treated VBD O
T NNP O
cells NNS O
retain VBP O
other JJ O
active JJ O
signaling NN O
pathways NNS O
throughout IN O
the DT O
exposure NN O
duration NN O
. . O

We PRP O
further VBP O
demonstrate VB O
that DT O
0 CD O
. . O
1 CD O
- : O
0 CD O
. . O
5 CD O
microM JJ O
DMDTC NNP O
inhibits NNS O
intracellular JJ O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
production NN O
and CC O
decreases VBZ O
surface JJ O
expression NN O
of IN O
CD25 NNP B-Gene
( ( O
the DT O
alpha NN B-Gene
subunit NN I-Gene
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
receptor NN I-Gene
) ) O
in IN O
T NNP O
cells NNS O
stimulated VBD O
with IN O
phorbol NN O
ester NN O
. . O

Using VBG O
deletion NN B-Gene
constructs NNS I-Gene
, , O
we PRP O
have VBP O
defined VBN O
an DT O
active JJ B-Gene
promoter NN I-Gene
region NN I-Gene
of IN O
1056 CD O
bp NN O
. . O

Ex NNP O
vivo JJ O
activation NN O
of IN O
tumor NN O
- : O
draining VBG O
lymph JJ O
node JJ O
T NNP O
cells NNS O
reverses VBZ O
defects NNS O
in IN O
signal JJ B-Gene
transduction NN I-Gene
molecules NNS I-Gene
. . O

To TO O
determine VB O
whether IN O
the DT O
acquisition NN O
of IN O
antitumor NN O
function NN O
during IN O
ex JJ O
vivo JJ O
activation NN O
is VBZ O
associated VBN O
with IN O
modifications NNS O
in IN O
signal JJ O
transduction NN O
capacity NN O
, , O
the DT O
protein NN O
tyrosine NN B-Gene
kinases VBZ I-Gene
p56lck NN B-Gene
and CC O
p59fyn NN B-Gene
and CC O
proteins NNS O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
family NN I-Gene
were VBD O
analyzed VBN O
in IN O
tumor NN O
- : O
draining VBG O
LN NNP O
T NNP O
cells NNS O
. . O

In IN O
contrast NN O
, , O
the DT O
cytoplasmic JJ O
levels NNS O
of IN O
c SYM B-Gene
- : I-Gene
Rel NN I-Gene
and CC O
Rel VB B-Gene
A NNP I-Gene
were VBD O
normal JJ O
in IN O
freshly RB O
isolated JJ O
tumor NN O
- : O
draining NN O
LN NNP O
, , O
as IN O
was VBD O
nuclear JJ O
kappaB NN B-Gene
DNA NNP O
- : O
binding NN O
activity NN O
induced VBN O
by IN O
anti JJ B-Gene
- : I-Gene
CD3 NNP I-Gene
mAb NN I-Gene
or CC O
phorbol NN O
myristate NN O
acetate NN O
. . O

BACKGROUND NN O
: : O
The DT O
class NN B-Gene
II NNP I-Gene
transactivator NN I-Gene
( ( O
CIITA NNP B-Gene
) ) O
is VBZ O
a DT O
bi JJ B-Gene
- : I-Gene
or CC I-Gene
multifunctional JJ I-Gene
domain NN I-Gene
protein NN I-Gene
that WDT O
acts VBZ O
as IN O
a DT O
transcriptional JJ B-Gene
activator NN I-Gene
and CC O
plays VBZ O
a DT O
critical JJ O
role NN O
in IN O
the DT O
expression NN O
of IN O
MHC NNP B-Gene
class NN I-Gene
II NNP I-Gene
genes NNS I-Gene
. . O

Porcine NNP B-Gene
MHC NNP I-Gene
class NN I-Gene
II NNP I-Gene
antigens NNS I-Gene
are VBP O
potent JJ O
stimulators NNS O
of IN O
direct JJ O
T NNP O
- : O
cell NN O
recognition NN O
by IN O
human JJ O
CD4 NNP O
+ NNP O
T NNP O
cells NNS O
and CC O
are VBP O
, , O
therefore RB O
, , O
likely RB O
to TO O
play VB O
an DT O
important JJ O
role NN O
in IN O
the DT O
rejection NN O
responses VBZ O
to TO O
transgenic VB O
pig NN O
donors NNS O
in IN O
clinical JJ O
xenotransplantation NN O
. . O

Transient JJ O
transfectants NNS O
of IN O
the DT O
porcine NN O
B NNP O
- : O
cell NN O
line NN O
L23 NNP O
with IN O
the DT O
mutated VBN O
CIITA NNP B-Gene
constructs NNS I-Gene
were VBD O
tested VBN O
for IN O
the DT O
suppression NN O
of IN O
constitutive JJ O
SLA NNP O
- : O
DR NN O
and CC O
SLA NNP O
- : O
DQ NNP O
expression NN O
. . O

Macrophages NNS O
in IN O
human JJ O
atheroma NN O
contain NN O
PPARgamma NNP B-Gene
: : O
differentiation NN B-Gene
- : I-Gene
dependent NN I-Gene
peroxisomal JJ I-Gene
proliferator NN I-Gene
- : I-Gene
activated VBN I-Gene
receptor NN I-Gene
gamma NN I-Gene
( ( O
PPARgamma NNP B-Gene
) ) O
expression NN O
and CC O
reduction NN O
of IN O
MMP NNP B-Gene
- : I-Gene
9 CD I-Gene
activity NN O
through IN O
PPARgamma NNP B-Gene
activation NN O
in IN O
mononuclear JJ O
phagocytes NNS O
in IN O
vitro NN O
. . O

Mononuclear NNP O
phagocytes VBZ O
play VBP O
an DT O
important JJ O
role NN O
in IN O
atherosclerosis NN O
and CC O
its PRP$ O
sequela NN O
plaque NN O
rupture NN O
in IN O
part NN O
by IN O
their PRP$ O
secretion NN O
of IN O
matrix NN B-Gene
metalloproteinases NNS I-Gene
( ( O
MMPs NNP B-Gene
) ) O
, , O
including VBG O
MMP NNP B-Gene
- : I-Gene
9 CD I-Gene
. . O

The DT O
role NN O
of IN O
PPARgamma NNP B-Gene
in IN O
human JJ O
atherosclerosis NN O
is VBZ O
unexplored JJ O
. . O

In IN O
addition NN O
, , O
PPARgamma NNP B-Gene
mRNA VBZ I-Gene
expression NN O
in IN O
U937 NNP O
cells NNS O
increased VBD O
during IN O
phorbol NN O
12 CD O
- : O
myristate NN O
13 CD O
acetate NN O
- : O
induced JJ O
differentiation NN O
. . O

We PRP O
examined VBD O
signaling VBG O
by IN O
erythropoietin NN B-Gene
in IN O
highly RB O
purified JJ O
human JJ O
colony NN O
forming VBG O
unit NN O
- : O
erythroid NN O
cells NNS O
, , O
generated VBN O
in IN O
vitro NN O
from IN O
CD34 NNP O
( ( O
+ NNP O
) ) O
cells NNS O
. . O

We PRP O
found VBD O
that IN O
erythropoietin NN B-Gene
induces NNS O
tyrosine VBP O
phosphorylation NN O
of IN O
Jak2 NNP B-Gene
, , O
STAT5A NNP B-Gene
, , O
and CC O
STAT5B NNP B-Gene
. . O

Tyrosine NNP O
phosphorylation NN O
of IN O
Jak2 NNP B-Gene
reaches VBZ O
a DT O
peak NN O
around IN O
10 CD O
minutes NNS O
after IN O
stimulation NN O
and CC O
is VBZ O
maximum JJ O
at IN O
5 CD O
U NNP O
/ NNP O
mL NN O
of IN O
erythropoietin NN B-Gene
. . O

Effects NNS O
of IN O
oxidative JJ O
stress NN O
on IN O
stimulation NN O
- : O
dependent JJ O
signal JJ O
transduction NN O
, , O
leading VBG O
to TO O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
expression NN O
, , O
were VBD O
studied VBN O
. . O

The DT O
cells NNS O
were VBD O
then RB O
stimulated VBN O
for IN O
6 CD O
h NN O
. . O

Eosinophils NNS O
infiltrating VBG O
hamster RB O
cutaneous JJ O
wounds NNS O
were VBD O
found VBN O
to TO O
express VB O
TGFs NNP B-Gene
sequentially RB O
. . O

IL NNP B-Gene
- : I-Gene
3 CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
and CC O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
independently RB O
up IN O
- : O
regulated VBN O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
mRNA NN I-Gene
and CC O
product NN O
expression NN O
by IN O
eosinophils NNS O
in IN O
all DT O
donors NNS O
. . O

The DT O
observation NN O
that IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
can MD O
differentially RB O
regulate VB O
the DT O
expression NN O
of IN O
TGF NNP B-Gene
- : I-Gene
alpha NN I-Gene
and CC O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
suggests VBZ O
that IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
may MD O
serve VB O
as IN O
a DT O
physiologic JJ O
molecular JJ O
switch NN O
of IN O
TGF NNP B-Gene
expression NN O
by IN O
the DT O
infiltrating NN O
eosinophils VBZ O
in IN O
wound NN O
healing NN O
and CC O
carcinogenesis NN O
. . O

A DT O
recent JJ O
study NN O
showed VBD O
a DT O
MLL NNP B-Gene
/ NNP I-Gene
AF10 NNP I-Gene
fusion NN I-Gene
in IN O
all DT O
cases NNS O
of IN O
AML NNP O
with IN O
t NN B-Gene
( ( I-Gene
10 CD I-Gene
; : I-Gene
11 CD I-Gene
) ) I-Gene
and CC O
various JJ O
breakpoints NNS O
on IN O
chromosome NN B-Gene
11 CD I-Gene
ranging VBG O
from IN O
q13 NN B-Gene
to TO O
q23 VB B-Gene
. . O

We PRP O
recently RB O
cloned VBD O
CALM NNP B-Gene
( ( O
Clathrin NNP B-Gene
Assembly NNP I-Gene
Lymphoid NNP I-Gene
Myeloid NNP I-Gene
leukemia NN I-Gene
gene NN I-Gene
) ) O
, , O
the DT O
fusion NN O
partner NN O
of IN O
AF10 NNP B-Gene
at IN O
11q14 CD B-Gene
in IN O
the DT O
monocytic JJ O
cell NN O
line NN O
U937 NNP O
. . O

MLL NNP O
was VBD O
rearranged VBN O
in IN O
3 CD O
AML NNP O
with IN O
myelomonocytic JJ O
differentiation NN O
( ( O
2 CD O
AML NNP O
- : O
M2 NNP O
and CC O
1 CD O
AML NNP O
- : O
M5 NN O
) ) O
, , O
including VBG O
1 CD O
secondary JJ O
AML NNP O
. . O

For IN O
the DT O
7 CD O
AML NNP O
cases NNS O
that WDT O
were VBD O
uniformly RB O
treated VBN O
according VBG O
to TO O
the DT O
AMLCG86 NNP O
/ NNP O
92 CD O
protocols NNS O
, , O
disease VB O
- : O
free JJ O
and CC O
overall JJ O
survival NN O
was VBD O
significantly RB O
worse JJR O
than IN O
for IN O
the DT O
overall JJ O
study NN O
group NN O
( ( O
P NNP O
= NNP O
. . O
3 CD O
and CC O
P NNP O
= NNP O
. . O
1 CD O
, , O
respectively RB O
) ) O
. . O

We PRP O
conclude VBP O
that IN O
the DT O
t NN B-Gene
( ( I-Gene
10 CD I-Gene
; : I-Gene
11 CD I-Gene
) ) I-Gene
( ( I-Gene
p13 NN I-Gene
; : I-Gene
q14 CC I-Gene
) ) I-Gene
indicates VBZ O
CALM NNP B-Gene
and CC I-Gene
MLL NNP I-Gene
rearrangements NNS I-Gene
in IN O
morphologically RB O
distinct JJ O
subsets NNS O
of IN O
acute JJ O
leukemia NN O
and CC O
may MD O
be VB O
associated VBN O
with IN O
a DT O
poor JJ O
prognosis NN O
. . O

In IN O
particular JJ O
, , O
one CD O
class NN O
of IN O
helix NN B-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
proteins NNS I-Gene
, , O
termed VBD O
E NNP B-Gene
- : I-Gene
proteins NNS I-Gene
, , O
have VBP O
been VBN O
implicated VBN O
in IN O
the DT O
regulation NN O
of IN O
gene NN O
expression NN O
during IN O
B NNP O
- : O
cell NN O
development NN O
. . O

Dominant JJ B-Gene
negative JJ I-Gene
mutants NNS I-Gene
of IN O
NIK NNP B-Gene
, , O
IKKalpha NNP B-Gene
, , O
or CC O
IKKbeta NNP B-Gene
substantially RB O
inhibited VBD O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
by IN O
LMP1 NNP B-Gene
or CC O
by IN O
each DT O
of IN O
its PRP$ O
effector NN B-Gene
sites NNS I-Gene
. . O

MyD88 NNP B-Gene
, , O
originally RB O
isolated VBN O
as IN O
a DT O
myeloid JJ O
differentiation NN O
primary JJ B-Gene
response NN I-Gene
gene NN I-Gene
, , O
is VBZ O
shown VBN O
to TO O
act VB O
as IN O
an DT O
adaptor NN O
in IN O
interleukin JJ B-Gene
- : I-Gene
1 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
signaling NN O
by IN O
interacting VBG O
with IN O
both DT O
the DT O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
receptor NN I-Gene
complex NN I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
receptor NN I-Gene
- : I-Gene
associated VBN I-Gene
kinase NN I-Gene
( ( O
IRAK NNP B-Gene
) ) O
. . O

In IN O
vivo JJ O
Th1 NNP O
response NN O
is VBZ O
also RB O
impaired JJ O
. . O

Furthermore RB O
, , O
IL NNP B-Gene
- : I-Gene
18 CD I-Gene
- : O
induced JJ O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
c SYM B-Gene
- : I-Gene
Jun NNP I-Gene
N NNP I-Gene
- : I-Gene
terminal JJ I-Gene
kinase NN I-Gene
( ( O
JNK NNP B-Gene
) ) O
is VBZ O
blocked VBN O
in IN O
MyD88 NNP O
- : O
/ SYM O
- : O
Th1 NNP O
- : O
developing VBG O
cells NNS O
. . O

Taken VBN O
together RB O
, , O
these DT O
results NNS O
demonstrate VBP O
that IN O
MyD88 NNP B-Gene
is VBZ O
a DT O
critical JJ O
component NN O
in IN O
the DT O
signaling VBG O
cascade NN O
that WDT O
is VBZ O
mediated VBN O
by IN O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
receptor NN I-Gene
as RB O
well RB O
as IN O
IL NNP B-Gene
- : I-Gene
18 CD I-Gene
receptor NN I-Gene
. . O

In IN O
addition NN O
, , O
transcriptional JJ O
activity NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
metallothionein JJ B-Gene
enhancer NN I-Gene
and CC I-Gene
promoter NN I-Gene
regions NNS I-Gene
and CC O
transcription NN B-Gene
factors NNS I-Gene
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
, , O
and CC O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
were VBD O
analyzed VBN O
by IN O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
( ( O
CAT NNP B-Gene
) ) O
and CC O
electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
, , O
respectively RB O
. . O

The DT O
concentration NN O
of IN O
c JJ B-Gene
- : I-Gene
fos NN I-Gene
, , I-Gene
c SYM I-Gene
- : I-Gene
jun NN I-Gene
, , I-Gene
c SYM I-Gene
- : I-Gene
myc NN I-Gene
, , I-Gene
junB NN I-Gene
, , I-Gene
and CC I-Gene
fra SYM I-Gene
- : I-Gene
1 CD I-Gene
mRNAs NN I-Gene
was VBD O
increased VBN O
in IN O
activated JJ O
peripheral JJ O
blood NN O
lymphocytes NNS O
incubated VBD O
with IN O
ciprofloxacin NNS O
compared VBN O
to TO O
that DT O
in IN O
untreated JJ O
controls NNS O
. . O

Simple JJ O
activation NN O
of IN O
RXRs NNP B-Gene
is VBZ O
not RB O
sufficient JJ O
to TO O
induce VB O
apoptosis NN O
of IN O
the DT O
cells NNS O
. . O

Thrombopoietin NNP B-Gene
supports NNS O
in IN O
vitro NN O
erythroid JJ O
differentiation NN O
via IN O
its PRP$ O
specific JJ O
receptor NN O
c SYM B-Gene
- : I-Gene
Mpl NN I-Gene
in IN O
a DT O
human JJ O
leukemia NN O
cell NN O
line NN O
. . O

More JJR O
than IN O
50 CD O
% NN O
of IN O
TPO NNP O
- : O
treated VBD O
UT NNP O
- : O
7 CD O
/ JJ O
GMT NNP O
cells NNS O
positively RB O
stained VBD O
for IN O
Hb NNP B-Gene
. . O

Because IN O
the DT O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
is VBZ O
located VBN O
on IN O
the DT O
X NNP B-Gene
chromosome NN I-Gene
, , O
which WDT O
is VBZ O
randomly RB O
inactivated VBN O
in IN O
every DT O
cell NN O
, , O
heterozygous JJ O
females NNS O
can MD O
bear VB O
either DT O
an DT O
active JJ O
wild JJ O
- : O
type NN O
or CC O
mutant NN O
( ( O
referred VBN O
to TO O
as IN O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
. . I-Gene
5 CD I-Gene
) ) O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
allele NN O
, , O
consequently RB O
leading VBG O
to TO O
variable JJ O
anemic JJ O
severity NN O
. . O

We PRP O
also RB O
observed VBD O
hematopoiesis NN O
outside IN O
of IN O
the DT O
bone NN O
marrow NN O
in IN O
the DT O
affected JJ O
mutant JJ O
mice NN O
. . O

The DT O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
heterozygous JJ O
mutant NN O
mouse NN O
shows VBZ O
a DT O
phenotype NN O
that WDT O
is VBZ O
analogous JJ O
to TO O
human JJ O
myelodysplastic JJ O
syndrome NN O
and CC O
thus RB O
may MD O
serve VB O
as IN O
a DT O
useful JJ O
model NN O
for IN O
this DT O
disorder NN O
. . O

Differential NNP O
regulation NN O
of IN O
the DT O
Janus NNP B-Gene
kinase NNP I-Gene
- : B-Gene
STAT NNP I-Gene
pathway NN O
and CC O
biologic JJ O
function NN O
of IN O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
in IN O
primary JJ O
human JJ O
NK NNP O
and CC O
T NNP O
cells NNS O
: : O
a DT O
comparative JJ O
study NN O
with IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
. . O

We PRP O
observed VBD O
that IN O
Abs NNP O
directed VBD O
against IN O
unique JJ O
domains NNS O
of IN O
STAT6 NNP B-Gene
have VBP O
differential JJ O
effects NNS O
on IN O
complexes NNS O
in IN O
T NNP O
cells NNS O
but CC O
not RB O
in IN O
NK NNP O
cells NNS O
, , O
suggesting VBG O
different JJ O
STAT6 NNP B-Gene
isoforms NNS I-Gene
. . O

These DT O
findings NNS O
show VBP O
that IN O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
have VBP O
the DT O
ability NN O
to TO O
regulate VB O
NK NNP O
and CC O
T NNP O
cell NN O
activation NN O
and CC O
that IN O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
is VBZ O
a DT O
potent JJ O
regulator NN O
of IN O
STAT6 NNP B-Gene
and CC O
JAK3 NNP B-Gene
in IN O
these DT O
cell NN O
types NNS O
. . O

NFkappaB NNP B-Gene
activity NN O
is VBZ O
independent JJ O
from IN O
FADD NNP B-Gene
, , O
caspases VBZ B-Gene
, , O
and CC O
apoptosis NN O
induction NN O
. . O

To TO O
study VB O
the DT O
influence NN O
of IN O
NFkappaB NNP B-Gene
activity NN O
on IN O
apoptosis NN O
mediated VBN O
by IN O
TRAIL NNP B-Gene
, , O
CD95 NNP O
, , O
TNFalpha NNP B-Gene
, , O
or CC O
doxorubicin NN O
, , O
NFkappaB NNP B-Gene
activation NN O
was VBD O
inhibited VBN O
using VBG O
the DT O
proteasome NN B-Gene
inhibitor NN O
N NNP O
- : O
acetyl NN O
- : O
L NNP O
- : O
leucinyl NN O
- : O
L NNP O
- : O
leucinyl NN O
- : O
L NNP O
- : O
norleucinal JJ O
or CC O
transient JJ O
overexpression NN O
of IN O
mutant JJ B-Gene
IkappaBalpha NNP I-Gene
. . O

Sensitivity NN O
for IN O
induction NN O
of IN O
apoptosis NN O
was VBD O
markedly RB O
increased VBN O
by IN O
these DT O
treatments NNS O
in IN O
apoptosis NN O
sensitive JJ O
cell NN O
lines NNS O
. . O

Loss NNP O
- : O
and CC O
gain VB O
- : O
of IN O
- : O
function NN O
mutations NNS O
reveal VBP O
an DT O
important JJ O
role NN O
of IN O
BSAP NNP B-Gene
( ( O
Pax NNP B-Gene
- : I-Gene
5 CD I-Gene
) ) O
at IN O
the DT O
start NN O
and CC O
end NN O
of IN O
B NNP O
cell NN O
differentiation NN O
. . O

However RB O
, , O
its PRP$ O
interactions NNS O
with IN O
these DT O
histone NN B-Gene
acetyltransferases NNS I-Gene
are VBP O
not RB O
equivalent JJ O
, , O
as IN O
CBP NNP B-Gene
and CC O
p300 NN B-Gene
, , O
but CC O
not RB O
P NNP B-Gene
/ NNP I-Gene
CAF NNP I-Gene
, , O
utilize JJ O
EKLF NNP B-Gene
as IN O
a DT O
substrate NN O
for IN O
in IN O
vitro JJ O
acetylation NN O
within IN O
its PRP$ O
trans NNS O
- : O
activation NN B-Gene
region NN I-Gene
. . O

We PRP O
conclude VBP O
that IN O
contact NN O
with IN O
fibrinogen NN B-Gene
- : I-Gene
derived JJ I-Gene
proteins NNS I-Gene
may MD O
contribute VB O
to TO O
mononuclear VB O
phagocyte JJ O
activation NN O
by IN O
signaling VBG O
through IN O
CD11b NNP B-Gene
/ NNP I-Gene
CD18 NNP I-Gene
, , O
resulting VBG O
in IN O
selective JJ O
activation NN O
of IN O
transcriptional JJ B-Gene
regulatory JJ I-Gene
factors NNS I-Gene
, , O
including VBG O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

OBJECTIVE NN O
: : O
To TO O
identify VB O
and CC O
characterize VB O
estrogen NN B-Gene
receptor NN I-Gene
( ( I-Gene
ER NNP I-Gene
) ) I-Gene
transcripts NNS I-Gene
expressed VBN O
in IN O
immune JJ O
cells NNS O
of IN O
patients NNS O
with IN O
systemic JJ O
lupus NN O
erythematosus NN O
( ( O
SLE NNP O
) ) O
and CC O
healthy JJ O
donors NNS O
. . O

There EX O
were VBD O
no DT O
notable JJ O
differences NNS O
in IN O
the DT O
ER NNP B-Gene
transcripts NNS I-Gene
between IN O
patients NNS O
and CC O
healthy JJ O
controls NNS O
. . O

Variant NNP O
receptor NN O
transcripts NNS O
lacking VBG O
exon JJ B-Gene
5 CD I-Gene
or CC O
exon VB B-Gene
7 CD I-Gene
, , O
which WDT O
encodes VBZ O
the DT O
hormone NN O
binding NN O
domain NN O
, , O
were VBD O
identified VBN O
in IN O
the DT O
majority NN O
of IN O
the DT O
cells NNS O
. . O

Whether IN O
the DT O
detected VBN O
transcripts NNS O
are VBP O
translated VBN O
into IN O
functional JJ O
receptor NN O
proteins NNS O
remains VBZ O
to TO O
be VB O
determined VBN O
. . O

A DT O
nondegradable JJ O
mutant NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
blocked VBD O
both DT O
FasL NNP B-Gene
expression NN O
and CC O
apoptosis NN O
induced VBN O
by IN O
DNA NNP O
damage NN O
but CC O
not RB O
Fas NNP B-Gene
ligation NN O
. . O

These DT O
stimuli NNS O
also RB O
induced VBD O
the DT O
stress NN O
- : O
activated JJ O
kinase NN O
pathway NN O
( ( O
SAPK NNP B-Gene
/ NNP B-Gene
JNK NNP I-Gene
) ) O
, , O
which WDT O
was VBD O
required VBN O
for IN O
the DT O
maximal JJ O
induction NN O
of IN O
apoptosis NN O
. . O

Simultaneously RB O
, , O
T NNP O
lymphocyte VBZ O
subsets NNS O
and CC O
NK NNP O
cells NNS O
from IN O
the DT O
peripheral JJ O
blood NN O
( ( O
PB NNP O
) ) O
and CC O
bone NN O
marrow NN O
( ( O
BM NNP O
) ) O
were VBD O
investigated VBN O
by IN O
flow JJ O
cytometric JJ O
analysis NN O
. . O

Four CD O
of IN O
the DT O
eight CD O
patients NNS O
in IN O
LT NNP O
and CC O
7 CD O
of IN O
the DT O
15 CD O
patients NNS O
in IN O
ST NNP O
remission NN O
were VBD O
MRD NNP O
- : O
positive JJ O
. . O

Thus RB O
, , O
the DT O
difference NN O
of IN O
the DT O
possible JJ O
T NNP O
/ NNP O
NK NNP O
- : O
cell NN O
phenotype NN O
in IN O
the DT O
BM NNP O
may MD O
strongly RB O
influence VB O
clinical JJ O
and CC O
molecular JJ O
remission NN O
. . O

The DT O
implication NN O
of IN O
protein JJ B-Gene
tyrosine JJ I-Gene
kinase NN I-Gene
( ( I-Gene
s NN I-Gene
) ) I-Gene
, , O
protein JJ B-Gene
kinase VBD I-Gene
A DT I-Gene
and CC O
/ NN O
or CC O
protein NN B-Gene
kinase NN I-Gene
C NNP I-Gene
was VBD O
highlighted VBN O
by IN O
the DT O
abrogation NN O
of IN O
the DT O
ManLAM NNP O
- : O
mediated VBD O
activation NN O
of IN O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
- : I-Gene
driven VBN I-Gene
gene NN I-Gene
expression NN O
using VBG O
herbimycin PDT O
A DT O
and CC O
H7 NNP O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
LTR NNP B-Gene
sequence NN I-Gene
changes NNS O
can MD O
significantly RB O
affect VB O
basal NN O
LTR NNP B-Gene
function NN O
and CC O
transcription NN B-Gene
factor NN I-Gene
recruitment NN O
, , O
which WDT O
may MD O
, , O
in IN O
turn NN O
, , O
alter VBP O
the DT O
course NN O
of IN O
viral JJ O
replication NN O
in IN O
cells NNS O
of IN O
CNS NNP O
and CC O
immune JJ O
system NN O
origin NN O
. . O

These DT O
insights NNS O
in IN O
the DT O
molecular JJ O
events NNS O
that WDT O
are VBP O
involved VBN O
in IN O
TCF NNP B-Gene
/ NNP I-Gene
LEF NNP I-Gene
function NN O
in IN O
these DT O
organisms NNS O
may MD O
eventually RB O
lead VB O
to TO O
the DT O
understanding NN O
of IN O
the DT O
function NN O
of IN O
these DT O
HMG NNP B-Gene
box NN I-Gene
proteins NNS I-Gene
in IN O
lymphoid NN O
development NN O

Molecular JJ O
genetic JJ O
characterization NN O
of IN O
the DT O
variant JJ B-Gene
allele NN I-Gene
can MD O
serve VB O
as IN O
a DT O
primary JJ O
tool NN O
for IN O
diagnosis NN O
and CC O
subsequent JJ O
therapy NN O
, , O
and CC O
can MD O
provide VB O
a DT O
basis NN O
for IN O
distinguishing VBG O
heterozygous JJ O
carriers NNS O
in IN O
familial JJ O
androgen NN O
resistance NN O
. . O

In IN O
this DT O
study NN O
, , O
the DT O
proliferative JJ O
activity NN O
of IN O
129 CD O
primary JJ O
breast NN O
cancers NNS O
was VBD O
investigated VBN O
, , O
and CC O
the DT O
results NNS O
were VBD O
related JJ O
to TO O
prognosis NN O
. . O

RESULTS NNP O
. . O

Elf NNP B-Gene
- : I-Gene
1 CD I-Gene
binds NNS O
exclusively RB O
to TO O
the DT O
underphosphorylated JJ O
form NN O
of IN O
Rb NNP B-Gene
and CC O
fails VBZ O
to TO O
bind VB O
to TO O
Rb NNP B-Gene
mutants NNS I-Gene
derived VBN O
from IN O
patients NNS O
with IN O
retinoblastoma NN O
. . O

In IN O
this DT O
study NN O
we PRP O
analyzed VBD O
the DT O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
( ( I-Gene
TcR NNP I-Gene
) ) I-Gene
delta NN I-Gene
transcripts NNS I-Gene
expressed VBN O
by IN O
CD3 NNP O
- : O
CD16 NNP O
+ NNP O
cells NNS O
and CC O
we PRP O
investigated VBD O
whether IN O
these DT O
cells NNS O
expressed VBD O
the DT O
hGATA NN B-Gene
- : I-Gene
3 CD I-Gene
T NNP I-Gene
cell NN I-Gene
transcription NN I-Gene
factor NN I-Gene
and CC O
the DT O
recombination NN B-Gene
- : I-Gene
activating VBG I-Gene
gene NN I-Gene
( ( I-Gene
RAG NNP I-Gene
) ) I-Gene
- : I-Gene
1 CD I-Gene
. . O

Sequence NNP O
analysis NN O
of IN O
nine CD O
different JJ O
2 CD O
. . O
3 CD O
- : O
kb NN O
cDNA NN O
clones NNS O
obtained VBN O
from IN O
NK NNP O
- : O
derived VBD O
polyA JJ O
+ NNP O
RNA NNP O
confirmed VBD O
that IN O
they PRP O
corresponded VBD O
to TO O
an DT O
unrearranged JJ O
TcR NNP B-Gene
delta NN I-Gene
gene NN I-Gene
. . O

However RB O
, , O
only RB O
that IN O
located VBN O
at IN O
the DT O
3 CD O
' POS O
end NN O
appeared VBD O
to TO O
be VB O
utilized VBN O
in IN O
the DT O
2 CD B-Gene
. . I-Gene
3 CD I-Gene
- : I-Gene
kb NN I-Gene
cDNA NN I-Gene
. . O

All DT O
NK NNP O
clones NNS O
and CC O
cell NN O
lines NNS O
studied VBN O
were VBD O
found VBN O
to TO O
express VB O
hGATA JJ B-Gene
- : I-Gene
3 CD I-Gene
- : I-Gene
specific JJ I-Gene
mRNA NN I-Gene
, , O
suggesting VBG O
that IN O
hGATA SYM B-Gene
- : I-Gene
3 CD I-Gene
may MD O
be VB O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
the DT O
unrearranged JJ O
TcR NNP B-Gene
delta NN I-Gene
gene NN I-Gene
expression NN O
in IN O
NK NNP O
cells NNS O
. . O

To TO O
correlate VB O
changes NNS O
in IN O
nuclear JJ O
factor NN O
binding VBG O
in IN O
vitro NN O
with IN O
transcriptional JJ O
activity NN O
in IN O
vivo NN O
and CC O
define VB O
the DT O
structural JJ O
requirements NNS O
for IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
repression NN O
, , O
we PRP O
used VBD O
transient JJ O
DNA NNP O
transfections NNS O
. . O

Jurkat NNP O
cells NNS O
were VBD O
transfected VBN O
with IN O
plasmids NNS B-Gene
containing VBG O
either CC O
the DT O
intact JJ O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
or CC O
its PRP$ O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , I-Gene
NF NNP I-Gene
- : I-Gene
AT NNP I-Gene
, , I-Gene
and CC I-Gene
NF NNP I-Gene
- : I-Gene
kB NN I-Gene
motifs NNS I-Gene
. . O

Other JJ O
bacterial JJ O
toxins NNS O
, , O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
) ) O
, , O
interleukin JJ B-Gene
- : I-Gene
1 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
, , O
T NNP B-Gene
cell NN I-Gene
mitogens NNS I-Gene
, , O
UV NNP O
light NN O
, , O
gamma NN O
rays NNS O
and CC O
oxidative JJ O
stress NN O
were VBD O
reported VBN O
to TO O
induce VB O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

We PRP O
further VBP O
characterize VB O
which WDT O
AP1 NNP B-Gene
family NN I-Gene
members NNS I-Gene
can MD O
assume VB O
this DT O
role NN O
. . O

Antisera NN O
to TO O
Fos NNP B-Gene
inhibits NNS O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
DNA NNP O
binding VBG O
as RB O
does VBZ O
an DT O
oligonucleotide NN O
containing VBG O
a DT O
binding NN B-Gene
site NN I-Gene
for IN I-Gene
AP1 NNP I-Gene
. . O

The DT O
patients NNS O
' POS O
plasma NN O
cortisol NN O
concentrations NNS O
were VBD O
normal JJ O
or CC O
slightly RB O
elevated VBN O
. . O

Despite IN O
a DT O
wide JJ O
range NN O
, , O
the DT O
mean JJ O
GR NNP B-Gene
count NN O
and CC O
affinity NN O
in IN O
MNC NNP O
from IN O
septic JJ O
patients NNS O
did VBD O
not RB O
differ VB O
from IN O
those DT O
in IN O
normal JJ O
controls NNS O
, , O
suggesting VBG O
that IN O
glucocorticoids NNS O
could MD O
still RB O
be VB O
effective JJ O
in IN O
the DT O
hemodynamic JJ O
compensatory NN O
phase NN O
of IN O
sepsis NN O
. . O

Activation NN O
of IN O
the DT O
HIV NNP O
- : O
1 CD O
provirus NN O
correlated VBN O
with IN O
the DT O
activation NN O
of IN O
binding NN O
of IN O
55 CD B-Gene
- : I-Gene
and CC I-Gene
85 CD I-Gene
- : I-Gene
kDa NN I-Gene
proteins VBZ I-Gene
to TO O
the DT O
kappa NN B-Gene
B NNP I-Gene
enhancer NN I-Gene
and CC O
binding NN O
of IN O
the DT O
50 CD B-Gene
- : I-Gene
kDa NN I-Gene
HLP NNP I-Gene
- : I-Gene
1 CD I-Gene
protein NN I-Gene
to TO O
the DT O
LBP NNP B-Gene
- : I-Gene
1 CD I-Gene
sequences NNS I-Gene
of IN O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
. . O

Surprisingly RB O
, , O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
HLP NNP O
- : O
1 CD O
binding NN O
activities NNS O
were VBD O
substantially RB O
inhibited VBN O
in IN O
acyclovir JJ O
- : O
treated JJ O
cells NNS O
. . O

Transcriptional JJ O
activation NN O
of IN O
the DT O
macrophage NN B-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
gene NN I-Gene
by IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
associated VBN O
with IN O
secretion NN O
of IN O
bioactive JJ O
macrophage NN B-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
protein NN I-Gene
by IN O
monocytes NNS O
and CC O
involves VBZ O
activation NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

Transcriptional JJ O
activation NN O
of IN O
the DT O
M NNP B-Gene
- : I-Gene
CSF NNP I-Gene
gene NN I-Gene
by IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
preceded VBN O
by IN O
enhanced JJ O
binding NN O
activity NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
to TO O
its PRP$ O
recognition NN O
sequence NN O
in IN O
the DT O
5 CD O
' POS O
regulatory JJ O
enhancer JJ O
region NN O
of IN O
the DT O
M NNP B-Gene
- : I-Gene
CSF NNP I-Gene
gene NN I-Gene
. . O

We PRP O
localized VBD O
the DT O
LAM NNP O
- : O
, , O
lipopolysaccharide NN O
( ( O
LPS NNP O
) ) O
- : O
, , O
and CC O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
- : B-Gene
inducible JJ I-Gene
promoter NN I-Gene
activity NN O
to TO O
a DT O
- : O
131 CD O
/ JJ O
+ NN O
15 CD O
( ( O
positions NNS O
- : O
131 CD O
to TO O
+ VB O
15 CD O
) ) O
DNA NNP O
fragment NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
gene NN I-Gene
by IN O
deletion NN O
analysis NN O
and CC O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
assay NN O
. . O

Site NNP O
- : O
directed VBD O
mutagenesis NN O
demonstrated VBD O
that IN O
the DT O
two CD O
NF NNP B-Gene
- : I-Gene
IL NNP I-Gene
- : I-Gene
6 CD I-Gene
motifs NNS I-Gene
could MD O
be VB O
independently RB O
activated VBN O
by IN O
LAM NNP O
, , O
LPS NNP O
, , O
or CC O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
and CC O
that IN O
they PRP O
acted VBD O
in IN O
an DT O
orientation NN O
- : O
independent JJ O
manner NN O
. . O

Additionally RB O
, , O
Nef NNP O
expressing VBG O
cells NNS O
were VBD O
transiently RB O
transfected VBN O
with IN O
a DT O
plasmid NN O
in IN O
which WDT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
DNA NNP I-Gene
recognition NN I-Gene
sequences NNS I-Gene
were VBD O
cloned VBN O
downstream NN O
of IN O
the DT O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
( ( O
CAT NNP B-Gene
) ) O
gene NN O
. . O

The DT O
in IN O
vitro JJ O
effect NN O
of IN O
17 CD O
beta NN O
- : O
estradiol NN O
on IN O
NK NNP O
activity NN O
was VBD O
studied VBN O
. . O

A DT O
serum NN B-Gene
response NN I-Gene
element NN I-Gene
and CC O
a DT O
binding NN B-Gene
site NN I-Gene
for IN I-Gene
NF NNP I-Gene
- : I-Gene
Y NN I-Gene
mediate VBP O
the DT O
serum NN O
response NN O
of IN O
the DT O
human JJ B-Gene
thrombospondin NN I-Gene
1 CD I-Gene
gene NN I-Gene
. . O

Two CD O
transcriptional JJ O
elements NNS O
in IN O
the DT O
TSP NNP B-Gene
1 CD I-Gene
promoter NN O
, , O
a DT O
distal JJ O
element NN O
at IN O
- : O
1280 CD O
and CC O
a DT O
proximal JJ O
element NN O
at IN O
- : O
65 CD O
, , O
were VBD O
required VBN O
for IN O
the DT O
response NN O
of IN O
the DT O
human JJ O
TSP NNP O
1 CD O
gene NN O
to TO O
serum VB O
. . O

Cell NNP O
- : O
type NN O
- : O
specific JJ O
transactivation NN O
of IN O
the DT O
parathyroid NN B-Gene
hormone NN I-Gene
- : I-Gene
related VBN I-Gene
protein JJ I-Gene
gene NN I-Gene
promoter NN I-Gene
by IN O
the DT O
human JJ B-Gene
T NNP I-Gene
- : I-Gene
cell NN I-Gene
leukemia NN I-Gene
virus NN I-Gene
type NN I-Gene
I PRP I-Gene
( ( I-Gene
HTLV NNP I-Gene
- : I-Gene
I PRP I-Gene
) ) I-Gene
tax NN I-Gene
and CC O
HTLV NNP B-Gene
- : I-Gene
II NNP I-Gene
tax NN I-Gene
proteins NNS I-Gene
. . O

The DT O
human JJ B-Gene
T NNP I-Gene
- : I-Gene
cell NN I-Gene
leukemia NN I-Gene
virus NN I-Gene
type NN I-Gene
I PRP I-Gene
( ( I-Gene
HTLV NNP I-Gene
- : I-Gene
I PRP I-Gene
) ) I-Gene
and CC I-Gene
HTLV NNP I-Gene
- : I-Gene
II NNP I-Gene
Tax NNP I-Gene
proteins NNS I-Gene
are VBP O
potent JJ O
transactivators NNS B-Gene
of IN O
viral JJ O
and CC O
cellular JJ O
gene NN O
expression NN O
. . O

A DT O
carboxy JJ B-Gene
terminal JJ I-Gene
Tax NNP I-Gene
deletion NN I-Gene
mutant NN I-Gene
was VBD O
deficient NN O
in IN O
transactivation NN O
of IN O
both CC O
the DT O
PTHrP NNP B-Gene
and CC I-Gene
IL2R NNP I-Gene
alpha VBP I-Gene
promoters NNS I-Gene
but CC O
not RB O
the DT O
HTLV NNP B-Gene
- : I-Gene
I PRP I-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
( ( O
LTR NNP B-Gene
) ) O
. . O

Here RB O
we PRP O
have VBP O
investigated VBN O
the DT O
transcriptional JJ O
regulation NN O
of IN O
the DT O
gamma NN B-Gene
chain NN I-Gene
gene NN O
by IN O
analyzing VBG O
the DT O
2 CD B-Gene
. . I-Gene
5 CD I-Gene
- : I-Gene
kilobase NN I-Gene
sequence NN I-Gene
upstream NN O
of IN O
the DT O
transcription NN O
start NN O
site NN O
. . O

This DT O
sequence NN O
contains VBZ O
a DT O
promoter NN B-Gene
specific NN O
to TO O
cells NNS O
of IN O
hematopoietic JJ O
lineage NN O
. . O

However RB O
, , O
the DT O
tissue NN O
specificity NN O
of IN O
this DT O
promoter NN B-Gene
is VBZ O
only RB O
partial JJ O
because IN O
it PRP O
is VBZ O
active JJ O
in IN O
all DT O
of IN O
the DT O
hematopoietic JJ O
cells NNS O
tested VBN O
here RB O
, , O
regardless RB O
of IN O
whether IN O
they PRP O
constitutively RB O
express VBP O
Fc NNP O
epsilon NN O
RI NNP O
- : O
gamma NN B-Gene
chain NN I-Gene
transcripts NNS O
. . O

Regression NNP O
analysis NN O
of IN O
our PRP$ O
data NNS O
revealed VBD O
slight JJ O
trends NNS O
for IN O
some DT O
of IN O
the DT O
biomarkers NNS O
( ( O
e NN O
. . O
g NN O
. . O
CD45R0 NNP O
+ NNP O
) ) O
. . O

HIV NNP O
- : O
1 CD O
can MD O
also RB O
establish VB O
a DT O
latent NN O
or CC O
persistent JJ O
infection NN O
in IN O
some DT O
T NNP O
cell NN O
lines NNS O
that WDT O
show VBP O
minimal JJ O
constitutive JJ O
virus NN O
expression NN O
. . O

On IN O
the DT O
basis NN O
of IN O
these DT O
observations NNS O
, , O
it PRP O
has VBZ O
been VBN O
proposed VBN O
that IN O
reactivation NN O
of IN O
latent NN O
HIV NNP O
- : O
1 CD O
harbored VBN O
in IN O
chronically RB O
infected VBN O
T NNP O
lymphocytes NNS O
, , O
monocytes NNS O
, , O
or CC O
macrophages NNS O
plays VBP O
an DT O
important JJ O
role NN O
in IN O
the DT O
pathogenesis NN O
of IN O
AIDS NNP O
. . O

ACH NNP O
- : O
2 CD O
can MD O
be VB O
converted VBN O
to TO O
productive JJ O
infection NN O
by IN O
stimulation NN O
of IN O
the DT O
cells NNS O
with IN O
12 CD O
- : O
O NNP O
- : O
tetradecanoylphorbol NN O
- : O
13 CD O
- : O
acetate NN O
( ( O
TPA NNP O
) ) O
, , O
mitogen NN O
or CC O
cytokines NNS B-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
, , O
or CC O
infection NN O
with IN O
HSV NNP O
. . O

Oxidoreductive JJ O
regulation NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

The DT O
promoter NN O
activity NN O
from IN O
HIV NNP B-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
was VBD O
greatly RB O
augmented VBN O
by IN O
co NN O
- : O
transfecting VBG O
the DT O
Trx NNP B-Gene
- : I-Gene
expressing VBG I-Gene
plasmid NN I-Gene
, , O
whose WP$ O
effect NN O
was VBD O
dependent VBN O
on IN O
the DT O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
- : O
binding NN O
sites NNS O
. . O

These DT O
results NNS O
may MD O
also RB O
provide VB O
a DT O
clue NN O
to TO O
understanding NN O
of IN O
the DT O
molecular JJ O
process NN O
of IN O
AIDS NNP O
pathogenesis NN O
and CC O
its PRP$ O
possible JJ O
biochemical JJ O
intervention NN O
. . O

Synergism NN O
between IN O
the DT O
CD3 NNP O
antigen NN O
- : O
and CC O
CD2 NNP O
antigen VBP O
- : O
derived VBN O
signals NNS O
. . O

We PRP O
have VBP O
demonstrated VBN O
earlier RBR O
that IN O
the DT O
crosslinkage NN O
of IN O
the DT O
CD3 NNP B-Gene
/ NNP I-Gene
TCR NNP I-Gene
complex NN I-Gene
with IN O
the DT O
CD2 NNP B-Gene
antigen NN I-Gene
results NNS O
in IN O
the DT O
proliferation NN O
of IN O
normal JJ O
human JJ O
T NNP O
cells NNS O
. . O

The DT O
human JJ O
erythroleukemia NN O
cell NN O
line NN O
K562 NNP O
can MD O
be VB O
induced VBN O
to TO O
differentiate VB O
along IN O
the DT O
erythroid NN O
and CC O
megakaryocytic JJ O
lineages NNS O
. . O

This DT O
was VBD O
accompanied VBN O
by IN O
downregulation NN O
of IN O
two CD O
transcription NN B-Gene
factors NNS I-Gene
normally RB O
expressed VBN O
in IN O
erythroid NN O
, , O
mast NN O
and CC O
megakaryocyte NN O
lineages NNS O
. . O

Northern NNP O
analysis NN O
demonstrated VBD O
coordinate JJ O
downregulation NN O
of IN O
alpha JJ B-Gene
globin NN I-Gene
and CC O
gamma NN B-Gene
globin NN I-Gene
in IN O
addition NN O
to TO O
the DT O
two CD O
lineage NN O
- : O
restricted VBN O
transcription NN B-Gene
factors NNS I-Gene
, , O
SCL NNP B-Gene
and CC O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Electron NNP O
microscopy NN O
revealed VBD O
a DT O
marked JJ O
increase NN O
in IN O
granules NNS O
resembling VBG O
those DT O
specific JJ O
for IN O
eosinophils NNS O
. . O

Surface NNP O
marker NN O
analysis NN O
showed VBD O
that IN O
HMBA NNP O
- : O
induced JJ O
cells NNS O
expressed VBD O
reduced JJ O
levels NNS O
of IN O
glycophorin NN B-Gene
A NNP I-Gene
, , O
CD5 NNP B-Gene
, , O
CD7 NNP B-Gene
and CC O
CD11b NNP B-Gene
. . O

Activation NN O
of IN O
primary JJ O
human JJ O
T NNP O
- : O
lymphocytes VBZ O
through IN O
CD2 NNP B-Gene
plus CC I-Gene
CD28 NNP I-Gene
adhesion NN I-Gene
molecules NNS I-Gene
induces NNS O
long RB O
- : O
term NN O
nuclear JJ O
expression NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

Long NNP O
- : O
lasting NN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
receptivity NN O
is VBZ O
associated VBN O
with IN O
high JJ O
- : O
level NN O
expression NN O
of IN O
the DT O
inducible JJ O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
receptor NN I-Gene
alpha NN I-Gene
chain NN I-Gene
( ( I-Gene
IL NNP I-Gene
- : I-Gene
2R CD I-Gene
alpha NN I-Gene
) ) I-Gene
gene NN I-Gene
that WDT O
is VBZ O
regulated VBN O
at IN O
both DT O
transcriptional JJ O
and CC O
posttranscriptional JJ O
levels NNS O
. . O

Resting VBG O
T NNP O
- : O
cell NN O
nuclear JJ O
extracts NNS O
contained VBN O
KBF1 NNP B-Gene
/ NNP I-Gene
p50 NN I-Gene
homodimer NN I-Gene
. . O

In IN O
addition NN O
, , O
an DT O
inhibitor NN O
of IN O
PKC NNP B-Gene
blocked VBD O
both DT O
activated VBN O
ras NN B-Gene
and CC O
phorbol NN O
ester NN O
stimulation NN O
, , O
suggesting VBG O
a DT O
role NN O
for IN O
ras JJ B-Gene
upstream NN O
of IN O
PKC NNP B-Gene
. . O

No DT O
such JJ O
increase NN O
was VBD O
observed VBN O
in IN O
control NN O
U937 NNP O
cells NNS O
. . O

We PRP O
show VBP O
that IN O
the DT O
ability NN O
to TO O
detect VB O
NF NNP B-Gene
- : I-Gene
ATp NN I-Gene
in IN O
a DT O
gel NN O
shift NN O
assay NN O
, , O
which WDT O
is VBZ O
essential JJ O
for IN O
purification NN O
and CC O
biochemical JJ O
studies NNS O
of IN O
this DT O
protein NN O
, , O
is VBZ O
strikingly RB O
dependent JJ O
on IN O
the DT O
precise JJ O
sequence NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
oligonucleotide RB O
used VBD O
as IN O
the DT O
labeled JJ O
probe NN O
. . O

One CD O
of IN O
these DT O
activities NNS O
was VBD O
found VBN O
to TO O
be VB O
a DT O
novel JJ O
, , O
less RBR O
abundant JJ O
, , O
Rb NNP O
- : O
E2F NN B-Gene
complex NN O
. . O

The DT O
most RBS O
prominent JJ O
E2F NNP B-Gene
activity NN O
in IN O
resting VBG O
T NNP O
cells NNS O
( ( O
termed VBN O
complex JJ O
X NN O
) ) O
was VBD O
abundant JJ O
in IN O
both DT O
G0 NNP O
and CC O
G1 NNP O
but CC O
disappeared VBD O
as IN O
cells NNS O
entered VBD O
S NNP O
phase NN O
, , O
suggesting VBG O
a DT O
possible JJ O
role NN O
in IN O
negatively RB O
regulating VBG O
E2F NNP B-Gene
function NN O
. . O

The DT O
present JJ O
studies NNS O
have VBP O
examined VBN O
the DT O
effects NNS O
of IN O
vincristine NN O
- : O
selected VBN O
, , O
multidrug JJ O
resistance NN O
on IN O
12 CD O
- : O
O NNP O
- : O
tetradecanoylphorbol NN O
- : O
13 CD O
- : O
acetate NN O
( ( O
TPA NNP O
) ) O
- : O
induced VBN O
HL NNP O
- : O
60 CD O
cell NN O
differentiation NN O
. . O

Since IN O
TPA NNP O
activates VBZ O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
( ( O
PKC NNP B-Gene
) ) O
, , O
we PRP O
examined VBD O
translocation NN O
of IN O
PKC NNP B-Gene
from IN O
the DT O
cytosol NN O
to TO O
the DT O
membrane NN O
fraction NN O
. . O

To TO O
determine VB O
whether IN O
the DT O
defect NN O
in IN O
the DT O
patient NN O
' POS O
s NN O
T NNP O
lymphocytes VBZ O
involved VBN O
a DT O
trans NNS B-Gene
- : I-Gene
acting VBG I-Gene
factor NN I-Gene
common JJ O
to TO O
the DT O
affected JJ O
lymphokine NN B-Gene
genes NNS I-Gene
, , O
we PRP O
examined VBD O
the DT O
ability NN O
of IN O
nuclear JJ B-Gene
factors NNS I-Gene
from IN O
the DT O
patient NN O
' POS O
s NN O
T NNP O
lymphocytes VBZ O
to TO O
bind VB O
response NN O
elements NNS O
present JJ O
in IN O
the DT O
regulatory JJ B-Gene
region NN I-Gene
of IN O
IL2 NNP B-Gene
. . O

In IN O
contrast NN O
, , O
the DT O
binding NN O
of IN O
the DT O
nuclear JJ B-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
cells NNS I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
AT NN I-Gene
) ) O
to TO O
its PRP$ O
response NN O
element NN O
in IN O
the DT O
IL2 NNP B-Gene
enhancer NN I-Gene
and CC O
to TO O
an DT O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
- : I-Gene
like IN I-Gene
response NN I-Gene
element NN I-Gene
present NN O
in IN O
the DT O
IL4 NNP B-Gene
enhancer NN I-Gene
was VBD O
abnormal JJ O
. . O

They PRP O
do VBP O
not RB O
directly RB O
intercept IN O
intracellular JJ O
signalling NN O
molecules NNS O
. . O

Instead RB O
, , O
they PRP O
form VBP O
tight JJ O
complexes NNS O
with IN O
two CD O
different JJ O
classes NNS O
of IN O
abundant JJ O
cytosolic JJ B-Gene
receptors NNS I-Gene
called VBD O
immunophilins NNS B-Gene
upon IN O
entering VBG O
the DT O
cell NN O
, , O
and CC O
consequently RB O
inhibit VB O
their PRP$ O
peptidyl NN B-Gene
prolyl NN I-Gene
cis SYM I-Gene
- : I-Gene
trans NNS I-Gene
isomerase JJ I-Gene
activities NNS O
. . O

p105 NN B-Gene
and CC O
p98 NN B-Gene
precursor NN B-Gene
proteins NNS I-Gene
play VBP O
an DT O
active JJ O
role NN O
in IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
- : O
mediated VBD O
signal JJ O
transduction NN O
. . O

Association NNP O
with IN O
the DT O
precursors NNS O
is VBZ O
sufficient JJ O
for IN O
cytoplasmic JJ O
retention NN O
of IN O
either DT O
p65 NN B-Gene
or CC O
c SYM B-Gene
- : I-Gene
Rel NN I-Gene
, , O
both DT O
of IN O
which WDT O
are VBP O
otherwise RB O
nuclear JJ O
. . O

The DT O
eukaryotic JJ O
transcription NN B-Gene
factor NN I-Gene
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
) ) O
participates VBZ O
in IN O
many JJ O
parts NNS O
of IN O
the DT O
genetic JJ O
program NN O
mediating NN O
T NNP O
lymphocyte NN O
activation NN O
and CC O
growth NN O
. . O

Transfection NN O
studies NNS O
indicate VBP O
that IN O
the DT O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
gene NN I-Gene
is VBZ O
specifically RB O
induced VBN O
by IN O
the DT O
65 CD B-Gene
- : I-Gene
kilodalton NN I-Gene
transactivating VBG I-Gene
subunit NN I-Gene
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

Together RB O
, , O
these DT O
results NNS O
show VBP O
that IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
controls VBZ O
the DT O
expression NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN O
by IN O
means NNS O
of IN O
an DT O
inducible JJ O
autoregulatory NN O
pathway NN O
. . O

A DT O
cell NN B-Gene
- : I-Gene
type NN I-Gene
- : I-Gene
independent JJ I-Gene
lipopolysaccharide NN I-Gene
( ( I-Gene
LPS NNP I-Gene
) ) I-Gene
- : I-Gene
responsive JJ I-Gene
enhancer NN I-Gene
element NN I-Gene
located VBN O
between IN O
- : B-Gene
3757 CD I-Gene
and CC I-Gene
- : I-Gene
2729 CD I-Gene
bp NN I-Gene
upstream NN I-Gene
from IN O
the DT O
transcription NN B-Gene
start NN I-Gene
site NN I-Gene
( ( O
cap JJ B-Gene
site NN I-Gene
) ) O
consisted VBD O
of IN O
at IN O
least JJS O
six CD O
discrete JJ O
subregions NNS O
which WDT O
were VBD O
essential JJ O
to TO O
the DT O
maximal JJ O
induction NN O
by IN O
LPS NNP O
in IN O
transfected JJ O
monocytes NNS O
. . O

The DT O
assessment NN O
of IN O
synovial JJ O
lymphocyte NN O
reactivity NN O
to TO O
adenovirus VB O
antigen JJ O
stimulation NN O
was VBD O
undertaken VBN O
in IN O
patients NNS O
with IN O
persistent JJ O
or CC O
recurrent JJ O
inflammatory JJ O
arthritis NN O
. . O

The DT O
3H CD O
- : O
thymidine NN O
uptake JJ O
procedure NN O
was VBD O
employed VBN O
, , O
incorporating VBG O
multiple JJ O
microbiological JJ B-Gene
antigens NNS I-Gene
. . O

Expression NN O
of IN O
PILOT NNP B-Gene
, , O
a DT O
putative JJ O
transcription NN B-Gene
factor NN I-Gene
, , O
requires VBZ O
two CD O
signals NNS O
and CC O
is VBZ O
cyclosporin VBG O
A NNP O
sensitive JJ O
in IN O
T NNP O
cells NNS O
. . O

Few JJ O
known VBN O
genes NNS B-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
members NNS O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
family NN I-Gene
, , O
interferon SYM B-Gene
- : I-Gene
gamma NN I-Gene
) ) O
are VBP O
induced VBN O
in IN O
T NNP O
cells NNS O
only RB O
through IN O
the DT O
combined JJ O
effect NN O
of IN O
phorbol NN O
myristic JJ O
acetate NN O
( ( O
PMA NNP O
) ) O
and CC O
a DT O
Ca NNP O
( ( O
2 CD O
+ NN O
) ) O
- : O
ionophore NN O
, , O
and CC O
expression NN O
of IN O
only RB O
these DT O
genes NNS B-Gene
can MD O
be VB O
fully RB O
suppressed VBN O
by IN O
Cyclosporin NNP O
A NNP O
( ( O
CyA NNP O
) ) O
. . O

The DT O
PILOT NNP B-Gene
protein NN O
has VBZ O
a DT O
calculated VBN O
M NNP O
( ( O
r NN O
) ) O
of IN O
42 CD O
. . O
6 CD O
kDa NN O
and CC O
contains NNS O
three CD O
zinc NN B-Gene
fingers NNS I-Gene
of IN O
the DT O
C2H2 NNP B-Gene
- : I-Gene
type NN I-Gene
at IN O
the DT O
carboxyl NN B-Gene
- : I-Gene
terminus NN I-Gene
which WDT O
are VBP O
highly RB O
homologous JJ O
to TO O
the DT O
zinc NN B-Gene
finger NN I-Gene
regions NNS I-Gene
of IN O
the DT O
transcription NN B-Gene
factors NNS I-Gene
EGR1 NNP B-Gene
, , O
EGR2 NNP B-Gene
, , O
and CC O
pAT RB B-Gene
133 CD I-Gene
. . O

In IN O
contrast NN O
to TO O
T NNP O
cells NNS O
, , O
in IN O
fibroblasts NNS O
PILOT NNP B-Gene
gene NN O
expression NN O
requires VBZ O
only RB O
one CD O
signal NN O
( ( O
PMA NNP O
) ) O
and CC O
is VBZ O
not RB O
affected VBN O
by IN O
CyA NNP O
. . O

NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
is VBZ O
a DT O
pleiotropic JJ B-Gene
regulator NN I-Gene
of IN O
a DT O
variety NN O
of IN O
genes NNS O
implicated VBN O
in IN O
the DT O
cellular JJ O
response NN O
to TO O
injury NN O
. . O

However RB O
, , O
the DT O
p65 NN B-Gene
antisense NN O
phosphorothioate NN O
oligodeoxynucleotide NN O
had VBD O
no DT O
significant JJ O
effect NN O
on IN O
the DT O
production NN O
of IN O
reactive JJ O
oxygen NN O
intermediates NNS O
or CC O
on IN O
phagocytosis NN O
by IN O
these DT O
cells NNS O
. . O

These DT O
findings NNS O
indicate VBP O
that IN O
antisense NN O
oligomers NNS O
to TO O
p65 VB B-Gene
can MD O
be VB O
used VBN O
to TO O
define VB O
the DT O
role NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
the DT O
activation NN O
pathways NNS O
of IN O
neutrophils NNS O
. . O

Overexpression NN O
of IN O
p65 NN B-Gene
increases NNS O
endogenous JJ O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
protein NN O
in IN O
both DT O
carcinoma NN O
and CC O
lymphoid JJ O
cells NNS O
by IN O
two CD O
mechanisms NNS O
: : O
protein NN O
stabilization NN O
and CC O
increased JJ O
transcription NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
mRNA NN I-Gene
. . O

The DT O
precise JJ O
molecular JJ O
abnormalities NNS O
that WDT O
cause VBP O
primary JJ O
cortisol NN O
resistance NN O
have VBP O
not RB O
been VBN O
completely RB O
described VBN O
. . O

At IN O
nucleotide RB O
2 CD O
, , O
317 CD O
we PRP O
identified VBD O
a DT O
homozygous JJ O
A NN O
for IN O
G NNP O
point NN O
mutation NN O
that WDT O
predicts VBZ O
an DT O
isoleucine NN O
( ( O
ATT NNP O
) ) O
for IN O
valine NN O
( ( O
GTT NNP O
) ) O
substitution NN O
at IN O
amino NN O
acid NN O
729 CD O
. . O

When WRB O
the DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
hGR NN I-Gene
and CC O
hGR NN B-Gene
- : I-Gene
Ile $ I-Gene
729 CD I-Gene
were VBD O
expressed VBN O
in IN O
COS NNP O
- : O
1 CD O
cells NNS O
and CC O
assayed VBN O
for IN O
[ JJ O
3H CD O
] SYM O
- : O
Dexamethasone NN O
binding NN O
, , O
the DT O
dissociation NN O
constants NNS O
were VBD O
0 CD O
. . O
799 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
68 CD O
and CC O
1 CD O
. . O
54 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
6 CD O
nM NN O
( ( O
mean JJ O
+ NNP O
/ NNP O
- : O
SEM NN O
) ) O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
, , O
respectively RB O
. . O

Transcriptional JJ O
regulation NN O
of IN O
interleukin JJ B-Gene
3 CD I-Gene
( ( O
IL3 NNP B-Gene
) ) O
in IN O
primary JJ O
human JJ O
T NNP O
lymphocytes NNS O
. . O

Dimerization NN O
of IN O
NF NNP B-Gene
- : I-Gene
KB2 NNP I-Gene
with IN O
RelA NNP B-Gene
( ( I-Gene
p65 NN I-Gene
) ) I-Gene
regulates VBZ O
DNA NNP O
binding NN O
, , O
transcriptional JJ O
activation NN O
, , O
and CC O
inhibition NN O
by IN O
an DT O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
- : I-Gene
alpha NN I-Gene
( ( O
MAD NNP B-Gene
- : I-Gene
3 CD I-Gene
) ) O
. . O

We PRP O
have VBP O
previously RB O
found VBN O
that IN O
NFKB2 NNP B-Gene
( ( I-Gene
p49 JJ I-Gene
/ NNP I-Gene
p52 NN I-Gene
) ) I-Gene
acts VBZ O
in IN O
concert NN O
with IN O
RelA NNP B-Gene
( ( I-Gene
p65 NN I-Gene
) ) I-Gene
to TO O
stimulate VB O
the DT O
HIV NNP B-Gene
enhancer NN I-Gene
in IN O
Jurkat NNP O
T NNP O
- : O
leukemia NN O
cells NNS O
. . O

Transcriptional JJ O
activation NN O
of IN O
the DT O
HIV NNP O
enhancer NN O
was VBD O
also RB O
subject JJ O
to TO O
regulation NN O
by IN O
recently RB O
cloned VBN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
- : I-Gene
alpha NN I-Gene
( ( O
MAD NNP B-Gene
- : I-Gene
3 CD I-Gene
) ) O
. . O

The DT O
c SYM B-Gene
- : I-Gene
rel NN I-Gene
protooncogene JJ I-Gene
product NN I-Gene
represses VBZ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
p65 NN B-Gene
- : O
mediated VBN O
transcriptional JJ O
activation NN O
of IN O
the DT O
long JJ O
terminal JJ O
repeat NN O
of IN O
type NN O
1 CD O
human JJ O
immunodeficiency NN O
virus NN O
. . O

This DT O
intracellular JJ O
signaling NN O
complex NN O
potently RB O
stimulates VBZ O
kappa NN O
B NNP O
- : O
directed VBN O
transcription NN O
from IN O
either CC O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
or CC O
the DT O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha JJ I-Gene
promoter NN I-Gene
via IN O
the DT O
strong JJ O
transactivation NN O
domain NN O
present JJ O
in IN O
p65 NN B-Gene
. . O

We PRP O
now RB O
demonstrate VBP O
that IN O
nuclear JJ O
expression NN O
of IN O
human JJ O
c SYM B-Gene
- : I-Gene
Rel NNP I-Gene
, , O
which WDT O
is VBZ O
induced VBN O
by IN O
either DT O
phorbol NN O
ester NN O
or CC O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha IN I-Gene
with IN O
delayed JJ O
kinetics NNS O
relative JJ O
to TO O
p65 VB B-Gene
, , O
markedly RB O
represses VBZ O
p65 JJ B-Gene
- : O
mediated VBN O
activation NN O
of IN O
these DT O
transcription NN O
units NNS O
. . O

The DT O
ras JJ O
- : O
transformed VBN O
lymphocytes VBZ O
displayed VBD O
a DT O
fully RB O
functional JJ O
IL NNP B-Gene
- : I-Gene
2r CD I-Gene
, , O
as IN O
assessed VBN O
by IN O
c SYM B-Gene
- : I-Gene
fos JJ I-Gene
induction NN O
following VBG O
treatment NN O
with IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
; : O
nevertheless RB O
, , O
they PRP O
were VBD O
not RB O
growth NN O
stimulated VBN O
by IN O
this DT O
lymphokine NN B-Gene
. . O

Somewhat RB O
unexpectedly RB O
, , O
the DT O
constitutive JJ O
p21ras NN B-Gene
activity NN O
did VBD O
not RB O
cause VB O
an DT O
increased JJ O
DNA NN O
binding NN O
of IN O
transcription NN B-Gene
factors NNS I-Gene
PEA1 NNP B-Gene
( ( O
AP1 NNP B-Gene
) ) O
, , O
PEA3 NNP B-Gene
, , O
Oct NNP B-Gene
- : I-Gene
2 CD I-Gene
or CC O
NF NNP B-Gene
- : I-Gene
kB NN I-Gene

Competition NN O
with IN O
an DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
motif NN I-Gene
or CC O
with IN O
anti JJ B-Gene
- : I-Gene
Jun NN I-Gene
and CC O
anti JJ B-Gene
- : I-Gene
Fos NNP I-Gene
antibodies NNS I-Gene
abolished VBD O
binding VBG O
to TO O
the DT O
NFAT NNP B-Gene
motif NN I-Gene
in IN O
both DT O
T NNP O
and CC O
B NNP O
cells NNS O
, , O
indicating VBG O
that IN O
Jun NNP O
and CC O
Fos NNP O
are VBP O
critical JJ O
for IN O
NFAT NNP B-Gene
complex JJ I-Gene
formation NN O
in IN O
both DT O
cell NN O
types NNS O
. . O

However RB O
, , O
when WRB O
combined VBN O
with IN O
unstimulated JJ O
B NNP O
or CC O
T NNP O
cell NN O
extracts NNS O
, , O
full JJ O
- : O
length NN O
, , O
but CC O
not RB O
truncated VBN O
, , O
Jun NNP O
/ NNP O
Fos NNP O
heterodimers NNS O
were VBD O
able JJ O
to TO O
form VB O
an DT O
NFAT NNP B-Gene
complex NN I-Gene
, , O
indicating VBG O
the DT O
presence NN O
of IN O
a DT O
constitutively RB B-Gene
expressed VBN I-Gene
nuclear JJ I-Gene
factor NN I-Gene
( ( O
s NN O
) ) O
in IN O
B NNP O
and CC O
T NNP O
cells NNS O
necessary JJ O
for IN O
the DT O
formation NN O
of IN O
the DT O
NFAT NNP B-Gene
complex NN I-Gene
in IN O
both DT O
cell NN O
types NNS O
. . O

Differential JJ O
autoregulation NN O
of IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
expression NN O
in IN O
human JJ O
T NNP O
- : O
and CC O
B NNP O
- : O
cell NN O
lines NNS O
. . O

In IN O
contrast NN O
to TO O
the DT O
decrease NN O
in IN O
GR NNP B-Gene
mRNA NN I-Gene
seen VBN O
in IN O
IM NNP O
- : O
9 CD O
cells NNS O
after IN O
treatment NN O
with IN O
1 CD O
microM NNS O
dexamethasone NN O
for IN O
16 CD O
- : O
18 CD O
h NN O
, , O
treatment NN O
of IN O
6TG1 CD O
. . O
1 CD O
cells NNS O
resulted VBD O
in IN O
an DT O
8 CD O
- : O
fold JJ O
increase NN O
in IN O
GR NNP B-Gene
mRNA NN I-Gene
, , O
as IN O
determined VBN O
by IN O
Northern NNP O
blot NN O
and CC O
RNase NNP B-Gene
protection NN O
analysis NN O
, , O
with IN O
a DT O
corresponding VBG O
3 CD O
- : O
to TO O
4 CD O
- : O
fold JJ O
increase NN O
in IN O
GR NNP B-Gene
protein NN I-Gene
. . O

Induction NN O
of IN O
CD8 NNP B-Gene
antigen NN I-Gene
and CC O
suppressor NN O
activity NN O
by IN O
glucocorticoids NNS O
in IN O
a DT O
CEM NNP O
human JJ O
leukemic NN O
cell NN O
clone NN O
. . O

It PRP O
has VBZ O
been VBN O
thought VBN O
that IN O
the DT O
virally RB O
induced JJ O
inhibition NN O
of IN O
IFN NNP B-Gene
- : O
MCP NNP O
is VBZ O
secondary JJ O
to TO O
the DT O
shutdown NN O
of IN O
cellular JJ O
macromolecular JJ O
synthesis NN O
that WDT O
accompanies VBZ O
cytopathic JJ O
virus NN O
infections NNS O
. . O

IFN NNP B-Gene
- : O
MCP NNP O
was VBD O
not RB O
inhibited VBN O
by IN O
infection NN O
with IN O
dl343 NN O
, , O
despite IN O
the DT O
production NN O
of IN O
large JJ O
amounts NNS O
of IN O
both DT O
early JJ O
( ( O
E1B NNP B-Gene
, , O
p55 NN B-Gene
) ) O
and CC O
late JJ O
( ( O
hexon NN B-Gene
) ) O
Ad NNP B-Gene
proteins NNS I-Gene
. . O

E1A NNP B-Gene
' POS O
s JJ O
inhibition NN O
of IN O
IFN NNP B-Gene
- : O
MCP NN O
has VBZ O
the DT O
net JJ O
effect NN O
of IN O
promoting VBG O
the DT O
selective JJ O
NK NNP O
cell NN O
- : O
mediated JJ O
clearance NN O
of IN O
Ad NNP O
- : O
infected VBD O
or CC O
Ad NNP O
- : O
transformed VBD O
human JJ O
cells NNS O
. . O

Nuclear JJ B-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
cells NNS I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
AT NN I-Gene
) ) O
is VBZ O
a DT O
transcriptional JJ B-Gene
activator NN I-Gene
involved VBN O
in IN O
the DT O
induction NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN O
expression NN O
. . O

We PRP O
find VBP O
that IN O
a DT O
short JJ O
enhancer NN O
element NN O
containing VBG O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
binding VBG I-Gene
site NN I-Gene
from IN O
the DT O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
receptor NN I-Gene
alpha SYM I-Gene
- : I-Gene
chain NN I-Gene
gene NN I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha NN I-Gene
) ) O
is VBZ O
preferentially RB O
activated VBN O
in IN O
T NNP O
cells NNS O
. . O

Serum NNP B-Gene
response NN I-Gene
factor NN I-Gene
( ( O
SRF NNP B-Gene
) ) O
binds VBZ O
to TO O
a DT O
site NN O
adjacent JJ O
to TO O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
site NN I-Gene
in IN O
the DT O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
enhancer NN I-Gene
, , O
and CC O
both DT O
sites NNS O
together RB O
have VBP O
strong JJ O
transcriptional JJ O
activity NN O
specifically RB O
in IN O
T NNP O
cells NNS O
. . O

Mutual JJ O
regulation NN O
of IN O
the DT O
transcriptional JJ B-Gene
activator NN I-Gene
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
its PRP$ O
inhibitor NN O
, , O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
- : I-Gene
alpha NN I-Gene
. . O

In IN O
previous JJ O
transfection NN O
analyses NNS O
using VBG O
the DT O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
reporter NN B-Gene
gene NN I-Gene
system NN O
, , O
we PRP O
determined VBD O
that IN O
linker NN O
substitution NN O
( ( O
LS NNP O
) ) O
mutations NNS O
between IN O
- : B-Gene
201 CD I-Gene
and CC I-Gene
- : I-Gene
130 CD I-Gene
( ( O
relative JJ O
to TO O
the DT O
transcription NN O
start VB O
site NN O
) ) O
of IN O
the DT O
human JJ O
immunodeficiency NN O
virus NN O
type VBD O
1 CD O
long JJ B-Gene
terminal JJ I-Gene
repeat NN I-Gene
( ( O
LTR NNP B-Gene
) ) O
caused VBD O
moderate JJ O
decreases NNS O
in IN O
LTR NNP B-Gene
transcriptional JJ O
activity NN O
in IN O
a DT O
T NNP O
- : O
cell NN O
line NN O
( ( O
S NNP O
. . O
L NNP O
. . O
Zeichner NNP O
, , O
J NNP O
. . O
Y NNP O
. . O
H NNP O
. . O
Kim NNP O
, , O
and CC O
J NNP O
. . O
C NNP O
. . O
Alwine NNP O
, , O
J NNP O
. . O
Virol NNP O
. . O
65 CD O
: : O
2436 CD O
- : O
2444 CD O
, , O
1991 CD O
) ) O
. . O

If IN O
GATA NNP O
- : O
1 CD O
- : O
red JJ O
cells NNS O
were VBD O
available JJ O
, , O
the DT O
analyses NNS O
would MD O
involve VB O
the DT O
actual JJ O
transcription NN O
of IN O
or CC O
chromatin VB O
structure NN O
surrounding VBG O
the DT O
globin NN B-Gene
genes NNS I-Gene
. . O

G0S24 NNP B-Gene
is VBZ O
a DT O
member NN O
of IN O
a DT O
set NN O
of IN O
genes NNS O
( ( O
putative JJ B-Gene
G0 NNP I-Gene
/ NNP I-Gene
G1 NNP I-Gene
switch VB I-Gene
regulatory JJ I-Gene
genes NNS I-Gene
) ) O
that WDT O
are VBP O
expressed VBN O
transiently RB O
within IN O
1 CD O
- : O
2 CD O
hr NN O
of IN O
the DT O
addition NN O
of IN O
lectin NN B-Gene
or CC O
cycloheximide NN O
to TO O
human JJ O
blood NN O
mononuclear NN O
cells NNS O
. . O

Comparison NNP O
of IN O
the DT O
derived JJ O
protein NN O
sequence NN O
with IN O
those DT O
of IN O
rodent JJ O
homologs NNS O
allows VBZ O
classification NN O
into IN O
three CD O
groups NNS O
. . O

Groups NNP O
1 CD O
and CC O
2 CD O
have VBP O
a DT O
serine JJ B-Gene
- : I-Gene
rich JJ I-Gene
region NN I-Gene
and CC O
an DT O
` `` O
` `` O
arginine VB B-Gene
element NN I-Gene
` `` O
` `` O
( ( O
RRLPIF NNP B-Gene
) ) O
at IN O
the DT O
carboxyl NN B-Gene
terminus NN I-Gene
. . O

All DT O
groups NNS O
contain VBP O
cysteine JJ B-Gene
- : I-Gene
and CC I-Gene
histidine VB I-Gene
- : I-Gene
rich JJ I-Gene
putative JJ I-Gene
zinc NN I-Gene
finger NN I-Gene
domains NNS I-Gene
and CC O
a DT O
serine JJ B-Gene
- : I-Gene
phenylalanine NN I-Gene
` `` I-Gene
` `` I-Gene
SFS NN I-Gene
' '' I-Gene
' POS I-Gene
domain NN I-Gene
similar JJ O
to TO O
part NN O
of IN O
the DT O
large JJ O
subunit NN O
of IN O
eukaryotic JJ B-Gene
RNA NNP I-Gene
polymerase NN I-Gene
II NNP I-Gene
. . O

Comparison NNP O
of IN O
group NN O
1 CD O
human NN B-Gene
and CC I-Gene
mouse NN I-Gene
genomic JJ I-Gene
sequences NNS I-Gene
shows VBZ O
high JJ O
conservation NN O
in IN O
the DT O
5 CD B-Gene
' POS I-Gene
flank NN I-Gene
and CC O
exons NNS B-Gene
. . O

A DT O
CpG NNP O
island NN O
suggests VBZ O
expression NN O
in IN O
the DT O
germ JJ O
line NN O
. . O

A DT O
microB NN B-Gene
binding VBG I-Gene
protein NN I-Gene
is VBZ O
encoded VBN O
by IN O
the DT O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
/ JJ I-Gene
Spi NNP I-Gene
- : I-Gene
1 CD I-Gene
proto NN I-Gene
- : I-Gene
oncogene NN I-Gene
. . O

One CD O
enigmatic JJ O
aspect NN O
of IN O
GATA NNP B-Gene
factor NN I-Gene
expression NN O
is VBZ O
that IN O
several JJ O
GATA NNP B-Gene
proteins NNS I-Gene
, , O
which WDT O
ostensibly RB O
share NN O
the DT O
same JJ O
DNA NNP B-Gene
- : I-Gene
binding NN I-Gene
site NN I-Gene
specificity NN O
, , O
are VBP O
coexpressed VBN O
in IN O
erythroid JJ O
cells NNS O
. . O

Thus RB O
, , O
the DT O
GATA NNP B-Gene
- : I-Gene
2 CD I-Gene
transcription NN I-Gene
factor NN I-Gene
appears VBZ O
to TO O
play VB O
a DT O
role NN O
in IN O
regulating VBG O
the DT O
self NN O
- : O
renewal NN O
capacity NN O
of IN O
early JJ O
erythroid NN O
progenitor NN O
cells NNS O
. . O

Endothelial JJ O
cells NNS O
( ( O
EC NNP O
) ) O
act NN O
as IN O
APC NNP O
for IN O
resting VBG O
PBL NNP O
in IN O
vitro NN O
, , O
and CC O
may MD O
have VB O
important JJ O
roles NNS O
in IN O
vivo NN O
in IN O
the DT O
pathogenesis NN O
of IN O
allograft NN O
rejection NN O
and CC O
delayed JJ O
hypersensitivity NN O
. . O

PBL NNP O
constitutively RB O
express VBP O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
transcripts NNS I-Gene
, , O
and CC O
the DT O
level NN O
of IN O
c JJ B-Gene
- : I-Gene
jun NN I-Gene
mRNA NN I-Gene
is VBZ O
not RB O
altered VBN O
by IN O
PHA NNP B-Gene
activation NN O
in IN O
the DT O
absence NN O
or CC O
presence NN O
of IN O
EC NNP O
. . O

In IN O
contrast NN O
, , O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
mRNA NN I-Gene
is VBZ O
absent JJ O
from IN O
resting VBG O
T NNP O
cells NNS O
and CC O
is VBZ O
induced VBN O
on IN O
PHA NNP B-Gene
activation NN O
. . O

Site NNP O
- : O
directed VBD O
mutagenesis NN O
demonstrated VBD O
that IN O
this DT O
HS NNP B-Gene
- : I-Gene
40 CD I-Gene
enhancer SYM O
- : O
zeta NN B-Gene
2 CD I-Gene
globin NN I-Gene
promoter NN I-Gene
interaction NN O
is VBZ O
mediated VBN O
by IN O
the DT O
two CD O
GATA NNP O
- : O
1 CD O
factor NN O
binding VBG O
motifs NNS O
located VBN O
at IN O
- : O
230 CD O
and CC O
- : O
104 CD O
, , O
respectively RB O
. . O

Site NNP O
- : O
directed VBD O
mutagenesis NN O
further RB O
demonstrated VBD O
that IN O
the DT O
enhancer NN B-Gene
function NN O
of IN O
one CD O
of IN O
the DT O
two CD O
NF NNP O
- : O
E2 NNP O
/ NNP O
AP1 NNP O
motifs NN O
of IN O
HS NNP B-Gene
- : I-Gene
40 CD I-Gene
is VBZ O
mediated VBN O
through IN O
its PRP$ O
binding NN O
to TO O
NF NNP B-Gene
- : I-Gene
E2 NN I-Gene
but CC O
not RB O
AP1 NNP B-Gene
transcription NN I-Gene
factor NN I-Gene
. . O

We PRP O
report VBP O
the DT O
characterization NN O
of IN O
the DT O
cis NN B-Gene
- : I-Gene
and CC I-Gene
trans VBZ I-Gene
- : I-Gene
acting VBG I-Gene
elements NNS I-Gene
involved VBN O
in IN O
the DT O
tissue NN O
- : O
specific JJ O
activity NN O
of IN O
the DT O
L NNP B-Gene
gene NN I-Gene
erythroid JJ I-Gene
promoter NN I-Gene
. . O

Within IN O
this DT O
region NN O
, , O
we PRP O
define VBP O
a DT O
minimal JJ B-Gene
promoter NN I-Gene
( ( O
- : O
62 CD O
to TO O
+ VB O
54 CD O
) ) O
that WDT O
displays VBZ O
erythroid SYM O
- : O
specific JJ O
activity NN O
and CC O
contains VBZ O
two CD O
DNA NN O
binding VBG O
sites NNS O
. . O

Mutations NNS O
and CC O
deletions NNS O
of IN O
both DT O
sites NNS O
indicate VBP O
that IN O
only RB O
the DT O
association NN O
of IN O
CCACC NNP B-Gene
/ NNP I-Gene
Sp1 NNP I-Gene
and CC O
GATA NNP B-Gene
binding NN I-Gene
sites NNS I-Gene
can MD O
drive VB O
efficient JJ O
and CC O
tissue NN O
- : O
specific JJ O
expression NN O
of IN O
this DT O
R NNP B-Gene
- : I-Gene
PK NNP I-Gene
minimal JJ B-Gene
promoter NN I-Gene
. . O

Protease NNP O
treatment NN O
of IN O
nuclear JJ O
extracts NNS O
distinguishes NNS O
between IN O
class NN B-Gene
II NNP I-Gene
MHC NNP I-Gene
X1 NNP I-Gene
box NN I-Gene
DNA NNP I-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
in IN O
wild JJ O
- : O
type NN O
and CC O
class NN O
II NNP O
- : O
deficient NN O
B NNP O
cells NNS O
. . O

The DT O
X NNP B-Gene
box NN I-Gene
region NN I-Gene
is VBZ O
critical JJ O
for IN O
directing VBG O
the DT O
expression NN O
of IN O
class NN B-Gene
II NNP I-Gene
major JJ I-Gene
histocompatibility NN I-Gene
complex JJ I-Gene
genes NNS I-Gene
in IN O
B NNP O
lymphocytes NNS O
. . O

To TO O
further RBR O
evaluate VB O
the DT O
role NN O
of IN O
X NNP B-Gene
box NN I-Gene
DNA NNP I-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
in IN O
class NN B-Gene
II NNP I-Gene
gene NN I-Gene
expression NN O
, , O
the DT O
role NN O
of IN O
the DT O
X NNP B-Gene
box NN I-Gene
region NN I-Gene
was VBD O
examined VBN O
in IN O
both DT O
class NN O
II NNP O
- : O
positive JJ O
and CC O
- : O
negative JJ O
lymphoid JJ O
cells NNS O
. . O

To TO O
determine VB O
whether IN O
these DT O
different JJ O
X1 NN O
box NN O
activities NNS O
represented VBD O
distinct JJ O
DNA NNP B-Gene
binding NN I-Gene
proteins NNS I-Gene
or CC O
multimeric JJ O
forms NNS O
of IN O
the DT O
same JJ O
factor NN O
( ( O
s NN O
) ) O
, , O
protease JJ B-Gene
treatment NN O
of IN O
the DT O
crude NN O
nuclear JJ O
extracts NNS O
followed VBN O
by IN O
DNA NNP O
- : O
binding NN O
assays NNS O
were VBD O
carried VBN O
out IN O
and CC O
demonstrated VBD O
that IN O
B NNP O
cell NN O
extracts VBZ O
contain VBP O
at IN O
least JJS O
two CD O
X1 SYM B-Gene
- : I-Gene
specific JJ I-Gene
factors NNS I-Gene
. . O

A DT O
similar JJ O
comparison NN O
with IN O
protease NN O
- : O
treated JJ O
extracts NNS O
prepared VBN O
from IN O
Jurkat NNP O
cells NNS O
demonstrated VBD O
the DT O
presence NN O
of IN O
the DT O
band NN O
1pk CD O
activity NN O
despite IN O
an DT O
absence NN O
of IN O
the DT O
native JJ O
RFX NNP B-Gene
activity NN O
. . O

In IN O
contrast NN O
, , O
protease NN O
treatment NN O
and CC O
analysis NN O
of IN O
SJO NNP O
extracts NNS O
showed VBD O
no DT O
detectable JJ O
levels NNS O
of IN O
the DT O
band NN O
1pk CD O
activity NN O
. . O

Human NNP O
immunodeficiency NN O
viruses NNS O
containing VBG O
heterologous JJ B-Gene
enhancer NN I-Gene
/ NN I-Gene
promoters NNS I-Gene
are VBP O
replication JJ O
competent NN O
and CC O
exhibit NN O
different JJ O
lymphocyte NN O
tropisms NN O
. . O

Viruses NNS O
containing VBG O
the DT O
human JJ B-Gene
cytomegalovirus NN I-Gene
immediate JJ I-Gene
- : I-Gene
early JJ I-Gene
enhancer NN I-Gene
exhibited VBD O
infectious JJ O
kinetics NNS O
similar JJ O
to TO O
that DT O
of IN O
wild JJ O
- : O
type NN O
HIV NNP O
in IN O
activated JJ O
human JJ O
peripheral JJ O
blood NN O
lymphocytes NNS O
and CC O
AA2 NNP O
cells NNS O
but CC O
replicated VBD O
less RBR O
efficiently RB O
in IN O
H9 NNP O
and CC O
CEM NNP O
cells NNS O
. . O

Our PRP$ O
report NN O
expands VBZ O
current JJ O
knowledge NN O
of IN O
the DT O
radiation NN O
- : O
induced JJ O
signaling VBG O
cascade NN O
by IN O
clarifying VBG O
the DT O
chronological JJ O
sequence NN O
of IN O
biochemical JJ O
events NNS O
that WDT O
follow VBP O
irradiation NN O
. . O

To TO O
test VB O
this DT O
hypothesis NN O
, , O
a DT O
more RBR O
sensitive JJ O
and CC O
specific JJ O
polymerase NN O
chain NN O
reaction NN O
( ( O
PCR NNP O
) ) O
assay NN O
was VBD O
developed VBN O
to TO O
detect VB O
adenovirus JJ B-Gene
DNA NNP I-Gene
. . O

The DT O
E1A NNP B-Gene
and CC I-Gene
hexon JJ I-Gene
primers NNS I-Gene
amplified VBD O
DNA NN O
from IN O
representative JJ O
adenoviral JJ O
serotypes NNS O
in IN O
all DT O
six CD O
adenoviral JJ O
groups NNS O
( ( O
A DT O
- : O
F NN O
) ) O
. . O

OBJECTIVE NN O
: : O
To TO O
examine VB O
the DT O
inter NN O
- : O
relationship NN O
between IN O
HIV NNP O
- : O
1 CD O
infection NN O
and CC O
the DT O
cell NN O
surface NN O
receptors NNS O
for IN O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
( ( I-Gene
TNF NNP I-Gene
) ) I-Gene
- : I-Gene
alpha NN I-Gene
, , O
an DT O
immunoregulatory JJ O
cytokine NN O
that WDT O
can MD O
enhance VB O
HIV NNP O
- : O
1 CD O
replication NN O
. . O

HIV NNP O
- : O
1 CD O
activation NN O
and CC O
expression NN O
was VBD O
quantitated VBN O
by IN O
reverse JJ B-Gene
transcriptase NN I-Gene
assay NN O
. . O

RESULTS NN O
: : O
In IN O
the DT O
OM NNP O
- : O
10 CD O
. . O
1 CD O
promyelocytic JJ O
model NN O
of IN O
chronic JJ O
infection NN O
, , O
TNF NNP O
- : O
alpha NN O
- : O
induced JJ O
HIV NNP O
- : O
1 CD O
expression NN O
also RB O
resulted VBD O
in IN O
a DT O
substantial JJ O
increase NN O
in IN O
75 CD B-Gene
kd NNS I-Gene
TNF NNP I-Gene
receptor NN I-Gene
( ( O
TR75 NNP B-Gene
) ) O
expression NN O
although IN O
55 CD B-Gene
kD NNS I-Gene
TNF NNP I-Gene
receptor NN I-Gene
( ( O
TR55 NNP B-Gene
) ) O
levels NNS O
were VBD O
not RB O
dramatically RB O
altered VBN O
. . O

Enhanced NNP O
TR75 NNP B-Gene
expression NN O
on IN O
OM NNP O
- : O
10 CD O
. . O
1 CD O
cells NNS O
followed VBD O
the DT O
same JJ O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
- : O
dose JJ O
dependency NN O
as IN O
that DT O
observed VBD O
for IN O
HIV NNP O
- : O
1 CD O
production NN O
. . O

Although IN O
TR55 NNP B-Gene
expression NN O
was VBD O
unaltered JJ O
during IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
- : O
induced JJ O
HIV NNP O
activation NN O
, , O
this DT O
receptor NN O
was VBD O
still RB O
involved VBN O
in IN O
the DT O
viral JJ O
activation NN O
process NN O
. . O

Surprisingly RB O
, , O
this DT O
was VBD O
the DT O
case NN O
even RB O
when WRB O
an DT O
antagonistic JJ B-Gene
anti NN I-Gene
- : I-Gene
TR55 NNP I-Gene
antibody NN I-Gene
was VBD O
used VBN O
. . O

Anti NNP B-Gene
- : I-Gene
TR55 NNP I-Gene
antibody NN I-Gene
cross NN O
- : O
linking NN O
in IN O
chronically RB O
infected VBN O
U1 NNP O
promonocytic JJ O
cultures NNS O
could MD O
only RB O
partially RB O
substitute JJ O
for IN O
TNF NNP O
- : O
alpha NN O
- : O
induced JJ O
HIV NNP O
- : O
1 CD O
expression NN O
. . O

We PRP O
have VBP O
used VBN O
in IN O
situ JJ O
hybridization NN O
to TO O
define VB O
these DT O
rearrangements NNS O
at IN O
the DT O
molecular JJ O
level NN O
. . O

A DT O
reporter NN B-Gene
gene NN I-Gene
under IN O
the DT O
control NN O
of IN O
a DT O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
antigen NN I-Gene
receptor NN I-Gene
element NN I-Gene
was VBD O
activated VBN O
in IN O
Jurkat NNP O
cells NNS O
by IN O
antigen NN O
receptor NN O
triggering VBG O
or CC O
by IN O
a DT O
combination NN O
of IN O
phorbol NN O
myristate NN O
acetate NN O
, , O
which WDT O
activates VBZ O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
, , O
and CC O
a DT O
calcium NN O
ionophore NN O
. . O

Both DT O
these DT O
signals NNS O
were VBD O
necessary JJ O
for IN O
expression NN O
of IN O
the DT O
reporter NN B-Gene
gene NN I-Gene
. . O

When WRB O
co SYM O
- : O
transfected VBN O
with IN O
a DT O
construct NN O
capable JJ O
of IN O
overexpressing VBG O
the DT O
tyrosine NN B-Gene
kinase NN I-Gene
p59fyn NN B-Gene
, , O
the DT O
reporter NN B-Gene
gene NN I-Gene
was VBD O
activated VBN O
by IN O
PMA NNP B-Gene
alone RB O
. . O

Dependence NN O
for IN O
the DT O
proliferative JJ O
response NN O
to TO O
erythropoietin VB B-Gene
on IN O
an DT O
established VBN O
erythroid JJ O
differentiation NN O
program NN O
in IN O
a DT O
human JJ O
hematopoietic JJ O
cell NN O
line NN O
, , O
UT NNP O
- : O
7 CD O
. . O

UT NNP B-Gene
- : I-Gene
7 CD I-Gene
Epo NNP I-Gene
and CC O
UT NNP O
- : O
7 CD O
expressed VBD O
similar JJ O
levels NNS O
of IN O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
and CC O
binding NN O
activity NN O
. . O

This DT O
difference NN O
in IN O
the DT O
number NN O
of IN O
binding VBG O
sites NNS O
could MD O
be VB O
due JJ O
to TO O
differences NNS O
in IN O
cell NN O
surface NN O
( ( O
UT NNP O
- : O
7 CD O
cells NNS O
are VBP O
20 CD O
% NN O
smaller JJR O
than IN O
the DT O
parental JJ O
UT NNP O
- : O
7 CD O
cells NNS O
) ) O
or CC O
in IN O
receptor NN O
turnover NN O
. . O

By IN O
Northern NNP O
analysis NN O
, , O
UT NNP O
- : O
7 CD O
cells NNS O
expressed VBN O
detectable JJ O
levels NNS O
of IN O
beta NN B-Gene
- : I-Gene
and CC I-Gene
gamma VB I-Gene
- : I-Gene
globin NN I-Gene
but CC O
not RB O
alpha JJ B-Gene
- : I-Gene
globin NN I-Gene
. . O

Globin NNP B-Gene
chains NNS I-Gene
( ( O
alpha NN B-Gene
, , O
beta NN B-Gene
and CC O
gamma NN B-Gene
) ) O
were VBD O
clearly RB O
detectable JJ O
by IN O
affinity NN O
chromatography NN O
in IN O
UT NNP B-Gene
- : I-Gene
7 CD I-Gene
Epo NNP I-Gene
but CC O
not RB O
in IN O
UT NNP O
- : O
7 CD O
cells NNS O
. . O

The DT O
myeloid NN B-Gene
integrin NN I-Gene
CD11b NNP I-Gene
is VBZ O
expressed VBN O
selectively RB O
on IN O
the DT O
surface NN O
of IN O
mature NN O
macrophages NNS O
, , O
monocytes NNS O
, , O
neutrophils NNS O
, , O
and CC O
natural JJ O
killer NN O
cells NNS O
. . O

Recent JJ O
isolation NN O
of IN O
the DT O
CD11b NNP B-Gene
promoter NN I-Gene
shows VBZ O
that IN O
92 CD O
base NN O
pairs NN O
( ( O
bp NN O
) ) O
of IN O
5 CD B-Gene
' POS I-Gene
- : I-Gene
flanking NN I-Gene
DNA NN I-Gene
are VBP O
sufficient JJ O
to TO O
direct VB O
myeloid JJ O
- : O
specific JJ O
expression NN O
of IN O
a DT O
reporter NN B-Gene
gene NN I-Gene
. . O

Transcription NNP O
factor NN O
jun NN O
- : O
B NN O
is VBZ O
target NN O
of IN O
autoreactive JJ O
T NNP O
- : O
cells NNS O
in IN O
IDDM NNP O
. . O

Target NN O
antigens NNS O
defined VBN O
by IN O
autoantibodies NNS B-Gene
in IN O
IDDM NNP O
include VBP O
insulin NN O
, , O
a DT O
putative JJ O
glycolipid NN O
that WDT O
reacts VBZ O
with IN O
islet NN B-Gene
cell NN I-Gene
antibodies NNS I-Gene
, , O
and CC O
a DT O
64 CD B-Gene
, , I-Gene
0 CD I-Gene
- : I-Gene
M NN I-Gene
( ( I-Gene
r NN I-Gene
) ) I-Gene
protein NN I-Gene
recently RB O
identified VBN O
as IN O
glutamic JJ B-Gene
acid NN I-Gene
decarboxylase NN I-Gene
. . O

Okadaic NNP O
acid NN O
increased VBD O
the DT O
synthesis NN O
of IN O
the DT O
interleukin JJ B-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
precursor NN O
and CC O
mature NN O
forms NNS O
and CC O
their PRP$ O
secretion NN O
. . O

Expression NN O
of IN O
tal JJ B-Gene
- : I-Gene
1 CD I-Gene
and CC O
GATA NNP B-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
during IN O
human JJ O
hematopoiesis NN O
. . O

Because IN O
the DT O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
is VBZ O
known VBN O
to TO O
transactivate VB O
several JJ O
genes NNS O
specific JJ O
for IN O
the DT O
erythroid NN O
, , O
megakaryocytic JJ O
, , O
and CC O
mastocytic JJ O
/ NNP O
basophilic NN O
lineages NNS O
, , O
we PRP O
studied VBD O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
in IN O
these DT O
purified VBN O
hematopoietic NN O
cells NNS O
. . O

The DT O
lytic JJ O
transition NN O
of IN O
Epstein NNP O
- : O
Barr NNP O
virus NN O
is VBZ O
imitated VBN O
by IN O
recombinant NN O
B NNP O
- : O
cells NNS O
. . O

We PRP O
developed VBD O
eukaryotic JJ O
vectors NNS O
suitable JJ O
to TO O
imitate VB O
the DT O
processes NNS O
involved VBN O
in IN O
lytic JJ O
transition NN O
in IN O
cell JJ O
culture NN O
systems NNS O
. . O

R7 NNP O
- : O
57 CD O
reporter NN O
cells NNS O
, , O
on IN O
the DT O
other JJ O
hand NN O
, , O
signaled VBD O
induced JJ O
activity NN O
of IN O
the DT O
lytic JJ B-Gene
origin NN I-Gene
of IN I-Gene
EBV NNP I-Gene
replication NN I-Gene
( ( O
ori JJ B-Gene
Lyt NNP I-Gene
) ) O
. . O

Different NNP O
modes NNS O
, , O
like IN O
chemical NN O
induction NN O
, , O
lytic JJ O
superinfection NN O
with IN O
EBV NNP O
and CC O
single JJ O
gene NN O
trans NNS O
- : O
activation NN O
converted VBD O
the DT O
recombinant JJ B-Gene
ori NN I-Gene
Lyt NNP I-Gene
element NN I-Gene
in IN O
R7 NNP O
- : O
57 CD O
reporter NN O
cells NNS O
. . O

Costimulation NN O
of IN O
cAMP NN O
and CC O
protein NN B-Gene
kinase NN I-Gene
C NNP I-Gene
pathways VBZ O
inhibits VBZ O
the DT O
CD3 NNP B-Gene
- : O
dependent NN O
T NNP O
cell NN O
activation NN O
and CC O
leads VBZ O
to TO O
a DT O
persistent JJ O
expression NN O
of IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
transcription NN I-Gene
factor NN I-Gene
. . O

Analysis NN O
of IN O
intracellular JJ O
Ca2 NNP O
+ NNP O
mobilization NN O
suggested VBD O
that IN O
the DT O
CD3 NNP B-Gene
/ NNP O
TcR NNP B-Gene
- : O
dependent JJ O
signal JJ O
transduction NN O
was VBD O
impaired VBN O
in IN O
PMA NNP O
/ NNP O
Bt2cAMP NNP O
- : O
treated VBD O
cells NNS O
. . O

The DT O
observation NN O
that IN O
a DT O
mutated JJ B-Gene
LT NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
construct NN I-Gene
( ( O
M1 NNP B-Gene
- : I-Gene
CAT NN I-Gene
) ) O
was VBD O
inactive JJ O
in IN O
C81 NNP O
- : O
66 CD O
- : O
45 CD O
, , O
confirmed VBD O
the DT O
importance NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
LT NNP B-Gene
gene NN O
expression NN O
. . O

In IN O
JM NNP O
T NNP O
cells NNS O
, , O
tax NN B-Gene
induced VBD O
LT NNP B-Gene
- : I-Gene
293 CD I-Gene
activity NN O
by IN O
two CD O
- : O
to TO O
four CD O
- : O
fold NN O
, , O
though IN O
there EX O
was VBD O
no DT O
induction NN O
of IN O
M1 NNP B-Gene
- : I-Gene
CAT NN I-Gene
. . O

We PRP O
combined VBD O
two CD O
techniques NNS O
to TO O
identify VB O
the DT O
productive JJ O
replicative JJ O
form NN O
of IN O
Epstein NNP B-Gene
- : I-Gene
Barr NNP I-Gene
viral JJ I-Gene
DNA NNP I-Gene
in IN O
the DT O
lytic JJ O
cycle NN O
- : O
induced JJ O
cells NNS O
. . O

This DT O
indicates VBZ O
an DT O
increase NN O
in IN O
either DT O
episomal JJ B-Gene
DNA NN I-Gene
or CC O
concatameric JJ B-Gene
linear JJ I-Gene
DNA NN I-Gene
. . O

This DT O
paper NN O
describes VBZ O
how WRB O
the DT O
expression NN O
of IN O
the DT O
monocyte NN B-Gene
- : I-Gene
macrophage NN I-Gene
Ag NNP I-Gene
, , O
CD14 NNP B-Gene
, , O
and CC O
the DT O
low JJ O
affinity NN B-Gene
Fc NNP I-Gene
receptor NN I-Gene
for IN O
IgE NNP B-Gene
, , O
CD23 NNP B-Gene
, , O
were VBD O
inversely RB O
regulated VBN O
during IN O
VitD3 NNP O
- : O
and CC O
RA NNP O
- : O
induced VBD O
monocytic JJ O
differentiation NN O
of IN O
human JJ O
U NNP O
- : O
937 CD O
monoblasts NNS O
. . O

The DT O
results NNS O
suggest VBP O
that IN O
there EX O
exists VBZ O
a DT O
functional JJ O
antagonism NN O
between IN O
VitD3 NNP O
and CC O
RA NNP O
that WDT O
may MD O
have VB O
important JJ O
implications NNS O
for IN O
the DT O
regulation NN O
of IN O
certain JJ O
immune NN O
and CC O
inflammatory NN O
responses NNS O
through IN O
their PRP$ O
inverse JJ O
effects NNS O
on IN O
CD14 NNP O
and CC O
CD23 NNP O
gene NN O
expression NN O
. . O

Cell NNP O
- : O
specific JJ O
bifunctional JJ O
role NN O
of IN O
Jun NNP B-Gene
oncogene NNP I-Gene
family NN I-Gene
members NNS I-Gene
on IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
- : O
dependent JJ O
transcription NN O
. . O

Here RB O
we PRP O
report VBP O
that IN O
this DT O
interference NN O
is VBZ O
cell VBN O
specific JJ O
, , O
as IN O
TPA NNP O
augmented VBD O
dexamethasone SYM O
- : O
induced JJ O
transcriptional JJ O
activation NN O
of IN O
the DT O
MMTV NNP B-Gene
LTR NNP I-Gene
in IN O
several JJ O
T NNP O
cell NN O
lines NNS O
but CC O
was VBD O
inhibitory NN O
in IN O
NIH NNP O
- : O
3T3 CD O
fibroblasts NNS O
. . O

Increased VBN O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
, , O
jun NN B-Gene
- : I-Gene
B NNP I-Gene
, , O
and CC O
jun SYM B-Gene
- : I-Gene
D NNP I-Gene
expression NN O
above IN O
basal NN O
levels NNS O
and CC O
increased VBD O
transcriptional JJ O
activity NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
/ JJ I-Gene
TPA NNP I-Gene
responsive JJ I-Gene
elements NNS I-Gene
fused VBN O
to TO O
chloramphenicol VB B-Gene
acetyl JJ I-Gene
- : I-Gene
transferase NN I-Gene
vectors NNS I-Gene
were VBD O
observed VBN O
in IN O
T NNP O
cells NNS O
treated VBD O
with IN O
TPA NNP O
alone RB O
or CC O
in IN O
combination NN O
with IN O
dexamethasone NN O
. . O

Studies NNS O
with IN O
5 CD B-Gene
' POS I-Gene
deletion NN I-Gene
CD20 NNP I-Gene
promoter NN I-Gene
- : I-Gene
CAT NN I-Gene
constructs NNS I-Gene
have VBP O
previously RB O
revealed VBN O
two CD O
regions NNS O
of IN O
the DT O
promoter NN B-Gene
between IN O
bases NNS O
- : O
186 CD O
and CC O
- : O
280 CD O
and CC O
between IN O
bases NNS O
- : O
280 CD O
and CC O
- : O
454 CD O
which WDT O
contained VBD O
positive JJ B-Gene
regulatory JJ I-Gene
elements NNS I-Gene
. . O

Cross NNP O
competition NN O
experiments NNS O
with IN O
an DT O
octamer JJ O
sequence NN O
from IN O
the DT O
Ig NNP O
heavy NN O
chain NN O
promoter NN O
, , O
the DT O
BAT NNP B-Gene
box NN I-Gene
, , O
and CC O
a DT O
TA NNP O
- : O
rich JJ O
sequence NN O
present NN O
in IN O
the DT O
CD21 NNP B-Gene
promoter NN I-Gene
revealed VBD O
that IN O
all DT O
three CD O
sequences NNS O
bound IN O
the DT O
same JJ O
nuclear JJ B-Gene
proteins NNS I-Gene
suggesting VBG O
that IN O
the DT O
BAT NNP B-Gene
box NN I-Gene
binding VBG I-Gene
proteins NNS I-Gene
were VBD O
Oct NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
Oct NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

Despite IN O
this DT O
lower JJR O
affinity NN O
, , O
a DT O
trimer NN O
of IN O
the DT O
BAT NNP B-Gene
box NN I-Gene
sequence NN I-Gene
was VBD O
as IN O
efficiently RB O
transactivated VBN O
by IN O
an DT O
Oct NNP B-Gene
- : I-Gene
2 CD I-Gene
expression NN I-Gene
vector NN I-Gene
as IN O
was VBD O
a DT O
trimer NN O
of IN O
the DT O
octamer JJ B-Gene
sequence NN I-Gene
in IN O
HeLa NNP O
cells NNS O
. . O

Control NNP O
peptides VBZ O
corresponding VBG O
to TO O
the DT O
normal JJ O
pml NN B-Gene
and CC O
RAR NNP B-Gene
alpha VBP I-Gene
proteins NNS I-Gene
were VBD O
not RB O
recognized VBN O
. . O

One CD O
cDNA NN B-Gene
clone NN I-Gene
of IN O
a DT O
primary JJ O
response NN O
gene NN O
, , O
expressed VBN O
upon IN O
macrophage NN O
differentiation NN O
, , O
encoded VBD O
for IN O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
a DT O
zinc NN B-Gene
finger NN I-Gene
transcription NN I-Gene
factor NN I-Gene
. . O

HL NNP O
- : O
60 CD O
cells NNS O
constitutively RB O
expressing VBG O
an DT O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
transgene NN I-Gene
( ( O
HL NNP B-Gene
- : I-Gene
60Egr CD I-Gene
- : I-Gene
1 CD I-Gene
) ) O
could MD O
be VB O
induced VBN O
for IN O
macrophage NN O
, , O
but CC O
not RB O
granulocyte JJ O
, , O
differentiation NN O
. . O

These DT O
observations NNS O
indicate VBP O
that IN O
expression NN O
of IN O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
essential JJ O
for IN O
and CC O
restricts VBZ O
differentiation NN O
of IN O
myeloblasts NNS O
along IN O
the DT O
macrophage NN O
lineage NN O
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
revealed VBD O
three CD O
specific JJ O
protein SYM B-Gene
- : I-Gene
DNA NN I-Gene
complexes NNS I-Gene
formed VBN O
with IN O
sequences NNS O
of IN O
the DT O
EBNA2 NNP B-Gene
responsive JJ I-Gene
element NN I-Gene
. . O

Thus RB O
, , O
these DT O
experiments NNS O
demonstrate VBP O
that IN O
EBNA2 NNP B-Gene
interacts VBZ O
with IN O
an DT O
EBNA2 NNP B-Gene
responsive NN I-Gene
cis NN I-Gene
- : I-Gene
element NN I-Gene
of IN O
the DT O
TP1 NNP B-Gene
promoter NN I-Gene

Agents NNS O
which WDT O
increased VBD O
cAMP NN O
levels NNS O
, , O
including VBG O
cholera NN O
toxin NN O
, , O
pertussis NN O
toxin NN O
, , O
dibutyryl NN O
cAMP NN O
, , O
and CC O
isoproterenol NN O
mimicked VBD O
the DT O
actions NNS O
of IN O
MM NNP B-Gene
- : I-Gene
LDL NN I-Gene
. . O

One CD O
member NN O
of IN O
this DT O
multigene JJ O
family NN O
, , O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
, , O
is VBZ O
most JJS O
abundantly RB O
expressed VBN O
in IN O
T NNP O
lymphocytes NNS O
, , O
a DT O
cellular JJ O
target NN O
for IN O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
infection NN O
and CC O
replication NN O
. . O

Cotransfection NN O
of IN O
an DT O
hGATA NN B-Gene
- : I-Gene
3 CD I-Gene
expression NN I-Gene
plasmid NN I-Gene
with IN O
a DT O
reporter NN B-Gene
plasmid NN I-Gene
whose WP$ O
transcription NN O
is VBZ O
directed VBN O
by IN O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
resulted VBD O
in IN O
6 CD O
- : O
to TO O
10 CD O
- : O
fold JJ O
stimulation NN O
of IN O
LTR NNP B-Gene
- : O
mediated VBN O
transcription NN O
, , O
whereas IN O
site NN O
specific JJ O
mutation NN O
of IN O
these DT O
GATA NNP B-Gene
sites NNS I-Gene
resulted VBD O
in IN O
virtual JJ O
abrogation NN O
of IN O
the DT O
activation NN O
by IN O
hGATA JJ B-Gene
- : I-Gene
3 CD I-Gene
. . O

Conversely RB O
, , O
several JJ O
cytokines NNS B-Gene
modulate VBP O
the DT O
levels NNS O
of IN O
HIV NNP O
expression NN O
in IN O
infected JJ O
cells NNS O
of IN O
both DT O
T NNP O
lymphocytic NN O
and CC O
mononuclear JJ O
phagocytic JJ O
lineage NN O
. . O

Cloning VBG O
and CC O
functional JJ O
characterization NN O
of IN O
early JJ B-Gene
B NNP I-Gene
- : I-Gene
cell NN I-Gene
factor NN I-Gene
, , O
a DT O
regulator NN O
of IN O
lymphocyte NN O
- : O
specific JJ O
gene NN O
expression NN O
. . O

Early RB B-Gene
B NNP I-Gene
- : I-Gene
cell NN I-Gene
factor NN I-Gene
( ( O
EBF NNP B-Gene
) ) O
was VBD O
identified VBN O
previously RB O
as IN O
a DT O
tissue NN O
- : O
specific NN O
and CC O
differentiation NN O
stage NN O
- : O
specific JJ O
DNA NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
that WDT O
participates VBZ O
in IN O
the DT O
regulation NN O
of IN O
the DT O
pre NN B-Gene
- : I-Gene
B NN I-Gene
and CC I-Gene
B NNP I-Gene
lymphocyte NN I-Gene
- : I-Gene
specific JJ I-Gene
mb SYM I-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
. . O

Partial NNP O
amino NN O
acid NN O
sequences NNS O
obtained VBN O
from IN O
purified VBN O
EBF NNP B-Gene
were VBD O
used VBN O
to TO O
isolate VB O
cDNA NN B-Gene
clones NNS I-Gene
, , O
which WDT O
by IN O
multiple JJ O
criteria NNS O
encode VBP O
EBF NNP B-Gene
. . O

DNA NNP O
- : O
binding NN O
assays NNS O
with IN O
cotranslated JJ O
wild JJ O
- : O
type NN O
and CC O
truncated VBD O
forms NNS O
of IN O
EBF NNP B-Gene
indicated VBD O
that IN O
the DT O
protein NN O
interacts VBZ O
with IN O
its PRP$ O
site NN O
as IN O
a DT O
homodimer NN B-Gene
. . O

Deletions NNS O
delineated VBD O
a DT O
carboxy JJ B-Gene
- : I-Gene
terminal JJ I-Gene
dimerization NN I-Gene
region NN I-Gene
containing VBG O
two CD O
repeats NNS O
of IN O
15 CD O
amino NN O
acids NNS O
that WDT O
show VBP O
similarity NN O
with IN O
the DT O
dimerization NN B-Gene
domains NNS I-Gene
of IN O
basic JJ B-Gene
- : I-Gene
helix NN I-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
proteins NNS I-Gene
. . O

A DT O
73 CD B-Gene
kDa NN I-Gene
protein NN I-Gene
was VBD O
identified VBN O
by IN O
this DT O
analysis NN O
: : O
this DT O
protein NN O
is VBZ O
highly RB O
enriched VBN O
in IN O
cell NN O
lines NNS O
of IN O
B NNP O
lymphoid JJ O
origin NN O
as IN O
compared VBN O
to TO O
pancreatic VB O
beta NN O
- : O
cells NNS O
and CC O
fibroblast JJ O
cells NNS O
. . O

The DT O
detection NN O
of IN O
this DT O
protein NN O
selectively RB O
in IN O
extracts NNS O
of IN O
lymphoid JJ O
cells NNS O
correlates VBZ O
with IN O
the DT O
presence NN O
of IN O
the DT O
E NNP B-Gene
box SYM I-Gene
- : O
binding NN O
activity NN O
LEF1 NNP B-Gene
/ NNP I-Gene
BCF1 NNP I-Gene
in IN O
these DT O
cells NNS O
; : O
this DT O
binding NN O
activity NN O
was VBD O
previously RB O
shown VBN O
to TO O
be VB O
efficiently RB O
recognized VBN O
by IN O
antiserum NN O
directed VBN O
against IN O
E2A NNP B-Gene
gene NN I-Gene
products NNS I-Gene
. . O

Pregnancy NNP O
- : O
induced JJ O
hypertension NN O
( ( O
PIH NNP O
) ) O
is VBZ O
a DT O
frequent JJ O
cause NN O
of IN O
maternal JJ O
and CC O
neonatal JJ O
morbidity NN O
and CC O
mortality NN O
. . O

In IN O
the DT O
present JJ O
study NN O
we PRP O
focused VBD O
on IN O
the DT O
pathophysiology NN O
of IN O
PIH NNP O
, , O
mainly RB O
on IN O
the DT O
role NN O
of IN O
mineralocorticoids NNS O
, , O
reversed VBD O
blood NN O
pressure NN O
patterns NNS O
, , O
and CC O
the DT O
resulting JJ O
necessity NN O
of IN O
continuous JJ O
monitoring NN O
of IN O
the DT O
preeclamptic JJ O
mother NN O
. . O

Furthermore RB O
, , O
we PRP O
evaluated VBD O
the DT O
mineralocorticoid NN B-Gene
receptor NN I-Gene
( ( O
MR NNP B-Gene
) ) O
count NN O
in IN O
mononuclear JJ O
leukocytes NNS O
in IN O
the DT O
2 CD O
groups NNS O
. . O

Induction NN O
by IN O
hemin NN O
increases NNS O
, , O
while IN O
induction NN O
with IN O
12 CD O
- : O
O NNP O
- : O
tetradecanoylphorbol NN O
- : O
13 CD O
- : O
acetate NN O
( ( O
TPA NNP O
) ) O
represses VBZ O
, , O
erythroid SYM B-Gene
- : I-Gene
specific JJ I-Gene
gene NN I-Gene
expression NN O
in IN O
the DT O
human JJ O
cell NN O
line NN O
K562 NNP O
. . O

Hemin NNP O
induction NN O
appears VBZ O
to TO O
nonspecifically RB O
increase VB O
the DT O
expression NN O
of IN O
transiently RB O
transfected VBN O
genes NNS O
in IN O
K562 NNP O
cells NNS O
. . O

The DT O
divergent JJ O
effects NNS O
of IN O
hemin NN O
and CC O
TPA NNP O
on IN O
gene NN O
expression NN O
in IN O
K562 NNP O
cells NNS O
are VBP O
mediated VBN O
, , O
in IN O
part NN O
, , O
by IN O
their PRP$ O
contrasting NN O
effects NNS O
on IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
NF NNP B-Gene
- : I-Gene
E2 NN I-Gene
. . O

We PRP O
studied VBD O
the DT O
effect NN O
of IN O
interleukin JJ B-Gene
- : I-Gene
4 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
) ) O
on IN O
the DT O
lipopolysaccharide NN O
( ( O
LPS NNP O
) ) O
induction NN O
of IN O
two CD O
immediate JJ O
early JJ O
genes NNS O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
and CC O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
. . O

The DT O
inhibition NN O
of IN O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
and CC O
c SYM O
- : O
jun NN O
expression NN O
by IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
in IN O
LPS NNP O
- : O
treated VBD O
cells NNS O
was VBD O
shown VBN O
to TO O
be VB O
due JJ O
to TO O
a DT O
lower JJR O
transcription NN O
rate NN O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
fos NN I-Gene
and CC I-Gene
c SYM I-Gene
- : I-Gene
jun NN I-Gene
genes NNS I-Gene
. . O

These DT O
involve VBP O
activation NN O
of IN O
the DT O
sodium NN B-Gene
/ NNP I-Gene
proton NN I-Gene
exchanger NN I-Gene
of IN O
the DT O
cell NN O
membrane NN O
at IN O
very RB O
low JJ O
, , O
physiological JJ O
concentrations NNS O
of IN O
aldosterone NN O
with IN O
an DT O
acute JJ O
onset NN O
within IN O
1 CD O
- : O
2 CD O
min NN O
. . O

The DT O
unique JJ O
characteristics NNS O
of IN O
this DT O
new JJ O
pathway NN O
for IN O
steroid JJ O
action NN O
include VBP O
its PRP$ O
rapid JJ O
time NN O
course NN O
, , O
10 CD O
, , O
0 CD O
- : O
fold NN O
selectivity NN O
for IN O
aldosterone NN O
over IN O
cortisol NN O
and CC O
the DT O
ineffectiveness NN O
of IN O
spironolactones NNS O
, , O
classical JJ O
mineralocorticoid NN O
antagonists NNS O
, , O
as IN O
antagonists NNS O
of IN O
the DT O
response NN O
. . O

Human NNP B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
type NN I-Gene
1 CD I-Gene
Nef NNP I-Gene
protein NN I-Gene
inhibits VBZ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
induction NN O
in IN O
human JJ O
T NNP O
cells NNS O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
defective JJ O
recruitment NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
may MD O
underlie VB O
Nef NNP B-Gene
' POS O
s NN O
negative JJ O
transcriptional JJ O
effects NNS O
on IN O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC I-Gene
interleukin JJ I-Gene
2 CD I-Gene
promoters NNS I-Gene
. . O

The DT O
expression NN O
of IN O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
, , I-Gene
c SYM I-Gene
- : I-Gene
jun NN I-Gene
and CC I-Gene
jun NN I-Gene
B NNP I-Gene
proto NN I-Gene
- : I-Gene
oncogenes NNS I-Gene
was VBD O
studied VBN O
in IN O
phytohemagglutinin NN O
( ( O
PHA NNP O
) ) O
activated VBD O
peripheral JJ O
blood NN O
lymphocytes NNS O
( ( O
PBL NNP O
) ) O
from IN O
young JJ O
and CC O
aged JJ O
humans NNS O
. . O

In IN O
PHA NNP O
- : O
activated VBD O
PBL NNP O
, , O
no DT O
age NN O
- : O
related JJ O
differences NNS O
were VBD O
observed VBN O
in IN O
c JJ O
- : O
fos NN O
or CC O
jun NN O
B NNP O
mRNA NN O
expression NN O
. . O

Because IN O
previous JJ O
work NN O
has VBZ O
demonstrated VBN O
that IN O
T NNP O
cells NNS O
from IN O
elderly JJ O
individuals NNS O
may MD O
display VB O
normal JJ O
proliferative JJ O
responses NNS O
when WRB O
activated VBN O
via IN O
the DT O
anti JJ B-Gene
- : I-Gene
CD2 NNP I-Gene
pathway NN O
, , O
c SYM O
- : O
jun NN O
and CC O
jun NN O
B NNP O
mRNA NN O
expression NN O
was VBD O
also RB O
studied VBN O
in IN O
anti JJ O
- : O
CD2 NNP O
- : O
activated VBD O
purified JJ O
T NNP O
cells NNS O
. . O

The DT O
CD19 NNP B-Gene
protein NN I-Gene
is VBZ O
expressed VBN O
on IN O
the DT O
surface NN O
of IN O
all DT O
B NNP O
- : O
lymphoid NN O
cells NNS O
with IN O
the DT O
exception NN O
of IN O
terminally RB O
differentiated VBN O
plasma NN O
cells NNS O
and CC O
has VBZ O
been VBN O
implicated VBN O
as IN O
a DT O
signal JJ O
- : O
transducing VBG O
receptor NN O
in IN O
the DT O
control NN O
of IN O
proliferation NN O
and CC O
differentiation NN O
. . O

This DT O
high JJ B-Gene
- : I-Gene
affinity NN I-Gene
site NN I-Gene
has VBZ O
been VBN O
conserved VBN O
in IN O
the DT O
promoters NNS B-Gene
of IN O
both DT O
human JJ B-Gene
and CC I-Gene
mouse NN I-Gene
CD19 NNP I-Gene
genes NNS I-Gene
and CC O
was VBD O
furthermore RB O
shown VBN O
to TO O
confer VB O
B NNP O
- : O
cell NN O
specificity NN O
to TO O
a DT O
beta NN O
- : O
globin NN O
reporter NN O
gene NN O
in IN O
transient JJ O
transfection NN O
experiments NNS O
. . O

In IN O
addition NN O
, , O
BSAP NNP B-Gene
was VBD O
found VBN O
to TO O
be VB O
the DT O
only JJ O
abundant JJ O
DNA NNP O
- : O
binding NN O
activity NN O
of IN O
B NNP O
- : O
cell NN O
nuclear JJ O
extracts VBZ O
that IN O
interacts NNS O
with IN O
the DT O
CD19 NNP B-Gene
promoter NN I-Gene
. . O

Compared VBN O
to TO O
benign VB O
tumor NN O
or CC O
mammary JJ O
reduction NN O
test NN O
material NN O
the DT O
eicosanoid NN O
profile NN O
of IN O
tissue NN O
obtained VBN O
from IN O
malignant JJ O
mammary JJ O
tumors NNS O
showed VBD O
important JJ O
differences NNS O
. . O

The DT O
implications NNS O
, , O
in IN O
particular JJ O
, , O
in IN O
relation NN O
to TO O
future JJ O
prognosis NN O
of IN O
the DT O
patient NN O
, , O
remain VBP O
obscure JJ O
. . O

To TO O
examine VB O
the DT O
role NN O
of IN O
mineralocorticoids NNS O
in IN O
the DT O
pathophysiology NN O
of IN O
pregnancy NN O
- : O
induced JJ O
hypertension NN O
( ( O
PIH NNP O
) ) O
, , O
we PRP O
studied VBD O
plasma JJ O
aldosterone NN O
and CC O
18 CD O
- : O
hydroxycorticosteron NN O
levels NNS O
in IN O
25 CD O
women NNS O
with IN O
PIH NNP O
and CC O
25 CD O
normal JJ O
pregnant JJ O
women NNS O
, , O
as IN O
controls NNS O
. . O

Plasma NNP O
18 CD O
- : O
hydroxycorticosteron NN O
was VBD O
also RB O
significantly RB O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
25 CD O
) ) O
lower JJR O
( ( O
PIH NNP O
, , O
1071 CD O
+ NN O
/ NNP O
- : O
149 CD O
pmol NN O
/ NNP O
L NNP O
; : O
controls NNS O
, , O
1907 CD O
+ NN O
/ NNP O
- : O
318 CD O
pmol NN O
/ NNP O
L NNP O
) ) O
. . O

Small JJ O
apolar JJ O
substitutions NNS O
( ( O
11 CD O
alpha SYM O
- : O
methyl NN O
, , O
11 CD O
alpha SYM O
- : O
fluoromethyl NN O
) ) O
did VBD O
not RB O
markedly RB O
decrease VB O
the DT O
affinity NN O
for IN O
the DT O
vitamin NN B-Gene
D NNP I-Gene
receptor NN I-Gene
, , O
but CC O
larger JJR O
( ( O
11 CD O
alpha SYM O
- : O
chloromethyl NN O
or CC O
11 CD O
alpha JJ O
- : O
or CC O
11 CD O
beta SYM O
- : O
phenyl NN O
) ) O
or CC O
more JJR O
polar JJ O
substitutions NNS O
( ( O
11 CD O
alpha SYM O
- : O
hydroxymethyl NN O
, , O
11 CD O
alpha SYM O
- : O
( ( O
2 CD O
- : O
hydroxyethyl NN O
] NN O
decreased VBD O
the DT O
affinity NN O
to TO O
less JJR O
than IN O
5 CD O
% NN O
of IN O
that DT O
of IN O
1 CD O
alpha NNS O
, , O
25 CD O
- : O
OH NN O
) ) O
2D3 CD O
. . O

The DT O
11 CD O
beta NN O
- : O
methyl NN O
analog NN O
had VBD O
a DT O
greater JJR O
than IN O
10 CD O
- : O
fold NN O
lower JJR O
activity NN O
. . O

In IN O
the DT O
present JJ O
paper NN O
, , O
the DT O
binding NN O
of IN O
a DT O
[ JJ O
125I CD O
] SYM O
- : O
labeled VBN O
aldosterone RB O
derivative JJ O
to TO O
plasma VB O
membrane NN O
rich JJ O
fractions NNS O
of IN O
HML NNP O
was VBD O
studied VBN O
. . O

This DT O
variation NN O
was VBD O
the DT O
result NN O
of IN O
a DT O
duplication NN O
of IN O
a DT O
short JJ B-Gene
DNA NN I-Gene
sequence NN I-Gene
( ( O
CTG NNP B-Gene
- : I-Gene
motif NN I-Gene
) ) O
. . O

No DT O
positive JJ O
effect NN O
of IN O
the DT O
duplicated VBN O
CTG NNP B-Gene
- : I-Gene
motif NN I-Gene
could MD O
be VB O
detected VBN O
. . O

Based VBN O
on IN O
these DT O
results NNS O
we PRP O
estimate VBP O
a DT O
5 CD O
- : O
10 CD O
% NN O
difference NN O
in IN O
virus JJ O
production NN O
of IN O
the DT O
LTR NNP B-Gene
variants NNS I-Gene
when WRB O
compared VBN O
to TO O
that DT O
of IN O
wild JJ O
- : O
type NN O
. . O

The DT O
helix NN B-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
( ( I-Gene
HLH NNP I-Gene
) ) I-Gene
proteins NNS I-Gene
are VBP O
a DT O
family NN O
of IN O
transcription NN B-Gene
factors NNS I-Gene
that WDT O
include VBP O
proteins VBZ O
critical JJ O
to TO O
differentiation NN O
and CC O
development NN O
in IN O
species NNS O
ranging VBG O
from IN O
plants NNS O
to TO O
mammals NNS O
. . O

Glucocorticoid NNP B-Gene
receptor NN I-Gene
in IN O
patients NNS O
with IN O
lupus JJ O
nephritis NN O
: : O
relationship NN O
between IN O
receptor NN O
levels NNS O
in IN O
mononuclear JJ O
leukocytes NNS O
and CC O
effect NN O
of IN O
glucocorticoid JJ O
therapy NN O
. . O

We PRP O
investigated VBD O
the DT O
clinical JJ O
significance NN O
of IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
determination NN O
in IN O
20 CD O
patients NNS O
with IN O
systemic JJ O
lupus NN O
erythematosus NN O
( ( O
SLE NNP O
) ) O
who WP O
afterwards VBP O
developed VBN O
nephrotic JJ O
syndrome NN O
. . O

Improvement NN O
in IN O
urinary JJ O
protein NN O
excretion NN O
and CC O
in IN O
disease NN O
activity NN O
, , O
which WDT O
was VBD O
scored VBN O
according VBG O
to TO O
the DT O
SLE NNP O
Disease NNP O
Activity NNP O
Index NNP O
system NN O
of IN O
the DT O
University NNP O
of IN O
Toronto NNP O
, , O
closely RB O
related VBN O
to TO O
the DT O
glucocorticoid NN B-Gene
receptor NN I-Gene
concentrations NNS O
in IN O
MNL NNP O
isolated VBD O
from IN O
the DT O
corresponding JJ O
patients NNS O
. . O

Possible JJ O
relationship NN O
between IN O
the DT O
changes NNS O
in IN O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
GR NNP B-Gene
in IN O
aged VBN O
long RB O
- : O
distance NN O
runner NN O
and CC O
its PRP$ O
physiological JJ O
significance NN O
are VBP O
discussed VBN O
. . O

Mineralocorticoid NNP O
effector NN O
mechanism NN O
in IN O
preeclampsia NN O
. . O

MR NNP B-Gene
were VBD O
reduced VBN O
before IN O
delivery NN O
( ( O
96 CD O
+ NN O
/ NNP O
- : O
27 CD O
receptors NNS O
/ NNP O
cell NN O
) ) O
, , O
and CC O
SPD NNP O
increased VBD O
( ( O
64 CD O
+ NN O
/ NNP O
- : O
8 CD O
mV NN O
) ) O
, , O
with IN O
both DT O
parameters NNS O
normalizing VBP O
after IN O
delivery NN O
( ( O
MR NNP B-Gene
, , O
242 CD O
+ NN O
/ NNP O
- : O
79 CD O
; : O
SPD NNP O
, , O
14 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
4 CD O
mV NN O
) ) O
. . O

Aldosterone NN O
levels NNS O
returned VBN O
to TO O
normal JJ O
nonpregnant JJ O
values NNS O
after IN O
delivery NN O
. . O

Kinetics NNS O
of IN O
nuclear JJ O
translocation NN O
and CC O
turnover NN O
of IN O
the DT O
vitamin NN B-Gene
D NNP I-Gene
receptor NN I-Gene
in IN O
human JJ O
HL60 NNP O
leukemia NN O
cells NNS O
and CC O
peripheral JJ O
blood NN O
lymphocytes VBZ O
- : O
- : O
coincident NN O
rise NN O
of IN O
DNA NNP O
- : O
relaxing NN O
activity NN O
in IN O
nuclear JJ O
extracts NNS O
. . O

HL60 NNP O
cells NNS O
, , O
expressing VBG O
some DT O
characteristics NNS O
of IN O
promyelocytes NNS O
, , O
can MD O
be VB O
induced VBN O
to TO O
monocytoid VB O
differentiation NN O
by IN O
calcitriol NN O
. . O

Pulse NNP O
exposure NN O
of IN O
HL60 NNP O
to TO O
radiolabeled VB O
hormone NN O
for IN O
3 CD O
h NN O
followed VBN O
by IN O
culture NN O
in IN O
medium NN O
without IN O
serum NN O
and CC O
calcitriol JJ O
lead NN O
to TO O
nuclear JJ O
retention NN O
of IN O
approximately RB O
1600 CD B-Gene
radiolabeled VBD I-Gene
VDR NNP I-Gene
by IN O
8 CD O
h NN O
and CC O
approximately RB O
1000 CD O
VDR NNP B-Gene
by IN O
24 CD O
h NN O
. . O

No DT O
specific JJ O
translocation NN O
into IN O
the DT O
nuclear JJ O
compartment NN O
was VBD O
seen VBN O
when WRB O
isolated JJ O
nuclei NN O
were VBD O
incubated VBN O
in IN O
[ JJ O
3H CD O
] JJ O
calcitriol NN O
. . O

Radiolabeled VBN B-Gene
hormone NN I-Gene
/ NNP I-Gene
receptor NN I-Gene
complexes NNS I-Gene
of IN O
nuclei RB O
isolated VBN O
from IN O
cells NNS O
exposed VBN O
for IN O
3 CD O
h NN O
to TO O
radiolabeled VB O
hormone NN O
- : O
- : O
in IN O
contrast NN O
to TO O
identical JJ O
experiments NNS O
with IN O
intact JJ O
cells NNS O
- : O
- : O
did VBD O
not RB O
disappear VB O
from IN O
the DT O
nuclear JJ O
compartment NN O
upon IN O
incubation NN O
of IN O
nuclei NN O
with IN O
identical JJ O
concentrations NNS O
of IN O
the DT O
unlabeled JJ O
compound NN O
. . O

We PRP O
conclude VBP O
that IN O
a DT O
specific JJ O
nuclear JJ O
translocation NN O
mechanism NN O
exists VBZ O
for IN O
calcitriol NN O
in IN O
both DT O
cell NN O
types NNS O
examined VBN O
, , O
most RBS O
likely JJ O
due JJ O
to TO O
translocation NN O
of IN O
receptor NN B-Gene
proteins NNS I-Gene
after IN O
hormone NN O
binding NN O
. . O

Enhanced NNP O
activity NN O
of IN O
topoisomerases NNS B-Gene
in IN O
nuclear JJ O
extracts NNS O
upon IN O
translocation NN O
of IN O
VDR NNP B-Gene
might MD O
reflect VB O
interaction NN O
of IN O
both DT O
within IN O
the DT O
nuclear JJ O
compartment NN O
, , O
thus RB O
initiating VBG O
DNA NNP O
- : O
unwinding NN O
, , O
a DT O
prerequisite NN O
of IN O
transcription NN O
initiation NN O
. . O

Estrogen NNP O
receptor NN O
positive JJ O
( ( O
ER NNP O
+ NN O
: : O
MCF NNP O
- : O
7 CD O
) ) O
and CC O
negative JJ O
( ( O
ER NNP O
- : O
: : O
MDA NNP O
- : O
MB NNP O
- : O
231 CD O
) ) O
human NN O
breast NN O
cancer NN O
cell NN O
lines NNS O
were VBD O
utilized VBN O
to TO O
evaluate VB O
the DT O
effects NNS O
of IN O
tamoxifen NN O
( ( O
TAM NNP O
) ) O
and CC O
estradiol $ O
( ( O
E2 NNP O
) ) O
on IN O
modulation NN O
of IN O
breast NN O
cancer NN O
target NN O
susceptibility NN O
to TO O
lysis NN O
by IN O
lymphokine JJ O
- : O
activated VBN O
killer NN O
( ( O
LAK NNP O
) ) O
cells NNS O
. . O

E2 NNP O
- : O
stimulated VBD O
ER NNP O
+ NNP O
cells NNS O
were VBD O
more RBR O
susceptible JJ O
to TO O
lysis VB O
by IN O
LAK NNP O
cells NNS O
than IN O
corresponding VBG O
TAM NNP O
- : O
treated VBD O
or CC O
control NN O
cells NNS O
, , O
while IN O
treatment NN O
of IN O
ER NNP O
- : O
cells NNS O
with IN O
either DT O
E2 NNP O
or CC O
TAM NNP O
alone RB O
did VBD O
not RB O
alter VB O
from IN O
control VB O
their PRP$ O
susceptibility NN O
to TO O
this DT O
immune JJ O
- : O
mediated VBN O
lysis NN O
. . O

Regulation NN O
of IN O
replicative JJ O
functions NNS O
in IN O
the DT O
Epstein NNP B-Gene
- : I-Gene
Barr NNP I-Gene
virus NN I-Gene
( ( I-Gene
EBV NNP I-Gene
) ) I-Gene
genome NN I-Gene
is VBZ O
mediated VBN O
through IN O
activation NN O
of IN O
a DT O
virally RB B-Gene
encoded VBN I-Gene
transcription NN I-Gene
factor NN I-Gene
, , O
Z NNP B-Gene
( ( O
BZLF1 NNP B-Gene
) ) O
. . O

The DT O
long JJ B-Gene
terminal JJ I-Gene
repeat NN I-Gene
( ( I-Gene
LTR NNP I-Gene
) ) I-Gene
region NN I-Gene
of IN O
HIV NNP B-Gene
proviral JJ I-Gene
DNA NNP I-Gene
contains VBZ O
binding VBG O
sites NNS O
for IN O
nuclear JJ B-Gene
factor NN I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
) ) O
, , O
and CC O
this DT O
transcriptional JJ B-Gene
activator NN I-Gene
appears VBZ O
to TO O
regulate VB O
HIV NNP O
activation NN O
. . O

The DT O
inhibitory JJ O
action NN O
of IN O
alpha JJ O
- : O
lipoic NN O
acid NN O
was VBD O
found VBN O
to TO O
be VB O
very RB O
potent JJ O
as IN O
only RB O
4 CD O
mM NN O
was VBD O
needed VBN O
for IN O
a DT O
complete JJ O
inhibition NN O
, , O
whereas IN O
20 CD O
mM NN O
was VBD O
required VBN O
for IN O
N NNP O
- : O
acetylcysteine NN O
. . O

REV NNP B-Gene
LTRs NNP I-Gene
work NN O
efficiently RB O
in IN O
human JJ O
lymphoid NN O
cells NNS O
, , O
and CC O
are VBP O
viable JJ O
alternatives NNS O
to TO O
promoters NNS B-Gene
commonly RB O
used VBD O
for IN O
expression NN O
of IN O
cloned VBN B-Gene
genes NNS I-Gene
. . O

Human NNP O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
and CC O
HIV NNP O
- : O
2 CD O
are VBP O
structurally RB O
related VBN O
retroviruses NNS O
which WDT O
both DT O
cause NN O
AIDS NNP O
in IN O
humans NNS O
. . O

Although IN O
both DT O
viruses NNS O
establish VB O
latency NN O
in IN O
quiescent JJ O
human JJ O
- : O
peripheral JJ O
- : O
blood NN O
T NNP O
cells NNS O
, , O
the DT O
asymptomatic JJ O
phase NN O
of IN O
HIV NNP O
- : O
2 CD O
infection NN O
may MD O
be VB O
more JJR O
prolonged JJ O
than IN O
that DT O
of IN O
HIV NNP O
- : O
1 CD O
. . O

The DT O
latent JJ O
phases NNS O
of IN O
both DT O
HIV NNP O
- : O
1 CD O
and CC O
HIV NNP O
- : O
2 CD O
infection NN O
have VBP O
been VBN O
shown VBN O
to TO O
be VB O
disrupted VBN O
by IN O
T NNP O
- : O
cell NN O
activation NN O
, , O
a DT O
process NN O
that WDT O
requires VBZ O
host NN O
cell NN O
transcription NN O
factors NNS O
. . O

Thus RB O
, , O
Elf NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
a DT O
novel JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
that WDT O
appears VBZ O
to TO O
be VB O
required VBN O
for IN O
the DT O
T NNP O
- : O
cell NN O
- : O
receptor NN O
- : O
mediated VBN O
trans NNS O
activation NN O
of IN O
HIV NNP O
- : O
2 CD O
gene NN O
expression NN O
. . O

These DT O
results NNS O
may MD O
explain VB O
differences NNS O
in IN O
the DT O
clinical JJ O
spectra NN O
of IN O
diseases NNS O
caused VBN O
by IN O
HIV NNP O
- : O
1 CD O
and CC O
HIV NNP O
- : O
2 CD O
and CC O
may MD O
also RB O
have VB O
implications NNS O
for IN O
the DT O
design NN O
of IN O
therapeutic JJ O
approaches NNS O
to TO O
HIV NNP O
- : O
2 CD O
infection NN O
. . O

Okadaic NNP O
acid NN O
is VBZ O
a DT O
potent JJ O
inducer NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
and CC O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
in IN O
human JJ O
B NNP O
lymphocytes NNS O
. . O

Treatment NN O
of IN O
human JJ O
B NNP O
lymphocytes VBZ O
with IN O
an DT O
optimal JJ O
concentration NN O
of IN O
okadaic JJ O
acid NN O
, , O
an DT O
inhibitor NN O
of IN O
phosphatases NNS B-Gene
1 CD I-Gene
and CC I-Gene
2A CD I-Gene
, , O
resulted VBD O
in IN O
the DT O
induction NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
, , O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
a DT O
marked JJ O
increase NN O
in IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
levels NNS O
. . O

Although IN O
okadaic JJ O
acid NN O
provides VBZ O
a DT O
potent JJ O
inductive JJ O
signal NN O
for IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B IN I-Gene
it PRP O
did VBD O
not RB O
induce VB O
either CC O
B NNP O
cell NN O
proliferation NN O
or CC O
immunoglobulin JJ B-Gene
secretion NN O
. . O

c SYM B-Gene
- : I-Gene
myc NN I-Gene
mRNA JJ I-Gene
expression NN O
in IN O
minor JJ O
salivary JJ O
glands NNS O
of IN O
patients NNS O
with IN O
Sjogren NNP O
' POS O
s JJ O
syndrome NN O
. . O

These DT O
data NNS O
show VBP O
that IN O
aged VBN O
subjects NNS O
have VBP O
reductions NNS O
of IN O
corticosteroid NN B-Gene
receptors NNS I-Gene
that WDT O
are VBP O
not RB O
associated VBN O
with IN O
increase NN O
of IN O
related JJ O
steroids NNS O
and CC O
that IN O
this DT O
situation NN O
probably RB O
represents VBZ O
a DT O
concomitant NN O
of IN O
the DT O
normal JJ O
aging VBG O
process NN O
. . O

IL NNP B-Gene
- : I-Gene
4 CD I-Gene
secreted VBN O
by IN O
activated JJ O
T NNP O
cells NNS O
is VBZ O
a DT O
pleiotropic JJ B-Gene
cytokine NN I-Gene
affecting VBG O
growth NN O
and CC O
differentiation NN O
of IN O
diverse NN O
cell NN O
types NNS O
such JJ O
as IN O
T NNP O
cells NNS O
, , O
B NNP O
cells NNS O
, , O
and CC O
mast JJS O
cells NNS O
. . O

A DT O
novel JJ B-Gene
T NNP I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
negative JJ I-Gene
regulatory JJ I-Gene
element NN I-Gene
( ( O
NRE NNP B-Gene
) ) O
composed VBD O
of IN O
two CD O
protein NNS O
- : O
binding VBG O
sites NNS O
were VBD O
mapped VBN O
in IN O
the DT O
5 CD O
' POS O
flanking JJ O
region NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
gene NN I-Gene
: : O
- : O
311CTCCCTTCT CD O
- : O
303 CD O
( ( O
NRE NNP B-Gene
- : I-Gene
I PRP I-Gene
) ) O
and CC O
- : O
288CTTTTTGCTT CD O
- : O
TGC NNP O
- : O
300 CD O
( ( O
NRE NNP B-Gene
- : I-Gene
II NN I-Gene
) ) O
. . O

A DT O
T NNP B-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
protein NN I-Gene
Neg NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
a DT O
ubiquitous JJ B-Gene
protein NN I-Gene
Neg NNP B-Gene
- : I-Gene
2 CD I-Gene
binding NN O
to TO O
NRE NNP B-Gene
- : I-Gene
I PRP I-Gene
and CC O
NRE NNP B-Gene
- : I-Gene
II NNP I-Gene
, , O
respectively RB O
, , O
were VBD O
identified VBN O
. . O

The DT O
addition NN O
of IN O
antisense NN O
oligonucleotides NNS O
to TO O
c VB B-Gene
- : I-Gene
fos NN I-Gene
significantly RB O
inhibited VBD O
IL NNP B-Gene
6 CD I-Gene
- : O
induced JJ O
IgM NNP B-Gene
production NN O
by IN O
SKW NNP O
6 CD O
. . O
4 CD O
cells NNS O
( ( O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
, , O
whereas JJ O
control NN O
oligonucleotides NNS O
had VBD O
no DT O
inhibitory JJ O
effect NN O
. . O

In IN O
this DT O
article NN O
, , O
transcriptional JJ O
regulation NN O
of IN O
the DT O
archetypal JJ B-Gene
T NNP I-Gene
- : I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
gene NN I-Gene
, , O
alpha JJ B-Gene
TCR NNP I-Gene
, , O
is VBZ O
discussed VBN O
. . O

Sodium NNP O
dodecyl NN O
sulfate NN O
- : O
polyacrylamide NN O
gel NN O
electrophoresis NN O
showed VBD O
significant JJ O
aldosterone NN O
binding NN O
at IN O
a DT O
molecular JJ O
weight NN O
of IN O
approximately RB O
50000 CD O
Dalton NNP O
which WDT O
was VBD O
absent NN O
with IN O
1 CD O
microM NNS O
cold JJ O
aldosterone NN O
, , O
but CC O
not RB O
cortisol VB O
in IN O
the DT O
binding NN O
media NNS O
. . O

We PRP O
used VBD O
phenolic JJ O
, , O
lipid JJ O
- : O
soluble JJ O
, , O
chain NN O
- : O
breaking NN O
antioxidants NNS O
( ( O
butylated VBN O
hydroxyanisole NN O
( ( O
BHA NNP O
) ) O
, , O
nordihydroquairetic JJ O
acid NN O
, , O
or CC O
alpha SYM O
- : O
tocopherol NN O
( ( O
vitamin JJ O
E NN O
) ) O
to TO O
show VB O
that IN O
peroxyl JJ O
radical JJ O
scavenging NN O
in IN O
unstimulated JJ O
and CC O
PMA NNP O
- : O
or CC O
TNF NNP O
- : O
stimulated VBD O
cells NNS O
blocks VBZ O
the DT O
functions NNS O
depending VBG O
on IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
. . O

Rather RB O
, , O
TNF NNP B-Gene
and CC O
PMA NNP B-Gene
can MD O
exert VB O
their PRP$ O
effect NN O
only RB O
if IN O
cells NNS O
are VBP O
in IN O
an DT O
appropriate JJ O
redox NN O
status NN O
, , O
because IN O
prior JJ O
modification NN O
toward IN O
reduction NN O
with IN O
BHA NNP O
treatment NN O
prevents NNS O
this DT O
activation NN O
. . O

Selection NN O
of IN O
optimal JJ O
kappa NN O
B NNP O
/ NNP O
Rel NNP O
DNA NNP O
- : O
binding VBG O
motifs NNS O
: : O
interaction NN O
of IN O
both DT O
subunits NNS O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
with IN O
DNA NNP O
is VBZ O
required VBN O
for IN O
transcriptional JJ O
activation NN O
. . O

Analysis NN O
of IN O
the DT O
p50 NN B-Gene
and CC O
p65 JJ B-Gene
subunits NNS I-Gene
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
transcription NN I-Gene
factor NN I-Gene
complex NN I-Gene
has VBZ O
revealed VBN O
that IN O
both DT O
proteins NNS O
can MD O
interact VB O
with IN O
related JJ O
DNA NN O
sequences NNS O
through IN O
either DT O
homo NN O
- : O
or CC O
heterodimer JJR O
formation NN O
. . O

However RB O
, , O
these DT O
studies NNS O
have VBP O
used VBN O
a DT O
limited JJ O
number NN O
of IN O
known VBN O
kappa NN O
B NNP O
DNA NNP O
motifs NN O
, , O
and CC O
the DT O
question NN O
of IN O
the DT O
optimal JJ O
DNA NNP O
sequences NNS O
preferred VBN O
by IN O
each DT O
homodimer NN O
has VBZ O
not RB O
been VBN O
addressed VBN O
. . O

Using VBG O
purified VBN O
recombinant JJ O
p50 NN B-Gene
, , O
p65 NN B-Gene
, , O
and CC O
c SYM B-Gene
- : I-Gene
Rel JJ I-Gene
proteins NNS I-Gene
, , O
optimal JJ O
DNA NNP O
- : O
binding NN O
motifs NNS O
were VBD O
selected VBN O
from IN O
a DT O
pool NN O
of IN O
random NN O
oligonucleotides NNS O
. . O

Differential JJ O
binding NN O
affinities NNS O
were VBD O
also RB O
obtained VBN O
with IN O
p50 JJ B-Gene
- : I-Gene
and CC I-Gene
c SYM I-Gene
- : I-Gene
Rel NNP I-Gene
- : I-Gene
selected VBN I-Gene
sequences NNS I-Gene
. . O

These DT O
findings NNS O
demonstrate VBP O
that IN O
interaction NN O
of IN O
both DT O
subunits NNS O
of IN O
the DT O
heterodimeric JJ B-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
complex NN I-Gene
with IN O
DNA NNP O
is VBZ O
required VBN O
for IN O
DNA NNP O
binding NN O
and CC O
transcriptional JJ O
activation NN O
and CC O
suggest VBP O
that IN O
transcriptional JJ O
activation NN O
mediated VBN O
by IN O
the DT O
individual JJ O
rel NN B-Gene
- : I-Gene
related JJ I-Gene
proteins NNS I-Gene
will MD O
differ VB O
dramatically RB O
, , O
depending VBG O
on IN O
the DT O
specific JJ O
kappa NN O
B NNP O
motifs NN O
present NN O
. . O

These DT O
observations NNS O
indicate VBP O
that IN O
during IN O
chronic JJ O
HIV NNP O
infection NN O
of IN O
U937 NNP O
cells NNS O
, , O
continuous JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( O
p50 JJ B-Gene
/ NNP I-Gene
p65 NN I-Gene
) ) O
translocation NN O
results NNS O
in IN O
p105 JJ O
promoter NN O
upregulation NN O
with IN O
subsequent JJ O
cytosolic NN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
accumulation NN O
, , O
ready JJ O
for IN O
further JJ O
translocation NN O
. . O

Similarly RB O
, , O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
activates NNS O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
the DT O
human JJ O
monocytic JJ O
cell NN O
line NN O
U NNP O
937 CD O
, , O
but CC O
not RB O
in IN O
resting VBG O
human JJ O
T NNP O
- : O
cells NNS O
. . O

Blockade NN O
of IN O
the DT O
DNA NNP B-Gene
- : I-Gene
binding NN I-Gene
complexes NNS I-Gene
with IN O
an DT O
anti JJ B-Gene
- : I-Gene
Fos NNP I-Gene
mAb NN I-Gene
demonstrated VBD O
a DT O
direct JJ O
participation NN O
of IN O
c SYM B-Gene
- : I-Gene
Fos NN I-Gene
in IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
complexes NNS I-Gene
induced VBN O
by IN O
anti JJ B-Gene
- : I-Gene
AIM NNP I-Gene
mAb NN I-Gene
. . O

These DT O
data NNS O
provide VBP O
the DT O
evidence NN O
that IN O
activation NN O
of IN O
human JJ O
peripheral JJ O
blood NN O
T NNP O
cells NNS O
through IN O
the DT O
AIM NNP O
activation NN O
pathway NN O
regulate VB O
the DT O
activity NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Gangliosides NNP O
suppress JJ O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
production NN O
in IN O
human JJ O
monocytes NNS O
. . O

Both DT O
normal JJ O
and CC O
malignant JJ O
cells NNS O
contain VBP O
gangliosides NNS O
as IN O
important JJ O
cell NN O
membrane NN O
constituents NNS O
that IN O
, , O
after IN O
being VBG O
shed VBN O
, , O
may MD O
influence VB O
cells NNS O
of IN O
the DT O
immune NN O
system NN O
. . O

Although IN O
under IN O
standard JJ O
culture NN O
conditions NNS O
, , O
bovine NN O
brain NN O
gangliosides NNS O
( ( O
100 CD O
micrograms NNS O
/ NNP O
ml NN O
) ) O
suppressed VBD O
LPS NNP O
- : O
stimulated VBD O
TNF NNP B-Gene
production NN O
5 CD O
- : O
fold NN O
in IN O
PBMC NNP O
and CC O
10 CD O
- : O
fold NN O
in IN O
Mono NNP O
Mac NNP O
6 CD O
cells NNS O
, , O
suppression NN O
was VBD O
more RBR O
efficient JJ O
under IN O
serum NN O
- : O
free JJ O
conditions NNS O
. . O

The DT O
suppressive JJ O
activity NN O
was VBD O
lost VBN O
in IN O
molecules NNS O
, , O
lacking VBG O
the DT O
sugar NN O
moiety NN O
or CC O
the DT O
lipid JJ O
moiety NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
phorbol NN O
ester SYM O
- : O
induced JJ O
production NN O
of IN O
O2 NNP O
- : O
was VBD O
similar JJ O
in IN O
cells NNS O
treated VBN O
with IN O
and CC O
without IN O
gangliosides NNS O
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
data NNS O
demonstrate NN O
that IN O
TNF NNP B-Gene
gene NN O
expression NN O
in IN O
monocytes NNS O
induced VBN O
by IN O
different JJ O
types NNS O
of IN O
stimuli NNS O
can MD O
be VB O
blocked VBN O
by IN O
gangliosides NNS O
at IN O
an DT O
early JJ O
step NN O
of IN O
signal JJ O
transduction NN O
. . O

Immunoglobulin NNP B-Gene
molecules NNS I-Gene
on IN O
the DT O
surface NN O
of IN O
a DT O
B NNP O
lymphocyte NN O
are VBP O
the DT O
endogenous JJ O
` `` O
` `` O
receptors NNS O
' '' O
' '' O
to TO O
which WDT O
specific JJ O
antigens NNS O
bind NN O
. . O

Because IN O
of IN O
the DT O
efficient JJ O
binding NN O
of IN O
TG NNP B-Gene
by IN O
surrogate JJ B-Gene
receptors NNS I-Gene
on IN O
non JJ O
- : O
T NN O
cells NNS O
, , O
we PRP O
assessed VBD O
the DT O
ability NN O
of IN O
such JJ O
cells NNS O
to TO O
present VB O
TG NNP B-Gene
to TO O
T NNP O
cells NNS O
. . O

Proliferation NN O
in IN O
response NN O
to TO O
TG NNP B-Gene
was VBD O
observed VBN O
in IN O
T NNP O
cells NNS O
from IN O
only RB O
1 CD O
of IN O
5 CD O
Hashimoto NNP O
patients NNS O
. . O

The DT O
transcriptional JJ O
activity NN O
of IN O
the DT O
heterodimer NN O
is VBZ O
regulated VBN O
by IN O
signal JJ O
- : O
dependent JJ O
phosphorylation NN O
and CC O
dephosphorylation NN O
events NNS O
. . O

A DT O
PMA NNP B-Gene
responsive JJ I-Gene
element NN I-Gene
was VBD O
localized VBN O
to TO O
a DT O
region NN O
between IN O
- : B-Gene
95 CD I-Gene
and CC I-Gene
- : I-Gene
36 CD I-Gene
bp NN I-Gene
relative NN O
to TO O
the DT O
transcription NN B-Gene
start NN I-Gene
site NN I-Gene
. . O

Within IN O
this DT O
region NN O
, , O
single JJ O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
- : I-Gene
and CC I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
like IN I-Gene
consensus NN I-Gene
sequences NNS I-Gene
were VBD O
noted VBN O
. . O

While IN O
all PDT O
the DT O
M10 NNP O
- : O
expressing VBG O
cell NN O
lines NNS O
remained VBD O
infectable JJ O
by IN O
HIV NNP O
- : O
1 CD O
, , O
these DT O
same JJ O
cells NNS O
failed VBD O
to TO O
support VB O
a DT O
productive JJ O
replication NN O
cycle NN O
when WRB O
infected VBN O
with IN O
a DT O
cloned JJ O
isolate NN O
of IN O
HIV NNP O
- : O
1 CD O
. . O

Expression NN O
of IN O
M10 NNP B-Gene
did VBD O
not RB O
affect JJ O
induction NN O
of IN O
HIV NNP O
transcription NN O
mediated VBN O
by IN O
the DT O
kappa NN B-Gene
B NNP I-Gene
regulatory JJ I-Gene
element NN I-Gene
or CC O
Tat NNP B-Gene
. . O

The DT O
inhibition NN O
of IN O
HIV NNP O
infection NN O
in IN O
cells NNS O
stably RB O
expressing VBG O
a DT O
transdominant JJ B-Gene
Rev NNP I-Gene
protein NN I-Gene
, , O
in IN O
the DT O
absence NN O
of IN O
any DT O
deleterious JJ O
effect NN O
on IN O
T NNP O
cell NN O
function NN O
, , O
suggests VBZ O
that IN O
such PDT O
a DT O
strategy NN O
could MD O
provide VB O
a DT O
therapeutic JJ O
effect NN O
in IN O
the DT O
T NNP O
lymphocytes NNS O
of IN O
acquired JJ O
immunodeficiency NN O
syndrome NN O
patients NNS O
. . O

The DT O
present JJ O
work NN O
has VBZ O
examined VBN O
the DT O
effects NNS O
of IN O
okadaic JJ O
acid NN O
, , O
an DT O
inhibitor NN O
of IN O
type NN B-Gene
1 CD I-Gene
and CC I-Gene
2A CD I-Gene
protein NN I-Gene
phosphatases NNS I-Gene
, , O
on IN O
the DT O
regulation NN O
of IN O
c SYM B-Gene
- : I-Gene
jun JJ I-Gene
expression NN O
during IN O
monocytic JJ O
differentiation NN O
of IN O
U NNP O
- : O
937 CD O
leukemia NN O
cells NNS O
. . O

( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

Mitogen NNP O
stimulation NN O
of IN O
T NNP O
- : O
cells NNS O
increases VBZ O
c SYM B-Gene
- : I-Gene
Fos NN I-Gene
and CC O
c SYM B-Gene
- : I-Gene
Jun NNP I-Gene
protein NN O
levels NNS O
, , O
AP NNP O
- : O
1 CD O
binding NN O
and CC O
AP NNP O
- : O
1 CD O
transcriptional JJ O
activity NN O
. . O

Both DT O
c SYM B-Gene
- : I-Gene
Fos NN I-Gene
and CC O
c SYM B-Gene
- : I-Gene
Jun NNP I-Gene
protein NN O
levels NNS O
were VBD O
increased VBN O
after IN O
Con NNP O
A NNP O
and CC O
PHA NNP O
stimulation NN O
. . O

The DT O
kinetics NNS O
of IN O
expression NN O
of IN O
the DT O
two CD O
genes NNS O
were VBD O
also RB O
slightly RB O
different JJ O
, , O
with IN O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
mRNA NN I-Gene
reaching VBG O
a DT O
peak NN O
at IN O
15 CD O
min NN O
after IN O
stimulation NN O
and CC O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
at IN O
30 CD O
min NN O
. . O

Nuclear JJ O
transcription NN O
studies NNS O
in IN O
vitro NN O
showed VBD O
that IN O
LTB4 NNP O
increased VBD O
the DT O
transcription NN O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
fos JJ I-Gene
gene NN I-Gene
7 CD O
- : O
fold NN O
and CC O
the DT O
c JJ B-Gene
- : I-Gene
jun NN I-Gene
gene NN I-Gene
1 CD O
. . O
4 CD O
- : O
fold NN O
. . O

Modulation NN O
of IN O
normal JJ O
erythroid JJ O
differentiation NN O
by IN O
the DT O
endogenous JJ O
thyroid NN O
hormone NN O
and CC O
retinoic NN B-Gene
acid NN I-Gene
receptors NNS I-Gene
: : O
a DT O
possible JJ O
target NN O
for IN O
v JJ B-Gene
- : I-Gene
erbA NN I-Gene
oncogene JJ I-Gene
action NN O
. . O

Thyroid NNP O
hormone NN O
( ( O
T3 NNP O
) ) O
alone RB O
caused VBD O
similar JJ O
but CC O
weaker JJR O
effects NNS O
. . O

Two CD O
types NNS O
of IN O
helper NN O
T NNP O
cell NN O
( ( O
Th NNP O
) ) O
clones NNS O
( ( O
Th1 NNP O
and CC O
Th2 NNP O
) ) O
are VBP O
defined VBN O
on IN O
the DT O
basis NN O
of IN O
different JJ O
patterns NNS O
of IN O
cytokine NN B-Gene
( ( O
lymphokine NN B-Gene
) ) O
secretion NN O
. . O

Yet RB O
phorbol JJ O
ester NN O
alone RB O
or CC O
calcium JJ O
ionophore NN O
alone RB O
produce VB O
several JJ O
lymphokines NNS B-Gene
. . O

GM2 NNP B-Gene
defines VBZ O
a DT O
binding NN B-Gene
site NN I-Gene
for IN O
protein NN O
( ( O
s JJ O
) ) O
whose WP$ O
binding NN O
is VBZ O
inducible JJ O
by IN O
PMA NNP O
. . O

Mutations NNS O
in IN O
the DT O
Pit NNP B-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
in IN O
children NNS O
with IN O
combined JJ O
pituitary JJ O
hormone NN O
deficiency NN O
. . O

Pit NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
a DT O
pituitary JJ B-Gene
- : I-Gene
specific JJ I-Gene
transcription NN I-Gene
factor NN I-Gene
that WDT O
binds VBZ O
to TO O
and CC O
transactivates VBZ O
promoters NNS B-Gene
of IN O
growth NN B-Gene
hormone NN I-Gene
and CC I-Gene
prolactin NN I-Gene
genes NNS I-Gene
. . O

Activation NN O
of IN O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
and CC O
elevation NN O
of IN O
cAMP NN O
interact NN O
synergistically RB O
to TO O
raise VB O
c SYM B-Gene
- : I-Gene
Fos NN I-Gene
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
activity NN O
in IN O
Jurkat NNP O
cells NNS O
. . O

We PRP O
have VBP O
earlier JJR O
found VBN O
that IN O
in IN O
Jurkat NNP O
cells NNS O
activation NN O
of IN O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
( ( O
PKC NNP B-Gene
) ) O
enhances VBZ O
the DT O
cyclic JJ O
adenosine NN O
monophosphate NN O
( ( O
cAMP NN O
) ) O
accumulation NN O
induced VBN O
by IN O
adenosine JJ O
receptor NN O
stimulation NN O
or CC O
activation NN O
of IN O
Gs NNP B-Gene
. . O

The DT O
former JJ O
two CD O
substances NNS O
interact JJ O
with IN O
T NNP O
cells NNS O
via IN O
the DT O
glucocorticoid NN B-Gene
and CC I-Gene
beta NN I-Gene
- : I-Gene
adrenergic JJ I-Gene
receptors NNS I-Gene
respectively RB O
. . O

When WRB O
occupied VBN O
by IN O
their PRP$ O
natural JJ O
ligands NNS O
, , O
glucocorticosteroids NNS O
and CC O
catecholamines NNS O
, , O
these DT O
receptors NNS O
have VBP O
a DT O
role NN O
in IN O
modulating VBG O
T NNP O
- : O
cell NN O
function NN O
during IN O
stress NN O
. . O

3 CD O
. . O

Synergistic JJ O
suppression NN O
of IN O
T NNP O
- : O
cell NN O
proliferation NN O
was VBD O
observed VBN O
when WRB O
various JJ O
concentrations NNS O
of IN O
DEX NNP O
and CC O
PGE2 NNP O
, , O
but CC O
not RB O
DEX NNP O
and CC O
ISO NNP O
, , O
were VBD O
added VBN O
to TO O
cultures NNS O
. . O

In IN O
vivo JJ O
footprint NN O
analysis NN O
of IN O
the DT O
HLA NNP B-Gene
- : I-Gene
DRA NNP I-Gene
gene NN I-Gene
promoter NN I-Gene
: : O
cell NN O
- : O
specific JJ O
interaction NN O
at IN O
the DT O
octamer NN B-Gene
site NN I-Gene
and CC O
up RB O
- : O
regulation NN O
of IN O
X NNP O
box NN O
binding NN O
by IN O
interferon NN B-Gene
gamma NN I-Gene
. . O

Danazol NNP O
bound NN O
to TO O
these DT O
sites NNS O
in IN O
high JJ O
concentration NN O
( ( O
10 CD O
( ( O
- : O
6 CD O
) ) O
M NNP O
, , O
clinical JJ O
serum NN O
concentration NN O
during IN O
danazol JJ O
therapy NN O
) ) O
and CC O
decreased VBD O
the DT O
number NN O
of IN O
both DT O
sites NNS O
. . O

Therefore RB O
, , O
we PRP O
describe VBP O
a DT O
microtitre NN O
assay NN O
system NN O
for IN O
glucocorticoid NN B-Gene
receptors NNS I-Gene
which WDT O
is VBZ O
a DT O
whole JJ O
- : O
cell NN O
competitive JJ O
binding NN O
radioassay NN O
using VBG O
[ JJ O
3H CD O
] SYM O
- : O
dexamethasone NN O
as IN O
radioligand NN O
. . O

Thus RB O
enabled VBN O
to TO O
perform VB O
the DT O
test NN O
on IN O
multiple JJ O
blood NN O
samples NNS O
in IN O
parallel JJ O
, , O
we PRP O
investigated VBD O
cardiac JJ O
infarction NN O
patients NNS O
over IN O
a DT O
12 CD O
- : O
day NN O
period NN O
to TO O
test VB O
if IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
binding NN O
is VBZ O
altered VBN O
in IN O
this DT O
' POS O
stressful JJ O
' POS O
disease NN O
. . O

On IN O
the DT O
first JJ O
day NN O
of IN O
the DT O
disease NN O
, , O
glucocorticoid JJ B-Gene
receptor NN I-Gene
capacity NN O
was VBD O
significantly RB O
decreased VBN O
without IN O
alteration NN O
of IN O
the DT O
receptor NN O
- : O
ligand NN O
affinity NN O
, , O
whereas NNS O
on IN O
days NNS O
4 CD O
and CC O
12 CD O
the DT O
number NN O
of IN O
receptor NN O
sites NNS O
was VBD O
normal JJ O
again RB O
. . O

CsA NNP O
was VBD O
found VBN O
not RB O
to TO O
inhibit VB O
lck JJ B-Gene
gene NN O
expression NN O
, , O
nor CC O
the DT O
activity NN O
of IN O
the DT O
lck JJ B-Gene
gene NN I-Gene
product NN O
. . O

The DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
contains NNS O
binding VBG B-Gene
sites NNS I-Gene
for IN O
nuclear JJ B-Gene
factors NNS I-Gene
including VBG O
NFAT NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
Oct NNP B-Gene
, , O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
which WDT O
are VBP O
all DT O
potentially RB O
sensitive JJ O
to TO O
activation NN O
of IN O
PKC NNP B-Gene
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
at IN O
- : B-Gene
150 CD I-Gene
bp NN I-Gene
represents VBZ O
a DT O
major JJ O
, , O
if IN O
not RB O
the DT O
only RB O
, , O
site NN O
of IN O
PKC NNP B-Gene
responsiveness NN O
in IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
. . O

Mice NNP O
transgenic NN O
for IN O
the DT O
human JJ B-Gene
T NNP I-Gene
cell NN I-Gene
leukemia NN I-Gene
virus NN I-Gene
( ( I-Gene
HTLV NNP I-Gene
- : I-Gene
I PRP I-Gene
) ) I-Gene
Tax NNP I-Gene
gene NN I-Gene
develop VB O
fibroblastic JJ O
tumors NNS O
that IN O
express NN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
- : I-Gene
inducible JJ I-Gene
early JJ I-Gene
genes NNS I-Gene
. . O

Mice NNP O
treated VBD O
with IN O
antisense NN O
to TO O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
ODNs NNP O
showed VBD O
rapid JJ O
regression NN O
of IN O
transplanted JJ O
fibrosarcomas NN O
. . O

Binding NNP O
of IN O
125I CD O
- : O
labeled VBD O
aldosterone NN O
to TO O
plasma VB O
membranes NNS O
of IN O
HML NNP O
shares NNS O
important JJ O
features NNS O
with IN O
these DT O
functional JJ O
data NNS O
. . O

Leukotriene NNP O
B4 NNP O
transcriptionally RB O
activates VBZ O
interleukin JJ B-Gene
- : I-Gene
6 CD I-Gene
expression NN O
involving VBG O
NK NNP B-Gene
- : I-Gene
chi NN I-Gene
B NNP I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
IL6 NN I-Gene
. . O

It PRP O
is VBZ O
, , O
however RB O
, , O
still RB O
unclear JJ O
whether IN O
LTB4 NNP O
acts VBZ O
in IN O
this DT O
regard NN O
directly RB O
or CC O
indirectly RB O
by IN O
stimulating VBG O
the DT O
release NN O
of IN O
chemotactic JJ O
and CC O
inflammatory JJ B-Gene
cytokines NNS I-Gene
. . O

We PRP O
furthermore VBP O
demonstrate JJ O
that IN O
this DT O
process NN O
involves VBZ O
activation NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
NF NNP B-Gene
- : I-Gene
chi NN I-Gene
B NNP I-Gene
and CC O
, , O
to TO O
a DT O
lesser JJR O
extent NN O
, , O
of IN O
NF NNP B-Gene
- : I-Gene
IL6 NNP I-Gene
, , O
while IN O
the DT O
activity NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
shown VBN O
to TO O
otherwise VB O
confer NN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
inducibility NN O
, , O
appeared VBD O
to TO O
be VB O
unaffected VBN O
by IN O
LTB4 NNP O
. . O

The DT O
signaling VBG O
events NNS O
mediating VBG O
this DT O
effect NN O
appeared VBD O
to TO O
involve VB O
the DT O
release NN O
of IN O
H2O2 NNP O
, , O
since IN O
LTB4 NNP O
failed VBD O
to TO O
induce VB O
NF NNP B-Gene
- : I-Gene
chi NN I-Gene
B NNP I-Gene
or CC O
NF NNP B-Gene
- : I-Gene
IL6 NN I-Gene
in IN O
the DT O
presence NN O
of IN O
the DT O
scavenger NN O
of IN O
H2O2 NNP O
, , O
N NNP O
- : O
acetyl NN O
- : O
L NNP O
- : O
cysteine NN O
. . O

The DT O
insertion NN O
was VBD O
not RB O
required VBN O
for IN O
Fc NNP B-Gene
gamma NN I-Gene
RII NNP I-Gene
to TO O
modulate VB O
surface NN B-Gene
immunoglobulin NN I-Gene
- : O
triggered VBN O
B NNP O
- : O
cell NN O
activation NN O
. . O

[ JJ O
Age NNP O
- : O
related JJ O
changes NNS O
in IN O
glucocorticoid NN B-Gene
and CC I-Gene
mineralocorticoid JJ I-Gene
receptors NNS I-Gene
in IN O
lymphocytes NNS O
of IN O
healthy JJ O
persons NNS O
and CC O
patients NNS O
with IN O
hypertension NN O
] NN O

Still RB O
a DT O
more RBR O
essential JJ O
rise NN O
in IN O
the DT O
number NN O
of IN O
receptors NNS O
is VBZ O
observed VBN O
in IN O
mid JJ O
- : O
age NN O
hypertensive JJ O
patients NNS O
than IN O
in IN O
elderly JJ O
ones NNS O
. . O

Here RB O
, , O
Stuart NNP O
Schreiber NNP O
and CC O
Gerald NNP O
Crabtree NNP O
review NN O
recent JJ O
findings NNS O
that WDT O
indicate VBP O
CsA NNP O
and CC O
FK506 NNP O
operate VBP O
as IN O
prodrugs NNS O
: : O
they PRP O
bind VBP O
endogenous JJ B-Gene
intracellular JJ I-Gene
receptors NNS I-Gene
, , O
the DT O
immunophilins NNS B-Gene
, , O
and CC O
the DT O
resulting VBG O
complex JJ O
targets NNS O
the DT O
protein NN B-Gene
phosphatase NN I-Gene
, , I-Gene
calcineurin NN B-Gene
, , O
to TO O
exert VB O
the DT O
immunosuppressive JJ O
effect NN O
. . O

PLB NNP O
- : O
985 CD O
cells NNS O
represent VBP O
a DT O
bipotential JJ O
myelomonoblastic NN O
cell NN O
population NN O
capable JJ O
of IN O
either CC O
granulocytic JJ O
or CC O
monocytic JJ O
differentiation NN O
after IN O
induction NN O
with IN O
appropriate JJ O
inducers NNS O
. . O

Mutations NNS O
affecting VBG O
the DT O
5 CD B-Gene
' POS I-Gene
guanine NN I-Gene
residues NNS I-Gene
of IN O
the DT O
kappa NN B-Gene
B NNP I-Gene
site NN I-Gene
were VBD O
unable JJ O
to TO O
compete VB O
for IN O
these DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
- : I-Gene
related JJ I-Gene
proteins NNS I-Gene
. . O

Inducibility NN O
of IN O
endogenous JJ O
IFN NNP B-Gene
- : I-Gene
beta NN I-Gene
and CC I-Gene
IFN NNP I-Gene
- : I-Gene
alpha NN I-Gene
RNA NNP I-Gene
was VBD O
also RB O
increased VBN O
in IN O
PLB NNP O
- : O
IIIB NNP O
cells NNS O
. . O

In IN O
the DT O
present JJ O
study NN O
we PRP O
report VBP O
on IN O
6 CD O
patients NNS O
( ( O
2 CD O
males NNS O
and CC O
4 CD O
females NNS O
) ) O
with IN O
the DT O
syndrome NN O
. . O

First NNP O
is VBZ O
an DT O
expansion NN O
phase NN O
prior RB O
to TO O
TCR NNP B-Gene
rearrangement NN O
, , O
which WDT O
appears VBZ O
to TO O
be VB O
correlated VBN O
with IN O
programming NN O
of IN O
at IN O
least JJS O
some DT O
response NN O
genes NNS O
for IN O
inducibility NN O
. . O

However RB O
, , O
the DT O
profound NN O
T NNP O
cell NN O
deficit NN O
of IN O
nude JJ O
mice NN O
indicates VBZ O
that IN O
the DT O
thymus NN O
is VBZ O
by IN O
far RB O
the DT O
most RBS O
potent JJ O
site NN O
for IN O
inducing VBG O
the DT O
expansion NN O
per IN O
se NN O
, , O
even RB O
if IN O
other JJ O
sites NNS O
can MD O
induce VB O
some DT O
response NN O
acquisition NN O
. . O

Second NNP O
is VBZ O
a DT O
controlled JJ O
phase NN O
of IN O
TCR NNP B-Gene
gene NN I-Gene
rearrangement NN O
. . O

It PRP O
seems VBZ O
that IN O
the DT O
rearrangement NN O
of IN O
the DT O
TCR NNP B-Gene
gamma NN I-Gene
loci NN I-Gene
in IN O
the DT O
gamma NN O
delta JJ O
lineage NN O
may MD O
not RB O
always RB O
take VB O
place NN O
at IN O
a DT O
developmental JJ O
stage NN O
strictly RB O
equivalent JJ O
to TO O
the DT O
rearrangement NN O
of IN O
TCR NNP B-Gene
beta NN I-Gene
in IN O
the DT O
alpha NN O
beta NN O
lineage NN O
, , O
and CC O
it PRP O
is VBZ O
not RB O
clear JJ O
just RB O
how WRB O
early JJ O
the DT O
two CD O
lineages NNS O
diverge VBP O
. . O

The DT O
genes NNS O
that WDT O
need VBP O
to TO O
be VB O
induced VBN O
for IN O
this DT O
response NN O
are VBP O
not RB O
yet RB O
identified VBN O
, , O
but CC O
it PRP O
is VBZ O
unquestionably RB O
a DT O
form NN O
of IN O
activation NN O
. . O

In IN O
contrast NN O
, , O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
p50 NN I-Gene
alone RB O
fails VBZ O
to TO O
stimulate VB O
kappa NN O
B NNP O
- : O
directed JJ O
transcription NN O
, , O
and CC O
based VBN O
on IN O
prior JJ O
in IN O
vitro JJ O
studies NNS O
, , O
is VBZ O
not RB O
directly RB O
regulated VBN O
by IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
. . O

Together RB O
, , O
these DT O
findings NNS O
suggest VBP O
that IN O
the DT O
nuclear JJ O
localization NN O
signal NN O
and CC O
transactivation NN B-Gene
domain NN I-Gene
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
p65 NN I-Gene
constitute NN O
a DT O
bipartite NN O
system NN O
that WDT O
is VBZ O
critically RB O
involved VBN O
in IN O
the DT O
inhibitory JJ O
function NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
/ NNP I-Gene
MAD NNP I-Gene
- : I-Gene
3 CD I-Gene
. . O

This DT O
interaction NN O
is VBZ O
functional JJ O
as IN O
it PRP O
leads VBZ O
to TO O
retargeting VBG O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
p50 NN I-Gene
from IN O
the DT O
nucleus NN O
to TO O
the DT O
cytoplasm NN O
. . O

However RB O
, , O
no DT O
loss NN O
of IN O
DNA NNP O
binding VBG O
activity NN O
is VBZ O
observed VBN O
, , O
presumably RB O
reflecting VBG O
the DT O
unique JJ O
C NNP B-Gene
- : I-Gene
terminal NN I-Gene
domain NN I-Gene
that WDT O
is VBZ O
distinct JJ O
from IN O
that DT O
present JJ O
in IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
p65 NN I-Gene
. . O

We PRP O
have VBP O
biochemically RB O
and CC O
functionally RB O
characterized VBD O
a DT O
new JJ O
transcription NN B-Gene
factor NN I-Gene
, , O
NP NNP B-Gene
- : I-Gene
TCII NN I-Gene
, , O
which WDT O
is VBZ O
present JJ O
in IN O
nuclei NN O
from IN O
unstimulated JJ O
T NNP O
and CC O
B NNP O
lymphocytes NNS O
but CC O
is VBZ O
not RB O
found VBN O
in IN O
nonhematopoietic JJ O
cells NNS O
. . O

[ JJ O
Mechanism NNP O
of IN O
action NN O
of IN O
steroid JJ O
hormones NNS O
. . O
I PRP O
. . O
Estrogens NNS O
] VBP O

The DT O
steroid NN O
hormone NN O
are VBP O
very RB O
versatile JJ O
molecules NNS O
: : O
although IN O
they PRP O
are VBP O
related VBN O
among IN O
them PRP O
by IN O
their PRP$ O
chemical NN O
structure NN O
, , O
they PRP O
have VBP O
very RB O
diverse JJ O
functions NNS O
and CC O
including VBG O
antagonic JJ O
. . O

Their PRP$ O
action NN O
mechanism NN O
is VBZ O
not RB O
completely RB O
cleared VBN O
. . O

Chloramphenicol NNP B-Gene
acetyl JJ I-Gene
transferase NN I-Gene
( ( O
CAT NNP B-Gene
) ) O
assays VBZ O
using VBG O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
( ( I-Gene
- : I-Gene
139 CD I-Gene
) ) I-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
- : I-Gene
CAT NNP I-Gene
construct NN I-Gene
showed VBD O
no DT O
PMA NNP O
induction NN O
of IN O
CAT NNP B-Gene
activity NN O
in IN O
these DT O
subclones NNS O
( ( O
unlike IN O
the DT O
parental JJ O
line NN O
and CC O
other JJ O
subclones NNS O
) ) O
. . O

Although IN O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
has VBZ O
not RB O
been VBN O
cloned VBN O
or CC O
purified VBN O
, , O
there EX O
is VBZ O
evidence NN O
that IN O
it PRP O
is VBZ O
a DT O
major JJ O
target NN O
for IN O
immunosuppression NN O
by IN O
cyclosporin NN O
A NNP O
( ( O
CsA NNP O
) ) O
and CC O
FK506 NNP O
( ( O
refs VB O
2 CD O
- : O
7 CD O
) ) O
. . O

Although IN O
it PRP O
has VBZ O
been VBN O
previously RB O
shown VBN O
that IN O
the DT O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
kappa NN I-Gene
B NNP I-Gene
motif NN I-Gene
functions NNS O
as IN O
a DT O
potent NN O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
/ JJ I-Gene
tumor NN I-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
responsive JJ I-Gene
element NN I-Gene
in IN O
nonlymphoid JJ O
cells NNS O
, , O
its PRP$ O
activity NN O
was VBD O
found VBN O
to TO O
be VB O
repressed VBN O
in IN O
lymphoid JJ O
cells NNS O
such JJ O
as IN O
a DT O
Jurkat NNP O
T NNP O
- : O
cell NN O
line NN O
. . O

Cortisol NNP O
resistance NN O
in IN O
acquired JJ O
immunodeficiency NN O
syndrome NN O
. . O

An DT O
acquired JJ O
form NN O
of IN O
peripheral JJ O
resistance NN O
to TO O
glucocorticoids NNS O
was VBD O
suspected VBN O
. . O

[ RB O
3H CD O
] JJ O
Thymidine NNP O
incorporation NN O
was VBD O
decreased VBN O
dose JJ O
- : O
dependently RB O
by IN O
dexamethasone NN O
in IN O
controls NNS O
and CC O
patients NNS O
; : O
the DT O
effect NN O
was VBD O
significantly RB O
blunted VBN O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
in IN O
group NN O
1 CD O
patients NNS O
, , O
which WDT O
suggests VBZ O
that IN O
activation NN O
of IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
is VBZ O
impaired VBN O
as IN O
a DT O
result NN O
of IN O
the DT O
glucocorticoid JJ B-Gene
receptor NN I-Gene
abnormality NN O
. . O

After IN O
the DT O
DNA NNP B-Gene
fragment NN I-Gene
containing VBG O
the DT O
CAG NNP B-Gene
repeats NN I-Gene
is VBZ O
amplified VBN O
by IN O
the DT O
polymerase NN O
chain NN O
reaction NN O
, , O
a DT O
primer NN O
extension NN O
is VBZ O
carried VBN O
out IN O
; : O
the DT O
extension NN O
of IN O
the DT O
end NN B-Gene
- : I-Gene
labelled JJ I-Gene
reverse NN I-Gene
primer NN I-Gene
adjacent NN O
to TO O
3 CD B-Gene
' '' I-Gene
end NN I-Gene
of IN O
CAG NNP B-Gene
repeats NNS I-Gene
stops VBP O
at IN O
the DT O
first JJ O
T NNP O
after IN O
CAG NNP B-Gene
repeats VBZ I-Gene
with IN O
the DT O
incorporation NN O
of IN O
dideoxy JJ O
ATP NNP O
in IN O
the DT O
reaction NN O
mixture NN O
. . O

Cells NNS O
of IN O
monocyte JJ O
lineage NN O
serve NN O
as IN O
effector NN O
cells NNS O
in IN O
the DT O
cellular JJ O
immune NN O
response NN O
. . O

The DT O
response NN O
to TO O
antigen VB O
proceeds NNS O
at IN O
the DT O
T NNP O
helper NN O
cell NN O
level NN O
through IN O
two CD O
independent JJ O
forms NNS O
of IN O
cellular JJ O
collaboration NN O
, , O
contact NN O
and CC O
lymphokine NN B-Gene
. . O

It PRP O
is VBZ O
evident JJ O
that IN O
assembly NN O
of IN O
the DT O
surface NN B-Gene
domain NN I-Gene
of IN O
TF NNP B-Gene
with IN O
VIIa NNP B-Gene
to TO O
form VB O
the DT O
binary JJ O
TF NNP B-Gene
. . I-Gene
VIIa NNP I-Gene
complex JJ I-Gene
induces NNS O
a DT O
significant JJ O
increase NN O
in IN O
the DT O
Kcat NNP O
of IN O
the DT O
catalytic JJ B-Gene
domain NN I-Gene
of IN O
VIIa NNP B-Gene
for IN O
small JJ O
peptidyl NN O
substrates NNS O
and CC O
more JJR O
profoundly RB O
for IN O
protein NN B-Gene
substrate NN I-Gene
. . O

It PRP O
is VBZ O
also RB O
evident JJ O
that IN O
association NN O
of IN O
X NN B-Gene
with IN O
charged VBN O
phospholipid JJ O
surfaces NNS O
enhances VBZ O
the DT O
proteolytic JJ O
activation NN O
of IN O
this DT O
zymogen NN B-Gene
by IN O
increasing VBG O
recognition NN O
and CC O
susceptibility NN O
of IN O
the DT O
sessile JJ O
peptide NN O
bond NN O
deduced VBD O
from IN O
the DT O
markedly RB O
decreased JJ O
Km NNP O
and CC O
increased VBD O
Kcat NNP O
. . O

NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
is VBZ O
a DT O
potent JJ O
mediator NN O
of IN O
specific JJ O
gene NN O
expression NN O
in IN O
human JJ O
monocytes NNS O
and CC O
has VBZ O
been VBN O
shown VBN O
to TO O
play VB O
a DT O
role NN O
in IN O
transcription NN O
of IN O
the DT O
HIV NNP O
- : O
1 CD O
genome NN O
in IN O
promonocytic JJ O
leukemias NN O
. . O

There EX O
is VBZ O
little JJ O
information NN O
available JJ O
on IN O
the DT O
response NN O
of IN O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
to TO O
cytokines VB B-Gene
in IN O
normal JJ O
human JJ O
monocytes NNS O
. . O

In IN O
THP NNP O
- : O
1 CD O
cells NNS O
, , O
TPA NNP O
also RB O
induced VBD O
a DT O
new JJ O
, , O
faster RBR B-Gene
- : I-Gene
migrating VBG I-Gene
NF NNP I-Gene
kappa NN I-Gene
B NNP I-Gene
species VBZ I-Gene
not RB O
induced VBN O
in IN O
monocytes NNS O
. . O

The DT O
endothelium NN O
plays VBZ O
a DT O
critical JJ O
role NN O
in IN O
inflammation NN O
by IN O
directing VBG O
circulating VBG O
leukocytes NNS O
into IN O
extravascular JJ O
tissues NNS O
by IN O
expressing VBG O
adhesive JJ B-Gene
molecules NNS I-Gene
for IN O
leukocytes NNS O
[ JJ O
e NN O
. . O
g NN O
. . O
, , O
endothelial JJ B-Gene
- : I-Gene
leukocyte NN I-Gene
adhesion NN I-Gene
molecule NN I-Gene
1 CD I-Gene
( ( O
ELAM NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
and CC O
intercellular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
1 CD I-Gene
( ( O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
] NN O
. . O

In IN O
contrast NN O
, , O
sodium NN O
salicylate NN O
( ( O
1 CD O
mM NN O
) ) O
inhibited VBD O
neither DT O
adhesion NN O
nor CC O
expression NN O
of IN O
these DT O
adhesion NN B-Gene
molecules NNS I-Gene
. . O

These DT O
studies NNS O
suggest VBP O
that IN O
antagonism NN O
by IN O
dexamethasone NN O
of IN O
endotoxin NN B-Gene
- : O
induced JJ O
inflammation NN O
is VBZ O
a DT O
specific JJ O
instance NN O
of IN O
the DT O
general JJ O
biological JJ O
principle NN O
that IN O
the DT O
glucocorticoid NN B-Gene
receptor NN I-Gene
is VBZ O
a DT O
hormone NN O
- : O
dependent JJ O
regulator NN O
of IN O
transcription NN O
. . O

Biochemical JJ O
purification NN O
and CC O
cDNA NN O
cloning NN O
has VBZ O
now RB O
revealed VBN O
that IN O
BSAP NNP B-Gene
belongs VBZ O
to TO O
the DT O
family NN O
of IN O
paired JJ B-Gene
domain NN I-Gene
proteins NNS I-Gene
. . O

BSAP NNP B-Gene
is VBZ O
encoded VBN O
by IN O
the DT O
Pax NNP B-Gene
- : I-Gene
5 CD I-Gene
gene NN I-Gene
and CC O
has VBZ O
been VBN O
highly RB O
conserved VBN O
between IN O
human JJ O
and CC O
mouse NN O
. . O

Later RB O
, , O
the DT O
expression NN O
of IN O
the DT O
BSAP NNP B-Gene
gene NN I-Gene
shifts NNS O
to TO O
the DT O
fetal NN O
liver NN O
where WRB O
it PRP O
correlates VBZ O
with IN O
the DT O
onset NN O
of IN O
B NNP O
lymphopoiesis NN O
. . O

Specific JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
subunits VBZ I-Gene
act NN O
in IN O
concert NN O
with IN O
Tat NNP B-Gene
to TO O
stimulate VB O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
transcription NN O
. . O

NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
is VBZ O
a DT O
protein NN B-Gene
complex NN I-Gene
which WDT O
functions NNS O
in IN O
concert NN O
with IN O
the DT O
tat NN B-Gene
- : I-Gene
I PRP I-Gene
gene NN I-Gene
product NN I-Gene
to TO O
stimulate VB O
human JJ O
immunodeficiency NN O
virus NN O
( ( O
HIV NNP O
) ) O
transcription NN O
. . O

We PRP O
have VBP O
found VBN O
that IN O
the DT O
p49 NN B-Gene
( ( I-Gene
100 CD I-Gene
) ) I-Gene
DNA NN I-Gene
binding VBG I-Gene
subunit NN I-Gene
, , O
together RB O
with IN O
p65 NN B-Gene
, , O
can MD O
act VB O
in IN O
concert NN O
with IN O
Tat NNP B-Gene
- : I-Gene
I PRP I-Gene
to TO O
stimulate VB O
the DT O
expression NN O
of IN O
HIV NNP B-Gene
- : I-Gene
CAT NNP I-Gene
plasmid NN I-Gene
. . O

Little JJ O
effect NN O
was VBD O
observed VBN O
with IN O
50 CD B-Gene
- : I-Gene
kDa NN I-Gene
forms NNS I-Gene
of IN O
p105 NN B-Gene
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
or CC O
rel NN B-Gene
, , O
in IN O
combination NN O
with IN O
p65 NN B-Gene
or CC O
full JJ B-Gene
- : I-Gene
length NN I-Gene
c SYM I-Gene
- : I-Gene
rel NN I-Gene
, , O
which WDT O
do VBP O
not RB O
stimulate VB O
the DT O
HIV NNP B-Gene
enhancer NN I-Gene
in IN O
these DT O
cells NNS O
. . O

Stable JJ O
expression NN O
of IN O
HB24 NNP B-Gene
, , O
a DT O
diverged JJ B-Gene
human JJ I-Gene
homeobox NN I-Gene
gene NN I-Gene
, , O
in IN O
T NNP O
lymphocytes VBZ O
induces NNS O
genes NNS O
involved VBN O
in IN O
T NNP O
cell NN O
activation NN O
and CC O
growth NN O
. . O

In IN O
the DT O
studies NNS O
described VBN O
in IN O
this DT O
report NN O
, , O
we PRP O
have VBP O
identified VBN O
two CD O
potential JJ O
Ets NNP B-Gene
binding VBG I-Gene
sites NNS I-Gene
, , O
EBS1 NNP O
and CC O
EBS2 NNP B-Gene
, , O
which WDT O
are VBP O
conserved VBN O
in IN O
both DT O
the DT O
human JJ B-Gene
and CC I-Gene
murine JJ I-Gene
interleukin NN I-Gene
- : I-Gene
2 CD I-Gene
enhancers NNS I-Gene
. . O

Possible JJ O
mechanisms NNS O
by IN O
which WDT O
these DT O
proteins NNS O
may MD O
regulate VB O
transcription NN O
of IN O
the DT O
epsilon NN B-Gene
- : I-Gene
globin NN I-Gene
- : I-Gene
encoding VBG I-Gene
gene NN I-Gene
in IN O
erythroid JJ O
and CC O
non JJ O
- : O
erythroid NN O
cells NNS O
are VBP O
discussed VBN O
. . O

A DT O
MEDLINE NNP O
search NN O
of IN O
the DT O
English NNP O
- : O
language NN O
literature NN O
was VBD O
conducted VBN O
using VBG O
the DT O
indexing NN O
terms NNS O
' POS O
immunology NN O
, , O
calcitriol NN O
and CC O
vitamin NN O
D NNP O
' POS O
to TO O
identify VB O
studies NNS O
indicating VBG O
a DT O
role NN O
for IN O
calcitriol NN O
as IN O
a DT O
primary JJ O
immunomodulator NN O
. . O

This DT O
protein NN O
is VBZ O
distinct JJ O
from IN O
other JJ O
members NNS O
of IN O
the DT O
steroid JJ B-Gene
/ NNP I-Gene
thyroid NN I-Gene
hormone NN I-Gene
receptor NN I-Gene
family NN I-Gene
including VBG O
the DT O
COUP NNP B-Gene
protein NN I-Gene
which WDT O
has VBZ O
a DT O
closely RB O
related JJ O
DNA NNP O
binding NN O
specificity NN O
. . O

A DT O
Tat NNP B-Gene
- : I-Gene
responsive JJ I-Gene
element NN I-Gene
is VBZ O
found VBN O
upstream RB O
within IN O
the DT O
viral JJ B-Gene
promoter NN I-Gene
that IN O
in IN O
glial JJ O
- : O
derived VBN O
cell NN O
lines NNS O
allows VBZ O
transactivation NN O
in IN O
the DT O
absence NN O
of IN O
TAR NNP B-Gene
. . O

Further RB O
, , O
we PRP O
observe VBP O
that DT O
TAR NNP B-Gene
- : I-Gene
deleted VBD I-Gene
mutants NNS I-Gene
of IN O
HIV NNP O
- : O
1 CD O
demonstrate NN O
normal JJ O
late JJ O
gene NN O
expression NN O
in IN O
glial JJ O
cells NNS O
as IN O
evidenced VBN O
by IN O
syncytia NN O
formation NN O
and CC O
production NN O
of IN O
viral JJ B-Gene
p24 NN I-Gene
antigen NN I-Gene
. . O

At IN O
least JJS O
two CD O
21 CD B-Gene
bp NNS I-Gene
repeats NNS I-Gene
were VBD O
required VBN O
for IN O
high JJ O
levels NNS O
of IN O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
activation NN O
and CC O
mutagenesis NN O
of IN O
the DT O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
consensus NN I-Gene
binding NN I-Gene
sequences NNS I-Gene
in IN O
the DT O
21 CD B-Gene
bp NN I-Gene
repeats NNS I-Gene
eliminate VBP O
this DT O
activation NN O
. . O

Activation NN O
of IN O
the DT O
human JJ B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
type NN I-Gene
1 CD I-Gene
enhancer NN I-Gene
is VBZ O
not RB O
dependent JJ O
on IN O
NFAT NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Activation NN O
by IN O
the DT O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
antigen NN I-Gene
receptor NN I-Gene
is VBZ O
minimal JJ O
in IN O
Jurkat NNP O
cells NNS O
and CC O
is VBZ O
mediated VBN O
by IN O
the DT O
kappa NN B-Gene
B NNP I-Gene
sites VBZ I-Gene
. . O

The DT O
promoter NN O
of IN O
the DT O
major JJ B-Gene
histocompatibility NN I-Gene
class NN I-Gene
II NNP I-Gene
gene NN I-Gene
DRA NNP B-Gene
contains VBZ O
an DT O
octamer JJ B-Gene
element NN I-Gene
( ( O
ATTTGCAT NNP O
) ) O
that WDT O
is VBZ O
required VBN O
for IN O
efficient JJ O
DRA NNP B-Gene
expression NN O
in IN O
B NNP O
cells NNS O
. . O

In IN O
vitro JJ O
transcription NN O
analysis NN O
using VBG O
protein JJ O
fractions NNS O
enriched VBD O
for IN O
the DT O
octamer JJR O
- : O
binding NN O
protein NN O
OTF NNP B-Gene
- : I-Gene
2 CD I-Gene
demonstrate NN O
a DT O
positive JJ O
functional JJ O
role NN O
for IN O
OTF NNP B-Gene
- : I-Gene
2 CD I-Gene
in IN O
DRA NNP B-Gene
gene NN I-Gene
transcription NN O
. . O

Recombinant NNP B-Gene
OTF NNP I-Gene
- : I-Gene
2 CD I-Gene
protein NN I-Gene
produced VBN O
by IN O
in IN O
vitro JJ O
transcription NN O
/ NNP O
translation NN O
could MD O
also RB O
enhance VB O
DRA NNP B-Gene
gene NN I-Gene
transcription NN O
in IN O
vitro NN O
. . O

However RB O
, , O
the DT O
increase NN O
in IN O
ISGF3 NNP B-Gene
activity NN O
ultimately RB O
correlates VBZ O
with IN O
the DT O
accumulation NN O
of IN O
ISGF3 NNP B-Gene
gamma NN I-Gene
induced VBN O
by IN O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
or CC O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
. . O

( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

An DT O
attempt NN O
was VBD O
also RB O
undertaken JJ O
to TO O
use VB O
a DT O
cell NN O
harvester NN O
for IN O
the DT O
separation NN O
of IN O
cells NNS O
from IN O
unbound JJ O
ligand NN O
. . O

Glucocorticoid NNP B-Gene
receptor NN I-Gene
and CC O
inhibition NN O
of IN O
3 CD O
- : O
O NNP O
- : O
methyl NN O
- : O
D NNP O
- : O
glucose JJ O
uptake JJ O
by IN O
glucocorticoids NNS O
in IN O
peripheral JJ O
blood NN O
leukocytes NNS O
from IN O
normal JJ O
humans NNS O
: : O
correlation NN O
between IN O
receptor NN O
level NN O
and CC O
hormone NN O
effect NN O
in IN O
vitro NN O
. . O

It PRP O
was VBD O
found VBN O
that IN O
lipopolysaccharide RB O
induced VBN O
strongly RB O
both DT O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
and CC O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
expression NN O
as RB O
well RB O
as IN O
AP1 NNP B-Gene
formation NN O
. . O

Regulation NN O
of IN O
interleukin JJ B-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
production NN O
by IN O
glucocorticoids NNS O
in IN O
human JJ O
monocytes NNS O
: : O
the DT O
mechanism NN O
of IN O
action NN O
depends VBZ O
on IN O
the DT O
activation NN O
signal NN O
. . O

Nuclear JJ B-Gene
transcription NN I-Gene
factors NNS I-Gene
that WDT O
bind VBP O
to TO O
elements NNS O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
. . O

However RB O
, , O
the DT O
signaling NN O
requirements NNS O
and CC O
sensitivity NN O
to TO O
protein VB O
synthesis NN O
inhibitors NNS O
differ VBP O
considerably RB O
. . O

In IN O
addition NN O
, , O
p65 NN B-Gene
gave VBD O
per IN O
se NN O
, , O
with IN O
low JJ O
affinity NN O
, , O
a DT O
protein NN B-Gene
- : I-Gene
DNA NN I-Gene
complex NN I-Gene
that WDT O
migrated VBD O
more RBR O
slowly RB O
than IN O
native JJ O
NF NNP B-Gene
- : I-Gene
GM2 NNP I-Gene
complex NN I-Gene
. . O

Furthermore RB O
, , O
an DT O
antiserum NN O
against IN O
KBF1 NNP B-Gene
( ( O
identical JJ O
to TO O
50 CD B-Gene
kDa NNS I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
protein NN I-Gene
) ) O
reacted VBD O
with IN O
the DT O
p50 NN B-Gene
of IN O
NF NNP B-Gene
- : I-Gene
GM2 NNP I-Gene
, , O
indicating VBG O
that IN O
the DT O
NF NNP B-Gene
- : I-Gene
GM2 NNP I-Gene
polypeptide NN I-Gene
can MD O
not RB O
be VB O
immunologically RB O
differentiated VBN O
from IN O
the DT O
50 CD B-Gene
kDa NNS I-Gene
subunit NN I-Gene
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

This DT O
suggests VBZ O
that IN O
the DT O
activation NN O
mechanism NN O
of IN O
the DT O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
gene NN I-Gene
through IN O
the DT O
GM2 NNP B-Gene
/ NNP I-Gene
GC NNP I-Gene
- : I-Gene
box NN I-Gene
sequence NN I-Gene
is VBZ O
different JJ O
from IN O
that DT O
of IN O
genes NNS O
carrying VBG O
the DT O
kappa NN B-Gene
B NNP I-Gene
enhancer NN I-Gene
alone RB O
. . O

Characterization NN O
of IN O
an DT O
immediate JJ B-Gene
- : I-Gene
early JJ I-Gene
gene NN I-Gene
induced VBN O
in IN O
adherent NN O
monocytes NNS O
that IN O
encodes VBZ O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
- : O
like IN O
activity NN O
. . O

The DT O
C NNP B-Gene
- : I-Gene
terminus NN I-Gene
has VBZ O
a DT O
putative JJ O
protein NN B-Gene
kinase VBD I-Gene
C NNP I-Gene
phosphorylation NN I-Gene
site NN I-Gene
. . O

In IN O
both DT O
wild JJ O
- : O
type NN O
and CC O
highly RB O
dexamethasone NN O
( ( O
dex NN O
) ) O
- : O
resistant JJ O
clones NNS O
of IN O
the DT O
human JJ O
leukemic JJ O
cell NN O
line NN O
CEM NNP O
, , O
exposure NN O
to TO O
cortivazol VB O
leads NNS O
to TO O
cell VB O
death NN O
. . O

Permissiveness NN O
to TO O
replication NN O
of IN O
human JJ O
immunodeficiency NN O
virus NN O
( ( O
HIV NNP O
) ) O
differs NNS O
in IN O
T NNP O
lymphocytes NNS O
and CC O
macrophages NNS O
. . O

A DT O
DNA NN B-Gene
probe NN I-Gene
that WDT O
spanned VBD O
a DT O
domain NN O
conserved VBN O
among IN O
the DT O
proto NN B-Gene
- : I-Gene
oncogene NN I-Gene
c SYM I-Gene
- : I-Gene
rel NN I-Gene
, , O
the DT O
Drosophila NNP B-Gene
morphogen NN I-Gene
dorsal NN I-Gene
, , O
and CC O
the DT O
p50 NN B-Gene
DNA NNP I-Gene
binding VBG I-Gene
subunit NN I-Gene
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
was VBD O
generated VBN O
from IN O
Jurkat NNP B-Gene
T NNP I-Gene
cell NN I-Gene
complementary JJ I-Gene
DNA NN I-Gene
with IN O
the DT O
polymerase NN O
chain NN O
reaction NN O
( ( O
PCR NNP O
) ) O
and CC O
degenerate JJ O
oligonucleotides NNS O
. . O

This DT O
probe NN O
was VBD O
used VBN O
to TO O
identify VB O
a DT O
rel NN B-Gene
- : I-Gene
related JJ I-Gene
complementary JJ I-Gene
DNA NN I-Gene
that WDT O
hybridized VBD O
to TO O
a DT O
2 CD B-Gene
. . I-Gene
6 CD I-Gene
- : I-Gene
kilobase NN I-Gene
messenger NN I-Gene
RNA NNP I-Gene
present NN O
in IN O
human JJ O
T NNP O
and CC O
B NNP O
lymphocytes NNS O
. . O

In IN O
vitro JJ O
transcription NN O
and CC O
translation NN O
of IN O
the DT O
complementary JJ B-Gene
DNA NN I-Gene
resulted VBD O
in IN O
the DT O
synthesis NN O
of IN O
a DT O
protein NN O
with IN O
an DT O
apparent JJ O
molecular JJ O
size NN O
of IN O
65 CD B-Gene
kilodaltons NNS I-Gene
( ( O
kD NN O
) ) O
. . O

This DT O
protein VBZ B-Gene
- : I-Gene
DNA NN I-Gene
complex JJ I-Gene
comigrated VBN O
with IN O
the DT O
complex JJ O
obtained VBN O
with IN O
the DT O
purified JJ B-Gene
human JJ I-Gene
p65 NN I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
subunit NN I-Gene
and CC O
binding NN O
was VBD O
inhibited VBN O
by IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
- : I-Gene
alpha NN I-Gene
and CC O
- : O
beta NN O
proteins NNS O
. . O

Regulation NN O
of IN O
M NNP B-Gene
- : I-Gene
CSF NNP I-Gene
expression NN O
by IN O
M NNP B-Gene
- : I-Gene
CSF NN I-Gene
: : O
role NN O
of IN O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
and CC O
transcription NN B-Gene
factor NN I-Gene
NF NNP I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

To TO O
date NN O
, , O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
intracellular JJ O
pathway NN O
of IN O
M NNP B-Gene
- : I-Gene
CSF NNP I-Gene
signal JJ O
transduction NN O
. . O

The DT O
pAT NN B-Gene
133 CD I-Gene
gene NN I-Gene
is VBZ O
immediately RB O
induced JJ O
, , O
with IN O
FOS NNP B-Gene
- : O
like IN O
kinetics NNS O
, , O
in IN O
human JJ O
T NNP O
cells NNS O
and CC O
in IN O
fibroblasts NNS O
. . O

However RB O
, , O
upon IN O
transition NN O
from IN O
a DT O
proliferating NN O
( ( O
G1 NNP O
) ) O
to TO O
a DT O
resting VBG O
state NN O
of IN O
the DT O
cell NN O
cycle NN O
the DT O
three CD O
genes NNS O
were VBD O
differently RB O
regulated VBN O
. . O

v SYM B-Gene
- : I-Gene
erbA JJ I-Gene
overexpression NN O
is VBZ O
required VBN O
to TO O
extinguish VB O
c SYM B-Gene
- : I-Gene
erbA JJ I-Gene
function NN O
in IN O
erythroid NN O
cell NN O
differentiation NN O
and CC O
regulation NN O
of IN O
the DT O
erbA NN B-Gene
target NN I-Gene
gene NN I-Gene
CAII NNP B-Gene
. . O

The DT O
v NN B-Gene
- : I-Gene
erbA NN I-Gene
oncoprotein NN I-Gene
represents VBZ O
a DT O
retrovirus NN O
- : O
transduced VBN O
oncogenic JJ O
version NN O
of IN O
the DT O
thyroid NN B-Gene
hormone NN I-Gene
( ( I-Gene
T3 NNP I-Gene
/ NNP I-Gene
T4 NNP I-Gene
) ) I-Gene
receptor NN I-Gene
c SYM B-Gene
- : I-Gene
erbA NN I-Gene
( ( I-Gene
type JJ I-Gene
alpha NN I-Gene
) ) I-Gene
. . O

This DT O
erbA VBZ B-Gene
- : I-Gene
binding NN I-Gene
site NN I-Gene
confers NNS O
thyroid VBP O
hormone NN O
responsiveness NN O
to TO O
a DT O
heterologous JJ B-Gene
promoter NN I-Gene
in IN O
transient JJ O
expression NN O
experiments NNS O
and CC O
is VBZ O
a DT O
target NN O
for IN O
efficient JJ O
down IN O
- : O
regulation NN O
of IN O
CAII NNP B-Gene
transcription NN O
by IN O
the DT O
v NN B-Gene
- : I-Gene
erbA NN I-Gene
oncoprotein NN I-Gene
. . O

The DT O
CD2 NNP B-Gene
T NNP I-Gene
lymphocyte NN I-Gene
glycoprotein NN I-Gene
surface NN I-Gene
molecule NN I-Gene
mediates VBZ O
both DT O
cell NN O
to TO O
cell VB O
adhesion NN O
and CC O
T NNP O
cell NN O
activation NN O
, , O
two CD O
processes NNS O
that WDT O
are VBP O
involved VBN O
in IN O
the DT O
spread NN O
of IN O
HIV NNP O
infection NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
show VBP O
that IN O
micromolar JJ O
concentrations NNS O
of IN O
H2O2 NNP O
can MD O
induce VB O
the DT O
expression NN O
and CC O
replication NN O
of IN O
HIV NNP O
- : O
1 CD O
in IN O
a DT O
human JJ O
T NNP O
cell NN O
line NN O
. . O

The DT O
effect NN O
is VBZ O
mediated VBN O
by IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
transcription NN B-Gene
factor NN I-Gene
which WDT O
is VBZ O
potently RB O
and CC O
rapidly RB O
activated VBN O
by IN O
an DT O
H2O2 NNP O
treatment NN O
of IN O
cells NNS O
from IN O
its PRP$ O
inactive JJ B-Gene
cytoplasmic JJ I-Gene
form NN I-Gene
. . O

ROI RB O
appear VBP O
to TO O
serve VB O
as IN O
messengers NNS O
mediating VBG O
directly RB O
or CC O
indirectly RB O
the DT O
release NN O
of IN O
the DT O
inhibitory JJ B-Gene
subunit NN I-Gene
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
from IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

Inhibition NN O
of IN O
transcription NN B-Gene
factors NNS I-Gene
belonging VBG O
to TO O
the DT O
rel NN B-Gene
/ NNP I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
family NN I-Gene
by IN O
a DT O
transdominant JJ B-Gene
negative JJ I-Gene
mutant NN I-Gene
. . O

A DT O
mutant NN O
of IN O
KBF1 NNP B-Gene
/ NNP I-Gene
p50 NN I-Gene
( ( O
delta JJ B-Gene
SP NNP I-Gene
) ) O
, , O
unable JJ O
to TO O
bind VB O
to TO O
DNA NNP O
but CC O
able JJ O
to TO O
form VB O
homo NN O
- : O
or CC O
heterodimers NNS B-Gene
, , O
has VBZ O
been VBN O
constructed VBN O
. . O

One CD O
gene NN O
of IN O
interest NN O
is VBZ O
the DT O
glycoprotein NN B-Gene
IIb NNP I-Gene
( ( I-Gene
GPIIb NNP I-Gene
) ) I-Gene
gene NN I-Gene
; : O
GPIIb NNP B-Gene
, , O
the DT O
alpha JJ B-Gene
subunit NN I-Gene
of IN O
the DT O
platelet NN B-Gene
cytoadhesin NN I-Gene
GPIIb NNP I-Gene
- : I-Gene
IIIa NN I-Gene
, , O
is VBZ O
produced VBN O
in IN O
megakaryocytes NNS O
at IN O
an DT O
early JJ O
stage NN O
of IN O
the DT O
differentiation NN O
, , O
whereas IN O
the DT O
other JJ O
subunit NN O
of IN O
this DT O
complex JJ O
, , O
GPIIIa NNP B-Gene
, , O
is VBZ O
expressed VBN O
in IN O
other JJ O
cells NNS O
. . O

No DT O
relationship NN O
could MD O
be VB O
established VBN O
between IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
binding NN O
and CC O
antidepressant JJ O
medication NN O
. . O

These DT O
data NNS O
support VBP O
the DT O
view NN O
of IN O
an DT O
impaired JJ O
ligand NN O
- : O
induced JJ O
plasticity NN O
of IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
regulation NN O
rather RB O
than IN O
the DT O
hypothesis NN O
of IN O
decreased JJ O
glucocorticoid NN B-Gene
receptor NN I-Gene
numbers NNS O
during IN O
depression NN O
. . O

The DT O
promoters NNS B-Gene
and CC O
enhancers NNS B-Gene
of IN O
cell NN O
type NN O
- : O
specific JJ O
genes NNS O
are VBP O
often RB O
conserved VBN O
in IN O
evolution NN O
, , O
and CC O
hence RB O
one CD O
might MD O
expect VB O
that IN O
a DT O
given VBN O
enhancer NN B-Gene
has VBZ O
evolved VBN O
to TO O
work VB O
best RB O
with IN O
its PRP$ O
own JJ O
promoter NN B-Gene
. . O

Towards IN O
a DT O
molecular JJ O
understanding NN O
of IN O
T NNP O
- : O
cell NN O
differentiation NN O
. . O

Lymphoid JJ O
differentiation NN O
is VBZ O
one CD O
of IN O
the DT O
best JJS O
studied JJ O
examples NNS O
of IN O
mammalian JJ O
development NN O
. . O

Circadian JJ O
rhythm NN O
in IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
( ( O
GR NNP B-Gene
) ) O
was VBD O
studied VBN O
in IN O
the DT O
rat NN O
liver NN O
and CC O
human JJ O
peripheral JJ O
leukocytes NNS O
. . O

The DT O
conversion NN O
of IN O
the DT O
TCEd NNP B-Gene
to TO O
a DT O
' '' B-Gene
perfect NN I-Gene
' '' I-Gene
NF NNP I-Gene
- : I-Gene
kB NN I-Gene
binding VBG I-Gene
site NN I-Gene
leads VBZ O
to TO O
a DT O
tighter NN O
binding NN O
of IN O
NF NNP B-Gene
- : I-Gene
kB NN I-Gene
to TO O
TCEd NNP B-Gene
DNA NNP I-Gene
and CC O
, , O
as IN O
a DT O
functional JJ O
consequence NN O
, , O
to TO O
the DT O
activity NN O
of IN O
the DT O
' POS B-Gene
converted VBN I-Gene
' POS I-Gene
TCEd NNP I-Gene
motifs NNS I-Gene
in IN O
HeLa NNP O
cells NNS O
. . O

A DT O
region NN O
upstream NN O
to TO O
the DT O
first JJ O
exon NN O
, , O
and CC O
highly RB O
conserved VBD O
between IN O
mouse NN O
and CC O
man NN O
, , O
acts VBZ O
as IN O
an DT O
erythroid NN O
specific JJ O
enhancer NN O
in IN O
transient NN O
assays NNS O
, , O
if IN O
linked VBN O
to TO O
the DT O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
or CC O
to TO O
the DT O
SV40 NNP O
promoter NN O
. . O

More RBR O
strikingly RB O
, , O
the DT O
80 CD B-Gene
- : I-Gene
kDa NN I-Gene
protein NN I-Gene
was VBD O
downregulated VBN O
in IN O
a DT O
dose JJ O
- : O
dependent JJ O
fashion NN O
by IN O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
; : O
this DT O
effect NN O
was VBD O
independent JJ O
of IN O
the DT O
mode NN O
of IN O
lymphocyte JJ O
activation NN O
and CC O
specific NN O
for IN O
the DT O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
metabolite NN O
of IN O
vitamin NN O
D3 NNP O
. . O

Prolonged VBN O
corticosteroid NN O
treatment NN O
resulted VBD O
in IN O
down RP O
- : O
regulation NN O
of IN O
GcR NNP B-Gene
, , O
while IN O
the DT O
mean JJ O
level NN O
of IN O
GcR NNP B-Gene
in IN O
Cushing NNP O
' POS O
s JJ O
disease NN O
was VBD O
normal JJ O
. . O

Furthermore RB O
, , O
GcR NNP B-Gene
were VBD O
unaltered JJ O
after IN O
these DT O
patients NNS O
received VBD O
ketoconazole JJ O
, , O
in IN O
spite NN O
of IN O
a DT O
marked JJ O
reduction NN O
in IN O
morning NN O
plasma NN O
cortisol NN O
and CC O
urinary JJ O
free JJ O
cortisol NN O
. . O

Human NNP O
T NNP O
- : O
cell NN O
leukemia NN O
virus NN O
type NN O
1 CD O
( ( O
HTLV NNP O
- : O
1 CD O
) ) O
is VBZ O
an DT O
etiological JJ O
agent NN O
of IN O
adult NN O
T NNP O
- : O
cell NN O
leukemia NN O
( ( O
ATL NNP O
) ) O
. . O

Previously RB O
, , O
transcription NN O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
fos NN I-Gene
gene NN I-Gene
has VBZ O
been VBN O
reported VBN O
to TO O
be VB O
transactivated VBN O
by IN O
the DT O
viral JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
, , O
Tax1 NNP B-Gene
. . O

Glucocorticoid NNP B-Gene
receptor NN I-Gene
characteristics NNS O
in IN O
monocytes NNS O
of IN O
patients NNS O
with IN O
corticosteroid JJ O
- : O
resistant JJ O
bronchial JJ O
asthma NN O
. . O

Vitamin NNP B-Gene
D NNP I-Gene
receptor NN I-Gene
expression NN O
in IN O
human JJ O
lymphocytes NNS O
. . O

Signal JJ O
requirements NNS O
and CC O
characterization NN O
by IN O
western JJ O
blots NNS O
and CC O
DNA NNP O
sequencing NN O
. . O

However RB O
, , O
combination NN O
of IN O
OKT3 NNP B-Gene
and CC O
phorbol NN O
myristate NN O
acetate NN O
produced VBD O
a DT O
concentration NN O
of IN O
binding VBG O
sites NNS O
similar JJ O
to TO O
the DT O
PHA NNP O
- : O
activated VBD O
cells NNS O
. . O

The DT O
receptor NN O
from IN O
OKT3 NNP B-Gene
and CC O
OKT3 NNP B-Gene
+ NNP O
phorbol NN O
myristate NN O
acetate NN O
- : O
activated VBN O
lymphocytes NNS O
exhibited VBD O
decreased JJ O
binding NN O
to TO O
DNA NNP O
- : O
cellulose NN O
compared VBN O
to TO O
PHA NNP O
- : O
activated VBN O
lymphocytes NNS O
. . O

In IN O
lymphocytes NNS O
activated VBN O
either RB O
by IN O
PHA NNP B-Gene
or CC O
OKT3 NNP B-Gene
( ( O
but CC O
not RB O
in IN O
resting VBG O
cells NNS O
) ) O
, , O
a DT O
50 CD B-Gene
- : I-Gene
kDa NN I-Gene
species NNS I-Gene
cross VBP O
- : O
reacting VBG O
with IN O
a DT O
monoclonal JJ B-Gene
antibody NN I-Gene
against IN O
the DT O
intestinal JJ B-Gene
vitamin NN I-Gene
D NNP I-Gene
receptor NN I-Gene
was VBD O
detected VBN O
. . O

Finally RB O
, , O
RNA NNP O
from IN O
activated VBN O
lymphocytes NNS O
was VBD O
amplified VBN O
by IN O
polymerase NN O
chain NN O
reaction NN O
using VBG O
oligonucleotide JJ O
primers NNS O
flanking VBG O
the DT O
196 CD B-Gene
base NN I-Gene
pair NN I-Gene
long JJ I-Gene
region NN I-Gene
encoding VBG O
the DT O
DNA NNP B-Gene
- : I-Gene
binding VBG I-Gene
domain NN I-Gene
of IN O
the DT O
human JJ B-Gene
intestinal JJ I-Gene
receptor NN I-Gene
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
expression NN O
of IN O
the DT O
1 CD B-Gene
, , I-Gene
25 CD I-Gene
- : I-Gene
( ( I-Gene
OH NNP I-Gene
) ) I-Gene
2D3 CD I-Gene
receptor NN I-Gene
in IN O
lymphocytes NNS O
is VBZ O
triggered VBN O
by IN O
distinct JJ O
and CC O
contingent JJ O
signals NNS O
, , O
and CC O
that IN O
the DT O
protein NN O
and CC O
the DT O
mRNA NN B-Gene
encoding VBG O
it PRP O
are VBP O
identical JJ O
to TO O
the DT O
classical JJ B-Gene
vitamin NN I-Gene
D NNP I-Gene
receptor NN I-Gene
. . O

The DT O
kappa NN B-Gene
B NNP I-Gene
sequence NN I-Gene
( ( O
GGGACTTTCC NNP O
) ) O
binds VBZ O
a DT O
factor NN O
, , O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
that WDT O
is VBZ O
constitutively RB O
found VBN O
in IN O
its PRP$ O
functional JJ O
, , O
DNA NNP O
binding VBG O
form NN O
only RB O
in IN O
B NNP O
lymphocytes NNS O
. . O

However RB O
, , O
these DT O
genes NNS O
are VBP O
not RB O
constitutively RB O
active JJ O
in IN O
B NNP O
lymphocytes NNS O
, , O
suggesting VBG O
that IN O
other JJ O
regulatory JJ O
mechanisms NNS O
must MD O
play VB O
a DT O
role NN O
in IN O
determining VBG O
the DT O
patterns NNS O
of IN O
expression NN O
. . O

We PRP O
have VBP O
investigated VBN O
the DT O
constitutive NN O
and CC O
inducible JJ O
transcriptional JJ O
activity NN O
mediated VBN O
by IN O
five CD O
kappa NNS B-Gene
B NNP I-Gene
- : I-Gene
related JJ I-Gene
sequence NN I-Gene
elements NNS I-Gene
in IN O
two CD O
different JJ O
cell NN O
types NNS O
. . O

However RB O
, , O
in IN O
either DT O
EL NNP O
- : O
4 CD O
( ( O
T NNP O
) ) O
cells NNS O
or CC O
S194 NNP O
cells NNS O
, , O
both DT O
lower JJR O
- : O
affinity NN O
sites NNS O
can MD O
be VB O
significantly RB O
induced VBN O
by IN O
the DT O
tax NN B-Gene
gene NN I-Gene
product NN I-Gene
of IN O
human JJ O
T NNP O
- : O
cell NN O
leukemia NN O
virus NN O
type NN O
I PRP O
, , O
showing VBG O
that IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activity NN O
can MD O
be VB O
modulated VBN O
even RB O
in IN O
a DT O
B NNP O
- : O
cell NN O
line NN O
that WDT O
constitutively RB O
expresses VBZ O
this DT O
factor NN O
. . O

Previously RB O
, , O
a DT O
nuclear JJ B-Gene
factor NN I-Gene
, , O
IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
( ( O
interferon NN B-Gene
regulatory JJ I-Gene
factor NN I-Gene
1 CD I-Gene
) ) O
, , O
which WDT O
binds VBZ O
to TO O
type VB B-Gene
I PRP I-Gene
IFN NNP I-Gene
and CC O
some DT O
IFN NNP B-Gene
- : I-Gene
inducible JJ I-Gene
gene NN I-Gene
promoters NNS I-Gene
, , O
was VBD O
identified VBN O
and CC O
cloned VBN O
. . O

A DT O
dimerization NN B-Gene
cofactor NN I-Gene
of IN O
HNF NNP B-Gene
- : I-Gene
1 CD I-Gene
alpha NN I-Gene
( ( O
DCoH NNP B-Gene
) ) O
was VBD O
identified VBN O
that IN O
displayed VBD O
a DT O
restricted JJ O
tissue NN O
distribution NN O
and CC O
did VBD O
not RB O
bind VB O
to TO O
DNA NNP O
, , O
but CC O
, , O
rather RB O
, , O
selectively RB O
stabilized VBN O
HNF NNP B-Gene
- : I-Gene
1 CD I-Gene
alpha NN I-Gene
dimers NNS I-Gene
. . O

Previous JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
treatment NN O
of IN O
human JJ O
myeloid NN O
leukemia NN O
cells NNS O
with IN O
12 CD O
- : O
O NNP O
- : O
tetradecanoylphorbol NN O
- : O
13 CD O
- : O
acetate NN O
( ( O
TPA NNP O
) ) O
is VBZ O
associated VBN O
with IN O
induction NN O
of IN O
monocytic JJ O
differentiation NN O
and CC O
expression NN O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
jun NN I-Gene
and CC I-Gene
c SYM I-Gene
- : I-Gene
fos RB I-Gene
early JJ I-Gene
response NN I-Gene
genes NNS I-Gene
. . O

Although IN O
absent NN O
in IN O
nonexpressing VBG O
erythroleukemia NN O
cell NN O
lines NNS O
, , O
the DT O
DNase NNP B-Gene
I PRP I-Gene
site NN I-Gene
is VBZ O
present JJ O
in IN O
uninduced JJ O
myelomonocytic JJ O
cell NN O
lines NNS O
and CC O
is VBZ O
not RB O
changed VBN O
after IN O
PMA NNP O
induction NN O
. . O

The DT O
nuclear JJ O
extracts NNS O
from IN O
resting VBG O
and CC O
induced JJ O
ML NNP O
- : O
1 CD O
cells NNS O
contain JJ O
proteins NNS O
binding VBG O
specifically RB O
to TO O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , I-Gene
AP NNP I-Gene
- : I-Gene
2 CD I-Gene
, , I-Gene
and CC I-Gene
NF NNP I-Gene
kappa NNP I-Gene
B NNP I-Gene
sequence NN I-Gene
located VBN O
within IN O
the DT O
TNF NNP B-Gene
promoter NN I-Gene
. . O

Enhancement NN O
of IN O
human JJ O
immunodeficiency NN O
virus NN O
1 CD O
replication NN O
in IN O
monocytes NNS O
by IN O
1 CD O
, , O
25 CD O
- : O
dihydroxycholecalcif NN O
. . O

Human NNP O
immunodeficiency NN O
virus NN O
( ( O
HIV NNP O
) ) O
expression NN O
and CC O
replication NN O
are VBP O
under IN O
tight JJ O
regulatory JJ O
control NN O
. . O

1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
is VBZ O
therefore RB O
one CD O
of IN O
the DT O
most RBS O
potent JJ O
regulators NNS O
of IN O
HIV NNP O
- : O
1 CD O
replication NN O
described VBN O
to TO O
date NN O
. . O

Transforming VBG B-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
beta NN I-Gene
suppresses NNS O
human JJ B-Gene
B NNP I-Gene
lymphocyte NN I-Gene
Ig NNP I-Gene
production NN O
by IN O
inhibiting VBG O
synthesis NN O
and CC O
the DT O
switch NN O
from IN O
the DT O
membrane NN B-Gene
form NN I-Gene
to TO O
the DT O
secreted JJ B-Gene
form NN I-Gene
of IN O
Ig NNP B-Gene
mRNA NN I-Gene
. . O

One CD O
of IN O
the DT O
members NNS O
of IN O
this DT O
multigene JJ O
family NN O
, , O
cGATA SYM B-Gene
- : I-Gene
3 CD I-Gene
, , O
is VBZ O
most JJS O
abundantly RB O
expressed VBN O
in IN O
the DT O
T NNP O
- : O
lymphocyte NN O
cell NN O
lineage NN O
. . O

The DT O
murine NN B-Gene
and CC I-Gene
human JJ I-Gene
factors NNS I-Gene
are VBP O
abundantly RB O
expressed VBN O
in IN O
a DT O
variety NN O
of IN O
human JJ O
and CC O
murine JJ O
T NNP O
- : O
cell NN O
lines NNS O
and CC O
can MD O
activate VB O
transcription NN O
through IN O
a DT O
tissue NN B-Gene
- : I-Gene
specific NN I-Gene
GATA NNP I-Gene
- : I-Gene
binding NN I-Gene
site NN I-Gene
identified VBN O
within IN O
the DT O
human JJ B-Gene
T NNP I-Gene
- : I-Gene
cell NN I-Gene
receptor NN I-Gene
delta JJ I-Gene
gene NN I-Gene
enhancer NN I-Gene
. . O

The DT O
expression NN O
of IN O
active JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
might MD O
therefore VB O
also RB O
be VB O
regulated VBN O
by IN O
the DT O
extent NN O
of IN O
processing NN O
of IN O
p105 NN B-Gene
. . O

Levels NNS O
of IN O
RNA NNP O
coding VBG O
for IN O
the DT O
receptor NN B-Gene
were VBD O
not RB O
modulated VBN O
by IN O
exposure NN O
to TO O
high JJ O
levels NNS O
of IN O
ligand NN O
. . O

Expression NN O
of IN O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
, , I-Gene
jun NN I-Gene
B NNP I-Gene
and CC I-Gene
jun NN I-Gene
D NNP I-Gene
proto NN I-Gene
- : I-Gene
oncogenes NNS I-Gene
in IN O
human JJ O
peripheral JJ O
- : O
blood NN O
granulocytes NNS O
. . O

We PRP O
have VBP O
found VBN O
that IN O
purified JJ O
human JJ O
peripheral JJ O
- : O
blood NN O
granulocytes NNS O
express RBR O
constitutively RB O
significant JJ O
levels NNS O
of IN O
proto NN B-Gene
- : I-Gene
oncogenes NNS I-Gene
c SYM B-Gene
- : I-Gene
jun NN I-Gene
, , I-Gene
jun NN I-Gene
B NNP I-Gene
and CC I-Gene
jun NN I-Gene
D NNP I-Gene
mRNA NN I-Gene
. . O

The DT O
29 CD B-Gene
- : I-Gene
kDa NN I-Gene
proteins NNS I-Gene
phosphorylated VBN O
in IN O
thrombin JJ O
- : O
activated VBN O
human JJ O
platelets NNS O
are VBP O
forms NNS O
of IN O
the DT O
estrogen NN B-Gene
receptor NN I-Gene
- : I-Gene
related JJ I-Gene
27 CD I-Gene
- : I-Gene
kDa NN I-Gene
heat NN I-Gene
shock NN I-Gene
protein NN I-Gene
. . O

We PRP O
have VBP O
isolated VBN O
a DT O
human JJ B-Gene
cDNA NN I-Gene
clone NN I-Gene
encoding VBG O
a DT O
zinc NN B-Gene
finger NN I-Gene
protein NN I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
E1 NN I-Gene
) ) O
that WDT O
binds VBZ O
to TO O
the DT O
negative JJ B-Gene
- : I-Gene
acting VBG I-Gene
segment NN I-Gene
of IN O
the DT O
kappa NN B-Gene
E3 NNP I-Gene
' POS I-Gene
enhancer NN I-Gene
. . O

This DT O
protein NN O
also RB O
binds VBZ O
to TO O
the DT O
immunoglobulin NN B-Gene
heavy JJ I-Gene
- : I-Gene
chain NN I-Gene
enhancer NN I-Gene
mu NN I-Gene
E1 NNP I-Gene
site NN I-Gene
. . O

NF NNP B-Gene
- : I-Gene
E1 NN I-Gene
is VBZ O
also RB O
the DT O
human JJ B-Gene
homologue NN I-Gene
of IN O
the DT O
mouse NN B-Gene
delta NN I-Gene
protein NN I-Gene
, , O
which WDT O
binds VBZ O
to TO O
ribosomal VB B-Gene
protein JJ I-Gene
gene NN I-Gene
promoters NNS I-Gene
. . O

Cotransfection NN O
studies NNS O
with IN O
this DT O
cDNA NN B-Gene
indicate VBP O
that IN O
it PRP O
can MD O
repress VB O
basal JJ B-Gene
promoter NN I-Gene
activity NN O
. . O

The DT O
apparent JJ O
dual JJ O
function NN O
of IN O
this DT O
protein NN O
is VBZ O
discussed VBN O
. . O

An DT O
upstream JJ B-Gene
segment NN I-Gene
contains NNS O
tandem JJ B-Gene
dinucleotide NN I-Gene
repeats NNS I-Gene
( ( B-Gene
CT NNP I-Gene
) ) I-Gene
19 CD I-Gene
/ NN I-Gene
( ( I-Gene
CA NNP I-Gene
) ) I-Gene
16 CD I-Gene
. . O

There EX O
is VBZ O
a DT O
suitably RB O
located VBN O
TATA NNP B-Gene
box NN I-Gene
, , O
but CC O
potential JJ O
sites NNS O
for IN O
CCAAT NNP B-Gene
- : I-Gene
box NN I-Gene
binding NN I-Gene
factors NNS I-Gene
are VBP O
far RB O
upstream JJ O
, , O
embedded VBN O
in IN O
a DT O
42 CD B-Gene
- : I-Gene
nucleotide RB I-Gene
repeat NN I-Gene
element NN I-Gene
. . O

HIV NNP B-Gene
- : I-Gene
TF1 NN I-Gene
had VBD O
a DT O
molecular JJ O
weight NN O
of IN O
39 CD O
, , O
0 CD O
. . O

A DT O
potentially RB O
more JJR O
common JJ O
pharmacogenetic JJ O
syndrome NN O
. . O

The DT O
activity NN O
of IN O
dihydropyrimidine NN B-Gene
dehydrogenase NN I-Gene
( ( O
DPD NNP B-Gene
) ) O
, , O
the DT O
initial JJ O
enzyme NN B-Gene
of IN O
pyrimidine NN O
( ( O
and CC O
FUra NNP O
) ) O
catabolism NN O
, , O
in IN O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
was VBD O
measured VBN O
in IN O
each DT O
subject NN O
by IN O
a DT O
specific JJ O
radiometric JJ O
assay NN O
using VBG O
FUra NNP O
as IN O
the DT O
substrate NN O
. . O

Monitoring VBG O
DPD NNP B-Gene
activity NN O
may MD O
be VB O
important JJ O
in IN O
the DT O
management NN O
of IN O
patients NNS O
experiencing VBG O
severe JJ O
toxicity NN O
secondary JJ O
to TO O
FUra NNP O
chemotherapy NN O
. . O

A DT O
thymus NN B-Gene
- : I-Gene
specific JJ I-Gene
member NN I-Gene
of IN O
the DT O
HMG NNP B-Gene
protein VBD I-Gene
family NN I-Gene
regulates VBZ O
the DT O
human JJ B-Gene
T NNP I-Gene
cell NN I-Gene
receptor NN I-Gene
C NNP I-Gene
alpha NN I-Gene
enhancer NN I-Gene
. . O

The DT O
human JJ B-Gene
T NNP I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
transcription NN I-Gene
factor NN I-Gene
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
alpha NN I-Gene
plays VBZ O
a DT O
key JJ O
role NN O
in IN O
the DT O
tissue NN O
- : O
specific JJ O
activation NN O
of IN O
the DT O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
( ( O
TCR NNP B-Gene
) ) O
C NNP O
alpha JJ O
enhancer NN O
and CC O
binds NNS O
to TO O
pyrimidine VB B-Gene
- : I-Gene
rich JJ I-Gene
elements NNS I-Gene
( ( O
5 CD O
' '' O
- : O
PyCTTTG NNP O
- : O
3 CD O
' '' O
) ) O
present NN O
in IN O
a DT O
variety NN O
of IN O
other JJ O
T NNP B-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
control NN I-Gene
regions NNS I-Gene
. . O

TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
alpha NN I-Gene
is VBZ O
currently RB O
unique JJ O
among IN O
the DT O
newly RB O
emerging VBG O
family NN O
of IN O
DNA NNP B-Gene
- : I-Gene
binding VBG I-Gene
regulatory JJ I-Gene
proteins NNS I-Gene
that WDT O
share NN O
the DT O
HMG NNP B-Gene
motif NN I-Gene
in IN O
that DT O
it PRP O
is VBZ O
a DT O
highly RB B-Gene
tissue NN I-Gene
- : I-Gene
specific JJ I-Gene
RNA NNP I-Gene
polymerase NN I-Gene
II NNP I-Gene
transcription NN B-Gene
factor NN I-Gene
. . O

Ectopic NNP O
expression NN O
of IN O
cloned VBN B-Gene
Oct2 NNP I-Gene
cDNA NN I-Gene
was VBD O
shown VBN O
to TO O
be VB O
sufficient JJ O
to TO O
reconstitute VB O
at IN O
least JJS O
some DT O
aspects NNS O
of IN O
this DT O
regulation NN O
in IN O
non JJ O
- : O
lymphoid NN O
cells NNS O
. . O

We PRP O
describe VBP O
the DT O
isolation NN O
and CC O
characterization NN O
of IN O
multiple JJ B-Gene
cDNAs NN I-Gene
encoding VBG O
mouse NN B-Gene
Oct2 NNP I-Gene
from IN O
a DT O
mature NN O
B NNP O
- : O
cell NN O
line NN O
and CC O
we PRP O
show VBP O
that IN O
a DT O
variety NN O
of IN O
isoforms NNS O
of IN O
this DT O
transcription NN B-Gene
factor NN I-Gene
is VBZ O
generated VBN O
from IN O
a DT O
single JJ O
gene NN O
by IN O
an DT O
alternative JJ O
splicing NN O
mechanism NN O
. . O

Different JJ O
amounts NNS O
of IN O
the DT O
various JJ O
isoforms NNS B-Gene
are VBP O
present JJ O
within IN O
the DT O
same JJ O
B NNP O
- : O
cell NN O
regardless RB O
of IN O
the DT O
developmental JJ O
stage NN O
of IN O
B NNP O
- : O
cell NN O
differentiation NN O
and CC O
at IN O
least JJS O
some DT O
of IN O
the DT O
isoforms NNS B-Gene
are VBP O
conserved VBN O
between IN O
mouse NN O
and CC O
humans NNS O
. . O

In IN O
cotransfection NN O
experiments NNS O
we PRP O
show VBP O
that IN O
all PDT O
the DT O
isoforms NNS B-Gene
are VBP O
able JJ O
to TO O
activate VB O
an DT O
octamer NN B-Gene
containing VBG O
promoter NN B-Gene
element NN I-Gene
in IN O
fibroblasts NNS O
revealing VBG O
an DT O
unexpected JJ O
functional JJ O
redundancy NN O
. . O

[ JJ O
Regulation NNP O
of IN O
intracellular JJ O
cholesterol NN O
synthesis NN O
in IN O
hypercholesterolemia NN O
by IN O
glucocorticoids NNS O
] NNS O

The DT O
rate NN O
of IN O
endogenous JJ O
cholesterol NN O
synthesis NN O
in IN O
blood NN O
lymphocytes NNS O
and CC O
skin JJ O
fibroblasts NNS O
from IN O
patients NNS O
with IN O
type JJ O
IIa NNP O
hyperlipidemia NN O
was VBD O
found VBN O
to TO O
be VB O
increased VBN O
in IN O
comparison NN O
with IN O
healthy JJ O
donors NNS O
. . O

The DT O
decrease NN O
of IN O
the DT O
number NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
patients NNS O
with IN O
type JJ O
IIa NNP O
hyperlipidemia NN O
seems VBZ O
to TO O
be VB O
a DT O
compensatory JJ O
response NN O
of IN O
cells NNS O
culminating VBG O
in IN O
activation NN O
of IN O
endogenous JJ O
cholesterol NN O
synthesis NN O
. . O

These DT O
differences NNS O
in IN O
gene NN O
expression NN O
have VBP O
not RB O
been VBN O
molecularly RB O
defined VBN O
. . O

Thus RB O
, , O
both DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
- : I-Gene
binding NN I-Gene
complexes NNS I-Gene
are VBP O
needed VBN O
for IN O
optimal JJ O
viral JJ O
transcription NN O
. . O

Binding NN O
of IN O
the DT O
65 CD B-Gene
- : I-Gene
kDa NN I-Gene
plus CC O
50 CD B-Gene
- : I-Gene
kDa NN I-Gene
heterodimer NN I-Gene
to TO O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
enhancer NN I-Gene
can MD O
be VB O
negatively RB O
regulated VBN O
in IN O
monocytes NNS O
, , O
providing VBG O
one CD O
mechanism NN O
restricting VBG O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
expression NN O
. . O

An DT O
age NN O
- : O
related JJ O
decrease NN O
in IN O
the DT O
number NN O
of IN O
GR NNP B-Gene
was VBD O
suggested VBN O
between IN O
subjects NNS O
younger JJR O
than IN O
20 CD O
years NNS O
and CC O
elderly JJ O
subjects NNS O
; : O
there EX O
was VBD O
no DT O
apparent JJ O
seasonal JJ O
variation NN O
in IN O
GR NNP B-Gene
. . O

Eight CD O
patients NNS O
with IN O
dermatomyositis NN O
/ NNS O
polymyositis NN O
were VBD O
examined VBN O
to TO O
determine VB O
whether IN O
the DT O
number NN O
of IN O
GR NNP B-Gene
in IN O
MNL NNP O
could MD O
be VB O
down RP O
- : O
regulated VBN O
by IN O
their PRP$ O
cognate NN O
ligands NNS O
. . O

Formation NN O
of IN O
the DT O
protein NN B-Gene
- : I-Gene
DNA NN I-Gene
complex NN I-Gene
with IN O
the DT O
C26 NNP B-Gene
subfragment NN I-Gene
was VBD O
positively RB O
affected VBN O
by IN O
p40tax NN B-Gene
. . O

Human NNP O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha IN I-Gene
gene NN O
regulation NN O
in IN O
phorbol NN O
ester NN O
stimulated VBD O
T NNP O
and CC O
B NNP O
cell NN O
lines NNS O
. . O

Moreover RB O
, , O
kappa VBD B-Gene
1 CD I-Gene
- : I-Gene
kappa NN I-Gene
3 CD I-Gene
can MD O
each DT O
be VB O
deleted VBN O
from IN O
the DT O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
promoter NN I-Gene
with IN O
little JJ O
effect NN O
on IN O
the DT O
gene NN O
' POS O
s JJ O
inducibility NN O
by IN O
PMA NNP O
. . O

We PRP O
have VBP O
generated VBN O
a DT O
monoclonal JJ B-Gene
antibody NN I-Gene
, , O
BZ1 NNP B-Gene
, , O
to TO O
BZLF1 NNP B-Gene
which WDT O
reacts VBZ O
in IN O
immunohistology NN O
, , O
immunoblotting NN O
, , O
and CC O
immunoprecipitation NN O
and CC O
which WDT O
recognizes VBZ O
both CC O
the DT O
active JJ B-Gene
, , I-Gene
dimeric JJ I-Gene
form NN I-Gene
and CC O
the DT O
inactive JJ B-Gene
, , I-Gene
monomeric JJ I-Gene
form NN I-Gene
of IN O
the DT O
protein NN O
. . O

The DT O
hormone NN B-Gene
receptors NNS I-Gene
of IN O
the DT O
primary JJ O
tumor NN O
were VBD O
known VBN O
in IN O
15 CD O
( ( O
ER NNP B-Gene
) ) O
and CC O
14 CD O
( ( O
PR NNP B-Gene
) ) O
patients NNS O
, , O
respectively RB O
. . O

In IN O
each DT O
cohort NN O
there EX O
was VBD O
only RB O
one CD O
case NN O
with IN O
a DT O
negative JJ O
reaction NN O
of IN O
the DT O
primary JJ O
tumor NN O
and CC O
a DT O
positive JJ O
reaction NN O
with IN O
the DT O
isolated JJ O
tumor NN O
cells NNS O
from IN O
the DT O
pleural JJ O
effusions NNS O
. . O

NF NNP B-Gene
- : I-Gene
kB NN I-Gene
is VBZ O
a DT O
eukaryotic JJ B-Gene
transcription NN I-Gene
regulatory JJ I-Gene
factor NN I-Gene
. . O

[ JJ O
Regulatory NNP O
effect NN O
of IN O
insulin NN B-Gene
on IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
in IN O
human JJ O
peripheral JJ O
leukocytes NNS O
] VBP O

After IN O
3 CD O
h JJ O
incubation NN O
the DT O
specific NN O
binding VBG O
power NN O
with IN O
[ JJ O
3H CD O
] JJ O
Dex NNP O
was VBD O
decreased VBN O
by IN O
23 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
10 CD O
. . O
0 CD O
, , O
32 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
13 CD O
. . O
2 CD O
and CC O
54 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
9 CD O
. . O
2 CD O
% NN O
( ( O
P NNP O
greater JJR O
than IN O
0 CD O
. . O
5 CD O
, , O
P NNP O
greater JJR O
than IN O
0 CD O
. . O
5 CD O
and CC O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
as IN O
compared VBN O
with IN O
the DT O
control NN O
value NN O
of IN O
100 CD O
in IN O
the DT O
absence NN O
of IN O
insulin NN B-Gene
) ) O
respectively RB O
in IN O
the DT O
presence NN O
of IN O
20 CD O
mU NNS O
/ JJ O
L NNP O
( ( O
physiological JJ O
testing VBG O
concentration NN O
) ) O
, , O
200 CD O
mU NN O
/ NN O
L NNP O
( ( O
physiological JJ O
upper JJ O
limit NN O
) ) O
and CC O
2 CD O
, , O
0 CD O
mU NN O
/ NN O
L NNP O
( ( O
pharmacological JJ O
concentration NN O
) ) O
insulin NN B-Gene
in IN O
the DT O
incubation NN O
medium NN O
. . O

Serum NNP O
Ig NNP O
levels NNS O
were VBD O
followed VBN O
up RP O
to TO O
two CD O
years NNS O
after IN O
or CC O
during IN O
the DT O
therapy NN O
. . O

Low JJ O
levels NNS O
of IN O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
transcripts NNS I-Gene
were VBD O
detectable JJ O
in IN O
resting VBG O
human JJ O
peripheral JJ O
blood NN O
monocytes NNS O
. . O

Moreover RB O
, , O
M NNP B-Gene
- : I-Gene
CSF NNP I-Gene
- : O
induced JJ O
expression NN O
of IN O
the DT O
fos JJ B-Gene
- : I-Gene
related JJ I-Gene
gene NN I-Gene
, , O
fra SYM B-Gene
- : I-Gene
1 CD I-Gene
, , O
was VBD O
delayed VBN O
compared VBN O
to TO O
that DT O
for IN O
both DT O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
and CC O
fos NN B-Gene
- : I-Gene
B NN I-Gene
. . O

Glucocorticosteroids NNS O
remain VBP O
the DT O
major JJ O
treatment NN O
modality NN O
for IN O
systemic JJ O
lupus NN O
erythematosus NN O
( ( O
SLE NNP O
) ) O
, , O
but CC O
their PRP$ O
mechanism NN O
of IN O
action NN O
is VBZ O
unclear JJ O
. . O

Over IN O
the DT O
past JJ O
decade NN O
it PRP O
has VBZ O
become VBN O
clear JJ O
that IN O
glucocorticosteroid NN B-Gene
receptors NNS I-Gene
play VBP O
a DT O
significant JJ O
role NN O
in IN O
the DT O
mechanism NN O
of IN O
glucocorticosteroid JJ O
action NN O
. . O

Glucocorticosteroid NNP B-Gene
receptors NNS I-Gene
on IN O
leukocytes NNS O
of IN O
patients NNS O
with IN O
SLE NNP O
were VBD O
significantly RB O
higher JJR O
than IN O
in IN O
healthy JJ O
controls NNS O
( ( O
4419 CD O
+ NNP O
/ NNP O
- : O
306 CD O
vs NN O
3369 CD O
+ NN O
/ NNP O
- : O
196 CD O
, , O
p NN O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
. . O

HIV1 NNP O
infection NN O
of IN O
human JJ O
monocytes NNS O
and CC O
macrophages NNS O
promotes VBZ O
induction NN O
or CC O
translocation NN O
of IN O
NF NNP B-Gene
- : I-Gene
KB NNP I-Gene
- : I-Gene
related JJ I-Gene
factors NNS I-Gene
. . O

The DT O
insertion NN O
of IN O
multiple JJ O
copies NNS O
of IN O
the DT O
binding NN B-Gene
site NN I-Gene
for IN O
the DT O
former JJ O
or CC O
latter JJ O
factor NN O
into IN O
a DT O
heterologous JJ B-Gene
promoter NN I-Gene
reduced VBD O
the DT O
promoter NN O
activity NN O
to TO O
one CD O
- : O
tenth NN O
or CC O
one CD O
- : O
third NN O
, , O
respectively RB O
. . O

Other JJ O
cellular JJ O
parameters NNS O
, , O
such JJ O
as IN O
glycosidase NN O
activities NNS O
, , O
cytokine NN B-Gene
release NN O
, , O
and CC O
filament JJ O
expression NN O
, , O
returned VBN O
to TO O
levels NNS O
similar JJ O
to TO O
that DT O
observed VBN O
in IN O
uninduced JJ O
cells NNS O
. . O

Levels NNS O
of IN O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
and CC I-Gene
c SYM I-Gene
- : I-Gene
jun NN I-Gene
transcripts NNS I-Gene
remained VBD O
elevated JJ O
during IN O
periods NNS O
of IN O
PKC NNP B-Gene
activation NN O
and CC O
also RB O
returned VBD O
to TO O
levels NNS O
observed VBN O
in IN O
control NN O
cells NNS O
by IN O
30 CD O
- : O
36 CD O
days NNS O
, , O
when WRB O
the DT O
cells NNS O
entered VBD O
retrodifferentiation NN O
. . O

DNA NN O
binding NN O
by IN O
all DT O
four CD O
of IN O
these DT O
Rel NNP B-Gene
- : I-Gene
related JJ I-Gene
factors NNS I-Gene
is VBZ O
blocked VBN O
by IN O
selective JJ O
chemical JJ O
modification NN O
of IN O
lysine NN O
and CC O
arginine NN O
residues NNS O
, , O
suggesting VBG O
that IN O
both DT O
of IN O
these DT O
basic JJ O
amino NN O
acids NNS O
are VBP O
required VBN O
for IN O
binding VBG O
to TO O
the DT O
kappa NN B-Gene
B NNP I-Gene
element NN I-Gene
. . O

In IN O
contrast NN O
, , O
mild JJ O
oxidation NN O
with IN O
glucose JJ B-Gene
oxidase NN I-Gene
selectively RB O
inhibits VBZ O
p75 NN B-Gene
and CC O
p85 NN B-Gene
binding VBG O
while IN O
not RB O
blocking VBG O
p50 NN B-Gene
and CC O
p55 JJ B-Gene
interactions NNS O
. . O

[ NN O
Changes NNS O
in IN O
leucocytic JJ O
estrogen NN B-Gene
receptor NN I-Gene
levels NNS O
in IN O
patients NNS O
with IN O
climacteric JJ O
syndrome NN O
and CC O
therapeutic JJ O
effect NN O
of IN O
liuwei NN O
dihuang NN O
pills NNS O
] VBP O

The DT O
numbers NNS O
of IN O
estrogen NN B-Gene
receptor NN I-Gene
( ( O
ER NNP B-Gene
) ) O
in IN O
human JJ O
peripheral JJ O
leucocytes NNS O
in IN O
22 CD O
women NNS O
with IN O
climacteric JJ O
syndrome NN O
were VBD O
measured VBN O
by IN O
radioligand NN O
method NN O
. . O

This DT O
may MD O
be VB O
the DT O
basis NN O
of IN O
the DT O
therapeutic JJ O
effect NN O
on IN O
the DT O
disease NN O
. . O

In IN O
addition NN O
, , O
cell NN B-Gene
- : I-Gene
free JJ I-Gene
synthesized VBD I-Gene
hGR NN I-Gene
was VBD O
capable JJ O
of IN O
specific JJ O
binding VBG O
to TO O
glucocorticoid VB B-Gene
response NN I-Gene
element NN I-Gene
( ( I-Gene
GRE NNP I-Gene
) ) I-Gene
- : I-Gene
containing VBG I-Gene
DNA NN I-Gene
fragments NNS I-Gene
. . O

DNA NN O
binding NN O
by IN O
in IN B-Gene
vitro NN I-Gene
synthesized VBN I-Gene
GR NNP I-Gene
was VBD O
blocked VBN O
by IN O
the DT O
addition NN O
of IN O
sodium NN O
molybdate NN O
to TO O
the DT O
receptor NN O
preparations NNS O
before IN O
steroid JJ O
addition NN O
and CC O
thermal JJ O
activation NN O
. . O

Addition NN O
of IN O
KCl NNP O
resulted VBD O
in IN O
less JJR O
DNA NN O
binding NN O
either CC O
due JJ O
to TO O
blockage VB O
of IN O
DNA NNP O
- : O
receptor NN B-Gene
complex JJ I-Gene
formation NN O
or CC O
disruption NN O
of IN O
the DT O
complexes NNS O
. . O

Oligonucleotides IN O
containing VBG O
the DT O
consensus NN B-Gene
GRE NNP I-Gene
were VBD O
the DT O
most RBS O
efficient JJ O
competitors NNS O
, , O
and CC O
fragments NNS O
containing VBG O
regulatory JJ B-Gene
sequences NNS I-Gene
from IN O
glucocorticoid JJ B-Gene
- : I-Gene
repressible JJ I-Gene
genes NNS I-Gene
were VBD O
somewhat RB O
competitive JJ O
, , O
whereas JJ O
single JJ O
stranded VBN O
oligonucleotides NNS O
were VBD O
unable JJ O
to TO O
compete VB O
for IN O
mouse NN B-Gene
mammary JJ I-Gene
tumor NN I-Gene
virus SYM I-Gene
- : I-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
DNA NNP O
binding NN O
, , O
except IN O
when WRB O
competitor NN O
was VBD O
present JJ O
at IN O
extremely RB O
high JJ O
concentrations NNS O
. . O

Expression NN O
of IN O
1 CD B-Gene
, , I-Gene
25 CD I-Gene
( ( I-Gene
OH NNP I-Gene
) ) I-Gene
2D3 CD I-Gene
receptors NNS I-Gene
on IN O
alveolar JJ O
lymphocytes NNS O
from IN O
patients NNS O
with IN O
pulmonary JJ O
granulomatous JJ O
diseases NNS O
. . O

1 CD B-Gene
, , I-Gene
25 CD I-Gene
( ( I-Gene
OH NNP I-Gene
) ) I-Gene
2D3 CD I-Gene
receptors NNS I-Gene
were VBD O
expressed VBN O
to TO O
a DT O
greater JJR O
extent NN O
on IN O
CD8 NNP O
+ NNP O
T NNP O
- : O
lymphocytes NNS O
than IN O
on IN O
CD4 NNP O
+ NNP O
T NNP O
- : O
lymphocytes VBZ O
in IN O
sarcoidosis NN O
, , O
whereas IN O
a DT O
greater JJR O
proportion NN O
of IN O
CD4 NNP O
+ NNP O
than IN O
of IN O
CD8 NNP O
+ NNP O
T NNP O
- : O
lymphocytes NNS O
from IN O
patients NNS O
with IN O
tuberculosis NN O
were VBD O
receptor JJ O
- : O
positive JJ O
. . O

Role NNP O
for IN O
the DT O
Epstein NNP B-Gene
- : I-Gene
Barr NNP I-Gene
virus NN I-Gene
nuclear JJ I-Gene
antigen NN I-Gene
2 CD I-Gene
in IN O
viral JJ B-Gene
promoter NN I-Gene
switching VBG O
during IN O
initial JJ O
stages NNS O
of IN O
infection NN O
. . O

These DT O
studies NNS O
have VBP O
been VBN O
extended VBN O
to TO O
show VB O
that IN O
( ( O
i NN O
) ) O
a DT O
mutant JJ O
EBV NNP O
strain NN O
lacking VBG O
the DT O
gene NN O
encoding VBG O
EBNA NNP B-Gene
2 CD I-Gene
fails NNS O
to TO O
switch VB O
from IN O
Wp NNP O
to TO O
Cp NNP B-Gene
usage NN O
in IN O
primary JJ O
B NNP O
lymphocytes NNS O
, , O
although IN O
the DT O
virus NN O
contains VBZ O
a DT O
functional JJ O
Cp NNP B-Gene
; : O
( ( O
ii NN O
) ) O
a DT O
region NN O
from IN O
- : B-Gene
429 CD I-Gene
to TO I-Gene
- : I-Gene
245 CD I-Gene
base NN I-Gene
pairs NNS I-Gene
upstream NN O
of IN O
Cp NNP B-Gene
is VBZ O
essential JJ O
for IN O
Cp NNP B-Gene
activity NN O
in IN O
B NNP O
lymphocytes NNS O
, , O
but CC O
only RB O
in IN O
the DT O
context NN O
of IN O
upstream NN B-Gene
and CC I-Gene
downstream NN I-Gene
sequences NNS I-Gene
; : O
( ( O
iii NN O
) ) O
this DT O
region NN O
contains VBZ O
an DT O
EBNA NNP B-Gene
2 CD I-Gene
- : I-Gene
dependent JJ I-Gene
enhancer NN I-Gene
; : O
and CC O
( ( O
iv NN O
) ) O
DNase NNP B-Gene
I PRP I-Gene
protection NN O
employing VBG O
nuclear JJ O
extracts NNS O
from IN O
B NNP O
and CC O
T NNP O
lymphocytes VBZ O
revealed VBD O
a DT O
B NNP B-Gene
- : I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
footprint NN I-Gene
in IN O
the DT O
region NN O
of IN O
the DT O
EBNA NNP B-Gene
2 CD I-Gene
- : I-Gene
dependent JJ I-Gene
enhancer NN I-Gene
. . O

Immune NNP O
response NN O
of IN O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
to TO O
HBx NNP B-Gene
- : I-Gene
antigen NN I-Gene
of IN O
hepatitis NN O
B NNP O
virus NN O
. . O

Five CD O
T NNP O
- : O
cell NN O
clones NNS O
specific VBP O
for IN O
a DT O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
epitope NN I-Gene
located VBN O
at IN O
the DT O
carboxyterminal JJ B-Gene
region NN I-Gene
of IN O
HBxAg NNP B-Gene
were VBD O
established VBN O
and CC O
found VBN O
to TO O
belong VB O
to TO O
the DT O
CD2 NNP O
/ NNP O
CD4 NNP O
- : O
positive JJ O
, , O
CD8 NNP O
- : O
negative JJ O
subtype NN O
. . O

[ NN O
Changes NNS O
in IN O
leucocytic JJ B-Gene
estrogen NN I-Gene
receptor NN I-Gene
levels NNS O
in IN O
patients NNS O
with IN O
gynecomastia JJ O
] NN O

The DT O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
independent JJ I-Gene
cis NN I-Gene
- : I-Gene
acting VBG I-Gene
sequences NNS I-Gene
in IN O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
responsive NN O
to TO O
T NNP O
- : O
cell NN O
activation NN O
. . O

The DT O
rate NN O
of IN O
transcription NN O
initiation NN O
directed VBN O
by IN O
the DT O
long JJ B-Gene
terminal JJ I-Gene
repeat NN I-Gene
( ( O
LTR NNP O
) ) O
of IN O
HIV NNP O
- : O
1 CD O
increases NNS O
in IN O
response NN O
to TO O
mitogenic JJ O
stimuli NNS O
of IN O
T NNP O
cells NNS O
. . O

The DT O
rate NN O
of IN O
LTR NNP B-Gene
- : O
directed VBD O
gene NN O
expression NN O
increased VBD O
in IN O
response NN O
to TO O
treatment NN O
with IN O
either CC O
a DT O
phorbol NN O
ester NN O
or CC O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha IN I-Gene
if IN O
either CC O
the DT O
NFAT NNP B-Gene
- : I-Gene
1 CD I-Gene
or CC O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
binding NN I-Gene
sites NNS I-Gene
were VBD O
deleted VBN O
, , O
but CC O
failed VBD O
to TO O
respond VB O
to TO O
these DT O
mitogenic JJ O
stimuli NN O
if IN O
both DT O
sequences NNS O
were VBD O
absent JJ O
. . O

Activation NN O
of IN O
proenkephalin NN O
transcription NN O
by IN O
JunD NNP B-Gene
is VBZ O
dependent JJ O
upon IN O
a DT O
previously RB O
characterized VBN O
cAMP NN B-Gene
- : I-Gene
, , I-Gene
phorbol NN I-Gene
ester NN I-Gene
- : I-Gene
, , I-Gene
and CC I-Gene
Ca NNP I-Gene
( ( I-Gene
2 CD I-Gene
+ NN I-Gene
) ) I-Gene
- : I-Gene
inducible JJ I-Gene
enhancer NN I-Gene
, , O
and CC O
JunD NNP B-Gene
is VBZ O
shown VBN O
to TO O
bind VB O
the DT O
enhancer NN B-Gene
as IN O
a DT O
homodimer NN B-Gene
. . O

Plasma NNP O
cortisol NN O
concentration NN O
and CC O
blood NN O
leukocyte NN O
content NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
( ( O
GCR NNP B-Gene
) ) O
were VBD O
assayed VBN O
in IN O
20 CD O
patients NNS O
with IN O
deficiency NN O
syndromes NNS O
, , O
10 CD O
cold NN O
in IN O
property NN O
( ( O
deficiency NN O
- : O
cold NN O
) ) O
, , O
the DT O
other JJ O
10 CD O
hot JJ O
in IN O
property NN O
( ( O
deficiency NN O
- : O
heat NN O
) ) O
, , O
and CC O
also RB O
in IN O
10 CD O
healthy JJ O
individuals NNS O
as IN O
normal JJ O
control NN O
for IN O
the DT O
purpose NN O
of IN O
investigating VBG O
the DT O
nature NN O
of IN O
cold NN O
and CC O
heat NN O
syndromes NNS O
. . O

Furthermore RB O
, , O
the DT O
ability NN O
of IN O
these DT O
complexes NNS O
to TO O
regulate VB O
gene NN O
expression NN O
is VBZ O
demonstrated VBN O
by IN O
increased JJ O
transcription NN O
from IN O
an DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
driven JJ I-Gene
reporter JJR I-Gene
construct NN I-Gene
and CC O
marked JJ O
increases NNS O
in IN O
the DT O
expression NN O
of IN O
endogenous JJ B-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
regulated VBN I-Gene
genes NNS I-Gene
. . O

This DT O
tight JJ O
correlation NN O
between IN O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
expression NN O
, , O
the DT O
generation NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
activity NN O
, , O
and CC O
differentiation NN O
suggests VBZ O
a DT O
critical JJ O
role NN O
for IN O
this DT O
gene NN O
and CC O
transcriptional JJ B-Gene
complex NN I-Gene
during IN O
this DT O
process NN O
. . O

Cyclosporin VB O
A DT O
and CC O
FK506 NNP O
inhibit NN O
T NNP O
- : O
and CC O
B NNP O
- : O
cell NN O
activation NN O
and CC O
other JJ O
processes NNS O
essential JJ O
to TO O
an DT O
effective JJ O
immune NN O
response NN O
. . O

A DT O
transcription NN B-Gene
factor NN I-Gene
, , O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
, , O
which WDT O
is VBZ O
essential JJ O
for IN O
early JJ O
T NNP O
- : O
cell NN O
gene NN O
activation NN O
, , O
seems VBZ O
to TO O
be VB O
a DT O
specific JJ O
target NN O
of IN O
cyclosporin NN O
A NNP O
and CC O
FK506 NNP O
action NN O
because IN O
transcription NN O
directed VBN O
by IN O
this DT O
protein NN O
is VBZ O
blocked VBN O
in IN O
T NNP O
cells NNS O
treated VBD O
with IN O
these DT O
drugs NNS O
, , O
with IN O
little JJ O
or CC O
no DT O
effect NN O
on IN O
other JJ O
transcription NN B-Gene
factors NNS I-Gene
such JJ O
as IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

Glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
lymphocytes NNS O
in IN O
anorexia JJ O
nervosa NN O
. . O

CONCLUSIONS NNP O
Hypercortisolaemia NNP O
does VBZ O
not RB O
down RP O
- : O
regulate VB O
the DT O
lymphocyte NN O
glucocorticoid NN B-Gene
receptors NNS I-Gene
in IN O
anorexia JJ O
nervosa NN O
and CC O
a DT O
post NN O
- : O
receptor NN O
defect NN O
might MD O
be VB O
involved VBN O
in IN O
peripheral JJ O
tissue NN O
resistance NN O
to TO O
the DT O
effects NNS O
of IN O
glucocorticoid JJ O
hormones NNS O
in IN O
undernutrition NN O
. . O

The DT O
induction NN O
of IN O
AP1 NNP B-Gene
by IN O
okadaic JJ O
acid NN O
suggests VBZ O
that IN O
protein NN B-Gene
phosphatases VBZ I-Gene
1 CD I-Gene
and CC I-Gene
2A CD I-Gene
( ( O
PP1 NNP B-Gene
and CC O
PP2A NNP B-Gene
) ) O
may MD O
be VB O
involved VBN O
in IN O
T NNP O
cell NN O
activation NN O
as IN O
important JJ O
negative JJ O
regulators NNS O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
AP1 NNP B-Gene
. . O

CD3 NNP B-Gene
- : O
epsilon NN O
gene NN O
expression NN O
is VBZ O
confined VBN O
to TO O
the DT O
T NNP O
cell NN O
lineage NN O
. . O

TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
belonged VBD O
to TO O
a DT O
novel JJ O
family NN O
of IN O
genes NNS O
that WDT O
contain VBP O
the DT O
so RB O
- : O
called VBN O
high JJ O
mobility NN B-Gene
group NN I-Gene
1 CD I-Gene
( ( I-Gene
HMG NNP I-Gene
) ) I-Gene
box NN I-Gene
. . O

Two CD O
splice JJ O
alternatives NNS O
were VBD O
identified VBN O
that WDT O
were VBD O
not RB O
previously RB O
observed VBN O
in IN O
human JJ B-Gene
TCF NNP I-Gene
- : I-Gene
1 CD I-Gene
. . O

Third NNP O
, , O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
bound NN O
specifically RB O
to TO O
a DT O
functional JJ O
T NNP B-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
element NN I-Gene
in IN O
the DT O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
alpha NN I-Gene
( ( I-Gene
TCR NNP I-Gene
- : I-Gene
alpha NN I-Gene
) ) I-Gene
enhancer NN I-Gene
. . O

Northern NNP O
blot NN O
analysis NN O
of IN O
polyadenylated JJ B-Gene
RNA NNP I-Gene
purified VBD O
from IN O
activated VBN O
human NN O
B NNP O
cells NNS O
revealed VBD O
a DT O
single JJ B-Gene
mRNA NN I-Gene
transcript NN I-Gene
of IN O
approximately RB O
2 CD O
. . O
3 CD O
kb NN O
. . O

There EX O
is VBZ O
a DT O
single JJ O
methionine NN B-Gene
codon SYM I-Gene
- : I-Gene
initiated VBN I-Gene
open JJ I-Gene
reading NN I-Gene
frame NN I-Gene
of IN O
1 CD O
, , O
458 CD O
nt NN O
in IN O
frame NN O
with IN O
a DT O
homeobox NN B-Gene
and CC O
a DT O
CAX NNP B-Gene
repeat NN I-Gene
, , O
and CC O
the DT O
open JJ B-Gene
reading NN I-Gene
frame NN I-Gene
is VBZ O
predicted VBN O
to TO O
encode VB O
a DT O
protein NN O
of IN O
51 CD O
, , O
659 CD O
daltons NNS O
. . O

Characterization NN O
of IN O
HB24 NNP B-Gene
expression NN O
in IN O
lymphoid NN O
and CC O
select JJ O
developing VBG O
tissues NNS O
was VBD O
performed VBN O
by IN O
in IN O
situ JJ O
hybridization NN O
. . O

Platelet NNP B-Gene
- : I-Gene
activating VBG I-Gene
factor NN I-Gene
induces NNS O
phospholipid JJ O
turnover NN O
, , O
calcium NN O
flux NN O
, , O
arachidonic JJ O
acid NN O
liberation NN O
, , O
eicosanoid JJ O
generation NN O
, , O
and CC O
oncogene JJ B-Gene
expression NN O
in IN O
a DT O
human JJ O
B NNP O
cell NN O
line NN O
. . O

Tandem NNP O
copies NNS O
of IN O
this DT O
67 CD B-Gene
- : I-Gene
bp NN I-Gene
MnlI NNP I-Gene
- : I-Gene
AluI NNP I-Gene
fragment NN I-Gene
, , O
when WRB O
fused VBN O
to TO O
the DT O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
gene NN I-Gene
driven VBN O
by IN O
the DT O
conalbumin NN B-Gene
promoter NN I-Gene
, , O
stimulated VBN O
transcription NN O
in IN O
B NNP O
cells NNS O
but CC O
not RB O
in IN O
Jurkat NNP O
T NNP O
cells NNS O
or CC O
HeLa NNP O
cells NNS O
. . O

Footprinting VBG O
analysis NN O
revealed VBD O
that IN O
the DT O
identical JJ O
sequence NN O
CCGAAACTGAAAAGG NNP O
, , O
designated VBD O
E6 NNP B-Gene
, , O
was VBD O
protected VBN O
by IN O
nuclear JJ O
extracts NNS O
from IN O
B NNP O
cells NNS O
, , O
T NNP O
cells NNS O
, , O
or CC O
HeLa NNP O
cells NNS O
. . O

Gel NNP O
mobility NN O
shift NN O
assays VBZ O
using VBG O
a DT O
synthetic JJ B-Gene
E6 NNP I-Gene
motif NN I-Gene
detected VBD O
a DT O
B NNP B-Gene
- : I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
complex NN I-Gene
in IN O
addition NN O
to TO O
a DT O
ubiquitous JJ O
band NN O
found VBD O
also RB O
in IN O
T NNP O
cells NNS O
and CC O
HeLa NNP O
cells NNS O
. . O

In IN O
agreement NN O
with IN O
the DT O
results NNS O
of IN O
gel JJ O
retardation NN O
assays NNS O
, , O
tandem JJ O
copies NNS O
of IN O
the DT O
E6 NNP B-Gene
motif NN I-Gene
stimulated VBD O
transcription NN O
in IN O
ARH77 NNP O
and CC O
Raji NNP O
cells NNS O
but CC O
not RB O
in IN O
Jurkat NNP O
or CC O
HeLa NNP O
cells NNS O
. . O

Interestingly RB O
, , O
the DT O
MnlI NNP B-Gene
- : I-Gene
AluI NNP I-Gene
fragment NN I-Gene
could MD O
suppress VB O
the DT O
basal NN O
- : O
level NN O
activity NN O
of IN O
the DT O
conalbumin NN B-Gene
promoter NN I-Gene
in IN O
both DT O
Jurkat NNP O
and CC O
HeLa NNP O
cells NNS O
. . O

Thus RB O
, , O
the DT O
novel JJ O
enhancer NN O
element NN O
identified VBN O
in IN O
this DT O
study NN O
is VBZ O
probably RB O
a DT O
target NN O
site NN O
for IN O
both DT O
positive JJ B-Gene
and CC I-Gene
negative JJ I-Gene
factors NNS I-Gene
. . O

Charybdotoxin NNP O
- : O
sensitive NN O
, , O
Ca NNP O
( ( O
2 CD O
+ NN O
) ) O
- : O
dependent JJ O
membrane NN O
potential NN O
changes NNS O
are VBP O
not RB O
involved VBN O
in IN O
human JJ O
T NNP O
or CC O
B NNP O
cell NN O
activation NN O
and CC O
proliferation NN O
. . O

The DT O
involvement NN O
of IN O
ion NN O
channels NNS O
in IN O
B NNP O
and CC O
T NNP O
lymphocyte JJ O
activation NN O
is VBZ O
supported VBN O
by IN O
many JJ O
reports NNS O
of IN O
changes NNS O
in IN O
ion NN O
fluxes NNS O
and CC O
membrane NN O
potential NN O
after IN O
mitogen NN B-Gene
binding NN O
. . O

However RB O
, , O
blockade NN O
of IN O
the DT O
Ca NNP B-Gene
( ( I-Gene
2 CD I-Gene
+ NN I-Gene
) ) I-Gene
- : I-Gene
activated VBN I-Gene
K NNP I-Gene
+ NNP I-Gene
channel NN I-Gene
is VBZ O
not RB O
associated VBN O
with IN O
changes NNS O
in IN O
cell NN O
- : O
cycle NN O
gene NN O
activation NN O
, , O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
production NN O
, , O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
expression NN O
or CC O
B NNP O
and CC O
T NNP O
cell NN O
mitogenesis NN O
. . O

From IN O
information NN O
available JJ O
in IN O
the DT O
literature NN O
on IN O
the DT O
substrate JJ O
specificity NN O
of IN O
the DT O
three CD O
enzymes NNS B-Gene
, , O
it PRP O
is VBZ O
clear JJ O
that IN O
a DT O
cysteine NN O
is VBZ O
not RB O
accepted VBN O
in IN O
any DT O
of IN O
the DT O
S2 NNP B-Gene
, , I-Gene
S1 NNP I-Gene
, , I-Gene
S1 NNP I-Gene
' POS I-Gene
, , I-Gene
and CC I-Gene
S2 NNP I-Gene
' POS I-Gene
subsites NNS I-Gene
of IN O
cathepsin NN B-Gene
B NNP I-Gene
and CC I-Gene
L NNP I-Gene
, , O
and CC O
not RB O
in IN O
the DT O
S1 NNP B-Gene
and CC O
S1 NNP B-Gene
' POS I-Gene
subsites NNS O
of IN O
cathepsin NN B-Gene
D NNP I-Gene
. . O

Starting VBG O
with IN O
a DT O
replication NN O
- : O
incompetent NN O
molecular JJ O
clone NN O
of IN O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
, , O
lacking VBG O
all PDT O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC I-Gene
Sp1 NNP I-Gene
binding VBG I-Gene
sites NNS I-Gene
present JJ O
in IN O
the DT O
native JJ B-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
( ( O
LTR NNP B-Gene
) ) O
, , O
proviruses VBZ O
containing VBG O
reconstructed VBN B-Gene
LTRs NNP I-Gene
with IN O
individual JJ O
or CC O
combinations NNS O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC I-Gene
Sp1 NNP I-Gene
elements NNS I-Gene
were VBD O
generated VBN O
and CC O
evaluated VBN O
for IN O
their PRP$ O
capacity NN O
to TO O
produce VB O
virus JJ O
progeny NN O
following VBG O
transfection NN O
- : O
cocultivation NN O
. . O

The DT O
human JJ B-Gene
interferon NN I-Gene
beta NN I-Gene
( ( I-Gene
IFN NNP I-Gene
- : I-Gene
beta NN I-Gene
) ) I-Gene
regulatory JJ I-Gene
element NN I-Gene
consists VBZ O
of IN O
multiple JJ O
enhanson NN B-Gene
domains NNS I-Gene
which WDT O
are VBP O
targets NNS O
for IN O
transcription NN B-Gene
factors NNS I-Gene
involved VBN O
in IN O
inducible JJ O
expression NN O
of IN O
the DT O
promoter NN B-Gene
. . O

A DT O
2 CD O
- : O
4 CD O
- : O
fold JJ O
increase NN O
in IN O
IFN NNP B-Gene
- : I-Gene
beta NN I-Gene
promoter NN I-Gene
transcription NN O
was VBD O
observed VBN O
in IN O
Sendai NNP O
virus NN O
induced VBD O
extracts NNS O
, , O
and CC O
deletion NN O
of IN O
PRDI NNP B-Gene
and CC O
PRDII NNP B-Gene
elements NNS I-Gene
decreased VBD O
this DT O
induced JJ O
level NN O
of IN O
transcription NN O
. . O

When WRB O
purified VBN O
PRDII NNP B-Gene
and CC I-Gene
tetrahexamer VB I-Gene
binding NN I-Gene
proteins NNS I-Gene
were VBD O
added VBN O
to TO O
the DT O
induced JJ O
extract NN O
, , O
a DT O
4 CD O
- : O
fold JJ O
increase NN O
in IN O
transcription NN O
was VBD O
observed VBN O
. . O

Human NNP B-Gene
and CC I-Gene
mouse NN I-Gene
Rhom NNP I-Gene
- : I-Gene
2 CD I-Gene
are VBP O
highly RB O
conserved VBN O
and CC O
, , O
like IN O
rhombotin NN B-Gene
, , O
encode RB O
two CD O
tandem NNS B-Gene
cysteine VBP I-Gene
- : I-Gene
rich JJ I-Gene
LIM NNP I-Gene
domains NNS I-Gene
. . O

NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
by IN O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
in IN O
the DT O
Jurkat NNP O
T NNP O
cell NN O
line NN O
is VBZ O
independent JJ O
of IN O
protein JJ B-Gene
kinase NN I-Gene
A NNP I-Gene
, , O
protein NN B-Gene
kinase NN I-Gene
C NNP I-Gene
, , O
and CC O
Ca NNP B-Gene
( ( I-Gene
2 CD I-Gene
+ NN I-Gene
) ) I-Gene
- : I-Gene
regulated VBN I-Gene
kinases NNS I-Gene
. . O

Furthermore RB O
, , O
while IN O
PMA NNP O
activation NN O
was VBD O
inhibited VBN O
by IN O
the DT O
PKC NNP B-Gene
inhibitor NN O
staurosporin NN O
, , O
the DT O
TNF NNP B-Gene
alpha NN I-Gene
effect NN O
was VBD O
unchanged JJ O
. . O

Here RB O
we PRP O
investigated VBD O
the DT O
transcriptional JJ O
basis NN O
for IN O
these DT O
changes NNS O
. . O

Mutations NNS O
at IN O
the DT O
B2 NNP B-Gene
site NN O
abolish NN O
this DT O
transcriptional JJ O
activation NN O
. . O

The DT O
purified JJ O
homodimer NN B-Gene
( ( O
two CD O
p50s NN B-Gene
) ) O
of IN O
the DT O
DNA NNP B-Gene
- : I-Gene
binding VBG I-Gene
subunit NN I-Gene
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
binds VBZ O
the DT O
B2 NNP B-Gene
site NN O
of IN O
proenkephalin NN O
relatively RB O
better RBR O
than IN O
does VBZ O
the DT O
heterotetramer NN B-Gene
( ( O
two CD O
p65s NN B-Gene
plus CC O
two CD O
p50s NN B-Gene
) ) O
form NN O
of IN O
the DT O
factor NN O
. . O

However RB O
, , O
as IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
is VBZ O
ubiquitous JJ O
and CC O
the DT O
transcriptional JJ O
activation NN O
through IN O
the DT O
B2 NNP B-Gene
site NN O
is VBZ O
T NNP O
cell NN O
specific NN O
, , O
yet RB O
another DT O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
factor NN I-Gene
which WDT O
synergizes VBZ O
with IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
should MD O
be VB O
considered VBN O
. . O

In IN O
nuclear JJ O
extracts NNS O
from IN O
monocytes NNS O
or CC O
macrophages NNS O
, , O
induction NN O
of IN O
NF NNP B-Gene
- : I-Gene
KB NNP I-Gene
occurred VBD O
only RB O
if IN O
the DT O
cells NNS O
were VBD O
previously RB O
infected VBN O
with IN O
HIV NNP O
- : O
1 CD O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
in IN O
monocytic JJ O
cell NN O
lineage NN O
, , O
HIV NNP O
- : O
1 CD O
could MD O
mimic VB O
some DT O
differentiation NN O
/ POS O
activation NN O
stimuli NNS O
allowing VBG O
nuclear JJ O
NF NNP B-Gene
- : I-Gene
KB NNP I-Gene
expression NN O
. . O

Disruption NN O
of IN O
the DT O
human JJ B-Gene
SCL NNP I-Gene
locus NN I-Gene
by IN O
` `` O
` `` O
illegitimate NN O
' '' O
' POS O
V NNP O
- : O
( ( O
D NNP O
) ) O
- : O
J JJ O
recombinase NN O
activity NN O
. . O

The DT O
fusion NN B-Gene
cDNA NN I-Gene
results NNS O
from IN O
an DT O
interstitial JJ O
deletion NN O
between IN O
a DT O
previously RB O
unknown JJ B-Gene
locus NN I-Gene
, , O
SIL NNP B-Gene
( ( O
SCL NNP B-Gene
interrupting VBG I-Gene
locus NN I-Gene
) ) O
, , O
and CC O
the DT O
5 CD B-Gene
' POS I-Gene
untranslated JJ I-Gene
region NN I-Gene
of IN O
SCL NNP B-Gene
. . O

Thus RB O
, , O
in IN O
lymphocytes NNS O
, , O
growth NN B-Gene
- : I-Gene
affecting NN I-Gene
genes NNS I-Gene
other JJ O
than IN O
immune JJ B-Gene
receptors NNS I-Gene
risk NN O
rearrangements NNS O
. . O

This DT O
was VBD O
compared VBN O
with IN O
the DT O
TREp NNP B-Gene
binding NN O
of IN O
reticulocyte NN B-Gene
lysate NN I-Gene
- : I-Gene
synthesized VBN I-Gene
TRs NNP I-Gene
. . O

Incubation NN O
of IN O
each DT O
of IN O
the DT O
TRs NNP B-Gene
with IN O
NE NNP O
from IN O
COS NNP O
- : O
7 CD O
cells NNS O
, , O
which WDT O
do VBP O
not RB O
possess VB O
sufficient JJ O
endogenous JJ O
TRs NNP B-Gene
to TO O
mediate VB O
T3 NNP O
- : O
responses NNS O
, , O
resulted VBD O
in IN O
formation NN O
of IN O
a DT O
new JJ O
, , O
more RBR O
greatly RB B-Gene
shifted VBN I-Gene
complex NN I-Gene
. . O

Cell NNP O
- : O
specific JJ O
differences NNS O
in IN O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
regulatory JJ I-Gene
elements NNS I-Gene
of IN O
human JJ B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
and CC I-Gene
beta NN I-Gene
interferon NN I-Gene
promoters NNS I-Gene
by IN O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
. . O

Tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
( ( I-Gene
TNF NNP I-Gene
- : I-Gene
alpha NN I-Gene
) ) I-Gene
mRNA NN I-Gene
production NN O
was VBD O
analyzed VBN O
by IN O
polymerase NN O
chain NN O
reaction NN O
amplification NN O
in IN O
monocytic JJ O
U937 NNP O
cells NNS O
and CC O
in IN O
a DT O
chronically RB O
HIV NNP O
infected VBD O
U937 NNP O
cell NN O
line NN O
( ( O
U9 NNP O
- : O
IIIB NN O
) ) O
. . O

Functional JJ O
analysis NN O
of IN O
cis NN B-Gene
- : I-Gene
linked VBN I-Gene
regulatory JJ I-Gene
sequences NNS I-Gene
in IN O
the DT O
HLA NNP B-Gene
DRA NNP I-Gene
promoter NN I-Gene
by IN O
transcription NN O
in IN O
vitro NN O
. . O

The DT O
effect NN O
of IN O
LPS NNP O
on IN O
HIV NNP O
- : O
1 CD O
replication NN O
occurs NNS O
at IN O
picogram JJ O
per IN O
milliliter NN O
concentrations NNS O
and CC O
may MD O
be VB O
clinically RB O
significant JJ O
in IN O
understanding VBG O
the DT O
variability NN O
of IN O
the DT O
natural JJ O
history NN O
of IN O
HIV NNP O
- : O
1 CD O
infection NN O
. . O

Inhibitory JJ O
drug NN O
interactions NNS O
affecting VBG O
the DT O
metabolism NN O
of IN O
methylprednisolone NN O
( ( O
MP NNP O
) ) O
may MD O
produce VB O
either CC O
steroid VB O
sparing NN O
or CC O
adverse JJ O
effects NNS O
partly RB O
by IN O
increasing VBG O
the DT O
exposure NN O
time NN O
to TO O
the DT O
steroid NN O
. . O

This DT O
phenomenon NN O
can MD O
be VB O
mimicked VBN O
by IN O
administering VBG O
MP NNP O
in IN O
divided JJ O
doses NNS O
. . O

To TO O
compare VB O
extra JJ O
- : O
renal JJ O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
production NN O
in IN O
different JJ O
types NNS O
of IN O
granulomatous JJ O
disease NN O
, , O
and CC O
to TO O
identify VB O
the DT O
cell NN O
types VBZ O
responsible JJ O
, , O
we PRP O
have VBP O
evaluated VBN O
the DT O
conversion NN O
of IN O
25 CD O
( ( O
OH NNP O
) ) O
D3 NNP O
in IN O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
by IN O
uncultured JJ O
cells NNS O
recovered VBN O
by IN O
bronchoalveolar JJ O
lavage NN O
and CC O
blood NN O
mononuclear VBP O
cells NNS O
from IN O
normocalcemic JJ O
patients NNS O
with IN O
sarcoidosis NN O
and CC O
tuberculosis NN O
. . O

1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
was VBD O
produced VBN O
both DT O
by IN O
lavage NN O
cells NNS O
( ( O
12 CD O
/ RB O
12 CD O
tuberculosis NN O
patients NNS O
, , O
2 CD O
/ NN O
6 CD O
sarcoidosis NN O
patients NNS O
) ) O
and CC O
blood NN O
mononuclear NN O
cells NNS O
( ( O
3 CD O
/ RB O
5 CD O
tuberculosis NN O
patients NNS O
, , O
0 CD O
/ NN O
3 CD O
sarcoidosis NN O
patients NNS O
) ) O
from IN O
patients NNS O
but CC O
not RB O
controls NNS O
, , O
but CC O
significantly RB O
greater JJR O
amounts NNS O
were VBD O
produced VBN O
by IN O
lavage NN O
cells NNS O
from IN O
tuberculosis NN O
patients NNS O
than IN O
those DT O
of IN O
sarcoidosis NN O
patients NNS O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
production NN O
by IN O
lavage NN O
cells NNS O
from IN O
tuberculosis NN O
patients NNS O
correlated VBN O
with IN O
the DT O
number NN O
of IN O
CD8 NNP O
+ NNP O
T NNP O
lymphocytes VBZ O
present JJ O
but CC O
not RB O
other JJ O
cell NN O
types NNS O
. . O

Because IN O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
can MD O
improve VB O
the DT O
capacity NN O
of IN O
macrophages NNS O
to TO O
kill VB O
mycobacteria NNS O
, , O
our PRP$ O
results NNS O
support VB O
the DT O
conclusion NN O
that WDT O
macrophage NN O
- : O
lymphocyte NN O
interactions NNS O
, , O
mediated VBN O
at IN O
least JJS O
in IN O
part NN O
by IN O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
, , O
may MD O
be VB O
an DT O
important JJ O
component NN O
of IN O
a DT O
successful JJ O
antituberculous JJ O
immune JJ O
response NN O
. . O

A DT O
closely RB O
related VBN O
( ( O
if IN O
not RB O
identical JJ O
) ) O
protein NN O
is VBZ O
found VBN O
in IN O
both DT O
a DT O
human JJ O
megakaryocytic JJ O
cell NN O
line NN O
and CC O
purified VBD O
human JJ O
megakaryocytes NNS O
; : O
it PRP O
binds VBZ O
to TO O
promoter VB B-Gene
regions NNS I-Gene
of IN O
two CD O
megakaryocytic JJ B-Gene
- : I-Gene
specific JJ I-Gene
genes NNS I-Gene
. . O

Furthermore RB O
, , O
point NN O
mutations NNS O
that IN O
abolish JJ O
binding NN O
of IN O
NF NNP B-Gene
- : I-Gene
E1 NNP I-Gene
result NN O
in IN O
a DT O
70 CD O
% NN O
decrease NN O
in IN O
the DT O
transcriptional JJ O
activity NN O
of IN O
a DT O
megakaryocytic JJ B-Gene
- : I-Gene
specific JJ I-Gene
promoter NN I-Gene
. . O

Transcriptional NNP O
down RP O
- : O
regulation NN O
of IN O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
expression NN O
by IN O
protein NN O
synthesis NN O
- : O
dependent NN O
and CC O
- : O
independent JJ O
pathways NNS O
in IN O
a DT O
human JJ O
T NNP O
lymphoblastic JJ O
tumor NN O
cell NN O
line NN O
. . O

We PRP O
studied VBD O
49 CD O
cases NNS O
of IN O
B NNP O
- : O
cell NN O
chronic JJ O
lymphocytic JJ O
leukemia NN O
( ( O
CLL NNP O
) ) O
using VBG O
immunostaining NN O
of IN O
cytospin NN O
preparations NNS O
. . O

In IN O
30 CD O
of IN O
these DT O
cases NNS O
ER NNP B-Gene
enzyme VBP O
immunoassay NN O
( ( O
ER NNP B-Gene
- : O
EIA NN O
) ) O
was VBD O
also RB O
performed VBN O
. . O

Type NNP B-Gene
- : I-Gene
II NNP I-Gene
estrogen SYM I-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
( ( O
type SYM B-Gene
- : I-Gene
II NNP I-Gene
EBS NNP I-Gene
) ) O
have VBP O
been VBN O
demonstrated VBN O
in IN O
the DT O
human JJ O
lymphoblastoid NN O
cell NN O
line NN O
IM NNP O
- : O
9 CD O
using VBG O
a DT O
whole JJ O
- : O
cell NN O
assay NN O
with IN O
( ( O
6 CD O
, , O
7 CD O
- : O
3H CD O
) ) O
estradiol NN O
( ( O
3H CD O
- : O
E2 NN O
) ) O
as IN O
tracer NN O
. . O

The DT O
relative JJ O
binding NN O
affinity NN O
of IN O
quercetin NN O
, , O
rutin NN O
, , O
DES NNP O
and CC O
TAM NNP O
for IN O
type NN B-Gene
- : I-Gene
II NNP I-Gene
EBS NNP I-Gene
correlated VBD O
well RB O
with IN O
their PRP$ O
potency NN O
as IN O
cell NN O
growth NN O
inhibitors NNS O
. . O

Moreover RB O
, , O
hesperidin NN O
, , O
a DT O
flavonoid NN O
which WDT O
does VBZ O
not RB O
bind VB O
to TO O
type VB B-Gene
- : I-Gene
II NNP I-Gene
EBS NNP I-Gene
, , O
was VBD O
ineffective JJ O
in IN O
inhibiting VBG O
cell NN O
growth NN O
. . O

[ JJ O
Glucocorticoid NNP B-Gene
receptors NNS I-Gene
in IN O
peripheral JJ O
blood NN O
lymphocytes NNS O
of IN O
patients NNS O
with IN O
bronchial JJ O
asthma NN O
] NN O

Quantitation NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
( ( O
GCR NNP B-Gene
) ) O
and CC O
the DT O
study NN O
of IN O
their PRP$ O
affinity NN O
for IN O
glucocorticosteroids NNS O
( ( O
GCS NNP O
) ) O
were VBD O
made VBN O
in IN O
peripheral JJ O
blood NN O
lymphocytes NNS O
of IN O
bronchial JJ O
asthma NN O
( ( O
BA NNP O
) ) O
patients NNS O
in IN O
consideration NN O
of IN O
GCR NNP B-Gene
treatment NN O
and CC O
serum NN O
levels NNS O
of IN O
endogenous JJ O
cortisol NN O
. . O

Two CD O
glucocorticoid JJ B-Gene
binding VBG I-Gene
sites NNS I-Gene
on IN O
the DT O
human JJ B-Gene
glucocorticoid NN I-Gene
receptor NN I-Gene
. . O

Cortivazol NNP O
( ( O
CVZ NNP O
) ) O
is VBZ O
a DT O
unique JJ O
, , O
high JJ O
potency NN O
synthetic JJ O
glucocorticoid NN O
, , O
which WDT O
has VBZ O
a DT O
phenylpyrazol NN O
fused VBN O
to TO O
the DT O
A NNP O
- : O
ring NN O
of IN O
the DT O
steroid JJ O
nucleus NN O
and CC O
displays NNS O
binding VBG O
consistent JJ O
with IN O
two CD O
or CC O
more JJR O
sites NNS O
in IN O
the DT O
cytosol NN O
from IN O
CEM NNP O
C7 NNP O
cells NNS O
( ( O
a DT O
human JJ O
acute NN O
lymphoblastic JJ O
T NNP O
- : O
cell NN O
line NN O
) ) O
. . O

We PRP O
have VBP O
carried VBN O
out RP O
experiments NNS O
to TO O
define VB O
the DT O
nature NN O
of IN O
the DT O
higher JJR B-Gene
affinity NN I-Gene
CVZ NNP I-Gene
binding NN I-Gene
site NN I-Gene
. . O

These DT O
data NNS O
indicate VBP O
that IN O
CVZ NNP O
is VBZ O
recognizing VBG O
two CD O
glucocorticoid JJ B-Gene
binding VBG I-Gene
sites NNS I-Gene
on IN O
the DT O
human JJ O
GR NNP B-Gene
or CC O
a DT O
protein JJ O
very RB O
similar JJ O
to TO O
it PRP O
. . O

Retroviral NNP O
mediated VBD O
transfer NN O
and CC O
expression NN O
of IN O
exogenous JJ B-Gene
genes NNS I-Gene
in IN O
primary JJ O
lymphoid JJ O
cells NNS O
: : O
assaying NN O
for IN O
a DT O
viral JJ O
transactivator NN B-Gene
activity NN O
in IN O
normal JJ O
and CC O
malignant JJ O
cells NNS O
. . O

Incidence NN O
of IN O
HLA NNP B-Gene
antigens NNS I-Gene
was VBD O
determined VBN O
in IN O
94 CD O
of IN O
them PRP O
. . O

Several JJ O
mutants NNS O
derived VBN O
from IN O
transformed VBN O
human JJ O
B NNP O
cell NN O
lines NNS O
are VBP O
defective JJ O
in IN O
expressing VBG O
major JJ B-Gene
histocompatibility NN I-Gene
complex NN I-Gene
( ( I-Gene
MHC NNP I-Gene
) ) I-Gene
class NN I-Gene
II NNP I-Gene
genes NNS I-Gene
. . O

There EX O
was VBD O
evidence NN O
for IN O
an DT O
autosomal JJ O
recessive JJ O
form NN O
of IN O
inheritance NN O
in IN O
four CD O
families NNS O
, , O
while IN O
the DT O
other JJ O
four CD O
families NNS O
appeared VBD O
to TO O
have VB O
an DT O
autosomal JJ O
dominant JJ O
mode NN O
of IN O
transmission NN O
. . O

These DT O
parents NNS O
were VBD O
entirely RB O
asymptomatic JJ O
. . O

ER NNP B-Gene
content NN O
in IN O
lymphocytes NNS O
of IN O
each DT O
sample NN O
was VBD O
expressed VBN O
by IN O
both DT O
fmol JJ O
/ NNP O
mg NN O
of IN O
lymphocyte JJ B-Gene
cytosolic JJ I-Gene
protein NN I-Gene
and CC O
fmol JJ O
/ NNP O
micrograms NN O
of IN O
lymphocyte JJ B-Gene
DNA NNP I-Gene
. . O

The DT O
results NNS O
showed VBD O
that IN O
there EX O
was VBD O
no DT O
significant JJ O
difference NN O
between IN O
the DT O
ER NNP B-Gene
content NN O
of IN O
lymphocytes NNS O
from IN O
the DT O
controls NNS O
and CC O
that IN O
from IN O
patients NNS O
with IN O
SLE NNP O
. . O

We PRP O
used VBD O
mouse RB O
embryonic JJ O
stem NN O
( ( O
ES NNP O
) ) O
cells NNS O
to TO O
study VB O
globin JJ B-Gene
gene NN I-Gene
expression NN O
and CC O
switching NN O
in IN O
vitro NN O
. . O

We PRP O
show VBP O
that IN O
ES NNP O
- : O
derived VBN O
embryoid JJ O
bodies NNS O
express VBP O
the DT O
full JJ O
complement NN O
of IN O
mouse NN B-Gene
embryonic JJ I-Gene
globin NN I-Gene
genes NNS I-Gene
in IN O
the DT O
correct JJ O
temporal JJ O
order NN O
and CC O
that IN O
on IN O
further JJ O
differentiation NN O
, , O
a DT O
switch NN O
occurs VBZ O
to TO O
the DT O
fetal JJ B-Gene
/ NNP I-Gene
adult NN I-Gene
genes NNS I-Gene
. . O

When WRB O
the DT O
human JJ B-Gene
epsilon NN I-Gene
- : I-Gene
or CC I-Gene
beta VB I-Gene
- : I-Gene
globin NN I-Gene
genes NNS I-Gene
driven VBN O
by IN O
the DT O
dominant JJ B-Gene
control NN I-Gene
region NN I-Gene
( ( O
DCR NNP B-Gene
) ) O
are VBP O
introduced VBN O
into IN O
this DT O
system NN O
, , O
the DT O
human JJ B-Gene
epsilon NN I-Gene
- : I-Gene
globin NN I-Gene
gene NN I-Gene
, , O
in IN O
contrast NN O
to TO O
the DT O
beta NN B-Gene
- : I-Gene
globin NN I-Gene
gene NN I-Gene
, , O
is VBZ O
not RB O
deregulated VBN O
by IN O
the DT O
presence NN O
of IN O
the DT O
DCR NNP B-Gene
and CC O
is VBZ O
expressed VBN O
strictly RB O
as IN O
an DT O
embryonic JJ B-Gene
gene NN I-Gene
. . O

These DT O
effects NNS O
of IN O
aldosterone NN O
were VBD O
blocked VBN O
by IN O
the DT O
aldosterone NN O
antagonist NN O
canrenone NN O
( ( O
140 CD O
nmol RB O
/ NNP O
l NN O
) ) O
. . O

Seventeen JJ O
cases NNS O
revealed VBD O
distinct JJ O
immunostaining NN O
against IN O
at IN O
least JJS O
1 CD O
of IN O
the DT O
5 CD O
steroid JJ O
hormones NNS O
. . O

ZRE NNP B-Gene
- : I-Gene
B NN I-Gene
is VBZ O
therefore RB O
not RB O
part NN O
of IN O
the DT O
R NNP B-Gene
- : I-Gene
inducible JJ I-Gene
enhancer NN I-Gene
. . O

However RB O
, , O
one CD O
palindrome NN B-Gene
, , O
either CC O
alone RB O
or CC O
duplicated VBN O
, , O
or CC O
the DT O
overlapping VBG B-Gene
palindromes NNS I-Gene
did VBD O
not RB O
respond VB O
to TO O
R NNP O
. . O

The DT O
clinical JJ O
implications NNS O
of IN O
nuclear JJ O
T3R NNP B-Gene
alterations NNS O
of IN O
circulating VBG O
lymphocytes NNS O
in IN O
hyperthyroidism NN O
, , O
hypothyroidism NN O
and CC O
nonthyroidal JJ O
diseases NNS O
were VBD O
investigated VBN O
. . O

The DT O
results NNS O
showed VBD O
that IN O
in IN O
hyper JJ O
- : O
and CC O
hypothyroid JJ O
patients NNS O
the DT O
nuclear JJ O
affinity NN O
( ( O
Ka NNP O
) ) O
for IN O
T3 NNP O
was VBD O
similar JJ O
to TO O
that DT O
of IN O
normal JJ O
subjects NNS O
. . O

In IN O
a DT O
fourth JJ O
cell NN O
line NN O
, , O
A1 NNP O
- : O
VDR NNP O
, , O
the DT O
receptor NN O
for IN O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
had VBD O
a DT O
low JJ O
binding NN O
capacity NN O
and CC O
25 CD B-Gene
( ( I-Gene
OH NNP I-Gene
) ) I-Gene
D3 NNP I-Gene
- : I-Gene
24 CD I-Gene
- : I-Gene
hydroxylase NN I-Gene
activity NN O
was VBD O
not RB O
detectable JJ O
. . O

Binding NNP O
and CC O
elution NN O
properties NNS O
to TO O
DNA NNP O
- : O
cellulose NN O
, , O
however RB O
, , O
differed VBD O
from IN O
normal JJ O
in IN O
both DT O
Ro NNP O
- : O
VDR NNP O
and CC O
A1 NNP O
- : O
VDR NNP O
cells NNS O
where WRB O
elution NN O
from IN O
DNA NNP O
- : O
cellulose NN O
occurred VBD O
at IN O
a DT O
lower JJR O
salt NN O
concentration NN O
than IN O
is VBZ O
typical JJ O
of IN O
the DT O
1 CD B-Gene
, , I-Gene
25 CD I-Gene
( ( I-Gene
OH NNP I-Gene
) ) I-Gene
2D3 CD I-Gene
receptor NN I-Gene
. . O

We PRP O
studied VBD O
the DT O
effects NNS O
of IN O
TPA NNP O
on IN O
the DT O
regulation NN O
of IN O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
gene NN O
expression NN O
in IN O
HL NNP O
- : O
60 CD O
cells NNS O
during IN O
monocytic JJ O
differentiation NN O
. . O

[ JJ O
Hormonal NNP O
interactions NNS O
and CC O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
patients NNS O
with IN O
the DT O
nephrotic JJ O
syndrome NN O
] NN O

These DT O
studies NNS O
detected VBD O
two CD O
novel NN B-Gene
domains NNS I-Gene
referred VBD O
to TO O
as IN O
L1 NNP B-Gene
and CC O
L2 NNP B-Gene
with IN O
a DT O
variety NN O
of IN O
lymphoid NN O
but CC O
not RB O
HeLa NNP O
extracts NNS O
. . O

Characterization NN O
of IN O
defensin NN B-Gene
resistance NN O
phenotypes NNS O
associated VBN O
with IN O
mutations NNS O
in IN O
the DT O
phoP NN B-Gene
virulence NN I-Gene
regulon NN I-Gene
of IN O
Salmonella NNP O
typhimurium NN O
. . O

The DT O
defensin NN B-Gene
sensitivities NNS O
of IN O
Salmonella NNP O
typhimurium NN O
strains NNS O
with IN O
mutations NNS O
in IN O
the DT O
phoP NN B-Gene
/ NNP I-Gene
phoQ NN I-Gene
two CD I-Gene
- : I-Gene
component NN I-Gene
virulence NN I-Gene
regulon NN I-Gene
were VBD O
tested VBN O
by IN O
using VBG O
purified JJ B-Gene
defensins NNS I-Gene
NP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
NP NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

The DT O
predicted JJ O
periplasmic JJ B-Gene
domain NN I-Gene
of IN O
the DT O
PhoQ NNP B-Gene
protein NN I-Gene
contained VBD O
a DT O
markedly RB O
anionic JJ O
domain NN O
that WDT O
could MD O
interact VB O
with IN O
cationic JJ B-Gene
proteins NNS I-Gene
and CC O
that DT O
could MD O
be VB O
responsible JJ O
for IN O
resistance NN O
to TO O
defensin VB B-Gene
. . O

This DT O
implied VBD O
that IN O
a DT O
pag NN B-Gene
( ( I-Gene
phoP JJ I-Gene
- : I-Gene
activated VBN I-Gene
gene NN I-Gene
) ) I-Gene
product NN I-Gene
is VBZ O
responsible JJ O
for IN O
defensin NN B-Gene
resistance NN O
. . O

Stimulation NN O
of IN O
a DT O
human JJ O
T NNP O
- : O
cell NN O
clone NN O
with IN O
anti JJ B-Gene
- : I-Gene
CD3 NN I-Gene
or CC O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
induces NNS O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
translocation NN O
but CC O
not RB O
human JJ O
immunodeficiency NN O
virus NN O
1 CD O
enhancer NN O
- : O
dependent JJ O
transcription NN O
. . O

The DT O
two CD O
latter NN O
signals NNS O
were VBD O
nevertheless RB O
able JJ O
to TO O
induce VB O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
translocation NN O
with IN O
a DT O
pattern NN O
in IN O
the DT O
band NN O
- : O
shift NN O
assay VBP O
indistinguishable JJ O
from IN O
that DT O
observed VBD O
using VBG O
phorbol NN O
ester NN O
. . O

However RB O
, , O
the DT O
resistance NN O
to TO O
vitamin VB O
D NNP O
treatment NN O
in IN O
XLH NNP O
can MD O
not RB O
be VB O
explained VBN O
by IN O
hypophosphatemia NN O
alone RB O
. . O

Two CD O
distinct JJ O
forms NNS O
of IN O
active JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
CREB NNP I-Gene
( ( O
cAMP JJ B-Gene
response NN I-Gene
element NN I-Gene
binding VBG I-Gene
protein NN I-Gene
) ) O
. . O

The DT O
two CD O
proteins NNS O
differ VBP O
by IN O
a DT O
14 CD B-Gene
- : I-Gene
amino NN I-Gene
acid JJ I-Gene
serine NN I-Gene
- : I-Gene
rich JJ I-Gene
insertion NN I-Gene
present NN O
in IN O
one CD O
of IN O
the DT O
CREB NNP B-Gene
isoforms NNS I-Gene
. . O

Both DT O
proteins NNS O
impart VBP O
cAMP SYM O
- : O
regulated JJ O
transcriptional JJ O
activity NN O
to TO O
a DT O
heterologous JJ B-Gene
DNA NNP I-Gene
- : I-Gene
binding NN I-Gene
domain NN I-Gene
, , O
showing VBG O
that IN O
cAMP NN O
directly RB O
modulates VBZ O
the DT O
transcriptional JJ O
stimulatory NN O
activity NN O
of IN O
CREB NNP B-Gene
. . O

Competition NN O
experiments NNS O
did VBD O
not RB O
reveal VB O
any DT O
high JJ B-Gene
- : I-Gene
affinity NN I-Gene
binding NN I-Gene
site NN I-Gene
for IN O
BSAP NNP B-Gene
in IN O
known JJ O
regulatory JJ B-Gene
regions NNS I-Gene
of IN O
immunoglobulin NN B-Gene
and CC I-Gene
class NN I-Gene
II NNP I-Gene
major JJ I-Gene
histocompatibility NN I-Gene
( ( I-Gene
MHC NNP I-Gene
) ) I-Gene
genes NNS I-Gene
, , O
suggesting VBG O
that IN O
BSAP NNP B-Gene
is VBZ O
a DT O
regulator NN O
of IN O
a DT O
different JJ O
set NN O
of IN O
B NNP B-Gene
- : I-Gene
lymphoid NN I-Gene
- : I-Gene
specific JJ I-Gene
genes NNS I-Gene
. . O

The DT O
expression NN O
of IN O
the DT O
antibody NN B-Gene
- : I-Gene
encoding NN I-Gene
genes NNS I-Gene
, , O
the DT O
immunoglobulin NN B-Gene
( ( I-Gene
Ig NNP I-Gene
) ) I-Gene
genes NNS I-Gene
, , O
is VBZ O
also RB O
restricted VBN O
to TO O
B NNP O
cells NNS O
. . O

It PRP O
appears VBZ O
that IN O
the DT O
B NNP O
cell NN O
- : O
specific JJ O
expression NN O
of IN O
Ig NNP B-Gene
genes NNS I-Gene
is VBZ O
mediated VBN O
at IN O
least JJS O
in IN O
part NN O
by IN O
cell NN O
type NN B-Gene
- : I-Gene
specific JJ I-Gene
Oct NNP I-Gene
factors NNS I-Gene
, , O
and CC O
that IN O
there EX O
are VBP O
both DT O
quantitative JJ O
and CC O
qualitative JJ O
differences NNS O
between IN O
Oct NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
Oct NNP B-Gene
- : I-Gene
2 CD I-Gene
factors NNS I-Gene
. . O

Recently RB O
, , O
a DT O
number NN O
of IN O
other JJ O
octamer JJ B-Gene
factor NN I-Gene
variants NNS I-Gene
were VBD O
identified VBN O
. . O

Many JJ O
of IN O
these DT O
may MD O
be VB O
created VBN O
by IN O
alternative JJ O
splicing NN O
of IN O
a DT O
primary JJ B-Gene
transcript NN I-Gene
of IN O
one CD O
Oct NNP O
factor NN O
gene NN O
and CC O
may MD O
serve VB O
a DT O
specific JJ O
function NN O
in IN O
the DT O
fine JJ O
tuning NN O
of IN O
gene NN O
expression NN O
. . O

We PRP O
find VBP O
that IN O
the DT O
factor NN O
that WDT O
binds VBZ O
to TO O
the DT O
E3 NNP B-Gene
enhancer NN I-Gene
motif NN I-Gene
, , O
CATGTGGC NNP O
, , O
is VBZ O
a DT O
ubiquitous JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
. . O

However RB O
, , O
despite IN O
its PRP$ O
ability NN O
to TO O
activate VB O
transcription NN O
of IN O
a DT O
transfected JJ B-Gene
reporter NN I-Gene
gene NN I-Gene
, , O
the DT O
factor NN O
is VBZ O
apparently RB O
unable JJ O
to TO O
bind VB O
to TO O
the DT O
endogenous JJ B-Gene
Ig NNP I-Gene
heavy NN I-Gene
chain NN I-Gene
enhancer NN I-Gene
in IN O
non JJ O
- : O
lymphoid JJ O
cells NNS O
: : O
In IN O
previous JJ O
experiments NNS O
by IN O
others NNS O
, , O
the DT O
characteristic NN O
in IN O
vivo JJ O
footprint NN O
of IN O
this DT O
factor NN O
, , O
designated VBN O
NF NNP B-Gene
- : I-Gene
muE3 NN I-Gene
, , O
was VBD O
detected VBN O
in IN O
B NNP O
cells NNS O
but CC O
not RB O
in IN O
non JJ O
- : O
B NNP O
cells NNS O
. . O

[ JJ O
Endocrine NNP O
status NN O
changes NNS O
in IN O
children NNS O
with IN O
bronchial JJ O
asthma NN O
] NN O

A DT O
study NN O
was VBD O
made VBN O
of IN O
adrenocortical JJ O
function NN O
by IN O
measuring VBG O
blood NN O
plasma NN O
cortisol NN O
concentration NN O
and CC O
amount NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
in IN O
lymphocytes NNS O
as RB O
well RB O
as IN O
thyroid JJ O
function NN O
by IN O
measuring VBG O
blood NN O
plasma NN O
triidothyronine NN O
and CC O
thyroxine JJ O
concentration NN O
in IN O
58 CD O
bronchial JJ O
asthma NN O
children NNS O
aged VBD O
1 CD O
to TO O
14 CD O
years NNS O
. . O

The DT O
authors NNS O
revealed VBD O
alterations NNS O
in IN O
the DT O
functional JJ O
activity NN O
of IN O
the DT O
indicated JJ O
endocrine NN O
glands NNS O
depending VBG O
on IN O
the DT O
intensity NN O
of IN O
bronchial JJ O
patency NN O
disorders NNS O
and CC O
the DT O
nature NN O
of IN O
the DT O
therapeutic JJ O
measures NNS O
carried VBD O
out RP O
. . O

TAR NNP B-Gene
independent JJ O
activation NN O
of IN O
the DT O
human JJ O
immunodeficiency NN O
virus NN O
in IN O
phorbol NN O
ester NN O
stimulated VBD O
T NNP O
lymphocytes NNS O
. . O

Multiple NNP B-Gene
regulatory JJ I-Gene
elements NNS I-Gene
in IN O
the DT O
human JJ B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
( ( O
HIV NNP B-Gene
LTR NNP I-Gene
) ) O
are VBP O
required VBN O
for IN O
activation NN O
of IN O
HIV NNP O
gene NN O
expression NN O
. . O

Results NNS O
in IN O
all DT O
cell NN O
lines NNS O
indicated VBD O
that IN O
mutations NNS O
of IN O
the DT O
SP1 NNP B-Gene
, , O
TATA NNP B-Gene
and CC O
the DT O
TAR NNP O
loop NN O
and CC O
stem NN O
secondary JJ O
structure NN O
resulted VBD O
in IN O
marked JJ O
decreases NNS O
in IN O
gene NN O
expression NN O
while IN O
mutations NNS O
of IN O
the DT O
enhancer NN B-Gene
motif NN I-Gene
or CC O
TAR NNP B-Gene
primary JJ I-Gene
sequence NN I-Gene
resulted VBD O
in IN O
only RB O
slight JJ O
decreases NNS O
. . O

The DT O
clinical JJ O
course NN O
and CC O
the DT O
laboratory NN O
data NNS O
suggest VBP O
that IN O
the DT O
tachycardia NN O
crises NNS O
are VBP O
the DT O
consequence NN O
of IN O
a DT O
hypersensitivity NN O
of IN O
the DT O
heart NN O
to TO O
thyroid VB O
hormones NNS O
, , O
associated VBN O
with IN O
an DT O
increased JJ O
number NN O
of IN O
T3 NNP B-Gene
nuclear JJ I-Gene
receptor NN I-Gene
sites NNS O
in IN O
lymphocytes NNS O
. . O

Induction NN O
of IN O
immediate JJ B-Gene
early JJ I-Gene
response NN I-Gene
genes NNS I-Gene
by IN O
macrophage NN B-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
in IN O
normal JJ O
human JJ O
monocytes NNS O
. . O

The DT O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
gene NN I-Gene
expression NN O
was VBD O
very RB O
transient JJ O
and CC O
was VBD O
not RB O
detectable JJ O
by IN O
60 CD O
min NNS O
after IN O
M NNP B-Gene
- : I-Gene
CSF NNP I-Gene
addition NN O
. . O

The DT O
protein NN O
synthesis NN O
inhibitor NN O
cycloheximide NN O
did VBD O
not RB O
block VB O
the DT O
induction NN O
of IN O
any DT O
of IN O
these DT O
genes NNS O
, , O
and CC O
in IN O
fact NN O
, , O
super JJR O
- : O
induced VBD O
the DT O
expression NN O
of IN O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
and CC O
hck NN B-Gene
. . O

These DT O
genes NNS O
may MD O
then RB O
play VB O
a DT O
role NN O
in IN O
altering VBG O
the DT O
physiologic JJ O
status NN O
of IN O
the DT O
cells NNS O
in IN O
response NN O
to TO O
CSF NNP B-Gene
. . O

Inducible JJ O
nuclear JJ B-Gene
factor NN I-Gene
binding VBG O
to TO O
the DT O
kappa NN B-Gene
B NNP I-Gene
elements NNS I-Gene
of IN O
the DT O
human JJ B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
enhancer NN I-Gene
in IN O
T NNP O
cells NNS O
can MD O
be VB O
blocked VBN O
by IN O
cyclosporin VBG O
A NNP O
in IN O
a DT O
signal JJ O
- : O
dependent JJ O
manner NN O
. . O

We PRP O
have VBP O
purified VBN O
a DT O
new JJ O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
factor NN I-Gene
, , O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
alpha NN I-Gene
, , O
that WDT O
is VBZ O
implicated VBN O
in IN O
the DT O
activation NN O
of IN O
genes NNS O
encoding VBG O
a DT O
major JJ O
component NN O
of IN O
the DT O
human JJ B-Gene
T NNP I-Gene
- : I-Gene
cell NN I-Gene
receptor NN I-Gene
( ( O
TCR NNP B-Gene
) ) O
. . O

Curiously RB O
, , O
the DT O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
alpha NN I-Gene
binding VBG O
element NN O
was VBD O
inactive JJ O
in IN O
vivo NN O
when WRB O
removed VBN O
from IN O
its PRP$ O
neighboring JJ O
elements NNS O
on IN O
the DT O
TCR NNP B-Gene
alpha NN I-Gene
enhancer NN I-Gene
and CC O
positioned VBN O
in IN O
one CD O
or CC O
more JJR O
copies NNS O
upstream NN O
of IN O
a DT O
heterologous JJ B-Gene
promoter NN I-Gene
. . O

A DT O
powerful JJ O
enhancer NN O
has VBZ O
been VBN O
mapped VBN O
to TO O
an DT O
18 CD B-Gene
- : I-Gene
bp NN I-Gene
DNA NNP I-Gene
segment NN I-Gene
located VBD O
11 CD O
kb NN O
5 CD O
' '' O
to TO O
the DT O
human JJ B-Gene
epsilon NN I-Gene
- : I-Gene
globin NN I-Gene
gene NN I-Gene
within IN O
the DT O
dominant JJ B-Gene
control NN I-Gene
or CC O
locus VB B-Gene
- : I-Gene
activating VBG I-Gene
region NN I-Gene
. . O

DNA NNP O
- : O
protein NN O
binding VBG O
assays NNS O
with IN O
nuclear JJ O
extracts NNS O
from IN O
induced JJ O
cells NNS O
demonstrate VBP O
a DT O
high JJ B-Gene
molecular JJ I-Gene
weight NN I-Gene
complex NN I-Gene
on IN O
the DT O
enhancer NN B-Gene
. . O

The DT O
tissue NN O
- : O
specific JJ O
expression NN O
of IN O
the DT O
MOPC NNP B-Gene
141 CD I-Gene
immunoglobulin NN I-Gene
heavy JJ I-Gene
- : I-Gene
chain NN I-Gene
gene NN I-Gene
was VBD O
studied VBN O
by IN O
using VBG O
in IN O
vitro JJ O
transcription NN O
. . O

Purified VBN O
OTF1 NNP B-Gene
from IN O
HeLa NNP O
cells NNS O
and CC O
OTF1 NNP B-Gene
and CC O
OTF2 NNP B-Gene
from IN O
B NNP O
cells NNS O
bound NN O
to TO O
identical JJ O
sequences NNS O
within IN O
the DT O
heavy JJ B-Gene
- : I-Gene
chain NN I-Gene
promoter NN I-Gene
. . O

In IN O
addition NN O
to TO O
these DT O
elements NNS O
, , O
we PRP O
identified VBD O
a DT O
second JJ O
regulatory JJ B-Gene
element NN I-Gene
, , O
the DT O
N NNP B-Gene
element NN I-Gene
with IN O
the DT O
sequence NN O
5 CD O
' '' O
- : O
GGAACCTCCCCC NNP O
- : O
3 CD O
' POS O
. . O

NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
as IN O
inducible JJ O
transcriptional JJ B-Gene
activator NN I-Gene
of IN O
the DT O
granulocyte NN B-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
gene NN I-Gene
. . O

The DT O
same JJ O
agents NNS O
induce VB O
transcription NN O
from IN O
the DT O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
receptor NN I-Gene
alpha SYM I-Gene
- : I-Gene
chain NN I-Gene
and CC I-Gene
interleukin JJ I-Gene
- : I-Gene
2 CD I-Gene
genes NNS I-Gene
, , O
depending VBG O
on IN O
promoter NN B-Gene
elements NNS I-Gene
that WDT O
bind VBP O
the DT O
inducible JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( O
or CC O
an DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
- : I-Gene
like IN I-Gene
factor NN I-Gene
) ) O
. . O

Two CD O
kappa NN B-Gene
B NNP I-Gene
- : I-Gene
like IN I-Gene
motifs NNS I-Gene
at IN O
positions NNS B-Gene
- : I-Gene
98 CD I-Gene
to TO I-Gene
- : I-Gene
108 CD I-Gene
of IN O
the DT O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
promoter NN I-Gene
were VBD O
also RB O
recognized VBN O
but CC O
with IN O
much JJ O
lower JJR O
affinities NNS O
. . O

Effects NNS O
of IN O
mitogenic JJ O
agents NNS O
upon IN O
glucocorticoid JJ O
action NN O
in IN O
human JJ O
tonsillar JJ O
T NNP O
- : O
lymphocytes NNS O
. . O

PMA NNP O
enhanced VBD O
slightly RB O
the DT O
stimulatory JJ O
effect NN O
of IN O
PHA NNP B-Gene
. . O

Accordingly RB O
, , O
the DT O
same JJ O
set NN O
of IN O
words NNS O
and CC O
phrases NNS O
( ( O
oligopeptides NNS O
) ) O
appear VBP O
in IN O
totally RB O
unrelated JJ O
proteins NNS O
. . O

Two CD O
distinct JJ O
signal JJ O
transmission NN O
pathways NNS O
in IN O
T NNP O
lymphocytes NNS O
are VBP O
inhibited VBN O
by IN O
complexes NNS O
formed VBN O
between IN O
an DT O
immunophilin NN B-Gene
and CC O
either DT O
FK506 NNP O
or CC O
rapamycin NN O
. . O

After IN O
in IN O
vitro JJ O
adherence NN O
, , O
human JJ O
monocytes NNS O
had VBD O
a DT O
biphasic JJ O
increase NN O
in IN O
PDGF NNP B-Gene
( ( I-Gene
B NNP I-Gene
) ) I-Gene
mRNA NN I-Gene
with IN O
peaks NNS O
at IN O
6 CD O
h NN O
and CC O
13 CD O
d NN O
. . O

Modulation NN O
of IN O
these DT O
events NNS O
at IN O
the DT O
time NN O
of IN O
adherence NN O
offers NNS O
a DT O
mechanism NN O
by IN O
which WDT O
differential JJ O
priming NN O
of IN O
the DT O
cells NNS O
may MD O
be VB O
accomplished VBN O
. . O

Unexpectedly RB O
, , O
stimulation NN O
of IN O
cloned VBN O
stably RB O
transfected VBN O
Jurkat NNP O
T NNP O
cells NNS O
leads VBZ O
to TO O
a DT O
bimodal JJ O
pattern NN O
of IN O
beta NN O
- : O
gal JJ O
expression NN O
in IN O
which WDT O
some DT O
cells NNS O
express VBP O
no DT O
beta NN B-Gene
- : I-Gene
gal NN I-Gene
and CC O
others NNS O
express VBP O
high JJ O
levels NNS O
. . O

Further JJ O
results NNS O
, , O
in IN O
which WDT O
beta SYM B-Gene
- : I-Gene
gal JJ I-Gene
activity NN O
is VBZ O
correlated VBN O
with IN O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
- : O
binding NN O
activity NN O
, , O
indicate VBP O
that IN O
the DT O
concentration NN O
of IN O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
must MD O
exceed VB O
a DT O
critical JJ O
threshold NN O
before IN O
transcription NN O
initiates NNS O
. . O

Similar JJ O
constructs NNS O
controlled VBN O
by IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
or CC O
the DT O
entire JJ O
interleukin NN B-Gene
- : I-Gene
2 CD I-Gene
enhancer NN I-Gene
show NN O
bimodal JJ O
expression NN O
patterns NNS O
during IN O
induction NN O
, , O
suggesting VBG O
that IN O
thresholds NNS O
set VBN O
by IN O
the DT O
concentration NN O
of IN O
transcription NN B-Gene
factors NNS I-Gene
may MD O
be VB O
a DT O
common JJ O
property NN O
of IN O
inducible JJ B-Gene
genes NNS I-Gene
. . O

In IN O
lymphoid JJ O
cells NNS O
, , O
Z NNP B-Gene
or CC O
R NNP B-Gene
alone RB O
produced VBD O
only RB O
small JJ O
increases NNS O
in IN O
EA NNP B-Gene
- : I-Gene
D NNP I-Gene
promoter NN I-Gene
activity NN O
, , O
whereas IN O
both DT O
transactivators NNS B-Gene
together RB O
produced VBD O
a DT O
large JJ O
stimulatory JJ O
effect NN O
. . O

In IN O
lymphoid JJ O
cells NNS O
, , O
only RB O
the DT O
upstream JJ B-Gene
sequences NNS I-Gene
are VBP O
required VBN O
for IN O
transactivation NN O
by IN O
the DT O
Z NNP B-Gene
/ NNP I-Gene
R NNP I-Gene
combination NN O
, , O
and CC O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
is VBZ O
dispensable JJ O
. . O

The DT O
DNA NNP O
isolated VBD O
contained VBD O
an DT O
open JJ O
reading NN O
frame NN O
encoding VBG O
108 CD O
amino JJ O
acid NN O
residues NNS O
. . O

This DT O
effect NN O
was VBD O
comparable JJ O
to TO O
or CC O
even RB O
stronger JJR O
than IN O
the DT O
effect NN O
of IN O
a DT O
mutation NN O
in IN O
the DT O
OCTA NNP B-Gene
site NN I-Gene
. . O

DNase NNP O
footprinting VBG O
analysis NN O
corroborated VBD O
the DT O
functional JJ O
data NNS O
showing VBG O
that IN O
a DT O
lymphoid JJ B-Gene
- : I-Gene
specific JJ I-Gene
protein NN I-Gene
binds VBZ O
to TO O
the DT O
microB NN B-Gene
DNA NNP I-Gene
motif NN I-Gene
. . O

This DT O
inducer NN O
can MD O
act VB O
in IN O
concert NN O
with IN O
the DT O
HIV NNP B-Gene
- : I-Gene
2 CD I-Gene
tat JJ I-Gene
gene NN I-Gene
and CC O
T NNP O
- : O
cell NN O
activation NN O
in IN O
enhancing VBG O
gene NN O
expression NN O
in IN O
human JJ O
CD4 NNP O
+ NNP O
lymphocytes VBZ O
. . O

Both DT O
HIV NNP O
- : O
2 CD O
and CC O
CMV NNP B-Gene
transactivators NNS I-Gene
enhance VBP O
HIV NNP O
- : O
2 CD O
gene NN O
expression NN O
by IN O
transcriptional JJ O
activation NN O
involving VBG O
transcript JJ O
initiation NN O
as RB O
well RB O
as IN O
elongation NN O
, , O
with IN O
CMV NNP B-Gene
transactivator NN I-Gene
affecting VBG O
elongation NN O
more JJR O
than IN O
the DT O
initiation NN O
. . O

Inflammatory JJ O
infiltrates NNS O
were VBD O
analysed VBN O
in IN O
tissue NN O
sections NNS O
of IN O
76 CD O
breast NN O
carcinomas NN O
by IN O
counting VBG O
the DT O
percentage NN O
of IN O
macrophages NNS O
, , O
IgA NNP O
+ NNP O
and CC O
IgG NNP O
+ NNP O
plasma NN O
cells NNS O
, , O
T NNP O
cells NNS O
with IN O
their PRP$ O
subpopulations NNS O
, , O
and CC O
natural JJ O
killer NN O
cells NNS O
, , O
and CC O
by IN O
measuring VBG O
postcapillary JJ O
venules NNS O
( ( O
PCVs NNP O
, , O
found VBD O
in IN O
12 CD O
cases NNS O
) ) O
within IN O
the DT O
infiltrates NNS O
. . O

In IN O
addition NN O
, , O
a DT O
direct JJ O
correlation NN O
exists VBZ O
between IN O
the DT O
diameter NN O
of IN O
the DT O
PCVs NNP O
and CC O
both CC O
the DT O
percentage NN O
of IN O
the DT O
OKT8 NNP O
+ NNP O
T NNP O
cells NNS O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
4 CD O
) ) O
and CC O
the DT O
Leu NNP O
- : O
7 CD O
+ JJ O
natural JJ O
killer NN O
cells NNS O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
3 CD O
) ) O
. . O

In IN O
this DT O
study NN O
we PRP O
present JJ O
evidence NN O
for IN O
reactivity NN O
of IN O
pregnancy NN O
lymphocytes NNS O
, , O
but CC O
not RB O
nonpregnancy JJ O
lymphocytes NNS O
, , O
with IN O
the DT O
progesterone NN B-Gene
receptor NN I-Gene
- : I-Gene
specific JJ I-Gene
monoclonal JJ I-Gene
antibody NN I-Gene
mPRI NN B-Gene
. . O

Depletion NN O
of IN O
CD8 NNP O
+ NNP O
cells NNS O
was VBD O
accompanied VBN O
by IN O
62 CD O
+ NNS O
/ SYM O
- : O
18 CD O
% NN O
loss NN O
of IN O
progesterone NN O
receptor NN O
- : O
bearing NN O
cells NNS O
, , O
while IN O
depletion NN O
of IN O
CD4 NNP O
+ NNP O
cells NNS O
resulted VBD O
in IN O
a DT O
twofold JJ O
increase NN O
in IN O
the DT O
number NN O
of IN O
positively RB O
staining VBG O
lymphocytes NNS O
. . O

Interaction NN O
of IN O
fibronectin NN B-Gene
with IN O
VLA NNP B-Gene
- : I-Gene
5 CD I-Gene
receptor NN I-Gene
on IN O
CD4 NNP O
cells NNS O
induces VBZ O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
transcription NN I-Gene
factor NN I-Gene
. . O

Int NNP B-Gene
- : I-Gene
2 CD I-Gene
was VBD O
amplified VBN O
in IN O
13 CD O
. . O
1 CD O
% NN O
and CC O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
was VBD O
amplified VBN O
in IN O
10 CD O
. . O
3 CD O
% NN O
. . O

A DT O
somewhat RB O
surprising JJ O
finding VBG O
however RB O
was VBD O
a DT O
very RB O
strong JJ O
association NN O
between IN O
oncogene JJ B-Gene
amplification NN O
and CC O
dense NN O
lymphocyte JJ O
infiltration NN O
of IN O
the DT O
tumor NN O
( ( O
P NNP O
= NNP O
. . O
5 CD O
) ) O
. . O
This DT O
correlation NN O
is VBZ O
even RB O
stronger JJR O
when WRB O
only RB O
high JJ O
levels NNS O
of IN O
amplification NN O
are VBP O
considered VBN O
, , O
either DT O
for IN O
each DT O
oncogene NN O
separately RB O
( ( O
P NNP O
= NNP O
. . O
48 CD O
) ) O
or CC O
in IN O
combination NN O
( ( O
P NNP O
= NNP O
. . O
7 CD O
) ) O
. . O

Suppression NN O
of IN O
signals NNS O
required VBN O
for IN O
activation NN O
of IN O
transcription NN B-Gene
factor NN I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
cells NNS O
constitutively RB O
expressing VBG O
the DT O
HTLV NNP B-Gene
- : I-Gene
I PRP I-Gene
Tax VBP I-Gene
protein NN I-Gene
. . O

Transcription NNP B-Gene
factor NN I-Gene
IID NNP I-Gene
( ( O
TFIID NNP B-Gene
) ) O
binds VBZ O
to TO O
the DT O
TATA NNP B-Gene
box NN I-Gene
promoter NN I-Gene
element NN I-Gene
and CC O
regulates VBZ O
the DT O
expression NN O
of IN O
most JJS O
eukaryotic JJ B-Gene
genes NNS I-Gene
transcribed VBN O
by IN O
RNA NNP B-Gene
polymerase NN I-Gene
II NNP I-Gene
. . O

Complementary JJ B-Gene
DNA NNP I-Gene
( ( O
cDNA NN B-Gene
) ) O
encoding VBG O
a DT O
human JJ B-Gene
TFIID NNP I-Gene
protein NN I-Gene
has VBZ O
been VBN O
cloned VBN O
. . O

Premenopausal NN O
patients NNS O
with IN O
neither DT O
risk NN O
factor NN O
had VBD O
a DT O
very RB O
low JJ O
failure NN O
rate NN O
( ( O
2 CD O
. . O
6 CD O
% NN O
at IN O
5 CD O
years NNS O
) ) O
, , O
regardless RB O
of IN O
age NN O
. . O

Second JJ O
, , O
TRE NNP B-Gene
- : I-Gene
DNA NN I-Gene
binding NN I-Gene
proteins NNS I-Gene
sedimented VBN O
through IN O
a DT O
glycerol NN O
density NN O
gradient NN O
at IN O
rates NNS O
corresponding VBG O
to TO O
proteins NNS O
of IN O
native JJ O
molecular JJ O
weights NNS O
of IN O
35 CD O
to TO O
50 CD O
kD NNS O
and CC O
110 CD O
kD NN O
. . O

Third NNP O
, , O
only RB O
the DT O
50 CD B-Gene
kD NN I-Gene
protein NN I-Gene
was VBD O
retained VBN O
on IN O
a DT O
biotinylated VBN O
DNA NNP O
- : O
streptavidin NN O
matrix NN O
when WRB O
the DT O
DNA NNP O
fragment NN O
contained VBD O
the DT O
TRE NNP B-Gene
- : I-Gene
DNA NN I-Gene
. . O

Fourth NNP O
, , O
extensive JJ O
purification NN O
by IN O
several JJ O
cycles NNS O
of IN O
TRE NNP B-Gene
- : O
DNA NN O
affinity NN O
chromatography NN O
resulted VBD O
in IN O
the DT O
32 CD B-Gene
, , I-Gene
36 CD I-Gene
to TO I-Gene
42 CD I-Gene
and CC I-Gene
110 CD I-Gene
kD NN I-Gene
proteins NNS I-Gene
and CC O
to TO O
less RBR O
extent VB O
the DT O
50 CD B-Gene
kD NN I-Gene
factor NN I-Gene
. . O

Two CD O
abundant JJ O
proteins NNS O
of IN O
75 CD O
and CC O
80 CD O
kD NNS O
were VBD O
competed VBN O
out RP O
by IN O
poly JJ O
[ NNP O
d NN O
( ( O
I PRP O
- : O
C NN O
) ) O
] NN O
in IN O
all DT O
reactions NNS O
. . O

The DT O
cAMP NN B-Gene
- : I-Gene
response NN I-Gene
element NN I-Gene
CRE NNP B-Gene
, , O
TGACGTCA NNP O
, , O
present NN O
in IN O
the DT O
21 CD B-Gene
base NN I-Gene
- : I-Gene
pair NN I-Gene
sequence NN I-Gene
, , O
appears VBZ O
to TO O
be VB O
essential JJ O
for IN O
specific JJ O
protein NN O
- : O
TRE NNP B-Gene
- : O
DNA NN O
interactions NNS O
because IN O
mutation NN O
of IN O
the DT O
two CD O
G NNP O
' POS O
s NN O
destroys VBZ O
this DT O
complex NN O
. . O

Activity NN O
of IN O
the DT O
immunoglobulin NN B-Gene
heavy JJ I-Gene
and CC I-Gene
kappa JJ I-Gene
light NN I-Gene
chain NN I-Gene
gene NN I-Gene
enhancers NNS I-Gene
depends VBZ O
on IN O
a DT O
complex JJ O
interplay NN O
of IN O
ubiquitous JJ B-Gene
and CC I-Gene
developmentally RB I-Gene
regulated JJ I-Gene
proteins NNS I-Gene
. . O

Elevated VBN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
concentrations NNS O
before IN O
and CC O
after IN O
glucocorticoid JJ O
therapy NN O
in IN O
peripheral JJ O
mononuclear JJ O
leukocytes NNS O
of IN O
patients NNS O
with IN O
atopic JJ O
dermatitis NN O
. . O

Patients NNS O
with IN O
AD NNP O
( ( O
n JJ O
= NNP O
15 CD O
) ) O
exhibited VBD O
significantly RB O
more RBR O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
( ( O
GR NNP B-Gene
) ) O
per IN O
cell NN O
than IN O
the DT O
control NN O
group NN O
( ( O
n JJ O
= NNP O
22 CD O
) ) O
, , O
while IN O
the DT O
GR NNP B-Gene
affinity NN O
did VBD O
not RB O
differ VB O
. . O

Methylprednisolone NNP O
treatment NN O
resulted VBD O
in IN O
a DT O
significant JJ O
reduction NN O
of IN O
the DT O
GR NNP B-Gene
sites VBZ O
per IN O
cell NN O
in IN O
the DT O
steroid JJ O
- : O
treated VBN O
control NN O
group NN O
( ( O
n JJ O
= NNP O
10 CD O
) ) O
in IN O
contrast NN O
to TO O
the DT O
patients NNS O
. . O

The DT O
internal JJ O
methionine NN O
codons NNS O
of IN O
human JJ B-Gene
T NNP I-Gene
- : I-Gene
cell NN I-Gene
leukemia NN I-Gene
virus NN I-Gene
type NN I-Gene
II NNP I-Gene
rex NN I-Gene
gene NN I-Gene
are VBP O
not RB O
required VBN O
for IN O
p24rex JJ B-Gene
production NN O
or CC O
virus NN O
replication NN O
and CC O
transformation NN O
. . O

Human NNP O
T NNP O
- : O
cell NN O
leukemia NN O
virus NN O
types NNS O
I PRP O
( ( O
HTLV NNP O
- : O
I PRP O
) ) O
and CC O
II NNP O
( ( O
HTLV NNP O
- : O
II NN O
) ) O
have VBP O
two CD O
nonstructural JJ B-Gene
trans NNS I-Gene
- : I-Gene
acting VBG I-Gene
regulatory JJ I-Gene
genes NNS I-Gene
, , O
tax NN B-Gene
and CC O
rex NN B-Gene
, , O
located VBN O
in IN O
the DT O
3 CD B-Gene
' POS I-Gene
region NN I-Gene
of IN O
the DT O
viral JJ B-Gene
genome NN I-Gene
. . O

Rex NNP B-Gene
acts VBZ O
posttranscriptionall NN O
to TO O
facilitate VB O
accumulation NN O
of IN O
full JJ O
- : O
length NN O
gag NN B-Gene
/ NNP I-Gene
pol NN I-Gene
and CC O
singly RB O
spliced VBD O
env JJ B-Gene
mRNA NN I-Gene
in IN O
the DT O
cytoplasm NN O
of IN O
HTLV NNP O
- : O
infected JJ O
cells NNS O
. . O

By IN O
using VBG O
an DT O
infectious JJ O
molecular JJ O
clone NN O
of IN O
HTLV NNP O
- : O
II NNP O
, , O
we PRP O
investigated VBD O
the DT O
importance NN O
of IN O
the DT O
internal JJ O
ATGs NNP O
of IN O
the DT O
rex JJ B-Gene
gene NN I-Gene
on IN O
Rex NNP B-Gene
protein NN O
production NN O
and CC O
function NN O
. . O

The DT O
' '' B-Gene
octamer NN I-Gene
' '' I-Gene
sequence NN I-Gene
, , O
ATGCAAAT NNP O
or CC O
its PRP$ O
complement JJ O
ATTTGCAT NNP O
, , O
is VBZ O
a DT O
key JJ O
element NN O
for IN O
the DT O
transcriptional JJ O
regulation NN O
of IN O
immunoglobulin NN B-Gene
genes NNS I-Gene
in IN O
B NNP O
- : O
lymphocytes VBZ O
as RB O
well RB O
as IN O
a DT O
number NN O
of IN O
housekeeping VBG B-Gene
genes NNS I-Gene
in IN O
all DT O
cell NN O
types NNS O
. . O

In IN O
lymphocytes NNS O
, , O
the DT O
octamer NN B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
Oct NNP B-Gene
- : I-Gene
2A CD I-Gene
and CC O
variants NNS O
thereof NNS O
are VBP O
thought VBN O
to TO O
contribute VB O
to TO O
the DT O
B NNP B-Gene
- : I-Gene
cell NN I-Gene
specific JJ I-Gene
gene NN I-Gene
expression NN O
, , O
while IN O
the DT O
ubiquitous JJ O
protein NN O
Oct NNP O
- : O
1 CD O
seems VBZ O
to TO O
control VB O
general JJ O
octamer NN B-Gene
site NN I-Gene
- : O
dependent JJ O
transcription NN O
. . O

Therefore RB O
, , O
the DT O
phosphorylation NN O
of IN O
Rex NNP B-Gene
is VBZ O
required VBN O
for IN O
the DT O
viral JJ O
RNA NNP O
partition NN O
of IN O
HTLV NNP O
- : O
I PRP O
. . O

Cell NNP O
proliferation NN O
of IN O
CEM NNP O
- : O
C7 NNP O
cells NNS O
cultured VBN O
in IN O
both DT O
serum JJ O
- : O
free JJ O
media NNS O
has VBZ O
been VBN O
sustained VBN O
for IN O
3 CD O
mo NN O
. . O

All DT O
immunoglobulin NN B-Gene
genes NNS I-Gene
contain VBP O
a DT O
conserved JJ O
octanucleotide NN B-Gene
promoter NN I-Gene
element NN I-Gene
, , O
ATGCAAAT NNP O
, , O
which WDT O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
required VBN O
for IN O
their PRP$ O
normal JJ O
B NNP O
- : O
cell NN O
- : O
specific JJ O
transcription NN O
. . O

Proteins NNS O
that WDT O
bind VBP O
this DT O
octamer NN O
have VBP O
been VBN O
purified VBN O
, , O
and CC O
cDNAs NN B-Gene
encoding VBG O
octamer JJR B-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
have VBP O
been VBN O
cloned VBN O
. . O

Addition NN O
of IN O
a DT O
highly RB O
enriched JJ O
preparation NN O
of IN O
OTF NNP B-Gene
- : I-Gene
1 CD I-Gene
made VBD O
from IN O
one CD O
of IN O
these DT O
pre FW O
- : O
B NNP O
cells NNS O
or CC O
from IN O
HeLa NNP O
cells NNS O
specifically RB O
stimulated VBN O
in IN O
vitro JJ O
transcription NN O
of IN O
an DT O
immunoglobulin JJ B-Gene
gene NN I-Gene
. . O

In IN O
vitro JJ O
binding NN O
of IN O
aldosterone NN O
to TO O
mineralocorticoid VB B-Gene
receptors NNS I-Gene
on IN O
human JJ O
mononuclear NN O
leukocytes NNS O
( ( O
HML NNP O
) ) O
and CC O
its PRP$ O
effects NNS O
on IN O
the DT O
intracellular JJ O
sodium NN O
and CC O
potassium NN O
concentrations NNS O
of IN O
HML NNP O
have VBP O
already RB O
been VBN O
described VBN O
. . O

In IN O
only RB O
four CD O
patients NNS O
sodium NN O
in IN O
HML NNP O
without IN O
incubation NN O
was VBD O
elevated VBN O
compared VBN O
with IN O
the DT O
range NN O
for IN O
normal JJ O
persons NNS O
. . O

A DT O
decrease NN O
of IN O
intracellular JJ O
sodium NN O
or CC O
potassium NN O
occurred VBD O
during IN O
incubation NN O
without IN O
aldosterone NN O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
2 CD O
) ) O
. . O

The DT O
number NN O
of IN O
mineralocorticoid JJ B-Gene
receptors NNS I-Gene
/ VBP O
cell NN O
were VBD O
within IN O
or CC O
close VB O
to TO O
the DT O
normal JJ O
range NN O
( ( O
n JJ O
= NNP O
9 CD O
) ) O
. . O

It PRP O
is VBZ O
proposed VBN O
that IN O
the DT O
character NN O
of IN O
their PRP$ O
expression NN O
under IN O
the DT O
influence NN O
of IN O
vitamin NN O
D NNP O
may MD O
be VB O
used VBN O
with IN O
differential JJ O
diagnostic JJ O
purposes NNS O
in IN O
view NN O
. . O

Regulation NN O
of IN O
gene NN O
expression NN O
with IN O
double JJ O
- : O
stranded JJ O
phosphorothioate NN O
oligonucleotides NNS O
. . O

We PRP O
now RB O
demonstrate VBP O
the DT O
following NN O
. . O

Thus RB O
, , O
EBNA NNP B-Gene
- : I-Gene
2 CD I-Gene
transactivation NN O
of IN O
LMP1 NNP B-Gene
amplifies VBZ O
the DT O
biological JJ O
impact NN O
of IN O
EBNA NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
underscores VBZ O
its PRP$ O
central JJ O
role NN O
in IN O
EBV NNP O
- : O
induced JJ O
growth NN O
transformation NN O
. . O

Heat NNP O
shock NN O
caused VBD O
an DT O
increase NN O
in IN O
c JJ O
- : O
fos NN O
and CC O
c SYM O
- : O
jun NN O
mRNA NN O
levels NNS O
and CC O
a DT O
decrease NN O
in IN O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
mRNA NN I-Gene
levels NNS O
in IN O
pre NN O
- : O
B NNP O
( ( O
Hyon NNP O
) ) O
and CC O
T NNP O
( ( O
DND NNP O
- : O
41 CD O
) ) O
cell NN O
lines NNS O
as RB O
well RB O
as IN O
in IN O
freshly RB O
isolated VBN O
normal JJ O
human JJ O
thymocytes NNS O
. . O

Mapping NN O
of IN O
B NNP B-Gene
- : I-Gene
cell NN I-Gene
epitopes NNS I-Gene
of IN O
the DT O
human JJ B-Gene
hepatitis NN I-Gene
B NNP I-Gene
virus NN I-Gene
X NNP I-Gene
protein NN I-Gene
. . O

Anti NNP O
- : O
HBx NNP B-Gene
antibody NN O
titers NNS O
as IN O
revealed VBN O
by IN O
peptide JJ O
ELISAs NNP O
were VBD O
highest JJS O
and CC O
most RBS O
frequent JJ O
in IN O
patients NNS O
with IN O
chronic JJ O
hepatitis NN O
and CC O
usually RB O
low JJ O
in IN O
acutely RB O
infected JJ O
patients NNS O
and CC O
asymptomatic JJ O
carriers NNS O
. . O

Random NNP O
migration NN O
( ( O
RM NNP O
) ) O
and CC O
chemotactic JJ O
migration NN O
( ( O
ChtM NNP O
) ) O
of IN O
human JJ O
leukocytes NNS O
to TO O
yeast VB O
activated JJ O
serum NN O
were VBD O
studied VBN O
with IN O
the DT O
modified VBN O
Boyden NNP O
chamber NN O
method NN O
. . O

The DT O
difference NN O
between IN O
the DT O
peak NN O
( ( O
0 CD O
: : O
0 CD O
) ) O
and CC O
trough JJ O
values NNS O
( ( O
8 CD O
: : O
0 CD O
) ) O
of IN O
RM NNP O
and CC O
ChtM NNP O
was VBD O
significant JJ O
statistically RB O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

ChtM NNP O
was VBD O
inhibited VBN O
by IN O
hydrocortisone NN O
( ( O
F NNP O
) ) O
of IN O
physiological JJ O
concentration NN O
( ( O
10 CD O
( ( O
- : O
9 CD O
) ) O
- : O
10 CD O
( ( O
- : O
7 CD O
) ) O
mol NN O
/ NNP O
L NNP O
) ) O
which WDT O
was VBD O
dose JJ O
- : O
dependent NN O
and CC O
completely RB O
antagonized VBN O
by IN O
the DT O
competitive JJ O
antagonist NN O
, , O
RU38486 NNP O
. . O

The DT O
inhibitory JJ O
effect NN O
was VBD O
much RB O
more RBR O
evident JJ O
with IN O
higher JJR O
dose NN O
( ( O
more JJR O
than IN O
10 CD O
( ( O
- : O
5 CD O
) ) O
mol NN O
/ NNP O
L NNP O
) ) O
and CC O
it PRP O
was VBD O
also RB O
reversed VBN O
by IN O
RU38486 NNP O
, , O
but CC O
only RB O
partially RB O
. . O

Lt NNP B-Gene
- : I-Gene
4 CD I-Gene
reacted VBN O
with IN O
all DT O
HTLV NNP O
- : O
I PRP O
- : O
bearing NN O
cell NN O
lines NNS O
tested VBN O
and CC O
five CD O
out IN O
of IN O
eight CD O
simian JJ O
cell NN O
lines NNS O
bearing VBG O
STLV NNP O
- : O
I PRP O
, , O
but CC O
not RB O
with IN O
an DT O
HTLV NNP O
- : O
II NNP O
- : O
bearing NN O
cell NN O
line NN O
. . O

In IN O
the DT O
STLV NNP O
- : O
I PRP O
- : O
bearing VBG O
T NNP O
cell NN O
lines NNS O
, , O
tax1 SYM B-Gene
- : I-Gene
related JJ I-Gene
antigen NN I-Gene
molecules NNS I-Gene
detected VBN O
by IN O
Lt NNP B-Gene
- : I-Gene
4 CD I-Gene
were VBD O
heterogeneous JJ O
, , O
having VBG O
molecular JJ O
weights NNS O
in IN O
the DT O
range NN O
of IN O
36 CD O
- : O
41 CD O
kd NN O
. . O

The DT O
transcription NN O
of IN O
the DT O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
is VBZ O
under IN O
the DT O
control NN O
of IN O
cellular JJ B-Gene
proteins NNS I-Gene
that WDT O
bind VBP O
to TO O
the DT O
viral JJ B-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
( ( O
LTR NNP B-Gene
) ) O
. . O

The DT O
corresponding JJ O
region NN O
in IN O
the DT O
second JJ O
AIDS NNP O
retrovirus NN O
, , O
HIV NNP O
- : O
2 CD O
, , O
contains VBZ O
a DT O
conserved JJ O
and CC O
a DT O
divergent JJ O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
binding NN I-Gene
site NN I-Gene
. . O

Instead RB O
of IN O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
the DT O
activator NN B-Gene
protein VBD I-Gene
3 CD I-Gene
binds NNS O
to TO O
the DT O
divergent NN O
site NN O
in IN O
HIV NNP O
- : O
2 CD O
. . O

Expression NNP O
cloning NN O
of IN O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
. . O

Whereas NNP O
c SYM B-Gene
- : I-Gene
Fos NNP I-Gene
/ NNP I-Gene
c SYM I-Gene
- : I-Gene
Jun NN I-Gene
heterodimers NNS I-Gene
do VBP O
not RB O
exist VB O
in IN O
B NNP O
cells NNS O
, , O
they PRP O
form VBP O
and CC O
bind VBP O
to TO O
the DT O
X2 NNP B-Gene
- : I-Gene
box NN I-Gene
in IN O
class NN O
II NNP O
nonexpressing NN O
cells NNS O
. . O

11 CD O
beta NN O
, , O
19 CD O
- : O
epoxy JJ O
- : O
4 CD O
, , O
21 CD O
- : O
dihydroxypregn NN O
- : O
4 CD O
- : O
ene NN O
- : O
3 CD O
, , O
20 CD O
- : O
dione NN O
( ( O
2 CD O
) ) O
was VBD O
hydrogenated VBN O
with IN O
Pd NNP O
- : O
C NN O
to TO O
yield VB O
a DT O
mixture NN O
of IN O
all DT O
four CD O
dihydro NN O
derivatives NNS O
5 CD O
, , O
accompanied VBN O
by IN O
4 CD O
, , O
21 CD O
- : O
diacetoxy NN O
- : O
11 CD O
beta NN O
, , O
19 CD O
- : O
epoxy JJ O
- : O
3 CD O
- : O
hydroxypregnan NN O
- : O
20 CD O
- : O
one NN O
( ( O
6 CD O
) ) O
and CC O
21 CD O
- : O
acetoxy JJ O
- : O
11 CD O
beta NN O
, , O
19 CD O
- : O
epoxy JJ O
- : O
4 CD O
- : O
hydroxypregnane NN O
- : O
3 CD O
, , O
20 CD O
- : O
dione NN O
( ( O
7 CD O
) ) O
. . O

Treatment NN O
of IN O
10 CD O
with IN O
warm JJ O
HCl NNP O
furnished VBD O
19 CD O
- : O
chloro NN O
- : O
4 CD O
, , O
21 CD O
- : O
dihydroxypregna NN O
- : O
4 CD O
, , O
9 CD O
( ( O
11 CD O
) ) O
- : O
diene NN O
- : O
3 CD O
, , O
20 CD O
- : O
dione NN O
( ( O
13 CD O
) ) O
. . O

When WRB O
tested VBN O
in IN O
a DT O
radioreceptor NN O
assay NN O
in IN O
human JJ O
mononuclear NN O
leukocytes VBZ O
the DT O
synthesized JJ O
compounds NNS O
showed VBD O
only RB O
low JJ O
relative JJ O
binding NN O
affinities NNS O
( ( O
RBA NNP O
) ) O
to TO O
type VB B-Gene
1 CD I-Gene
receptor NN I-Gene
, , O
the DT O
highest JJS O
being VBG O
0 CD O
. . O
72 CD O
% NN O
for IN O
13 CD O
( ( O
aldosterone NN O
= RB O
100 CD O
% NN O
) ) O
. . O

We PRP O
have VBP O
developed VBN O
a DT O
system NN O
to TO O
monitor VB O
the DT O
transcriptional JJ O
activity NN O
of IN O
NFAT NNP B-Gene
- : I-Gene
1 CD I-Gene
at IN O
the DT O
single JJ O
cell NN O
level NN O
in IN O
whole JJ O
animals NNS O
. . O

This DT O
report NN O
represents VBZ O
the DT O
first JJ O
demonstration NN O
that IN O
a DT O
multimerized VBN O
short JJ O
binding VBG O
motif NN O
can MD O
function VB O
appropriately RB O
in IN O
transgenic JJ O
mice NN O
. . O

This DT O
similarity NN O
in IN O
expression NN O
and CC O
the DT O
fact NN O
that IN O
NFAT NNP B-Gene
- : I-Gene
1 CD I-Gene
has VBZ O
been VBN O
shown VBN O
to TO O
bind VB O
functional JJ B-Gene
sequences NNS I-Gene
in IN O
HIV NNP B-Gene
- : I-Gene
LTR NNP I-Gene
suggest VBP O
a DT O
role NN O
for IN O
NFAT NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
dermal JJ O
activation NN O
of IN O
the DT O
HIV NNP B-Gene
- : I-Gene
LTR NN I-Gene
. . O

A DT O
novel JJ O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
protein RB I-Gene
recognized VBD O
the DT O
palindromic JJ B-Gene
sequence NN I-Gene
within IN O
site NN B-Gene
B NNP I-Gene
and CC O
also RB O
bound VBD O
estrogen SYM B-Gene
- : I-Gene
or CC I-Gene
thyroid VB I-Gene
hormone CD I-Gene
- : I-Gene
response NN I-Gene
elements NNS I-Gene
with IN O
lower JJR O
affinity NN O
. . O

The DT O
effects NNS O
of IN O
a DT O
competitive JJ O
progesterone NN O
antagonist NN O
( ( O
RU486 NNP O
) ) O
and CC O
a DT O
specific JJ O
glucocorticoid NN B-Gene
receptor NN I-Gene
blocker NN O
( ( O
RU43044 NNP O
) ) O
were VBD O
tested VBN O
on IN O
the DT O
release NN O
of IN O
a DT O
blocking VBG B-Gene
factor NN I-Gene
by IN O
progesterone NN O
- : O
treated JJ O
pregnancy NN O
lymphocytes NNS O
. . O

It PRP O
has VBZ O
previously RB O
been VBN O
shown VBN O
that IN O
9S CD B-Gene
, , O
untransformed VBD B-Gene
progestin NN I-Gene
, , I-Gene
estrogen NN I-Gene
, , I-Gene
androgen NN I-Gene
, , I-Gene
and CC I-Gene
glucocorticoid JJ I-Gene
receptor NN I-Gene
complexes NNS I-Gene
in IN O
rabbit NN O
uterine JJ O
and CC O
liver JJ O
cytosols NNS O
contain VBP O
a DT O
59 CD B-Gene
- : I-Gene
kDa NN I-Gene
protein NN I-Gene
[ NNP O
Tai NNP O
, , O
P NNP O
. . O
K NNP O
. . O
, , O
Maeda NNP O
, , O
Y NNP O
. . O
, , O
Nakao NNP O
, , O
K NNP O
. . O
, , O
Wakim NNP O
, , O
N NNP O
. . O
G NNP O
. . O
, , O
Duhring NNP O
, , O
J NNP O
. . O
L NNP O
. . O
, , O
& CC O
Faber NNP O
, , O
L NNP O
. . O
E NN O
. . O
( ( O
1986 CD O
) ) O
Biochemistry NNP O
25 CD O
, , O
5269 CD O
- : O
5275 CD O
] NN O
. . O

Sequence NNP O
- : O
specific JJ O
DNA NNP O
binding NN O
of IN O
the DT O
proto NN B-Gene
- : I-Gene
oncoprotein NN I-Gene
ets VBZ B-Gene
- : I-Gene
1 CD I-Gene
defines NNS O
a DT O
transcriptional JJ B-Gene
activator NN I-Gene
sequence NN I-Gene
within IN O
the DT O
long JJ B-Gene
terminal JJ I-Gene
repeat NN I-Gene
of IN O
the DT O
Moloney NNP O
murine NN O
sarcoma NN O
virus NN O
. . O

A DT O
mutant JJ B-Gene
LTR NNP I-Gene
containing VBG O
four CD O
base NN O
pair NN O
substitutions NNS O
in IN O
the DT O
ets NNS B-Gene
- : I-Gene
1 CD I-Gene
binding VBG I-Gene
site NN I-Gene
was VBD O
constructed VBN O
and CC O
was VBD O
shown VBN O
to TO O
have VB O
reduced VBN O
binding NN O
in IN O
vitro NN O
. . O

We PRP O
propose VBP O
that IN O
ets VBZ B-Gene
- : I-Gene
1 CD I-Gene
functions NNS O
as IN O
a DT O
transcriptional JJ O
activator NN O
of IN O
mammalian JJ O
type NN O
- : O
C NNP O
retroviruses NNS O
and CC O
speculate VB O
that DT O
ets VBZ B-Gene
- : I-Gene
related VBN I-Gene
genes NNS I-Gene
constitute VBP O
a DT O
new JJ O
group NN O
of IN O
eukaryotic JJ B-Gene
DNA NNP I-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
. . O

We PRP O
have VBP O
previously RB O
reported VBN O
that IN O
human JJ O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
( ( O
PBMC NNP O
) ) O
contain VBP O
type JJ O
II NNP B-Gene
estrogen NN I-Gene
binding VBG I-Gene
sites NNS I-Gene
( ( O
type JJ B-Gene
II NNP I-Gene
EBS NNP I-Gene
) ) O
. . O

In IN O
postmenopausal JJ O
women NNS O
the DT O
mean NN O
type NN B-Gene
II NNP I-Gene
EBS NNP I-Gene
levels NNS O
were VBD O
similar JJ O
to TO O
those DT O
observed VBN O
in IN O
the DT O
follicular JJ O
phase NN O
of IN O
the DT O
cycle NN O
. . O

Tamoxifen NNP O
was VBD O
also RB O
found VBN O
to TO O
compete VB O
with IN O
17 CD O
beta NN O
- : O
estradiol NN O
for IN O
type NN B-Gene
II NNP I-Gene
EBS NNP I-Gene
in IN O
PBMC NNP O
, , O
although IN O
to TO O
a DT O
lesser JJR O
extent NN O
than IN O
diethylstilbestrol NN O
. . O

These DT O
results NNS O
do VBP O
not RB O
lend VB O
support NN O
to TO O
previous JJ O
reports NNS O
suggesting VBG O
that IN O
GC NNP O
resistance NN O
in IN O
MDD NNP O
results NNS O
from IN O
a DT O
GC NNP O
receptor NN O
- : O
binding NN O
abnormality NN O
, , O
and CC O
they PRP O
emphasize VBP O
the DT O
importance NN O
of IN O
considering VBG O
receptor NN O
studies NNS O
in IN O
the DT O
context NN O
of IN O
GC NNP O
- : O
mediated VBN O
cell NN O
processes VBZ O
in IN O
order NN O
to TO O
identify VB O
the DT O
exact JJ O
cellular JJ O
defect NN O
( ( O
s NN O
) ) O
leading VBG O
to TO O
GC NNP O
resistance NN O
. . O

Proteins NNS O
exist VBP O
in IN O
leukocytes NNS O
able JJ O
to TO O
modify VB O
GTP NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
function NN O
in IN O
this DT O
manner NN O
, , O
and CC O
their PRP$ O
activity NN O
may MD O
be VB O
regulated VBN O
by IN O
signals NNS O
generated VBN O
on IN O
phagocyte JJ O
stimulation NN O
. . O

Proteins NNS O
of IN O
the DT O
Ras NNP B-Gene
superfamily NN I-Gene
are VBP O
likely JJ O
to TO O
be VB O
involved VBN O
in IN O
a DT O
variety NN O
of IN O
normal JJ O
phagocyte JJ O
functions NNS O
through IN O
their PRP$ O
ability NN O
to TO O
modulate VB O
the DT O
assembly NN O
of IN O
actin NN B-Gene
filaments NNS I-Gene
, , O
direct JJ O
vesicle NN O
trafficking NN O
and CC O
fusion NN O
, , O
and CC O
so RB O
forth JJ O
. . O

The DT O
effect NN O
of IN O
1 CD O
, , O
25 CD O
- : O
dihydroxyvitamin NN O
D3 NNP O
[ NNP O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2 CD O
) ) O
D3 NNP O
] NNP O
, , O
a DT O
steroid JJ O
hormone NN O
with IN O
immunomodulating VBG O
properties NNS O
, , O
on IN O
nuclear JJ B-Gene
factor NN I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
) ) O
proteins VBZ O
was VBD O
examined VBN O
in IN O
in IN O
vitro NN O
activated VBN O
normal JJ O
human JJ O
lymphocytes NNS O
by IN O
Western JJ O
blot NN O
analysis NN O
. . O

Over IN O
a DT O
72 CD O
- : O
hr JJ O
period NN O
of IN O
activation NN O
, , O
the DT O
expression NN O
of IN O
the DT O
50 CD B-Gene
- : I-Gene
kDa NN I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
p50 NN B-Gene
, , O
and CC O
its PRP$ O
precursor NN O
, , O
p105 NN B-Gene
, , O
was VBD O
increased VBN O
progressively RB O
. . O

When WRB O
cells NNS O
were VBD O
activated VBN O
in IN O
the DT O
presence NN O
of IN O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
, , O
the DT O
levels NNS O
of IN O
the DT O
mature NN O
protein NN O
as RB O
well RB O
as IN O
its PRP$ O
precursor NN O
were VBD O
decreased VBN O
. . O

Further RB O
, , O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
inhibited VBD O
the DT O
transcriptional JJ O
activity NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
Jurkat NNP O
cells NNS O
transiently RB O
transfected VBN O
with IN O
a DT O
construct NN B-Gene
containing VBG O
four CD O
tandem JJ B-Gene
repeats NNS I-Gene
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
binding VBG I-Gene
sequence NN I-Gene
of IN O
the DT O
immunoglobulin NN B-Gene
kappa NN I-Gene
light NN I-Gene
chain NN I-Gene
gene NN I-Gene
linked VBD O
to TO O
the DT O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
reporter NN I-Gene
gene NN I-Gene
. . O

These DT O
observations NNS O
demonstrate VBP O
directly RB O
that IN O
there EX O
is VBZ O
de JJ O
novo JJ O
synthesis NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
during IN O
human JJ O
lymphocyte JJ O
activation NN O
and CC O
suggest VBP O
that IN O
this DT O
process NN O
is VBZ O
hormonally RB O
regulated VBN O
. . O

We PRP O
previously RB O
identified VBD O
the DT O
DNA NNP B-Gene
consensus NN I-Gene
binding VBG I-Gene
site NN I-Gene
recognized VBN O
by IN O
the DT O
two CD O
DNA NNP B-Gene
binding NN I-Gene
domains NNS I-Gene
. . O

The DT O
expression NN O
vector NN O
was VBD O
cotransfected VBN O
with IN O
the DT O
chloramphenicol NN B-Gene
acetyl NN I-Gene
transferase NN I-Gene
( ( I-Gene
CAT NNP I-Gene
) ) I-Gene
reporter NN I-Gene
gene NN I-Gene
regulated VBN O
by IN O
the DT O
thymidine NN B-Gene
kinase NN I-Gene
promoter NN I-Gene
containing VBG O
GAL4 NNP B-Gene
DNA NNP I-Gene
binding VBG I-Gene
sites NNS I-Gene
into IN O
NIH NNP O
3T3 CD O
, , O
293 CD O
, , O
K562 NNP O
, , O
and CC O
Jurkat NNP O
cell NN O
lines NNS O
. . O

In IN O
contrast NN O
, , O
MZF NNP B-Gene
- : I-Gene
1 CD I-Gene
activates NNS O
CAT NNP B-Gene
reporter NN I-Gene
gene NN I-Gene
expression NN O
in IN O
the DT O
hematopoietic JJ O
cell NN O
lines NNS O
K562 NNP O
and CC O
Jurkat NNP O
. . O

The DT O
MZF NNP B-Gene
- : I-Gene
1 CD I-Gene
binding NN I-Gene
sites NNS I-Gene
are VBP O
present JJ O
in IN O
the DT O
promoters NNS B-Gene
of IN O
several JJ O
genes NNS B-Gene
expressed VBD O
during IN O
myeloid JJ O
differentiation NN O
, , O
including VBG O
the DT O
CD34 NNP B-Gene
promoter NN I-Gene
. . O

This DT O
induction NN O
was VBD O
not RB O
inhibited VBN O
by IN O
treatment NN O
of IN O
the DT O
cells NNS O
with IN O
a DT O
protein NN O
synthesis NN O
inhibitor NN O
, , O
cycloheximide NN O
. . O

The DT O
role NN O
of IN O
BSAP NNP B-Gene
( ( O
Pax NNP B-Gene
- : I-Gene
5 CD I-Gene
) ) O
in IN O
B NNP O
- : O
cell NN O
development NN O
. . O

Analysis NN O
of IN O
the DT O
biochemical JJ O
and CC O
cell JJ O
biological JJ O
properties NNS O
of IN O
these DT O
HSFs NNP B-Gene
reveals NNS O
that WDT O
HSF3 NNP B-Gene
has VBZ O
properties NNS O
in IN O
common JJ O
with IN O
both DT O
HSF1 NNP B-Gene
and CC O
HSF2 NNP B-Gene
and CC O
yet RB O
has VBZ O
features NNS O
which WDT O
are VBP O
distinct JJ O
from IN O
both DT O
. . O

HSF3 NNP B-Gene
is VBZ O
constitutively RB O
expressed VBN O
in IN O
the DT O
erythroblast NN O
cell NN O
line NN O
HD6 NNP O
, , O
the DT O
lymphoblast NN O
cell NN O
line NN O
MSB NNP O
, , O
and CC O
embryo JJ O
fibroblasts NNS O
, , O
and CC O
yet RB O
its PRP$ O
DNA NNP O
- : O
binding NN O
activity NN O
is VBZ O
induced VBN O
only RB O
upon JJ O
exposure NN O
of IN O
HD6 NNP O
cells NNS O
to TO O
heat VB O
shock NN O
. . O

Nuclear JJ B-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
cells NNS I-Gene
( ( O
NFAT NNP B-Gene
) ) O
regulates VBZ O
transcription NN O
of IN O
a DT O
number NN O
of IN O
cytokine JJ B-Gene
genes NNS I-Gene
, , O
and CC O
NFAT NNP B-Gene
DNA NNP O
binding NN O
activity NN O
is VBZ O
stimulated VBN O
following VBG O
T NNP O
cell NN O
activation NN O
. . O

Treatment NN O
of IN O
immunoprecipitated JJ O
NFATp NNP B-Gene
from IN O
untreated JJ O
HT NNP O
- : O
2 CD O
cells NNS O
with IN O
calcineurin NN B-Gene
resulted VBN O
in IN O
the DT O
dephosphorylation NN O
of IN O
NFATp NNP B-Gene
, , O
demonstrating VBG O
that IN O
NFATp NNP B-Gene
is VBZ O
an DT O
in IN O
vitro NN O
substrate NN O
for IN O
calcineurin NN B-Gene
. . O

Both DT O
of IN O
these DT O
events NNS O
were VBD O
blocked VBN O
by IN O
preincubation NN O
of IN O
the DT O
cells NNS O
with IN O
FK506 NNP O
, , O
a DT O
calcineurin NN B-Gene
inhibitor NN O
, , O
consistent JJ O
with IN O
the DT O
hypothesis NN O
that IN O
NFATp NNP B-Gene
is VBZ O
a DT O
calcineurin JJ B-Gene
substrate NN O
in IN O
cells NNS O
. . O

Activation NN O
and CC O
expression NN O
of IN O
the DT O
nuclear JJ B-Gene
factors NNS I-Gene
of IN O
activated JJ O
T NNP O
cells NNS O
, , O
NFATp NNP B-Gene
and CC O
NFATc NNP B-Gene
, , O
in IN O
human JJ O
natural JJ O
killer NN O
cells NNS O
: : O
regulation NN O
upon IN O
CD16 NNP B-Gene
ligand NN O
binding NN O
. . O

The DT O
results NNS O
of IN O
supershift NN O
assays NNS O
using VBG O
NFATp NNP B-Gene
- : I-Gene
and CC I-Gene
NFATc NNP I-Gene
- : I-Gene
specific JJ I-Gene
antibodies NNS I-Gene
indicate VBP O
that IN O
NK NNP O
cell NN O
activation NN O
early RB O
after IN O
CD16 NNP B-Gene
ligand VBP O
binding VBG O
involves NNS O
primarily RB O
, , O
if IN O
not RB O
exclusively RB O
, , O
NFATp NNP B-Gene
, , O
and CC O
Western JJ O
blot NN O
analysis NN O
shows VBZ O
that IN O
this DT O
has VBZ O
the DT O
same JJ O
electrophoretic JJ O
mobility NN O
( ( O
approximately RB O
120 CD O
kD NNS O
) ) O
as IN O
that DT O
of IN O
T NNP O
lymphocytes NNS O
. . O

Since IN O
many JJ O
cytokines NNS B-Gene
that WDT O
activate VBP O
Jak NNP B-Gene
kinases NNS I-Gene
also RB O
lead VBP O
to TO O
the DT O
tyrosine NN O
phosphorylation NN O
and CC O
activation NN O
of IN O
members NNS O
of IN O
the DT O
Stat NNP B-Gene
family NN I-Gene
of IN O
transcription NN B-Gene
factors NNS I-Gene
, , O
the DT O
ability NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
to TO O
trigger VB O
Stat NNP O
phosphorylation NN O
was VBD O
examined VBN O
. . O

Exposure NN O
of IN O
activated JJ O
human JJ O
T NNP O
lymphocytes VBZ O
or CC O
of IN O
a DT O
natural JJ O
killer NN O
cell NN O
line NN O
( ( O
NKL NNP O
) ) O
to TO O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
leads NNS O
to TO O
the DT O
phosphorylation NN O
of IN O
Stat1 NNP B-Gene
alpha NN I-Gene
, , O
Stat1 NNP O
beta NN O
, , O
and CC O
Stat3 NNP B-Gene
, , O
as RB O
well RB O
as IN O
of IN O
two CD O
Stat NNP B-Gene
- : I-Gene
related JJ I-Gene
proteins NNS I-Gene
, , O
p94 NN B-Gene
and CC O
p95 NN B-Gene
. . O

These DT O
Stat NNP B-Gene
proteins NNS I-Gene
were VBD O
found VBN O
to TO O
translocate VB O
to TO O
the DT O
nucleus NN O
and CC O
to TO O
bind VB O
to TO O
a DT O
specific JJ B-Gene
DNA NNP I-Gene
sequence NN I-Gene
. . O

Results NNS O
indicated VBD O
that IN O
( ( O
i NN O
) ) O
constitutive VBP O
c SYM B-Gene
- : I-Gene
fos JJ I-Gene
transcript NN I-Gene
levels NNS O
are VBP O
significantly RB O
higher JJR O
in IN O
patients NNS O
subsequently RB O
responding VBG O
to TO O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
therapy NN O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
) ) O
and CC O
positively RB O
correlated VBN O
with IN O
the DT O
proportion NN O
of IN O
lymphocytes NNS O
( ( O
r VB O
= RB O
0 CD O
. . O
6895 CD O
, , O
p VBD O
< JJ O
0 CD O
. . O
1 CD O
) ) O
and CC O
negatively RB O
with IN O
the DT O
proportion NN O
of IN O
immature NN O
cells NNS O
( ( O
r NN O
= NNP O
- : O
0 CD O
. . O
568 CD O
, , O
p NN O
< VBD O
0 CD O
. . O
1 CD O
) ) O
contained VBN O
in IN O
the DT O
pbmc NN O
preparations NNS O
tested VBN O
, , O
( ( O
ii NN O
) ) O
constitutive VBP B-Gene
mRNA NN I-Gene
levels NNS O
of IN O
the DT O
hybrid JJ B-Gene
bcr NN I-Gene
/ NNP I-Gene
abl NN I-Gene
, , O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
and CC O
p53 NN B-Gene
are VBP O
positively RB O
correlated VBN O
with IN O
each DT O
other JJ O
, , O
but CC O
failed VBD O
to TO O
relate VB O
to TO O
disease VB O
parameters NNS O
, , O
and CC O
( ( O
iii NN O
) ) O
acute NN O
and CC O
chronic NN O
in IN O
vivo NN O
exposure NN O
to TO O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
is VBZ O
accompanied VBN O
by IN O
upregulation NN O
of IN O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
and CC O
downregulation NN O
of IN O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
mRNA NN I-Gene
levels NNS O
in IN O
responder NN O
patients NNS O
. . O

In IN O
parallel JJ O
experiments NNS O
, , O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
- : O
driven VBN O
proliferation NN O
was VBD O
inhibited VBN O
significantly RB O
. . O

Yet RB O
, , O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
- : O
driven VBN O
proliferation NN O
remained VBD O
profoundly RB O
inhibited VBN O
, , O
suggesting VBG O
that IN O
signaling VBG O
events NNS O
other JJ O
than IN O
Jak3 NNP B-Gene
/ NNP B-Gene
Stat NNP I-Gene
activation NN O
had VBD O
also RB O
been VBN O
changed VBN O
following VBG O
SE NNP B-Gene
stimulation NN O
. . O

In IN O
contrast NN O
to TO O
hematopoietic JJ O
cells NNS O
, , O
I PRP O
kappa VBP O
B NNP O
alpha SYM O
- : O
/ SYM O
- : O
embryonic JJ O
fibroblasts NNS O
show VBP O
minimal JJ O
constitutive JJ B-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
as RB O
well RB O
as IN O
normal JJ O
signal JJ O
- : O
dependent NN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
that WDT O
is VBZ O
concomitant JJ O
with IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
beta NN I-Gene
degradation NN O
. . O

Moreover RB O
, , O
the DT O
induction NN O
of IN O
both DT O
Jak NNP B-Gene
1 CD I-Gene
and CC I-Gene
3 CD I-Gene
, , O
and CC O
STAT NNP B-Gene
5 CD I-Gene
activity NN O
strongly RB O
correlated VBN O
with IN O
the DT O
growth NN O
- : O
promoting NN O
effects NNS O
of IN O
IL NNP B-Gene
- : I-Gene
7 CD I-Gene
, , O
suggesting VBG O
that IN O
this DT O
signal JJ O
transduction NN O
mechanism NN O
may MD O
play VB O
a DT O
key JJ O
role NN O
in IN O
IL NNP B-Gene
- : I-Gene
7 CD I-Gene
- : O
induced JJ O
proliferation NN O
. . O

Cytokine NNP B-Gene
- : O
modulating NN O
activity NN O
of IN O
tepoxalin NN O
, , O
a DT O
new JJ O
potential JJ O
antirheumatic NN O
. . O

In IN O
human JJ O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
( ( O
PBMC NNP O
) ) O
stimulated VBD O
with IN O
OKT3 NNP O
/ NNP O
PMA NNP O
, , O
tepoxalin NN O
inhibited VBD O
lymphocyte JJ O
proliferation NN O
with IN O
an DT O
IC50 NNP O
of IN O
6 CD O
microM NN O
. . O

Cytotoxicity NN O
was VBD O
not RB O
demonstrated VBN O
at IN O
these DT O
concentrations NNS O
. . O

Tepoxalin NNP O
also RB O
inhibits VBZ O
the DT O
activation NN O
of IN O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
a DT O
transcription NN B-Gene
factor NN I-Gene
which WDT O
acts VBZ O
on IN O
several JJ O
cytokine NN B-Gene
genes NNS I-Gene
. . O

Analysis NN O
of IN O
the DT O
expression NN O
of IN O
human JJ B-Gene
I PRP I-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
protein NN I-Gene
in IN O
stable JJ O
transfectants NNS O
of IN O
mouse NN O
70Z CD O
/ NN O
3 CD O
cells NNS O
shows VBZ O
that RB O
, , O
as IN O
for IN O
the DT O
endogenous JJ O
murine NN O
protein NN O
, , O
exogenous JJ O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
is VBZ O
degraded VBN O
in IN O
response NN O
to TO O
inducers NNS O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activity NN O
, , O
such JJ O
as IN O
phorbol NN O
myristate NN O
acetate NN O
or CC O
lipopolysaccharide NN O
. . O

By IN O
expressing VBG O
mutant JJ O
forms NNS O
of IN O
the DT O
human JJ O
protein NN O
in IN O
this DT O
cell NN O
line NN O
, , O
we PRP O
have VBP O
been VBN O
able JJ O
to TO O
delineate VB O
the DT O
sequences NNS O
responsible JJ O
for IN O
both DT O
the DT O
ligand NN O
- : O
induced JJ O
phosphorylation NN O
and CC O
the DT O
degradation NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
. . O

Interestingly RB O
, , O
microtubule NN B-Gene
disruption NN O
also RB O
decreased VBD O
monocyte JJ O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
synthesis NN O
, , O
not RB O
by IN O
decreasing VBG O
the DT O
Vmax NNP O
of IN O
monocyte JJ B-Gene
mitochondrial JJ I-Gene
1 CD I-Gene
alpha SYM I-Gene
- : I-Gene
hydroxylase NN I-Gene
but CC O
through IN O
an DT O
increase NN O
in IN O
the DT O
Km NNP O
for IN O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
. . O

We PRP O
examined VBD O
25 CD O
( ( O
OH NNP O
) ) O
D3 NNP O
transport NN O
. . O

Finally RB O
, , O
by IN O
studying VBG O
a DT O
further JJ O
series NN O
of IN O
patients NNS O
, , O
we PRP O
could MD O
confirm VB O
that IN O
the DT O
decrease NN O
in IN O
Rap1 NNP B-Gene
protein NN I-Gene
expression NN O
in IN O
heart NN O
failure NN O
, , O
whatever WDT O
its PRP$ O
extent NN O
, , O
was VBD O
variable JJ O
, , O
and CC O
could MD O
strictly RB O
correlate VB O
the DT O
expression NN O
of IN O
Rap1 NNP B-Gene
protein NN I-Gene
with IN O
the DT O
stimulatory JJ O
effect NN O
of IN O
C NNP B-Gene
. . I-Gene
Sub NNP I-Gene
. . I-Gene
on IN O
Ca2 NNP O
+ NNP O
transport NN O
. . O

An DT O
IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
dependent JJ O
pathway NN O
of IN O
DNA NNP O
damage NN O
- : O
induced JJ O
apoptosis NN O
in IN O
mitogen NN O
- : O
activated VBN O
T NNP O
lymphocytes NNS O
. . O

Here RB O
we PRP O
show VBP O
DNA JJ O
damage NN O
- : O
induced JJ O
apoptosis NN O
in IN O
these DT O
T NNP O
lymphocytes NNS O
is VBZ O
dependent JJ O
on IN O
the DT O
antioncogenic JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
interferon NN I-Gene
regulatory JJ I-Gene
factor NN I-Gene
( ( B-Gene
IRF NNP I-Gene
) ) I-Gene
- : I-Gene
1 CD I-Gene
. . O

Activation NNP O
through IN O
the DT O
Ca2 NNP O
+ NNP O
/ NNP O
calcineurin NN B-Gene
pathway NN O
is VBZ O
essential JJ O
to TO O
the DT O
transcription NN O
of IN O
many JJ O
cytokine NN B-Gene
genes NNS I-Gene
. . O

Results NNS O
from IN O
site NN O
- : O
directed JJ O
mutations NNS O
and CC O
electrophoretic JJ O
mobility NN O
shift NN O
assays VBZ O
strongly RB O
suggest VBP O
that IN O
this DT O
sequence NN O
mediates VBZ O
the DT O
ionomycin JJ O
- : O
induced JJ O
activation NN O
of IN O
the DT O
TCRG NNP B-Gene
enhancer NN I-Gene
. . O

Our PRP$ O
studies NNS O
provide VBP O
an DT O
explanation NN O
for IN O
a DT O
previous JJ O
observation NN O
that IN O
TCRG NNP B-Gene
mRNA NN I-Gene
levels NNS O
, , O
but CC O
not RB O
mRNA JJ O
levels NNS O
for IN O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
alpha NN I-Gene
and CC I-Gene
- : I-Gene
beta NN I-Gene
, , O
are VBP O
increased VBN O
by IN O
ionomycin JJ O
treatment NN O
. . O

Coexpression NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
/ NNP I-Gene
Rel NNP I-Gene
and CC O
Sp1 NNP B-Gene
transcription NN B-Gene
factors NNS I-Gene
in IN O
human JJ O
immunodeficiency NN O
virus NN O
1 CD O
- : O
induced VBN O
, , O
dendritic JJ O
cell NN O
- : O
T NNP O
- : O
cell NN O
syncytia NN O
. . O

These DT O
syncytia JJ O
lack NN O
activated JJ O
cells NNS O
as IN O
determined VBN O
by IN O
an DT O
absence NN O
of IN O
staining VBG O
for IN O
Ki NNP O
- : O
67 CD O
cell NN O
cycle NN O
antigen NN O
. . O

We PRP O
have VBP O
used VBN O
immunolabeling NN O
, , O
Western JJ O
blot NN O
analysis NN O
, , O
and CC O
electrophoretic JJ O
mobility NN O
shift NN O
and CC O
supershift NN O
assays NNS O
. . O

T NNP O
cells NNS O
lack VBP O
active JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
but CC O
express RB O
Sp1 NNP B-Gene
as IN O
expected VBN O
. . O

Therefore RB O
, , O
HIV NNP O
- : O
1 CD O
- : O
induced VBN O
cell NN O
fusion NN O
brings VBZ O
together RB O
factors NNS O
that IN O
upregulate JJ O
virus NN O
transcription NN O
. . O

Deoxycholate NNP O
treatment NN O
of IN O
the DT O
cytoplasmic JJ O
extract NN O
prepared VBN O
from IN O
cells NNS O
stimulated VBN O
by IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
in IN O
the DT O
presence NN O
of IN O
Cu2 NNP O
+ NNP O
resulted VBD O
in IN O
the DT O
release NN O
of IN O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
from IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
, , O
indicating VBG O
that IN O
Cu2 NNP O
+ NNP O
interferes VBZ O
with IN O
the DT O
dissociation NN O
of IN O
the DT O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
- : I-Gene
I PRP I-Gene
kappa VBP I-Gene
B NNP I-Gene
complex NN I-Gene
. . O

Neither DT O
phosphorylation NN O
nor CC O
degradation NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
was VBD O
observed VBN O
upon IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
stimulation NN O
in IN O
the DT O
presence NN O
of IN O
Cu2 NNP O
+ NNP O
. . O

Cloning VBG O
a DT O
cDNA NN B-Gene
from IN O
human JJ O
NK NNP O
/ NNP O
T NNP O
cells NNS O
which WDT O
codes VBP O
for IN O
a DT O
protein NN O
with IN O
high JJ O
proline NN O
content NN O
. . O

The DT O
present JJ O
study NN O
verified VBD O
the DT O
ability NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
to TO O
cause VB O
tyrosine JJ O
phosphorylation NN O
and CC O
activation NN O
of IN O
JAK1 NNP B-Gene
and CC O
JAK3 NNP B-Gene
, , O
but CC O
demonstrated VBD O
that IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
stimulated VBD O
JAK3 NNP B-Gene
to TO O
a DT O
significantly RB O
larger JJR O
extent NN O
than IN O
JAK1 NNP B-Gene
in IN O
human JJ O
T NNP O
lymphocytes NNS O
and CC O
the DT O
YT NNP O
cell NN O
line NN O
. . O

Nonetheless RB O
, , O
a DT O
membrane NN B-Gene
- : I-Gene
proximal JJ I-Gene
region NN I-Gene
of IN O
human JJ O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
beta NN I-Gene
( ( O
Asn240 NNP B-Gene
- : I-Gene
Leu335 NN I-Gene
) ) O
was VBD O
critical JJ O
for IN O
JAK3 NNP B-Gene
activation NN O
, , O
and CC O
the DT O
amount NN O
of IN O
JAK3 NNP B-Gene
present NN O
in IN O
activated JJ O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
receptor NN I-Gene
complexes NNS I-Gene
increased VBD O
with IN O
time NN O
, , O
suggesting VBG O
that IN O
stabilization NN O
of IN O
JAK3 NNP B-Gene
binding VBG O
to TO O
the DT O
receptor NN B-Gene
complex JJ I-Gene
relies NNS O
on IN O
both DT O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
beta NN I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
gamma NN I-Gene
. . O

DHEA NNP O
binding VBG O
sites NNS O
were VBD O
examined VBN O
using VBG O
a DT O
whole JJ O
- : O
cell NN O
binding VBG O
assay NN O
in IN O
a DT O
human JJ O
T NNP O
lymphoid NN O
cell NN O
line NN O
, , O
PEER NNP O
, , O
revealing VBG O
that IN O
a DT O
single JJ O
class NN O
of IN O
high JJ O
- : O
affinity NN O
binding NN O
sites NNS O
for IN O
DHEA NNP O
( ( O
dissociation NN O
constant NN O
= VBD O
7 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
53 CD O
nmol JJ O
/ NNP O
L NNP O
, , O
mean JJ O
+ NNP O
/ NNP O
- : O
SE NNP O
, , O
n JJ O
= NNP O
4 CD O
) ) O
was VBD O
greatly RB O
increased VBN O
when WRB O
treated VBN O
with IN O
DHEA NNP O
, , O
phorbol NN O
- : O
12 CD O
- : O
myristate NN O
- : O
13 CD O
- : O
acetate NN O
, , O
and CC O
the DT O
Ca2 NNP O
+ NNP O
ionophore NN O
A23187 NNP O
. . O

In IN O
most JJS O
cases NNS O
, , O
the DT O
transcriptional JJ B-Gene
factor NN I-Gene
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
is VBZ O
a DT O
heterodimer JJ B-Gene
consisting NN O
of IN O
two CD O
subunits NNS O
, , O
p50 NN B-Gene
and CC O
p65 NN B-Gene
, , O
which WDT O
are VBP O
encoded VBN O
by IN O
two CD O
distinct JJ O
genes NNS O
of IN O
the DT O
Rel NNP B-Gene
family NN I-Gene
. . O

It PRP O
has VBZ O
been VBN O
suggested VBN O
that IN O
the DT O
ubiquitin JJ B-Gene
- : B-Gene
proteasome NN I-Gene
system NN O
is VBZ O
involved VBN O
in IN O
the DT O
process NN O
; : O
however RB O
, , O
the DT O
specific JJ O
enzymes NNS B-Gene
involved VBN O
and CC O
the DT O
mechanism NN O
of IN O
limited JJ O
proteolysis NN O
, , O
in IN O
which WDT O
half NN O
of IN O
the DT O
molecule NN O
is VBZ O
spared VBN O
, , O
have VBP O
been VBN O
obscure JJ O
. . O

This DT O
novel JJ O
enzyme NN O
is VBZ O
distinct JJ O
from IN O
E6 NNP B-Gene
- : I-Gene
AP NNP I-Gene
, , O
the DT O
p53 NN B-Gene
- : I-Gene
conjugating NN I-Gene
ligase NN I-Gene
, , O
and CC O
from IN O
E3 NNP B-Gene
alpha NN I-Gene
, , O
the DT O
` `` B-Gene
` `` I-Gene
N NNP I-Gene
- : I-Gene
end NN I-Gene
rule NN I-Gene
' '' I-Gene
' POS I-Gene
ligase NN I-Gene
. . O

Cycles NNS O
remained VBD O
ovulatory JJ O
. . O

Before IN O
treatment NN O
, , O
the DT O
number NN O
of IN O
androgen NN B-Gene
receptors NNS I-Gene
was VBD O
higher RBR O
in IN O
the DT O
luteal NN O
than IN O
in IN O
the DT O
follicular JJ O
phase NN O
. . O

CONCLUSIONS NN O
: : O
Flutamide NNP O
is VBZ O
effective JJ O
in IN O
the DT O
treatment NN O
of IN O
hirsutism NN O
but CC O
requires VBZ O
constant JJ O
surveillance NN O
of IN O
liver NN O
function NN O
. . O

An DT O
increased JJ O
growth NN O
rate NN O
of IN O
these DT O
Jurkat NNP O
- : O
tat NN O
cell NN O
lines NNS O
as IN O
compared VBN O
with IN O
control NN O
cell NN O
lines NNS O
was VBD O
observed VBN O
. . O

To TO O
identify VB O
osteoblast JJ B-Gene
- : I-Gene
specific JJ I-Gene
cis NN I-Gene
- : I-Gene
acting JJ I-Gene
elements NNS I-Gene
and CC O
trans NNS B-Gene
- : I-Gene
acting VBG I-Gene
factors NNS I-Gene
, , O
we PRP O
initiated VBD O
an DT O
analysis NN O
of IN O
the DT O
promoter NN B-Gene
of IN O
a DT O
mouse NN B-Gene
osteocalcin JJ I-Gene
gene NN I-Gene
, , O
an DT O
osteoblast NN B-Gene
- : I-Gene
specific JJ I-Gene
gene NN I-Gene
. . O

By IN O
DNA NNP O
cotransfection NN O
experiments NNS O
, , O
we PRP O
also RB O
demonstrate VBP O
that IN O
AML NNP B-Gene
- : I-Gene
1B CD I-Gene
can MD O
increase VB O
the DT O
activity NN O
of IN O
a DT O
short JJ O
osteocalcin NN B-Gene
promoter NN I-Gene
through IN O
its PRP$ O
binding NN O
to TO O
OSE2 NNP O
. . O

A DT O
variety NN O
of IN O
other JJ O
cells NNS O
, , O
including VBG O
transformed VBN O
erythroid JJ O
precursors NNS O
, , O
do VBP O
not RB O
have VB O
IBR NNP B-Gene
but CC O
a DT O
factor NN O
referred VBD O
to TO O
as IN O
IBF NNP B-Gene
( ( O
68 CD O
to TO O
70 CD O
kDa NN O
) ) O
that WDT O
recognizes VBZ O
the DT O
same JJ O
IBR NNP B-Gene
sites NNS O
. . O

IBR NNP B-Gene
is VBZ O
a DT O
503 JJ B-Gene
- : I-Gene
amino NN I-Gene
- : I-Gene
acid NN I-Gene
- : I-Gene
long JJ I-Gene
acidic JJ I-Gene
protein NN I-Gene
which WDT O
is VBZ O
99 CD O
. . O
0 CD O
% NN O
identical JJ O
to TO O
the DT O
recently RB O
reported VBN O
human JJ B-Gene
NRF NNP I-Gene
- : I-Gene
1 CD I-Gene
/ NN I-Gene
alpha SYM I-Gene
- : I-Gene
Pal NNP I-Gene
factor NN I-Gene
and CC O
highly RB O
related VBN O
to TO O
the DT O
invertebrate JJ O
transcription NN B-Gene
factors NNS I-Gene
P3A2 NNP B-Gene
and CC O
erected VBD B-Gene
wing VBG I-Gene
gene NN I-Gene
product NN I-Gene
( ( O
EWG NNP B-Gene
) ) O
. . O

We PRP O
present JJ O
evidence NN O
that IN O
IBR NNP B-Gene
and CC O
IBF NNP B-Gene
are VBP O
most RBS O
likely JJ O
identical JJ O
proteins NNS O
, , O
differing VBG O
in IN O
their PRP$ O
degree NN O
of IN O
glycosylation NN O
. . O

Mutation NN O
of IN O
Jak3 NNP B-Gene
in IN O
a DT O
patient NN O
with IN O
SCID NNP O
: : O
essential JJ O
role NN O
of IN O
Jak3 NNP B-Gene
in IN O
lymphoid JJ O
development NN O
. . O

A DT O
girl NN O
with IN O
immunological JJ O
features NNS O
indistinguishable JJ O
from IN O
those DT O
of IN O
XSCID NNP O
was VBD O
therefore RB O
selected VBN O
for IN O
analysis NN O
. . O

The DT O
lack NN O
of IN O
Jak3 NNP B-Gene
expression NN O
correlated VBD O
with IN O
impaired JJ O
B NNP O
cell NN O
signaling VBG O
, , O
as IN O
demonstrated VBN O
by IN O
the DT O
inability NN O
of IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
to TO O
activate VB O
Stat6 NNP B-Gene
in IN O
the DT O
EBV NNP O
- : O
transformed VBD O
cell JJ O
line NN O
from IN O
the DT O
patient NN O
. . O
These DT O
observations NNS O
indicate VBP O
that IN O
the DT O
functions NNS O
of IN O
gamma NN B-Gene
c NNS I-Gene
are VBP O
dependent JJ O
on IN O
Jak3 NNP B-Gene
and CC O
that IN O
Jak3 NNP B-Gene
is VBZ O
essential JJ O
for IN O
lymphoid JJ O
development NN O
and CC O
signaling NN O
. . O

L NNP B-Gene
- : I-Gene
selectin NN I-Gene
is VBZ O
an DT O
adhesion NN O
molecule NN O
of IN O
the DT O
selectin JJ O
family NN O
that WDT O
mediates VBZ O
the DT O
initial JJ O
step NN O
of IN O
leukocyte JJ O
adhesion NN O
to TO O
vascular JJ O
endothelium NN O
. . O

Upon IN O
cellular JJ O
activation NN O
, , O
expression NN O
of IN O
the DT O
L NNP B-Gene
- : I-Gene
selectin NN I-Gene
gene NN I-Gene
is VBZ O
downregulated VBN O
at IN O
both DT O
the DT O
protein NN O
and CC O
mRNA NN O
levels NNS O
. . O

The DT O
induction NN O
of IN O
Tax NNP B-Gene
expression NN O
in IN O
JPX9 NNP O
cells NNS O
resulted VBD O
in IN O
about IN O
a DT O
twofold JJ O
increase NN O
in IN O
the DT O
mRNA JJ B-Gene
expression NN O
levels NNS O
compared VBN O
with IN O
the DT O
basal NN O
level NN O
. . O

These DT O
results NNS O
indicated VBD O
that IN O
ATL NNP O
cells NNS O
constitutively RB O
overexpress IN O
the DT O
L NNP B-Gene
- : I-Gene
selectin NN I-Gene
gene NN I-Gene
that WDT O
can MD O
be VB O
transactivated VBN O
by IN O
HTLV NNP O
- : O
1 CD O
Tax NNP B-Gene
. . O

Human NNP O
herpesvirus NN O
6 CD O
, , O
a DT O
predominantly RB O
T NNP O
lymphotropic NN O
virus NN O
, , O
has VBZ O
been VBN O
recently RB O
shown VBN O
to TO O
infect VB O
some DT O
EBV NNP O
- : O
positive JJ O
B NNP O
cell NN O
lines NNS O
, , O
and CC O
to TO O
induce VB O
in IN O
them PRP O
the DT O
activation NN O
of IN O
the DT O
EBV NNP O
lytic JJ O
cycle NN O
. . O

Here RB O
we PRP O
have VBP O
confirmed VBN O
and CC O
extended VBN O
such JJ O
observations NNS O
, , O
showing VBG O
that IN O
( ( O
1 CD O
) ) O
this DT O
phenomenon NN O
is VBZ O
restricted VBN O
to TO O
the DT O
variant NN O
A NNP O
of IN O
HHV NNP O
- : O
6 CD O
: : O
in IN O
fact NN O
two CD O
isolates NNS O
belonging VBG O
to TO O
the DT O
HHV NNP O
- : O
6 CD O
variant NN O
B NNP O
( ( O
BA92 NNP O
and CC O
Z29 NNP O
) ) O
were VBD O
neither RB O
able JJ O
to TO O
infect VB O
any DT O
B NNP O
cell NN O
line NN O
, , O
independently RB O
of IN O
the DT O
EBV NNP O
status NN O
, , O
nor CC O
to TO O
induce VB O
the DT O
EBV NNP O
genome JJ O
expression NN O
. . O

Evidence NN O
for IN O
normal JJ O
vitamin NN B-Gene
D NNP I-Gene
receptor NN I-Gene
messenger NN I-Gene
ribonucleic NN I-Gene
acid NN I-Gene
and CC O
genotype NN O
in IN O
absorptive JJ O
hypercalciuria NN O
. . O

There EX O
was VBD O
no DT O
difference NN O
between IN O
the DT O
distribution NN O
of IN O
the DT O
VDR NNP B-Gene
alleles NNS O
in IN O
the DT O
patient JJ O
population NN O
when WRB O
compared VBN O
with IN O
the DT O
normal JJ O
population NN O
. . O

Sequence NNP O
analysis NN O
of IN O
the DT O
5 CD B-Gene
' POS I-Gene
- : I-Gene
flanking VBG I-Gene
region NN I-Gene
of IN O
the DT O
CD69 NNP B-Gene
gene NN I-Gene
revealed VBD O
the DT O
presence NN O
of IN O
a DT O
potential JJ O
TATA NNP B-Gene
element NN I-Gene
30 CD B-Gene
base NN I-Gene
pairs NNS I-Gene
upstream NN I-Gene
of IN O
the DT O
major JJ O
transcription NN B-Gene
initiation NN I-Gene
site NN I-Gene
and CC O
several JJ O
putative JJ O
binding NN O
sequences NNS O
for IN O
inducible JJ O
transcription NN B-Gene
factors NNS I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
, , O
which WDT O
might MD O
mediate VB O
the DT O
inducible JJ O
expression NN O
of IN O
this DT O
gene NN O
. . O

( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

The DT O
exon JJ B-Gene
- : I-Gene
intron NN I-Gene
structure NN I-Gene
of IN O
the DT O
5 CD B-Gene
' POS I-Gene
portion NN I-Gene
of IN O
the DT O
thromboxane NN B-Gene
receptor NN I-Gene
gene NN I-Gene
was VBD O
determined VBN O
initially RB O
by IN O
comparing VBG O
the DT O
nucleotide JJ B-Gene
sequence NN I-Gene
of IN O
the DT O
5 CD B-Gene
' POS I-Gene
flanking VBG I-Gene
genomic JJ I-Gene
clone NN I-Gene
with IN O
that DT O
of IN O
a DT O
novel JJ B-Gene
human JJ I-Gene
uterine JJ I-Gene
thromboxane NN I-Gene
receptor NN I-Gene
cDNA NN I-Gene
that WDT O
extended VBD O
the DT O
mRNA NN B-Gene
141 CD B-Gene
bp NN I-Gene
further RBR I-Gene
upstream RB I-Gene
than IN O
the DT O
previously RB B-Gene
identified VBN I-Gene
human JJ I-Gene
placental JJ I-Gene
cDNA NN I-Gene
. . O

Promoter NNP O
function NN O
of IN O
the DT O
5 CD B-Gene
' POS I-Gene
flanking JJ I-Gene
region NN I-Gene
of IN O
the DT O
thromboxane NN B-Gene
receptor NN I-Gene
gene NN I-Gene
was VBD O
evaluated VBN O
by IN O
transfection NN O
of IN O
thromboxane NN B-Gene
receptor NN I-Gene
gene NN I-Gene
promoter NN I-Gene
/ NNP I-Gene
chloramphenicol NN I-Gene
acetyltransferase NN I-Gene
( ( I-Gene
CAT NNP I-Gene
) ) I-Gene
chimera NN I-Gene
plasmids NNS I-Gene
into IN O
platelet JJ O
- : O
like IN O
K562 NNP O
cells NNS O
. . O

These DT O
studies NNS O
are VBP O
the DT O
first JJ O
to TO O
determine VB O
the DT O
structure NN O
and CC O
organization NN O
of IN O
the DT O
5 CD O
' POS O
end NN O
of IN O
the DT O
thromboxane NN B-Gene
receptor NN I-Gene
gene NN I-Gene
and CC O
demonstrate VB O
that DT O
thromboxane NN B-Gene
receptor NN I-Gene
gene NN I-Gene
expression NN O
can MD O
be VB O
regulated VBN O
by IN O
activation NN O
of IN O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
via IN O
induction NN O
of IN O
an DT O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
- : I-Gene
like IN I-Gene
nuclear JJ I-Gene
factor NN I-Gene
binding VBG O
to TO O
upstream VB B-Gene
promoter NN I-Gene
elements NNS I-Gene
. . O

Proteins NNS O
in IN O
the DT O
first JJ O
group NN O
contain NN O
multiple JJ O
HMG NNP B-Gene
boxes NNS I-Gene
, , O
are VBP O
non JJ O
- : O
sequence NN O
- : O
specific NN O
, , O
and CC O
recognize VB O
structural JJ O
features NNS O
as IN O
found VBN O
in IN O
cruciform NN B-Gene
DNA NN I-Gene
and CC O
cross NN B-Gene
- : I-Gene
over IN I-Gene
DNA NNP I-Gene
. . O

The DT O
abundant JJ O
chromosomal JJ B-Gene
protein NN I-Gene
HMG NNP B-Gene
- : I-Gene
1 CD I-Gene
belongs NNS O
to TO O
this DT O
subgroup NN O
. . O

As IN O
in IN O
HMG1B NNP B-Gene
, , O
the DT O
overall JJ O
structure NN O
of IN O
the DT O
Sox NNP B-Gene
- : I-Gene
4 CD I-Gene
HMG NNP B-Gene
box NN I-Gene
is VBZ O
L NNP O
- : O
shaped NN O
and CC O
is VBZ O
maintained VBN O
by IN O
a DT O
cluster NN O
of IN O
conserved VBN O
, , O
mainly RB O
aromatic JJ O
residues NNS O
. . O

Nuclear JJ B-Gene
factor NN I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
) ) O
is VBZ O
stored VBN O
in IN O
the DT O
cytoplasm NN O
as IN O
an DT O
inactive JJ O
form NN O
through IN O
interaction NN O
with IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
. . O

We PRP O
have VBP O
recently RB O
reported VBN O
the DT O
establishment NN O
of IN O
a DT O
lipopolysaccharide NN O
( ( O
LPS NNP O
) ) O
- : O
dependent NN O
cell NN O
- : O
free JJ O
activation NN O
system NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
association NN O
with IN O
the DT O
induction NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
phosphorylation NN O
. . O

This DT O
death NN O
- : O
promoting NN O
activity NN O
of IN O
Bik NNP B-Gene
can MD O
be VB O
suppressed VBN O
by IN O
coexpression NN O
of IN O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
Bcl NNP B-Gene
- : I-Gene
XL NN I-Gene
, , O
EBV NNP B-Gene
- : I-Gene
BHRF1 NNP I-Gene
and CC O
E1B NNP B-Gene
- : I-Gene
19 CD I-Gene
kDa NN I-Gene
proteins NNS O
suggesting VBG O
that IN O
Bik NNP B-Gene
may MD O
be VB O
a DT O
common JJ O
target NN O
for IN O
both DT O
cellular JJ B-Gene
and CC I-Gene
viral JJ I-Gene
anti NN I-Gene
- : I-Gene
apoptotic JJ I-Gene
proteins NNS I-Gene
. . O

TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
was VBD O
originally RB O
found VBN O
to TO O
be VB O
expressed VBN O
in IN O
a DT O
T NNP O
cell NN O
- : O
specific JJ O
fashion NN O
within IN O
a DT O
set NN O
of IN O
human JJ O
and CC O
mouse NN O
cell NN O
lines NNS O
. . O

In IN O
contrast NN O
, , O
expression NN O
reportedly RB O
occurs VBZ O
in IN O
multiple JJ O
nonlymphoid JJ O
tissues NNS O
during IN O
murine JJ O
embryogenesis NN O
. . O

Immunohistochemistry NN O
on IN O
a DT O
panel NN O
of IN O
human JJ O
tissues NNS O
revealed VBD O
that IN O
the DT O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
protein NN I-Gene
was VBD O
found VBN O
exclusively RB O
in IN O
thymocytes NNS O
and CC O
in IN O
CD3 NNP O
+ NNP O
T NNP O
cells NNS O
in IN O
peripheral JJ O
lymphoid NN O
tissues NNS O
. . O

Signalling VBG O
via IN O
CD28 NNP B-Gene
of IN O
human JJ O
naive JJ O
neonatal JJ O
T NNP O
lymphocytes NNS O
. . O

We PRP O
have VBP O
examined VBN O
the DT O
role NN O
of IN O
CD28 NNP B-Gene
in IN O
modulating VBG O
the DT O
' '' O
naive JJ O
' POS O
neonatal JJ O
T NNP O
cell NN O
response NN O
to TO O
anti VB B-Gene
- : I-Gene
CD2 NNP I-Gene
- : O
mediated VBN O
activation NN O
. . O

Costimulation NN O
with IN O
anti JJ B-Gene
- : I-Gene
CD28 NNP I-Gene
MoAb NNP I-Gene
greatly RB O
enhanced VBD O
the DT O
proliferative JJ O
response NN O
of IN O
neonatal JJ O
T NNP O
cells NNS O
to TO O
levels NNS O
equivalent JJ O
to TO O
those DT O
of IN O
adult JJ O
T NNP O
cells NNS O
, , O
whereas NNS O
adult VBP O
T NNP O
cells NNS O
showed VBD O
only RB O
slight JJ O
increases NNS O
. . O

Although IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
secretion NN O
was VBD O
increased VBN O
in IN O
the DT O
presence NN O
of IN O
anti JJ B-Gene
- : I-Gene
CD28 NNP I-Gene
MoAb NNP I-Gene
, , O
neonatal JJ O
T NNP O
cell NN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
production NN O
remained VBD O
lower JJR O
than IN O
in IN O
adults NNS O
. . O

TCL1 NNP O
oncogene MD O
activation VB O
in IN O
preleukemic JJ O
T NNP O
cells NNS O
from IN O
a DT O
case NN O
of IN O
ataxia NN O
- : O
telangiectasia NN O
. . O

We PRP O
have VBP O
analyzed VBN O
the DT O
expression NN O
of IN O
TCL1 NNP B-Gene
mRNA NN I-Gene
and CC O
protein NN B-Gene
in IN O
peripheral JJ O
blood NN O
lymphocytes NNS O
( ( O
PBLs NNP O
) ) O
from IN O
four CD O
AT NNP O
cases NNS O
and CC O
from IN O
healthy JJ O
controls NNS O
. . O

We PRP O
found VBD O
that IN O
the DT O
TCL1 NNP B-Gene
gene NN I-Gene
was VBD O
overexpressed VBN O
in IN O
the DT O
PBLs NNP O
of IN O
an DT O
AT NNP O
patient NN O
with IN O
a DT O
large JJ O
clonal JJ O
T NNP O
- : O
cell NN O
population NN O
exhibiting VBG O
the DT O
t NN O
( ( O
14 CD O
; : O
14 CD O
) ) O
translocation NN O
but CC O
not RB O
in IN O
the DT O
lymphocytes NNS O
of IN O
the DT O
other JJ O
cases NNS O
. . O

Fluorescence NN O
in IN O
situ JJ O
hybridization NN O
of IN O
the DT O
TCL1 NNP B-Gene
genomic JJ I-Gene
locus NN I-Gene
to TO O
lymphocyte VB O
metaphases NNS O
from IN O
the DT O
AT NNP O
patient NN O
with IN O
the DT O
T NNP O
- : O
cell NN O
clonal JJ O
expansion NN O
showed VBD O
that IN O
the DT O
breakpoint NN O
of IN O
the DT O
t NN O
( ( O
14 CD O
; : O
14 CD O
) ) O
translocation NN O
lies VBZ O
within IN O
the DT O
TCL1 NNP B-Gene
locus NN I-Gene
and CC O
is VBZ O
accompanied VBN O
by IN O
an DT O
inverted JJ O
duplication NN O
of IN O
the DT O
distal JJ B-Gene
part NN I-Gene
of IN O
chromosome NN B-Gene
14 CD I-Gene
. . O

Deregulation NN O
of IN O
TCL1 NNP B-Gene
is VBZ O
the DT O
first JJ O
event NN O
in IN O
the DT O
initiation NN O
of IN O
malignancy NN O
in IN O
these DT O
types NNS O
of IN O
leukemias NN O
and CC O
represents VBZ O
a DT O
potential JJ O
tool NN O
for IN O
clinical JJ O
evaluation NN O
. . O

Inhibition NN O
of IN O
endogenous JJ B-Gene
C NNP I-Gene
/ NNP I-Gene
EBP NNP I-Gene
proteins VBZ I-Gene
, , O
using VBG O
either CC O
an DT O
excess NN O
of IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
binding VBG I-Gene
sites NNS I-Gene
or CC O
a DT O
trans JJ B-Gene
- : I-Gene
dominant JJ I-Gene
negative JJ I-Gene
inhibitor NN I-Gene
, , O
demonstrated VBD O
that IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
proteins NNS I-Gene
are VBP O
required VBN O
for IN O
basal NN O
and CC O
activated JJ O
levels NNS O
of IN O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
transcription NN O
in IN O
the DT O
promonocytic JJ O
cell NN O
line NN O
U937 NNP O
. . O

Northern NNP O
( ( O
RNA NNP O
) ) O
blots NNS O
and CC O
binding VBG O
assays NNS O
showed VBD O
that IN O
NF NNP B-Gene
- : I-Gene
IL6 NN I-Gene
is VBZ O
the DT O
only JJ O
known JJ O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
family NN I-Gene
member NN I-Gene
which WDT O
is VBZ O
increased VBN O
when WRB O
U937 NNP O
cells NNS O
are VBP O
activated VBN O
. . O

However RB O
, , O
transcription NN O
from IN O
crippled VBN B-Gene
HIV NNP I-Gene
- : I-Gene
1 CD I-Gene
LTRs NNP I-Gene
lacking VBG O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
sites NNS I-Gene
can MD O
still RB O
be VB O
induced VBN O
following VBG O
activation NN O
of IN O
U937 NNP O
cells NNS O
. . O

Since IN O
expression NN O
of IN O
the DT O
viruses NNS O
is VBZ O
in IN O
large JJ O
part NN O
regulated VBN O
by IN O
the DT O
sequence NN B-Gene
elements NNS I-Gene
in IN O
their PRP$ O
long JJ B-Gene
terminal JJ I-Gene
repeats NNS I-Gene
( ( O
LTRs NNP B-Gene
) ) O
, , O
this DT O
study NN O
was VBD O
directed VBN O
to TO O
an DT O
analysis NN O
of IN O
the DT O
regulatory JJ B-Gene
elements NNS I-Gene
in IN O
the DT O
HIV NNP B-Gene
- : I-Gene
2 CD I-Gene
LTR NNP I-Gene
. . O

The DT O
HIV NNP B-Gene
- : I-Gene
2 CD I-Gene
LTR NNP I-Gene
was VBD O
found VBN O
to TO O
contain VB O
two CD O
enhancers NNS B-Gene
. . O

We PRP O
report VBP O
here RB O
that IN O
both DT O
NF NNP B-Gene
- : I-Gene
M NNP I-Gene
- : I-Gene
dependent NN I-Gene
promoter NN I-Gene
constructs NNS I-Gene
and CC O
resident NN O
genes NNS O
could MD O
be VB O
activated VBN O
by IN O
addition NN O
of IN O
beta NN O
- : O
estradiol NN O
to TO O
the DT O
NF NNP O
- : O
M NNP O
- : O
estrogen NN O
receptor NN O
expressing VBG O
progenitors NNS O
. . O

In IN O
addition NN O
to TO O
the DT O
onset NN O
of IN O
differentiation NN O
, , O
cell VBP O
death NN O
was VBD O
induced VBN O
with IN O
typical JJ O
apoptotic JJ O
features NNS O
. . O

A DT O
comparison NN O
with IN O
the DT O
Stat NNP B-Gene
proteins NNS I-Gene
induced VBN O
by IN O
interferon NN B-Gene
- : I-Gene
gamma NN I-Gene
, , O
PRL NNP B-Gene
, , O
and CC O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
in IN O
T47D NNP O
mammary JJ O
tumor NN O
cells NNS O
was VBD O
made VBN O
. . O

Activation NN O
of IN O
a DT O
second JJ O
protein NN O
related VBN O
to TO O
Stat1 NNP B-Gene
was VBD O
also RB O
observed VBN O
. . O

Granulocyte NNP B-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
( ( O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
) ) O
is VBZ O
one CD O
such JJ O
cytokine NN B-Gene
whose WP$ O
increased JJ O
expression NN O
results NNS O
partly RB O
from IN O
increases NNS O
in IN O
transcription NN O
. . O

A DT O
number NN O
of IN O
the DT O
ETS NNP B-Gene
family NN I-Gene
of IN O
transcription NN B-Gene
factors NNS I-Gene
are VBP O
expressed VBN O
in IN O
T NNP O
cells NNS O
, , O
including VBG O
ETS1 NNP B-Gene
and CC O
ELF1 NNP B-Gene
. . O

Other JJ O
unidentified JJ O
ETS NNP B-Gene
- : I-Gene
like IN I-Gene
factors NNS I-Gene
present VBP O
in IN O
Jurkat NNP O
cells NNS O
are VBP O
also RB O
capable JJ O
of IN O
binding VBG O
GM5 NNP B-Gene
. . O

No DT O
up RP O
- : O
regulation NN O
of IN O
hTR NN B-Gene
beta NN I-Gene
1 CD I-Gene
was VBD O
seen VBN O
in IN O
hypothyroid JJ O
relative NN O
to TO O
euthyroid VB O
patients NNS O
. . O

Using VBG O
varying VBG O
conditions NNS O
, , O
three CD O
distinct NN O
complexes NNS O
were VBD O
shown VBN O
to TO O
interact VB O
specifically RB O
with IN O
the DT O
NIP NNP B-Gene
region NN I-Gene
, , O
although IN O
only RB O
one CD O
correlates VBZ O
with IN O
repressor NN O
activity NN O
. . O

DNA NN O
binding VBG O
specificity NN O
of IN O
complex JJ O
3 CD O
overlaps NNS O
with IN O
that DT O
of IN O
upstream JJ B-Gene
stimulatory NN I-Gene
factor NN I-Gene
but CC O
is VBZ O
clearly RB O
distinct JJ O
. . O

Functional NNP O
specificity NN O
for IN O
repression NN O
matches VBZ O
the DT O
DNA NN O
binding VBG O
specificity NN O
of IN O
complex JJ B-Gene
3 CD I-Gene
; : O
both DT O
repressor NN O
activity NN O
and CC O
complex JJ B-Gene
3 CD I-Gene
binding NN O
require VB O
the DT O
consensus NN B-Gene
sequence NN I-Gene
CTCACNTNC NNP O
. . O

The DT O
hematopoietic JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
is VBZ O
downregulated VBN O
in IN O
human JJ O
multiple JJ O
myeloma NN O
cell NN O
lines NNS O
. . O

PU NNP B-Gene
. . I-Gene
1 CD I-Gene
is VBZ O
a DT O
hematopoietic JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
belonging VBG O
to TO O
the DT O
Ets NNP B-Gene
- : I-Gene
family NN I-Gene
. . O

It PRP O
binds VBZ O
the DT O
so RB O
- : O
called VBN O
Pu NNP B-Gene
box NN I-Gene
, , O
an DT O
important JJ O
tissue NN B-Gene
- : I-Gene
specific JJ I-Gene
regulatory JJ I-Gene
DNA NNP I-Gene
element NN I-Gene
present NN O
in IN O
a DT O
number NN O
of IN O
genes NNS O
expressed VBN O
in IN O
these DT O
cell NN O
lineages NNS O
. . O

We PRP O
have VBP O
analyzed VBN O
the DT O
expression NN O
and CC O
activity NN O
of IN O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
during IN O
human JJ O
B NNP O
- : O
cell NN O
development NN O
using VBG O
a DT O
panel NN O
of IN O
B NNP O
- : O
cell NN O
lines NNS O
representing VBG O
different JJ O
stages NNS O
of IN O
maturation NN O
, , O
from IN O
early JJ O
precursors NNS O
to TO O
differentiated VB O
plasma NN O
cells NNS O
. . O

The DT O
effects NNS O
of IN O
CsA NNP O
on IN O
endothelial JJ O
cells NNS O
were VBD O
also RB O
detected VBN O
at IN O
the DT O
chromatin NN B-Gene
structure NN O
level NN O
, , O
as IN O
DNasel NNP B-Gene
hypersensitive VBP I-Gene
sites NNS I-Gene
within IN O
both DT O
the DT O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
enhancer NN O
and CC O
the DT O
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
promoter NN I-Gene
were VBD O
suppressed VBN O
by IN O
CsA NNP O
. . O

Protein NNP O
phosphorylation NN O
has VBZ O
an DT O
important JJ O
role NN O
in IN O
the DT O
regulation NN O
of IN O
these DT O
two CD O
factors NNS O
: : O
( ( O
1 CD O
) ) O
it PRP O
induces VBZ O
the DT O
transactivating VBG O
capacity NN O
of IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
protein NN I-Gene
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
; : O
and CC O
( ( O
2 CD O
) ) O
it PRP O
is VBZ O
involved VBN O
in IN O
the DT O
release NN O
of IN O
the DT O
cytoplasmic JJ B-Gene
inhibitor NN I-Gene
, , O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
, , O
from IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
allowing VBG O
translocation NN O
of IN O
the DT O
latter NN O
into IN O
the DT O
nucleus NN O
. . O

We PRP O
have VBP O
recently RB O
shown VBN O
that IN O
both DT O
phosphorylation NN O
processes VBZ O
require VBP O
T NNP O
- : O
cell NN O
costimulation NN O
. . O

According VBG O
to TO O
our PRP$ O
results NNS O
, , O
however RB O
, , O
the DT O
kinases NNS O
responsible JJ O
for IN O
the DT O
two CD O
processes NNS O
are VBP O
distinct JJ O
entities NNS O
. . O

We PRP O
, , O
therefore RB O
, , O
propose VBD O
the DT O
activation NN O
scheme NN O
presented VBN O
in IN O
FIGURE NNP O
3 CD O
for IN O
T NNP O
- : O
cell NN O
costimulation NN O
. . O

Integration NN O
of IN O
the DT O
signals NNS O
generated VBN O
by IN O
TCR NNP B-Gene
and CC O
CD28 NNP B-Gene
engagement NN O
occurs VBZ O
along IN O
this DT O
pathway NN O
, , O
which WDT O
then RB O
bifurcates VBZ O
to TO O
induce VB O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
phosphorylation NN O
and CC O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
on IN O
the DT O
one CD O
hand NN O
, , O
and CC O
JNK NNP B-Gene
activation NN O
and CC O
c SYM B-Gene
- : I-Gene
Jun NNP I-Gene
phosphorylation NN O
on IN O
the DT O
other JJ O
. . O

We PRP O
are VBP O
currently RB O
engaged VBN O
in IN O
defining VBG O
where WRB O
the DT O
two CD O
signals NNS O
integrate VBP O
along IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
/ NN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
pathway NN O
. . O

Enhancement NN O
of IN O
HIV NNP O
- : O
1 CD O
replication NN O
is VBZ O
related VBN O
in IN O
part NN O
to TO O
increased VBN O
DNA NNP O
- : O
binding NN O
activity NN O
of IN O
cellular JJ B-Gene
transcription NN I-Gene
factors NNS I-Gene
such JJ O
as IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

Increased VBN O
intracellular JJ O
stores NNS O
of IN O
latent NN B-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
may MD O
also RB O
result VB O
in IN O
rapid JJ O
inducibility NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
- : O
dependent JJ O
cytokine NN B-Gene
gene NN O
expression NN O
. . O

Elevated JJ O
levels NNS O
of IN O
several JJ O
inflammatory JJ B-Gene
cytokines NNS I-Gene
have VBP O
been VBN O
detected VBN O
in IN O
the DT O
sera NN O
of IN O
HIV NNP O
- : O
1 CD O
- : O
infected JJ O
individuals NNS O
. . O

We PRP O
measured VBD O
steroid RB O
mediated VBN O
lysis NN O
, , O
receptor NN O
number NN O
and CC O
induction NN O
of IN O
glutamine JJ B-Gene
synthetase NN I-Gene
in IN O
the DT O
transfected JJ O
cells NNS O
. . O

The DT O
DNA NNP B-Gene
binding NN I-Gene
region NN I-Gene
specifying VBG O
high JJ O
affinity NN O
for IN O
GRE NNP B-Gene
sites NNS I-Gene
is VBZ O
required VBN O
. . O

Our PRP$ O
data NNS O
support VB O
the DT O
view NN O
that IN O
steroid VBZ O
- : O
mediated VBN O
cell NN O
death NN O
occurs NNS O
by IN O
a DT O
process NN O
requiring VBG O
direct JJ O
interaction NN O
of IN O
steroid JJ B-Gene
- : I-Gene
receptor NN I-Gene
complexes NNS I-Gene
with IN O
the DT O
genome NN O
. . O

Full NNP O
- : O
length NN O
cDNAs NN B-Gene
and CC O
genomic JJ B-Gene
clones NNS I-Gene
were VBD O
isolated VBN O
, , O
and CC O
the DT O
gene NN O
structure NN O
was VBD O
determined VBN O
. . O
Comparison NNP O
of IN O
the DT O
deduced JJ O
amino NN O
acids NNS O
shows VBZ O
88 CD O
% NN O
sequence NN O
identity NN O
between IN O
mouse NN B-Gene
and CC I-Gene
human JJ I-Gene
BOB NNP I-Gene
. . I-Gene
1 CD I-Gene
/ JJ I-Gene
OBF NNP I-Gene
. . I-Gene
1 CD I-Gene
. . O

The DT O
NH2 NNP B-Gene
- : I-Gene
terminal JJ I-Gene
126 CD I-Gene
amino JJ I-Gene
acids NNS I-Gene
of IN O
BOB NNP B-Gene
. . I-Gene
1 CD I-Gene
/ JJ I-Gene
OBF NNP I-Gene
. . I-Gene
1 CD I-Gene
are VBP O
both DT O
essential JJ O
and CC O
sufficient JJ O
for IN O
interaction NN O
with IN O
the DT O
POU NNP B-Gene
domains NNS I-Gene
of IN O
either DT O
Oct1 NNP B-Gene
or CC O
Oct2 NNP B-Gene
. . O

As IN O
this DT O
phosphorylation NN O
was VBD O
independent JJ O
of IN O
protein JJ B-Gene
kinase FW I-Gene
C NNP I-Gene
activity NN O
, , O
we PRP O
tested VBD O
whether IN O
a DT O
calcium NN B-Gene
/ NNP I-Gene
calmodulin NN I-Gene
- : I-Gene
dependent JJ I-Gene
protein NN I-Gene
kinase NN I-Gene
( ( O
CaM NNP B-Gene
kinase NNP I-Gene
) ) O
might MD O
phosphorylate VB O
the DT O
Ets NNP B-Gene
- : I-Gene
1 CD I-Gene
protein NN I-Gene
after IN O
elevation NN O
of IN O
intracellular JJ O
free JJ O
calcium NN O
concentrations NNS O
. . O

Furthermore RB O
, , O
we PRP O
identified VBD O
a DT O
repression NN O
domain NN O
at IN O
the DT O
N NNP O
- : O
terminus NN O
of IN O
Oct NNP B-Gene
- : I-Gene
2a CD I-Gene
. . O

Whereas IN O
the DT O
mechanism NN O
of IN O
nonopsonic JJ O
phagocytosis NN O
of IN O
Pseudomonas NNP O
aeruginosa NN O
has VBZ O
been VBN O
described VBN O
, , O
the DT O
bacterial JJ O
ligands NNS O
required VBN O
are VBP O
poorly RB O
understood JJ O
. . O

GP NNP B-Gene
Ib NNP I-Gene
alpha VBP I-Gene
promoter NN I-Gene
activity NN O
was VBD O
evaluated VBN O
by IN O
transfection NN O
of IN O
human JJ O
erythroleukemia NN O
cells NNS O
with IN O
reporter NN O
plasmids NNS O
coding VBG O
for IN O
the DT O
enzyme NN B-Gene
, , O
luciferase NN B-Gene
. . O

The DT O
results NNS O
define VBP O
essential JJ O
cis NN B-Gene
- : I-Gene
acting JJ I-Gene
elements NNS I-Gene
responsible JJ O
for IN O
the DT O
expression NN O
of IN O
GP NNP B-Gene
Ib NNP I-Gene
alpha NN I-Gene
and CC O
provide VB O
insights NNS O
into IN O
molecular JJ O
events NNS O
coinciding VBG O
with IN O
the DT O
release NN O
of IN O
normal JJ O
platelets NNS O
into IN O
the DT O
bloodstream NN O
. . O

CD30 NNP B-Gene
is VBZ O
a DT O
recently RB O
described VBN O
member NN O
of IN O
the DT O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
/ NNP I-Gene
nerve NN I-Gene
growth NN I-Gene
factor NN I-Gene
receptor NN I-Gene
superfamily RB I-Gene
. . O

In IN O
all DT O
cell NN O
lines NNS O
investigated VBN O
, , O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
complexes NNS I-Gene
induced VBD O
following VBG O
CD30 NNP B-Gene
engagement NN O
were VBD O
shown VBN O
to TO O
contain VB O
p50 JJ B-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B1 NNP I-Gene
, , O
p65 NN B-Gene
RelA NNP I-Gene
, , O
and CC O
possibly RB O
other JJ O
transcription NN B-Gene
factors NNS I-Gene
. . O

Estrogen NN B-Gene
and CC O
progesterone NN B-Gene
receptors NNS I-Gene
in IN O
vernal JJ O
keratoconjunctivitis NN O
. . O

RESULTS NN O
: : O
Both DT O
the DT O
epithelium NN O
and CC O
subepithelium NN O
of IN O
the DT O
tarsal NN O
and CC O
bulbar NN O
conjunctiva NN O
of IN O
patients NNS O
with IN O
VKC NNP O
, , O
but CC O
not RB O
those DT O
of IN O
four CD O
nonatopic NNS O
control NN O
subjects NNS O
, , O
showed VBD O
intense JJ O
positive JJ O
staining NN O
for IN O
estrogen NN O
and CC O
progesterone NN B-Gene
receptors NNS I-Gene
. . O

The DT O
expression NN O
of IN O
MHC NNP B-Gene
class NN I-Gene
II NNP I-Gene
genes NNS I-Gene
in IN O
mouse NN O
T NNP O
cells NNS O
can MD O
be VB O
reconstituted VBN O
upon IN O
transfection NN O
with IN O
the DT O
human JJ B-Gene
CIITA NNP I-Gene
cDNA NN I-Gene
. . O

Because IN O
HLA NNP B-Gene
class NN I-Gene
II NNP I-Gene
molecules VBZ I-Gene
present JJ O
antigen NN O
to TO O
T NNP B-Gene
cell NN I-Gene
receptors NNS I-Gene
( ( O
TCRs NNP B-Gene
) ) O
, , O
we PRP O
have VBP O
searched VBN O
for IN O
a DT O
TCR NNP B-Gene
gene NN I-Gene
associated VBN O
with IN O
the DT O
production NN O
of IN O
anti JJ B-Gene
- : I-Gene
Ro NNP I-Gene
( ( I-Gene
SSA NNP I-Gene
) ) I-Gene
antibodies NNS I-Gene
. . O

This DT O
RFLP NNP B-Gene
pair NN I-Gene
occurs VBZ O
in IN O
76 CD O
% NN O
of IN O
patients NNS O
with IN O
Ro NNP B-Gene
( ( I-Gene
SSA NNP I-Gene
) ) I-Gene
precipitins VBZ O
, , O
84 CD O
% NN O
of IN O
anti JJ O
- : O
Ro NNP B-Gene
( ( I-Gene
SSA NNP I-Gene
) ) I-Gene
- : O
positive JJ O
patients NNS O
lacking VBG O
La NNP B-Gene
( ( I-Gene
SSB NNP I-Gene
) ) I-Gene
precipitins VBZ B-Gene
, , O
but CC O
only RB O
41 CD O
% NN O
of IN O
the DT O
patients NNS O
lacking VBG O
both DT O
precipitins NNS B-Gene
( ( O
P NNP O
= VBZ O
0 CD O
. . O
4 CD O
) ) O
. . O

The DT O
majority NN O
of IN O
patients NNS O
who WP O
have VBP O
these DT O
RFLPs NNP B-Gene
and CC O
HLA NNP B-Gene
class NN I-Gene
II NNP I-Gene
antigens VBZ I-Gene
previously RB O
associated VBN O
with IN O
the DT O
anti JJ O
- : O
Ro NNP B-Gene
( ( I-Gene
SSA NNP I-Gene
) ) I-Gene
response NN O
make VBP O
this DT O
antibody NN O
, , O
suggesting VBG O
that IN O
interactions NNS O
between IN O
products NNS O
of IN O
these DT O
loci JJ B-Gene
occur NN I-Gene
in IN O
response NN O
to TO O
Ro NNP B-Gene
( ( I-Gene
SSA NNP I-Gene
) ) I-Gene
. . O

However RB O
, , O
while IN O
IL2 NNP B-Gene
expression NN O
requires VBZ O
the DT O
contribution NN O
of IN O
Ca NNP O
( ( O
2 CD O
+ NN O
) ) O
- : O
and CC O
protein VB B-Gene
kinase NN I-Gene
C NNP I-Gene
- : O
dependent NN O
signals NNS O
, , O
we PRP O
report VBP O
that DT O
activation NN O
of IN O
human JJ B-Gene
IL4 NNP I-Gene
transcription NN O
through IN O
the DT O
Ca NNP O
( ( O
2 CD O
+ NN O
) ) O
- : O
dependent JJ O
pathway NN O
is VBZ O
diminished VBN O
by IN O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
stimulation NN O
in IN O
Jurkat NNP O
T NNP O
cells NNS O
. . O

Human NNP B-Gene
IL4 NNP I-Gene
promoter NN I-Gene
- : O
mediated VBN O
transcription NN O
is VBZ O
downregulated VBN O
in IN O
Jurkat NNP O
cells NNS O
stimulated VBN O
with IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
- : I-Gene
activating VBG I-Gene
cytokine JJ I-Gene
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
and CC O
suppressed VBN O
in IN O
RelA NNP O
- : O
overexpressing VBG O
cells NNS O
. . O

Many JJ O
cytokines NNS B-Gene
activate VBP O
signal JJ B-Gene
transducer NN I-Gene
and CC I-Gene
activation NN I-Gene
of IN I-Gene
transcription NN I-Gene
( ( I-Gene
STAT NNP I-Gene
) ) I-Gene
transcription NN I-Gene
factors NNS I-Gene
, , O
which WDT O
, , O
in IN O
turn NN O
, , O
activate JJ O
transcription NN O
of IN O
inflammatory JJ O
effector NN O
genes NNS O
. . O

The DT O
present JJ O
study NN O
demonstrates VBZ O
that IN O
triggering VBG O
of IN O
complement NN B-Gene
receptors NNS I-Gene
CR1 NNP B-Gene
( ( O
CD35 NNP B-Gene
) ) O
and CC O
CR3 NNP B-Gene
( ( O
CD11b NNP B-Gene
/ NNP I-Gene
CD18 NNP I-Gene
) ) O
enhances VBZ O
viral JJ O
replication NN O
in IN O
HIV NNP O
- : O
infected JJ O
human JJ O
monocytic JJ O
cells NNS O
. . O

Monocytic NNP O
cell NN O
lines NNS O
and CC O
normal JJ O
peripheral JJ O
blood NN O
monocytes NNS O
were VBD O
infected VBN O
with IN O
HIV NNP O
- : O
1 CD O
in IN O
vitro NN O
and CC O
cultured VBN O
in IN O
the DT O
presence NN O
or CC O
absence NN O
of IN O
F NNP B-Gene
( ( I-Gene
ab IN I-Gene
' POS I-Gene
) ) I-Gene
2 CD I-Gene
fragments NNS I-Gene
of IN O
monoclonal JJ B-Gene
anti NNS I-Gene
- : I-Gene
CR1 NNP I-Gene
or CC O
anti SYM B-Gene
- : I-Gene
CR3 NNP I-Gene
Abs NNP I-Gene
or CC O
with IN O
C3 NNP B-Gene
fragments NNS I-Gene
. . O

In IN O
contrast NN O
, , O
in IN O
cells NNS O
infected VBN O
with IN O
L NNP O
. . O
donovani NN O
, , O
tyrosine JJ O
phosphorylation NN O
of IN O
Jak1 NNP B-Gene
, , O
Jak2 NNP B-Gene
, , O
and CC O
Stat1 NNP B-Gene
was VBD O
markedly RB O
impaired JJ O
. . O

Unresponsiveness NN O
to TO O
gamma VB B-Gene
interferon NN I-Gene
for IN O
activation NN O
of IN O
this DT O
pathway NN O
may MD O
explain VB O
impaired JJ O
transcriptional JJ O
responses NNS O
in IN O
leishmania JJ O
- : O
infected JJ O
cells NNS O
. . O

Mutually RB O
exclusive JJ O
interaction NN O
of IN O
a DT O
novel JJ O
matrix NN B-Gene
attachment JJ I-Gene
region NN I-Gene
binding VBG I-Gene
protein NN I-Gene
and CC O
the DT O
NF NNP B-Gene
- : I-Gene
muNR NN I-Gene
enhancer NN I-Gene
repressor NN I-Gene
. . O

Implications NNS O
for IN O
regulation NN O
of IN O
immunoglobulin JJ B-Gene
heavy JJ I-Gene
chain NN I-Gene
expression NN O
. . O

To TO O
understand VB O
the DT O
role NN O
of IN O
MARs NNP B-Gene
in IN O
IgH NNP B-Gene
enhancer NN I-Gene
regulation NN O
, , O
we PRP O
have VBP O
identified VBN O
a DT O
novel JJ O
MAR NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
, , O
MAR NNP B-Gene
- : I-Gene
BP1 NNP I-Gene
, , O
from IN O
soluble JJ O
nuclear JJ O
matrix NN O
preparations NNS O
based VBN O
on IN O
its PRP$ O
ability NN O
to TO O
bind VB O
to TO O
the DT O
MARs NNP B-Gene
associated VBN O
with IN O
the DT O
IgH NNP B-Gene
enhancer NN I-Gene
. . O

Purified NNP O
MAR NNP B-Gene
- : I-Gene
BP1 NNP I-Gene
migrates VBZ O
as IN O
a DT O
33 CD B-Gene
- : I-Gene
kDa NN I-Gene
protein NN I-Gene
, , O
and CC O
it PRP O
can MD O
be VB O
found VBN O
in IN O
nuclear JJ O
matrix JJ O
preparations NNS O
from IN O
a DT O
number NN O
of IN O
different JJ O
types NNS O
of IN O
lymphoid NN O
cell NN O
lines NNS O
. . O

The DT O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
receptor NN I-Gene
alpha NN I-Gene
promoter NN I-Gene
contains VBZ O
an DT O
important JJ O
functional JJ O
site NN O
between IN O
positions NNS O
- : O
53 CD O
and CC O
- : O
41 CD O
as IN O
identified VBN O
by IN O
deletion NN O
analysis NN O
of IN O
reporter NN B-Gene
constructs NNS I-Gene
. . O

C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
alpha NN I-Gene
is VBZ O
the DT O
major JJ O
CCAAT NNP B-Gene
/ NNP I-Gene
enhancer SYM I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
( ( O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
) ) O
form NN O
binding VBG O
to TO O
this DT O
site NN O
in IN O
nuclear JJ O
extracts NNS O
of IN O
U937 NNP O
cells NNS O
. . O

Tyrosine NNP O
phosphorylation NN O
of IN O
this DT O
protein NN O
could MD O
also RB O
be VB O
induced VBN O
in IN O
Balb NNP O
/ NNP O
c3T3 NN O
cells NNS O
using VBG O
a DT O
supernatant NN O
from IN O
the DT O
B NNP O
line NN O
, , O
which WDT O
was VBD O
associated VBN O
with IN O
induction NN O
of IN O
cell NN O
proliferation NN O
. . O

Regulation NN O
of IN O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
mRNA NN I-Gene
expression NN O
by IN O
hydroxyurea NN O
in IN O
human JJ O
K562 NNP O
cells NNS O
during IN O
erythroid JJ O
differentiation NN O
[ NNP O
published VBD O
erratum JJ O
appears VBZ O
in IN O
Biochim NNP O
Biophys NNP O
Acta NNP O
1995 CD O
Dec NNP O
27 CD O
; : O
1264 CD O
( ( O
3 CD O
) ) O
: : O
409 CD O
] NN O

In IN O
addition NN O
, , O
HU NNP O
stimulates VBZ O
the DT O
synthesis NN O
of IN O
fetal JJ B-Gene
hemoglobin NN I-Gene
in IN O
sickle NN O
cell NN O
anemia NN O
patients NNS O
. . O

HU NNP O
induced VBD O
a DT O
dose JJ O
- : O
dependent JJ O
stimulation NN O
of IN O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
synthesis NN O
. . O

Glucocorticoid JJ O
effects NNS O
were VBD O
assessed VBN O
in IN O
vivo NN O
by IN O
depletion NN O
of IN O
endogenous JJ O
glucocorticoids NNS O
after IN O
oral JJ O
administration NN O
of IN O
1 CD O
. . O
5 CD O
g NN O
metyrapone NN O
( ( O
MET NNP O
) ) O
and CC O
subsequent JJ O
glucocorticoid NN O
replacement NN O
, , O
and CC O
in IN O
vitro NN O
by IN O
incubation NN O
of IN O
the DT O
cells NNS O
with IN O
different JJ O
doses NNS O
of IN O
dexamethasone NN O
( ( O
DEX NNP O
) ) O
. . O

In IN O
comparison NN O
, , O
isolated JJ O
nuclei NN O
of IN O
human JJ O
lymphocytes NNS O
in IN O
which WDT O
no DT O
need NN O
for IN O
the DT O
expression NN O
of IN O
this DT O
gene NN O
exists VBZ O
, , O
show VBP O
barely RB O
hybridization NN O
signals NNS O
. . O

Because IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activates VBZ O
many JJ O
immunoregulatory JJ B-Gene
genes NNS I-Gene
in IN O
response NN O
to TO O
pro VB O
- : O
inflammatory NN O
stimuli NN O
, , O
the DT O
inhibition NN O
of IN O
its PRP$ O
activity NN O
can MD O
be VB O
a DT O
major JJ O
component NN O
of IN O
the DT O
anti JJ O
- : O
inflammatory JJ O
activity NN O
of IN O
glucocorticoids NNS O
. . O

Transcriptional JJ O
repression NN O
of IN O
the DT O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
by IN O
vitamin JJ O
D3 NNP O
: : O
direct JJ O
inhibition NN O
of IN O
NFATp NNP B-Gene
/ NNP I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
complex JJ I-Gene
formation NN O
by IN O
a DT O
nuclear JJ B-Gene
hormone NN I-Gene
receptor NN I-Gene
. . O

We PRP O
therefore VBP O
examined JJ O
vitamin NN O
D3 NNP O
- : O
mediated VBD O
repression NN O
of IN O
activated JJ O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
expression NN O
by IN O
cotransfecting VBG O
Jurkat NNP O
cells NNS O
with IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
/ NNP I-Gene
reporter NN I-Gene
constructs NNS I-Gene
and CC O
a DT O
VDR NNP B-Gene
overexpression NN I-Gene
vector NN I-Gene
and CC O
by IN O
DNA NNP O
binding NN O
. . O

The DT O
5 CD B-Gene
' POS I-Gene
flanking NN I-Gene
DNA NNP I-Gene
also RB O
contains VBZ O
a DT O
cluster NN O
of IN O
three CD O
binding VBG B-Gene
sites NNS I-Gene
for IN O
the DT O
GATA NNP B-Gene
family NN I-Gene
of IN O
transcription NN B-Gene
factors NNS I-Gene
. . O

This DT O
effect NN O
is VBZ O
thought VBN O
to TO O
be VB O
largely RB O
mediated VBN O
through IN O
inactivation NN O
of IN O
the DT O
phosphatase NN O
calcineurin NN B-Gene
, , O
which WDT O
in IN O
turn NN O
inhibits NNS O
translocation NN O
of IN O
an DT O
NFAT NNP B-Gene
component NN O
to TO O
the DT O
nucleus NN O
. . O

These DT O
data NNS O
point NN O
to TO O
a DT O
new JJ O
mechanism NN O
for IN O
CsA NNP O
- : O
sensitive JJ O
regulation NN O
of IN O
NFATp NNP B-Gene
in IN O
which WDT O
dephosphorylation NN O
is VBZ O
critical JJ O
for IN O
DNA NNP O
binding NN O
. . O

Cysteamine NNP O
treatment NN O
inhibited VBD O
both DT O
expression NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
mRNA NN I-Gene
and CC O
secretion NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
into IN O
the DT O
culture NN O
medium NN O
. . O

The DT O
mean JJ O
dissociation NN O
constant NN O
( ( O
Kd NNP O
) ) O
was VBD O
similar JJ O
in IN O
both DT O
sexes NNS O
( ( O
1 CD O
. . O
35 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
70 CD O
x JJ O
10 CD O
( ( O
- : O
10 CD O
) ) O
M NNP O
in IN O
males NNS O
, , O
1 CD O
. . O
13 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
66 CD O
x JJ O
10 CD O
( ( O
- : O
10 CD O
) ) O
M NNP O
in IN O
females NNS O
) ) O
, , O
but CC O
the DT O
concentration NN O
of IN O
binding VBG O
sites NNS O
( ( O
Nmax NNP O
) ) O
was VBD O
significantly RB O
lower JJR O
in IN O
females NNS O
( ( O
2 CD O
. . O
32 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
92 CD O
fmol JJ O
/ NN O
10 CD O
( ( O
7 CD O
) ) O
PBMC NNP O
vs $ O
4 CD O
. . O
43 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
38 CD O
fmol JJ O
/ NN O
10 CD O
( ( O
7 CD O
) ) O
PBMC NN O
in IN O
males NNS O
; : O
p VB O
= $ O
0 CD O
. . O
1 CD O
) ) O
. . O

Neither DT O
Kd NNP O
nor CC O
Nmax NNP O
were VBD O
significantly RB O
correlated VBN O
with IN O
age NN O
. . O

We PRP O
examined VBN O
by IN O
northern JJ O
hybridization NN O
the DT O
expression NN O
of IN O
Id2 NNP B-Gene
and CC I-Gene
Id3 NNP I-Gene
mRNA NN I-Gene
in IN O
human JJ O
leukemia NN O
/ NNP O
lymphoma NN O
lines NNS O
and CC O
patient JJ O
samples NNS O
, , O
as RB O
well RB O
as IN O
resting NN O
and CC O
activated VBD O
normal JJ O
human JJ O
lymphocytes NNS O
from IN O
peripheral JJ O
blood NN O
( ( O
PBL NNP O
) ) O
. . O

The DT O
Id2 NNP B-Gene
mRNA NN I-Gene
was VBD O
abundantly RB O
expressed VBN O
in IN O
5 CD O
/ JJ O
12 CD O
T NNP O
- : O
cell NN O
and CC O
3 CD O
/ NN O
4 CD O
B NNP O
- : O
cell NN O
lines NNS O
, , O
and CC O
Id3 NNP B-Gene
mRNA NN I-Gene
was VBD O
detected VBN O
in IN O
4 CD O
/ JJ O
12 CD O
T NNP O
- : O
cell NN O
and CC O
3 CD O
/ NN O
4 CD O
B NNP O
- : O
cell NN O
lines NNS O
. . O

In IN O
addition NN O
, , O
resting VBG O
PBL NNP O
constitutively RB O
expressed VBD O
prominent JJ O
levels NNS O
of IN O
Id2 NNP B-Gene
mRNA NN I-Gene
, , O
but CC O
not RB O
Id3 NNP B-Gene
mRNA NN I-Gene
. . O

Salicylates NNS O
inhibit VBP O
lipopolysaccharide JJ O
- : O
induced JJ O
transcriptional JJ O
activation NN O
of IN O
the DT O
tissue NN O
factor NN O
gene NN O
in IN O
human JJ O
monocytic JJ O
cells NNS O
. . O

Here RB O
, , O
we PRP O
report VBP O
that IN O
a DT O
family NN O
of IN O
anti JJ O
- : O
inflammatory NN O
agents NNS O
, , O
known VBN O
as IN O
the DT O
salicylates NNS O
, , O
inhibited VBN O
LPS NNP O
induction NN O
of IN O
TF NNP O
activity NN O
and CC O
TF NNP B-Gene
gene NN I-Gene
transcription NN O
in IN O
human JJ O
monocytes NNS O
and CC O
monocytic JJ O
THP NNP O
- : O
1 CD O
cells NNS O
at IN O
clinically RB O
relevant JJ O
doses NNS O
. . O

Furthermore RB O
, , O
sodium NN O
salicylate NN O
blocked VBD O
the DT O
LPS NNP O
- : O
induced VBD O
proteolytic JJ O
degradation NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
, , O
which WDT O
prevented VBD O
the DT O
nuclear JJ O
translocation NN O
of IN O
c SYM B-Gene
- : I-Gene
Rel NNP I-Gene
/ NNP I-Gene
p65 NN I-Gene
heterodimers NNS I-Gene
. . O

In IN O
contrast NN O
, , O
two CD O
other JJ O
nonsteroidal JJ O
anti SYM O
- : O
inflammatory NN O
drugs NNS O
, , O
ibuprofen NN O
and CC O
indomethacin NN O
, , O
did VBD O
not RB O
inhibit VB O
LPS NNP O
induction NN O
of IN O
the DT O
TF NNP B-Gene
gene NN I-Gene
. . O

Critical JJ O
role NN O
for IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
. . O

The DT O
T NNP O
cell NN O
activation NN O
is VBZ O
initiated VBN O
by IN O
interaction NN O
of IN O
specific JJ O
Ags NNP B-Gene
with IN O
TCR NNP B-Gene
, , O
followed VBN O
by IN O
activation NN O
of IN O
intracellular JJ O
biochemical JJ O
events NNS O
leading VBG O
to TO O
activation NN O
of IN O
several JJ O
genes NNS O
. . O

As IN O
neutralizing VBG B-Gene
anti SYM I-Gene
- : I-Gene
IL NNP I-Gene
- : I-Gene
6 CD I-Gene
Abs NNP I-Gene
effectively RB O
down RP O
- : O
regulated VBD O
the DT O
early JJ O
induction NN O
of IN O
STAT NNP B-Gene
proteins NNS I-Gene
and CC O
as IN O
exogenously RB O
added VBD O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
rapidly RB O
activated VBD O
DNA NNP O
binding VBG O
similar JJ O
to TO O
TCR NNP B-Gene
- : O
mediated VBD O
bindings NNS O
, , O
it PRP O
can MD O
be VB O
concluded VBN O
that IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
is VBZ O
the DT O
factor NN O
responsible JJ O
for IN O
the DT O
activation NN O
of IN O
STAT NNP B-Gene
proteins NNS I-Gene
in IN O
a DT O
primary JJ O
T NNP O
cell NN O
response NN O
. . O

Our PRP$ O
data NNS O
suggest VBP O
an DT O
involvement NN O
of IN O
BLR2 NNP B-Gene
in IN O
the DT O
regulation NN O
of IN O
migration NN O
in IN O
activated JJ O
lymphocytes NNS O
and CC O
in IN O
viral JJ O
pathogenesis NN O
. . O

A DT O
central JJ O
role NN O
for IN O
a DT O
single JJ B-Gene
c SYM I-Gene
- : I-Gene
Myb NNP I-Gene
binding VBG I-Gene
site NN I-Gene
in IN O
a DT O
thymic JJ B-Gene
locus NN I-Gene
control NN I-Gene
region NN I-Gene
. . O

We PRP O
now RB O
show VBP O
that IN O
the DT O
core NN O
contains VBZ O
a DT O
single JJ O
critical JJ O
c NN B-Gene
- : I-Gene
Myb NNP I-Gene
binding VBG I-Gene
site NN I-Gene
. . O

c SYM B-Gene
- : I-Gene
Myb NNP I-Gene
protein NN I-Gene
was VBD O
strongly RB O
evident JJ O
in IN O
T NNP O
lymphoblasts NNS O
in IN O
which WDT O
the DT O
enhancer NN B-Gene
was VBD O
active JJ O
and CC O
was VBD O
localized VBN O
within IN O
discrete JJ O
nuclear JJ O
structures NNS O
. . O

Lymphoid NNP B-Gene
enhancer SYM I-Gene
- : I-Gene
binding VBG I-Gene
factor NN I-Gene
1 CD I-Gene
( ( O
LEF NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
is VBZ O
a DT O
regulatory JJ B-Gene
high JJ I-Gene
mobility NN I-Gene
group NN I-Gene
( ( I-Gene
HMG NNP I-Gene
) ) I-Gene
protein VBP I-Gene
that WDT O
activates VBZ O
the DT O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
alpha NN I-Gene
( ( I-Gene
TCR NNP I-Gene
alpha RB I-Gene
) ) I-Gene
enhancer NN I-Gene
in IN O
a DT O
context NN O
- : O
restricted JJ O
manner NN O
in IN O
T NNP O
cells NNS O
. . O

We PRP O
conclude VBP O
that DT O
transcription NN O
activation NN O
by IN O
LEF NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
vitro NN O
is VBZ O
a DT O
chromatin JJ B-Gene
- : O
dependent JJ O
process NN O
that WDT O
requires VBZ O
a DT O
functional JJ O
trans NNS B-Gene
- : I-Gene
activation NN I-Gene
domain NN I-Gene
in IN O
addition NN O
to TO O
the DT O
HMG NNP B-Gene
domain NN I-Gene
. . O

HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
envelope NN I-Gene
glycoproteins NNS I-Gene
induce VBP O
activation NN O
of IN O
activated JJ O
protein NN B-Gene
- : I-Gene
1 CD I-Gene
in IN O
CD4 NNP O
+ NNP O
T NNP O
cells NNS O
[ RB O
published VBN O
erratum NN O
appears VBZ O
in IN O
J NNP O
Biol NNP O
Chem NNP O
1995 CD O
Dec NNP O
1 CD O
; : O
270 CD O
( ( O
48 CD O
) ) O
: : O
29038 CD O
] NN O

Immunoprecipitation NN O
of IN O
the DT O
gp NN B-Gene
160 CD I-Gene
- : O
induced JJ O
nuclear JJ O
extracts NNS O
with IN O
polyclonal JJ B-Gene
antibodies NNS I-Gene
to TO O
Fos NNP B-Gene
and CC O
Jun NNP B-Gene
proteins VBZ I-Gene
indicates VBZ O
that IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
complex NN I-Gene
is VBZ O
comprised VBN O
of IN O
members NNS O
of IN O
these DT O
family NN O
of IN O
proteins NNS O
. . O

This DT O
stimulation NN O
can MD O
also RB O
be VB O
abolished VBN O
by IN O
inhibitors NNS O
of IN O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
, , O
but CC O
it PRP O
is VBZ O
unaffected VBN O
by IN O
calcium NN O
channel NN O
blocker NN O
or CC O
cyclosporine VB O
A DT O
. . O
